PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Steckbeck, JD; Sun, CQ; Sturgeon, TJ; Montelaro, RC				Steckbeck, Jonathan D.; Sun, Chengqun; Sturgeon, Timothy J.; Montelaro, Ronald C.			Topology of the C-Terminal Tail of HIV-1 gp41: Differential Exposure of the Kennedy Epitope on Cell and Viral Membranes	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; CYTOPLASMIC TAIL; TYPE-1 MATRIX; TRANSMEMBRANE GLYCOPROTEIN; SYNTHETIC PEPTIDES; PROTEIN TOPOLOGY; SURFACE; FUSION; REGION	The C-terminal tail (CTT) of the HIV-1 gp41 envelope (Env) protein is increasingly recognized as an important determinant of Env structure and functional properties, including fusogenicity and antigenicity. While the CTT has been commonly referred to as the "intracytoplasmic domain'' based on the assumption of an exclusive localization inside the membrane lipid bilayer, early antigenicity studies and recent biochemical analyses have produced a credible case for surface exposure of specific CTT sequences, including the classical "Kennedy epitope'' (KE) of gp41, leading to an alternative model of gp41 topology with multiple membrane-spanning domains. The current study was designed to test these conflicting models of CTT topology by characterizing the exposure of native CTT sequences and substituted VSV-G epitope tags in cell-and virion-associated Env to reference monoclonal antibodies (MAbs). Surface staining and FACS analysis of intact, Env-expressing cells demonstrated that the KE is accessible to binding by MAbs directed to both an inserted VSV-G epitope tag and the native KE sequence. Importantly, the VSV-G tag was only reactive when inserted into the KE; no reactivity was observed in cells expressing Env with the VSV-G tag inserted into the LLP2 domain. In contrast to cell-surface expressed Env, no binding of KE-directed MAbs was observed to Env on the surface of intact virions using either immune precipitation or surface plasmon resonance spectroscopy. These data indicate apparently distinct CTT topologies for virion-and cell-associated Env species and add to the case for a reconsideration of CTT topology that is more complex than currently envisioned.	[Steckbeck, Jonathan D.; Sturgeon, Timothy J.; Montelaro, Ronald C.] Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA; [Sun, Chengqun; Montelaro, Ronald C.] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Montelaro, RC (corresponding author), Univ Pittsburgh, Ctr Vaccine Res, Pittsburgh, PA 15260 USA.	rmont@pitt.edu			National Institutes of Health (NIH) [1R21 AI070033]; National Institute of Allergy and Infectious Diseases [5T32 AI065380-05]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087533, R21AI070033, T32AI065380] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported by National Institutes of Health (NIH) Grant 1R21 AI070033 (RCM) and by NIH Grant 5T32 AI065380-05 (JDS) from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand R, 2000, BIOCHEM BIOPH RES CO, V276, P157, DOI 10.1006/bbrc.2000.3457; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Bogdanov M, 2008, J CELL BIOL, V182, P925, DOI 10.1083/jcb.200803097; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Chan WE, 2005, J VIROL, V79, P8374, DOI 10.1128/JVI.79.13.8374-8387.2005; CHANH TC, 1986, EMBO J, V5, P3065, DOI 10.1002/j.1460-2075.1986.tb04607.x; Cheung L, 2005, J GEN VIROL, V86, P131, DOI 10.1099/vir.0.80439-0; Cleveland SM, 2003, J GEN VIROL, V84, P591, DOI 10.1099/vir.0.18630-0; Craigo JK, 2007, P NATL ACAD SCI USA, V104, P15105, DOI 10.1073/pnas.0706449104; Das S, 2008, CANCER RES, V68, P6306, DOI 10.1158/0008-5472.CAN-08-0870; Dougherty DA, 1996, SCIENCE, V271, P163, DOI 10.1126/science.271.5246.163; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Epand RM, 2008, BBA-BIOMEMBRANES, V1778, P1576, DOI 10.1016/j.bbamem.2008.03.016; Evans DT, 2001, IMMUNOL REV, V183, P141, DOI 10.1034/j.1600-065x.2001.1830112.x; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FUJII G, 1992, PROTEIN SCI, V1, P1454, DOI 10.1002/pro.5560011107; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Heap CJ, 2005, J GEN VIROL, V86, P1499, DOI 10.1099/vir.0.80414-0; Hessa T, 2005, SCIENCE, V307, P1427, DOI 10.1126/science.1109176; Hollier MJ, 2005, VIROLOGY, V337, P284, DOI 10.1016/j.virol.2005.04.015; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Jiang YX, 2003, NATURE, V423, P42, DOI 10.1038/nature01581; Kalia V, 2005, J VIROL, V79, P2097, DOI 10.1128/JVI.79.4.2097-2107.2005; KENNEDY RC, 1986, SCIENCE, V231, P1556, DOI 10.1126/science.3006246; Kol N, 2007, BIOPHYS J, V92, P1777, DOI 10.1529/biophysj.106.093914; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; Lu L, 2008, J BIOL CHEM, V283, P16723, DOI 10.1074/jbc.M801083200; LUCIW PA, 2002, FIELDS VIROLOGY, P1881; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Obermeyer T, 2007, J LIPID RES, V48, P2354, DOI 10.1194/jlr.M700300-JLR200; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Reading SA, 2003, VIROLOGY, V315, P362, DOI 10.1016/S0042-6822(03)00533-6; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; ROWELL JF, 1995, J IMMUNOL, V155, P473; Schibli DJ, 2001, BIOCHEMISTRY-US, V40, P9570, DOI 10.1021/bi010640u; SRINIVAS SK, 1992, J BIOL CHEM, V267, P7121; Steckbeck JD, 2006, J MED PRIMATOL, V35, P248, DOI 10.1111/j.1600-0684.2006.00173.x; Steckbeck JD, 2005, J VIROL, V79, P12311, DOI 10.1128/JVI.79.19.12311-12320.2005; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Viard M, 2008, BIOCHEMISTRY-US, V47, P1977, DOI 10.1021/bi701920f; von Heijne G, 1999, Q REV BIOPHYS, V32, P285, DOI 10.1017/S0033583500003541; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyma DJ, 2004, J VIROL, V78, P3429, DOI 10.1128/JVI.78.7.3429-3435.2004; Yang PL, 2010, J VIROL, V84, P59, DOI 10.1128/JVI.00899-09; YUAN T, 1995, BIOCHEMISTRY-US, V34, P10690, DOI 10.1021/bi00033a045; Zanetti G, 2006, PLOS PATHOG, V2, DOI 10.1371/journal.ppat.0020083; Zhu P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000203; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817; Zwick MB, 2005, AIDS, V19, P1725, DOI 10.1097/01.aids.0000189850.83322.41	59	29	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15261	10.1371/journal.pone.0015261	http://dx.doi.org/10.1371/journal.pone.0015261			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151874	gold, Green Published, Green Accepted			2022-12-27	WOS:000285041800012
J	Foucaud, J; Burns, JG; Mery, F				Foucaud, Julien; Burns, James G.; Mery, Frederic			Use of Spatial Information and Search Strategies in a Water Maze Analog in Drosophila melanogaster	PLOS ONE			English	Article							VISUAL-PATTERN MEMORY; SEX-DIFFERENCES; PLACE MEMORY; EMIGRATION BEHAVIOR; GENETIC DISSECTION; ANIMAL COGNITION; CENTRAL COMPLEX; NAVIGATION; HIPPOCAMPUS; MICE	Learning the spatial organization of the environment is crucial to fitness in most animal species. Understanding proximate and ultimate factors underpinning spatial memory is thus a major goal in the study of animal behavior. Despite considerable interest in various aspects of its behavior and biology, the model species Drosophila melanogaster lacks a standardized apparatus to investigate spatial learning and memory. We propose here a novel apparatus, the heat maze, conceptually based on the Morris water maze used in rodents. Using the heat maze, we demonstrate that D. melanogaster flies are able to use either proximal or distal visual cues to increase their performance in navigating to a safe zone. We also show that flies are actively using the orientation of distal visual cues when relevant in targeting the safe zone, i.e., Drosophila display spatial learning. Parameter-based classification of search strategies demonstrated the progressive use of spatially precise search strategies during learning. We discuss the opportunity to unravel the mechanistic and evolutionary bases of spatial learning in Drosophila using the heat maze.	[Foucaud, Julien; Burns, James G.; Mery, Frederic] UPR CNRS 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France; [Burns, James G.] Univ Toronto, Dept Biol, Mississauga, ON L5L 1C6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Toronto; University Toronto Mississauga	Foucaud, J (corresponding author), UPR CNRS 9034, Lab Evolut Genomes & Speciat, Gif Sur Yvette, France.	julien.foucaud@legs.cnrs-gif.fr		Foucaud, Julien/0000-0003-2272-3149	European Research Council under European Community/ERC [FP7/2007-2013, 209540]	European Research Council under European Community/ERC(European Research Council (ERC))	This work was supported by the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement no 209540. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMMASSARITEULE M, 1985, BEHAV BRAIN RES, V17, P9, DOI 10.1016/0166-4328(85)90003-8; Balschun D, 2003, J NEUROSCI, V23, P6304; Barkley CL, 2007, BEHAV NEUROSCI, V121, P291, DOI 10.1037/0735-7044.121.2.291; Brembs B, 2006, LEARN MEMORY, V13, P618, DOI 10.1101/lm.318606; Brembs B, 2009, CURR BIOL, V19, P1351, DOI 10.1016/j.cub.2009.06.014; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Burgess N, 2006, TRENDS COGN SCI, V10, P551, DOI 10.1016/j.tics.2006.10.005; Burns JG, 2006, BEHAV ECOL, V17, P48, DOI 10.1093/beheco/arj002; Carman HM, 2002, NEUROBIOL LEARN MEM, V78, P332, DOI 10.1006/nlme.2002.4062; Chai XJ, 2010, BEHAV BRAIN RES, V208, P336, DOI 10.1016/j.bbr.2009.11.039; Davis RL, 1996, PHYSIOL REV, V76, P299, DOI 10.1152/physrev.1996.76.2.299; Devineni AV, 2009, CURR BIOL, V19, P2126, DOI 10.1016/j.cub.2009.10.070; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; DILL M, 1993, NATURE, V365, P751, DOI 10.1038/365751a0; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Dukas R, 2004, ANNU REV ECOL EVOL S, V35, P347, DOI 10.1146/annurev.ecolsys.35.112202.130152; Dyer FC, 1996, J EXP BIOL, V199, P147; GALEA LAM, 1994, BRAIN RES, V635, P18, DOI 10.1016/0006-8993(94)91419-2; Garelick MG, 2009, J NEUROSCI, V29, P10835, DOI 10.1523/JNEUROSCI.0553-09.2009; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Holscher C, 2003, REV NEUROSCIENCE, V14, P253; Iliadi KG, 2002, BEHAV GENET, V32, P173, DOI 10.1023/A:1016017028041; Jacobs LF, 1996, TRENDS ECOL EVOL, V11, pA82; Jones CM, 2003, BEHAV NEUROSCI, V117, P403, DOI 10.1037/0735-7044.117.3.403; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Liu G, 2006, NATURE, V439, P551, DOI 10.1038/nature04381; Markow TA, 2000, OIKOS, V89, P378, DOI 10.1034/j.1600-0706.2000.890219.x; McHugh TJ, 1996, CELL, V87, P1339, DOI 10.1016/S0092-8674(00)81828-0; Menzel R, 2000, P ROY SOC B-BIOL SCI, V267, P961, DOI 10.1098/rspb.2000.1097; Menzel R, 2006, J COMP PHYSIOL A, V192, P889, DOI 10.1007/s00359-006-0136-3; Micheau J, 2004, BEHAV NEUROSCI, V118, P1022, DOI 10.1037/0735-7044.118.5.1022; MIKASA K, 1992, JPN J GENET, V67, P463, DOI 10.1266/jjg.67.463; MIKASA K, 1980, RES NOTES, V55, P111; Mizunami M, 1998, J COMP NEUROL, V402, P520; Mizunami Makoto, 1993, P199; Moffat SD, 1998, EVOL HUM BEHAV, V19, P73, DOI 10.1016/S1090-5138(97)00104-9; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muller RU, 1996, J GEN PHYSIOL, V107, P663, DOI 10.1085/jgp.107.6.663; Neuser K, 2008, NATURE, V453, P1244, DOI 10.1038/nature07003; Pan YF, 2009, LEARN MEMORY, V16, P289, DOI 10.1101/lm.1331809; Pitman JL, 2009, FLY, V3, P3, DOI 10.4161/fly.3.1.7726; Pravosudov VV, 2002, BEHAV NEUROSCI, V116, P515, DOI 10.1037//0735-7044.116.4.515; Prusky GT, 2000, BEHAV BRAIN RES, V116, P135, DOI 10.1016/S0166-4328(00)00267-9; Putz G, 2002, LEARN MEMORY, V9, P349, DOI 10.1101/lm.50402; R-Development-Core-Team, 2010, R LANGUAGE ENV STAT; Roudez RJ, 2008, BIOL INVASIONS, V10, P1191, DOI 10.1007/s10530-007-9195-9; Save E, 2000, BEHAV BRAIN RES, V109, P195, DOI 10.1016/S0166-4328(99)00173-4; Shettleworth SJ, 2005, BEHAV PROCESS, V69, P147, DOI 10.1016/j.beproc.2005.02.016; Shettleworth SJ, 2001, ANIM BEHAV, V61, P277, DOI 10.1006/anbe.2000.1606; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2010, J COMP PHYSIOL A, V196, P299, DOI 10.1007/s00359-010-0517-5; Strauss R, 2002, CURR OPIN NEUROBIOL, V12, P633, DOI 10.1016/S0959-4388(02)00385-9; Tamara C, 2010, ANIM COGN, V13, P565, DOI 10.1007/s10071-009-0307-z; Venables WN., 2002, MODERN APPL STAT S 4; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Wang ZP, 2008, LEARN MEMORY, V15, P133, DOI 10.1101/lm.873008; Wehner R, 1996, J EXP BIOL, V199, pAR1; Wessnitzer J, 2008, P ROY SOC B-BIOL SCI, V275, P915, DOI 10.1098/rspb.2007.1647; WOLF R, 1991, J COMP PHYSIOL A, V169, P699; Wolfer DP, 2001, PHYSIOL BEHAV, V73, P745, DOI 10.1016/S0031-9384(01)00531-5; Wustmann G, 1996, J COMP PHYSIOL A, V179, P429, DOI 10.1007/BF00194996; Yamamoto D, 1997, ANNU REV ENTOMOL, V42, P551, DOI 10.1146/annurev.ento.42.1.551; Zars M, 2006, J COMP PHYSIOL A, V192, P727, DOI 10.1007/s00359-006-0109-6; Zars M, 2009, NATURWISSENSCHAFTEN, V96, P927, DOI 10.1007/s00114-009-0550-9; Zars T, 2001, J COMP PHYSIOL A, V187, P235, DOI 10.1007/s003590100194; ZOLADEK L, 1978, ANIM LEARN BEHAV, V6, P77, DOI 10.3758/BF03212006	69	40	40	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15231	10.1371/journal.pone.0015231	http://dx.doi.org/10.1371/journal.pone.0015231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151940	Green Submitted, gold, Green Published			2022-12-27	WOS:000284939600034
J	Ploski, R; Brand, OJ; Jurecka-Lubieniecka, B; Franaszczyk, M; Kula, D; Krajewski, P; Karamat, MA; Simmonds, MJ; Franklyn, JA; Gough, SCL; Jarzab, B; Bednarczuk, T				Ploski, Rafal; Brand, Oliver J.; Jurecka-Lubieniecka, Beata; Franaszczyk, Maria; Kula, Dorota; Krajewski, Pawel; Karamat, Muhammad A.; Simmonds, Matthew J.; Franklyn, Jayne A.; Gough, Stephen C. L.; Jarzab, Barbara; Bednarczuk, Tomasz			Thyroid Stimulating Hormone Receptor (TSHR) Intron 1 Variants Are Major Risk Factors for Graves' Disease in Three European Caucasian Cohorts	PLOS ONE			English	Article							HUMAN THYROTROPIN RECEPTOR; AUTOIMMUNE-DISEASE; ASSOCIATION; GENE; POLYMORPHISM; SUSCEPTIBILITY; GENOME; CTLA-4; POPULATION; ALLELES	Background: The thyroid stimulating hormone receptor (TSHR) gene is an established susceptibility locus for Graves' disease (GD), with recent studies refining association to two single nucleotide polymorphisms (SNPs), rs179247 and rs12101255, within TSHR intron 1. Methodology and Principal Findings: We aimed to validate association of rs179247 and rs12101255 in Polish and UK Caucasian GD case-control subjects, determine the mode of inheritance and to see if association correlates with specific GD clinical manifestations. We investigated three case-control populations; 558 GD patients and 520 controls from Warsaw, Poland, 196 GD patients and 198 controls from Gliwice, Poland and 2504 GD patients from the UK National collection and 2784 controls from the 1958 British Birth cohort. Both rs179247 (P = 1.2x10(-2) -6.2x10(-15), OR = 1.38-1.45) and rs12101255 (P = 1.0x10(-4)-3.68x10(-21), OR = 1.47-1.87) exhibited strong association with GD in all three cohorts. Logistic regression suggested association of rs179247 is secondary to rs12101255 in all cohorts. Inheritance modeling suggested a co-dominant mode of inheritance in all cohorts. Genotype-phenotype correlations provided no clear evidence of association with any specific clinical characteristics. Conclusions: We have validated association of TSHR intron 1 SNPs with GD in three independent European cohorts and have demonstrated that the aetiological variant within the TSHR is likely to be in strong linkage disequilibrium with rs12101255. Fine mapping is now required to determine the exact location of the aetiological DNA variants within the TSHR.	[Ploski, Rafal; Franaszczyk, Maria] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland; [Ploski, Rafal; Krajewski, Pawel] Med Univ Warsaw, Dept Forens Med, Warsaw, Poland; [Brand, Oliver J.; Karamat, Muhammad A.; Simmonds, Matthew J.; Franklyn, Jayne A.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England; [Brand, Oliver J.; Simmonds, Matthew J.; Gough, Stephen C. L.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [Jurecka-Lubieniecka, Beata; Kula, Dorota; Jarzab, Barbara] Maria Sklodowska Curie Mem Canc Ctr, Dept Nucl Med & Endocrine Oncol, Gliwice, Poland; [Jurecka-Lubieniecka, Beata; Kula, Dorota; Jarzab, Barbara] Inst Oncol, Gliwice, Poland; [Bednarczuk, Tomasz] Med Univ Warsaw, Dept Endocrinol, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; University of Birmingham; University of Oxford; Maria Sklodowska-Curie National Research Institute of Oncology; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Warsaw	Ploski, R (corresponding author), Med Univ Warsaw, Dept Med Genet, Warsaw, Poland.	oliver.brand@ocdem.ox.ac.uk	Jarząb, Barbara/AAI-7942-2020; Barbara, Jarzab/I-4654-2019; Bednarczuk, Tomasz/AFQ-8418-2022	Jarząb, Barbara/0000-0001-9811-9584; Kula, Dorota/0000-0002-0986-1929; Ploski, Rafal/0000-0001-6286-5526; Jurecka-Lubieniecka, Beata/0000-0001-6333-0451; Simmonds, Matt/0000-0003-3154-3510	Warsaw Medical University [1WN/NK1W, 1WY/N/09]; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; MRC [G0000934] Funding Source: UKRI	Warsaw Medical University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by Warsaw Medical University grants 1WN/NK1W and 1WY/N/09. The authors acknowledge use of DNA from the 1958 British Birth Cohort Collection, funded by the Medical Research Council grant G0000934 and the Wellcome Trust grant 068545/Z/02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamizu T, 2000, THYROID, V10, P851, DOI 10.1089/thy.2000.10.851; Allahabadia A, 1998, THYROID, V8, P777, DOI 10.1089/thy.1998.8.777; Ban Y, 2002, THYROID, V12, P1079, DOI 10.1089/105072502321085171; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bednarczuk T, 2004, HUM IMMUNOL, V65, P632, DOI 10.1016/j.humimm.2004.02.033; Brand OJ, 2009, HUM MOL GENET, V18, P1704, DOI 10.1093/hmg/ddp087; CUDDIHY RM, 1995, THYROID, V5, P89, DOI 10.1089/thy.1995.5.89; Dechairo BM, 2005, EUR J HUM GENET, V13, P1223, DOI 10.1038/sj.ejhg.5201485; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gough SCL, 2007, CURR GENOMICS, V8, P453, DOI 10.2174/138920207783591690; Hiratani H, 2005, J CLIN ENDOCR METAB, V90, P2898, DOI 10.1210/jc.2004-2148; Kaczur V, 2000, EUR J IMMUNOGENET, V27, P17, DOI 10.1046/j.1365-2370.2000.00187.x; Kisiel B, 2008, CLIN ENDOCRINOL, V68, P429, DOI 10.1111/j.1365-2265.2007.03060.x; Kula D, 2006, THYROID, V16, P447, DOI 10.1089/thy.2006.16.447; Manji N, 2006, J CLIN ENDOCR METAB, V91, P4873, DOI 10.1210/jc.2006-1402; Newport M, 2007, NAT GENET, V39, P1329, DOI 10.1038/ng.2007.17; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sale MM, 1997, P ASSOC AM PHYSICIAN, V109, P453; Simanainen J, 1999, THYROID, V9, P7, DOI 10.1089/thy.1999.9.7; Smith BR, 2007, THYROID, V17, P923, DOI 10.1089/thy.2007.0239; Smyth D, 2004, DIABETES, V53, P3020, DOI 10.2337/diabetes.53.11.3020; Tomer Y, 2003, AM J HUM GENET, V73, P736, DOI 10.1086/378588; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621	24	28	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2010	5	11							e15512	10.1371/journal.pone.0015512	http://dx.doi.org/10.1371/journal.pone.0015512			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686GM	21124799	Green Submitted, Green Published, gold			2022-12-27	WOS:000284684800002
J	Kuchenreuther, JM; Grady-Smith, CS; Bingham, AS; George, SJ; Cramer, SP; Swartz, JR				Kuchenreuther, Jon M.; Grady-Smith, Celestine S.; Bingham, Alyssa S.; George, Simon J.; Cramer, Stephen P.; Swartz, James R.			High-Yield Expression of Heterologous [FeFe] Hydrogenases in Escherichia coli	PLOS ONE			English	Article							CLOSTRIDIUM-PASTEURIANUM; ONLY HYDROGENASE; ACTIVE-SITE; DESULFOVIBRIO-DESULFURICANS; THERMOTOGA-MARITIMA; LIGHT SENSITIVITY; IRON-HYDROGENASE; MATURATION; PROTEIN; FERREDOXIN	Background: The realization of hydrogenase-based technologies for renewable H-2 production is presently limited by the need for scalable and high-yielding methods to supply active hydrogenases and their required maturases. Principal Findings: In this report, we describe an improved Escherichia coli-based expression system capable of producing 8-30 mg of purified, active [FeFe] hydrogenase per liter of culture, volumetric yields at least 10-fold greater than previously reported. Specifically, we overcame two problems associated with other in vivo production methods: low protein yields and ineffective hydrogenase maturation. The addition of glucose to the growth medium enhances anaerobic metabolism and growth during hydrogenase expression, which substantially increases total yields. Also, we combine iron and cysteine supplementation with the use of an E. coli strain upregulated for iron-sulfur cluster protein accumulation. These measures dramatically improve in vivo hydrogenase activation. Two hydrogenases, HydA1 from Chlamydomonas reinhardtii and HydA (CpI) from Clostridium pasteurianum, were produced with this improved system and subsequently purified. Biophysical characterization and FTIR spectroscopic analysis of these enzymes indicate that they harbor the H-cluster and catalyze H-2 evolution with rates comparable to those of enzymes isolated from their respective native organisms. Significance: The production system we describe will facilitate basic hydrogenase investigations as well as the development of new technologies that utilize these prolific H-2-producing enzymes. These methods can also be extended for producing and studying a variety of oxygen-sensitive iron-sulfur proteins as well as other proteins requiring anoxic environments.	[Kuchenreuther, Jon M.; Bingham, Alyssa S.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Grady-Smith, Celestine S.; George, Simon J.; Cramer, Stephen P.] Univ Calif Davis, Dept Appl Sci, Davis, CA 95616 USA; [Grady-Smith, Celestine S.; George, Simon J.; Cramer, Stephen P.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; University of California System; University of California Davis; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University	Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		George, Simon/0000-0002-4864-5479	United States Department of Energy BioEnergy Science	United States Department of Energy BioEnergy Science(United States Department of Energy (DOE))	This work was funded by the United States Department of Energy BioEnergy Science Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1984, J BIOL CHEM, V259, P7045; ADAMS MWW, 1989, P NATL ACAD SCI USA, V86, P4932, DOI 10.1073/pnas.86.13.4932; ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Akhtar MK, 2008, APPL MICROBIOL BIOT, V78, P853, DOI 10.1007/s00253-008-1377-6; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Boyer ME, 2006, BIOTECHNOL BIOENG, V94, P128, DOI 10.1002/bit.20830; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Chen ZJ, 2002, BIOCHEMISTRY-US, V41, P2036, DOI 10.1021/bi011510o; Czech I, 2010, FEBS LETT, V584, P638, DOI 10.1016/j.febslet.2009.12.016; Driesener RC, 2010, ANGEW CHEM INT EDIT, V49, P1687, DOI 10.1002/anie.200907047; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Ghirardi ML, 2009, CHEM SOC REV, V38, P52, DOI 10.1039/b718939g; Girbal L, 2005, APPL ENVIRON MICROB, V71, P2777, DOI 10.1128/AEM.71.5.2777-2781.2005; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; HAPPE T, 1993, EUR J BIOCHEM, V214, P475, DOI 10.1111/j.1432-1033.1993.tb17944.x; Kamp C, 2008, BBA-BIOENERGETICS, V1777, P410, DOI 10.1016/j.bbabio.2008.02.002; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Krassen H, 2009, ACS NANO, V3, P4055, DOI 10.1021/nn900748j; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Laffly E, 2010, INT J HYDROGEN ENERG, V35, P10761, DOI 10.1016/j.ijhydene.2010.02.070; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; Moulis JM, 1995, BIOCHEMISTRY-US, V34, P16781, DOI 10.1021/bi00051a028; Mulder DW, 2010, NATURE, V465, P248, DOI 10.1038/nature08993; Mulder DW, 2009, BIOCHEMISTRY-US, V48, P6240, DOI 10.1021/bi9000563; Nakamura M, 1999, J BIOCHEM, V126, P10, DOI 10.1093/oxfordjournals.jbchem.a022409; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2010, INT J HYDROGEN ENERG, V35, P10750, DOI 10.1016/j.ijhydene.2010.02.056; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reisner E, 2009, J AM CHEM SOC, V131, P18457, DOI 10.1021/ja907923r; Roseboom W, 2006, J BIOL INORG CHEM, V11, P102, DOI 10.1007/s00775-005-0040-2; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Schut GJ, 2009, J BACTERIOL, V191, P4451, DOI 10.1128/JB.01582-08; Schwartz CJ, 2001, P NATL ACAD SCI USA, V98, P14895, DOI 10.1073/pnas.251550898; Shepard EM, 2010, J AM CHEM SOC, V132, P9247, DOI 10.1021/ja1012273; Silakov A, 2009, BIOCHEMISTRY-US, V48, P7780, DOI 10.1021/bi9009105; Soboh B, 2006, J BIOL CHEM, V281, P36701, DOI 10.1074/jbc.M606820200; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; Turner JA, 2004, SCIENCE, V305, P972, DOI 10.1126/science.1103197; von Abendroth G, 2008, INT J HYDROGEN ENERG, V33, P6076, DOI 10.1016/j.ijhydene.2008.07.122; Woodward J, 2000, NATURE, V405, P1014, DOI 10.1038/35016633; Zhang YL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000414	44	115	117	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15491	10.1371/journal.pone.0015491	http://dx.doi.org/10.1371/journal.pone.0015491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124800	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000030
J	Shi, YL; Nenadic, Z; Xu, XM				Shi, Yulin; Nenadic, Zoran; Xu, Xiangmin			Novel Use of Matched Filtering for Synaptic Event Detection and Extraction	PLOS ONE			English	Article							TURTLE VISUAL-CORTEX; PYRAMIDAL NEURONS; CORTICAL-NEURONS; LAMINAR; NETWORKS; CONNECTIVITY; ORGANIZATION; SPECIFICITY; RECORDINGS; RESOLUTION	Efficient and dependable methods for detection and measurement of synaptic events are important for studies of synaptic physiology and neuronal circuit connectivity. As the published methods with detection algorithms based upon amplitude thresholding and fixed or scaled template comparisons are of limited utility for detection of signals with variable amplitudes and superimposed events that have complex waveforms, previous techniques are not applicable for detection of evoked synaptic events in photostimulation and other similar experimental situations. Here we report on a novel technique that combines the design of a bank of approximate matched filters with the detection and estimation theory to automatically detect and extract photostimluation-evoked excitatory postsynaptic currents (EPSCs) from individually recorded neurons in cortical circuit mapping experiments. The sensitivity and specificity of the method were evaluated on both simulated and experimental data, with its performance comparable to that of visual event detection performed by human operators. This new technique was applied to quantify and compare the EPSCs obtained from excitatory pyramidal cells and fast-spiking interneurons. In addition, our technique has been further applied to the detection and analysis of inhibitory postsynaptic current (IPSC) responses. Given the general purpose of our matched filtering and signal recognition algorithms, we expect that our technique can be appropriately modified and applied to detect and extract other types of electrophysiological and optical imaging signals.	[Shi, Yulin; Xu, Xiangmin] Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Nenadic, Zoran; Xu, Xiangmin] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Shi, YL (corresponding author), Univ Calif Irvine, Sch Med, Dept Anat & Neurobiol, Irvine, CA 92717 USA.	znenadic@uci.edu; xiangmin.xu@uci.edu		Nenadic, Zoran/0000-0001-5569-3797	United States National Institutes of Health [DA023700, DA023700-04S1]; NATIONAL INSTITUTE ON DRUG ABUSE [K99DA023700, R00DA023700] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was funded by the United States National Institutes of Health grants DA023700 and DA023700-04S1 to X.X. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbdulGhani MA, 1996, J PHYSIOL-LONDON, V495, P113, DOI 10.1113/jphysiol.1996.sp021578; BANKMAN IN, 1993, IEEE T BIO-MED ENG, V40, P836, DOI 10.1109/10.238472; Benitez R, 2008, IEEE T BIO-MED ENG, V55, P1344, DOI 10.1109/TBME.2007.912433; CALLAWAY EM, 1993, P NATL ACAD SCI USA, V90, P7661, DOI 10.1073/pnas.90.16.7661; Clements JD, 1997, BIOPHYS J, V73, P220, DOI 10.1016/S0006-3495(97)78062-7; COCHRAN SL, 1993, J NEUROSCI METH, V50, P105, DOI 10.1016/0165-0270(93)90061-U; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hwang TN, 1999, J NEUROSCI METH, V92, P65, DOI 10.1016/S0165-0270(99)00095-3; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kay S. M., 1998, FUNDAMENTALS STAT SI; Li GH, 2007, J NEUROSCI METH, V164, P139, DOI 10.1016/j.jneumeth.2007.04.010; LIAO D, 1992, NEURON, V9, P1089, DOI 10.1016/0896-6273(92)90068-O; Nenadic Z, 2006, IEEE T BIO-MED ENG, V53, P941, DOI 10.1109/TBME.2005.863930; Nenadic Z, 2005, IEEE T BIO-MED ENG, V52, P74, DOI 10.1109/TBME.2004.839800; Nenadic Z, 2003, J COMPUT NEUROSCI, V14, P161, DOI 10.1023/A:1021954701494; Nenadic Z, 2002, IEEE T BIO-MED ENG, V49, P753, DOI [10.1109/TBME.2002.800753, 10.1109/FBME.2002.800753]; Nenadic Z, 2000, NEUROCOMPUTING, V32, P479, DOI 10.1016/S0925-2312(00)00202-2; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; Oppenheim A.V., 2009, DISCRETE TIME SIGNAL; Shepherd GMG, 2005, J NEUROSCI, V25, P5670, DOI 10.1523/JNEUROSCI.1173-05.2005; Silberberg G, 2007, NEURON, V53, P735, DOI 10.1016/j.neuron.2007.02.012; Weiler N, 2008, NAT NEUROSCI, V11, P360, DOI 10.1038/nn2049; XU X, 2010, J NEUROPHYSIOL, V103; Xu XM, 2009, J NEUROSCI, V29, P70, DOI 10.1523/JNEUROSCI.4104-08.2009; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565	27	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15517	10.1371/journal.pone.0015517	http://dx.doi.org/10.1371/journal.pone.0015517			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124805	Green Published, gold			2022-12-27	WOS:000284572000034
J	Wierda, SM; van Rijn, H; Taatgen, NA; Martens, S				Wierda, Stefan M.; van Rijn, Hedderik; Taatgen, Niels A.; Martens, Sander			Distracting the Mind Improves Performance: An ERP Study	PLOS ONE			English	Article							ATTENTIONAL BLINK; INDIVIDUAL-DIFFERENCES; PERCEPTUAL LOAD; TASK; SELECTION; P3	Background: When a second target (T2) is presented in close succession of a first target (T1), people often fail to identify T2, a phenomenon known as the attentional blink (AB). However, the AB can be reduced substantially when participants are distracted during the task, for instance by a concurrent task, without a cost for T1 performance. The goal of the current study was to investigate the electrophysiological correlates of this paradoxical effect. Methodology/Principal Findings: Participants successively performed three tasks, while EEG was recorded. The first task (standard AB) consisted of identifying two target letters in a sequential stream of distractor digits. The second task (grey dots task) was similar to the first task with the addition of an irrelevant grey dot moving in the periphery, concurrent with the central stimulus stream. The third task (red dot task) was similar to the second task, except that detection of an occasional brief color change in the moving grey dot was required. AB magnitude in the latter task was significantly smaller, whereas behavioral performance in the standard and grey dots tasks did not differ. Using mixed effects models, electrophysiological activity was compared during trials in the grey dots and red dot tasks that differed in task instruction but not in perceptual input. In the red dot task, both target-related parietal brain activity associated with working memory updating (P3) as well as distractor-related occipital activity was significantly reduced. Conclusions/Significance: The results support the idea that the AB might (at least partly) arise from an overinvestment of attentional resources or an overexertion of attentional control, which is reduced when a distracting secondary task is carried out. The present findings bring us a step closer in understanding why and how an AB occurs, and how these temporal restrictions in selective attention can be overcome.	[Wierda, Stefan M.; Martens, Sander] Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Wierda, Stefan M.; Martens, Sander] Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [van Rijn, Hedderik] Univ Groningen, Dept Psychol, NL-9712 TS Groningen, Netherlands; [Taatgen, Niels A.] Univ Groningen, Dept Artificial Intelligence, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Wierda, SM (corresponding author), Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.m.wierda@med.umcg.nl	van Rijn, Hedderik/L-3685-2014; Taatgen, Niels/A-3216-2008	van Rijn, Hedderik/0000-0002-0461-9850; Lauwereyns, Jan/0000-0003-0551-2550; Taatgen, Niels/0000-0001-7286-3460	Behavioural and Cognitive Neurosciences (BCN) Research School	Behavioural and Cognitive Neurosciences (BCN) Research School	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arend I, 2006, PSYCHON B REV, V13, P600, DOI 10.3758/BF03193969; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Bates D., 2008, LME4 LINEAR MIXED EF; Ferlazzo F, 2007, EXP PSYCHOL, V54, P89, DOI 10.1027/1618-3169.54.2.89; Handy TC, 2001, PSYCHOL SCI, V12, P213, DOI 10.1111/1467-9280.00338; Kliegl R., 2009, VIS COGN, V18, P655; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; Loach D, 2003, VIS COGN, V10, P513, DOI 10.1080/13506280244000203; MANGUN GR, 1991, J EXP PSYCHOL HUMAN, V17, P1057, DOI 10.1037/0096-1523.17.4.1057; Martens S, 2005, MEM COGNITION, V33, P234, DOI 10.3758/BF03195312; MARTENS S, 2010, PLOS ONE IN PRESS; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; Nieuwenstein MR, 2005, J EXP PSYCHOL HUMAN, V31, P1463, DOI 10.1037/0096-1523.31.6.1463; Olivers CNL, 2008, PSYCHOL REV, V115, P836, DOI 10.1037/a0013395; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P1083, DOI 10.1037/0096-1523.32.5.1083; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Quene H, 2008, J MEM LANG, V59, P413, DOI 10.1016/j.jml.2008.02.002; R Core Team, 2020, R LANG ENV STAT COMP; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Strayer DL, 2001, PSYCHOL SCI, V12, P462, DOI 10.1111/1467-9280.00386; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P324, DOI 10.1037/a0013903	31	36	36	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15024	10.1371/journal.pone.0015024	http://dx.doi.org/10.1371/journal.pone.0015024			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684TK	21124833	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000019
J	Schafer, A; Schomacher, L; Barreto, G; Doderlein, G; Niehrs, C				Schaefer, Andrea; Schomacher, Lars; Barreto, Guillermo; Doederlein, Gabi; Niehrs, Christof			Gemcitabine Functions Epigenetically by Inhibiting Repair Mediated DNA Demethylation	PLOS ONE			English	Article							EXCISION-REPAIR; DRUG-RESISTANCE; MISMATCH REPAIR; HUMAN-CELLS; CANCER; DAMAGE; METHYLATION; MECHANISM; CISPLATIN; 2',2'-DIFLUORODEOXYCYTIDINE	Gemcitabine is a cytotoxic cytidine analog, which is widely used in anti-cancer therapy. One mechanism by which gemcitabine acts is by inhibiting nucleotide excision repair (NER). Recently NER was implicated in Gadd45 mediated DNA demethylation and epigenetic gene activation. Here we analyzed the effect of gemcitabine on DNA demethylation. We find that gemcitabine inhibits specifically Gadd45a mediated reporter gene activation and DNA demethylation, similar to the topoisomerase I inhibitor camptothecin, which also inhibits NER. In contrast, base excision repair inhibitors had no effect on DNA demethylation. In Xenopus oocytes, gemcitabine inhibits DNA repair synthesis accompanying demethylation of oct4. In mammalian cells, gemcitabine induces DNA hypermethylation and silencing of MLH1. The results indicate that gemcitabine induces epigenetic gene silencing by inhibiting repair mediated DNA demethylation. Thus, gemcitabine can function epigenetically and provides a tool to manipulate DNA methylation.	[Schaefer, Andrea; Schomacher, Lars; Barreto, Guillermo; Doederlein, Gabi; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany; [Niehrs, Christof] Inst Mol Biol, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Institute of Molecular Biology (IMB)	Schafer, A (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-6900 Heidelberg, Germany.	Niehrs@DKFZ-Heidelberg.de	Schomacher, Lars/AAC-3462-2019; Barreto, Guillermo/U-5718-2017	Schomacher, Lars/0000-0002-3841-5258; Barreto, Guillermo/0000-0002-7777-4712	Deutsche Forschungsgemeinschaft [NI 286/12-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (NI 286/12-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2001, CANCER RES, V61, P8723; BAKER CH, 1991, J MED CHEM, V34, P1879, DOI 10.1021/jm00110a019; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BOUFFARD DY, 1991, ANTI-CANCER DRUG, V2, P49, DOI 10.1097/00001813-199102000-00007; Crul M, 2003, BIOCHEM PHARMACOL, V65, P275, DOI 10.1016/S0006-2952(02)01508-3; DOWNES CS, 1987, CARCINOGENESIS, V8, P1613, DOI 10.1093/carcin/8.11.1613; Gao Z, 2008, BIOORGAN MED CHEM, V16, P4331, DOI 10.1016/j.bmc.2008.02.071; HAJKOVA P, SCIENCE, V329, P78; HEINEMANN V, 1990, MOL PHARMACOL, V38, P567; HEINEMANN V, 1988, CANCER RES, V48, P4024; HEINEMANN V, 1995, SEMIN ONCOL, V22, P11; Horton TM, 2009, MOL CANCER THER, V8, P2232, DOI 10.1158/1535-7163.MCT-09-0142; HUANG P, 1991, CANCER RES, V51, P6110; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jung HJ, 2007, ONCOGENE, V26, P7517, DOI 10.1038/sj.onc.1210557; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Larsen AK, 2003, PHARMACOL THERAPEUT, V99, P167, DOI 10.1016/S0163-7258(03)00058-5; Liu LF, 2000, ANN NY ACAD SCI, V922, P1; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Moufarij MA, 2003, MOL PHARMACOL, V63, P862, DOI 10.1124/mol.63.4.862; NYCE J, 1989, CANCER RES, V49, P5829; Nyce JW, 1997, MUTAT RES-REV MUTAT, V386, P153, DOI 10.1016/S1383-5742(96)00051-8; Qu GZ, 1999, MUTAT RES-FUND MOL M, V423, P91, DOI 10.1016/S0027-5107(98)00229-2; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Stach D, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng002; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Sun DY, 2002, CLIN CANCER RES, V8, P1189; Suzuki K, 2006, CANCER CELL, V9, P199, DOI 10.1016/j.ccr.2006.02.016; Toschi L, 2005, Future Oncol, V1, P7, DOI 10.1517/14796694.1.1.7; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Wade-Martins R, 1999, NUCLEIC ACIDS RES, V27, P1674, DOI 10.1093/nar/27.7.1674; Xiong ZG, 1997, NUCLEIC ACIDS RES, V25, P2532, DOI 10.1093/nar/25.12.2532; Yang LY, 2000, CLIN CANCER RES, V6, P773	37	197	198	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14060	10.1371/journal.pone.0014060	http://dx.doi.org/10.1371/journal.pone.0014060			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124914	gold, Green Published, Green Submitted			2022-12-27	WOS:000284400100009
J	Holder, B; Miles, DJC; Kaye, S; Crozier, S; Mohammed, NI; Duah, NO; Roberts, E; Ojuola, O; Palmero, MS; Touray, ES; Waight, P; Cotten, M; Rowland-Jones, S; van der Sande, M; Whittle, H				Holder, Beth; Miles, David J. C.; Kaye, Steve; Crozier, Sarah; Mohammed, Nuredin Ibrahim; Duah, Nancy O.; Roberts, Elishia; Ojuola, Olubukola; Palmero, Melba S.; Touray, Ebrima S.; Waight, Pauline; Cotten, Matthew; Rowland-Jones, Sarah; van der Sande, Marianne; Whittle, Hilton			Epstein-Barr Virus but Not Cytomegalovirus Is Associated with Reduced Vaccine Antibody Responses in Gambian Infants	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; PLASMODIUM-FALCIPARUM; NEISSERIA-MENINGITIDIS; DEVELOPING-COUNTRIES; MATERNAL ANTIBODIES; MEASLES; INFECTION; MORTALITY; MALARIA; IMMUNIZATION	Background: Epstein-Barr virus (EBV) and cytomegalovirus (CMV) are persistent herpesviruses that have various immunomodulatory effects on their hosts. Both viruses are usually acquired in infancy in Sub-Saharan Africa, a region where childhood vaccines are less effective than in high income settings. To establish whether there is an association between these two observations, we tested the hypothesis that infection with one or both viruses modulate antibody responses to the T-cell independent meningococcal polysaccharide vaccine and the T-cell dependent measles vaccines. Methodology/Principal Findings: Infection with EBV and CMV was diagnosed by the presence of virus-specific IgM in the peripheral blood or by the presence of IgG at higher levels than that found in umbilical cord blood. Anti-meningococcus IgG and IgM were quantified by ELISA. Anti-measles antibody responses were quantified by haemagglutinin antibody inhibition assay. Infants infected with EBV had reduced IgG and IgM antibody responses to meningococcal polysaccharides and to measles vaccine. Infection with CMV alone predicted no changes in the response to meningococcal polysaccharide. While CMV alone had no discernable effect on the antibody response to measles, the response of infants infected with both CMV and EBV was similar to that of infants infected with neither, suggesting that the effects of CMV infection countered the effects of EBV on measles antibody responses. Conclusions: The results of this exploratory study indicate that infection with EBV is associated with reduced antibody responses to polysaccharides and to measles vaccine, but suggest that the response to T-cell dependent antigens such as measles haemagglutinin may be restored by infection with CMV.	[Holder, Beth; Miles, David J. C.; Crozier, Sarah; Mohammed, Nuredin Ibrahim; Duah, Nancy O.; Roberts, Elishia; Ojuola, Olubukola; Palmero, Melba S.; Touray, Ebrima S.; Cotten, Matthew; Rowland-Jones, Sarah; Whittle, Hilton] MRC Labs Gambia, Banjul, Gambia; [Miles, David J. C.] Univ Cape Town, S African TB Vaccine Initiat, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kaye, Steve] Univ London Imperial Coll Sci Technol & Med, Jefferiss Trust Lab, London, England; [Crozier, Sarah] Univ Southampton, Southampton Gen Hosp, MRC Epidemiol Resource Ctr, Southampton, Hants, England; [Mohammed, Nuredin Ibrahim; Duah, Nancy O.] London Sch Hyg & Trop Med, London WC1, England; [Waight, Pauline] Hlth Protect Agcy Ctr Infect, Immunisat Dept, London, England; [van der Sande, Marianne] Ctr Infect Dis Control CIb, Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [van der Sande, Marianne] Univ Med Ctr Utrecht, Julius Ctr, Utrecht, Netherlands	University of Cape Town; Imperial College London; University of Southampton; University of London; London School of Hygiene & Tropical Medicine; Health Protection Agency; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University Medical Center	Holder, B (corresponding author), MRC Labs Gambia, Banjul, Gambia.	hcwhittle@yahoo.co.uk	Holder, Beth/AAD-8341-2020	Holder, Beth/0000-0003-2157-9819; Duah-Quashie, Nancy/0000-0001-8819-1793; Cotten, Matthew/0000-0002-3361-3351; Mohammed, Nuredin/0000-0002-4067-1103; van der Sande, Marianne AB/0000-0002-4778-6739; Crozier, Sarah/0000-0002-9524-1127	MRC; Sukuta Health Centre; Western Division Health Team; MRC [MC_U190081978] Funding Source: UKRI; Medical Research Council [MC_U190081978] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Sukuta Health Centre; Western Division Health Team; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the MRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the staff of the Sukuta birth cohort, Omar Badjie, Fatou Bah, Saihou Bobb, Sarah Burl, Janko Camara, Sulayman Colley, Momodou Cox, Isatou Drammeh, Mam Maram Drammeh, Momodou Lamin Fatty, Tisbeh Faye-Joof, Samboujang Makalo, John S Mendy, Ngui Ndow, Bala Musa Sambou, Sarjo Sanneh and Lady Chilel Sanyang. We are extremely grateful for the support of Sally Savage of Sukuta Health Centre and the Western Division Health Team, and to Professor Brian Greenwood of the London School of Hygiene and Tropical Medicine for advice and help. Some reagents for the meningococcus ELISA were a gift from Dr. Musa King of Chiron. The method for quantification of EBV DNA was adapted from methods developed by Prof A. Rickinson of the Division of Cancer Studies, University of Birmingham. Dr David Jefferies and Dr. John Townend of the MRC Unit, The Gambia provided statistical advice.	AABY P, 1990, J INFECT DIS, V162, P1043, DOI 10.1093/infdis/162.5.1043; AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; AABY P, 1984, AM J EPIDEMIOL, V120, P49, DOI 10.1093/oxfordjournals.aje.a113874; Aaby P, 2007, PEDIATR INFECT DIS J, V26, P247, DOI 10.1097/01.inf.0000256735.05098.01; Ben-Smith A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-139; BIGGAR RJ, 1978, INT J CANCER, V22, P239, DOI 10.1002/ijc.2910220304; BLAKEBROUGH IS, 1982, J INFECT DIS, V146, P626, DOI 10.1093/infdis/146.5.626; Cavanagh DR, 1998, J IMMUNOL, V161, P347; Cisse B, 1999, AM J EPIDEMIOL, V149, P295, DOI 10.1093/oxfordjournals.aje.a009811; Clute SC, 2005, J CLIN INVEST, V115, P3602, DOI 10.1172/JCI25078; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; DETHE G, 1978, NATURE, V274, P756, DOI 10.1038/274756a0; Duah NO, 2010, PARASITE IMMUNOL, V32, P125, DOI 10.1111/j.1365-3024.2009.01165.x; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; GHEESLING LL, 1994, J CLIN MICROBIOL, V32, P1475, DOI 10.1128/JCM.32.6.1475-1482.1994; GRATAMA JW, 1987, BLOOD, V70, P516; Grivel JC, 2005, J INFECT DIS, V192, P71, DOI 10.1086/430743; Grivel JC, 2001, NAT MED, V7, P1232, DOI 10.1038/nm1101-1232; Hochberg D, 2004, J VIROL, V78, P5194, DOI 10.1128/JVI.78.10.5194-5204.2004; Janaszek W, 2003, VACCINE, V21, P473, DOI 10.1016/S0264-410X(02)00482-6; Jaye A, 1998, J INFECT DIS, V177, P1282, DOI 10.1086/515271; KAYE S, 2008, J INFECT DIS, V197; KLEIN G, 1972, INT J CANCER, V10, P44, DOI 10.1002/ijc.2910100108; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Lynn TV, 2004, J INFECT DIS, V189, pS86, DOI 10.1086/377699; MALFAIT P, 1994, PEDIATR INFECT DIS J, V13, P38, DOI 10.1097/00006454-199401000-00009; Martro E, 2004, J MED VIROL, V72, P126, DOI 10.1002/jmv.10548; Miles DJC, 2008, IMMUNOLOGY, V124, P388, DOI 10.1111/j.1365-2567.2007.02787.x; Miles DJC, 2007, J VIROL, V81, P5766, DOI 10.1128/JVI.00052-07; MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383; *MIN HLTH N POL CO, 1966, B WORLD HEALTH ORGAN, V34, P865; NORRBY E, 1972, INFECT IMMUN, V6, P240, DOI 10.1128/IAI.6.3.240-247.1972; ODempsey TJD, 1996, ARCH DIS CHILD-FETAL, V74, pF43, DOI 10.1136/fn.74.1.F43; Olsson J, 2000, MECH AGEING DEV, V121, P187; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; REINGOLD AL, 1985, LANCET, V2, P114; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; Sinclair J, 2006, J GEN VIROL, V87, P1763, DOI 10.1099/vir.0.81891-0; SODERBERG C, 1993, J VIROL, V67, P3166; Souza TA, 2007, J IMMUNOL, V179, P3153, DOI 10.4049/jimmunol.179.5.3153; Sze DMY, 2000, J EXP MED, V192, P813, DOI 10.1084/jem.192.6.813; Trzonkowski P, 2003, VACCINE, V21, P3826, DOI 10.1016/S0264-410X(03)00309-8; Usen S, 2000, PEDIATR INFECT DIS J, V19, P444, DOI 10.1097/00006454-200005000-00010; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; Vitek CR, 1999, PEDIATR INFECT DIS J, V18, P620, DOI 10.1097/00006454-199907000-00010; WHITTLE H, 1988, LANCET, V331, P963; WHITTLE HC, 1984, NATURE, V312, P449, DOI 10.1038/312449a0; WHO, 2005, WKLY EPIDEMIOL REC, V80, P313; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P331; WILLIAMSON WA, 1978, LANCET, V1, P1328; Xiao LH, 1998, J INFECT DIS, V177, P437, DOI 10.1086/514212	53	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14013	10.1371/journal.pone.0014013	http://dx.doi.org/10.1371/journal.pone.0014013			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103338	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000284327800005
J	Kim, Y; Rajagopalan, P				Kim, Yeonhee; Rajagopalan, Padmavathy			3D Hepatic Cultures Simultaneously Maintain Primary Hepatocyte and Liver Sinusoidal Endothelial Cell Phenotypes	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; RAT-LIVER; MICROPATTERNED SURFACES; SANDWICH CONFIGURATION; NONPARENCHYMAL CELLS; MONOCLONAL-ANTIBODY; HYALURONIC-ACID; KUPFFER CELLS	Developing in vitro engineered hepatic tissues that exhibit stable phenotype is a major challenge in the field of hepatic tissue engineering. However, the rapid dedifferentiation of hepatic parenchymal (hepatocytes) and non-parenchymal (liver sinusoidal endothelial, LSEC) cell types when removed from their natural environment in vivo remains a major obstacle. The primary goal of this study was to demonstrate that hepatic cells cultured in layered architectures could preserve or potentially enhance liver-specific behavior of both cell types. Primary rat hepatocytes and rat LSECs (rLSECs) were cultured in a layered three-dimensional (3D) configuration. The cell layers were separated by a chitosan-hyaluronic acid polyelectrolyte multilayer (PEM), which served to mimic the Space of Disse. Hepatocytes and rLSECs exhibited several key phenotypic characteristics over a twelve day culture period. Immunostaining for the sinusoidal endothelial 1 antibody (SE-1) demonstrated that rLSECs cultured in the 3D hepatic model maintained this unique feature over twelve days. In contrast, rLSECs cultured in monolayers lost their phenotype within three days. The unique stratified structure of the 3D culture resulted in enhanced heterotypic cell-cell interactions, which led to improvements in hepatocyte functions. Albumin production increased three to six fold in the rLSEC-PEM-Hepatocyte cultures. Only rLSEC-PEM-Hepatocyte cultures exhibited increasing CYP1A1/2 and CYP3A activity. Well-defined bile canaliculi were observed only in the rLSEC-PEM-Hepatocyte cultures. Together, these data suggest that rLSEC-PEM-Hepatocyte cultures are highly suitable models to monitor the transformation of toxins in the liver and their transport out of this organ. In summary, these results indicate that the layered rLSEC-PEM-hepatocyte model, which recapitulates key features of hepatic sinusoids, is a potentially powerful medium for obtaining comprehensive knowledge on liver metabolism, detoxification and signaling pathways in vitro.	[Kim, Yeonhee; Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA; [Rajagopalan, Padmavathy] Virginia Polytech Inst & State Univ, ICTAS Ctr Syst Biol Engn Tissues, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Kim, Y (corresponding author), Virginia Polytech Inst & State Univ, Dept Chem Engn, Blacksburg, VA 24061 USA.	padmar@vt.edu			National Institutes of Health [NIDDK-1R21DK077802]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK077802] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors gratefully acknowledge financial support from the National Institutes of Health (NIDDK-1R21DK077802, P. R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias I. M., 2001, LIVER BIOL PATHOLOGY; Behnia K, 2000, TISSUE ENG, V6, P467, DOI 10.1089/107632700750022125; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bhatia SN, 1997, J BIOMED MATER RES, V34, P189, DOI 10.1002/(SICI)1097-4636(199702)34:2<189::AID-JBM8>3.0.CO;2-M; Chung TW, 2002, BIOMATERIALS, V23, P2827, DOI 10.1016/S0142-9612(01)00399-4; Corlu A, 1997, CELL BIOL TOXICOL, V13, P235, DOI 10.1023/A:1007475122321; DeLeve LD, 2004, AM J PHYSIOL-GASTR L, V287, pG757, DOI 10.1152/ajpgi.00017.2004; Deo AK, 2008, DRUG METAB DISPOS, V36, P1983, DOI 10.1124/dmd.108.022194; DUNN JCY, 1989, FASEB J, V3, P174, DOI 10.1096/fasebj.3.2.2914628; DUNN JCY, 1991, BIOTECHNOL PROGR, V7, P237, DOI 10.1021/bp00009a007; Elvevold Kjetil H, 2004, Comp Hepatol, V3, P4, DOI 10.1186/1476-5926-3-4; FRASER R, 1995, HEPATOLOGY, V21, P863, DOI 10.1016/0270-9139(95)90542-1; Gao WS, 1998, HEPATOLOGY, V27, P1652, DOI 10.1002/hep.510270626; Hofmann AF, 2008, CELL MOL LIFE SCI, V65, P2461, DOI 10.1007/s00018-008-7568-6; Hwa AJ, 2007, FASEB J, V21, P2564, DOI 10.1096/fj.06-7473com; Joddar B, 2006, BIOMATERIALS, V27, P5698, DOI 10.1016/j.biomaterials.2006.07.020; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Khetani SR, 2004, HEPATOLOGY, V40, P545, DOI 10.1002/hep.20351; Kim Y, 2010, TISSUE ENG PT A, V16, P2731, DOI 10.1089/ten.tea.2009.0695; KURIHARCUCH W, 1989, DIFFERENTIATION, V41, P148, DOI 10.1111/j.1432-0436.1989.tb00742.x; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; March S, 2009, HEPATOLOGY, V50, P920, DOI 10.1002/hep.23085; McCuskey RS, 2006, CLIN HEMORHEOL MICRO, V34, P5; MCGUIRE RF, 1992, HEPATOLOGY, V15, P989, DOI 10.1002/hep.1840150603; Moghe PV, 1996, BIOMATERIALS, V17, P373, DOI 10.1016/0142-9612(96)85576-1; Nahmias Y, 2006, TISSUE ENG, V12, P1627, DOI 10.1089/ten.2006.12.1627; OHMURA T, 1993, J HISTOCHEM CYTOCHEM, V41, P1253, DOI 10.1177/41.8.8331290; Omiecinski CJ, 1999, TOXICOL SCI, V48, P151, DOI 10.1093/toxsci/48.2.151; Park IK, 2003, BIOMATERIALS, V24, P2331, DOI 10.1016/S0142-9612(03)00108-X; Park IK, 2001, J CONTROL RELEASE, V76, P349, DOI 10.1016/S0168-3659(01)00448-5; Rajagopalan P, 2005, TISSUE ENG, V11, P1527, DOI 10.1089/ten.2005.11.1527; Rajagopalan P, 2006, TISSUE ENG, V12, P1553, DOI 10.1089/ten.2006.12.1553; Remuzzi A, 2004, TISSUE ENG, V10, P699, DOI 10.1089/1076327041348347; RIEDER H, 1992, J HEPATOL, V15, P237, DOI 10.1016/0168-8278(92)90042-N; Sellaro TL, 2007, TISSUE ENG, V13, P2301, DOI 10.1089/ten.2006.0437; Sellaro TL, 2010, TISSUE ENG PT A, V16, P1075, DOI [10.1089/ten.tea.2008.0587, 10.1089/ten.TEA.2008.0587]; Smedsrod B, 1997, BIOCHEM J, V322, P567, DOI 10.1042/bj3220567; Smedsrod Bard, 2004, Comp Hepatol, V3 Suppl 1, pS22, DOI 10.1186/1476-5926-2-S1-S22; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Thummel KE, 1998, ANNU REV PHARMACOL, V38, P389, DOI 10.1146/annurev.pharmtox.38.1.389; Tokairin T, 2002, J HEPATOL, V36, P725, DOI 10.1016/S0168-8278(02)00048-X; Ueno, 1999, LIVER DIS HEPATIC SI, P17, DOI DOI 10.1007/978-4-431-67935-6_2; Wang S, 2008, TISSUE ENG PT A, V14, P227, DOI 10.1089/tea.2007.0143; Wang XJ, 1997, BIOCHEM J, V328, P937, DOI 10.1042/bj3280937; ZIMNIAK P, 1991, BIOCHEM J, V275, P105, DOI 10.1042/bj2750105; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751; Zinchenko YS, 2005, J BIOMED MATER RES A, V75A, P242, DOI 10.1002/jbm.a.30399	47	79	80	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15456	10.1371/journal.pone.0015456	http://dx.doi.org/10.1371/journal.pone.0015456			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103392	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700029
J	Michel, S; Liang, LM; Depner, M; Klopp, N; Ruether, A; Kumar, A; Schedel, M; Vogelberg, C; von Mutius, E; von Berg, A; Bufe, A; Rietschel, E; Heinzmann, A; Laub, O; Simma, B; Frischer, T; Genuneit, J; Gut, IG; Schreiber, S; Lathrop, M; Illig, T; Kabesch, M				Michel, Sven; Liang, Liming; Depner, Martin; Klopp, Norman; Ruether, Andreas; Kumar, Ashish; Schedel, Michaela; Vogelberg, Christian; von Mutius, Erika; von Berg, Andrea; Bufe, Albrecht; Rietschel, Ernst; Heinzmann, Andrea; Laub, Otto; Simma, Burkhard; Frischer, Thomas; Genuneit, Jon; Gut, Ivo G.; Schreiber, Stefan; Lathrop, Mark; Illig, Thomas; Kabesch, Michael			Unifying Candidate Gene and GWAS Approaches in Asthma	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ETHNICALLY DIVERSE POPULATIONS; GENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; BRONCHIAL HYPERRESPONSIVENESS; RECEPTOR POLYMORPHISMS; ADAM33 POLYMORPHISMS; ATOPIC ASTHMA; ADULT ASTHMA; BIRTH COHORT	The first genome wide association study (GWAS) for childhood asthma identified a novel major susceptibility locus on chromosome 17q21 harboring the ORMDL3 gene, but the role of previous asthma candidate genes was not specifically analyzed in this GWAS. We systematically identified 89 SNPs in 14 candidate genes previously associated with asthma in >3 independent study populations. We re-genotyped 39 SNPs in these genes not covered by GWAS performed in 703 asthmatics and 658 reference children. Genotyping data were compared to imputation data derived from Illumina HumanHap300 chip genotyping. Results were combined to analyze 566 SNPs covering all 14 candidate gene loci. Genotyped polymorphisms in ADAM33, GSTP1 and VDR showed effects with p-values <0.0035 (corrected for multiple testing). Combining genotyping and imputation, polymorphisms in DPP10, EDN1, IL12B, IL13, IL4, IL4R and TNF showed associations at a significance level between p = 0.05 and p = 0.0035. These data indicate that (a) GWAS coverage is insufficient for many asthma candidate genes, (b) imputation based on these data is reliable but incomplete, and (c) SNPs in three previously identified asthma candidate genes replicate in our GWAS population with significance after correction for multiple testing in 14 genes.	[Michel, Sven; Schedel, Michaela; Kabesch, Michael] Hannover Med Sch, Ctr Pediat, Clin Pediat Pneumol Allergol & Neonatol, D-3000 Hannover, Germany; [Liang, Liming] Univ Michigan, Dept Biostat, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Depner, Martin; von Mutius, Erika] Univ Munich, Univ Childrens Hosp, Munich, Germany; [Klopp, Norman; Illig, Thomas] Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Ruether, Andreas] Univ Hosp Schleswig Holstein, Inst Clin Mol Biol, Kiel, Germany; [Kumar, Ashish] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Vogelberg, Christian] Tech Univ Dresden, Univ Childrens Hosp, Dresden, Germany; [von Berg, Andrea] Marien Hosp, Childrens Dept, Res Inst Prevent Allerg Dis, Wesel, Germany; [Bufe, Albrecht] Ruhr Univ Bochum, Dept Expt Pneumol, Bochum, Germany; [Rietschel, Ernst] Univ Cologne, Univ Childrens Hosp, Cologne, Germany; [Heinzmann, Andrea] Univ Freiburg, Univ Childrens Hosp, Freiburg, Germany; [Laub, Otto] Kinder & Jugendarztpraxis Laub, Rosenheim, Germany; [Simma, Burkhard] Landeskrankenhaus Feldkirch, Childrens Dept, Univ Teaching Hosp, Feldkirch, Austria; [Frischer, Thomas] Univ Childrens Hosp Vienna, Vienna, Austria; [Genuneit, Jon] Univ Ulm, Inst Epidemiol, Ulm, Germany; [Gut, Ivo G.; Lathrop, Mark] Commissariat Energie Atom, Inst Genom, Ctr Natl Genotypage, Evry, France; [Gut, Ivo G.] Ctr Nacl Anal Genom, Barcelona, Spain	Hannover Medical School; University of Michigan System; University of Michigan; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Kiel; Schleswig Holstein University Hospital; University of Oxford; Wellcome Centre for Human Genetics; Technische Universitat Dresden; University of Hamburg; University Medical Center Hamburg-Eppendorf; St. Marien Hospital; Ruhr University Bochum; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University Hospital Vienna; Ulm University; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay	Michel, S (corresponding author), Hannover Med Sch, Ctr Pediat, Clin Pediat Pneumol Allergol & Neonatol, D-3000 Hannover, Germany.	kabesch.michael@mh-hannover.de	Schedel, Michaela/B-3065-2019; Kabesch, Michael/AAB-5701-2020; Gut, Ivo/ABF-3188-2020; Kabesch, Michael/GZM-1583-2022; Genuneit, Jon/I-9323-2012	Schedel, Michaela/0000-0001-8465-2986; Gut, Ivo/0000-0001-7219-632X; Genuneit, Jon/0000-0001-5764-1528; Kumar, Ashish/0000-0002-7075-5930; Bufe, Albrecht/0000-0001-7335-9362; Michel, Sven/0000-0003-3604-3187; von Mutius, Erika/0000-0002-8893-4515	German ministry of education and research (BMBF) of national genome research network (NGFN) [01GS0810]; European Commission of GABRIEL [018996, LSH-2004-1.2.5-1]; PINA (Prevention and Information Network for Asthma and Allergy)	German ministry of education and research (BMBF) of national genome research network (NGFN)(Federal Ministry of Education & Research (BMBF)); European Commission of GABRIEL; PINA (Prevention and Information Network for Asthma and Allergy)	This work was funded by the German ministry of education and research (BMBF) as part of the national genome research network (NGFN), with grant NGFN 01GS0810 and by the European Commission as part of the GABRIEL (a multidisciplinary study to identify the genetic and environmental causes of asthma in the European Community) contract number 018996 under the Integrated Program LSH-2004-1.2.5-1. SM is supported by a research fellowship from PINA (Prevention and Information Network for Asthma and Allergy). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albuquerque RV, 1998, CLIN EXP ALLERGY, V28, P578; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beghe B, 2003, CLIN EXP ALLERGY, V33, P1111, DOI 10.1046/j.1365-2222.2003.01731.x; Black S, 2009, ALLERGY, V64, P1172, DOI 10.1111/j.1398-9995.2009.01988.x; Blakey JD, 2009, THORAX, V64, P381, DOI 10.1136/thx.2008.102053; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Castro-Giner F, 2008, EUR RESPIR J, V32, P350, DOI 10.1183/09031936.00155607; Chagani T, 1999, AM J RESP CRIT CARE, V160, P278, DOI 10.1164/ajrccm.160.1.9808032; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Eyre TA, 2006, NUCLEIC ACIDS RES, V34, pD319, DOI 10.1093/nar/gkj147; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gudbjartsson DF, 2009, NAT GENET, V41, P342, DOI 10.1038/ng.323; Haas SL, 2007, SCAND J IMMUNOL, V65, P166, DOI 10.1111/j.1365-3083.2006.01876.x; Heinzmann A, 2000, HUM MOL GENET, V9, P549, DOI 10.1093/hmg/9.4.549; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2006, CLIN EXP ALLERGY, V36, P884, DOI 10.1111/j.1365-2222.2006.02522.x; Hosseini-Farahabadi S, 2007, IRAN J ALLERGY ASTHM, V6, P9; Howard TD, 2003, J ALLERGY CLIN IMMUN, V112, P717, DOI 10.1016/S0091-6749(03)01939-0; Hytonen AM, 2004, CLIN EXP ALLERGY, V34, P1570, DOI 10.1111/j.1365-2222.2004.02069.x; Jimenez-Morales S, 2009, HUM IMMUNOL, V70, P251, DOI 10.1016/j.humimm.2009.01.027; Kabesch M, 2009, THORAX, V64, P370, DOI 10.1136/thx.2008.105197; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Kormann MSD, 2005, AM J RESP CRIT CARE, V171, P1358, DOI 10.1164/rccm.200410-1312OC; Kumar Ajay, 2008, Indian J Med Sci, V62, P323; Kumar V, 2008, NATL MED J INDIA, V21, P120; Li GS, 2007, HUM MUTAT, V28, P950, DOI 10.1002/humu.20543; Li YF, 2006, AM J RESP CRIT CARE, V173, P970, DOI 10.1164/rccm.200508-1256OC; Menashe I, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-36; Moffatt MF, 1997, HUM MOL GENET, V6, P551, DOI 10.1093/hmg/6.4.551; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Munthe-Kaas MC, 2007, ALLERGY, V62, P991, DOI 10.1111/j.1398-9995.2007.01377.x; Ober C, 2000, AM J HUM GENET, V66, P517, DOI 10.1086/302781; Ober C, 2008, NEW ENGL J MED, V358, P1682, DOI 10.1056/NEJMoa0708801; Poon AH, 2004, AM J RESP CRIT CARE, V170, P967, DOI 10.1164/rccm.200403-412oc; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raby BA, 2004, AM J RESP CRIT CARE, V170, P1057, DOI 10.1164/rccm.200404-447OC; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Thongngarm T, 2008, ASIAN PAC J ALLERGY, V26, P205; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Wang TN, 2004, CLIN EXP ALLERGY, V34, P184, DOI 10.1111/j.1365-2222.2004.01867.x; Weidinger S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000166; Weiland SK, 1999, EUR RESPIR J, V14, P862, DOI 10.1034/j.1399-3003.1999.14d23.x; Winchester EC, 2000, HUM GENET, V107, P591, DOI 10.1007/s004390000410; Witte JS, 2002, EUR J HUM GENET, V10, P82, DOI 10.1038/sj.ejhg.5200746; Wu H, 2007, ENVIRON HEALTH PERSP, V115, P616, DOI 10.1289/ehp.9740; Zhang WD, 2007, RESP MED, V101, P186, DOI 10.1016/j.rmed.2006.04.004; Zhu G, 2008, GENES IMMUN, V9, P23, DOI 10.1038/sj.gene.6364441	49	75	78	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13894	10.1371/journal.pone.0013894	http://dx.doi.org/10.1371/journal.pone.0013894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103062	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700005
J	Tamura, EK; Fernandes, PA; Marcola, M; Cruz-Machado, SD; Markus, RP				Tamura, Eduardo Koji; Fernandes, Pedro Augusto; Marcola, Marina; Cruz-Machado, Sanseray da Silveira; Markus, Regina Pekelmann			Long-Lasting Priming of Endothelial Cells by Plasma Melatonin Levels	PLOS ONE			English	Article							RAT PINEAL-GLAND; NITRIC-OXIDE PRODUCTION; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; NEUTROPHIL MOBILIZATION; IN-VITRO; LIPOPOLYSACCHARIDE; INHIBITION; MECHANISMS; PATHWAY	Background: Endothelial cells are of great interest for cell therapy and tissue engineering. Understanding the heterogeneity among cell lines originating from different sources and culture protocols may allow more standardized material to be obtained. In a recent paper, we showed that adrenalectomy interferes with the expression of membrane adhesion molecules on endothelial cells maintained in culture for 16 to 18 days. In addition, the pineal hormone, melatonin, reduces the adhesion of neutrophils to post-capillary veins in rats. Here, we evaluated whether the reactivity of cultured endothelial cells maintained for more than two weeks in culture is inversely correlated to plasma melatonin concentration. Methodology/Principal Findings: The nocturnal levels of melatonin were manipulated by treating rats with LPS. Nocturnal plasma melatonin, significantly reduced two hours after LPS treatment, returned to control levels after six hours. Endothelial cells obtained from animals that had lower nocturnal melatonin levels significantly express enhanced adhesion molecules and iNOS, and have more leukocytes adhered than cells from animals that had normal nocturnal levels of melatonin (naive or injected with vehicle). Endothelial cells from animals sacrificed two hours after a simultaneous injection of LPS and melatonin present similar phenotype and function than those obtained fromcontrol animals. Analyzing together all the data, taking into account the plasma melatonin concentration versus the expression of adhesion molecules or iNOS we detected a significant inverse correlation. Conclusions/Significance: Our data strongly suggest that the plasma melatonin level primes endothelial cells "in vivo," indicating that the state of the donor animal is translated to cells in culture and therefore, should be considered for establishing cell banks in ideal conditions.	[Tamura, Eduardo Koji; Fernandes, Pedro Augusto; Marcola, Marina; Cruz-Machado, Sanseray da Silveira; Markus, Regina Pekelmann] Univ Sao Paulo, Lab Chronopharmacol, Dept Physiol, Inst Biosci, Sao Paulo, Brazil	Universidade de Sao Paulo	Tamura, EK (corresponding author), Univ Sao Paulo, Lab Chronopharmacol, Dept Physiol, Inst Biosci, Sao Paulo, Brazil.	rpmarkus@usp.br	Markus, Regina P/K-2954-2012; Marçola, Marina/D-4097-2015; Tamura, Eduardo Koji/L-4360-2019; Markus, Regina P./AAC-1505-2021; Tamura, Eduardo Koji/F-7068-2012; Fernandes, Pedro/L-1869-2013	Markus, Regina P/0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Markus, Regina P./0000-0003-4606-6120; Tamura, Eduardo Koji/0000-0002-6105-7452; Carlos Magno Fernandes, Pedro Augusto/0000-0002-4871-8201; da Silveira Cruz-Machado, Sanseray/0000-0002-6937-7207	FAPESP [07/07871-6]; CNPq [472881/2009-4]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	EKT and PACMF are post-doctoral fellows. MM and SSCM are graduate fellows of the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). RPM is a senior fellow of the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). This article was supported by grants from FAPESP (07/07871-6) and CNPq (472881/2009-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; BERGHE WV, 2006, BIOCHEM PHARMACOL, V72, P1114; Cavalcanti DMH, 2007, BRIT J PHARMACOL, V152, P1291, DOI 10.1038/sj.bjp.0707512; Cavalcanti DMH, 2006, MOL CELL ENDOCRINOL, V249, P32, DOI 10.1016/j.mce.2006.01.007; Cecon E, 2010, CHRONOBIOL INT, V27, P52, DOI 10.3109/07420521003661615; Cruz-Machado SD, 2010, J PINEAL RES, V49, P183, DOI 10.1111/j.1600-079X.2010.00785.x; Fernandes PACM, 2009, J NEUROENDOCRINOL, V21, P90, DOI 10.1111/j.1365-2826.2008.01817.x; Fernandes PACM, 2006, J PINEAL RES, V41, P344, DOI 10.1111/j.1600-079X.2006.00373.x; Ferreira ZS, 2005, J PINEAL RES, V38, P182, DOI 10.1111/j.1600-079X.2004.00191.x; Gilad E, 1998, FASEB J, V12, P685, DOI 10.1096/fasebj.12.9.685; Kakizaki Y, 1999, ENDOCR J, V46, P487, DOI 10.1507/endocrj.46.487; Laude K, 2002, CARDIOVASC RES, V55, P466, DOI 10.1016/S0008-6363(02)00277-8; Lotufo CMC, 2006, EUR J PHARMACOL, V534, P258, DOI 10.1016/j.ejphar.2006.01.050; Lotufo CMC, 2001, EUR J PHARMACOL, V430, P351, DOI 10.1016/S0014-2999(01)01369-3; Markus RP, 2007, NEUROIMMUNOMODULAT, V14, P126, DOI 10.1159/000110635; POHLMAN TH, 1986, J IMMUNOL, V136, P4548; Silva CLM, 2007, BRIT J PHARMACOL, V151, P195, DOI 10.1038/sj.bjp.0707225; Tamura EK, 2006, J PINEAL RES, V41, P267, DOI 10.1111/j.1600-079X.2006.00366.x; Tamura EK, 2009, J PINEAL RES, V46, P268, DOI 10.1111/j.1600-079X.2008.00657.x; Wada Y, 2005, FASEB J, V19, P1914, DOI 10.1096/fj.05-4037fje	20	40	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13958	10.1371/journal.pone.0013958	http://dx.doi.org/10.1371/journal.pone.0013958			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103056	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700009
J	Shao, H; Wang, JHC; Pollak, MR; Wells, A				Shao, Hanshuang; Wang, James H. -C.; Pollak, Martin R.; Wells, Alan			alpha-Actinin-4 Is Essential for Maintaining the Spreading, Motility and Contractility of Fibroblasts	PLOS ONE			English	Article							ALPHA-ACTININ; GENE AMPLIFICATION; CELL MOTILITY; CANCER; CYTOKINESIS; ADHESIONS; KINASE	Background: alpha-Actinins cross-link actin filaments, with this cross-linking activity regulating the formation of focal adhesions, intracellular tension, and cell migration. Most non-muscle cells such as fibroblasts express two isoforms, alpha-actinin-1 (ACTN1) and alpha-actinin-4 (ACTN4). The high homology between these two isoforms would suggest redundancy of their function, but recent studies have suggested different regulatory roles. Interestingly, ACTN4 is phosphorylated upon growth factor stimulation, and this loosens its interaction with actin. Methodology/Principal Findings: Using molecular, biochemical and cellular techniques, we probed the cellular functions of ACTN4 in fibroblasts. Knockdown of ACTN4 expression in murine lung fibroblasts significantly impaired cell migration, spreading, adhesion, and proliferation. Surprisingly, knockdown of ACTN4 enhanced cellular compaction and contraction force, and increased cellular and nuclear cross-sectional area. These results, except the increased contractility, are consistent with a putative role of ACTN4 in cytokinesis. For the transcellular tension, knockdown of ACTN4 significantly increased the expression of myosin light chain 2, a element of the contractility machinery. Re-expression of wild type human ACTN4 in ACTN4 knockdown murine lung fibroblasts reverted cell spreading, cellular and nuclear cross-sectional area, and contractility back towards baseline, demonstrating that the defect was due to absence of ACTN4. Significance: These results suggest that ACTN4 is essential for maintaining normal spreading, motility, cellular and nuclear cross-sectional area, and contractility of murine lung fibroblasts by maintaining the balance between transcellular contractility and cell-substratum adhesion.	[Shao, Hanshuang; Wells, Alan] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA; [Wang, James H. -C.] Univ Pittsburgh, Dept Orthopaed Surg, Pittsburgh, PA USA; [Pollak, Martin R.] Beth Israel Deaconess Med Ctr, Dept Med, Div Nephrol, Boston, MA 02215 USA; [Pollak, Martin R.] Harvard Univ, Sch Med, Boston, MA USA; [Wells, Alan] Pittsburgh VA Hlth Syst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Shao, H (corresponding author), Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15260 USA.	wellsa@upmc.edu		Wells, Alan/0000-0002-1637-8150	National Institute of General Medical Science [R01GM069668]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) (USA) [R01DK054931]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054931] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069668] Funding Source: NIH RePORTER	National Institute of General Medical Science(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute of General Medical Science (R01GM069668) and the National Institute of Diabetes and Digestive and Kidney Diseases (R01DK054931) of the National Institutes of Health (NIH) (USA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FD, 2002, WOUND REPAIR REGEN, V10, P67, DOI 10.1046/j.1524-475X.2002.10701.x; Assoian RK, 2008, TRENDS CELL BIOL, V18, P347, DOI 10.1016/j.tcb.2008.05.002; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; CHEN P, 1994, J CELL BIOL, V124, P547, DOI 10.1083/jcb.124.4.547; Choi CK, 2008, NAT CELL BIOL, V10, P1039, DOI 10.1038/ncb1763; Dandapani SV, 2007, J BIOL CHEM, V282, P467, DOI 10.1074/jbc.M605024200; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Hauge H, 2009, CELL SIGNAL, V21, P1866, DOI 10.1016/j.cellsig.2009.08.001; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Iwabu A, 2004, J BIOL CHEM, V279, P14551, DOI 10.1074/jbc.M311981200; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; Kumeta M, 2010, J CELL SCI, V123, P1020, DOI 10.1242/jcs.059568; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Li B, 2008, J BIOMECH, V41, P3349, DOI 10.1016/j.jbiomech.2008.09.025; Low SH, 2010, EXP CELL RES, V316, P1925, DOI 10.1016/j.yexcr.2010.03.004; Michaud JLR, 2009, CELL MOTIL CYTOSKEL, V66, P166, DOI 10.1002/cm.20339; Mukhina S, 2007, DEV CELL, V13, P554, DOI 10.1016/j.devcel.2007.08.003; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao HS, 2010, J BIOL CHEM, V285, P2591, DOI 10.1074/jbc.M109.035790; Smith KD, 2006, EXP CELL RES, V312, P1970, DOI 10.1016/j.yexcr.2006.02.022; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Yamamoto S, 2009, MODERN PATHOL, V22, P499, DOI 10.1038/modpathol.2008.234	27	66	66	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13921	10.1371/journal.pone.0013921	http://dx.doi.org/10.1371/journal.pone.0013921			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085685	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000284087800004
J	Tasaki, S; Nagasaki, M; Kozuka-Hata, H; Semba, K; Gotoh, N; Hattori, S; Inoue, J; Yamamoto, T; Miyano, S; Sugano, S; Oyama, M				Tasaki, Shinya; Nagasaki, Masao; Kozuka-Hata, Hiroko; Semba, Kentaro; Gotoh, Noriko; Hattori, Seisuke; Inoue, Jun-ichiro; Yamamoto, Tadashi; Miyano, Satoru; Sugano, Sumio; Oyama, Masaaki			Phosphoproteomics-Based Modeling Defines the Regulatory Mechanism Underlying Aberrant EGFR Signaling	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; TYROSINE PHOSPHORYLATION; MASS-SPECTROMETRY; BINDING-SITE; MAPK CASCADE; PROTEIN; DYNAMICS; NETWORK; PATHWAYS; REVEALS	Background: Mutation of the epidermal growth factor receptor (EGFR) results in a discordant cell signaling, leading to the development of various diseases. However, the mechanism underlying the alteration of downstream signaling due to such mutation has not yet been completely understood at the system level. Here, we report a phosphoproteomics-based methodology for characterizing the regulatory mechanism underlying aberrant EGFR signaling using computational network modeling. Methodology/Principal Findings: Our phosphoproteomic analysis of the mutation at tyrosine 992 (Y992), one of the multifunctional docking sites of EGFR, revealed network-wide effects of the mutation on EGF signaling in a time-resolved manner. Computational modeling based on the temporal activation profiles enabled us to not only rediscover already-known protein interactions with Y992 and internalization property of mutated EGFR but also further gain model-driven insights into the effect of cellular content and the regulation of EGFR degradation. Our kinetic model also suggested critical reactions facilitating the reconstruction of the diverse effects of the mutation on phosphoproteome dynamics. Conclusions/Significance: Our integrative approach provided a mechanistic description of the disorders of mutated EGFR signaling networks, which could facilitate the development of a systematic strategy toward controlling disease-related cell signaling.	[Tasaki, Shinya; Kozuka-Hata, Hiroko; Inoue, Jun-ichiro; Oyama, Masaaki] Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan; [Tasaki, Shinya; Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Tokyo, Japan; [Nagasaki, Masao; Miyano, Satoru] Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; [Semba, Kentaro] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo, Japan; [Gotoh, Noriko] Univ Tokyo, Inst Med Sci, Div Syst Biomed Technol, Tokyo, Japan; [Hattori, Seisuke] Univ Tokyo, Inst Med Sci, Div Cellular Prote BML, Tokyo, Japan; [Hattori, Seisuke] Kitasato Univ, Sch Pharmaceut Sci, Dept Biochem, Tokyo 108, Japan; [Inoue, Jun-ichiro; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Dept Canc Biol, Tokyo, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Waseda University; University of Tokyo; University of Tokyo; Kitasato University; University of Tokyo	Tasaki, S (corresponding author), Univ Tokyo, Inst Med Sci, Med Prote Lab, Tokyo, Japan.	moyama@ims.u-tokyo.ac.jp	GOTOH, Noriko/D-8430-2015	Gotoh, Noriko/0000-0003-3733-260X; Miyano, Satoru/0000-0002-1753-6616; Oyama, Masaaki/0000-0001-6478-3735; Kozuka-Hata, Hiroko/0000-0002-9286-6594; Nagasaki, Masao/0000-0002-4292-8785	Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research on Priority Areas and Japan Society for the Promotion of Science (JSPS) Fellows from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, MOL CELL BIOL, V23, P7875, DOI 10.1128/MCB.23.21.7875-7886.2003; Anastasi S, 2007, ONCOGENE, V26, P7833, DOI 10.1038/sj.onc.1210590; Beebe JA, 2003, J BIOL CHEM, V278, P26810, DOI 10.1074/jbc.M301397200; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Birtwistle MR, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100188; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blinov ML, 2006, BIOSYSTEMS, V83, P136, DOI 10.1016/j.biosystems.2005.06.014; Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103; Brightman FA, 2000, FEBS LETT, V482, P169, DOI 10.1016/S0014-5793(00)02037-8; Bublil EM, 2007, CURR OPIN CELL BIOL, V19, P124, DOI 10.1016/j.ceb.2007.02.008; CHEN D, 1995, SCIENCE, V269, P1699, DOI 10.1126/science.269.5231.1699; Chen WW, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.74; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Dengjel J, 2009, MOL BIOSYST, V5, P1112, DOI 10.1039/b909534a; Doi Atsushi, 2004, In Silico Biol, V4, P271; Emlet DR, 1997, J BIOL CHEM, V272, P4079, DOI 10.1074/jbc.272.7.4079; Fujioka A, 2006, J BIOL CHEM, V281, P8917, DOI 10.1074/jbc.M509344200; GOTOH N, 1994, P NATL ACAD SCI USA, V91, P167, DOI 10.1073/pnas.91.1.167; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Hatakeyama M, 2003, BIOCHEM J, V373, P451, DOI 10.1042/BJ20021824; Hendriks BS, 2003, J BIOL CHEM, V278, P23343, DOI 10.1074/jbc.M300477200; Holbrook MR, 1999, BIOCHEMISTRY-US, V38, P9348, DOI 10.1021/bi990195r; Jones RB, 2006, NATURE, V439, P168, DOI 10.1038/nature04177; Joughin BA, 2009, MOL BIOSYST, V5, P59, DOI 10.1039/b815075c; Kaushansky A, 2008, MOL BIOSYST, V4, P643, DOI 10.1039/b801018h; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Koh G, 2006, BIOINFORMATICS, V22, pE271, DOI 10.1093/bioinformatics/btl264; MATSUNO H, 2000, PAC S BIOC, V5, P341; MILARSKI KL, 1993, J BIOL CHEM, V268, P23634; Nagasaki Masao, 2006, Genome Inform, V17, P46; Nagasaki Masao, 2004, Genome Inform, V15, P180; Nakamura K, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P227; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oyama M, 2004, GENOME RES, V14, P2048, DOI 10.1101/gr.2384604; Oyama M, 2007, MOL CELL PROTEOMICS, V6, P1000, DOI 10.1074/mcp.M600297-MCP200; Oyama M, 2009, MOL CELL PROTEOMICS, V8, P226, DOI 10.1074/mcp.M800186-MCP200; Resat H, 2003, BIOPHYS J, V85, P730, DOI 10.1016/S0006-3495(03)74516-0; ROTIN D, 1992, EMBO J, V11, P559, DOI 10.1002/j.1460-2075.1992.tb05087.x; Saito A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-15; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Selvarajoo K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003430; Shankaran H, 2006, BIOPHYS J, V90, P3993, DOI 10.1529/biophysj.105.080580; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; SOLER C, 1993, J BIOL CHEM, V268, P22010; Tamas P, 2003, J BIOL CHEM, V278, P5163, DOI 10.1074/jbc.M207555200; Tasaki Shinya, 2006, Genome Inform, V17, P226; Thien CBF, 2001, NAT REV MOL CELL BIO, V2, P294, DOI 10.1038/35067100; Tong JF, 2009, MOL CELL PROTEOMICS, V8, P2131, DOI 10.1074/mcp.M900148-MCP200; TRONCALE S, 2006, PAC S BIOC, V11, P427; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Yoshida R, 2008, BIOINFORMATICS, V24, P2592, DOI 10.1093/bioinformatics/btn483; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	57	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13926	10.1371/journal.pone.0013926	http://dx.doi.org/10.1371/journal.pone.0013926			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085658	gold, Green Submitted, Green Published			2022-12-27	WOS:000284036800017
J	Wiley, MR; Roberts, LO; Adelman, ZN; Myles, KM				Wiley, Michael R.; Roberts, Lisa O.; Adelman, Zach N.; Myles, Kevin M.			Double Subgenomic Alphaviruses Expressing Multiple Fluorescent Proteins Using a Rhopalosiphum padi Virus Internal Ribosome Entry Site Element	PLOS ONE			English	Article							ONYONG-NYONG VIRUS; RNA INTERFERENCE; 5'-UNTRANSLATED REGION; GENE-EXPRESSION; MOSQUITO; VECTORS; REPLICATION; INFECTION; PLANT	Double subgenomic Sindbis virus (dsSINV) vectors are widely used for the expression of proteins, peptides, and RNA sequences. These recombinant RNA viruses permit high level expression of a heterologous sequence in a wide range of animals, tissues, and cells. However, the alphavirus genome structure and replication strategy is not readily amenable to the expression of more than one heterologous sequence. The Rhopalosiphum padi virus (RhPV) genome contains two internal ribosome entry site (IRES) elements that mediate cap-independent translation of the virus nonstructural and structural proteins. Most IRES elements that have been characterized function only in mammalian cells but previous work has shown that the IRES element present in the 5' untranslated region (UTR) of the RhPV genome functions efficiently in mammalian, insect, and plant systems. To determine if the 5' RhPV IRES element could be used to express more than one heterologous sequence from a dsSINV vector, RhPV 5' IRES sequences were placed between genes for two different fluorescent marker proteins in the dsSINV, TE/3'2J/mcs. While mammalian and insect cells infected with recombinant viruses containing the RhPV sequences expressed both fluorescent marker proteins, only single marker proteins were routinely observed in cells infected with dsSINV vectors in which the RhPV IRES had been replaced by a luciferase fragment, an antisense RhPV IRES, or no intergenic sequence. Thus, we report development of a versatile tool for the expression of multiple sequences in diverse cell types.	[Wiley, Michael R.; Adelman, Zach N.; Myles, Kevin M.] Virginia Tech, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [Roberts, Lisa O.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 5XH, Surrey, England	Virginia Polytechnic Institute & State University; University of Surrey	Wiley, MR (corresponding author), Virginia Tech, Dept Entomol, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	mylesk@vt.edu		Adelman, Zach/0000-0001-5901-7171; Wiley, Michael/0000-0001-6688-007X	National Institute of Allergy and Infectious Diseases [AI077726]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077726] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Grant Number AI077726 from National Institute of Allergy and Infectious Diseases. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2008, INSECT BIOCHEM MOLEC, V38, P705, DOI 10.1016/j.ibmb.2008.04.002; Attardo GM, 2003, P NATL ACAD SCI USA, V100, P13374, DOI 10.1073/pnas.2235649100; Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582; Brault AC, 2004, INSECT MOL BIOL, V13, P625, DOI 10.1111/j.0962-1075.2004.00521.x; Donnelly MLL, 2001, J GEN VIROL, V82, P1013, DOI 10.1099/0022-1317-82-5-1013; Frolov I, 1996, P NATL ACAD SCI USA, V93, P11371, DOI 10.1073/pnas.93.21.11371; Garoff H, 1998, CURR OPIN BIOTECH, V9, P464, DOI 10.1016/S0958-1669(98)80030-X; Groppelli E, 2007, J GEN VIROL, V88, P1583, DOI 10.1099/vir.0.82682-0; HAHN CS, 1992, P NATL ACAD SCI USA, V89, P2679, DOI 10.1073/pnas.89.7.2679; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Kamrud KI, 2007, VIROLOGY, V360, P376, DOI 10.1016/j.virol.2006.10.049; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Lundstrom K, 2005, GENE THER, V12, pS92, DOI 10.1038/sj.gt.3302620; Myles KM, 2006, J VIROL, V80, P4992, DOI 10.1128/JVI.80.10.4992-4997.2006; Olson KE, 1996, SCIENCE, V272, P884, DOI 10.1126/science.272.5263.884; Pijlman GP, 2006, J BIOTECHNOL, V123, P13, DOI 10.1016/j.jbiotec.2005.10.022; Pugachev KV, 2000, J VIROL, V74, P10811, DOI 10.1128/JVI.74.22.10811-10815.2000; Rayner JO, 2002, REV MED VIROL, V12, P279, DOI 10.1002/rmv.360; Roberts LO, 2009, PROG MOL BIOL TRANSL, V90, P313, DOI 10.1016/S1877-1173(09)90009-6; Royall E, 2004, J GEN VIROL, V85, P1565, DOI 10.1099/vir.0.79992-0; Schlesinger S, 2001, EXPERT OPIN BIOL TH, V1, P177, DOI 10.1517/14712598.1.2.177; Shiao SH, 2001, INSECT MOL BIOL, V10, P315, DOI 10.1046/j.0962-1075.2001.00268.x; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Strauss JH, 1990, SEMIN VIROL, V1, P347; Thomas JM, 2003, J VIROL, V77, P5598, DOI 10.1128/JVI.77.10.5598-5606.2003; Uhlirova M, 2003, P NATL ACAD SCI USA, V100, P15607, DOI 10.1073/pnas.2136837100; Volkova E, 2008, VIROLOGY, V377, P160, DOI 10.1016/j.virol.2008.04.020; Woolaway KE, 2001, J VIROL, V75, P10244, DOI 10.1128/JVI.75.21.10244-10249.2001	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13924	10.1371/journal.pone.0013924	http://dx.doi.org/10.1371/journal.pone.0013924			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085714	Green Published, gold, Green Submitted			2022-12-27	WOS:000284036800015
J	Yang, C; McCoy, K; Davis, JL; Schmidt-Supprian, M; Sasaki, Y; Faccio, R; Novack, DV				Yang, Chang; McCoy, Kathleen; Davis, Jennifer L.; Schmidt-Supprian, Marc; Sasaki, Yoshiteru; Faccio, Roberta; Novack, Deborah Veis			NIK Stabilization in Osteoclasts Results in Osteoporosis and Enhanced Inflammatory Osteolysis	PLOS ONE			English	Article							NF-KAPPA-B; ALPHA-DEPENDENT APOPTOSIS; TUMOR-NECROSIS-FACTOR; CELL-DIFFERENTIATION; MULTIPLE-MYELOMA; MICE; ACTIVATION; PATHWAY; INDUCTION; LIGAND	Background: Maintenance of healthy bone requires the balanced activities of osteoclasts (OCs), which resorb bone, and osteoblasts, which build bone. Disproportionate action of OCs is responsible for the bone loss associated with postmenopausal osteoporosis and rheumatoid arthritis. NF-kappa B inducing kinase (NIK) controls activation of the alternative NF-kappa B pathway, a critical pathway for OC differentiation. Under basal conditions, TRAF3-mediated NIK degradation prevents downstream signaling, and disruption of the NIK: TRAF3 interaction stabilizes NIK leading to constitutive activation of the alternative NF-kappa B pathway. Methodology/Principal Findings: Using transgenic mice with OC-lineage expression of NIK lacking its TRAF3 binding domain (NT3), we now find that alternative NF-kappa B activation enhances not only OC differentiation but also OC function. Activating NT3 with either lysozyme M Cre or cathepsinK Cre causes high turnover osteoporosis with increased activity of OCs and osteoblasts. In vitro, NT3-expressing precursors form OCs more quickly and at lower doses of RANKL. When cultured on bone, they exhibit larger actin rings and increased resorptive activity. OC-specific NT3 transgenic mice also have an exaggerated osteolytic response to the serum transfer model of arthritis. Conclusions: Constitutive activation of NIK drives enhanced osteoclastogenesis and bone resorption, both in basal conditions and in response to inflammatory stimuli.	[Yang, Chang; McCoy, Kathleen; Davis, Jennifer L.; Novack, Deborah Veis] Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA; [Novack, Deborah Veis] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA; [Faccio, Roberta] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO 63110 USA; [Schmidt-Supprian, Marc] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Sasaki, Yoshiteru] RIKEN Ctr Dev Biol, Kobe, Hyogo, Japan	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Max Planck Society; RIKEN	Yang, C (corresponding author), Washington Univ, Sch Med, Dept Med, Div Bone & Mineral Dis, St Louis, MO 63110 USA.	novack@wustl.edu	Schmidt-Supprian, Marc/F-5893-2011	Schmidt-Supprian, Marc/0000-0002-8543-6166; Novack, Deborah/0000-0001-7101-5582	National Institutes of Health (NIH) [AR052705, EB007568, AR52921, 63181]; Barnes-Jewish Foundation; Children's Discovery Institute; Arthritis Foundation; Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [AR057235]; NATIONAL CANCER INSTITUTE [T32CA113275] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053628, R01AR052705, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB007568] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barnes-Jewish Foundation; Children's Discovery Institute; Arthritis Foundation; Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was supported by the National Institutes of Health (NIH), grant numbers AR052705 and EB007568 (DVN) and AR52921 and 63181 (RF), the Barnes-Jewish Foundation (DVN), the Children's Discovery Institute (RF and DVN), and the Arthritis Foundation (RF). Histological and microCT analysis was supported in part by the Washington University Center for Musculoskeletal Research NIH/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), grant number AR057235. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman MJ, 2000, MOL CELL BIOL, V20, P3576, DOI 10.1128/MCB.20.10.3576-3589.2000; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Aya K, 2005, J CLIN INVEST, V115, P1848, DOI 10.1172/JCI23763; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Fazal F, 2009, J BIOL CHEM, V284, P21047, DOI 10.1074/jbc.M109.016444; Foehr ED, 2000, J BIOL CHEM, V275, P34021, DOI 10.1074/jbc.C000507200; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Iwasawa M, 2009, J CLIN INVEST, V119, P3149, DOI 10.1172/JCI39819; Jin W, 2009, BLOOD, V113, P6603, DOI 10.1182/blood-2008-12-192914; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Kim HJ, 2006, J CLIN INVEST, V116, P2152, DOI 10.1172/JCI28084; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kustermans G, 2005, BIOCHEM J, V387, P531, DOI 10.1042/BJ20041318; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Nadiminty N, 2007, BIOCHEM BIOPH RES CO, V359, P379, DOI 10.1016/j.bbrc.2007.05.119; Nakamura T, 2007, CELL, V130, P811, DOI 10.1016/j.cell.2007.07.025; Novack DV, 2008, ANNU REV PATHOL-MECH, V3, P457, DOI 10.1146/annurev.pathmechdis.3.121806.151431; Novack DV, 2003, J EXP MED, V198, P771, DOI 10.1084/jem.20030116; NOVACK DV, 2009, AGEING RES REV; Otero JE, 2008, J BIOL CHEM, V283, P24546, DOI 10.1074/jbc.M800434200; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Vaira S, 2008, J CLIN INVEST, V118, P2088, DOI 10.1172/JCI33392; Vaira S, 2008, P NATL ACAD SCI USA, V105, P3897, DOI 10.1073/pnas.0708576105; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; YAMADA H, 1991, BLOOD, V78, P1988; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676	34	103	118	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15383	10.1371/journal.pone.0015383	http://dx.doi.org/10.1371/journal.pone.0015383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21151480	Green Published, gold, Green Submitted			2022-12-27	WOS:000283920000021
J	Chattopadhyay, R; Velmurugan, S; Chakiath, C; Donkor, LA; Milhous, W; Barnwell, JW; Collins, WE; Hoffman, SL				Chattopadhyay, Rana; Velmurugan, Soundarapandian; Chakiath, Chinnamma; Donkor, Lucy Andrews; Milhous, Wilbur; Barnwell, John W.; Collins, William E.; Hoffman, Stephen L.			Establishment of an In Vitro Assay for Assessing the Effects of Drugs on the Liver Stages of Plasmodium vivax Malaria	PLOS ONE			English	Article							EXOERYTHROCYTIC PARASITES; MOLECULAR ANALYSIS; PRIMAQUINE; RELAPSES; HYPNOZOITES; ANTIBODIES; FALCIPARUM; CULTURE; VACCINE; STRAIN	Plasmodium vivax (Pv) is the second most important human malaria parasite. Recent data indicate that the impact of Pv malaria on the health and economies of the developing world has been dramatically underestimated. Pv has a unique feature in its life cycle. Uninucleate sporozoites (spz), after invasion of human hepatocytes, either proceed to develop into tens of thousands of merozoites within the infected hepatocytes or remain as dormant forms called hypnozoites, which cause relapses of malaria months to several years after the primary infection. Elimination of malaria caused by Pv will be facilitated by developing a safe, highly effective drug that eliminates Pv liver stages, including hypnozoites. Identification and development of such a drug would be facilitated by the development of a medium to high throughput assay for screening drugs against Pv liver stages. We undertook the present pilot study to (1) assess the feasibility of producing large quantities of purified, vialed, cryopreserved Pv sporozoites and (2) establish a system for culturing the liver stages of Pv in order to assess the effects of drugs on the liver stages of Pv. We used primaquine (PQ) to establish this assay model, because PQ is the only licensed drug known to clear all Pv hepatocyte stages, including hypnozoites, and the effect of PQ on Pv hepatocyte stage development in vitro has not previously been reported. We report that we have established the capacity to reproducibly infect hepatoma cells with purified, cyropreserved Pv spz from the same lot, quantitate the primary outcome variable of infected hepatoma cells and demonstrate the inhibitory activity of primaquine on the infected hepatoma cells. We have also identified small parasite forms that may be hypnozoites. These data provide the foundation for finalizing a medium throughput, high content assay to identify new drugs for the elimination of all Pv liver stages.	[Chattopadhyay, Rana; Velmurugan, Soundarapandian; Chakiath, Chinnamma; Donkor, Lucy Andrews; Hoffman, Stephen L.] Sanaria Inc, Rockville, MD USA; [Milhous, Wilbur] Walter Reed Army Inst Res, Silver Spring, MD USA; [Barnwell, John W.; Collins, William E.] Ctr Dis Control & Prevent, CDC NCID Malaria Branch, Natl Ctr Infect Dis, Chamblee, GA USA	Sanaria Inc.; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Centers for Disease Control & Prevention - USA	Chattopadhyay, R (corresponding author), Sanaria Inc, Rockville, MD USA.	slhoffman@sanaria.com	Murugan, Vel/AAX-9679-2020; Murugan, Vel/AAA-3554-2019	Murugan, Vel/0000-0002-7368-7742; 	Sanaria; Medicine for Malaria Venture	Sanaria; Medicine for Malaria Venture	Funding for this project was provided by a grant by Sanaria (www.sanaria.com) and Medicine for Malaria Venture (www.mmv.org). Sanaria, a for-profit organization, played a critical role in design, execution, analysis and publication of this work. MMV, a not-for-profit public-private partnership, participated in study design, but had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY SB, 1987, EXP PARASITOL, V64, P188, DOI 10.1016/0014-4894(87)90142-1; Baird JK, 2004, CLIN INFECT DIS, V39, P1336, DOI 10.1086/424663; BATES MD, 1990, AM J TROP MED HYG, V42, P532, DOI 10.4269/ajtmh.1990.42.532; CHAROENVIT Y, 1991, SCIENCE, V251, P668, DOI 10.1126/science.1704150; Chen NH, 2007, J INFECT DIS, V195, P934, DOI 10.1086/512242; Craig AA, 1996, J INFECT DIS, V174, P373, DOI 10.1093/infdis/174.2.373; Fernandez-Becerra C, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-55; FISK TL, 1989, AM J TROP MED HYG, V40, P235, DOI 10.4269/ajtmh.1989.40.235; Hoffman SL, 2010, HUM VACCINES, V6, P97, DOI 10.4161/hv.6.1.10396; HOLLINGDALE MR, 1986, AM J TROP MED HYG, V35, P275, DOI 10.4269/ajtmh.1986.35.275; HOLLINGDALE MR, 1985, AM J TROP MED HYG, V34, P216, DOI 10.4269/ajtmh.1985.34.216; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Kirchgatter K, 1998, J INFECT DIS, V177, P511, DOI 10.1086/517389; Kitchener S, 2007, AM J TROP MED HYG, V76, P494, DOI 10.4269/ajtmh.2007.76.494; Kochar DK, 2009, AM J TROP MED HYG, V80, P194, DOI 10.4269/ajtmh.2009.80.194; KROTOSKI WA, 1982, AM J TROP MED HYG, V31, P1291, DOI 10.4269/ajtmh.1982.31.1291; KROTOSKI WA, 1985, T ROY SOC TROP MED H, V79, P1, DOI 10.1016/0035-9203(85)90221-4; MAZIER D, 1984, NATURE, V307, P367, DOI 10.1038/307367a0; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Roberts L, 2008, SCIENCE, V322, P26, DOI 10.1126/science.322.5898.26; Sattabongkot J, 2006, AM J TROP MED HYG, V74, P708, DOI 10.4269/ajtmh.2006.74.708; Sharma A, 2009, J VECTOR DIS, V46, P141; Sina Barbara, 2002, Trends in Parasitology, V18, P287, DOI 10.1016/S1471-4922(02)02329-2; Smoak BL, 1997, AM J TROP MED HYG, V56, P231, DOI 10.4269/ajtmh.1997.56.231; Sullivan JS, 2001, J PARASITOL, V87, P1398, DOI 10.1645/0022-3395(2001)087[1398:AOASOP]2.0.CO;2; Tjitra E, 2008, PLOS MED, V5, P890, DOI 10.1371/journal.pmed.0050128; World Health Organization, 2008, WORLD MAL REP	28	48	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14275	10.1371/journal.pone.0014275	http://dx.doi.org/10.1371/journal.pone.0014275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151554	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800008
J	Garcia-Faroldi, G; Rodriguez, CE; Urdiales, JL; Perez-Pomares, JM; Davilla, JC; Pejler, G; Sanchez-Jimenez, F; Fajardo, I				Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Perez-Pomares, Jose M.; Davilla, Jose C.; Pejler, Gunnar; Sanchez-Jimenez, Francisca; Fajardo, Ignacio			Polyamines Are Present in Mast Cell Secretory Granules and Are Important for Granule Homeostasis	PLOS ONE			English	Article							MAJOR VAULT PROTEIN; ORNITHINE-DECARBOXYLASE; SERGLYCIN PROTEOGLYCAN; MAMMALIAN-CELLS; GENE-EXPRESSION; ALBUMIN UPTAKE; STORAGE; KINASE; PROTEASES; RECEPTOR	Background: Mast cell secretory granules accommodate a large number of components, many of which interact with highly sulfated serglycin proteoglycan (PG) present within the granules. Polyamines (putrescine, spermidine and spermine) are absolutely required for the survival of the vast majority of living cells. Given the reported ability of polyamines to interact with PGs, we investigated the possibility that polyamines may be components of mast cell secretory granules. Methodology/Principal Findings: Spermidine was released by mouse bone marrow derived mast cells (BMMCs) after degranulation induced by IgE/anti-IgE or calcium ionophore A23187. Additionally, both spermidine and spermine were detected in isolated mouse mast cell granules. Further, depletion of polyamines by culturing BMMCs with alpha-difluoromethylomithine (DFMO) caused aberrant secretory granule ultrastructure, impaired histamine storage, reduced serotonin levels and increased beta-hexosaminidase content. A proteomic approach revealed that DFMO-induced polyamine depletion caused an alteration in the levels of a number of proteins, many of which are connected either with the regulated exocytosis or with the endocytic system. Conclusions/Significance: Taken together, our results show evidence that polyamines are present in mast cell secretory granules and, furthermore, indicate an essential role of these polycations during the biogenesis and homeostasis of these organelles.	[Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Sanchez-Jimenez, Francisca; Fajardo, Ignacio] Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain; [Garcia-Faroldi, Gianni; Rodriguez, Carlos E.; Urdiales, Jose L.; Sanchez-Jimenez, Francisca; Fajardo, Ignacio] Univ Malaga, Fac Sci, CIBER ER, E-29071 Malaga, Spain; [Perez-Pomares, Jose M.] Univ Malaga, Fac Sci, Dept Anim Biol, E-29071 Malaga, Spain; [Davilla, Jose C.] Univ Malaga, Fac Sci, Dept Cell Biol Genet & Physiol, E-29071 Malaga, Spain; [Pejler, Gunnar] Swedish Univ Agr Sci, Uppsala Biomed Ctr BMC, Dept Anat Physiol & Biochem, Uppsala, Sweden	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; Swedish University of Agricultural Sciences; Uppsala University	Garcia-Faroldi, G (corresponding author), Univ Malaga, Fac Sci, Dept Mol Biol & Biochem, E-29071 Malaga, Spain.	ifajardo@uma.es	Urdiales, José Luis/K-1125-2014; Jiménez, Francisca María Sánchez/H-2513-2015; Rodríguez, Carlos/AAJ-6122-2020; Perez-Pomares, Jose/G-7885-2015; Fajardo, Ignacio/L-2943-2014	Urdiales, José Luis/0000-0002-2519-9293; Jiménez, Francisca María Sánchez/0000-0002-4958-6060; Rodríguez, Carlos/0000-0002-6831-0588; Perez-Pomares, Jose/0000-0001-5487-7252; Fajardo, Ignacio/0000-0001-6676-7579; Davila Cansino, Jose Carlos/0000-0001-7016-288X	Ministerio de Ciencia e Innovacion, Spain [SAF2008-02522]; Junta de Andalucia, Spain [P07-CVI-02999, BIO-267]; Fundacion Ramon Areces (Spain); European Union (EU)	Ministerio de Ciencia e Innovacion, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia, Spain(Junta de AndaluciaEuropean Commission); Fundacion Ramon Areces (Spain); European Union (EU)(CGIAREuropean Commission)	This work was supported by grants SAF2008-02522 (Ministerio de Ciencia e Innovacion, Spain), P07-CVI-02999 and BIO-267 group (Junta de Andalucia, Spain) and funds provided by Fundacion Ramon Areces (Spain). It was also helped by the European Cooperation in Science and Technology (COST) Action BM0806, supported by the European Union (EU) Framework Programme for Research and Technological Development (RTD). The CIBER-ER is an initiative of the Instituto de Salud Carlos III (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrink M, 2004, J BIOL CHEM, V279, P40897, DOI 10.1074/jbc.M405856200; AMENDE LM, 1985, BIOCHIM BIOPHYS ACTA, V812, P713, DOI 10.1016/0005-2736(85)90265-2; Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200; Belting M, 2002, P NATL ACAD SCI USA, V99, P371, DOI 10.1073/pnas.012346499; Belting M, 1996, GLYCOBIOLOGY, V6, P121, DOI 10.1093/glycob/6.2.121; Berger W, 2009, CELL MOL LIFE SCI, V66, P43, DOI 10.1007/s00018-008-8364-z; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Braga T, 2007, BIOCHEM J, V403, P49, DOI 10.1042/BJ20061257; Braga T, 2009, MOL IMMUNOL, V46, P422, DOI 10.1016/j.molimm.2008.10.019; BRAND K, 1987, J BIOL CHEM, V262, P15232; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Cao TT, 1999, NATURE, V401, P286, DOI 10.1038/45816; Childs AC, 2003, CELL MOL LIFE SCI, V60, P1394, DOI 10.1007/s00018-003-2332-4; Cohen S.S., 1998, GUIDE POLYAMINES, V1st ed.; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; DEYOUNG MB, 1987, ARCH BIOCHEM BIOPHYS, V254, P222, DOI 10.1016/0003-9861(87)90098-1; Diaz E, 1998, CELL, V93, P433, DOI 10.1016/S0092-8674(00)81171-X; Espinosa EJ, 2009, CELL, V137, P938, DOI 10.1016/j.cell.2009.03.043; Fajardo I, 2001, BIOCHEM PHARMACOL, V61, P1101, DOI 10.1016/S0006-2952(01)00567-6; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158; Garcia-Faroldi G, 2009, J CELL BIOCHEM, V108, P261, DOI 10.1002/jcb.22246; Gross B, 2002, EUR J IMMUNOL, V32, P1121; Henningsson F, 2002, BIOL CHEM, V383, P793, DOI 10.1515/BC.2002.083; Henningsson F, 2006, FEBS J, V273, P4901, DOI 10.1111/j.1742-4658.2006.05489.x; Herlevsen M, 2007, MOL CANCER THER, V6, P1804, DOI 10.1158/1535-7163.MCT-06-0372; Hryciw DH, 2006, J BIOL CHEM, V281, P16068, DOI 10.1074/jbc.M512559200; Hryciw DH, 2005, AM J PHYSIOL-RENAL, V288, pF1227, DOI 10.1152/ajprenal.00428.2003; Hryciw DH, 2003, J BIOL CHEM, V278, P40169, DOI 10.1074/jbc.M307890200; Humphries DE, 1999, NATURE, V400, P769, DOI 10.1038/23481; Hyvonen MT, 2007, BIOCHEM SOC T, V35, P326, DOI 10.1042/BST0350326; Kanerva K, 2010, EXP CELL RES, V316, P1896, DOI 10.1016/j.yexcr.2010.02.021; Kanerva K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006858; Kim JY, 2008, INT ARCH ALLERGY IMM, V146, P287, DOI 10.1159/000121463; Kowalski MP, 2007, SCIENCE, V317, P130, DOI 10.1126/science.1142311; KRUGER PG, 1980, EXP CELL RES, V129, P83, DOI 10.1016/0014-4827(80)90333-X; KUROSAWA M, 1989, J ALLERGY CLIN IMMUN, V84, P118, DOI 10.1016/0091-6749(89)90185-1; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Liu WH, 2002, ANAL BIOCHEM, V302, P52, DOI 10.1006/abio.2001.5530; Medina MA, 2003, CRIT REV BIOCHEM MOL, V38, P23, DOI 10.1080/713609209; METCALF BW, 1978, J AM CHEM SOC, V100, P2551, DOI 10.1021/ja00476a050; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Pejler G, 2009, BIOFACTORS, V35, P61, DOI 10.1002/biof.11; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573; Ringvall M, 2008, J ALLERGY CLIN IMMUN, V121, P1020, DOI 10.1016/j.jaci.2007.11.031; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiz-Chica J, 2001, BIOCHEM BIOPH RES CO, V285, P437, DOI 10.1006/bbrc.2001.5192; Ryu H, 2008, BRIT J PHARMACOL, V154, P1035, DOI 10.1038/bjp.2008.148; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Secor VH, 2000, J EXP MED, V191, P813, DOI 10.1084/jem.191.5.813; SEILER N, 1990, INT J BIOCHEM, V22, P211, DOI 10.1016/0020-711X(90)90332-W; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Soucek L, 2007, NAT MED, V13, P1211, DOI 10.1038/nm1649; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; STEVENS RL, 1989, IMMUNOL TODAY, V10, P381, DOI 10.1016/0167-5699(89)90272-7; Sun JS, 2007, NAT MED, V13, P719, DOI 10.1038/nm1601; Tchougounova E, 2003, J EXP MED, V198, P423, DOI 10.1084/jem.20030671; Yu M, 2006, J CLIN INVEST, V116, P1633, DOI 10.1172/JCI25702	60	47	49	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15071	10.1371/journal.pone.0015071	http://dx.doi.org/10.1371/journal.pone.0015071			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151498	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100059
J	Moustafa, DA; Jain, N; Sriranganathan, N; Vemulapalli, R				Moustafa, Dina A.; Jain, Neeta; Sriranganathan, Nammalwar; Vemulapalli, Ramesh			Identification of a Single-Nucleotide Insertion in the Promoter Region Affecting the sodC Promoter Activity in Brucella neotomae	PLOS ONE			English	Article							ZN SUPEROXIDE-DISMUTASE; VOLE MICROTUS-ARVALIS; ABORTUS STRAIN RB51; ESCHERICHIA-COLI; IMMUNE-RESPONSES; B-ABORTUS; EXPRESSION; MICE; VIRULENCE; CLONING	Brucella neotomae is not known to be associated with clinical disease in any host species. Previous research suggested that B. neotomae might not express detectable levels of Cu/Zn superoxide dismutase ( SOD), a periplasmic enzyme known to be involved in protecting Brucella from oxidative bactericidal effects of host phagocytes. This study was undertaken to investigate the genetic basis for the disparity in SOD expression in B. neotomae. Our Western blot and SOD enzyme assay analyses indicated that B. neotomae does express SOD, but at a substantially reduced level. Nucleotide sequence analysis of region upstream to the sodC gene identified a single-nucleotide insertion in the potential promoter region. The same single-nucleotide insertion was also detected in the sodC promoter of B. suis strain Thomsen, belonging to biovar 2 in which SOD expression was undetectable previously. Examination of the sodC promoter activities using translational fusion constructs with E. coli beta-galactosidase demonstrated that the B. neotomae and B. suis biovar 2 promoters were very weak in driving gene expression. Site-directed mutation studies indicated that the insertion of A in the B. neotomae sodC promoter reduced the promoter activity. Increasing the level of SOD expression in B. neotomae through complementation with B. abortus sodC gene did not alter the bacterial survival in J774A.1 macrophage-like cells and in tissues of BALB/c and C57BL/6 mice. These results for the first time demonstrate the occurrence of a single-nucleotide polymorphism affecting promoter function and gene expression in Brucella.	[Moustafa, Dina A.; Vemulapalli, Ramesh] Purdue Univ, Dept Comparat Pathobiol, Indiana, PA USA; [Jain, Neeta; Sriranganathan, Nammalwar] Virginia Tech, Dept Biomed Sci & Pathobiol, Blacksburg, VA USA	Purdue University System; Purdue University; Virginia Polytechnic Institute & State University	Moustafa, DA (corresponding author), Purdue Univ, Dept Comparat Pathobiol, Indiana, PA USA.	rvemulap@purdue.edu		Vemulapalli, Ramesh/0000-0002-2473-2906	Egyptian Cultural and Educational Bureau	Egyptian Cultural and Educational Bureau(Egyptian Cultural & Educational Bureau)	Dina Moustafa's PhD program was supported by a fellowship from Egyptian Cultural and Educational Bureau. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAL GA, 1959, AM J VET RES, V20, P872; BECK BL, 1990, BIOCHEMISTRY-US, V29, P372, DOI 10.1021/bi00454a010; BENOV LT, 1994, J BIOL CHEM, V269, P25310; BRICKER BJ, 1990, INFECT IMMUN, V58, P2935, DOI 10.1128/IAI.58.9.2935-2939.1990; Celli J, 2006, RES MICROBIOL, V157, P93, DOI 10.1016/j.resmic.2005.10.002; Corbel MJ, 1997, EMERG INFECT DIS, V3, P213, DOI 10.3201/eid0302.970219; Cutler SJ, 2005, J APPL MICROBIOL, V98, P1270, DOI 10.1111/j.1365-2672.2005.02622.x; Foster G, 2007, INT J SYST EVOL MICR, V57, P2688, DOI 10.1099/ijs.0.65269-0; Gee JM, 2005, INFECT IMMUN, V73, P2873, DOI 10.1128/IAI.73.5.2873-2880.2005; Godfroid J, 2005, VET RES, V36, P313, DOI 10.1051/vetres:2005003; Gort AS, 1999, MOL MICROBIOL, V32, P179, DOI 10.1046/j.1365-2958.1999.01343.x; Gronewold TMA, 2007, J BACTERIOL, V189, P1836, DOI 10.1128/JB.01618-06; Hengge-Aronis R, 2004, BULLETIN OF THE INTERNATIONAL DAIRY FEDERATION NO 392/2004, P31; Hubalek Z, 2007, VECTOR-BORNE ZOONOT, V7, P679, DOI 10.1089/vbz.2007.0143; Korshunov SS, 2002, MOL MICROBIOL, V43, P95, DOI 10.1046/j.1365-2958.2002.02719.x; McQuiston J R, 1995, Methods Mol Biol, V47, P143; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Muffler A, 1997, J BACTERIOL, V179, P445; Onate AA, 1999, INFECT IMMUN, V67, P986; Roop RM, 2003, ANNU REV MICROBIOL, V57, P57, DOI 10.1146/annurev.micro.57.030502.090803; Scholz HC, 2008, INT J SYST EVOL MICR, V58, P375, DOI 10.1099/ijs.0.65356-0; Seleem MN, 2004, BIOTECHNIQUES, V37, P740, DOI 10.2144/04375BM05; STABEL TJ, 1994, VET MICROBIOL, V38, P307, DOI 10.1016/0378-1135(94)90149-X; Stermann M, 2004, J BACTERIOL, V186, P2856, DOI 10.1128/JB.186.9.2856-2861.2004; STOENNER HG, 1963, AM J VET RES, V24, P376; STOENNER HG, 1957, AM J VET RES, V18, P947; TATUM FM, 1992, INFECT IMMUN, V60, P2863, DOI 10.1128/IAI.60.7.2863-2869.1992; Vemulapalli R, 1999, CLIN DIAGN LAB IMMUN, V6, P760, DOI 10.1128/CDLI.6.5.760-764.1999; Vemulapalli R, 2000, INFECT IMMUN, V68, P3286, DOI 10.1128/IAI.68.6.3286-3289.2000; Vemulapalli R, 1998, INFECT IMMUN, V66, P5684, DOI 10.1128/IAI.66.12.5684-5691.1998; Vemullpalli R, 2000, INFECT IMMUN, V68, P3290, DOI 10.1128/IAI.68.6.3290-3296.2000; WISE DJ, 1998, NETWORKING BRUCELLOS, V2	32	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14112	10.1371/journal.pone.0014112	http://dx.doi.org/10.1371/journal.pone.0014112			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124845	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000013
J	Kim, HM; Wangemann, P				Kim, Hyoung-Mi; Wangemann, Philine			Failure of Fluid Absorption in the Endolymphatic Sac Initiates Cochlear Enlargement that Leads to Deafness in Mice Lacking Pendrin Expression	PLOS ONE			English	Article							NONSYNDROMIC HEARING IMPAIRMENT; GENOTYPE-PHENOTYPE CORRELATION; KCNJ10 PROTEIN EXPRESSION; NA+-H+ EXCHANGER; INNER-EAR; SENSORY TRANSDUCTION; GUINEA-PIG; DEVELOPMENTAL ACQUISITION; CONGENITAL DEAFNESS; VESTIBULAR AQUEDUCT	Mutations of SLC26A4 are among the most prevalent causes of hereditary deafness. Deafness in the corresponding mouse model, Slc26a4(-/-), results from an abnormally enlarged cochlear lumen. The goal of this study was to determine whether the cochlear enlargement originates with defective cochlear fluid transport or with a malfunction of fluid transport in the connected compartments, which are the vestibular labyrinth and the endolymphatic sac. Embryonic inner ears from Slc26a4(+/-) and Slc26a4(-/-) mice were examined by confocal microscopy ex vivo or after 2 days of organ culture. Culture allowed observations of intact, ligated or partially resected inner ears. Cochlear lumen formation was found to begin at the base of the cochlea between embryonic day (E) 13.5 and 14.5. Enlargement was immediately evident in Slc26a4(-/-) compared to Slc26a4(+/-) mice. In Slc26a4(+/-) and Slc26a4(-/-) mice, separation of the cochlea from the vestibular labyrinth by ligation at E14.5 resulted in a reduced cochlear lumen. Resection of the endolymphatic sacs at E14.5 led to an enlarged cochlear lumen in Slc26a4(+/-) mice but caused no further enlargement of the already enlarged cochlear lumen in Slc26a4(-/-) mice. Ligation or resection performed later, at E17.5, did not alter the cochlea lumen. In conclusion, the data suggest that cochlear lumen formation is initiated by fluid secretion in the vestibular labyrinth and temporarily controlled by fluid absorption in the endolymphatic sac. Failure of fluid absorption in the endolymphatic sac due to lack of Slc26a4 expression appears to initiate cochlear enlargement in mice, and possibly humans, lacking functional Slc26a4 expression.	[Kim, Hyoung-Mi; Wangemann, Philine] Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA	Kansas State University	Kim, HM (corresponding author), Kansas State Univ, Dept Anat & Physiol, Manhattan, KS 66506 USA.	wange@vet.ksu.edu	Wangemann, Philine/N-2826-2013		NIH [R01 DC01098, R01 DC00212, P20 RR017686]; SMILE-Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC001098, R01DC000212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SMILE-Kansas State University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	NIH R01 DC01098; NIH R01 DC00212; NIH P20 RR017686; SMILE-Kansas State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert S, 2006, EUR J HUM GENET, V14, P773, DOI 10.1038/sj.ejhg.5201611; AMANO H, 1983, ARCH OTO-RHINO-LARYN, V237, P273, DOI 10.1007/BF00453732; Campos-Barros A, 2000, P NATL ACAD SCI USA, V97, P1287, DOI 10.1073/pnas.97.3.1287; Choi BY, 2009, HUM MUTAT, V30, P599, DOI 10.1002/humu.20884; Colvin IB, 2006, LARYNGOSCOPE, V116, P2027, DOI 10.1097/01.mlg.0000240908.88759.fe; Couloigner V, 1998, LARYNGOSCOPE, V108, P592, DOI 10.1097/00005537-199804000-00024; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; DEOL MS, 1973, J MED GENET, V10, P235, DOI 10.1136/jmg.10.3.235; Dou HW, 2004, J HISTOCHEM CYTOCHEM, V52, P1377, DOI 10.1369/jhc.3A6228.2004; Everett LA, 2001, HUM MOL GENET, V10, P153, DOI 10.1093/hmg/10.2.153; Everett LA, 1999, P NATL ACAD SCI USA, V96, P9727, DOI 10.1073/pnas.96.17.9727; FRASER GR, 1965, ANN HUM GENET, V28, P201; Geleoc GSG, 2003, NAT NEUROSCI, V6, P1019, DOI 10.1038/nn1120; Grunder S, 2001, EUR J NEUROSCI, V13, P641, DOI 10.1046/j.1460-9568.2001.01426.x; HARVEY BJ, 1992, J EXP BIOL, V172, P289; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; KIMURA RS, 1967, ANN OTO RHINOL LARYN, V76, P664, DOI 10.1177/000348946707600311; Lelli A, 2009, J NEUROPHYSIOL, V101, P2961, DOI 10.1152/jn.00136.2009; LUNDQUIST P G, 1964, Acta Otolaryngol, V57, P65, DOI 10.3109/00016486409136947; Luxon LM, 2003, INT J AUDIOL, V42, P82, DOI 10.3109/14992020309078339; MANSOUR SL, 2005, SPRINGER HDB AUDITOR, P43; MORI N, 1987, ARCH OTO-RHINO-LARYN, V244, P61, DOI 10.1007/BF00453493; Mori N, 1996, PFLUG ARCH EUR J PHY, V433, P58, DOI 10.1007/s004240050248; Nakaya K, 2007, AM J PHYSIOL-RENAL, V292, pF1314, DOI 10.1152/ajprenal.00432.2006; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Park HJ, 2003, J MED GENET, V40, P242, DOI 10.1136/jmg.40.4.242; Reardon W, 1997, QJM-MON J ASSOC PHYS, V90, P443, DOI 10.1093/qjmed/90.7.443; Royaux IE, 2003, JARO-J ASSOC RES OTO, V4, P394, DOI 10.1007/s10162-002-3052-4; Rueda J, 2003, NEUROSCI RES, V45, P401, DOI 10.1016/S0168-0102(03)00009-9; RUGH R, 1968, MOUSE ITS REPROD DEV; Shcheynikov N, 2008, J PHYSIOL-LONDON, V586, P3813, DOI 10.1113/jphysiol.2008.154468; Singh R, 2008, AM J PHYSIOL-RENAL, V294, pF139, DOI 10.1152/ajprenal.00433.2007; Son EJ, 2009, J CELL BIOCHEM, V107, P965, DOI 10.1002/jcb.22201; Stankovic KM, 1997, HEARING RES, V114, P21, DOI 10.1016/S0378-5955(97)00072-5; Suzuki H, 2007, ACTA OTO-LARYNGOL, V127, P1292, DOI 10.1080/00016480701258739; TENCATE WJF, 1994, ORL J OTO-RHINO-LARY, V56, P257; Theiler K., 1972, HOUSE MOUSE; VANDEWATER TR, 1973, ANN OTOLRHINOLLARY S, V82, P21; Wangemann P, 2007, AM J PHYSIOL-RENAL, V292, pF1345, DOI 10.1152/ajprenal.00487.2006; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Wangemann P, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-30; Wangemann P, 2009, AM J PHYSIOL-RENAL, V297, pF1435, DOI 10.1152/ajprenal.00011.2009; Wu DZ, 1998, PFLUG ARCH EUR J PHY, V436, P182, DOI 10.1007/s004240050621; Yamasaki M, 2000, ORL J OTO-RHINO-LARY, V62, P241, DOI 10.1159/000027753; Yuan Y, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-79	46	81	83	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14041	10.1371/journal.pone.0014041	http://dx.doi.org/10.1371/journal.pone.0014041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103348	Green Submitted, Green Published, gold			2022-12-27	WOS:000284327800019
J	Gusev, O; Nakahara, Y; Vanyagina, V; Malutina, L; Cornette, R; Sakashita, T; Hamada, N; Kikawada, T; Kobayashi, Y; Okuda, T				Gusev, Oleg; Nakahara, Yuichi; Vanyagina, Veronica; Malutina, Ludmila; Cornette, Richard; Sakashita, Tetsuya; Hamada, Nobuyuki; Kikawada, Takahiro; Kobayashi, Yasuhiko; Okuda, Takashi			Anhydrobiosis-Associated Nuclear DNA Damage and Repair in the Sleeping Chironomid: Linkage with Radioresistance	PLOS ONE			English	Article							RADIATION TOLERANCE; POLYPEDILUM-VANDERPLANKI; CHROMATIN-STRUCTURE; BDELLOID ROTIFERS; OXIDATIVE STRESS; ANTARCTIC MIDGE; HEAT-SHOCK; DEHYDRATION; TREHALOSE; APOPTOSIS	Anhydrobiotic chironomid larvae can withstand prolonged complete desiccation as well as other external stresses including ionizing radiation. To understand the cross-tolerance mechanism, we have analyzed the structural changes in the nuclear DNA using transmission electron microscopy and DNA comet assays in relation to anhydrobiosis and radiation. We found that dehydration causes alterations in chromatin structure and a severe fragmentation of nuclear DNA in the cells of the larvae despite successful anhydrobiosis. Furthermore, while the larvae had restored physiological activity within an hour following rehydration, nuclear DNA restoration typically took 72 to 96 h. The DNA fragmentation level and the recovery of DNA integrity in the rehydrated larvae after anhydrobiosis were similar to those of hydrated larvae irradiated with 70 Gy of high-linear energy transfer (LET) ions (He-4). In contrast, low-LET radiation (gamma-rays) of the same dose caused less initial damage to the larvae, and DNA was completely repaired within within 24 h. The expression of genes encoding the DNA repair enzymes occurred upon entering anhydrobiosis and exposure to high-and low-LET radiations, indicative of DNA damage that includes double-strand breaks and their subsequent repair. The expression of antioxidant enzymes-coding genes was also elevated in the anhydrobiotic and the gamma-ray-irradiated larvae that probably functions to reduce the negative effect of reactive oxygen species upon exposure to these stresses. Indeed the mature antioxidant proteins accumulated in the dry larvae and the total activity of antioxidants increased by a 3-4 fold in association with anhydrobiosis. We conclude that one of the factors explaining the relationship between radioresistance and the ability to undergo anhydrobiosis in the sleeping chironomid could be an adaptation to desiccation-inflicted nuclear DNA damage. There were also similarities in the molecular response of the larvae to damage caused by desiccation and ionizing radiation.	[Gusev, Oleg; Nakahara, Yuichi; Cornette, Richard; Kikawada, Takahiro; Okuda, Takashi] Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan; [Gusev, Oleg; Vanyagina, Veronica; Malutina, Ludmila] Kazan VI Lenin State Univ, Dept Invertebrate Zool, Kazan 420008, Russia; [Sakashita, Tetsuya; Kobayashi, Yasuhiko] Japan Atom Energy Agcy, Microbeam Radiat Biol Grp, Takasaki, Gunma, Japan; [Hamada, Nobuyuki] Cent Res Inst Elect Power Ind, Radiat Safety Res Ctr, Nucl Technol Res Lab, Tokyo 201, Japan	National Institute of Agrobiological Sciences - Japan; Kazan Federal University; Japan Atomic Energy Agency; Central Research Institute of Electric Power Industry - Japan	Gusev, O (corresponding author), Natl Inst Agrobiol Sci, Anhydrobiosis Res Unit, Tsukuba, Ibaraki, Japan.	oku@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikawada, Takahiro/A-1289-2010	Gusev, Oleg/0000-0002-6203-9758; Kikawada, Takahiro/0000-0002-2329-9282; Hamada, Nobuyuki/0000-0003-2518-6131; CORNETTE, Richard/0000-0002-0185-1443	Ministry of Education, Culture, Sport and Technology of Japan;  [21688004]	Ministry of Education, Culture, Sport and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This study is the result of the "Elucidation of mechanisms underlying radiation-tolerance linked to anhydrobiosis" project carried under the Strategic Promotion program for basic Nuclear Research by the Ministry of Education, Culture, Sport and Technology of Japan. Funding was provided by the Grant-in-Aid for Young Scientists (A) Kakenhi (21688004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert P, 2006, J EXP BIOL, V209, P1575, DOI 10.1242/jeb.02179; BARRETT J, 1985, ANN APPL BIOL, V106, P121, DOI 10.1111/j.1744-7348.1985.tb03101.x; Benoit JB, 2007, AM J TROP MED HYG, V76, P987, DOI 10.4269/ajtmh.2007.76.987; Benoit JB, 2007, EUR J ENTOMOL, V104, P9, DOI 10.14411/eje.2007.002; Benoit JB, 2009, COMP BIOCHEM PHYS A, V152, P518, DOI 10.1016/j.cbpa.2008.12.009; Billi D, 2009, EXTREMOPHILES, V13, P49, DOI 10.1007/s00792-008-0196-0; Blokhina O, 2003, ANN BOT-LONDON, V91, P179, DOI 10.1093/aob/mcf118; Boubriak II, 2008, ANN BOT-LONDON, V101, P267, DOI 10.1093/aob/mcm276; Cashio P, 2005, SEMIN CELL DEV BIOL, V16, P225, DOI 10.1016/j.semcdb.2005.01.002; CLEAVER JE, 1982, AM J HUM GENET, V34, P566; Clegg JS, 2007, BIOL BULL-US, V212, P74, DOI 10.2307/25066582; CORNETTE R, 2010, J BIOL CHEM; Cox MM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000815; Cox MM, 2005, NAT REV MICROBIOL, V3, P882, DOI 10.1038/nrmicro1264; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Crowe JH, 2002, INTEGR COMP BIOL, V42, P497, DOI 10.1093/icb/42.3.497; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; CROWE LM, 1992, ADV SPACE RES-SERIES, V12, P239, DOI 10.1016/0273-1177(92)90178-Z; Cuiffo B P, 1985, J Free Radic Biol Med, V1, P139, DOI 10.1016/0748-5514(85)90018-2; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Dinant C, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-9; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; Gladyshev E, 2008, P NATL ACAD SCI USA, V105, P5139, DOI 10.1073/pnas.0800966105; Gladyshev EA, 2008, SCIENCE, V320, P1210, DOI 10.1126/science.1156407; Gladyshev EA, 2010, J HERED, V101, pS85, DOI 10.1093/jhered/esq008; GUSEV O, 2010, CELL STRESS CHAPERON; Hashimoto H, 1998, Biol Sci Space, V12, P106, DOI 10.2187/bss.12.106; Hengherr S, 2009, PHYSIOL BIOCHEM ZOOL, V82, P749, DOI 10.1086/605954; Hengherr S, 2008, FEBS J, V275, P281, DOI 10.1111/j.1742-4658.2007.06198.x; Horikawa DD, 2006, INT J RADIAT BIOL, V82, P843, DOI 10.1080/09553000600972956; Horneck G, 1992, Adv Space Biol Med, V2, P229, DOI 10.1016/S1569-2574(08)60023-4; Huang ZY, 2008, ANN BOT-LONDON, V101, P277, DOI 10.1093/aob/mcm089; Jenks M.A., 2007, PLANT DESICCATION TO; Jia J, 2001, STRUCTURE, V9, P267, DOI 10.1016/S0969-2126(01)00585-8; Jonsson KI, 2008, CURR BIOL, V18, pR729, DOI 10.1016/j.cub.2008.06.048; Jonsson KI, 2005, INT J RADIAT BIOL, V81, P649, DOI 10.1080/09553000500368453; Kikawada T, 2008, BBA-BIOMEMBRANES, V1778, P514, DOI 10.1016/j.bbamem.2007.11.009; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; KING RC, 1982, INSECT ULTRASTRUCTUR; Kornbluth S, 2005, J CELL SCI, V118, P1779, DOI 10.1242/jcs.02377; Kranner I, 2005, INTEGR COMP BIOL, V45, P734, DOI 10.1093/icb/45.5.734; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Lushchak VI, 2001, BIOCHEMISTRY-MOSCOW+, V66, P476, DOI 10.1023/A:1010294415625; McLennan AG, 2009, J EXP BIOL, V212, P785, DOI 10.1242/jeb.023663; Menze MA, 2007, AM J PHYSIOL-REG I, V292, pR2039, DOI 10.1152/ajpregu.00659.2006; Michaud MR, 2008, J INSECT PHYSIOL, V54, P645, DOI 10.1016/j.jinsphys.2008.01.003; MORASON RT, 1994, J INSECT PHYSIOL, V40, P155, DOI 10.1016/0022-1910(94)90087-6; Nakahara Y, 2008, J INSECT PHYSIOL, V54, P1220, DOI 10.1016/j.jinsphys.2008.05.007; Nakahara Y, 2010, CRYOBIOLOGY, V60, P138, DOI 10.1016/j.cryobiol.2009.10.004; Neumann S, 2009, COMP BIOCHEM PHYS A, V153, P425, DOI 10.1016/j.cbpa.2009.04.611; NICKOLOFF JA, 1998, DNA DAMAGE REPAIR; OSBORNE DJ, 1984, FOLIA BIOL-PRAGUE, V30, P155; Pitcher RS, 2005, CELL CYCLE, V4, P675, DOI 10.4161/cc.4.5.1676; Reardon W, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-6; Rebecchi L, 2009, J EXP BIOL, V212, P4033, DOI 10.1242/jeb.033266; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schill RO, 2009, BIOTECHNOL ADV, V27, P348, DOI 10.1016/j.biotechadv.2009.01.011; Simonin H, 2007, BBA-BIOMEMBRANES, V1768, P1600, DOI 10.1016/j.bbamem.2007.03.017; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Villenueve TS, 2006, CELL STRESS CHAPERON, V11, P71, DOI 10.1379/CSC-154R.1; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Watanabe M, 2005, J INSECT PHYSIOL, V51, P727, DOI 10.1016/j.jinsphys.2005.02.008; Watanabe M, 2003, J EXP BIOL, V206, P2281, DOI 10.1242/jeb.00418; Watanabe M, 2002, J EXP BIOL, V205, P2799; Watanabe M, 2007, J INSECT PHYSIOL, V53, P573, DOI 10.1016/j.jinsphys.2007.02.008; Watanabe M, 2006, INT J RADIAT BIOL, V82, P835, DOI 10.1080/09553000600979100; Watanabe M, 2006, INT J RADIAT BIOL, V82, P587, DOI 10.1080/09553000600876652; Yoshinaga K, 1997, BIOSCI BIOTECH BIOCH, V61, P160, DOI 10.1271/bbb.61.160; Zhou L, 2003, DEV CELL, V4, P599, DOI 10.1016/S1534-5807(03)00085-6	71	48	49	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14008	10.1371/journal.pone.0014008	http://dx.doi.org/10.1371/journal.pone.0014008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103355	gold, Green Published, Green Submitted			2022-12-27	WOS:000284257400012
J	Mao, G; Brody, JP				Mao, Grace; Brody, James P.			Reverse Engineering the Yeast RNR1 Transcriptional Control System	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; PLASMON RESONANCE SPECTROSCOPY; CHROMATIN IMMUNOPRECIPITATION; BINDING; DATABASE; APTAMER; SENSORS; JASPAR	Transcription is controlled by multi-protein complexes binding to short non-coding regions of genomic DNA. These complexes interact combinatorially. A major goal of modern biology is to provide simple models that predict this complex behavior. The yeast gene RNR1 is transcribed periodically during the cell cycle. Here, we present a pilot study to demonstrate a new method of deciphering the logic behind transcriptional regulation. We took regular samples from cell cycle synchronized cultures of Saccharomyces cerevisiae and extracted nuclear protein. We tested these samples to measure the amount of protein that bound to seven different 16 base pair sequences of DNA that have been previously identified as protein binding locations in the promoter of the RNR1 gene. These tests were performed using surface plasmon resonance. We found that the surface plasmon resonance signals showed significant variation throughout the cell cycle. We correlated the protein binding data with previously published mRNA expression data and interpreted this to show that transcription requires protein bound to a particular site and either five different sites or one additional sites. We conclude that this demonstrates the feasibility of this approach to decipher the combinatorial logic of transcription.	[Mao, Grace; Brody, James P.] Univ Calif Irvine, Henry Samueli Sch Engn, Dept Biomed Engn, Irvine, CA 92717 USA	University of California System; University of California Irvine	Mao, G (corresponding author), Univ Calif Irvine, Henry Samueli Sch Engn, Dept Biomed Engn, Irvine, CA 92717 USA.	jpbrody@uci.edu		Brody, James/0000-0002-7995-5197	Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center	Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	This work was supported by the Defense Advanced Research Projects Agency (DARPA) Micro/Nano Fluidics Fundamentals Focus (MF3) Center, http://www.inrf.uci.edu/mf3/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BONDESON K, 1993, ANAL BIOCHEM, V214, P245, DOI 10.1006/abio.1993.1484; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenowitz M, 2001, Curr Protoc Mol Biol, VChapter 12, DOI 10.1002/0471142727.mb1204s07; Brockman JM, 2000, ANNU REV PHYS CHEM, V51, P41, DOI 10.1146/annurev.physchem.51.1.41; Buck MJ, 2004, GENOMICS, V83, P349, DOI 10.1016/j.ygeno.2003.11.004; Bulyk ML, 2006, CURR OPIN BIOTECH, V17, P422, DOI 10.1016/j.copbio.2006.06.015; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Chinowsky TM, 2007, BIOSENS BIOELECTRON, V22, P2208, DOI 10.1016/j.bios.2006.10.030; Davidson E. H., 2001, DEV EVOLUTION; GALAS DJ, 1978, NUCLEIC ACIDS RES, V5, P3157, DOI 10.1093/nar/5.9.3157; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; Homola J, 1999, SENSOR ACTUAT B-CHEM, V54, P3, DOI 10.1016/S0925-4005(98)00321-9; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Kim DK, 2008, ANAL BIOCHEM, V379, P1, DOI 10.1016/j.ab.2008.04.029; Kim HD, 2009, SCIENCE, V325, P429, DOI 10.1126/science.1171347; Kyo M, 2004, GENES CELLS, V9, P153, DOI 10.1111/j.1356-9597.2004.00711.x; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; LIN L, 2005, THESIS U CALIFORNIA; Lin LM, 2004, ANAL CHEM, V76, P6555, DOI 10.1021/ac049371e; Majka J, 2007, ADV BIOCHEM ENG BIOT, V104, P13, DOI 10.1007/10_026; Mao G, 2007, BIOCHEM BIOPH RES CO, V363, P153, DOI 10.1016/j.bbrc.2007.08.130; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Moyroud E, 2009, PLANT J, V59, P851, DOI 10.1111/j.1365-313X.2009.03903.x; NEO SJ, 2009, ANAL CHEM; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Smith EA, 2003, APPL SPECTROSC, V57, p320A, DOI 10.1366/000370203322554446; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Su XD, 2008, ANAL BIOCHEM, V376, P137, DOI 10.1016/j.ab.2008.02.002; Teh HF, 2007, BIOCHEMISTRY-US, V46, P2127, DOI 10.1021/bi061903t; Tirosh I, 2009, SCIENCE, V324, P659, DOI 10.1126/science.1169766; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wang ZZ, 2007, ANAL BIOANAL CHEM, V389, P819, DOI 10.1007/s00216-007-1510-x; Weinstock GM, 2007, GENOME RES, V17, P667, DOI 10.1101/gr.6534207	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13895	10.1371/journal.pone.0013895	http://dx.doi.org/10.1371/journal.pone.0013895			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103376	Green Published, gold			2022-12-27	WOS:000284257400002
J	Kamat, A; Ancuta, P; Blumberg, RS; Gabuzda, D				Kamat, Anupa; Ancuta, Petronela; Blumberg, Richard S.; Gabuzda, Dana			Serological Markers for Inflammatory Bowel Disease in AIDS Patients with Evidence of Microbial Translocation	PLOS ONE			English	Article							ANTI-SACCHAROMYCES-CEREVISIAE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; T-CELL DEPLETION; IMMUNODEFICIENCY-VIRUS-INFECTION; ULCERATIVE-COLITIS PATIENTS; MEMBRANE PORIN-C; CROHNS-DISEASE; MANNAN ANTIBODIES; IMMUNE-RESPONSES; DIAGNOSTIC-VALUE	Background: Breakdown of the gut mucosal barrier during chronic HIV infection allows translocation of bacterial products such as lipopolysaccharides (LPS) from the gut into the circulation. Microbial translocation also occurs in inflammatory bowel disease (IBD). IBD serological markers are useful in the diagnosis of IBD and to differentiate between Crohn's disease (CD) and ulcerative colitis (UC). Here, we evaluate detection of IBD serological markers in HIV-infected patients with advanced disease and their relationship to HIV disease markers. Methods: IBD serological markers (ASCA, pANCA, anti-OmpC, and anti-CBir1) were measured by ELISA in plasma from AIDS patients (n = 26) with low CD4 counts (<300 cells/mu l) and high plasma LPS levels, and results correlated with clinical data. For meta-analysis, relevant data were abstracted from 20 articles. Results: IBD serological markers were detected in approximately 65% of AIDS patients with evidence of microbial translocation. An antibody pattern consistent with IBD was detected in 46%; of these, 75% had a CD-like pattern. Meta-analysis of data from 20 published studies on IBD serological markers in CD, UC, and non-IBD control subjects indicated that IBD serological markers are detected more frequently in AIDS patients than in non-IBD disease controls and healthy controls, but less frequently than in CD patients. There was no association between IBD serological markers and HIV disease markers (plasma viral load and CD4 counts) in the study cohort. Conclusions: IBD serological markers may provide a non-invasive approach to monitor HIV-related inflammatory gut disease. Further studies to investigate their clinical significance in HIV-infected individuals are warranted.	[Kamat, Anupa; Gabuzda, Dana] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Blumberg, Richard S.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Ancuta, Petronela] INSERM, U743, Montreal, PQ, Canada; [Ancuta, Petronela] Univ Montreal, Dept Microbiol & Immunol, Ctr Rech Ctr Hosp Univ Montreal CRCHUM, Montreal, PQ H3C 3J7, Canada	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montreal	Kamat, A (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	dana_gabuzda@dfci.harvard.edu			NIH [DA26322, MH083588, DK44319, DK51362, DK53056]; Harvard Digestive Diseases Center for AIDS Research and DFCI/Harvard Center for Cancer Research; Fonds de la Recherche en Sante Quebec (FRSQ); INSERM;  [MH59745];  [NS38841];  [MH59656];  [NS54591];  [MH59724]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053056, R37DK044319, R01DK044319, R56DK053056, R01DK051362, R01DK088199] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059656, R01MH083588, R24MH059745, U01MH083545, R24MH059724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026322] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Digestive Diseases Center for AIDS Research and DFCI/Harvard Center for Cancer Research; Fonds de la Recherche en Sante Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ; ; ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NIH DA26322 and MH083588. R. B. was supported by NIH DK44319, DK51362, DK53056, and the Harvard Digestive Diseases Center. P.A. was supported by New Investigator Awards from Fonds de la Recherche en Sante Quebec (FRSQ) and INSERM. Core facilities were supported by the Harvard Center for AIDS Research and DFCI/Harvard Center for Cancer Research grants. NNTC sites were supported by MH59745, NS38841, MH59656, NS54591, and MH59724. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams RJ, 2008, AM J GASTROENTEROL, V103, P386, DOI 10.1111/j.1572-0241.2007.01577.x; Ancuta P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002516; Arnott IDR, 2004, AM J GASTROENTEROL, V99, P2376, DOI 10.1111/j.1572-0241.2004.40417.x; Austin GL, 2006, AM J GASTROENTEROL, V101, P413, DOI 10.1111/j.1572-0241.2006.00475.x; Austin GL, 2007, CLIN GASTROENTEROL H, V5, P545, DOI 10.1016/j.cgh.2007.03.006; Balagopal A, 2008, GASTROENTEROLOGY, V135, P226, DOI 10.1053/j.gastro.2008.03.022; Bjarnason I, 1996, AIDS, V10, P1385, DOI 10.1097/00002030-199610000-00011; Bossuyt X, 2006, CLIN CHEM, V52, P171, DOI 10.1373/clinchem.2005.058560; Brenchley JM, 2008, MUCOSAL IMMUNOL, V1, P23, DOI 10.1038/mi.2007.1; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2006, NAT IMMUNOL, V7, P235, DOI 10.1038/ni1316; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Buckland MS, 2005, CLIN DIAGN LAB IMMUN, V12, P1328, DOI 10.1128/CDLI.12.11.1328-1330.2005; Caradonna L, 2000, AM J GASTROENTEROL, V95, P1495; Caradonna L, 2000, J ENDOTOXIN RES, V6, P205, DOI 10.1177/09680519000060030101; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Cornely OA, 1999, INFECTION, V27, P92, DOI 10.1007/BF02560504; Dandekar Satya, 2007, Curr HIV/AIDS Rep, V4, P10, DOI 10.1007/s11904-007-0002-0; Davis MK, 2007, J PEDIATR GASTR NUTR, V45, P409, DOI 10.1097/MPG.0b013e31812f7f6e; Desir B, 2004, CLIN GASTROENTEROL H, V2, P139, DOI 10.1016/S1542-3565(03)00321-5; Devlin SM, 2007, GASTROENTEROLOGY, V132, P576, DOI 10.1053/j.gastro.2006.11.013; Dubinsky M, 2009, DIGEST DIS, V27, P259, DOI 10.1159/000228559; Dubinsky MC, 2008, INFLAMM BOWEL DIS, V14, pS185, DOI 10.1002/ibd.20585; Dubinsky MC, 2006, AM J GASTROENTEROL, V101, P360, DOI 10.1111/j.1572-0241.2006.00456.x; Dubinsky MC, 2001, AM J GASTROENTEROL, V96, P758; DUERR RH, 1991, GASTROENTEROLOGY, V100, P1590, DOI 10.1016/0016-5085(91)90657-7; Ferrante M, 2007, GUT, V56, P1394, DOI 10.1136/gut.2006.108043; Fleshner P, 2008, CLIN GASTROENTEROL H, V6, P561, DOI 10.1016/j.cgh.2008.01.002; Fleshner PR, 2001, GUT, V49, P671, DOI 10.1136/gut.49.5.671; Friedman H, 2003, CLIN MICROBIOL REV, V16, P209, DOI 10.1128/CMR.16.2.209-219.2003; GARDINER KR, 1995, GUT, V36, P897, DOI 10.1136/gut.36.6.897; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Haynes BF, 2006, NAT MED, V12, P1351, DOI 10.1038/nm1206-1351; HOFER U, 2009, SEMIN IMMUNOPATHOL; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Israeli E, 2005, GUT, V54, P1232, DOI 10.1136/gut.2004.060228; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Kewenig S, 1999, GASTROENTEROLOGY, V116, P1115, DOI 10.1016/S0016-5085(99)70014-4; KLAASSEN RJL, 1992, CLIN EXP IMMUNOL, V87, P24, DOI 10.1111/j.1365-2249.1992.tb06408.x; Kotler DP, 2005, AIDS, V19, P107, DOI 10.1097/00002030-200501280-00002; Koutroubakis IE, 2001, AM J GASTROENTEROL, V96, P449; KUCHARZIK T, 1995, CLIN EXP IMMUNOL, V100, P452; Lackner AA, 2009, GASTROENTEROLOGY, V136, P1966, DOI 10.1053/j.gastro.2008.12.071; Landers CJ, 2002, GASTROENTEROLOGY, V123, P689, DOI 10.1053/gast.2002.35379; Lautenbach E, 1997, J CLIN GASTROENTEROL, V25, P456, DOI 10.1097/00004836-199709000-00013; Linskens RK, 2002, EUR J GASTROEN HEPAT, V14, P1013, DOI 10.1097/00042737-200209000-00013; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Mainardi E, 2007, DIGESTION, V75, P210, DOI 10.1159/000109928; Marchetti G, 2008, AIDS, V22, P2035, DOI 10.1097/QAD.0b013e3283112d29; Markowitz J, 2009, INFLAMM BOWEL DIS, V15, P714, DOI 10.1002/ibd.20831; McGuckin MA, 2009, INFLAMM BOWEL DIS, V15, P100, DOI 10.1002/ibd.20539; Mei L, 2006, GASTROENTEROLOGY, V130, P1078, DOI 10.1053/j.gastro.2006.02.013; Mitsuyama K, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/26875; Mow WS, 2004, GASTROENTEROLOGY, V126, P414, DOI 10.1053/j.gastro.2003.11.015; Murphy SJ, 2008, AM J GASTROENTEROL, V103, P397, DOI 10.1111/j.1572-0241.2007.01571.x; Mustila A, 2000, ARTHRITIS RHEUM-US, V43, P1371, DOI 10.1002/1529-0131(200006)43:6<1371::AID-ANR22>3.0.CO;2-R; Nikolova M, 2002, ISR MED ASSOC J, V4, P908; Olsson J, 2000, J INFECT DIS, V182, P1625, DOI 10.1086/317625; Paiardini M, 2008, AIDS REV, V10, P36; Papadakis KA, 2000, ANNU REV MED, V51, P289, DOI 10.1146/annurev.med.51.1.289; Papadakis KA, 2007, INFLAMM BOWEL DIS, V13, P524, DOI 10.1002/ibd.20106; Papp M, 2008, AM J GASTROENTEROL, V103, P665, DOI 10.1111/j.1572-0241.2007.01652.x; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Peeters M, 2001, AM J GASTROENTEROL, V96, P730, DOI 10.1111/j.1572-0241.2001.03613.x; Peyrin-Biroulet L, 2007, INFLAMM BOWEL DIS, V13, P1561, DOI 10.1002/ibd.20226; Quinton JF, 1998, GUT, V42, P788, DOI 10.1136/gut.42.6.788; Reese GE, 2006, AM J GASTROENTEROL, V101, P2410, DOI 10.1111/j.1572-0241.2006.00840.x; Rutgeerts P, 2000, LANCET, V356, P2117, DOI 10.1016/S0140-6736(00)03488-7; Sabery N, 2007, PEDIATRICS, V119, pE193, DOI 10.1542/peds.2006-1361; Sandborn WJ, 2001, INFLAMM BOWEL DIS, V7, P192, DOI 10.1097/00054725-200108000-00003; SAVIGE JA, 1993, ADV EXP MED BIOL, V336, P349; Seibold F, 2005, GUT, V54, P1212, DOI 10.1136/gut.2005.065227; Sharpstone D, 1999, GUT, V45, P70, DOI 10.1136/gut.45.1.70; Sharpstone DR, 1996, EUR J GASTROEN HEPAT, V8, P575, DOI 10.1097/00042737-199606000-00015; Shen C, 2008, INFLAMM BOWEL DIS, V14, P1641, DOI 10.1002/ibd.20645; Shih David Q, 2008, Curr Gastroenterol Rep, V10, P568, DOI 10.1007/s11894-008-0104-x; Targan SR, 2005, GASTROENTEROLOGY, V128, P2020, DOI 10.1053/j.gastro.2005.03.046; Targan SR, 1999, INFLAMM BOWEL DIS, V5, P61, DOI 10.1097/00054725-199902000-00008; Vermeire S, 2001, INFLAMM BOWEL DIS, V7, P8, DOI 10.1097/00054725-200102000-00002; Vermeire S, 2001, GASTROENTEROLOGY, V120, P827, DOI 10.1053/gast.2001.22546; VIAZIS N, 2009, INFLAMM BOWEL DIS; WINTER HS, 1994, J PEDIATR-US, V125, P707, DOI 10.1016/S0022-3476(94)70061-3; Yoshida EM, 1996, J CLIN GASTROENTEROL, V23, P24, DOI 10.1097/00004836-199607000-00008; Zholudev A, 2004, AM J GASTROENTEROL, V99, P2235, DOI 10.1111/j.1572-0241.2004.40369.x	85	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15533	10.1371/journal.pone.0015533	http://dx.doi.org/10.1371/journal.pone.0015533			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125014	Green Published, gold, Green Submitted			2022-12-27	WOS:000284231800040
J	Siervo, M; Horta, BL; Stephan, BCM; Victora, CG; Wells, JCK				Siervo, Mario; Horta, Bernardo L.; Stephan, Blossom C. M.; Victora, Cesar G.; Wells, Jonathan C. K.			First-Borns Carry a Higher Metabolic Risk in Early Adulthood: Evidence from a Prospective Cohort Study	PLOS ONE			English	Article							BIRTH-WEIGHT; PSYCHOLOGICAL STRESS; CHILDHOOD GROWTH; BODY-COMPOSITION; FETAL; PREGNANCY; OBESITY; ASSOCIATION; PREMATURITY; DISTRESS	Background: Birth order has been associated with early growth variability and subsequent increased adiposity, but the consequent effects of increased fat mass on metabolic risk during adulthood have not been assessed. We aimed to quantify the metabolic risk in young adulthood of being first-born relative to those born second or subsequently. Methodology and Principal Findings: Body composition and metabolic risk were assessed in 2,249 men, aged 17-19 years, from a birth cohort in southern Brazil. Metabolic risk was assessed using a composite z-score integrating standardized measurements of blood pressure, total cholesterol, high density lipoprotein, triglycerides and fat mass. First-borns had lower birth weight z-score (Delta = -0.25, 95%CI -0.35, -0.15, p<0.001) but showed greater weight gain during infancy (change in weight z-score from birth to 20 months: Delta = 0.39, 95%CI 0.28-0.50, P<0.0001) and had greater mean height (Delta = 1.2 cm, 95%CI: 0.7-1.6, p<0.0001) and weight (Delta = 0.34 kg, 95%CI: 0.13-0.55, p<0.002) at 43 months. This greater weight and height tracked into early adulthood, with first-borns being significantly taller, heavier and with significantly higher fat mass than later-borns. The metabolic risk z-score was significantly higher in first-borns. Conclusions/Significance: First-born status is associated with significantly elevated adiposity and metabolic risk in young adult men in Brazil. Our results, linking cardiovascular risk with life history variables, suggest that metabolic risk may be associated with the worldwide trend to smaller family size and it may interact with changes in behavioural or environmental risk factors.	[Siervo, Mario] Univ Naples Federico II, Dept Neurosci, Naples, Italy; [Horta, Bernardo L.; Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Stephan, Blossom C. M.] Univ Cambridge, Inst Publ Hlth, Cambridge, England; [Wells, Jonathan C. K.] UCL Inst Child Hlth, Childhood Nutr Res Ctr, London, England	University of Naples Federico II; Universidade Federal de Pelotas; University of Cambridge; University of London; University College London	Siervo, M (corresponding author), Univ Naples Federico II, Dept Neurosci, Naples, Italy.	masiervo@yahoo.com	Victora, Cesar G/D-4476-2013; Horta, Bernardo/A-7604-2008; Victora, Cesar Gomes/Y-2455-2019; Siervo, Mario/AAB-9302-2019; Wells, Jonathan/A-4604-2009	Victora, Cesar G/0000-0002-2465-2180; Horta, Bernardo/0000-0001-9843-412X; Victora, Cesar Gomes/0000-0002-2465-2180; Wells, Jonathan/0000-0003-0411-8025; Stephan, Blossom/0000-0002-1235-360X; Siervo, Mario/0000-0001-5515-0944	International Development research Center (Canada); World Health Organization (Department of Child and Adolescent Health and Development); Overseas Development Administration (United Kingdom); United Nations Development Fund for Women; National Program for Centers of Excellence (Brazil); National Research Council (Brazil); Ministry of Health (Brazil); Medical Research Council [G0701539] Funding Source: researchfish; MRC [G0701539] Funding Source: UKRI	International Development research Center (Canada)(CGIAR); World Health Organization (Department of Child and Adolescent Health and Development)(World Health Organization); Overseas Development Administration (United Kingdom); United Nations Development Fund for Women; National Program for Centers of Excellence (Brazil); National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Earlier phases of the 1982 cohort study were funded by the International Development research Center (Canada), the World Health Organization (Department of Child and Adolescent Health and Development, and Human Reproduction Programme), the Overseas Development Administration (United Kingdom), the United Nations Development Fund for Women, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil) and the Ministry of Health (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelow B, 2006, EUR PSYCHIAT, V21, P495, DOI 10.1016/j.eurpsy.2005.11.005; Barker DJP, 2007, J INTERN MED, V261, P412, DOI 10.1111/j.1365-2796.2007.01809.x; Barker DJP, 2007, HYPERTENSION, V50, P565, DOI 10.1161/HYPERTENSIONAHA.107.091512; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barros FC, 2008, REV SAUDE PUBL, V42, P7, DOI 10.1590/S0034-89102008000900003; Brage S, 2004, DIABETES CARE, V27, P2141, DOI 10.2337/diacare.27.9.2141; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Dunger DB, 2007, P NUTR SOC, V66, P451, DOI 10.1017/S0029665107005721; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Fewtrell MS, 2004, AM J CLIN NUTR, V80, P436, DOI 10.1093/ajcn/80.2.436; Flaherty JH, 2007, J AM GERIATR SOC, V55, P1295, DOI 10.1111/j.1532-5415.2007.01273.x; Forsen T, 2000, ANN INTERN MED, V133, P176, DOI 10.7326/0003-4819-133-3-200008010-00008; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gitau R, 1998, LANCET, V352, P707, DOI 10.1016/S0140-6736(05)60824-0; GRIMM ER, 1961, PSYCHOSOM MED, V23, P520, DOI 10.1097/00006842-196111000-00006; HAIG D, 1993, Q REV BIOL, V68, P495, DOI 10.1086/418300; HALES CN, 1991, BMJ-BRIT MED J, V303, P1019, DOI 10.1136/bmj.303.6809.1019; HALES CN, 2002, J PHYSL, P5; HAMILL PVV, 1979, AM J CLIN NUTR, V32, P607, DOI 10.1093/ajcn/32.3.607; Hoa HT, 1996, BRIT MED J, V313, P1113, DOI 10.1136/bmj.313.7065.1113; Horta BL, 2003, J EPIDEMIOL COMMUN H, V57, P226, DOI 10.1136/jech.57.3.226; Khong TY, 2003, PLACENTA, V24, P348, DOI 10.1053/plac.2002.0922; Kivlighan KT, 2008, PSYCHONEUROENDOCRINO, V33, P1225, DOI 10.1016/j.psyneuen.2008.06.008; Leunissen RWJ, 2009, CLIN ENDOCRINOL, V70, P245, DOI 10.1111/j.1365-2265.2008.03320.x; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Macbeth AH, 2010, NEUROSCI BIOBEHAV R, V34, P452, DOI 10.1016/j.neubiorev.2009.08.011; O'Rahilly S, 2008, INT J OBESITY, V32, pS55, DOI 10.1038/ijo.2008.239; Ong KK, 2007, PLOS MED, V4, P737, DOI 10.1371/journal.pmed.0040132; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Petry CJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-22; RASHEED FN, 1993, LANCET, V341, P828, DOI 10.1016/0140-6736(93)90602-D; Ritchie SA, 2007, NUTR METAB CARDIOVAS, V17, P319, DOI 10.1016/j.numecd.2006.07.005; Rondo PHC, 2003, EUR J CLIN NUTR, V57, P266, DOI 10.1038/sj.ejcn.1601526; Stettler N, 2000, AM J CLIN NUTR, V72, P378; STUBBS RJ, 1995, AM J CLIN NUTR, V62, P330, DOI 10.1093/ajcn/62.2.330; Teixeira JMA, 1999, BRIT MED J, V318, P153, DOI 10.1136/bmj.318.7177.153; United Nations, 2007, WORLD POP AG; VANITALLIE TB, 1990, AM J CLIN NUTR, V52, P953, DOI 10.1093/ajcn/52.6.953; Wells JCK, 2007, P NUTR SOC, V66, P423, DOI 10.1017/S0029665107005691; Wisborg K, 2008, BJOG-INT J OBSTET GY, V115, P882, DOI 10.1111/j.1471-0528.2008.01734.x; Wolf AM, 2009, AM J MED, V122, pS19, DOI 10.1016/j.amjmed.2009.01.004	44	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e13907	10.1371/journal.pone.0013907	http://dx.doi.org/10.1371/journal.pone.0013907			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085691	gold, Green Published, Green Submitted			2022-12-27	WOS:000284035900014
J	Acevedo, P; Ruiz-Fons, F; Estrada, R; Marquez, AL; Miranda, MA; Gortazar, C; Lucientes, J				Acevedo, Pelayo; Ruiz-Fons, Francisco; Estrada, Rosa; Luz Marquez, Ana; Angel Miranda, Miguel; Gortazar, Christian; Lucientes, Javier			A Broad Assessment of Factors Determining Culicoides imicola Abundance: Modelling the Present and Forecasting Its Future in Climate Change Scenarios	PLOS ONE			English	Article							AFRICAN HORSE SICKNESS; BLUETONGUE VIRUS; SPECIES DISTRIBUTION; SEASONAL DISTRIBUTION; SPATIAL-DISTRIBUTION; WILD RUMINANTS; VECTOR; DISTRIBUTIONS; OBSOLETUS; RANGE	Bluetongue (BT) is still present in Europe and the introduction of new serotypes from endemic areas in the African continent is a possible threat. Culicoides imicola remains one of the most relevant BT vectors in Spain and research on the environmental determinants driving its life cycle is key to preventing and controlling BT. Our aim was to improve our understanding of the biotic and abiotic determinants of C. imicola by modelling its present abundance, studying the spatial pattern of predicted abundance in relation to BT outbreaks, and investigating how the predicted current distribution and abundance patterns might change under future (2011-2040) scenarios of climate change according to the Intergovernmental Panel on Climate Change. C. imicola abundance data from the bluetongue national surveillance programme were modelled with spatial, topoclimatic, host and soil factors. The influence of these factors was further assessed by variation partitioning procedures. The predicted abundance of C. imicola was also projected to a future period. Variation partitioning demonstrated that the pure effect of host and topoclimate factors explained a high percentage (>80%) of the variation. The pure effect of soil followed in importance in explaining the abundance of C. imicola. A close link was confirmed between C. imicola abundance and BT outbreaks. To the best of our knowledge, this study is the first to consider wild and domestic hosts in predictive modelling for an arthropod vector. The main findings regarding the near future show that there is no evidence to suggest that there will be an important increase in the distribution range of C. imicola; this contrasts with an expected increase in abundance in the areas where it is already present in mainland Spain. What may be expected regarding the future scenario for orbiviruses in mainland Spain, is that higher predicted C. imicola abundance may significantly change the rate of transmission of orbiviruses.	[Acevedo, Pelayo; Luz Marquez, Ana] Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain; [Ruiz-Fons, Francisco; Gortazar, Christian] Inst Invest Recursos Cineget IREC CSIC UCLM JCCM, Dept Anim Hlth, Ciudad Real, Spain; [Ruiz-Fons, Francisco] Inst Vasco Invest & Desarrollo Agr Neiker Tecnali, Dept Anim Hlth, Derio, Spain; [Estrada, Rosa; Lucientes, Javier] Univ Zaragoza, Fac Vet, Dept Anim Pathol, Zaragoza, Spain; [Angel Miranda, Miguel] Univ Balearic Isl, Dept Biol, Palma De Mallorca, Spain	Universidad de Malaga; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigacion en Recursos Cinegeticos (IREC); Universidad de Castilla-La Mancha; University of Zaragoza; Universitat de les Illes Balears	Acevedo, P (corresponding author), Univ Malaga, Fac Sci, Dept Anim Biol, Biogeog Divers & Conservat Res Team, E-29071 Malaga, Spain.	pacevedo@irec.csic.es	Miranda, Miguel/I-8718-2019; Márquez, Ana Luz/K-8345-2014; Gortazar, Christian/E-7918-2012; Ruiz-Fons, Francisco/K-3161-2014; Acevedo, Pelayo/L-6737-2013	Miranda, Miguel/0000-0003-0770-2593; Márquez, Ana Luz/0000-0001-5586-9334; Gortazar, Christian/0000-0003-0012-4006; Ruiz-Fons, Francisco/0000-0002-0820-5292; Acevedo, Pelayo/0000-0002-3509-7696	Castilla-La Mancha [POII09-0141-8176]; Principado de Asturias; FEDER [CGL2009-11316/BOS]; Spanish Ministry of Science and Innovation; Castilla-La Mancha and Principado de Asturias	Castilla-La Mancha; Principado de Asturias(Principality of Asturias); FEDER(European Commission); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Castilla-La Mancha and Principado de Asturias	This study was supported by grant POII09-0141-8176 (Castilla-La Mancha) and by funds from Castilla-La Mancha and Principado de Asturias. P. Acevedo currently holds a Juan de la Cierva research contract awarded by the Spanish Ministry of Science and Innovation-European Social Fund and partially by the project CGL2009-11316/BOS - FEDER. F. Ruiz-Fons is currently supported by the Spanish Ministry of Science and Innovation under a contract awarded by the 'Instituto de Salud Carlos III'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo P, 2008, J ZOOL, V276, P37, DOI 10.1111/j.1469-7998.2008.00464.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alzaga V, 2009, NATURWISSENSCHAFTEN, V96, P1157, DOI 10.1007/s00114-009-0577-y; Barbosa A.M., 2005, Wildlife Biology in Practice, V1, P3; Barbosa AM, 2009, ECOL MODEL, V220, P747, DOI 10.1016/j.ecolmodel.2008.12.004; Baylis M, 2004, VETER ITAL SER, V40, P176; Baylis M, 1997, MED VET ENTOMOL, V11, P203, DOI 10.1111/j.1365-2915.1997.tb00397.x; Baylis M, 2001, VET REC, V149, P639, DOI 10.1136/vr.149.21.639; Beaumont LJ, 2008, ECOL LETT, V11, P1135, DOI 10.1111/j.1461-0248.2008.01231.x; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Boyce MS, 2001, J WILDLIFE MANAGE, V65, P498, DOI 10.2307/3803103; BRAVERMAN Y, 1974, MOSQ NEWS, V34, P303; Brunet M, 2007, GENERACION ESCENARIO; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Calistri P, 2003, J VET MED B, V50, P132, DOI 10.1046/j.1439-0442.2003.00513.x; Calvete C, 2008, MED VET ENTOMOL, V22, P124, DOI 10.1111/j.1365-2915.2008.00728.x; Calvete C, 2006, VET REC, V158, P130, DOI 10.1136/vr.158.4.130; Calvete C, 2009, VET J, V182, P235, DOI 10.1016/j.tvjl.2008.06.010; Capela R, 2003, MED VET ENTOMOL, V17, P165, DOI 10.1046/j.1365-2915.2003.00419.x; Caracappa S, 2003, VET REC, V153, P71, DOI 10.1136/vr.153.3.71; Conte A, 2007, VET PARASITOL, V150, P333, DOI 10.1016/j.vetpar.2007.09.021; Conte A, 2009, J APPL ECOL, V46, P1332, DOI 10.1111/j.1365-2664.2009.01723.x; Davis AJ, 1998, NATURE, V391, P783, DOI 10.1038/35842; Diniz JAF, 2009, ECOGRAPHY, V32, P897, DOI 10.1111/j.1600-0587.2009.06196.x; Eastman JR, 2004, IDRISI KILIMANJARO G; Epstein PR, 2000, SCI AM, V283, P50, DOI 10.1038/scientificamerican0800-50; Estrada-Pena A, 2007, J MED ENTOMOL, V44, P1130, DOI 10.1603/0022-2585(2007)44[1130:CNOTSI]2.0.CO;2; Estrada-Pena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002999; *EUR ENV AG, 2000, NATLAN NAT LAND COV; FONT I, 2000, CLIMATOLOGI ESPANA P; Fowler J., 1998, PRACTICAL STAT FIELD, P130; Garcia I, 2009, EUR J WILDLIFE RES, V55, P173, DOI 10.1007/s10344-008-0231-6; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; Gu WD, 2006, P NATL ACAD SCI USA, V103, P17560, DOI 10.1073/pnas.0608452103; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Illan JG, 2010, GLOBAL ECOL BIOGEOGR, V19, P159, DOI 10.1111/j.1466-8238.2009.00507.x; Heikkinen RK, 2005, P ROY SOC B-BIOL SCI, V272, P2203, DOI 10.1098/rspb.2005.3212; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Hortal J, 2008, J BIOGEOGR, V35, P1202, DOI 10.1111/j.1365-2699.2007.01850.x; Hudson P., 2002, ECOLOGY WILDLIFE DIS; I. G. M. E, 1979, MAP HIDR NAC EXPL MA; Jimenez-Valverde A, 2006, ENVIRON ENTOMOL, V35, P1491, DOI 10.1603/0046-225X-35.6.1491; Kirkeby C, 2009, ENTOMOL FENNICA, V20, P228; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; LEGENDRE P, 1993, ECOLOGY, V74, P1659, DOI 10.2307/1939924; Legendre P., 2012, NUMERICAL ECOLOGY; MARQUEZ AL, 2010, CLIMATIC CH IN PRESS; Meiswinkel R, 1997, ONDERSTEPOORT J VET, V64, P81; Meiswinkel R, 1998, ARCH VIROL, P69; MEISWINKEL R, 1994, INFECT DIS LIVESTOCK, V1, P93; Miranda MA, 2004, VETER ITAL SER, V40, P292; Montgomery D. C., 1992, INTRO LINEAR REGRESS; Nakicenovic N., 2000, IPCC SPECIAL REPORT; NICHOLSON SE, 1994, REMOTE SENS ENVIRON, V50, P107, DOI 10.1016/0034-4257(94)90038-8; Ortega MD, 1998, ARCH VIROL, P85; Ortega MD, 1999, J AM MOSQUITO CONTR, V15, P391; Palomo LJ., 2007, ATLAS LIBRO ROJO MAM; Pearce J, 2001, BIOL CONSERV, V98, P33, DOI 10.1016/S0006-3207(00)00139-7; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; Peterson AT, 2002, EMERG INFECT DIS, V8, P662, DOI 10.3201/eid0807.010454; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2004, MED VET ENTOMOL, V18, P90, DOI 10.1111/j.0269-283X.2004.00492.x; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Real R, 2003, J BIOGEOGR, V30, P939, DOI 10.1046/j.1365-2699.2003.00871.x; Real R, 2006, ENVIRON ECOL STAT, V13, P237, DOI 10.1007/s10651-005-0003-3; Real R, 2010, ECOGRAPHY, V33, P304, DOI 10.1111/j.1600-0587.2010.06251.x; Real R, 2009, DIVERS DISTRIB, V15, P390, DOI 10.1111/j.1472-4642.2008.00546.x; Rodriguez-Sanchez B, 2010, EMERG INFECT DIS, V16, P518, DOI 10.3201/eid1603.090626; Ruiz-Fons F, 2008, EUR J WILDLIFE RES, V54, P549, DOI 10.1007/s10344-008-0179-6; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Ruiz-Fons F, 2010, INT J PARASITOL, V40, P1013, DOI 10.1016/j.ijpara.2010.02.006; Savini L, 2006, Vet Ital, V42, P201; Scheiner SM, 2009, ECOHEALTH, V6, P483, DOI 10.1007/s10393-010-0298-x; Slenning BD, 2010, VET PATHOL, V47, P28, DOI 10.1177/0300985809354465; Soberon J, 2007, ECOL LETT, V10, P1115, DOI 10.1111/j.1461-0248.2007.01107.x; Soberon JM, 2010, ECOGRAPHY, V33, P159, DOI 10.1111/j.1600-0587.2009.06074.x; Tatem AJ, 2003, VET MICROBIOL, V97, P13, DOI 10.1016/j.vetmic.2003.08.009; Veronesi E, 2009, VET PARASITOL, V163, P370, DOI 10.1016/j.vetpar.2009.04.031; Watson DM, 1999, ECOGRAPHY, V22, P582, DOI 10.1111/j.1600-0587.1999.tb00547.x; Wittman EJ, 2001, REV SCI TECH OIE, V20, P731, DOI 10.20506/rst.20.3.1306; Woodward FI, 1997, GLOBAL ECOL BIOGEOGR, V6, P413, DOI 10.2307/2997350; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; 2008, EFSA J, V735, P1	84	87	90	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14236	10.1371/journal.pone.0014236	http://dx.doi.org/10.1371/journal.pone.0014236			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151914	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300008
J	Ferreira, L; Castano, SV; Sanchez-Juanes, F; Gonzalez-Cabrero, S; Menegotto, F; Orduna-Domingo, A; Gonzalez-Buitrago, JM; Munoz-Bellido, JL				Ferreira, Laura; Vega Castano, Silvia; Sanchez-Juanes, Fernando; Gonzalez-Cabrero, Sandra; Menegotto, Fabiola; Orduna-Domingo, Antonio; Manuel Gonzalez-Buitrago, Jose; Luis Munoz-Bellido, Juan			Identification of Brucella by MALDI-TOF Mass Spectrometry. Fast and Reliable Identification from Agar Plates and Blood Cultures	PLOS ONE			English	Article							DESORPTION IONIZATION-TIME; RAPID IDENTIFICATION; GENUS BRUCELLA; PCR ASSAY; MELITENSIS; BACTERIA; DIFFERENTIATION; DIAGNOSIS	Background: MALDI-TOF mass spectrometry (MS) is a reliable method for bacteria identification. Some databases used for this purpose lack reference profiles for Brucella species, which is still an important pathogen in wide areas around the world. We report the creation of profiles for MALDI-TOF Biotyper 2.0 database (Bruker Daltonics, Germany) and their usefulness for identifying brucellae from culture plates and blood cultures. Methodology/Principal Findings: We created MALDI Biotyper 2.0 profiles for type strains belonging to B. melitensis biotypes 1, 2 and 3; B. abortus biotypes 1, 2, 5 and 9; B. suis, B. canis, B ceti and B. pinnipedialis. Then, 131 clinical isolates grown on plate cultures were used in triplicate to check identification. Identification at genus level was always correct, although in most cases the three replicates reported different identification at species level. Simulated blood cultures were performed with type strains belonging to the main human pathogenic species (B. melitensis, B. abortus, B. suis and B. canis), and studied by MALDI-TOF MS in triplicate. Identification at genus level was always correct. Conclusions/Significance: MALDI-TOF MS is reliable for Brucella identification to the genus level from culture plates and directly from blood culture bottles.	[Ferreira, Laura; Sanchez-Juanes, Fernando; Manuel Gonzalez-Buitrago, Jose] Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain; [Vega Castano, Silvia; Luis Munoz-Bellido, Juan] Hosp Univ Salamanca, Dept Microbiol, Salamanca, Spain; [Gonzalez-Cabrero, Sandra; Menegotto, Fabiola; Orduna-Domingo, Antonio] Univ Valladolid, Dept Anat Patol Microbiol Med Prevent & Salud Pub, Valladolid, Spain; [Manuel Gonzalez-Buitrago, Jose] Univ Salamanca, Dept Bioquim & Biol Mol, E-37008 Salamanca, Spain; [Luis Munoz-Bellido, Juan] Univ Salamanca, Dept Med Prevent Salud Publ & Microbiol Med, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; Universidad de Valladolid; University of Salamanca; University of Salamanca	Ferreira, L (corresponding author), Hosp Univ Salamanca, Unidad Invest, Salamanca, Spain.	jlmubel@usal.es	IBSAL, Secretaría/H-3719-2011; MUNOZ-BELLIDO, JUAN LUIS/B-3684-2017; Sánchez-Juanes, Fernando/AAO-2626-2020	MUNOZ-BELLIDO, JUAN LUIS/0000-0002-5981-8785; Gonzalez-Buitrago, Jose Manuel/0000-0003-4674-071X; Sanchez-Juanes, Fernando/0000-0003-1687-5891	Consejeria de Sanidad, Junta de Castilla y Leon (Spain); Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura)	Consejeria de Sanidad, Junta de Castilla y Leon (Spain)(Junta de Castilla y Leon); Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura)(Instituto de Salud Carlos IIISpanish Government)	This work was partly supported by a grant from the Consejeria de Sanidad, Junta de Castilla y Leon (Spain) and by the Instituto de Salud Carlos III (Ministerio de Sanidad, Spain) (Ayuda de Infraestructura). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIZA J, 1995, CLIN INFECT DIS, V20, P1241, DOI 10.1093/clinids/20.5.1241; Barbuddhe SB, 2008, APPL ENVIRON MICROB, V74, P5402, DOI 10.1128/AEM.02689-07; Brew SD, 1999, VET REC, V144, P483; Bricker BJ, 2000, J CLIN MICROBIOL, V38, P1258, DOI 10.1128/JCM.38.3.1258-1262.2000; Christner M, 2010, J CLIN MICROBIOL, V48, P1584, DOI 10.1128/JCM.01831-09; Colmenero JD, 1996, MEDICINE, V75, P195, DOI 10.1097/00005792-199607000-00003; Elsaghir AAF, 2003, J MED MICROBIOL, V52, P441, DOI 10.1099/jmm.0.05153-0; FERREIRA L, CLIN MICROBIOL 0428; Ferreira L, 2010, ENFERM INFEC MICR CL, V28, P492, DOI 10.1016/j.eimc.2009.12.009; Garcia-Yoldi D, 2006, CLIN CHEM, V52, P779, DOI 10.1373/clinchem.2005.062596; La Scola B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008041; Lindquist D, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P815; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Navarro E, 2004, EXPERT REV MOL DIAGN, V4, P115, DOI 10.1586/14737159.4.1.115; Prod'hom G, 2010, J CLIN MICROBIOL, V48, P1481, DOI 10.1128/JCM.01780-09; Queipo-Ortuno MI, 2005, CLIN INFECT DIS, V40, P260, DOI 10.1086/426818; Seibold E, 2010, J CLIN MICROBIOL, V48, P1061, DOI 10.1128/JCM.01953-09; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Sohn AH, 2003, EMERG INFECT DIS, V9, P485, DOI 10.3201/eid0904.020576; SOLERA J, 1995, ANTIMICROB AGENTS CH, V39, P2061, DOI 10.1128/AAC.39.9.2061; Stevenson LG, 2010, J CLIN MICROBIOL, V48, P444, DOI 10.1128/JCM.01541-09; VERGER JM, 1987, ANN INST PASTEUR MIC, V138, P235, DOI 10.1016/0769-2609(87)90199-2; Vizcaino N, 2000, MICROBES INFECT, V2, P1089, DOI 10.1016/S1286-4579(00)01263-6; Yagupsky P, 1997, J CLIN MICROBIOL, V35, P1382, DOI 10.1128/JCM.35.6.1382-1384.1997; ZA J, 1992, ANN INTERN MED, V17, P25	25	57	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14235	10.1371/journal.pone.0014235	http://dx.doi.org/10.1371/journal.pone.0014235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151913	Green Published, Green Submitted, gold			2022-12-27	WOS:000284995300007
J	Gao, DY; Jin, GD; Yao, BL; Zhang, DH; Gu, LL; Lu, ZM; Gong, QM; Lone, YC; Deng, QA; Zhang, XX				Gao, De-Yong; Jin, Gen-Di; Yao, Bi-Lian; Zhang, Dong-Hua; Gu, Lei-Lei; Lu, Zhi-Meng; Gong, Qiming; Lone, Yu-Chun; Deng, Qiang; Zhang, Xin-Xin			Characterization of the Specific CD4(+) T Cell Response against the F Protein during Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTIONS; TRANSGENIC MICE; HCV INFECTION; CORE PROTEIN; B-VIRUS; PROGRESS; CLEARANCE	Background: The hepatitis C virus (HCV) Alternate Reading Frame Protein (ARFP or F protein) presents a double-frame shift product of the HCV core gene. We and others have previously reported that the specific antibodies against the F protein could be raised in the sera of HCV chronically infected patients. However, the specific CD4(+) T cell responses against the F protein during HCV infection and the pathological implications remained unclear. In the current study, we screened the MHC class II-presenting epitopes of the F protein through HLA-transgenic mouse models and eventually validated the specific CD4+ T cell responses in HCV chronically infected patients. Methodology: DNA vaccination in HLA-DR1 and-DP4 transgenic mouse models, proliferation assay to test the F protein specific T cell response, genotyping of Chronic HCV patients and testing the F-peptide stimulated T cell response in the peripheral blood mononuclear cell (PBMC) by in vitro expansion and interferon (IFN)- gamma intracellular staining. Principal Findings: At least three peptides within HCV F protein were identified as HLA-DR or HLA-DP4 presenting epitopes by the proliferation assays in mouse models. Further study with human PBMCs evidenced the specific CD4(+) T cell responses against HCV F protein as well in patients chronically infected with HCV. Conclusion: The current study provided the evidence for the first time that HCV F protein could elicit specific CD4(+) T cell response, which may provide an insight into the immunopathogenesis during HCV chronic infection.	[Gao, De-Yong; Jin, Gen-Di; Yao, Bi-Lian; Zhang, Dong-Hua; Gu, Lei-Lei; Lu, Zhi-Meng; Gong, Qiming; Zhang, Xin-Xin] Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [Gao, De-Yong] Shanghai Jiao Tong Univ, Songjiang Hosp, Shanghai Peoples Hosp 1, Shanghai 200030, Peoples R China; [Lone, Yu-Chun] Hop Paul Brousse, INSERM, U542, Villejuif, France; [Deng, Qiang] Chinese Acad Sci, Unit Tumor Virol, Inst Pasteur Shanghai, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Gao, DY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China.	dengqiang@sibs.ac.cn; zhangxinxin@rjh.com.cn		LONE, Yu Chun/0000-0002-7417-4930	National Nature Science Grant [30471523, 30671839]; National Special Key Research Grant [2008ZX10005-009]; CAS [KSCX1-YW-10]	National Nature Science Grant; National Special Key Research Grant; CAS(Defence Research & Development Organisation (DRDO)Chinese Academy of Sciences)	This study was supported by National Nature Science Grant (30471523 and 30671839), National Special Key Research Grant (2008ZX10005-009), and Major Program of Knowledge Innovation, CAS (KSCX1-YW-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain C, 2004, J VIROL, V78, P10460, DOI 10.1128/JVI.78.19.10460-10469.2004; Barrett S, 1999, J HEPATOL, V30, P979, DOI 10.1016/S0168-8278(99)80249-9; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Berzofsky JA, 2004, J CLIN INVEST, V114, P450, DOI 10.1172/JCI200422674; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Branch AD, 2005, SEMIN LIVER DIS, V25, P105, DOI 10.1055/s-2005-864786; Cardin RD, 1996, J EXP MED, V184, P863, DOI 10.1084/jem.184.3.863; Cohen J, 1999, SCIENCE, V285, P26, DOI 10.1126/science.285.5424.26; Day CL, 2003, J EXP MED, V198, P1773, DOI 10.1084/jem.20031947; Day CL, 2002, J VIROL, V76, P12584, DOI 10.1128/JVI.76.24.12584-12595.2002; DIEPOLDER HM, 1995, LANCET, V346, P1006, DOI 10.1016/S0140-6736(95)91691-1; Drouin C, 2010, J CLIN VIROL, V47, P102, DOI 10.1016/j.jcv.2009.10.016; Eckels DD, 2000, IMMUNOL REV, V174, P90, DOI 10.1034/j.1600-0528.2002.017403.x; Gao DY, 2008, J CLIN MICROBIOL, V46, P3746, DOI 10.1128/JCM.00612-08; Gremion C, 2005, REV MED VIROL, V15, P235, DOI 10.1002/rmv.466; Komurian-Pradel F, 2004, HEPATOLOGY, V40, P900, DOI 10.1002/hep.20406; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Liang T. Jake, 2000, Annals of Internal Medicine, V132, P296; Mancini M, 1996, J BIOTECHNOL, V44, P47, DOI 10.1016/0168-1656(95)00098-4; Mancini-Bourgine M, 2007, J VIROL, V81, P4963, DOI 10.1128/JVI.02619-06; Missale G, 1996, J CLIN INVEST, V98, P706, DOI 10.1172/JCI118842; NAKABAYASHI H, 1984, GANN, V75, P151; Pascolo S, 2005, EXPERT OPIN BIOL TH, V5, P919, DOI 10.1517/14712598.5.7.919; Planz O, 1997, P NATL ACAD SCI USA, V94, P6874, DOI 10.1073/pnas.94.13.6874; Rosen HR, 2002, HEPATOLOGY, V35, P190, DOI 10.1053/jhep.2002.30293; Semmo N, 2007, J VIRAL HEPATITIS, V14, P492, DOI 10.1111/j.1365-2893.2007.00842.x; Shoukry NH, 2004, ANNU REV MICROBIOL, V58, P391, DOI 10.1146/annurev.micro.58.030603.123836; Singh R, 2007, WORLD J GASTROENTERO, V13, P1770, DOI 10.3748/wjg.v13.i12.1770; Tsai SL, 1997, HEPATOLOGY, V25, P449; Ulsenheimer A, 2003, HEPATOLOGY, V37, P1189, DOI 10.1053/jhep.2003.50194; Vassilaki N, 2009, IUBMB LIFE, V61, P739, DOI 10.1002/iub.201; Wertheimer AM, 2003, HEPATOLOGY, V37, P577, DOI 10.1053/jhep.2003.50115; Woitas RP, 1997, J IMMUNOL, V159, P1012	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14237	10.1371/journal.pone.0014237	http://dx.doi.org/10.1371/journal.pone.0014237			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151917	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300009
J	Grizenkova, J; Akhtar, S; Collinge, J; Lloyd, SE				Grizenkova, Julia; Akhtar, Shaheen; Collinge, John; Lloyd, Sarah E.			The Retinoic Acid Receptor Beta (Rarb) Region of Mmu14 Is Associated with Prion Disease Incubation Time in Mouse	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; QUANTITATIVE TRAIT LOCI; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; PROTEIN; GENE; EXPRESSION; PERIOD; COMPLEX; LINKAGE	In neurodegenerative conditions such as Alzheimer's and prion disease it has been shown that host genetic background can have a significant effect on susceptibility. Indeed, human genome-wide association studies (GWAS) have implicated several candidate genes. Understanding such genetic susceptibility is relevant to risks of developing variant CJD (vCJD) in populations exposed to bovine spongiform encephalopathy (BSE) and understanding mechanisms of neurodegeneration. In mice, aspects of prion disease susceptibility can be modelled by examining the incubation period following experimental inoculation. Quantitative trait linkage studies have already identified multiple candidate genes; however, it is also possible to take an individual candidate gene approach. Rarb and Stmn2 were selected as candidates based on the known association with vCJD. Because of the increasing overlap described between prion and Alzheimer's diseases we also chose Clu, Picalm and Cr1, which were identified as part of Alzheimer's disease GWAS. Clusterin (Clu) was considered to be of particular interest as it has already been implicated in prion disease. Approximately 1,000 heterogeneous stock (HS) mice were inoculated intra-cerebrally with Chandler/RML prions and incubation times were recorded. Candidate genes were evaluated by sequencing the whole transcript including exon-intron boundaries and potential promoters in the parental lines of the HS mice. Representative SNPs were genotyped in the HS mice. No SNPs were identified in Cr1 and no statistical association with incubation time was seen for Clu (P=0.96) and Picalm (P=0.91). Significant associations were seen for both Stmn2 (P=0.04) and Rarb (P=0.0005), however, this was only highly significant for Rarb. This data provides significant further support for a role for the Rarb region of Mmu14 and Stmn2 in prion disease.	[Grizenkova, Julia] UCL, MRC Prion Unit, London, England; UCL, Dept Neurodegenerat Dis, UCL Inst Neurol, London, England	University of London; University College London; University of London; University College London	Grizenkova, J (corresponding author), UCL, MRC Prion Unit, London, England.	s.lloyd@prion.ucl.ac.uk			Medical Research Council UK; MRC [MC_U123160652] Funding Source: UKRI; Medical Research Council [MC_U123160652] Funding Source: researchfish	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was funded by the Medical Research Council UK. http://www.mrc.ac.uk/index.htm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bate C, 2004, J NEUROSCI METH, V138, P217, DOI 10.1016/j.jneumeth.2004.04.001; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Cabral ALB, 2002, J BIOL CHEM, V277, P5675, DOI 10.1074/jbc.M104815200; CARLSON GA, 1993, GENETICS, V133, P979; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; Collinge J, 2005, J NEUROL NEUROSUR PS, V76, P906, DOI 10.1136/jnnp.2004.048660; COLLINGE J, 1991, LANCET, V337, P1441, DOI 10.1016/0140-6736(91)93128-V; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; DARVASI A, 1992, THEOR APPL GENET, V85, P353, DOI 10.1007/BF00222881; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; HITZEMANN B, 1994, J PHARMACOL EXP THER, V271, P969; Kempster S, 2004, NEUROREPORT, V15, P1735, DOI 10.1097/01.wnr.0000134990.97051.22; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LANDER ES, 1989, GENETICS, V121, P185; Lloyd SE, 2010, NEUROGENETICS, V11, P185, DOI 10.1007/s10048-009-0219-8; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Lloyd SE, 2002, NEUROGENETICS, V4, P77, DOI 10.1007/s10048-002-0133-9; Lloyd SE, 2001, P NATL ACAD SCI USA, V98, P6279, DOI 10.1073/pnas.101130398; Manolakou K, 2001, P NATL ACAD SCI USA, V98, P7402, DOI 10.1073/pnas.121172098; Mead S, 2003, SCIENCE, V300, P640, DOI 10.1126/science.1083320; Mead S, 2009, LANCET NEUROL, V8, P57, DOI 10.1016/S1474-4422(08)70265-5; MELLON PL, 1990, NEURON, V5, P1, DOI 10.1016/0896-6273(90)90028-E; Moore RC, 1998, NAT GENET, V18, P118, DOI 10.1038/ng0298-118; Moreno CR, 2003, GENETICS, V165, P2085; O'Shea M, 2008, GENETICS, V180, P559, DOI 10.1534/genetics.108.090894; PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0; PARKIN ET, 2007, P NATL ACAD SCI US; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Stephenson DA, 2000, GENOMICS, V69, P47, DOI 10.1006/geno.2000.6320; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; Xu F, 2008, BBA-MOL BASIS DIS, V1782, P615, DOI 10.1016/j.bbadis.2008.08.004; Yamazaki K, 2003, BIOCHEM BIOPH RES CO, V305, P1034, DOI 10.1016/S0006-291X(03)00801-5	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15019	10.1371/journal.pone.0015019	http://dx.doi.org/10.1371/journal.pone.0015019			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151910	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300013
J	Chew, C; Eysenbach, G				Chew, Cynthia; Eysenbach, Gunther			Pandemics in the Age of Twitter: Content Analysis of Tweets during the 2009 H1N1 Outbreak	PLOS ONE			English	Article							RISK	Background: Surveys are popular methods to measure public perceptions in emergencies but can be costly and time consuming. We suggest and evaluate a complementary "infoveillance" approach using Twitter during the 2009 H1N1 pandemic. Our study aimed to: 1) monitor the use of the terms "H1N1" versus "swine flu" over time; 2) conduct a content analysis of "tweets"; and 3) validate Twitter as a real-time content, sentiment, and public attention trend-tracking tool. Methodology/Principal Findings: Between May 1 and December 31, 2009, we archived over 2 million Twitter posts containing keywords "swine flu," "swineflu," and/or "H1N1." using Infovigil, an infoveillance system. Tweets using "H1N1" increased from 8.8% to 40.5% (R-2 =.788; p<.001), indicating a gradual adoption of World Health Organization-recommended terminology. 5,395 tweets were randomly selected from 9 days, 4 weeks apart and coded using a tri-axial coding scheme. To track tweet content and to test the feasibility of automated coding, we created database queries for keywords and correlated these results with manual coding. Content analysis indicated resource-related posts were most commonly shared (52.6%). 4.5% of cases were identified as misinformation. News websites were the most popular sources (23.2%), while government and health agencies were linked only 1.5% of the time. 7/10 automated queries correlated with manual coding. Several Twitter activity peaks coincided with major news stories. Our results correlated well with H1N1 incidence data. Conclusions: This study illustrates the potential of using social media to conduct "infodemiology" studies for public health. 2009 H1N1-related tweets were primarily used to disseminate information from credible sources, but were also a source of opinions and experiences. Tweets can be used for real-time content analysis and knowledge translation research, allowing health authorities to respond to public concerns.	[Chew, Cynthia; Eysenbach, Gunther] Univ Hlth Network, Ctr Global eHlth Innovat, Toronto, ON, Canada; [Chew, Cynthia; Eysenbach, Gunther] Univ Toronto, Dept Hlth Policy Management & Evaluat, Fac Med, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Chew, C (corresponding author), Univ Hlth Network, Ctr Global eHlth Innovat, Toronto, ON, Canada.	geysenba@gmail.com	Eysenbach, Gunther/AAJ-7158-2020	Eysenbach, Gunther/0000-0001-6479-5330	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	Mrs. Chew was generously supported by a Canadian Institutes of Health Research Frederick Banting and Charles Best Canada Graduate Scholarship Master's Award. Infovigil.com is a non-commercial project/website, partly funded by the Canadian Institutes of Health Research (CIHR) [Pandemics in the Age of Social Media: Content Analysis of Tweets for Infoveillance and Knowledge Translation Research, PI: Gunther Eysenbach]. Other parts of the project costs may in the future be defrayed by consulting and collaborating with commercial entities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS M, 2009, 10 SWIN FLU LIES TOL; *AG AUT, 2009, CBS REP PAR CONC H1N; Balkhy HH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-42; Blendon RJ, 2003, J HEALTH COMMUN, V8, P83, DOI 10.1080/10810730390224884; *CBC, 2009, H POTT ACT REC SWIN; Center for Disease Control and Prevention, 2010, UPD CDC EST 2009 H1N; *CNN, 2009, 1 DOS H1N1 FLU VACC; Eysenbach G, 2002, BMJ-BRIT MED J, V324, P573, DOI 10.1136/bmj.324.7337.573; Eysenbach Gunther, 2006, AMIA Annu Symp Proc, P244; Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157; HUGHES A, 2009, P 6 INT ISCRAM C 200; Jones JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008032; Kallan F V, 1997, Ugeskr Laeger, V159, P6528; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Lau JTF, 2009, J INFECTION, V59, P122, DOI 10.1016/j.jinf.2009.06.004; Lau JTF, 2009, BRIT MED J, V338, pb4164, DOI DOI 10.1136/bmj.b4164; Lenhart A., 2009, TWITTER STATUS UPDAT; MASTRAPA G, 2009, PAX SWINE FLU OUTBRE; PICARD A, 2010, LESSONS H1N1 PREACH; Prue CE, 2003, J HEALTH COMMUN, V8, P35, DOI 10.1080/10810730390224866; Quantcast, 2010, TWITT DEM; Ripberger JT, 2010, CULTIVATING CURIOSIT; Rubin GJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2651; Seale H, 2009, MED J AUSTRALIA, V191, P267, DOI 10.5694/j.1326-5377.2009.tb02781.x; STARBIRD K, 2010, P 7 INT ISCRAM C 201; STARBIRD K, 2010, P ACM 2010 COMP SUPP; SUTTER J, 2009, SWINE FLU CREATES CO; Sypsa V, 2009, EUROSURVEILLANCE, V14; Sysomos, 2010, EXPL US TWITT WORLD; Sysomos, 2009, INS TWITT IN DEPTH L; *TIM IND, 2009, CARB MON POIS CAN CR; Van D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-130; *WHO, 2009, CHRON INFL A H1N1; Woien G, 2009, EUROSURVEILLANCE, V14; Wong LP, 2010, PREV MED, V51, P92, DOI 10.1016/j.ypmed.2010.04.010; World Health Organization, 2009, WORLD NOW START 2009; 2009, PORK MAGAZINE	37	843	858	32	473	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14118	10.1371/journal.pone.0014118	http://dx.doi.org/10.1371/journal.pone.0014118			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124761	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500008
J	Iyoda, M; Kasamatsu, A; Ishigami, T; Nakashima, D; Endo-Sakamoto, Y; Ogawara, K; Shiiba, M; Tanzawa, H; Uzawa, K				Iyoda, Manabu; Kasamatsu, Atsushi; Ishigami, Takashi; Nakashima, Dai; Endo-Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro			Epithelial Cell Transforming Sequence 2 in Human Oral Cancer	PLOS ONE			English	Article							CYTOKINESIS REGULATOR ECT2; LYMPH-NODE METASTASIS; RHO-GTPASES; ABERRANT EXPRESSION; G2/M PHASE; G(1) PHASE; CARCINOMA; CYCLE; PROGRESSION; OVEREXPRESSION	Background: Epithelial cell transforming sequence 2 (ECT2) is a guanine nucleotide exchange factor for Rho family GTPase, which has been implicated in the malignant phenotype of human cancers. Little is known about the effect of a high level of ECT2 in regulating oral cancer cell behavior. In this study, we investigated the involvement of ECT2 in oral squamous cell carcinoma (OSCC). Methodology/Principal Findings: We analyzed ECT2 expression in OSCC-derived cell lines and primary OSCCs compared with matched normal tissue (n = 96) by quantitative reverse transcriptase-polymerase chain reaction, Western blot, and immunohistochemistry. We then evaluated the correlation between the ECT2 expression status in primary OSCCs and the clinicopathological features. ECT2 expression was significantly up-regulated in OSCCs in vitro and in vivo (p<0.05). Among the clinical variables analyzed, higher ECT2 expression also was associated with the TNM stage grading (p<0.05). When we performed functional analyses of ECT2 in OSCC-derived cells using the shRNA system, the cellular proliferation of the ECT2 knockdown cells decreased significantly compared with the control cells (p<0.05). Cell cycle analysis by flow cytometry showed arrest of cell cycle progression at the G1 phase in the ECT2 knockdown cells. We also found up-regulation of the Cip/Kip family of the cyclin-dependent kinase inhibitors, p21(cip1) and p27(kip1), and down-regulation of cyclin D1, cyclin E, and CDK4. These data suggested that the elevated Cip/Kip family induced inhibition of the cyclin D1-CDK complex activity leading to cell cycle arrest at the G1 phase. Conclusions/Significance: Our results proposed for the first time that ECT2 is an indicator of cellular proliferation in OSCCs and that ECT2 might be a potential therapeutic target for the development of new treatments for OSCCs.	[Iyoda, Manabu; Kasamatsu, Atsushi; Ishigami, Takashi; Nakashima, Dai; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Kasamatsu, Atsushi; Endo-Sakamoto, Yosuke; Ogawara, Katsunori; Shiiba, Masashi; Tanzawa, Hideki; Uzawa, Katsuhiro] Chiba Univ Hosp, Div Dent & Oral Maxillofacial Surg, Chiba, Japan	Chiba University; Chiba University	Iyoda, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan.	uzawak@faculty.chiba-u.jp		Uzawa, Katsuhiro/0000-0002-7036-0859	Ministry of Education, Culture, Sports, Science and Technology of Japan [20592353]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid Scientific Research (No. 20592353) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boettner B, 2002, GENE, V286, P155, DOI 10.1016/S0378-1119(02)00426-2; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Coleman ML, 2006, ONCOGENE, V25, P2708, DOI 10.1038/sj.onc.1209322; Coleman ML, 2003, EMBO J, V22, P2036, DOI 10.1093/emboj/cdg189; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; del Pulgar TG, 2005, BIOESSAYS, V27, P602, DOI 10.1002/bies.20238; Endo Y, 2004, INT J CANCER, V110, P225, DOI 10.1002/ijc.20118; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hara T, 2006, ONCOGENE, V25, P566, DOI 10.1038/sj.onc.1209078; Hussenet T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008960; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Kasamatsu A, 2005, INT J MOL MED, V16, P269; Kato Y, 2007, INT J ONCOL, V31, P1021; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kouzu Y, 2006, BRIT J CANCER, V94, P717, DOI 10.1038/sj.bjc.6602991; MACFARLANE GJ, 1995, ORAL ONCOL, V31B, P181; MARSHALL CJ, 1991, CELL, V64, P313, DOI 10.1016/0092-8674(91)90641-B; MASHBERG A, 1993, CANCER-AM CANCER SOC, V72, P1369, DOI 10.1002/1097-0142(19930815)72:4<1369::AID-CNCR2820720436>3.0.CO;2-L; McFarlane C, 2010, CANCER RES, V70, P3329, DOI 10.1158/0008-5472.CAN-09-4152; MUSGROVE EA, 1994, P NATL ACAD SCI USA, V91, P8022, DOI 10.1073/pnas.91.17.8022; Niiya F, 2006, ONCOGENE, V25, P827, DOI 10.1038/sj.onc.1209124; Niiya F, 2005, J BIOL CHEM, V280, P36502, DOI 10.1074/jbc.M508007200; Nomura H, 2009, HUM PATHOL, V40, P83, DOI 10.1016/j.humpath.2008.06.018; OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Onda T, 2006, BRIT J CANCER, V94, P698, DOI 10.1038/sj.bjc.6602986; Pan YL, 2004, BIOCHEM BIOPH RES CO, V315, P686, DOI 10.1016/j.bbrc.2004.01.108; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; Ridley AJ, 2001, TRENDS CELL BIOL, V11, P471, DOI 10.1016/S0962-8924(01)02153-5; Saito K, 2006, ONCOL REP, V15, P49; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Sakuma T, 2006, INT J ONCOL, V29, P117; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sano M, 2006, ONCOL REP, V16, P1093; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shimada K, 2005, BRIT J CANCER, V92, P1915, DOI 10.1038/sj.bjc.6602594; Sudbo J, 2005, INT J CANCER, V115, P339, DOI 10.1002/ijc.20896; TAM SW, 1994, ONCOGENE, V9, P2663; Tanaka C, 2003, J DENT RES, V82, P607, DOI 10.1177/154405910308200807; Tatsumoto T, 1999, J CELL BIOL, V147, P921, DOI 10.1083/jcb.147.5.921; Villalonga P, 2006, GROWTH FACTORS, V24, P159, DOI 10.1080/08977190600560651; YAMAMOTO M, 1993, ONCOGENE, V8, P1449; Yamano Y, 2008, INT J ONCOL, V32, P1001; Yang YL, 2008, GENE CHROMOSOME CANC, V47, P127, DOI 10.1002/gcc.20514; YONGLIU, 2010, J ATHEROSCLER T 0611; Zhang ML, 2008, HEPATOB PANCREAT DIS, V7, P533	47	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14082	10.1371/journal.pone.0014082	http://dx.doi.org/10.1371/journal.pone.0014082			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124766	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500003
J	Schoep, TD; Fulurija, A; Good, F; Lu, W; Himbeck, RP; Schwan, C; Choi, SS; Berg, DE; Mittl, PRE; Benghezal, M; Marshall, BJ				Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Choi, Sung Sook; Berg, Douglas E.; Mittl, Peer R. E.; Benghezal, Mohammed; Marshall, Barry J.			Surface Properties of Helicobacter pylori Urease Complex Are Essential for Persistence	PLOS ONE			English	Article							GASTRIC EPITHELIAL-CELLS; B-SUBUNIT; ACTIVATION; CD74; MHC; MACROPHAGES; INFECTION; MIGRATION; BINDS; PH	The enzymatic activity of Helicobacter pylori's urease neutralises stomach acidity, thereby promoting infection by this pathogen. Urease protein has also been found to interact with host cells in vitro, although this property's possible functional importance has not been studied in vivo. To test for a role of the urease surface in the host/pathogen interaction, surface exposed loops that display high thermal mobility were targeted for inframe insertion mutagenesis. H. pylori expressing urease with insertions at four of eight sites tested retained urease activity, which in three cases was at least as stable as was wild-type urease at pH 3. Bacteria expressing one of these four mutant ureases, however, failed to colonise mice for even two weeks, and a second had reduced bacterial titres after longer term (3 to 6 months) colonisation. These results indicate that a discrete surface of the urease complex is important for H. pylori persistence during gastric colonisation. We propose that this surface interacts directly with host components important for the host-pathogen interaction, immune modulation or other actions that underlie H. pylori persistence in its special gastric mucosal niche.	[Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Benghezal, Mohammed; Marshall, Barry J.] Ondek Pty Ltd, Nedlands, WA, Australia; [Schoep, Tobias D.; Fulurija, Alma; Good, Fayth; Lu, Wei; Himbeck, Robyn P.; Schwan, Carola; Benghezal, Mohammed; Marshall, Barry J.] Univ Western Australia, H Pylori Res Lab, Nedlands, WA 6009, Australia; [Mittl, Peer R. E.] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland; [Choi, Sung Sook; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA	University of Western Australia; University of Zurich; Washington University (WUSTL)	Schoep, TD (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	mohammed.benghezal@uwa.edu.au	Mittl, Peer/E-5352-2017	Benghezal, Mohammed/0000-0002-4207-0192; Schoep, Tobias/0000-0003-1083-292X; Marshall, Barry/0000-0003-4853-5015; Fulurija, Alma/0000-0003-1776-785X				Beswick EJ, 2006, INFECT IMMUN, V74, P1148, DOI 10.1128/IAI.74.2.1148-1155.2006; Casares S, 1997, VIRAL IMMUNOL, V10, P129, DOI 10.1089/vim.1997.10.129; Cho YS, 2007, J BIOL CHEM, V282, P23447, DOI 10.1074/jbc.M702950200; DAILIDIENE D, 2006, COUNTERSELE IN PRESS; Dailidiene D, 2006, APPL ENVIRON MICROB, V72, P5908, DOI 10.1128/AEM.01135-06; Ding SZ, 2007, INFECT IMMUN, V75, P4030, DOI 10.1128/IAI.00172-07; EATON KA, 1994, INFECT IMMUN, V62, P3604, DOI 10.1128/IAI.62.9.3604-3607.1994; Fan XJ, 2000, J IMMUNOL, V165, P1918, DOI 10.4049/jimmunol.165.4.1918; Faure-Andre G, 2008, SCIENCE, V322, P1705, DOI 10.1126/science.1159894; FERRERO RL, 1994, INFECT IMMUN, V62, P4981, DOI 10.1128/IAI.62.11.4981-4989.1994; Ha NC, 2001, NAT STRUCT BIOL, V8, P505, DOI 10.1038/88563; Harris PR, 1998, J INFECT DIS, V178, P1516, DOI 10.1086/314426; Harris PR, 1996, GASTROENTEROLOGY, V111, P419, DOI 10.1053/gast.1996.v111.pm8690207; HU LT, 1990, INFECT IMMUN, V58, P992, DOI 10.1128/IAI.58.4.992-998.1990; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Kleanthous H., 1995, Gut, V37, pA94; Kuwahara H, 2000, INFECT IMMUN, V68, P4378, DOI 10.1128/IAI.68.8.4378-4383.2000; MAI UEH, 1992, J EXP MED, V175, P517, DOI 10.1084/jem.175.2.517; Makristathis A, 1998, J INFECT DIS, V177, P803, DOI 10.1086/517814; Marcus EA, 2001, HELICOBACTER, V6, P93, DOI 10.1046/j.1523-5378.2001.00014.x; McConnell EL, 2008, J PHARM PHARMACOL, V60, P63, DOI 10.1211/jpp.60.1.0008; Pinkse MWH, 2003, J MASS SPECTROM, V38, P315, DOI 10.1002/jms.443; Rokita E, 1998, J INFECT DIS, V178, P1521, DOI 10.1086/314459; Sambrook J, 2001, MOL CLONING LAB MANU; Schwartz JT, 2006, J LEUKOCYTE BIOL, V79, P1214, DOI 10.1189/jlb.0106030; Shevchuk NA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh014; Shi Y, 2007, VACCINE, V25, P2583, DOI 10.1016/j.vaccine.2006.12.024; SUZUKI T, 2006, CARCINOGENESIS; Tanahashi T, 2000, INFECT IMMUN, V68, P664, DOI 10.1128/IAI.68.2.664-671.2000; Wang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010844; Williams CL, 1996, FEMS IMMUNOL MED MIC, V13, P87, DOI 10.1111/j.1574-695X.1996.tb00220.x; Wroblewski LE, 2009, GASTROENTEROLOGY, V136, P236, DOI 10.1053/j.gastro.2008.10.011	32	44	49	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15042	10.1371/journal.pone.0015042	http://dx.doi.org/10.1371/journal.pone.0015042			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124783	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500022
J	Su, RW; Lei, W; Liu, JL; Zhang, ZR; Jia, B; Feng, XH; Ren, G; Hu, SJ; Yang, ZM				Su, Ren-Wei; Lei, Wei; Liu, Ji-Long; Zhang, Zhi-Rong; Jia, Bo; Feng, Xu-Hui; Ren, Gang; Hu, Shi-Jun; Yang, Zeng-Ming			The Integrative Analysis of microRNA and mRNA Expression in Mouse Uterus under Delayed Implantation and Activation	PLOS ONE			English	Article							EMBRYO IMPLANTATION; GENE-EXPRESSION; MATRIX METALLOPROTEINASES; PERIIMPLANTATION PERIOD; UTERINE RECEPTIVITY; SERIAL ANALYSIS; MICE; DECIDUALIZATION; RECEPTOR; MIRNAS	Background: Delayed implantation is a developmental arrest at the blastocyst stage and a good model for embryo implantation. MicroRNAs (miRNAs) have been shown to be involved in mouse embryo implantation through regulating uterine gene expression. This study was to have an integrative analysis on global miRNA and mRNA expression in mouse uterus under delayed implantation and activation through Illumina sequencing. Methodology/Principal Findings: By deep sequencing and analysis, we found that there are 20 miRNAs up-regulated and 42 miRNAs down-regulated at least 1.2 folds, and 268 genes up-regulated and 295 genes down-regulated at least 2 folds under activation compared to delayed implantation, respectively. Many different forms of editing in mature miRNAs are detected. The percentage of editing at positions 4 and 5 of mature miRNAs is significantly higher under delayed implantation than under activation. Although the number of miR-21 reference sequence under activation is slightly lower than that under delayed implantation, the total level of miR-21 under activation is higher than that under delayed implantation. Six novel miRNAs are predicted and confirmed. The target genes of significantly up-regulated miRNAs under activation are significantly enriched. Conclusions: miRNA and mRNA expression patterns are closely related. The target genes of up-regulated miRNAs are significantly enriched. A high level of editing at positions 4 and 5 of mature miRNAs is detected under delayed implantation than under activation. Our data should be valuable for future study on delayed implantation.	[Su, Ren-Wei; Zhang, Zhi-Rong; Jia, Bo; Feng, Xu-Hui; Yang, Zeng-Ming] Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, Xiamen, Peoples R China; [Su, Ren-Wei; Lei, Wei; Liu, Ji-Long; Ren, Gang; Hu, Shi-Jun] NE Agr Univ, Sch Sci, Harbin, Peoples R China	Xiamen University; Northeast Agricultural University - China	Su, RW (corresponding author), Xiamen Univ, Sch Life Sci, Minist Educ Cell Biol & Tumor Cell Engn, Key Lab, Xiamen, Peoples R China.	zmyang@xmu.edu.cn	Lei, Wei/I-3640-2014; feng, xuhui/D-9450-2017; Yang, ZM/G-4627-2010; Hu, Shijun/I-5818-2012; feng, xuhui/AAD-9832-2019; Lei, Wei/N-7611-2013; ZHANG, Zhirong/A-3422-2015	feng, xuhui/0000-0003-4649-183X; Lei, Wei/0000-0002-8342-8859; ZHANG, Zhirong/0000-0002-7331-783X; Ren, Gang/0000-0002-2555-7804; Hu, Shijun/0000-0002-0068-8429; Liu, Ji-Long/0000-0002-6948-2576	National Basic Research Program of China [2011CB944402]; Chinese National Natural Science Foundation [30770244, 30930013]	National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (2011CB944402) and Chinese National Natural Science Foundation grants (30770244 and 30930013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bany BM, 2000, J REPROD FERTIL, V120, P125, DOI 10.1530/reprod/120.1.125; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hanriot L, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-418; Hewitt SC, 2003, MOL ENDOCRINOL, V17, P2070, DOI 10.1210/me.2003-0146; Hobert O, 2007, CELL, V131, P22, DOI 10.1016/j.cell.2007.09.031; Hogh Annabeth Laursen, 2008, V387, P3; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; KAISER M, 1990, ENDOCRINOLOGY, V126, P2768, DOI 10.1210/endo-126-5-2768; Kal AJ, 1999, MOL BIOL CELL, V10, P1859, DOI 10.1091/mbc.10.6.1859; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim YK, 2007, EMBO J, V26, P775, DOI 10.1038/sj.emboj.7601512; Kin T, 2007, NUCLEIC ACIDS RES, V35, pD145, DOI 10.1093/nar/gkl837; Korgun ET, 2007, J MOL HISTOL, V38, P253, DOI 10.1007/s10735-007-9095-4; Kuchenbauer F, 2008, GENOME RES, V18, P1787, DOI 10.1101/gr.077578.108; Lakshmi SS, 2008, NUCLEIC ACIDS RES, V36, pD173, DOI 10.1093/nar/gkm696; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Luu KC, 2004, P NATL ACAD SCI USA, V101, P8028, DOI 10.1073/pnas.0401069101; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Ma XH, 2006, J BIOL CHEM, V281, P9351, DOI 10.1074/jbc.M511512200; Mantena SR, 2006, P NATL ACAD SCI USA, V103, P1870, DOI 10.1073/pnas.0507261103; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; MCLAREN A, 1968, J ENDOCRINOL, V42, P453, DOI 10.1677/joe.0.0420453; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Ni H, 2009, FERTIL STERIL, V91, P2123, DOI 10.1016/j.fertnstert.2008.04.053; PARIA BC, 1993, P NATL ACAD SCI USA, V90, P10159, DOI 10.1073/pnas.90.21.10159; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; Reid JG, 2008, GENOME RES, V18, P1571, DOI 10.1101/gr.078246.108; Robb L, 1998, NAT MED, V4, P303, DOI 10.1038/nm0398-303; Salamonsen LA, 1999, REV REPROD, V4, P11; Sharma N, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-61; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; SIMON C, 1994, ENDOCRINOLOGY, V134, P521, DOI 10.1210/en.134.2.521; Skrzypczak J, 2007, AM J REPROD IMMUNOL, V57, P40, DOI 10.1111/j.1600-0897.2006.00443.x; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tan Y, 2004, DEV BIOL, V265, P181, DOI 10.1016/j.ydbio.2003.09.019; Tranguch S, 2007, BIOL REPROD, V77, P425, DOI 10.1095/biolreprod.107.062414; Wang BQ, 2007, AM J PHYSIOL-HEART C, V293, pH1282, DOI 10.1152/ajpheart.00910.2006; Wang D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004421; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Xin FX, 2009, BIOINFORMATICS, V25, P430, DOI 10.1093/bioinformatics/btn646; Yoshie M, 2006, MOL REPROD DEV, V73, P164, DOI 10.1002/mrd.20408; Zhao YC, 2008, ENDOCRINOLOGY, V149, P2325, DOI 10.1210/en.2007-1420; Zhou XF, 2007, PLOS COMPUT BIOL, V3, P412, DOI 10.1371/journal.pcbi.0030037	56	29	30	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15513	10.1371/journal.pone.0015513	http://dx.doi.org/10.1371/journal.pone.0015513			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124741	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500043
J	Bisazza, A; Piffer, L; Serena, G; Agrillo, C				Bisazza, Angelo; Piffer, Laura; Serena, Giovanna; Agrillo, Christian			Ontogeny of Numerical Abilities in Fish	PLOS ONE			English	Article							ANALOG NUMBER REPRESENTATIONS; SEQUENTIALLY PRESENTED SETS; CHIMPANZEE PAN-TROGLODYTES; SMALL NUMEROSITIES; TRACKING MULTIPLE; OBJECT FILES; SHOAL SIZE; INFANTS; DISCRIMINATION; QUANTITY	Background: It has been hypothesised that human adults, infants, and non-human primates share two non-verbal systems for enumerating objects, one for representing precisely small quantities (up to 3-4 items) and one for representing approximately larger quantities. Recent studies exploiting fish's spontaneous tendency to join the larger group showed that their ability in numerical discrimination closely resembles that of primates but little is known as to whether these capacities are innate or acquired. Methodology/Principal Findings: We used the spontaneous tendency to join the larger shoal to study the limits of the quantity discrimination of newborn and juvenile guppies. One-day old fish chose the larger shoal when the choice was between numbers in the small quantity range, 2 vs. 3 fish, but not when they had to choose between large numbers, 4 vs. 8 or 4 vs. 12, although the numerical ratio was larger in the latter case. To investigate the relative role of maturation and experience in large number discrimination, fish were raised in pairs (with no numerical experience) or in large social groups and tested at three ages. Forty-day old guppies from both treatments were able to discriminate 4 vs. 8 fish while at 20 days this was only observed in fish grown in groups. Control experiments showed that these capacities were maintained after guppies were prevented from using non numerical perceptual variables that co-vary with numerosity. Conclusions/Significance: Overall, our results suggest the ability of guppies to discriminate small numbers is innate and is displayed immediately at birth while discrimination of large numbers emerges later as a result of both maturation and social experience. This developmental dissociation suggests that fish like primates might have separate systems for small and large number representation.	[Bisazza, Angelo; Piffer, Laura; Serena, Giovanna; Agrillo, Christian] Univ Padua, Dept Gen Psychol, Padua, Italy	University of Padua	Bisazza, A (corresponding author), Univ Padua, Dept Gen Psychol, Padua, Italy.	christian.agrillo@unipd.it		Agrillo, Christian/0000-0002-7391-8934; Bisazza, Angelo/0000-0003-0209-7638	ASAB; University of Padova to Angelo Bisazza [CPDA087853/08]	ASAB; University of Padova to Angelo Bisazza	This study was supported by an ASAB research grant to Christian Agrillo and 'Progetti di Ricerca di Ateneo', No. CPDA087853/08 from University of Padova to Angelo Bisazza. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrillo C, 2008, ANIM COGN, V11, P495, DOI 10.1007/s10071-008-0140-9; Agrillo C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004786; ANTELL SE, 1983, CHILD DEV, V54, P695, DOI 10.2307/1130057; ATKINSON J, 1976, PERCEPTION, V5, P335, DOI 10.1068/p050335; Barth H, 2003, COGNITION, V86, P201, DOI 10.1016/S0010-0277(02)00178-6; Beran MJ, 2008, AM J PRIMATOL, V70, P191, DOI 10.1002/ajp.20474; Beran MJ, 2007, J EXP PSYCHOL-ANIM B, V33, P42, DOI 10.1037/0097-7403.33.1.42; Beran MJ, 2004, PSYCHOL SCI, V15, P94, DOI 10.1111/j.0963-7214.2004.01502004.x; BIJELJACBABIC R, 1993, DEV PSYCHOL, V29, P711, DOI 10.1037/0012-1649.29.4.711; Bonanni R, 2011, ANIM COGN, V14, P103, DOI 10.1007/s10071-010-0348-3; Buckingham JN, 2007, BEHAVIOUR, V144, P1333, DOI 10.1163/156853907782418196; Cantlon JF, 2007, J EXP PSYCHOL-ANIM B, V33, P32, DOI 10.1037/0097-7403.33.1.32; Cantlon JF, 2010, DEVELOPMENTAL SCI, V13, P289, DOI 10.1111/j.1467-7687.2009.00887.x; Cantlon JF, 2006, PSYCHOL SCI, V17, P401, DOI 10.1111/j.1467-9280.2006.01719.x; Cordes S, 2001, PSYCHON B REV, V8, P698, DOI 10.3758/BF03196206; Cordes S, 2008, DEVELOPMENTAL SCI, V11, P803, DOI 10.1111/j.1467-7687.2008.00770.x; Cordes S, 2009, DEV PSYCHOL, V45, P1583, DOI 10.1037/a0015666; Cordes S, 2009, DEVELOPMENTAL SCI, V12, P453, DOI 10.1111/j.1467-7687.2008.00781.x; Dacke M, 2008, ANIM COGN, V11, P683, DOI 10.1007/s10071-008-0159-y; Dadda M, 2009, COGNITION, V112, P343, DOI 10.1016/j.cognition.2009.05.009; Demeyere N, 2010, NEUROCASE, V16, P219, DOI 10.1080/13554790903405719; Feigenson L, 2002, PSYCHOL SCI, V13, P150, DOI 10.1111/1467-9280.00427; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feigenson L, 2004, TRENDS COGN SCI, V8, P307, DOI 10.1016/j.tics.2004.05.002; Flombaum JI, 2005, COGNITION, V97, P315, DOI 10.1016/j.cognition.2004.09.004; Gomez-Laplaza LM, 2011, ANIM COGN, V14, P1, DOI 10.1007/s10071-010-0337-6; Gross HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004263; HAGER MC, 1991, BEHAV ECOL SOCIOBIOL, V29, P271, DOI 10.1007/BF00163984; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Hauser MD, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P853; Hauser MD, 2000, P ROY SOC B-BIOL SCI, V267, P829, DOI 10.1098/rspb.2000.1078; Hauser MD, 2003, COGNITIVE PSYCHOL, V47, P367, DOI 10.1016/S0010-0285(03)00050-1; Hunt S, 2008, P ROY SOC B-BIOL SCI, V275, P2373, DOI 10.1098/rspb.2008.0702; Hyde DC, 2009, J COGNITIVE NEUROSCI, V21, P1039, DOI 10.1162/jocn.2009.21090; Irie-Sugimoto N, 2009, ANIM COGN, V12, P193, DOI 10.1007/s10071-008-0185-9; Izard V, 2009, P NATL ACAD SCI USA, V106, P10382, DOI 10.1073/pnas.0812142106; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Kobayashi T, 2005, DEVELOPMENTAL SCI, V8, P409, DOI 10.1111/j.1467-7687.2005.00429.x; Lewis KP, 2005, ANIM COGN, V8, P247, DOI 10.1007/s10071-004-0251-x; Lipton JS, 2003, PSYCHOL SCI, V14, P396, DOI 10.1111/1467-9280.01453; Magellan K, 2009, J FISH BIOL, V74, P2329, DOI 10.1111/j.1095-8649.2009.02245.x; Matsuzawa T, 2009, CURR OPIN NEUROBIOL, V19, P92, DOI 10.1016/j.conb.2009.04.007; MCCOMB K, 1994, ANIM BEHAV, V47, P379, DOI 10.1006/anbe.1994.1052; MECK WH, 1983, J EXP PSYCHOL ANIM B, V9, P320, DOI 10.1037/0097-7403.9.3.320; Murofushi K, 1997, JPN PSYCHOL RES, V39, P140, DOI 10.1111/1468-5884.00050; OYAMA T, 1981, PERCEPT PSYCHOPHYS, V29, P106, DOI 10.3758/BF03207273; Pisa P, 2009, J ETHOL, V27, P289, DOI 10.1007/s10164-008-0121-0; Pritchard VL, 2001, ANIM BEHAV, V62, P1085, DOI 10.1006/anbe.2001.1858; PYLYSHYN Z, 1987, B PSYCHONOMIC SOC, V25, P332; Revkin SK, 2008, PSYCHOL SCI, V19, P607, DOI 10.1111/j.1467-9280.2008.02130.x; Rugani R, 2008, J EXP PSYCHOL-ANIM B, V34, P388, DOI 10.1037/0097-7403.34.3.388; Rugani R, 2009, P ROY SOC B-BIOL SCI, V276, P2451, DOI 10.1098/rspb.2009.0044; Scholl BJ, 1999, COGNITIVE PSYCHOL, V38, P259, DOI 10.1006/cogp.1998.0698; Simon TJ, 1999, TRENDS COGN SCI, V3, P363, DOI 10.1016/S1364-6613(99)01383-2; Sokal R.R., 2012, BIOMETRY; Stevens JR, 2007, ANIM COGN, V10, P429, DOI 10.1007/s10071-007-0081-8; Tomonaga M, 2002, ANIM LEARN BEHAV, V30, P143, DOI 10.3758/BF03192916; TRICK LM, 1993, J EXP PSYCHOL HUMAN, V19, P331, DOI 10.1037/0096-1523.19.2.331; TRICK LM, 1994, PSYCHOL REV, V101, P80, DOI 10.1037/0033-295X.101.1.80; Uller C, 1999, COGNITIVE DEV, V14, P1, DOI 10.1016/S0885-2014(99)80016-1; Uller C, 2003, ANIM COGN, V6, P105, DOI 10.1007/s10071-003-0167-x; Uller C, 2009, ANIM COGN, V12, P733, DOI 10.1007/s10071-009-0225-0; Van Herwegen J, 2008, DEVELOPMENTAL SCI, V11, P637, DOI 10.1111/j.1467-7687.2008.00711.x; vanMarle K, 2009, COGNITION, V111, P302, DOI 10.1016/j.cognition.2009.01.011; West RE, 2002, ANIM COGN, V5, P183, DOI 10.1007/s10071-002-0140-0; Wynn K, 1996, PSYCHOL SCI, V7, P164, DOI 10.1111/j.1467-9280.1996.tb00350.x; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0; Xu F, 2003, COGNITION, V89, pB15, DOI 10.1016/S0010-0277(03)00050-7; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; Xu F, 2007, BRIT J DEV PSYCHOL, V25, P103, DOI 10.1348/026151005X90704	70	65	65	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15516	10.1371/journal.pone.0015516	http://dx.doi.org/10.1371/journal.pone.0015516			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124802	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000033
J	Nelson, DE; Van der Pol, B; Dong, QF; Revanna, KV; Fan, B; Easwaran, S; Sodergren, E; Weinstock, GM; Diao, LX; Fortenberry, JD				Nelson, David E.; Van der Pol, Barbara; Dong, Qunfeng; Revanna, Kashi V.; Fan, Baochang; Easwaran, Shraddha; Sodergren, Erica; Weinstock, George M.; Diao, Lixia; Fortenberry, J. Dennis			Characteristic Male Urine Microbiomes Associate with Asymptomatic Sexually Transmitted Infection	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; TESTING 1ST-VOID URINE; LIGASE CHAIN-REACTION; CHLAMYDIA-TRACHOMATIS; NONGONOCOCCAL URETHRITIS; BACTERIAL VAGINOSIS; GUT MICROBIOME; MEN; WOMEN; COMMUNITIES	Background: The microbiome of the male urogenital tract is poorly described but it has been suggested that bacterial colonization of the male urethra might impact risk of sexually transmitted infection (STI). Previous cultivation-dependent studies showed that a variety of non-pathogenic bacteria colonize the urethra but did not thoroughly characterize these microbiomes or establish links between the compositions of urethral microbiomes and STI. Methodology/Findings: Here, we used 16S rRNA PCR and sequencing to identify bacteria in urine specimens collected from men who lacked symptoms of urethral inflammation but who differed in status for STI. All of the urine samples contained multiple bacterial genera and many contained taxa that colonize the human vagina. Uncultivated bacteria associated with female genital tract pathology were abundant in specimens from men who had STI. Conclusions: Urine microbiomes from men with STI were dominated by fastidious, anaerobic and uncultivated bacteria. The same taxa were rare in STI negative individuals. Our findings suggest that the composition of male urine microbiomes is related to STI.	[Nelson, David E.; Fan, Baochang; Easwaran, Shraddha] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Van der Pol, Barbara] Indiana Univ Sch Med, Div Infect Dis, Dept Med, Indianapolis, IN USA; [Dong, Qunfeng; Revanna, Kashi V.] Univ N Texas, Dept Biol Sci, Denton, TX 76203 USA; [Dong, Qunfeng] Univ N Texas, Dept Comp Sci & Engn, Denton, TX 76203 USA; [Sodergren, Erica; Weinstock, George M.] Washington Univ, Dept Genet, St Louis Sch Med, St Louis, MO 63110 USA; [Diao, Lixia] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Fortenberry, J. Dennis] Indiana Univ Sch Med, Sect Adolescent Med, Dept Pediat, Indiana, PA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; Saint Louis University; Washington University (WUSTL); University of Texas System; UTMD Anderson Cancer Center	Nelson, DE (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	nelsonde@indiana.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592; Van Der Pol, Barbara/0000-0003-3064-8564	National Institutes of Health [UH2KD083980, U54HG004968]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	JD Fortenberry and GM Weinstock were supported by National Institutes of Health grants UH2KD083980 and U54HG004968, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BIANCHI A, 1994, SEX TRANSM DIS, V21, P196, DOI 10.1097/00007435-199407000-00003; BOWIE WR, 1977, J CLIN INVEST, V59, P735, DOI 10.1172/JCI108694; BOWIE WR, 1977, J CLIN MICROBIOL, V6, P482; Bradshaw CS, 2006, J INFECT DIS, V193, P336, DOI 10.1086/499434; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CHERNESKY MA, 1994, J CLIN MICROBIOL, V32, P2682, DOI 10.1128/JCM.32.11.2682-2685.1994; CHERNESKY MA, 1994, J INFECT DIS, V170, P1308, DOI 10.1093/infdis/170.5.1308; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Crotchfelt KA, 1997, J CLIN MICROBIOL, V35, P1536, DOI 10.1128/JCM.35.6.1536-1540.1997; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Forney LJ, 2010, J CLIN MICROBIOL, V48, P1741, DOI 10.1128/JCM.01710-09; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2001, CURR OPIN GASTROEN, V17, P52, DOI 10.1097/00001574-200101000-00010; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; FREUND JE, 1992, MATH STAT, P494; Gao Z, 2007, P NATL ACAD SCI USA, V104, P2927, DOI 10.1073/pnas.0607077104; GOLDMAN RN, 1985, STAT INTRO, P72; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Ivanov Yuri Boris, 2007, Journal of Microbiology Immunology and Infection, V40, P157; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lozupone CA, 2007, APPL ENVIRON MICROB, V73, P1576, DOI 10.1128/AEM.01996-06; Marrazzo JM, 2008, ANN INTERN MED, V149, P20, DOI 10.7326/0003-4819-149-1-200807010-00006; Mazuecos J, 1998, J EUR ACAD DERMATOL, V10, P237, DOI 10.1111/j.1468-3083.1998.tb00743.x; Ness RB, 2005, SEX TRANSM DIS, V32, P413, DOI 10.1097/01.olq.0000154493.87451.8d; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; RAVEL J, 2010, P NATL ACAD SCI US; Riemersma WA, 2003, J CLIN MICROBIOL, V41, P1977, DOI 10.1128/JCM.41.5.1977-1986.2003; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Schwebke JR, 2005, SEX TRANSM DIS, V32, P654, DOI 10.1097/01.olq.0000175396.10304.62; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Willen M, 1996, SCAND J UROL NEPHROL, V30, P387, DOI 10.3109/00365599609181315; Zhou X, 2004, MICROBIOL-SGM, V150, P2565, DOI 10.1099/mic.0.26905-0	45	157	163	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14116	10.1371/journal.pone.0014116	http://dx.doi.org/10.1371/journal.pone.0014116			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124791	Green Submitted, gold, Green Published			2022-12-27	WOS:000284572000014
J	Ramos, C; Rocha, S; Gaspar, C; Henrique, D				Ramos, Catarina; Rocha, Susana; Gaspar, Claudia; Henrique, Domingos			Two Notch Ligands, Dll1 and Jag1, Are Differently Restricted in Their Range of Action to Control Neurogenesis in the Mammalian Spinal Cord	PLOS ONE			English	Article							VENTRAL NEURAL-TUBE; EXPRESSION PATTERNS; LATERAL INHIBITION; NERVOUS-SYSTEM; INTERNEURONS; FRINGE; DELTA; SERRATE; DROSOPHILA; JAGGED1	Background: Notch signalling regulates neuronal differentiation in the vertebrate nervous system. In addition to a widespread function in maintaining neural progenitors, Notch signalling has also been involved in specific neuronal fate decisions. These functions are likely mediated by distinct Notch ligands, which show restricted expression patterns in the developing nervous system. Two ligands, in particular, are expressed in non-overlapping complementary domains of the embryonic spinal cord, with Jag1 being restricted to the V1 and dI6 progenitor domains, while Dll1 is expressed in the remaining domains. However, the specific contribution of different ligands to regulate neurogenesis in vertebrate embryos is still poorly understood. Methodology/Principal Findings: In this work, we investigated the role of Jag1 and Dll1 during spinal cord neurogenesis, using conditional knockout mice where the two genes are deleted in the neuroepithelium, singly or in combination. Our analysis showed that Jag1 deletion leads to a modest increase in V1 interneurons, while dI6 neurogenesis was unaltered. This mild Jag1 phenotype contrasts with the strong neurogenic phenotype detected in Dll1 mutants and led us to hypothesize that neighbouring Dll1-expressing cells signal to V1 and dI6 progenitors and restore neurogenesis in the absence of Jag1. Analysis of double Dll1;Jag1 mutant embryos revealed a stronger increase in V1-derived interneurons and overproduction of dI6 interneurons. In the presence of a functional Dll1 allele, V1 neurogenesis is restored to the levels detected in single Jag1 mutants, while dI6 neurogenesis returns to normal, thereby confirming that Dll1-mediated signalling compensates for Jag1 deletion in V1 and dI6 domains. Conclusions/Significance: Our results reveal that Dll1 and Jag1 are functionally equivalent in controlling the rate of neurogenesis within their expression domains. However, Jag1 can only activate Notch signalling within the V1 and dI6 domains, whereas Dll1 can signal to neural progenitors both inside and outside its domains of expression.	[Ramos, Catarina; Rocha, Susana; Gaspar, Claudia; Henrique, Domingos] Inst Mol Med, Fac Med Lisboa, Lisbon, Portugal	Universidade de Lisboa	Ramos, C (corresponding author), Inst Mol Med, Fac Med Lisboa, Lisbon, Portugal.	henrique@fm.ul.pt	Henrique, Domingos M/E-5460-2010; Gaspar, Claudia/I-6402-2013	Henrique, Domingos M/0000-0001-8869-1894; Gaspar, Claudia/0000-0003-1051-0998	Fundacao para a Ciencia e Tecnologia [PTDC/SAU-OBD/75106/2006]	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was funded by Fundacao para a Ciencia e Tecnologia (www.fct.mctes.pt), project PTDC/SAU-OBD/75106/2006. Catarina Ramos, Susana Rocha and Claudia Gaspar are supported with fellowships from Fundacao para a Ciencia e Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711; Benedito R, 2005, GENE EXPR PATTERNS, V5, P750, DOI 10.1016/j.modgep.2005.04.004; Benedito R, 2009, CELL, V137, P1124, DOI 10.1016/j.cell.2009.03.025; Briscoe J, 2001, CURR OPIN NEUROBIOL, V11, P43, DOI 10.1016/S0959-4388(00)00172-0; Briscoe J, 2008, PHILOS T R SOC B, V363, P57, DOI 10.1098/rstb.2006.2012; Brooker R, 2006, DEVELOPMENT, V133, P1277, DOI 10.1242/dev.02284; Burrill JD, 1997, DEVELOPMENT, V124, P4493; Carr PA, 1998, NEUROREPORT, V9, P2657, DOI 10.1097/00001756-199808030-00043; Cohen M, 2010, DEV CELL, V19, P78, DOI 10.1016/j.devcel.2010.06.006; de Joussineau C, 2003, NATURE, V426, P555, DOI 10.1038/nature02157; Del Barrio MG, 2007, DEVELOPMENT, V134, P3427, DOI 10.1242/dev.005868; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Dottori M, 2001, DEVELOPMENT, V128, P4127; Dunwoodie SL, 1997, DEVELOPMENT, V124, P3065; Fleming RJ, 1997, DEVELOPMENT, V124, P2973; GU Y, 1995, DEVELOPMENT, V121, P855; Hatakeyama J, 2006, CEREB CORTEX, V16, pI132, DOI 10.1093/cercor/bhj166; Hicks C, 2000, NAT CELL BIOL, V2, P515, DOI 10.1038/35019553; Hozumi K, 2004, NAT IMMUNOL, V5, P638, DOI 10.1038/ni1075; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Lindsell CE, 1996, MOL CELL NEUROSCI, V8, P14, DOI 10.1006/mcne.1996.0040; Liu B, 2007, DEV DYNAM, V236, P829, DOI 10.1002/dvdy.21061; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x; Marklund U, 2010, DEVELOPMENT, V137, P437, DOI 10.1242/dev.036806; Matise MP, 1997, J NEUROSCI, V17, P7805; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Moran-Rivard L, 2001, NEURON, V29, P385, DOI 10.1016/S0896-6273(01)00213-6; Morikawa Y, 2009, NEUROSCIENCE, V162, P1150, DOI 10.1016/j.neuroscience.2009.05.022; Myat A, 1996, DEV BIOL, V174, P233, DOI 10.1006/dbio.1996.0069; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019; Pierani A, 1999, CELL, V97, P903, DOI 10.1016/S0092-8674(00)80802-8; Rocha SF, 2009, DEV BIOL, V328, P54, DOI 10.1016/j.ydbio.2009.01.011; Shawber C, 1996, DEV BIOL, V180, P370, DOI 10.1006/dbio.1996.0310; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; VALSECCHI C, 1997, MECH DEV, V0069; Wu JY, 1999, CURR OPIN NEUROBIOL, V9, P537, DOI 10.1016/S0959-4388(99)00020-3; Yang LT, 2005, MOL BIOL CELL, V16, P927, DOI 10.1091/mbc.e04-07-0614; Yang XD, 2006, DEV NEUROSCI-BASEL, V28, P102, DOI 10.1159/000090757; Zeng CY, 1998, GENE DEV, V12, P1086, DOI 10.1101/gad.12.8.1086	42	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15515	10.1371/journal.pone.0015515	http://dx.doi.org/10.1371/journal.pone.0015515			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124801	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000032
J	Wickstead, B; Carrington, JT; Gluenz, E; Gull, K				Wickstead, Bill; Carrington, Jamie T.; Gluenz, Eva; Gull, Keith			The Expanded Kinesin-13 Repertoire of Trypanosomes Contains Only One Mitotic Kinesin Indicating Multiple Extra-Nuclear Roles	PLOS ONE			English	Article							CENTROMERE-ASSOCIATED KINESIN; INDUCIBLE EXPRESSION SYSTEM; CELL-CYCLE; MICROTUBULE DYNAMICS; BRUCEI; MCAK; PROTEIN; MINICHROMOSOMES; SEGREGATION; MITOSIS	Background: Kinesin-13 proteins have a critical role in animal cell mitosis, during which they regulate spindle microtubule dynamics through their depolymerisation activity. Much of what is known about Kinesin-13 function emanates from a relatively small sub-family of proteins containing MCAK and Kif2A/B. However, recent work on kinesins from the much more widely distributed, ancestral Kinesin-13 family, which includes human Kif24, have identified a second function in flagellum length regulation that may exist either alongside or instead of the mitotic role. Methodology/Principal Findings: The African trypanosome Trypanosoma brucei encodes 7 distinct Kinesin-13 proteins, allowing scope for extensive specialisation of roles. Here, we show that of all the trypanosomal Kinesin-13 proteins, only one is nuclear. This protein, TbKIN13-1, is present in the nucleoplasm throughout the cell cycle, but associates with the spindle during mitosis, which in trypanosomes is closed. TbKIN13-1 is necessary for the segregation of both large and minichromosomes in this organism and reduction in TbKIN13-1 levels mediated by RNA interference causes deflects in spindle disassembly with spindle-like structures persisting in non-mitotic cells. A second Kinesin-13 is localised to the flagellum tip, but the majority of the Kinesin-13 family members are in neither of these cellular locations. Conclusions/Significance: These data show that the expanded Kinesin-13 repertoire of trypanosomes is not associated with diversification of spindle-associated roles. TbKIN13-1 is required for correct spindle function, but the extra-nuclear localisation of the remaining paralogues suggests that the biological roles of the Kinesin-13 family is wider than previously thought.	[Wickstead, Bill; Carrington, Jamie T.; Gluenz, Eva; Gull, Keith] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Wickstead, B (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	bill.wickstead@path.ox.ac.uk		Wickstead, Bill/0000-0002-4620-9091; Carrington, Jamie/0000-0001-5437-1921; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsford S, 2001, MOL BIOCHEM PARASIT, V113, P79, DOI 10.1016/S0166-6851(00)00388-1; Andrews PD, 2004, DEV CELL, V6, P253, DOI 10.1016/S1534-5807(04)00025-5; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bessat M, 2009, MOL MICROBIOL, V71, P1371, DOI 10.1111/j.1365-2958.2009.06611.x; BIRKETT CR, 1985, FEBS LETT, V187, P211, DOI 10.1016/0014-5793(85)81244-8; Blaineau C, 2007, CURR BIOL, V17, P778, DOI 10.1016/j.cub.2007.03.048; BRUN R, 1979, ACTA TROP, V36, P289; Buster DW, 2007, MOL BIOL CELL, V18, P3094, DOI 10.1091/mbc.E06-11-0994; Cameron LA, 2006, J CELL BIOL, V173, P173, DOI 10.1083/jcb.200601075; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dawson SC, 2007, EUKARYOT CELL, V6, P2354, DOI 10.1128/EC.00128-07; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Douzery EJP, 2004, P NATL ACAD SCI USA, V101, P15386, DOI 10.1073/pnas.0403984101; Dubessay P, 2006, MOL MICROBIOL, V59, P1162, DOI 10.1111/j.1365-2958.2005.05013.x; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Ersfeld K, 1999, PARASITOL TODAY, V15, P58, DOI 10.1016/S0169-4758(98)01378-7; Ersfeld K, 1997, SCIENCE, V276, P611, DOI 10.1126/science.276.5312.611; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Ganem NJ, 2004, J CELL BIOL, V166, P473, DOI 10.1083/jcb.200404012; Goshima G, 2003, J CELL BIOL, V162, P1003, DOI 10.1083/jcb.200303022; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gull K, 1998, TRENDS MICROBIOL, V6, P319, DOI 10.1016/S0966-842X(98)01314-6; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Homma N, 2003, CELL, V114, P229, DOI 10.1016/S0092-8674(03)00522-1; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; Jackson AP, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-432; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kelly S, 2007, MOL BIOCHEM PARASIT, V154, P103, DOI 10.1016/j.molbiopara.2007.03.012; Kline-Smith SL, 2004, MOL BIOL CELL, V15, P1146, DOI 10.1091/mbc.E03-08-0581; Kline-Smith SL, 2002, MOL BIOL CELL, V13, P2718, DOI 10.1091/mbc.E01-12-0143; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Lan WJ, 2004, CURR BIOL, V14, P273, DOI 10.1016/j.cub.2004.01.055; Lawrence CJ, 2004, J CELL BIOL, V167, P19, DOI 10.1083/jcb.200408113; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002354; Lu L, 2005, MOL BIOL CELL, V16, P811, DOI 10.1091/mbc.E04-05-0400; Maney T, 1998, J CELL BIOL, V142, P787, DOI 10.1083/jcb.142.3.787; Manning AL, 2007, MOL BIOL CELL, V18, P2970, DOI 10.1091/mbc.E07-02-0110; Miki H, 2005, TRENDS CELL BIOL, V15, P467, DOI 10.1016/j.tcb.2005.07.006; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Morfini G, 1997, J CELL BIOL, V138, P657, DOI 10.1083/jcb.138.3.657; NODA Y, 1995, J CELL BIOL, V129, P157, DOI 10.1083/jcb.129.1.157; Obado SO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r37; Ogawa T, 2004, CELL, V116, P591, DOI 10.1016/S0092-8674(04)00129-1; Ohi R, 2004, MOL BIOL CELL, V15, P2895, DOI 10.1091/mbc.E04-02-0082; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; Rizk RS, 2009, MOL BIOL CELL, V20, P1639, DOI 10.1091/mbc.E08-09-0985; ROBINSON DR, 1995, J CELL BIOL, V128, P1163, DOI 10.1083/jcb.128.6.1163; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shipley K, 2004, EMBO J, V23, P1422, DOI 10.1038/sj.emboj.7600165; SOLARI AJ, 1995, BIOCELL, V19, P65; Tikhonenko I, 2009, EUKARYOT CELL, V8, P723, DOI 10.1128/EC.00018-09; Vader G, 2008, CELL DIV, V3, DOI 10.1186/1747-1028-3-10; Walczak CE, 1996, CELL, V84, P37, DOI 10.1016/S0092-8674(00)80991-5; Walczak CE, 2002, CURR BIOL, V12, P1885, DOI 10.1016/S0960-9822(02)01227-7; Wickstead B, 2006, MOL BIOL CELL, V17, P1734, DOI 10.1091/mbc.E05-11-1090; Wickstead B, 2003, MOL BIOCHEM PARASIT, V132, P97, DOI 10.1016/j.molbiopara.2003.08.007; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wickstead B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; WOODWARD R, 1990, J CELL SCI, V95, P49; WORDEMAN L, 1995, J CELL BIOL, V128, P95, DOI 10.1083/jcb.128.1.95; Wordeman L, 2005, CURR OPIN CELL BIOL, V17, P82, DOI 10.1016/j.ceb.2004.12.003; Wordeman L, 2007, J CELL BIOL, V179, P869, DOI 10.1083/jcb.200707120	69	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15020	10.1371/journal.pone.0015020	http://dx.doi.org/10.1371/journal.pone.0015020			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124853	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000284527900017
J	Zimmerman, M; Yang, DF; Hu, XL; Liu, FY; Singh, N; Browning, D; Ganapathy, V; Chandler, P; Choubey, D; Abrams, SI; Liu, KB				Zimmerman, Mary; Yang, Dafeng; Hu, Xiaolin; Liu, Feiyan; Singh, Nagendra; Browning, Darren; Ganapathy, Vadivel; Chandler, Phillip; Choubey, Divaker; Abrams, Scott I.; Liu, Kebin			IFN-gamma Upregulates Survivin and Ifi202 Expression to Induce Survival and Proliferation of Tumor-Specific T Cells	PLOS ONE			English	Article							CTL ADOPTIVE IMMUNOTHERAPY; IN-VIVO PERSISTENCE; TRANSFER THERAPY; CUTTING EDGE; REPLICATIVE SENESCENCE; METASTATIC MELANOMA; NEGATIVE REGULATOR; ANTITUMOR IMMUNITY; CANCER REGRESSION; CLONAL EXPANSION	Background: A common procedure in human cytotoxic T lymphocyte (CTL) adoptive transfer immunotherapy is to expand tumor-specific CTLs ex vivo using CD3 mAb prior to transfer. One of the major obstacles of CTL adoptive immunotherapy is a lack of CTL persistence in the tumor-bearing host after transfer. The aim of this study is to elucidate the molecular mechanisms underlying the effects of stimulation conditions on proliferation and survival of tumor-specific CTLs. Methodology/Principal Findings: Tumor-specific CTLs were stimulated with either CD3 mAb or cognate Ag and analyzed for their proliferation and survival ex vivo and persistence in tumor-bearing mice. Although both Ag and CD3 mAb effectively induced the cytotoxic effecter molecules of the CTLs, we observed that Ag stimulation is essential for sustained CTL proliferation and survival. Further analysis revealed that Ag stimulation leads to greater proliferation rates and less apoptosis than CD3 mAb stimulation. Re-stimulation of the CD3 mAb-stimulated CTLs with Ag resulted in restored CTL proliferative potential, suggesting that CD3 mAb-induced loss of proliferative potential is reversible. Using DNA microarray technology, we identified that survivin and ifi202, two genes with known functions in T cell apoptosis and proliferation, are differentially induced between Ag- and CD3 mAb-stimulated CTLs. Analysis of the IFN-gamma signaling pathway activation revealed that Ag stimulation resulted in rapid phosphorylation of STAT1 (pSTAT1), whereas CD3 mAb stimulation failed to activate STAT1. Chromatin immunoprecipitation revealed that pSTAT1 is associated with the promoters of both survivin and ifi202 in T cells and electrophoresis mobility shift assay indicated that pSTAT1 directly binds to the gamma activation sequence element in the survivin and ifi202 promoters. Finally, silencing ifi202 expression significantly decreased T cell proliferation. Conclusions/Significance: Our findings delineate a new role of the IFN-gamma signaling pathway in regulating T cell proliferation and apoptosis through upregulating survivin and ifi202 expression.	[Zimmerman, Mary; Yang, Dafeng; Hu, Xiaolin; Liu, Feiyan; Singh, Nagendra; Browning, Darren; Ganapathy, Vadivel; Liu, Kebin] Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA; [Chandler, Phillip] Georgia Hlth Sci Univ, Med Coll Georgia, Immunotherapy Ctr, Augusta, GA USA; [Choubey, Divaker] Univ Cincinnati, Dept Environm Hlth, Cincinnati, OH USA; [Abrams, Scott I.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Ohio; University of Cincinnati; Roswell Park Cancer Institute	Zimmerman, M (corresponding author), Georgia Hlth Sci Univ, Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA USA.	Kliu@mcg.edu	Choubey, Divaker/A-4771-2008	Browning, Darren/0000-0003-0497-7620; Liu, Kebin/0000-0003-1965-7240	National Institutes of Health [CA133085]; American Cancer Society [RSG-09-209-01-TBG]; NATIONAL CANCER INSTITUTE [R01CA133085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (CA133085 to K.L.) and the American Cancer Society (RSG-09-209-01-TBG to K.L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, NAT MED, V14, P623, DOI 10.1038/nm.f.1774; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Caldwell SA, 2003, J IMMUNOL, V171, P2402, DOI 10.4049/jimmunol.171.5.2402; Camus M, 2009, CANCER RES, V69, P2685, DOI 10.1158/0008-5472.CAN-08-2654; Chen JM, 2008, IMMUNOL LETT, V118, P13, DOI 10.1016/j.imlet.2008.02.005; CHOUBEY D, 1993, J INTERFERON RES, V13, P43, DOI 10.1089/jir.1993.13.43; Choubey D, 2008, IMMUNOL LETT, V119, P32, DOI 10.1016/j.imlet.2008.06.001; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; D'Souza S, 2001, J BIOL CHEM, V276, P298, DOI 10.1074/jbc.M007155200; Deeths MJ, 1999, J IMMUNOL, V163, P102; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Driessens G, 2009, IMMUNOL REV, V229, P126, DOI 10.1111/j.1600-065X.2009.00771.x; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Effros RB, 1997, IMMUNOL TODAY, V18, P450, DOI 10.1016/S0167-5699(97)01079-7; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fallarino F, 1999, J IMMUNOL, V163, P4109; Fauce SR, 2008, J IMMUNOL, V181, P7400, DOI 10.4049/jimmunol.181.10.7400; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; June CH, 2009, NAT REV IMMUNOL, V9, P704, DOI 10.1038/nri2635; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kobayashi Y, 2002, HUM IMMUNOL, V63, P101, DOI 10.1016/S0198-8859(01)00369-X; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Koul D, 1998, BIOCHEM BIOPH RES CO, V247, P379, DOI 10.1006/bbrc.1998.8804; Lee PP, 1999, NAT MED, V5, P677, DOI 10.1038/9525; Leen AM, 2007, ANNU REV IMMUNOL, V25, P243, DOI 10.1146/annurev.immunol.25.022106.141527; Liu KB, 2006, J IMMUNOL, V176, P3374, DOI 10.4049/jimmunol.176.6.3374; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Mescher MF, 2007, SEMIN CANCER BIOL, V17, P299, DOI 10.1016/j.semcancer.2007.06.008; MUKHERJI B, 1989, J EXP MED, V169, P1961, DOI 10.1084/jem.169.6.1961; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Parry RV, 2003, J IMMUNOL, V171, P166, DOI 10.4049/jimmunol.171.1.166; Robbins PF, 2004, J IMMUNOL, V173, P7125, DOI 10.4049/jimmunol.173.12.7125; Rolle CE, 2008, CANCER RES, V68, P2984, DOI 10.1158/0008-5472.CAN-07-3040; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Ryan MH, 2001, J IMMUNOL, V167, P4286, DOI 10.4049/jimmunol.167.8.4286; Schumacher TNM, 2009, CURR OPIN IMMUNOL, V21, P187, DOI 10.1016/j.coi.2009.03.006; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shen XL, 2007, J IMMUNOTHER, V30, P123, DOI 10.1097/01.cji.0000211321.07654.b8; Song JX, 2008, CELL MOL IMMUNOL, V5, P239, DOI 10.1038/cmi.2008.30; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Strater J, 2005, GUT, V54, P661, DOI 10.1136/gut.2004.052696; Veeranki S, 2010, IMMUNOL LETT, V133, P1, DOI 10.1016/j.imlet.2010.06.008; WESSELBORG S, 1993, J IMMUNOL, V150, P4338; WHITE J, 1993, J EXP MED, V177, P119, DOI 10.1084/jem.177.1.119; Winter H, 2001, J IMMUNOL, V166, P7370, DOI 10.4049/jimmunol.166.12.7370; Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc; Xin H, 2003, ONCOGENE, V22, P4775, DOI 10.1038/sj.onc.1206780; Xin H, 2006, J IMMUNOL, V176, P5863, DOI 10.4049/jimmunol.176.10.5863; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Yang DF, 2008, INT J CANCER, V122, P350, DOI 10.1002/ijc.23090; Yang D, 2007, CLIN CANCER RES, V13, P5202, DOI 10.1158/1078-0432.CCR-07-1161; Yang DF, 2007, CANCER RES, V67, P3301, DOI 10.1158/0008-5472.CAN-06-4068; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099; Zhao BH, 2009, J IMMUNOL, V182, P6744, DOI 10.4049/jimmunol.0804387; Zhou JH, 2005, J IMMUNOL, V175, P7046, DOI 10.4049/jimmunol.175.10.7046	60	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14076	10.1371/journal.pone.0014076	http://dx.doi.org/10.1371/journal.pone.0014076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124930	Green Submitted, Green Published, gold			2022-12-27	WOS:000284467200010
J	Canini, L; Andreoletti, L; Ferrari, P; D'Angelo, R; Blanchon, T; Lemaitre, M; Filleul, L; Ferry, JP; Desmaizieres, M; Smadja, S; Valleron, AJ; Carrat, F				Canini, Laetitia; Andreoletti, Laurent; Ferrari, Pascal; D'Angelo, Romina; Blanchon, Thierry; Lemaitre, Magali; Filleul, Laurent; Ferry, Jean-Pierre; Desmaizieres, Michel; Smadja, Serge; Valleron, Alain-Jacques; Carrat, Fabrice			Surgical Mask to Prevent Influenza Transmission in Households: A Cluster Randomized Trial	PLOS ONE			English	Article							A H1N1 VIRUS; HAND HYGIENE; ILLNESS; ADULTS	Background: Facemasks and respirators have been stockpiled during pandemic preparedness. However, data on their effectiveness for limiting transmission are scarce. We evaluated the effectiveness of facemask use by index cases for limiting influenza transmission by large droplets produced during coughing in households. Methodology and Principal Findings: A cluster randomized intervention trial was conducted in France during the 20082009 influenza season. Households were recruited during a medical visit of a household member with a positive rapid influenza A test and symptoms lasting less than 48 hours. Households were randomized either to the mask or control group for 7 days. In the intervention arm, the index case had to wear a surgical mask from the medical visit and for a period of 5 days. The trial was initially intended to include 372 households but was prematurely interrupted after the inclusion of 105 households (306 contacts) following the advice of an independent steering committee. We used generalized estimating equations to test the association between the intervention and the proportion of household contacts who developed an influenza-like illness during the 7 days following the inclusion. Influenza-like illness was reported in 24/148 (16.2%) of the contacts in the intervention arm and in 25/158 (15.8%) of the contacts in the control arm and the difference between arms was 0.40% (95% CI: 210% to 11%, P = 1.00). We observed a good adherence to the intervention. In various sensitivity analyses, we did not identify any trend in the results suggesting effectiveness of facemasks. Conclusion: This study should be interpreted with caution since the lack of statistical power prevents us to draw formal conclusion regarding effectiveness of facemasks in the context of a seasonal epidemic.	[Canini, Laetitia; Ferrari, Pascal; Blanchon, Thierry; Lemaitre, Magali; Valleron, Alain-Jacques; Carrat, Fabrice] Univ Paris 06, UMR S 707, Paris, France; [Canini, Laetitia; Ferrari, Pascal; Blanchon, Thierry; Lemaitre, Magali; Valleron, Alain-Jacques; Carrat, Fabrice] INSERM, U707, Paris, France; [Andreoletti, Laurent] Univ Reims Ctr Hosp, Lab Virol Med & Mol, Reims, France; [Andreoletti, Laurent] Fac Med, EA 4303, Reims, France; [Ferrari, Pascal; D'Angelo, Romina; Valleron, Alain-Jacques; Carrat, Fabrice] Hop St Antoine, Assistance Publ Hop Paris, Unite St Publ, F-75571 Paris, France; [Filleul, Laurent] Inst Veille Sanitaire, Bordeaux, France; [Smadja, Serge] SOS Med, Paris, France; [Ferry, Jean-Pierre] Cabinet Med, Audincourt, France; [Desmaizieres, Michel] Urgences Med Paris, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Institute of Public Health Surveillance	Canini, L (corresponding author), Univ Paris 06, UMR S 707, Paris, France.	carrat@u707.jussieu.fr	BLANCHON, Thierry/AAK-6254-2020; Andreoletti, Laurent/AAQ-2756-2020; Carrat, Fabrice/AAU-8480-2020; Canini, Laetitia/K-1278-2019	Carrat, Fabrice/0000-0002-8672-7918; Canini, Laetitia/0000-0001-7643-1219; ANDREOLETTI, LAURENT/0000-0002-7440-8880	Ministere de la Sante and la Direction des Hopitaux [P070160]; Assistance Publique des Hopitaux de Paris	Ministere de la Sante and la Direction des Hopitaux; Assistance Publique des Hopitaux de Paris	The study was supported by a grant from Ministere de la Sante and la Direction des Hopitaux (PHRC 2008, P070160) and was sponsored by Assistance Publique des Hopitaux de Paris. The funding sources and the sponsor had no role in the design, analysis, or reporting of the study or in the decision to submit the manuscript for publication.	Aiello AE, 2010, J INFECT DIS, V201, P491, DOI 10.1086/650396; Brankston G, 2007, LANCET INFECT DIS, V7, P257, DOI 10.1016/S1473-3099(07)70029-4; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; CAREY V, 1993, BIOMETRIKA, V80, P517, DOI 10.2307/2337173; Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Carrat F, 1998, J EPIDEMIOL COMMUN H, V52, p32S; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Cowling BJ, 2010, EPIDEMIOL INFECT, V138, P449, DOI 10.1017/S0950268809991658; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Cowling BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002101; Field CA, 2007, J R STAT SOC B, V69, P369, DOI 10.1111/j.1467-9868.2007.00593.x; France AM, 2010, J INFECT DIS, V201, P984, DOI 10.1086/651145; INSEE, 2006, RES REC POP; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MacIntyre C.R., 2010, EMERG INFECT DIS, V15, P233; *RESEAUSENTINELLES, 2009, B HEBD 04 09 2009; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	18	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e13998	10.1371/journal.pone.0013998	http://dx.doi.org/10.1371/journal.pone.0013998			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103330	Green Published, gold, Green Submitted			2022-12-27	WOS:000284327800003
J	Alves, G; Ogurtsov, AY; Yu, YK				Alves, Gelio; Ogurtsov, Aleksey Y.; Yu, Yi-Kuo			RAId_aPS: MS/MS Analysis with Multiple Scoring Functions and Spectrum-Specific Statistics	PLOS ONE			English	Article							PEPTIDE IDENTIFICATION; PROTEIN IDENTIFICATIONS; IMPROVING SENSITIVITY; SEARCH; TANDEM; CONFIDENCE; ACCURACY; DESIGN	Statistically meaningful comparison/combination of peptide identification results from various search methods is impeded by the lack of a universal statistical standard. Providing an E-value calibration protocol, we demonstrated earlier the feasibility of translating either the score or heuristic E-value reported by any method into the textbook-defined E-value, which may serve as the universal statistical standard. This protocol, although robust, may lose spectrum-specific statistics and might require a new calibration when changes in experimental setup occur. To mitigate these issues, we developed a new MS/MS search tool, RAId_aPS, that is able to provide spectrum-specific E-values for additive scoring functions. Given a selection of scoring functions out of RAId score, K-score, Hyperscore and XCorr, RAId_aPS generates the corresponding score histograms of all possible peptides using dynamic programming. Using these score histograms to assign E-values enables a calibration-free protocol for accurate significance assignment for each scoring function. RAId_aPS features four different modes: (i) compute the total number of possible peptides for a given molecular mass range, (ii) generate the score histogram given a MS/MS spectrum and a scoring function, (iii) reassign E-values for a list of candidate peptides given a MS/MS spectrum and the scoring functions chosen, and (iv) perform database searches using selected scoring functions. In modes (iii) and (iv), RAId_aPS is also capable of combining results from different scoring functions using spectrum-specific statistics. The web link is http://www.ncbi.nlm.nih.gov/ CBBresearch/Yu/raid_aps/index.html. Relevant binaries for Linux, Windows, and Mac OS X are available from the same page.	[Alves, Gelio; Ogurtsov, Aleksey Y.; Yu, Yi-Kuo] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Alves, G (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	yyu@ncbi.nlm.nih.gov			National Library of Medicine of the National Institutes of Health/DHHS; NATIONAL LIBRARY OF MEDICINE [ZIALM092404] Funding Source: NIH RePORTER	National Library of Medicine of the National Institutes of Health/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the Intramural Research Program of the National Library of Medicine of the National Institutes of Health/DHHS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 2005, BIOINFORMATICS, V21, P3726, DOI 10.1093/bioinformatics/bti620; ALVES G, 2007, BIOL DIRECT, V2; Alves G, 2008, PHYSICA A, V387, P6538, DOI 10.1016/j.physa.2008.08.024; Alves G, 2008, J PROTEOME RES, V7, P3102, DOI 10.1021/pr700798h; Alves G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-505; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Doerr TP, 2005, PHYSICA A, V354, P558, DOI 10.1016/j.physa.2005.03.004; Edwards N., 2009, CLIN PROTEOM, V5, P23; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Eng JK, 2008, J PROTEOME RES, V7, P4598, DOI 10.1021/pr800420s; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Jones AR, 2009, PROTEOMICS, V9, P1220, DOI 10.1002/pmic.200800473; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Keller A, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100024; Keller Andrew, 2002, OMICS A Journal of Integrative Biology, V6, P207, DOI 10.1089/153623102760092805; Kim S, 2008, J PROTEOME RES, V7, P3354, DOI 10.1021/pr8001244; Klammer AA, 2009, J PROTEOME RES, V8, P2106, DOI 10.1021/pr8011107; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; McIntosh M, 2008, J PROTEOME RES, V7, P18, DOI 10.1021/pr083686j; Oberg AL, 2009, J PROTEOME RES, V8, P2144, DOI 10.1021/pr8010099; Park CY, 2008, J PROTEOME RES, V7, P3022, DOI 10.1021/pr800127y; Prakash A, 2007, MOL CELL PROTEOMICS, V6, P1741, DOI 10.1074/mcp.M600470-MCP200; Press W. H., 1999, NUMERICAL RECIPES C; ROBINSON AB, 1991, P NATL ACAD SCI USA, V88, P8880, DOI 10.1073/pnas.88.20.8880; Searle BC, 2008, J PROTEOME RES, V7, P245, DOI 10.1021/pr070540w; Taylor CF, 2007, NAT BIOTECHNOL, V25, P887, DOI 10.1038/nbt1329; Yu YK, 2006, NUCLEIC ACIDS RES, V34, P5966, DOI 10.1093/nar/gkl731; Zhang N, 2002, PROTEOMICS, V2, P1406, DOI 10.1002/1615-9861(200210)2:10<1406::AID-PROT1406>3.0.CO;2-9	30	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15438	10.1371/journal.pone.0015438	http://dx.doi.org/10.1371/journal.pone.0015438			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103371	Green Published, gold, Green Submitted			2022-12-27	WOS:000284257400022
J	Henriques, A; Pitzer, C; Schneider, A				Henriques, Alexandre; Pitzer, Claudia; Schneider, Armin			Characterization of a Novel SOD-1(G93A) Transgenic Mouse Line with Very Decelerated Disease Development	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MODEL; MICE; ALS	Amyotrophic Lateral Sclerosis (ALS) is a fatal motoneuron disease, characterized by progressive weakness, muscle wasting and death ensuing 3-5 years after diagnosis. The etiology of ALS is complex and therapeutic approaches rely mostly on transgenic animal models with SOD-1 mutations. Most frequently employed is a mouse line transgenic for SOD-1 (SOD-1 Tg) that contains a point mutation at amino acid position 93 (G- > A), present in patients suffering from a familial form of amyotrophic lateral sclerosis. Here we report on a SOD-1 (G93A) Tg mouse line with abnormally delayed onset of disease and prolonged survival. This phenotype arose spontaneously in our colony of the classic SOD-1 (G93A) line. We found that the copy number of the SOD-1 transgene was drastically decreased. We established a new breeding colony, the SOD-1 (G93A) PS line (PS for prolonged survival) where the phenotype is stably inherited for 4 generations now. The mice develop symptoms at an age of approximately 12 months and die at 15 months of age. The delayed development of disease may more closely mimic human pathophysiology, and studying drug effects in this model may yield added confidence for potential efficacy of ALS drug candidates.	[Henriques, Alexandre; Pitzer, Claudia; Schneider, Armin] SYGNIS Biosci, Dept Mol Neurol, Heidelberg, Germany; [Henriques, Alexandre] INSERM, U692, Strasbourg, France; [Henriques, Alexandre] Univ Strasbourg, Fac Med, UMRS692, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Henriques, A (corresponding author), SYGNIS Biosci, Dept Mol Neurol, Heidelberg, Germany.	schneider@sygnis.de		Schneider, Armin/0000-0003-0296-0059				Alexander GM, 2004, MOL BRAIN RES, V130, P7, DOI 10.1016/j.molbrainres.2004.07.002; DalCanto MC, 1997, ACTA NEUROPATHOL, V93, P537; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Feeney SJ, 2001, MUSCLE NERVE, V24, P1510, DOI 10.1002/mus.1176; FRIDOVICH I, 1986, ADV ENZYMOL RAMB, V58, P61; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Henriques A, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00032; Mitchell JD, 2007, LANCET, V369, P2031, DOI 10.1016/S0140-6736(07)60944-1; Pambo-Pambo A, 2009, J NEUROPHYSIOL, V102, P3627, DOI 10.1152/jn.00482.2009; Pitzer C, 2008, BRAIN, V131, P3335, DOI 10.1093/brain/awn243; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Stieber A, 1998, ACTA NEUROPATHOL, V95, P245, DOI 10.1007/s004010050794; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	13	36	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15445	10.1371/journal.pone.0015445	http://dx.doi.org/10.1371/journal.pone.0015445			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21102999	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800023
J	Cantuti-Castelvetri, I; Hernandez, LF; Keller-McGandy, CE; Kett, LR; Landy, A; Hollingsworth, ZR; Saka, E; Crittenden, JR; Nillni, EA; Young, AB; Standaert, DG; Graybiel, AM				Cantuti-Castelvetri, Ippolita; Hernandez, Ledia F.; Keller-McGandy, Christine E.; Kett, Lauren R.; Landy, Alex; Hollingsworth, Zane R.; Saka, Esen; Crittenden, Jill R.; Nillni, Eduardo A.; Young, Anne B.; Standaert, David G.; Graybiel, Ann M.			Levodopa-Induced Dyskinesia Is Associated with Increased Thyrotropin Releasing Hormone in the Dorsal Striatum of Hemi-Parkinsonian Rats	PLOS ONE			English	Article							DOPA-INDUCED DYSKINESIA; MEDIUM SPINY NEURONS; BASAL GANGLIA; NUCLEUS-ACCUMBENS; IMMUNOHISTOCHEMICAL LOCALIZATION; ANTITHYROID TREATMENT; DEPLETED STRIATUM; INDUCED BEHAVIOR; GENE-EXPRESSION; DISEASE	Background: Dyskinesias associated with involuntary movements and painful muscle contractions are a common and severe complication of standard levodopa (L-DOPA, L-3,4-dihydroxyphenylalanine) therapy for Parkinson's disease. Pathologic neuroplasticity leading to hyper-responsive dopamine receptor signaling in the sensorimotor striatum is thought to underlie this currently untreatable condition. Methodology/Principal Findings: Quantitative real-time polymerase chain reaction (PCR) was employed to evaluate the molecular changes associated with L-DOPA-induced dyskinesias in Parkinson's disease. With this technique, we determined that thyrotropin releasing hormone (TRH) was greatly increased in the dopamine-depleted striatum of hemi-parkinsonian rats that developed abnormal movements in response to L-DOPA therapy, relative to the levels measured in the contralateral non-dopamine-depleted striatum, and in the striatum of non-dyskinetic control rats. ProTRH immunostaining suggested that TRH peptide levels were almost absent in the dopamine-depleted striatum of control rats that did not develop dyskinesias, but in the dyskinetic rats, proTRH immunostaining was dramatically up-regulated in the striatum, particularly in the sensorimotor striatum. This up-regulation of TRH peptide affected striatal medium spiny neurons of both the direct and indirect pathways, as well as neurons in striosomes. Conclusions/Significance: TRH is not known to be a key striatal neuromodulator, but intrastriatal injection of TRH in experimental animals can induce abnormal movements, apparently through increasing dopamine release. Our finding of a dramatic and selective up-regulation of TRH expression in the sensorimotor striatum of dyskinetic rat models suggests a TRH-mediated regulatory mechanism that may underlie the pathologic neuroplasticity driving dopamine hyper-responsivity in Parkinson's disease.	[Cantuti-Castelvetri, Ippolita; Kett, Lauren R.; Landy, Alex; Hollingsworth, Zane R.; Young, Anne B.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA; [Hernandez, Ledia F.; Keller-McGandy, Christine E.; Crittenden, Jill R.; Graybiel, Ann M.] MIT, Dept Brain & Cognit Sci, McGovern Inst Brain Res, Cambridge, MA 02139 USA; [Saka, Esen] Hacettepe Univ, Fac Med, Dept Neurol, TR-06100 Ankara, Turkey; [Standaert, David G.] Univ Alabama Birmingham, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL USA; [Nillni, Eduardo A.] Brown Univ, Rhode Isl Hosp, Warren Alpert Med Sch, Dept Med,Div Endocrinol, Providence, RI 02903 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Hacettepe University; University of Alabama System; University of Alabama Birmingham; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Cantuti-Castelvetri, I (corresponding author), Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Charlestown, MA USA.	can-cas@helix.mgh.harvard.edu	Young, Anne/AAF-4283-2020; Hernandez, Ledia F./J-3077-2012; Crittenden, Jill/V-5490-2019	Hernandez, Ledia F./0000-0002-5293-3748; Crittenden, Jill/0000-0002-1981-1917; Graybiel, Ann/0000-0002-4326-7720; Standaert, David/0000-0003-2921-8348	MGH/MIT Morris Udall Center of Excellence [NIH NS38372]; American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital; University of Alabama Birmingham; NIDDK/NIH [R01 DK58148, NS045231]; Stanley H. and Sheila G. Sydney Fund; Parkinson's Disease Foundation; Fulbright Fellowship; Michael J. Fox Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058148] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045231, P50NS038372] Funding Source: NIH RePORTER	MGH/MIT Morris Udall Center of Excellence; American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital; University of Alabama Birmingham; NIDDK/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanley H. and Sheila G. Sydney Fund; Parkinson's Disease Foundation; Fulbright Fellowship; Michael J. Fox Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by the MGH/MIT Morris Udall Center of Excellence in PD Research (NIH NS38372) (ICC, LRK, ZRH, ABY, LFH, AMG, CEKMcG, JRC), and the American Parkinson Disease Association Advanced Centers for Parkinson Research at Massachusetts General Hospital (ICC, ABY) and University of Alabama Birmingham (DGS); NIDDK/NIH grant R01 DK58148 and R01 NINDS/NIH grant NS045231 (EAN); Stanley H. and Sheila G. Sydney Fund (AMG); Parkinson's Disease Foundation Fellowship and Fulbright Fellowship (LFH); Michael J. Fox Foundation (AMG, JRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000664; Bezard E, 2001, NAT REV NEUROSCI, V2, P577, DOI 10.1038/35086062; Calabresi P, 2008, MOVEMENT DISORD, V23, pS570, DOI 10.1002/mds.22019; Canales JJ, 2000, NAT NEUROSCI, V3, P377, DOI 10.1038/73949; Canales JJ, 2000, ANN NEUROL, V47, pS53; Cantuti-Castelvetri I, 2005, J NEUROPATH EXP NEUR, V64, P1058, DOI 10.1097/01.jnen.0000190063.90440.69; Cantuti-Castelvetri I, 2002, BRAIN RES, V930, P170, DOI 10.1016/S0006-8993(02)02244-8; CARADOCDAVIES TH, 1986, BRIT MED J, V293, P38, DOI 10.1136/bmj.293.6538.38; Cenci MA, 2002, AMINO ACIDS, V23, P105, DOI 10.1007/s00726-001-0116-4; Cenci MA, 1999, NEUROSCIENCE, V94, P515, DOI 10.1016/S0306-4522(99)00294-8; Chase TN, 2000, ANN NEUROL, V47, pS122; Crittenden JR, 2009, P NATL ACAD SCI USA, V106, P2892, DOI 10.1073/pnas.0812822106; delaCruz IP, 1996, J BIOL CHEM, V271, P22736, DOI 10.1074/jbc.271.37.22736; Dunah AW, 1999, MOL NEUROBIOL, V19, P151, DOI 10.1007/BF02743658; Fabbrini G, 2007, MOVEMENT DISORD, V22, P1379, DOI 10.1002/mds.21475; Faiz M, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-26; Fink L, 1998, NAT MED, V4, P1329, DOI 10.1038/3327; FRIEDMAN TC, 1995, ENDOCRINOLOGY, V136, P4462, DOI 10.1210/en.136.10.4462; Gerfen CR, 2002, J NEUROSCI, V22, P5042, DOI 10.1523/JNEUROSCI.22-12-05042.2002; Grace AA, 2008, MOVEMENT DISORD, V23, pS560, DOI 10.1002/mds.22020; Graybiel AM, 2000, TRENDS NEUROSCI, V23, pS71, DOI 10.1016/S1471-1931(00)00027-6; Isaacs JD, 2005, MOVEMENT DISORD, V20, P1656, DOI 10.1002/mds.20603; JACKSON IMD, 1985, SCIENCE, V229, P1097, DOI 10.1126/science.3929378; JaworskaFeil L, 1997, NEUROPEPTIDES, V31, P253, DOI 10.1016/S0143-4179(97)90056-1; Johansson PA, 2001, NEUROBIOL DIS, V8, P220, DOI 10.1006/nbdi.2000.0372; Kim HT, 2005, PARKINSONISM RELAT D, V11, P331, DOI 10.1016/j.parkreldis.2005.01.009; KISH SJ, 1988, NEW ENGL J MED, V318, P876, DOI 10.1056/NEJM198804073181402; Konradi C, 2004, NEUROBIOL DIS, V17, P219, DOI 10.1016/j.nbd.2004.07.005; KREUTZ MR, 1990, BRAIN RES, V536, P347, DOI 10.1016/0006-8993(90)90049-H; LAVY S, 1974, EUR NEUROL, V12, P20, DOI 10.1159/000114600; LECHAN RM, 1986, SCIENCE, V231, P159, DOI 10.1126/science.3079917; LECHAN RM, 1986, ENDOCRINOLOGY, V119, P1210, DOI 10.1210/endo-119-3-1210; LECHAN RM, 1982, ENDOCRINOLOGY, V111, P55, DOI 10.1210/endo-111-1-55; Lee J, 2008, BRAIN, V131, P1574, DOI 10.1093/brain/awn085; Linazasoro G, 2006, EUR NEUROL, V55, P108, DOI 10.1159/000092786; Lindgren HS, 2007, BEHAV BRAIN RES, V177, P150, DOI 10.1016/j.bbr.2006.09.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MIWA Y, 1995, EUR J PHARMACOL, V277, P63, DOI 10.1016/0014-2999(95)00066-T; NILLNI EA, 1993, ENDOCRINOLOGY, V132, P1260, DOI 10.1210/en.132.3.1260; Nillni EA, 1999, ENDOCR REV, V20, P599, DOI 10.1210/er.20.5.599; NILLNI EA, 1995, J NEUROCHEM, V65, P2462; Nillni EA, 1996, ENDOCRINOLOGY, V137, P5651, DOI 10.1210/en.137.12.5651; NILLNI EA, 1991, METHODS NEUROSCIENCE, P51; Obeso JA, 2000, TRENDS NEUROSCI, V23, pS1, DOI 10.1016/S1471-1931(00)00060-4; Obeso JA, 2008, ANN NEUROL, V64, pS30, DOI 10.1002/ana.21481; Paille V, 2007, MOVEMENT DISORD, V22, P533, DOI 10.1002/mds.21308; Pierret P, 2002, NEUROSCIENCE, V111, P83, DOI 10.1016/S0306-4522(01)00597-8; POPOLI P, 1989, EUR J PHARMACOL, V173, P211, DOI 10.1016/0014-2999(89)90523-2; POPOLI P, 1993, BEHAV BRAIN RES, V57, P105, DOI 10.1016/0166-4328(93)90066-Y; POPOLI P, 1991, EUR J PHARMACOL, V201, P11, DOI 10.1016/0014-2999(91)90316-I; PRZEGALINSKI E, 1993, NEUROPEPTIDES, V25, P277, DOI 10.1016/0143-4179(93)90044-B; PRZEGALINSKI E, 1991, NEUROPEPTIDES, V19, P189, DOI 10.1016/0143-4179(91)90118-3; Richardson RM, 2005, BRAIN RES, V1032, P11, DOI 10.1016/j.brainres.2004.10.043; Ristic AJ, 2004, MOVEMENT DISORD, V19, P982, DOI 10.1002/mds.20119; Rylander D, 2010, NEUROBIOL DIS, V39, P352, DOI 10.1016/j.nbd.2010.05.001; Saka E, 1999, BRAIN RES, V825, P104, DOI 10.1016/S0006-8993(99)01231-7; Santini E, 2009, J NEUROCHEM, V108, P621, DOI 10.1111/j.1471-4159.2008.05831.x; Sato K, 2008, P NATL ACAD SCI USA, V105, P12551, DOI 10.1073/pnas.0806065105; Sato K, 2007, MOVEMENT DISORD, V22, P2365, DOI 10.1002/mds.21732; Schaner P, 1997, J BIOL CHEM, V272, P19958, DOI 10.1074/jbc.272.32.19958; Tippett LJ, 2007, BRAIN, V130, P206, DOI 10.1093/brain/awl243; VERGES B, 1988, LANCET, V2, P564; Winkler C, 2002, NEUROBIOL DIS, V10, P165, DOI 10.1006/nbdi.2002.0499; WU P, 1988, BRAIN RES, V456, P22, DOI 10.1016/0006-8993(88)90342-3; WU P, 1991, METHODS NEUROSCIENCE, P337; Yen DJ, 1998, MOVEMENT DISORD, V13, P361, DOI 10.1002/mds.870130231; Young B, 2007, MOVEMENT DISORD, V22, P434, DOI 10.1002/mds.21279	67	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13861	10.1371/journal.pone.0013861	http://dx.doi.org/10.1371/journal.pone.0013861			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085660	Green Submitted, Green Published, gold			2022-12-27	WOS:000284036800007
J	Mondal, S; Burgute, B; Rieger, D; Muller, R; Rivero, F; Faix, J; Schleicher, M; Noegel, AA				Mondal, Subhanjan; Burgute, Bhagyashri; Rieger, Daniela; Mueller, Rolf; Rivero, Francisco; Faix, Jan; Schleicher, Michael; Noegel, Angelika A.			Regulation of the Actin Cytoskeleton by an Interaction of IQGAP Related Protein GAPA with Filamin and Cortexillin I	PLOS ONE			English	Article							GELATION FACTOR ABP120; DICTYOSTELIUM-DISCOIDEUM; BINDING PROTEINS; CLEAVAGE FURROW; CELL MOTILITY; MONOCLONAL-ANTIBODIES; BUNDLING PROTEIN; HOMOLOGY DOMAIN; TARGETS FILAMIN; CROSS-LINKING	Filamin and Cortexillin are F-actin crosslinking proteins in Dictyostelium discoideum allowing actin filaments to form three-dimensional networks. GAPA, an IQGAP related protein, is required for cytokinesis and localizes to the cleavage furrow during cytokinesis. Here we describe a novel interaction with Filamin which is required for cytokinesis and regulation of the F-actin content. The interaction occurs through the actin binding domain of Filamin and the GRD domain of GAPA. A similar interaction takes place with Cortexillin I. We further report that Filamin associates with Rac1a implying that filamin might act as a scaffold for small GTPases. Filamin and activated Rac associate with GAPA to regulate actin remodelling. Overexpression of filamin and GAPA in the various strains suggests that GAPA regulates the actin cytoskeleton through interaction with Filamin and that it controls cytokinesis through association with Filamin and Cortexillin.	[Mondal, Subhanjan; Burgute, Bhagyashri; Mueller, Rolf; Rivero, Francisco; Noegel, Angelika A.] Univ Cologne, CMMC, Inst Biochem 1, Fac Med, Cologne, Germany; [Rieger, Daniela; Schleicher, Michael] Univ Munich, Inst Anat & Cell Biol, Munich, Germany; [Rieger, Daniela; Schleicher, Michael] Univ Munich, Ctr Integrated Prot Sci CIPSM, Munich, Germany; [Rivero, Francisco] Univ Hull, Hull York Med Sch, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England; [Faix, Jan] Hannover Med Sch, Inst Biophys Chem, D-3000 Hannover, Germany	University of Cologne; University of Munich; University of Munich; University of Hull; University of York - UK; Hannover Medical School	Mondal, S (corresponding author), Univ Cologne, CMMC, Inst Biochem 1, Fac Med, Cologne, Germany.	noegel@uni-koeln.de	Rivero, Francisco/N-2969-2013	Rivero, Francisco/0000-0001-5435-6991	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Research was supported by the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi H, 1997, J CELL BIOL, V137, P891, DOI 10.1083/jcb.137.4.891; Bandala-Sanchez E, 2006, EUR J CELL BIOL, V85, P1099, DOI 10.1016/j.ejcb.2006.04.005; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; Blau-Wasser R, 2009, MOL BIOL CELL, V20, P4348, DOI 10.1091/mbc.E09-03-0180; Brandt DT, 2007, EMBO REP, V8, P1019, DOI 10.1038/sj.embor.7401089; Briggs MW, 2003, FEBS LETT, V542, P7, DOI 10.1016/S0014-5793(03)00333-8; BRINK M, 1990, J CELL BIOL, V111, P1477, DOI 10.1083/jcb.111.4.1477; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CLAVIEZ M, 1982, EMBO J, V1, P1017, DOI 10.1002/j.1460-2075.1982.tb01287.x; CONDEELIS J, 1984, J CELL BIOL, V99, pS119, DOI 10.1083/jcb.99.1.119s; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dumontier M, 2000, J CELL SCI, V113, P2253; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; Faix J, 1996, FEBS LETT, V394, P251, DOI 10.1016/0014-5793(96)00963-5; Faix J, 1998, J CELL SCI, V111, P3059; Faix J, 2001, EMBO J, V20, P3705, DOI 10.1093/emboj/20.14.3705; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Fucini P, 1999, J MOL BIOL, V291, P1017, DOI 10.1006/jmbi.1999.3046; Fukata M, 1997, J BIOL CHEM, V272, P29579, DOI 10.1074/jbc.272.47.29579; Gerisch G, 2000, CURR OPIN CELL BIOL, V12, P126, DOI 10.1016/S0955-0674(99)00066-6; Girard KD, 2004, EMBO J, V23, P1536, DOI 10.1038/sj.emboj.7600167; Gloss A, 2003, MOL BIOL CELL, V14, P2716, DOI 10.1091/mbc.E02-12-0827; HARTMANN H, 1989, J BIOL CHEM, V264, P12639; Ho YD, 1999, J BIOL CHEM, V274, P464, DOI 10.1074/jbc.274.1.464; HOFMANN A, 1992, CELL MOTIL CYTOSKEL, V23, P133, DOI 10.1002/cm.970230206; Khaire N, 2007, J BIOL CHEM, V282, P1948, DOI 10.1074/jbc.M610262200; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Knecht D, 1995, Methods Mol Biol, V47, P321; Knuth M, 2004, J CELL SCI, V117, P5013, DOI 10.1242/jcs.01366; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Larochelle DA, 1996, J CELL BIOL, V133, P1321, DOI 10.1083/jcb.133.6.1321; Lim RWL, 1999, BIOCHEMISTRY-US, V38, P800, DOI 10.1021/bi981392d; Loo DT, 1998, J BIOL CHEM, V273, P23304, DOI 10.1074/jbc.273.36.23304; MANSTEIN DJ, 1989, EMBO J, V8, P923, DOI 10.1002/j.1460-2075.1989.tb03453.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; McCoy AJ, 1999, NAT STRUCT BIOL, V6, P836; MCROBBIE SJ, 1983, BIOCHEM BIOPH RES CO, V115, P351, DOI 10.1016/0006-291X(83)91011-2; Nakamura F, 2005, J BIOL CHEM, V280, P32426, DOI 10.1074/jbc.M502203200; Noegel AA, 2000, J CELL SCI, V113, P759; Noegel AA, 2004, MOL BIOL CELL, V15, P934, DOI 10.1091/mbc.E03-05-0269; NUNNALLY MH, 1980, J CELL BIOL, V87, P219, DOI 10.1083/jcb.87.1.219; Ohta Y, 1999, P NATL ACAD SCI USA, V96, P2122, DOI 10.1073/pnas.96.5.2122; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Pang KM, 1998, CURR BIOL, V8, P405, DOI 10.1016/S0960-9822(98)70159-9; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; Robinson DN, 2002, J BIOL CHEM, V277, P9088, DOI 10.1074/jbc.M112144200; SHARMA CP, 1995, J IMMUNOL, V154, P3461; SIMPSON PA, 1984, J CELL BIOL, V99, P287, DOI 10.1083/jcb.99.1.287; Stock A, 1999, EMBO J, V18, P5274, DOI 10.1093/emboj/18.19.5274; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Ueda K, 2003, BIOCHEM BIOPH RES CO, V301, P886, DOI 10.1016/S0006-291X(03)00048-2; Uyeda TQP, 2004, CURR OPIN CELL BIOL, V16, P55, DOI 10.1016/j.ceb.2003.11.004; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vlahou G, 2006, EUR J CELL BIOL, V85, P947, DOI 10.1016/j.ejcb.2006.04.011; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Weber I, 1999, EMBO J, V18, P586, DOI 10.1093/emboj/18.3.586; Xiong HJ, 2008, TRAFFIC, V9, P708, DOI 10.1111/j.1600-0854.2008.00721.x; YANG F, 1990, NATURE, V347, P494, DOI 10.1038/347494a0; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020	61	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15440	10.1371/journal.pone.0015440	http://dx.doi.org/10.1371/journal.pone.0015440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085675	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800030
J	Gustavsson, N; Wang, XR; Wang, Y; Seah, T; Xu, J; Radda, GK; Sudhof, TC; Han, WP				Gustavsson, Natalia; Wang, Xiaorui; Wang, Yue; Seah, Tingting; Xu, Jun; Radda, George K.; Suedhof, Thomas C.; Han, Weiping			Neuronal Calcium Sensor Synaptotagmin-9 Is Not Involved in the Regulation of Glucose Homeostasis or Insulin Secretion	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; CA2+ SENSOR; CAPACITANCE MEASUREMENTS; EXOCYTOSIS; RELEASE; ISLETS; MICE	Background: Insulin secretion is a complex and highly regulated process. It is well established that cytoplasmic calcium is a key regulator of insulin secretion, but how elevated intracellular calcium triggers insulin granule exocytosis remains unclear, and we have only begun to define the identities of proteins that are responsible for sensing calcium changes and for transmitting the calcium signal to release machineries. Synaptotagmins are primarily expressed in brain and endocrine cells and exhibit diverse calcium binding properties. Synaptotagmin-1, -2 and -9 are calcium sensors for fast neurotransmitter release in respective brain regions, while synaptotagmin-7 is a positive regulator of calcium-dependent insulin release. Unlike the three neuronal calcium sensors, whose deletion abolished fast neurotransmitter release, synaptotagmin-7 deletion resulted in only partial loss of calcium-dependent insulin secretion, thus suggesting that other calcium-sensors must participate in the regulation of insulin secretion. Of the other synaptotagmin isoforms that are present in pancreatic islets, the neuronal calcium sensor synaptotagmin-9 is expressed at the highest level after synaptotagmin-7. Methodology/Principal Findings: In this study we tested whether synaptotagmin-9 participates in the regulation of glucose-stimulated insulin release by using pancreas-specific synaptotagmin-9 knockout (p-S9X) mice. Deletion of synaptotagmin-9 in the pancreas resulted in no changes in glucose homeostasis or body weight. Glucose tolerance, and insulin secretion in vivo and from isolated islets were not affected in the p-S9X mice. Single-cell capacitance measurements showed no difference in insulin granule exocytosis between p-S9X and control mice. Conclusions: Thus, synaptotagmin-9, although a major calcium sensor in the brain, is not involved in the regulation of glucose-stimulated insulin release from pancreatic beta-cells.	[Gustavsson, Natalia; Wang, Xiaorui; Wang, Yue; Seah, Tingting; Radda, George K.; Han, Weiping] Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore; [Xu, Jun; Suedhof, Thomas C.] Howard Hughes Med Inst, Palo Alto, CA USA; [Xu, Jun; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94304 USA; [Han, Weiping] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore 117595, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); Howard Hughes Medical Institute; Stanford University; National University of Singapore	Gustavsson, N (corresponding author), Agcy Sci Technol & Res, Singapore Bioimaging Consortium, Lab Metab Med, Singapore, Singapore.	natalia_gustavsson@sbic.a-star.edu.sg; weiping_han@sbic.a-star.edu.sg	Holt, Janet E/B-2415-2013; Petersen, Natalia/J-8800-2015	Petersen, Natalia/0000-0001-9344-6041; Seah, Ting Ting/0000-0002-2050-0171	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council	A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This study was supported by intramural funding from A*STAR (Agency for Science, Technology and Research, Singapore) Biomedical Research Council (W.H.). T.C.S. is a Howard Hughes Medical Institute investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT FM, 1994, J CELL BIOCHEM, V55, P54, DOI 10.1002/jcb.240550007; Barg S, 2004, J GEN PHYSIOL, V124, P623, DOI 10.1085/jgp.200409206; Gauthier BR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1279, DOI 10.1152/ajpendo.90568.2008; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Gerber SH, 2002, DIABETES, V51, pS3, DOI 10.2337/diabetes.51.2007.S3; Gopel S, 2004, J PHYSIOL-LONDON, V556, P711, DOI 10.1113/jphysiol.2003.059675; Gustavsson N, 2008, P NATL ACAD SCI USA, V105, P3992, DOI 10.1073/pnas.0711700105; Gustavsson N, 2009, BIOSCIENCE REP, V29, P245, DOI 10.1042/BSR20090031; Gustavsson N, 2009, J PHYSIOL-LONDON, V587, P1169, DOI 10.1113/jphysiol.2008.168005; Henquin JC, 2009, DIABETES OBES METAB, V11, P168, DOI 10.1111/j.1463-1326.2009.01109.x; Iezzi M, 2005, FEBS LETT, V579, P5241, DOI 10.1016/j.febslet.2005.08.047; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; LERNMARK A, 1974, DIABETOLOGIA, V10, P431, DOI 10.1007/BF01221634; LINDAU M, 1988, PFLUG ARCH EUR J PHY, V411, P137, DOI 10.1007/BF00582306; Marshall C, 2005, MOL ENDOCRINOL, V19, P213, DOI 10.1210/me.2004-0064; Ort T, 2001, EMBO J, V20, P4013, DOI 10.1093/emboj/20.15.4013; Pang ZPP, 2006, J NEUROSCI, V26, P13493, DOI 10.1523/JNEUROSCI.3519-06.2006; Rettig J, 2002, SCIENCE, V298, P781, DOI 10.1126/science.1075375; Schonn JS, 2008, P NATL ACAD SCI USA, V105, P3998, DOI 10.1073/pnas.0712373105; Sudhof TC, 2002, J BIOL CHEM, V277, P7629, DOI 10.1074/jbc.R100052200; Svoboda P, 2007, CURR OPIN MOL THER, V9, P248; Turner MD, 2007, MOL GENET METAB, V91, P305, DOI 10.1016/j.ymgme.2007.04.019; Turner MD, 2007, BIOCHEM BIOPH RES CO, V352, P650, DOI 10.1016/j.bbrc.2006.11.077; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Zawalich WS, 2008, METABOLISM, V57, P30, DOI 10.1016/j.metabol.2007.07.020; Zawalich WS, 1996, ENDOCRINOLOGY, V137, P1664, DOI 10.1210/en.137.5.1664	26	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15414	10.1371/journal.pone.0015414	http://dx.doi.org/10.1371/journal.pone.0015414			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085706	Green Published, gold, Green Submitted			2022-12-27	WOS:000284035900029
J	Djawe, K; Huang, L; Daly, KR; Levin, L; Koch, J; Schwartzman, A; Fong, S; Roth, B; Subramanian, A; Grieco, K; Jarlsberg, L; Walzer, PD				Djawe, Kpandja; Huang, Laurence; Daly, Kieran R.; Levin, Linda; Koch, Judy; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah; Walzer, Peter D.			Serum Antibody Levels to the Pneumocystis jirovecii Major Surface Glycoprotein in the Diagnosis of P. jirovecii Pneumonia in HIV plus Patients	PLOS ONE			English	Article							VIRUS-INFECTED PATIENTS; SEROLOGIC RESPONSES; CARINII-PNEUMONIA; HUMORAL IMMUNITY; IGG ANTIBODIES; ANTIGEN; PREDICTORS; PROGRESSION; VACCINE; GLUCAN	Pneumocystis jirovecii remains an important cause of fatal pneumonia (Pneumocystis pneumonia or PcP) in HIV+ patients and other immunocompromised hosts. Despite many previous attempts, a clinically useful serologic test for P. jirovecii infection has never been developed. Methods/Principal Findings: We analyzed serum antibody responses to the P. jirovecii major surface glycoprotein recombinant fragment C1 (MsgC1) in 110 HIV+ patients with active PcP (cases) and 63 HIV+ patients with pneumonia due to other causes (controls) by an enzyme-linked immunosorbent assay (ELISA). The cases had significantly higher IgG and IgM antibody levels to MsgC1 than the controls at hospital admission (week 0) and intervals up to at least 1 month thereafter. The sensitivity, specificity and positive predictive value (PPV) of IgG antibody levels increased from 57.2%, 61.7% and 71.5% at week 0 to 63.4%, 100%, and 100%, respectively, at weeks 3-4. The sensitivity, specificity and PPV of IgM antibody levels rose from 59.7%, 61.3%, and 79.3% at week 0 to 74.6%, 73.7%, and 89.8%, respectively, at weeks 3-4. Multivariate analysis revealed that a diagnosis of PcP was the only independent predictor of high IgG and IgM antibody levels to MsgC1. A high LDH level, a nonspecific marker of lung damage, was an independent predictor of low IgG antibody levels to MsgC1. Conclusions/Significance: The results suggest that the ELISA shows promise as an aid to the diagnosis of PCP in situations where diagnostic procedures cannot be performed. Further studies in other patient populations are needed to better define the usefulness of this serologic test.	[Djawe, Kpandja; Daly, Kieran R.; Koch, Judy; Walzer, Peter D.] Vet Affairs Med Ctr, Cincinnati, OH 45267 USA; [Djawe, Kpandja; Levin, Linda; Walzer, Peter D.] Univ Coll Med, Dept Environm Hlth, Div Epidemiol & Biostat, Cincinnati, OH USA; [Huang, Laurence; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah] Univ Calif San Francisco, San Francisco Gen Hosp, Div Pulm & Crit Care Med, San Francisco, CA USA; [Huang, Laurence; Schwartzman, Alexandra; Fong, Serena; Roth, Brenna; Subramanian, Anuradha; Grieco, Katherine; Jarlsberg, Leah] Univ Calif San Francisco, San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA USA; [Daly, Kieran R.; Koch, Judy; Walzer, Peter D.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Infect Dis, Cincinnati, OH USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University System of Ohio; University of Cincinnati	Djawe, K (corresponding author), Vet Affairs Med Ctr, Cincinnati, OH 45267 USA.	peter.walzer@med.va.gov	Huang, Laurence/AAE-1590-2019; Huang, Laurence/AAZ-7120-2021	Huang, Laurence/0000-0003-3888-2195; Fong, Serena/0000-0002-9803-3016; Jarlsberg, Leah/0000-0001-6548-6337	Medical Research Service; Department of Veterans Affairs [RO1AI-06492]; National Institutes of Health (NIH) [K24 HL087713, R01 HL090335]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090335, K24HL087713] Funding Source: NIH RePORTER	Medical Research Service; Department of Veterans Affairs(US Department of Veterans Affairs); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the Medical Research Service, Department of Veterans Affairs, RO1AI-06492 (to PDW), National Institutes of Health (NIH) K24 HL087713 and R01 HL090335 (LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop LR, 2003, J INFECT DIS, V187, P1844, DOI 10.1086/375354; BURNS SM, 1990, J INFECTION, V20, P33, DOI 10.1016/S0163-4453(90)92280-X; Cagigi A, 2008, VACCINE, V26, P3016, DOI 10.1016/j.vaccine.2007.11.063; Choukri F, 2010, CLIN INFECT DIS, V51, P259, DOI 10.1086/653933; Daly K, 2009, CLIN MICROBIOL INFEC, V15, P937, DOI 10.1111/j.1469-0691.2009.02716.x; Daly KR, 2006, CLIN VACCINE IMMUNOL, V13, P1071, DOI 10.1128/CVI.00140-06; Daly KR, 2006, EMERG INFECT DIS, V12, P1231, DOI 10.3201/eid1708.060230; Daly KR, 2004, EMERG INFECT DIS, V10, P848, DOI 10.3201/eid1005.030497; Daly KR, 2002, J INFECT DIS, V186, P644, DOI 10.1086/341565; Davis JL, 2008, THORAX, V63, P329, DOI 10.1136/thx.2007.088104; De Milito A, 2004, BLOOD, V103, P2180, DOI 10.1182/blood-2003-07-2375; DJAWE K, 2010, INTERNAT J IN PRESS; Duggal P, 2003, GENES IMMUN, V4, P245, DOI 10.1038/sj.gene.6363950; ELVIN K, 1994, SCAND J INFECT DIS, V26, P33, DOI 10.3109/00365549409008588; Forthal DN, 2007, J IMMUNOL, V179, P7916, DOI 10.4049/jimmunol.179.11.7916; GARBE TR, 1994, INFECT IMMUN, V62, P3092, DOI 10.1128/IAI.62.8.3092-3101.1994; GOLDENBERG DM, 1994, J NUD MED, V35, P1034; HOFMANN B, 1985, J INFECT DIS, V152, P838, DOI 10.1093/infdis/152.4.838; HUANG L, 1995, AM J RESP CRIT CARE, V151, P1866, DOI 10.1164/ajrccm.151.6.7767533; Kaplan JE, 1998, J INFECT DIS, V178, P1126, DOI 10.1086/515658; KEELY SP, 1995, J INFECT DIS, V172, P595, DOI 10.1093/infdis/172.2.595; KOVACS JA, 1993, J BIOL CHEM, V268, P6034; Krajicek BJ, 2009, CLIN CHEST MED, V30, P265, DOI 10.1016/j.ccm.2009.02.005; Kroon FP, 1997, CLIN INFECT DIS, V25, P600, DOI 10.1086/513750; Kutty G, 2003, INFECT IMMUN, V71, P571, DOI 10.1128/IAI.71.1.571-574.2003; Laursen AL, 1998, SCAND J INFECT DIS, V30, P495, DOI 10.1080/00365549850161511; LUNDGREN B, 1993, SCAND J INFECT DIS, V25, P515, DOI 10.3109/00365549309008535; LUNDGREN B, 1992, J INFECT DIS, V165, P1151, DOI 10.1093/infdis/165.6.1151; Morris A, 2004, EMERG INFECT DIS, V10, P1713, DOI 10.3201/eid1010.030985; Morris A, 2008, CLIN INFECT DIS, V47, pE64, DOI 10.1086/591701; MORROW BM, 2010, PEDIAT INFECT DIS J; Nkinin SW, 2009, ACTA TROP, V112, P219, DOI 10.1016/j.actatropica.2009.07.030; PEGLOW SL, 1990, J INFECT DIS, V161, P296, DOI 10.1093/infdis/161.2.296; PIFER LLW, 1987, J CLIN MICROBIOL, V25, P991, DOI 10.1128/JCM.25.6.991-995.1987; Pisculli ML, 2008, CLIN INFECT DIS, V46, P1928, DOI 10.1086/588564; Rimland D, 2002, AIDS, V16, P85, DOI 10.1097/00002030-200201040-00011; Selwyn PA, 1998, AIDS, V12, P885, DOI 10.1097/00002030-199808000-00011; Singh MP, 2005, BRIT J BIOMED SCI, V62, P81, DOI 10.1080/09674845.2005.11732690; Stansell JD, 1997, AM J RESP CRIT CARE, V155, P60, DOI 10.1164/ajrccm.155.1.9001290; Stringer JR, 2001, INFECT IMMUN, V69, P627, DOI 10.1128/IAI.69.2.627-639.2001; Tasaka S, 2007, CHEST, V131, P1173, DOI 10.1378/chest.06-1467; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588; Tipirneni R, 2009, EMERG INFECT DIS, V15, P1590, DOI 10.3201/eid1510.090207; Walzer PD, 1999, CLIN DIAGN LAB IMMUN, V6, P149, DOI 10.1128/CDLI.6.2.149-155.1999; Walzer PD, 2008, CLIN INFECT DIS, V46, P625, DOI 10.1086/526778; Walzer PD, 2009, J INFECT DIS, V199, P1335, DOI 10.1086/597803; Watanabe T, 2009, CLIN INFECT DIS, V49, P1128, DOI 10.1086/605579	47	20	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14259	10.1371/journal.pone.0014259	http://dx.doi.org/10.1371/journal.pone.0014259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151564	gold, Green Submitted, Green Published			2022-12-27	WOS:000285135800002
J	Roca, CP; Lozano, S; Arenas, A; Sanchez, A				Roca, Carlos P.; Lozano, Sergi; Arenas, Alex; Sanchez, Angel			Topological Traps Control Flow on Real Networks: The Case of Coordination Failures	PLOS ONE			English	Article							STATISTICAL-MECHANICS; SOCIAL DILEMMAS; DYNAMICS; EVOLUTION; BEHAVIOR	We study evolutionary games in real social networks, with a focus on coordination games. We find that populations fail to coordinate in the same behavior for a wide range of parameters, a novel phenomenon not observed in most artificial model networks. We show that this result arises from the relevance of correlations beyond the first neighborhood, in particular from topological traps formed by links between nodes of different degrees in regions with few or no redundant paths. This specificity of real networks has not been modeled so far with synthetic networks. We thus conclude that model networks must be improved to include these mesoscopic structures, in order to successfully address issues such as the emergence of cooperation in real societies. We finally show that topological traps are a very generic phenomenon that may arise in very many different networks and fields, such as opinion models, spread of diseases or ecological networks.	[Roca, Carlos P.; Lozano, Sergi] Swiss Fed Inst Technol, Chair Sociol Particular Modeling & Simulat, Dept Humanities Social & Polit Sci, Zurich, Switzerland; [Roca, Carlos P.; Sanchez, Angel] Univ Carlos III Madrid, Dept Matemat, GISC, Leganes, Spain; [Arenas, Alex] Univ Rovira & Virgili, Dept Engn Informat & Matemat, Tarragona, Spain; [Arenas, Alex; Sanchez, Angel] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain; [Sanchez, Angel] CSIC UAM UC3M UCM, Inst Ciencias Matemat, Madrid, Spain	Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidad Carlos III de Madrid; Universitat Rovira i Virgili; University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); CSIC - Instituto de Ciencias Matematicas (ICMAT)	Roca, CP (corresponding author), Swiss Fed Inst Technol, Chair Sociol Particular Modeling & Simulat, Dept Humanities Social & Polit Sci, Zurich, Switzerland.	cproca@ethz.ch	Lozano, Sergi/B-5974-2015; Roca, Carlos P./F-3846-2014; Sánchez, Angel/A-9229-2008; Arenas, Alex/A-5216-2009	Lozano, Sergi/0000-0003-1895-9327; Roca, Carlos P./0000-0003-0230-1926; Sánchez, Angel/0000-0003-1874-2881; Arenas, Alex/0000-0003-0937-0334	Ministerio de Ciencia e Innovacion (Spain) [FIS2009-13730-C02-02, MOSAICO]; Comunidad de Madrid (Spain) [MODELICO-CM]; Generalitat de Catalunya (Spain) [2009 SGR 838]; European Commission [231200]	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid (Spain)(Comunidad de Madrid); Generalitat de Catalunya (Spain)(Generalitat de Catalunya); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was partially supported by Ministerio de Ciencia e Innovacion (Spain) through Grants MOSAICO (to C. P. R. and A. S.), FIS2009-13730-C02-02 (to A. A.), by Comunidad de Madrid (Spain) through Grant MODELICO-CM (to A. S.) and by Generalitat de Catalunya (Spain) through Grant 2009 SGR 838. S. L. was partially supported by the Future and Emerging Technologies programme FP7-COSI-ICT of the European Commission through project QLectives (grant no. 231200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured]; [Anonymous], [No title captured]; [Anonymous], 2009, GAM THEOR EV PROBL; [Anonymous], 1988, SOCIAL STRUCTURES NE; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; Bergstrom TC, 2002, J ECON PERSPECT, V16, P67, DOI 10.1257/0895330027265; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Boguna M, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056122; Castello X, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/66006; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; HELBING D, 1992, PHYSICA A, V181, P29, DOI 10.1016/0378-4371(92)90195-V; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Jensen HJ, 2008, P ROY SOC A-MATH PHY, V464, P2207, DOI 10.1098/rspa.2008.0032; KIRKPATRICK S, 1977, PHYS REV B, V16, P4630, DOI 10.1103/PhysRevB.16.4630; Kollock P, 1998, ANNU REV SOCIOL, V24, P183, DOI 10.1146/annurev.soc.24.1.183; Licht AN, 1999, YALE J INT L, V24, P61; Lozano S, 2008, J ECON INTERACT COOR, V3, P183, DOI 10.1007/s11403-008-0041-7; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Macy MW, 2002, P NATL ACAD SCI USA, V99, P7229, DOI 10.1073/pnas.092080099; Mahadevan P, 2006, ACM SIGCOMM COMP COM, V36, P135, DOI 10.1145/1151659.1159930; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; MATSUI A, 1992, J ECON THEORY, V57, P343, DOI 10.1016/0022-0531(92)90040-O; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Pennisi E, 2005, SCIENCE, V309, P93, DOI 10.1126/science.309.5731.93; Pennisi E, 2009, SCIENCE, V325, P1196, DOI 10.1126/science.325_1196; Poncela J, 2009, EPL-EUROPHYS LETT, V88, DOI 10.1209/0295-5075/88/38003; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Rapoport A, 1965, PRISONERS DILEMMA; Rilling JK, 2002, NEURON, V35, P395, DOI 10.1016/S0896-6273(02)00755-9; Roca CP, 2009, EUR PHYS J B, V71, P587, DOI 10.1140/epjb/e2009-00189-0; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; Saavedra S, 2009, NATURE, V457, P463, DOI 10.1038/nature07532; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Skyrms B, 2003, STAG HUNT EVOLUTION; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1976, AM SCI, V64, P41; Sreenivasan S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.036105; Sugden R, 2005, ECONOMICS OF RIGHTS, COOPERATION AND WELFARE, P1, DOI 10.1057/9780230536791; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; SZATHMARY E, 1995, NATURE, V374, P227, DOI 10.1038/374227a0; Toivonen R, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016109; Wolfe AW, 1997, AM ETHNOL, V24, P219, DOI 10.1525/ae.1997.24.1.219	54	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15210	10.1371/journal.pone.0015210	http://dx.doi.org/10.1371/journal.pone.0015210			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692ES	21151565	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800018
J	Wilson, ME; Boumaza, I; Lacomis, D; Bowser, R				Wilson, Meghan E.; Boumaza, Imene; Lacomis, David; Bowser, Robert			Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							IN-VIVO; CEREBROSPINAL-FLUID; PROGNOSTIC-FACTORS; ALS; DEATH; CSF; IDENTIFICATION; EXPRESSION; SURVIVAL; NEURONS	Amyotrophic lateral sclerosis (ALS) is a fatal neurologic disease characterized by progressive motor neuron degeneration. Clinical disease management is hindered by both a lengthy diagnostic process and the absence of effective treatments. Reliable panels of diagnostic, surrogate, and prognostic biomarkers are needed to accelerate disease diagnosis and expedite drug development. The cysteine protease inhibitor cystatin C has recently gained interest as a candidate diagnostic biomarker for ALS, but further studies are required to fully characterize its biomarker utility. We used quantitative enzyme-linked immunosorbent assay (ELISA) to assess initial and longitudinal cerebrospinal fluid (CSF) and plasma cystatin C levels in 104 ALS patients and controls. Cystatin C levels in ALS patients were significantly elevated in plasma and reduced in CSF compared to healthy controls, but did not differ significantly from neurologic disease controls. In addition, the direction of longitudinal change in CSF cystatin C levels correlated to the rate of ALS disease progression, and initial CSF cystatin C levels were predictive of patient survival, suggesting that cystatin C may function as a surrogate marker of disease progression and survival. These data verify prior results for reduced cystatin C levels in the CSF of ALS patients, identify increased cystatin C levels in the plasma of ALS patients, and reveal correlations between CSF cystatin C levels to both ALS disease progression and patient survival.	[Wilson, Meghan E.; Boumaza, Imene; Bowser, Robert] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA; [Lacomis, David] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wilson, ME (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	bowserrp@upmc.edu			University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research; NIH [NS061867]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061867, R56NS061867] Funding Source: NIH RePORTER	University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research funding was provided by the University of Pittsburgh Center for Amyotrophic Lateral Sclerosis (ALS) Research and NIH grant NS061867 to Robert Bowser. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowser R, 2006, EXPERT REV MOL DIAGN, V6, P387, DOI 10.1586/14737159.6.3.387; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, pS1, DOI 10.1080/14660820050515638; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; DiBernardo AB, 2006, BBA-MOL BASIS DIS, V1762, P1139, DOI 10.1016/j.bbadis.2006.03.007; GEORGE PM, 1989, CLIN CHEM, V35, P179; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Louwerse ES, 1997, J NEUROL SCI, V152, pS10, DOI 10.1016/S0022-510X(97)00238-4; Madero M, 2009, CURR OPIN NEPHROL HY, V18, P258, DOI 10.1097/MNH.0b013e328326f3dd; Magnus T, 2002, MUSCLE NERVE, V25, P709, DOI 10.1002/mus.10090; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Mitchell RM, 2009, NEUROLOGY, V72, P14, DOI 10.1212/01.wnl.0000333251.36681.a5; Nagai A, 2005, BRAIN RES, V1066, P120, DOI 10.1016/j.brainres.2005.10.063; Nagai A, 2002, ANN NY ACAD SCI, V977, P315, DOI 10.1111/j.1749-6632.2002.tb04832.x; Nishiyama K, 2005, BRAIN RES BULL, V67, P94, DOI 10.1016/j.brainresbull.2005.05.020; Okamoto K, 2008, NEUROPATHOLOGY, V28, P109, DOI 10.1111/j.1440-1789.2007.00873.x; Paraoan L, 2007, EXP EYE RES, V84, P1019, DOI 10.1016/j.exer.2006.01.024; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Ranganathan S, 2005, J NEUROCHEM, V95, P1461, DOI 10.1111/j.1471-4159.2005.03478.x; Ryberg H, 2008, EXPERT REV PROTEOMIC, V5, P249, DOI 10.1586/14789450.5.2.249; Ryberg H, 2010, MUSCLE NERVE, V42, P104, DOI 10.1002/mus.21683; Seronie-Vivien S, 2008, CLIN CHEM LAB MED, V46, P1664, DOI 10.1515/CCLM.2008.336; Sorensen EJ, 2004, AMYOTROPH LATERAL SC, V5, P86, DOI 10.1080/17434470410020030; Testa D, 2004, AMYOTROPH LATERAL SC, V5, P208, DOI 10.1080/14660820410021311; Traynor BJ, 2004, NEUROLOGY, V63, P1933, DOI 10.1212/01.WNL.0000144345.49510.4E; Tsuji-Akimoto S, 2009, NEUROSCI LETT, V452, P52, DOI 10.1016/j.neulet.2009.01.026; TU GF, 1992, AM J PHYSIOL, V263, pR195, DOI 10.1152/ajpregu.1992.263.1.R195; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; Wagner KR, 2009, NEUROLOGY, V72, P11, DOI 10.1212/01.wnl.0000338538.18938.9d; Xu L, 2005, NEUROBIOL DIS, V18, P152, DOI 10.1016/j.nbd.2004.08.012	30	63	66	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15133	10.1371/journal.pone.0015133	http://dx.doi.org/10.1371/journal.pone.0015133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151566	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000285135800015
J	Bruno, JC; Freitag, NE				Bruno, Joseph C., Jr.; Freitag, Nancy E.			Constitutive Activation of PrfA Tilts the Balance of Listeria monocytogenes Fitness Towards Life within the Host versus Environmental Survival	PLOS ONE			English	Article							CENTRAL VIRULENCE REGULATOR; IN-VITRO TRANSCRIPTION; SIGMA-B; GENE-EXPRESSION; PLEIOTROPIC ACTIVATOR; MUTATIONAL ACTIVATION; CARBON METABOLISM; STRESS TOLERANCE; ACID TOLERANCE; GROWTH	PrfA is a key regulator of Listeria monocytogenes pathogenesis and induces the expression of multiple virulence factors within the infected host. PrfA is post-translationally regulated such that the protein becomes activated upon bacterial entry into the cell cytosol. The signal that triggers PrfA activation remains unknown, however mutations have been identified (prfA* mutations) that lock the protein into a high activity state. In this report we examine the consequences of constitutive PrfA activation on L. monocytogenes fitness both in vitro and in vivo. Whereas prfA* mutants were hyper-virulent during animal infection, the mutants were compromised for fitness in broth culture and under conditions of stress. Broth culture prfA*-associated fitness defects were alleviated when glycerol was provided as the principal carbon source; under these conditions prfA* mutants exhibited a competitive advantage over wild type strains. Glycerol and other three carbon sugars have been reported to serve as primary carbon sources for L. monocytogenes during cytosolic growth, thus prfA* mutants are metabolically-primed for replication within eukaryotic cells. These results indicate the critical need for environment-appropriate regulation of PrfA activity to enable L. monocytogenes to optimize bacterial fitness inside and outside of host cells.	[Bruno, Joseph C., Jr.; Freitag, Nancy E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Freitag, Nancy E.] Univ Illinois, Dept Microbiol & Immunol, Chicago, IL 60680 USA	University of Washington; University of Washington Seattle; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bruno, JC (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	nfreitag@uic.edu			NIAID [AI41816]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI041816, R29AI041816, R01AI041816] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public health service grant AI41816 (N.E.F) from NIAID. The contents of the article are solely the responsibility of the authors and do not necessarily represent the official views of the funding sources. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram F, 2008, APPL ENVIRON MICROB, V74, P6848, DOI 10.1128/AEM.00442-08; Allerberger F, 2010, CLIN MICROBIOL INFEC, V16, P16, DOI 10.1111/j.1469-0691.2009.03109.x; Alonzo F, 2009, INFECT IMMUN, V77, P2612, DOI 10.1128/IAI.00280-09; Auerbuch V, 2001, INFECT IMMUN, V69, P5953, DOI 10.1128/IAI.69.9.5953-5957.2001; Barbuddhe SB, 2009, CURR TOP MICROBIOL, V337, P173, DOI 10.1007/978-3-642-01846-6_6; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; BISHOP DK, 1987, J IMMUNOL, V139, P2005; Blackman IC, 1996, J FOOD PROTECT, V59, P827, DOI 10.4315/0362-028X-59.8.827; Bohne J, 1996, MOL MICROBIOL, V20, P1189, DOI 10.1111/j.1365-2958.1996.tb02639.x; Bortolussi R, 2008, CAN MED ASSOC J, V179, P795, DOI 10.1503/cmaj.081377; Bubert A, 1999, MOL GEN GENET, V261, P323, DOI 10.1007/s004380050973; Centers for Disease Control and Prevention (CDC), 2008, MMWR Morb Mortal Wkly Rep, V57, P1097; Davis MJ, 1996, MICROBIOL-UK, V142, P2975, DOI 10.1099/13500872-142-10-2975; Drevets DA, 2008, FEMS IMMUNOL MED MIC, V53, P151, DOI 10.1111/j.1574-695X.2008.00404.x; Dussurget O, 2002, MOL MICROBIOL, V45, P1095, DOI 10.1046/j.1365-2958.2002.03080.x; EDMAN DC, 1968, J BACTERIOL, V96, P352, DOI 10.1128/JB.96.2.352-357.1968; Eisenreich W, 2010, NAT REV MICROBIOL, V8, P401, DOI 10.1038/nrmicro2351; Eylert E, 2008, MOL MICROBIOL, V69, P1008, DOI 10.1111/j.1365-2958.2008.06337.x; Fenlon D. R., 1999, Listeria, listeriosis and food safety., P21; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; FREITAG NE, 1993, INFECT IMMUN, V61, P2537, DOI 10.1128/IAI.61.6.2537-2544.1993; Freitag NE, 1999, INFECT IMMUN, V67, P1844; FREITAG NE, 1994, MOL MICROBIOL, V12, P845, DOI 10.1111/j.1365-2958.1994.tb01070.x; Gahan CGM, 2005, J APPL MICROBIOL, V98, P1345, DOI 10.1111/j.1365-2672.2005.02559.x; Garner MR, 2006, INFECT IMMUN, V74, P876, DOI 10.1128/IAI.74.2.876-886.2006; Gottlieb SL, 2006, CLIN INFECT DIS, V42, P29, DOI 10.1086/498113; Gray MJ, 2006, INFECT IMMUN, V74, P2505, DOI 10.1128/IAI.74.5.2505-2512.2006; GRAY ML, 1966, BACTERIOL REV, V30, P309, DOI 10.1128/MMBR.30.2.309-382.1966; Hodgson DA, 2000, MOL MICROBIOL, V35, P312, DOI 10.1046/j.1365-2958.2000.01643.x; Johansson J, 2002, CELL, V110, P551, DOI 10.1016/S0092-8674(02)00905-4; Joseph B, 2008, J BACTERIOL, V190, P5412, DOI 10.1128/JB.00259-08; Kazmierczak MJ, 2006, MICROBIOL-SGM, V152, P1827, DOI 10.1099/mic.0.28758-0; Kim H, 2005, MICROBIOL-SGM, V151, P3215, DOI 10.1099/mic.0.28070-0; Kim H, 2004, INFECT IMMUN, V72, P7374, DOI 10.1128/IAI.72.12.7374-7378.2004; Korner H, 2003, FEMS MICROBIOL REV, V27, P559, DOI 10.1016/S0168-6445(03)00066-4; Lalic-Multhaler M, 2001, MOL MICROBIOL, V42, P111, DOI 10.1046/j.1365-2958.2001.02607.x; LAMPIDIS R, 1994, MOL MICROBIOL, V13, P141, DOI 10.1111/j.1365-2958.1994.tb00409.x; Lauer P, 2002, J BACTERIOL, V184, P4177, DOI 10.1128/JB.184.15.4177-4186.2002; LEIMEISTERWACHTER M, 1990, P NATL ACAD SCI USA, V87, P8336, DOI 10.1073/pnas.87.21.8336; LEIMEISTERWACHTER M, 1992, J BACTERIOL, V174, P947, DOI 10.1128/jb.174.3.947-952.1992; Lemon KP, 2010, J BACTERIOL, V192, P3969, DOI 10.1128/JB.00179-10; LENNOX ES, 1955, VIROLOGY, V1, P190, DOI 10.1016/0042-6822(55)90016-7; LINGNAU A, 1995, INFECT IMMUN, V63, P3896, DOI 10.1128/IAI.63.10.3896-3903.1995; Marr AK, 2006, J BACTERIOL, V188, P3887, DOI 10.1128/JB.01978-05; MENGAUD J, 1991, MOL MICROBIOL, V5, P2273, DOI 10.1111/j.1365-2958.1991.tb02158.x; Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x; Milohanic E, 2003, MOL MICROBIOL, V47, P1613, DOI 10.1046/j.1365-2958.2003.03413.x; Miner MD, 2008, MICROB PATHOGENESIS, V45, P273, DOI 10.1016/j.micpath.2008.06.006; Miner MD, 2008, MICROBIOL-SGM, V154, P3579, DOI 10.1099/mic.0.2008/021063-0; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Moors MA, 1999, INFECT IMMUN, V67, P131, DOI 10.1128/IAI.67.1.131-139.1999; Mueller KJ, 2005, INFECT IMMUN, V73, P1917, DOI 10.1128/IAI.73.4.1917-1926.2005; O'Byrne CP, 2008, ADV APPL MICROBIOL, V65, P115, DOI 10.1016/S0065-2164(08)00605-9; Oliver HF, 2010, APPL ENVIRON MICROB, V76, P4216, DOI 10.1128/AEM.00031-10; Ollinger J, 2009, INFECT IMMUN, V77, P2113, DOI 10.1128/IAI.01205-08; PARK SF, 1993, MOL MICROBIOL, V8, P653, DOI 10.1111/j.1365-2958.1993.tb01609.x; PARK SF, 1990, GENE, V94, P129, DOI 10.1016/0378-1119(90)90479-B; Port GC, 2007, INFECT IMMUN, V75, P5886, DOI 10.1128/IAI.00845-07; Rauch M, 2005, J BACTERIOL, V187, P800, DOI 10.1128/JB.187.2.800-804.2005; Renzoni A, 1997, INFECT IMMUN, V65, P1515, DOI 10.1128/IAI.65.4.1515-1518.1997; Ripio MT, 1998, FEMS MICROBIOL LETT, V158, P45, DOI 10.1016/S0378-1097(97)00498-9; Ripio MT, 1997, J BACTERIOL, V179, P1533, DOI 10.1128/jb.179.5.1533-1540.1997; Ripio MT, 1996, RES MICROBIOL, V147, P371, DOI 10.1016/0923-2508(96)84712-7; Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005; Rocourt J., 1999, Listeria, listeriosis and food safety., P1; Rouquette C, 1996, MOL MICROBIOL, V21, P977, DOI 10.1046/j.1365-2958.1996.641432.x; Ryser E. T., 1999, Listeria, listeriosis and food safety., P299; Schmid B, 2009, APPL ENVIRON MICROB, V75, P1621, DOI 10.1128/AEM.02154-08; Schwab U, 2005, FEMS MICROBIOL LETT, V245, P329, DOI 10.1016/j.femsle.2005.03.025; Scortti M, 2007, MICROBES INFECT, V9, P1196, DOI 10.1016/j.micinf.2007.05.007; SHEEHAN B, 1995, J BACTERIOL, V177, P6469, DOI 10.1128/jb.177.22.6469-6476.1995; Shetron-Rama LM, 2003, MOL MICROBIOL, V48, P1537, DOI 10.1046/j.1365-2958.2003.03534.x; Shetron-Rama LM, 2002, INFECT IMMUN, V70, P1087, DOI 10.1128/IAI.70.3.1087-1096.2002; Sleator RD, 2005, MOL MICROBIOL, V55, P1183, DOI 10.1111/j.1365-2958.2004.04454.x; SMITH K, 1992, BIOCHIMIE, V74, P705, DOI 10.1016/0300-9084(92)90143-3; Soderholm JD, 2001, AM J PHYSIOL-GASTR L, V280, pG7, DOI 10.1152/ajpgi.2001.280.1.G7; Stoll R, 2008, MICROBIOL-SGM, V154, P3856, DOI 10.1099/mic.0.2008/018283-0; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; Vega Y, 2004, MOL MICROBIOL, V52, P1553, DOI 10.1111/j.1365-2958.2004.04052.x; Vega Y, 1998, J BACTERIOL, V180, P6655, DOI 10.1128/JB.180.24.6655-6660.1998; Velge P, 2007, MICROBIOL-SGM, V153, P995, DOI 10.1099/mic.0.2006/002238-0; Vugia D., 2009, Morbidity and Mortality Weekly Report, V58, P333; Walecka E, 2009, POL J VET SCI, V12, P575; Wiedmann M, 1998, J BACTERIOL, V180, P3650, DOI 10.1128/JB.180.14.3650-3656.1998; Wollert T, 2007, CELL, V129, P891, DOI 10.1016/j.cell.2007.03.049; Wong KKY, 2004, J BACTERIOL, V186, P6265, DOI 10.1128/JB.186.18.6265-6276.2004; Xayarath B, 2009, MOL MICROBIOL, V74, P956, DOI 10.1111/j.1365-2958.2009.06910.x; YOUNGMAN P, 1987, PLASMIDS PRACTICAL A, P79	90	50	50	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15138	10.1371/journal.pone.0015138	http://dx.doi.org/10.1371/journal.pone.0015138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151923	Green Published, gold, Green Submitted			2022-12-27	WOS:000285041800007
J	Levitan, O; Sudhaus, S; LaRoche, J; Berman-Frank, I				Levitan, Orly; Sudhaus, Stefanie; LaRoche, Julie; Berman-Frank, Ilana			The Influence of pCO(2) and Temperature on Gene Expression of Carbon and Nitrogen Pathways in Trichodesmium IMS101	PLOS ONE			English	Article							CO2 CONCENTRATING MECHANISMS; MARINE CYANOBACTERIUM; N-2 FIXATION; CO2-CONCENTRATING MECHANISM; NATURAL-POPULATIONS; LIGHT; PHOTOSYNTHESIS; PCR; METABOLISM; DIVERSITY	Growth, protein amount, and activity levels of metabolic pathways in Trichodesmium are influenced by environmental changes such as elevated pCO(2) and temperature. This study examines changes in the expression of essential metabolic genes in Trichodesmium grown under a matrix of pCO(2) (400 and 900 mu atm) and temperature (25 and 31 degrees C). Using RT-qPCR, we studied 21 genes related to four metabolic functional groups: CO2 concentrating mechanism (bicA1, bicA2, ccmM, ccmK2, ccmK3, ndhF4, ndhD4, ndhL, chpX), energy metabolism (atpB, sod, prx, glcD), nitrogen metabolism (glnA, hetR, nifH), and inorganic carbon fixation and photosynthesis (rbcL, rca, psaB, psaC, psbA). nifH and most photosynthetic genes exhibited relatively high abundance and their expression was influenced by both environmental parameters. A two to three orders of magnitude increase was observed for glnA and hetR only when both pCO(2) and temperature were elevated. CO2 concentrating mechanism genes were not affected by pCO(2) and temperature and their expression levels were markedly lower than that of the nitrogen metabolism and photosynthetic genes. Many of the CO2 concentrating mechanism genes were co-expressed throughout the day. Our results demonstrate that in Trichodesmium, CO2 concentrating mechanism genes are constitutively expressed. Co-expression of genes from different functional groups were frequently observed during the first half of the photoperiod when oxygenic photosynthesis and N-2 fixation take place, pointing at the tight and complex regulation of gene expression in Trichodesmium. Here we provide new data linking environmental changes of pCO(2) and temperature to gene expression in Trichodesmium. Although gene expression indicates an active metabolic pathway, there is often an uncoupling between transcription and enzyme activity, such that transcript level cannot usually be directly extrapolated to metabolic activity.	[Levitan, Orly; Berman-Frank, Ilana] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel; [Sudhaus, Stefanie; LaRoche, Julie] Univ Kiel, IFM GEOMAR, Leibniz Inst Marine Sci, Kiel, Germany	Bar Ilan University; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Kiel	Levitan, O (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, Ramat Gan, Israel.	levitao@gmail.com	LaRoche, Julie/A-1109-2010	Levitan, Orly/0000-0001-5248-8501; LaRoche, Julie/0000-0003-4809-6411; Berman-Frank, Ilana/0000-0003-3497-1844	BMBF-MOST [1950]; Reiger Fellowship for Environmental Studies; Israeli Ministry of Science; Office of Science of the U. S. Department of Energy [DE-AC02-05CH11231]	BMBF-MOST(Federal Ministry of Education & Research (BMBF)); Reiger Fellowship for Environmental Studies; Israeli Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Office of Science of the U. S. Department of Energy(United States Department of Energy (DOE))	This work was conducted as part of the BMBF-MOST grant No. 1950 to IBF and JLR. O. Levitan was supported by a Reiger Fellowship for Environmental Studies and by the Eshkol scholarship from the Israeli Ministry of Science. Trichodesmium genome published on the Joint Genome Institute (JGI) website (http://genome.jgi-psf.org/finished_microbes/trier/trier.home.html), conducted by the U. S. Department of Energy Joint Genome Institute is supported by the Office of Science of the U. S. Department of Energy under Contract No. DE-AC02-05CH11231. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader MR, 2000, PHILOS T R SOC B, V355, P1433, DOI 10.1098/rstb.2000.0704; Badger MR, 2006, J EXP BOT, V57, P249, DOI 10.1093/jxb/eri286; Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Beardall J, 2002, FUNCT PLANT BIOL, V29, P335, DOI 10.1071/PP01195; Bergman B, 1997, FEMS MICROBIOL REV, V19, P139, DOI 10.1016/S0168-6445(96)00028-9; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Bernroitner M, 2009, J EXP BOT, V60, P423, DOI 10.1093/jxb/ern309; Breitbarth E, 2007, BIOGEOSCIENCES, V4, P53, DOI 10.5194/bg-4-53-2007; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carpenter EJ, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P141, DOI 10.1016/B978-0-12-372522-6.00004-9; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Chen YB, 1998, J BACTERIOL, V180, P3598, DOI 10.1128/JB.180.14.3598-3605.1998; Chen YB, 1999, PLANT MOL BIOL, V41, P89, DOI 10.1023/A:1006231805030; Dietz KJ, 2003, ANNU REV PLANT BIOL, V54, P93, DOI 10.1146/annurev.arplant.54.031902.134934; Eisenhut M, 2008, P NATL ACAD SCI USA, V105, P17199, DOI 10.1073/pnas.0807043105; Eisenhut M, 2007, PLANT PHYSIOL, V144, P1946, DOI 10.1104/pp.107.103341; El-Shehawy R, 2003, MICROBIOL-SGM, V149, P1139, DOI 10.1099/mic.0.26170-0; Hewson I, 2009, ISME J, V3, P1286, DOI 10.1038/ismej.2009.75; Hutchins DA, 2007, LIMNOL OCEANOGR, V52, P1293, DOI 10.4319/lo.2007.52.4.1293; Janson S, 1998, FEMS MICROBIOL LETT, V168, P173, DOI 10.1111/j.1574-6968.1998.tb13270.x; KANA TM, 1993, LIMNOL OCEANOGR, V38, P18, DOI 10.4319/lo.1993.38.1.0018; Kaneko T, 1996, PLANT MOL BIOL, V31, P193, DOI 10.1007/BF00020621; Kaplan A, 1999, ANNU REV PLANT PHYS, V50, P539, DOI 10.1146/annurev.arplant.50.1.539; Kaplan A, 1994, MOL BIOL CYANOBACTER, P469, DOI DOI 10.1007/978-94-011-0227-8_15; Kaplan Aaron, 2008, P305; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kranz SA, 2009, LIMNOL OCEANOGR, V54, P548, DOI 10.4319/lo.2009.54.2.0548; Kupper H, 2004, PLANT PHYSIOL, V135, P2120, DOI 10.1104/pp.104.045963; Langlois RJ, 2005, APPL ENVIRON MICROB, V71, P7910, DOI 10.1128/AEM.71.12.7910-7919.2005; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, PLANT PHYSIOL, V154, P346, DOI 10.1104/pp.110.159285; Levitan O, 2010, ENVIRON MICROBIOL, V12, P1899, DOI 10.1111/j.1462-2920.2010.02195.x; Lin SJ, 1998, APPL ENVIRON MICROB, V64, P3052; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McGinn PJ, 2003, PLANT PHYSIOL, V132, P218, DOI 10.1104/pp.102.019349; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; OHKI K, 1992, J GEN MICROBIOL, V138, P2679, DOI 10.1099/00221287-138-12-2679; PALMQVIST K, 1994, PHYSIOL PLANTARUM, V90, P537; Pena KL, 2010, P NATL ACAD SCI USA, V107, P2455, DOI 10.1073/pnas.0910866107; POSTGATE JR, 1998, ORIGINS UNIT NITROGE; Price GD, 2008, J EXP BOT, V59, P1441, DOI 10.1093/jxb/erm112; Price GD, 2004, P NATL ACAD SCI USA, V101, P18228, DOI 10.1073/pnas.0405211101; Price GD, 1998, CAN J BOT, V76, P973, DOI 10.1139/b98-081; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Sandh G, 2009, FEMS MICROBIOL LETT, V295, P281, DOI 10.1111/j.1574-6968.2009.01608.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shi T, 2005, MOL BIOL EVOL, V22, P2179, DOI 10.1093/molbev/msi216; Shi T, 2007, ENVIRON MICROBIOL, V9, P2945, DOI 10.1111/j.1462-2920.2007.01406.x; Shi T, 2010, ISME J, V4, P621, DOI 10.1038/ismej.2009.148; Stork T, 2005, J EXP BOT, V56, P3193, DOI 10.1093/jxb/eri316; Sultemeyer D, 1998, PLANT PHYSIOL, V116, P183, DOI 10.1104/pp.116.1.183; Veal EA, 2004, MOL CELL, V15, P129, DOI 10.1016/j.molcel.2004.06.021; Woodger FJ, 2007, J BACTERIOL, V189, P3335, DOI 10.1128/JB.01745-06; Wyman M, 1996, APPL ENVIRON MICROB, V62, P1073, DOI 10.1128/AEM.62.3.1073-1075.1996; Wyman M, 1999, APPL ENVIRON MICROB, V65, P3651; ZEHR JP, 1993, APPL ENVIRON MICROB, V59, P669, DOI 10.1128/AEM.59.3.669-676.1993; Zhang JY, 2009, MICROBIOL-SGM, V155, P1418, DOI 10.1099/mic.0.027540-0	59	20	21	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15104	10.1371/journal.pone.0015104	http://dx.doi.org/10.1371/journal.pone.0015104			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151907	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000284995300015
J	Dreon, MS; Ituarte, S; Heras, H				Sebastian Dreon, Marcos; Ituarte, Santiago; Heras, Horacio			The Role of the Proteinase Inhibitor Ovorubin in Apple Snail Eggs Resembles Plant Embryo Defense against Predation	PLOS ONE			English	Article							POMACEA-CANALICULATA GASTROPODA; TRYPSIN-INHIBITOR; BIOCHEMICAL-COMPOSITION; PROTEASE INHIBITOR; ALBUMIN GLAND; STABILITY; MOLLUSCA; AMPULLARIIDAE; SEEDS; LIPOPROTEIN	Background: Fieldwork has thoroughly established that most eggs are intensely predated. Among the few exceptions are the aerial egg clutches from the aquatic snail Pomacea canaliculata which have virtually no predators. Its defenses are advertised by the pigmented ovorubin perivitellin providing a conspicuous reddish coloration. The nature of the defense however, was not clear, except for a screening for defenses that identified a neurotoxic perivitellin with lethal effect on rodents. Ovorubin is a proteinase inhibitor (PI) whose role to protect against pathogens was taken for granted, according to the prevailing assumption. Through biochemical, biophysical and feeding experiments we studied the proteinase inhibitor function of ovorubin in egg defenses. Methodology/Principal Findings: Mass spectrometry sequencing indicated ovorubin belongs to the Kunitz-type serine proteinase inhibitor family. It specifically binds trypsin as determined by small angle X-ray scattering (SAXS) and cross-linking studies but, in contrast to the classical assumption, it does not prevent bacterial growth. Ovorubin was found extremely resistant to in vitro gastrointestinal proteolysis. Moreover feeding studies showed that ovorubin ingestion diminishes growth rate in rats indicating that this highly stable PI is capable of surviving passage through the gastrointestinal tract in a biologically active form. Conclusions: To our knowledge, this is the first direct evidence of the interaction of an egg PI with a digestive protease of potential predators, limiting predator's ability to digest egg nutrients. This role has not been reported in the animal kingdom but it is similar to plant defenses against herbivory. Further, this would be the only defense model with no trade-offs between conspicuousness and noxiousness by encoding into the same molecule both the aposematic warning signal and an antinutritive/antidigestive defense. These defenses, combined with a neurotoxin and probably unpalatable factors would explain the near absence of predators, opening new perspectives in the study of the evolution and ecology of egg defensive strategies.	[Sebastian Dreon, Marcos; Ituarte, Santiago; Heras, Horacio] CONICET Univ Nacl La Plata, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of La Plata	Dreon, MS (corresponding author), CONICET Univ Nacl La Plata, Inst Invest Bioquim La Plata INIBIOLP, La Plata, Buenos Aires, Argentina.	h-heras@med.unlp.edu.ar	; Heras, Horacio/R-9555-2018	Ituarte, Santiago/0000-0002-3670-2843; Heras, Horacio/0000-0003-3379-0216	Consejo Nacional de Investigaciones Cientificas y Tecnicas [5888]; Comision de Investigaciones Cientificas; LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia [D11A-SAXS1-7586/06, 8583]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Comision de Investigaciones Cientificas; LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia	This work was partially supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas PIP No. 5888 to HH and Comision de Investigaciones Cientificas 2009 to MSD. The authors also thank LNLS/MCT-Brazilian Synchrotron Light Laboratory/Ministerio da Ciencia e Tecnologia for access to their facilities and partial financial support (Projects D11A-SAXS1-7586/06 and 8583). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht EA, 1996, VELIGER, V39, P142; Azarkan M, 2006, BBA-PROTEINS PROTEOM, V1764, P1063, DOI 10.1016/j.bbapap.2006.02.014; Benkendorff K, 2001, J INVERTEBR PATHOL, V78, P109, DOI 10.1006/jipa.2001.5047; Birk Y, 1996, Arch Latinoam Nutr, V44, p26S; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrells C, 1999, VET IMMUNOL IMMUNOP, V72, P277, DOI 10.1016/S0165-2427(99)00143-9; Christeller JT, 2005, FEBS J, V272, P5710, DOI 10.1111/j.1742-4658.2005.04975.x; Chye ML, 2006, IN VITRO CELL DEV-PL, V42, P100, DOI 10.1079/IVP2005741; Clauser KR, 1999, ANAL CHEM, V71, P2871, DOI 10.1021/ac9810516; Darst CR, 2006, P NATL ACAD SCI USA, V103, P5852, DOI 10.1073/pnas.0600625103; Denbow D. Michael, 2000, P299, DOI 10.1016/B978-012747605-6/50013-4; Dreon M, 2002, J EXP ZOOL, V292, P323, DOI 10.1002/jez.10043; Dreon MS, 2008, FEBS J, V275, P4522, DOI 10.1111/j.1742-4658.2008.06595.x; Dreon MS, 2007, ARCH BIOCHEM BIOPHYS, V460, P107, DOI 10.1016/j.abb.2006.12.033; Dreon MS, 2006, BIOCELL, V30, P359; Dreon MS, 2004, MOL REPROD DEV, V68, P359, DOI 10.1002/mrd.20078; Dreon MS, 2004, ARCH BIOCHEM BIOPHYS, V422, P1, DOI 10.1016/j.abb.2003.11.018; Dreon MS, 2003, MOL CELL BIOCHEM, V243, P9, DOI 10.1023/A:1021616610241; EDGE ASB, 1981, ANAL BIOCHEM, V118, P131, DOI 10.1016/0003-2697(81)90168-8; Estebenet AL, 2002, BIOCELL, V26, P83; Estebenet Alejandra L., 1993, Apex (Brussels), V8, P129; Felton GW, 2005, P NATL ACAD SCI USA, V102, P18771, DOI 10.1073/pnas.0509895102; Garcia VA, 2004, PROTEIN J, V23, P343, DOI 10.1023/B:JOPC.0000032654.67733.d5; Garin CF, 1996, J EXP ZOOL, V276, P307, DOI 10.1002/(SICI)1097-010X(19961201)276:5&lt;307::AID-JEZ1&gt;3.0.CO;2-S; HAJOS G, 1995, J AGR FOOD CHEM, V43, P165, DOI 10.1021/jf00049a030; Hammersley A., 1997, ESRF97HAO2T; Han YP, 2008, COMP BIOCHEM PHYS B, V149, P58, DOI 10.1016/j.cbpb.2007.08.003; Heras H, 2007, COMP BIOCHEM PHYS C, V146, P158, DOI 10.1016/j.cbpc.2006.10.013; Heras H, 1998, J EXP ZOOL, V280, P375, DOI 10.1002/(SICI)1097-010X(19980415)280:6<375::AID-JEZ1>3.3.CO;2-V; Heras H, 2008, TOXICON, V52, P481, DOI 10.1016/j.toxicon.2008.06.022; Ituarte S, 2010, COMP BIOCHEM PHYS B, V157, P66, DOI 10.1016/j.cbpb.2010.05.004; Moreno FJ, 2007, BIOMED PHARMACOTHER, V61, P50, DOI 10.1016/j.biopha.2006.10.005; JOHNSON R, 1989, P NATL ACAD SCI USA, V86, P9871, DOI 10.1073/pnas.86.24.9871; Jongsma MA, 1997, J INSECT PHYSIOL, V43, P885, DOI 10.1016/S0022-1910(97)00040-1; KAMIYA H, 2006, SUBSERIES MARINE MOL; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Macedo MLR, 2003, BBA-GEN SUBJECTS, V1621, P170, DOI 10.1016/S0304-4165(03)00055-2; Maketon M, 2009, MALACOLOGIA, V51, P181, DOI 10.4002/040.051.0114; Moreno FJ, 2005, BBA-PROTEINS PROTEOM, V1752, P142, DOI 10.1016/j.bbapap.2005.07.022; Moreno FJ, 2005, FEBS J, V272, P341, DOI 10.1111/j.1742-4658.2004.04472.x; Mosolov VV, 2005, APPL BIOCHEM MICRO+, V41, P227, DOI 10.1007/s10438-005-0040-6; Mukai ST, 2004, INVERTEBR BIOL, V123, P83; Nagle GT, 2001, EUR J BIOCHEM, V268, P1213, DOI 10.1046/j.1432-1327.2001.01972.x; Nagle GT, 1999, INVERTEBR REPROD DEV, V36, P171, DOI 10.1080/07924259.1999.9652695; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Nation JI, 2002, INSECT PHYSL BIOCH, P27; NORDEN DA, 1972, COMP BIOCHEM PHYSIOL, V42, P569, DOI 10.1016/0305-0491(72)90319-7; PAPAYANNOPOULOS IA, 1992, PROTEIN SCI, V1, P278; PECHENIK JA, 1986, AM MALACOL BULL, V4, P165; POLYA GM, 2003, STUDIES NATURAL PROD, P567; Przeslawski R, 2004, MAR ECOL PROG SER, V268, P151, DOI 10.3354/meps268151; Przeslawski Rachel, 2004, Molluscan Research, V24, P43, DOI 10.1071/MR04001; RANDALL D, 1997, ECKERT ANIMAL PHYSL, P683; Ricklefs R., 1969, SMITHSON CONTRIB ZOO, P1, DOI [10.5479/si.00810282.9, DOI 10.5479/SI.00810282.9]; Roch P, 1998, DEV COMP IMMUNOL, V22, P1, DOI 10.1016/S0145-305X(97)00047-5; Sanchez JF, 2006, J BIOL CHEM, V281, P20171, DOI 10.1074/jbc.M603452200; Sasaki SD, 2006, BIOCHEM BIOPH RES CO, V341, P266, DOI 10.1016/j.bbrc.2005.12.178; SCHWERT GW, 1955, BIOCHIM BIOPHYS ACTA, V16, P570, DOI 10.1016/0006-3002(55)90280-8; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; SNYDER NFR, 1971, BEHAVIOUR, V40, P175, DOI 10.1163/156853971X00384; Stevens Lewis, 1996, Science Progress, V79, P65; Teles RCL, 2005, BIOPHYS J, V88, P3509, DOI 10.1529/biophysj.104.045682; Frassa MV, 2010, BBA-PROTEINS PROTEOM, V1804, P1492, DOI 10.1016/j.bbapap.2010.02.013; WALSH TA, 1991, PLANT PHYSIOL, V97, P15, DOI 10.1104/pp.97.1.15; WINGATE VPM, 1989, J BIOL CHEM, V264, P17734; Yusa Y, 2001, J MOLLUS STUD, V67, P275, DOI 10.1093/mollus/67.3.275	66	46	50	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15059	10.1371/journal.pone.0015059	http://dx.doi.org/10.1371/journal.pone.0015059			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151935	Green Published, gold			2022-12-27	WOS:000284939600022
J	Chen, FW; Li, CL; Ioannou, YA				Chen, Fannie W.; Li, Chunlei; Ioannou, Yiannis A.			Cyclodextrin Induces Calcium-Dependent Lysosomal Exocytosis	PLOS ONE			English	Article							CHOLESTEROL DEPLETION; GAMMA-CYCLODEXTRINS; ALPHA-CYCLODEXTRINS; BETA-CYCLODEXTRINS; CELL-SURFACE; RELEASE; MODEL; TRANSPORT; DISEASE; PROTEIN	Cyclodextrins (CDs) have long been used to manipulate cellular cholesterol levels both in vitro and in vivo, but their direct effects at a cellular level are not well characterized. Recently, CDs have garnered much interest because of their ability to clear stored cholesterol from Niemann Pick Type C (NPC) cells and markedly prolong the life of NPC1 disease mice. Here, we investigate the hypothesis that treatment with 2-hydroxypropyl- beta-cyclodextrin (HPB-CD) stimulates lysosomal exocytosis in a calcium-enhanced manner. We propose that this exocytosis is the mechanism by which HPB-CD ameliorates the endolysosomal cholesterol storage phenotype in NPC cells. These findings have significant implications for the use of HPB-CD in biochemical assays and data interpretation as well as for their use for the treatment for NPC and other disorders.	[Chen, Fannie W.; Li, Chunlei; Ioannou, Yiannis A.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA	Icahn School of Medicine at Mount Sinai	Chen, FW (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY USA.	Yiannis.Ioannou@mssm.edu			National Institutes of Health [DK082712]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant DK082712 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEGLEY D, 2010, CYCLODEXTRIN BLOOD B; Blanc L, 2009, BLOOD, V114, P3928, DOI 10.1182/blood-2009-06-230086; Camargo F, 2001, LIFE SCI, V70, P131, DOI 10.1016/S0024-3205(01)01384-4; Chen FW, 2005, BIOCHEM J, V390, P549, DOI 10.1042/BJ20050236; Christian AE, 1997, J LIPID RES, V38, P2264; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Dedkova E N, 2000, Membr Cell Biol, V13, P357; Giocondi MC, 2004, BIOPHYS J, V86, P861, DOI 10.1016/S0006-3495(04)74161-2; Gould S, 2005, FOOD CHEM TOXICOL, V43, P1451, DOI 10.1016/j.fct.2005.03.007; Graham DRM, 2003, J VIROL, V77, P8237, DOI 10.1128/JVI.77.15.8237-8248.2003; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Jaiswal JK, 2004, PLOS BIOL, V2, P1224, DOI 10.1371/journal.pbio.0020233; KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250; Langhorst MF, 2008, EUR J CELL BIOL, V87, P211, DOI 10.1016/j.ejcb.2007.12.001; Laulagnier K, 2004, FEBS LETT, V572, P11, DOI 10.1016/j.febslet.2004.06.082; LENCER WI, 1990, AM J PHYSIOL, V258, pC309, DOI 10.1152/ajpcell.1990.258.2.C309; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; MARCUS AD, 2009, WALL STREET J, pA13; MCGAHON AJ, 1995, METHOD CELL BIOL, V46, P153; McNeil PL, 2002, J CELL SCI, V115, P873; Monnaert V, 2004, J PHARMACOL EXP THER, V310, P745, DOI 10.1124/jpet.104.067512; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rosenbaum AI, 2010, P NATL ACAD SCI USA, V107, P5477, DOI 10.1073/pnas.0914309107; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Simons M, 2009, CURR OPIN CELL BIOL, V21, P575, DOI 10.1016/j.ceb.2009.03.007; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; Strauss K, 2010, J BIOL CHEM, V285, P26279, DOI 10.1074/jbc.M110.134775; Taylor AR, 2007, DEV NEUROBIOL, V67, P1815, DOI 10.1002/dneu.20559; WANG MS, 2009, BIOCH BIOPHYS RES CO; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yu LQ, 2006, J BIOL CHEM, V281, P6616, DOI 10.1074/jbc.M511123200	37	85	88	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15054	10.1371/journal.pone.0015054	http://dx.doi.org/10.1371/journal.pone.0015054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124786	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500026
J	Takahashi, N; Kashino, M; Hironaka, N				Takahashi, Nobuaki; Kashino, Makio; Hironaka, Naoyuki			Structure of Rat Ultrasonic Vocalizations and Its Relevance to Behavior	PLOS ONE			English	Article							LABORATORY RATS; SEXUAL-BEHAVIOR; RHESUS-MONKEYS; NORVEGICUS; REWARD; ANTICIPATION; AMPHETAMINE; GLUTAMATE; PLAYBACK; CONTEXT	Rats are known to emit ultrasonic vocalizations (USVs). These USVs have been hypothesized to hold biological meaning, and the relationship between USVs and behavior has been extensively studied. However, most of these studies looked at specific conditions, such as fear-inducing situations and sexual encounters. In the present experiment, the USVs of pairs of rats in ordinary housing conditions were recorded and their features were examined. Three clusters of USVs in the 25-, 40-, and 60-kHz range were detected, which roughly corresponded to fighting, feeding, and moving, respectively. We analyzed sequential combinations of two or more clusters using a state transition model. The results revealed a more specific correspondence between the USVs and behaviors, suggesting that rat USV may work as a type of communication tool.	[Takahashi, Nobuaki; Kashino, Makio; Hironaka, Naoyuki] NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan; [Takahashi, Nobuaki; Kashino, Makio; Hironaka, Naoyuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Takahashi, Nobuaki] Kwansei Gakuin Univ, Grad Sch Humanities, Nishinomiya, Hyogo, Japan	Nippon Telegraph & Telephone Corporation; Japan Science & Technology Agency (JST); Kwansei Gakuin University	Takahashi, N (corresponding author), NTT Corp, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan.	ntakahas@cs.brl.ntt.co.jp			Japan Science and Technology Agency	Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by Japan Science and Technology Agency (http://www.jst.go.jp/EN/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; Antoniadis EA, 1999, BEHAV BRAIN RES, V101, P1, DOI 10.1016/S0166-4328(98)00056-4; BARFIELD RJ, 1979, AM ZOOL, V19, P469; BLANCHARD RJ, 1991, PHYSIOL BEHAV, V50, P967, DOI 10.1016/0031-9384(91)90423-L; BRUDZYNSKI SM, 1992, PHYSIOL BEHAV, V52, P655, DOI 10.1016/0031-9384(92)90393-G; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Burgdorf J, 2000, BEHAV NEUROSCI, V114, P320, DOI 10.1037//0735-7044.114.2.320; Burgdorf J, 2001, BEHAV NEUROSCI, V115, P940, DOI 10.1037/0735-7044.115.4.940; Burgdorf J, 2001, PSYCHOPHARMACOLOGY, V155, P35, DOI 10.1007/s002130100685; Burgdorf J, 2008, J COMP PSYCHOL, V122, P357, DOI 10.1037/a0012889; DEPAULIS A, 1992, EXP BRAIN RES, V90, P307; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; Farrell WJ, 2002, J COMP PSYCHOL, V116, P286, DOI 10.1037//0735-7036.116.3.286; FU XW, 1994, PHARMACOL BIOCHEM BE, V49, P835, DOI 10.1016/0091-3057(94)90231-3; GEYER LA, 1978, J COMP PHYSIOL PSYCH, V92, P438, DOI 10.1037/h0077480; Gump BB, 1997, J PERS SOC PSYCHOL, V72, P305, DOI 10.1037/0022-3514.72.2.305; HAUSER MD, 1992, P NATL ACAD SCI USA, V89, P12137, DOI 10.1073/pnas.89.24.12137; Hauser MD, 1998, ANIM BEHAV, V55, P1647, DOI 10.1006/anbe.1997.0712; Hietanen JK, 1998, PSYCHOPHYSIOLOGY, V35, P530, DOI 10.1017/S0048577298970445; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Knutson B, 1999, PHYSIOL BEHAV, V66, P639, DOI 10.1016/S0031-9384(98)00337-0; Knutson B, 1998, J COMP PSYCHOL, V112, P65, DOI 10.1037/0735-7036.112.1.65; Knutson B, 2002, PSYCHOL BULL, V128, P961, DOI 10.1037//0033-2909.128.6.961; MITCHELL PJ, 1994, ETHOLOGY AND PSYCHOPHARMACOLOGY, P85; NORUSIS MJ, 2010, PASW STAT 18 STAT PR, P380; Panksepp J, 2000, BEHAV BRAIN RES, V115, P25, DOI 10.1016/S0166-4328(00)00238-2; PARROTT RF, 1976, PHYSIOL BEHAV, V16, P689, DOI 10.1016/0031-9384(76)90237-7; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; SALES G D, 1972, Journal of Zoology (London), V168, P149; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; SEWELL GD, 1967, NATURE, V215, P512, DOI 10.1038/215512a0; Wintink AJ, 2001, PHARMACOL BIOCHEM BE, V70, P317, DOI 10.1016/S0091-3057(01)00615-3; Wright JM, 2010, PSYCHOPHARMACOLOGY, V211, P1, DOI 10.1007/s00213-010-1859-y; YAJIMA Y, 1980, BRAIN RES, V198, P446, DOI 10.1016/0006-8993(80)90759-3	34	69	70	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14115	10.1371/journal.pone.0014115	http://dx.doi.org/10.1371/journal.pone.0014115			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124767	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500007
J	Xiao, JH; Wang, NX; Li, YW; Murphy, RW; Wan, DG; Niu, LM; Hu, HY; Fu, YG; Huang, DW				Xiao, Jin-Hua; Wang, Ning-Xin; Li, Yan-Wei; Murphy, Robert W.; Wan, Dong-Guang; Niu, Li-Ming; Hu, Hao-Yuan; Fu, Yue-Guan; Huang, Da-Wei			Molecular Approaches to Identify Cryptic Species and Polymorphic Species within a Complex Community of Fig Wasps	PLOS ONE			English	Article							WOLBACHIA INFECTION; MITOCHONDRIAL GENE; POLLINATING WASPS; EVOLUTION; DNA; PHYLOGENIES; DIMORPHISM; DIVERSITY; PRECISION; SEQUENCES	Cryptic and polymorphic species can complicate traditional taxonomic research and both of these concerns are common in fig wasp communities. Species identification is very difficult, despite great effort and the ecological importance of fig wasps. Herein, we try to identify all chalcidoid wasp species hosted by one species of fig, using both morphological and molecular methods. We compare the efficiency of four different DNA regions and find that ITS2 is highly effective for species identification, while mitochondrial COI and Cytb regions appear less reliable, possibly due to the interference signals from either nuclear copies of mtDNA, i.e. NUMTs, or the effects of Wolbachia infections. The analyses suggest that combining multiple markers is the best choice for inferring species identifications as any one marker may be unsuitable in a given case.	[Xiao, Jin-Hua; Niu, Li-Ming; Hu, Hao-Yuan; Huang, Da-Wei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Wang, Ning-Xin; Li, Yan-Wei; Wan, Dong-Guang; Huang, Da-Wei] Shandong Agr Univ, Coll Plant Protect, Tai An, Shandong, Peoples R China; [Murphy, Robert W.] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Murphy, Robert W.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Fu, Yue-Guan] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Hainan, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Shandong Agricultural University; Chinese Academy of Sciences; Kunming Institute of Zoology; Royal Ontario Museum; Chinese Academy of Tropical Agricultural Sciences	Xiao, JH (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China.	huangdw@ioz.ac.cn	Murphy, Robert W/D-8586-2011; li, yan/GTI-4638-2022	Murphy, Robert/0000-0001-8555-2338	National Natural Science Foundation of China (NSFC) [30900137, 30770302]; Chinese Academy of Sciences [KSCX2-YW-N-0807]; Ministry of Science and Technology of the People's Republic of China [2006FY110500]; National Science Fund for Fostering Talents in Basic Research [NSFC-J0930004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); National Science Fund for Fostering Talents in Basic Research	This project was supported by the National Natural Science Foundation of China (NSFC grant no. 30900137, 30770302), partially by Major Innovation Program of Chinese Academy of Sciences (KSCX2-YW-N-0807), Program of Ministry of Science and Technology of the People's Republic of China (2006FY110500), and by National Science Fund for Fostering Talents in Basic Research (Special Subjects in Animal Taxonomy, NSFC-J0930004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCTANDER P, 1995, P ROY SOC B-BIOL SCI, V262, P13, DOI 10.1098/rspb.1995.0170; Ballard JWO, 2000, J MOL EVOL, V51, P64, DOI 10.1007/s002390010067; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Chen LL, 2010, INSECT SCI, V17, P101, DOI 10.1111/j.1744-7917.2009.01291.x; CHO SW, 1995, MOL BIOL EVOL, V12, P650; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; Danforth BN, 1998, MOL BIOL EVOL, V15, P225, DOI 10.1093/oxfordjournals.molbev.a025920; FRANK SA, 1987, TRENDS ECOL EVOL, V2, P259, DOI 10.1016/0169-5347(87)90029-2; GOLDMAN N, 1993, J MOL EVOL, V36, P182, DOI 10.1007/BF00166252; Haine ER, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-83; Haine ER, 2005, P ROY SOC B-BIOL SCI, V272, P421, DOI 10.1098/rspb.2004.2956; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Herre EA, 1996, J BIOGEOGR, V23, P521, DOI 10.1111/j.1365-2699.1996.tb00014.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUELSENBECK JP, 2001, SYSTEMATIC BIOL, V50; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Jiang ZF, 2006, MOL PHYLOGENET EVOL, V38, P306, DOI 10.1016/j.ympev.2005.11.008; Jousselin E, 2006, J EVOLUTION BIOL, V19, P253, DOI 10.1111/j.1420-9101.2005.00968.x; Kerdelhue C, 1999, MOL PHYLOGENET EVOL, V11, P401, DOI 10.1006/mpev.1998.0590; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Leigh EG, 2007, J EVOLUTION BIOL, V20, P2075, DOI 10.1111/j.1420-9101.2007.01410.x; Lopez-Vaamonde C, 2001, MOL PHYLOGENET EVOL, V21, P55, DOI 10.1006/mpev.2001.0993; Machado CA, 1996, J BIOGEOGR, V23, P531, DOI 10.1111/j.1365-2699.1996.tb00015.x; Machado CA, 2001, P ROY SOC B-BIOL SCI, V268, P685, DOI 10.1098/rspb.2000.1418; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; PAMILO P, 2007, MOL BIOL EVOLUTION; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rasplus JY, 1998, CR ACAD SCI III-VIE, V321, P517, DOI 10.1016/S0764-4469(98)80784-1; ROFF DA, 1986, EVOLUTION, V40, P1009, DOI 10.1111/j.1558-5646.1986.tb00568.x; Shoemaker DD, 2004, GENETICS, V168, P2049, DOI 10.1534/genetics.104.030890; Shuker DM, 2004, P NATL ACAD SCI USA, V101, P10363, DOI 10.1073/pnas.0308034101; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Weiblen GD, 2002, MOL ECOL, V11, P1573, DOI 10.1046/j.1365-294X.2002.01529.x; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; WEIBLEN GD, 2001, SYSTEMATIC BIOL, V50; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winker K, 2005, AUK, V122, P706, DOI 10.1642/0004-8038(2005)122[0706:SSWFRB]2.0.CO;2	38	31	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15067	10.1371/journal.pone.0015067	http://dx.doi.org/10.1371/journal.pone.0015067			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124735	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500032
J	Matsuda, D; Mauro, VP				Matsuda, Daiki; Mauro, Vincent P.			Determinants of Initiation Codon Selection during Translation in Mammalian Cells	PLOS ONE			English	Article							MESSENGER-RNA DECAY; SHINE-DALGARNO SEQUENCE; RIBOSOME ENTRY SITE; LOCKED NUCLEIC-ACID; EUKARYOTIC RIBOSOMES; SECONDARY STRUCTURE; ESCHERICHIA-COLI; GENE-EXPRESSION; VIRUS-RNA; IN-VIVO	Factors affecting translation of mRNA contribute to the complexity of eukaryotic proteomes. In some cases, translation of a particular mRNA can generate multiple proteins. However, the factors that determine whether ribosomes initiate translation from the first AUG codon in the transcript, from a downstream codon, or from multiple sites are not completely understood. Various mRNA properties, including AUG codon-accessibility and 5' leader length have been proposed as potential determinants that affect where ribosomes initiate translation. To explore this issue, we performed studies using synthetic mRNAs with two in-frame AUG codons-both in excellent context. Open reading frames initiating at AUG1 and AUG2 encode large and small isoforms of a reporter protein, respectively. Translation of such an mRNA in COS-7 cells was shown to be 5' cap-dependent and to occur efficiently from both AUG codons. AUG codon-accessibility was modified by using two different elements: an antisense locked nucleic acid oligonucleotide and an exon-junction complex. When either element was used to mask AUG1, the ratio of the proteins synthesized changed, favoring the smaller (AUG2-initiated) protein. In addition, we observed that increased leader length by itself changed the ratio of the proteins and favored initiation at AUG1. These observations demonstrate that initiation codon selection is affected by various factors, including AUG codon-accessibility and 5' leader length, and is not necessarily determined by the order of AUG codons (5'-> 3'). The modulation of AUG codon accessibility may provide a powerful means of translation regulation in eukaryotic cells.	[Matsuda, Daiki] Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; Skaggs Inst Chem Biol, La Jolla, CA USA	Scripps Research Institute; Scripps Research Institute	Matsuda, D (corresponding author), Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA.	vmauro@scripps.edu			National Institutes of Health [GM078071]; Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078071] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding was provided by the National Institutes of Health Grant GM078071 and from the Skaggs Institute for Chemical Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry KE, 2010, RNA, V16, P1559, DOI 10.1261/rna.2197210; Chappell SA, 2000, P NATL ACAD SCI USA, V97, P1536, DOI 10.1073/pnas.97.4.1536; Chappell SA, 2006, P NATL ACAD SCI USA, V103, P18077, DOI 10.1073/pnas.0608212103; CHEN HY, 1994, NUCLEIC ACIDS RES, V22, P4953, DOI 10.1093/nar/22.23.4953; Dostie J, 2002, CURR BIOL, V12, P1060, DOI 10.1016/S0960-9822(02)00902-8; Gallie DR, 2000, NUCLEIC ACIDS RES, V28, P2943, DOI 10.1093/nar/28.15.2943; Gehring NH, 2009, CELL, V137, P536, DOI 10.1016/j.cell.2009.02.042; Gu S, 2008, MOL PHARMACOL, V73, P1, DOI 10.1124/mol.107.036285; Gu WJ, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000664; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; JACKSON RJ, 1996, TRANSLATIONAL CONTRO, P71; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jin HN, 2006, MOL MICROBIOL, V60, P480, DOI 10.1111/j.1365-2958.2006.05110.x; Kaminishi T, 2007, STRUCTURE, V15, P289, DOI 10.1016/j.str.2006.12.008; KAMINSKI A, 1994, EMBO J, V13, P1673, DOI 10.1002/j.1460-2075.1994.tb06431.x; Kataoka N, 2000, MOL CELL, V6, P673, DOI 10.1016/S1097-2765(00)00065-4; KOCH T, 2007, LOCKED NUCL ACID ANT, P519; Kochetov AV, 2006, MOL BIOL+, V40, P705, DOI 10.1134/S0026893306050049; Koh DC, 2009, RNA BIOL, V6, P54, DOI 10.4161/rna.6.1.7567; KOZAK M, 1991, GENE EXPRESSION, V1, P111; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; Kunz JB, 2006, RNA, V12, P1015, DOI 10.1261/rna.12506; Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860; Lejeune F, 2005, CURR OPIN CELL BIOL, V17, P309, DOI 10.1016/j.ceb.2005.03.002; Matsuda D, 2004, J VIROL, V78, P9325, DOI 10.1128/JVI.78.17.9325-9335.2004; Matsuda D, 2006, RNA, V12, P1338, DOI 10.1261/rna.67906; Nott A, 2004, GENE DEV, V18, P210, DOI 10.1101/gad.1163204; Panopoulos P, 2008, J BIOL CHEM, V283, P33087, DOI 10.1074/jbc.M804904200; PEABODY DS, 1989, J BIOL CHEM, V264, P5031; PELLETIER J, 1985, CELL, V40, P515, DOI 10.1016/0092-8674(85)90200-4; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisarev AV, 2005, CR BIOL, V328, P589, DOI 10.1016/j.crvi.2005.02.004; Preiss T, 1998, NATURE, V392, P516, DOI 10.1038/33192; REDDY VB, 1978, NUCLEIC ACIDS RES, V5, P4195, DOI 10.1093/nar/5.11.4195; Rogers GW, 2004, P NATL ACAD SCI USA, V101, P2794, DOI 10.1073/pnas.0308576101; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starck SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003460; Stockklausner C, 2006, NUCLEIC ACIDS RES, V34, P2355, DOI 10.1093/nar/gkl277; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Tuller T, 2010, P NATL ACAD SCI USA, V107, P3645, DOI 10.1073/pnas.0909910107; Vester B, 2004, BIOCHEMISTRY-US, V43, P13233, DOI 10.1021/bi0485732; Wengel J, 1999, ACCOUNTS CHEM RES, V32, P301, DOI 10.1021/ar980051p; Zhang J, 1997, EMBO J, V16, P826, DOI 10.1093/emboj/16.4.826	46	12	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15057	10.1371/journal.pone.0015057	http://dx.doi.org/10.1371/journal.pone.0015057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124832	gold, Green Published, Green Submitted			2022-12-27	WOS:000284572000024
J	Priyadharshini, B; Welsh, RM; Greiner, DL; Gerstein, RM; Brehm, MA				Priyadharshini, Bhavana; Welsh, Raymond M.; Greiner, Dale L.; Gerstein, Rachel M.; Brehm, Michael A.			Maturation-Dependent Licensing of Naive T Cells for Rapid TNF Production	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; RECENT THYMIC EMIGRANTS; FACTOR-ALPHA; CUTTING EDGE; IN-VIVO; PERIPHERAL-BLOOD; FACTOR RECEPTORS; VIRAL-INFECTION; DENDRITIC CELLS; TRANSGENIC MICE	The peripheral naive T cell pool is comprised of a heterogeneous population of cells at various stages of development, which is a process that begins in the thymus and is completed after a post-thymic maturation phase in the periphery. One hallmark of naive T cells in secondary lymphoid organs is their unique ability to produce TNF rapidly after activation and prior to acquiring other effector functions. To determine how maturation influences the licensing of naive T cells to produce TNF, we compared cytokine profiles of CD4(+) and CD8(+) single positive (SP) thymocytes, recent thymic emigrants (RTEs) and mature-naive (MN) T cells during TCR activation. SP thymocytes exhibited a poor ability to produce TNF when compared to splenic T cells despite expressing similar TCR levels and possessing comparable activation kinetics (upregulation of CD25 and CD69). Provision of optimal antigen presenting cells from the spleen did not fully enable SP thymocytes to produce TNF, suggesting an intrinsic defect in their ability to produce TNF efficiently. Using a thymocyte adoptive transfer model, we demonstrate that the ability of T cells to produce TNF increases progressively with time in the periphery as a function of their maturation state. RTEs that were identified in NG-BAC transgenic mice by the expression of GFP showed a significantly enhanced ability to express TNF relative to SP thymocytes but not to the extent of fully MN T cells. Together, these findings suggest that TNF expression by naive T cells is regulated via a gradual licensing process that requires functional maturation in peripheral lymphoid organs.	[Priyadharshini, Bhavana; Welsh, Raymond M.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Priyadharshini, Bhavana; Welsh, Raymond M.; Greiner, Dale L.; Gerstein, Rachel M.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Immunol & Virol, Worcester, MA 01605 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Greiner, Dale L.; Brehm, Michael A.] Univ Massachusetts, Sch Med, Diabet Ctr Excellence, Worcester, MA 01605 USA; [Gerstein, Rachel M.] Univ Massachusetts, Sch Med, Dept Mol Genet & Microbiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Priyadharshini, B (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	michael.brehm@umassmed.edu		Brehm, Michael/0000-0001-6813-3262	National Institutes of Health [AI017672, AI081675, AI46629, AI43534, AI083911]; institutional Center for AIDS Research (CFAR) [AI042845]; Juvenile Diabetes Research Foundation; UMASS Diabetes Endocrinology Research Center (DERC) [DK32520]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI042845, R01AI043534, R01AI017672, R21AI083911, R01AI081675, P01AI046629, R56AI043534, R37AI017672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); institutional Center for AIDS Research (CFAR); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); UMASS Diabetes Endocrinology Research Center (DERC); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grants AI017672 and AI081675 to R. M. W., AI46629 to D. L. G., AI43534 to R. M. G., AI083911 to M. A. B., and an institutional Center for AIDS Research (CFAR) grant AI042845 and grants from the Juvenile Diabetes Research Foundation. R. M. W., D. L. G. and R. M. G. are members of the UMASS Diabetes Endocrinology Research Center (DERC) grant DK32520. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2003, NAT REV IMMUNOL, V3, P745, DOI 10.1038/nri1184; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; Badovinac VP, 2006, IMMUNOL REV, V211, P67, DOI 10.1111/j.0105-2896.2006.00384.x; Baseta JG, 2000, J IMMUNOL, V165, P5621, DOI 10.4049/jimmunol.165.10.5621; Berzins SP, 1999, P NATL ACAD SCI USA, V96, P9787, DOI 10.1073/pnas.96.17.9787; Berzins SP, 2002, TRENDS MOL MED, V8, P469, DOI 10.1016/S1471-4914(02)02415-2; Boursalian TE, 2004, NAT IMMUNOL, V5, P418, DOI 10.1038/ni1049; Brehm MA, 2005, J IMMUNOL, V175, P5043, DOI 10.4049/jimmunol.175.8.5043; Brehm MA, 2007, BLOOD, V109, P819, DOI 10.1182/blood-2006-03-008219; Bruns H, 2009, J CLIN INVEST, V119, P1167, DOI 10.1172/JCI38482; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Calzascia T, 2007, J CLIN INVEST, V117, P3833, DOI 10.1172/JCI32567; Chen WF, 2004, CELL MOL IMMUNOL, V1, P3; Clark J, 2005, ANN RHEUM DIS, V64, P70, DOI 10.1136/ard.2005.042523; CRISPE IN, 1987, J IMMUNOL, V138, P2013; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Deman J, 1992, Dev Immunol, V2, P103, DOI 10.1155/1992/48713; Elkon KB, 1997, P NATL ACAD SCI USA, V94, P9814, DOI 10.1073/pnas.94.18.9814; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Gunnlaugsdottir B, 2008, SCAND J IMMUNOL, V68, P624, DOI 10.1111/j.1365-3083.2008.02181.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houston EG, 2008, J IMMUNOL, V181, P5213, DOI 10.4049/jimmunol.181.8.5213; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Joshi NS, 2008, J IMMUNOL, V180, P1309, DOI 10.4049/jimmunol.180.3.1309; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kasahara S, 2003, J VIROL, V77, P2469, DOI 10.1128/JVI.77.4.2469-2476.2003; Kim EY, 2009, J IMMUNOL, V183, P6051, DOI 10.4049/jimmunol.0803482; Kim EY, 2006, J IMMUNOL, V176, P1026, DOI 10.4049/jimmunol.176.2.1026; Kim EY, 2004, J IMMUNOL, V173, P4500, DOI 10.4049/jimmunol.173.7.4500; Kollias G, 1999, ANN RHEUM DIS, V58, P32, DOI 10.1136/ard.58.2008.i32; LEWICKI H, 1995, VIROLOGY, V210, P29, DOI 10.1006/viro.1995.1314; Liepinsh DJ, 2009, EUR J IMMUNOL, V39, P2906, DOI 10.1002/eji.200839191; Liu F, 2005, J IMMUNOL, V174, P5936, DOI 10.4049/jimmunol.174.10.5936; Makaroff LE, 2009, P NATL ACAD SCI USA, V106, P4799, DOI 10.1073/pnas.0812354106; McCaughtry TM, 2007, J EXP MED, V204, P2513, DOI 10.1084/jem.20070601; McKarns SC, 2008, J IMMUNOL, V181, P1272, DOI 10.4049/jimmunol.181.2.1272; Mercado R, 2000, J IMMUNOL, V165, P6833, DOI 10.4049/jimmunol.165.12.6833; MURPHY M, 1993, J IMMUNOL, V150, P5696; MURPHY M, 1992, J IMMUNOL, V149, P2506; MURPHY M, 1992, CLIN IMMUNOL IMMUNOP, V62, P245, DOI 10.1016/0090-1229(92)90079-4; Notley CA, 2008, J EXP MED, V205, P2491, DOI 10.1084/jem.20072707; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.0.CO;2-O; Pang LP, 2008, J RHEUMATOL, V35, P2220, DOI 10.3899/jrheum.080219; Perez AR, 2007, BRAIN BEHAV IMMUN, V21, P890, DOI 10.1016/j.bbi.2007.02.004; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Proietto AI, 2008, IMMUNOL CELL BIOL, V86, P700, DOI 10.1038/icb.2008.63; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Schodin BA, 1996, IMMUNITY, V5, P137, DOI 10.1016/S1074-7613(00)80490-2; Schott E, 2002, P NATL ACAD SCI USA, V99, P13735, DOI 10.1073/pnas.212515399; Sims TN, 2002, IMMUNOL REV, V186, P100, DOI 10.1034/j.1600-065X.2002.18610.x; Singh A, 2007, J LEUKOCYTE BIOL, V82, P1201, DOI 10.1189/jlb.0407240; Singh A, 2007, J VIROL, V81, P6502, DOI 10.1128/JVI.00163-07; Smyth MJ, 2000, MICROSC RES TECHNIQ, V50, P196, DOI 10.1002/1097-0029(20000801)50:3<196::AID-JEMT3>3.0.CO;2-9; Suresh M, 2005, J VIROL, V79, P202, DOI 10.1128/JVI.79.1.202-213.2005; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Trevejo JM, 2001, P NATL ACAD SCI USA, V98, P12162, DOI 10.1073/pnas.211423598; Tuma RA, 2002, CURR OPIN IMMUNOL, V14, P348, DOI 10.1016/S0952-7915(02)00338-2; Uldrich AP, 2006, J IMMUNOL, V176, P4553, DOI 10.4049/jimmunol.176.8.4553; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; van Stipdonk MJB, 2001, NAT IMMUNOL, V2, P423, DOI 10.1038/87730; VERNACHIO J, 1989, J IMMUNOL, V142, P48; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wong P, 2001, J IMMUNOL, V166, P5864, DOI 10.4049/jimmunol.166.10.5864; Yang Y, 1998, J EXP MED, V188, P247, DOI 10.1084/jem.188.2.247; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200; ZUNIGAPFLUCKER JC, 1995, SCIENCE, V268, P1906, DOI 10.1126/science.7541554	75	32	33	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15038	10.1371/journal.pone.0015038	http://dx.doi.org/10.1371/journal.pone.0015038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124839	Green Published, gold			2022-12-27	WOS:000284572000022
J	Skovran, E; Crowther, GJ; Guo, XF; Yang, S; Lidstrom, ME				Skovran, Elizabeth; Crowther, Gregory J.; Guo, Xiaofeng; Yang, Song; Lidstrom, Mary E.			A Systems Biology Approach Uncovers Cellular Strategies Used by Methylobacterium extorquens AM1 During the Switch from Multi- to Single-Carbon Growth	PLOS ONE			English	Article							BETA-HYDROXYBUTYRATE BIOSYNTHESIS; ENZYME-ACTIVITIES; PSEUDOMONAS AM1; METABOLISM; FORMALDEHYDE; DEHYDROGENASE; PATHWAY; FORMATE; RECONSTRUCTION; IDENTIFICATION	Background: When organisms experience environmental change, how does their metabolic network reset and adapt to the new condition? Methylobacterium extorquens is a bacterium capable of growth on both multi-and single-carbon compounds. These different modes of growth utilize dramatically different central metabolic pathways with limited pathway overlap. Methodology/Principal Findings: This study focused on the mechanisms of metabolic adaptation occurring during the transition from succinate growth (predicted to be energy-limited) to methanol growth (predicted to be reducing-power-limited), analyzing changes in carbon flux, gene expression, metabolites and enzymatic activities over time. Initially, cells experienced metabolic imbalance with excretion of metabolites, changes in nucleotide levels and cessation of cell growth. Though assimilatory pathways were induced rapidly, a transient block in carbon flow to biomass synthesis occurred, and enzymatic assays suggested methylene tetrahydrofolate dehydrogenase as one control point. This "downstream priming'' mechanism ensures that significant carbon flux through these pathways does not occur until they are fully induced, precluding the buildup of toxic intermediates. Most metabolites that are required for growth on both carbon sources did not change significantly, even though transcripts and enzymatic activities required for their production changed radically, underscoring the concept of metabolic setpoints. Conclusions/Significance: This multi-level approach has resulted in new insights into the metabolic strategies carried out to effect this shift between two dramatically different modes of growth and identified a number of potential flux control and regulatory check points as a further step toward understanding metabolic adaptation and the cellular strategies employed to maintain metabolic setpoints.	[Skovran, Elizabeth; Crowther, Gregory J.; Guo, Xiaofeng; Yang, Song; Lidstrom, Mary E.] Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA; [Lidstrom, Mary E.] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Skovran, E (corresponding author), Univ Washington, Dept Chem Engn, Seattle, WA 98195 USA.	eskovran@u.washington.edu		Skovran, Elizabeth/0000-0002-1737-5621; Crowther, Gregory/0000-0003-0530-9130	National Institute of General Medical Sciences [GM58933]; Ruth Kirschstein National Research Service Award [08FGM78835A, 5F32GM070297]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM070297, R01GM058933] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Ruth Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grants from National Institute of General Medical Sciences (GM58933 to MEL) and the Ruth Kirschstein National Research Service Award, 08FGM78835A to ES, and 5F32GM070297 to GJC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony C., 1982, BIOCH METHYLOTROPHS; BERGMEYER HU, 1974, METHOD ENZYMAT AN, V1, P501; Bosch G, 2008, PROTEOMICS, V8, P3494, DOI 10.1002/pmic.200800152; Chistoserdova L, 2004, J BACTERIOL, V186, P22, DOI 10.1128/JB.186.1.22-28.2004; Chistoserdova L, 2003, J BACTERIOL, V185, P2980, DOI 10.1128/JB.185.10.2980-2987.2003; Chistoserdova L, 2007, J BACTERIOL, V189, P9076, DOI 10.1128/JB.01229-07; Chistoserdova L, 2007, J BACTERIOL, V189, P4020, DOI 10.1128/JB.00045-07; CORPE WA, 1989, FEMS MICROBIOL ECOL, V62, P243, DOI 10.1111/j.1574-6968.1989.tb03698.x; Crowther GJ, 2008, J BACTERIOL, V190, P5057, DOI 10.1128/JB.00228-08; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; GOLDBERG I, 1976, BIOTECHNOL BIOENG, V18, P1657, DOI 10.1002/bit.260181202; GREEN PN, 1991, PROKARYOTES, P2342; GRUER MJ, 1994, MICROBIOL-SGM, V140, P2531, DOI 10.1099/00221287-140-10-2531; Guo XF, 2008, BIOTECHNOL BIOENG, V99, P929, DOI 10.1002/bit.21652; Guo XF, 2006, ARCH MICROBIOL, V186, P139, DOI 10.1007/s00203-006-0131-7; HARDER W, 1971, BIOCHEM J, V121, P763, DOI 10.1042/bj1210763; HARDER W, 1971, BIOCHEM J, V121, P753, DOI 10.1042/bj1210753; HEPINSTALL J, 1970, BIOCHEM J, V117, P563; Huve K, 2007, J EXP BOT, V58, P1783, DOI 10.1093/jxb/erm038; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Korotkova N, 2002, J BACTERIOL, V184, P6174, DOI 10.1128/JB.184.22.6174-6181.2002; Korotkova N, 2002, J BACTERIOL, V184, P1750, DOI 10.1128/JB.184.6.1750-1758.2002; Korotkova N, 2001, J BACTERIOL, V183, P1038, DOI 10.1128/JB.183.3.1038-1046.2001; Kromer JO, 2004, J BACTERIOL, V186, P1769, DOI 10.1128/JB.186.6.1769-1784.2004; LARGE PJ, 1963, BIOCHEM J, V87, P386, DOI 10.1042/bj0870386; Laukel M, 2004, PROTEOMICS, V4, P1247, DOI 10.1002/pmic.200300713; Lee IY, 1996, BIOTECHNOL BIOENG, V52, P707, DOI 10.1002/(SICI)1097-0290(19961220)52:6<707::AID-BIT8>3.0.CO;2-S; Lee YH, 1996, J MICROBIOL BIOTECHN, V6, P120; LIDSTROM ME, 2001, PROKARYOTES, P223; Mangos TJ, 1997, ANAL BIOCHEM, V244, P357, DOI 10.1006/abio.1996.9908; Marx CJ, 2005, PLOS BIOL, V3, P244, DOI 10.1371/journal.pbio.0030016; Marx CJ, 2003, J BACTERIOL, V185, P7160, DOI 10.1128/JB.185.23.7160-7168.2003; Marx CJ, 2004, MICROBIOL-SGM, V150, P9, DOI 10.1099/mic.0.26587-0; MCNERNEY T, 1980, APPL ENVIRON MICROB, V40, P370, DOI 10.1128/AEM.40.2.370-375.1980; MILLER JA, 2009, THESIS U WASHINGTON; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; Okubo Y, 2007, OMICS, V11, P325, DOI 10.1089/omi.2007.0027; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; SALEM AR, 1974, J GEN MICROBIOL, V81, P525, DOI 10.1099/00221287-81-2-525; Sauer U, 2004, J BIOL CHEM, V279, P6613, DOI 10.1074/jbc.M311657200; Schrader J, 2009, TRENDS BIOTECHNOL, V27, P107, DOI 10.1016/j.tibtech.2008.10.009; Skovran E, 2000, J BACTERIOL, V182, P3896, DOI 10.1128/JB.182.14.3896-3903.2000; SPENCER ME, 1973, J BACTERIOL, V114, P563, DOI 10.1128/JB.114.2.563-570.1973; STOSCHECK CM, 1990, METHOD ENZYMOL, V182, P50; Van Dien SJ, 2003, MICROBIOL-SGM, V149, P601, DOI 10.1099/mic.0.25955-0; Van Dien SJ, 2002, BIOTECHNOL BIOENG, V78, P296, DOI 10.1002/bit.10200; Vorholt JA, 1998, J BACTERIOL, V180, P5351, DOI 10.1128/JB.180.20.5351-5356.1998; Vorholt JA, 2000, J BACTERIOL, V182, P6645, DOI 10.1128/JB.182.23.6645-6650.2000; Yang S, 2009, J CHROMATOGR A, V1216, P3280, DOI 10.1016/j.chroma.2009.02.030; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	51	38	39	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14091	10.1371/journal.pone.0014091	http://dx.doi.org/10.1371/journal.pone.0014091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124828	gold, Green Published, Green Submitted			2022-12-27	WOS:000284572000002
J	McDonald, AT; Kirkland, JI; DeBlieux, DD; Madsen, SK; Cavin, J; Milner, ARC; Panzarin, L				McDonald, Andrew T.; Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott K.; Cavin, Jennifer; Milner, Andrew R. C.; Panzarin, Lukas			New Basal Iguanodonts from the Cedar Mountain Formation of Utah and the Evolution of Thumb-Spiked Dinosaurs	PLOS ONE			English	Article							CRETACEOUS AGE; ORNITHISCHIA; ORNITHOPODA; CHINA; PHYLOGENY; TAXONOMY; ENGLAND; TEXAS	Background: Basal iguanodontian dinosaurs were extremely successful animals, found in great abundance and diversity almost worldwide during the Early Cretaceous. In contrast to Europe and Asia, the North American record of Early Cretaceous basal iguanodonts has until recently been limited largely to skulls and skeletons of Tenontosaurus tilletti. Methodology/Principal Findings: Herein we describe two new basal iguanodonts from the Yellow Cat Member of the Cedar Mountain Formation of eastern Utah, each known from a partial skull and skeleton. Iguanacolossus fortis gen. et sp. nov. and Hippodraco scutodens gen. et sp. nov. are each diagnosed by a single autapomorphy and a unique combination of characters. Conclusions/Significance: Iguanacolossus and Hippodraco add greatly to our knowledge of North American basal iguanodonts and prompt a new comprehensive phylogenetic analysis of basal iguanodont relationships. This analysis indicates that North American Early Cretaceous basal iguanodonts are more basal than their contemporaries in Europe and Asia.	[McDonald, Andrew T.] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Kirkland, James I.; DeBlieux, Donald D.; Madsen, Scott K.] Utah Geol Survey, Salt Lake City, UT USA; [Cavin, Jennifer] John Day Fossil Beds Natl Monument, Kimberly, OR USA; [Milner, Andrew R. C.] Johnson Farm, St George Dinosaur Discovery Site, St George, UT USA	University of Pennsylvania	McDonald, AT (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	mcandr@sas.upenn.edu			Utah Geological Survey; Quest Grant	Utah Geological Survey; Quest Grant	Excavation and preparation of the specimens was supported by funds provided by the Utah Geological Survey (http://geology.utah.gov/) with excavations at Don's Ridge funded in part by a Quest Grant to JIK administered by the Discovery Channel (http://dsc.discovery.com/convergence/quest/quest.html). ATM thanks the Evolving Earth Foundation (http://www.evolvingearth.org/), Jurassic Foundation (http://jurassicfoundation.org/index.html), University of Pennsylvania Paleobiology Summer Stipend (http://www.sas.upenn.edu/earth/graduate.htm), and Utah Friends of Paleontology (http://www.utahpaleo.org/utahvalley.html) for funding his research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allain R, 2003, CR PALEVOL, V2, P27, DOI 10.1016/S1631-0683(03)00002-2; Barrett PM, 2009, ACTA PALAEONTOL POL, V54, P35, DOI 10.4202/app.2009.0105; BARTHOLOMAI A, 1981, Memoirs of the Queensland Museum, V20, P319; Brill Kathleen, 2007, P49; Britt B.B., 2007, GEOLOGICAL SOC AM AB, V39, P16; Carpenter K, 2008, ANN CARNEGIE MUS, V76, P227, DOI 10.2992/0097-4463(2008)76[227:ANSOCO]2.0.CO;2; Chure D, 2010, NATURWISSENSCHAFTEN, V97, P379, DOI 10.1007/s00114-010-0650-6; Deblieux D, 2008, J VERTEBR PALEONTOL, V28, p70A; DiCroce Tony, 2001, P183; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gilmore C. W., 1909, P US NATIONAL MUSEUM, V36, P197, DOI DOI 10.5479/SI.00963801.36-1666.197; Gilpin David, 2007, P79; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Gradstein FM, 2008, NEWSL STRATIGR, V43, P5, DOI 10.1127/0078-0421/2008/0043-0005; Head JJ, 1998, J VERTEBR PALEONTOL, V18, P718, DOI 10.1080/02724634.1998.10011101; Kirkland James I., 1997, Brigham Young University Geology Studies, V42, P69; KIRKLAND JI, 1998, NEW MEXICO MUSEUM NA, V14, P283; Kirkland JI, 2007, UTAH GEOLOGICAL ASS, V35, P1; Kobayashi Y, 2003, J VERTEBR PALEONTOL, V23, P166, DOI 10.1671/0272-4634(2003)23[166:ANIDOF]2.0.CO;2; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2010, ZOOTAXA, P1; Molnar Ralph E., 1996, Memoirs of the Queensland Museum, V39, P639; Naish D, 2008, J GEOL SOC LONDON, V165, P613, DOI 10.1144/0016-76492007-154; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman DB, 2010, ZOOTAXA, P47; Norman DB, 2002, ZOOL J LINN SOC-LOND, V136, P113, DOI 10.1046/j.1096-3642.2002.00027.x; NORMAN DB, 1980, I ROYAL SCI NATURELL, V178, P1; OSTROM JH, 1970, PEABODY MUSEUM NATUR, V35, P1; OSTROM JOHN H., 1961, BULL AMER MUS NAT HIST, V122, P33; Owen R., 1842, REPORT BRIT ASS ADV, V9, P60; Paul GS, 2008, CRETACEOUS RES, V29, P192, DOI 10.1016/j.cretres.2007.04.009; Prieto-Marquez A, 2010, ZOOL J LINN SOC-LOND, V159, P435, DOI 10.1111/j.1096-3642.2009.00617.x; Schnyder J, 2009, PALAEOGEOGR PALAEOCL, V281, P79, DOI 10.1016/j.palaeo.2009.07.014; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno P. C, 2005, STEM ARCHOSAURIA VER; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Swisher CC, 1999, NATURE, V400, P58, DOI 10.1038/21872; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; TSCHUDY R.H., 1984, US GEOL SURV PROF PA, V1281, P1; Weishampel D.B., 1989, Journal of Vertebrate Paleontology, V9, P56; Weishampel David B., 2003, Journal of Systematic Palaeontology, V1, P65, DOI 10.1017/S1477201903001032; WILKINSON M, 1992, CLADISTICS, V8, P375, DOI 10.1111/j.1096-0031.1992.tb00079.x; Wilkinson M, 2001, TAXEQ3 SOFTWARE DOCU; Wilkinson M, 2001, REDCON 3 0 SOFTWARE; Winkler DA, 1997, J VERTEBR PALEONTOL, V17, P330, DOI 10.1080/02724634.1997.10010978; You HL, 2003, CRETACEOUS RES, V24, P347, DOI 10.1016/S0195-6671(03)00048-X	47	64	68	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14075	10.1371/journal.pone.0014075	http://dx.doi.org/10.1371/journal.pone.0014075			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124919	Green Published, Green Submitted, gold			2022-12-27	WOS:000284467200009
J	Leung, ELH; Fiscus, RR; Tung, JW; Tin, VPC; Cheng, LC; Sihoe, ADL; Fink, LM; Ma, YP; Wong, MP				Leung, Elaine Lai-Han; Fiscus, Ronald R.; Tung, James W.; Tin, Vicky Pui-Chi; Cheng, Lik Cheung; Sihoe, Alan Dart-Loon; Fink, Louis M.; Ma, Yupo; Wong, Maria Pik			Non-Small Cell Lung Cancer Cells Expressing CD44 Are Enriched for Stem Cell-Like Properties	PLOS ONE			English	Article							COLON-CANCER; FLOW-CYTOMETRY; IDENTIFICATION; HYALURONAN; MARKER; PLURIPOTENCY; POPULATION; CD133(+); GROWTH; TUMORS	Background: The cancer stem cell theory hypothesizes that cancers are perpetuated by cancer stem cells (CSC) or tumor initiating cells (TIC) possessing self-renewal and other stem cell-like properties while differentiated non-stem/initiating cells have a finite life span. To investigate whether the hypothesis is applicable to lung cancer, identification of lung CSC and demonstration of these capacities is essential. Methodology/Principal Finding: The expression profiles of five stem cell markers (CD34, CD44, CD133, BMI1 and OCT4) were screened by flow cytometry in 10 lung cancer cell lines. CD44 was further investigated by testing for in vitro and in vivo tumorigenecity. Formation of spheroid bodies and in vivo tumor initiation ability were demonstrated in CD44(+) cells of 4 cell lines. Serial in vivo tumor transplantability in nude mice was demonstrated using H1299 cell line. The primary xenografts initiated from CD44(+) cells consisted of mixed CD44(+) and CD44(-) cells in similar ratio as the parental H1299 cell line, supporting in vivo differentiation. Semi-quantitative Real-Time PCR (RT-PCR) showed that both freshly sorted CD44(+) and CD44(+) cells derived from CD44(+)-initiated tumors expressed the pluripotency genes OCT4/POU5F1, NANOG, SOX2. These stemness markers were not expressed by CD44(-) cells. Furthermore, freshly sorted CD44(+) cells were more resistant to cisplatin treatment with lower apoptosis levels than CD44(-) cells. Immunohistochemical analysis of 141 resected non-small cell lung cancers showed tumor cell expression of CD44 in 50.4% of tumors while no CD34, and CD133 expression was observed in tumor cells. CD44 expression was associated with squamous cell carcinoma but unexpectedly, a longer survival was observed in CD44-expressing adenocarcinomas. Conclusion/Significance: Overall, our results demonstrated that stem cell-like properties are enriched in CD44-expressing subpopulations of some lung cancer cell lines. Further investigation is required to clarify the role of CD44 in tumor cell renewal and cancer propagation in the in vivo environment.	[Leung, Elaine Lai-Han; Tin, Vicky Pui-Chi; Wong, Maria Pik] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Fiscus, Ronald R.] Nevada Canc Inst, Canc Mol Biol Sect, Las Vegas, NV USA; [Fiscus, Ronald R.] Univ So Nevada, Coll Pharm, Henderson, NV USA; [Tung, James W.; Fink, Louis M.; Ma, Yupo] Nevada Canc Inst, Div Lab Med, Las Vegas, NV USA; [Cheng, Lik Cheung; Sihoe, Alan Dart-Loon] Queen Mary Hosp, Cardiothorac Surg Unit, Hong Kong, Hong Kong, Peoples R China; [Ma, Yupo] Stony Brook Univ Med Ctr, Dept Pathol, Stony Brook, NY USA	University of Hong Kong; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Hong Kong; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Stony Brook University Hospital	Leung, ELH (corresponding author), Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	mwpik@hkucc.hku.hk			HKU [10400863, 200907176141]; China Medical Board, University of Hong Kong; National Institutes of Health [R01HL087948]; National Cancer Institute [R21CA131522]; DOE at Nevada Cancer Institute [DOE-FG02-08ER64608]; Nevada Cancer Institute; University of Southern Nevada; NATIONAL CANCER INSTITUTE [R21CA131522] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087948] Funding Source: NIH RePORTER	HKU(University of Hong Kong); China Medical Board, University of Hong Kong(University of Hong Kong); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DOE at Nevada Cancer Institute(United States Department of Energy (DOE)); Nevada Cancer Institute(University of California System); University of Southern Nevada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Seed Fund for Basic Research (HKU 10400863 to M. P. Wong), a small project grant (HKU 200907176141 to E. L. Leung) and an overseas research training grant from China Medical Board, University of Hong Kong, awarded to E. L. Leung. This work was also supported in part by National Institutes of Health Grants R01HL087948, National Cancer Institute Grant R21CA131522 (to Y. Ma). DOE Funding DOE-FG02-08ER64608 at Nevada Cancer Institute (to L. M. Fink), a Startup Funding from the Nevada Cancer Institute and the University of Southern Nevada (to R. R. Fiscus). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Basak SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005884; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brivanlou AH, 2003, SCIENCE, V300, P913, DOI 10.1126/science.1082940; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; DICK JE, 1994, RES IMMUNOL, V145, P380, DOI 10.1016/S0923-2494(94)80203-3; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fasano M, 1997, CANCER, V80, P34, DOI 10.1002/(SICI)1097-0142(19970701)80:1<34::AID-CNCR5>3.0.CO;2-F; Gai H, 2009, CELL BIOL INT, V33, P1184, DOI 10.1016/j.cellbi.2009.08.008; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lam DCL, 2006, J THORAC ONCOL, V1, P932, DOI 10.1097/01243894-200611000-00003; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; MA L, ACTA BIOCH BIOPHYS S, V42, P593; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Madjd Zahra, 2009, Cancer Immun, V9, P4; Marhaba R, 2008, CURR MOL MED, V8, P784, DOI 10.2174/156652408786733667; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Napier SL, 2007, J BIOL CHEM, V282, P3433, DOI 10.1074/jbc.M607219200; Orian-Rousseau V, 2002, GENE DEV, V16, P3074, DOI 10.1101/gad.242602; PENNO MB, 1994, CANCER RES, V54, P1381; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STUELTEN C, 2010, STEM CELLS; Takanami I, 2000, ONCOL REP, V7, P1065; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; TIRINO V, 2009, EUR J CARDIOTHORAC S; Toole BP, 2008, DRUG RESIST UPDATE, V11, P110, DOI 10.1016/j.drup.2008.04.002; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Tung JW, 2007, CLIN LAB MED, V27, P453, DOI 10.1016/j.cll.2007.05.001; Ucar D, 2009, CHEM-BIOL INTERACT, V178, P48, DOI 10.1016/j.cbi.2008.09.029; WU Y, 2009, STEM CELLS DEV; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	48	329	345	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14062	10.1371/journal.pone.0014062	http://dx.doi.org/10.1371/journal.pone.0014062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124918	gold, Green Published, Green Submitted			2022-12-27	WOS:000284400100011
J	Martin, MR; Kopstein, A; Janice, JM				Martin, Michael R.; Kopstein, Andrea; Janice, Joy M.			An Analysis of Preliminary and Post-Discussion Priority Scores for Grant Applications Peer Reviewed by the Center for Scientific Review at the NIH	PLOS ONE			English	Article							OUTCOMES	There has been the impression amongst many observers that discussion of a grant application has little practical impact on the final priority scores. Rather the final score is largely dictated by the range of preliminary scores given by the assigned reviewers. The implication is that the preliminary and final scores are the same and the discussion has little impact. The purpose of this examination of the peer review process at the National Institutes of Health is to describe the relationship between preliminary priority scores of the assigned reviewers and the final priority score given by the scientific review group. This study also describes the practical importance of any differences in priority scores. Priority scores for a sample of standard (R01) research grant applications were used in this assessment. The results indicate that the preliminary meeting evaluation is positively correlated with the final meeting outcome but that they are on average significantly different. The results demonstrate that discussion at the meeting has an important practical impact on over 13% of the applications.	[Martin, Michael R.] Ctr Sci Review, Bethesda, MD USA; [Kopstein, Andrea] Substance Abuse & Mental Hlth Serv Adm, Off Program Anal, Bethesda, MD USA; [Janice, Joy M.] Tunnell Govt Serv, Bethesda, MD USA		Martin, MR (corresponding author), Ctr Sci Review, Bethesda, MD USA.	martinm@csr.nih.gov			National Institutes of Health [HHSN268200800287U]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support for this research was from the National Institutes of Health and contract number HHSN268200800287U. The funders participated in the decision to publish.	Johnson VE, 2008, P NATL ACAD SCI USA, V105, P11076, DOI 10.1073/pnas.0804538105; Kaplan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002761; Kotchen TA, 2006, J INVEST MED, V54, P13, DOI 10.2310/6650.2005.05026; Kotchen TA, 2004, JAMA-J AM MED ASSOC, V291, P836, DOI 10.1001/jama.291.7.836; Martin MR, 2008, AM J MED, V121, P637, DOI 10.1016/j.amjmed.2008.03.031; National Institutes of Health. Office of Extramural Research, NIH GUID GRANTS CONT; *NIH, NIH PEER REV PROC; Smith R, 2006, J ROY SOC MED, V99, P178, DOI 10.1258/jrsm.99.4.178; [No title captured]	9	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e13526	10.1371/journal.pone.0013526	http://dx.doi.org/10.1371/journal.pone.0013526			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103331	gold, Green Published, Green Submitted			2022-12-27	WOS:000284327800001
J	So, HC; Yip, BHK; Sham, PC				So, Hon-Cheong; Yip, Benjamin H. K.; Sham, Pak Chung			Estimating the Total Number of Susceptibility Variants Underlying Complex Diseases from Genome-Wide Association Studies	PLOS ONE			English	Article							CROHNS-DISEASE; ODDS RATIOS; POPULATION; GENETICS; TRAITS; LOCI; BIAS	Recently genome-wide association studies (GWAS) have identified numerous susceptibility variants for complex diseases. In this study we proposed several approaches to estimate the total number of variants underlying these diseases. We assume that the variance explained by genetic markers (Vg) follow an exponential distribution, which is justified by previous studies on theories of adaptation. Our aim is to fit the observed distribution of Vg from GWAS to its theoretical distribution. The number of variants is obtained by the heritability divided by the estimated mean of the exponential distribution. In practice, due to limited sample sizes, there is insufficient power to detect variants with small effects. Therefore the power was taken into account in fitting. Besides considering the most significant variants, we also tried to relax the significance threshold, allowing more markers to be fitted. The effects of false positive variants were removed by considering the local false discovery rates. In addition, we developed an alternative approach by directly fitting the z-statistics from GWAS to its theoretical distribution. In all cases, the "winner's curse" effect was corrected analytically. Confidence intervals were also derived. Simulations were performed to compare and verify the performance of different estimators (which incorporates various means of winner's curse correction) and the coverage of the proposed analytic confidence intervals. Our methodology only requires summary statistics and is able to handle both binary and continuous traits. Finally we applied the methods to a few real disease examples (lipid traits, type 2 diabetes and Crohn's disease) and estimated that hundreds to nearly a thousand variants underlie these traits.	[So, Hon-Cheong; Yip, Benjamin H. K.; Sham, Pak Chung] Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, Genome Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Sham, Pak Chung] Univ Hong Kong, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	So, HC (corresponding author), Univ Hong Kong, Dept Psychiat, Hong Kong, Hong Kong, Peoples R China.	pcsham@hkucc.hku.hk	YIP, Benjamin HK/I-2336-2013; So, Hon-Cheong/I-1100-2016; Yip, Benjamin/AAC-7845-2019	Yip, Benjamin/0000-0002-4749-7611; So, Hon-Cheong/0000-0002-7102-833X	Hong Kong Research Grants Council [HKU 766906M, HKU 774707M]; University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	Hong Kong Research Grants Council(Hong Kong Research Grants Council); University of Hong Kong Strategic Research Theme of Genomics; Croucher Foundation	The work was supported by the Hong Kong Research Grants Council General Research Fund HKU 766906M and HKU 774707M and the University of Hong Kong Strategic Research Theme of Genomics. HCS was supported by a Croucher Foundation Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Bost B, 1999, GENETICS, V153, P2001; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Efron B, 2004, J AM STAT ASSOC, V99, P96, DOI 10.1198/016214504000000089; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Ghosh A, 2008, AM J HUM GENET, V82, P1064, DOI 10.1016/j.ajhg.2008.03.002; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Pawitan Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007969; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; So H. C., 2010, GENETICS COMPLEX HUM, P49; SO HC, 2010, EVALUATING HER UNPUB; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zhong H, 2008, BIOSTATISTICS, V9, P621, DOI 10.1093/biostatistics/kxn001	22	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e13898	10.1371/journal.pone.0013898	http://dx.doi.org/10.1371/journal.pone.0013898			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103334	gold, Green Submitted, Green Published			2022-12-27	WOS:000284327800002
J	Meng, L; Sefah, K; O'Donoghue, MB; Zhu, GZ; Shangguan, D; Noorali, A; Chen, Y; Zhou, L; Tan, WH				Meng, Ling; Sefah, Kwame; O'Donoghue, Meghan B.; Zhu, Guizhi; Shangguan, Dihua; Noorali, Afshan; Chen, Yan; Zhou, Lei; Tan, Weihong			Silencing of PTK7 in Colon Cancer Cells: Caspase-10-Dependent Apoptosis via Mitochondrial Pathway	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; EXPRESSION; INTERFERENCE; P53; METASTASIS; ACTIVATION; CASPASES; POLARITY; GENES	Protein tyrosine kinase-7 (PTK7) is a catalytically inactive receptor tyrosine kinase (RTK). PTK7 is upregulated in many common human cancers, including colon cancer, lung cancer, gastric cancer and acute myeloid leukemia. The reason for this up-regulation is not yet known. To explore the functional role of PTK7, the expression of PTK7 in HCT 116 cells was examined using small interference (siRNA)-mediated gene silencing. Following transfection, the siRNA successfully suppressed PTK7 mRNA and protein expression. Knocking down of PTK7 in HCT 116 cells inhibited cell proliferation compared to control groups and induced apoptosis. Furthermore, this apoptosis was characterized by decreased mitochondrial membrane potential and activation of caspase-9 and -10. Addition of a caspase-10 inhibitor totally blocked this apoptosis, suggesting that caspase-10 may play a critical role in PTK7-knockdown-induced apoptosis, downstream of mitochondria. These observations may indicate a role for PTK7 in cell proliferation and cell apoptosis and may provide a potential therapeutic pathway for the treatment of a variety of cancers.	[Meng, Ling] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; Univ Florida, Shands Canc Ctr, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA; Univ Florida, UF Genet Inst, Ctr Res Bio Nano Interface, Gainesville, FL 32611 USA; Univ Florida, McKnight Brain Inst, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Meng, L (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.	tan@chem.ufl.edu	Tan, Weihong/AAA-4536-2020; Zhu, Guizhi/AAN-2888-2020; Zhu, Guizhi/C-9150-2015; Meng, Ling/B-4170-2012; Tan, Weihong/A-5412-2008; Altman, Meghan O/J-2975-2015; Shangguan, Dihua/G-4530-2011	Tan, Weihong/0000-0002-8066-1524; Altman, Meghan O/0000-0002-8910-9074; Shangguan, Dihua/0000-0002-5746-803X; Zhu, Guizhi/0000-0002-2945-7982	National Institutes of Health (NIH) [R01GM066137]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066137] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH), Agency #R01GM066137 (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnemri ES, 1996, CELL, V87, P171, DOI 10.1016/S0092-8674(00)81334-3; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Boudeau J, 2006, TRENDS CELL BIOL, V16, P443, DOI 10.1016/j.tcb.2006.07.003; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Devi GR, 2006, CANCER GENE THER, V13, P819, DOI 10.1038/sj.cgt.7700931; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; FernandesAlnemri T, 1996, P NATL ACAD SCI USA, V93, P7464, DOI 10.1073/pnas.93.15.7464; Filomenko R, 2006, ONCOGENE, V25, P7635, DOI 10.1038/sj.onc.1209733; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Harada K, 2002, CANCER RES, V62, P5897; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Karagiannis TC, 2005, CANCER GENE THER, V12, P787, DOI 10.1038/sj.cgt.7700857; Katoh M, 2007, INT J MOL MED, V20, P405; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; MATLASHEWSKI G, 1984, EMBO J, V3, P3257, DOI 10.1002/j.1460-2075.1984.tb02287.x; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Park SK, 1996, J BIOCHEM, V119, P235; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Shangguan D, 2008, J PROTEOME RES, V7, P2133, DOI 10.1021/pr700894d; Shin MS, 2002, ONCOGENE, V21, P4129, DOI 10.1038/sj.onc.1205527; Shin WS, 2008, BIOCHEM BIOPH RES CO, V371, P793, DOI 10.1016/j.bbrc.2008.04.168; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; 2002, BLOOD, V99	33	72	75	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14018	10.1371/journal.pone.0014018	http://dx.doi.org/10.1371/journal.pone.0014018			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103379	Green Submitted, Green Published, gold			2022-12-27	WOS:000284257400017
J	Park, J; Jeon, Y; In, D; Fishel, R; Ban, C; Lee, JB				Park, Jonghyun; Jeon, Yongmoon; In, Daekil; Fishel, Richard; Ban, Changill; Lee, Jong-Bong			Single-Molecule Analysis Reveals the Kinetics and Physiological Relevance of MutL-ssDNA Binding	PLOS ONE			English	Article							DNA MISMATCH REPAIR; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PROTEIN MUTS; COMPLEX; TIME; ATP; REPLICATION; ALPHA	DNA binding by MutL homologs (MLH/PMS) during mismatch repair (MMR) has been considered based on biochemical and genetic studies. Bulk studies with MutL and its yeast homologs Mlh1-Pms1 have suggested an integral role for a single-stranded DNA (ssDNA) binding activity during MMR. We have developed single-molecule Forster resonance energy transfer (smFRET) and a single-molecule DNA flow-extension assays to examine MutL interaction with ssDNA in real time. The smFRET assay allowed us to observe MutL-ssDNA association and dissociation. We determined that MutL-ssDNA binding required ATP and was the greatest at ionic strength below 25 mM (K(D) = 29 nM) while it dramatically decreases above 100 mM (K(D)>2 mM). Single-molecule DNA flow-extension analysis suggests that multiple MutL proteins may bind ssDNA at low ionic strength but this activity does not enhance stability at elevated ionic strengths. These studies are consistent with the conclusion that a stable MutL-ssDNA interaction is unlikely to occur at physiological salt eliminating a number of MMR models. However, the activity may infer some related dynamic DNA transaction process during MMR.	[Park, Jonghyun; Jeon, Yongmoon; In, Daekil; Lee, Jong-Bong] Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, Kyungbuk, South Korea; [Fishel, Richard] Ohio State Univ, Med Ctr, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fishel, Richard] Ohio State Univ, Dept Phys, Columbus, OH 43210 USA; [Ban, Changill] Pohang Univ Sci & Technol POSTECH, Dept Chem, Pohang, Kyungbuk, South Korea; [Lee, Jong-Bong] Pohang Univ Sci & Technol POSTECH, Sch Interdisciplinary Biosci & Bioengn, Pohang, Kyungbuk, South Korea	Pohang University of Science & Technology (POSTECH); University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Pohang University of Science & Technology (POSTECH); Pohang University of Science & Technology (POSTECH)	Park, J (corresponding author), Pohang Univ Sci & Technol POSTECH, Dept Phys, Pohang, Kyungbuk, South Korea.	rfishel@osu.edu; ciban@postech.ac.kr; jblee@postech.ac.kr	Ban, Changill/F-5426-2013; Lee, Jong-Bong/AAH-4669-2020		Republic of Korea government (Ministry of Education, Science and Technology) [2008-0061211, 2009-0091507]; National Institutes of Health [CA067007]; NATIONAL CANCER INSTITUTE [R01CA067007] Funding Source: NIH RePORTER	Republic of Korea government (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by Brain Korea 21, the National Research Foundation of Korea grant funded by the Republic of Korea government (Ministry of Education, Science and Technology) (No. 2008-0061211, 2009-0091507), and National Institutes of Health grant CA067007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Ban C, 1998, CELL, V95, P541, DOI 10.1016/S0092-8674(00)81621-9; Ban C, 1999, CELL, V97, P85, DOI 10.1016/S0092-8674(00)80717-5; BENDE SM, 1991, NUCLEIC ACIDS RES, V19, P1549, DOI 10.1093/nar/19.7.1549; Bronson JE, 2009, BIOPHYS J, V97, P3196, DOI 10.1016/j.bpj.2009.09.031; Drotschmann K, 1998, NUCLEIC ACIDS RES, V26, P948, DOI 10.1093/nar/26.4.948; Dutta R, 2000, TRENDS BIOCHEM SCI, V25, P24, DOI 10.1016/S0968-0004(99)01503-0; Fischer CJ, 2004, J MOL BIOL, V344, P1287, DOI 10.1016/j.jmb.2004.10.005; Gorman J, 2010, NAT STRUCT MOL BIOL, V17, P932, DOI 10.1038/nsmb.1858; Guarne A, 2004, EMBO J, V23, P4134, DOI 10.1038/sj.emboj.7600412; Hall MC, 2001, J MOL BIOL, V312, P637, DOI 10.1006/jmbi.2001.4958; Joo C., 2008, SINGLE MOL TECHNIQUE; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kim SJ, 2007, NAT METHODS, V4, P397, DOI 10.1038/NMETH1037; Kosinski J, 2005, J MOL BIOL, V351, P895, DOI 10.1016/j.jmb.2005.06.044; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lee JY, 2006, CELL, V127, P1349, DOI 10.1016/j.cell.2006.10.049; Lee JB, 2006, NATURE, V439, P621, DOI 10.1038/nature04317; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Mechanic LE, 2000, J BIOL CHEM, V275, P38337, DOI 10.1074/jbc.M006268200; Modrich P, 1996, ANNU REV BIOCHEM, V65, P101, DOI 10.1146/annurev.bi.65.070196.000533; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Robertson A, 2006, J BIOL CHEM, V281, P8399, DOI 10.1074/jbc.M509184200; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sacho EJ, 2008, MOL CELL, V29, P112, DOI 10.1016/j.molcel.2007.10.030; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Selmane T, 2003, J MOL BIOL, V334, P949, DOI 10.1016/j.jmb.2003.10.010; van Oijen AM, 2003, SCIENCE, V301, P1235, DOI 10.1126/science.1084387; VONHIPPE PH, 1972, ANNU REV BIOCHEM, V41, P231, DOI 10.1146/annurev.bi.41.070172.001311; Warren JJ, 2007, MOL CELL, V26, P579, DOI 10.1016/j.molcel.2007.04.018	32	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15496	10.1371/journal.pone.0015496	http://dx.doi.org/10.1371/journal.pone.0015496			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103398	Green Submitted, Green Published, gold			2022-12-27	WOS:000284147700035
J	Bishop, JR; Passos-Bueno, MR; Fong, L; Stanford, KI; Gonzales, JC; Yeh, E; Young, SG; Bensadoun, A; Witztum, JL; Esko, JD; Moulton, KS				Bishop, Joseph R.; Passos-Bueno, Maria Rita; Fong, Loren; Stanford, Kristin I.; Gonzales, Jon C.; Yeh, Erika; Young, Stephen G.; Bensadoun, Andre; Witztum, Joseph L.; Esko, Jeffrey D.; Moulton, Karen S.			Deletion of the Basement Membrane Heparan Sulfate Proteoglycan Type XVIII Collagen Causes Hypertriglyceridemia in Mice and Humans	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; KNOBLOCH-SYNDROME; NONFASTING TRIGLYCERIDES; MORPHOGEN GRADIENT; KNOCKOUT MICE; HEART-DISEASE; LDL RECEPTOR; LIPASE; BINDING; IDENTIFICATION	Background: Lipoprotein lipase (Lpl) acts on triglyceride-rich lipoproteins in the peripheral circulation, liberating free fatty acids for energy metabolism or storage. This essential enzyme is synthesized in parenchymal cells of adipose tissue, heart, and skeletal muscle and migrates to the luminal side of the vascular endothelium where it acts upon circulating lipoproteins. Prior studies suggested that Lpl is immobilized by way of heparan sulfate proteoglycans on the endothelium, but genetically altering endothelial cell heparan sulfate had no effect on Lpl localization or lipolysis. The objective of this study was to determine if extracellular matrix proteoglycans affect Lpl distribution and triglyceride metabolism. Methods and Findings: We examined mutant mice defective in collagen XVIII (Col18), a heparan sulfate proteoglycan present in vascular basement membranes. Loss of Col18 reduces plasma levels of Lpl enzyme and activity, which results in mild fasting hypertriglyceridemia and diet-induced hyperchylomicronemia. Humans with Knobloch Syndrome caused by a null mutation in the vascular form of Col18 also present lower than normal plasma Lpl mass and activity and exhibit fasting hypertriglyceridemia. Conclusions: This is the first report demonstrating that Lpl presentation on the lumenal side of the endothelium depends on a basement membrane proteoglycan and demonstrates a previously unrecognized phenotype in patients lacking Col18.	[Bishop, Joseph R.; Stanford, Kristin I.; Gonzales, Jon C.; Esko, Jeffrey D.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Passos-Bueno, Maria Rita; Yeh, Erika] Univ Sao Paulo, Inst Biosci, Dept Genet & Evolutionary Biol, Ctr Human Genome, Sao Paulo, Brazil; [Fong, Loren; Young, Stephen G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Cardiol, Los Angeles, CA 90095 USA; [Bensadoun, Andre] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA; [Witztum, Joseph L.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Moulton, Karen S.] Univ Colorado Denver, Div Cardiol, Aurora, CO USA	University of California System; University of California San Diego; Universidade de Sao Paulo; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cornell University; University of California System; University of California San Diego; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Bishop, JR (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	jesko@ucsd.edu; karen.moulton@ucdenver.edu	Passos-Bueno, Maria Rita/I-6796-2016; Cetgen, Inct/I-2412-2013	Passos-Bueno, Maria Rita/0000-0002-9248-3008; Yeh, Erika/0000-0002-2374-1528; Young, Stephen/0000-0001-7270-3176	National Institute of Health [HL087228, GM33063, HL67255]; CEPID/FAPESP; CNPq; University of Colorado Denver Department of Medicine; Leducq Foundation; American Heart Association [0735038N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087228, R01HL067255] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033063, R37GM033063] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CEPID/FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); University of Colorado Denver Department of Medicine; Leducq Foundation(Leducq Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of Health grants HL087228 (A.B.), GM33063 (J.D.E.) and HL67255 (K.S.M.); CEPID/FAPESP and CNPq (M.R.B-P.), a University of Colorado Denver Department of Medicine Pilot Grant (K.S.M.), the Leducq Foundation. (J.L.W.). J.R.B. is funded by a Scientist Development Grant 0735038N from the American Heart Association. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa-Hirasawa E, 1999, NAT GENET, V23, P354, DOI 10.1038/15537; Augustus AS, 2003, AM J PHYSIOL-ENDOC M, V284, pE331, DOI 10.1152/ajpendo.00298.2002; Baeg GH, 2004, DEV BIOL, V276, P89, DOI 10.1016/j.ydbio.2004.08.023; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Beigneux AP, 2007, CELL METAB, V5, P279, DOI 10.1016/j.cmet.2007.02.002; Beigneux AP, 2009, J BIOL CHEM, V284, P30240, DOI 10.1074/jbc.M109.046391; BEISSWENGER PJ, 1970, SCIENCE, V168, P596, DOI 10.1126/science.168.3931.596; BERRYMAN DE, 1993, J BIOL CHEM, V268, P3272; Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074; Bornemann DJ, 2008, DEVELOPMENT, V135, P1039, DOI 10.1242/dev.017061; Briquet-Laugier V, 1999, METH MOL B, V109, P81; BRUNZELL JD, 2001, METABOLIC MOL BASES, P2789; Davies BSJ, 2010, CELL METAB, V12, P42, DOI 10.1016/j.cmet.2010.04.016; Echtermeyer F, 2001, J CLIN INVEST, V107, pR9, DOI 10.1172/JCI10559; Frank PG, 2008, AM J PHYSIOL-CELL PH, V295, pC242, DOI 10.1152/ajpcell.00185.2008; FRANK RN, 1983, INVEST OPHTH VIS SCI, V24, P1519; Fukai N, 2002, EMBO J, V21, P1535, DOI 10.1093/emboj/21.7.1535; Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2; Gin P, 2008, J BIOL CHEM, V283, P29554, DOI 10.1074/jbc.M802579200; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; HATA A, 1993, J BIOL CHEM, V268, P8447; Hirano T, 2001, AM J PHYSIOL-ENDOC M, V281, pE665, DOI 10.1152/ajpendo.2001.281.4.E665; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Ishibashi S, 1996, J BIOL CHEM, V271, P22422, DOI 10.1074/jbc.271.37.22422; Keren B, 2007, AM J MED GENET A, V143A, P1514, DOI 10.1002/ajmg.a.31784; Knox SM, 2006, CELL MOL LIFE SCI, V63, P2435, DOI 10.1007/s00018-006-6162-z; KOBAYASHI J, 1993, CLIN CHIM ACTA, V216, P113, DOI 10.1016/0009-8981(93)90144-S; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lander AD, 2002, DEV CELL, V2, P785, DOI 10.1016/S1534-5807(02)00179-X; Lander AD, 2007, CELL, V128, P245, DOI 10.1016/j.cell.2007.01.004; Lutz EP, 2001, J CLIN INVEST, V107, P1183, DOI 10.1172/JCI11774; MA YH, 1994, J LIPID RES, V35, P2049; MacArthur JM, 2007, J CLIN INVEST, V117, P153, DOI 10.1172/JCI29154; Marneros AG, 2005, FASEB J, V19, P716, DOI 10.1096/fj.04-2134rev; Marneros AG, 2004, EMBO J, V23, P89, DOI 10.1038/sj.emboj.7600014; Menzel O, 2004, HUM MUTAT, V23, P77, DOI 10.1002/humu.10284; Moulton KS, 2004, CIRCULATION, V110, P1330, DOI 10.1161/01.CIR.0000140720.79015.3C; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Nybakken K, 2002, BBA-GEN SUBJECTS, V1573, P280, DOI 10.1016/S0304-4165(02)00395-1; Orchard TJ, 2002, KIDNEY INT, V62, P963, DOI 10.1046/j.1523-1755.2002.00507.x; Page S, 2006, J BIOL CHEM, V281, P13931, DOI 10.1074/jbc.M600995200; Park PW, 2001, NATURE, V411, P98, DOI 10.1038/35075100; PASSOSBUENO MR, 1994, AM J MED GENET, V52, P170, DOI 10.1002/ajmg.1320520209; Qi D, 2006, CARDIOVASC RES, V72, P124, DOI 10.1016/j.cardiores.2006.07.022; Reizes O, 2001, CELL, V106, P105, DOI 10.1016/S0092-8674(01)00415-9; Rossi M, 2003, EMBO J, V22, P236, DOI 10.1093/emboj/cdg019; Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8; Saarela J, 1998, AM J PATHOL, V153, P611, DOI 10.1016/S0002-9440(10)65603-9; SAXENA U, 1991, J BIOL CHEM, V266, P17516; SAXENA U, 1991, P NATL ACAD SCI USA, V88, P2254, DOI 10.1073/pnas.88.6.2254; SEAVER LH, 1993, AM J MED GENET, V46, P203, DOI 10.1002/ajmg.1320460221; Sendak RA, 2000, J LIPID RES, V41, P260; Serpinskaya AS, 1999, DEV BIOL, V205, P65, DOI 10.1006/dbio.1998.9112; Sertie AL, 1996, HUM MOL GENET, V5, P843, DOI 10.1093/hmg/5.6.843; Stanford KI, 2010, J BIOL CHEM, V285, P286, DOI 10.1074/jbc.M109.063701; Stanford KI, 2009, J CLIN INVEST, V119, P3236, DOI 10.1172/JCI38251; Tran-Lundmark K, 2008, CIRC RES, V103, P43, DOI 10.1161/CIRCRESAHA.108.172833; Utriainen A, 2004, HUM MOL GENET, V13, P2089, DOI 10.1093/hmg/ddh213; VILARO S, 1988, AM J PHYSIOL, V254, pG711, DOI 10.1152/ajpgi.1988.254.5.G711; WALLINDER L, 1979, BIOCHIM BIOPHYS ACTA, V575, P166, DOI 10.1016/0005-2760(79)90142-5; Weinstein MM, 2008, J BIOL CHEM, V283, P34511, DOI 10.1074/jbc.M806067200; Weinstock PH, 1995, J CLIN INVEST, V96, P2555, DOI 10.1172/JCI118319; Wilson C, 1998, AM J MED GENET, V78, P286, DOI 10.1002/(SICI)1096-8628(19980707)78:3<286::AID-AJMG16>3.0.CO;2-B; WINGARD DL, 1983, AM J EPIDEMIOL, V117, P19, DOI 10.1093/oxfordjournals.aje.a113510	64	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13919	10.1371/journal.pone.0013919	http://dx.doi.org/10.1371/journal.pone.0013919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085708	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800012
J	Jia, DL; Rahbar, R; Chan, RWY; Lee, SMY; Chan, MCW; Wang, BXH; Baker, DP; Sun, B; Peiris, JSM; Nicholls, JM; Fish, EN				Jia, Danlin; Rahbar, Ramtin; Chan, Renee W. Y.; Lee, Suki M. Y.; Chan, Michael C. W.; Wang, Ben Xuhao; Baker, Darren P.; Sun, Bing; Peiris, J. S. Malik; Nicholls, John M.; Fish, Eleanor N.			Influenza Virus Non-Structural Protein 1 (NS1) Disrupts Interferon Signaling	PLOS ONE			English	Article							H5N1 AVIAN INFLUENZA; CHRONIC HEPATITIS-C; A VIRUS; ANTIVIRAL RESPONSES; NEURAMINIDASE INHIBITORS; ALPHA-INTERFERON; IMMUNE-RESPONSE; BETA-INTERFERON; VIRAL DISEASE; CORE PROTEIN	Type I interferons (IFNs) function as the first line of defense against viral infections by modulating cell growth, establishing an antiviral state and influencing the activation of various immune cells. Viruses such as influenza have developed mechanisms to evade this defense mechanism and during infection with influenza A viruses, the non-structural protein 1 (NS1) encoded by the virus genome suppresses induction of IFNs-alpha/beta. Here we show that expression of avian H5N1 NS1 in HeLa cells leads to a block in IFN signaling. H5N1 NS1 reduces IFN-inducible tyrosine phosphorylation of STAT1, STAT2 and STAT3 and inhibits the nuclear translocation of phospho-STAT2 and the formation of IFN-inducible STAT1:1-, STAT1:3- and STAT3:3-DNA complexes. Inhibition of IFN-inducible STAT signaling by NS1 in HeLa cells is, in part, a consequence of NS1-mediated inhibition of expression of the IFN receptor subunit, IFNAR1. In support of this NS1-mediated inhibition, we observed a reduction in expression of ifnar1 in ex vivo human non-tumor lung tissues infected with H5N1 and H1N1 viruses. Moreover, H1N1 and H5N1 virus infection of human monocyte-derived macrophages led to inhibition of both ifnar1 and ifnar2 expression. In addition, NS1 expression induces up-regulation of the JAK/STAT inhibitors, SOCS1 and SOCS3. By contrast, treatment of ex vivo human lung tissues with IFN-alpha results in the up-regulation of a number of IFN-stimulated genes and inhibits both H5N1 and H1N1 virus replication. The data suggest that NS1 can directly interfere with IFN signaling to enhance viral replication, but that treatment with IFN can nevertheless override these inhibitory effects to block H5N1 and H1N1 virus infections.	[Jia, Danlin; Rahbar, Ramtin; Wang, Ben Xuhao; Fish, Eleanor N.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Chan, Renee W. Y.; Nicholls, John M.] Univ Hong Kong, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Chan, Renee W. Y.; Lee, Suki M. Y.; Chan, Michael C. W.; Peiris, J. S. Malik] Univ Hong Kong, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Baker, Darren P.] Biogen Idec Inc, Cambridge, MA USA; [Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Fish, Eleanor N.] Univ Hlth Network, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON, Canada	University of Toronto; University of Hong Kong; University of Hong Kong; Biogen; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Jia, DL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	en.fish@utoronto.ca	Chan, Michael Chi Wai/C-4212-2009; Chan, Renee Wan Yi/AAA-6598-2020; Nicholls, John Malcolm/C-4375-2009	Chan, Michael Chi Wai/0000-0001-8174-8405; Chan, Renee Wan Yi/0000-0001-6485-0926; Nicholls, John Malcolm/0000-0001-7217-7444	Canadian Institutes of Health Research [MOP-15094]; Public Health Agency of Canada; Research Funds for the Control of Infectious Diseases [10090202]; University Grants Committee of the Hong Kong Special Administrative Region, China [AoE/M-12/-06]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Research Funds for the Control of Infectious Diseases; University Grants Committee of the Hong Kong Special Administrative Region, China	These studies were supported by a Canadian Institutes of Health Research grant (MOP-15094) and a Public Health Agency of Canada grant to E.N.F., Research Funds for the Control of Infectious Diseases grant to J.M.N. (10090202) and funding to R.W.Y.C., M.C.W.C. and J.S.M.P. from the Area of Excellence Scheme of the University Grants Committee (grant AoE/M-12/-06 of the Hong Kong Special Administrative Region, China). D.J. and R.R. are recipients of Canadian Institutes of Health Research scholarship awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. D.P.B. is employed by Biogen Idec, thus Biogen Idec did have a role in providing IFN-beta and in the review and editing of the manuscript.	Aragon T, 2000, MOL CELL BIOL, V20, P6259, DOI 10.1128/MCB.20.17.6259-6268.2000; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; Aucan C, 2003, GENES IMMUN, V4, P275, DOI 10.1038/sj.gene.6363962; Bode JG, 2003, FASEB J, V17, P488, DOI 10.1096/fj.02-0664fje; Bonjardim CA, 2009, IMMUNOL LETT, V122, P1, DOI 10.1016/j.imlet.2008.11.002; Bornholdt ZA, 2008, NATURE, V456, P985, DOI 10.1038/nature07444; Brierley MM, 2006, FEBS J, V273, P1569, DOI 10.1111/j.1742-4658.2006.05176.x; Bright RA, 2005, LANCET, V366, P1175, DOI 10.1016/S0140-6736(05)67338-2; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; *CDC, 2009, MMWR-MORBID MORTAL W, P893; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Chen XP, 2000, IMMUNITY, V13, P287, DOI 10.1016/S1074-7613(00)00028-5; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Cheng PKC, 2009, EMERG INFECT DIS, V15, P966, DOI 10.3201/eid1506.081357; Cheung CL, 2006, J INFECT DIS, V193, P1626, DOI 10.1086/504723; Diop G, 2006, BIOMED PHARMACOTHER, V60, P569, DOI 10.1016/j.biopha.2006.08.002; Donelan NR, 2004, J VIROL, V78, P11574, DOI 10.1128/JVI.78.21.11574-11582.2004; Dupuis S, 2003, NAT GENET, V33, P388, DOI 10.1038/ng1097; Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Fernandez-Sesma A, 2006, J VIROL, V80, P6295, DOI 10.1128/JVI.02381-05; FREY KG, 2009, J IMMUNOL; Fuke H, 2008, NUCLEIC ACIDS RES, V36, P1037, DOI 10.1093/nar/gkm1120; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Goldman LA, 1999, J INTERF CYTOK RES, V19, P15, DOI 10.1089/107999099314379; Gregorieff A, 2000, J BIOL CHEM, V275, P21596, DOI 10.1074/jbc.M910087199; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hengel H, 2005, TRENDS IMMUNOL, V26, P396, DOI 10.1016/j.it.2005.05.004; Hill AW, 2009, INFECT GENET EVOL, V9, P169, DOI 10.1016/j.meegid.2008.10.006; Hui KPY, 2009, J IMMUNOL, V182, P1088, DOI 10.4049/jimmunol.182.2.1088; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jefferson T., 2004, COCHRANE DB SYST REV, V2, DOI [10.1002/14651858.CD001169.pub2, DOI 10.1002/14651858.CD001169.PUB2]; Karber G., 1931, ARCH EXP PATHOL PH, V162, P480, DOI DOI 10.1007/BF01863914; Kim CU, 1997, J AM CHEM SOC, V119, P681, DOI 10.1021/ja963036t; Krebs DL, 2000, J CELL SCI, V113, P2813; Kugel D, 2009, J VIROL, V83, P3843, DOI 10.1128/JVI.02453-08; Lee SMY, 2008, J INFECT DIS, V198, P525, DOI 10.1086/590499; Leyva L, 2005, J NEUROIMMUNOL, V163, P165, DOI 10.1016/j.jneuroim.2005.02.010; Lin WY, 2006, J VIROL, V80, P9226, DOI 10.1128/JVI.00459-06; Matsumoto A, 1999, MOL CELL BIOL, V19, P6396; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; MOWSHOWITZ SL, 1983, J NEURAL TRANSM, V57, P121, DOI 10.1007/BF01250054; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Oshansky CM, 2009, VIRAL IMMUNOL, V22, P147, DOI 10.1089/vim.2008.0098; Park C, 2000, IMMUNITY, V13, P795, DOI 10.1016/S1074-7613(00)00077-7; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Precious B, 2005, J GEN VIROL, V86, P151, DOI 10.1099/vir.0.80263-0; QIU Y, 1995, RNA, V1, P304; Rahbar R, 2006, J VIROL, V80, P7245, DOI 10.1128/JVI.00463-06; Saito T, 2007, CURR OPIN IMMUNOL, V19, P17, DOI 10.1016/j.coi.2006.11.003; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Tena-Tomas C, 2007, EUR CYTOKINE NETW, V18, P136; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Vlotides G, 2004, BIOCHEM BIOPH RES CO, V320, P1007, DOI 10.1016/j.bbrc.2004.06.051; von Itzstein Mark, 2009, V189, P111, DOI 10.1007/978-3-540-79086-0_5; WANG SQ, 2009, BIOCH BIOPHYS RES CO; Wang W, 1999, RNA, V5, P195, DOI 10.1017/S1355838299981621; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Welzel TM, 2009, HEPATOLOGY, V49, P1847, DOI 10.1002/hep.22877; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Zurney J, 2007, J VIROL, V81, P13668, DOI 10.1128/JVI.01172-07	66	119	125	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13927	10.1371/journal.pone.0013927	http://dx.doi.org/10.1371/journal.pone.0013927			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085662	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800018
J	Bojer, MS; Struve, C; Ingmer, H; Hansen, DS; Krogfelt, KA				Bojer, Martin Saxtorph; Struve, Carsten; Ingmer, Hanne; Hansen, Dennis Schroder; Krogfelt, Karen Angeliki			Heat Resistance Mediated by a New Plasmid Encoded Clp ATPase, ClpK, as a Possible Novel Mechanism for Nosocomial Persistence of Klebsiella pneumoniae	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; SHOCK-PROTEIN; LACTOCOCCUS-LACTIS; STRESS TOLERANCE; BACTEREMIA; INFECTIONS; EPIDEMIOLOGY; PROTEOLYSIS; GENES	Klebsiella pneumoniae is an important opportunistic pathogen and a frequent cause of nosocomial infections. We have characterized a K. pneumoniae strain responsible for a series of critical infections in an intensive care unit over a two-year period. The strain was found to be remarkably thermotolerant providing a conceivable explanation of its persistence in the hospital environment. This marked phenotype is mediated by a novel type of Clp ATPase, designated ClpK. The clpK gene is encoded by a conjugative plasmid and we find that the clpK gene alone renders an otherwise sensitive E. coli strain resistant to lethal heat shock. Furthermore, one third of a collection of nosocomial K. pneumoniae isolates carry clpK and exhibit a heat resistant phenotype. The discovery of ClpK as a plasmid encoded factor and its profound impact on thermal stress survival sheds new light on the biological relevance of Clp ATPases in acquired environmental fitness and highlights the challenges of mobile genetic elements in fighting nosocomial infections.	[Bojer, Martin Saxtorph; Struve, Carsten; Krogfelt, Karen Angeliki] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark; [Ingmer, Hanne] Univ Copenhagen, Fac Life Sci, Dept Vet Pathobiol, Frederiksberg, Denmark; [Hansen, Dennis Schroder] Univ Copenhagen, Hvidovre Hosp, Dept Clin Microbiol, DK-2650 Hvidovre, Denmark; [Hansen, Dennis Schroder] Hillerod Hosp, Dept Clin Microbiol, Hillerod, Denmark	Statens Serum Institut; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bojer, MS (corresponding author), Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen, Denmark.	cas@ssi.dk	Krogfelt, Karen Angeliki A/O-8145-2016; Krogfelt, Karen Angeliki/P-2430-2018	Krogfelt, Karen Angeliki A/0000-0001-7536-3453; Ingmer, Hanne/0000-0002-8350-5631; Bojer, Martin Saxtorph/0000-0002-8488-9593				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Banecki B, 2001, J BIOL CHEM, V276, P18843, DOI 10.1074/jbc.M007507200; BINGEN EH, 1993, J CLIN MICROBIOL, V31, P179, DOI 10.1128/JCM.31.2.179-184.1993; Branger C, 1997, J HOSP INFECT, V36, P23, DOI 10.1016/S0195-6701(97)90088-8; Brisse S, 2001, INT J SYST EVOL MICR, V51, P915, DOI 10.1099/00207713-51-3-915; Chaveroche MK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.22.e97; Cordery RJ, 2008, J HOSP INFECT, V68, P108, DOI 10.1016/j.jhin.2007.10.011; Couto RC, 2007, AM J INFECT CONTROL, V35, P183, DOI 10.1016/j.ajic.2006.06.013; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DELATORRE MG, 1985, REV INFECT DIS, V7, P143; FELDMAN C, 1990, J INFECTION, V20, P21, DOI 10.1016/S0163-4453(90)92258-M; Frees D, 2004, MOL MICROBIOL, V54, P1445, DOI 10.1111/j.1365-2958.2004.04368.x; Gaillot O, 1998, J CLIN MICROBIOL, V36, P1357, DOI 10.1128/JCM.36.5.1357-1360.1998; Ghotaslou R, 2007, JPN J INFECT DIS, V60, P126; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Hansen DS, 1998, J HOSP INFECT, V38, P119, DOI 10.1016/S0195-6701(98)90065-2; HUANG DC, 1993, MOL MICROBIOL, V7, P957, DOI 10.1111/j.1365-2958.1993.tb01187.x; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; Kim YI, 2001, NAT STRUCT BIOL, V8, P230, DOI 10.1038/84967; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laskowska E, 1996, BIOCHIMIE, V78, P117, DOI 10.1016/0300-9084(96)82643-5; Matuszewska M, 2005, J BIOL CHEM, V280, P12292, DOI 10.1074/jbc.M412706200; Mogk A, 2003, MOL MICROBIOL, V50, P585, DOI 10.1046/j.1365-2958.2003.03710.x; Mogk A, 2003, J BIOL CHEM, V278, P31033, DOI 10.1074/jbc.M303587200; MONTGOMERIE JZ, 1979, REV INFECT DIS, V1, P736; Naas T, 2010, J ANTIMICROB CHEMOTH, V65, P1305, DOI 10.1093/jac/dkq117; Oelschlaeger TA, 1997, INFECT IMMUN, V65, P2950, DOI 10.1128/IAI.65.7.2950-2958.1997; ORSKOV I, 1984, SEROTYPING KLEBSIELL, P143; Paterson DL, 2004, ANN INTERN MED, V140, P26, DOI 10.7326/0003-4819-140-1-200401060-00008; Perez-Gonzalez LF, 2007, INFECT CONT HOSP EP, V28, P418, DOI 10.1086/513025; Podschun R, 2001, APPL ENVIRON MICROB, V67, P3325, DOI 10.1128/AEM.67.7.3325-3327.2001; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; Reisner A, 2002, FEMS MICROBIOL ECOL, V42, P251, DOI 10.1111/j.1574-6941.2002.tb01015.x; Rouquette C, 1996, MOL MICROBIOL, V21, P977, DOI 10.1046/j.1365-2958.1996.641432.x; Sahly H, 2000, ADV EXP MED BIOL, V479, P237; Sahly H, 1997, CLIN DIAGN LAB IMMUN, V4, P393, DOI 10.1128/CDLI.4.4.393-399.1997; Schirmer EC, 1996, TRENDS BIOCHEM SCI, V21, P289, DOI 10.1016/0968-0004(96)10038-4; Schlothauer T, 2003, P NATL ACAD SCI USA, V100, P2306, DOI 10.1073/pnas.0535717100; Schwaber MJ, 2006, ANTIMICROB AGENTS CH, V50, P1257, DOI 10.1128/AAC.50.4.1257-1262.2006; Singh SK, 2001, J BIOL CHEM, V276, P29420, DOI 10.1074/jbc.M103489200; SQUIRES C, 1992, J BACTERIOL, V174, P1081, DOI 10.1128/jb.174.4.1081-1085.1992; Struve C, 2004, ENVIRON MICROBIOL, V6, P584, DOI 10.1111/j.1462-2920.2004.00590.x; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Suokko A, 2005, APPL ENVIRON MICROB, V71, P2061, DOI 10.1128/AEM.71.4.2061-2069.2005; THRELFALL EJ, 1986, J HYG-CAMBRIDGE, V97, P419, DOI 10.1017/S0022172400063609; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; van't Veen A, 2005, J CLIN MICROBIOL, V43, P4961, DOI 10.1128/JCM.43.10.4961-4967.2005; Varmanen P, 2003, J BACTERIOL, V185, P5117, DOI 10.1128/JB.185.17.5117-5124.2003; Veinger L, 1998, J BIOL CHEM, V273, P11032, DOI 10.1074/jbc.273.18.11032; WAWRZYNOW A, 1995, EMBO J, V14, P1867, DOI 10.1002/j.1460-2075.1995.tb07179.x; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; WICKNER S, 1994, P NATL ACAD SCI USA, V91, P12218, DOI 10.1073/pnas.91.25.12218; Zolkiewski M, 2006, MOL MICROBIOL, V61, P1094, DOI 10.1111/j.1365-2958.2006.05309.x; Zuhlsdorf B, 2003, J HOSP INFECT, V55, P276, DOI 10.1016/j.jhin.2003.08.014	55	53	53	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15467	10.1371/journal.pone.0015467	http://dx.doi.org/10.1371/journal.pone.0015467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085699	gold, Green Submitted, Green Published			2022-12-27	WOS:000284035900031
J	Mohan, S; Sheena, A; Poulose, N; Anilkumar, G				Mohan, Suma; Sheena, Aswathy; Poulose, Ninu; Anilkumar, Gopalakrishnapillai			Molecular Dynamics Simulation Studies of GLUT4: Substrate-Free and Substrate-Induced Dynamics and ATP-Mediated Glucose Transport Inhibition	PLOS ONE			English	Article							CYSTEINE-SCANNING MUTAGENESIS; ERYTHROCYTE SUGAR TRANSPORTER; INSULIN-INDUCED TRANSLOCATION; INTERHELICAL HYDROGEN-BONDS; CONFORMATIONAL-CHANGE; DOPAMINE TRANSPORTER; LACTOSE PERMEASE; OUTER HELIX; TRANSMEMBRANE SEGMENT-3; 3-DIMENSIONAL STRUCTURE	Background: Glucose transporter 4 (GLUT4) is an insulin facilitated glucose transporter that plays an important role in maintaining blood glucose homeostasis. GLUT4 is sequestered into intracellular vesicles in unstimulated cells and translocated to the plasma membrane by various stimuli. Understanding the structural details of GLUT4 will provide insights into the mechanism of glucose transport and its regulation. To date, a crystal structure for GLUT4 is not available. However, earlier work from our laboratory proposed a well validated homology model for GLUT4 based on the experimental data available on GLUT1 and the crystal structure data obtained from the glycerol 3-phosphate transporter. Methodology/Principal Findings: In the present study, the dynamic behavior of GLUT4 in a membrane environment was analyzed using three forms of GLUT4 (apo, substrate and ATP-substrate bound states). Apo form simulation analysis revealed an extracellular open conformation of GLUT4 in the membrane favoring easy exofacial binding of substrate. Simulation studies with the substrate bound form proposed a stable state of GLUT4 with glucose, which can be a substrate-occluded state of the transporter. Principal component analysis suggested a clockwise movement for the domains in the apo form, whereas ATP substrate-bound form induced an anti-clockwise rotation. Simulation studies suggested distinct conformational changes for the GLUT4 domains in the ATP substrate-bound form and favor a constricted behavior for the transport channel. Various inter-domain hydrogen bonds and switching of a salt-bridge network from E345-R350-E409 to E345-R169-E409 contributed to this ATP-mediated channel constriction favoring substrate occlusion and prevention of its release into cytoplasm. These data are consistent with the biochemical studies, suggesting an inhibitory role for ATP in GLUT-mediated glucose transport. Conclusions/Significance: In the absence of a crystal structure for any glucose transporter, this study provides mechanistic details of the conformational changes in GLUT4 induced by substrate and its regulator.	[Mohan, Suma; Sheena, Aswathy; Poulose, Ninu; Anilkumar, Gopalakrishnapillai] Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India	Amrita Vishwa Vidyapeetham; Amrita Vishwa Vidyapeetham Amritapuri	Mohan, S (corresponding author), Amrita Vishwa Vidyapeetham, Amrita Sch Biotechnol, Kollam, Kerala, India.	ammasanil@am.amrita.edu	gopala, Anilkumar/AAG-2713-2021; Mohan S, Suma/GNW-4180-2022	Mohan S, Suma/0000-0001-7692-163X; Gopalakrishnapillai, Anilkumar/0000-0002-0465-578X	Department of Biotechnology, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	This work was funded by Department of Biotechnology, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alisio A, 2004, J BIOL CHEM, V279, P26540, DOI 10.1074/jbc.M402303200; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Arinaminpathy Y, 2003, FEBS LETT, V553, P321, DOI 10.1016/S0014-5793(03)01036-6; Ballesteros JA, 2001, J BIOL CHEM, V276, P29171, DOI 10.1074/jbc.M103747200; Bansal A, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-27; Barrett CP, 2004, ACTA CRYSTALLOGR D, V60, P2280, DOI 10.1107/S0907444904019171; Bazuine M, 2005, BIOCHEM BIOPH RES CO, V326, P511, DOI 10.1016/j.bbrc.2004.11.055; BEGUM N, 1993, J BIOL CHEM, V268, P3352; Bennett M, 2006, BIOCHEMISTRY-US, V45, P8088, DOI 10.1021/bi060355g; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; Bogan JS, 2010, CURR OPIN CELL BIOL, V22, P506, DOI 10.1016/j.ceb.2010.03.012; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; CARRUTHERS A, 1986, J BIOL CHEM, V261, P1028; CHANG KI, 1974, J BIOL CHEM, V249, P3170; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Chiang SH, 2001, NATURE, V410, P944, DOI 10.1038/35073608; Choi MY, 2004, BIOCHEMISTRY-US, V43, P8077, DOI 10.1021/bi0494525; Cloherty EK, 2002, BIOCHEMISTRY-US, V41, P12639, DOI 10.1021/bi0259002; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; D'rozario RSG, 2008, MOL MEMBR BIOL, V25, P571, DOI 10.1080/09687680802549113; DEISENHOFER J, 1995, J MOL BIOL, V246, P429, DOI 10.1006/jmbi.1994.0097; DeLano W.L., PYMOL MOL GRAPHICS S; Dwyer DS, 2001, PROTEINS, V42, P531, DOI 10.1002/1097-0134(20010301)42:4<531::AID-PROT110>3.3.CO;2-0; Ermolova NV, 2005, BIOCHEMISTRY-US, V44, P7669, DOI 10.1021/bi0502801; Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481; FUKUMOTO H, 1989, J BIOL CHEM, V264, P7776; GIBBS EM, 1988, BIOCHEMISTRY-US, V27, P6681, DOI 10.1021/bi00418a006; Govaerts C, 2001, J BIOL CHEM, V276, P22991, DOI 10.1074/jbc.M102244200; Heard KS, 2000, BIOCHEMISTRY-US, V39, P3005, DOI 10.1021/bi991931u; HEBERT DN, 1986, J BIOL CHEM, V261, P93; Heinze M, 2004, BIOCHEMISTRY-US, V43, P931, DOI 10.1021/bi030175w; Hildebrand PW, 2008, BIOPHYS J, V94, P1945, DOI 10.1529/biophysj.107.110395; Hirai T, 2002, NAT STRUCT BIOL, V9, P597, DOI 10.1038/nsb821; Holyoake J, 2007, STRUCTURE, V15, P873, DOI 10.1016/j.str.2007.06.004; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; Hruz PW, 2000, BIOCHEMISTRY-US, V39, P9367, DOI 10.1021/bi000821g; Huang X, 2007, BIOPHYS J, V93, P3627, DOI 10.1529/biophysj.107.110924; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Javadpour MM, 1999, BIOPHYS J, V77, P1609, DOI 10.1016/S0006-3495(99)77009-8; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; JUNG EKY, 1986, J BIOL CHEM, V261, P9155; Kniazeff J, 2008, J BIOL CHEM, V283, P17691, DOI 10.1074/jbc.M800475200; Lachaal M, 2001, BBA-BIOMEMBRANES, V1511, P123, DOI 10.1016/S0005-2736(01)00272-3; Law CJ, 2008, J MOL BIOL, V378, P828, DOI 10.1016/j.jmb.2008.03.029; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Law RJ, 2009, BIOPHYS J, V97, P1586, DOI 10.1016/j.bpj.2009.06.044; LAWRENCE JC, 1990, J BIOL CHEM, V265, P2324; Leney SE, 2009, J ENDOCRINOL, V203, P1, DOI 10.1677/JOE-09-0037; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; Levine KB, 2001, BLOOD CELL MOL DIS, V27, P139, DOI 10.1006/bcmd.2000.0359; *LLC, 2008, GLID; Loland CJ, 2004, J BIOL CHEM, V279, P3228, DOI 10.1074/jbc.M304755200; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; MARETTE A, 1992, AM J PHYSIOL, V263, pC443, DOI 10.1152/ajpcell.1992.263.2.C443; MARGER MD, 1993, TRENDS BIOCHEM SCI, V18, P13, DOI 10.1016/0968-0004(93)90081-W; Melis C, 2008, BIOPHYS J, V95, P4115, DOI 10.1529/biophysj.107.127589; MITSUMOTO Y, 1992, J BIOL CHEM, V267, P4957; Mohan S, 2009, J BIOMOL STRUCT DYN, V26, P455, DOI 10.1080/07391102.2009.10507260; MORI H, 1994, J BIOL CHEM, V269, P11578; Mueckler M, 1999, J BIOL CHEM, V274, P10923, DOI 10.1074/jbc.274.16.10923; Mueckler M, 2004, J BIOL CHEM, V279, P46876, DOI 10.1074/jbc.M408632200; Mueckler M, 2004, J BIOL CHEM, V279, P10494, DOI 10.1074/jbc.M310786200; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2006, J BIOL CHEM, V281, P36993, DOI 10.1074/jbc.M608158200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; O'Mara ML, 2005, BIOPHYS J, V88, p150A; Olsowski A, 2000, BIOCHEMISTRY-US, V39, P2469, DOI 10.1021/bi992160x; Osolodkin DI, 2009, J MOL GRAPH MODEL, V27, P813, DOI 10.1016/j.jmgm.2008.12.004; PADMAVATHI GV, 2009, ONLINE J BIOINFO, V10, P1; Parravicini C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-263; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; Prasad CNV, 2009, BIOCHEM BIOPH RES CO, V380, P39, DOI 10.1016/j.bbrc.2009.01.008; REUSCH JEB, 1993, J BIOL CHEM, V268, P3348; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Saam J, 2002, BIOPHYS J, V83, P3097, DOI 10.1016/S0006-3495(02)75314-9; Saladino AC, 2005, BIOPHYS J, V88, P1009, DOI 10.1529/biophysj.104.053421; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Schurmann A, 1997, BIOCHEMISTRY-US, V36, P12897, DOI 10.1021/bi971173c; Senes A, 2001, P NATL ACAD SCI USA, V98, P9056, DOI 10.1073/pnas.161280798; Shim JY, 2009, BIOPHYS J, V96, P3251, DOI 10.1016/j.bpj.2008.12.3934; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; Therien AG, 2001, NAT STRUCT BIOL, V8, P597, DOI 10.1038/89631; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1987, GROMOS 87 MANUAL; XMGRACE, XMGRACE; Yi MG, 2008, P NATL ACAD SCI USA, V105, P8280, DOI 10.1073/pnas.0710530105; Yin Y, 2006, SCIENCE, V312, P741, DOI 10.1126/science.1125629; Yin Y, 2006, BIOPHYS J, V91, P3972, DOI 10.1529/biophysj.106.085993; Zaid H, 2009, BIOCHEM J, V419, P475, DOI 10.1042/BJ20081319; Zeng H, 1996, BIOPHYS J, V70, P14, DOI 10.1016/S0006-3495(96)79560-7; Zuniga FA, 2001, J BIOL CHEM, V276, P44970, DOI 10.1074/jbc.M107350200; PRODRG	97	19	20	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14217	10.1371/journal.pone.0014217	http://dx.doi.org/10.1371/journal.pone.0014217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151967	Green Published, Green Submitted, gold			2022-12-27	WOS:000284939600010
J	Gupta, K; Kumar, P; Chatterji, D				Gupta, Kajal; Kumar, Prasun; Chatterji, Dipankar			Identification, Activity and Disulfide Connectivity of C-di-GMP Regulating Proteins Mycobacterium tuberculosis	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; CYCLIC DIGUANYLATE; DOMAIN PROTEIN; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; BIOFILM FORMATION; GENE-EXPRESSION; IN-VITRO; EAL; GGDEF	C-di-GMP, a bacterial second messenger plays a key role in survival and adaptation of bacteria under different environmental conditions. The level of c-di-GMP is regulated by two opposing activities, namely diguanylate cyclase (DGC) and phosphodiesterase (PDE-A) exhibited by GGDEF and EAL domain, respectively in the same protein. Previously, we reported a bifunctional GGDEF-EAL domain protein, MSDGC-1 from Mycobacterium smegmatis showing both these activities (Kumar and Chatterji, 2008). In this current report, we have identified and characterized the homologous protein from Mycobacterium tuberculosis (Rv 1354c) named as MtbDGC. MtbDGC is also a bifunctional protein, which can synthesize and degrade c-di-GMP in vitro. Further we expressed Mtbdgc in M. smegmatis and it was able to complement the MSDGC-1 knock out strain by restoring the long term survival of M. smegmatis. Another protein Rv 1357c, named as MtbPDE, is an EAL domain protein and degrades c-di-GMP to pGpG in vitro. Rv1354c and 1357c have seven cysteine amino acids in their sequence, distributed along the full length of the protein. Disulfide bonds play an important role in stabilizing protein structure and regulating protein function. By proteolytic digestion and mass spectrometric analysis of MtbDGC, connectivity between cysteine pairs Cys(94)-Cys(584), Cys(2)-Cys(479) and Cys(429)-Cys(614) was determined, whereas the third cysteine (Cys(406)) from N terminal was found to be free in MtbDGC protein, which was further confirmed by alkylation with iodoacetamide labeling. Bioinformatics modeling investigations also supported the pattern of disulfide connectivity obtained by Mass spectrometric analysis. Cys(406) was mutated to serine by site directed mutagenesis and the mutant MtbC406S was not found to be active and was not able to synthesize or degrade c-di-GMP. The disulfide connectivity established here would help further in understanding the structure - function relationship in MtbDGC.	[Gupta, Kajal; Kumar, Prasun; Chatterji, Dipankar] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Gupta, K (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	kajalgupta@mbu.iisc.ernet.in	Gupta, Kajal/A-6472-2018; kumar, prasun/A-5474-2012; kumar, prasun/H-8634-2013; Kumar, Prasun/I-4083-2014	kumar, prasun/0000-0002-2008-3347; Chatterji, Dipankar/0000-0002-9985-0632; Gupta, Kajal/0000-0002-0665-1539	Department of Biotechnology, Government of India; Department of Biotechnology; DBT-BINC, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Department of Biotechnology; DBT-BINC, Government of India(Department of Biotechnology (DBT) India)	This work is financially supported by the Department of Biotechnology, Government of India. KG would like to thank the Department of Biotechnology and PK would like to thank DBT-BINC, Government of India, for the fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2001, PYMOL MOL GRAPH SYST; Avarbock A, 2005, BIOCHEMISTRY-US, V44, P9913, DOI 10.1021/bi0505316; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barik S, 1996, Methods Mol Biol, V57, P203; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Clark ED, 1999, METHOD ENZYMOL, V309, P217; DENG WP, 1992, ANAL BIOCHEM, V200, P81, DOI 10.1016/0003-2697(92)90280-K; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35; Gorman JJ, 2002, MASS SPECTROM REV, V21, P183, DOI 10.1002/mas.10025; Guo YL, 2001, EMBO J, V20, P3667, DOI 10.1093/emboj/20.14.3667; Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429; Hisert KB, 2005, MOL MICROBIOL, V56, P1234, DOI 10.1111/j.1365-2958.2005.04632.x; Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08; Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007; Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu CH, 2007, PROTEINS, V67, P262, DOI 10.1002/prot.21309; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mormann M, 2008, ANAL BIOANAL CHEM, V392, P831, DOI 10.1007/s00216-008-2258-7; Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504; Pesavento C, 2009, CURR OPIN MICROBIOL, V12, P170, DOI 10.1016/j.mib.2009.01.007; Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; REGINE H, 2009, NAT REV MICORBIOL, V7, P263; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0; Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103; RYJENKOW DA, 2005, J BACTERIOL, V187, P1972; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SALONA C, 2009, P NATL ACAD SCI USA, V106, P7997; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Shang F, 2009, INFECT IMMUN, V77, P2849, DOI 10.1128/IAI.01405-08; Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x; Steen H, 2004, NAT REV MOL CELL BIO, V5, P699, DOI 10.1038/nrm1468; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; TAKAGI T, 1997, BIOCHIM BIOPHYS ACTA, V578, P68; Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998; Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426; Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Weinhouse H, 1997, FEBS LETT, V416, P207, DOI 10.1016/S0014-5793(97)01202-7; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu J, 1997, PROTEIN SCI, V6, P391; Yen TY, 2000, J MASS SPECTROM, V35, P990, DOI 10.1002/1096-9888(200008)35:8<990::AID-JMS27>3.0.CO;2-K	58	37	39	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15072	10.1371/journal.pone.0015072	http://dx.doi.org/10.1371/journal.pone.0015072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151497	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100060
J	Wang, MX; Bai, J; Chen, WN; Ching, CB				Wang, Mingxuan; Bai, Jing; Chen, Wei Ning; Ching, Chi Bun			Metabolomic Profiling of Cellular Responses to Carvedilol Enantiomers in Vascular Smooth Muscle Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; LC-MS/MS; PROTEOMIC ANALYSIS; HEART-FAILURE; L-SERINE; GC-MS; MECHANISMS; SPECTROMETRY; PROPRANOLOL; ENDOTHELIUM	Carvedilol is a non-selective beta-blocker indicated in the treatment of hypertension and heart failure. Although the differential pharmacological effects of individual Carvedilol enantiomer is supported by preceding studies, the cellular response to each enantiomer is not well understood. Here we report the use of GC-MS metabolomic profiling to study the effects of Carvedilol enantiomers on vascular smooth muscle cells (A7r5) and to shed new light on molecular events underlying Carvedilol treatment. The metabolic analysis revealed alternations in the levels of 8 intracellular metabolites and 5 secreted metabolites in A7r5 cells incubated separately with S-and R-Carvedilol. Principal component analysis of the metabolite data demonstrated the characteristic metabolic signatures in S- and R-Carvedilol-treated cells. A panel of metabolites, including L-serine, L-threonine, 5-oxoproline, myristic acid, palmitic acid and inositol are closely correlated to the vascular smooth muscle contraction. Our findings reveal the differentiating metabolites for A7r5 cells incubated with individual enantiomer of Carvedilol, which opens new perspectives to employ metabolic profiling platform to study chiral drug-cell interactions and aid their incorporation into future improvement of beta-blocker therapy.	[Wang, Mingxuan; Bai, Jing; Chen, Wei Ning; Ching, Chi Bun] Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wang, MX (corresponding author), Nanyang Technol Univ, Coll Engn, Sch Chem & Biomed Engn, Singapore, Singapore.	WNChen@ntu.edu.sg	bai, jing/R-1506-2016	, Yang/0000-0002-6620-8897	Ministry of Education, Singapore	Ministry of Education, Singapore(Ministry of Education, Singapore)	Financial support was provided by Academic Research Funds, Ministry of Education, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTSCH W, 1990, EUR J CLIN PHARMACOL, V38, pS104, DOI 10.1007/BF01409475; Bian K, 2008, J CLIN HYPERTENS, V10, P304, DOI 10.1111/j.1751-7176.2008.06632.x; BOLTON TB, 1979, PHYSIOL REV, V59, P606, DOI 10.1152/physrev.1979.59.3.606; Chrysanthopoulos PK, 2010, METAB ENG, V12, P212, DOI 10.1016/j.ymben.2009.11.001; Danielsson APH, 2010, ANAL BIOCHEM, V404, P30, DOI 10.1016/j.ab.2010.04.013; Devantier R, 2005, BIOTECHNOL BIOENG, V90, P703, DOI 10.1002/bit.20457; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Fernandez C, 2008, J PROTEOME RES, V7, P400, DOI 10.1021/pr070547d; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162; FILO RS, 1965, SCIENCE, V147, P1581, DOI 10.1126/science.147.3665.1581; Gagyi L, 2008, J BIOCHEM BIOPH METH, V70, P1268, DOI 10.1016/j.jbbm.2007.10.004; Jalil JE, 2008, HYPERTENSION, V51, P626, DOI 10.1161/HYPERTENSIONAHA.107.104133; Koller A, 2003, BIOCHEM BIOPH RES CO, V300, P155, DOI 10.1016/S0006-291X(02)02799-7; Kumar A, 2010, J BIOSCIENCES, V35, P21, DOI 10.1007/s12038-010-0004-8; Lincoln TM, 2001, J APPL PHYSIOL, V91, P1421, DOI 10.1152/jappl.2001.91.3.1421; Mal M, 2009, RAPID COMMUN MASS SP, V23, P487, DOI 10.1002/rcm.3898; Mayr M, 2008, CIRC RES, V102, P1046, DOI 10.1161/CIRCRESAHA.108.174623; Mishra RC, 2008, HYPERTENSION, V51, P791, DOI 10.1161/HYPERTENSIONAHA.107.099598; Nakajima T, 2003, JPN HEART J, V44, P963, DOI 10.1536/jhj.44.963; Naseem Khalid M., 2005, Molecular Aspects of Medicine, V26, P33, DOI 10.1016/j.mam.2004.09.003; ODDIS CV, 1995, BIOCHEM BIOPH RES CO, V213, P1002, DOI 10.1006/bbrc.1995.2228; OHLSTEIN EH, 1993, P NATL ACAD SCI USA, V90, P6189, DOI 10.1073/pnas.90.13.6189; Rainaldi G, 2008, RADIAT RES, V169, P170, DOI 10.1667/RR0958.1; RAVNIKAR PD, 1987, J BACTERIOL, V169, P2611, DOI 10.1128/jb.169.6.2611-2617.1987; Ruffolo RR, 1997, CARDIOVASC DRUG THER, V11, P247; SMITH DF, 1989, PHARMACOL TOXICOL, V65, P321, DOI 10.1111/j.1600-0773.1989.tb01182.x; Sui JJ, 2008, MOL PHARMACEUT, V5, P885, DOI 10.1021/mp800012x; Sui JJ, 2008, MOL CELL PROTEOMICS, V7, P1007, DOI 10.1074/mcp.M700485-MCP200; Sui JJ, 2007, J PROTEOME RES, V6, P1643, DOI 10.1021/pr0605926; Sui J, 2010, RAPID COMMUN MASS SP, V24, P1717, DOI 10.1002/rcm.4565; Taccetta-Chapnick Marie, 2002, Crit Care Nurse, V22, P36; TACCETTACHAPNIC.M, 2002, CRIT CARE NURSE, V22, P48; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; TAKEDA S, 1993, ANTICANCER RES, V13, P193; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; VANBREEMEN C, 1989, ANNU REV PHYSIOL, V51, P315, DOI 10.1146/annurev.physiol.51.1.315; Wallukat G, 2002, HERZ, V27, P683, DOI 10.1007/s00059-002-2434-z; Wang MX, 2010, J PROTEOMICS, V73, P1601, DOI 10.1016/j.jprot.2010.03.015; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Zhu WF, 2005, J BIOL CHEM, V280, P29543, DOI 10.1074/jbc.M501238200; 1996, CIRCULATION, V94, P592	42	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15441	10.1371/journal.pone.0015441	http://dx.doi.org/10.1371/journal.pone.0015441			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124793	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000026
J	Adamaszek, M; Khaw, AV; Buck, U; Andresen, B; Thomasius, R				Adamaszek, Michael; Khaw, Alexander V.; Buck, Ulrike; Andresen, Burghard; Thomasius, Rainer			Evidence of Neurotoxicity of Ecstasy: Sustained Effects on Electroencephalographic Activity in Polydrug Users	PLOS ONE			English	Article							COGNITIVE PERFORMANCE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; EEG; IMPAIRMENT; MOOD	Objective: According to previous EEG reports of indicative disturbances in Alpha and Beta activities, a systematic search for distinct EEG abnormalities in a broader population of Ecstasy users may especially corroborate the presumed specific neurotoxicity of Ecstasy in humans. Methods: 105 poly-drug consumers with former Ecstasy use and 41 persons with comparable drug history without Ecstasy use, and 11 drug naives were investigated for EEG features. Conventional EEG derivations of 19 electrodes according to the 10-20-system were conducted. Besides standard EEG bands, quantitative EEG analyses of 1-Hz-subdivided power ranges of Alpha, Theta and Beta bands have been considered. Results: Ecstasy users with medium and high cumulative Ecstasy doses revealed an increase in Theta and lower Alpha activities, significant increases in Beta activities, and a reduction of background activity. Ecstasy users with low cumulative Ecstasy doses showed a significant Alpha activity at 11 Hz. Interestingly, the spectral power of low frequencies in medium and high Ecstasy users was already significantly increased in the early phase of EEG recording. Statistical analyses suggested the main effect of Ecstasy to EEG results. Conclusions: Our data from a major sample of Ecstasy users support previous data revealing alterations of EEG frequency spectrum due rather to neurotoxic effects of Ecstasy on serotonergic systems in more detail. Accordingly, our data may be in line with the observation of attentional and memory impairments in Ecstasy users with moderate to high misuse. Despite the methodological problem of polydrug use also in our approach, our EEG results may be indicative of the neuropathophysiological background of the reported memory and attentional deficits in Ecstasy abusers. Overall, our findings may suggest the usefulness of EEG in diagnostic approaches in assessing neurotoxic sequela of this common drug abuse.	[Adamaszek, Michael] Univ Leipzig, Neurol Rehabil Zentrum Leipzig, Bennewitz, Germany; [Adamaszek, Michael; Andresen, Burghard; Thomasius, Rainer] Univ Med Ctr Hamburg Eppendorf, Clin Psychiat & Psychotherapy, Hamburg, Germany; [Khaw, Alexander V.] Ernst Moritz Arndt Univ Greifswald, Dept Neurol, Greifswald, Germany; [Buck, Ulrike] Hosp Rissen, Dept Psychiat, Hamburg, Germany; [Thomasius, Rainer] Univ Med Ctr Hamburg Eppendorf, Deutsch Zentrum Suchtfragen Kindes & Jugendalter, Hamburg, Germany	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Ernst Moritz Arndt Universitat Greifswald; University of Hamburg; University Medical Center Hamburg-Eppendorf	Adamaszek, M (corresponding author), Univ Leipzig, Neurol Rehabil Zentrum Leipzig, Bennewitz, Germany.	michael.adamaszek@sachsenklinik.de			Federal Institute for Drugs and Medical Devices, Germany [FZ: Z12.01-68503-206]	Federal Institute for Drugs and Medical Devices, Germany	The study was supported by the Federal Institute for Drugs and Medical Devices (FZ: Z12.01-68503-206), Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENTE D, 1982, ORGANIC PSYCHOSYNDRO; Capela JP, 2007, NEUROTOXICOLOGY, V28, P868, DOI 10.1016/j.neuro.2007.04.005; Cowan RL, 2007, PSYCHOPHARMACOLOGY, V189, P539, DOI 10.1007/s00213-006-0467-3; Croft RJ, 2001, AM J PSYCHIAT, V158, P1687, DOI 10.1176/appi.ajp.158.10.1687; Dafters RI, 1999, PSYCHOPHARMACOLOGY, V145, P82, DOI 10.1007/s002130051035; de Sola S, 2008, PSYCHOPHARMACOLOGY, V200, P425, DOI 10.1007/s00213-008-1217-5; DOLAN RJ, 1997, HUMAN BRAIN FUNCTION, P405; FISCHER C, 1995, J NEUROSCI, V15, P5476; Gamma A, 2000, NEUROREPORT, V11, P157, DOI 10.1097/00001756-200001170-00031; Gouzoulis-Mayfrank E, 2000, J NEUROL NEUROSUR PS, V68, P719, DOI 10.1136/jnnp.68.6.719; Gouzoulis-Mayfrank E, 2006, J PSYCHOPHARMACOL, V20, P188, DOI 10.1177/0269881106059939; Hatzidimitriou G, 1999, J NEUROSCI, V19, P5096; HERRMANN WM, 1988, Z GERONTOPSYCHOL PSY, V1, P1; INSEL TR, 1989, J PHARMACOL EXP THER, V249, P713; LUCAS RA, 1992, INT J OBESITY, V16, pS49; LUU P, 2003, COGNITIVE ELECTROPHY, P199; McCann UD, 1998, LANCET, V352, P1433, DOI 10.1016/S0140-6736(98)04329-3; MCKENNA DJ, 1990, J NEUROCHEM, V54, P14, DOI 10.1111/j.1471-4159.1990.tb13277.x; Meyer JS, 2006, ANN NY ACAD SCI, V1074, P365, DOI 10.1196/annals.1369.036; Morgan MJ, 1999, PSYCHOPHARMACOLOGY, V141, P30, DOI 10.1007/s002130050803; NYSTROM C, 1988, ACTA PSYCHIAT SCAND, V77, P457, DOI 10.1111/j.1600-0447.1988.tb05151.x; OKEN BS, 1992, J CLIN NEUROPHYSIOL, V9, P480, DOI 10.1097/00004691-199210000-00003; Olbrich S, 2009, NEUROIMAGE, V45, P319, DOI 10.1016/j.neuroimage.2008.11.014; Reneman L, 2006, J PSYCHOPHARMACOL, V20, P164, DOI 10.1177/0269881106061515; RICAURTE GA, 1988, BRAIN RES, V446, P165, DOI 10.1016/0006-8993(88)91309-1; Robbins Trevor W., 1995, P703; Robertson IH, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P631; SATO N, NEUROREPORT; Struder HK, 2001, INT J SPORTS MED, V22, P482, DOI 10.1055/s-2001-17606; Thomasius R, 2006, J PSYCHOPHARMACOL, V20, P211, DOI 10.1177/0269881106059486; Thomasius R, 1997, FORTSCHR NEUROL PSYC, V65, P49, DOI 10.1055/s-2007-996309; THOMASIUS R, 2000, ECSTASY STUDY HLTH P; Tuchtenhagen F, 2000, NEUROPSYCHOPHARMACOL, V22, P608, DOI 10.1016/S0893-133X(99)00140-2; Verkes RJ, 2001, PSYCHOPHARMACOLOGY, V153, P196, DOI 10.1007/s002130000563; Zakzanis KK, 2001, NEUROLOGY, V56, P966, DOI 10.1212/WNL.56.7.966	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14097	10.1371/journal.pone.0014097	http://dx.doi.org/10.1371/journal.pone.0014097			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124854	Green Published, Green Submitted, gold			2022-12-27	WOS:000284527900010
J	Wang, ZY; Matsudaira, P; Gong, ZY				Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan			STORM: A General Model to Determine the Number and Adaptive Changes of Epithelial Stem Cells in Teleost, Murine and Human Intestinal Tracts	PLOS ONE			English	Article							COLORECTAL-CANCER; MOLECULAR-BIOLOGY; COLONIC CRYPT; GOBLET CELLS; DIFFERENTIATION; PROLIFERATION; ZEBRAFISH; MIGRATION; LINEAGE; GROWTH	Intestinal stem cells play a pivotal role in the epithelial tissue renewal, homeostasis and cancer development. The lack of a general marker for intestinal stem cells across species has hampered analysis of stem cell number in different species and their adaptive changes upon intestinal lesions or during development of cancer. Here a two-dimensional model, named STORM, has been developed to address this issue. By optimizing epithelium renewal dynamics, the model examines the epithelial stem cell number by taking experimental input information regarding epithelium proliferation and differentiation. As the results suggest, there are 2.0-4.1 epithelial stem cells on each pocket section of zebrafish intestine, 2.0-4.1 stem cells on each crypt section of murine small intestine and 1.8-3.5 stem cells on each crypt section of human duodenum. The model is able to provide quick results for stem cell number and its adaptive changes, which is not easy to measure through experiments. Its general applicability to different species makes it a valuable tool for analysis of intestinal stem cells under various pathological conditions.	[Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan] Singapore MIT Alliance, Singapore, Singapore; [Wang, Zhengyuan; Matsudaira, Paul; Gong, Zhiyuan] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Wang, Zhengyuan; Matsudaira, Paul] Natl Univ Singapore, Ctr BioImaging Sci, Singapore 117548, Singapore	Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Singapore-MIT Alliance for Research & Technology Centre (SMART); National University of Singapore; National University of Singapore	Wang, ZY (corresponding author), Singapore MIT Alliance, Singapore, Singapore.	wzhengyuan@gmail.com	wang, zhengyuan/HGA-0435-2022; Gong, Zhiyuan/H-8794-2012; Wang, Zhengyuan/GWV-6069-2022; Matsudaira, Paul/H-1475-2012	wang, zhengyuan/0000-0002-8447-9674; Gong, Zhiyuan/0000-0002-9660-5260; Matsudaira, Paul/0000-0002-8399-3276	Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore	Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore	The authors would like to thank Singapore-MIT Alliance and Department of Biological Sciences of National University of Singapore for support of this work.	Ahuja V, 2006, CURR OPIN GASTROEN, V22, P90, DOI 10.1097/01.mog.0000203865.25384.65; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Biasco G, 2004, HUM PATHOL, V35, P622, DOI 10.1016/j.humpath.2004.01.018; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2001, P NATL ACAD SCI USA, V98, P12497, DOI 10.1073/pnas.211278098; Boman BM, 2001, CANCER RES, V61, P8408; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Booth C, 2004, CELL PROLIFERAT, V37, P385, DOI 10.1111/j.1365-2184.2004.00320.x; BRANSOM CJ, 1981, GUT, V22, P277, DOI 10.1136/gut.22.4.277; Crosnier C, 2005, DEVELOPMENT, V132, P1093, DOI 10.1242/dev.01644; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; d'Onofrio A, 2007, J THEOR BIOL, V244, P367, DOI 10.1016/j.jtbi.2006.08.022; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; GALHAARD H, 1972, EXP CELL RES, V72, P197; Gerike TG, 1998, CELL PROLIFERAT, V31, P93, DOI 10.1046/j.1365-2184.1998.00113.x; GORELICK F, 1979, GASTROENTEROLOGY, V76, P1141; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; He XC, 2005, ANN NY ACAD SCI, V1049, P28, DOI 10.1196/annals.1334.005; Ishizuya-Oka A, 2007, DEV GROWTH DIFFER, V49, P99, DOI 10.1111/j.1440-169x.2007.00913.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Johnston MD, 2007, P NATL ACAD SCI USA, V104, P4008, DOI 10.1073/pnas.0611179104; Li X, 2007, PHYSIOL GENOMICS, V29, P290, DOI 10.1152/physiolgenomics.00269.2006; LI YQ, 1994, J CELL SCI, V107, P3271; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; MACDONALD WC, 1964, GASTROENTEROLOGY, V46, P405; McGarvey MA, 2007, DIGEST DIS SCI, V52, P2087, DOI 10.1007/s10620-006-9197-y; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Michor F, 2005, SEMIN CANCER BIOL, V15, P484, DOI 10.1016/j.semcancer.2005.06.005; Mills JC, 2001, P NATL ACAD SCI USA, V98, P12334, DOI 10.1073/pnas.231487198; Ng ANY, 2005, DEV BIOL, V286, P114, DOI 10.1016/j.ydbio.2005.07.013; PAULUS U, 1992, CELL PROLIFERAT, V25, P559, DOI 10.1111/j.1365-2184.1992.tb01460.x; PAULUS U, 1993, J CELL SCI, V106, P473; Pinto D, 2005, BIOL CELL, V97, P185; POTTEN C, 2004, APOPTOSIS LIFE DEATH, P136; POTTEN CS, 1984, SCAND J GASTROENTERO, V19, P3; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; POTTEN CS, 1990, DEVELOPMENT, V110, P1001; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; Rubin DC, 2007, CURR OPIN GASTROEN, V23, P111, DOI 10.1097/MOG.0b013e3280145082; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; TOMLINSON IPM, 1995, P NATL ACAD SCI USA, V92, P11130, DOI 10.1073/pnas.92.24.11130; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wallace KN, 2005, MECH DEVELOP, V122, P157, DOI 10.1016/j.mod.2004.10.009; Wallace KN, 2003, DEV BIOL, V255, P12, DOI 10.1016/S0012-1606(02)00034-9; Walters JRF, 2004, CURR OPIN GASTROEN, V20, P70, DOI 10.1097/00001574-200403000-00004; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; WINTON DJ, 1988, NATURE, V333, P463, DOI 10.1038/333463a0; Yang K, 2008, CANCER RES, V68, P7313, DOI 10.1158/0008-5472.CAN-08-0598; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; [No title captured]	60	9	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14063	10.1371/journal.pone.0014063	http://dx.doi.org/10.1371/journal.pone.0014063			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124758	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100012
J	Yovel, Y; Au, WWL				Yovel, Yossi; Au, Whitlow W. L.			How Can Dolphins Recognize Fish According to Their Echoes? A Statistical Analysis of Fish Echoes	PLOS ONE			English	Article							TURSIOPS-TRUNCATUS; PREY SELECTION; ECHOLOCATION; BAT; DISCRIMINATION; TARGETS	Echo-based object classification is a fundamental task of animals that use a biosonar system. Dolphins and porpoises should be able to rely on echoes to discriminate a predator from a prey or to select a desired prey from an undesired object. Many studies have shown that dolphins and porpoises can discriminate between objects according to their echoes. All of these studies however, used unnatural objects that can be easily characterized in human terminologies (e. g., metallic spheres, disks, cylinders). In this work, we collected real fish echoes from many angles of acquisition using a sonar system that mimics the emission properties of dolphins and porpoises. We then tested two alternative statistical approaches in classifying these echoes. Our results suggest that fish species can be classified according to echoes returning from porpoise- and dolphin-like signals. These results suggest how dolphins and porpoises can classify fish based on their echoes and provide some insight as to which features might enable the classification.	[Yovel, Yossi] Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel; [Au, Whitlow W. L.] Univ Hawaii, Hawaii Inst Marine Biol, Marine Mammal Res Program, Kailua, HI USA	Tel Aviv University; University of Hawaii System	Yovel, Y (corresponding author), Tel Aviv Univ, Dept Zool, IL-69978 Tel Aviv, Israel.	yossiyovel@hotmail.com		Yovel, Yossi/0000-0001-5429-9245	US Office of Naval Research; Netherlands Ministry for Agriculture, Nature, and Food Quality [418]	US Office of Naval Research(Office of Naval Research); Netherlands Ministry for Agriculture, Nature, and Food Quality	This work was supported by the US Office of Naval Research, Mardi Hastings, Program Manager, and the Netherlands Ministry for Agriculture, Nature, and Food Quality (DKW-program 418: North Sea and Coast). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Au W.W.L., 2008, PRINCIPLES MARINE BI; Au WWL, 2009, J ACOUST SOC AM, V126, P460, DOI 10.1121/1.3147497; Aubauer R, 2000, J ACOUST SOC AM, V107, P2750, DOI 10.1121/1.428661; Boonman A, 2007, BIOL CYBERN, V97, P159, DOI 10.1007/s00422-007-0164-2; Cristianini N, 2000, INTRO SUPPORT VECTOR; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Ibsen SD, 2009, J ACOUST SOC AM, V125, P1214, DOI 10.1121/1.3050274; McCabe EJB, 2010, MAR BIOL, V157, P931, DOI 10.1007/s00227-009-1371-2; Muller R, 2000, J ACOUST SOC AM, V108, P836, DOI 10.1121/1.429617; Popov VV, 1997, J ACOUST SOC AM, V102, P1169, DOI 10.1121/1.419935; Scholkopf B., 2002, LEARNING KERNELS; Siemers BM, 2004, NATURE, V429, P657, DOI 10.1038/nature02547; SIMMONS JA, 1971, J EXP ZOOL, V176, P315, DOI 10.1002/jez.1401760307; Witteveen BH, 2008, MAR MAMMAL SCI, V24, P516, DOI 10.1111/j.1748-7692.2008.00193.x; Yovel Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000032; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000429; Yovel Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000400	18	13	14	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14054	10.1371/journal.pone.0014054	http://dx.doi.org/10.1371/journal.pone.0014054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124908	Green Published, Green Submitted, gold			2022-12-27	WOS:000284400100006
J	Johnson, JA; Talbot, SL; Sage, GK; Burnham, KK; Brown, JW; Maechtle, TL; Seegar, WS; Yates, MA; Anderson, B; Mindell, DP				Johnson, Jeff A.; Talbot, Sandra L.; Sage, George K.; Burnham, Kurt K.; Brown, Joseph W.; Maechtle, Tom L.; Seegar, William S.; Yates, Michael A.; Anderson, Bud; Mindell, David P.			The Use of Genetics for the Management of a Recovering Population: Temporal Assessment of Migratory Peregrine Falcons in North America	PLOS ONE			English	Article							MICROSATELLITE DNA; ALLELE FREQUENCIES; ENVIRONMENTAL CONTAMINANTS; EFFECTIVE SIZE; CENSUS SIZE; CONSERVATION; PROGRAM; DIVERSITY; G(ST); DIFFERENTIATION	Background: Our ability to monitor populations or species that were once threatened or endangered and in the process of recovery is enhanced by using genetic methods to assess overall population stability and size over time. This can be accomplished most directly by obtaining genetic measures from temporally-spaced samples that reflect the overall stability of the population as given by changes in genetic diversity levels (allelic richness and heterozygosity), degree of population differentiation (F-ST and D-EST), and effective population size (Ne). The primary goal of any recovery effort is to produce a long-term self-sustaining population, and these genetic measures provide a metric by which we can gauge our progress and help make important management decisions. Methodology/Principal Findings: The peregrine falcon in North America (Falco peregrinus tundrius and anatum) was delisted in 1994 and 1999, respectively, and its abundance will be monitored by the species Recovery Team every three years until 2015. Although the United States Fish and Wildlife Service makes a distinction between tundrius and anatum subspecies, our genetic results based on eleven microsatellite loci suggest limited differentiation that can be attributed to an isolation by distance relationship and warrant no delineation of these two subspecies in its northern latitudinal distribution from Alaska through Canada into Greenland. Using temporal samples collected at Padre Island, Texas during migration (seven temporal time periods between 1985-2007), no significant differences in genetic diversity or significant population differentiation in allele frequencies between time periods were observed and were indistinguishable from those obtained from tundrius/anatum breeding locations throughout their northern distribution. Estimates of harmonic mean Ne were variable and imprecise, but always greater than 500 when employing multiple temporal genetic methods. Conclusions/Significance: These results, including those from simulations to assess the power of each method to estimate Ne, suggest a stable or growing population, which is consistent with ongoing field-based monitoring surveys. Therefore, historic and continuing efforts to prevent the extinction of the peregrine falcon in North America appear successful with no indication of recent decline, at least from the northern latitude range-wide perspective. The results also further highlight the importance of archiving samples and their use for continual assessment of population recovery and long-term viability.	[Johnson, Jeff A.] Univ N Texas, Inst Appl Sci, Dept Biol Sci, Denton, TX 76203 USA; [Talbot, Sandra L.; Sage, George K.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK USA; [Burnham, Kurt K.] High Arctic Inst, Orion, IL USA; [Brown, Joseph W.] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Maechtle, Tom L.] Sheridan, Sheridan, WY USA; [Seegar, William S.] Edgewood Res Dev & Engn Ctr, Dept Army, Aberdeen Proving Ground, MD USA; [Yates, Michael A.] Boise State Univ, Raptor Res Ctr, Minden, NV USA; [Anderson, Bud] Falcon Res Grp, Bow, WA USA; [Mindell, David P.] Calif Acad Sci, San Francisco, CA 94118 USA	University of North Texas System; University of North Texas Denton; United States Department of the Interior; United States Geological Survey; Idaho; University of Idaho; Idaho; Boise State University; California Academy of Sciences	Johnson, JA (corresponding author), Univ N Texas, Inst Appl Sci, Dept Biol Sci, Denton, TX 76203 USA.	jajohnson@unt.edu	Brown, Joseph W/A-7713-2009; Talbot, Sandra L/C-9433-2011	Brown, Joseph W/0000-0002-3835-8062; 	U.S. Army's Edgewood Research Development and Engineering Center; Wolf Creek Charitable Foundation; Grassland Charitable Foundation; Ruth and Brian Mutch; North American Falconers' Association; Offield Family Foundation; Peregrine Fund; U.S. Geological Survey Alaska Science Center	U.S. Army's Edgewood Research Development and Engineering Center; Wolf Creek Charitable Foundation; Grassland Charitable Foundation; Ruth and Brian Mutch; North American Falconers' Association; Offield Family Foundation; Peregrine Fund; U.S. Geological Survey Alaska Science Center(United States Geological Survey)	Funding for field work and sample collection was generously provided by the U.S. Army's Edgewood Research Development and Engineering Center, The Wolf Creek Charitable Foundation, The Grassland Charitable Foundation, Ruth and Brian Mutch, the North American Falconers' Association, The Offield Family Foundation, and The Peregrine Fund. Funding for the genetic portion of this study was provided by The Peregrine Fund and the U.S. Geological Survey Alaska Science Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE RE, 2003, RETURN PEREGRINE, P189; Antao T, 2011, EVOL APPL, V4, P144, DOI 10.1111/j.1752-4571.2010.00150.x; Backstroem N, 2008, MOL ECOL, V17, P964, DOI 10.1111/j.1365-294X.2007.03551.x; Balloux F, 2000, EVOLUTION, V54, P1414, DOI 10.1111/j.0014-3820.2000.tb00573.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Berger D. D., 1969, P165; BERRY RB, 2003, RETURN PEREGRINE, P35; Berthier P, 2002, GENETICS, V160, P741; Brown JW, 2007, MOL ECOL, V16, P327, DOI 10.1111/j.1365-294X.2007.03151.x; BURNHAM KK, 2010, BIOSCIENCE IN PRESS; BURNHAM W, 2003, RETURN PEREGRINE, P127; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; CABALLERO IC, 2006, FORTH N AM ORN C VER; Cade T. J., 1982, FALCONS WORLD; CADE TJ, 1971, SCIENCE, V172, P955, DOI 10.1126/science.172.3986.955; Cade TJ, 2003, RETURN PEREGRINE N A; CADE TJ, 2000, REINTRODUCTION NEWS, V19, P19; Cade Tom J., 1996, P3, DOI 10.1016/B978-012100130-8/50003-1; CHAO A, SPADE; Chen C, 2007, MOL ECOL NOTES, V7, P747, DOI 10.1111/j.1471-8286.2007.01769.x; Dawnay N, 2009, FORENSIC SCI INT-GEN, V3, pE63, DOI 10.1016/j.fsigen.2008.07.001; De Barba M, 2010, MOL ECOL, V19, P3938, DOI 10.1111/j.1365-294X.2010.04791.x; Demandt MH, 2010, CONSERV GENET, V11, P249, DOI 10.1007/s10592-009-0027-6; DeYoung RW, 2003, MOL ECOL, V12, P3237, DOI 10.1046/j.1365-294X.2003.01996.x; Durand E, 2009, MOL BIOL EVOL, V26, P1963, DOI 10.1093/molbev/msp106; Eckert CG, 2008, MOL ECOL, V17, P1170, DOI 10.1111/j.1365-294X.2007.03659.x; Edmands S, 2007, MOL ECOL, V16, P463, DOI 10.1111/j.1365-294X.2006.03148.x; Eldridge WH, 2007, MOL ECOL, V16, P2407, DOI 10.1111/j.1365-294X.2007.03271.x; Enderson J. H., 1969, P73; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Ewing SR, 2008, CONSERV BIOL, V22, P395, DOI 10.1111/j.1523-1739.2008.00884.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falk K., 1988, P37; Falush D, 2003, GENETICS, V164, P1567; Farmer Christopher J., 2008, P303; Ferguson-Lees J, 2001, RAPTORS WORLD; Fitzpatrick BM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-176; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Francois O, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000075; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; Fuller MR, 1998, J AVIAN BIOL, V29, P433, DOI 10.2307/3677162; Fyfe R., 1969, P101; FYFE R W, 1976, Canadian Field-Naturalist, V90, P228; Gautschi B, 2003, HEREDITY, V91, P9, DOI 10.1038/sj.hdy.6800278; Gerlach G, 2010, MOL ECOL, V19, P3845, DOI 10.1111/j.1365-294X.2010.04784.x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Green M., 2006, BIOL TECHNICAL PUBLI; Groombridge JJ, 2000, NATURE, V403, P616, DOI 10.1038/35001148; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; HALL D, 2005, COMMUNICATION   0127; Hansson B, 2000, MOL ECOL, V9, P1529, DOI 10.1046/j.1365-294x.2000.01028.x; Heller R, 2009, MOL ECOL, V18, P2080, DOI 10.1111/j.1365-294X.2009.04185.x; Henny CJ, 2009, J RAPTOR RES, V43, P37, DOI 10.3356/JRR-08-45.1; HILL WG, 1981, GENET RES, V38, P209, DOI 10.1017/S0016672300020553; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jacobsen F, 2008, CONSERV GENET, V9, P581, DOI 10.1007/s10592-007-9373-4; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JEFFERIES D. J., 1966, BRIT BIRDS, V59, P49; JENSEN JL, BMC GENETICS, V6, P13; Johnson JA, 2004, MOL ECOL, V13, P2617, DOI 10.1111/j.1365-294X.2004.02264.x; Johnson JA, 2008, BIOL CONSERV, V141, P2403, DOI 10.1016/j.biocon.2008.07.001; Johnson JA, 2007, MOL ECOL, V16, P3145, DOI 10.1111/j.1365-294X.2007.03373.x; Jorde PE, 2007, GENETICS, V177, P927, DOI 10.1534/genetics.107.075481; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Jost L, 2009, MOL ECOL, V18, P2088, DOI 10.1111/j.1365-294X.2009.04186.x; Keller LF, 2001, P ROY SOC B-BIOL SCI, V268, P1387, DOI 10.1098/rspb.2001.1607; Kiff L.F., 1988, P123; KRIMBAS CB, 1971, EVOLUTION, V25, P454, DOI 10.1111/j.1558-5646.1971.tb01904.x; Kuo CH, 2003, MOL ECOL NOTES, V3, P669, DOI 10.1046/j.1471-8286.2003.00532.x; Laikre L, 2010, CONSERV BIOL, V24, P86, DOI 10.1111/j.1523-1739.2009.01425.x; Laikre L, 2009, CONSERV BIOL, V23, P1378, DOI 10.1111/j.1523-1739.2009.01360.x; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Leberg P, 2005, J WILDLIFE MANAGE, V69, P1385, DOI 10.2193/0022-541X(2005)69[1385:GAFETE]2.0.CO;2; Leberg PL, 2002, MOL ECOL, V11, P2445, DOI 10.1046/j.1365-294X.2002.01612.x; LERNER HRL, 2009, PLOS ONE, V4, pNI102, DOI DOI 10.1371/J0URNAL.P0NE.0007336); Lewis PO, 2001, GENETIC DATA ANAL GD; Lindberg P., 1988, P619; Lott CA, 2006, J RAPTOR RES, V40, P200, DOI 10.3356/0892-1016(2006)40[200:ANRMMS]2.0.CO;2; Luikart G, 1999, CONSERV BIOL, V13, P523, DOI 10.1046/j.1523-1739.1999.98133.x; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; MASEVEU OB, 2009, TUNDRA TROPICS CONNE, P171; McGrady MJ, 2002, CONDOR, V104, P39, DOI 10.1650/0010-5422(2002)104[0039:MAROPF]2.0.CO;2; Mora M, 2002, ENVIRON POLLUT, V116, P169, DOI 10.1016/S0269-7491(01)00207-X; Mora MA, 2007, SOUTHWEST NAT, V52, P54, DOI 10.1894/0038-4909(2007)52[54:FAOECI]2.0.CO;2; MORGENWECK R, 2005, COMMUNICATION   0311; Morin PA, 2004, TRENDS ECOL EVOL, V19, P208, DOI 10.1016/j.tree.2004.01.009; Morin PA, 2009, MOL ECOL RESOUR, V9, P66, DOI 10.1111/j.1755-0998.2008.02392.x; NELSON RW, 1990, CAN FIELD NAT, V104, P193; Nesje M, 2000, ANIM CONSERV, V3, P267; Nesje M, 2000, MOL ECOL, V9, P53, DOI 10.1046/j.1365-294x.2000.00834.x; Newton I., 1988, P761; Ortego J, 2007, BIOL LETTERS, V3, P585, DOI 10.1098/rsbl.2007.0268; Ovenden JR, 2007, MOL ECOL, V16, P127, DOI 10.1111/j.1365-294X.2006.03132.x; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; PEAKALL DB, 1976, BIRD STUDY, V23, P183; Pertoldi C, 2001, P ROY SOC B-BIOL SCI, V268, P1775, DOI 10.1098/rspb.2001.1762; POLLAK E, 1983, GENETICS, V104, P531; Poulsen NA, 2006, MOL ECOL, V15, P321, DOI 10.1111/j.1365-294X.2005.02777.x; Pritchard JK, 2000, GENETICS, V155, P945; RATCLIFF.DA, 1967, NATURE, V215, P208, DOI 10.1038/215208a0; Ratcliffe D.A., 1993, PEREGRINE FALCON; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Ryman N, 2009, MOL ECOL, V18, P2084, DOI 10.1111/j.1365-294X.2009.04187.x; SCHMUTZ JK, 1991, WILSON BULL, V103, P44; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Septon Greg, 2000, P455; SMITH JP, 2008, SERIES ORNITHOLOGY, V3, P253; Soule ME, 2005, BIOSCIENCE, V55, P168, DOI 10.1641/0006-3568(2005)055[0168:SISCPM]2.0.CO;2; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; TALBOT SL, 2010, AVIAN BIOL IN PRESS; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Temple S.A., 1988, P843; TEMPLE SA, 1988, P INT S RAPT REINTR, P17; Tordoff HB, 1997, J RAPTOR RES, V31, P339; Tordoff HB, 2001, CONSERV BIOL, V15, P528, DOI 10.1046/j.1523-1739.2001.015002528.x; Turner TF, 2006, P R SOC B, V273, P3065, DOI 10.1098/rspb.2006.3677; Turner TF, 2001, CONSERV GENET, V2, P297, DOI 10.1023/A:1012538611944; *US FISH WILD SERV, 2003, MON PLAN AM PER FALC; *US FISH WILDL SER, 2008, FIN ENV ASS MAN PLAN; Vernesi C, 2003, MOL ECOL, V12, P585, DOI 10.1046/j.1365-294X.2003.01763.x; Vila C, 2003, P ROY SOC B-BIOL SCI, V270, P91, DOI 10.1098/rspb.2002.2184; Wakamiya SM, 2009, BIOL CONSERV, V142, P1767, DOI 10.1016/j.biocon.2009.03.015; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Wang JL, 1999, HEREDITY, V82, P212, DOI 10.1038/sj.hdy.6884670; Wang JL, 2001, GENET RES, V78, P243, DOI 10.1017/S0016672301005286; Wang JL, 2003, GENETICS, V163, P429; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2006, CONSERV GENET, V7, P167, DOI 10.1007/s10592-005-9100-y; Waples RS, 2006, MOL ECOL, V15, P1419, DOI 10.1111/j.1365-294X.2006.02890.x; WAPLES RS, 1990, J HERED, V81, P277, DOI 10.1093/oxfordjournals.jhered.a110990; WAPLES RS, 1989, GENETICS, V121, P379; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White C.M., 1988, P789; White C. M., 2002, BIRDS N AM; WHITE CM, 1973, CONDOR, V75, P306, DOI 10.2307/1366171; WHITE CM, 1968, AUK, V85, P179, DOI 10.2307/4083579; 2008, FED REG, V73, P74508	143	16	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14042	10.1371/journal.pone.0014042	http://dx.doi.org/10.1371/journal.pone.0014042			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124969	Green Submitted, gold, Green Published			2022-12-27	WOS:000284356900005
J	Tinnemann, P; Ozbay, J; Saint, VA; Willich, SN				Tinnemann, Peter; Oezbay, Jonas; Saint, Victoria A.; Willich, Stefan N.			Patenting of University and Non-University Public Research Organisations in Germany: Evidence from Patent Applications for Medical Research Results	PLOS ONE			English	Article								Background: Patents are one of the most important forms of intellectual property. They grant a time-limited exclusivity on the use of an invention allowing the recuperation of research costs. The use of patents is fiercely debated for medical innovation and especially controversial for publicly funded research, where the patent holder is an institution accountable to public interest. Despite this controversy, for the situation in Germany almost no empirical information exists. The purpose of this study is to examine the amount, types and trends of patent applications for health products submitted by German public research organisations. Methods/Principal Findings: We conducted a systematic search for patent documents using the publicly accessible database search interface of the German Patent and Trademark Office. We defined keywords and search criteria and developed search patterns for the database request. We retrieved documents with application date between 1988 and 2006 and processed the collected data stepwise to compile the most relevant documents in patent families for further analysis. We developed a rationale and present individual steps of a systematic method to request and process patent data from a publicly accessible database. We retrieved and processed 10194 patent documents. Out of these, we identified 1772 relevant patent families, applied for by 193 different universities and non-university public research organisations. 827 (47%) of these patent families contained granted patents. The number of patent applications submitted by universities and university-affiliated institutions more than tripled since the introduction of legal reforms in 2002, constituting almost half of all patent applications and accounting for most of the post-reform increase. Patenting of most non-university public research organisations remained stable. Conclusions: We search, process and analyse patent applications from publicly accessible databases. Internationally mounting evidence questions the viability of policies to increase commercial exploitation of publicly funded research results. To evaluate the outcome of research policies a transparent evidence base for public debate is needed in Germany.	[Tinnemann, Peter; Oezbay, Jonas; Saint, Victoria A.; Willich, Stefan N.] Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Tinnemann, P (corresponding author), Charite Univ Med Ctr, Inst Social Med Epidemiol & Hlth Econ, Berlin, Germany.	Peter.Tinnemann@charite.de		Saint, Victoria/0000-0003-4663-1716; Tinnemann, Peter/0000-0003-3071-9772	Volkswagen Foundation; Rosa Luxemburg Foundation	Volkswagen Foundation(Volkswagen); Rosa Luxemburg Foundation	PT's research is funded by Volkswagen Foundation (http://www.volkswagen-stiftung.de). JO receives a scholarship of the Rosa Luxemburg Foundation (http://www.rosalux.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta M, 2009, REG STUD, V43, P1167, DOI 10.1080/00343400802154573; [Anonymous], MONITORING FINANCIAL; Azoulay P, 2007, NEW ENGL J MED, V357, P2049, DOI 10.1056/NEJMsa067417; Baldini N, 2010, TECHNOVATION, V30, P109, DOI 10.1016/j.technovation.2009.09.007; Baldini N, 2009, RES POLICY, V38, P1217, DOI 10.1016/j.respol.2009.06.013; *BUND BILD FORSCH, 2001, FORD BMBF VERW; *BUND JUST, 1957, GES ARB; Chapman AR, 2002, J INT ECON LAW, V5, P861, DOI 10.1093/jiel/5.4.861; Chokshi DA, 2006, PLOS MED, V3, P723, DOI 10.1371/journal.pmed.0030136; Chokshi DA, 2007, JAMA-J AM MED ASSOC, V298, P1934, DOI 10.1001/jama.298.16.1934; CLEMENTE F, 2002, AM OTHER DRUG PROBLE; DAVID PA, 2007, M EC DG RES EXP GROU; *DTSCH ARZT, 2010, KAB BESCHL ECKP ARZN; *DTSCH PAT MARK, 2008, JAH 2007; *DTSCH PAT MARK, 2005, DEPATISNET; Eisenberg RS, 2002, ACAD MED, V77, P1392, DOI 10.1097/00001888-200212001-00011; ETZKOWITZ H, 1983, MINERVA, V21, P198; FORMAN L, 2007, ETHICS INT AFFAIRS, V21, P357; GEIGER K, WILL HEALTHCARE LAW; GEUNA A, 2003, 99 SPRU; Geuna A, 2006, RES POLICY, V35, P790, DOI 10.1016/j.respol.2006.04.005; Godt Christine, 2007, EIGENTUM INFORM; Grover Anand, 2009, REPORT SPECIAL RAPPO; Kapczynski A., 2005, BERKELEY TECHNOLOGY, V20, P1031; Kirschenbaum SR, 2002, NAT NEUROSCI, V5, P1025, DOI 10.1038/nn932; Lehrer M, 2009, RES POLICY, V38, P268, DOI 10.1016/j.respol.2008.11.007; Light DW, 2006, MONITORING FINANCIAL, P27; MALIK T, 2006, PAR GLOB STRAT ALL B; *MED FAK BUND DEUT, 2009, LANDK HOCHSCH; Moschini G., 2006, 06WP432 IOW STAT U C; Mowery DC, 2001, RES POLICY, V30, P99, DOI 10.1016/S0048-7333(99)00100-6; Nelsen L, 1998, SCIENCE, V279, P1460, DOI 10.1126/science.279.5356.1460; Rai Arti K., 2003, LAW CONTEMP PROBL, V66, P289; RICHARD PR, 1998, J WORLD INTELLECTUAL, V1, P179; Sampat BN, 2009, AM J PUBLIC HEALTH, V99, P9, DOI 10.2105/AJPH.2007.128769; Saragossi S, 2003, J TECHNOLOGY TRANSFE, V28, P47, DOI DOI 10.1023/A:1021678719567; SCHMOCH U, 2000, WISSENS TECHNOLOGIET, P17; SCHMOCH U, 2007, PATENTANMELDUNGEN DT; Smith RD, 2009, LANCET, V373, P684, DOI 10.1016/S0140-6736(08)61779-1; So AD, 2008, PLOS BIOL, V6, P2078, DOI 10.1371/journal.pbio.0060262; *TECHN ALL, 2009, TECHN ALL UNS MITGL; VANOVERWALLE G, 2006, ETHICAL PERSPECT, V13, P231; *WHO, 2008, 6121 WHO WHA; Wong PK, 2010, SCIENTOMETRICS, V83, P271, DOI 10.1007/s11192-009-0003-4; *WORLD INT PROP OR, WORLD INT PROP ORG I; World Intellectual Property Organization, 1970, PAT COOP TREAT	46	5	5	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14059	10.1371/journal.pone.0014059	http://dx.doi.org/10.1371/journal.pone.0014059			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681XH	21124982	Green Published, gold, Green Submitted			2022-12-27	WOS:000284356900016
J	Price, DL; Rockenstein, E; Ubhi, K; Van, P; MacLean-Lewis, N; Askay, D; Cartier, A; Spencer, B; Patrick, C; Desplats, P; Ellisman, MH; Masliah, E				Price, Diana L.; Rockenstein, Edward; Ubhi, Kiren; Van Phung; MacLean-Lewis, Natalie; Askay, David; Cartier, Anna; Spencer, Brian; Patrick, Christina; Desplats, Paula; Ellisman, Mark H.; Masliah, Eliezer			Alterations in mGluR5 Expression and Signaling in Lewy Body Disease and in Transgenic Models of Alpha-Synucleinopathy - Implications for Excitotoxicity	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BASAL-GANGLIA; NEURODEGENERATIVE DISORDERS; UNSTRUCTURED PROTEINS; HIPPOCAMPAL-NEURONS; PRESYNAPTIC PROTEIN; STRIATAL DOPAMINE	Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are neurodegenerative disorders of the aging population characterized by the abnormal accumulation of alpha-synuclein (alpha-syn). Previous studies have suggested that excitotoxicity may contribute to neurodegeneration in these disorders, however the underlying mechanisms and their relationship to alpha-syn remain unclear. For this study we proposed that accumulation of alpha-syn might result in alterations in metabotropic glutamate receptors (mGluR), particularly mGluR5 which has been linked to deficits in murine models of PD. In this context, levels of mGluR5 were analyzed in the brains of PD and DLB human cases and alpha-syn transgenic (tg) mice and compared to age-matched, unimpaired controls, we report a 40% increase in the levels of mGluR5 and beta-arrestin immunoreactivity in the frontal cortex, hippocampus and putamen in DLB cases and in the putamen in PD cases. In the hippocampus, mGluR5 was more abundant in the CA3 region and co-localized with alpha-syn aggregates. Similarly, in the hippocampus and basal ganglia of alpha-syn tg mice, levels of mGluR5 were increased and mGluR5 and alpha-syn were co-localized and co-immunoprecipated, suggesting that alpha-syn interferes with mGluR5 trafficking. The increased levels of mGluR5 were accompanied by a concomitant increase in the activation of downstream signaling components including ERK, Elk-1 and CREB. Consistent with the increased accumulation of alpha-syn and alterations in mGluR5 in cognitive-and motor-associated brain regions, these mice displayed impaired performance in the water maze and pole test, these behavioral alterations were reversed with the mGluR5 antagonist, MPEP. Taken together the results from study suggest that mGluR5 may directly interact with alpha-syn resulting in its over activation and that this over activation may contribute to excitotoxic cell death in select neuronal regions. These results highlight the therapeutic importance of mGluR5 antagonists in alpha-synucleinopathies.	[Price, Diana L.; Rockenstein, Edward; Ubhi, Kiren; Askay, David; Cartier, Anna; Spencer, Brian; Patrick, Christina; Desplats, Paula; Ellisman, Mark H.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Masliah, Eliezer] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Price, Diana L.; Van Phung; MacLean-Lewis, Natalie; Askay, David; Ellisman, Mark H.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Van Phung; MacLean-Lewis, Natalie; Ellisman, Mark H.] Univ Calif San Diego, Ctr Res Biol Syst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Price, DL (corresponding author), ACADIA Pharmaceut Inc, San Diego, CA USA.	emasliah@ucsd.edu	Askay, David/I-8080-2019; Desplats, Paula/AFW-5030-2022	Askay, David/0000-0001-5612-9944; Desplats, Paula/0000-0002-4758-4280	Branfman Family and MJ Fox Foundations; National Center for Research Resources [RR004050]; National Institute on Deafness and Other Communication Disorders [DC03192, RR043050]; National Institute on Aging [AG18840, AG022074, AG10435]; National Institutes of Health [LM07292]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010435, P01AG022074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003192] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM007292] Funding Source: NIH RePORTER	Branfman Family and MJ Fox Foundations; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by The Branfman Family and MJ Fox Foundations, National Center for Research Resources RR004050, National Institute on Deafness and Other Communication Disorders DC03192 (CCDB), RR043050 (Mouse BIRN), National Institute on Aging AG18840, AG022074, AG10435 and National Institutes of Health LM07292. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre JA, 2005, BRAIN RES, V1033, P216, DOI 10.1016/j.brainres.2004.11.040; Aronica E, 2001, NEUROSCIENCE, V105, P509, DOI 10.1016/S0306-4522(01)00181-6; Battaglia G, 2004, J NEUROSCI, V24, P828, DOI 10.1523/JNEUROSCI.3831-03.2004; Braak H, 2000, J NEUROL, V247, P3; Breysse N, 2003, J NEUROSCI, V23, P8302; Breysse N, 2002, J NEUROSCI, V22, P5669; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Chase TN, 2000, TRENDS NEUROSCI, V23, pS86, DOI 10.1016/S1471-1931(00)00018-5; Chow SK, 2006, J MICROSC-OXFORD, V222, P76, DOI 10.1111/j.1365-2818.2006.01577.x; Coccurello R, 2004, NEUROPSYCHOPHARMACOL, V29, P1451, DOI 10.1038/sj.npp.1300444; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Dale LB, 2001, MOL PHARMACOL, V60, P1243, DOI 10.1124/mol.60.6.1243; Dale LB, 2002, NEUROCHEM INT, V41, P319, DOI 10.1016/S0197-0186(02)00073-6; De Leonibus E, 2009, NEUROPSYCHOPHARMACOL, V34, P729, DOI 10.1038/npp.2008.129; DICKSON DW, 1989, ACTA NEUROPATHOL, V78, P572, DOI 10.1007/BF00691284; DICKSON DW, 1987, ACTA NEUROPATHOL, V75, P8, DOI 10.1007/BF00686786; Fan GY, 1999, BIOPHYS J, V76, P2412, DOI 10.1016/S0006-3495(99)77396-0; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Fernagut PO, 2003, NEUROSCIENCE, V116, P1123, DOI 10.1016/S0306-4522(02)00778-9; Galasko D, 1996, BRAIN COGNITION, V31, P166, DOI 10.1006/brcg.1996.0040; Gasparini F, 1999, NEUROPHARMACOLOGY, V38, P1493, DOI 10.1016/S0028-3908(99)00082-9; Greenamyre JT, 2001, CLIN NEUROPHARMACOL, V24, P65, DOI 10.1097/00002826-200103000-00001; Gregoire L, 2009, PARKINSONISM RELAT D, V15, P445, DOI 10.1016/j.parkreldis.2008.11.001; Halliday GM, 2005, BRAIN, V128, P2272, DOI 10.1093/brain/awh596; Hansen LA, 1997, NEUROLOGY, V48, P126, DOI 10.1212/WNL.48.1.126; Harding AJ, 2002, ANN NEUROL, V51, P125, DOI 10.1002/ana.10071; Harding AJ, 2001, ACTA NEUROPATHOL, V102, P355; Hilton GD, 2006, EUR J NEUROSCI, V24, P3008, DOI 10.1111/j.1460-9568.2006.05189.x; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; IWAI A, 1995, NEURON, V14, P467, DOI 10.1016/0896-6273(95)90302-X; Iwata A, 2001, J NEUROCHEM, V77, P239, DOI 10.1046/j.1471-4159.2001.t01-1-00232.x; Iwata A, 2001, J BIOL CHEM, V276, P45320, DOI 10.1074/jbc.M103736200; Kachroo A, 2005, J NEUROSCI, V25, P10414, DOI 10.1523/JNEUROSCI.3660-05.2005; Kearney JAF, 2003, EXP NEUROL, V184, pS30, DOI 10.1016/S0014-4886(03)00391-1; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee H, 2004, ACTA NEUROBIOL EXP, V64, P89; Lee H, 2004, ACTA NEUROPATHOL, V107, P365, DOI 10.1007/s00401-004-0820-8; Lee HG, 2002, NEUROSIGNALS, V11, P282, DOI 10.1159/000067427; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2004, TRENDS NEUROSCI, V27, P129, DOI 10.1016/j.tins.2004.01.007; Marino MJ, 2003, DRUG AGING, V20, P377, DOI 10.2165/00002512-200320050-00006; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Mattila PM, 2000, ACTA NEUROPATHOL, V100, P285, DOI 10.1007/s004019900168; Mattson MP, 2007, AGING CELL, V6, P337, DOI 10.1111/j.1474-9726.2007.00275.x; Mcgeehan AJ, 2004, PSYCHOPHARMACOLOGY, V174, P266, DOI 10.1007/s00213-003-1733-2; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mundell SJ, 2001, J NEUROCHEM, V78, P546, DOI 10.1046/j.1471-4159.2001.00421.x; Murphy DD, 2000, J NEUROSCI, V20, P3214, DOI 10.1523/JNEUROSCI.20-09-03214.2000; Nafia I, 2008, J NEUROCHEM, V105, P484, DOI 10.1111/j.1471-4159.2007.05146.x; Naie K, 2004, CEREB CORTEX, V14, P189, DOI 10.1093/cercor/bhg118; Nicoletti F, 1996, TRENDS NEUROSCI, V19, P267, DOI 10.1016/S0166-2236(96)20019-0; O'Leary DM, 2000, BRIT J PHARMACOL, V131, P1429, DOI 10.1038/sj.bjp.0703715; OHNO Y, 1994, PHARMACOL BIOCHEM BE, V49, P19, DOI 10.1016/0091-3057(94)90451-0; Oka A, 1999, ACTA NEUROPATHOL, V97, P275, DOI 10.1007/s004010050985; Ossowska K, 2001, NEUROPHARMACOLOGY, V41, P413, DOI 10.1016/S0028-3908(01)00083-1; Ouattara B, 2010, J NEUROCHEM, V113, P715, DOI 10.1111/j.1471-4159.2010.06635.x; Outeiro TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006906; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Phillips JM, 2006, EUR J NEUROSCI, V23, P151, DOI 10.1111/j.1460-9568.2005.04550.x; Popoli P, 2001, NEUROPSYCHOPHARMACOL, V25, P505, DOI 10.1016/S0893-133X(01)00256-1; Price DL, 2006, NEUROINFORMATICS, V4, P65, DOI 10.1385/NI:4:1:65; Rascovsky K, 2002, NEUROLOGY, V58, P1801, DOI 10.1212/WNL.58.12.1801; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Rockenstein E, 2003, J NEURAL TRANSM, V110, P1313, DOI 10.1007/s00702-003-0025-7; Rockenstein E, 2002, J NEUROSCI RES, V68, P568, DOI 10.1002/jnr.10231; ROMANO C, 1995, J COMP NEUROL, V355, P455, DOI 10.1002/cne.903550310; Rouse ST, 2000, PHARMACOL THERAPEUT, V88, P427, DOI 10.1016/S0163-7258(00)00098-X; RYLANDER D, 2010, NEUROBIOL DIS; SALMON DP, 1990, NEUROLOGY, V40, P1225, DOI 10.1212/WNL.40.8.1225; Sanchez-Pernaute R, 2008, NEUROIMAGE, V42, P248, DOI 10.1016/j.neuroimage.2008.04.170; Shastry BS, 2001, NEUROSCI RES, V41, P5, DOI 10.1016/S0168-0102(01)00254-1; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Simonyi A, 2005, DRUG NEWS PERSPECT, V18, P353, DOI 10.1358/dnp.2005.18.6.927927; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takeda A, 1998, LAB INVEST, V78, P1169; Takeda A, 1998, AM J PATHOL, V152, P367; Thorns V, 1997, ACTA NEUROPATHOL, V94, P539, DOI 10.1007/s004010050748; Tisch S, 2004, PSYCHIAT CLIN N AM, V27, P757, DOI 10.1016/j.psc.2004.06.004; Trojanowski JQ, 1998, CELL DEATH DIFFER, V5, P832, DOI 10.1038/sj.cdd.4400432; Tsigelny IF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003135; Tsigelny IF, 2008, NANOMED-NANOTECHNOL, V4, P350, DOI 10.1016/j.nano.2008.05.005; Turle-Lorenzo N, 2005, PSYCHOPHARMACOLOGY, V179, P117, DOI 10.1007/s00213-005-2202-x; Wakabayashi K, 1998, ACTA NEUROPATHOL, V96, P445, DOI 10.1007/s004010050918; Wakabayashi K, 1997, NEUROSCI LETT, V239, P45, DOI 10.1016/S0304-3940(97)00891-4; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yamakawa K, 2010, BIOCHEM BIOPH RES CO, V391, P129, DOI 10.1016/j.bbrc.2009.11.015; Zhu JH, 2002, AM J PATHOL, V161, P2087, DOI 10.1016/S0002-9440(10)64487-2	90	58	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14020	10.1371/journal.pone.0014020	http://dx.doi.org/10.1371/journal.pone.0014020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103359	Green Published, gold			2022-12-27	WOS:000284257400019
J	Xie, X; Ma, YT; Yang, YN; Fu, ZY; Li, XM; Huang, D; Ma, XA; Chen, BD; Liu, F				Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Huang, Ding; Ma, Xiang; Chen, Bang-Dang; Liu, Fen			Polymorphisms in the SAA1/2 Gene Are Associated with Carotid Intima Media Thickness in Healthy Han Chinese Subjects: The Cardiovascular Risk Survey	PLOS ONE			English	Article							SERUM AMYLOID-A; HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ACUTE-PHASE REACTANT; PROTEIN SAA; ANKYLOSING-SPONDYLITIS; MYOCARDIAL-INFARCTION; HDL; ATHEROSCLEROSIS; INFLAMMATION	Background: Serum amyloid A protein (SAA) is not only an inflammatory factor, but also an apolipoprotein that can replace apolipoprotein A1 (apoA1) as the major apolipoprotein of high-density lipoprotein (HDL), which has been linked to atherosclerosis. However, the relationship between genetic polymorphisms of SAA and the intima-media thickness (IMT) of the common carotid artery in healthy subjects remains unclear. We investigated the role of SAA1 and SAA2 gene polymorphisms with IMT in a cohort of healthy subjects participating in the Cardiovascular Risk Survey (CRS) study. Methodology/Principal Findings: Anthropometric and B-mode ultrasound of the carotid IMT were measured in 1914 subjects (849 men; 1065 women) recruited from seven cities in Xinjiang province, (western China). Four SNPs (rs12218, rs2229338, rs1059559, and rs2468844) were genotyped by use of the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method. The SNP rs12218 was associated with carotid IMT by analyses of a dominate model (P<0.001) and additive model (P=0.003), and the difference remained significant after multivariate adjustment (P=0.008, P<0.001, respectively). This relationship was also observed in rs2468844 after multivariate adjustment by recessive model analysis (P=0.011) but this was not observed in rs2229338 and rs1059559 before and after multivariate adjustment. These associations were not modified by serum HDL concentration. Furthermore, there were significant interactions between rs2468844 and rs12218 (interaction P<0.001) and rs2229338 (interaction P=0.001) on carotid IMT. Conclusion/Significance: Both rs12218 of the SAA1 gene and rs2468844 of SAA2 gene are associated with carotid IMT in healthy Han Chinese subjects.	[Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Huang, Ding; Ma, Xiang] Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China; [Xie, Xiang; Ma, Yi-Tong; Yang, Yi-Ning; Fu, Zhen-Yan; Li, Xiao-Mei; Ma, Xiang; Chen, Bang-Dang; Liu, Fen] Xinjiang Key Lab Cardiovasc Dis Res, Urumqi, Peoples R China	Xinjiang Medical University	Ma, YT (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, Dept Cardiol, Urumqi, Peoples R China.	myt-xj@163.com	xie, xiang/AAG-2128-2021		Great Technology Special Item Foundation of Xinjiang, China [200733146-3]	Great Technology Special Item Foundation of Xinjiang, China	This work was supported financially by grants from the Great Technology Special Item Foundation of Xinjiang, China (200733146-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artl A, 2000, ARTERIOSCL THROM VAS, V20, P763, DOI 10.1161/01.ATV.20.3.763; BENDITT EP, 1971, FEBS LETT, V19, P169, DOI 10.1016/0014-5793(71)80506-9; BENDITT EP, 1979, P NATL ACAD SCI USA, V76, P4092, DOI 10.1073/pnas.76.8.4092; BENDITT EP, 1977, P NATL ACAD SCI USA, V74, P4025, DOI 10.1073/pnas.74.9.4025; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; Carty CL, 2009, J ATHEROSCLER THROMB, V16, P419, DOI 10.5551/jat.No968; CLIFTON PM, 1985, J LIPID RES, V26, P1389; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Fyfe AI, 1997, CIRCULATION, V96, P2914, DOI 10.1161/01.CIR.96.9.2914; Graversen JH, 2008, LIPIDS, V43, P467, DOI 10.1007/s11745-008-3169-2; Hayat S, 2000, SCAND J IMMUNOL, V51, P141; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kimchi-Sarfaty C, 2007, SCIENCE, V318, P1382; KIRWAN J, 1993, BRIT J RHEUMATOL, V32, P729; Lee YI, 2009, CURR APPL PHYS, V9, pS79, DOI 10.1016/j.cap.2008.08.024; LEVIN M, 1972, J CLIN INVEST, V51, pA56; Liao YC, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-93; Liu GM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-66; LOWELL CA, 1986, J BIOL CHEM, V261, P8453; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Moriguchi M, 2001, ARTHRITIS RHEUM, V44, P1266, DOI 10.1002/1529-0131(200106)44:6<1266::AID-ART218>3.0.CO;2-3; Navarro MA, 2005, CYTOKINE, V31, P52, DOI 10.1016/j.cyto.2005.03.002; O'Brien KD, 2005, ARTERIOSCL THROM VAS, V25, P785, DOI 10.1161/01.ATV.0000158383.65277.2b; Patel S, 2008, EUR HEART J, V29, P386, DOI 10.1093/eurheartj/ehm526; Scalapino KJ, 2003, CLIN EXP MED, V2, P159, DOI 10.1007/s102380300000; Schillinger M, 2005, CIRCULATION, V111, P2203, DOI 10.1161/01.CIR.0000163569.97918.C0; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Xie X, 2009, CLIN APPL THROMB-HEM, V15, P574, DOI 10.1177/1076029608329581; Xie X, 2009, CLIN CHEM LAB MED, V47, P347, DOI 10.1515/CCLM.2009.078; Yamada T, 1999, AMYLOID, V6, P199, DOI 10.3109/13506129909007327	30	70	73	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13997	10.1371/journal.pone.0013997	http://dx.doi.org/10.1371/journal.pone.0013997			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103356	gold, Green Published, Green Submitted			2022-12-27	WOS:000284257400005
J	Aspelund, T; Gudnason, V; Magnusdottir, BT; Andersen, K; Sigurdsson, G; Thorsson, B; Steingrimsdottir, L; Critchley, J; Bennett, K; O'Flaherty, M; Capewell, S				Aspelund, Thor; Gudnason, Vilmundur; Magnusdottir, Bergrun Tinna; Andersen, Karl; Sigurdsson, Gunnar; Thorsson, Bolli; Steingrimsdottir, Laufey; Critchley, Julia; Bennett, Kathleen; O'Flaherty, Martin; Capewell, Simon			Analysing the Large Decline in Coronary Heart Disease Mortality in the Icelandic Population Aged 25-74 between the Years 1981 and 2006	PLOS ONE			English	Article							RISK-FACTOR CHANGES; VASCULAR MORTALITY; INDIVIDUAL DATA; BLOOD-PRESSURE; ENGLAND; WALES; DEATHS; PREVENTION; LIFE; METAANALYSIS	Background: Coronary heart disease (CHD) mortality rates have been decreasing in Iceland since the 1980s. We examined how much of the decrease between 1981 and 2006 could be attributed to medical and surgical treatments and how much to changes in cardiovascular risk factors. Methodology: The previously validated IMPACT CHD mortality model was applied to the Icelandic population. The data sources were official statistics, national quality registers, published trials and meta-analyses, clinical audits and a series of national population surveys. Principal Findings: Between 1981 and 2006, CHD mortality rates in Iceland decreased by 80% in men and women aged 25 to 74 years, which resulted in 295 fewer deaths in 2006 than if the 1981 rates had persisted. Incidence of myocardial infarction (MI) decreased by 66% and resulted in some 500 fewer incident MI cases per year, which is a major determinant of possible deaths from MI. Based on the IMPACT model approximately 73% (lower and upper bound estimates: 54%-93%) of the mortality decrease was attributable to risk factor reductions: cholesterol 32%; smoking 22%; systolic blood pressure 22%, and physical inactivity 5% with adverse trends for diabetes (-5%), and obesity (-4%). Approximately 25% (lower and upper bound estimates: 8%-40%) of the mortality decrease was attributable to treatments in individuals: secondary prevention 8%; heart failure treatments 6%; acute coronary syndrome treatments 5%; revascularisation 3%; hypertension treatments 2%, and statins 0.5%. Conclusions: Almost three quarters of the large CHD mortality decrease in Iceland between 1981 and 2006 was attributable to reductions in major cardiovascular risk factors in the population. These findings emphasize the value of a comprehensive prevention strategy that promotes tobacco control and a healthier diet to reduce incidence of MI and highlights the potential importance of effective, evidence based medical treatments.	[Aspelund, Thor; Gudnason, Vilmundur; Magnusdottir, Bergrun Tinna; Sigurdsson, Gunnar; Thorsson, Bolli] Iceland Heart Assoc, Kopavogur, Iceland; [Aspelund, Thor; Gudnason, Vilmundur; Andersen, Karl; Steingrimsdottir, Laufey] Univ Iceland, Reykjavik, Iceland; [Andersen, Karl; Sigurdsson, Gunnar] Landspitali Univ Hosp, Reykavik, Iceland; [Critchley, Julia] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Bennett, Kathleen] St James Hosp, Dept Pharmacol & Therapeut, Trinity Ctr Hlth Sci, Dublin, Ireland; [O'Flaherty, Martin; Capewell, Simon] Univ Liverpool, Div Publ Hlth, Liverpool L69 3BX, Merseyside, England	Icelandic Heart Association; University of Iceland; Landspitali National University Hospital; Newcastle University - UK; Trinity College Dublin; University of Liverpool	Aspelund, T (corresponding author), Iceland Heart Assoc, Kopavogur, Iceland.	v.gudnason@hjarta.is	Steingrimsdottir, Laufey/L-3150-2015; Aspelund, Thor/K-7022-2019; Aspelund, Thor/F-4826-2011; Gudnason, Vilmundur/AAE-7126-2019; Aspelund, Thor/C-5983-2008; Shao, Ruitai/AAU-7642-2021; Thorsson, Bolli/V-7992-2017; Gudnason, Vilmundur/K-6885-2015	Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Aspelund, Thor/0000-0002-7998-5433; Gudnason, Vilmundur/0000-0001-5696-0084; Bennett, Kathleen/0000-0002-2861-7665; O'Flaherty, Martin/0000-0001-8944-4131; Critchley, Julia/0000-0002-5248-4188	Icelandic Heart Association; University of Iceland	Icelandic Heart Association; University of Iceland	This work was supported by the Icelandic Heart Association and the University of Iceland Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAGLEHOLE R, 1986, BMJ-BRIT MED J, V292, P33, DOI 10.1136/bmj.292.6512.33; Bennett K, 2006, J EPIDEMIOL COMMUN H, V60, P322, DOI 10.1136/jech.2005.038638; Bjorck L, 2009, EUR HEART J, V30, P1046, DOI 10.1093/eurheartj/ehn554; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Bots M L, 1996, J Cardiovasc Risk, V3, P271, DOI 10.1097/00043798-199606000-00002; BRIGGS A, 1994, HEALTH ECON, V3, P95, DOI 10.1002/hec.4730030206; Capewell S, 1999, HEART, V81, P380, DOI 10.1136/hrt.81.4.380; Capewell S, 2006, HEART, V92, P521, DOI 10.1136/hrt.2004.053645; Capewell S, 2000, CIRCULATION, V102, P1511, DOI 10.1161/01.CIR.102.13.1511; CAPEWELL S, 2008, WHO B IN PRESS; Critchley J, 2004, CIRCULATION, V110, P1236, DOI 10.1161/01.CIR.0000140668.91896.AE; Critchley JA, 2003, J CLIN EPIDEMIOL, V56, P583, DOI 10.1016/S0895-4356(03)00059-3; Critchley JA, 2003, JAMA-J AM MED ASSOC, V290, P86, DOI 10.1001/jama.290.1.86; Critchley JA, 2003, J EPIDEMIOL COMMUN H, V57, P243, DOI 10.1136/jech.57.4.243; Fidan D, 2007, QJM-INT J MED, V100, P277, DOI 10.1093/qjmed/hcm020; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gudnason V, 2008, CIRCULATION, V118, pS1080; Heiat A, 2002, ARCH INTERN MED, V162, P1682, DOI 10.1001/archinte.162.15.1682; Hu FB, 2002, JAMA-J AM MED ASSOC, V288, P2569, DOI 10.1001/jama.288.20.2569; Hunink MGM, 1997, JAMA-J AM MED ASSOC, V277, P535, DOI 10.1001/jama.277.7.535; Laatikainen T, 2005, AM J EPIDEMIOL, V162, P764, DOI 10.1093/aje/kwi274; Lewington S, 2008, LANCET, V372, P292; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lewington S, 2003, LANCET, V361, P1060; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; MANT J, 1995, BMJ-BRIT MED J, V311, P793, DOI 10.1136/bmj.311.7008.793; OLAFSSON O, 1969, MANUAL EPIDEMIOLOGIC; *PUBL HLTH I IC, 2009, IC FOOD SUPPL DAT; SIGFUSSON N, 1991, BRIT MED J, V302, P1371, DOI 10.1136/bmj.302.6789.1371; *STAT IC, 2008, BIRTHS DEATHS; Thorsson B, 2009, LAEKNABLADID, V95, P259; Unal B, 2005, BMJ-BRIT MED J, V331, P614, DOI 10.1136/bmj.38561.633345.8F; Unal B, 2005, J CLIN EPIDEMIOL, V58, P733, DOI 10.1016/j.jclinepi.2004.09.015; Unal B, 2005, AM J PUBLIC HEALTH, V95, P103, DOI 10.2105/AJPH.2003.029579; Unal B, 2004, CIRCULATION, V109, P1101, DOI 10.1161/01.CIR.0000118498.35499.B2; VARTIAINEN E, 1994, BMJ-BRIT MED J, V309, P23, DOI 10.1136/bmj.309.6946.23; Weintraub WS, 2008, NEW ENGL J MED, V359, P677, DOI 10.1056/NEJMoa072771	37	87	92	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13957	10.1371/journal.pone.0013957	http://dx.doi.org/10.1371/journal.pone.0013957			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103050	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000284147700008
J	de Mol, P; Krabbe, HG; de Vries, ST; Fokkert, MJ; Dikkeschei, BD; Rienks, R; Bilo, KM; Bilo, HJG				de Mol, Pieter; Krabbe, Hans G.; de Vries, Suzanna T.; Fokkert, Marion J.; Dikkeschei, Bert D.; Rienks, Rienk; Bilo, Karin M.; Bilo, Henk J. G.			Accuracy of Handheld Blood Glucose Meters at High Altitude	PLOS ONE			English	Article							PERFORMANCE; SYSTEMS	Background: Due to increasing numbers of people with diabetes taking part in extreme sports (e. g., high-altitude trekking), reliable handheld blood glucose meters (BGMs) are necessary. Accurate blood glucose measurement under extreme conditions is paramount for safe recreation at altitude. Prior studies reported bias in blood glucose measurements using different BGMs at high altitude. We hypothesized that glucose-oxidase based BGMs are more influenced by the lower atmospheric oxygen pressure at altitude than glucose dehydrogenase based BGMs. Methodology/Principal Findings: Glucose measurements at simulated altitude of nine BGMs (six glucose dehydrogenase and three glucose oxidase BGMs) were compared to glucose measurement on a similar BGM at sea level and to a laboratory glucose reference method. Venous blood samples of four different glucose levels were used. Moreover, two glucose oxidase and two glucose dehydrogenase based BGMs were evaluated at different altitudes on Mount Kilimanjaro. Accuracy criteria were set at a bias <15% from reference glucose (when >6.5 mmol/L) and <1 mmol/L from reference glucose (when <6.5 mmol/L). No significant difference was observed between measurements at simulated altitude and sea level for either glucose oxidase based BGMs or glucose dehydrogenase based BGMs as a group phenomenon. Two GDH based BGMs did not meet set performance criteria. Most BGMs are generally overestimating true glucose concentration at high altitude. Conclusion: At simulated high altitude all tested BGMs, including glucose oxidase based BGMs, did not show influence of low atmospheric oxygen pressure. All BGMs, except for two GDH based BGMs, performed within predefined criteria. At true high altitude one GDH based BGM had best precision and accuracy.	[de Mol, Pieter] Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands; [Krabbe, Hans G.; Fokkert, Marion J.; Dikkeschei, Bert D.] Isala Clin, Dept Clin Chem, Zwolle, Netherlands; [de Vries, Suzanna T.] Isala Clin, Dept Cardiol, Zwolle, Netherlands; [Rienks, Rienk] Dutch Airforce, Ctr Human Aviat, Soesterberg, Netherlands; [Bilo, Karin M.; Bilo, Henk J. G.] Isala Clin, Dept Internal Med, Zwolle, Netherlands; [Bilo, Henk J. G.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, NL-9713 AV Groningen, Netherlands	Canisius-Wilhelmina Hospital; Isala Clinics; Isala Clinics; Isala Clinics; University of Groningen	de Mol, P (corresponding author), Canisius Wilhelmina Hosp, Dept Internal Med, Nijmegen, Netherlands.	P.deMol@aig.umcn.nl			Isala Clinics, Zwolle, The Netherlands	Isala Clinics, Zwolle, The Netherlands(Netherlands Government)	This study was funded by the Isala Clinics, Zwolle, The Netherlands. The funders had no role in study design, data collection and analysis, decisions to publish or preparation of the manuscript.	Bilen H., 2007, Journal of Medical Engineering & Technology, V31, P152, DOI 10.1080/03091900600861590; CHAN AYW, 1989, CLIN CHEM, V35, P315; CLARKE WL, 1987, DIABETES CARE, V10, P622, DOI 10.2337/diacare.10.5.622; Fink Kenneth S, 2002, Diabetes Technol Ther, V4, P627, DOI 10.1089/152091502320798259; GAULTIER JF, 1996, DIABETES CARE, V19, P1430; Ginsberg Barry H, 2009, J Diabetes Sci Technol, V3, P903; Moore K, 2001, DIABETIC MED, V18, P749, DOI 10.1046/j.0742-3071.2001.00568.x; Oberg D, 2005, DIABETES CARE, V28, P1261, DOI 10.2337/diacare.28.5.1261; Pecchio O, 2000, DIABETES CARE, V23, P129, DOI 10.2337/diacare.23.1.129a	9	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15485	10.1371/journal.pone.0015485	http://dx.doi.org/10.1371/journal.pone.0015485			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103399	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700033
J	Gandille, P; Narbonne-Reveau, K; Boissonneau, E; Randsholt, N; Busson, D; Pret, AM				Gandille, Pierre; Narbonne-Reveau, Karine; Boissonneau, Elisabeth; Randsholt, Neel; Busson, Denise; Pret, Anne-Marie			Mutations in the Polycomb Group Gene polyhomeotic Lead to Epithelial Instability in both the Ovary and Wing Imaginal Disc in Drosophila	PLOS ONE			English	Article							TUMOR-SUPPRESSOR ACTIVITY; TRITHORAX GROUP PROTEINS; BORDER-CELL-MIGRATION; HOX GENES; EXPRESSION; OOGENESIS; POLARITY; MELANOGASTER; BOUNDARIES; JUNCTIONS	Background: Most human cancers originate from epithelial tissues and cell polarity and adhesion defects can lead to metastasis. The Polycomb-Group of chromatin factors were first characterized in Drosophila as repressors of homeotic genes during development, while studies in mammals indicate a conserved role in body plan organization, as well as an implication in other processes such as stem cell maintenance, cell proliferation, and tumorigenesis. We have analyzed the function of the Drosophila Polycomb-Group gene polyhomeotic in epithelial cells of two different organs, the ovary and the wing imaginal disc. Results: Clonal analysis of loss and gain of function of polyhomeotic resulted in segregation between mutant and wild-type cells in both the follicular and wing imaginal disc epithelia, without excessive cell proliferation. Both basal and apical expulsion of mutant cells was observed, the former characterized by specific reorganization of cell adhesion and polarity proteins, the latter by complete cytoplasmic diffusion of these proteins. Among several candidate target genes tested, only the homeotic gene Abdominal-B was a target of PH in both ovarian and wing disc cells. Although overexpression of Abdominal-B was sufficient to cause cell segregation in the wing disc, epistatic analysis indicated that the presence of Abdominal-B is not necessary for expulsion of polyhomeotic mutant epithelial cells suggesting that additional POLYHOMEOTIC targets are implicated in this phenomenon. Conclusion: Our results indicate that polyhomeotic mutations have a direct effect on epithelial integrity that can be uncoupled from overproliferation. We show that cells in an epithelium expressing different levels of POLYHOMEOTIC sort out indicating differential adhesive properties between the cell populations. Interestingly, we found distinct modalities between apical and basal expulsion of ph mutant cells and further studies of this phenomenon should allow parallels to be made with the modified adhesive and polarity properties of different types of epithelial tumors.	[Gandille, Pierre; Boissonneau, Elisabeth; Randsholt, Neel; Pret, Anne-Marie] CNRS, Ctr Genet Mol FRE 3144, Gif Sur Yvette, France; Univ Mediterannee Aix Marseille II, CNRS, Marseille, France; [Narbonne-Reveau, Karine] Univ Mediterannee Aix Marseille II, CNRS, Inst Biol Dev Marseille Luminy, UMR 6216, Marseille, France; [Narbonne-Reveau, Karine; Busson, Denise; Pret, Anne-Marie] Univ Paris 07, Univ Paris 06, CNRS, Inst Jacques Monod,UMR7592, Paris, France; [Busson, Denise] Univ Paris 06, Systemat Adaptat Evolut UMR7138, Paris, France; [Randsholt, Neel] Univ Paris 06, CNRS, Dev Biol Lab, UMR7622, Paris, France; [Pret, Anne-Marie] Univ Versailles St Quentin, Versailles, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Saclay	Gandille, P (corresponding author), CNRS, Ctr Genet Mol FRE 3144, Gif Sur Yvette, France.	pret@cgm.cnrs-gif.fr		Narbonne-Reveau, Karine/0000-0002-4650-4576	Centre National de la Recherche Scientifique ATIP; Fondation pour la Recherch Medicale [INE20050303456]; Ministe de l'Enseignement Superieure et de la Recherche Technologique	Centre National de la Recherche Scientifique ATIP(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherch Medicale; Ministe de l'Enseignement Superieure et de la Recherche Technologique	This work was supported by the Centre National de la Recherche Scientifique ATIP (http://www.cnrs.fr/); the Fondation pour la Recherch Medicale INE20050303456 (http://www.frm.org/); and the Ministe de l'Enseignement Superieure et de la Recherche Technologique (http://www.enseignementsup-recherche.gouv.fr/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becam IE, 2005, NAT CELL BIOL, V7, P510, DOI 10.1038/ncb1253; Beuchle D, 2001, DEVELOPMENT, V128, P993; Bokel C, 2002, DEV CELL, V3, P311, DOI 10.1016/S1534-5807(02)00265-4; Breiling A, 2007, INT REV CYTOL, V258, P83, DOI 10.1016/S0074-7696(07)58002-2; Bruggeman SWM, 2009, BBA-GEN SUBJECTS, V1790, P351, DOI 10.1016/j.bbagen.2009.03.009; BUSTURIA A, 1988, DEVELOPMENT, V104, P713; Castelli-Gair J, 1998, INT J DEV BIOL, V42, P437; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; DeFalco T, 2004, MECH DEVELOP, V121, P1323, DOI 10.1016/j.mod.2004.07.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; DUNCAN IM, 1982, GENETICS, V102, P49; DURA JM, 1988, DEVELOPMENT, V103, P733; DURA JM, 1987, CELL, V51, P829, DOI 10.1016/0092-8674(87)90106-1; Faucheux M, 2003, MOL CELL BIOL, V23, P1181, DOI 10.1128/MCB.23.4.1181-1195.2003; Forbes AJ, 1996, DEVELOPMENT, V122, P3283; Forbes AJ, 1996, DEVELOPMENT, V122, P1125; Gates J, 2005, CELL, V123, P769, DOI 10.1016/j.cell.2005.11.009; Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751; Gibson MC, 2003, CURR OPIN CELL BIOL, V15, P747, DOI 10.1016/j.ceb.2003.10.008; Godt D, 2009, NAT CELL BIOL, V11, P536, DOI 10.1038/ncb0509-536; Goode S, 2005, DEV DYNAM, V232, P855, DOI 10.1002/dvdy.20336; Goode S, 1997, GENE DEV, V11, P2532, DOI 10.1101/gad.11.19.2532; Grammont M, 2007, J CELL BIOL, V177, P139, DOI 10.1083/jcb.200609079; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Lovegrove B, 2006, CURR BIOL, V16, P2206, DOI 10.1016/j.cub.2006.09.029; Madsen CD, 2010, DEV CELL, V19, P13, DOI 10.1016/j.devcel.2010.06.013; Martinez AM, 2006, CELL CYCLE, V5, P1189, DOI 10.4161/cc.5.11.2781; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092; McNeill H, 2000, NAT REV GENET, V1, P100, DOI 10.1038/35038540; Muller HAJ, 2000, DEV DYNAM, V218, P52; Narbonne K, 2004, DEVELOPMENT, V131, P1389, DOI 10.1242/dev.01003; Netter S, 2001, DNA CELL BIOL, V20, P483, DOI 10.1089/104454901316976118; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pallavi SK, 2005, J CELL SCI, V118, P3363, DOI 10.1242/jcs.02464; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Randsholt NB, 2000, MECH DEVELOP, V95, P89, DOI 10.1016/S0925-4773(00)00342-7; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ringrose L, 2007, CURR OPIN CELL BIOL, V19, P290, DOI 10.1016/j.ceb.2007.04.010; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; SANTAMARIA P, 1989, ROUX ARCH DEV BIOL, V198, P65, DOI 10.1007/BF02447741; Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784; SIMON J, 1992, DEVELOPMENT, V114, P493; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; Szafranski P, 2007, DEV DYNAM, V236, P364, DOI 10.1002/dvdy.21020; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tepass U, 1999, CURR OPIN CELL BIOL, V11, P540, DOI 10.1016/S0955-0674(99)00025-3; Tepass U, 2002, CURR OPIN GENET DEV, V12, P572, DOI 10.1016/S0959-437X(02)00342-8; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Widmann TJ, 2009, J CELL SCI, V122, P1362, DOI 10.1242/jcs.044271; XU T, 1993, DEVELOPMENT, V117, P1223; ZECCA M, 1995, DEVELOPMENT, V121, P2265	61	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13946	10.1371/journal.pone.0013946	http://dx.doi.org/10.1371/journal.pone.0013946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085656	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800012
J	Krasemann, S; Neumann, M; Geissen, M; Bodemer, W; Kaup, FJ; Schulz-Schaeffer, W; Morel, N; Aguzzi, A; Glatzel, M				Krasemann, Susanne; Neumann, Melanie; Geissen, Markus; Bodemer, Walter; Kaup, Franz-Josef; Schulz-Schaeffer, Walter; Morel, Nathalie; Aguzzi, Adriano; Glatzel, Markus			Preclinical Deposition of Pathological Prion Protein in Muscle of Experimentally Infected Primates	PLOS ONE			English	Article							CREUTZFELDT-JAKOB-DISEASE; SPONGIFORM ENCEPHALOPATHY AGENT; TISSUE DISTRIBUTION; BLOOD-TRANSFUSION; INCUBATION-TIME; VARIANT; PRPSC; TRANSMISSION; RISK; EPIDEMIOLOGY	Prion diseases are transmissible fatal neurodegenerative disorders affecting humans and animals. A central step in disease progression is the accumulation of a misfolded form (PrPSc) of the host encoded prion protein (PrPC) in neuronal and non-neuronal tissues. The involvement of peripheral tissues in preclinical states increases the risk of accidental transmission. On the other hand, detection of PrPSc in non-neuronal easy-accessible compartments such as muscle may offer a novel diagnostic tool. Primate models have proven invaluable to investigate prion diseases. We have studied the deposition of PrPSc in muscle and central nervous system of rhesus monkeys challenged with sporadic Creutzfeldt-Jakob disease (sCJD), variant CJD (vCJD) and bovine spongiform encephalopathy (BSE) in preclinical and clinical stage using biochemical and morphological methods. Here, we show the preclinical presence of PrPSc in muscle and central nervous system of rhesus monkeys experimentally infected with vCJD.	[Krasemann, Susanne; Neumann, Melanie; Geissen, Markus; Glatzel, Markus] Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany; [Schulz-Schaeffer, Walter] Univ Hosp Gottingen, Inst Neuropathol, Gottingen, Germany; [Morel, Nathalie] CEA Saclay, Serv Pharmacol & Immunoanal, IBitec S, F-91191 Gif Sur Yvette, France; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gottingen; CEA; UDICE-French Research Universities; Universite Paris Saclay; University of Zurich; University Zurich Hospital	Krasemann, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuropathol, Hamburg, Germany.	adriano.aguzzi@usz.ch; m.glatzel@uke.de	Aguzzi, Adriano/A-3351-2008; Glatzel, Markus/V-8844-2019; Glatzel, Markus/G-3356-2011; Morel, Nathalie/O-9012-2016	Glatzel, Markus/0000-0002-7720-8817; Glatzel, Markus/0000-0002-7720-8817; Krasemann, Susanne/0000-0001-8795-818X; Aguzzi, Adriano/0000-0002-0344-6708	European Union [EU BMH4 CT 98 7026]; Deutsche Forschungs Gemeinschaft (DFG) [KA 864/2-1, FOR885, Gl 589/2-1]; Deutsches Primaten Zentrum Foerderpreis	European Union(European Commission); Deutsche Forschungs Gemeinschaft (DFG)(German Research Foundation (DFG)); Deutsches Primaten Zentrum Foerderpreis	This work was financed by the European Union grant EU BMH4 CT 98 7026, the Deutsche Forschungs Gemeinschaft (DFG) grants KA 864/2-1 and FOR885. S. K. was supported by the Deutsches Primaten Zentrum Foerderpreis, M. N. was supported by DFG grant Gl 589/2-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Aguzzi A, 2006, NAT CLIN PRACT NEURO, V2, P321, DOI 10.1038/ncpneuro0214; Aguzzi A, 2006, NAT REV MICROBIOL, V4, P765, DOI 10.1038/nrmicro1492; Aguzzi A, 2006, J NEUROCHEM, V97, P1726, DOI 10.1111/j.1471-4159.2006.03909.x; Andreoletti O, 2004, NAT MED, V10, P591, DOI 10.1038/nm1055; Bartz JC, 2003, J VIROL, V77, P583, DOI 10.1128/JVI.77.1.583-591.2003; Belay ED, 1999, ANNU REV MICROBIOL, V53, P283, DOI 10.1146/annurev.micro.53.1.283; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; BUELER H, 1994, MOL MED, V1, P19; Casalone C, 2005, J VIROL, V79, P5847, DOI 10.1128/JVI.79.9.5847-5849.2005; CAUGHEY B, 1991, J VIROL, V65, P6597, DOI 10.1128/JVI.65.12.6597-6603.1991; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Comoy EE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003017; Dietz K, 2007, EMERG INFECT DIS, V13, P89, DOI 10.3201/eid1301.060396; GEISSEN M, 2007, VACCINE; Glatzel M, 2005, ARCH NEUROL-CHICAGO, V62, P545, DOI 10.1001/archneur.62.4.545; Glatzel M, 2003, LANCET NEUROL, V2, P757, DOI 10.1016/S1474-4422(03)00588-X; Glatzel M, 2002, LANCET, V360, P139, DOI 10.1016/S0140-6736(02)09384-4; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Head MW, 2003, BRIT DENT J, V195, P339, DOI 10.1038/sj.bdj.4810536; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Herzog C, 2004, LANCET, V363, P422, DOI 10.1016/S0140-6736(04)15487-1; Hill AF, 2003, BRAIN, V126, P1333, DOI 10.1093/brain/awg125; Horiuchi M, 1999, EMBO J, V18, P3193, DOI 10.1093/emboj/18.12.3193; Ironside JW, 1998, J PATHOL, V186, P227, DOI 10.1002/(SICI)1096-9896(1998110)186:3&lt;227::AID-PATH174&gt;3.0.CO;2-3; Kovacs GG, 2004, ANN NEUROL, V55, P121, DOI 10.1002/ana.10813; Krasemann S, 1996, MOL MED, V2, P725, DOI 10.1007/BF03401656; Lasmezas CI, 2001, P NATL ACAD SCI USA, V98, P4142, DOI 10.1073/pnas.041490898; Lasmezas CI, 2005, LANCET, V365, P781, DOI 10.1016/S0140-6736(05)17985-9; Lefrere JJ, 2009, TRANSFUSION, V49, P797, DOI 10.1111/j.1537-2995.2008.02044.x; Notari S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008765; Peden A, 2010, HAEMOPHILIA; Peden AH, 2006, AM J PATHOL, V168, P927, DOI 10.2353/ajpath.2006.050788; Prusiner SB, 1997, ANNU REV GENET, V31, P139, DOI 10.1146/annurev.genet.31.1.139; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Schulz-Schaeffer WJ, 2000, AM J PATHOL, V156, P51, DOI 10.1016/S0002-9440(10)64705-0; Thomzig A, 2006, J GEN VIROL, V87, P251, DOI 10.1099/vir.0.81277-0; Thomzig A, 2004, J CLIN INVEST, V113, P1465, DOI 10.1172/JCI200421083; Thomzig A, 2003, EMBO REP, V4, P530, DOI 10.1038/sj.embor.embor827; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Zou S, 2008, TRANSFUS MED REV, V22, P58, DOI 10.1016/j.tmrv.2007.09.003	44	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13906	10.1371/journal.pone.0013906	http://dx.doi.org/10.1371/journal.pone.0013906			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085647	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000284087800003
J	Li, JA; Kuruba, R; Wilson, A; Gao, XA; Zhang, YF; Li, S				Li, Jiang; Kuruba, Ramalinga; Wilson, Annette; Gao, Xiang; Zhang, Yifei; Li, Song			Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL-CELLS; FARNESOID-X-RECEPTOR; TRANSCRIPTIONAL REGULATION; PORTAL-HYPERTENSION; NUCLEAR RECEPTORS; LIVER FIBROSIS; ACID; RAT; EXPRESSION; PATHOPHYSIOLOGY	Activation of hepatic stellate cells (HSCs) plays an important role in the development of cirrhosis through the increased production of collagen and the enhanced contractile response to vasoactive mediators such as endothelin-1 (ET-1). The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is highly expressed in liver, kidneys, adrenals, and intestine. FXR is also expressed in HSCs and activation of FXR in HSCs is associated with significant decreases in collagen production. However, little is known about the roles of FXR in the regulation of contraction of HSCs. We report in this study that treatment of quiescent HSCs with GW4064, a synthetic FXR agonist, significantly inhibited the HSC transdifferentiation, which was associated with an inhibition of the upregulation of ET-1 expression. These GW4064-treated cells also showed reduced contractile response to ET-1 in comparison to HSCs without GW4064 treatment. We have further shown that GW4064 treatment inhibited the ET-1-mediated contraction in fully activated HSCs. To elucidate the potential mechanism we showed that GW4064 inhibited ET-1-mediated activation of Rho/ROCK pathway in activated HSCs. Our studies unveiled a new mechanism that might contribute to the anti-cirrhotic effects of FXR ligands.	[Li, Jiang; Kuruba, Ramalinga; Wilson, Annette; Gao, Xiang; Zhang, Yifei; Li, Song] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Li, JA (corresponding author), Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA.	sol4@pitt.edu		Wilson, Annette/0000-0002-7426-1786	National Institutes of Health [HL091828]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091828] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported in part by the National Institutes of Health [Grant HL091828] (to S. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2000, GASTROENTEROLOGY, V118, P1149, DOI 10.1016/S0016-5085(00)70368-4; Bertolotti M, 2008, CURR MED CHEM, V15, P2271, DOI 10.2174/092986708785747544; BLOMHOFF R, 1991, FASEB J, V5, P271, DOI 10.1096/fasebj.5.3.2001786; Casini A, 1997, HEPATOLOGY, V25, P361; Chi XD, 2003, BRIT J PHARMACOL, V139, P765, DOI 10.1038/sj.bjp.0705303; Chiang JYL, 2002, ENDOCR REV, V23, P443, DOI 10.1210/er.2000-0035; Cichoz-Lach H, 2008, J PHYSIOL PHARMACOL, V59, P231; Eloranta JJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P397, DOI 10.1016/j.abb.2004.09.019; Fiorucci S, 2005, J PHARMACOL EXP THER, V314, P584, DOI 10.1124/jpet.105.084905; Fiorucci S, 2004, GASTROENTEROLOGY, V127, P1497, DOI 10.1053/j.gastro.2004.08.001; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Galli A, 2000, HEPATOLOGY, V31, P101, DOI 10.1002/hep.510310117; Haughton EL, 2006, GASTROENTEROLOGY, V131, P194, DOI 10.1053/j.gastro.2006.04.012; He FT, 2006, CIRC RES, V98, P192, DOI 10.1161/01.RES.0000200400.55539.85; Hellemams K, 2004, HEPATOLOGY, V39, P97, DOI 10.1002/hep.20015; KAWADA N, 1992, BIOCHEM J, V285, P367, DOI 10.1042/bj2850367; Kharbanda KK, 2004, J HEPATOL, V41, P60, DOI 10.1016/j.jhep.2004.03.019; Li J, 2008, CARDIOVASC RES, V77, P169, DOI 10.1093/cvr/cvm016; Li J, 2009, J PHARMACOL EXP THER, V331, P234, DOI 10.1124/jpet.109.153510; Liu CH, 2003, J BIOL CHEM, V278, P11721, DOI 10.1074/jbc.M207728200; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Reynaert H, 2002, GUT, V50, P571, DOI 10.1136/gut.50.4.571; Rockey DC, 1998, HEPATOLOGY, V27, P472, DOI 10.1002/hep.510270222; Rockey DC, 1996, HEPATOLOGY, V24, P233; Sancho-Bru P, 2006, AM J PHYSIOL-GASTR L, V291, pG877, DOI 10.1152/ajpgi.00537.2005; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Sohail MA, 2009, HEPATOLOGY, V49, P185, DOI 10.1002/hep.22589; Soon RK, 2008, CLIN LIVER DIS, V12, P791, DOI 10.1016/j.cld.2008.07.004; Willson TM, 2001, MED RES REV, V21, P513, DOI 10.1002/med.1023; Yee HF, 1998, HEPATOLOGY, V28, P843, DOI 10.1002/hep.510280336	31	47	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13955	10.1371/journal.pone.0013955	http://dx.doi.org/10.1371/journal.pone.0013955			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085652	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800019
J	Rule, NO; Garrett, JV; Ambady, N				Rule, Nicholas O.; Garrett, James V.; Ambady, Nalini			On the Perception of Religious Group Membership from Faces	PLOS ONE			English	Article							SKIN COLOR DISTRIBUTION; MALE SEXUAL ORIENTATION; FACIAL ATTRACTIVENESS; HEALTH; MORMONS; AGE; CATEGORIZATION; MORTALITY; ACCURACY; SYMMETRY	Background: The study of social categorization has largely been confined to examining groups distinguished by perceptually obvious cues. Yet many ecologically important group distinctions are less clear, permitting insights into the general processes involved in person perception. Although religious group membership is thought to be perceptually ambiguous, folk beliefs suggest that Mormons and non-Mormons can be categorized from their appearance. We tested whether Mormons could be distinguished from non-Mormons and investigated the basis for this effect to gain insight to how subtle perceptual cues can support complex social categorizations. Methodology/Principal Findings: Participants categorized Mormons' and non-Mormons' faces or facial features according to their group membership. Individuals could distinguish between the two groups significantly better than chance guessing from their full faces and faces without hair, with eyes and mouth covered, without outer face shape, and inverted 180 degrees; but not from isolated features (i.e., eyes, nose, or mouth). Perceivers' estimations of their accuracy did not match their actual accuracy. Exploration of the remaining features showed that Mormons and non-Mormons significantly differed in perceived health and that these perceptions were related to perceptions of skin quality, as demonstrated in a structural equation model representing the contributions of skin color and skin texture. Other judgments related to health (facial attractiveness, facial symmetry, and structural aspects related to body weight) did not differ between the two groups. Perceptions of health were also responsible for differences in perceived spirituality, explaining folk hypotheses that Mormons are distinct because they appear more spiritual than non-Mormons. Conclusions/Significance: Subtle markers of group membership can influence how others are perceived and categorized. Perceptions of health from non-obvious and minimal cues distinguished individuals according to their religious group membership. These data illustrate how the non-conscious detection of very subtle differences in others' appearances supports cognitively complex judgments such as social categorization.	[Rule, Nicholas O.] Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada; [Garrett, James V.; Ambady, Nalini] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	University of Toronto; Tufts University	Rule, NO (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON M5S 1A1, Canada.	rule@psych.utoronto.ca			National Science Foundation [BCS-0435547]; Canada Research Chair fellowship	National Science Foundation(National Science Foundation (NSF)); Canada Research Chair fellowship	This research was supported by a National Science Foundation Graduate Research Fellowship and Canada Research Chair fellowship to Nicholas O. Rule and National Science Foundation grant BCS-0435547 to Nalini Ambady (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blair IV, 2002, J PERS SOC PSYCHOL, V83, P5, DOI 10.1037/0022-3514.83.1.5; Brebner JL, 2009, EUR J SOC PSYCHOL, V39, P1109, DOI 10.1002/ejsp.600; BROWN E, 1993, PERCEPTION, V22, P829, DOI 10.1068/p220829; Coetzee V, 2010, PERCEPTION, V39, P51, DOI 10.1068/p6560; Coetzee V, 2009, PERCEPTION, V38, P1700, DOI 10.1068/p6423; Cortina JM, 2002, J MANAGE, V28, P339, DOI 10.1016/S0149-2063(02)00131-9; Eberhardt JL, 2006, PSYCHOL SCI, V17, P383, DOI 10.1111/j.1467-9280.2006.01716.x; Elfenbein HA, 2002, PSYCHOL BULL, V128, P243, DOI 10.1037//0033-2909.128.2.243; ELLIS HD, 1975, INT J PSYCHOL, V10, P119, DOI 10.1080/00207597508247325; Enstrom JE, 2008, PREV MED, V46, P133, DOI 10.1016/j.ypmed.2007.07.030; ENSTROM JE, 1978, CANCER, V42, P1943, DOI 10.1002/1097-0142(197810)42:4<1943::AID-CNCR2820420437>3.0.CO;2-L; ENSTROM JE, 1989, J NATL CANCER I, V81, P1807, DOI 10.1093/jnci/81.23.1807; Fink B, 2008, J EUR ACAD DERMATOL, V22, P493, DOI 10.1111/j.1468-3083.2007.02512.x; Fink B, 2001, J COMP PSYCHOL, V115, P92, DOI 10.1037//0735-7036.115.1.92; Fink B, 2006, EVOL HUM BEHAV, V27, P433, DOI 10.1016/j.evolhumbehav.2006.08.007; Jones BC, 2004, PERCEPTION, V33, P569, DOI 10.1068/p3463; Jones BC, 2004, EVOL HUM BEHAV, V25, P24, DOI 10.1016/S1090-5138(03)00080-1; Kline R.B., 1998, STRUCT EQU MODELING; LYON JL, 1994, CANCER CAUSE CONTROL, V5, P149, DOI 10.1007/BF01830261; MacLin OH, 2003, PERCEPTION, V32, P249, DOI 10.1068/p5046; MacLin OH, 2001, PSYCHOL PUBLIC POL L, V7, P98, DOI 10.1037//1076-8971.7.1.98; Macrae CN, 2005, J PERS SOC PSYCHOL, V89, P686, DOI 10.1037/0022-3514.89.5.686; Macrae CN, 2000, ANNU REV PSYCHOL, V51, P93, DOI 10.1146/annurev.psych.51.1.93; Maddox KB, 2004, PERS SOC PSYCHOL REV, V8, P383, DOI 10.1207/s15327957pspr0804_4; MANTON KG, 1991, POPUL DEV REV, V17, P603, DOI 10.2307/1973599; Matts PJ, 2007, J AM ACAD DERMATOL, V57, P977, DOI 10.1016/j.jaad.2007.07.040; Merrill R. M., 2004, DEMOGR RES, V10, P61; Pratt Parley P., 1855, KEY SCI THEOLOGY; QUANTY MB, 1975, J PERS SOC PSYCHOL, V32, P449, DOI 10.1037/h0077093; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Rhodes G, 2007, PERCEPTION, V36, P1244, DOI 10.1068/p5712; Roberts SC, 2005, EVOL HUM BEHAV, V26, P213, DOI 10.1016/j.evolhumbehav.2004.09.002; ROBERTS T, 1988, PERCEPTION, V17, P475, DOI 10.1068/p170475; Rule NO, 2008, J PERS SOC PSYCHOL, V95, P1019, DOI 10.1037/a0013194; Rule NO, 2008, J EXP SOC PSYCHOL, V44, P1100, DOI 10.1016/j.jesp.2007.12.001; Rule NO, 2007, PSYCHON B REV, V14, P687, DOI 10.3758/BF03196822; Rule NO, 2010, J PERS SOC PSYCHOL, V98, P343, DOI 10.1037/a0018589; Rule NO, 2009, PERCEPTION, V38, P1688, DOI 10.1068/p6384; Rule NO, 2009, J EXP SOC PSYCHOL, V45, P1245, DOI 10.1016/j.jesp.2009.07.010; Rule NO, 2009, PSYCHOL SCI, V20, P441, DOI 10.1111/j.1467-9280.2009.02314.x; Santos IM, 2008, PERCEPTION, V37, P1061, DOI 10.1068/p5278; Stephen ID, 2009, INT J PRIMATOL, V30, P845, DOI 10.1007/s10764-009-9380-z; Stephen ID, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005083; THORNHILL R, 1993, HUM NATURE-INT BIOS, V4, P237, DOI 10.1007/BF02692201; Wright DB, 2002, LAW HUMAN BEHAV, V26, P641, DOI 10.1023/A:1020981501383; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Zebrowitz L. A., 1997, READING FACES WINDOW	49	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14241	10.1371/journal.pone.0014241	http://dx.doi.org/10.1371/journal.pone.0014241			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	690XB	21151864	Green Published, gold			2022-12-27	WOS:000285041800002
J	Shrikhande, GV; Scali, ST; da Silva, CG; Damrauer, SM; Csizmadia, E; Putheti, P; Matthey, M; Arjoon, R; Patel, R; Siracuse, JJ; Maccariello, ER; Andersen, ND; Monahan, T; Peterson, C; Essayagh, S; Studer, P; Guedes, RP; Kocher, O; Usheva, A; Veves, A; Kaczmarek, E; Ferran, C				Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Putheti, Prabhakar; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kocher, Olivier; Usheva, Anny; Veves, Aristidis; Kaczmarek, Elzbieta; Ferran, Christiane			O-Glycosylation Regulates Ubiquitination and Degradation of the Anti-Inflammatory Protein A20 to Accelerate Atherosclerosis in Diabetic ApoE-Null Mice	PLOS ONE			English	Article							NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; ENDOTHELIAL-CELL ACTIVATION; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; GLYCEMIC CONTROL; FACTOR-ALPHA; NUCLEOCYTOPLASMIC GLYCOSYLATION; HEXOSAMINE PATHWAY; GLUCOSE-TRANSPORT	Background: Accelerated atherosclerosis is the leading cause of morbidity and mortality in diabetic patients. Hyperglycemia is a recognized independent risk factor for heightened atherogenesis in diabetes mellitus (DM). However, our understanding of the mechanisms underlying glucose damage to the vasculature remains incomplete. Methodology/Principal Findings: High glucose and hyperglycemia reduced upregulation of the NF-kappa B inhibitory and atheroprotective protein A20 in human coronary endothelial (EC) and smooth muscle cell (SMC) cultures challenged with Tumor Necrosis Factor alpha (TNF), aortae of diabetic mice following Lipopolysaccharide (LPS) injection used as an inflammatory insult and in failed vein-grafts of diabetic patients. Decreased vascular expression of A20 did not relate to defective transcription, as A20 mRNA levels were similar or even higher in EC/SMC cultured in high glucose, in vessels of diabetic C57BL/6 and FBV/N mice, and in failed vein grafts of diabetic patients, when compared to controls. Rather, decreased A20 expression correlated with post-translational O-Glucosamine-N-Acetylation (O-GlcNAcylation) and ubiquitination of A20, targeting it for proteasomal degradation. Restoring A20 levels by inhibiting O-GlcNAcylation, blocking proteasome activity, or overexpressing A20, blocked upregulation of the receptor for advanced glycation end-products (RAGE) and phosphorylation of PKC beta II, two prime atherogenic signals triggered by high glucose in EC/SMC. A20 gene transfer to the aortic arch of diabetic ApoE null mice that develop accelerated atherosclerosis, attenuated vascular expression of RAGE and phospho-PKC beta II, significantly reducing atherosclerosis. Conclusions: High glucose/hyperglycemia regulate vascular A20 expression via O-GlcNAcylation-dependent ubiquitination and proteasomal degradation. This could be key to the pathogenesis of accelerated atherosclerosis in diabetes.	[Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kaczmarek, Elzbieta; Ferran, Christiane] Harvard Univ, Sch Med, Dept Surg, Div Vasc Surg, Boston, MA 02115 USA; [Shrikhande, Gautam V.; Scali, Salvatore T.; da Silva, Cleide G.; Damrauer, Scott M.; Csizmadia, Eva; Matthey, Michaela; Arjoon, Roy; Patel, Rakesh; Siracuse, Jeffrey J.; Maccariello, Elizabeth R.; Andersen, Nicholas D.; Monahan, Thomas; Peterson, Clayton; Essayagh, Sanah; Studer, Peter; Guedes, Renata Padilha; Kaczmarek, Elzbieta; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Vasc Biol Res Ctr, Sch Med,Dept Med, Boston, MA 02215 USA; [Putheti, Prabhakar; Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Transplant Inst, Sch Med,Dept Med, Boston, MA 02215 USA; [Kocher, Olivier] Harvard Univ, Beth Israel Deaconess Med Ctr, Dept Pathol, Sch Med,Dept Med, Boston, MA 02215 USA; [Usheva, Anny] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Endocrinol, Sch Med,Dept Med, Boston, MA 02215 USA; [Veves, Aristidis] Harvard Univ, Sch Med, Joslin Beth Israel Deaconess Foot Ctr, Boston, MA USA; [Veves, Aristidis] Harvard Univ, Beth Israel Deaconess Med Ctr, Microcirculat Lab, Sch Med,Dept Med, Boston, MA 02215 USA; [Ferran, Christiane] Harvard Univ, Beth Israel Deaconess Med Ctr, Div Nephrol, Sch Med,Dept Med, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Shrikhande, GV (corresponding author), Columbia Univ, Med Ctr, Div Vasc Surg, New York, NY 10027 USA.	cferran@bidmc.harvard.edu	Angolano, Cleide/AAZ-4154-2021; Siracuse, Jeffrey/AAN-2987-2020	Damrauer, Scott/0000-0001-8009-1632; Andersen, Nicholas/0000-0002-0905-1694; Matthey, Michaela/0000-0002-1841-2906	National Institutes of Health (NIH) [HL080130, RO1 DK063275, HL057791, HL075678, HL062458, HL07734]; Juvenile Diabetes Research Foundation [1-2007-567]; American Diabetes Association; Swiss National foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062458, R01HL075678, R01HL080130, R01HL057791, T32HL007734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063275] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Swiss National foundation(Swiss National Science Foundation (SNSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by National Institutes of Health (NIH) Research Project Grant Program (R01) grants HL080130, RO1 DK063275, and HL057791; Juvenile Diabetes Research Foundation grant 1-2007-567 to CF; NIH R01 grant HL075678; an American Diabetes Association clinical research grant to AV; and NIH RO1 grant HL062458 to AU. GVS, STS, SMD, VIP, JSJ, CP and MDF are recipients of a fellowship award from the NIH T32 fellowship grant HL07734. PS is the recipient of a fellowship grant from the Swiss National foundation. RPG is the recipient of a research fellowship grant from the CNPQ, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2006, INVEST OPHTH VIS SCI, V47, P86, DOI 10.1167/iovs.05-0757; Alpert E, 2005, DIABETOLOGIA, V48, P752, DOI 10.1007/s00125-005-1681-y; Bach FH, 1997, IMMUNOL TODAY, V18, P483, DOI 10.1016/S0167-5699(97)01129-8; Boonyasrisawat W, 2007, DIABETES, V56, P499, DOI 10.2337/db06-0946; BROWNLEE M, 1995, ANNU REV MED, V46, P223, DOI 10.1146/annurev.med.46.1.223; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Butkinaree C., 2009, BIOCHIM BIOPHYS ACTA, V1800, P96; Chew EY, 2010, NEW ENGL J MED, V363, P233, DOI 10.1056/NEJMoa1001288; Cipollone F, 2003, CIRCULATION, V108, P1070, DOI 10.1161/01.CIR.0000086014.80477.0D; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; Daniel S, 2004, BLOOD, V104, P2376, DOI 10.1182/blood-2003-02-0635; Dluhy RG, 2008, NEW ENGL J MED, V358, P2630, DOI 10.1056/NEJMe0804182; Du XL, 2000, P NATL ACAD SCI USA, V97, P12222, DOI 10.1073/pnas.97.22.12222; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Faxon DP, 2004, CIRCULATION, V109, P2617, DOI 10.1161/01.CIR.0000128520.37674.EF; Federici M, 2002, CIRCULATION, V106, P466, DOI 10.1161/01.CIR.0000023043.02648.51; FOSS MC, 1992, BRAZ J MED BIOL RES, V25, P239; GUINEZ C, 2008, FASEB J; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Han I, 1997, MOL CELL BIOL, V17, P2550, DOI 10.1128/MCB.17.5.2550; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; HUTTI JE, 2007, MOL CELL BIOL; Idel S, 2003, P NATL ACAD SCI USA, V100, P14235, DOI 10.1073/pnas.1835672100; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; James LR, 2002, DIABETES, V51, P1146, DOI 10.2337/diabetes.51.4.1146; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kouroedov A, 2004, CIRCULATION, V110, P91, DOI 10.1161/01.CIR.0000133384.38551.A8; LAHERTY CD, 1992, J BIOL CHEM, V267, P24157; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Lechleitner M, 2000, J INTERN MED, V248, P67, DOI 10.1046/j.1365-2796.2000.00705.x; Longo CR, 2003, CIRCULATION, V108, P1113, DOI 10.1161/01.CIR.0000083718.76889.D0; Medzihradszky Katalin F., 2008, V446, P293, DOI 10.1007/978-1-60327-084-7_21; MONSIGNY M, 1980, EUR J BIOCHEM, V104, P147, DOI 10.1111/j.1432-1033.1980.tb04410.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OPIPARI AW, 1990, J BIOL CHEM, V265, P14705; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Patel VI, 2006, FASEB J, V20, P1418, DOI 10.1096/fj.05-4981com; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Su KH, 1999, J BIOL CHEM, V274, P15194, DOI 10.1074/jbc.274.21.15194; Tanaka N, 2000, J BIOL CHEM, V275, P25781, DOI 10.1074/jbc.M001235200; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tuttle KR, 2003, AM J KIDNEY DIS, V42, P456, DOI 10.1016/S0272-6386(03)00741-8; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Vosseller K, 2002, P NATL ACAD SCI USA, V99, P5313, DOI 10.1073/pnas.072072399; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Willfort-Ehringer A, 2004, DIABETOLOGIA, V47, P400, DOI 10.1007/s00125-004-1345-3; Wolfrum S, 2007, P NATL ACAD SCI USA, V104, P18601, DOI 10.1073/pnas.0709011104; Yan SF, 2003, CIRC RES, V93, P1159, DOI 10.1161/01.RES.0000103862.26506.3D; Zachara Natasha Elizabeth, 2004, Methods Mol Biol, V284, P175; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016; Zachara NE, 2004, TRENDS CELL BIOL, V14, P218, DOI 10.1016/j.tcb.2004.03.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7	57	60	62	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14240	10.1371/journal.pone.0014240	http://dx.doi.org/10.1371/journal.pone.0014240			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151899	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300012
J	Zhou, YM; Li, MH; Cheng, XB; Wang, CG; Fan, AN; Shi, LX; Wang, XX; Han, SJ				Zhou, Yumei; Li, Mai-He; Cheng, Xu-Bing; Wang, Cun-Guo; Fan, A-Nan; Shi, Lian-Xuan; Wang, Xiu-Xiu; Han, Shijie			Soil Respiration in Relation to Photosynthesis of Quercus mongolica Trees at Elevated CO2	PLOS ONE			English	Article							ATMOSPHERIC-CARBON-DIOXIDE; PINE PINUS-PONDEROSA; FINE-ROOT PRODUCTION; TEMPERATE FOREST; N FERTILIZATION; WATER-CONTENT; GAS-EXCHANGE; EFFLUX; RESPONSES; NITROGEN	Knowledge of soil respiration and photosynthesis under elevated CO2 is crucial for exactly understanding and predicting the carbon balance in forest ecosystems in a rapid CO2-enriched world. Quercus mongolica Fischer ex Ledebour seedlings were planted in open-top chambers exposed to elevated CO2 (EC = 500 mu mol mol(-1)) and ambient CO2 (AC = 370 mu mol mol(-1)) from 2005 to 2008. Daily, seasonal and inter-annual variations in soil respiration and photosynthetic assimilation were measured during 2007 and 2008 growing seasons. EC significantly stimulated the daytime soil respiration by 24.5% (322.4 at EC vs. 259.0 mg CO2 m(-2) hr(-1) at AC) in 2007 and 21.0% (281.2 at EC vs. 232.6 mg CO2 m(-2) hr(-1) at AC) in 2008, and increased the daytime CO2 assimilation by 28.8% (624.1 at EC vs. 484.6 mg CO2 m(-2) hr(-1) at AC) across the two growing seasons. The temporal variation in soil respiration was positively correlated with the aboveground photosynthesis, soil temperature, and soil water content at both EC and AC. EC did not affect the temperature sensitivity of soil respiration. The increased daytime soil respiration at EC resulted mainly from the increased aboveground photosynthesis. The present study indicates that increases in CO2 fixation of plants in a CO2-rich world will rapidly return to the atmosphere by increased soil respiration.	[Zhou, Yumei; Cheng, Xu-Bing; Wang, Cun-Guo; Han, Shijie] Chinese Acad Sci, Dept Forest Ecol, Inst Appl Ecol, Shenyang, Peoples R China; [Li, Mai-He] Swiss Fed Res Inst WSL, Tree Physiol Grp, Birmensdorf, Switzerland; [Cheng, Xu-Bing; Wang, Cun-Guo] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Fan, A-Nan] Dalian Forest Inst, Dalian, Peoples R China; [Shi, Lian-Xuan] NE Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Wang, Xiu-Xiu] Chinese Acad Sci, Res Stn Changbai Mt Forest Ecosyst, Erdao, Peoples R China	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Northeast Normal University - China; Chinese Academy of Sciences	Zhou, YM (corresponding author), Chinese Acad Sci, Dept Forest Ecol, Inst Appl Ecol, Shenyang, Peoples R China.	zhouyumei73@126.com	Zhou, Yu/HHN-3071-2022; Li, Mai-He/L-6390-2013	Li, Mai-He/0000-0002-7029-2841	Chinese Academy of Sciences [KZCX2-YW-JC404]; National Natural Science Foundation of China [40930107]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the important research direction project of the Chinese Academy of Sciences (KZCX2-YW-JC404) and projects of key program of the National Natural Science Foundation of China (40930107). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Andrews JA, 2001, GLOBAL BIOGEOCHEM CY, V15, P149, DOI 10.1029/2000GB001278; Aranjuelo I, 2009, GLOBAL CHANGE BIOL, V15, P97, DOI 10.1111/j.1365-2486.2008.01829.x; Bahn M, 2009, NEW PHYTOL, V182, P451, DOI 10.1111/j.1469-8137.2008.02755.x; Ball AS, 2000, SOIL BIOL BIOCHEM, V32, P721, DOI 10.1016/S0038-0717(99)00198-4; Ball BA, 2009, SOIL BIOL BIOCHEM, V41, P1510, DOI 10.1016/j.soilbio.2009.04.011; Barron-Gafford G, 2005, GLOBAL CHANGE BIOL, V11, P1220, DOI 10.1111/j.1365-2486.2005.00985.x; Bernhardt ES, 2006, BIOGEOCHEMISTRY, V77, P91, DOI 10.1007/s10533-005-1062-0; Buchmann N, 2000, SOIL BIOL BIOCHEM, V32, P1625, DOI 10.1016/S0038-0717(00)00077-8; Butnor JR, 2003, GLOBAL CHANGE BIOL, V9, P849, DOI 10.1046/j.1365-2486.2003.00630.x; Carbone MS, 2007, GLOBAL CHANGE BIOL, V13, P466, DOI 10.1111/j.1365-2486.2006.01300.x; Cardon ZG, 2001, SOIL BIOL BIOCHEM, V33, P365, DOI 10.1016/S0038-0717(00)00151-6; Cheng WX, 1998, PLANT SOIL, V202, P167, DOI 10.1023/A:1004315321332; Curtis PS, 2000, ECOL APPL, V10, P3, DOI 10.2307/2640982; Daly E, 2009, BIOGEOCHEMISTRY, V94, P271, DOI 10.1007/s10533-009-9327-7; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Davidson Eric A., 2009, P187, DOI 10.1007/978-1-4419-0026-5_8; Drake JE, 2008, PLANT CELL ENVIRON, V31, P1663, DOI 10.1111/j.1365-3040.2008.01869.x; Drewitt GB, 2002, AGR FOREST METEOROL, V110, P299, DOI 10.1016/S0168-1923(01)00294-5; Gaumont-Guay D, 2006, AGR FOREST METEOROL, V140, P220, DOI 10.1016/j.agrformet.2006.08.003; Griffin KL, 1997, PLANT SOIL, V190, P11, DOI 10.1023/A:1004253232103; Guan DX, 2006, AGR FOREST METEOROL, V137, P138, DOI 10.1016/j.agrformet.2006.02.003; Hartley IP, 2006, GLOBAL CHANGE BIOL, V12, P1954, DOI 10.1111/j.1365-2486.2006.01214.x; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Jach ME, 2000, ANN BOT-LONDON, V85, P789, DOI 10.1006/anbo.2000.1138; Janssens IA, 1998, GLOBAL CHANGE BIOL, V4, P871, DOI 10.1046/j.1365-2486.1998.00199.x; JOHNSON D, 1994, PLANT SOIL, V165, P129, DOI 10.1007/BF00009969; Khomik M, 2006, AGR FOREST METEOROL, V140, P244, DOI 10.1016/j.agrformet.2006.08.006; King JS, 2004, GLOBAL CHANGE BIOL, V10, P1027, DOI 10.1111/j.1529-8817.2003.00789.x; King JS, 2001, OECOLOGIA, V128, P237, DOI 10.1007/s004420100656; Liberloo M, 2007, NEW PHYTOL, V173, P537, DOI 10.1111/j.1469-8137.2006.01926.x; Lin GH, 1999, GLOB CHANGE BIOL, V5, P157, DOI 10.1046/j.1365-2486.1999.00211.x; Lin GH, 2001, PLANT SOIL, V229, P259, DOI 10.1023/A:1004883221036; LIU SY, 1995, TREE PHYSIOL, V15, P351, DOI 10.1093/treephys/15.6.351; Luo YQ, 1996, OECOLOGIA, V108, P130, DOI 10.1007/BF00333224; Matamala R, 2000, GLOB CHANGE BIOL, V6, P967, DOI 10.1046/j.1365-2486.2000.00374.x; Mielnick PC, 2000, SOIL BIOL BIOCHEM, V32, P221, DOI 10.1016/S0038-0717(99)00150-9; Moren AS, 2000, AGR FOREST METEOROL, V101, P1, DOI 10.1016/S0168-1923(99)00160-4; Niinisto SM, 2004, GLOBAL CHANGE BIOL, V10, P1363, DOI 10.1111/j.1365-2486.2004.00799.x; Nsabimana D, 2009, SOIL BIOL BIOCHEM, V41, P396, DOI 10.1016/j.soilbio.2008.12.004; Pendall E, 2004, NEW PHYTOL, V162, P311, DOI 10.1111/j.1469-8137.2004.01053.x; Pregitzer KS, 2000, NEW PHYTOL, V147, P105, DOI 10.1046/j.1469-8137.2000.00689.x; PREGITZER KS, 1995, NEW PHYTOL, V129, P579, DOI 10.1111/j.1469-8137.1995.tb03025.x; Pregitzer KS, 2000, ECOL APPL, V10, P18, DOI 10.1890/1051-0761(2000)010[0018:IEOACA]2.0.CO;2; Pregitzer K, 2006, OECOLOGIA, V148, P503, DOI 10.1007/s00442-006-0381-8; RAICH JW, 1995, GLOBAL BIOGEOCHEM CY, V9, P23, DOI 10.1029/94GB02723; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; Rasse DP, 2005, GLOBAL CHANGE BIOL, V11, P369, DOI 10.1111/j.1365-2486.2005.00913.x; Rayment MB, 2000, SOIL BIOL BIOCHEM, V32, P35, DOI 10.1016/S0038-0717(99)00110-8; Saiz G, 2006, GLOBAL CHANGE BIOL, V12, P1007, DOI 10.1111/j.1365-2486.2006.01145.x; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Sholtis JD, 2004, NEW PHYTOL, V162, P343, DOI 10.1111/j.1469-8137.2004.01028.x; Soe ARB, 2004, PLANT SOIL, V262, P85, DOI 10.1023/B:PLSO.0000037025.78016.9b; Sommerkorn M, 2008, SOIL BIOL BIOCHEM, V40, P1792, DOI 10.1016/j.soilbio.2008.03.002; Steinmann KTW, 2004, OECOLOGIA, V141, P489, DOI 10.1007/s00442-004-1674-4; Subke JA, 2003, SOIL BIOL BIOCHEM, V35, P1467, DOI 10.1016/S0038-0717(03)00241-4; Taneva L, 2008, SOIL BIOL BIOCHEM, V40, P2670, DOI 10.1016/j.soilbio.2008.07.013; Tang JW, 2005, GLOBAL CHANGE BIOL, V11, P1298, DOI 10.1111/j.1365-2486.2005.00978.x; Thomas SM, 2000, GLOBAL CHANGE BIOL, V6, P393, DOI 10.1046/j.1365-2486.2000.00321.x; Tingey DT, 2006, SOIL BIOL BIOCHEM, V38, P1764, DOI 10.1016/j.soilbio.2005.12.003; Tingey DT, 2006, NEW PHYTOL, V170, P107, DOI 10.1111/j.1469-8137.2006.01646.x; Vose JM, 1997, PLANT SOIL, V190, P19, DOI 10.1023/A:1004204129128; VOSE JM, 1995, CAN J FOREST RES, V25, P1243, DOI 10.1139/x95-137; Wieser G, 2004, TREE PHYSIOL, V24, P475, DOI 10.1093/treephys/24.4.475; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Xu WH, 2008, SOIL BIOL BIOCHEM, V40, P679, DOI 10.1016/j.soilbio.2007.10.003; Yuste JC, 2004, GLOBAL CHANGE BIOL, V10, P161, DOI 10.1111/j.1529-8817.2003.00727.x; Zak DR, 2000, NEW PHYTOL, V147, P201, DOI 10.1046/j.1469-8137.2000.00687.x; ZHENG JQ, 2008, THESIS	70	13	14	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15134	10.1371/journal.pone.0015134	http://dx.doi.org/10.1371/journal.pone.0015134			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151897	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300017
J	Semo, M; Gias, C; Ahmado, A; Sugano, E; Allen, AE; Lawrence, JM; Tomita, H; Coffey, PJ; Vugler, AA				Semo, Ma'ayan; Gias, Carlos; Ahmado, Ahmad; Sugano, Eriko; Allen, Annette E.; Lawrence, Jean M.; Tomita, Hiroshi; Coffey, Peter J.; Vugler, Anthony A.			Dissecting a Role for Melanopsin in Behavioural Light Aversion Reveals a Response Independent of Conventional Photoreception	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; MICE LACKING; PUPILLARY CONSTRICTION; OCULAR PHOTORECEPTORS; RETROSPLENIAL CORTEX; VISUAL-CORTEX; MOUSE MODEL; NON-CONE; NON-ROD	Melanopsin photoreception plays a vital role in irradiance detection for non-image forming responses to light. However, little is known about the involvement of melanopsin in emotional processing of luminance. When confronted with a gradient in light, organisms exhibit spatial movements relative to this stimulus. In rodents, behavioural light aversion (BLA) is a well-documented but poorly understood phenomenon during which animals attribute salience to light and remove themselves from it. Here, using genetically modified mice and an open field behavioural paradigm, we investigate the role of melanopsin in BLA. While wildtype (WT), melanopsin knockout (Opn4(-/-)) and rd/rd cl (melanopsin only (MO)) mice all exhibit BLA, our novel methodology reveals that isolated melanopsin photoreception produces a slow, potentiating response to light. In order to control for the involvement of pupillary constriction in BLA we eliminated this variable with topical atropine application. This manipulation enhanced BLA in WT and MO mice, but most remarkably, revealed light aversion in triple knockout (TKO) mice, lacking three elements deemed essential for conventional photoreception (Opn4(-/-) Gnat1(-/-) Cnga3(-/-)). Using a number of complementary strategies, we determined this response to be generated at the level of the retina. Our findings have significant implications for the understanding of how melanopsin signalling may modulate aversive responses to light in mice and humans. In addition, we also reveal a clear potential for light perception in TKO mice.	[Semo, Ma'ayan; Gias, Carlos; Ahmado, Ahmad; Lawrence, Jean M.; Coffey, Peter J.; Vugler, Anthony A.] UCL, Dept Ocular Biol & Therapeut, Inst Ophthalmol, London, England; [Sugano, Eriko; Tomita, Hiroshi] Tohoku Univ, Inst Int Adv Interdisciplinary Res, Aoba Ku, Sendai, Miyagi 980, Japan; [Allen, Annette E.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of London; University College London; Tohoku University; University of Manchester	Semo, M (corresponding author), UCL, Dept Ocular Biol & Therapeut, Inst Ophthalmol, London, England.	m.semo@ucl.ac.uk; a.vugler@ucl.ac.uk	Tomita, Hiroshi/O-2135-2018; Ahmado, Ahmad/R-5537-2019	Tomita, Hiroshi/0000-0003-1051-2301; Allen, Annette/0000-0003-0214-7076; Semo, Ma'ayan/0000-0002-3890-721X; Coffey, Peter/0000-0002-5427-2939	London Project to Cure Blindness; Lincy Foundation	London Project to Cure Blindness; Lincy Foundation	This work was funded by the London Project to Cure Blindness (www.thelondonproject.org/) and the Lincy Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Altimus CM, 2008, P NATL ACAD SCI USA, V105, P19998, DOI 10.1073/pnas.0808312105; ALTMAN J, 1962, AM J PHYSIOL, V202, P1208, DOI 10.1152/ajplegacy.1962.202.6.1208; ARAI M, 1993, BRAIN RES, V613, P341, DOI 10.1016/0006-8993(93)90924-C; Barnard AR, 2004, VISUAL NEUROSCI, V21, P675, DOI 10.1017/S0952523804215024; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Crozier WJ, 1927, J GEN PHYSIOL, V10, P407, DOI 10.1085/jgp.10.3.407; Dacey DM, 2005, NATURE, V433, P749, DOI 10.1038/nature03387; Del Cano GG, 2000, J COMP NEUROL, V425, P393, DOI 10.1002/1096-9861(20000925)425:3<393::AID-CNE5>3.0.CO;2-G; DRUMMOND PD, 1986, HEADACHE, V26, P465, DOI 10.1111/j.1526-4610.1986.hed2609465.x; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; FLYNN JP, 1952, J COMP PHYSIOL PSYCH, V45, P336, DOI 10.1037/h0054587; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; GARCIAFERNANDEZ JM, 1995, NEUROSCI LETT, V187, P33; Gobersztejn F, 1996, BRAZ J MED BIOL RES, V29, P1507; Goz D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003153; Guler AD, 2008, NATURE, V453, P102, DOI 10.1038/nature06829; Hannibal J, 2004, NEUROREPORT, V15, P2317, DOI 10.1097/00001756-200410250-00003; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2006, J COMP NEUROL, V497, P326, DOI 10.1002/cne.20970; Hetherington L, 2000, INVEST OPHTH VIS SCI, V41, P3979; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Jimenez AJ, 1996, CELL TISSUE RES, V284, P193, DOI 10.1007/s004410050579; Keller FS, 1941, PSYCHOL REC, V4, P235, DOI 10.1007/BF03393248; KING V, 1972, J AM OPTOM ASSOC, V43, P53; LAU KC, 1992, J NEUROL SCI, V113, P70, DOI 10.1016/0022-510X(92)90267-O; Lebensohn JE, 1934, ARCH OPHTHALMOL-CHIC, V12, P380; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Lin B, 2008, P NATL ACAD SCI USA, V105, P16009, DOI 10.1073/pnas.0806114105; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lupi D, 2008, NAT NEUROSCI, V11, P1068, DOI 10.1038/nn.2179; MACLEAN PD, 1949, PSYCHOSOM MED, V11, P338, DOI 10.1097/00006842-194911000-00003; May CA, 2002, INVEST OPHTH VIS SCI, V43, P2206; MISSLIN R, 1989, BEHAV PROCESS, V18, P119, DOI 10.1016/S0376-6357(89)80010-5; MISSLIN R, 1986, BEHAV PROCESS, V12, P45, DOI 10.1016/0376-6357(86)90069-0; Mojumder DK, 2010, INVEST OPHTH VIS SCI, V51, P567, DOI 10.1167/iovs.09-4168; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; Mrosovsky N, 2002, NATURWISSENSCHAFTEN, V89, P525, DOI 10.1007/s00114-002-0369-0; Mrosovsky N, 1997, NEUROSCI LETT, V222, P204, DOI 10.1016/S0304-3940(97)13374-2; Mrosovsky N, 2001, J BIOL RHYTHM, V16, P585, DOI 10.1177/074873001129002277; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Ochsner KN, 2007, TRENDS COGN SCI, V11, P317, DOI 10.1016/j.tics.2007.06.008; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; ONAIVI ES, 1989, PROG NEURO-PSYCHOPH, V13, P963, DOI 10.1016/0278-5846(89)90047-X; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Papez JW, 1937, ARCH NEURO PSYCHIATR, V38, P725, DOI 10.1001/archneurpsyc.1937.02260220069003; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; READER AL, 1977, AM J OPHTHALMOL, V84, P263, DOI 10.1016/0002-9394(77)90861-3; Recober A, 2010, NEUROPHARMACOLOGY, V58, P156, DOI 10.1016/j.neuropharm.2009.07.009; Robinson GA, 2004, VISION RES, V44, P2667, DOI 10.1016/j.visres.2004.06.010; Russo Andrew F, 2009, Mol Cell Pharmacol, V1, P264; Schmucker C, 2005, INVEST OPHTH VIS SCI, V46, P398, DOI 10.1167/iovs.04-0959; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Semo M, 2003, EUR J NEUROSCI, V18, P3007, DOI 10.1111/j.1460-9568.2003.03061.x; Sliney DH, 1997, DEV OPHTHALMOL, V27, P63; Stringham JM, 2004, INVEST OPHTH VIS SCI, V45, P3838, DOI 10.1167/iovs.04-0038; Stringham JM, 2003, J OPT SOC AM A, V20, P1852, DOI 10.1364/JOSAA.20.001852; Sugano E, 2005, INVEST OPHTH VIS SCI, V46, P3341, DOI 10.1167/iovs.04-1351; Thiels E, 2008, CURR EYE RES, V33, P483, DOI 10.1080/02713680802130347; Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1; Tomita H, 2007, INVEST OPHTH VIS SCI, V48, P3821, DOI 10.1167/iovs.06-1501; Tomita H, 2010, EXP EYE RES, V90, P429, DOI 10.1016/j.exer.2009.12.006; Tsai JW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000125; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Vugler AA, 2003, EXP NEUROL, V184, P464, DOI 10.1016/S0014-4886(03)00267-X; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; WELKER WI, 1959, J COMP PHYSIOL PSYCH, V52, P106, DOI 10.1037/h0042241; WYSS JM, 1992, HIPPOCAMPUS, V2, P1; Zaidi FH, 2007, CURR BIOL, V17, P2122, DOI 10.1016/j.cub.2007.11.034	80	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15009	10.1371/journal.pone.0015009	http://dx.doi.org/10.1371/journal.pone.0015009			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124784	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500014
J	Cao, F; Chen, Y; Cierpicki, T; Liu, YF; Basrur, V; Lei, M; Dou, YL				Cao, Fang; Chen, Yong; Cierpicki, Tomasz; Liu, Yifan; Basrur, Venkatesha; Lei, Ming; Dou, Yali			An Ash2L/RbBP5 Heterodimer Stimulates the MLL1 Methyltransferase Activity through Coordinated Substrate Interactions with the MLL1 SET Domain	PLOS ONE			English	Article							LINEAGE LEUKEMIA PROTEIN-1; H3 LYSINE 4; HISTONE H3; STRUCTURAL BASIS; TRANSCRIPTIONAL REGULATION; CORE COMPLEX; METHYLATION; RECOGNITION; SPECIFICITY; MECHANISMS	Histone H3 lysine 4 (K4) methylation is a prevalent mark associated with transcription activation and is mainly catalyzed by the MLL/SET1 family histone methyltransferases. A common feature of the mammalian MLL/SET1 complexes is the presence of three core components (RbBP5, Ash2L and WDR5) and a catalytic subunit containing a SET domain. Unlike most other histone lysine methyltransferases, all four proteins are required for efficient H3 K4 methylation. Despite extensive efforts, mechanisms for how three core components regulate MLL/SET1 methyltransferase activity remain elusive. Here we show that a heterodimer of Ash2L and RbBP5 has intrinsic histone methyltransferase activity. This activity requires the highly conserved SPRY domain of Ash2L and a short peptide of RbBP5. We demonstrate that both Ash2L and the MLL1 SET domain are capable of binding to S-adenosyl-L- [methyl-(3)H] methionine in the MLL1 core complex. Mutations in the MLL1 SET domain that fail to support overall H3 K4 methylation also compromise SAM binding by Ash2L. Taken together, our results show that the Ash2L/RbBP5 heterodimer plays a critical role in the overall catalysis of MLL1 mediated H3 K4 methylation. The results we describe here provide mechanistic insights for unique regulation of the MLL1 methyltransferase activity. It suggests that both Ash2L/RbBP5 and the MLL1 SET domain make direct contacts with the substrates and contribute to the formation of a joint catalytic center. Given the shared core configuration among all MLL/SET1 family HMTs, it will be interesting to test whether the mechanism we describe here can be generalized to other MLL/SET1 family members in the future.	[Cao, Fang; Cierpicki, Tomasz; Liu, Yifan; Basrur, Venkatesha; Dou, Yali] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chen, Yong; Lei, Ming; Dou, Yali] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Lei, Ming] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan	Cao, F (corresponding author), Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA.	leim@umich.edu; yalid@umich.edu	cao, fang/G-4926-2012; Chen, Yong/AAF-9915-2020	Chen, Yong/0000-0001-5857-6086; Liu, Yifan/0000-0002-3896-0002	NIH [R01GM082856]; American Cancer Society [RSG-10-150-01-DMC]; American Association for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082856] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); American Association for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Dou is supported by grants from NIH (R01GM082856), American Cancer Society (RSG-10-150-01-DMC) and American Association for Cancer Research. Dr. Lei is an early-stage investigator of Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Cummings MD, 2006, J BIOMOL SCREEN, V11, P854, DOI 10.1177/1087057106292746; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Dou YL, 2008, INT J HEMATOL, V87, P10, DOI 10.1007/s12185-007-0009-8; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Guenther MG, 2005, P NATL ACAD SCI USA, V102, P8603, DOI 10.1073/pnas.0503072102; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jacobs SA, 2002, NAT STRUCT BIOL, V9, P833, DOI 10.1038/nsb861; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Kuang ZH, 2009, J MOL BIOL, V386, P662, DOI 10.1016/j.jmb.2008.12.078; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Luger K, 1997, J MOL BIOL, V272, P301, DOI 10.1006/jmbi.1997.1235; Milne TA, 2005, CANCER RES, V65, P11367, DOI 10.1158/0008-5472.CAN-05-1041; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakamura T, 2002, MOL CELL, V10, P1119, DOI 10.1016/S1097-2765(02)00740-2; Odho Z, 2010, J BIOL CHEM, V285, P32967, DOI 10.1074/jbc.M110.159921; Patel A, 2008, J BIOL CHEM, V283, P32162, DOI 10.1074/jbc.M806317200; Patel A, 2008, J BIOL CHEM, V283, P32158, DOI 10.1074/jbc.C800164200; Patel A, 2009, J BIOL CHEM, V284, P24242, DOI 10.1074/jbc.M109.014498; Qian CM, 2006, J MOL BIOL, V359, P86, DOI 10.1016/j.jmb.2006.03.006; Rhodes DA, 2005, IMMUNOLOGY, V116, P411, DOI 10.1111/j.1365-2567.2005.02248.x; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Song JJ, 2008, J BIOL CHEM, V283, P35258, DOI 10.1074/jbc.M806900200; Southall SM, 2009, MOL CELL, V33, P181, DOI 10.1016/j.molcel.2008.12.029; Thiel AT, 2010, CANCER CELL, V17, P148, DOI 10.1016/j.ccr.2009.12.034; Wilson JR, 2002, CELL, V111, P105, DOI 10.1016/S0092-8674(02)00964-9; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Xu ZJ, 2009, J CELL BIOL, V186, P343, DOI 10.1083/jcb.200902146; Zhang X, 2002, CELL, V111, P117, DOI 10.1016/S0092-8674(02)00999-6; Zhang X, 2003, MOL CELL, V12, P177, DOI 10.1016/S1097-2765(03)00224-7	39	74	81	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14102	10.1371/journal.pone.0014102	http://dx.doi.org/10.1371/journal.pone.0014102			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124902	gold, Green Published, Green Submitted			2022-12-27	WOS:000284527900014
J	Hayashi, Y; Chan, TC; Warashina, M; Fukuda, M; Ariizumi, T; Okabayashi, K; Takayama, N; Otsu, M; Eto, K; Furue, MK; Michiue, T; Ohnuma, K; Nakauchi, H; Asashima, M				Hayashi, Yohei; Chan, Techuan; Warashina, Masaki; Fukuda, Masakazu; Ariizumi, Takashi; Okabayashi, Koji; Takayama, Naoya; Otsu, Makoto; Eto, Koji; Furue, Miho Kusuda; Michiue, Tatsuo; Ohnuma, Kiyoshi; Nakauchi, Hiromitsu; Asashima, Makoto			Reduction of N-Glycolylneuraminic Acid in Human Induced Pluripotent Stem Cells Generated or Cultured under Feeder- and Serum-Free Defined Conditions	PLOS ONE			English	Article							HUMAN FIBROBLASTS; GROWTH; INDUCTION	Background: The successful establishment of human induced pluripotent stem cells (hiPSCs) has increased the possible applications of stem cell research in biology and medicine. In particular, hiPSCs are a promising source of cells for regenerative medicine and pharmacology. However, one of the major obstacles to such uses for hiPSCs is the risk of contamination from undefined pathogens in conventional culture conditions that use serum replacement and mouse embryonic fibroblasts as feeder cells. Methodology/Principal Findings: Here we report a simple method for generating or culturing hiPSCs under feeder- and serum-free defined culture conditions that we developed previously for human embryonic stem cells. The defined culture condition comprises a basal medium with a minimal number of defined components including five highly purified proteins and fibronectin as a substrate. First, hiPSCs, which were generated using Yamanaka's four factors and conventional undefined culture conditions, adapted to the defined culture conditions. These adapted cells retained the property of self renewal as evaluated morphologically, the expression of self-renewal marker proteins, standard growth rates, and pluripotency as evaluated by differentiation into derivatives of all three primary germ layers in vitro and in vivo (teratoma formation in immunodeficient mice). Moreover, levels of nonhuman N-glycolylneuraminic acid (Neu5Gc), which is a xenoantigenic indicator of pathogen contamination in human iPS cell cultures, were markedly decreased in hiPSCs cultured under the defined conditions. Second, we successfully generated hiPSCs using adult dermal fibroblast under the defined culture conditions from the reprogramming step. For a long therm culture, the generated cells also had the property of self renewal and pluripotency, they carried a normal karyotype, and they were Neu5Gc negative. Conclusion/Significance: This study suggested that generation or adaption culturing under defined culture conditions can eliminate the risk posed by undefined pathogens. This success in generating hiPSCs using adult fibroblast would be beneficial for clinical application.	[Hayashi, Yohei; Chan, Techuan; Ariizumi, Takashi; Okabayashi, Koji; Michiue, Tatsuo; Ohnuma, Kiyoshi; Asashima, Makoto] Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo, Japan; [Warashina, Masaki] Wako Pure Chem Ind Ltd, Genome Res Labs, Hyogo, Japan; [Fukuda, Masakazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; [Takayama, Naoya; Otsu, Makoto; Eto, Koji; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell & Regenerat Med, Div Stem Cell Therapy, Tokyo 113, Japan; [Furue, Miho Kusuda] Natl Inst Biomed Innovat, Dept Dis Bioresources, Lab Cell Cultures, Osaka, Japan; [Ohnuma, Kiyoshi] Nagaoka Univ Technol, Top Runner Incubat Ctr Acad Ind Fus, Nagaoka, Niigata 94021, Japan; [Asashima, Makoto] Natl Inst Adv Ind Sci & Technol, Organ Dev Res Lab, Ibaraki, Japan	University of Tokyo; University of Tokyo; University of Tokyo; National Institute of Health Sciences - Japan; Nagaoka University of Technology; National Institute of Advanced Industrial Science & Technology (AIST)	Hayashi, Y (corresponding author), Univ Tokyo, Dept Life Sci Biol, Grad Sch Arts & Sci, Tokyo, Japan.	kohnuma@vos.nagaokaut.ac.jp; asashi@bio.c.u-tokyo.ac.jp	Okabayashi, Koji/G-6317-2013; Hayashi, Yohei/AAF-6059-2020; Asashima, Makoto/O-8389-2018; Hayashi, Yohei/L-8190-2019	Hayashi, Yohei/0000-0001-5490-7052; Asashima, Makoto/0000-0002-0012-026X; Ohnuma, Kiyoshi/0000-0002-2272-3643; Furue, Miho/0000-0001-5032-9953; Otsu, Makoto/0000-0002-9769-0217	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan; Ministry of Health, Labor, and Welfare of Japan; Promotion of Independent Research Environment for Young researchers; Grants-in-Aid for Scientific Research [21390321] Funding Source: KAKEN	Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Promotion of Independent Research Environment for Young researchers; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for Scientific Research and the Project for Realization of Regenerative Medicine from the Ministry of Education, Science, Sports, Culture and Technology (MEXT) of Japan, by grants from the Ministry of Health, Labor, and Welfare of Japan to M.K.F. and by Promotion of Independent Research Environment for Young researchers to K. Oh. The funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian V, 2010, IN VITRO CELL DEV-AN, V46, P247, DOI 10.1007/s11626-010-9297-z; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Bardor M, 2005, J BIOL CHEM, V280, P4228, DOI 10.1074/jbc.M412040200; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Furue M, 2005, IN VITRO CELL DEV-AN, V41, P19; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Furue MK, 2010, IN VITRO CELL DEV-AN, V46, P573, DOI 10.1007/s11626-010-9317-z; Hayashi Y, 2007, STEM CELLS, V25, P3005, DOI 10.1634/stemcells.2007-0103; Hayashi Y, 2010, IN VITRO CELL DEV-AN, V46, P416, DOI 10.1007/s11626-009-9266-6; Heiskanen A, 2007, STEM CELLS, V25, P197, DOI 10.1634/stemcells.2006-0444; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; ODORICO J, 2005, HUMAN EMBRYONIC STEM; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Price PJ, 1998, International Publication, Patent No. [WO/1998/30679, 199830679]; Price PJ, 1998, International Application, Patent No. [PCT/US1998/ 000467, 1998000467]; Rodriguez-Piza I, 2010, STEM CELLS, V28, P36, DOI 10.1002/stem.248; Ross PJ, 2010, STEM CELLS DEV, V19, P1221, DOI 10.1089/scd.2009.0459; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	26	39	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14099	10.1371/journal.pone.0014099	http://dx.doi.org/10.1371/journal.pone.0014099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124894	Green Published, Green Submitted, gold			2022-12-27	WOS:000284527900011
J	Wang, CL; Chen, YH; Ku, LX; Wang, TG; Sun, ZH; Cheng, FF; Wu, LC				Wang, Cuiling; Chen, Yanhui; Ku, Lixia; Wang, Tiegu; Sun, Zhaohui; Cheng, Fangfang; Wu, Liancheng			Mapping QTL Associated with Photoperiod Sensitivity and Assessing the Importance of QTLxEnvironment Interaction for Flowering Time in Maize	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; X ENVIRONMENT INTERACTIONS; TROPICAL MAIZE; PLANT HEIGHT; GENETIC ARCHITECTURE; IDENTIFICATION; TEMPERATURE; RESISTANCE; CULTIVARS; PROGENY	Background: An understanding of the genetic determinism of photoperiod response of flowering is a prerequisite for the successful exchange of germplasm across different latitudes. In order to contribute to resolve the genetic basis of photoperiod sensitivity in maize, a set of 201 recombinant inbred lines (RIL), derived from a temperate and tropical inbred line cross were evaluated in 5 field trials spread in short-and long-day environments. Methodology/Principal Findings: Firstly, QTL analyses for flowering time and photoperiod sensitivity in maize were conducted in individual photoperiod environments separately, and then, the total genetic effect was partitioned into additive effect (A) and additive-by-environment interaction effect (AE) by using a mixed-model-based composite interval mapping (MCIM) method. Conclusions/Significance: Seven putative QTL were found associated with DPS thermal time based on the data estimated in individual environments. Nine putative QTL were found associated with DPS thermal time across environments and six of them showed significant QTLxenviroment (QE) interactions. Three QTL for photoperiod sensitivity were identified on chromosome 4, 9 and 10, which had the similar position to QTL for DPS thermal time in the two long-day environment. The major photoperiod sensitive loci qDPS10 responded to both short and long-day photoperiod environments and had opposite effects in different photoperiod environment. The QTL qDPS3, which had the greatest additive effect exclusively in the short-day environment, were photoperiod independent and should be classified in autonomous promotion pathway.	[Wang, Cuiling; Chen, Yanhui; Ku, Lixia; Wang, Tiegu; Sun, Zhaohui; Cheng, Fangfang; Wu, Liancheng] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China; [Wang, Cuiling] Henan Univ Sci & Technol, Coll Agron, Luoyang, Peoples R China; [Wang, Tiegu] Henan Inst Sci & Technol, Coll Life Sci, Xinxiang, Peoples R China; [Cheng, Fangfang] Gongyi Meteorol Off, Gongyi, Peoples R China	Henan Agricultural University; Henan University of Science & Technology; Henan Institute of Science & Technology	Wang, CL (corresponding author), Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China.	chy989@sohu.com		Wang, Cuiling/0000-0001-8918-195X	National Natural Science Foundation of China [30571167, 30971789]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Natural Science Foundation of China (No. 30571167 and No. 30971789). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DF, 2001, THEOR APPL GENET, V102, P163, DOI 10.1007/s001220051632; Balint-Kurti PJ, 2007, GENETICS, V176, P645, DOI 10.1534/genetics.106.067892; BEAVIS WD, 1994, CROP SCI, V34, P882, DOI 10.2135/cropsci1994.0011183X003400040010x; Birch CJ, 1998, FIELD CROP RES, V55, P93, DOI 10.1016/S0378-4290(97)00062-2; Bohn M, 1997, CROP SCI, V37, P1892, DOI 10.2135/cropsci1997.0011183X003700060038x; BONHOMME R, 1994, CROP SCI, V34, P156, DOI 10.2135/cropsci1994.0011183X003400010028x; Bouchez A, 2002, GENETICS, V162, P1945; Briggs WH, 2007, GENETICS, V177, P1915, DOI 10.1534/genetics.107.076497; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Chardon F, 2004, GENETICS, V168, P2169, DOI 10.1534/genetics.104.032375; Chardon F, 2005, THEOR APPL GENET, V112, P1, DOI 10.1007/s00122-005-0050-z; Chen YanHui, 2003, Scientia Agricultura Sinica, V36, P248; COLES ND, 2009, GENETICS, V162, P2169; Doerge RW, 1996, GENETICS, V142, P285; Ducrocq S, 2008, GENETICS, V178, P2433, DOI 10.1534/genetics.107.084830; ELLIS RH, 1992, CROP SCI, V32, P1225, DOI 10.2135/cropsci1992.0011183X003200050033x; FRANCIS CA, 1969, CROP SCI, V9, P675, DOI 10.2135/cropsci1969.0011183X000900050054x; Giauffret C, 2000, CROP SCI, V40, P1004, DOI 10.2135/cropsci2000.4041004x; Goodman MM, 2000, MAYDICA, V45, P221; Gouesnard B, 2002, GENET RESOUR CROP EV, V49, P471, DOI 10.1023/A:1020982827604; Jiang C, 1999, THEOR APPL GENET, V99, P1106, DOI 10.1007/s001220051315; Khairallah MM, 1998, PLANT BREEDING, V117, P309, DOI 10.1111/j.1439-0523.1998.tb01947.x; KINIRY JR, 1983, AGRON J, V75, P687, DOI 10.2134/agronj1983.00021962007500040026x; KNAPP SJ, 1985, CROP SCI, V25, P192, DOI 10.2135/cropsci1985.0011183X002500010046x; KOESTER RP, 1993, CROP SCI, V33, P1209, DOI 10.2135/cropsci1993.0011183X003300060020x; Kozumplik V, 1996, MAYDICA, V41, P211; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liu Guifu, 2007, Journal of Genetics and Genomics, V34, P608, DOI 10.1016/S1673-8527(07)60069-1; Moutiq R., 2002, P257, DOI 10.1079/9780851996011.0257; Ribaut JM, 2007, MOL BREEDING, V20, P15, DOI 10.1007/s11032-006-9041-2; Ribaut JM, 1996, THEOR APPL GENET, V92, P905, DOI 10.1007/BF00221905; RUSSEL WK, 1983, AGRON J, V75, P795; Salvi S, 2002, PLANT MOL BIOL, V48, P601, DOI 10.1023/A:1014838024509; Searle SR., 1992, VARIANCE COMPONENTS; STUBER CW, 1992, GENETICS, V132, P823; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; van Nocker S, 2000, PLANT MOL BIOL, V44, P107, DOI 10.1023/A:1006472929800; Veldboom LR, 1996, CROP SCI, V36, P1320, DOI 10.2135/cropsci1996.0011183X003600050041x; Vladutu C, 1999, GENETICS, V153, P993; Wang CL, 2008, THEOR APPL GENET, V117, P1129, DOI 10.1007/s00122-008-0851-y; Wang DL, 1999, THEOR APPL GENET, V99, P1255, DOI 10.1007/s001220051331; Yang J, 2008, BIOINFORMATICS, V24, P721, DOI 10.1093/bioinformatics/btm494; ZHANG KP, 2008, J GENET GENOMICS, V35, P119, DOI DOI 10.1016/S1673-8527(08)60017-X; Zhang KP, 2009, EUPHYTICA, V165, P471, DOI 10.1007/s10681-008-9756-8	44	19	22	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14068	10.1371/journal.pone.0014068	http://dx.doi.org/10.1371/journal.pone.0014068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124912	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100015
J	Du, JA; Zhao, F; Zhou, Y; Yan, H; Duan, XG; Liang, SQ; Wang, YL; Fu, QX; Wang, XH; Peng, JC; Zhan, LS				Du, Juan; Zhao, Fang; Zhou, Yong; Yan, Hu; Duan, Xiang-guo; Liang, Sheng-qiang; Wang, Ying-li; Fu, Qiu-xia; Wang, Xiao-hui; Peng, Jian-chun; Zhan, Lin-sheng			Bioluminescence Imaging Allows Monitoring Hepatitis C Virus Core Protein Inhibitors in Mice	PLOS ONE			English	Article							SMALL INTERFERING RNAS; TAIL VEIN INJECTION; GENOMIC INTEGRATION; GENE-EXPRESSION; PHI-C31 INTEGRASE; TRANSGENIC MICE; PLASMID DNA; CELLS; REPLICATION; DELIVERY	Background: The development of small molecule inhibitors of hepatitis C virus (HCV) core protein as antiviral agents has been intensively pursued as a viable strategy to eradicate HCV infection. However, lack of a robust and convenient small animal model has hampered the assessment of in vivo efficacy of any antiviral compound. Methodology/Principal Findings: The objective of this work was to develop a novel method to screen anti-core protein siRNA in the mouse liver by bioluminescence imaging. The inhibitory effect of two shRNAs targeting the highly conserved core region of the HCV genome, shRNA452 and shRNA523, was examined using this method. In the transient mouse model, the effect of shRNA-523 was detectable at as early as 24 h and became even more pronounced at later time points. The effect of shRNA-452 was not detectable until 48 h post-transduction. In a stable mouse model, shRNA523 reduced luciferase levels by up to 76.4 +/- 26.0% and 91.8 +/- 8.0% at 6 h and 12 h after injection respectively, and the inhibitory effect persisted for 1 day after a single injection while shRNA-Scramble did not seem to have an effect on the luciferase activity in vivo. Conclusions/Significance: Thus, we developed a simple and quantitative assay for real-time monitoring of HCV core protein inhibitors in mice.	[Du, Juan; Zhao, Fang; Zhou, Yong; Yan, Hu; Liang, Sheng-qiang; Wang, Ying-li; Fu, Qiu-xia; Wang, Xiao-hui; Peng, Jian-chun; Zhan, Lin-sheng] Beijing Inst Transfus Med, Beijing, Peoples R China; [Duan, Xiang-guo] Ningxia Med Univ, Yinchuan, Peoples R China	Ningxia Medical University	Du, JA (corresponding author), Beijing Inst Transfus Med, Beijing, Peoples R China.	lszhan91@yahoo.com	ZHANG, LIN/GYD-9123-2022; Zhan, Linsheng/AAR-5687-2021; zhan, lin/AAP-5149-2020		National Nature Science Foundation of China [30700757, 30771919, 30900824]; Mega-Project of Science Research for the 11th FiveYear Plan [2009ZX10004-4001]; High Technology Research and Development Program of China [2008AA02Z132]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Mega-Project of Science Research for the 11th FiveYear Plan; High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by funding under the National Nature Science Foundation of China (30700757, 30771919 and 30900824), Mega-Project of Science Research for the 11th FiveYear Plan (#2009ZX10004-4001) and High Technology Research and Development Program of China (#2008AA02Z132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aneja MK, 2007, J GENE MED, V9, P967, DOI 10.1002/jgm.1090; Bertoni C, 2006, P NATL ACAD SCI USA, V103, P419, DOI 10.1073/pnas.0504505102; Budker VG, 2006, J GENE MED, V8, P874, DOI 10.1002/jgm.920; BUKH J, 1994, P NATL ACAD SCI USA, V91, P8239, DOI 10.1073/pnas.91.17.8239; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Held PK, 2005, MOL THER, V11, P399, DOI 10.1016/j.ymthe.2004.11.001; Ishikawa T, 2003, COMP IMMUNOL MICROB, V26, P115, DOI 10.1016/S0147-9571(02)00038-3; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; Keravala A, 2009, MOL THER, V17, P112, DOI 10.1038/mt.2008.241; Kim M, 2006, VIRUS RES, V122, P1, DOI 10.1016/j.virusres.2006.05.003; Kronke J, 2004, J VIROL, V78, P3436, DOI 10.1128/JVI.78.7.3436-3446.2004; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lecocq M, 2003, J GENE MED, V5, P142, DOI 10.1002/jgm.328; Lewis DL, 2005, METHOD ENZYMOL, V392, P336, DOI 10.1016/S0076-6879(04)92020-4; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; Moriya K, 1997, J GEN VIROL, V78, P1527, DOI 10.1099/0022-1317-78-7-1527; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Ortiz-Urda S, 2002, NAT MED, V8, P1166, DOI 10.1038/nm766; Ray RB, 2000, VIROLOGY, V271, P197, DOI 10.1006/viro.2000.0295; Sacco R, 2003, VIROLOGY, V317, P24, DOI 10.1016/j.virol.2003.08.028; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Siavoshian S, 2005, J MED VIROL, V75, P402, DOI 10.1002/jmv.20283; Sioud M, 2005, J MOL BIOL, V348, P1079, DOI 10.1016/j.jmb.2005.03.013; Suzuki H, 2008, FEBS LETT, V582, P3085, DOI 10.1016/j.febslet.2008.07.056; Suzuki H, 2007, NUCLEOS NUCLEOT NUCL, V26, P815, DOI 10.1080/15257770701503787; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wilson JA, 2003, P NATL ACAD SCI USA, V100, P2783, DOI 10.1073/pnas.252758799; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yokota T, 2003, EMBO REP, V4, P602, DOI 10.1038/sj.embor.embor840; Zhao F, 2010, VIRUS RES, V149, P162, DOI 10.1016/j.virusres.2010.01.012	35	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14043	10.1371/journal.pone.0014043	http://dx.doi.org/10.1371/journal.pone.0014043			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124971	Green Published, gold, Green Submitted			2022-12-27	WOS:000284356900006
J	Dietrich, EA; Jones-Engel, L; Hu, SL				Dietrich, Elizabeth A.; Jones-Engel, Lisa; Hu, Shiu-Lok			Evolution of the Antiretroviral Restriction Factor TRIMCyp in Old World Primates	PLOS ONE			English	Article							CYCLOPHILIN-A; TRIM5-ALPHA RESTRICTION; MOLECULAR PHYLOGENY; RETROTRANSPOSITION; CERCOPITHECIDAE; RETROVIRUS; RESISTANCE; SELECTION; PROTEINS; HISTORY	The retroviral restriction factor TRIMCyp, which is a fusion protein derived from the TRIM5 gene, blocks replication at a post-entry step. Among Old World primates, TRIMCyp has been found in four species of Asian macaques, but not in African monkeys. To further define the evolutionary origin of Old World TRIMCyp, we examined two species of baboons (genus Papio) and three additional macaque species, including M. sylvanus, which is the only macaque species found outside Asia, and represents the earliest diverging branch of the macaque lineage. None of four P. cynocephalus anubis, one P. hamadryas, and 36 M. sylvanus had either TRIMCyp mRNA or the genetic features required for its expression. M. sylvanus genomic sequences indicated that the lack of TRIMCyp in this species was not due to genetic homogeneity among specimens studied and revealed the existence of four TRIM5 alpha alleles, all distinct from M. mulatta and Papio counterparts. Together with existing data on macaque evolution, our findings indicate that TRIMCyp evolved in the ancestors of Asian macaques approximately 5-6 million years before present (ybp), likely as a result of a retroviral threat. TRIMCyp then became fixed in the M. nemestrina lineage after it diverged from M. nigra, approximately 2 million ybp. The macaque lineage is unique among primates studied so far due to the presence and diversity of both TRIM5 and TRIMCyp restriction factors. Studies of these antiviral proteins may provide valuable information about natural antiviral mechanisms, and give further insight into the factors that shaped the evolution of macaque species.	[Dietrich, Elizabeth A.; Hu, Shiu-Lok] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Jones-Engel, Lisa; Hu, Shiu-Lok] Univ Washington, Washington Natl Primate Res Ctr, Seattle, WA 98195 USA; [Hu, Shiu-Lok] Univ Washington, Dept Pharmaceut, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Dietrich, EA (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.	hus@uw.edu		Jones-Engel, Lisa/0000-0001-6912-494X; Dietrich, Elizabeth/0000-0002-1698-9568	NIH [P51 RR000166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work is supported by NIH grant P51 RR000166 to the Washington National Primate Research Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan G, 2007, J VIROL, V81, P12210, DOI 10.1128/JVI.02499-06; Brennan G, 2008, P NATL ACAD SCI USA, V105, P3569, DOI 10.1073/pnas.0709511105; DELSON E, 1996, INT S EV AS PRIM IN; Diaz-Griffero F, 2009, J VIROL, V83, P10737, DOI 10.1128/JVI.01307-09; Drummond AJ, 2009, GENEIOUS 4 8; Emerman M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000301; Engel GA, 2008, EMERG INFECT DIS, V14, P1112, DOI [10.3201/eid1407.071643, 10.3201/eid1407.071673]; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; Javanbakht H, 2006, VIROLOGY, V353, P234, DOI 10.1016/j.virol.2006.05.017; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; Kanthaswamy S, 2008, INT J PRIMATOL, V29, P1295, DOI 10.1007/s10764-008-9295-0; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kohler M, 2000, J HUM EVOL, V38, P447, DOI 10.1006/jhev.1999.0388; Kuang YQ, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-58; Li J, 2009, GENE, V448, P242, DOI 10.1016/j.gene.2009.05.013; Liao CH, 2007, AIDS, V21, pS19, DOI 10.1097/01.aids.0000304692.09143.1b; Modolo L, 2005, P NATL ACAD SCI USA, V102, P7392, DOI 10.1073/pnas.0502186102; Newman RM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000003; Newman RM, 2006, P NATL ACAD SCI USA, V103, P19134, DOI 10.1073/pnas.0605838103; Nisole S, 2004, P NATL ACAD SCI USA, V101, P13324, DOI 10.1073/pnas.0404640101; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Page SL, 1999, MOL PHYLOGENET EVOL, V13, P348, DOI 10.1006/mpev.1999.0653; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Ribeiro IP, 2005, J VIROL, V79, P14998, DOI 10.1128/JVI.79.23.14998-15003.2005; Sawyer SL, 2005, P NATL ACAD SCI USA, V102, P2832, DOI 10.1073/pnas.0409853102; Sayah DM, 2004, NATURE, V430, P569, DOI 10.1038/nature02777; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tosi AJ, 2003, EVOLUTION, V57, P1419; Virgen CA, 2008, P NATL ACAD SCI USA, V105, P3563, DOI 10.1073/pnas.0709258105; Wilson SJ, 2008, P NATL ACAD SCI USA, V105, P3557, DOI 10.1073/pnas.0709003105; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015	37	15	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14019	10.1371/journal.pone.0014019	http://dx.doi.org/10.1371/journal.pone.0014019			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103414	Green Submitted, gold, Green Published			2022-12-27	WOS:000284257400018
J	Weyrich, P; Staiger, H; Stancakova, A; Machicao, F; Machann, J; Schick, F; Stefan, N; Kuusisto, J; Laakso, M; Schafer, S; Fritsche, A; Haring, HU				Weyrich, Peter; Staiger, Harald; Stancakova, Alena; Machicao, Fausto; Machann, Juergen; Schick, Fritz; Stefan, Norbert; Kuusisto, Johanna; Laakso, Markku; Schaefer, Silke; Fritsche, Andreas; Haering, Hans-Ulrich			The D299G/T399I Toll-Like Receptor 4 Variant Associates with Body and Liver Fat: Results from the TULIP and METSIM Studies	PLOS ONE			English	Article							INSULIN-RESISTANCE; ADIPOSE-TISSUE; FUNCTIONAL CONSEQUENCES; TLR4 POLYMORPHISMS; METABOLIC SYNDROME; TOLL-LIKE-RECEPTOR-4; GLUCOSE; OBESITY; EXPRESSION; MUTATIONS	Background: Toll-like-receptor 4 (TLR) is discussed to provide a molecular link between obesity, inflammation and insulin resistance. Genetic studies with replications in non-diabetic individuals in regard to their fat distribution or insulin resistance according to their carrier status of a common toll-like receptor 4 (TLR4) variant (TLR4(D299G/T399I)) are still lacking. Methodology/Principal Findings: We performed a cross-sectional analysis in individuals phenotyped for prediabetic traits as body fat composition (including magnetic resonance imaging), blood glucose levels and insulin resistance (oral glucose tolerance testing, euglycemic hyperinsulinemic clamp), according to TLR4 genotype determined by candidate SNP analyses (rs4986790). We analyzed N = 1482 non-diabetic individuals from the TUF/TULIP cohort (South Germany, aged 39 +/- 13 y, BMI 28.5 +/- 7.9, mean +/- SD) and N = 5327 non-diabetic participants of the METSIM study (Finland, males aged 58 +/- 6 y, BMI 26.8 +/- 3.8) for replication purposes. German TLR4(D299G/T399I) carriers had a significantly increased body fat (XG in rs4986790: +6.98%, p=0.03, dominant model, adjusted for age, gender) and decreased insulin sensitivity (XG: -15.3%, Matsuda model, p=0.04; XG: -20.6%, p=0.016, clamp; both dominant models adjusted for age, gender, body fat). In addition, both liver fat (AG: +49.7%; p=0.002) and visceral adipose tissue (AG: +8.2%; p=0.047, both adjusted for age, gender, body fat) were significantly increased in rs4986790 minor allele carriers, and the effect on liver fat remained significant also after additional adjustment for visceral fat (p=0.014). The analysis in METSIM confirmed increased body fat content in association with the rare G allele in rs4986790 (AG: +1.26%, GG: +11.0%; p=0.010, additive model, adjusted for age) and showed a non-significant trend towards decreased insulin sensitivity (AG: -0.99%, GG: -10.62%). Conclusions/Significance: TLR4(D299G/T399I) associates with increased total body fat, visceral fat, liver fat and decreased insulin sensitivity in non-diabetic Caucasians and may contribute to diabetes risk. This finding supports the role of TLR4 as a molecular link between obesity and insulin resistance.	[Weyrich, Peter; Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Schaefer, Silke; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Paul Langerhans Inst Tubingen, Div Endocrinol, D-7400 Tubingen, Germany; [Stancakova, Alena; Kuusisto, Johanna; Laakso, Markku] Kuopio Univ Hosp, Dept Med, SF-70210 Kuopio, Finland; [Machann, Juergen; Schick, Fritz] Univ Tubingen, Sect Expt Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Kuopio University Hospital; University of Eastern Finland; Eberhard Karls University of Tubingen	Weyrich, P (corresponding author), Univ Tubingen, Dept Internal Med, Paul Langerhans Inst Tubingen, Div Endocrinol, D-7400 Tubingen, Germany.	harald.staiger@med.uni-tuebingen.de	Stancakova, Alena/AAN-6723-2020; Staiger, Harald/N-5871-2014	Stancakova, Alena/0000-0002-1375-0252; Schick, Fritz/0000-0002-4231-3406; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	European Community [LSHM-CT-2004-512013]; German Federal Ministry of Education and Research (BMBF)	European Community(European Commission); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This study was in part supported by a grant from the European Community's FP6 EUGENE2 (LSHM-CT-2004-512013, see also: http://www.eugene2.com) and by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Awomoyi AA, 2007, J IMMUNOL, V179, P3171, DOI 10.4049/jimmunol.179.5.3171; BAGAROLLI RA, 2009, J DIABETES COMPLICAT; Bastard JP, 2006, EUR CYTOKINE NETW, V17, P4; Bochud PY, 2008, NEW ENGL J MED, V359, P1766, DOI 10.1056/NEJMoa0802629; Buraczynska M, 2009, HUM IMMUNOL, V70, P121, DOI 10.1016/j.humimm.2008.12.003; de Mello VDF, 2008, DIABETOLOGIA, V51, P2060, DOI 10.1007/s00125-008-1132-7; Ferwerda B, 2008, MOL MED, V14, P346, DOI 10.2119/2007-00135.Ferwerda; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; FESSLER MB, 2009, CURR OPIN LIPIDOL; Feterowski C, 2003, IMMUNOLOGY, V109, P426, DOI 10.1046/j.1365-2567.2003.01674.x; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Illig T, 2003, DIABETES, V52, P2861, DOI 10.2337/diabetes.52.11.2861; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kolz M, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-9; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Machann J, 2005, J MAGN RESON IMAGING, V21, P455, DOI 10.1002/jmri.20292; MacLaren R, 2008, ADV EXP MED BIOL, V632, P1, DOI 10.1007/978-0-387-78952-1_1; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; O'Neill LAJ, 2008, IMMUNOL REV, V226, P10, DOI 10.1111/j.1600-065X.2008.00701.x; Steinhardt AP, 2010, METABOLISM, V59, P711, DOI 10.1016/j.metabol.2009.09.015; Poggi M, 2007, DIABETOLOGIA, V50, P1267, DOI 10.1007/s00125-007-0654-8; Radin MS, 2008, DIABETOLOGIA, V51, P336, DOI 10.1007/s00125-007-0861-3; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Rudofsky G, 2004, DIABETES CARE, V27, P179, DOI 10.2337/diacare.27.1.179; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Song MJ, 2006, BIOCHEM BIOPH RES CO, V346, P739, DOI 10.1016/j.bbrc.2006.05.170; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Suganami T, 2007, ARTERIOSCL THROM VAS, V27, P84, DOI 10.1161/01.ATV.0000251608.09329.9a; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; van der Graaf C, 2005, CYTOKINE, V30, P264, DOI 10.1016/j.cyto.2005.02.001; Weyrich P, 2007, DIABETOLOGIA, V50, P2097, DOI 10.1007/s00125-007-0788-8; WONG SW, 2009, J BIOL CHEM; ZHA JM, 2009, ENDOCR J; ZHANG HM, 2009, NUTR METAB CARDIOVAS; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	49	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13980	10.1371/journal.pone.0013980	http://dx.doi.org/10.1371/journal.pone.0013980			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125016	gold, Green Published, Green Submitted			2022-12-27	WOS:000284231800010
J	Green, BS; Gardner, C; Linnane, A; Hawthorne, PJ				Green, Bridget S.; Gardner, Caleb; Linnane, Adrian; Hawthorne, Peter J.			The Good, the Bad and the Recovery in an Assisted Migration	PLOS ONE			English	Article							SOUTHERN ROCK LOBSTER; JASUS-EDWARDSII; CLIMATE-CHANGE; LIFE-HISTORY; SPATIAL VARIATION; MATURITY; GROWTH; SIZE; COLONIZATION; RESILIENCE	Background: Assisted migration or translocation of species to ameliorate effects of habitat loss or changing environment is currently under scrutiny as a conservation tool. A large scale experiment of assisted migration over hundreds of kilometres was tested on a morph from a commercial fishery of southern rock lobster Jasus edwardsii, to enhance depleted populations, improve the yield and sustainability of the fishery, and test resilience to a changing climate. Methodology and Principal Findings: Approximately 10,000 lower-valued, pale-coloured lobsters were moved from deep water to inshore sites (2 in Tasmania [TAS] and 2 in South Australia [SA]) where the high-value, red morph occurs. In TAS this was a northwards movement of 1 degrees latitude. Growth was measured only in TAS lobsters, and reproductive status was recorded in lobsters from all locations. Pale females (TAS) grew 4 times faster than resident pale lobsters from the original site and twice as fast as red lobsters at their new location. Approximately 30% of translocated pale lobsters deferred reproduction for one year after release (SA and TAS), and grew around 1 mm yr(-1) less compared to translocated pale lobsters that did not defer reproduction. In spite of this stress response to translocation, females that deferred reproduction still grew 2-6 mm yr(-1) more than lobsters at the source site. Lobsters have isometric growth whereby volume increases as a cube of length. Consequently despite the one-year hiatus in reproduction, increased growth increases fecundity of translocated lobsters, as the increase in size provided a larger volume for producing and incubating eggs in future years. Conclusions and Significance: Assisted migration improved egg production and growth, despite a temporary stress response, and offers a tool to improve the production, sustainability and resilience of the fishery.	[Green, Bridget S.; Gardner, Caleb] Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia; [Linnane, Adrian; Hawthorne, Peter J.] S Australian Res & Dev Inst, Henley Beach, SA, Australia	University of Tasmania	Green, BS (corresponding author), Univ Tasmania, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia.	bridget.green@utas.edu.au	Green, Bridget/G-3368-2014; Gardner, Caleb/I-7086-2013	Green, Bridget/0000-0001-8214-6430; Gardner, Caleb/0000-0003-0324-4337	Australian CRC Seafood; Australian Fisheries Research Development Corporation [2006/220]	Australian CRC Seafood(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Fisheries Research Development Corporation	This research was supported by Australian CRC Seafood and Australian Fisheries Research Development Corporation grant 2006/220. The funders had no role on study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alonso-Alvarez C, 2007, FUNCT ECOL, V21, P873, DOI 10.1111/j.1365-2435.2007.01300.x; ATCHLEY WR, 1984, AM NAT, V123, P519, DOI 10.1086/284220; BOOTH JD, 1994, CRUSTACEANA, V66, P271, DOI 10.1163/156854094X00035; Bradshaw M, 2004, FISH RES, V67, P99, DOI 10.1016/j.fishres.2003.11.007; BULL JJ, 1979, AM NAT, V114, P296, DOI 10.1086/283476; BURTON MPM, 1994, J ZOOL, V233, P405, DOI 10.1111/j.1469-7998.1994.tb05273.x; Carroll MJ, 2009, BIOL CONSERV, V142, P2114, DOI 10.1016/j.biocon.2009.04.010; Chandrapavan A, 2009, J EXP MAR BIOL ECOL, V375, P9, DOI 10.1016/j.jembe.2009.04.021; Chandrapavan A, 2009, NEW ZEAL J MAR FRESH, V43, P537, DOI 10.1080/00288330909510020; Chapron G, 2008, SCIENCE, V322, P1049, DOI 10.1126/science.322.5904.1049b; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Cochrane A, 2004, SCI PRAC ECOL REST, P40; Davidson I, 2008, SCIENCE, V322, P1048, DOI 10.1126/science.322.5904.1048b; Fischer B, 2009, AM NAT, V173, pE108, DOI 10.1086/596536; Gardner C, 2005, SCI MAR, V69, P123, DOI 10.3989/scimar.2005.69n1123; Gardner C, 2003, B MAR SCI, V73, P653; Gardner C, 2010, TASMANIAN ROCK LOBST; GARDNER C, 2008, REV FISH SCI, V16, P1; Gardner C, 2006, SCI MAR, V70, P423, DOI 10.3989/scimar.2006.70n3423; Godwin H., 1975, HIST BRIT FLORA; Green BS, 2009, MAR BIOL, V156, P1941, DOI 10.1007/s00227-009-1226-x; Green BS, 2009, ICES J MAR SCI, V66, P656, DOI 10.1093/icesjms/fsp030; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Harlioglu MM, 2006, REV FISH BIOL FISHER, V16, P171, DOI 10.1007/s11160-006-9010-1; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Hughes TP, 2005, TRENDS ECOL EVOL, V20, P380, DOI 10.1016/j.tree.2005.03.022; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Johnston FD, 2009, ECOL APPL, V19, P449, DOI 10.1890/07-1507.1; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; Ling SD, 2009, P NATL ACAD SCI USA, V106, P22341, DOI 10.1073/pnas.0907529106; Linnane A, 2005, NEW ZEAL J MAR FRESH, V39, P335, DOI 10.1080/00288330.2005.9517314; Linnane AJ, 2008, J MAR BIOL ASSOC UK, V88, P583, DOI 10.1017/S0025315408001021; Linnane A, 2010, FISH RES, V105, P163, DOI 10.1016/j.fishres.2010.04.001; Linnane A, 2009, FISH RES, V96, P238, DOI 10.1016/j.fishres.2008.11.008; Linnane A, 2009, NEW ZEAL J MAR FRESH, V43, P475, DOI 10.1080/00288330909510016; Mack RN, 2001, BIOSCIENCE, V51, P95, DOI 10.1641/0006-3568(2001)051[0095:HAGPDG]2.0.CO;2; McGarvey R, 1999, MAR FRESHWATER RES, V50, P333, DOI 10.1071/MF97172; Mills DJ, 2006, AQUACULTURE, V254, P256, DOI 10.1016/j.aquaculture.2005.09.007; Mueller JM, 2008, CONSERV BIOL, V22, P562, DOI 10.1111/j.1523-1739.2008.00952.x; Pecl G, 2009, E COAST TASMANIAN RO; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P476, DOI 10.1016/j.tree.2009.05.005; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; RICKLEFS RE, 1994, EVOLUTION, V48, P1080, DOI 10.1111/j.1558-5646.1994.tb05295.x; Rideout RM, 2006, MAR ECOL PROG SER, V320, P267, DOI 10.3354/meps320267; Roff Derek A., 1992; Rout TM, 2009, ECOL APPL, V19, P515, DOI 10.1890/07-1989.1; Sax DF, 2009, TRENDS ECOL EVOL, V24, P472, DOI 10.1016/j.tree.2009.05.004; Schlaepfer MA, 2009, TRENDS ECOL EVOL, V24, P471, DOI 10.1016/j.tree.2009.05.008; Solomon S., 2007, PHYS SCI BASIS WORKI; Stearns S.C., 1992, pi; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; Stelzer CP, 2001, ECOLOGY, V82, P2521; Tavecchia G, 2009, BIOL CONSERV, V142, P3005, DOI 10.1016/j.biocon.2009.07.035; van der Meeren GI, 2000, CAN J FISH AQUAT SCI, V57, P1794, DOI 10.1139/cjfas-57-9-1794; van der Meeren GI, 1997, MAR FRESHWATER RES, V48, P915, DOI 10.1071/MF97126; Vitt P, 2010, BIOL CONSERV, V143, P18, DOI 10.1016/j.biocon.2009.08.015; Wang QY, 2006, FISH RES, V80, P67, DOI 10.1016/j.fishres.2006.03.015; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2	58	26	27	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14160	10.1371/journal.pone.0014160	http://dx.doi.org/10.1371/journal.pone.0014160			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151965	Green Published, gold			2022-12-27	WOS:000284755100038
J	Le Nouen, C; Hillyer, P; Munir, S; Winter, CC; McCarty, T; Bukreyev, A; Collins, PL; Rabin, RL; Buchholz, UJ				Le Nouen, Cyril; Hillyer, Philippa; Munir, Shirin; Winter, Christine C.; McCarty, Thomas; Bukreyev, Alexander; Collins, Peter L.; Rabin, Ronald L.; Buchholz, Ursula J.			Effects of Human Respiratory Syncytial Virus, Metapneumovirus, Parainfluenza Virus 3 and Influenza Virus on CD4+T Cell Activation by Dendritic Cells	PLOS ONE			English	Article							T-HELPER TYPE-1; IN-VITRO; DIFFERENTIAL RESPONSE; CILIATED CELLS; HUMAN NAIVE; INFECTION; CD4(+); MEMORY; INTERFERON; LYMPHOCYTES	Background: Human respiratory syncytial virus (HRSV), and to a lesser extent human metapneumovirus (HMPV) and human parainfluenza virus type 3 (HPIV3), re-infect symptomatically throughout life without antigenic change, suggestive of incomplete immunity. One causative factor is thought to be viral interference with dendritic cell (DC)-mediated stimulation of CD4+ T cells. Methodology, Principal Findings: We infected human monocyte-derived DC with purified HRSV, HMPV, HPIV3, or influenza A virus (IAV) and compared their ability to induce activation and proliferation of autologous CD4+ T cells in vitro. IAV was included because symptomatic re-infection without antigenic change is less frequent, suggesting that immune protection is more complete and durable. We examined virus-specific memory responses and superantigen-induced responses by multiparameter flow cytometry. Live virus was more stimulatory than inactivated virus in inducing DC-mediated proliferation of virus-specific memory CD4+ T cells, suggesting a lack of strong suppression by live virus. There were trends of increasing proliferation in the order: HMPV, HRSV, HPIV3, IAV, and greater production of interferon-gamma c and tumor necrosis factor-alpha by proliferating cells in response to IAV, but differences were not significant. Exposure of DC to HRSV, HPIV3, or IAV reduced CD4+ T cell proliferation in response to secondary stimulus with superantigen, but the effect was transitory and greatest for IAV. T cell cytokine production was similar, with no evidence of Th2 or Th17 skewing. Conclusions, Significance: Understanding the basis for the ability of HRSV in particular to symptomatically re-infect without significant antigenic change is of considerable interest. The present results show that these common respiratory viruses are similar in their ability to induce DC to activate CD4+ T cells. Thus, the results do not support the common model in which viral suppression of CD4+ T cell activation and proliferation by HRSV, HMPV, and HPIV3 is a major factor in the difference in re-infectability compared to IAV.	[Le Nouen, Cyril; Munir, Shirin; Winter, Christine C.; McCarty, Thomas; Bukreyev, Alexander; Collins, Peter L.; Buchholz, Ursula J.] NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA; [Hillyer, Philippa; Rabin, Ronald L.] US FDA, Ctr Biol Evaluat & Res, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); US Food & Drug Administration (FDA)	Le Nouen, C (corresponding author), NIAID, Infect Dis Lab, NIH, Bethesda, MD 20892 USA.	ubuchholz@niaid.nih.gov	Munir, Shirin/AAA-7943-2021; McCarty, Tom/ABG-6003-2020; Buchholz, Ursula/AAA-4547-2022; McCarty, Thomas/GVU-0812-2022	McCarty, Tom/0000-0001-5815-2531; Buchholz, Ursula/0000-0002-2329-3198; McCarty, Thomas/0000-0001-5815-2531; Tripp, Ralph/0000-0002-2924-9956; Rabin, Ronald/0000-0003-3496-0504	NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000372] Funding Source: NIH RePORTER	NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID, NIH. Disclaimer: The views expressed in this report are the personal opinions of the authors and are not the official opinion of the U.S. Food and Drug Administration, the National Institutes of Health, or the Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartz H, 2003, IMMUNOLOGY, V109, P49, DOI 10.1046/j.1365-2567.2003.01629.x; Biacchesi S, 2004, VIROLOGY, V321, P247, DOI 10.1016/j.virol.2003.12.020; Biacchesi S, 2007, J VIROL, V81, P6057, DOI 10.1128/JVI.00128-07; BUYNAK EB, 1978, P SOC EXP BIOL MED, V157, P636; Castellino F, 2006, ANNU REV IMMUNOL, V24, P519, DOI 10.1146/annurev.immunol.23.021704.115825; Chaiwatpongsakorn S, 2011, FIELDS VIROLOGY, V85, P3968; Chi B, 2006, J VIROL, V80, P5032, DOI 10.1128/JVI.80.10.5032-5040.2006; Collins PL, 2008, J VIROL, V82, P2040, DOI 10.1128/JVI.01625-07; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; de Bree GJ, 2005, J EXP MED, V202, P1433, DOI 10.1084/jem.20051365; de Graaff PAA, 2005, J IMMUNOL, V175, P5904, DOI 10.4049/jimmunol.175.9.5904; DiNapoli JM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-105; Falsey AR, 2000, CLIN MICROBIOL REV, V13, P371, DOI 10.1128/CMR.13.3.371-384.2000; Foster Barbara, 2007, Curr Protoc Immunol, VChapter 6, DOI 10.1002/0471142735.im0624s78; Fulton RB, 2008, J VIROL, V82, P7799, DOI 10.1128/JVI.00840-08; Geiger R, 2009, J EXP MED, V206, P1525, DOI 10.1084/jem.20090504; GEISSMANN F, 2008, IMMUNOL CELL BIOL; Geissmann F, 2007, NAT IMMUNOL, V8, P558, DOI 10.1038/ni0607-558; Gimeno R, 2005, MOL CELL BIOL, V25, P5456, DOI 10.1128/MCB.25.13.5456-5465.2005; Guerrero-Plata A, 2006, AM J RESP CELL MOL, V34, P320, DOI 10.1165/rcmb.2005-0287OC; Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877; Hall CB, 2001, NEW ENGL J MED, V344, P1917, DOI 10.1056/NEJM200106213442507; Hallak LK, 2000, J VIROL, V74, P10508, DOI 10.1128/JVI.74.22.10508-10513.2000; Hamelin ME, 2004, CLIN INFECT DIS, V38, P983, DOI 10.1086/382536; Jakubzick C, 2008, J IMMUNOL, V180, P3019, DOI 10.4049/jimmunol.180.5.3019; Jones A, 2006, CLIN EXP IMMUNOL, V143, P513, DOI 10.1111/j.1365-2249.2005.03004.x; Kapsenberg ML, 2003, NAT REV IMMUNOL, V3, P984, DOI 10.1038/nri1246; King C, 2009, NAT REV IMMUNOL, V9, P757, DOI 10.1038/nri2644; LENOUEN C, 2009, VIROLOGY; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; MacLeod MKL, 2009, SEMIN IMMUNOL, V21, P53, DOI 10.1016/j.smim.2009.02.006; Nakano H, 2009, NAT IMMUNOL, V10, P394, DOI 10.1038/ni.1707; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; PRESTON FM, 1995, J INFECT DIS, V172, P919, DOI 10.1093/infdis/172.4.919; PRESTON FM, 1992, J INFECT DIS, V165, P819, DOI 10.1093/infdis/165.5.819; ROBERTS NJ, 1982, INFECT IMMUN, V35, P1142, DOI 10.1128/IAI.35.3.1142-1146.1982; Rothoeft T, 2007, CLIN EXP IMMUNOL, V150, P263, DOI 10.1111/j.1365-2249.2007.03497.x; SALKIND AR, 1991, J CLIN INVEST, V88, P505, DOI 10.1172/JCI115332; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schlender J, 2002, J VIROL, V76, P1163, DOI 10.1128/JVI.76.3.1163-1170.2002; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sieg S, 1996, J VIROL, V70, P4845, DOI 10.1128/JVI.70.7.4845-4848.1996; SIEG S, 1994, P NATL ACAD SCI USA, V91, P6293, DOI 10.1073/pnas.91.14.6293; Tanabe Y, 2005, J IMMUNOL, V174, P609, DOI 10.4049/jimmunol.174.2.609; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; WELLIVER RC, 1986, AM J DIS CHILD, V140, P34, DOI 10.1001/archpedi.1986.02140150036029; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472; Xu YK, 2007, J IMMUNOL, V179, P7577, DOI 10.4049/jimmunol.179.11.7577; Zhang LQ, 2005, J VIROL, V79, P1113, DOI 10.1128/JVI.79.2.1113-1124.2005; Zhang LQ, 2002, J VIROL, V76, P5654, DOI 10.1128/JVI.76.11.5654-5666.2002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; 2008, MMWR MORB MORTAL WKL, V59, P230	60	32	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15017	10.1371/journal.pone.0015017	http://dx.doi.org/10.1371/journal.pone.0015017			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124776	Green Submitted, gold, Green Published			2022-12-27	WOS:000284686500016
J	Schmerbach, K; Pfab, T; Zhao, Y; Culman, J; Mueller, S; Villringer, A; Muller, DN; Hocher, B; Unger, T; Thoene-Reineke, C				Schmerbach, Kristin; Pfab, Thiemo; Zhao, Yi; Culman, Juraj; Mueller, Susanne; Villringer, Arno; Muller, Dominik N.; Hocher, Berthold; Unger, Thomas; Thoene-Reineke, Christa			Effects of Aliskiren on Stroke in Rats Expressing Human Renin and Angiotensinogen Genes	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; TRANSGENIC RATS; ISCHEMIC-STROKE; ORGAN DAMAGE; RENAL DAMAGE; PRONE RATS; BRAIN; CANDESARTAN; INHIBITOR; HYPERTENSION	Objective: Pre-treatment with angiotensin receptor blockers is known to improve neurological outcome after stroke. This study investigated for the first time, whether the renin inhibitor aliskiren has similar neuroprotective effects. Methods: Since aliskiren specifically blocks human renin, double transgenic rats expressing human renin and angiotensinogen genes were used. To achieve a systolic blood pressure of 150 or 130 mmHg animals were treated with aliskiren (7.5 or 12.5 mg/kg*d) or candesartan (1.5 or 10 mg/kg*d) via osmotic minipump starting five days before middle cerebral artery occlusion with reperfusion. Infarct size was determined by magnetic resonance imaging. mRNA of inflammatory marker genes was studied in different brain regions. Results: The mortality of 33.3% (7 of 21 animals) in the vehicle group was reduced to below 10% by treatment with candesartan or aliskiren (p<0.05). Aliskiren-treated animals had a better neurological outcome 7 days post-ischemia, compared to candesartan (Garcia scale: 9.9+/-0.7 vs. 7.3+/-0.7; p<0.05). The reduction of infarct size in the aliskiren group did not reach statistical significance compared to candesartan and vehicle (24 h post-ischemia: 314+/-81 vs. 377+/-70 and 403+/-70 mm(3) respectively). Only aliskiren was able to significantly reduce stroke-induced gene expression of CXC chemokine ligand 1, interleukin-6 and tumor necrosis factor-alpha in the ischemic core. Conclusions: Head-to-head comparison suggests that treatment with aliskiren before and during cerebral ischemia is at least as effective as candesartan in double transgenic rats. The improved neurological outcome in the aliskiren group was blood pressure independent. Whether this effect is due to primary anti-inflammatory mechanisms has to be investigated further.	[Schmerbach, Kristin; Pfab, Thiemo; Hocher, Berthold; Unger, Thomas; Thoene-Reineke, Christa] Charite, Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany; [Pfab, Thiemo] Charite Campus Benjamin Franklin, Dept Nephrol, Berlin, Germany; [Zhao, Yi; Culman, Juraj] Univ Hosp Schleswig Holstein, Inst Expt & Clin Pharmacol, Kiel, Germany; [Mueller, Susanne] Charite, Ctr Stroke Res Berlin, Berlin, Germany; [Villringer, Arno] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Muller, Dominik N.] Max Delbrueck Ctr Mol Med, Berlin, Germany; [Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Thoene-Reineke, Christa] Charite, Dept Expt Med FEM, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Kiel; Schleswig Holstein University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Potsdam; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Schmerbach, K (corresponding author), Charite, Inst Pharmacol, Cardiovasc Res Ctr, Berlin, Germany.	christa.thoene-reineke@charite.de	Hocher, Berthold/AAC-3510-2020; Zhao, Yi/A-8806-2010	Mueller, Susanne/0000-0002-5053-2211; Hocher, Berthold/0000-0001-8143-0579; Villringer, Arno/0000-0003-2604-2404; Muller, Dominik N/0000-0003-3650-5644	Novartis AG ( Basel, Switzerland)	Novartis AG ( Basel, Switzerland)	This study was supported by Novartis AG ( Basel, Switzerland). The study design was set up together with Novartis AG. Novartis AG had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Blezer ELA, 1998, STROKE, V29, P167, DOI 10.1161/01.STR.29.1.167; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dai WJ, 1999, STROKE, V30, P2391, DOI 10.1161/01.STR.30.11.2391; Dandona P, 2003, J CLIN ENDOCR METAB, V88, P4496, DOI 10.1210/jc.2002-021836; Dechend R, 2007, J RENIN-ANGIO-ALDO S, V8, P81, DOI 10.3317/jraas.2007.008; Ferrario CM, 2006, AM J CARDIOL, V98, P121, DOI 10.1016/j.amjcard.2006.01.059; GANTEN D, 1992, P NATL ACAD SCI USA, V89, P7806, DOI 10.1073/pnas.89.16.7806; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gelosa P, 2009, J HYPERTENS, V27, P2444, DOI 10.1097/HJH.0b013e3283311ba1; Gohlke P, 2002, J HYPERTENS, V20, P909, DOI 10.1097/00004872-200205000-00026; Groth W, 2003, J HYPERTENS, V21, P2175, DOI 10.1097/00004872-200311000-00028; Iadecola C, 2001, CURR OPIN NEUROL, V14, P89, DOI 10.1097/00019052-200102000-00014; Ino J, 2009, ARTERIOSCL THROM VAS, V29, P1858, DOI 10.1161/ATVBAHA.108.182519; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Li J, 2005, FASEB J, V19, P617, DOI 10.1096/fj.04-2960fje; Loos M, 2003, NEUROSCIENCE, V122, P373, DOI 10.1016/S0306-4522(03)00498-6; Losy J, 2005, FOLIA NEUROPATHOL, V43, P97; McCarthy CA, 2009, STROKE, V40, P1482, DOI 10.1161/STROKEAHA.108.531509; Muller DN, 2008, J MOL MED, V86, P659, DOI 10.1007/s00109-008-0330-6; Parving HH, 2008, NEW ENGL J MED, V358, P2433, DOI 10.1056/NEJMoa0708379; Pilz B, 2005, HYPERTENSION, V46, P569, DOI 10.1161/01.HYP.0000179573.91016.3f; Quaschning T, 2007, J AM SOC NEPHROL, V18, P730, DOI 10.1681/ASN.2006050541; Sandoval KE, 2008, NEUROBIOL DIS, V32, P200, DOI 10.1016/j.nbd.2008.08.005; Sanoski CA, 2009, PHARMACOTHERAPY, V29, P193, DOI 10.1592/phco.29.2.193; Schmerbach K, 2008, BRAIN RES, V1208, P225, DOI 10.1016/j.brainres.2008.02.032; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Yang GY, 1998, NEUROREPORT, V9, P2131, DOI 10.1097/00001756-199806220-00041	29	28	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15052	10.1371/journal.pone.0015052	http://dx.doi.org/10.1371/journal.pone.0015052			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124781	Green Published, Green Accepted, gold			2022-12-27	WOS:000284686500025
J	Albrecht, I; Kopfstein, L; Strittmatter, K; Schomber, T; Falkevall, A; Hagberg, CE; Lorentz, P; Jeltsch, M; Alitalo, K; Eriksson, U; Christofori, G; Pietras, K				Albrecht, Imke; Kopfstein, Lucie; Strittmatter, Karin; Schomber, Tibor; Falkevall, Annelie; Hagberg, Carolina E.; Lorentz, Pascal; Jeltsch, Michael; Alitalo, Kari; Eriksson, Ulf; Christofori, Gerhard; Pietras, Kristian			Suppressive Effects of Vascular Endothelial Growth Factor-B on Tumor Growth in a Mouse Model of Pancreatic Neuroendocrine Tumorigenesis	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; VEGF-B; ANGIOGENIC SWITCH; CELL LINES; FACTOR-C; FACTOR-A; EXPRESSION; MICE; GENE; RECEPTOR	Background: The family of vascular endothelial growth factors (VEGF) contains key regulators of blood and lymph vessel development, including VEGF-A, -B, -C, -D, and placental growth factor. The role of VEGF-B during physiological or pathological angiogenesis has not yet been conclusively delineated. Herein, we investigate the function of VEGF-B by the generation of mouse models of cancer with transgenic expression of VEGF-B or homozygous deletion of Vegfb. Methodology/Principal Findings: Ectopic expression of VEGF-B in the insulin-producing beta-cells of the pancreas did not alter the abundance or architecture of the islets of Langerhans. The vasculature from transgenic mice exhibited a dilated morphology, but was of similar density as that of wildtype mice. Unexpectedly, we found that transgenic expression of VEGF-B in the RIP1-Tag2 mouse model of pancreatic neuroendocrine tumorigenesis retarded tumor growth. Conversely, RIP1-Tag2 mice deficient for Vegfb presented with larger tumors. No differences in vascular density, perfusion or immune cell infiltration upon altered Vegfb gene dosage were noted. However, VEGF-B acted to increase blood vessel diameter both in normal pancreatic islets and in RIP1-Tag2 tumors. Conclusions/Significance: Taken together, our results illustrate the differences in biological function between members of the VEGF family, and highlight the necessity of in-depth functional studies of VEGF-B to fully understand the effects of VEGFR-1 inhibitors currently used in the clinic.	[Albrecht, Imke; Kopfstein, Lucie; Schomber, Tibor; Lorentz, Pascal; Christofori, Gerhard] Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland; [Strittmatter, Karin] German Canc Res Ctr Heidelberg DKFZ, Heidelberg, Germany; [Jeltsch, Michael; Alitalo, Kari] Univ Helsinki, Mol & Canc Biol Program, Biomedicum, Helsinki, Finland; [Falkevall, Annelie; Hagberg, Carolina E.; Eriksson, Ulf; Pietras, Kristian] Karolinska Inst, Div Vasc Biol, Dept Med Biochem & Biophys, Stockholm, Sweden; [Falkevall, Annelie; Hagberg, Carolina E.; Eriksson, Ulf] Karolinska Inst, Ludwig Inst Canc Res Ltd, Stockholm Branch, Stockholm, Sweden	University of Basel; Helmholtz Association; German Cancer Research Center (DKFZ); University of Helsinki; Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research	Albrecht, I (corresponding author), Univ Basel, Dept Biomed, Inst Biochem & Genet, Basel, Switzerland.	Kristian.Pietras@ki.se	Pietras, Kristian/ABG-2097-2021; Alitalo, Kari K/J-5013-2014; Pietras, Kristian/ABE-8727-2020; Jeltsch, Michael/I-5340-2012	Pietras, Kristian/0000-0001-6738-4705; Alitalo, Kari K/0000-0002-7331-0902; Jeltsch, Michael/0000-0003-2890-7790; Lorentz, Pascal/0000-0002-9910-2052; Hagberg, Carolina/0000-0002-5497-2855	Swedish Cancer Society; Karolinska Institutet Cancer network; Swedish Childhood Cancer Foundation; Jeansson's Foundation; Swedish Research Council; EU [LSHG-CT-2004-503573]; National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation; Swiss Cancer League; Novo Nordisk Foundation; Dr. Peter Wallenbergs Foundation for Economics and Technology; Solderberg's Foundation; Karolinska Institutet	Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet Cancer network; Swedish Childhood Cancer Foundation(European Commission); Jeansson's Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); EU(European Commission); National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Dr. Peter Wallenbergs Foundation for Economics and Technology; Solderberg's Foundation; Karolinska Institutet(Karolinska Institutet)	KP is supported by a Young Investigator Award by the Swedish Cancer Society, as well as by grants from the Karolinska Institutet Cancer network, the Swedish Childhood Cancer Foundation, Jeansson's Foundation and a Linnaeus grant to the STARGET consortium from the Swedish Research Council. GC received support by the EU-FP6 framework programme LYMPHANGIOGENOMICS LSHG-CT-2004-503573, the National Centre of Competence in Research (NCCR) Molecular Oncology of the Swiss National Science Foundation, and a Comprehensive Cancer Research Project (CCRP) of the Swiss Cancer League. UE was supported by The Novo Nordisk Foundation, The Swedish Cancer Society, The Swedish Research Council, Dr. Peter Wallenbergs Foundation for Economics and Technology, Solderberg's Foundation and the Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Bergers G, 1999, SCIENCE, V284, P808, DOI 10.1126/science.284.5415.808; Bergers G, 2003, J CLIN INVEST, V111, P1287, DOI 10.1172/JCI200317929; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Compagni A, 2000, CANCER RES, V60, P7163; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; EFRAT S, 1988, P NATL ACAD SCI USA, V85, P9037, DOI 10.1073/pnas.85.23.9037; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Eriksson A, 2002, CANCER CELL, V1, P99, DOI 10.1016/S1535-6108(02)00028-4; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2007, CELL, V131, P463, DOI 10.1016/j.cell.2007.08.038; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Gannon G, 2002, CANCER RES, V62, P603; Gunningham SP, 2001, J PATHOL, V193, P325, DOI 10.1002/path.814; Gunningham SP, 2001, CANCER RES, V61, P3206; Hagberg CE, 2010, NATURE, V464, P917, DOI 10.1038/nature08945; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hanrahan V, 2003, J PATHOL, V200, P183, DOI 10.1002/path.1339; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Karpanen T, 2008, ANNU REV PATHOL-MECH, V3, P367, DOI 10.1146/annurev.pathol.3.121806.151515; Kawakami M, 2003, J EXP CLIN CANC RES, V22, P229; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; LABOSKY PA, 1994, CIBA F SYMP, V182, P157; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Li Y, 2008, J CLIN INVEST, V118, P913, DOI 10.1172/JCI33673; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Mylona E, 2007, GYNECOL ONCOL, V104, P557, DOI 10.1016/j.ygyno.2006.09.031; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OHZATO H, 1991, TRANSPLANTATION, V51, P566, DOI 10.1097/00007890-199103000-00004; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; Olofsson B, 1996, P NATL ACAD SCI USA, V93, P2576, DOI 10.1073/pnas.93.6.2576; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Petrova TV, 2008, CANCER CELL, V13, P554, DOI 10.1016/j.ccr.2008.04.022; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Sawano A, 2001, BLOOD, V97, P785, DOI 10.1182/blood.V97.3.785; Schomber T, 2007, CANCER RES, V67, P10840, DOI 10.1158/0008-5472.CAN-07-1034; Serini G, 2009, ANGIOGENESIS, V12, P187, DOI 10.1007/s10456-009-9138-4; Shimabukuro M, 1997, J CLIN INVEST, V100, P290, DOI 10.1172/JCI119534; Shintani S, 2004, ORAL ONCOL, V40, P13, DOI 10.1016/S1368-8375(03)00127-1; Strauss LG, 2008, J NUCL MED, V49, P1238, DOI 10.2967/jnumed.108.051599; Van de Veire S, 2010, CELL, V141, P178, DOI 10.1016/j.cell.2010.02.039; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309	50	41	43	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14109	10.1371/journal.pone.0014109	http://dx.doi.org/10.1371/journal.pone.0014109			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124841	gold, Green Submitted, Green Published			2022-12-27	WOS:000284572000011
J	Safdie, G; Farrah, IY; Yahia, R; Marva, E; Wilamowski, A; Sawalha, SS; Wald, N; Schmiedel, J; Moter, A; Gobel, UB; Bercovier, H; Abdeen, Z; Assous, MV; Fishman, Y				Safdie, Gracia; Farrah, Iba Y.; Yahia, Reem; Marva, Esther; Wilamowski, Amos; Sawalha, Samer S.; Wald, Naama; Schmiedel, Judith; Moter, Annette; Goebel, Ulf B.; Bercovier, Herve; Abdeen, Ziad; Assous, Marc V.; Fishman, Yolanta			Molecular Characterization of Borrelia persica, the Agent of Tick Borne Relapsing Fever in Israel and the Palestinian Authority	PLOS ONE			English	Article							GLYCEROPHOSPHODIESTER PHOSPHODIESTERASE GLPQ; LARGE PHYLOGENIES; PURINE SALVAGE; FORGOTTEN; DIVERSITY; DISEASE; TREE	The identification of the Tick Borne Relapsing Fever (TBRF) agent in Israel and the Palestinian Authority relies on the morphology and the association of Borrelia persica with its vector Ornithodoros tholozani. Molecular based data on B. persica are very scarce as the organism is still non-cultivable. In this study, we were able to sequence three complete 16S rRNA genes, 12 partial flaB genes, 18 partial glpQ genes, 16 rrs-ileT intergenic spacers (IGS) from nine ticks and ten human blood samples originating from the West Bank and Israel. In one sample we sequenced 7231 contiguous base pairs that covered completely the region from the 5'end of the 16S rRNA gene to the 5'end of the 23S rRNA gene comprising the whole 16S rRNA (rrs), and the following genes: Ala tRNA (alaT), Ile tRNA (ileT), adenylosuccinate lyase (purB), adenylosuccinate synthetase (purA), methylpurine-DNA glycosylase (mag), hypoxanthine-guanine phosphoribosyltransferase (hpt), an hydrolase (HAD superfamily) and a 135 bp 5' fragment of the 23S rRNA (rrlA) genes. Phylogenic sequence analysis defined all the Borrelia isolates from O. tholozani and from human TBRF cases in Israel and the West Bank as B. persica that clustered between the African and the New World TBRF species. Gene organization of the intergenic spacer between the 16S rRNA and the 23S rRNA was similar to that of other TBRF Borrelia species and different from the Lyme disease Borrelia species. Variants of B. persica were found among the different genes of the different isolates even in the same sampling area.	[Safdie, Gracia; Farrah, Iba Y.; Yahia, Reem; Wald, Naama; Bercovier, Herve; Assous, Marc V.; Fishman, Yolanta] Hebrew Univ Jerusalem, Dept Mol Genet & Microbiol, Fac Med, Jerusalem, Israel; [Marva, Esther; Wilamowski, Amos] Cent State Labs, Minist Hlth, Jerusalem, Israel; [Sawalha, Samer S.] Palestinian Minist Hlth, Dept Primary Hlth Care, Ramallah, Palestine; [Schmiedel, Judith; Moter, Annette; Goebel, Ulf B.] Charite, Dept Microbiol & Hyg, D-13353 Berlin, Germany; [Farrah, Iba Y.; Abdeen, Ziad] Al Quds Univ, Dept Community Hlth, Sch Med, Jerusalem, Israel; [Assous, Marc V.] Shaare Zedek Med Ctr, Lab Microbiol & Immunol, Jerusalem, Israel	Hebrew University of Jerusalem; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Hebrew University of Jerusalem; Shaare Zedek Medical Center	Safdie, G (corresponding author), Hebrew Univ Jerusalem, Dept Mol Genet & Microbiol, Fac Med, Jerusalem, Israel.	yolaf@ekmd.huji.ac.il	Abdeen, Ziad/AAC-7889-2019; ASSOUS, Marc Victor/CAH-0946-2022; Bercovier, Herve/AHC-6851-2022	Kikhney, Judith/0000-0002-4849-7947; Moter, Annette/0000-0003-1318-5780	DFG, German Research Foundation [GO 363/11-1]	DFG, German Research Foundation(German Research Foundation (DFG))	This work was supported by a grant number GO 363/11-1 from the DFG, German Research Foundation: http://www.dfg.de/en/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assous MV, 2009, CLIN MICROBIOL INFEC, V15, P407, DOI 10.1111/j.1469-0691.2009.02767.x; Assous MV, 2006, EMERG INFECT DIS, V12, P1740, DOI 10.3201/eid1211.060715; Barbour AG, 2005, INFECT IMMUN, V73, P6165, DOI 10.1128/IAI.73.9.6165-6168.2005; Bunikis J, 2004, MICROBIOL-SGM, V150, P1741, DOI 10.1099/mic.0.26944-0; Cutler SJ, 2010, J APPL MICROBIOL, V108, P1115, DOI 10.1111/j.1365-2672.2009.04598.x; Cutler SJ, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.11.011; De Zulueta J, 1971, Ann Trop Med Parasitol, V65, P491; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halperin T, 2006, ACTA TROP, V98, P189, DOI 10.1016/j.actatropica.2006.04.004; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Lescot M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000185; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Morrison DA, 1996, INT J PARASITOL, V26, P589, DOI 10.1016/0020-7519(96)00044-6; Pettersson J, 2007, INFECT IMMUN, V75, P3877, DOI 10.1128/IAI.00199-07; PICKEN RN, 1992, J CLIN MICROBIOL, V30, P99, DOI 10.1128/JCM.30.1.99-114.1992; Porcella SF, 2000, J CLIN MICROBIOL, V38, P3561, DOI 10.1128/JCM.38.10.3561-3571.2000; Ras NM, 1996, INT J SYST BACTERIOL, V46, P859; RODHAIN F, 1976, B I PASTEUR, V74, P173; Sarih M, 2009, EMERG INFECT DIS, V15, P1626, DOI 10.3201/eid1510.090403; Schwan TG, 2003, J BACTERIOL, V185, P1346, DOI 10.1128/JB.185.4.1346-1356.2003; Schwan TG, 1996, J CLIN MICROBIOL, V34, P2483, DOI 10.1128/JCM.34.10.2483-2492.1996; Schwan TG, 2007, EMERG INFECT DIS, V13, P436, DOI 10.3201/eid1303.060958; Scott JC, 2005, EMERG INFECT DIS, V11, P1722, DOI 10.3201/eid1111.050483; Sidi G, 2005, EMERG INFECT DIS, V11, P1784, DOI 10.3201/eid1111.050521; Stackebrandt E., 2006, MICROBIOL TODAY, V33, P152; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toledo A, 2010, J CLIN MICROBIOL, V48, P2484, DOI 10.1128/JCM.00541-10	29	18	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14105	10.1371/journal.pone.0014105	http://dx.doi.org/10.1371/journal.pone.0014105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124792	gold, Green Published, Green Submitted			2022-12-27	WOS:000284572000007
J	Lorenz, AJ; Hamblin, MT; Jannink, JL				Lorenz, Aaron J.; Hamblin, Martha T.; Jannink, Jean-Luc			Performance of Single Nucleotide Polymorphisms versus Haplotypes for Genome-Wide Association Analysis in Barley	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; HEAD BLIGHT RESISTANCE; LINKAGE DISEQUILIBRIUM; PHENOTYPIC ASSOCIATIONS; POPULATION-STRUCTURE; MODEL; MARKERS; POWER	Genome-wide association studies (GWAS) may benefit from utilizing haplotype information for making marker-phenotype associations. Several rationales for grouping single nucleotide polymorphisms (SNPs) into haplotype blocks exist, but any advantage may depend on such factors as genetic architecture of traits, patterns of linkage disequilibrium in the study population, and marker density. The objective of this study was to explore the utility of haplotypes for GWAS in barley (Hordeum vulgare) to offer a first detailed look at this approach for identifying agronomically important genes in crops. To accomplish this, we used genotype and phenotype data from the Barley Coordinated Agricultural Project and constructed haplotypes using three different methods. Marker-trait associations were tested by the efficient mixed-model association algorithm (EMMA). When QTL were simulated using single SNPs dropped from the marker dataset, a simple sliding window performed as well or better than single SNPs or the more sophisticated methods of blocking SNPs into haplotypes. Moreover, the haplotype analyses performed better 1) when QTL were simulated as polymorphisms that arose subsequent to marker variants, and 2) in analysis of empirical heading date data. These results demonstrate that the information content of haplotypes is dependent on the particular mutational and recombinational history of the QTL and nearby markers. Analysis of the empirical data also confirmed our intuition that the distribution of QTL alleles in nature is often unlike the distribution of marker variants, and hence utilizing haplotype information could capture associations that would elude single SNPs. We recommend routine use of both single SNP and haplotype markers for GWAS to take advantage of the full information content of the genotype data.	[Lorenz, Aaron J.; Jannink, Jean-Luc] Cornell Univ, USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Hamblin, Martha T.] Cornell Univ, Inst Genom Divers, Ithaca, NY USA	Cornell University; United States Department of Agriculture (USDA); Cornell University	Lorenz, AJ (corresponding author), Cornell Univ, USDA ARS, RW Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.	jeanluc.jannink@ars.usda.gov		Jannink, Jean-Luc/0000-0003-4849-628X	United States Department of Agriculture, National Institute of Food and Agriculture [2009-85606-05701]	United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	United States Department of Agriculture, National Institute of Food and Agriculture Grant No. 2009-85606-05701, "Barley Coordinated Agricultural Project: Leveraging Genomics, Genetics, and Breeding for Gene Discovery and Barley Improvement." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bardel C, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-24; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calus MPL, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-11; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Clark AG, 2004, GENET EPIDEMIOL, V27, P321, DOI 10.1002/gepi.20025; Close TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-582; Dimas AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000244; Felsenstein J, 2009, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Grapes L, 2004, GENETICS, V166, P1561, DOI 10.1534/genetics.166.3.1561; Hagenblad J, 2004, GENETICS, V168, P1627, DOI 10.1534/genetics.104.029470; Hamblin MT, 2010, CROP SCI, V50, P556, DOI 10.2135/cropsci2009.04.0198; Hamon SC, 2006, HUM HERED, V61, P87, DOI 10.1159/000093384; Hartigan J., 1975, CLUSTERING ALGORITHM; Hayes BJ, 2007, GENET RES, V89, P215, DOI 10.1017/S0016672307008865; HAYES PM, 1993, THEOR APPL GENET, V87, P392, DOI 10.1007/BF01184929; Horsley RD, 2006, CROP SCI, V46, P145, DOI 10.2135/cropsci2005.0247; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Khatkar MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-187; Long AD, 1999, GENOME RES, V9, P720; Lu X, 2003, GENOME RES, V13, P2112, DOI 10.1101/gr.586803; Meuwissen THE, 2000, GENETICS, V155, P421; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Nduulu LM, 2007, THEOR APPL GENET, V115, P561, DOI 10.1007/s00122-007-0590-5; Parker HG, 2009, SCIENCE, V325, P995, DOI 10.1126/science.1173275; Pillen K, 2004, THEOR APPL GENET, V108, P1591, DOI 10.1007/s00122-004-1586-z; Posada D, 2005, BIOINFORMATICS, V21, P2130, DOI 10.1093/bioinformatics/bti293; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; Shim Heejung, 2009, BMC Proc, V3 Suppl 7, pS35; TEMPLETON AR, 1987, GENETICS, V117, P343; THOMAS WTB, 1995, THEOR APPL GENET, V91, P1037, DOI 10.1007/BF00223917; Yan L, 2006, P NATL ACAD SCI USA, V103, P19581, DOI 10.1073/pnas.0607142103; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang K, 2002, P NATL ACAD SCI USA, V99, P7335, DOI 10.1073/pnas.102186799; Zhao H, 2005, GENET RES, V86, P77, DOI 10.1017/S001667230500769X; Zhao HH, 2007, GENETICS, V175, P1975, DOI 10.1534/genetics.106.066480; Zhao HY, 2003, PHARMACOGENOMICS, V4, P171, DOI 10.1517/phgs.4.2.171.22636; Zhao KY, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030004; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	46	92	94	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14079	10.1371/journal.pone.0014079	http://dx.doi.org/10.1371/journal.pone.0014079			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124933	Green Submitted, gold, Green Published			2022-12-27	WOS:000284467200012
J	Antunes, FM; Nelken, I; Covey, E; Malmierca, MS				Antunes, Flora M.; Nelken, Israel; Covey, Ellen; Malmierca, Manuel S.			Stimulus-Specific Adaptation in the Auditory Thalamus of the Anesthetized Rat	PLOS ONE			English	Article							MEDIAL GENICULATE-BODY; FREQUENCY-RESPONSE AREAS; INFERIOR COLLICULUS; MISMATCH NEGATIVITY; BARN OWL; CORTICOFUGAL MODULATION; CORTICAL-NEURONS; SINGLE UNITS; CORTEX; PROJECTIONS	The specific adaptation of neuronal responses to a repeated stimulus (Stimulus-specific adaptation, SSA), which does not fully generalize to other stimuli, provides a mechanism for emphasizing rare and potentially interesting sensory events. Previous studies have demonstrated that neurons in the auditory cortex and inferior colliculus show SSA. However, the contribution of the medial geniculate body (MGB) and its main subdivisions to SSA and detection of rare sounds remains poorly characterized. We recorded from single neurons in the MGB of anaesthetized rats while presenting a sequence composed of a rare tone presented in the context of a common tone (oddball sequences). We demonstrate that a significant percentage of neurons in MGB adapt in a stimulus-specific manner. Neurons in the medial and dorsal subdivisions showed the strongest SSA, linking this property to the non-lemniscal pathway. Some neurons in the non-lemniscal regions showed strong SSA even under extreme testing conditions (e. g., a frequency interval of 0.14 octaves combined with a stimulus onset asynchrony of 2000 ms). Some of these neurons were able to discriminate between two very close frequencies (frequency interval of 0.057 octaves), revealing evidence of hyperacuity in neurons at a subcortical level. Thus, SSA is expressed strongly in the rat auditory thalamus and contribute significantly to auditory change detection.	[Antunes, Flora M.; Malmierca, Manuel S.] Univ Salamanca, Inst Neurosci Castilla & Leon, Lab Neurobiol Hearing, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain; [Malmierca, Manuel S.] Univ Salamanca, Fac Med, Dept Cell Biol & Pathol, E-37008 Salamanca, Spain; [Nelken, Israel] Hebrew Univ Jerusalem, Dept Neurobiol, Inst Life Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Covey, Ellen] Univ Washington, Dept Psychol, Seattle, WA 98195 USA	University of Salamanca; University of Salamanca; Hebrew University of Jerusalem; Hebrew University of Jerusalem; University of Washington; University of Washington Seattle	Antunes, FM (corresponding author), Univ Salamanca, Inst Neurosci Castilla & Leon, Lab Neurobiol Hearing, Auditory Neurophysiol Unit, E-37008 Salamanca, Spain.	msm@usal.es	Malmierca, Manuel S./K-9285-2014; Nelken, Israel/B-7753-2011; Antunes, Flora M/AAI-4560-2021	Malmierca, Manuel S./0000-0003-0168-7572; Nelken, Israel/0000-0002-6645-107X; Antunes, Flora M/0000-0001-8740-3539	Spanish MEC [BFU2009-07286, BES-2007-15642]; EU [EUI2009-04083]; JCYL-UE [GR221]; Israeli Science Foundation (ISF); NSF [IOS-0719295]; NIH (NIDCD) [P30DC004661]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [P30DC004661] Funding Source: NIH RePORTER	Spanish MEC(Spanish Government); EU(European Commission); JCYL-UE(Junta de Castilla y Leon); Israeli Science Foundation (ISF)(Israel Science Foundation); NSF(National Science Foundation (NSF)); NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Financial support was provided by the Spanish MEC (BFU2009-07286), EU (EUI2009-04083) and JCYL-UE (GR221) to MSM, the EU (EUI2009-04083) and the Israeli Science Foundation (ISF) to IN and the NSF (IOS-0719295) to EC. Support for software development was provided by NIH (NIDCD P30DC004661); FMA held a fellowship from the Spanish MEC (BES-2007-15642). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LA, 2009, J NEUROSCI, V29, P7359, DOI 10.1523/JNEUROSCI.0793-09.2009; ANTUNES F, 2009, FRONT HUM NEUROSCI, DOI DOI 10.3389/CONF.NEURO.09.2009.05.144; ANTUNES F, 2009, ARO ABSTR, V32, P35; Antunes FM, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P535, DOI 10.1007/978-1-4419-5686-6_49; BAEUERLE P, 2009, ARO ABSTR, V33, P646; BORDI F, 1994, EXP BRAIN RES, V98, P261, DOI 10.1007/BF00228414; BORDI F, 1994, EXP BRAIN RES, V98, P275, DOI 10.1007/BF00228415; Carrasco A, 2009, J NEUROSCI, V29, P8350, DOI 10.1523/JNEUROSCI.6001-08.2009; CLERICI WJ, 1990, J COMP NEUROL, V297, P14, DOI 10.1002/cne.902970103; COSTAFAIDELLA J, 2010, PSYCHOPHYSI IN PRESS; Drew PJ, 2006, J NEUROPHYSIOL, V96, P826, DOI 10.1152/jn.00134.2006; Drew PJ, 2006, P NATL ACAD SCI USA, V103, P8876, DOI 10.1073/pnas.0600676103; Edeline JM, 1999, HEARING RES, V131, P135, DOI 10.1016/S0378-5955(99)00026-X; Escera C, 1998, J COGNITIVE NEUROSCI, V10, P590, DOI 10.1162/089892998562997; Escera C, 2007, J PSYCHOPHYSIOL, V21, P251, DOI 10.1027/0269-8803.21.34.251; Faure PA, 2003, J NEUROSCI, V23, P3052; GRIMM S, 2010, PSYCHOPHYSI IN PRESS; Haenschel C, 2005, J NEUROSCI, V25, P10494, DOI 10.1523/JNEUROSCI.1227-05.2005; Hara K, 2002, ANESTH ANALG, V94, P313, DOI 10.1097/00000539-200202000-00015; He JF, 2003, EXP BRAIN RES, V153, P579, DOI 10.1007/s00221-003-1680-5; He JF, 2003, J NEUROPHYSIOL, V89, P367, DOI 10.1152/jn.00593.2002; Hernandez O, 2005, NEUROSCIENCE, V132, P203, DOI 10.1016/j.neuroscience.2005.01.001; Jaaskelainen IP, 2007, TRENDS NEUROSCI, V30, P653, DOI 10.1016/j.tins.2007.09.003; Jaaskelainen IP, 2004, P NATL ACAD SCI USA, V101, P6809, DOI 10.1073/pnas.0303760101; Kilgard MP, 1999, HEARING RES, V134, P16, DOI 10.1016/S0378-5955(99)00061-1; Kimura A, 2003, NEUROSCIENCE, V117, P1003, DOI 10.1016/S0306-4522(02)00949-1; Kimura A, 2009, EUR J NEUROSCI, V30, P783, DOI 10.1111/j.1460-9568.2009.06880.x; KRAUS N, 1994, J NEUROPHYSIOL, V72, P1270, DOI 10.1152/jn.1994.72.3.1270; Lee CC, 2005, CEREB CORTEX, V15, P1804, DOI 10.1093/cercor/bhi057; Lee CC, 2008, J COMP NEUROL, V507, P1879, DOI 10.1002/cne.21611; Lomber SG, 1999, J NEUROSCI METH, V86, P109, DOI 10.1016/S0165-0270(98)00160-5; Lomber SG, 2008, NAT NEUROSCI, V11, P609, DOI 10.1038/nn.2108; Malmierca MS, 2008, J NEUROSCI, V28, P4767, DOI 10.1523/JNEUROSCI.0238-08.2008; Malmierca MS, 2009, J NEUROSCI, V29, P5483, DOI 10.1523/JNEUROSCI.4153-08.2009; Malmierca MS, 2005, EUR J NEUROSCI, V21, P2701, DOI 10.1111/j.1460-9568.2005.04103.x; Malmierca MS, 2003, INT REV NEUROBIOL, V56, P147, DOI 10.1016/S0074-7742(03)56005-6; Malmierca MS, 2003, EXP BRAIN RES, V153, P522, DOI 10.1007/s00221-003-1615-1; MERRILL EG, 1972, MED BIOL ENG, V10, P662, DOI 10.1007/BF02476084; Naatanen R, 2007, CLIN NEUROPHYSIOL, V118, P2544, DOI 10.1016/j.clinph.2007.04.026; NAATANEN R, 1979, BIOL PSYCHOL, V8, P81, DOI 10.1016/0301-0511(79)90053-X; NAATANEN R, 1978, ACTA PSYCHOL, V42, P313, DOI 10.1016/0001-6918(78)90006-9; Naatanen R., 2018, ATTENTION BRAIN FUNC; Nelken I, 2003, BIOL CYBERN, V89, P397, DOI 10.1007/s00422-003-0445-3; Nelken I, 2007, J PSYCHOPHYSIOL, V21, P214, DOI 10.1027/0269-8803.21.34.214; Oliver DL, 1999, NEUROSCIENCE, V93, P643, DOI 10.1016/S0306-4522(99)00143-8; Paxinos G., 2005, RAT BRAIN STEREOTAXI, V5th Edn, DOI 10.1016/c2009-0-63235-9; Perez-Gonzalez D, 2006, J NEUROPHYSIOL, V95, P823, DOI 10.1152/jn.00741.2005; Perez-Gonzalez D, 2005, EUR J NEUROSCI, V22, P2879, DOI 10.1111/j.1460-9568.2005.04472.x; Peruzzi D, 1997, J NEUROSCI, V17, P3766; Reches A, 2008, J NEUROSCI, V28, P1523, DOI 10.1523/JNEUROSCI.3785-07.2008; Reches A, 2010, J NEUROSCI, V30, P6991, DOI 10.1523/JNEUROSCI.5723-09.2010; Reches A, 2009, J NEUROSCI, V29, P9602, DOI 10.1523/JNEUROSCI.6117-08.2009; Rees A, 1997, J NEUROPHYSIOL, V77, P2945, DOI 10.1152/jn.1997.77.6.2945; Rees A, 1990, J PHYSL, V430, P2; Sambeth A, 2004, INT J PSYCHOPHYSIOL, V53, P197, DOI 10.1016/j.ijpsycho.2004.04.004; Sambeth A, 2004, NEUROSCI LETT, V359, P143, DOI 10.1016/j.neulet.2004.01.064; Slabu L, 2010, EUR J NEUROSCI, V32, P859, DOI 10.1111/j.1460-9568.2010.07324.x; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; von der Behrens W, 2009, J NEUROSCI, V29, P13837, DOI 10.1523/JNEUROSCI.3475-09.2009; WEINBERGER NM, 2010, HEAR RES; Winer JA, 1999, HEARING RES, V130, P19, DOI 10.1016/S0378-5955(98)00216-0; Winer JA, 2001, J COMP NEUROL, V430, P27; Winkler I, 2009, TRENDS COGN SCI, V13, P532, DOI 10.1016/j.tics.2009.09.003; Yu XJ, 2009, NAT NEUROSCI, V12, P1165, DOI 10.1038/nn.2373	66	178	179	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14071	10.1371/journal.pone.0014071	http://dx.doi.org/10.1371/journal.pone.0014071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124913	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100016
J	da Silva, MAS; Tee, JM; Paridaen, J; Brouwers, A; Runtuwene, V; Zivkovic, D; Diks, SH; Guardavaccaro, D; Peppelenbosch, MP				da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Diks, Sander H.; Guardavaccaro, Daniele; Peppelenbosch, Maikel P.			Essential Role for the d-Asb11 cul5 Box Domain for Proper Notch Signaling and Neural Cell Fate Decisions In Vivo	PLOS ONE			English	Article							SOCS-BOX; ANKYRIN REPEAT; CUL5-RBX2 MODULES; PROTEIN-SYNTHESIS; GENE; EXPRESSION; DIFFERENTIATION; UBIQUITINATION; TRANSCRIPTION; NEUROGENIN1	ECS (Elongin BC-Cul2/Cul5-SOCS-box protein) ubiquitin ligases recruit substrates to E2 ubiquitin-conjugating enzymes through a SOCS-box protein substrate receptor, an Elongin BC adaptor and a cullin (Cul2 or Cul5) scaffold which interacts with the RING protein. In vitro studies have shown that the conserved amino acid sequence of the cullin box in SOCS-box proteins is required for complex formation and function. However, the in vivo importance of cullin boxes has not been addressed. To explore the biological functions of the cullin box domain of ankyrin repeat and SOCS-box containing protein 11 (d-Asb11), a key mediator of canonical Delta-Notch signaling, we isolated a zebrafish mutant lacking the Cul5 box (Asb11(Cul)). We found that homozygous zebrafish mutants for this allele were defective in Notch signaling as indicated by the impaired expression of Notch target genes. Importantly, asb11(Cul) fish were not capable to degrade the Notch ligand DeltaA during embryogenesis, a process essential for the initiation of Notch signaling during neurogenesis. Accordingly, proper cell fate specification within the neurogenic regions of the zebrafish embryo was impaired. In addition, Asb11(Cul) mRNA was defective in the ability to transactivate a her4::gfp reporter DNA when injected in embryos. Thus, our study reporting the generation and the characterization of a metazoan organism mutant in the conserved cullin binding domain of the SOCS-box demonstrates a hitherto unrecognized importance of the SOCS-box domain for the function of this class of cullin-RING ubiquitin ligases and establishes that the d-Asb11 cullin box is required for both canonical Notch signaling and proper neurogenesis.	[da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Guardavaccaro, Daniele] Hubrecht Inst KNAW, Utrecht, Netherlands; [da Silva, Maria A. Sartori; Tee, Jin-Ming; Paridaen, Judith; Brouwers, Anke; Runtuwene, Vincent; Zivkovic, Danica; Guardavaccaro, Daniele] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Diks, Sander H.] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Groningen, Netherlands; [Peppelenbosch, Maikel P.] Erasmus MC Univ Med Ctr Rotterdam, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; University of Groningen; Erasmus University Rotterdam; Erasmus MC	da Silva, MAS (corresponding author), Hubrecht Inst KNAW, Utrecht, Netherlands.	M.Peppelenbosch@erasmusmc.nl	Sartori, Maria A/R-9317-2016; Paridaen, Judith/O-1159-2015	Sartori, Maria A/0000-0002-6474-280X; Paridaen, Judith/0000-0003-3253-6646; Guardavaccaro, Daniele/0000-0002-4517-1765; Peppelenbosch, Maikel/0000-0001-9112-6028	Algemene Levens Wetenschappen [817.02.002, 81502006]; Top Institute Pharma [T1-215, T3-103]	Algemene Levens Wetenschappen; Top Institute Pharma	MASdS and JMT are paid by Algemene Levens Wetenschappen Grant #817.02.002 and #81502006 respectively (www.nwo.nl) and SHD and MPP receive financial support from Top Institute Pharma grant T1-215 and T3-103 (http://www.tipharma.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appel B, 1998, DEVELOPMENT, V125, P371; Appel B, 1999, CURR BIOL, V9, P247, DOI 10.1016/S0960-9822(99)80113-4; Beatus P, 1999, DEVELOPMENT, V126, P3925; Blader P, 1997, DEVELOPMENT, V124, P4557; Boengler K, 2003, BIOCHEM BIOPH RES CO, V302, P17, DOI 10.1016/S0006-291X(03)00095-0; Braat H, 2005, J MOL MED, V83, P601, DOI 10.1007/s00109-005-0685-x; Chung AS, 2005, MOL CELL BIOL, V25, P4716, DOI 10.1128/MCB.25.11.4716-4726.2005; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Diks SH, 2008, NAT CELL BIOL, V10, P1190, DOI 10.1038/ncb1779; Diks SH, 2006, J CELL BIOL, V174, P581, DOI 10.1083/jcb.200601081; Ferguson JE, 2007, MOL CELL BIOL, V27, P6407, DOI 10.1128/MCB.00511-07; Gao M, 2005, MOL CELL, V19, P581, DOI 10.1016/j.molcel.2005.08.017; Geling A, 2004, DEVELOPMENT, V131, P1993, DOI 10.1242/dev.01093; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Hans S, 2004, DEVELOPMENT, V131, P2957, DOI 10.1242/dev.01167; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Katoh M, 2007, INT J ONCOL, V31, P461; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kile BT, 2001, MOL CELL BIOL, V21, P6189, DOI 10.1128/MCB.21.18.6189-6197.2001; Kim KS, 2004, ZYGOTE, V12, P151, DOI 10.1017/S0967199404002722; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kohroki J, 2005, FEBS LETT, V579, P6796, DOI 10.1016/j.febslet.2005.11.016; Krebs DL, 2000, J CELL SCI, V113, P2813; Ma QF, 1998, NEURON, V20, P469, DOI 10.1016/S0896-6273(00)80988-5; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; McDaneld TG, 2008, J ANIM SCI, V86, P2897, DOI 10.2527/jas.2008-1076; McDaneld TG, 2006, AM J PHYSIOL-REG I, V290, pR1672, DOI 10.1152/ajpregu.00239.2005; OXTOBY E, 1993, NUCLEIC ACIDS RES, V21, P1087, DOI 10.1093/nar/21.5.1087; Peppelenbosch M, 1999, J IMMUNOL, V162, P837; Piessevaux J, 2008, CYTOKINE GROWTH F R, V19, P371, DOI 10.1016/j.cytogfr.2008.08.006; PLEASURE SJ, 1993, J NEUROSCI RES, V35, P585, DOI 10.1002/jnr.490350603; Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2; So JH, 2009, BIOCHEM BIOPH RES CO, V379, P22, DOI 10.1016/j.bbrc.2008.11.149; Takke C, 1999, DEVELOPMENT, V126, P3005; Versteeg HH, 2002, J BIOL CHEM, V277, P27065, DOI 10.1074/jbc.M110325200; Wienholds E, 2003, GENOME RES, V13, P2700, DOI 10.1101/gr.1725103; Yeo SY, 2007, DEV BIOL, V301, P555, DOI 10.1016/j.ydbio.2006.10.020	38	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14023	10.1371/journal.pone.0014023	http://dx.doi.org/10.1371/journal.pone.0014023			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124961	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100003
J	Kolata, S; Light, K; Wass, CD; Colas-Zelin, D; Roy, D; Matzel, LD				Kolata, Stefan; Light, Kenneth; Wass, Christopher D.; Colas-Zelin, Danielle; Roy, Debasri; Matzel, Louis D.			A Dopaminergic Gene Cluster in the Prefrontal Cortex Predicts Performance Indicative of General Intelligence in Genetically Heterogeneous Mice	PLOS ONE			English	Article							WORKING-MEMORY CAPACITY; INDIVIDUAL-DIFFERENCES; LEARNING-ABILITY; CELLULAR-DISTRIBUTION; STRESS REACTIVITY; BASAL GANGLIA; DARPP-32; BRAIN; FGF	Background: Genetically heterogeneous mice express a trait that is qualitatively and psychometrically analogous to general intelligence in humans, and as in humans, this trait co-varies with the processing efficacy of working memory (including its dependence on selective attention). Dopamine signaling in the prefrontal cortex (PFC) has been established to play a critical role in animals' performance in both working memory and selective attention tasks. Owing to this role of the PFC in the regulation of working memory, here we compared PFC gene expression profiles of 60 genetically diverse CD-1 mice that exhibited a wide range of general learning abilities (i.e., aggregate performance across five diverse learning tasks). Methodology/Principal Findings: Animals' general cognitive abilities were first determined based on their aggregate performance across a battery of five diverse learning tasks. With a procedure designed to minimize false positive identifications, analysis of gene expression microarrays (comprised of approximate to 25,000 genes) identified a small number (<20) of genes that were differentially expressed across animals that exhibited fast and slow aggregate learning abilities. Of these genes, one functional cluster was identified, and this cluster (Darpp-32, Drd1a, and Rgs9) is an established modulator of dopamine signaling. Subsequent quantitative PCR found that expression of these dopaminegic genes plus one vascular gene (Nudt6) were significantly correlated with individual animal's general cognitive performance. Conclusions/Significance: These results indicate that D1-mediated dopamine signaling in the PFC, possibly through its modulation of working memory, is predictive of general cognitive abilities. Furthermore, these results provide the first direct evidence of specific molecular pathways that might potentially regulate general intelligence.	[Kolata, Stefan; Light, Kenneth; Wass, Christopher D.; Colas-Zelin, Danielle; Roy, Debasri; Matzel, Louis D.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Kolata, S (corresponding author), Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA.	matzel@rci.rutgers.edu		Matzel, Louis/0000-0003-0462-7188	National Institute of Aging [AG022698]; Busch Foundation; NATIONAL INSTITUTE ON AGING [R03AG022698, R01AG029289] Funding Source: NIH RePORTER	National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Busch Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the National Institute of Aging (AG022698) and the Busch Foundation (to LDM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouhamdan M, 2004, BBA-MOL CELL RES, V1691, P141, DOI 10.1016/j.bbamcr.2004.01.005; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Colom R, 2004, INTELLIGENCE, V32, P277, DOI 10.1016/j.intell.2003.12.002; Conway ARA, 2003, TRENDS COGN SCI, V7, P547, DOI 10.1016/j.tics.2003.10.005; Conway ARA, 1996, MEMORY, V4, P577, DOI 10.1080/741940997; Cross MJ, 2001, TRENDS PHARMACOL SCI, V22, P201, DOI 10.1016/S0165-6147(00)01676-X; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Frank MJ, 2001, COGN AFFECT BEHAV NE, V1, P137, DOI 10.3758/CABN.1.2.137; Garzon J, 2001, EUR J NEUROSCI, V13, P801, DOI 10.1046/j.0953-816x.2000.01444.x; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GomezPinilla F, 1997, BRAIN RES, V764, P1, DOI 10.1016/S0006-8993(97)00375-2; GOMEZPINILLA F, 1992, J NEUROSCI, V12, P345; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Grossman HC, 2007, BEHAV NEUROSCI, V121, P949, DOI 10.1037/0735-7044.121.5.949; Jensen A.R., 1998, G FACTOR SCI MENTAL; Jung RE, 2007, BEHAV BRAIN SCI, V30, P135, DOI 10.1017/S0140525X07001185; Kolata S, 2005, NEUROBIOL LEARN MEM, V84, P241, DOI 10.1016/j.nlm.2005.07.006; Kolata S, 2007, LEARN MEMORY, V14, P22, DOI 10.1101/lm.408507; Kolata S, 2008, INTELLIGENCE, V36, P619, DOI 10.1016/j.intell.2007.12.001; Light KR, 2010, CURR BIOL, V20, P777, DOI 10.1016/j.cub.2010.02.034; Mackintosh Nicholas J., 2011, IQ HUMAN INTELLIGENC; MARCHAL G, 1992, ARCH NEUROL-CHICAGO, V49, P1013, DOI 10.1001/archneur.1992.00530340029014; Matzel LD, 2003, J NEUROSCI, V23, P6423; Matzel LD, 2006, NEUROBIOL LEARN MEM, V86, P228, DOI 10.1016/j.nlm.2006.03.004; Mcnab F, 2008, NAT NEUROSCI, V11, P103, DOI 10.1038/nn2024; Meyer-Lindenberg A, 2007, J CLIN INVEST, V117, P672, DOI 10.1172/JCI30413; MORRISON RS, 1986, P NATL ACAD SCI USA, V83, P7537, DOI 10.1073/pnas.83.19.7537; Muzzio IA, 1999, BEHAV NEUROSCI, V113, P103, DOI 10.1037/0735-7044.113.1.103; Plomin R, 2006, INTELLIGENCE, V34, P513, DOI 10.1016/j.intell.2006.01.001; RACHMAN Z, 2003, NEURON US, V6, P941; RICE MC, 1980, NATURE, V283, P157, DOI 10.1038/283157a0; Rowe JB, 2000, SCIENCE, V288, P1656, DOI 10.1126/science.288.5471.1656; SAWAGUCHI T, 1991, SCIENCE, V251, P947, DOI 10.1126/science.1825731; SCHULTZ W, 1993, J NEUROSCI, V13, P900; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Thurley K, 2008, J NEUROPHYSIOL, V99, P2985, DOI 10.1152/jn.01098.2007; WALAAS SI, 1984, J NEUROSCI, V4, P84; Wickens JR, 2007, J NEUROSCI, V27, P8181, DOI 10.1523/JNEUROSCI.1671-07.2007	41	25	25	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14036	10.1371/journal.pone.0014036	http://dx.doi.org/10.1371/journal.pone.0014036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103339	Green Submitted, gold, Green Published			2022-12-27	WOS:000284327800017
J	Cusini, A; Rampini, SK; Bansal, V; Ledergerber, B; Kuster, SP; Ruef, C; Weber, R				Cusini, Alexia; Rampini, Silvana K.; Bansal, Vineeta; Ledergerber, Bruno; Kuster, Stefan P.; Ruef, Christian; Weber, Rainer			Different Patterns of Inappropriate Antimicrobial Use in Surgical and Medical Units at a Tertiary Care Hospital in Switzerland: A Prevalence Survey	PLOS ONE			English	Article							ANTIBIOTIC RESTRICTION POLICY; INFECTIOUS-DISEASES; ECONOMIC-IMPACT; DRUG-USE; THERAPY; RESISTANCE; MISUSE; AUDIT; APPROPRIATENESS; BACTEREMIA	Background: Unnecessary or inappropriate use of antimicrobials is associated with the emergence of antimicrobial resistance, drug toxicity, increased morbidity and health care costs. Antimicrobial use has been reported to be incorrect or not indicated in 9-64% of inpatients. We studied the quality of antimicrobial therapy and prophylaxis in hospitalized patients at a tertiary care hospital to plan interventions to improve the quality of antimicrobial prescription. Methodology/Principal Findings: Experienced infectious diseases (ID) fellows performed audits of antimicrobial use at regular intervals among all patients-with or without antimicrobials-hospitalized in predefined surgical, medical, haemato-oncological, or intensive care units. Data were collected from medical and nursing patient charts with a standardized questionnaire. Appropriateness of antimicrobial use was evaluated using a modified algorithm developed by Gyssens et al.; the assessment was double-checked by a senior ID specialist. We evaluated 1577 patients of whom 700 (44.4%) had antimicrobials, receiving a total of 1270 prescriptions. 958 (75.4%) prescriptions were for therapy and 312 (24.6%) for prophylaxis. 37.0% of therapeutic and 16.6% of prophylactic prescriptions were found to be inappropriate. Most frequent characteristics of inappropriate treatments included: No indication (17.5%); incorrect choice of antimicrobials (7.6%); incorrect application of drugs (9.3%); and divergence from institutional guidelines (8%). Characteristics of inappropriate prophylaxes were: No indication (9%); incorrect choice of antimicrobials (1%); duration too long or other inappropriate use (6.7%). Patterns of inappropriate antimicrobial varied widely in the different hospital units; empirical prescriptions were more frequently incorrect than prescriptions based on available microbiological results. Conclusions/Significance: Audits of individual patient care provide important data to identify local problems in antimicrobial prescription practice. In our study, antimicrobial prescriptions without indication, and divergence from institutional guidelines were frequent errors. Based on these results, we will tailor education, amend institutional guidelines and further develop the infectious diseases consultation service.	[Cusini, Alexia; Bansal, Vineeta; Ledergerber, Bruno; Kuster, Stefan P.; Ruef, Christian; Weber, Rainer] Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland; [Rampini, Silvana K.] Univ Zurich Hosp, Div Internal Med, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Cusini, A (corresponding author), Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, CH-8091 Zurich, Switzerland.	infweb@usz.uzh.ch	Kuster, Stefan/T-7388-2019; Ledergerber, Bruno/B-5656-2009; Weber, Rainer/D-5175-2012	Kuster, Stefan/0000-0002-0525-6529; Ledergerber, Bruno/0000-0002-6881-4401; 	Abbott; Aventis; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Merck Sharp Dohme; Roche and Tibotec; Tibotec; Pfizer; Wyeth; Boehringer Ingelheim; Gilead; Merck; Roche; TRB Chemedica	Abbott(Abbott Laboratories); Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); Gilead Sciences(Gilead Sciences); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp Dohme(Merck & Company); Roche and Tibotec; Tibotec; Pfizer(Pfizer); Wyeth(Wyeth); Boehringer Ingelheim(Boehringer Ingelheim); Gilead(Gilead Sciences); Merck(Merck & Company); Roche(Roche Holding); TRB Chemedica	BL has received travel grants and/or speakers honoraria from Abbott, Aventis, Bristol-Myers Squibb, Gilead Sciences, GlaxoSmithKline, Merck Sharp & Dohme, and Roche and Tibotec. SPK has received travel grants from Tibotec. CR has received travel grants from Pfizer and Wyeth and honoraria for teaching from Merck Sharp & Dohme and is a member of the advisory board of Pfizer and Novartis. RW has received travel grants and honoraria for teaching from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead, GlaxoSmithKline, Merck, Pfizer, Roche and TRB Chemedica. These competing interests do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Albrich WC, 2004, EMERG INFECT DIS, V10, P514, DOI 10.3201/eid1003.030252; Bugnon-Reber AV, 2004, SWISS MED WKLY, V134, P481; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Erbay A, 2005, J HOSP INFECT, V59, P53, DOI 10.1016/j.jhin.2004.07.026; Erbay AE, 2003, INT J ANTIMICROB AG, V21, P308, DOI 10.1016/S0924-8579(02)00392-8; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gyssens IC, 2001, INT J ANTIMICROB AG, V17, P9, DOI 10.1016/S0924-8579(00)00208-9; GYSSENS IC, 1992, J ANTIMICROB CHEMOTH, V30, P724, DOI 10.1093/jac/30.5.724; Hecker MT, 2003, ARCH INTERN MED, V163, P972, DOI 10.1001/archinte.163.8.972; Hsueh PR, 2005, INT J ANTIMICROB AG, V26, P463, DOI 10.1016/j.ijantimicag.2005.08.016; JONES SR, 1977, AM J MED SCI, V273, P79, DOI 10.1097/00000441-197701000-00008; Kumarasamy Y, 2003, CLIN MICROBIOL INFEC, V9, P406, DOI 10.1046/j.1469-0691.2003.00577.x; KUNIN CM, 1973, ANN INTERN MED, V79, P555, DOI 10.7326/0003-4819-79-4-555; Kuster SP, 2008, INFECTION, V36, P549, DOI 10.1007/s15010-008-7462-z; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P1451, DOI 10.1093/jac/dkn384; Kuster SP, 2008, J ANTIMICROB CHEMOTH, V62, P837, DOI 10.1093/jac/dkn275; Lee NY, 2007, INFECT CONT HOSP EP, V28, P713, DOI 10.1086/517954; Lodise TP, 2005, DIAGN MICR INFEC DIS, V52, P113, DOI 10.1016/j.diagmicrobio.2005.02.007; Malhotra-Kumar S, 2007, LANCET, V369, P482, DOI 10.1016/S0140-6736(07)60235-9; Ozkurt Z, 2005, JPN J INFECT DIS, V58, P338; Paterson DL, 2004, CLIN INFECT DIS, V38, pS341, DOI 10.1086/382690; Pulcini C, 2007, EUR J CLIN MICROBIOL, V26, P277, DOI 10.1007/s10096-007-0277-5; Raineri E, 2008, AM J INFECT CONTROL, V36, P283, DOI 10.1016/j.ajic.2007.06.009; Raveh D, 2001, QJM-INT J MED, V94, P141, DOI 10.1093/qjmed/94.3.141; Seaton RA, 2007, INT J ANTIMICROB AG, V29, P693, DOI 10.1016/j.ijantimicag.2006.10.020; Tunger O, 2000, INT J ANTIMICROB AG, V15, P131, DOI 10.1016/S0924-8579(00)00158-8; Tunger O, 2009, J INFECT DEV COUNTR, V3, P88, DOI 10.3855/jidc.54; Vlahovic-Palcevski V, 2007, INT J CLIN PHARM TH, V45, P169; Vlahovic-Palevski V, 2005, PHARMACOEPIDEM DR S, V14, P561, DOI 10.1002/pds.1097; WHO Collaborating Center for Drug Statistics Methodology, 2010, ATC IND DDDS 2009; Willemsen I, 2007, ANTIMICROB AGENTS CH, V51, P864, DOI 10.1128/AAC.00994-06; Zahar JR, 2003, PRESSE MED, V32, P1208	33	79	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14011	10.1371/journal.pone.0014011	http://dx.doi.org/10.1371/journal.pone.0014011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103362	gold, Green Published, Green Submitted			2022-12-27	WOS:000284257400015
J	Tassie, JM; Malateste, K; Pujades-Rodriguez, M; Poulet, E; Bennett, D; Harries, A; Mahy, M; Schechter, M; Souteyrand, Y; Dabis, F				Tassie, Jean-Michel; Malateste, Karen; Pujades-Rodriguez, Mar; Poulet, Elisabeth; Bennett, Diane; Harries, Anthony; Mahy, Mary; Schechter, Mauro; Souteyrand, Yves; Dabis, Francois		IeDEA Collaboration; MSF Collaboration	Evaluation of Three Sampling Methods to Monitor Outcomes of Antiretroviral Treatment Programmes in Low- and Middle-Income Countries	PLOS ONE			English	Article							RESOURCE-LIMITED SETTINGS; SUB-SAHARAN AFRICA; PATIENT RETENTION; THERAPY PROGRAMS; FOLLOW-UP; EXPERIENCE; MORTALITY; COVERAGE; QUALITY; TRENDS	Background: Retention of patients on antiretroviral therapy (ART) over time is a proxy for quality of care and an outcome indicator to monitor ART programs. Using existing databases (Antiretroviral in Lower Income Countries of the International Databases to Evaluate AIDS and Medecins Sans Frontieres),we evaluated three sampling approaches to simplify the generation of outcome indicators. Methods and Findings: We used individual patient data from 27 ART sites and included 27,201 ART-naive adults (>= 15 years) who initiated ART in 2005. For each site, we generated two outcome indicators at 12 months, retention on ART and proportion of patients lost to follow-up (LFU), first using all patient data and then within a smaller group of patients selected using three sampling methods (random, systematic and consecutive sampling). For each method and each site, 500 samples were generated, and the average result was compared with the unsampled value. The 95% sampling distribution (SD) was expressed as the 2.5(th) and 97.5(th) percentile values from the 500 samples. Overall, retention on ART was 76.5% (range 58.9-88.6) and the proportion of patients LFU, 13.5% (range 0.8-31.9). Estimates of retention from sampling (n = 5696) were 76.5% (SD 75.4-77.7) for random, 76.5% (75.3-77.5) for systematic and 76.0% (74.1-78.2) for the consecutive method. Estimates for the proportion of patients LFU were 13.5% (12.6-14.5), 13.5% (12.6-14.3) and 14.0% (12.5-15.5), respectively. With consecutive sampling, 50% of sites had SD within +/- 5% of the unsampled site value. Conclusions: Our results suggest that random, systematic or consecutive sampling methods are feasible for monitoring ART indicators at national level. However, sampling may not produce precise estimates in some sites.	[Tassie, Jean-Michel; Souteyrand, Yves] WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland; [Malateste, Karen; Dabis, Francois] Univ Victor Segalen, INSERM, U857, Bordeaux, France; [Malateste, Karen; Dabis, Francois] Univ Victor Segalen, ISPED, Bordeaux, France; [Pujades-Rodriguez, Mar; Poulet, Elisabeth] Epictr, Paris, France; [Bennett, Diane] Ctr Dis Control & Prevent, Atlanta, GA USA; [Harries, Anthony] Int Union TB & Lung Dis, Paris, France; [Harries, Anthony] London Sch Hyg & Trop Med, London WC1, England; [Mahy, Mary] Joint United Nat Programme HIV AIDS UNAIDS, Geneva, Switzerland; [Schechter, Mauro] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil	World Health Organization; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Centers for Disease Control & Prevention - USA; University of London; London School of Hygiene & Tropical Medicine; UNAIDS; Universidade Federal do Rio de Janeiro	Tassie, JM (corresponding author), WHO, Dept HIV AIDS, CH-1211 Geneva, Switzerland.	tassiej@who.int	Schechter, Mauro/AAG-7445-2020; Pujades-Rodriguez, Mar/G-4388-2014; DABIS, FRANCOIS/S-9298-2019; Pujades-Rodriguez, Mar/T-1129-2018	Pujades-Rodriguez, Mar/0000-0002-7778-3520; DABIS, FRANCOIS/0000-0002-1614-8857; Pujades-Rodriguez, Mar/0000-0002-1375-1028	World Health Organisation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924] Funding Source: NIH RePORTER	World Health Organisation(World Health Organization); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this collaborative analysis using existing databases was provided by the World Health Organisation. The World Health Organisation participated in study design, data analysis, decision to publish, and preparation of the manuscript.	Alemayehu YK, 2009, INT J QUAL HEALTH C, V21, P356, DOI 10.1093/intqhc/mzp030; Bennett DE, 2008, ANTIVIR THER, V13, P1; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Dabis F, 2005, INT J EPIDEMIOL, V34, P979, DOI 10.1093/ije/dyi164; Douglas GP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000319; Forster M, 2008, B WORLD HEALTH ORGAN, V86, P939, DOI 10.2471/BLT.07.049908; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Geng EH, 2008, JAMA-J AM MED ASSOC, V300, P506, DOI 10.1001/jama.300.5.506; Harries AD, 2010, TROP MED INT HEALTH, V15, P70, DOI 10.1111/j.1365-3156.2010.02506.x; HENDERSON RH, 1982, B WORLD HEALTH ORGAN, V60, P253; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, MON DECL COMM HIV AI; Mahy M, 2010, CURR OPIN HIV AIDS, V5, P97, DOI 10.1097/COH.0b013e328333b892; O'Brien DP, 2007, CLIN INFECT DIS, V44, P1245, DOI 10.1086/513433; Pujades-Rodriguez M, 2008, AIDS, V22, P1305, DOI 10.1097/QAD.0b013e3282fa75b9; Tassie JM, 2010, JAIDS-J ACQ IMM DEF, V54, P437, DOI 10.1097/QAI.0b013e3181d73e1b; *UNAIDS, WHO AIDS EP UPD 09; *WHO, UNICEF UN ACC SCAL P; Yiannoutsos CT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003843	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13899	10.1371/journal.pone.0013899	http://dx.doi.org/10.1371/journal.pone.0013899			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085709	gold, Green Accepted, Green Submitted, Green Published			2022-12-27	WOS:000284036800009
J	Huang, CB; Zhou, JW; Zhou, YF; Lu, ZL				Huang, Chang-Bing; Zhou, Jiawei; Zhou, Yifeng; Lu, Zhong-Lin			Contrast and Phase Combination in Binocular Vision	PLOS ONE			English	Article							MASKING-LEVEL DIFFERENCES; VISUAL-CORTEX; CORTICAL-NEURONS; GAIN-CONTROL; SIMPLE CELLS; RIVALRY; SUMMATION; MODEL; ARCHITECTURE; SUPPRESSION	Background: How the visual system combines information from the two eyes to form a unitary binocular representation of the external world is a fundamental question in vision science that has been the focus of many psychophysical and physiological investigations. Ding & Sperling (2006) measured perceived phase of the cyclopean image, and developed a binocular combination model in which each eye exerts gain control on the other eye's signal and over the other eye's gain control. Critically, the relative phase of the monocular sine-waves plays a central role. Methodology/Principal Findings: We used the Ding-Sperling paradigm but measured both the perceived contrast and phase of cyclopean images in three hundred and eighty combinations of base contrast, interocular contrast ratio, eye origin of the probe, and interocular phase difference. We found that the perceived contrast of the cyclopean image was independent of the relative phase of the two monocular gratings, although the perceived phase depended on the relative phase and contrast ratio of the monocular images. We developed a new multi-pathway contrast-gain control model (MCM) that elaborates the Ding-Sperling binocular combination model in two ways: (1) phase and contrast of the cyclopean images are computed in separate pathways, although with shared cross-eye contrast-gain control; and (2) phase-independent local energy from the two monocular images are used in binocular contrast combination. With three free parameters, the model yielded an excellent account of data from all the experimental conditions. Conclusions/Significance: Binocular phase combination depends on the relative phase and contrast ratio of the monocular images but binocular contrast combination is phase-invariant. Our findings suggest the involvement of at least two separate pathways in binocular combination.	[Huang, Chang-Bing; Lu, Zhong-Lin] Univ So Calif, Dept Psychol & Biomed Engn, Grad Program Neurosci, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA; [Zhou, Jiawei; Zhou, Yifeng] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230026, Peoples R China; [Zhou, Jiawei; Zhou, Yifeng] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	University of Southern California; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Huang, CB (corresponding author), Univ So Calif, Dept Psychol & Biomed Engn, Grad Program Neurosci, Lab Brain Proc LOBES, Los Angeles, CA 90089 USA.	zhonglin@usc.edu	Zhou, Jiawei/AGN-8024-2022; HUANG, CHANG-BING/D-3855-2011; Huang, Chang-Bing/AAE-2909-2020; Zhou, Jiawei/J-8770-2013	Zhou, Jiawei/0000-0003-4220-344X; huang, chang bing/0000-0003-4694-0834; Lu, Zhong-Lin/0000-0002-7295-727X	National Eye Institute [EY017491]; National Natural Science Foundation of China [30630027]; NATIONAL EYE INSTITUTE [R01EY017491] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The National Eye Institute (EY017491) and the National Natural Science Foundation of China (30630027) supported the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRECHT DG, 1991, VISUAL NEUROSCI, V7, P531, DOI 10.1017/S0952523800010336; ANDERSON PA, 1989, VISION RES, V29, P1115, DOI 10.1016/0042-6989(89)90060-6; ARDITI AR, 1981, VISION RES, V21, P329, DOI 10.1016/0042-6989(81)90160-7; Baker DH, 2009, VISION RES, V49, P451, DOI 10.1016/j.visres.2008.12.002; BLAKE R, 1981, PERCEPT PSYCHOPHYS, V30, P266, DOI 10.3758/BF03214282; BLAKE R, 1974, NATURE, V249, P488, DOI 10.1038/249488a0; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V225, P437, DOI 10.1113/jphysiol.1972.sp009948; Blaser E, 1999, P NATL ACAD SCI USA, V96, P11681, DOI 10.1073/pnas.96.20.11681; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; CAMPBELL FW, 1965, NATURE, V208, P191, DOI 10.1038/208191a0; Chance FS, 1999, NAT NEUROSCI, V2, P277, DOI 10.1038/6381; Cormack LK, 1997, PERCEPTION, V26, P1121, DOI 10.1068/p261121; Ding J, 2006, P NATL ACAD SCI USA, V103, P1141, DOI 10.1073/pnas.0509629103; Ding J, 2007, COMPUTATIONAL VISION IN NEURAL AND MACHINE SYSTEMS, P257; DUDLEY LP, 1951, STEREOPTICS INTRO LO; FRISEN L, 1988, J PHYSIOL-LONDON, V402, P773, DOI 10.1113/jphysiol.1988.sp017233; GEISLER WS, 1992, VISION RES, V32, P1409, DOI 10.1016/0042-6989(92)90196-P; Grossberg S, 2006, SPATIAL VISION, V19, P263, DOI 10.1163/156856806776923399; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; HEEGER DJ, 1992, VISUAL NEUROSCI, V9, P181, DOI 10.1017/S0952523800009640; HENNING GB, 1973, VISION RES, V13, P2455, DOI 10.1016/0042-6989(73)90243-5; HENNING GB, 1977, VISION RES, V17, P399, DOI 10.1016/0042-6989(77)90030-X; HUANG CB, 2010, DEFICIENT BINOCULAR; Huang Chang-Bing, 2009, J Vis, V9, DOI 10.1167/9.3.17; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Hyvarinen A., 2009, NATURAL IMAGE STAT P; Julesz B., 1971, FDN CYCLOPEAN PERCEP; Kovacs I, 1996, P NATL ACAD SCI USA, V93, P15508, DOI 10.1073/pnas.93.26.15508; Lee SH, 2007, NAT NEUROSCI, V10, P1048, DOI 10.1038/nn1939; LEGGE GE, 1984, VISION RES, V24, P385, DOI 10.1016/0042-6989(84)90064-6; LEGGE GE, 1981, PERCEPT PSYCHOPHYS, V30, P49, DOI 10.3758/BF03206136; Li XR, 2003, J NEUROSCI METH, V130, P9, DOI 10.1016/S0165-0270(03)00174-2; Logothetis NK, 1996, NATURE, V380, P621, DOI 10.1038/380621a0; Maehara G, 2005, OPT REV, V12, P76, DOI 10.1007/s10043-004-0076-5; MARR D, 1979, PROC R SOC SER B-BIO, V204, P301, DOI 10.1098/rspb.1979.0029; Meese TS, 2006, J VISION, V6, P1224, DOI 10.1167/6.11.7; Moradi F, 2009, J VISION, V9, DOI 10.1167/9.3.13; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pirenne MH, 1943, NATURE, V152, P698, DOI 10.1038/152698a0; Raizada RDS, 2003, CEREB CORTEX, V13, P100, DOI 10.1093/cercor/13.1.100; RAMACHANDRAN VS, 1972, NATURE, V237, P347, DOI 10.1038/237347a0; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; Simmons DR, 2005, PERCEPTION, V34, P1035, DOI 10.1068/p5279; Smith EL, 1997, J NEUROPHYSIOL, V78, P366, DOI 10.1152/jn.1997.78.1.366; van der Smagt MJ, 2005, J NEUROPHYSIOL, V94, P576, DOI 10.1152/jn.00366.2004; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019	47	56	59	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15075	10.1371/journal.pone.0015075	http://dx.doi.org/10.1371/journal.pone.0015075			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151558	Green Submitted, gold, Green Published			2022-12-27	WOS:000285135800014
J	Proenca, DN; Francisco, R; Santos, CV; Lopes, A; Fonseca, L; Abrantes, IMO; Morais, PV				Proenca, Diogo Neves; Francisco, Romeu; Santos, Clara Vieira; Lopes, Andre; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.			Diversity of Bacteria Associated with Bursaphelenchus xylophilus and Other Nematodes Isolated from Pinus pinaster Trees with Pine Wilt Disease	PLOS ONE			English	Article							WOOD NEMATODE	The pinewood nematode (PWN), Bursaphelenchus xylophilus, has been thought to be the only causal agent of pine wilt disease (PWD), however, since bacteria have been suggested to play a role in PWD, it is important to know the diversity of the microbial community associated to it. This study aimed to assess the microbial community associated with B. xylophilus and with other nematodes isolated from pine trees, Pinus pinaster, with PWD from three different affected forest areas in Portugal. One hundred and twenty three bacteria strains were isolated from PWN and other nematodes collected from 14 P. pinaster. The bacteria strains were identified by comparative analysis of the 16S rRNA gene partial sequence. All except one Gram-positive strain (Actinobacteria) belonged to the Gram-negative Beta and Gammaproteobacteria. Most isolates belonged to the genus Pseudomonas, Burkholderia and to the family Enterobacteriaceae. Species isolated in higher percentage were Pseudomonas lutea, Yersinia intermedia and Burkholderia tuberum. The major bacterial population associated to the nematodes differed according to the forest area and none of the isolated bacterial species was found in all different forest areas. For each of the sampled areas, 60 to 100% of the isolates produced siderophores and at least 40% produced lipases. The ability to produce siderophores and lipases by most isolates enables these bacteria to have a role in plant physiological response. This research showed a high diversity of the microbial community associated with B. xylophilus and other nematodes isolated from P. pinaster with PWD.	[Proenca, Diogo Neves; Francisco, Romeu; Santos, Clara Vieira; Lopes, Andre; Fonseca, Luis; Abrantes, Isabel M. O.; Morais, Paula V.] Inst Marine Res IMAR CMA, Coimbra, Portugal; [Abrantes, Isabel M. O.; Morais, Paula V.] Univ Coimbra, Fac Sci & Technol FCTUC, Dept Life Sci, Coimbra, Portugal	Universidade de Coimbra; Universidade de Coimbra	Proenca, DN (corresponding author), Inst Marine Res IMAR CMA, Coimbra, Portugal.	pvmorais@ci.uc.pt	Francisco, Romeu/I-1080-2012; Morais, Paula Vasconcelos/C-9756-2014; Proença, Diogo Neves/K-1801-2015; Abrantes, Isabel/CAG-1426-2022	Francisco, Romeu/0000-0002-4643-6075; Morais, Paula Vasconcelos/0000-0002-1939-6389; Proença, Diogo Neves/0000-0002-1284-9082; Abrantes, Isabel/0000-0002-8761-2151; Fonseca, Luis/0000-0001-7405-8916	Fundacao para a Ciencia e a Tecnologia [POCI/AGR/59097/2004]; Fundo Florestal Permanente	Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundo Florestal Permanente	This research was partially supported by the Fundacao para a Ciencia e a Tecnologia (POCI/AGR/59097/2004) http://alfa.fct.mctes.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This research was also partially supported by Fundo Florestal Permanente, through a national project "O nematode-da-madeira-do-pinheiro (NMP), Bursaphelenchus xylophilus'' http://www.afn.min-agricultura.pt/ portal/apoios-invest/ffp.	ABRANTES I M O, 1976, Ciencia Biologica Ecologia e Sistematica, V1, P139; Castagnone C, 2005, EUR J PLANT PATHOL, V112, P191, DOI 10.1007/s10658-004-0580-2; *EPPO OEPP, 2009, B OEPP EPPO, V39, P344; GUO DS, 2000, J NANJING FOR U, V4, P69; Guo QQ, 2007, J NEMATOL, V39, P243; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Hofte M, 2006, PLANT-ASSOCIATED BACTERIA, P507; Jukes T., 1969, MAMMALIAN PROTEIN ME, P21; Kwon SJ, 2009, PLANT J, V58, P235, DOI 10.1111/j.1365-313X.2008.03772.x; Maidak BL, 2001, NUCLEIC ACIDS RES, V29, P173, DOI 10.1093/nar/29.1.173; MAMIYA Y, 1979, NEMATOLOGICA, V25, P353, DOI 10.1163/187529279X00091; Hunzicker GM, 2009, PLANTA, V231, P143, DOI 10.1007/s00425-009-1032-1; NICKLE WR, 1981, J NEMATOL, V13, P385; NIELSEN P, 1995, MICROBIOL-UK, V141, P1745, DOI 10.1099/13500872-141-7-1745; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Peix A, 2004, INT J SYST EVOL MICR, V54, P847, DOI 10.1099/ijs.0.02966-0; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; Pirttila AM, 2000, APPL ENVIRON MICROB, V66, P3073, DOI 10.1128/AEM.66.7.3073-3077.2000; Pirttila AM, 2008, PLANT CELL TISS ORG, V95, P47, DOI 10.1007/s11240-008-9413-x; RAINEY FA, 1992, SYST APPL MICROBIOL, V15, P197, DOI 10.1016/S0723-2020(11)80092-5; Salles JF, 2004, APPL ENVIRON MICROB, V70, P4012, DOI 10.1128/AEM.70.7.4012-4020.2004; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Torres AR, 2008, J MICROBIOL, V46, P373, DOI 10.1007/s12275-007-0165-9; Wang Z, 2010, AFR J MICROBIOL RES, V4, P437; WHITAKER JR, 1995, ACS SYM SER, V600, P2; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; Zhao BG, 2007, J PHYTOPATHOL, V155, P26, DOI 10.1111/j.1439-0434.2006.01188.x; Zhao B.G., 2008, PINE WILT DIS, DOI DOI 10.1007/978-4-431-75655-2; Zhao BG, 2005, FOREST PATHOL, V35, P339, DOI 10.1111/j.1439-0329.2005.00417.x; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817	32	68	72	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15191	10.1371/journal.pone.0015191	http://dx.doi.org/10.1371/journal.pone.0015191			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151611	gold, Green Published			2022-12-27	WOS:000285135800017
J	Solberg, R; Loberg, EM; Andresen, JH; Wright, MS; Charrat, E; Khrestchatisky, M; Rivera, S; Saugstad, OD				Solberg, Ronnaug; Loberg, Else Marit; Andresen, Jannicke H.; Wright, Marianne S.; Charrat, Eliane; Khrestchatisky, Michel; Rivera, Santiago; Saugstad, Ola Didrik			Resuscitation of Newborn Piglets. Short-Term Influence of FiO(2) on Matrix Metalloproteinases, Caspase-3 and BDNF	PLOS ONE			English	Article							NEONATAL HYPOXIA-ISCHEMIA; DOSE-DEPENDENT INCREASE; ROOM-AIR RESUSCITATION; NEURONAL CELL-DEATH; 100-PERCENT OXYGEN; DEVELOPING BRAIN; PATHOLOGICAL APOPTOSIS; ANIMAL-MODELS; INJURY; ACTIVATION	Background: Perinatal hypoxia-ischemia is a major cause of mortality and cerebral morbidity, and using oxygen during newborn resuscitation may further harm the brain. The aim was to examine how supplementary oxygen used for newborn resuscitation would influence early brain tissue injury, cell death and repair processes and the regulation of genes related to apoptosis, neurodegeneration and neuroprotection. Methods and Findings: Anesthetized newborn piglets were subjected to global hypoxia and then randomly assigned to resuscitation with 21%, 40% or 100% O-2 for 30 min and followed for 9 h. An additional group received 100% O-2 for 30 min without preceding hypoxia. The left hemisphere was used for histopathology and immunohistochemistry and the right hemisphere was used for in situ zymography in the corpus striatum; gene expression and the activity of various relevant biofactors were measured in the frontal cortex. There was an increase in the net matrix metalloproteinase gelatinolytic activity in the corpus striatum from piglets resuscitated with 100% oxygen vs. 21%. Hematoxylin-eosin (HE) staining revealed no significant changes. Nine hours after oxygen-assisted resuscitation, caspase-3 expression and activity was increased by 30-40% in the 100% O-2 group (n = 9/10) vs. the 21% O-2 group (n = 10; p<0.04), whereas brain-derived neurotrophic factor (BDNF) activity was decreased by 65% p<0.03. Conclusions: The use of 100% oxygen for resuscitation resulted in increased potentially harmful proteolytic activities and attenuated BDNF activity when compared with 21%. Although there were no significant changes in short term cell loss, hyperoxia seems to cause an early imbalance between neuroprotective and neurotoxic mechanisms that might compromise the final pathological outcome.	[Solberg, Ronnaug; Andresen, Jannicke H.; Wright, Marianne S.; Saugstad, Ola Didrik] Univ Oslo, Dept Paediat Res, Oslo, Norway; [Solberg, Ronnaug; Andresen, Jannicke H.; Wright, Marianne S.; Saugstad, Ola Didrik] Univ Oslo, Rikshosp, Oslo Univ Hosp, N-0027 Oslo, Norway; [Solberg, Ronnaug; Andresen, Jannicke H.] Univ Oslo, Dept Surg Res, Oslo, Norway; [Solberg, Ronnaug] Vestfold Cent Hosp, Dept Pediat, Tonsberg, Norway; [Loberg, Else Marit] Oslo Univ Hosp, Dept Pathol, Oslo, Norway; [Charrat, Eliane; Khrestchatisky, Michel; Rivera, Santiago] Univ Aix Marseille 2, Fac Med, CNRS, UMR NICN 6184, F-13284 Marseille 07, France	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Solberg, R (corresponding author), Univ Oslo, Dept Paediat Res, Oslo, Norway.	ronnaug.solberg@medisin.uio.no	Saugstad, Ola/AAS-9041-2021	Saugstad, Ola/0000-0002-3166-5254	Health South-East Research Foundation, Norway; Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod	Health South-East Research Foundation, Norway; Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod	This work was supported by Health South-East Research Foundation, Norway and Norwegian Sudden Infant Death Syndrom and Stillbirth Society, Landsforeningen Uventet Barnedod. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almli CR, 2000, EXP NEUROL, V166, P99, DOI 10.1006/exnr.2000.7492; Amess PN, 1997, PEDIATR RES, V41, P803, DOI 10.1203/00006450-199706000-00002; Andresen JH, 2009, J MATERN-FETAL NEO M, V22, P161, DOI 10.1080/14767050802663186; Berchtold NC, 2005, NEUROSCIENCE, V133, P853, DOI 10.1016/j.neuroscience.2005.03.026; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Blomgren K, 2007, APOPTOSIS, V12, P993, DOI 10.1007/s10495-007-0754-4; CANDELARIOJALIL E, 2008, NEUROSCIENCE; Chen WQ, 2009, J NEUROCHEM, V111, P726, DOI 10.1111/j.1471-4159.2009.06362.x; Chiang MC, 2007, NEUROSCI LETT, V421, P67, DOI 10.1016/j.neulet.2007.05.024; Davis PG, 2004, LANCET, V364, P1329, DOI 10.1016/S0140-6736(04)17189-4; DOBBING J, 1979, EARLY HUM DEV, V3, P79, DOI 10.1016/0378-3782(79)90022-7; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Geddes R, 2001, DEV NEUROSCI-BASEL, V23, P180, DOI 10.1159/000046140; Gerstner B, 2006, J NEUROSCI RES, V84, P306, DOI 10.1002/jnr.20880; Gill MB, 2008, J NEUROSCI RES, V86, P3584, DOI 10.1002/jnr.21795; Greenwood K, 2000, PEDIATR RES, V48, P346, DOI 10.1203/00006450-200009000-00014; Gressens P, 2008, BRAIN PATHOL, V18, P10, DOI 10.1111/j.1750-3639.2007.00095.x; Gu ZZ, 2002, SCIENCE, V297, P1186, DOI 10.1126/science.1073634; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Han BH, 2000, NEUROBIOL DIS, V7, P38; Han BH, 2000, J NEUROSCI, V20, P5775, DOI 10.1523/jneurosci.20-15-05775.2000; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Iwata O, 2007, BRAIN RES, V1154, P173, DOI 10.1016/j.brainres.2007.03.083; Jantzie LL, 2008, RESUSCITATION, V77, P111, DOI 10.1016/j.resuscitation.2007.10.008; Jourquin J, 2003, EUR J NEUROSCI, V18, P1507, DOI 10.1046/j.1460-9568.2003.02876.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marini AM, 2007, AMINO ACIDS, V32, P299, DOI 10.1007/s00726-006-0414-y; Markus T, 2007, PEDIATR RES, V62, P71, DOI 10.1203/PDR.0b013e31811ead6e; Mattson MP, 2002, AGEING RES REV, V1, pIII; Mendoza-Paredes A, 2008, RESUSCITATION, V76, P261, DOI 10.1016/j.resuscitation.2007.07.022; Mukae N, 1998, P NATL ACAD SCI USA, V95, P9123, DOI 10.1073/pnas.95.16.9123; Munkeby BH, 2005, PEDIATR RES, V58, P542, DOI 10.1203/01.PDR.0000179407.46810.2D; Munkeby BH, 2004, PEDIATR RES, V56, P783, DOI 10.1203/01.PDR.0000141988.89820.E3; Nicholson DW, 1997, TRENDS BIOCHEM SCI, V22, P299, DOI 10.1016/S0968-0004(97)01085-2; Nikolaou KE, 2006, ANN NY ACAD SCI, V1092, P426, DOI 10.1196/annals.1365.041; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; O'Brien FE, 2006, PEDIATRICS, V117, P1549, DOI 10.1542/peds.2005-1649; Presti AL, 2006, PEDIATR RES, V60, P55, DOI 10.1203/01.pdr.0000223766.98760.88; Rabi Y, 2007, RESUSCITATION, V72, P353, DOI 10.1016/j.resuscitation.2006.06.134; Ranasinghe HS, 2009, NEUROSCIENCE, V158, P732, DOI 10.1016/j.neuroscience.2008.07.069; Richards JG, 2006, RESUSCITATION, V69, P319, DOI 10.1016/j.resuscitation.2005.08.012; Rivera S, 2002, EUR J NEUROSCI, V15, P19, DOI 10.1046/j.0953-816x.2001.01838.x; RIVERA S, 2010, J NEUROSCIE IN PRESS; Roohey T, 1997, EARLY HUM DEV, V47, P115, DOI 10.1016/S0378-3782(96)01773-2; Saugstad OD, 2003, PEDIATRICS, V112, P296, DOI 10.1542/peds.112.2.296; Saugstad OD, 2008, NEONATOLOGY, V94, P176, DOI 10.1159/000143397; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sbai O, 2008, MOL CELL NEUROSCI, V39, P549, DOI 10.1016/j.mcn.2008.08.004; Solberg R, 2007, PEDIATR RES, V62, P559, DOI 10.1203/PDR.0b013e318156e8aa; Solberg R, 2010, PEDIATR RES, V67, P250, DOI 10.1203/PDR.0b013e3181cde843; Svedin P, 2007, J NEUROSCI, V27, P1511, DOI 10.1523/JNEUROSCI.4391-06.2007; Takizawa Y, 2006, BRAIN RES, V1095, P200, DOI 10.1016/j.brainres.2006.04.027; Tanaka H, 2004, J NEUROSCI, V24, P2750, DOI 10.1523/JNEUROSCI.5475-03.2004; Vento M, 2005, AM J RESP CRIT CARE, V172, P1393, DOI 10.1164/rccm.200412-1740OC; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Yang Y, 2010, J NEUROCHEM, V112, P134, DOI 10.1111/j.1471-4159.2009.06433.x; Zhao BQ, 2007, STROKE, V38, P748, DOI 10.1161/01.STR.0000253500.32979.d1; Zhao BQ, 2006, NAT MED, V12, P441, DOI 10.1038/nm1387	58	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14261	10.1371/journal.pone.0014261	http://dx.doi.org/10.1371/journal.pone.0014261			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151608	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800003
J	Yang, CR; Miao, DQ; Zhang, QH; Guo, L; Tong, JS; Wei, YC; Huang, X; Hou, Y; Schatten, H; Liu, ZH; Sun, QY				Yang, Cai-Rong; Miao, De-Qiang; Zhang, Qing-Hua; Guo, Lei; Tong, Jing-Shan; Wei, Yanchang; Huang, Xin; Hou, Yi; Schatten, Heide; Liu, ZhongHua; Sun, Qing-Yuan			Short-term Preservation of Porcine Oocytes in Ambient Temperature: Novel Approaches	PLOS ONE			English	Article							IN-VITRO MATURATION; EARLY EMBRYO DEVELOPMENT; GERMINAL VESICLE STAGE; PIG OOCYTES; DEVELOPMENTAL COMPETENCE; ADENOSINE-TRIPHOSPHATE; CUMULUS CELLS; ACTIVE MITOCHONDRIA; MEIOTIC MATURATION; CORTICAL GRANULES	The objective of this study was to evaluate the feasibility of preserving porcine oocytes without freezing. To optimize preservation conditions, porcine cumulus-oocyte complexes (COCs) were preserved in TCM-199, porcine follicular fluid (pFF) and FCS at different temperatures (4 degrees C, 20 degrees C, 25 degrees C, 27.5 degrees C, 30 degrees C and 38.5 degrees C) for 1 day, 2 days or 3 days. After preservation, oocyte morphology, germinal vesicle (GV) rate, actin cytoskeleton organization, cortical granule distribution, mitochondrial translocation and intracellular glutathione level were evaluated. Oocyte maturation was indicated by first polar body emission and spindle morphology after in vitro culture. Strikingly, when COCs were stored at 27.5 degrees C for 3 days in pFF or FCS, more than 60% oocytes were still arrested at the GV stage and more than 50% oocytes matured into MII stages after culture. Almost 80% oocytes showed normal actin organization and cortical granule relocation to the cortex, and approximately 50% oocytes showed diffused mitochondria distribution patterns and normal spindle configurations. While stored in TCM-199, all these criteria decreased significantly. Glutathione (GSH) level in the pFF or FCS group was higher than in the TCM-199 group, but lower than in the non-preserved control group. The preserved oocytes could be fertilized and developed to blastocysts (about 10%) with normal cell number, which is clear evidence for their retaining the developmental potentiality after 3d preservation. Thus, we have developed a simple method for preserving immature pig oocytes at an ambient temperature for several days without evident damage of cytoplasm and keeping oocyte developmental competence.	[Yang, Cai-Rong; Miao, De-Qiang; Zhang, Qing-Hua; Guo, Lei; Tong, Jing-Shan; Wei, Yanchang; Huang, Xin; Hou, Yi; Sun, Qing-Yuan] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China; [Yang, Cai-Rong; Liu, ZhongHua] NE Agr Univ China, Coll Life Sci, Harbin, Peoples R China; [Schatten, Heide] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA	Chinese Academy of Sciences; Institute of Zoology, CAS; Northeast Agricultural University - China; University of Missouri System; University of Missouri Columbia	Yang, CR (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	liu086@yahoo.com; sunqy@ioz.ac.cn	Yang, Cairong/AAB-1440-2021; Miao, Deqiang/F-1226-2015	Yang, Cairong/0000-0001-9594-0529; Miao, Deqiang/0000-0001-9731-9322; Tong, Jingshan/0000-0003-1640-5769	National Natural Science Foundation of China [30930065, 30570944]; Major State Basic Research Program [2006CB944001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Program(National Basic Research Program of China)	This study was supported by the National Natural Science Foundation of China (30930065, 30570944), and Major State Basic Research Program to QYS (2006CB944001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg LK, 1997, DEVELOPMENT, V124, P1845; Brad AM, 2003, MOL REPROD DEV, V64, P492, DOI 10.1002/mrd.10254; Brevini TAL, 2007, ANIM REPROD SCI, V98, P23, DOI 10.1016/j.anireprosci.2006.10.018; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; Brevini TAL, 2004, EUR J HISTOCHEM, V48, P347; DELOOS F, 1989, GAMETE RES, V24, P197, DOI 10.1002/mrd.1120240207; DIDION BA, 1990, J ANIM SCI, V68, P2803; FUNAHASHI H, 1994, BIOL REPROD, V51, P633, DOI 10.1095/biolreprod51.4.633; Gasparrini B, 2006, THERIOGENOLOGY, V65, P275, DOI 10.1016/j.theriogenology.2005.05.036; Gosden R, 1997, BIOESSAYS, V19, P875, DOI 10.1002/bies.950191007; Han D, 2008, MOL REPROD DEV, V75, P838, DOI 10.1002/mrd.20823; Hao ZD, 2009, REPROD FERT DEVELOP, V21, P323, DOI 10.1071/RD08157; Herrick JR, 2003, ANIM REPROD SCI, V78, P123, DOI 10.1016/S0378-4320(03)00081-2; JIANG Q, 1992, J NE AGR COLL, V23, P3; Kim HJ, 2006, J REPROD DEVELOP, V52, P633, DOI 10.1262/jrd.17103; Ledda S, 2007, REPROD FERT DEVELOP, V19, P13, DOI 10.1071/RD06126; Li M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007701; Liu RH, 2003, ZYGOTE, V11, P299, DOI 10.1017/S0967199403002351; Liu XY, 2005, HUM REPROD, V20, P3402, DOI 10.1093/humrep/dei265; Miao YL, 2009, ENVIRON MOL MUTAGEN, V50, P666, DOI 10.1002/em.20506; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; NAGASHIMA H, 1994, BIOL REPROD, V51, P618, DOI 10.1095/biolreprod51.4.618; SHA W, FERTIL STERIL, V93, P1650; Shi LY, 2007, ANIM REPROD SCI, V100, P128, DOI 10.1016/j.anireprosci.2006.06.020; Sun QY, 2001, REPRODUCTION, V122, P155, DOI 10.1530/rep.0.1220155; Sun QY, 2001, MOL REPROD DEV, V59, P192, DOI 10.1002/mrd.1022; Sun QY, 2001, MOL REPROD DEV, V60, P481, DOI 10.1002/mrd.1113; Sun XS, 2004, MOL REPROD DEV, V69, P228, DOI 10.1002/mrd.20123; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; TSAFRIRI A, 1975, ENDOCRINOLOGY, V96, P922, DOI 10.1210/endo-96-4-922; Vajta G, 2006, REPROD BIOMED ONLINE, V12, P779, DOI 10.1016/S1472-6483(10)61091-7; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; Wakayama S, 2004, J REPROD DEVELOP, V50, P627, DOI 10.1262/jrd.50.627; Wang Q, 2007, REPROD FERT DEVELOP, V19, P1, DOI 10.1071/RD06103; Wang WH, 1999, BIOL REPROD, V60, P1020, DOI 10.1095/biolreprod60.4.1020; Wang WH, 2000, BIOL REPROD, V62, P1177, DOI 10.1095/biolreprod62.5.1177; Welch MD, 1997, CURR OPIN CELL BIOL, V9, P54, DOI 10.1016/S0955-0674(97)80152-4; Wessel GM, 2002, DEVELOPMENT, V129, P4315; Wu CH, 2006, MOL REPROD DEV, V73, P1454, DOI 10.1002/mrd.20579; Xu BZ, 2009, ANIM REPROD SCI, V111, P17, DOI 10.1016/j.anireprosci.2008.02.010; Yang X, 1998, THERIOGENOLOGY, V49, P471, DOI 10.1016/S0093-691X(97)00419-6; YOSHIDA M, 1993, BIOL REPROD, V49, P89, DOI 10.1095/biolreprod49.1.89; Zhou GB, 2009, MOL HUM REPROD, V15, P279, DOI 10.1093/molehr/gap016	43	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14242	10.1371/journal.pone.0014242	http://dx.doi.org/10.1371/journal.pone.0014242			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151922	gold, Green Published, Green Submitted			2022-12-27	WOS:000285041800003
J	Wang, LR; Wang, X; Chen, J; Yang, ZY; Yu, LA; Hu, LH; Shen, X				Wang, Lirui; Wang, Xu; Chen, Jing; Yang, Zhengyi; Yu, Liang; Hu, Lihong; Shen, Xu			Activation of Protein Serine/Threonine Phosphatase PP2C alpha Efficiently Prevents Liver Fibrosis	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; HEPATIC STELLATE CELLS; I RECEPTOR KINASE; APOPTOSIS; INHIBITOR; 2C-ALPHA; RATS; 2C; PROLIFERATION; AMPLIFICATION	Background: Over-activation of TGF beta signaling pathway and uncontrolled cell proliferation of hepatic stellate cells (HSCs) play pivotal roles in liver fibrogenesis, while the protein serine/threonine phosphatase PP2C alpha was reported to negatively regulate TGF beta signaling pathway and cell cycle. Our study aimed to investigate the role of PP2C alpha in liver fibrogenesis. Methodology/Principal Findings: The effects of PP2C alpha activation on liver fibrosis were investigated in human HSCs and primary rat HSCs in vitro using western blotting, real-time PCR, nuclear translocation, cell viability and cell cycle analyses. The antifibrogenic effects in carbon tetrachloride (CCl4)-and bile duct ligation (BDL)-induced mice in vivo were assessed using biochemical, histological and immunohistochemical analyses. The results demonstrated that activation of PP2C alpha by overexpression or the new discovered small molecular activator NPLC0393 terminated TGF beta-Smad3 and TGF beta-p38 signaling pathways, induced cell cycle arrest in HSCs and decreased alpha-smooth muscle actin (alpha-SMA) expression, collagen deposition and hepatic hydroxyproline (HYP) level in CCl4- and BDL-induced mice. Conclusions/Significance: Our findings suggested that PP2C alpha activation might be an attractive new strategy for treating liver fibrosis while the small molecular activator NPLC0393 might represent a lead compound for antifibrogenic drug development. Moreover, our study might provide the first evidence for the role of PP2C family members in the fibrotic disease.	[Wang, Lirui; Wang, Xu; Chen, Jing; Yang, Zhengyi; Yu, Liang; Hu, Lihong; Shen, Xu] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Shen, Xu] Shanghai Jiao Tong Univ, Sch Med, E Inst Shanghai Municipal Educ Commiss, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Jiao Tong University	Wang, LR (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	simmhlh@mail.shcnc.ac.cn; xshen@mail.shcnc.ac.cn			State Key Program of Basic Research of China [2010CB912501, 2007CB914304, 2009CB918502]; National Natural Science Foundation of China [30925040, 30890044, 10979072]; Key New Drug Creation and Manufacturing Program [2009ZX09301-001]; Science foundation of Shanghai [08431902900]; E-Institutes of Shanghai Municipal Education Commission [E09013]; Foundation of Chinese Academy of Sciences [KSCX2-YW-R-168, SCX1-YW-02-2]	State Key Program of Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key New Drug Creation and Manufacturing Program; Science foundation of Shanghai(Natural Science Foundation of Shanghai); E-Institutes of Shanghai Municipal Education Commission; Foundation of Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by the State Key Program of Basic Research of China (grants 2010CB912501, 2007CB914304, 2009CB918502), the National Natural Science Foundation of China (grants 30925040, 30890044, 10979072), Key New Drug Creation and Manufacturing Program (2009ZX09301-001), Science foundation of Shanghai (08431902900), E-Institutes of Shanghai Municipal Education Commission (E09013) and Foundation of Chinese Academy of Sciences (grants KSCX2-YW-R-168, SCX1-YW-02-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Chen JC, 2000, AM J CHINESE MED, V28, P175, DOI 10.1142/S0192415X00000222; CHEN MH, 2007, J INTEGRATED CHINESE, V9, P1; Chen MH, 2008, J ETHNOPHARMACOL, V117, P309, DOI 10.1016/j.jep.2008.02.009; Cheng AY, 2000, J BIOL CHEM, V275, P34744, DOI 10.1074/jbc.M006210200; Das AK, 1996, EMBO J, V15, P6798, DOI 10.1002/j.1460-2075.1996.tb01071.x; de Gouville AC, 2005, BRIT J PHARMACOL, V145, P166, DOI 10.1038/sj.bjp.0706172; Dietrich C, 1997, EXP CELL RES, V232, P72, DOI 10.1006/excr.1997.3507; FENG YLH, 2005, HELV CHIM ACTA, V88, P1126; Fjeld CC, 1999, J BIOL CHEM, V274, P20336, DOI 10.1074/jbc.274.29.20336; Flanders KC, 2004, INT J EXP PATHOL, V85, P47, DOI 10.1111/j.0959-9673.2004.00377.x; Grygielko ET, 2005, J PHARMACOL EXP THER, V313, P943, DOI 10.1124/jpet.104.082099; Hjelmeland MD, 2004, MOL CANCER THER, V3, P737; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Lammers T, 2007, CRIT REV BIOCHEM MOL, V42, P437, DOI 10.1080/10409230701693342; Lammers T, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-65; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Li J, 2002, NAT GENET, V31, P133, DOI 10.1038/ng888; Lin CC, 2000, AM J CHINESE MED, V28, P87, DOI 10.1142/S0192415X00000118; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; LIU Q, J STEROID BIOCH MOL, V120, P155; Lotersztajn S, 2005, ANNU REV PHARMACOL, V45, P605, DOI 10.1146/annurev.pharmtox.45.120403.095906; Mantena SK, 2006, CARCINOGENESIS, V27, P2018, DOI 10.1093/carcin/bgl043; Ofek P, 2003, J BIOL CHEM, V278, P14299, DOI 10.1074/jbc.M211699200; Piek E, 2001, J BIOL CHEM, V276, P19945, DOI 10.1074/jbc.M102382200; Planaguma A, 2005, FASEB J, V19, P1120, DOI 10.1096/fj.04-2753fje; Rauta J, 2006, BREAST CANCER RES TR, V95, P257, DOI 10.1007/s10549-005-9017-7; Rogers JP, 2006, J MED CHEM, V49, P1658, DOI 10.1021/jm051033y; Ruddell RG, 2006, AM J PATHOL, V169, P861, DOI 10.2353/ajpath.2006.050767; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Shek FW, 2004, EUR J GASTROEN HEPAT, V16, P123, DOI 10.1097/00042737-200402000-00001; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sun T, 2006, CYTOKINE, V35, P88, DOI 10.1016/j.cyto.2006.07.013; Sun WJ, 2009, CELL SIGNAL, V21, P95, DOI 10.1016/j.cellsig.2008.09.012; Takekawa M, 1998, EMBO J, V17, P4744, DOI 10.1093/emboj/17.16.4744; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Teixeira-Clerc F, 2006, NAT MED, V12, P671, DOI 10.1038/nm1421; Tsukada S, 2005, J BIOL CHEM, V280, P10055, DOI 10.1074/jbc.M409381200; TSUKAMOTO H, 1990, SEMIN LIVER DIS, V10, P56, DOI 10.1055/s-2008-1040457; Wang XM, 2005, HEPATOLOGY, V42, P935, DOI 10.1002/hep.20853; Wang Y, 2010, J HEPATOL, V53, P132, DOI 10.1016/j.jhep.2010.02.027; Wasser S., 1999, Annals Academy of Medicine Singapore, V28, P109; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Yang YC, 2003, P NATL ACAD SCI USA, V100, P10269, DOI 10.1073/pnas.1834070100; Yingling JM, 2004, NAT REV DRUG DISCOV, V3, P1011, DOI 10.1038/nrd1580	47	20	21	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14230	10.1371/journal.pone.0014230	http://dx.doi.org/10.1371/journal.pone.0014230			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151953	gold, Green Submitted, Green Published			2022-12-27	WOS:000284995300002
J	Lv, J; Qiao, H; Liu, HB; Wu, XT; Zhu, JA; Su, JZ; Wang, F; Cui, Y; Zhang, Y				Lv, Jie; Qiao, Hong; Liu, Hongbo; Wu, Xueting; Zhu, Jiang; Su, Jianzhong; Wang, Fang; Cui, Ying; Zhang, Yan			Discovering Cooperative Relationships of Chromatin Modifications in Human T Cells Based on a Proposed Closeness Measure	PLOS ONE			English	Article							HISTONE MODIFICATION PATTERNS; DNA METHYLATION; GENE-EXPRESSION; GENOME-WIDE; CPG ISLANDS; SEMANTIC SIMILARITY; GO TERMS; TRANSCRIPTION; BINDING; EPIGENETICS	Background: Eukaryotic transcription is accompanied by combinatorial chromatin modifications that serve as functional epigenetic markers. Composition of chromatin modifications specifies histone codes that regulate the associated gene. Discovering novel chromatin regulatory relationships are of general interest. Methodology/Principal Findings: Based on the premise that the interaction of chromatin modifications is hypothesized to influence CpG methylation, we present a closeness measure to characterize the regulatory interactions of epigenomic features. The closeness measure is applied to genome-wide CpG methylation and histone modification datasets in human CD4+T cells to select a subset of potential features. To uncover epigenomic and genomic patterns, CpG loci are clustered into nine modules associated with distinct chromatin and genomic signatures based on terms of biological function. We then performed Bayesian network inference to uncover inherent regulatory relationships from the feature selected closeness measure profile and all nine module-specific profiles respectively. The global and module-specific network exhibits topological proximity and modularity. We found that the regulatory patterns of chromatin modifications differ significantly across modules and that distinct patterns are related to specific transcriptional levels and biological function. DNA methylation and genomic features are found to have little regulatory function. The regulatory relationships were partly validated by literature reviews. We also used partial correlation analysis in other cells to verify novel regulatory relationships. Conclusions/Significance: The interactions among chromatin modifications and genomic elements characterized by a closeness measure help elucidate cooperative patterns of chromatin modification in transcriptional regulation and help decipher complex histone codes.	[Lv, Jie; Liu, Hongbo; Wu, Xueting; Zhu, Jiang; Su, Jianzhong; Wang, Fang; Cui, Ying; Zhang, Yan] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Qiao, Hong] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University	Lv, J (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	yanyou1225@yahoo.com.cn	Liu, Hongbo/M-2162-2015; Lyu, Jie/AAP-4077-2020	Liu, Hongbo/0000-0002-0733-8616; Lyu, Jie/0000-0002-6530-5257	National High Tech Development Project of China; 863 Program [2007AA02Z329]; National Natural Science Foundation of China [61075023, 30971645]; Harbin Medical University for Graduate Students [HCXS2010011]	National High Tech Development Project of China(National High Technology Research and Development Program of China); 863 Program(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Harbin Medical University for Graduate Students	This work was supported in part by the National High Tech Development Project of China, the 863 Program (No. 2007AA02Z329; http://www.most.gov.cn/eng/programmes1/200610/t20061009_36225.htm), National Natural Science Foundation of China (Nos. 61075023, 30971645; http://www.nsfc.gov.cn/Portal0/default106.htm) and the Innovation Fund of Harbin Medical University for Graduate Students (No. HCXS2010011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen ML, 2007, EPIGENETICS-US, V2, P227, DOI 10.4161/epi.2.4.5231; Allen ML, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-51; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010851; Ayton PM, 2004, MOL CELL BIOL, V24, P10470, DOI 10.1128/MCB.24.23.10470-10478.2004; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2009, GENE DEV, V23, P781, DOI 10.1101/gad.1787609; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Bock C, 2008, BIOINFORMATICS, V24, P1, DOI 10.1093/bioinformatics/btm546; Calvanese V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003294; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chernukhin I, 2007, MOL CELL BIOL, V27, P1631, DOI 10.1128/MCB.01993-06; Choi JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013020; Chung CAB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009320; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Feng YP, 2009, FEBS J, V276, P4197, DOI 10.1111/j.1742-4658.2009.07128.x; Garfinkel Mark D, 2004, Methods Mol Biol, V287, P151; Gebhard C, 2010, CANCER RES, V70, P1398, DOI 10.1158/0008-5472.CAN-09-3406; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hackenberg M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-446; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Herranz Michel, 2007, Methods Mol Biol, V361, P25; Hon G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000566; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Hsieh TF, 2005, ANNU REV PLANT BIOL, V56, P327, DOI 10.1146/annurev.arplant.56.032604.144118; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illingworth RS, 2009, FEBS LETT, V583, P1713, DOI 10.1016/j.febslet.2009.04.012; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; JUNG I, 2009, IBC, V1, P1; Ke XS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004687; Kondo Y, 2009, YONSEI MED J, V50, P455, DOI 10.3349/ymj.2009.50.4.455; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lennartsson A, 2009, BBA-GEN SUBJECTS, V1790, P863, DOI 10.1016/j.bbagen.2008.12.006; Lv J, 2010, COMPUT BIOL MED, V40, P159, DOI 10.1016/j.compbiomed.2009.11.012; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Miranda TB, 2007, J CELL PHYSIOL, V213, P384, DOI 10.1002/jcp.21224; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Rakyan VK, 2008, GENOME RES, V18, P1518, DOI 10.1101/gr.077479.108; Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Su JZ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp882; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Tan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006792; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Vaissiere T, 2008, MUTAT RES-REV MUTAT, V659, P40, DOI 10.1016/j.mrrev.2008.02.004; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CURR OPIN GENET DEV, V19, P127, DOI 10.1016/j.gde.2009.02.001; Yu GC, 2010, BIOINFORMATICS, V26, P976, DOI 10.1093/bioinformatics/btq064; Yu H, 2008, GENOME RES, V18, P1314, DOI 10.1101/gr.073080.107; Zhang Y, 2010, NUCLEIC ACIDS RES, V38, pD149, DOI 10.1093/nar/gkp968; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14219	10.1371/journal.pone.0014219	http://dx.doi.org/10.1371/journal.pone.0014219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151929	Green Published, Green Submitted, gold			2022-12-27	WOS:000284939600012
J	Yin, XL; Hou, TW; Liu, Y; Chen, J; Yao, ZY; Ma, CQ; Yang, LJ; Wei, L				Yin, Xiaolin; Hou, Tianwen; Liu, Ying; Chen, Jing; Yao, Zhiyan; Ma, Cuiqing; Yang, Lijuan; Wei, Lin			Association of Toll-Like Receptor 4 Gene Polymorphism and Expression with Urinary Tract Infection Types in Adults	PLOS ONE			English	Article							BLADDER EPITHELIAL-CELLS; ESCHERICHIA-COLI; IMMUNE-RESPONSES; SUSCEPTIBILITY; INTERLEUKIN-8; CXCR1; POLYSACCHARIDES; PYELONEPHRITIS; RECRUITMENT; INNATE	Background: Innate immunity of which Toll-like receptor (TLR) 4 and CXCR1 are key elements plays a central role in the development of urinary tract infection (UTI). Although the relation between the genetics of TLR4 and CXCR1 and UTI is investigated partly, the polymorphisms and expression of TLR4 and CXCR1 in different types of UTI in adults are not extremely clear. Methodology/Principal Findings: This study investigates the presence of TLR4 A (896) G and CXCR1 G (2608) C polymorphisms in 129 UTI patients using RFLP-PCR. Gene and allelic prevalence were compared with 248 healthy controls. Flow cytometry was used to detect TLR4 and CXCR1 expression in the monocytes of UTI patients and healthy controls. TLR4 (896) AG genotype and TLR4 (896) G allele had higher prevalence in UTI (especially in acute cystitis and urethritis) patients, whereas CXCR1 (2608) GC genotype and CXCR1 (2608) C allele had lower prevalence in UTI patients than controls. TLR4 expression was significantly lower in chronic UTI patients than in acute pyelonephritis or healthy controls. CXCR1 expression was similar in both controls and patients. TLR4 expression in chronic UTI patients after astragalus treatment was higher than pre-treatment. Conclusions: The results indicate the relationship between the carrier status of TLR4 (896) G alleles and the development of UTI, especially acute cystitis and urethritis, in adults. TLR4 expression levels are correlated with chronic UTI.	[Yin, Xiaolin; Liu, Ying; Yao, Zhiyan; Ma, Cuiqing; Yang, Lijuan; Wei, Lin] Hebei Med Univ, Dept Immunol, Shijiazhuan, Peoples R China; [Hou, Tianwen; Chen, Jing] Bethune Int Peace Hosp, Dept Lab Med, Shijiazhuan, Peoples R China	Hebei Medical University	Yin, XL (corresponding author), Hebei Med Univ, Dept Immunol, Shijiazhuan, Peoples R China.	weilin_212603@yahoo.com						Andersen-Nissen E, 2007, J IMMUNOL, V178, P4717, DOI 10.4049/jimmunol.178.8.4717; Artifoni L, 2007, J UROLOGY, V177, P1102, DOI 10.1016/j.juro.2006.10.037; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Frendeus B, 2000, J EXP MED, V192, P881, DOI 10.1084/jem.192.6.881; Godaly G, 2000, J IMMUNOL, V165, P5287, DOI 10.4049/jimmunol.165.9.5287; HAGBERG L, 1984, INFECT IMMUN, V46, P839, DOI 10.1128/IAI.46.3.839-844.1984; Hawn TR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005990; Hopkins WJ, 1999, AM J MED GENET, V83, P422, DOI 10.1002/(SICI)1096-8628(19990423)83:5<422::AID-AJMG16>3.0.CO;2-1; Karoly E, 2007, PEDIATR RES, V61, P371, DOI 10.1203/pdr.0b013e318030d1f4; Lundstedt AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000825; Lundstedt AC, 2007, J INFECT DIS, V195, P1227, DOI 10.1086/512620; Miyazaki J, 2006, BJU INT, V97, P860, DOI 10.1111/j.1464-410X.2006.06026.x; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ragnarsdottir B, 2007, J INFECT DIS, V196, P475, DOI 10.1086/518893; Schilling JD, 2003, INFECT IMMUN, V71, P1470, DOI 10.1128/IAI.71.3.1470-1480.2003; SHAHIN RD, 1987, J IMMUNOL, V138, P3475; Shao BM, 2004, BIOCHEM BIOPH RES CO, V320, P1103, DOI 10.1016/j.bbrc.2004.06.065; Smithson A, 2005, CLIN DIAGN LAB IMMUN, V12, P1358, DOI 10.1128/CDLI.12.12.1358-1363.2005; Song J, 2008, EUR J CLIN INVEST, V38, P21, DOI 10.1111/j.1365-2362.2008.02005.x; Song J, 2008, CURR OPIN MICROBIOL, V11, P66, DOI 10.1016/j.mib.2007.12.001; Song JM, 2007, CELL HOST MICROBE, V1, P287, DOI 10.1016/j.chom.2007.05.007; Song JM, 2009, P NATL ACAD SCI USA, V106, P14966, DOI 10.1073/pnas.0900527106; Szebeni B, 2006, J PEDIATR GASTR NUTR, V42, P27, DOI 10.1097/01.mpg.0000192246.47959.b2; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Yin XL, 2010, BIOCHEM BIOPH RES CO, V397, P232, DOI 10.1016/j.bbrc.2010.05.090; Zhang DK, 2004, SCIENCE, V303, P1522, DOI 10.1126/science.1094351	26	35	39	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14223	10.1371/journal.pone.0014223	http://dx.doi.org/10.1371/journal.pone.0014223			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151974	Green Published, gold, Green Submitted			2022-12-27	WOS:000284939600016
J	van Bemmel, JG; Pagie, L; Braunschweig, U; Brugman, W; Meuleman, W; Kerkhoven, RM; van Steensel, B				van Bemmel, Joke G.; Pagie, Ludo; Braunschweig, Ulrich; Brugman, Wim; Meuleman, Wouter; Kerkhoven, Ron M.; van Steensel, Bas			The Insulator Protein SU(HW) Fine-Tunes Nuclear Lamina Interactions of the Drosophila Genome	PLOS ONE			English	Article							HUTCHINSON-GILFORD-PROGERIA; CHROMATIN DOMAIN BOUNDARY; ENHANCER-BLOCKING; IN-VIVO; BITHORAX COMPLEX; TRANSCRIPTION; POSITION; BINDING; GENES; DNA	Specific interactions of the genome with the nuclear lamina (NL) are thought to assist chromosome folding inside the nucleus and to contribute to the regulation of gene expression. High-resolution mapping has recently identified hundreds of large, sharply defined lamina-associated domains (LADs) in the human genome, and suggested that the insulator protein CTCF may help to demarcate these domains. Here, we report the detailed structure of LADs in Drosophila cells, and investigate the putative roles of five insulator proteins in LAD organization. We found that the Drosophila genome is also organized in discrete LADs, which are about five times smaller than human LADs but contain on average a similar number of genes. Systematic comparison to new and published insulator binding maps shows that only SU(HW) binds preferentially at LAD borders and at specific positions inside LADs, while GAF, CTCF, BEAF-32 and DWG are mostly absent from these regions. By knockdown and overexpression studies we demonstrate that SU(HW) weakens genome -NL interactions through a local antagonistic effect, but we did not obtain evidence that it is essential for border formation. Our results provide insights into the evolution of LAD organization and identify SU(HW) as a fine-tuner of genome -NL interactions.	[van Bemmel, Joke G.; Pagie, Ludo; Braunschweig, Ulrich; Meuleman, Wouter; van Steensel, Bas] Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands; [Meuleman, Wouter] Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands; [Brugman, Wim; Kerkhoven, Ron M.] Netherlands Canc Inst, Cent Microarray Facil, Amsterdam, Netherlands; [Meuleman, Wouter] Delft Univ Technol, Delft Bioinformat Lab, Delft, Netherlands	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Delft University of Technology	van Bemmel, JG (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Amsterdam, Netherlands.	b.v.steensel@nki.nl	Braunschweig, Ulrich/I-1070-2019	Braunschweig, Ulrich/0000-0001-6653-0926; Meuleman, Wouter/0000-0002-1196-5401	Netherlands Genomics Initiative; European Young Investigator Award	Netherlands Genomics Initiative; European Young Investigator Award	This work was financially supported by the Netherlands Genomics Initiative and a European Young Investigator Award to BvS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adryan B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r167; [Anonymous], 2010, R LANG ENV STAT COMP; BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671; Blanton J, 2003, GENE DEV, V17, P664, DOI 10.1101/gad.1052003; Braunschweig U, 2009, EMBO J, V28, P3635, DOI 10.1038/emboj.2009.301; Bushey AM, 2008, MOL CELL, V32, P1, DOI 10.1016/j.molcel.2008.08.017; Bushey AM, 2009, GENE DEV, V23, P1338, DOI 10.1101/gad.1798209; Byrd K, 2003, J CELL BIOL, V162, P565, DOI 10.1083/jcb.200305013; Capelson M, 2005, MOL CELL, V20, P105, DOI 10.1016/j.molcel.2005.08.031; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Columbaro M, 2005, CELL MOL LIFE SCI, V62, P2669, DOI 10.1007/s00018-005-5318-6; Comet I, 2006, DEV CELL, V11, P117, DOI 10.1016/j.devcel.2006.05.009; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Fedorova E, 2009, CURR OPIN GENET DEV, V19, P166, DOI 10.1016/j.gde.2009.02.003; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Gaszner M, 1999, GENE DEV, V13, P2098, DOI 10.1101/gad.13.16.2098; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Gerasimova TI, 2007, MOL CELL, V28, P761, DOI 10.1016/j.molcel.2007.09.024; Gerasimova TI, 2000, MOL CELL, V6, P1025, DOI 10.1016/S1097-2765(00)00101-5; Gerasimova TI, 1998, CELL, V92, P511, DOI 10.1016/S0092-8674(00)80944-7; GERASIMOVA TI, 1995, CELL, V82, P587, DOI 10.1016/0092-8674(95)90031-4; GEYER PK, 1992, GENE DEV, V6, P1865, DOI 10.1101/gad.6.10.1865; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hagstrom K, 1996, GENE DEV, V10, P3202, DOI 10.1101/gad.10.24.3202; Holohan EE, 2007, PLOS GENET, V3, P1211, DOI 10.1371/journal.pgen.0030112; KELLUM R, 1992, MOL CELL BIOL, V12, P2424, DOI 10.1128/MCB.12.5.2424; Kyrchanova O, 2008, NUCLEIC ACIDS RES, V36, P7019, DOI 10.1093/nar/gkn781; Lankenau DH, 2000, CHROMOSOMA, V109, P148, DOI 10.1007/s004120050423; Lenhard B, 2002, BIOINFORMATICS, V18, P1135, DOI 10.1093/bioinformatics/18.8.1135; Malhas A, 2007, J CELL BIOL, V176, P593, DOI 10.1083/jcb.200607054; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mihaly J, 1997, DEVELOPMENT, V124, P1809; Mohan M, 2007, EMBO J, V26, P4203, DOI 10.1038/sj.emboj.7601851; Moorman C, 2006, P NATL ACAD SCI USA, V103, P12027, DOI 10.1073/pnas.0605003103; Ohtsuki S, 1998, GENE DEV, V12, P3325, DOI 10.1101/gad.12.21.3325; Pai CY, 2004, MOL CELL, V16, P737, DOI 10.1016/j.molcel.2004.11.004; Parnell TJ, 2003, P NATL ACAD SCI USA, V100, P13436, DOI 10.1073/pnas.2333111100; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Sun FL, 1999, CELL, V99, P459, DOI 10.1016/S0092-8674(00)81534-2; Takizawa T, 2008, CELL, V135, P9, DOI 10.1016/j.cell.2008.09.026; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2010, GENOME RES, V20, P190, DOI 10.1101/gr.098822.109; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Williams RRE, 2006, J CELL SCI, V119, P132, DOI 10.1242/jcs.02727; Yokochi T, 2009, P NATL ACAD SCI USA, V106, P19363, DOI 10.1073/pnas.0906142106; ZHAO K, 1995, CELL, V81, P879, DOI 10.1016/0092-8674(95)90008-X; Zink D, 2004, J CELL BIOL, V166, P815, DOI 10.1083/jcb.200404107; [No title captured]	62	72	75	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15013	10.1371/journal.pone.0015013	http://dx.doi.org/10.1371/journal.pone.0015013			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124834	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000017
J	von Ballmoos, MW; Yang, ZJ; Volzmann, J; Baumgartner, I; Kalka, C; Di Santo, S				von Ballmoos, Moritz Wyler; Yang, Zijiang; Voelzmann, Jan; Baumgartner, Iris; Kalka, Christoph; Di Santo, Stefano			Endothelial Progenitor Cells Induce a Phenotype Shift in Differentiated Endothelial Cells towards PDGF/PDGFR beta Axis-Mediated Angiogenesis	PLOS ONE			English	Article							FACTOR RECEPTOR-BETA	Background: Endothelial Progenitor Cells (EPC) support neovascularization and regeneration of injured endothelium both by providing a proliferative cell pool capable of differentiation into mature vascular endothelial cells and by secretion of angiogenic growth factors. Objective: The aim of this study was to investigate the role of PDGF-BB and PDGFR beta in EPC-mediated angiogenesis of differentiated endothelial cells. Methods and Results: Conditioned medium from human EPC (EPC-CM) cultured in hypoxic conditions contained substantially higher levels of PDGF-BB as compared to normoxic conditions (P < 0.01). EPC-CM increased proliferation (1.39-fold; P < 0.001) and migration (2.13-fold; P < 0.001) of isolated human umbilical vein endothelial cells (HUVEC), as well as sprouting of vascular structures from ex vivo cultured aortic rings (2.78-fold increase; P = 0.01). The capacity of EPC-CM to modulate the PDGFRb expression in HUVEC was assessed by western blot and RT-PCR. All the pro-angiogenic effects of EPC-CM on HUVEC could be partially inhibited by inactivation of PDGFR beta (P < 0.01). EPC-CM triggered a distinct up-regulation of PDGFRb (2.5 +/- 0.5; P<0.05) and its phosphorylation (3.6 +/- 0.6; P<0.05) in HUVEC. This was not observed after exposure of HUVEC to recombinant human PDGF-BB alone. Conclusion: These data indicate that EPC-CM sensitize endothelial cells and induce a pro-angiogenic phenotype including the up-regulation of PDGFR beta, thereby turning the PDGF/PDGFR beta signaling-axis into a critical element of EPC-induced endothelial angiogenesis. This finding may be utilized to enhance EPC-based therapy of ischemic tissue in future.	[von Ballmoos, Moritz Wyler] Childrens Hosp, Dept Cardiac Surg, Boston, MA 02115 USA; [von Ballmoos, Moritz Wyler] Harvard Univ, Sch Med, Boston, MA USA; [von Ballmoos, Moritz Wyler; Yang, Zijiang; Voelzmann, Jan; Baumgartner, Iris; Kalka, Christoph; Di Santo, Stefano] Univ Bern, Inselspital, Div Vasc Med, Swiss Cardiovasc Ctr,Bern Univ Hosp, CH-3010 Bern, Switzerland	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Bern; University Hospital of Bern	von Ballmoos, MW (corresponding author), Childrens Hosp, Dept Cardiac Surg, 300 Longwood Ave, Boston, MA 02115 USA.	Vascmed.unibe@gmail.com	Di Santo, Stefano/K-5739-2014; Di Santo, Stefano/P-2433-2019; Reardon, Michael/ABF-8880-2021; Yang, Zijiang/E-8837-2012	Di Santo, Stefano/0000-0002-4032-999X; Di Santo, Stefano/0000-0002-4032-999X; 	Swiss Foundation for Medical- Biological Grants (SSMBS) [PASMP3_129387]; Swiss National Science Foundation [PASMP3_129387, 406340_128124]; Novartis [PASMP3_129387]	Swiss Foundation for Medical- Biological Grants (SSMBS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis(Novartis)	Moritz Wyler von Ballmoos received a fellowship grant jointly sponsored by the Swiss Foundation for Medical- Biological Grants (SSMBS), Swiss National Science Foundation, and Novartis (Grant Number: PASMP3_129387). This work was supported in part by the Swiss National Science Foundation (NRP63 Grant Number: 406340_128124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Aplin AC, 2008, METHOD ENZYMOL, V443, P119, DOI 10.1016/S0076-6879(08)02007-7; Blacher Silvia, 2001, Angiogenesis, V4, P133, DOI 10.1023/A:1012251229631; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Di Santo S, 2008, BIOCHEM BIOPH RES CO, V373, P528, DOI 10.1016/j.bbrc.2008.06.066; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; Di Santo S, 2009, THROMB HAEMOSTASIS, V101, P460, DOI 10.1160/TH08-07-0453; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; HERMANSSON M, 1988, P NATL ACAD SCI USA, V85, P7748, DOI 10.1073/pnas.85.20.7748; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hristov M, 2004, J CELL MOL MED, V8, P498, DOI 10.1111/j.1582-4934.2004.tb00474.x; JAFFE EA, 1973, J CLIN INVEST, V52, P2745, DOI 10.1172/JCI107470; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kovalenko M, 1997, BIOCHEMISTRY-US, V36, P6260, DOI 10.1021/bi962553l; Lu HX, 2007, P NATL ACAD SCI USA, V104, P12140, DOI 10.1073/pnas.0704966104; Nissen LJ, 2007, J CLIN INVEST, V117, P2766, DOI 10.1172/JCI32479; PLATE KH, 1992, LAB INVEST, V67, P529; Pula G, 2009, CIRC RES, V104, P32, DOI 10.1161/CIRCRESAHA.108.182261; Rehman J, 2003, CIRCULATION, V107, P1164, DOI 10.1161/01.CIR.0000058702.69484.A0; Rolny C, 2006, BLOOD, V108, P1877, DOI 10.1182/blood-2006-04-014894; SCHEUBEL RJ, 2008, INT J CARDI IN PRESS; Urbich C, 2005, J MOL CELL CARDIOL, V39, P733, DOI 10.1016/j.yjmcc.2005.07.003; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; YANG Z, ATHEROSCLEROSIS; Yang ZJ, 2010, ATHEROSCLEROSIS, V211, P103, DOI 10.1016/j.atherosclerosis.2010.02.022; Yang Z, 2009, VASC PHARMACOL, V51, P268, DOI 10.1016/j.vph.2009.07.001; Zisch AH, 2004, CURR OPIN BIOTECH, V15, P424, DOI 10.1016/j.copbio.2004.08.005	28	31	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14107	10.1371/journal.pone.0014107	http://dx.doi.org/10.1371/journal.pone.0014107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124835	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000009
J	Quiding-Jarbrink, M; Raghavan, S; Sundquist, M				Quiding-Jarbrink, Marianne; Raghavan, Sukanya; Sundquist, Malin			Enhanced M1 Macrophage Polarization in Human Helicobacter pylori-Associated Atrophic Gastritis and in Vaccinated Mice	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; HUMAN DENDRITIC CELLS; REGULATORY T-CELLS; IN-VIVO; ALTERNATIVE ACTIVATION; INFECTED CHILDREN; IMMUNE-RESPONSE; INFLAMMATION; TUBERCULOSIS; RECEPTOR	Background: Infection with Helicobacter pylori triggers a chronic gastric inflammation that can progress to atrophy and gastric adenocarcinoma. Polarization of macrophages is a characteristic of both cancer and infection, and may promote progression or resolution of disease. However, the role of macrophages and their polarization during H. pylori infection has not been well defined. Methodology/Principal Findings: By using a mouse model of infection and gastric biopsies from 29 individuals, we have analyzed macrophage recruitment and polarization during H. pylori infection by flow cytometry and real-time PCR. We found a sequential recruitment of neutrophils, eosinophils and macrophages to the gastric mucosa of infected mice. Gene expression analysis of stomach tissue and sorted macrophages revealed that gastric macrophages were polarized to M1 after H. pylori infection, and this process was substantially accelerated by prior vaccination. Human H. pylori infection was characterized by a mixed M1/M2 polarization of macrophages. However, in H. pylori-associated atrophic gastritis, the expression of inducible nitric oxide synthase was markedly increased compared to uncomplicated gastritis, indicative of an enhanced M1 macrophage polarization in this pre-malignant lesion. Conclusions/Significance: These results show that vaccination of mice against H. pylori amplifies M1 polarization of gastric macrophages, and that a similar enhanced M1 polarization is present in human H. pylori-induced atrophic gastritis.	[Quiding-Jarbrink, Marianne; Raghavan, Sukanya; Sundquist, Malin] Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden	University of Gothenburg	Quiding-Jarbrink, M (corresponding author), Univ Gothenburg, Dept Microbiol & Immunol, Gothenburg, Sweden.	malin.sundquist@immuno.gu.se	Quiding-JÃrbrink, Marianne/AAU-5746-2021	Quiding-JÃrbrink, Marianne/0000-0002-1978-8091	Swedish Foundation for Strategic Research; Adlerbert Research Foundation; Wilhelm & Martina Lundgren's foundation; Inga-Britt & Arne Lundberg's foundation; Sahlgrenska University Hospital	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Adlerbert Research Foundation; Wilhelm & Martina Lundgren's foundation; Inga-Britt & Arne Lundberg's foundation; Sahlgrenska University Hospital	This study was supported by the centre of excellence MIVAC, funded by the Swedish Foundation for Strategic Research, the Adlerbert Research Foundation, Wilhelm & Martina Lundgren's foundation, Inga-Britt & Arne Lundberg's foundation, and the Sahlgrenska University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bergin PJ, 2004, HELICOBACTER, V9, P201, DOI 10.1111/j.1083-4389.2004.00232.x; Bergquist C, 2000, J IMMUNOL METHODS, V234, P51, DOI 10.1016/S0022-1759(99)00213-6; Bimczok D, 2010, MUCOSAL IMMUNOL, V3, P260, DOI 10.1038/mi.2010.10; Correa P, 2007, GASTROENTEROLOGY, V133, P659, DOI 10.1053/j.gastro.2007.06.026; Cuburu N, 2009, J IMMUNOL, V183, P7851, DOI 10.4049/jimmunol.0803740; Dixon MF, 1997, HELICOBACTER, V2, pS17; Dzierzanowska-Fangrat K, 2008, EUR J GASTROEN HEPAT, V20, P314, DOI 10.1097/MEG.0b013e3282f340da; Garhart CA, 2003, INFECT IMMUN, V71, P910, DOI 10.1128/IAI.71.2.910-921.2003; Ghiara P, 1997, INFECT IMMUN, V65, P4996, DOI 10.1128/IAI.65.12.4996-5002.1997; Hafsi N, 2004, J IMMUNOL, V173, P1249, DOI 10.4049/jimmunol.173.2.1249; Hansson M, 2006, MICROBES INFECT, V8, P841, DOI 10.1016/j.micinf.2005.10.007; Ihrig M, 2005, INFECT IMMUN, V73, P1664, DOI 10.1128/IAI.73.3.1664-1670.2005; Kahnert A, 2006, EUR J IMMUNOL, V36, P631, DOI 10.1002/eji.200535496; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; Kaparakis M, 2008, INFECT IMMUN, V76, P2235, DOI 10.1128/IAI.01481-07; Kranzer K, 2004, INFECT IMMUN, V72, P4416, DOI 10.1128/IAI.72.8.4416-4423.2004; Kusugami K, 1999, J GASTROEN HEPATOL, V14, P20, DOI 10.1046/j.1440-1746.1999.01810.x; Leung SY, 2004, GASTROENTEROLOGY, V127, P457, DOI 10.1053/j.gastro.2004.05.031; Lienhardt C, 2002, EUR J IMMUNOL, V32, P1605, DOI 10.1002/1521-4141(200206)32:6<1605::AID-IMMU1605>3.0.CO;2-6; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; MAI UEH, 1991, J CLIN INVEST, V87, P894, DOI 10.1172/JCI115095; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mattsson A, 1998, CLIN DIAGN LAB IMMUN, V5, P288, DOI 10.1128/CDLI.5.3.288-293.1998; MCGARRY MP, 1991, J LEUKOCYTE BIOL, V50, P471, DOI 10.1002/jlb.50.5.471; Mitchell P, 2007, INFECT IMMUN, V75, P810, DOI 10.1128/IAI.00228-06; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nam KT, 2004, GUT, V53, P1250, DOI 10.1136/gut.2003.030684; Pignatelli B, 2001, AM J GASTROENTEROL, V96, P1758, DOI 10.1111/j.1572-0241.2001.03869.x; Rad R, 2007, GASTROENTEROLOGY, V133, P150, DOI 10.1053/j.gastro.2007.04.071; Rad R, 2006, GASTROENTEROLOGY, V131, P525, DOI 10.1053/j.gastro.2006.05.001; Rad R, 2009, GASTROENTEROLOGY, V136, P2247, DOI 10.1053/j.gastro.2009.02.066; RAGHAVAN S, 2010, INFECT IMMUN; Redente EF, 2010, J LEUKOCYTE BIOL, V88, P159, DOI 10.1189/jlb.0609378; Sarsfield P, 1996, J PATHOL, V180, P18; Seah GT, 2000, J INFECT DIS, V181, P385, DOI 10.1086/315200; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Tatemichi M, 2005, CANCER LETT, V217, P197, DOI 10.1016/j.canlet.2004.09.002; Touati E, 2003, GASTROENTEROLOGY, V124, P1408, DOI 10.1016/S0016-5085(03)00266-X; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Whitney AE, 2000, DIGEST DIS SCI, V45, P1337, DOI 10.1023/A:1005551903029; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008; Yamazaki S, 2006, IMMUNOL REV, V212, P314, DOI 10.1111/j.0105-2896.2006.00422.x; Zhang JQQ, 2004, EUR J IMMUNOL, V34, P1175, DOI 10.1002/eji.200324723; Zu YL, 2000, ULTRASTRUCT PATHOL, V24, P319, DOI 10.1080/019131200750035049	51	65	72	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15018	10.1371/journal.pone.0015018	http://dx.doi.org/10.1371/journal.pone.0015018			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124899	Green Submitted, Green Published, gold			2022-12-27	WOS:000284527900016
J	Geyer, T; Mol, X; Blass, S; Helms, V				Geyer, Tihamer; Mol, Xavier; Blass, Sarah; Helms, Volkhard			Bridging the Gap: Linking Molecular Simulations and Systemic Descriptions of Cellular Compartments	PLOS ONE			English	Article							RHODOBACTER-SPHAEROIDES; CHROMATOPHORE VESICLES; PHOTOSYNTHETIC GROWTH; ELECTRON-TRANSFER; REACTION CENTERS; PUFX PROTEIN; Q(B) SITE; MODEL; PROTON; DRIVEN	Metabolic processes in biological cells are commonly either characterized at the level of individual enzymes and metabolites or at the network level. Often these two paradigms are considered as mutually exclusive because concepts from neither side are suited to describe the complete range of scales. Additionally, when modeling metabolic or regulatory cellular systems, often a large fraction of the required kinetic parameters are unknown. This even applies to such simple and extensively studied systems like the photosynthetic apparatus of purple bacteria. Using the chromatophore vesicles of Rhodobacter sphaeroides as a model system, we show that a consistent kinetic model emerges when fitting the dynamics of a molecular stochastic simulation to a set of time dependent experiments even though about two thirds of the kinetic parameters in this system are not known from experiment. Those kinetic parameters that were previously known all came out in the expected range. The simulation model was built from independent protein units composed of elementary reactions processing single metabolites. This pools-and-proteins approach naturally compiles the wealth of available molecular biological data into a systemic model and can easily be extended to describe other systems by adding new protein or nucleic acid types. The automated parameter optimization, performed with an evolutionary algorithm, reveals the sensitivity of the model to the value of each parameter and the relative importances of the experiments used. Such an analysis identifies the crucial system parameters and guides the setup of new experiments that would add most knowledge for a systemic understanding of cellular compartments. The successful combination of the molecular model and the systemic parametrization presented here on the example of the simple machinery for bacterial photosynthesis shows that it is actually possible to combine molecular and systemic modeling. This framework can now straightforwardly be applied to other currently less well characterized but biologically more relevant systems.	[Geyer, Tihamer; Mol, Xavier; Blass, Sarah; Helms, Volkhard] Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany	Saarland University	Geyer, T (corresponding author), Univ Saarland, Ctr Bioinformat, D-6600 Saarbrucken, Germany.	tihamer.geyer@bioinformatik.uni-saarland.de		Helms, Volkhard/0000-0002-2180-9154				BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15248, DOI 10.1021/bi00046a033; BARZ WP, 1995, BIOCHEMISTRY-US, V34, P15235, DOI 10.1021/bi00046a032; BLANKENSHIP RE, 1995, ANOXYGENIC PHOTOSYNT; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; BOXER SG, 1989, J PHYS CHEM-US, V93, P8280, DOI 10.1021/j100363a004; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Chandler DE, 2008, BIOPHYS J, V95, P2822, DOI 10.1529/biophysj.108.132852; Chandler DE, 2009, BIOPHYS J, V97, P2978, DOI 10.1016/j.bpj.2009.09.007; CLAYTON RE, 1978, PHOTOSYNTHETIC BACTE; Crofts AR, 2004, PHOTOSYNTH RES, V80, P223, DOI 10.1023/B:PRES.0000030444.52579.10; Faeder James R., 2009, V500, P113, DOI 10.1007/978-1-59745-525-1_5; Feniouk BA, 2004, BIOPHYS J, V86, P4094, DOI 10.1529/biophysj.103.036962; Feniouk BA, 2002, BIOPHYS J, V82, P1115, DOI 10.1016/S0006-3495(02)75470-2; Gerencser L, 1999, BIOCHEMISTRY-US, V38, P16866, DOI 10.1021/bi991563u; Geyer T, 2007, J BIOTECHNOL, V129, P212, DOI 10.1016/j.jbiotec.2006.12.018; Geyer T, 2006, BIOPHYS J, V91, P927, DOI 10.1529/biophysj.105.067561; Geyer T, 2006, BIOPHYS J, V91, P921, DOI 10.1529/biophysj.105.078501; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Goldstein B, 2004, NAT REV IMMUNOL, V4, P445, DOI 10.1038/nri1374; Helms V, 2008, PRINCIPLES COMPUTATI; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Klamt S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100191; Milano F, 2003, EUR J BIOCHEM, V270, P4595, DOI 10.1046/j.1432-1033.2003.03845.x; Mulkidjanian AY, 2006, BBA-BIOENERGETICS, V1757, P415, DOI 10.1016/j.bbabio.2006.04.023; MULKIDJANIAN AY, 1994, FEBS LETT, V353, P189, DOI 10.1016/0014-5793(94)01031-5; PADDOCK ML, 1988, PHOTOSYNTH RES, V17, P75, DOI 10.1007/BF00047682; Rechenberg I., 1973, EVOLUTIONSSTRATEGIE; Schilling CH, 2000, J THEOR BIOL, V203, P229, DOI 10.1006/jtbi.2000.1073; Sener MK, 2007, P NATL ACAD SCI USA, V104, P15723, DOI 10.1073/pnas.0706861104; Stein M, 2007, CURR OPIN STRUC BIOL, V17, P166, DOI 10.1016/j.sbi.2007.03.014; STRYER L, 1996, BIOCHEMIE; Sturgis JN, 2009, BIOCHEMISTRY-US, V48, P3679, DOI 10.1021/bi900045x; TURINA P, 1991, EUR J BIOCHEM, V196, P225, DOI 10.1111/j.1432-1033.1991.tb15808.x; Xiao KH, 2000, J BIOL CHEM, V275, P38597, DOI 10.1074/jbc.M007444200; [No title captured], DOI DOI 10.1142/S0218339094000131	36	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14070	10.1371/journal.pone.0014070	http://dx.doi.org/10.1371/journal.pone.0014070			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124924	gold, Green Submitted, Green Published			2022-12-27	WOS:000284467200007
J	Gao, X; Shin, YH; Li, M; Wang, F; Tong, QA; Zhang, PM				Gao, Xue; Shin, Yong-Hyun; Li, Min; Wang, Fei; Tong, Qiang; Zhang, Pumin			The Fat Mass and Obesity Associated Gene FTO Functions in the Brain to Regulate Postnatal Growth in Mice	PLOS ONE			English	Article							ENERGY-INTAKE; FOOD-INTAKE; COMMON VARIANT; EXPRESSION; POLYMORPHISMS; POPULATION; MOUSE; BMI; REPLICATION; CHILDHOOD	FTO (fat mass and obesity associated) was identified as an obesity-susceptibility gene by several independent large-scale genome association studies. A cluster of SNPs (single nucleotide polymorphism) located in the first intron of FTO was found to be significantly associated with obesity-related traits, such as body mass index, hip circumference, and body weight. FTO encodes a protein with a novel C-terminal alpha-helical domain and an N-terminal double-strand beta-helix domain which is conserved in Fe(II) and 2-oxoglutarate-dependent oxygenase family. In vitro, FTO protein can demethylate single-stranded DNA or RNA with a preference for 3-methylthymine or 3-methyluracil. Its physiological substrates and function, however, remain to be defined. Here we report the generation and analysis of mice carrying a conditional deletion allele of Fto. Our results demonstrate that Fto plays an essential role in postnatal growth. The mice lacking Fto completely display immediate postnatal growth retardation with shorter body length, lower body weight, and lower bone mineral density than control mice, but their body compositions are relatively normal. Consistent with the growth retardation, the Fto mutant mice have reduced serum levels of IGF-1. Moreover, despite the ubiquitous expression of Fto, its specific deletion in the nervous system results in similar phenotypes as the whole body deletion, indicating that Fto functions in the central nerve system to regulate postnatal growth.	[Gao, Xue; Zhang, Pumin] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Shin, Yong-Hyun; Li, Min; Zhang, Pumin] Baylor Coll Med, Dept Mol Physiol & Biophys, Houston, TX 77030 USA; [Wang, Fei; Tong, Qiang] Baylor Coll Med, Dept Pediat, Childrens Nutr Res Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Gao, X (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	pzhang@bcm.tmc.edu			BCM Diabetes and Endocrinology Research Center (DERC) [P30 DK079638]; National Institutes of Health [CA116097, CA122623, EY019075]; NATIONAL CANCER INSTITUTE [R01CA116097, R01CA122623] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY019075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079638] Funding Source: NIH RePORTER	BCM Diabetes and Endocrinology Research Center (DERC); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The CLAMS experiments were performed using the service of the Mouse Metabolism Core at Baylor College of Medicine which is supported by the BCM Diabetes and Endocrinology Research Center (DERC) grant (P30 DK079638). XG is supported in part by a pilot grant from the DERC. PZ is supported by grants from National Institutes of Health (CA116097, CA122623, and EY019075). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; Berentzen T, 2008, J CLIN ENDOCR METAB, V93, P2904, DOI 10.1210/jc.2008-0007; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Chang YC, 2008, DIABETES, V57, P2245, DOI 10.2337/db08-0377; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cornes BK, 2009, INT J OBESITY, V33, P75, DOI 10.1038/ijo.2008.223; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FISCHER J, 2009, NATURE; Fischer J, 2010, NATURE, V464, pE2, DOI 10.1038/nature08808; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gonzalez-Sanchez JL, 2009, CLIN ENDOCRINOL, V70, P390, DOI 10.1111/j.1365-2265.2008.03335.x; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; HAN Z, NATURE, V464, P1205; Haupt A, 2009, EXP CLIN ENDOCR DIAB, V117, P194, DOI 10.1055/s-0028-1087176; Hinney A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001361; Hotta K, 2008, J HUM GENET, V53, P546, DOI 10.1007/s10038-008-0283-1; Hubacek JA, 2008, OBESITY, V16, P2764, DOI 10.1038/oby.2008.421; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jonsson A, 2009, DIABETOLOGIA, V52, P1334, DOI 10.1007/s00125-009-1355-2; Kloting N, 2008, DIABETOLOGIA, V51, P641, DOI 10.1007/s00125-008-0928-9; Kreitschmann-Andermahr I, 2010, HORM RES PAEDIAT, V73, P153, DOI 10.1159/000284355; Loenarz C, 2008, NAT CHEM BIOL, V4, P152, DOI 10.1038/nchembio0308-152; Meyer CWE, 2004, ENDOCRINOLOGY, V145, P2531, DOI 10.1210/en.2003-1125; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Mishina Y, 2006, CHEM REV, V106, P215, DOI 10.1021/cr0404702; Mullis PE, 2005, EUR J ENDOCRINOL, V152, P11, DOI 10.1530/eje.1.01797; Ohashi J, 2007, J HUM GENET, V52, P1031, DOI 10.1007/s10038-007-0198-2; Ozer A, 2007, NAT CHEM BIOL, V3, P144, DOI 10.1038/nchembio863; Peeters A, 2008, MOL GENET METAB, V93, P481, DOI 10.1016/j.ymgme.2007.10.011; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Sanchez-Pulido Luis, 2007, BMC Biochemistry, V8, P23, DOI 10.1186/1471-2091-8-23; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Speakman JR, 2008, OBESITY, V16, P1961, DOI 10.1038/oby.2008.318; Speakman JR, 2010, NATURE, V464, pE1, DOI 10.1038/nature08807; SRIVENUGOPAL K, 1994, EXPERIENTIA, V50, P451, DOI 10.1007/BF01920745; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tung YCL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008771; Villalobos-Comparan M, 2008, OBESITY, V16, P2296, DOI 10.1038/oby.2008.367; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Zabena C, 2009, OBES SURG, V19, P87, DOI 10.1007/s11695-008-9727-0; Zhang F, 2008, J ENDOCRINOL INVEST, V31, P1043, DOI 10.1007/BF03345646; Zhang PM, 2002, NAT GENET, V30, P31, DOI 10.1038/ng797	51	156	168	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14005	10.1371/journal.pone.0014005	http://dx.doi.org/10.1371/journal.pone.0014005			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103374	Green Published, gold, Green Submitted			2022-12-27	WOS:000284257400009
J	Perez, PD; Hagen, SJ				Perez, Pablo Delfino; Hagen, Stephen J.			Heterogeneous Response to a Quorum-Sensing Signal in the Luminescence of Individual Vibrio fischeri	PLOS ONE			English	Article							GENE-EXPRESSION; BACTERIAL-CELLS; LIVING CELLS; BIOLUMINESCENCE; COLONIZATION; DIFFUSION; SYSTEMS; STOCHASTICITY; COMMUNICATION; REGULATOR	The marine bacterium Vibrio fischeri regulates its bioluminescence through a quorum sensing mechanism: the bacterium releases diffusible small molecules (autoinducers) that accumulate in the environment as the population density increases. This accumulation of autoinducer (AI) eventually activates transcriptional regulators for bioluminescence as well as host colonization behaviors. Although V. fischeri quorum sensing has been extensively characterized in bulk populations, far less is known about how it performs at the level of the individual cell, where biochemical noise is likely to limit the precision of luminescence regulation. We have measured the time-dependence and AI-dependence of light production by individual V. fischeri cells that are immobilized in a perfusion chamber and supplied with a defined concentration of exogenous AI. We use low-light level microscopy to record and quantify the photon emission from the cells over periods of several hours as they respond to the introduction of AI. We observe an extremely heterogeneous response to the AI signal. Individual cells differ widely in the onset time for their luminescence and in their resulting brightness, even in the presence of high AI concentrations that saturate the light output from a bulk population. The observed heterogeneity shows that although a given concentration of quorum signal may determine the average light output from a population of cells, it provides far weaker control over the luminescence output of each individual cell.	[Perez, Pablo Delfino; Hagen, Stephen J.] Univ Florida, Dept Phys, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Perez, PD (corresponding author), Univ Florida, Dept Phys, Gainesville, FL 32611 USA.	sjhagen@ufl.edu	Hagen, Stephen J/E-9737-2015	Hagen, Stephen J/0000-0002-3373-5033	National Science Foundation [MCB 0347124]	National Science Foundation(National Science Foundation (NSF))	National Science Foundation award MCB 0347124 (http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger C, 2009, MOL MICROBIOL, V73, P267, DOI 10.1111/j.1365-2958.2009.06768.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Boyer M, 2009, FEMS MICROBIOL ECOL, V70, P1, DOI 10.1111/j.1574-6941.2009.00745.x; Cox Chris D., 2003, OMICS A Journal of Integrative Biology, V7, P317, DOI 10.1089/153623103322452422; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Dunlap P.V., 1991, MICROBIAL CELL CELL, P219; Dunlap Paul V., 1999, Journal of Molecular Microbiology and Biotechnology, V1, P5; Dunn AK, 2007, ANAL BIOANAL CHEM, V387, P391, DOI 10.1007/s00216-006-0730-9; EBERHARD A, 1972, J BACTERIOL, V109, P1101, DOI 10.1128/JB.109.3.1101-1105.1972; Goryachev AB, 2006, BIOSYSTEMS, V83, P178, DOI 10.1016/j.biosystems.2005.04.006; Greer LF, 2002, LUMINESCENCE, V17, P43, DOI 10.1002/bio.676; HAAS E, 1980, BIOPHYS J, V31, P301, DOI 10.1016/S0006-3495(80)85060-0; Hagen SJ, 2010, J BIOL PHYS, V36, P317, DOI 10.1007/s10867-010-9186-4; Hense BA, 2007, NAT REV MICROBIOL, V5, P230, DOI 10.1038/nrmicro1600; James S, 2000, J MOL BIOL, V296, P1127, DOI 10.1006/jmbi.1999.3484; Kaern M, 2005, NAT REV GENET, V6, P451, DOI 10.1038/nrg1615; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Kuttler C, 2008, J THEOR BIOL, V251, P167, DOI 10.1016/j.jtbi.2007.11.015; Long T, 2009, PLOS BIOL, V7, P640, DOI 10.1371/journal.pbio.1000068; Lupp C, 2005, J BACTERIOL, V187, P3620, DOI 10.1128/JB.187.11.3620-3629.2005; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mandel MJ, 2009, NATURE, V458, P215, DOI 10.1038/nature07660; Mehta P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.79; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Muller J, 2006, J MATH BIOL, V53, P672, DOI 10.1007/s00285-006-0024-z; Parent ME, 2008, COLLOID SURFACE B, V62, P180, DOI 10.1016/j.colsurfb.2007.09.031; Phiefer CB, 1999, LUMINESCENCE, V14, P147, DOI 10.1002/(SICI)1522-7243(199905/06)14:3<147::AID-BIO532>3.0.CO;2-C; Redfield RJ, 2002, TRENDS MICROBIOL, V10, P365, DOI 10.1016/S0966-842X(02)02400-9; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; RUBY EG, 1976, BIOL BULL, V151, P574, DOI 10.2307/1540507; Schwille P, 1999, BIOPHYS J, V77, P2251, DOI 10.1016/S0006-3495(99)77065-7; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Sternberg C, 1997, J BIOLUM CHEMILUM, V12, P7, DOI 10.1002/(SICI)1099-1271(199701/02)12:1<7::AID-BIO427>3.0.CO;2-3; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tanouchi Y, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000167; Teng SW, 2010, BIOPHYS J, V98, P2024, DOI 10.1016/j.bpj.2010.01.031; Tong D, 2009, P NATL ACAD SCI USA, V106, P9836, DOI 10.1073/pnas.0904571106; Visick KL, 2000, J BACTERIOL, V182, P4578, DOI 10.1128/JB.182.16.4578-4586.2000; Visick KL, 2005, J BACTERIOL, V187, P3603, DOI 10.1128/JB.187.11.3603-3606.2005; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yarwood JM, 2005, P NATL ACAD SCI USA, V102, P9008, DOI 10.1073/pnas.0503728102; Zhou TS, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.178103	45	47	48	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15473	10.1371/journal.pone.0015473	http://dx.doi.org/10.1371/journal.pone.0015473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103327	Green Submitted, gold, Green Published			2022-12-27	WOS:000284257400025
J	Brandariz-Nunez, A; Menaya-Vargas, R; Benavente, J; Martinez-Costas, J				Brandariz-Nunez, Alberto; Menaya-Vargas, Rebeca; Benavente, Javier; Martinez-Costas, Jose			A Versatile Molecular Tagging Method for Targeting Proteins to Avian Reovirus muNS Inclusions. Use in Protein Immobilization and Purification	PLOS ONE			English	Article							SIGMA-NS; VIRUS; MORPHOGENESIS; AGGRESOMES; SITES	Background: Avian reoviruses replicate in viral factories, which are dense cytoplasmic compartments estabilished by protein-protein interactions. The non-structural protein muNS forms the factory scaffold that attracts other viral components in a controlled fashion. To create such a three-dimensional network, muNS uses several different self-interacting domains. Methodology/Principal Findings: In this study we have devised a strategy to identify muNS regions containing self-interacting domains, based on the capacity of muNS-derived inclusions to recruit muNS fragments. The results revealed that the muNS region consisting of residues 477-542 was recruited with the best efficiency, and this raised the idea of using this fragment as a molecular tag for delivering foreign proteins to muNS inclusions. By combining such tagging system with our previously established method for purifying muNS inclusions from baculovirus-infected insect cells, we have developed a novel protein purification protocol. Conclusions/Significance: We show that our tagging and inclusion-targeting system can be a simple, versatile and efficient method for immobilizing and purifying active proteins expressed in baculovirus-infected cells. We also demonstrate that muNS inclusions can simultaneously recruit several tagged proteins, a finding which may be used to generate protein complexes and create multiepitope particulate material for immunization purposes.	[Brandariz-Nunez, Alberto] Univ Santiago de Compostela, Dept Biochem & Mol Biol, Fac Pharm, Santiago De Compostela, Spain; Univ Santiago de Compostela, Ctr Res Biol Chem & Mol Mat, Santiago De Compostela, Spain	Universidade de Santiago de Compostela; Universidade de Santiago de Compostela; CiQUS	Brandariz-Nunez, A (corresponding author), Univ Santiago de Compostela, Dept Biochem & Mol Biol, Fac Pharm, Santiago De Compostela, Spain.		Brandariz, Alberto/S-2630-2016; Benavente, Javier/N-6475-2016; Martinez-Costas, Jose/E-9005-2011	Brandariz, Alberto/0000-0002-0640-1599; Benavente, Javier/0000-0003-4857-0312; Martinez-Costas, Jose/0000-0002-8877-7775	European Commission [ERAS-CT-2003-980409]; European Science Foundation; Spanish Ministerio de Ciencia y Tecnologia [BFU2007-61330, BFU 205-24982-E]; Xunta de Galicia [08CSA009203PR]	European Commission(European CommissionEuropean Commission Joint Research Centre); European Science Foundation(European Science Foundation (ESF)European Commission); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was supported by grants from the European Commission under contracts ERAS-CT-2003-980409 (as part of the European Science Foundation EUROCORES Programme EuroSCOPE, web: http://www.esf.org/euroscope); the Spanish Ministerio de Ciencia y Tecnologia (BFU2007-61330, BFU 205-24982-E, web: http://www.mityc.es/) and Xunta de Galicia (08CSA009203PR, web: http://www.conselleriaiei.org/ga/dxidi/index.php). ABN was the recipient of a predoctoral FPI fellowship from the Spanish Ministerio de Ciencia y Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2000, J GEN VIROL, V81, P1507, DOI 10.1099/0022-1317-81-6-1507; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Benavente J, 2006, CURR TOP MICROBIOL, V309, P67; Benavente J, 2007, VIRUS RES, V123, P105, DOI 10.1016/j.virusres.2006.09.005; Brandariz-Nunez A, 2010, J VIROL, V84, P4289, DOI 10.1128/JVI.02534-09; Broering TJ, 2005, J VIROL, V79, P6194, DOI 10.1128/JVI.79.10.6194-6206.2005; Broering TJ, 2002, J VIROL, V76, P8285, DOI 10.1128/JVI.76.16.8285-8297.2002; Duncan R, 1996, VIROLOGY, V224, P453, DOI 10.1006/viro.1996.0552; Friedlander P, 1996, MOL CELL BIOL, V16, P4961; Hsiao J, 2002, VIROLOGY, V296, P288, DOI 10.1006/viro.2002.1427; Jones RC, 2000, REV SCI TECH OIE, V19, P614, DOI 10.20506/rst.19.2.1237; Los GV, 2007, METH MOL B, V356, P195; MARTINEZCOSTAS J, 1995, VIROLOGY, V206, P1017, DOI 10.1006/viro.1995.1024; Mertens P, 2004, VIRUS RES, V101, P3, DOI 10.1016/j.virusres.2003.12.002; Miller CL, 2010, J VIROL, V84, P867, DOI 10.1128/JVI.01571-09; Roy P, 1996, INTERVIROLOGY, V39, P62, DOI 10.1159/000150476; Touris-Otero F, 2004, J MOL BIOL, V341, P361, DOI 10.1016/j.jmb.2004.06.026; Touris-Otero F, 2004, VIROLOGY, V319, P94, DOI 10.1016/j.virol.2003.10.034; van der Heide L, 2000, AVIAN DIS, V44, P638, DOI 10.2307/1593104; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wileman T, 2007, ANNU REV MICROBIOL, V61, P149, DOI 10.1146/annurev.micro.57.030502.090836; Zhang X, 2005, VIROLOGY, V343, P25, DOI 10.1016/j.virol.2005.08.002	22	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13961	10.1371/journal.pone.0013961	http://dx.doi.org/10.1371/journal.pone.0013961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103063	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700012
J	Krichevsky, A; Meyers, B; Vainstein, A; Maliga, P; Citovsky, V				Krichevsky, Alexander; Meyers, Benjamin; Vainstein, Alexander; Maliga, Pal; Citovsky, Vitaly			Autoluminescent Plants	PLOS ONE			English	Article							BACTERIAL BIOLUMINESCENCE; MOLECULAR-BIOLOGY; FLAVIN REDUCTASE; GENES; EXPRESSION; PHOTOBACTERIUM; TRANSFORMATION; CHLOROPLASTS; EVOLUTION; VECTORS	Prospects of obtaining plants glowing in the dark have captivated the imagination of scientists and layman alike. While light emission has been developed into a useful marker of gene expression, bioluminescence in plants remained dependent on externally supplied substrate. Evolutionary conservation of the prokaryotic gene expression machinery enabled expression of the six genes of the lux operon in chloroplasts yielding plants that are capable of autonomous light emission. This work demonstrates that complex metabolic pathways of prokaryotes can be reconstructed and function in plant chloroplasts and that transplastomic plants can emit light that is visible by naked eye.	[Krichevsky, Alexander; Meyers, Benjamin; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Vainstein, Alexander] Hebrew Univ Jerusalem, Fac Agr Food & Environm Qual Sci, Robert H Smith Inst Plant Sci & Genet Agr, IL-76100 Rehovot, Israel; [Maliga, Pal] Rutgers State Univ, Waksman Inst, Piscataway, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Hebrew University of Jerusalem; Rutgers State University New Brunswick	Krichevsky, A (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	akrichevsky@notes.cc.sunysb.edu		Citovsky, Vitaly/0000-0003-2024-6844	National Institutes of Health; United States Department of Agriculture; National Science Foundation; Binational Agricultural Research and Development Fund; Binational Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); National Science Foundation(National Science Foundation (NSF)); Binational Agricultural Research and Development Fund; Binational Science Foundation(US-Israel Binational Science Foundation)	The work is supported by grants from the National Institutes of Health, United States Department of Agriculture, National Science Foundation, Binational Agricultural Research and Development Fund, and Binational Science Foundation to Vitaly Citovsky. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai Y, 2004, PLANT CELL PHYSIOL, V45, P1176, DOI 10.1093/pcp/pch139; BAUMANN P, 1983, ANNU REV MICROBIOL, V37, P369, DOI 10.1146/annurev.mi.37.100183.002101; Bock Ralph, 2007, V19, P29, DOI 10.1007/4735_2007_0223; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Gould SB, 2008, ANNU REV PLANT BIOL, V59, P491, DOI 10.1146/annurev.arplant.59.032607.092915; GREER LF, 2002, LUMINESC, V17; Hagemann R, 2004, MOLECULAR BIOLOGY AND BIOTECHNOLOGY OF PLANT ORGANELLES: CHLOROPLASTS AND MITOCHONDRIA, P93, DOI 10.1007/978-1-4020-3166-3_4; Lin JW, 1998, BIOCHEM BIOPH RES CO, V246, P446, DOI 10.1006/bbrc.1998.8641; Lutz KA, 2007, PLANT PHYSIOL, V145, P1201, DOI 10.1104/pp.107.106963; Lutz KA, 2006, NAT PROTOC, V1, P900, DOI 10.1038/nprot.2006.118; Maliga P, 2003, TRENDS BIOTECHNOL, V21, P20, DOI 10.1016/S0167-7799(02)00007-0; Mathieu O, 2004, J CELL SCI, V117, P4881, DOI 10.1242/jcs.01479; MEIGHEN EA, 1993, FASEB J, V7, P1016, DOI 10.1096/fasebj.7.11.8370470; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Nijvipakul S, 2008, J BACTERIOL, V190, P1531, DOI 10.1128/JB.01660-07; Reyes-Prieto A, 2007, ANNU REV GENET, V41, P147, DOI 10.1146/annurev.genet.41.110306.130134; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Sakamoto W, 2006, ANNU REV PLANT BIOL, V57, P599, DOI 10.1146/annurev.arplant.57.032905.105401; Shapiro E, 2005, PROTEIN ENG DES SEL, V18, P581, DOI 10.1093/protein/gzi066; SLABAS AR, 1992, PLANT MOL BIOL, V19, P169, DOI 10.1007/BF00015613; SMITH S, 1994, FASEB J, V8, P1248, DOI 10.1096/fasebj.8.15.8001737; SVAB Z, 1991, MOL GEN GENET, V228, P316, DOI 10.1007/BF00282483; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Verma D, 2008, NAT PROTOC, V3, P739, DOI 10.1038/nprot.2007.522; Verma D, 2007, PLANT PHYSIOL, V145, P1129, DOI 10.1104/pp.107.106690; Wilson T, 1998, ANNU REV CELL DEV BI, V14, P197, DOI 10.1146/annurev.cellbio.14.1.197; Zerges W, 2000, BIOCHIMIE, V82, P583, DOI 10.1016/S0300-9084(00)00603-9	28	55	59	5	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15461	10.1371/journal.pone.0015461	http://dx.doi.org/10.1371/journal.pone.0015461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103397	Green Submitted, Green Published, gold			2022-12-27	WOS:000284147700031
J	Sainsbury, F; Sack, M; Stadlmann, J; Quendler, H; Fischer, R; Lomonossoff, GP				Sainsbury, Frank; Sack, Markus; Stadlmann, Johannes; Quendler, Heribert; Fischer, Rainer; Lomonossoff, George P.			Rapid Transient Production in Plants by Replicating and Non-Replicating Vectors Yields High Quality Functional Anti-HIV Antibody	PLOS ONE			English	Article							COWPEA MOSAIC-VIRUS; MONOCLONAL-ANTIBODY; ENDOPLASMIC-RETICULUM; PASSIVE TRANSFER; VIRAL VECTORS; HIGH-LEVEL; FULL-LENGTH; PROTEINS; EXPRESSION; PROTECTION	Background: The capacity of plants and plant cells to produce large amounts of recombinant protein has been well established. Due to advantages in terms of speed and yield, attention has recently turned towards the use of transient expression systems, including viral vectors, to produce proteins of pharmaceutical interest in plants. However, the effects of such high level expression from viral vectors and concomitant effects on host cells may affect the quality of the recombinant product. Methodology/Principal Findings: To assess the quality of antibodies transiently expressed to high levels in plants, we have expressed and characterised the human anti-HIV monoclonal antibody, 2G12, using both replicating and non-replicating systems based on deleted versions of Cowpea mosaic virus (CPMV) RNA-2. The highest yield (approximately 100 mg/kg wet weight leaf tissue) of affinity purified 2G12 was obtained when the non-replicating CPMV-HT system was used and the antibody was retained in the endoplasmic reticulum (ER). Glycan analysis by mass-spectrometry showed that the glycosylation pattern was determined exclusively by whether the antibody was retained in the ER and did not depend on whether a replicating or non-replicating system was used. Characterisation of the binding and neutralisation properties of all the purified 2G12 variants from plants showed that these were generally similar to those of the Chinese hamster ovary (CHO) cell-produced 2G12. Conclusions: Overall, the results demonstrate that replicating and non-replicating CPMV-based vectors are able to direct the production of a recombinant IgG similar in activity to the CHO-produced control. Thus, a complex recombinant protein was produced with no apparent effect on its biochemical properties using either high-level expression or viral replication. The speed with which a recombinant pharmaceutical with excellent biochemical characteristics can be produced transiently in plants makes CPMV-based expression vectors an attractive option for biopharmaceutical development and production.	[Sainsbury, Frank; Lomonossoff, George P.] John Innes Ctr, Dept Biol Chem, Norwich, Norfolk, England; [Sack, Markus; Fischer, Rainer] Rhein Westfal TH Aachen, Inst Mol Biotechnol, Aachen, Germany; [Stadlmann, Johannes] Univ Nat Resources & Appl Life Sci, Dept Chem, Vienna, Austria; [Quendler, Heribert] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria; [Fischer, Rainer] Fraunhofer Inst Mol Biol & Appl Ecol, Aachen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; RWTH Aachen University; University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna; Fraunhofer Gesellschaft	Sainsbury, F (corresponding author), Univ Laval, Dept Phytol, Quebec City, PQ G1K 7P4, Canada.	frank.sainsbury.1@ulaval.ca	Sack, Markus/K-6681-2013; Sainsbury, Frank/I-2311-2013; Sack, Markus/AAP-9252-2021; Stadlmann, Johannes/AAC-3157-2021	Sack, Markus/0000-0002-7380-9228; Sainsbury, Frank/0000-0001-8152-3820; Stadlmann, Johannes/0000-0001-5693-6690	EU; Marie Curie Early Stage Training Fellowship [MEST-CT-2004-504273]; Trustees of the John Innes Foundation; Biotechnology and Biological Sciences Research Council, U.K.; Biotechnology and Biological Sciences Research Council [BBS/E/J/0000A182] Funding Source: researchfish	EU(European Commission); Marie Curie Early Stage Training Fellowship(European Commission); Trustees of the John Innes Foundation; Biotechnology and Biological Sciences Research Council, U.K.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The work described in this report was funded under the EU FP6 PharmaPlanta project. F. S. also acknowledges funding from a Marie Curie Early Stage Training Fellowship MEST-CT-2004-504273 and the Trustees of the John Innes Foundation. The John Innes Centre is supported by a Grant-in-Aid from the Biotechnology and Biological Sciences Research Council, U.K. (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, VACCINE, V23, P1784, DOI 10.1016/j.vaccine.2004.11.005; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Canizares MC, 2006, PLANT BIOTECHNOL J, V4, P183, DOI 10.1111/j.1467-7652.2005.00170.x; Canizares MC, 2005, IMMUNOL CELL BIOL, V83, P263, DOI 10.1111/j.1440-1711.2005.01339.x; Carette JE, 2000, J VIROL, V74, P6556, DOI 10.1128/JVI.74.14.6556-6563.2000; Carette JE, 2002, J VIROL, V76, P6235, DOI 10.1128/JVI.76.12.6235-6243.2002; Carette JE, 2002, J VIROL, V76, P6293, DOI 10.1128/JVI.76.12.6293-6301.2002; Castro C, 2005, VIRUS RES, V107, P141, DOI 10.1016/j.virusres.2004.11.004; Domingo E, 2000, VIROLOGY, V270, P251, DOI 10.1006/viro.2000.0320; Domingo E, 1996, FASEB J, V10, P859, DOI 10.1096/fasebj.10.8.8666162; Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gomord W, 2004, PLANT BIOTECHNOL J, V2, P83, DOI 10.1111/j.1467-7652.2004.00062.x; Goulet C, 2010, PROTEOMICS, V10, P2536, DOI 10.1002/pmic.200900382; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; HOLLAND J, 1982, SCIENCE, V215, P1577, DOI 10.1126/science.7041255; Holland T, 2010, BIOTECHNOL BIOENG, V107, P278, DOI 10.1002/bit.22800; Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652; Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299; Kathuria S, 2002, HUM REPROD, V17, P2054, DOI 10.1093/humrep/17.8.2054; KEESE P, 1993, CURR OPIN GENET DEV, V3, P873, DOI 10.1016/0959-437X(93)90007-C; Kolarich D, 2000, ANAL BIOCHEM, V285, P64, DOI 10.1006/abio.2000.4737; Komarova TV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P846, DOI 10.1134/S0006297906080049; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Lico C, 2008, J CELL PHYSIOL, V216, P366, DOI 10.1002/jcp.21423; Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377; Mascola JR, 2002, J VIROL, V76, P4810, DOI 10.1128/JVI.76.10.4810-4821.2002; Mascola JR, 2002, VACCINE, V20, P1922, DOI 10.1016/S0264-410X(02)00068-3; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Rademacher T, 2008, PLANT BIOTECHNOL J, V6, P189, DOI 10.1111/j.1467-7652.2007.00306.x; Ramessar K, 2008, P NATL ACAD SCI USA, V105, P3727, DOI 10.1073/pnas.0708841104; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sack M, 2007, FASEB J, V21, P1655, DOI 10.1096/fj.06-5863com; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2008, PLANT BIOTECHNOL J, V6, P82, DOI 10.1111/j.1467-7652.2007.00303.x; Sainsbury F, 2010, ANNU REV PHYTOPATHOL, V48, P437, DOI 10.1146/annurev-phyto-073009-114242; Sainsbury F, 2009, PLANT BIOTECHNOL J, V7, P682, DOI 10.1111/j.1467-7652.2009.00434.x; Sainsbury Frank, 2009, V483, P25, DOI 10.1007/978-1-59745-407-0_2; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Sriraman R, 2004, PLANT BIOTECHNOL J, V2, P279, DOI 10.1111/j.1467-7652.2004.00078.x; Stevens LH, 2000, PLANT PHYSIOL, V124, P173, DOI 10.1104/pp.124.1.173; Stoger E, 2005, CURR PHARM DESIGN, V11, P2439, DOI 10.2174/1381612054367535; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Trkola A, 2005, NAT MED, V11, P615, DOI 10.1038/nm1244; Trkola A, 1996, J VIROL, V70, P1100, DOI 10.1128/JVI.70.2.1100-1108.1996; van der Hoorn RAL, 2004, CURR OPIN PLANT BIOL, V7, P400, DOI 10.1016/j.pbi.2004.04.003; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Vaquero C, 1999, P NATL ACAD SCI USA, V96, P11128, DOI 10.1073/pnas.96.20.11128; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Verch T, 1998, J IMMUNOL METHODS, V220, P69, DOI 10.1016/S0022-1759(98)00149-5; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villani ME, 2009, PLANT BIOTECHNOL J, V7, P59, DOI 10.1111/j.1467-7652.2008.00371.x; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252	58	58	59	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13976	10.1371/journal.pone.0013976	http://dx.doi.org/10.1371/journal.pone.0013976			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103044	gold, Green Published, Green Submitted			2022-12-27	WOS:000284147700021
J	Sapir, N; Wikelski, M; McCue, MD; Pinshow, B; Nathan, R				Sapir, Nir; Wikelski, Martin; McCue, Marshall D.; Pinshow, Berry; Nathan, Ran			Flight Modes in Migrating European Bee-Eaters: Heart Rate May Indicate Low Metabolic Rate during Soaring and Gliding	PLOS ONE			English	Article							BLACK-BROWED ALBATROSSES; DOUBLY LABELED WATER; OXYGEN-CONSUMPTION; ENERGY-EXPENDITURE; WIND-TUNNEL; HERRING-GULLS; BIRDS; PENGUINS; THERMOREGULATION; RADIOTELEMETRY	Background: Many avian species soar and glide over land. Evidence from large birds (m(b) > 0.9 kg) suggests that soaring-gliding is considerably cheaper in terms of energy than flapping flight, and costs about two to three times the basal metabolic rate (BMR). Yet, soaring-gliding is considered unfavorable for small birds because migration speed in small birds during soaring-gliding is believed to be lower than that of flapping flight. Nevertheless, several small bird species routinely soar and glide. Methodology/Principal Findings: To estimate the energetic cost of soaring-gliding flight in small birds, we measured heart beat frequencies of free-ranging migrating European bee-eaters (Merops apiaster, m(b) similar to 55 g) using radio telemetry, and established the relationship between heart beat frequency and metabolic rate (by indirect calorimetry) in the laboratory. Heart beat frequency during sustained soaring-gliding was 2.2 to 2.5 times lower than during flapping flight, but similar to, and not significantly different from, that measured in resting birds. We estimated that soaring-gliding metabolic rate of European bee-eaters is about twice their basal metabolic rate (BMR), which is similar to the value estimated in the black-browed albatross Thalassarche (previously Diomedea) melanophrys, m(b) similar to 4 kg). We found that soaring-gliding migration speed is not significantly different from flapping migration speed. Conclusions/Significance: We found no evidence that soaring-gliding speed is slower than flapping flight in bee-eaters, contradicting earlier estimates that implied a migration speed penalty for using soaring-gliding rather than flapping flight. Moreover, we suggest that small birds soar and glide during migration, breeding, dispersal, and other stages in their annual cycle because it may entail a low energy cost of transport. We propose that the energy cost of soaring-gliding may be proportional to BMR regardless of bird size, as theoretically deduced by earlier studies.	[Sapir, Nir; Nathan, Ran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Movement Ecol Lab, Dept Evolut Systemat & Ecol, Jerusalem, Israel; [Wikelski, Martin] Max Planck Inst Ornithol, Vogelwarte Radolfzell, Radolfzell, Germany; [McCue, Marshall D.] St Marys Univ, Dept Biol Sci, San Antonio, TX USA; [Pinshow, Berry] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Wikelski, Martin] Univ Konstanz, Dept Biol, Constance, Germany	Hebrew University of Jerusalem; Max Planck Society; Ben Gurion University; University of Konstanz	Sapir, N (corresponding author), Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA.	nir.sapir@mail.huji.ac.il	Sapir, Nir/V-9634-2019; Nathan, Ran/A-9380-2008; McCue, Marshall/A-6227-2011	Sapir, Nir/0000-0002-2477-0515; Nathan, Ran/0000-0002-5733-6715; McCue, Marshall/0000-0003-1255-285X	U.S. - Israel Binational Science Foundation [229/2002, 124/2004]; Ring Foundation; Robert Szold Fund; Rieger - JNF fellowships; Fulbright	U.S. - Israel Binational Science Foundation(US-Israel Binational Science Foundation); Ring Foundation; Robert Szold Fund; Rieger - JNF fellowships; Fulbright	This study was supported by the U.S. - Israel Binational Science Foundation (grants 229/2002 and 124/2004), the Ring Foundation and the Robert Szold Fund. N.S. was supported by Rieger - JNF fellowships (in 2005-2007) and a Fulbright doctoral dissertation grant (in 2004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS NJ, 1986, PHYSIOL ZOOL, V59, P583, DOI 10.1086/physzool.59.6.30158606; Alerstam T., 1990, P331; BAUDINETTE RV, 1974, NATURE, V248, P83, DOI 10.1038/248083b0; Bevan RM, 1995, PHILOS T R SOC B, V350, P119, DOI 10.1098/rstb.1995.0146; BEVAN RM, 1994, J EXP BIOL, V193, P119; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; Cochran W.W., 1975, HAWK CHALK, V14, P28; Cochran William W., 2005, P274; Cochran WW, 2004, SCIENCE, V304, P405, DOI 10.1126/science.1095844; Cochran WW, 1972, ANIMAL ORIENTATION N, P39; Ellis H.I., 1984, P203; Fry C. H., 1984, BEE EATERS; GESSAMAN JA, 1965, AM ZOOL, V5, P696; Green JA, 2008, COMP BIOCHEM PHYS A, V150, P222, DOI 10.1016/j.cbpa.2006.06.017; Green JA, 2001, J EXP BIOL, V204, P673; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; KANWISHER JW, 1978, AUK, V95, P288; Kish Leslie., 1992, J OFF STAT, V8, P183; KORN EL, 1995, AM STAT, V49, P291, DOI 10.2307/2684203; LORD RD, 1962, SCIENCE, V137, P39, DOI 10.1126/science.137.3523.39; LUSTICK S, 1978, SCIENCE, V200, P81, DOI 10.1126/science.635577; MAAS S, 1989, ERGONOMICS, V32, P141, DOI 10.1080/00140138908966074; McKechnie AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P502, DOI 10.1086/383511; NOLET BA, 1992, PHYSIOL ZOOL, V65, P1188, DOI 10.1086/physzool.65.6.30158275; Pennycuick CJ, 2008, THEOR ECOL SER, P1; Pennycuick CJ, 1997, J EXP BIOL, V200, P1441; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PINSHOW B, 1976, AM J PHYSIOL, V231, P903, DOI 10.1152/ajplegacy.1976.231.3.903; RAIM A, 1978, Bird-Banding, V49, P326; Rayner JMV, 2001, AM ZOOL, V41, P188, DOI 10.1668/0003-1569(2001)041[0188:AAEOIF]2.0.CO;2; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Rosen M, 2001, J EXP BIOL, V204, P1153; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Steiger SS, 2009, PHYSIOL BIOCHEM ZOOL, V82, P580, DOI 10.1086/605336; WALSBERG GE, 1995, J EXP BIOL, V198, P213; Ward S, 2002, J EXP BIOL, V205, P3347; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Weimerskirch H, 2001, NATURE, V413, P697, DOI 10.1038/35099670; WHITE SB, 1980, J FIELD ORNITHOL, V51, P6; WITHERS PC, 1977, J APPL PHYSIOL, V42, P120, DOI 10.1152/jappl.1977.42.1.120; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	48	62	63	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13956	10.1371/journal.pone.0013956	http://dx.doi.org/10.1371/journal.pone.0013956			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085655	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800020
J	Zagami, CJ; Stifani, S				Zagami, Chrissandra J.; Stifani, Stefano			Molecular Characterization of the Mouse Superior Lateral Parabrachial Nucleus through Expression of the Transcription Factor Runx1	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FOOD-INTAKE; BRAIN-STEM; SPINOPARABRACHIAL PATHWAY; REGULATES DEVELOPMENT; NOCICEPTIVE PROCESSES; NEUROPATHIC PAIN; SENSORY NEURONS; C-FOS; RAT	Background: The ability to precisely identify separate neuronal populations is essential to the understanding of the development and function of different brain structures. This necessity is particularly evident in regions such as the brainstem, where the anatomy is quite complex and little is known about the identity, origin, and function of a number of distinct nuclei due to the lack of specific cellular markers. In this regard, the gene encoding the transcription factor Runx1 has emerged as a specific marker of restricted neuronal populations in the murine central and peripheral nervous systems. The aim of this study was to precisely characterize the expression of Runx1 in the developing and postnatal mouse brainstem. Methods and Principal Findings: Anatomical and immunohistochemical studies were used to characterize mouse Runx1 expression in the brainstem. It is shown here that Runx1 is expressed in a restricted population of neurons located in the dorsolateral rostral hindbrain. These neurons define a structure that is ventromedial to the dorsal nucleus of the lateral lemniscus, dorsocaudal to the medial paralemniscal nucleus and rostral to the cerebellum. Runx1 expression in these cells is first observed at approximately gestational day 12.5, persists into the adult brain, and is lost in knockout mice lacking the transcription factor Atoh1, an important regulator of the development of neuronal lineages of the rhombic lip. Runx1-expressing neurons in the rostral hindbrain produce cholecystokinin and also co-express members of the Groucho/Transducin-like Enhancer of split protein family. Conclusion: Based on the anatomical and molecular characteristics of the Runx1-expressing cells in the rostral hindbrain, we propose that Runx1 expression in this region of the mouse brain defines the superior lateral parabrachial nucleus.	[Zagami, Chrissandra J.; Stifani, Stefano] McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada	McGill University	Zagami, CJ (corresponding author), McGill Univ, Montreal Neurol Inst, Ctr Neuronal Survival, Montreal, PQ, Canada.	stefano.stifani@mcgill.ca		Stifani, Stefano/0000-0002-2376-7701	Canadian Institutes of Health Research [MOP-84577, MOP-42479]; Montreal Neurological Institute	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Montreal Neurological Institute	This research was supported by grants from the Canadian Institutes of Health Research-Neuromuscular Research Partnership to S. S. (MOP-84577 and MOP-42479). C.Z. was supported in part by a Montreal Neurological Institute J. Timmins Costello Fellowship and S. S. is a Chercheur National of the Fonds de la Recherche en Sante du Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban CD, 2002, PHYSIOL BEHAV, V77, P469, DOI 10.1016/S0031-9384(02)00935-6; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; BESTER H, 1995, J NEUROPHYSIOL, V73, P568, DOI 10.1152/jn.1995.73.2.568; Bester H, 1997, J COMP NEUROL, V383, P439; BLOCK CH, 1987, PEPTIDES, V8, P267, DOI 10.1016/0196-9781(87)90102-1; Buritova J, 1998, J COMP NEUROL, V397, P10, DOI 10.1002/(SICI)1096-9861(19980720)397:1<10::AID-CNE2>3.0.CO;2-L; Buscarlet M, 2007, TRENDS CELL BIOL, V17, P353, DOI 10.1016/j.tcb.2007.07.002; Chamberlin NL, 2004, RESP PHYSIOL NEUROBI, V143, P115, DOI 10.1016/j.resp.2004.03.015; Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036; Cheng LP, 2004, NAT NEUROSCI, V7, P510, DOI 10.1038/nn1221; Dai JX, 2008, J COMP NEUROL, V509, P341, DOI 10.1002/cne.21759; DAY NC, 1986, NEUROPEPTIDES, V8, P1, DOI 10.1016/0143-4179(86)90059-4; Dobolyi A, 2003, J COMP NEUROL, V455, P547, DOI 10.1002/cne.10515; Dykes IM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-3; Elmquist JK, 1999, NEURON, V22, P221, DOI 10.1016/S0896-6273(00)81084-3; Fujiyama T, 2009, DEVELOPMENT, V136, P2049, DOI 10.1242/dev.033480; FULWILER CE, 1985, NEUROSCI LETT, V53, P289, DOI 10.1016/0304-3940(85)90553-1; Fulwiler CE, 1984, BRAIN RES, V319, P229; Gauriau C, 2002, EXP PHYSIOL, V87, P251, DOI 10.1113/eph8702357; GIBBS J, 1973, J COMP PHYSIOL PSYCH, V84, P488, DOI 10.1037/h0034870; GIBBS J, 1976, AM J PHYSIOL, V230, P15, DOI 10.1152/ajplegacy.1976.230.1.15; GLENDENNING KK, 1981, J COMP NEUROL, V197, P673, DOI 10.1002/cne.901970409; Hermanson O, 1998, J COMP NEUROL, V400, P255; Husain J, 1996, BIOCHEM J, V317, P523, DOI 10.1042/bj3170523; Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370; Lohmann C, 1996, J COMP NEUROL, V367, P90, DOI 10.1002/(SICI)1096-9861(19960325)367:1<90::AID-CNE7>3.0.CO;2-E; Malick A, 2001, P NATL ACAD SCI USA, V98, P9930, DOI 10.1073/pnas.171616898; Marmigere F, 2006, NAT NEUROSCI, V9, P180, DOI 10.1038/nn1631; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Mercer LD, 2000, NEUROSCI LETT, V293, P167, DOI 10.1016/S0304-3940(00)01504-4; NAGAI K, 1987, J CLIN BIOCHEM NUTR, V3, P103, DOI 10.3164/jcbn.3.103; North T, 1999, DEVELOPMENT, V126, P2563; Ray RS, 2009, CURR OPIN CELL BIOL, V21, P741, DOI 10.1016/j.ceb.2009.10.003; Rose MF, 2009, P NATL ACAD SCI USA, V106, P22462, DOI 10.1073/pnas.0911579106; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Samad OA, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-45; SIMEONE A, 1995, DEV DYNAM, V203, P61, DOI 10.1002/aja.1002030107; Stifani N, 2008, P NATL ACAD SCI USA, V105, P6451, DOI 10.1073/pnas.0711299105; Stifani S, 2009, BLOOD CELL MOL DIS, V43, P20, DOI 10.1016/j.bcmd.2009.03.001; STOYKOVA A, 1994, J NEUROSCI, V14, P1395, DOI 10.1523/JNEUROSCI.14-03-01395.1994; Theriault FM, 2005, J NEUROSCI, V25, P2050, DOI 10.1523/JNEUROSCI.5108-04.2005; Theriault FM, 2004, P NATL ACAD SCI USA, V101, P10343, DOI 10.1073/pnas.0400768101; Varga T, 2008, J COMP NEUROL, V511, P221, DOI 10.1002/cne.21829; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Yao J, 1998, DEV GROWTH DIFFER, V40, P133; Yao J, 2000, MECH DEVELOP, V93, P105, DOI 10.1016/S0925-4773(00)00278-1; Yates BJ, 1998, EXP BRAIN RES, V119, P269, DOI 10.1007/s002210050342; Yoshikawa M, 2007, DEV BIOL, V303, P663, DOI 10.1016/j.ydbio.2006.12.007; Zagami CJ, 2009, J CELL BIOCHEM, V107, P1063, DOI 10.1002/jcb.22221	52	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13944	10.1371/journal.pone.0013944	http://dx.doi.org/10.1371/journal.pone.0013944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085653	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800011
J	Chen, EYT; Wang, YC; Chen, CS; Chin, WC				Chen, Eric Y. T.; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun			Functionalized Positive Nanoparticles Reduce Mucin Swelling and Dispersion	PLOS ONE			English	Article							CYSTIC-FIBROSIS; TITANIUM-DIOXIDE; MUCUS CLEARANCE; GASTRIC MUCIN; PULMONARY; SECRETION; LUNG; ULTRAFINE; RELEASE; NANOMEDICINE	Multi-functionalized nanoparticles (NPs) have been extensively investigated for their potential in household and commercial products, and biomedical applications. Previous reports have confirmed the cellular nanotoxicity and adverse inflammatory effects on pulmonary systems induced by NPs. However, possible health hazards resulting from mucus rheological disturbances induced by NPs are underexplored. Accumulation of viscous, poorly dispersed, and less transportable mucus leading to improper mucus rheology and dysfunctional mucociliary clearance are typically found to associate with many respiratory diseases such as asthma, cystic fibrosis (CF), and COPD (Chronic Obstructive Pulmonary Disease). Whether functionalized NPs can alter mucus rheology and its operational mechanisms have not been resolved. Herein, we report that positively charged functionalized NPs can hinder mucin gel hydration and effectively induce mucin aggregation. The positively charged NPs can significantly reduce the rate of mucin matrix swelling by a maximum of 7.5 folds. These NPs significantly increase the size of aggregated mucin by approximately 30 times within 24 hrs. EGTA chelation of indigenous mucin crosslinkers (Ca2+ ions) was unable to effectively disperse NP-induced aggregated mucins. Our results have demonstrated that positively charged functionalized NPs can impede mucin gel swelling by crosslinking the matrix. This report also highlights the unexpected health risk of NP-induced change in mucus rheological properties resulting in possible mucociliary transport impairment on epithelial mucosa and related health problems. In addition, our data can serve as a prospective guideline for designing nanocarriers for airway drug delivery applications.	[Chen, Eric Y. T.; Wang, Yung-Chen; Chen, Chi-Shuo; Chin, Wei-Chun] Univ Calif Merced, Merced, CA USA	University of California System; University of California Merced	Chen, EYT (corresponding author), Univ Calif Merced, Merced, CA USA.	wchin2@ucmerced.edu	Chin, Wei-Chun/A-6068-2008	Chin, Wei-Chun/0000-0003-4881-9085	NIH [1R15HL095039]; NSF [CBET-0932404]; UC CITRIS; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities [1P20MD005049-01]; UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD005049] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R15HL095039] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); UC CITRIS; UC Merced Center of Excellence on Health Disparities from the National Center on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); UC Merced; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants from NIH (1R15HL095039), NSF (CBET-0932404) and UC CITRIS Program. CSC was supported by UC Merced Center of Excellence on Health Disparities (1P20MD005049-01 from the National Center on Minority Health and Health Disparities). EYTC was supported by GRC summer fellowship from UC Merced. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; BANSIL R, 1995, ANNU REV PHYSIOL, V57, P635, DOI 10.1146/annurev.ph.57.030195.003223; Berger JT, 1999, AM J RESP CELL MOL, V20, P500, DOI 10.1165/ajrcmb.20.3.3383; BHASKAR KR, 1991, AM J PHYSIOL, V261, pG827, DOI 10.1152/ajpgi.1991.261.5.G827; Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Byrne James D, 2008, Mcgill J Med, V11, P43; Cao XX, 1999, BIOPHYS J, V76, P1250, DOI 10.1016/S0006-3495(99)77288-7; Card JW, 2008, AM J PHYSIOL-LUNG C, V295, pL400, DOI 10.1152/ajplung.00041.2008; Centi G, 2002, CATAL TODAY, V75, P3, DOI 10.1016/S0920-5861(02)00037-8; Chen E, 2008, J EXP NANOSCI, V3, P171, DOI 10.1080/17458080802412430; Chen EYT, 2010, AM J PHYSIOL-LUNG C, V299, pL542, DOI 10.1152/ajplung.00180.2010; Chin WC, 2005, MACROMOL SYMP, V227, P89, DOI 10.1002/masy.200550908; Chin WC, 1998, NATURE, V391, P568, DOI 10.1038/35345; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Cone RA, 2009, ADV DRUG DELIVER REV, V61, P75, DOI 10.1016/j.addr.2008.09.008; Dawson M, 2003, J BIOL CHEM, V278, P50393, DOI 10.1074/jbc.M309026200; Di Cola E, 2008, BIOMACROMOLECULES, V9, P3216, DOI 10.1021/bm800799u; Donaldson SH, 2006, NEW ENGL J MED, V354, P241, DOI 10.1056/NEJMoa043891; EDWARDS SF, 1973, J PHYS A-MATH GEN, V6, pL31, DOI 10.1088/0305-4470/6/4/001; Espinosa M, 2002, HUM REPROD, V17, P1964, DOI 10.1093/humrep/17.8.1964; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; Gelis C, 2003, PHOTODERMATOL PHOTO, V19, P242, DOI 10.1034/j.1600-0781.2003.00045.x; Gwinn MR, 2006, ENVIRON HEALTH PERSP, V114, P1818, DOI 10.1289/ehp.8871; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Hyun JS, 2008, TOXICOL LETT, V182, P24, DOI 10.1016/j.toxlet.2008.08.003; Kas HS, 1997, J MICROENCAPSUL, V14, P689, DOI 10.3109/02652049709006820; Klaine SJ, 2008, ENVIRON TOXICOL CHEM, V27, P1825, DOI 10.1897/08-090.1; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Levine KE, 2003, ANAL LETT, V36, P563, DOI 10.1081/AL-120018244; Liu K, 2006, LANGMUIR, V22, P9453, DOI 10.1021/la061729+; Lkhasuren O, 2007, INT J OCCUP ENV HEAL, V13, P195, DOI 10.1179/oeh.2007.13.2.195; Lodge TP, 1999, PHYS REV LETT, V83, P3218, DOI 10.1103/PhysRevLett.83.3218; Lomer MCE, 2002, P NUTR SOC, V61, P123, DOI 10.1079/PNS2001134; LORIMER WV, 1978, SCAND J WORK ENV HEA, V4, P220, DOI 10.5271/sjweh.2743; Lu L, 2006, J PHYS CHEM B, V110, P25013, DOI 10.1021/jp060155e; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mayo L, 2008, EUR J PHARM BIOPHARM, V70, P199, DOI 10.1016/j.ejpb.2008.04.025; Mossman Brooke T, 2007, Part Fibre Toxicol, V4, P4, DOI 10.1186/1743-8977-4-4; Pirkanniemi K, 2002, CHEMOSPHERE, V48, P1047, DOI 10.1016/S0045-6535(02)00168-6; Pison U, 2006, EUR J PHARMACOL, V533, P341, DOI 10.1016/j.ejphar.2005.12.068; Quinton PM, 2008, LANCET, V372, P415, DOI 10.1016/S0140-6736(08)61162-9; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Rogers DF, 2006, ANN MED, V38, P116, DOI 10.1080/07853890600585795; Rogers DF, 2007, RESP CARE, V52, P46; Rogers DF, 2007, RESP CARE, V52, P1134; ROSE MC, 1992, AM J PHYSIOL, V263, pL413, DOI 10.1152/ajplung.1992.263.4.L413; Sandberg T, 2009, J BIOMED MATER RES A, V91A, P773, DOI 10.1002/jbm.a.32315; Sandberg T, 2009, J BIOMED MATER RES A, V91A, P762, DOI 10.1002/jbm.a.32266; Satija J, 2007, CRIT REV THER DRUG, V24, P257, DOI 10.1615/CritRevTherDrugCarrierSyst.v24.i3.20; Sethi S, 2004, CURR OPIN INFECT DIS, V17, P113, DOI 10.1097/00001432-200404000-00008; SHEEHAN JK, 1986, BIOCHEM J, V239, P147, DOI 10.1042/bj2390147; SHEEHAN JK, 1984, BIOCHEM J, V217, P93, DOI 10.1042/bj2170093; Song JS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-28; Stone V, 2007, IEEE T NANOBIOSCI, V6, P331, DOI 10.1109/TNB.2007.909005; TANAKA T, 1979, J CHEM PHYS, V70, P1214, DOI 10.1063/1.437602; Truong-Le VL, 1999, ARCH BIOCHEM BIOPHYS, V361, P47, DOI 10.1006/abbi.1998.0975; VERDUGO P, 1987, BIORHEOLOGY, V24, P625; VERDUGO P, 1990, ANNU REV PHYSIOL, V52, P157, DOI 10.1146/annurev.ph.52.030190.001105; VERDUGO P, 1983, BIORHEOLOGY, V20, P223; Voynow JA, 2009, CHEST, V135, P505, DOI 10.1378/chest.08-0412; Wagner V, 2006, NAT BIOTECHNOL, V24, P1211, DOI 10.1038/nbt1006-1211; Wu DYC, 2007, AM J PATHOL, V170, P20, DOI 10.2353/ajpath.2007.060452; Xia T, 2009, ANNU REV PUBL HEALTH, V30, P137, DOI 10.1146/annurev.publhealth.031308.100155; Yakubov GE, 2007, BIOMACROMOLECULES, V8, P3467, DOI 10.1021/bm700607w	65	43	44	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15434	10.1371/journal.pone.0015434	http://dx.doi.org/10.1371/journal.pone.0015434			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085670	gold, Green Published, Green Submitted			2022-12-27	WOS:000284036800029
J	Houk, P; Musburger, C; Wiles, P				Houk, Peter; Musburger, Craig; Wiles, Phil			Water Quality and Herbivory Interactively Drive Coral-Reef Recovery Patterns in American Samoa	PLOS ONE			English	Article							LONG-TERM; NUTRIENT ENRICHMENT; CLIMATE-CHANGE; PNEOPHYLLUM CONICUM; COMMUNITY DYNAMICS; FLORIDA-KEYS; RED ALGA; DIVERSITY; SCALE; MANAGEMENT	Background: Compared with a wealth of information regarding coral-reef recovery patterns following major disturbances, less insight exists to explain the cause(s) of spatial variation in the recovery process. Methodology/Principal Findings: This study quantifies the influence of herbivory and water quality upon coral reef assemblages through space and time in Tutuila, American Samoa, a Pacific high island. Widespread declines in dominant corals (Acropora and Montipora) resulted from cyclone Heta at the end of 2003, shortly after the study began. Four sites that initially had similar coral reef assemblages but differential temporal dynamics four years following the disturbance event were classified by standardized measures of 'recovery status', defined by rates of change in ecological measures that are known to be sensitive to localized stressors. Status was best predicted, interactively, by water quality and herbivory. Expanding upon temporal trends, this study examined if similar dependencies existed through space; building multiple regression models to identify linkages between similar status measures and local stressors for 17 localities around Tutuila. The results highlighted consistent, interactive interdependencies for coral reef assemblages residing upon two unique geological reef types. Finally, the predictive regression models produced at the island scale were graphically interpreted with respect to hypothesized site-specific recovery thresholds. Conclusions/Significance: Cumulatively, our study purports that moving away from describing relatively well-known patterns behind recovery, and focusing upon understanding causes, improves our foundation to predict future ecological dynamics, and thus improves coral reef management.	[Houk, Peter; Musburger, Craig] Pacific Marine Resources Inst, Saipan, CM USA; [Musburger, Craig] Univ Hawaii Manoa, Dept Zool, Honolulu, HI 96822 USA; [Wiles, Phil] Amer Samoa Environm Protect Agcy, Pago Pago, AS USA	University of Hawaii System; University of Hawaii Manoa	Houk, P (corresponding author), Pacific Marine Resources Inst, Saipan, CM USA.	peterhouk@pacmares.com			American Samoa Environmental Protection Agency; United States Environmental Protection Agency Region IX; NOAA	American Samoa Environmental Protection Agency; United States Environmental Protection Agency Region IX(United States Environmental Protection Agency); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	Thanks to the American Samoa Environmental Protection Agency and the United States Environmental Protection Agency Region IX for their funding and collaboration. Partial funding also originated from the NOAA coral reef management grant program awarded to American Samoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Antonius A, 1999, CORAL REEFS, V18, P301, DOI 10.1007/s003380050200; Antonius A, 2001, CORAL REEFS, V19, P418, DOI 10.1007/s003380000126; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Baskett ML, 2010, GLOBAL CHANGE BIOL, V16, P1229, DOI 10.1111/j.1365-2486.2009.02062.x; Birkeland C., 1997, LIFE DEATH CORAL REE; Bohnsack JA, 1986, STATIONARY VISUAL CE; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Brainard R., 2008, CORAL REEF ECOSYSTEM; Bruno JF, 2009, ECOLOGY, V90, P1478, DOI 10.1890/08-1781.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Connell JH, 1997, CORAL REEFS, V16, pS101, DOI 10.1007/s003380050246; Connell JH, 2004, ECOL MONOGR, V74, P179, DOI 10.1890/02-4043; Cooper TF, 2009, CORAL REEFS, V28, P589, DOI 10.1007/s00338-009-0512-x; Costa OS, 2000, HYDROBIOLOGIA, V440, P307, DOI 10.1023/A:1004104118208; COTTINGHAM LJ, 2005, P NATL ACAD SCI BIOL, V3, P145; Crawley M.J., 2007, R BOOK; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; DUTILLEUL P, 1993, ECOLOGY, V74, P1646, DOI 10.2307/1939923; Edmunds PJ, 2001, P NATL ACAD SCI USA, V98, P5067, DOI 10.1073/pnas.071524598; Elmqvist T, 2003, FRONT ECOL ENVIRON, V1, P488, DOI 10.2307/3868116; Fowler-Walker MJ, 2005, MAR BIOL, V147, P823, DOI 10.1007/s00227-005-1605-x; Fraschetti S, 2006, J EXP MAR BIOL ECOL, V339, P148, DOI 10.1016/j.jembe.2006.07.007; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Green A.L., 2009, MONITORING FUNCTIONA; Guillemot N, 2010, CORAL REEFS, V29, P445, DOI 10.1007/s00338-010-0587-4; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Houk P, 2006, PAC SCI, V60, P177, DOI 10.1353/psc.2006.0005; Houk P, 2005, ENVIRON MONIT ASSESS, V107, P11, DOI 10.1007/s10661-005-2019-4; Houk P, 2010, CORAL REEFS, V29, P59, DOI 10.1007/s00338-009-0545-1; HOUK P, 2008, ASSESSING EFFE UNPUB; Houk P, 2010, MAR ECOL-EVOL PERSP, V31, P318, DOI 10.1111/j.1439-0485.2009.00301.x; Hughes TP, 2007, TRENDS ECOL EVOL, V22, P1, DOI 10.1016/j.tree.2006.10.009; Idjadi JA, 2010, MAR ECOL PROG SER, V403, P91, DOI 10.3354/meps08463; Insalaco E, 1998, SEDIMENT GEOL, V118, P159, DOI 10.1016/S0037-0738(98)00011-6; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Keats DW, 1997, BOT MAR, V40, P263, DOI 10.1515/botm.1997.40.1-6.263; Keitt TH, 2006, ECOLOGY, V87, P2895, DOI 10.1890/0012-9658(2006)87[2895:DOSCDU]2.0.CO;2; KNOWLTON N, 1992, AM ZOOL, V32, P674; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V308, P23, DOI 10.1016/j.jembe.2004.01.019; Lapointe BE, 2004, J EXP MAR BIOL ECOL, V298, P275, DOI 10.1016/S0022-0981(03)00363-0; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; McClanahan T, 2002, CONSERV ECOL, V6; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; Mork E, 2009, ESTUAR COAST SHELF S, V84, P331, DOI 10.1016/j.ecss.2009.03.033; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Sandin SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001548; Smith JE, 2001, CORAL REEFS, V19, P332, DOI 10.1007/s003380000124; Smith LD, 2005, MAR POLLUT BULL, V51, P399, DOI 10.1016/j.marpolbul.2004.11.021; Somerfield PJ, 2008, CORAL REEFS, V27, P951, DOI 10.1007/s00338-008-0390-7; TERBRAAK CJF, 1983, ECOLOGY, V64, P454, DOI 10.2307/1939964; *US FOR SERV, US FOR SERV LAND US; Veron J.E.N., 2009, Galaxea - Tokyo, V11, P91; Walker ND, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023716; WASHINGTON HG, 1984, WATER RES, V18, P653, DOI 10.1016/0043-1354(84)90164-7; Wooldridge SA, 2009, ECOL APPL, V19, P1492, DOI 10.1890/08-0963.1; Zvuloni A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009941; AM SAMOA GIS LAYERS; BIOMASS COEFFICIENTS	62	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13913	10.1371/journal.pone.0013913	http://dx.doi.org/10.1371/journal.pone.0013913			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085715	gold, Green Published, Green Submitted			2022-12-27	WOS:000284036800011
J	Sun, YZ; Bian, C; Xu, K; Hu, WB; Wang, TY; Cui, J; Wu, HQ; Ling, ZY; Ji, YY; Lin, GM; Tian, L; Zhou, YY; Li, BN; Hu, GY; Yu, N; An, WQ; Pan, RW; Zhou, P; Leng, QB; Huang, Z; Ma, XW; Sun, B				Sun, Yizhuo; Bian, Chao; Xu, Ke; Hu, Weibin; Wang, Tongyan; Cui, Jun; Wu, Hongqiang; Ling, Zhiyang; Ji, Yongyong; Lin, Guomei; Tian, Lin; Zhou, Yanyan; Li, Bingnan; Hu, Guiyu; Yu, Ning; An, Wenqi; Pan, Ruowen; Zhou, Paul; Leng, Qibin; Huang, Zhong; Ma, Xiaowei; Sun, Bing			Immune Protection Induced on Day 10 Following Administration of the 2009 A/H1N1 Pandemic Influenza Vaccine	PLOS ONE			English	Article							A H1N1 VACCINE; VIRUS; EMERGENCE; RESPONSES; ANTIBODY; HUMANS	Background: The 2009 swine-origin influenza virus (S-OIV) H1N1 pandemic has caused more than 18,000 deaths worldwide. Vaccines against the 2009 A/H1N1 influenza virus are useful for preventing infection and controlling the pandemic. The kinetics of the immune response following vaccination with the 2009 A/H1N1 influenza vaccine need further investigation. Methodology/Principal Findings: 58 volunteers were vaccinated with a 2009 A/H1N1 pandemic influenza monovalent split-virus vaccine (15 mu g, single-dose). The sera were collected before Day 0 (pre-vaccination) and on Days 3, 5, 10, 14, 21, 30, 45 and 60 post vaccination. Specific antibody responses induced by the vaccination were analyzed using hemagglutination inhibition (HI) assay and enzyme-linked immunosorbent assay (ELISA). After administration of the 2009 A/H1N1 influenza vaccine, specific and protective antibody response with a major subtype of IgG was sufficiently developed as early as Day 10 (seroprotection rate: 93%). This specific antibody response could maintain for at least 60 days without significant reduction. Antibody response induced by the 2009 A/H1N1 influenza vaccine could not render protection against seasonal H1N1 influenza (seroconversion rate: 3% on Day 21). However, volunteers with higher pre-existing seasonal influenza antibody levels (pre-vaccination HI titer >= 1:40, Group 1) more easily developed a strong antibody protection effect against the 2009 A/H1N1 influenza vaccine as compared with those showing lower pre-existing seasonal influenza antibody levels (pre-vaccination HI titer <1:40, Group 2). The titer of the specific antibody against the 2009 A/H1N1 influenza was much higher in Group 1 (geometric mean titer: 146 on Day 21) than that in Group 2 (geometric mean titer: 70 on Day 21). Conclusions/Significance: Recipients could gain sufficient protection as early as 10 days after vaccine administration. The protection could last at least 60 days. Individuals with a stronger pre-existing seasonal influenza antibody response may have a relatively higher potential for developing a stronger humoral immune response after vaccination with the 2009 A/H1N1 pandemic influenza vaccine.	[Sun, Yizhuo; Bian, Chao; Cui, Jun; Wu, Hongqiang; Ling, Zhiyang; Ji, Yongyong; Lin, Guomei; Tian, Lin; Sun, Bing] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai, Peoples R China; [Xu, Ke; Hu, Weibin; Wang, Tongyan; Hu, Guiyu; Yu, Ning; Zhou, Paul; Leng, Qibin; Huang, Zhong; Sun, Bing] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Zhou, Yanyan; Li, Bingnan] Shanghai Immune Biotech Co, Shanghai, Peoples R China; [An, Wenqi; Pan, Ruowen; Ma, Xiaowei] Hualan Biol Bacterin Co, Xinxiang, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Sun, YZ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Key Lab Mol Cell Biol, Shanghai, Peoples R China.	mxwhualan@126.com; bsun@sibs.ac.cn		LING, Zhiyang/0000-0001-8873-6773	Hualan Biological Bacterin Company; CAS [KSCX2-YW-R-161, KSCX2-YW-R-169]; National Ministry of Science and Technology [20072714]; National Natural Science Foundation of China [30950002, 30623003, 30721065, 30801011, 30870126, 30949019, 90713044]; Technology Commission of Shanghai Municipality [08DZ2291703, 088014199]; Leadership Foundation from the Technology Commission of Shanghai Municipality; National Science and Technology Major Project [2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016]; SPHRF [SPHRF2008001, SPHRF2009001]; National 973 key project [2007CB512404]; E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	Hualan Biological Bacterin Company; CAS(Chinese Academy of Sciences); National Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Leadership Foundation from the Technology Commission of Shanghai Municipality; National Science and Technology Major Project; SPHRF; National 973 key project(National Basic Research Program of China); E-institutes of the Shanghai Universities Immunology Division; Li Kha Shing Foundation	Hualan Biological Bacterin Company is one of the funders of this research and helped to carry out volunteer recruitment and clinical sample collection. The company was not involved in sample testing and data statistical analysis of this research. This work was also supported by grants from CAS project (KSCX2-YW-R-161, KSCX2-YW-R-169), the National Ministry of Science and Technology (20072714), the National Natural Science Foundation of China (30950002, 30623003, 30721065, 30801011, 30870126, 30949019, 90713044), the Technology Commission of Shanghai Municipality (08DZ2291703, 088014199), the Leadership Foundation from the Technology Commission of Shanghai Municipality, the National Science and Technology Major Project (2008ZX10002-014, 2008ZX10004-002, 2009ZX10004-105, 2009ZX10004-016), SPHRF (SPHRF2008001, SPHRF2009001), a grant from National 973 key project (2007CB512404), a grant from E-institutes of the Shanghai Universities Immunology Division and a grant from the Li Kha Shing Foundation. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALKHAYATT R, 1984, J HYG-CAMBRIDGE, V93, P301, DOI 10.1017/S0022172400064834; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cohen J, 2009, SCIENCE, V324, P1496, DOI 10.1126/science.324_1496; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Del Giudice G, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000564; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; PANDEMIC H1N1 2009 U; 2009, MMWR MORB MORTAL WKL, V58, P521; H1N1 POSTPANDEMIC PE	18	11	14	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14270	10.1371/journal.pone.0014270	http://dx.doi.org/10.1371/journal.pone.0014270			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151563	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800006
J	Kashiwagi, T; Hara, K; Nakazono, Y; Hamada, N; Watanabe, H				Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi			Artificial Hybrids of Influenza A Virus RNA Polymerase Reveal PA Subunit Modulates Its Thermal Sensitivity	PLOS ONE			English	Article							SINGLE AMINO-ACID; H1N1 VIRUS; IN-VITRO; CRYSTAL-STRUCTURE; NUCLEAR IMPORT; CAP-BINDING; PB2; REPLICATION; COMPLEX; PROTEIN	Background: Influenza A virus can infect a variety of different hosts and therefore has to adapt to different host temperatures for its efficient viral replication. Influenza virus codes for an RNA polymerase of 3 subunits: PB1, PB2 and PA. It is well known that the PB2 subunit is involved in temperature sensitivity, such as cold adaptation. On the other hand the role of the PA subunit in thermal sensitivity is still poorly understood. Methodology/Principal Findings: To test which polymerase subunit(s) were involved in thermal stress we reconstituted artificial hybrids of influenza RNA polymerase in ribonucleoprotein (RNP) complexes and measured steady-state levels of mRNA, cRNA and vRNA at different temperatures. The PA subunit was involved in modulating RNP activity under thermal stress. Residue 114 of the PA subunit was an important determinant of this activity. Conclusions/Significance: These findings suggested that influenza A virus may acquire an RNA polymerase adapted to different body temperatures of the host by reassortment of the RNA polymerase genes.	[Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Med, Div Infect Dis, Kurume, Fukuoka 830, Japan	Kurume University	Kashiwagi, T (corresponding author), Kurume Univ, Sch Med, Dept Infect Med, Div Infect Dis, Kurume, Fukuoka 830, Japan.	takahito@med.kurume-u.ac.jp			Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan [21791015]	Ishibashi Foundation for the Promotion of Science; Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by grants from the Ishibashi Foundation for the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Young Scientists (B), 21791015, 2009-2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453; Bradel-Tretheway BG, 2008, J GEN VIROL, V89, P2923, DOI 10.1099/vir.0.2008/006254-0; Chase G, 2008, VIROLOGY, V377, P431, DOI 10.1016/j.virol.2008.04.040; Cordova J. A., 2009, Morbidity and Mortality Weekly Report, V58, P585; COX NJ, 1988, VIROLOGY, V167, P554, DOI 10.1016/S0042-6822(88)90118-3; Dalton RM, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-58; Danishuddin M, 2009, BIOINFORMATION, V4, P94, DOI 10.6026/97320630004094; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Deng T, 2006, J VIROL, V80, P2337, DOI 10.1128/JVI.80.5.2337-2348.2006; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Deng T, 2006, J GEN VIROL, V87, P3373, DOI 10.1099/vir.0.82199-0; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; DUBOIS MF, 1994, J CELL PHYSIOL, V158, P417, DOI 10.1002/jcp.1041580305; Engelhardt OG, 2005, J VIROL, V79, P5812, DOI 10.1128/JVI.79.9.5812-5818.2005; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Gabriel G, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040011; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hatta M, 2001, SCIENCE, V293, P1840, DOI 10.1126/science.1062882; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; Honda A, 2002, P NATL ACAD SCI USA, V99, P13166, DOI 10.1073/pnas.152456799; Huarte M, 2001, J VIROL, V75, P8597, DOI 10.1128/JVI.75.18.8597-8604.2001; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; Kiseleva IV, 2010, J GEN VIROL, V91, P931, DOI 10.1099/vir.0.017996-0; Kuzuhara T, 2009, ACTA CRYSTALLOGR F, V65, P144, DOI 10.1107/S1744309108042942; Lee MTM, 2002, NUCLEIC ACIDS RES, V30, P429, DOI 10.1093/nar/30.2.429; Leung BW, 2010, VIROLOGY, V401, P96, DOI 10.1016/j.virol.2010.01.036; Maier HJ, 2008, VIROLOGY, V370, P194, DOI 10.1016/j.virol.2007.08.029; Massin P, 2001, J VIROL, V75, P5398, DOI 10.1128/JVI.75.11.5398-5404.2001; Mehle A, 2009, P NATL ACAD SCI USA, V106, P21312, DOI 10.1073/pnas.0911915106; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Naito T, 2007, J VIROL, V81, P1339, DOI 10.1128/JVI.01917-06; ODAGIRI T, 1986, ARCH VIROL, V88, P91, DOI 10.1007/BF01310893; Palese P., 2007, FIELDS VIROLOGY, P1647; Pappaioanou M, 2009, COMP IMMUNOL MICROB, V32, P287, DOI 10.1016/j.cimid.2008.01.003; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Perez-Gonzalez A, 2006, J MOL BIOL, V362, P887, DOI 10.1016/j.jmb.2006.07.085; Resa-Infante P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003904; SanzEzquerro JJ, 1996, J VIROL, V70, P1905, DOI 10.1128/JVI.70.3.1905-1911.1996; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Song MS, 2009, J VIROL, V83, P12325, DOI 10.1128/JVI.01373-09; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tarendeau F, 2007, NAT STRUCT MOL BIOL, V14, P229, DOI 10.1038/nsmb1212; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; World Health Organization, 2010, PAND H1N1 2009; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	51	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15140	10.1371/journal.pone.0015140	http://dx.doi.org/10.1371/journal.pone.0015140			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151876	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800008
J	Coulon, C; Vinogradov, E; Filloux, A; Sadovskaya, I				Coulon, Charlene; Vinogradov, Evgeny; Filloux, Alain; Sadovskaya, Irina			Chemical Analysis of Cellular and Extracellular Carbohydrates of a Biofilm-Forming Strain Pseudomonas aeruginosa PA14	PLOS ONE			English	Article							MOLECULAR-WEIGHT POLYSACCHARIDE; AIR-LIQUID INTERFACE; ESCHERICHIA-COLI; ANTIBIOTIC-RESISTANCE; SPONTANEOUS RELEASE; O-ANTIGEN; LIPOPOLYSACCHARIDE; GENES; EXPRESSION; MATRIX	Background: Pseudomonas aeruginosa is a Gram-negative bacterium and an opportunistic pathogen, which causes persisting life-threatening infections in cystic fibrosis (CF) patients. Biofilm mode of growth facilitates its survival in a variety of environments. Most P. aeruginosa isolates, including the non-mucoid laboratory strain PA14, are able to form a thick pellicle, which results in a surface-associated biofilm at the air-liquid (A-L) interface in standing liquid cultures. Exopolysaccharides (EPS) are considered as key components in the formation of this biofilm pellicle. In the non-mucoid P. aeruginosa strain PA14, the "scaffolding" polysaccharides of the biofilm matrix, and the molecules responsible for the structural integrity of rigid A-L biofilm have not been identified. Moreover, the role of LPS in this process is unclear, and the chemical structure of the LPS O-antigen of PA14 has not yet been elucidated. Principal Findings: In the present work we carried out a systematic analysis of cellular and extracellular (EC) carbohydrates of P. aeruginosa PA14. We also elucidated the chemical structure of the LPS O-antigen by chemical methods and 2-D NMR spectroscopy. Our results showed that it is composed of linear trisaccharide repeating units, identical to those described for P. aeruginosa Lanyi type O:2a,c (Lanyi-Bergman O-serogroup 10a, 10c; IATS serotype 19) and having the following structure: -4)-alpha-L-GalNAcA-(1-3)-alpha-D-QuiNAc-(1-3)-alpha-L-Rha-(1-. Furthermore, an EC O-antigen polysaccharide (EC O-PS) and the glycerol-phosphorylated cyclic beta-(1,3)-glucans were identified in the culture supernatant of PA14, grown statically in minimal medium. Finally, the extracellular matrix of the thick biofilm formed at the A-L interface contained, in addition to eDNA, important quantities (at least similar to 20% of dry weight) of LPS-like material. Conclusions: We characterized the chemical structure of the LPS O-antigen and showed that the O-antigen polysaccharide is an abundant extracellular carbohydrate of PA14. We present evidence that LPS-like material is found as a component of a biofilm matrix of P. aeruginosa.	[Coulon, Charlene; Sadovskaya, Irina] Univ Lille Nord France, Lille, France; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Coulon, Charlene] Univ Littoral Cote dOpale, LR2B, Bassin Napoleon, Boulogne Mer, France; [Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, Fac Nat Sci, Div Cell & Mol Biol, London, England; [Sadovskaya, Irina] Univ Littoral Cote dOpale, UMT 08, Boulogne Sur Mer, France	Universite de Lille - ISITE; Universite de Lille; National Research Council Canada; Universite du Littoral-Cote-d'Opale; Imperial College London; Universite du Littoral-Cote-d'Opale	Coulon, C (corresponding author), Univ Lille Nord France, Lille, France.	Irina.Sadovskaya@univ-littoral.fr		Vinogradov, Evgeny/0000-0002-5364-1376	le Ministere de l'Enseignement Superieur et de la Recherche; Arcir [54R01]; Royal Society; ERA-NET Pathogenomics	le Ministere de l'Enseignement Superieur et de la Recherche; Arcir; Royal Society(Royal Society of London); ERA-NET Pathogenomics	This study was supported by le Ministere de l'Enseignement Superieur et de la Recherche to CC and by Arcir 54R01 to IS. AF is supported by the Royal Society and the ERA-NET Pathogenomics grant EPS-MATRIX. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham T, 2008, BIOMACROMOLECULES, V9, P2799, DOI 10.1021/bm800562r; Al-Tahhan RA, 2000, APPL ENVIRON MICROB, V66, P3262, DOI 10.1128/AEM.66.8.3262-3268.2000; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; Apicella MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011060; BORDI C, 2010, MOL MICROBIOL; Buchanan PJ, 2009, BIOCHEM SOC T, V37, P863, DOI 10.1042/BST0370863; Byrd MS, 2009, MOL MICROBIOL, V73, P622, DOI 10.1111/j.1365-2958.2009.06795.x; CADIEUX JE, 1983, J BACTERIOL, V155, P817, DOI 10.1128/JB.155.2.817-825.1983; CRUTCHLE.MJ, 1967, NATURE, V214, P1052, DOI 10.1038/2141052a0; DAVIES DG, 1993, APPL ENVIRON MICROB, V59, P1181, DOI 10.1128/AEM.59.4.1181-1186.1993; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; Filloux A, 2003, M S-MED SCI, V19, P77, DOI 10.1051/medsci/200319177; Friedman L, 2004, MOL MICROBIOL, V51, P675, DOI 10.1046/j.1365-2958.2003.03877.x; Fujise O, 2008, ORAL MICROBIOL IMMUN, V23, P226, DOI 10.1111/j.1399-302X.2007.00416.x; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; GOLDMAN RC, 1982, J BACTERIOL, V151, P1210, DOI 10.1128/JB.151.3.1210-1221.1982; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996; ISHIGURO EE, 1986, J BACTERIOL, V168, P328, DOI 10.1128/jb.168.1.328-333.1986; JOHNSON KG, 1975, CAN J MICROBIOL, V21, P1969, DOI 10.1139/m75-285; KARKHANIS YD, 1978, ANAL BIOCHEM, V85, P595, DOI 10.1016/0003-2697(78)90260-9; KNIREL YA, 1982, EUR J BIOCHEM, V125, P221, DOI 10.1111/j.1432-1033.1982.tb06672.x; Knirel YA, 2006, J ENDOTOXIN RES, V12, P324, DOI 10.1179/096805106X118906; KOCHAROVA NA, 1988, BIOORG KHIM+, V14, P701; Lau PCY, 2009, J BACTERIOL, V191, P6618, DOI 10.1128/JB.00698-09; Lee YW, 2010, LETT APPL MICROBIOL, V50, P452, DOI 10.1111/j.1472-765X.2010.02813.x; Lequette Y, 2007, MICROBIOL-SGM, V153, P3255, DOI 10.1099/mic.0.2007/008953-0; Matsukawa M, 2004, J BACTERIOL, V186, P4449, DOI 10.1128/JB.186.14.4449-4456.2004; Mulcahy H, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000213; Nakamura S, 2008, JPN J INFECT DIS, V61, P375; PIER GB, 1984, INFECT IMMUN, V45, P309, DOI 10.1128/IAI.45.2.309-313.1984; PIER GB, 1989, INFECT IMMUN, V57, P426, DOI 10.1128/IAI.57.2.426-431.1989; PIER GB, 1981, INFECT IMMUN, V34, P461, DOI 10.1128/IAI.34.2.461-468.1981; PIER GB, 1978, INFECT IMMUN, V22, P908, DOI 10.1128/IAI.22.3.908-918.1978; PIKE RM, 1974, J GEN MICROBIOL, V81, P59, DOI 10.1099/00221287-81-1-59; Reuhs BL, 1998, APPL ENVIRON MICROB, V64, P4930; Ryder C, 2007, CURR OPIN MICROBIOL, V10, P644, DOI 10.1016/j.mib.2007.09.010; Sadovskaya I, 2010, GLYCOBIOLOGY, V20, P895, DOI 10.1093/glycob/cwq047; Sakuragi Y, 2007, J BACTERIOL, V189, P5383, DOI 10.1128/JB.00137-07; Scher K, 2005, APPL ENVIRON MICROB, V71, P1163, DOI 10.1128/AEM.71.3.1163-1168.2005; Schwudke D, 2003, J BIOL CHEM, V278, P27502, DOI 10.1074/jbc.M303012200; Snyder DS, 2006, CARBOHYD RES, V341, P2388, DOI 10.1016/j.carres.2006.06.010; Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x; Spiers AJ, 2005, MICROBIOL-SGM, V151, P2829, DOI 10.1099/mic.0.27984-0; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Vasseur P, 2007, BIOCHIMIE, V89, P903, DOI 10.1016/j.biochi.2007.04.002; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; WESTPHAL O., 1965, METHOD CARBOHYD CHEM, V5, P83; White AP, 2003, J BACTERIOL, V185, P5398, DOI 10.1128/JB.185.18.5398-5407.2003; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Wozniak DJ, 2003, P NATL ACAD SCI USA, V100, P7907, DOI 10.1073/pnas.1231792100	54	46	48	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14220	10.1371/journal.pone.0014220	http://dx.doi.org/10.1371/journal.pone.0014220			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151973	Green Submitted, gold, Green Published			2022-12-27	WOS:000284939600013
J	Andersen, LG; Angquist, L; Eriksson, JG; Forsen, T; Gamborg, M; Osmond, C; Baker, JL; Sorensen, TIA				Andersen, Lise Geisler; Angquist, Lars; Eriksson, Johan G.; Forsen, Tom; Gamborg, Michael; Osmond, Clive; Baker, Jennifer L.; Sorensen, Thorkild I. A.			Birth Weight, Childhood Body Mass Index and Risk of Coronary Heart Disease in Adults: Combined Historical Cohort Studies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PARENTAL RECALL; YOUNG ADULTHOOD; FETAL ORIGINS; INFANT GROWTH; STROKE; DEATH; BORN; LIFE; AGE	Background: Low birth weight and high childhood body mass index (BMI) is each associated with an increased risk of coronary heart disease (CHD) in adult life. We studied individual and combined associations of birth weight and childhood BMI with the risk of CHD in adulthood. Methods/Principal Findings: Birth weight and BMI at age seven years were available in 216,771 Danish and Finnish individuals born 1924-1976. Linkage to national registers for hospitalization and causes of death identified 8,805 CHD events during up to 33 years of follow-up (median = 24 years) after age 25 years. Analyses were conducted with Cox regression based on restricted cubic splines. Using median birth weight of 3.4 kg as reference, a non-linear relation between birth weight and CHD was found. It was not significantly different between cohorts, or between men and women, nor was the association altered by childhood BMI. For birth weights below 3.4 kg, the risk of CHD increased linearly and reached 1.28 (95% confidence limits: 1.13 to 1.44) at 2 kg. Above 3.4 kg the association weakened, and from about 4 kg there was virtually no association. BMI at age seven years was strongly positively associated with the risk of CHD and the relation was not altered by birth weight. The excess risk in individuals with a birth weight of 2.5 kg and a BMI of 17.7 kg/m(2) at age seven years was 44% (95% CI: 30% to 59%) compared with individuals with median values of birth weight (3.4 kg) and BMI (15.3 kg/m(2)). Conclusions/Significance: Birth weight and BMI at age seven years appeared independently associated with the risk of CHD in adulthood. From a public health perspective we suggest that particular attention should be paid to children with a birth weight below the average in combination with excess relative weight in childhood.	[Andersen, Lise Geisler; Angquist, Lars; Gamborg, Michael; Baker, Jennifer L.; Sorensen, Thorkild I. A.] Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark; [Eriksson, Johan G.; Forsen, Tom] Univ Helsinki, Dept Gen Practice & Primary Hlth Care, Helsinki, Finland; [Eriksson, Johan G.] Univ Helsinki, Cent Hosp, Unit Gen Practice, Helsinki, Finland; [Eriksson, Johan G.] Folkhalsan Res Ctr, Helsinki, Finland; [Eriksson, Johan G.] Vasa Cent Hosp, Vaasa, Finland; [Eriksson, Johan G.; Forsen, Tom] Natl Inst Hlth & Welf, Dept Hlth Promot & Chron Dis Prevent, Helsinki, Finland; [Forsen, Tom] Vasa Hlth Care Ctr, Vaasa, Finland; [Osmond, Clive] Univ Southampton, Southampton Gen Hosp, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England	University of Copenhagen; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Folkhalsan Research Center; Vaasa Central Hospital; Finland National Institute for Health & Welfare; University of Southampton	Andersen, LG (corresponding author), Copenhagen Univ Hosp, Inst Prevent Med, Copenhagen, Denmark.	lg@ipm.regionh.dk	Baker, Jennifer/F-1917-2010; Bjerregaard, Lise Geisler/F-3818-2014; Baker, Jennifer L./AAH-4693-2020	Baker, Jennifer/0000-0002-9649-6615; Bjerregaard, Lise Geisler/0000-0001-8471-0832; Baker, Jennifer L./0000-0002-9649-6615; Eriksson, Johan/0000-0002-2516-2060; Angquist, Lars/0000-0002-9516-4424; Osmond, Clive/0000-0002-9054-4655	NordForsk [50440]; Danish Medical Research Council; Danish National Science Foundation; Academy of Finland; British Heart Foundation; Finska Lakaresallskapet; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Nordic Research Council; Medical Research Council [U1475000004] Funding Source: researchfish	NordForsk; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish National Science Foundation(Danmarks Grundforskningsfond); Academy of Finland(Academy of Finland); British Heart Foundation(British Heart Foundation); Finska Lakaresallskapet; Paivikki and Sakari Sohlberg Foundation; Signe and Ane Gyllenberg Foundation; Yrjo Jahnsson Foundation; Samfundet Folkhalsan; Diabetes Research Foundation; Finnish Foundation for Cardiovascular Research; Nordic Research Council; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study is part of the Nordic longitudinal epidemiologic research program "Prenatal and Childhood Growth in Relation to Cardiovascular Disease" (the NordNet Study), which is a Nordic collaborative research project using existing Nordic cohorts, supported by the Nordic Research Council, NordForsk, grant no 50440. The building-up of the included cohorts has been based on support from many granting bodies (the Danish cohort has primarily been built on support from the Danish Medical Research Council and the Danish National Science Foundation, and the Helsinki Birth Cohort Study was supported by the Academy of Finland, British Heart Foundation, Finska Lakaresallskapet, Paivikki and Sakari Sohlberg Foundation, Signe and Ane Gyllenberg Foundation, Yrjo Jahnsson Foundation, Samfundet Folkhalsan, The Diabetes Research Foundation, and The Finnish Foundation for Cardiovascular Research). The current activity is part of the Danish Obesity Research Centre (DanORC, http://www.danorc.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008192; Andersen TF, 1999, DAN MED BULL, V46, P263; Baker JL, 2008, EPIDEMIOLOGY, V19, P197, DOI 10.1097/EDE.0b013e31816339c6; Baker JL, 2007, NEW ENGL J MED, V357, P2329, DOI 10.1056/NEJMoa072515; Baker JL, 2009, INT J EPIDEMIOL, V38, P656, DOI 10.1093/ije/dyn164; Barker DJP, 2006, CLIN OBSTET GYNECOL, V49, P270, DOI 10.1097/00003081-200606000-00009; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 2002, TRENDS ENDOCRIN MET, V13, P364, DOI 10.1016/S1043-2760(02)00689-6; Byrne CD, 2000, J CLIN PATHOL, V53, P822, DOI 10.1136/jcp.53.11.822; Clausen TD, 2009, J CLIN ENDOCR METAB, V94, P2464, DOI 10.1210/jc.2009-0305; Cleves M., 2008, INTRO SURVIVAL ANAL; COX DR, 1972, J R STAT SOC B, V34, P187; Eriksson J, 2002, HORM METAB RES, V34, P72, DOI 10.1055/s-2002-20518; Eriksson JG, 1999, BMJ-BRIT MED J, V318, P427, DOI 10.1136/bmj.318.7181.427; Eriksson JG, 2001, BRIT MED J, V322, P949, DOI 10.1136/bmj.322.7292.949; Eriksson JG, 2002, ANN MED, V34, P157, DOI 10.1080/713782141; Falkstedt D, 2007, INT J OBESITY, V31, P777, DOI 10.1038/sj.ijo.0803480; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Forsen T, 2004, HEART, V90, P20, DOI 10.1136/heart.90.1.20; Forsen T, 1997, BRIT MED J, V315, P837, DOI 10.1136/bmj.315.7112.837; Forsen TJ, 2004, ANN MED, V36, P389, DOI 10.1080/07853890410028438; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; GREENLAND S, 1995, EPIDEMIOLOGY, V6, P356, DOI 10.1097/00001648-199507000-00005; Gunnarsdottir I, 2002, AM J CLIN NUTR, V76, P1290, DOI 10.1093/ajcn/76.6.1290; Haennel RG, 2002, CAN FAM PHYSICIAN, V48, P65; Harrell FE, 2001, REGRESSION MODELING; Huxley R, 2007, AM J CLIN NUTR, V85, P1244, DOI 10.1093/ajcn/85.5.1244; Juel K, 1999, DAN MED BULL, V46, P354; Kaijser M, 2008, CIRCULATION, V117, P405, DOI 10.1161/CIRCULATIONAHA.107.710715; Kajantie E, 2008, INT J EPIDEMIOL, V37, P280, DOI 10.1093/ije/dyn012; Lawlor DA, 2005, CIRCULATION, V112, P1414, DOI 10.1161/CIRCULATIONAHA.104.528356; Lawlor DA, 2006, AM J CLIN NUTR, V83, P767, DOI 10.1093/ajcn/83.4.767; Leon DA, 1998, BMJ-BRIT MED J, V317, P241, DOI 10.1136/bmj.317.7153.241; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Mahonen M, 1997, EUR J EPIDEMIOL, V13, P403, DOI 10.1023/A:1007306110822; Meas T, 2008, J CLIN ENDOCR METAB, V93, P3804, DOI 10.1210/jc.2008-0488; O'Sullivan JJ, 2000, ARCH DIS CHILD, V82, P202, DOI 10.1136/adc.82.3.202; Osler M, 2009, EUR J EPIDEMIOL, V24, P57, DOI 10.1007/s10654-008-9301-z; OSMOND C, 1993, BRIT MED J, V307, P1519, DOI 10.1136/bmj.307.6918.1519; Osmond C, 2007, STROKE, V38, P264, DOI 10.1161/01.STR.0000254471.72186.03; Rapola JM, 1997, EUR J EPIDEMIOL, V13, P133, DOI 10.1023/A:1007380408729; Rugholm S, 2005, OBES RES, V13, P2187, DOI 10.1038/oby.2005.271; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Solomons NW, 2009, NUTR REV, V67, pS12, DOI 10.1111/j.1753-4887.2009.00152.x; Therneau T.M., 2000, MODELING SURVIVAL DA; Tzoulaki I, 2008, EUR HEART J, V29, P1049, DOI 10.1093/eurheartj/ehn105; Walton KA, 2000, EUR J EPIDEMIOL, V16, P793, DOI 10.1023/A:1007625030509; Whincup PH, 2008, JAMA-J AM MED ASSOC, V300, P2886, DOI 10.1001/jama.2008.886; Yang L, 2008, J INTERN MED, V264, P39, DOI 10.1111/j.1365-2796.2007.01907.x	51	78	81	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14126	10.1371/journal.pone.0014126	http://dx.doi.org/10.1371/journal.pone.0014126			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124730	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000284686500012
J	Wandernoth, PM; Raubuch, M; Mannowetz, N; Becker, HM; Deitmer, JW; Sly, WS; Wennemuth, G				Wandernoth, Petra M.; Raubuch, Michael; Mannowetz, Nadja; Becker, Holger M.; Deitmer, Joachim W.; Sly, William S.; Wennemuth, Gunther			Role of Carbonic Anhydrase IV in the Bicarbonate-Mediated Activation of Murine and Human Sperm	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; MOUSE SPERMATOZOA; PLASMA-MEMBRANE; O-18 EXCHANGE; CA-IV; CAPACITATION; EXPRESSION; FLAGELLAR; FLUID; EPIDIDYMIS	HCO(3)(-) is the signal for early activation of sperm motility. In vivo, this occurs when sperm come into contact with the HCO(3)(-) containing fluids in the reproductive tract. The activated motility enables sperm to travel the long distance to the ovum. In spermatozoa HCO(3)(-) stimulates the atypical sperm adenylyl cyclase (sAC) to promote the cAMP-mediated pathway that increases flagellar beat frequency. Stimulation of sAC may occur when HCO(3)(-) enters spermatozoa either directly by anion transport or indirectly via diffusion of CO(2) with subsequent hydration by intracellular carbonic anhydrase (CA). We here show that murine sperm possess extracellular CA IV that is transferred to the sperm surface as the sperm pass through the epididymis. Comparison of CA IV expression by qRT PCR analysis confirms that the transfer takes place in the corpus epididymidis. We demonstrate murine and human sperm respond to CO(2) with an increase in beat frequency, an effect that can be inhibited by ethoxyzolamide. Comparing CA activity in sperm from wild-type and CA IV(-/-) mice we found a 32.13% reduction in total CA activity in the latter. The CA IV(-/-) sperm also have a reduced response to CO(2). While the beat frequency of wild-type sperm increases from 2.86 +/- 0.12 Hz to 6.87 +/- 0.34 Hz after CO(2) application, beat frequency of CA IV(-/-) sperm only increases from 3.06 +/- 0.20 Hz to 5.29 +/- 0.47 Hz. We show, for the first time, a physiological role of CA IV that supplies sperm with HCO(3)(-), which is necessary for stimulation of sAC and hence early activation of spermatozoa.	[Wandernoth, Petra M.; Raubuch, Michael; Mannowetz, Nadja; Wennemuth, Gunther] Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Saar, Germany; [Becker, Holger M.] Univ Kaiserslautern, Div Zool Membrane Transport, Dept Biol, Kaiserslautern, Germany; [Deitmer, Joachim W.] Univ Kaiserslautern, Div Gen Zool, Dept Biol, Kaiserslautern, Germany; [Sly, William S.] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saarland University; University of Kaiserslautern; University of Kaiserslautern; Saint Louis University	Wandernoth, PM (corresponding author), Univ Saarland, Dept Anat & Cell Biol, D-6650 Homburg, Saar, Germany.	angwen@uks.eu	Becker, Holger/AAB-4322-2020	Wennemuth, Gunther/0000-0003-3313-2475	HOMFOR [T201 00 044]	HOMFOR	The study was supported by HOMFOR T201 00 044 to GW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AU CL, 1980, J PHYSIOL-LONDON, V309, P419, DOI 10.1113/jphysiol.1980.sp013517; BADGER MR, 1989, PLANT PHYSIOL, V89, P51, DOI 10.1104/pp.89.1.51; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; BOATMAN DE, 1991, BIOL REPROD, V44, P806, DOI 10.1095/biolreprod44.5.806; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; DAVID A, 1969, J REPROD FERTIL, V19, P285, DOI 10.1530/jrf.0.0190285; DAVID A, 1973, FERTIL STERIL, V24, P227; Ekstedt E, 2004, J MOL HISTOL, V35, P167; Flesch FM, 2001, MOL REPROD DEV, V60, P107, DOI 10.1002/mrd.1067; Gadella BM, 2000, DEVELOPMENT, V127, P2407; Kaunisto K, 1999, BIOL REPROD, V61, P1521, DOI 10.1095/biolreprod61.6.1521; KAUNISTO K, 1995, BIOL REPROD, V52, P1350, DOI 10.1095/biolreprod52.6.1350; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; PARKKILA S, 1993, J HISTOCHEM CYTOCHEM, V41, P751, DOI 10.1177/41.5.8468457; Schuh SM, 2007, BIOL REPROD, V77, P960, DOI 10.1095/biolreprod.107.062562; SILVERMAN DN, 1982, METHOD ENZYMOL, V87, P732; Sullivan R, 2007, ASIAN J ANDROL, V9, P483, DOI 10.1111/j.1745-7262.2007.00281.x; SULTEMEYER DF, 1990, PLANT PHYSIOL, V94, P1250, DOI 10.1104/pp.94.3.1250; Supuran CT, 2008, CURR PHARM DESIGN, V14, P603, DOI 10.2174/138161208783877884; Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467; Svichar N, 2006, GLIA, V53, P241, DOI 10.1002/glia.20277; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; WAHEED A, 1992, ARCH BIOCHEM BIOPHYS, V294, P550, DOI 10.1016/0003-9861(92)90724-B; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Wennemuth G, 2003, DEVELOPMENT, V130, P1317, DOI 10.1242/dev.00353; Zhang H, 2003, J ANDROL, V24, P51	27	34	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15061	10.1371/journal.pone.0015061	http://dx.doi.org/10.1371/journal.pone.0015061			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124840	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000025
J	Nduati, EW; Ng, DHL; Ndungu, FM; Gardner, P; Urban, BC; Langhorne, J				Nduati, Eunice W.; Ng, Dorothy H. L.; Ndungu, Francis M.; Gardner, Peter; Urban, Britta C.; Langhorne, Jean			Distinct Kinetics of Memory B-Cell and Plasma-Cell Responses in Peripheral Blood Following a Blood-Stage Plasmodium chabaudi Infection in Mice	PLOS ONE			English	Article							MALARIA-ENDEMIC AREA; BONE-MARROW; FALCIPARUM-MALARIA; IMMUNE-RESPONSE; NEGATIVE SELECTION; HUMORAL IMMUNITY; ANTIGEN; EXPRESSION; LYMPHOCYTES; ACTIVATION	B cell and plasma cell responses take place in lymphoid organs, but because of the inaccessibility of these organs, analyses of human responses are largely performed using peripheral blood mononuclear cells (PBMC). To determine whether PBMC are a useful source of memory B cells and plasma cells in malaria, and whether they reflect Plasmodium-specific B cell responses in spleen or bone marrow, we have investigated these components of the humoral response in PBMC using a model of Plasmodium chabaudi blood-stage infections in C57BL/6 mice. We detected memory B cells, defined as isotype-switched IgD(-) IgM(-) CD19(+) B cells, and low numbers of Plasmodium chabaudi Merozoite Surface Protein-1 (MSP1)-specific memory B cells, in PBMC at all time points sampled for up to 90 days following primary or secondary infection. By contrast, we only detected CD138(+) plasma cells and MSP1-specific antibody-secreting cells within a narrow time frame following primary (days 10 to 25) or secondary (day 10) infection. CD138(+) plasma cells in PBMC at these times expressed CD19, B220 and MHC class II, suggesting that they were not dislodged bone-marrow long-lived plasma cells, but newly differentiated migratory plasmablasts migrating to the bone marrow; thus reflective of an ongoing or developing immune response. Our data indicates that PBMC can be a useful source for malaria-specific memory B cells and plasma cells, but extrapolation of the results to human malaria infections suggests that timing of sampling, particularly for plasma cells, may be critical. Studies should therefore include multiple sampling points, and at times of infection/immunisation when the B-cell phenotypes of interest are likely to be found in peripheral blood.	[Nduati, Eunice W.; Urban, Britta C.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Collaborat Res Programme, Kilifi, Kenya; [Nduati, Eunice W.; Ng, Dorothy H. L.; Ndungu, Francis M.; Gardner, Peter; Langhorne, Jean] MRC Natl Inst Med Res, Div Parasitol, London, England; [Urban, Britta C.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	MRC National Institute for Medical Research; Liverpool School of Tropical Medicine; University of Liverpool	Nduati, EW (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Collaborat Res Programme, Kilifi, Kenya.	jlangho@nimr.mrc.ac.uk	Ndungu, Francis Maina/C-2199-2019; Urban, Britta/W-6087-2018	Ndungu, Francis Maina/0000-0002-8977-0030; Urban, Britta/0000-0002-4197-8393; Langhorne, Jean/0000-0002-2257-9733; Gardner, Pete/0000-0002-4940-2639	Medical Research Council, UK [U117584248]; BioMalPar PhD fellowship; A*STAR, Singapore; MRC; Wellcome Trust [07908]; Priority 1 "Life Sciences, Genomics and Biotechnology for Health" [LSHP-CT-2004-503578]; Evimalar European Network of Excellence; MRC [MC_U117584248] Funding Source: UKRI; Medical Research Council [MC_U117584248] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BioMalPar PhD fellowship; A*STAR, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Priority 1 "Life Sciences, Genomics and Biotechnology for Health"; Evimalar European Network of Excellence; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council, UK (File reference, U117584248). Eunice W. Nduati was the recipient of a BioMalPar PhD fellowship, Dorothy H. L. Ng is a recipient of an A*STAR MBBS-PhD National Science Scholarship (A*STAR, Singapore) and Peter Gardner a recipient of an MRC PhD studentship. Britta Urban is supported by a Wellcome Trust Senior Fellowship (Grant number 07908). This work is part of the activities of the BioMalPar European Network of Excellence supported by a European grant (LSHP-CT-2004-503578) from the Priority 1 "Life Sciences, Genomics and Biotechnology for Health" in the sixth framework, and Evimalar European Network of Excellence in the seventh Framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2003, J IMMUNOL, V171, P317, DOI 10.4049/jimmunol.171.1.317; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Asito AS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-238; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Benschop RJ, 1999, J EXP MED, V190, P749, DOI 10.1084/jem.190.6.749; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Blanchard-Rohner G, 2009, BLOOD, V114, P4998, DOI 10.1182/blood-2009-03-211052; Blink EJ, 2005, J EXP MED, V201, P545, DOI 10.1084/jem.20042060; Cadman ET, 2008, INFECT IMMUN, V76, P3924, DOI 10.1128/IAI.00372-08; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Carsetti R, 2004, IMMUNOL REV, V197, P179, DOI 10.1111/j.0105-2896.2004.0109.x; Cervenak L, 2001, IMMUNOL LETT, V78, P89, DOI 10.1016/S0165-2478(01)00239-5; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2009, J IMMUNOL, V182, P3318, DOI 10.4049/jimmunol.0803596; Crotty S, 2003, J IMMUNOL, V171, P4969, DOI 10.4049/jimmunol.171.10.4969; Cyster JG, 2002, ADV EXP MED BIOL, V512, P35; DILOSA RM, 1991, J IMMUNOL, V146, P4071; Dorfman JR, 2005, J INFECT DIS, V191, P1623, DOI 10.1086/429671; ELHASSAN IM, 1994, AM J TROP MED HYG, V51, P372, DOI 10.4269/ajtmh.1994.51.372; Fairfax KA, 2008, SEMIN IMMUNOL, V20, P49, DOI 10.1016/j.smim.2007.12.002; Han SH, 1996, SCIENCE, V274, P2094, DOI 10.1126/science.274.5295.2094; Han SH, 1997, SCIENCE, V278, P301, DOI 10.1126/science.278.5336.301; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Helmby H, 2000, INFECT IMMUN, V68, P1485, DOI 10.1128/IAI.68.3.1485-1490.2000; Hensmann M, 2004, EUR J IMMUNOL, V34, P639, DOI 10.1002/eji.200324514; HO M, 1986, J INFECT DIS, V153, P763, DOI 10.1093/infdis/153.4.763; HVIID L, 1991, EUR J IMMUNOL, V21, P1249, DOI 10.1002/eji.1830210523; KELSO A, 1984, J IMMUNOL, V132, P2924; KUMARARATNE DS, 1987, CLIN EXP IMMUNOL, V68, P65; Kunkel EJ, 2003, NAT REV IMMUNOL, V3, P822, DOI 10.1038/nri1203; LANGHORNE J, 1991, J IMMUNOL, V146, P2771; Lanzavecchia A, 2006, IMMUNOL REV, V211, P303, DOI 10.1111/j.0105-2896.2006.00403.x; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mamani-Matsuda M, 2008, BLOOD, V111, P4653, DOI 10.1182/blood-2007-11-123844; Manz RA, 1998, INT IMMUNOL, V10, P1703, DOI 10.1093/intimm/10.11.1703; Manz RA, 2002, EUR J IMMUNOL, V32, P923, DOI 10.1002/1521-4141(200204)32:4<923::AID-IMMU923>3.0.CO;2-1; MCGREGOR IA, 1964, AM J TROP MED HYG, V13, P237, DOI 10.4269/ajtmh.1964.13.237; Medina F, 2002, BLOOD, V99, P2154, DOI 10.1182/blood.V99.6.2154; MELCHERS F, 1995, CURR OPIN IMMUNOL, V7, P214, DOI 10.1016/0952-7915(95)80006-9; Murasawa M, 2002, EUR J IMMUNOL, V32, P291, DOI 10.1002/1521-4141(200201)32:1<291::AID-IMMU291>3.0.CO;2-L; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nagaoka H, 2000, CURR OPIN IMMUNOL, V12, P187, DOI 10.1016/S0952-7915(99)00070-9; Ndungu FM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000690; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; OSMOND DG, 1986, IMMUNOL REV, V93, P103, DOI 10.1111/j.1600-065X.1986.tb01504.x; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sandel PC, 1999, IMMUNITY, V10, P289, DOI 10.1016/S1074-7613(00)80029-1; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Sims GP, 2005, BLOOD, V105, P4390, DOI 10.1182/blood-2004-11-4284; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Slifka MK, 1996, J IMMUNOL METHODS, V199, P37, DOI 10.1016/S0022-1759(96)00146-9; Smith KGC, 1996, EUR J IMMUNOL, V26, P444, DOI 10.1002/eji.1830260226; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2008, CURR OPIN IMMUNOL, V20, P162, DOI 10.1016/j.coi.2008.03.016; Traore B, 2009, VACCINE, V27, P7299, DOI 10.1016/j.vaccine.2009.08.023; TROYEBLOMBERG M, 1983, CLIN EXP IMMUNOL, V53, P335; vonderWeid T, 1996, J IMMUNOL, V156, P2510; Weiss GE, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000912; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wykes MN, 2005, J IMMUNOL, V175, P2510, DOI 10.4049/jimmunol.175.4.2510	66	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15007	10.1371/journal.pone.0015007	http://dx.doi.org/10.1371/journal.pone.0015007			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124900	gold, Green Published, Green Accepted			2022-12-27	WOS:000284527900015
J	Oikawa, A; Joshi, HJ; Rennie, EA; Ebert, B; Manisseri, C; Heazlewood, JL; Scheller, HV				Oikawa, Ai; Joshi, Hiren J.; Rennie, Emilie A.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe			An Integrative Approach to the Identification of Arabidopsis and Rice Genes Involved in Xylan and Secondary Wall Development	PLOS ONE			English	Article							CARBOHYDRATE-ACTIVE ENZYMES; GENOME-WIDE ANALYSIS; REDUCING END-GROUPS; SUBCELLULAR-LOCALIZATION; ARABINOGALACTAN PROTEINS; ENDOPLASMIC-RETICULUM; TRANSCRIPTION FACTORS; CELLULOSE SYNTHESIS; BIOSYNTHESIS; EXPRESSION	Xylans constitute the major non-cellulosic component of plant biomass. Xylan biosynthesis is particularly pronounced in cells with secondary walls, implying that the synthesis network consists of a set of highly expressed genes in such cells. To improve the understanding of xylan biosynthesis, we performed a comparative analysis of co-expression networks between Arabidopsis and rice as reference species with different wall types. Many co-expressed genes were represented by orthologs in both species, which implies common biological features, while some gene families were only found in one of the species, and therefore likely to be related to differences in their cell walls. To predict the subcellular location of the identified proteins, we developed a new method, PFANTOM ((p) under bar lant protein (fa) under bar mily i (n) under bar formation-based predic (to) under barr for endo (m) under bar embrane), which was shown to perform better for proteins in the endomembrane system than other available prediction methods. Based on the combined approach of co-expression and predicted cellular localization, we propose a model for Arabidopsis and rice xylan synthesis in the Golgi apparatus and signaling from plasma membrane to nucleus for secondary cell wall differentiation. As an experimental validation of the model, we show that an Arabidopsis mutant in the PGSIP1 gene encoding one of the Golgi localized candidate proteins has a highly decreased content of glucuronic acid in secondary cell walls and substantially reduced xylan glucuronosyltransferase activity.	[Oikawa, Ai; Joshi, Hiren J.; Rennie, Emilie A.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe] Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA USA; [Oikawa, Ai; Joshi, Hiren J.; Ebert, Berit; Manisseri, Chithra; Heazlewood, Joshua L.; Scheller, Henrik Vibe] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Rennie, Emilie A.; Scheller, Henrik Vibe] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Oikawa, A (corresponding author), Joint BioEnergy Inst, Feedstocks Div, Emeryville, CA USA.	HScheller@lbl.gov	Scheller, Henrik/AAH-4770-2020; Ebert, Berit/F-1856-2016; Manisseri, Chithra/ABD-2712-2021; Scheller, Henrik V/A-8106-2008; Ebert, Berit/C-1748-2019; Heazlewood, Joshua L/A-2554-2008; Joshi, Hiren/B-5739-2016	Scheller, Henrik/0000-0002-6702-3560; Ebert, Berit/0000-0002-6914-5473; Manisseri, Chithra/0000-0002-9402-4577; Scheller, Henrik V/0000-0002-6702-3560; Ebert, Berit/0000-0002-6914-5473; Heazlewood, Joshua L/0000-0002-2080-3826; Joshi, Hiren/0000-0002-8192-2829; Oikawa, Ai/0000-0003-4581-0974	US Department of Energy, Office of Science, Office of Biological and Environmental Research [DE-AC02-05CH11231]; Lawrence Berkeley National Laboratory; Japanese Yamada Science Foundation; National Institutes of Health (NIH)	US Department of Energy, Office of Science, Office of Biological and Environmental Research(United States Department of Energy (DOE)); Lawrence Berkeley National Laboratory(United States Department of Energy (DOE)); Japanese Yamada Science Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the US Department of Energy, Office of Science, Office of Biological and Environmental Research, through contract DE-AC02-05CH11231 with Lawrence Berkeley National Laboratory. A.O. was additionally supported by funds from Japanese Yamada Science Foundation, and E.A.R. was supported by a National Institutes of Health (NIH) Pre-doctoral Training Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman V, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-1; ANDERSSON SI, 1983, CARBOHYD RES, V111, P283, DOI 10.1016/0008-6215(83)88312-8; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Aspeborg H, 2005, PLANT PHYSIOL, V137, P983, DOI 10.1104/pp.104.055087; Balazsi G, 2005, P NATL ACAD SCI USA, V102, P7841, DOI 10.1073/pnas.0500365102; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bischoff V, 2010, PLANT PHYSIOL, V153, P590, DOI 10.1104/pp.110.153320; Boevink P, 1996, PLANT J, V10, P935, DOI 10.1046/j.1365-313X.1996.10050935.x; Brembu T, 2005, J EXP BOT, V56, P2465, DOI 10.1093/jxb/eri239; Brill S, 1996, MOL CELL BIOL, V16, P4869; Brown DM, 2007, PLANT J, V52, P1154, DOI 10.1111/j.1365-313X.2007.03307.x; Brown DM, 2009, PLANT J, V57, P732, DOI 10.1111/j.1365-313X.2008.03729.x; Brown DM, 2005, PLANT CELL, V17, P2281, DOI 10.1105/tpc.105.031542; Buanafina MMD, 2009, MOL PLANT, V2, P861, DOI 10.1093/mp/ssp067; Caffall KH, 2009, CARBOHYD RES, V344, P1879, DOI 10.1016/j.carres.2009.05.021; Chatterjee M, 2005, PLANT SCI, V168, P501, DOI 10.1016/j.plantsci.2004.09.015; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Da Silva CA, 2008, J IMMUNOL, V181, P4279, DOI 10.4049/jimmunol.181.6.4279; Dunkley TPJ, 2004, MOL CELL PROTEOMICS, V3, P1128, DOI 10.1074/mcp.T400009-MCP200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fincher GB, 2009, PLANT PHYSIOL, V149, P27, DOI 10.1104/pp.108.130096; Geisler-Lee J, 2006, PLANT PHYSIOL, V140, P946, DOI 10.1104/pp.105.072652; Geisler-Lee J, 2007, PLANT PHYSIOL, V145, P317, DOI 10.1104/pp.107.103465; Gu Y, 2005, J CELL BIOL, V169, P127, DOI 10.1083/jcb.200409140; Guda C, 2005, BIOINFORMATICS, V21, P3963, DOI 10.1093/bioinformatics/bti650; Harholt J, 2006, PLANT PHYSIOL, V140, P49, DOI 10.1104/pp.105.072744; Harholt J, 2010, PLANT PHYSIOL, V153, P384, DOI 10.1104/pp.110.156588; Heazlewood JL, 2007, NUCLEIC ACIDS RES, V35, pD213, DOI 10.1093/nar/gkl863; Hermans C, 2010, PLANT PHYSIOL, V152, P904, DOI 10.1104/pp.109.149849; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; JOHANSSON MH, 1977, WOOD SCI TECHNOL, V11, P251, DOI 10.1007/BF00356924; Jung KH, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000164; Kaundal R, 2010, PLANT PHYSIOL, V154, P36, DOI 10.1104/pp.110.156851; Kinoshita K, 2009, BIOINFORMATICS, V25, P2677, DOI 10.1093/bioinformatics/btp442; Ko JH, 2006, MOL GENET GENOMICS, V276, P517, DOI 10.1007/s00438-006-0157-1; Konishi T, 2007, GLYCOBIOLOGY, V17, P345, DOI 10.1093/glycob/cwl081; Kzhyshkowska J, 2006, BLOOD, V107, P3221, DOI 10.1182/blood-2005-07-2843; Lafarguette F, 2004, NEW PHYTOL, V164, P107, DOI 10.1111/j.1469-8137.2004.01175.x; Lee CH, 2007, PLANT CELL PHYSIOL, V48, P1624, DOI 10.1093/pcp/pcm135; Li XM, 2004, PLANT PHYSIOL, V134, P940, DOI 10.1104/pp.103.036285; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liepman AH, 2010, PLANT J, V61, P1107, DOI 10.1111/j.1365-313X.2010.04161.x; Lin BY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010210; Liu DQ, 2008, PLANT MOL BIOL REP, V26, P98, DOI 10.1007/s11105-008-0026-7; Mitchell RAC, 2007, PLANT PHYSIOL, V144, P43, DOI 10.1104/pp.106.094995; Mitsuda N, 2007, PLANT CELL, V19, P270, DOI 10.1105/tpc.106.047043; Mutwil M, 2008, NUCLEIC ACIDS RES, V36, pW320, DOI 10.1093/nar/gkn292; Mutwil M, 2009, MOL PLANT, V2, P1015, DOI 10.1093/mp/ssp055; Nelson BK, 2007, PLANT J, V51, P1126, DOI 10.1111/j.1365-313X.2007.03212.x; Nibau C, 2006, TRENDS PLANT SCI, V11, P309, DOI 10.1016/j.tplants.2006.04.003; Obayashi T, 2009, DNA RES, V16, P249, DOI 10.1093/dnares/dsp016; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pauly M, 2008, PLANT J, V54, P559, DOI 10.1111/j.1365-313X.2008.03463.x; Pena MJ, 2007, PLANT CELL, V19, P549, DOI 10.1105/tpc.106.049320; Persson S, 2005, P NATL ACAD SCI USA, V102, P8633, DOI 10.1073/pnas.0503392102; Piston F, 2010, PLANTA, V231, P677, DOI 10.1007/s00425-009-1077-1; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Rastogi S, 2010, METHODS MOL BIOL, V619, P285, DOI 10.1007/978-1-60327-412-8_17; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Ruse M, 2006, IMMUNOL RES, V34, P33, DOI 10.1385/IR:34:1:33; Scheller HV, 2010, ANNU REV PLANT BIOL, V61, P263, DOI 10.1146/annurev-arplant-042809-112315; Shibolet O, 2007, J BIOL CHEM, V282, P35308, DOI 10.1074/jbc.M704426200; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Tanaka K, 2003, PLANT PHYSIOL, V133, P73, DOI 10.1104/pp.103.022442; Toole GA, 2010, PLANTA, V232, P677, DOI 10.1007/s00425-010-1199-5; van Dijk ADJ, 2008, BIOINFORMATICS, V24, P1779, DOI 10.1093/bioinformatics/btn309; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wightman R, 2008, PLANT J, V54, P794, DOI 10.1111/j.1365-313X.2008.03444.x; Wrzeszczynski KO, 2004, CELL MOL LIFE SCI, V61, P1341, DOI 10.1007/s00018-004-4005-3; Wu AM, 2010, PLANT PHYSIOL, V153, P542, DOI 10.1104/pp.110.154971; Wu G, 2001, PLANT CELL, V13, P2841, DOI 10.1105/tpc.13.12.2841; Yang TB, 2004, J BIOL CHEM, V279, P42552, DOI 10.1074/jbc.M402830200; Yin YB, 2010, PLANT PHYSIOL, V153, P1729, DOI 10.1104/pp.110.154229; York WS, 2008, CURR OPIN PLANT BIOL, V11, P258, DOI 10.1016/j.pbi.2008.02.007; Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd; Zhong RQ, 2007, CURR OPIN PLANT BIOL, V10, P564, DOI 10.1016/j.pbi.2007.09.001	82	70	85	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15481	10.1371/journal.pone.0015481	http://dx.doi.org/10.1371/journal.pone.0015481			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124849	Green Submitted, gold, Green Published			2022-12-27	WOS:000284527900020
J	de Medina-Redondo, M; Arnaiz-Pita, Y; Clavaud, C; Fontaine, T; del Rey, F; Latge, JP; de Aldana, CRV				de Medina-Redondo, Maria; Arnaiz-Pita, Yolanda; Clavaud, Cecile; Fontaine, Thierry; del Rey, Francisco; Latge, Jean Paul; Vazquez de Aldana, Carlos R.			beta(1,3)-Glucanosyl-Transferase Activity Is Essential for Cell Wall Integrity and Viability of Schizosaccharomyces pombe	PLOS ONE			English	Article							1,3-BETA-GLUCAN SYNTHASE SUBUNIT; PH-REGULATED GENE; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; CANDIDA-ALBICANS; ASCOSPORE WALL; CROSS-LINKING; ASPERGILLUS-FUMIGATUS; HETEROLOGOUS MODULES; POLARIZED GROWTH	Background: The formation of the cell wall in Schizosaccharomyces pombe requires the coordinated activity of enzymes involved in the biosynthesis and modification of beta-glucans. The beta(1,3)-glucan synthase complex synthesizes linear beta(1,3)glucans, which remain unorganized until they are cross-linked to other beta(1,3)-glucans and other cell wall components. Transferases of the GH72 family play important roles in cell wall assembly and its rearrangement in Saccharomyces cerevisiae and Aspergillus fumigatus. Four genes encoding beta(1,3)-glucanosyl-transferases -gas1(+), gas2(+), gas4(+) and gas5(+)-are present in S. pombe, although their function has not been analyzed. Methodology/Principal Findings: Here, we report the characterization of the catalytic activity of gas1p, gas2p and gas5p together with studies directed to understand their function during vegetative growth. From the functional point of view, gas1p is essential for cell integrity and viability during vegetative growth, since gas1 Delta mutants can only grow in osmotically supported media, while gas2p and gas5p play a minor role in cell wall construction. From the biochemical point of view, all of them display beta(1,3)-glucanosyl-transferase activity, although they differ in their specificity for substrate length, cleavage point and product size. In light of all the above, together with the differences in expression profiles during the life cycle, the S. pombe GH72 proteins may accomplish complementary, non-overlapping functions in fission yeast. Conclusions/Significance: We conclude that beta(1,3)-glucanosyl-transferase activity is essential for viability in fission yeast, being required to maintain cell integrity during vegetative growth.	[de Medina-Redondo, Maria; Arnaiz-Pita, Yolanda; del Rey, Francisco; Vazquez de Aldana, Carlos R.] Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Microbiol & Genet, E-37008 Salamanca, Spain; [Clavaud, Cecile; Fontaine, Thierry; Latge, Jean Paul] Inst Pasteur, Unite Aspergillus, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Funcional y Genomica (IBFG); University of Salamanca; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	de Medina-Redondo, M (corresponding author), Univ Salamanca, CSIC, Inst Microbiol Bioquim, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	cvazquez@usal.es	Latge, Jean Paul/C-9846-2014; Fontaine, Thierry/F-8227-2011; Fontaine, thierry/Q-2201-2018; del Rey, Francisco/L-7132-2014; de Aldana, Carlos Vazquez/B-7772-2008	Fontaine, thierry/0000-0002-8184-789X; del Rey, Francisco/0000-0002-6517-7400; de Aldana, Carlos Vazquez/0000-0002-4513-3654	Comision Interministerial de Ciencia y Tecnologia [BFU2004-00778]; Junta de Castilla y Leon [GR231]; European Community [LSHB-CT-2004-511952]; Ministerio de Educacion y Ciencia	Comision Interministerial de Ciencia y Tecnologia(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)); Junta de Castilla y Leon(Junta de Castilla y Leon); European Community(European Commission); Ministerio de Educacion y Ciencia(Spanish Government)	This research was supported by grants from the Comision Interministerial de Ciencia y Tecnologia (BFU2004-00778) and Junta de Castilla y Leon (GR231) to C. R. V-A and from the European Community (LSHB-CT-2004-511952) to C.R.V-A. and J.P.L. M. M-R. held a fellowship from the Ministerio de Educacion y Ciencia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Barral P, 2005, BIOCHEM J, V390, P77, DOI 10.1042/BJ20050456; BUSH DA, 1974, J GEN MICROBIOL, V81, P199, DOI 10.1099/00221287-81-1-199; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Cabib E, 2007, MOL MICROBIOL, V63, P921, DOI 10.1111/j.1365-2958.2006.05565.x; Carotti C, 2004, EUR J BIOCHEM, V271, P3635, DOI 10.1111/j.1432-1033.2004.04297.x; Carotti C, 2002, YEAST, V19, P1113, DOI 10.1002/yea.905; Cortes JCG, 2005, J CELL SCI, V118, P157, DOI 10.1242/jcs.01585; Cortes JCG, 2002, J CELL SCI, V115, P4081, DOI 10.1242/jcs.00085; de Medina-Redondo M, 2008, MOL MICROBIOL, V68, P1283, DOI 10.1111/j.1365-2958.2008.06233.x; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Hartland RP, 1996, J BIOL CHEM, V271, P26843, DOI 10.1074/jbc.271.43.26843; HORISBERGER M, 1985, EXPERIENTIA, V41, P748, DOI 10.1007/BF02012578; Ishiguro J, 1997, J BACTERIOL, V179, P7653, DOI 10.1128/jb.179.24.7653-7662.1997; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; Katayama S, 1999, J CELL BIOL, V144, P1173, DOI 10.1083/jcb.144.6.1173; KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215; Latge JP, 2007, MOL MICROBIOL, V66, P279, DOI 10.1111/j.1365-2958.2007.05872.x; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Liu JH, 2000, FEBS LETT, V478, P105, DOI 10.1016/S0014-5793(00)01828-7; Liu JH, 1999, GENETICS, V153, P1193; Liu JH, 2002, MOL BIOL CELL, V13, P989, DOI 10.1091/mbc.01-12-0581; MANNERS DJ, 1977, CARBOHYD RES, V57, P189, DOI 10.1016/S0008-6215(00)81930-8; Martin V, 2000, MOL MICROBIOL, V38, P308, DOI 10.1046/j.1365-2958.2000.02118.x; Martin V, 2003, EUKARYOT CELL, V2, P159, DOI 10.1128/EC.2.1.159-169.2003; Moreno MB, 2000, YEAST, V16, P861; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; NURSE P, 1994, MOL BIOL CELL, V5, P613, DOI 10.1091/mbc.5.6.613; Osumi M, 1998, MICRON, V29, P207; Papaleo E, 2006, J MOL MODEL, V12, P237, DOI 10.1007/s00894-005-0025-7; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; Rolli E, 2009, MOL BIOL CELL, V20, P4856, DOI 10.1091/mbc.E08-11-1155; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; VAI M, 1990, BIOCHIM BIOPHYS ACTA, V1038, P277, DOI 10.1016/0167-4838(90)90237-A; Valdivieso MH, 2000, J BACTERIOL, V182, P4752, DOI 10.1128/JB.182.17.4752-4757.2000; Wach A, 1996, YEAST, V12, P259, DOI 10.1002/(SICI)1097-0061(19960315)12:3<259::AID-YEA901>3.0.CO;2-C; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Zverlov VV, 1997, MICROBIOL-SGM, V143, P1701, DOI 10.1099/00221287-143-5-1701	49	25	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14046	10.1371/journal.pone.0014046	http://dx.doi.org/10.1371/journal.pone.0014046			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124977	Green Published, gold, Green Submitted			2022-12-27	WOS:000284356900009
J	Ferandon, C; Moukha, S; Callac, P; Benedetto, JP; Castroviejo, M; Barroso, G				Ferandon, Cyril; Moukha, Serge; Callac, Philippe; Benedetto, Jean-Pierre; Castroviejo, Michel; Barroso, Gerard			The Agaricus bisporus cox1 Gene: The Longest Mitochondrial Gene and the Largest Reservoir of Mitochondrial Group I Introns	PLOS ONE			English	Article							BASIDIOMYCOTA AGROCYBE-AEGERITA; HORIZONTAL TRANSFER; RIBOSOMAL-RNA; COX1 GENE; SEQUENCE; ENDONUCLEASE; EVOLUTION; ORGANIZATION; HISTORY; GENOME	In eukaryotes, introns are located in nuclear and organelle genes from several kingdoms. Large introns (up to 5 kbp) are frequent in mitochondrial genomes of plant and fungi but scarce in Metazoa, even if these organisms are grouped with fungi among the Opisthokonts. Mitochondrial introns are classified in two groups (I and II) according to their RNA secondary structure involved in the intron self-splicing mechanism. Most of these mitochondrial group I introns carry a 'Homing Endonuclease Gene'' (heg) encoding a DNA endonuclease acting in transfer and site-specific integration ("homing'') and allowing intron spreading and gain after lateral transfer even between species from different kingdoms. Opposed to this gain mechanism, is another which implies that introns, which would have been abundant in the ancestral genes, would mainly evolve by loss. The importance of both mechanisms (loss and gain) is matter of debate. Here we report the sequence of the cox1 gene of the button mushroom Agaricus bisporus, the most widely cultivated mushroom in the world. This gene is both the longest mitochondrial gene (29,902 nt) and the largest group I intron reservoir reported to date with 18 group I and 1 group II. An exhaustive analysis of the group I introns available in cox1 genes shows that they are mobile genetic elements whose numerous events of loss and gain by lateral transfer combine to explain their wide and patchy distribution extending over several kingdoms. An overview of intron distribution, together with the high frequency of eroded heg, suggests that they are evolving towards loss. In this landscape of eroded and lost intron sequences, the A. bisporus cox1 gene exhibits a peculiar dynamics of intron keeping and catching, leading to the largest collection of mitochondrial group I introns reported to date in a Eukaryote.	[Ferandon, Cyril; Benedetto, Jean-Pierre; Castroviejo, Michel; Barroso, Gerard] Univ Victor Segalen Bordeaux 2, CNRS, UMR 5234, Bordeaux, France; [Moukha, Serge] Univ Victor Segalen Bordeaux 2, UFR Sci Pharmaceut, Lab Toxicol & Hyg Appl, Bordeaux, France; [Moukha, Serge; Callac, Philippe] INRA, UR Mycol & Securite Aliments 1264, Villenave Dornon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; INRAE	Ferandon, C (corresponding author), Univ Victor Segalen Bordeaux 2, CNRS, UMR 5234, Bordeaux, France.	gerard.barroso@u-bordeaux2.fr	Barroso, Gérard/AAB-5828-2021	Callac, Philippe/0000-0001-6860-0983				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; CUMMINGS DJ, 1989, CURR GENET, V16, P381, DOI 10.1007/BF00340719; Cusimano N, 2008, MOL BIOL EVOL, V25, P265, DOI 10.1093/molbev/msm241; DAMBERGER SH, 1994, NUCLEIC ACIDS RES, V22, P3508, DOI 10.1093/nar/22.17.3508; Fukami H, 2007, J MOL EVOL, V64, P591, DOI 10.1007/s00239-006-0279-4; FUKUMASANAKAI Y, 1992, REPT TOTTORI MYCOL I, V30, P60; Goddard MR, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000003; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Gonzalez P, 1999, NUCLEIC ACIDS RES, V27, P1754, DOI 10.1093/nar/27.7.1754; Gonzalez P, 1998, GENE, V220, P45, DOI 10.1016/S0378-1119(98)00421-1; Haridas S, 2010, FEMS MICROBIOL LETT, V308, P29, DOI 10.1111/j.1574-6968.2010.01979.x; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; LAMBOWITZ AM, 1990, TRENDS BIOCHEM SCI, V15, P440, DOI 10.1016/0968-0004(90)90283-H; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; Lang BF, 2002, CURR BIOL, V12, P1773, DOI 10.1016/S0960-9822(02)01187-9; LAZOWSKA J, 1980, CELL, V22, P333, DOI 10.1016/0092-8674(80)90344-X; LOIZOS N, 1994, P NATL ACAD SCI USA, V91, P11983, DOI 10.1073/pnas.91.25.11983; MANIATIS T, 1982, MOL CLONING LAB MANU; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; Nesbo CL, 2003, P NATL ACAD SCI USA, V100, P10806, DOI 10.1073/pnas.1434268100; ODA K, 1992, J MOL BIOL, V223, P1, DOI 10.1016/0022-2836(92)90708-R; Pellenz S, 2002, J MOL EVOL, V55, P302, DOI 10.1007/s00239-001-2327-4; RAPER JR, 1974, HDB GENETICS, V1, P597; Rot C, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-71; Saguez C, 2000, NUCLEIC ACIDS RES, V28, P1299, DOI 10.1093/nar/28.6.1299; SALDANHA R, 1993, FASEB J, V7, P15, DOI 10.1096/fasebj.7.1.8422962; Sanchez-Puerta MV, 2008, MOL BIOL EVOL, V25, P1762, DOI 10.1093/molbev/msn129; Sandegren L, 2004, J BIOL CHEM, V279, P22218, DOI 10.1074/jbc.M400929200; Santamaria M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S15; Seligman LM, 1997, GENETICS, V147, P1653; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VAUGHN JC, 1995, J MOL EVOL, V41, P563, DOI 10.1007/BF00175814; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; WESSELS JGH, 1987, J GEN MICROBIOL, V133, P2557	38	65	65	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14048	10.1371/journal.pone.0014048	http://dx.doi.org/10.1371/journal.pone.0014048			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124976	gold, Green Submitted, Green Published			2022-12-27	WOS:000284356900011
J	Sjolinder, H; Jonsson, AB				Sjolinder, Hong; Jonsson, Ann-Beth			Olfactory Nerve-A Novel Invasion Route of Neisseria meningitidis to Reach the Meninges	PLOS ONE			English	Article							CEREBROSPINAL-FLUID TRANSPORT; COFACTOR PROTEIN MCP; BLOOD-BRAIN-BARRIER; MENINGOCOCCAL DISEASE; ENDOTHELIAL-CELLS; INFLUENZA-VIRUS; INFECTION; CD46; MICE; INTRANASAL	Neisseria meningitidis is a human-specific pathogen with capacity to cause septic shock and meningitis. It has been hypothesized that invasion of the central nervous system (CNS) is a complication of a bacteremic condition. In this study, we aimed to characterize the invasion route of N. meningitidis to the CNS. Using an intranasally challenged mouse disease model, we found that twenty percent of the mice developed lethal meningitis even though no bacteria could be detected in blood. Upon bacterial infection, epithelial lesions and redistribution of intracellular junction protein N-cadherin were observed at the nasal epithelial mucosa, especially at the olfactory epithelium, which is functionally and anatomically connected to the CNS. Bacteria were detected in the submucosa of the olfactory epithelium, along olfactory nerves in the cribriform plate, at the olfactory bulb and subsequently at the meninges and subarachnoid space. Furthermore, our data suggest that a threshold level of bacteremia is required for the development of meningococcal sepsis. Taken together, N. meningitidis is able to pass directly from nasopharynx to meninges through the olfactory nerve system. This study enhances our understanding how N. meningitidis invades the meninges. The nasal olfactory nerve system may be a novel target for disease prevention that can improve outcome and survival.	[Sjolinder, Hong; Jonsson, Ann-Beth] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	Stockholm University	Sjolinder, H (corresponding author), Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden.	Hong.Sjolinder@gmt.su.se			Swedish Research Council [2006-2911, 2006-6304, 2006-4112, 2006-5073, 2007-3369, 2008-2572, 2008-3367, 2009-5679]; Swedish Cancer Society; Knut och Alice Wallenbergs Foundation; Torsten and Ragnar Soderbergs Foundation; Swedish Society for Medicine; Magnus Bergvalls Foundation; Olga Jeanssons Foundation; Lars Hiertas Minne Foundation; Harald och Greta Jeanssons Foundation; Petrus och Augusta Hedlunds Foundation; Anna Brita och Bo Castegrens Minne Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Knut och Alice Wallenbergs Foundation(Knut & Alice Wallenberg Foundation); Torsten and Ragnar Soderbergs Foundation; Swedish Society for Medicine; Magnus Bergvalls Foundation; Olga Jeanssons Foundation; Lars Hiertas Minne Foundation; Harald och Greta Jeanssons Foundation; Petrus och Augusta Hedlunds Foundation; Anna Brita och Bo Castegrens Minne Foundation; Tore Nilsons Foundation; Ake Wiberg Foundation	This work was supported by the Swedish Research Council (Grant nr 2006-2911, 2006-6304, 2006-4112, 2006-5073, 2007-3369, 2008-2572, 2008-3367 and 2009-5679), The Swedish Cancer Society, Knut och Alice Wallenbergs Foundation, Torsten and Ragnar Soderbergs Foundation, Swedish Society for Medicine, Magnus Bergvalls Foundation, Olga Jeanssons Foundation, Lars Hiertas Minne Foundation, Harald och Greta Jeanssons Foundation, Petrus och Augusta Hedlunds Foundation, Anna Brita och Bo Castegrens Minne Foundation, Tore Nilsons Foundation, Ake Wiberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DR, 1972, AM J ANAT, V133, P37, DOI 10.1002/aja.1001330104; BRODEUR BR, 1985, INFECT IMMUN, V50, P510, DOI 10.1128/IAI.50.2.510-516.1985; Coureuil M, 2009, SCIENCE, V325, P83, DOI 10.1126/science.1173196; Filippidis A, 2009, MED HYPOTHESES, V72, P694, DOI 10.1016/j.mehy.2008.10.031; Iwasaki T, 2004, ACTA NEUROPATHOL, V108, P485, DOI 10.1007/s00401-004-0909-0; Jarolim KL, 2000, J PARASITOL, V86, P50, DOI 10.1645/0022-3395(2000)086[0050:ALMSOT]2.0.CO;2; Johansson L, 2005, J IMMUNOL, V175, P433, DOI 10.4049/jimmunol.175.1.433; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Johnson JB, 2009, J VIROL, V83, P7602, DOI 10.1128/JVI.00713-09; Johnston M, 2002, NEWS PHYSIOL SCI, V17, P227, DOI 10.1152/nips.01400.2002; Johnston Miles, 2004, Cerebrospinal Fluid Res, V1, P2, DOI 10.1186/1743-8454-1-2; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; Liszewski MK, 2000, J BIOL CHEM, V275, P37692, DOI 10.1074/jbc.M004650200; Lovkvist L, 2008, INFECT IMMUN, V76, P3951, DOI 10.1128/IAI.00109-08; MACKINNON FG, 1992, MICROB PATHOGENESIS, V12, P415, DOI 10.1016/0882-4010(92)90004-8; Marra A, 2001, INFECT IMMUN, V69, P7318, DOI 10.1128/IAI.69.12.7318-7325.2001; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Mori I, 2005, J NEUROVIROL, V11, P129, DOI 10.1080/13550280590922793; Mrkic B, 1998, J VIROL, V72, P7420, DOI 10.1128/JVI.72.9.7420-7427.1998; Muenzner P, 2000, INFECT IMMUN, V68, P3601, DOI 10.1128/IAI.68.6.3601-3607.2000; Nagra G, 2006, AM J PHYSIOL-REG I, V291, pR1383, DOI 10.1152/ajpregu.00235.2006; Nassif X, 2002, TRENDS MICROBIOL, V10, P227, DOI 10.1016/S0966-842X(02)02349-1; Nikulin J, 2006, INT J MED MICROBIOL, V296, P553, DOI 10.1016/j.ijmm.2006.06.006; Nishioku T, 2009, CELL MOL NEUROBIOL, V29, P309, DOI 10.1007/s10571-008-9322-x; Park CH, 2002, ARCH VIROL, V147, P1425, DOI 10.1007/s00705-001-0750-x; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Schubert-Unkmeir A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000874; Sjolinder H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000241; Stephens DS, 2007, LANCET, V369, P2196, DOI 10.1016/S0140-6736(07)61016-2; Tubbs RS, 2007, J NEUROSURG-SPINE, V7, P328, DOI 10.3171/SPI-07/09/328; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; van Ginkel FW, 2003, P NATL ACAD SCI USA, V100, P14363, DOI 10.1073/pnas.2235844100; Yi K, 2003, INFECT IMMUN, V71, P1849, DOI 10.1128/IAI.71.4.1849-1855.2003; Zakharov Andrei, 2004, Lymphat Res Biol, V2, P139, DOI 10.1089/1539685042564372	36	48	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14034	10.1371/journal.pone.0014034	http://dx.doi.org/10.1371/journal.pone.0014034			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124975	gold, Green Published, Green Submitted			2022-12-27	WOS:000284356900003
J	Ye, BP; Rui, Q; Wu, QL; Wang, DY				Ye, Boping; Rui, Qi; Wu, Qiuli; Wang, Dayong			Metallothioneins Are Required for Formation of Cross-Adaptation Response to Neurobehavioral Toxicity from Lead and Mercury Exposure in Nematodes	PLOS ONE			English	Article							LONG-LIVED MUTANTS; CAENORHABDITIS-ELEGANS; BEHAVIORAL DEFECTS; END-POINTS; C-ELEGANS; LIFE-SPAN; TRANSFERABLE PROPERTIES; ADAPTIVE RESPONSE; HYDROGEN-PEROXIDE; HUMAN-LYMPHOCYTES	Metallothioneins (MTs) are small, cysteine-rich polypeptides, but the role of MTs in inducing the formation of adaptive response is still largely unknown. We investigated the roles of metallothionein genes (mtl-1 and mtl-2) in the formation of cross-adaptation response to neurobehavioral toxicity from metal exposure in Caenorhabditis elegans. Pre-treatment with mild heat-shock at L2-larva stage effectively prevented the formation of the neurobehavioral defects and the activation of severe stress response in metal exposed nematodes at concentrations of 50 and 100 mM, but pre-treatment with mild heat-shock did not prevent the formation of neurobehavioral defects in 200 mM of metal exposed nematodes. During the formation of cross-adaptation response, the induction of mtl-1 and mtl-2 promoter activity and subsequent GFP gene expression were sharply increased in 50 mu M or 100 mM of metal exposed Pmtl-1::GFP and Pmtl-2::GFP transgenic adult animals after mild heat-shock treatment compared with those treated with mild heat-shock or metal exposure alone. Moreover, after pre-treatment with mild heat-shock, no noticeable increase of locomotion behaviors could be observed in metal exposed mtl-1 or mtl-2 mutant nematodes compared to those without mild heat-shock pre-treatment. The defects of adaptive response to neurobehavioral toxicity induced by metal exposure formed in mtl-1 and mtl-2 mutants could be completely rescued by the expression of mtl-1 and mtl-2 with the aid of their native promoters. Furthermore, overexpression of MTL-1 and MTL-2 at the L2-larval stage significantly suppressed the toxicity on locomotion behaviors from metal exposure at all examined concentrations. Therefore, the normal formation of cross-adaptation response to neurobehavioral toxicity induced by metal exposure may need the enough accumulation of MTs protein in animal tissues.	[Ye, Boping; Rui, Qi; Wu, Qiuli; Wang, Dayong] Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China; [Ye, Boping] China Pharmaceut Univ, Coll Life Sci & Technol, Nanjing 210009, Peoples R China; [Rui, Qi] Nanjing Agr Univ, Coll Life Sci, Nanjing, Peoples R China	Southeast University - China; China Pharmaceutical University; Nanjing Agricultural University	Ye, BP (corresponding author), Southeast Univ, Inst Life Sci, Minist Educ, Key Lab Dev Genes & Human Dis, Nanjing, Peoples R China.	dayongw@seu.edu.cn			National Natural Science Foundation of China [30870810]; Program for New Century Excellent Talents in University of China; NIH National Center for Research Resource, USA	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); NIH National Center for Research Resource, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the grants from the National Natural Science Foundation of China (No. 30870810) and the Program for New Century Excellent Talents in University of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some strains used in this study were provided by the Caenorhabdits Genetics Center (funded by the NIH National Center for Research Resource, USA) and the Mitani laboratory (Tokyo Women's Medical University School of Medicine, Japan). We thank Dan Chase for the pCL40 (Pdop-1::rfp) vector, and King L. Chow for the KC136 strain.	Anderson GL, 2004, ENVIRON TOXICOL CHEM, V23, P1235, DOI 10.1897/03-264; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Barsyte D, 2001, FASEB J, V15, P627, DOI 10.1096/fj.99-0966com; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; BRENNER S, 1974, GENETICS, V77, P71; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Chu KW, 2002, AQUAT TOXICOL, V61, P53, DOI 10.1016/S0166-445X(02)00017-6; Cypser J, 2001, HUM EXP TOXICOL, V20, P295, DOI 10.1191/096032701701548070; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; DARR D, 1995, FREE RADICAL BIO MED, V18, P195, DOI 10.1016/0891-5849(94)00118-4; Dhawan R, 1999, J TOXICOL ENV HEAL A, V58, P451, DOI 10.1080/009841099157179; DOMINGUEZ I, 1993, MUTAT RES, V301, P135, DOI 10.1016/0165-7992(93)90036-U; DONKIN SG, 1995, ENVIRON TOXICOL CHEM, V14, P2139, DOI 10.1002/etc.5620141218; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; Hughes S, 2007, ENVIRON POLLUT, V145, P395, DOI 10.1016/j.envpol.2006.06.003; Hughes SL, 2009, J PROTEOME RES, V8, P3512, DOI 10.1021/pr9001806; IMAGAWA M, 1990, BIOCHEM J, V268, P237, DOI 10.1042/bj2680237; Knapen D, 2005, COMP BIOCHEM PHYS C, V140, P347, DOI 10.1016/j.cca.2005.03.002; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Ma HB, 2009, ENVIRON TOXICOL CHEM, V28, P1311, DOI 10.1897/08-496.1; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Moilanen LH, 1999, J BIOL CHEM, V274, P29655, DOI 10.1074/jbc.274.42.29655; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Peredney CL, 2000, ARCH ENVIRON CON TOX, V39, P113; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Priess J. R., 1997, C ELEGANS 2; SAMSON L, 1980, NATURE, V287, P861, DOI 10.1038/287861a0; SAMSON L, 1977, NATURE, V267, P281, DOI 10.1038/267281a0; SLICE LW, 1990, J BIOL CHEM, V265, P256; STEPHAN W, 1994, GENETICS, V138, P135, DOI 10.1093/genetics/138.1.135; Swain SC, 2004, J MOL BIOL, V341, P951, DOI 10.1016/j.jmb.2004.06.050; Ura K, 2002, J HEALTH SCI, V48, P583, DOI 10.1248/jhs.48.583; Wang DY, 2008, ARCH ENVIRON CON TOX, V54, P447, DOI 10.1007/s00244-007-9050-0; Wang DY, 2007, J ENVIRON SCI, V19, P1367, DOI 10.1016/S1001-0742(07)60223-X; Wang DY, 2008, J ENVIRON SCI-CHINA, V20, P1132, DOI 10.1016/S1001-0742(08)62160-9; Wang DY, 2008, ENVIRON POLLUT, V151, P585, DOI 10.1016/j.envpol.2007.04.003; Wang D, 2007, ENVIRON TOXICOL PHAR, V24, P223, DOI 10.1016/j.etap.2007.05.009; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang DY, 2010, ECOTOX ENVIRON SAFE, V73, P423, DOI 10.1016/j.ecoenv.2009.12.014; Wang DY, 2009, ENVIRON TOXICOL PHAR, V28, P459, DOI 10.1016/j.etap.2009.07.008; Wang Y, 2007, ENVIRON TOXICOL CHEM, V26, P2405, DOI 10.1897/06-646R1.1; WILLIAMS PL, 1990, ENVIRON TOXICOL CHEM, V9, P1285, DOI [10.1897/1552-8618(1990)9[1285:ATTUTN]2.0.CO;2, 10.1002/etc.5620091007]; Xing XJ, 2009, ECOTOX ENVIRON SAFE, V72, P1819, DOI 10.1016/j.ecoenv.2009.06.006; Yanase S, 1999, MUTAT RES-FUND MOL M, V426, P31, DOI 10.1016/S0027-5107(99)00079-2; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3; Yoshida M, 2006, TOXICOL LETT, V161, P210, DOI 10.1016/j.toxlet.2005.09.007; Yoshida M, 2005, TOXICOL LETT, V155, P361, DOI 10.1016/j.toxlet.2004.11.001	49	23	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14052	10.1371/journal.pone.0014052	http://dx.doi.org/10.1371/journal.pone.0014052			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124968	gold, Green Published, Green Submitted			2022-12-27	WOS:000284356900014
J	Domagalska, MA; Sarnowska, E; Nagy, F; Davis, SJ				Domagalska, Malgorzata A.; Sarnowska, Elzbieta; Nagy, Ferenc; Davis, Seth J.			Genetic Analyses of Interactions among Gibberellin, Abscisic Acid, and Brassinosteroids in the Control of Flowering Time in Arabidopsis thaliana	PLOS ONE			English	Article							CROSS-TALK; EXPRESSION; MUTANTS; TRANSITION; OVEREXPRESSION; BIOSYNTHESIS; PATHWAY; GROWTH; LOCUS	Background: Genetic interactions between phytohormones in the control of flowering time in Arabidopsis thaliana have not been extensively studied. Three phytohormones have been individually connected to the floral-timing program. The inductive function of gibberellins (GAs) is the most documented. Abscisic acid (ABA) has been demonstrated to delay flowering. Finally, the promotive role of brassinosteroids (BRs) has been established. It has been reported that for many physiological processes, hormone pathways interact to ensure an appropriate biological response. Methodology: We tested possible genetic interactions between GA-, ABA-, and BR-dependent pathways in the control of the transition to flowering. For this, single and double mutants deficient in the biosynthesis of GAs, ABA, and BRs were used to assess the effect of hormone deficiency on the timing of floral transition. Also, plants that over-express genes encoding rate-limiting enzymes in each biosynthetic pathway were generated and the flowering time of these lines was investigated. Conclusions: Loss-of-function studies revealed a complex relationship between GAs and ABA, and between ABA and BRs, and suggested a cross-regulatory relation between GAs to BRs. Gain-of-function studies revealed that GAs were clearly limiting in their sufficiency of action, whereas increases in BRs and ABA led to a more modest phenotypic effect on floral timing. We conclude from our genetic tests that the effects of GA, ABA, and BR on timing of floral induction are only in partially coordinated action.	[Domagalska, Malgorzata A.; Sarnowska, Elzbieta; Davis, Seth J.] Max Planck Inst Plant Breeding Res, Cologne, Germany; [Nagy, Ferenc] Hungarian Acad Sci, Biol Res Ctr, Inst Plant Biol, H-6701 Szeged, Hungary; [Nagy, Ferenc] Univ Edinburgh, Sch Biol Sci, Inst Mol Plant Sci, Edinburgh, Midlothian, Scotland	Max Planck Society; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; University of Edinburgh	Domagalska, MA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	davis@mpipz.mpg.de	Nagy, Ferenc/D-3532-2015	Nagy, Ferenc/0000-0002-6157-9269; Sarnowska, Elzbieta/0000-0001-7723-1198	Deutsche Forschungsgemeinschaft [DA1061/2-1]; Max Planck Society; German Israeli Project Cooperation (DIP) [H 3.1]; IMPRS; OTKA [81399]; HHMI	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Max Planck Society(Max Planck Society); German Israeli Project Cooperation (DIP); IMPRS; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); HHMI(Howard Hughes Medical Institute)	This work was supported in the SJD group by a grant from the Deutsche Forschungsgemeinschaft (DA1061/2-1), the German Israeli Project Cooperation (DIP project H 3.1), and from the Max Planck Society. MAD was supported by a fellowship within the IMPRS program. Funding in the FN group was supported by the grant OTKA 81399 and by a HHMI International Scholar Fellowship. The funders of this work had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Achard P, 2006, SCIENCE, V311, P91, DOI 10.1126/science.1118642; Azpiroz R, 1998, PLANT CELL, V10, P219, DOI 10.1105/tpc.10.2.219; Bernier G, 2005, PLANT BIOTECHNOL J, V3, P3, DOI 10.1111/j.1467-7652.2004.00114.x; Bouquin T, 2001, PLANT PHYSIOL, V127, P450, DOI 10.1104/pp.010173; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; Choe S, 2001, PLANT J, V26, P573, DOI 10.1046/j.1365-313x.2001.01055.x; CHORY J, 1991, PLANT CELL, V3, P445, DOI 10.1105/tpc.3.5.445; Coles JP, 1999, PLANT J, V17, P547, DOI 10.1046/j.1365-313X.1999.00410.x; Davis AM, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-3; Davis SJ, 2009, PLANT CELL ENVIRON, V32, P1201, DOI 10.1111/j.1365-3040.2009.01968.x; Domagalska MA, 2007, DEVELOPMENT, V134, P2841, DOI 10.1242/dev.02866; Finkelstein RR, 2002, CURR OPIN PLANT BIOL, V5, P26, DOI 10.1016/S1369-5266(01)00225-4; Gazzarrini S, 2003, ANN BOT-LONDON, V91, P605, DOI 10.1093/aob/mcg064; Gray WM, 2004, PLOS BIOL, V2, P1270, DOI 10.1371/journal.pbio.0020311; Hanano S, 2006, GENES CELLS, V11, P1381, DOI 10.1111/j.1365-2443.2006.01026.x; Huang SS, 1998, PLANT PHYSIOL, V118, P773, DOI 10.1104/pp.118.3.773; Iuchi S, 2001, PLANT J, V27, P325, DOI 10.1046/j.1365-313x.2001.01096.x; JACOBSEN SE, 1993, PLANT CELL, V5, P887, DOI 10.1105/tpc.5.8.887; Jager CE, 2005, PLANTA, V221, P141, DOI 10.1007/s00425-004-1454-8; JANG YH, 2008, PLANT CELL PHYSL, V14, P14; Kania T, 1997, PLANT CELL, V9, P1327, DOI 10.1105/tpc.9.8.1327; KONCZ C, 1986, MOL GEN GENET, V204, P383, DOI 10.1007/BF00331014; KOORNNEEF M, 1991, MOL GEN GENET, V229, P57, DOI 10.1007/BF00264213; Koornneef M, 1998, GENETICS, V148, P885; Kuppusamy K, 2009, PLANT MOL BIOL, V69, P375, DOI 10.1007/s11103-008-9389-2; LANGRIDGE J, 1957, NATURE, V180, P36, DOI 10.1038/180036a0; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Levy YY, 1998, PLANT CELL, V10, P1973, DOI 10.1105/tpc.10.12.1973; Liu YX, 2007, PLANT CELL, V19, P433, DOI 10.1105/tpc.106.049221; Martinez-Zapater JM, 1994, ARABIDOPSIS, P403; Noguchi T, 1999, PLANT PHYSIOL, V121, P743, DOI 10.1104/pp.121.3.743; Putterill J, 2004, BIOESSAYS, V26, P363, DOI 10.1002/bies.20021; Razem FA, 2006, NATURE, V439, P290, DOI 10.1038/nature04373; Razem FA, 2006, CURR OPIN PLANT BIOL, V9, P454, DOI 10.1016/j.pbi.2006.07.007; Razem FA, 2008, NATURE, V456, P824, DOI 10.1038/nature07645; Reid JB, 2004, PLANT HORMONES: BIOSYNTHESIS, SIGNAL TRANSDUCTION, ACTION, P179; Risk JM, 2008, NATURE, V456, DOI 10.1038/nature07646; Srivastava L.M, 2002, PLANT GROWTH DEV HOR, DOI 10.1016/B978-012660570-9/50152-0; Steber CM, 2001, PLANT PHYSIOL, V125, P763, DOI 10.1104/pp.125.2.763; SUN TP, 1992, PLANT CELL, V4, P119, DOI 10.1105/tpc.4.2.119; Szekeres M, 1996, CELL, V85, P171, DOI 10.1016/S0092-8674(00)81094-6; Turk EM, 2005, PLANT J, V42, P23, DOI 10.1111/j.1365-313X.2005.02358.x; Wang L, 2009, PLANT J, V57, P498, DOI 10.1111/j.1365-313X.2008.03707.x; Weigel D, 2000, PLANT PHYSIOL, V122, P1003, DOI 10.1104/pp.122.4.1003; WILSON RN, 1995, PLANT PHYSIOL, V108, P495, DOI 10.1104/pp.108.2.495; WILSON RN, 1992, PLANT PHYSIOL, V100, P403, DOI 10.1104/pp.100.1.403; Yu XF, 2008, P NATL ACAD SCI USA, V105, P7618, DOI 10.1073/pnas.0802254105; Zentella R, 2007, PLANT CELL, V19, P3037, DOI 10.1105/tpc.107.054999	49	85	96	9	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14012	10.1371/journal.pone.0014012	http://dx.doi.org/10.1371/journal.pone.0014012			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103336	gold, Green Published, Green Submitted			2022-12-27	WOS:000284327800004
J	Parsons, JB; Lawrence, AD; McLean, KJ; Munro, AW; Rigby, SEJ; Warren, MJ				Parsons, Joshua B.; Lawrence, Andrew D.; McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.; Warren, Martin J.			Characterisation of PduS, the pdu Metabolosome Corrin Reductase, and Evidence of Substructural Organisation within the Bacterial Microcompartment	PLOS ONE			English	Article							SEROVAR TYPHIMURIUM LT2; SALMONELLA-ENTERICA; ADENOSYLCOBALAMIN BIOSYNTHESIS; ENZYMATIC CONVERSION; COBALAMIN; ORGANELLES; ENZYMES; 1,2-PROPANEDIOL; VITAMIN-B-12; DEGRADATION	PduS is a corrin reductase and is required for the reactivation of the cobalamin-dependent diol dehydratase. It is one component encoded within the large propanediol utilisation (pdu) operon, which is responsible for the catabolism of 1,2-propanediol within a self-assembled proteinaceous bacterial microcompartment. The enzyme is responsible for the reactivation of the cobalamin coenzyme required by the diol dehydratase. The gene for the cobalamin reductase from Citrobacter freundii (pduS) has been cloned to allow the protein to be overproduced recombinantly in E. coli with an N-terminal His-tag. Purified recombinant PduS is shown to be a flavoprotein with a non-covalently bound FMN that also contains two coupled [4Fe-4S] centres. It is an NADH-dependent flavin reductase that is able to mediate the one-electron reductions of cob(III) alamin to cob(II) alamin and cob(II) alamin to cob(I) alamin. The [4Fe-4S] centres are labile to oxygen and their presence affects the midpoint redox potential of flavin. Evidence is presented that PduS is able to bind cobalamin, which is inconsistent with the view that PduS is merely a flavin reductase. PduS is also shown to interact with one of the shell proteins of the metabolosome, PduT, which is also thought to contain an [Fe-S] cluster. PduS is shown to act as a corrin reductase and its interaction with a shell protein could allow for electron passage out of the bacterial microcompartment.	[Parsons, Joshua B.; Lawrence, Andrew D.; Warren, Martin J.] Univ Kent, Ctr Mol Proc, Sch Biosci, Canterbury, Kent, England; [McLean, Kirsty J.; Munro, Andrew W.; Rigby, Stephen E. J.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester, Lancs, England	University of Kent; University of Manchester	Parsons, JB (corresponding author), Univ Kent, Ctr Mol Proc, Sch Biosci, Canterbury, Kent, England.	m.j.warren@kent.ac.uk	Munro, Andrew/G-5639-2019; McLean, Kirsty J/GXI-2853-2022	Munro, Andrew/0000-0002-4642-180X; McLean, Kirsty/0000-0002-7193-5044; Parsons, Joshua/0000-0002-0589-3587; Warren, Martin/0000-0002-6028-6456	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E002889, BB/E024203]; Biotechnology and Biological Sciences Research Council [BB/E010563/1] Funding Source: researchfish; BBSRC [BB/E010563/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors acknowledge financial support from the Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E002889 and BB/E024203]. The web site of the BBSRC can be found at www.bbsrc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banerjee R, 2003, ANNU REV BIOCHEM, V72, P209, DOI 10.1146/annurev.biochem.72.121801.161828; BLANCHE F, 1992, J BACTERIOL, V174, P7452, DOI 10.1128/jb.174.22.7452-7454.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Brinsmade SR, 2005, J BACTERIOL, V187, P8039, DOI 10.1128/JB.187.23.8039-8046.2005; CHENG S, J BACTERIOL, V192, P5071; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Dutton P L, 1978, Methods Enzymol, V54, P411; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fonseca MV, 2001, J BIOL CHEM, V276, P32101, DOI 10.1074/jbc.M102510200; Fonseca MV, 2000, J BACTERIOL, V182, P4304, DOI 10.1128/JB.182.15.4304-4309.2000; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Lawrence AD, 2008, J BIOL CHEM, V283, P10813, DOI 10.1074/jbc.M710431200; LEXA D, 1977, J AM CHEM SOC, V99, P2786, DOI 10.1021/ja00450a061; Mera PE, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.059485; Mera PE, 2009, BIOCHEMISTRY-US, V48, P3138, DOI 10.1021/bi9000134; Munro AW, 2001, BIOCHEMISTRY-US, V40, P1956, DOI 10.1021/bi001718u; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; Roth JR, 1996, ANNU REV MICROBIOL, V50, P137, DOI 10.1146/annurev.micro.50.1.137; Sampson EM, 2005, MICROBIOL-SGM, V151, P1169, DOI 10.1099/mic.0.27755-0; St Maurice M, 2008, BIOCHEMISTRY-US, V47, P5755, DOI 10.1021/bi800132d; Stich TA, 2005, J AM CHEM SOC, V127, P8710, DOI 10.1021/ja042142p; Toraya T, 2000, CELL MOL LIFE SCI, V57, P106, DOI 10.1007/s000180050502; WALKER GA, 1969, ARCH BIOCHEM BIOPHYS, V134, P95, DOI 10.1016/0003-9861(69)90255-0; Warren MJ, 2002, NAT PROD REP, V19, P390, DOI 10.1039/B108967F; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	26	28	31	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14009	10.1371/journal.pone.0014009	http://dx.doi.org/10.1371/journal.pone.0014009			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103360	Green Submitted, gold, Green Published			2022-12-27	WOS:000284257400013
J	Brawley, CM; Uysal, S; Kossiakoff, AA; Rock, RS				Brawley, Crista M.; Uysal, Serdar; Kossiakoff, Anthony A.; Rock, Ronald S.			Characterization of Engineered Actin Binding Proteins That Control Filament Assembly and Structure	PLOS ONE			English	Article							SYNTHETIC ANTIBODIES; PHAGE DISPLAY; POINTED ENDS; TROPOMODULIN; LIBRARIES; MEMBRANE; RECEPTOR; COMPLEX; CAPS	Background: Eukaryotic cells strictly regulate the structure and assembly of their actin filament networks in response to various stimuli. The actin binding proteins that control filament assembly are therefore attractive targets for those who wish to reorganize actin filaments and reengineer the cytoskeleton. Unfortunately, the naturally occurring actin binding proteins include only a limited set of pointed-end cappers, or proteins that will block polymerization from the slow-growing end of actin filaments. Of the few that are known, most are part of large multimeric complexes that are challenging to manipulate. Methodology/Principal Findings: We describe here the use of phage display mutagenesis to generate of a new class of binding protein that can be targeted to the pointed-end of actin. These proteins, called synthetic antigen binders (sABs), are based on an antibody-like scaffold where sequence diversity is introduced into the binding loops using a novel "reduced genetic code" phage display library. We describe effective strategies to select and screen for sABs that ensure the generated sABs bind to the pointed-end surface of actin exclusively. Conclusions/Significance: From our set of pointed-end binders, we identify three sABs with particularly useful properties to systematically probe actin dynamics: one protein that caps the pointed end, a second that crosslinks actin filaments, and a third that severs actin filaments and promotes disassembly.	[Brawley, Crista M.; Uysal, Serdar; Kossiakoff, Anthony A.; Rock, Ronald S.] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Brawley, CM (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58th St, Chicago, IL 60637 USA.	koss@bsd.uchicago.edu; rrock@uchicago.edu			National Institutes of Health (NIH) [GM078450, GM072688]; AHA MWA; National Cancer Institute [T32CA009594]; NATIONAL CANCER INSTITUTE [T32CA009594] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078450, R01GM072688] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA MWA; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grants GM078450 (to R. S. R.) and GM072688 (to A. A. K.); an AHA MWA postdoctoral fellowship (to C. M. B.); and a National Cancer Institute grant T32CA009594 (to C. M. B.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	COLUCCIO LM, 1994, J CELL BIOL, V127, P1497, DOI 10.1083/jcb.127.6.1497; Dominguez R, 2004, TRENDS BIOCHEM SCI, V29, P572, DOI 10.1016/j.tibs.2004.09.004; Dos Remedios CG, 2003, PHYSIOL REV, V83, P433, DOI 10.1152/physrev.00026.2002; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fellouse FA, 2007, J MOL BIOL, V373, P924, DOI 10.1016/j.jmb.2007.08.005; Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231; Howard J., 2001, MECH MOTOR PROTEINS; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; LairdOffringa IA, 1996, METHOD ENZYMOL, V267, P149; Lee CV, 2004, J IMMUNOL METHODS, V284, P119, DOI 10.1016/j.jim.2003.11.001; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Nagy S, 2008, P NATL ACAD SCI USA, V105, P9616, DOI 10.1073/pnas.0802592105; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Palmgren S, 2001, J CELL BIOL, V155, P251, DOI 10.1083/jcb.200106157; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PODOLSKI JL, 1988, J BIOL CHEM, V263, P638; POLLARD TD, 1986, ANNU REV BIOCHEM, V55, P987, DOI 10.1146/annurev.bi.55.070186.005011; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Qualmann B, 2009, TRENDS CELL BIOL, V19, P276, DOI 10.1016/j.tcb.2009.03.004; Rizk SS, 2009, P NATL ACAD SCI USA, V106, P11011, DOI 10.1073/pnas.0904907106; Rock RS, 2000, METHODS, V22, P373, DOI 10.1006/meth.2000.1089; Schafer DA, 1995, ANNU REV CELL DEV BI, V11, P497, DOI 10.1146/annurev.cellbio.11.1.497; Sidhu SS, 2000, METHOD ENZYMOL, V328, P333, DOI 10.1016/S0076-6879(00)28406-1; Statsuk AV, 2005, NAT CHEM BIOL, V1, P383, DOI 10.1038/nchembio748; WEBER A, 1994, J CELL BIOL, V127, P1627, DOI 10.1083/jcb.127.6.1627	26	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13960	10.1371/journal.pone.0013960	http://dx.doi.org/10.1371/journal.pone.0013960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103060	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700011
J	Greenland, KB; Ding, H; Costanzo, M; Boone, C; Davis, TN				Greenland, Kristen B.; Ding, Huiming; Costanzo, Michael; Boone, Charles; Davis, Trisha N.			Identification of Saccharomyces cerevisiae Spindle Pole Body Remodeling Factors	PLOS ONE			English	Article							NUCLEAR-PORE COMPLEX; GAMMA-TUBULIN; INTERACTION NETWORK; TRANSFER-RNA; YEAST; CENTROSOMES; EFFICIENT; PROTEINS; MULTIPOLARITY; AMPLIFICATION	The Saccharomyces cerevisiae centrosome or spindle pole body (SPB) is a dynamic structure that is remodeled in a cell cycle dependent manner. The SPB increases in size late in the cell cycle and during most cell cycle arrests and exchanges components during G1/S. We identified proteins involved in the remodeling process using a strain in which SPB remodeling is conditionally induced. This strain was engineered to express a modified SPB component, Spc110, which can be cleaved upon the induction of a protease. Using a synthetic genetic array analysis, we screened for genes required only when Spc110 cleavage is induced. Candidate SPB remodeling factors fell into several functional categories: mitotic regulators, microtubule motors, protein modification enzymes, and nuclear pore proteins. The involvement of candidate genes in SPB assembly was assessed in three ways: by identifying the presence of a synthetic growth defect when combined with an Spc110 assembly defective mutant, quantifying growth of SPBs during metaphase arrest, and comparing distribution of SPB size during asynchronous growth. These secondary screens identified four genes required for SPB remodeling: NUP60, POM152, and NCS2 are required for SPB growth during a mitotic cell cycle arrest, and UBC4 is required to maintain SPB size during the cell cycle. These findings implicate the nuclear pore, urmylation, and ubiquitination in SPB remodeling and represent novel functions for these genes.	[Greenland, Kristen B.; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Greenland, Kristen B.; Davis, Trisha N.] Univ Washington, Program Mol & Cellular Biol, Seattle, WA 98195 USA; [Ding, Huiming; Costanzo, Michael; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol, Toronto, ON, Canada	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Toronto	Greenland, KB (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	tdavis@u.washington.edu	Davis, Trisha/F-8584-2010	Greenland, Kristen/0000-0002-7491-5372; Davis, Trisha/0000-0003-4797-3152	Molecular & Cellular Biology, University of Washington; National Institute of General Medical Sciences [T32 GM07270, R01GM40506]; Genome Canada, Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270, R01GM040506] Funding Source: NIH RePORTER	Molecular & Cellular Biology, University of Washington(University of Washington); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Genome Canada, Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Molecular & Cellular Biology, University of Washington and the Public Health Service, National Research Service Award, T32 GM07270, from the National Institute of General Medical Sciences (http://www.nigms.nih.gov/) to K. G. and Public Health Service grant R01GM40506 from the National Institute of General Medical Sciences to T.N.D. C. B. was supported by Genome Canada (http://www.genomecanada.ca/) through the Ontario Genomics Institute (2004-OGI-3-01) and the Canadian Institutes of Health Research (GSP-41567) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acilan C, 2008, CELL, V134, P572, DOI 10.1016/j.cell.2008.08.007; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Ashraf SS, 1999, RNA, V5, P188, DOI 10.1017/S1355838299981529; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Burke D., 2000, METHODS YEAST GENETI, P171; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; GEISER JR, 1993, MOL CELL BIOL, V13, P7913, DOI 10.1128/MCB.13.12.7913; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107; Hawkins KM, 2006, J BIOL CHEM, V281, P13485, DOI 10.1074/jbc.M512317200; Hazbun TR, 2003, MOL CELL, V12, P1353, DOI 10.1016/S1097-2765(03)00476-3; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Loeillet S, 2005, DNA REPAIR, V4, P459, DOI 10.1016/j.dnarep.2004.11.010; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Onischenko E, 2009, J CELL BIOL, V185, P475, DOI 10.1083/jcb.200810030; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Sankaran S, 2007, CANCER BIOL THER, V6, P1853, DOI 10.4161/cbt.6.12.5164; Saunders W, 2005, SEMIN CANCER BIOL, V15, P25, DOI 10.1016/j.semcancer.2004.09.003; SEUFERT W, 1990, EMBO J, V9, P543, DOI 10.1002/j.1460-2075.1990.tb08141.x; Sezen B, 2009, GENE DEV, V23, P1559, DOI 10.1101/gad.524209; SIKORSKI RS, 1989, GENETICS, V122, P19; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Sundberg HA, 1996, J CELL BIOL, V133, P111, DOI 10.1083/jcb.133.1.111; Sundberg HA, 1997, MOL BIOL CELL, V8, P2575, DOI 10.1091/mbc.8.12.2575; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; WARGACKI MM, 2010, CELL CYCLE, V9; Xia Y, 2003, J BIOL CHEM, V278, P5255, DOI 10.1074/jbc.M204591200; Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738; Yoder TJ, 2005, MOL BIOL CELL, V16, P141, DOI 10.1091/mbc.E04-08-0703; Yoder TJ, 2003, MOL BIOL CELL, V14, P3494, DOI 10.1091/mbc.E02-10-0655; Young A, 2000, MOL BIOL CELL, V11, P2047, DOI 10.1091/mbc.11.6.2047; Zhao XL, 2004, J CELL BIOL, V167, P605, DOI 10.1083/jcb.200405168	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15426	10.1371/journal.pone.0015426	http://dx.doi.org/10.1371/journal.pone.0015426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103054	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700025
J	Guldevall, K; Vanherberghen, B; Frisk, T; Hurtig, J; Christakou, AE; Manneberg, O; Lindstrom, S; Andersson-Svahn, H; Wiklund, M; Onfelt, B				Guldevall, Karolin; Vanherberghen, Bruno; Frisk, Thomas; Hurtig, Johan; Christakou, Athanasia E.; Manneberg, Otto; Lindstrom, Sara; Andersson-Svahn, Helene; Wiklund, Martin; Onfelt, Bjorn			Imaging Immune Surveillance of Individual Natural Killer Cells Confined in Microwell Arrays	PLOS ONE			English	Article							T-CELLS; SINGLE CELLS; IMMUNOLOGICAL SYNAPSE; MICROFLUIDIC DEVICE; LYMPH-NODE; ON-CHIP; ACTIVATION; PLATFORM; SEGREGATION; CYTOMETRY	New markers are constantly emerging that identify smaller and smaller subpopulations of immune cells. However, there is a growing awareness that even within very small populations, there is a marked functional heterogeneity and that measurements at the population level only gives an average estimate of the behaviour of that pool of cells. New techniques to analyze single immune cells over time are needed to overcome this limitation. For that purpose, we have designed and evaluated microwell array systems made from two materials, polydimethylsiloxane (PDMS) and silicon, for high-resolution imaging of individual natural killer (NK) cell responses. Both materials were suitable for short-term studies (<4 hours) but only silicon wells allowed long-term studies (several days). Time-lapse imaging of NK cell cytotoxicity in these microwell arrays revealed that roughly 30% of the target cells died much more rapidly than the rest upon NK cell encounter. This unexpected heterogeneity may reflect either separate mechanisms of killing or different killing efficiency by individual NK cells. Furthermore, we show that high-resolution imaging of inhibitory synapse formation, defined by clustering of MHC class I at the interface between NK and target cells, is possible in these microwells. We conclude that live cell imaging of NK-target cell interactions in multi-well microstructures are possible. The technique enables novel types of assays and allow data collection at a level of resolution not previously obtained. Furthermore, due to the large number of wells that can be simultaneously imaged, new statistical information is obtained that will lead to a better understanding of the function and regulation of the immune system at the single cell level.	[Guldevall, Karolin; Vanherberghen, Bruno; Christakou, Athanasia E.; Wiklund, Martin; Onfelt, Bjorn] Royal Inst Technol, Dept Appl Phys, Stockholm, Sweden; [Frisk, Thomas; Onfelt, Bjorn] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Hurtig, Johan] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Manneberg, Otto] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Lindstrom, Sara; Andersson-Svahn, Helene] Royal Inst Technol, Dept Biotechnol, Stockholm, Sweden	Royal Institute of Technology; Karolinska Institutet; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health; Royal Institute of Technology	Guldevall, K (corresponding author), Royal Inst Technol, Dept Appl Phys, Stockholm, Sweden.	onfelt@kth.se	Manneberg, Otto/C-7708-2011; Manneberg, Otto/O-7012-2014; Hurtig, Johan/C-2634-2009; Hurtig, Johan/AGO-2079-2022; Önfelt, Björn/X-3302-2019	Manneberg, Otto/0000-0002-4720-2756; Hurtig, Johan/0000-0003-0167-5416; Guldevall, Karolin/0000-0003-1016-2460; Wiklund, Martin/0000-0002-3247-1945; Frisk, Thomas/0000-0002-3996-9279	Stiftelsen for Strategisk Forskning (SSF) [F06-0020]; Swedish Research Council [2009-2734, 2007-5520]; Hellmuth Hertz' Foundation	Stiftelsen for Strategisk Forskning (SSF)(Swedish Foundation for Strategic Research); Swedish Research Council(Swedish Research CouncilEuropean Commission); Hellmuth Hertz' Foundation	Stiftelsen for Strategisk Forskning (SSF), www.stratresearch.se, grant number: F06-0020. The Swedish Research Council, www.vr.se, grant numbers: 2009-2734 and 2007-5520. Hellmuth Hertz' Foundation, www.gustafssonsstiftelse.se, www.jeanssonsstiftelser.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida CR, 2006, J IMMUNOL, V177, P6904, DOI 10.4049/jimmunol.177.10.6904; Arcibal IG, 2007, ANAL BIOANAL CHEM, V387, P51, DOI 10.1007/s00216-006-0690-0; Bajenoff M, 2006, J EXP MED, V203, P619, DOI 10.1084/jem.20051474; Beltman JB, 2007, J EXP MED, V204, P771, DOI 10.1084/jem.20061278; Bhat R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000326; Bodas D, 2006, MICROELECTRON ENG, V83, P1277, DOI 10.1016/j.mee.2006.01.195; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Chin VI, 2004, BIOTECHNOL BIOENG, V88, P399, DOI 10.1002/bit.20254; Davis DM, 1999, P NATL ACAD SCI USA, V96, P15062, DOI 10.1073/pnas.96.26.15062; Delamarche E, 2001, ADV MATER, V13, P1164; Di Carlo D, 2006, ANAL CHEM, V78, P7918; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Faley S, 2008, LAB CHIP, V8, P1700, DOI 10.1039/b719799c; GAIL MH, 1970, BIOPHYS J, V10, P980, DOI 10.1016/S0006-3495(70)86347-0; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; GROTH T, 1994, J BIOMAT SCI-POLYM E, V6, P729; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Harnett MM, 2007, NAT REV IMMUNOL, V7, P897, DOI 10.1038/nri2188; Hosokawa K, 1999, ANAL CHEM, V71, P4781, DOI 10.1021/ac990571d; Jewett A, 1996, J IMMUNOL, V156, P907; JEWETT A, 1995, CELL IMMUNOL, V160, P91, DOI 10.1016/0008-8749(95)80013-9; Johansson S, 2005, J EXP MED, V201, P1145, DOI 10.1084/jem.20050167; Kehr J, 2003, CURR OPIN PLANT BIOL, V6, P617, DOI 10.1016/j.pbi.2003.09.002; Kim J, 2000, J COLLOID INTERF SCI, V226, P231, DOI 10.1006/jcis.2000.6817; LAERMER F, 1994, VERFAHREN ANISOTROPE; Longo D, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100110; Love JC, 2006, NAT BIOTECHNOL, V24, P703, DOI 10.1038/nbt1210; Miller MJ, 2003, P NATL ACAD SCI USA, V100, P2604, DOI 10.1073/pnas.2628040100; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Mrass P, 2006, J EXP MED, V203, P2749, DOI 10.1084/jem.20060710; NOBLE PB, 1979, CAN J PHYSIOL PHARM, V57, P108, DOI 10.1139/y79-016; Orange JS, 2008, NAT REV IMMUNOL, V8, P713, DOI 10.1038/nri2381; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Revzin A, 2003, LANGMUIR, V19, P9855, DOI 10.1021/la035129b; Revzin A, 2005, LAB CHIP, V5, P30, DOI 10.1039/b405557h; Schiffenbauer YS, 2009, LAB CHIP, V9, P2965, DOI 10.1039/b904778f; Sims CE, 2007, LAB CHIP, V7, P423, DOI 10.1039/b615235j; Song Q, 2010, ANAL CHEM, V82, P473, DOI 10.1021/ac9024363; Svahn HA, 2007, LAB CHIP, V7, P544, DOI 10.1039/b704632b; TRINCHIERI G, 1989, ADV IMMUNOL, V47, P187, DOI 10.1016/S0065-2776(08)60664-1; Vanherberghen B, 2010, LAB CHIP, V10, P2727, DOI 10.1039/c004707d; Villas B H, 1998, Cell Vis, V5, P56; Voldman J, 2006, CURR OPIN BIOTECH, V17, P532, DOI 10.1016/j.copbio.2006.07.001; Wheeler AR, 2003, ANAL CHEM, V75, P3581, DOI 10.1021/ac0340758; Wulfing C, 2003, P NATL ACAD SCI USA, V100, P7767, DOI 10.1073/pnas.1336920100; Yamamura S, 2005, ANAL CHEM, V77, P8050, DOI 10.1021/ac0515632; Yu MC, 2008, NAT IMMUNOL, V9, P898, DOI 10.1038/ni.1635; Zhu H, 2009, ANAL CHEM, V81, P8150, DOI 10.1021/ac901390j	53	52	52	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15453	10.1371/journal.pone.0015453	http://dx.doi.org/10.1371/journal.pone.0015453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103395	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700028
J	Starcevic, A; Dunlap, WC; Cullum, J; Shick, JM; Hranueli, D; Long, PF				Starcevic, Antonio; Dunlap, Walter C.; Cullum, John; Shick, J. Malcolm; Hranueli, Daslav; Long, Paul F.			Gene Expression in the Scleractinian Acropora microphthalma Exposed to High Solar Irradiance Reveals Elements of Photoprotection and Coral Bleaching	PLOS ONE			English	Article							GREAT-BARRIER-REEF; AMINO-ACIDS MAAS; OXIDATIVE STRESS; ULTRAVIOLET-RADIATION; MONTASTRAEA-FAVEOLATA; ABSORBING COMPOUNDS; ZOOXANTHELLAE; LIGHT; PATHWAY; GENOME	Background: The success of tropical reef-building corals depends on the metabolic co-operation between the animal host and the photosynthetic performance of endosymbiotic algae residing within its cells. To examine the molecular response of the coral Acropora microphthalma to high levels of solar irradiance, a cDNA library was constructed by PCR-based suppression subtractive hybridisation (PCR-SSH) from mRNA obtained by transplantation of a colony from a depth of 12.7 m to near-surface solar irradiance, during which the coral became noticeably paler from loss of endosymbionts in sun-exposed tissues. Methodology/Principal Findings: A novel approach to sequence annotation of the cDNA library gave genetic evidence for a hypothetical biosynthetic pathway branching from the shikimic acid pathway that leads to the formation of 4-deoxygadusol. This metabolite is a potent antioxidant and expected precursor of the UV-protective mycosporine-like amino acids (MAAs), which serve as sunscreens in coral phototrophic symbiosis. Empirical PCR based evidence further upholds the contention that the biosynthesis of these MAA sunscreens is a 'shared metabolic adaptation' between the symbiotic partners. Additionally, gene expression induced by enhanced solar irradiance reveals a cellular mechanism of light-induced coral bleaching that invokes a Ca2+-binding synaptotagmin-like regulator of SNARE protein assembly of phagosomal exocytosis, whereby algal partners are lost from the symbiosis. Conclusions/Significance: Bioinformatics analyses of DNA sequences obtained by differential gene expression of a coral exposed to high solar irradiance has revealed the identification of putative genes encoding key steps of the MAA biosynthetic pathway. Revealed also by this treatment are genes that implicate exocytosis as a cellular process contributing to a breakdown in the metabolically essential partnership between the coral host and endosymbiotic algae, which manifests as coral bleaching.	[Starcevic, Antonio; Hranueli, Daslav] Univ Zagreb, Sect Bioinformat, Dept Biochem Engn, Fac Food Technol & Biotechnol, Zagreb 41000, Croatia; [Dunlap, Walter C.] Australian Inst Marine Sci, Ctr Marine Microbiol & Genet, Townsville, Qld 4810, Australia; [Cullum, John] Univ Kaiserslautern, Dept Genet, Kaiserslautern, Germany; [Shick, J. Malcolm] Univ Maine, Sch Marine Sci, Orono, ME USA; [Long, Paul F.] Univ London, Sch Pharm, London WC1N 1AX, England	University of Zagreb; Australian Institute of Marine Science; University of Kaiserslautern; University of Maine System; University of Maine Orono; University of London; University College London; University of London School of Pharmacy	Starcevic, A (corresponding author), Univ Zagreb, Sect Bioinformat, Dept Biochem Engn, Fac Food Technol & Biotechnol, Zagreb 41000, Croatia.	paul.long@kcl.ac.uk	Starcevic, Antonio/AAB-9379-2021	Long, Paul/0000-0001-6698-4602	Australian Institute of Marine Science; German Academic Exchange Service (DAAD); Ministry of Science, Education and Sports, Republic of Croatia [058-0000000-3475]; University of Maine, USA; United Kingdom by The University of London School of Pharmacy; Leverhulme Trust; Royal Society of London; BBSRC [BB/H010009/2]; Biotechnology and Biological Sciences Research Council [BB/H010009/2] Funding Source: researchfish	Australian Institute of Marine Science; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Ministry of Science, Education and Sports, Republic of Croatia(Ministry of Science, Education and Sports, Republic of Croatia); University of Maine, USA; United Kingdom by The University of London School of Pharmacy; Leverhulme Trust(Leverhulme Trust); Royal Society of London(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Financial support for this work has come from the Australian Institute of Marine Science (WCD PFL); from a cooperation grant of the German Academic Exchange Service (DAAD, DH JC), by a stipendium of the DAAD (AS) and from the Ministry of Science, Education and Sports, Republic of Croatia (058-0000000-3475, DH); the University of Maine, USA (JMS) and from the United Kingdom by The University of London School of Pharmacy and grants from the Leverhulme Trust, the Royal Society of London (PFL) and the BBSRC (BB/H010009/2, PFL WCD JMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, CORAL REEFS, V27, P593, DOI 10.1007/s00338-008-0355-x; BALSKUS EP, 2010, SCIENCE         0902, DOI DOI 10.1126/SCIENCE.1193637; Banaszak AT, 2006, J EXP MAR BIOL ECOL, V337, P131, DOI 10.1016/j.jembe.2006.06.014; Banaszak AT, 2000, J EXP MAR BIOL ECOL, V249, P219; Chen YB, 2004, PLANT PHYSIOL, V136, P3737, DOI 10.1104/pp.104.038919; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; DUNLAP WC, 1986, J EXP MAR BIOL ECOL, V104, P239, DOI 10.1016/0022-0981(86)90108-5; Dunn SR, 2007, P ROY SOC B-BIOL SCI, V274, P3079, DOI 10.1098/rspb.2007.0711; Edge SE, 2005, MAR POLLUT BULL, V51, P507, DOI 10.1016/j.marpolbul.2005.07.007; FAVREBONVIN J, 1987, PHYTOCHEMISTRY, V26, P2509, DOI 10.1016/S0031-9422(00)83866-2; Fitt WK, 2009, J EXP MAR BIOL ECOL, V373, P102, DOI 10.1016/j.jembe.2009.03.011; Foret S, 2007, CORAL REEFS, V26, P475, DOI 10.1007/s00338-007-0206-1; Garcia-Pichel F, 1998, ORIGINS LIFE EVOL B, V28, P321, DOI 10.1023/A:1006545303412; GORLICH D, 1996, EMBO J, V15, P5558; Harithsa S, 2005, CORAL REEFS, V24, P463, DOI 10.1007/s00338-005-0008-2; Jeffrey SW, 1999, MAR ECOL PROG SER, V189, P35, DOI 10.3354/meps189035; Jones AM, 2008, P ROY SOC B-BIOL SCI, V275, P1359, DOI 10.1098/rspb.2008.0069; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kloepper TH, 2007, MOL BIOL CELL, V18, P3463, DOI 10.1091/mbc.E07-03-0193; KUHL M, 1995, MAR ECOL PROG SER, V117, P159, DOI 10.3354/meps117159; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; LESSER MP, 1990, CORAL REEFS, V8, P225, DOI 10.1007/BF00265015; Li HY, 2003, TRENDS CELL BIOL, V13, P553, DOI 10.1016/j.tcb.2003.09.003; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; MathieuDaude F, 1996, NUCLEIC ACIDS RES, V24, P2080, DOI 10.1093/nar/24.11.2080; Meesters EH, 2002, MAR ECOL PROG SER, V227, P233, DOI 10.3354/meps227233; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; MICHELMORE CL, 2002, MAR ENVIRON RES, V54, P345, DOI DOI 10.1016/S0141-1136(02)00201-5; MUSCATINE L, 1990, ECOSYSTEMS WORLD, V25, P75; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Portwich A, 2003, PHYCOLOGIA, V42, P384, DOI 10.2216/i0031-8884-42-4-384.1; Rebrikov Denis V., 2004, V258, P107; Richier S, 2008, J EXP MAR BIOL ECOL, V357, P48, DOI 10.1016/j.jembe.2007.12.026; Rodriguez-Lanetty M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-23; Rodriguez-Lanetty M, 2008, J BIOCHEM BIOPH METH, V70, P985, DOI 10.1016/j.jbbm.2007.08.005; Rodriguez-Lanetty M, 2009, MOL ECOL, V18, P5101, DOI 10.1111/j.1365-294X.2009.04419.x; Seneca FO, 2010, MAR BIOTECHNOL, V12, P594, DOI 10.1007/s10126-009-9247-5; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Shick JM, 1999, LIMNOL OCEANOGR, V44, P1667, DOI 10.4319/lo.1999.44.7.1667; SHICK JM, 1995, MAR BIOL, V122, P41, DOI 10.1007/BF00349276; Shick JM, 2002, BIOL BULL-US, V203, P315, DOI 10.2307/1543574; SHICK JM, 1993, INT CONGR SER, V1021, P561; Singh SP, 2010, GENOMICS, V95, P120, DOI 10.1016/j.ygeno.2009.10.002; Singh SP, 2008, PHOTOCHEM PHOTOBIOL, V84, P1500, DOI 10.1111/j.1751-1097.2008.00376.x; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Starcevic A, 2008, P NATL ACAD SCI USA, V105, P2533, DOI 10.1073/pnas.0707388105; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ulstrup KE, 2003, MOL ECOL, V12, P3477, DOI 10.1046/j.1365-294X.2003.01988.x; VERON JEN, 1984, AUSTR I MARINE SCI M, V6, P242; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660	56	25	25	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13975	10.1371/journal.pone.0013975	http://dx.doi.org/10.1371/journal.pone.0013975			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103042	Green Submitted, gold, Green Published			2022-12-27	WOS:000284147700020
J	Judah, D; Chang, WY; Dagnino, L				Judah, David; Chang, Wing Y.; Dagnino, Lina			EBP1 Is a Novel E2F Target Gene Regulated by Transforming Growth Factor-beta	PLOS ONE			English	Article							EXPRESSION; INSIGHTS; PATHWAY; PROTEIN; ERBB3	Regulation of gene expression requires transcription factor binding to specific DNA elements, and a large body of work has focused on the identification of such sequences. However, it is becoming increasingly clear that eukaryotic transcription factors can exhibit widespread, nonfunctional binding to genomic DNA sites. Conversely, some of these proteins, such as E2F, can also modulate gene expression by binding to non-consensus elements. E2F comprises a family of transcription factors that play key roles in a wide variety of cellular functions, including survival, differentiation, activation during tissue regeneration, metabolism, and proliferation. E2F factors bind to the Erb3-binding protein 1 (EBP1) promoter in live cells. We now show that E2F binding to the EBP1 promoter occurs through two tandem DNA elements that do not conform to typical consensus E2F motifs. Exogenously expressed E2F1 activates EBP1 reporters lacking one, but not both sites, suggesting a degree of redundancy under certain conditions. E2F1 increases the levels of endogenous EBP1 mRNA in breast carcinoma and other transformed cell lines. In contrast, in non-transformed primary epidermal keratinocytes, E2F, together with the retinoblastoma family of proteins, appears to be involved in decreasing EBP1 mRNA abundance in response to growth inhibition by transforming growth factor-beta 1. Thus, E2F is likely a central coordinator of multiple responses that culminate in regulation of EBP1 gene expression, and which may vary depending on cell type and context.	[Judah, David; Chang, Wing Y.; Dagnino, Lina] Univ Western Ontario, Dept Physiol & Pharmacol, Children Hlth Res Inst, London, ON, Canada; [Judah, David; Chang, Wing Y.; Dagnino, Lina] Univ Western Ontario, Lawson Hlth Res Inst, London, ON, Canada; [Dagnino, Lina] Univ Western Ontario, Dept Paediat, Children Hlth Res Inst, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Judah, D (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, Children Hlth Res Inst, London, ON, Canada.	ldagnino@uwo.ca		Dagnino, Lina/0000-0003-1483-5159	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was provided by the Canadian Institutes of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Apostolova MD, 2002, J BIOL CHEM, V277, P34471, DOI 10.1074/jbc.M205827200; Burkhart DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001003; Chang WY, 2006, CELL CYCLE, V5, P1872, DOI 10.4161/cc.5.16.3136; Chang WY, 2004, METH MOL B, V289, P147; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; DAGNINO L, 2009, METH MOL BI IN PRESS; de Jonge HJM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000898; DOBROWOLSKI SF, 1994, ONCOGENE, V9, P2605; Emmrich S, 2010, CELL CYCLE, V9, P2555, DOI 10.4161/cc.9.13.12061; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; GERARD C, 2009, P NATL ACAD SCI US; Hallstrom TC, 2009, CELL CYCLE, V8, P532, DOI 10.4161/cc.8.4.7609; Hamburger AW, 2008, J MAMMARY GLAND BIOL, V13, P225, DOI 10.1007/s10911-008-9077-5; Iavarone A, 1999, MOL CELL BIOL, V19, P916; Ivanova IA, 2006, ONCOGENE, V25, P430, DOI 10.1038/sj.onc.1208999; Kherrouche Z, 2006, BIOCHEM J, V396, P547, DOI 10.1042/BJ20051981; Lacerte A, 2008, CELL SIGNAL, V20, P50, DOI 10.1016/j.cellsig.2007.08.012; Lavrrar JL, 2004, J BIOL CHEM, V279, P46343, DOI 10.1074/jbc.M402692200; LU Y, 2010, BREAST CANC RES TREA; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; Rabinovich A, 2008, GENOME RES, V18, P1763, DOI 10.1101/gr.080622.108; RADOMSKI N, 1995, EXP CELL RES, V220, P434, DOI 10.1006/excr.1995.1335; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; SUN B, 2010, CELL CYCLE, V9; Swiss VA, 2010, GLIA, V58, P377, DOI 10.1002/glia.20933; Tao YX, 1997, MOL CELL BIOL, V17, P6994, DOI 10.1128/MCB.17.12.6994; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Xia XM, 2001, BIOCHEM BIOPH RES CO, V289, P240, DOI 10.1006/bbrc.2001.5942; Zhang YX, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-69; Zhang YX, 2005, NUCLEIC ACIDS RES, V33, P6024, DOI 10.1093/nar/gki903; Zheng N, 1999, GENE DEV, V13, P666, DOI 10.1101/gad.13.6.666; Zhu WC, 2005, CELL CYCLE, V4, P633, DOI 10.4161/cc.4.5.1650	36	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13941	10.1371/journal.pone.0013941	http://dx.doi.org/10.1371/journal.pone.0013941			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085677	Green Submitted, gold, Green Published			2022-12-27	WOS:000284036800026
J	Mahler, SV; de Wit, H				Mahler, Stephen V.; de Wit, Harriet			Cue-Reactors: Individual Differences in Cue-Induced Craving after Food or Smoking Abstinence	PLOS ONE			English	Article							INCENTIVE SALIENCE; ATTRIBUTION; ADDICTION; COCAINE; REWARD; DEPRESSION; RELEVANCE; DOPAMINE; APPETITE; STIMULUS	Background: Pavlovian conditioning plays a critical role in both drug addiction and binge eating. Recent animal research suggests that certain individuals are highly sensitive to conditioned cues, whether they signal food or drugs. Are certain humans also more reactive to both food and drug cues? Methods: We examined cue-induced craving for both cigarettes and food, in the same individuals (n = 15 adult smokers). Subjects viewed smoking-related or food-related images after abstaining from either smoking or eating. Results: Certain individuals reported strong cue-induced craving after both smoking and food cues. That is, subjects who reported strong cue-induced craving for cigarettes also rated stronger cue-induced food craving. Conclusions: In humans, like in nonhumans, there may be a "cue-reactive'' phenotype, consisting of individuals who are highly sensitive to conditioned stimuli. This finding extends recent reports from nonhuman studies. Further understanding this subgroup of smokers may allow clinicians to individually tailor therapies for smoking cessation.	[Mahler, Stephen V.] Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA; [de Wit, Harriet] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA	Medical University of South Carolina; University of Chicago	Mahler, SV (corresponding author), Med Univ S Carolina, Dept Neurosci, Charleston, SC 29425 USA.	mahler@musc.edu	Mahler, Stephen V/P-8594-2018	Mahler, Stephen V/0000-0002-8698-0905; de Wit, Harriet/0000-0002-7211-8994	NIDA [R01 DA002812]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA002812] Funding Source: NIH RePORTER	NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	NIDA R01 DA002812 funded this experiment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsene KM, 2003, BEHAV PHARMACOL, V14, P145, DOI 10.1097/00008877-200303000-00006; CASON AM, 2010, PHYSL BEHAV; Ferguson SG, 2009, J SUBST ABUSE TREAT, V36, P235, DOI 10.1016/j.jsat.2008.06.005; FERNSTROM MH, 1989, APPETITE, V13, P71, DOI 10.1016/0195-6663(89)90027-5; FERNSTROM MH, 1987, BIOL PSYCHIAT, V22, P529, DOI 10.1016/0006-3223(87)90180-6; Flagel SB, 2008, BEHAV BRAIN RES, V186, P48, DOI 10.1016/j.bbr.2007.07.022; Flagel SB, 2007, PSYCHOPHARMACOLOGY, V191, P599, DOI 10.1007/s00213-006-0535-8; Flagel SB, 2010, NEUROPSYCHOPHARMACOL, V35, P388, DOI 10.1038/npp.2009.142; Flagel SB, 2009, NEUROPHARMACOLOGY, V56, P139, DOI 10.1016/j.neuropharm.2008.06.027; Hearst E., 1974, SIGN TRACKING STIMUL; Jansen A, 1998, BEHAV RES THER, V36, P257, DOI 10.1016/S0005-7967(98)00055-2; Kelley AE, 2005, PHYSIOL BEHAV, V86, P11, DOI 10.1016/j.physbeh.2005.06.018; Kelley AE, 2002, J NEUROSCI, V22, P3306; Nair SG, 2009, PROG NEUROBIOL, V89, P18, DOI 10.1016/j.pneurobio.2009.05.003; Nestler EJ, 2005, NAT NEUROSCI, V8, P1445, DOI 10.1038/nn1578; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; TIFFANY ST, 1991, BRIT J ADDICT, V86, P1467, DOI 10.1111/j.1360-0443.1991.tb01732.x; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Wise RA, 2006, PHILOS T R SOC B, V361, P1149, DOI 10.1098/rstb.2006.1854; YAGER LM, 2010, BEHAV BRAIN RES	20	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15475	10.1371/journal.pone.0015475	http://dx.doi.org/10.1371/journal.pone.0015475			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085667	Green Published, gold			2022-12-27	WOS:000284036800032
J	Gryganskyi, AP; Lee, SC; Litvintseva, AP; Smith, ME; Bonito, G; Porter, TM; Anishchenko, IM; Heitman, J; Vilgalys, R				Gryganskyi, Andrii P.; Lee, Soo Chan; Litvintseva, Anastasia P.; Smith, Matthew E.; Bonito, Gregory; Porter, Teresita M.; Anishchenko, Iryna M.; Heitman, Joseph; Vilgalys, Rytas			Structure, Function, and Phylogeny of the Mating Locus in the Rhizopus oryzae Complex	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SUBUNIT RIBOSOMAL DNA; GENUS RHIZOPUS; IDENTIFICATION; POPULATIONS; ZYGOSPORE; SEX; STRATEGIES; VIRULENCE; MUCORALES	The Rhizopus oryzae species complex is a group of zygomycete fungi that are common, cosmopolitan saprotrophs. Some strains are used beneficially for production of Asian fermented foods but they can also act as opportunistic human pathogens. Although R. oryzae reportedly has a heterothallic (+/-) mating system, most strains have not been observed to undergo sexual reproduction and the genetic structure of its mating locus has not been characterized. Here we report on the mating behavior and genetic structure of the mating locus for 54 isolates of the R. oryzae complex. All 54 strains have a mating locus similar in overall organization to Phycomyces blakesleeanus and Mucor circinelloides (Mucoromycotina, Zygomycota). In all of these fungi, the minus (-) allele features the SexM high mobility group (HMG) gene flanked by an RNA helicase gene and a TP transporter gene (TPT). Within the R. oryzae complex, the plus (+) mating allele includes an inserted region that codes for a BTB/POZ domain gene and the SexP HMG gene. Phylogenetic analyses of multiple genes, including the mating loci (HMG, TPT, RNA helicase), ITS1-5.8S-ITS2 rDNA, RPB2, and LDH genes, identified two distinct groups of strains. These correspond to previously described sibling species R. oryzae sensu stricto and R. delemar. Within each species, discordant gene phylogenies among multiple loci suggest an outcrossing population structure. The hypothesis of random-mating is also supported by a 50:50 ratio of plus and minus mating types in both cryptic species. When crossed with tester strains of the opposite mating type, most isolates of R. delemar failed to produce zygospores, while isolates of R. oryzae produced sterile zygospores. In spite of the reluctance of most strains to mate in vitro, the conserved sex locus structure and evidence for outcrossing suggest that a normal sexual cycle occurs in both species.	[Gryganskyi, Andrii P.; Smith, Matthew E.; Bonito, Gregory; Porter, Teresita M.; Vilgalys, Rytas] Duke Univ, Dept Biol, Durham, NC 27706 USA; [Gryganskyi, Andrii P.; Anishchenko, Iryna M.] Natl Acad Sci Ukraine, NG Kholodnyi Bot Inst, Dept Mycol, Kiev, Ukraine; [Lee, Soo Chan; Litvintseva, Anastasia P.; Heitman, Joseph] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; National Academy of Sciences Ukraine; M.G. Kholodny Institute of Botany, NAS of Ukraine; Duke University	Gryganskyi, AP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27706 USA.	apg10@duke.edu	Heitman, Joseph/ABC-6006-2021; Porter, Teresita M/H-4072-2011; M., Anishchenko Iryna/AAC-2366-2020; Smith, Matthew E/A-8115-2012; Smith, Matthew E./ABC-3015-2020	Smith, Matthew E/0000-0002-0878-0932; Smith, Matthew E./0000-0002-0878-0932; Gryganskyi, Andrii/0000-0002-6037-0092; Vilgalys, Rytas/0000-0001-8299-3605	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases [AI50113, AI085331]; NIH [AI52080]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050113, T32AI052080, R21AI085331] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by National Institutes of Health (NIH)/National Institute of Allergy and Infectious Diseases R01 grant AI50113 to J. H. and R21 grant AI085331 to J. H. S. C. L. was supported by the NIH Molecular Mycology and Pathogenesis Training Program (AI52080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELHAFEZ SII, 1984, MYCOPATHOLOGIA, V85, P53, DOI 10.1007/BF00436702; Abe A, 2003, BIOSCI BIOTECH BIOCH, V67, P1725, DOI 10.1271/bbb.67.1725; Abe A, 2007, MYCOLOGIA, V99, P714, DOI 10.3852/mycologia.99.5.714; Abe A, 2006, BIOSCI BIOTECH BIOCH, V70, P2387, DOI 10.1271/bbb.60101; AINSWORTH G. C, 1955, TRANS BRIT MYCOL SOC, V38, P369; Aldenderfer MS., 1984, CLUSTER ANAL; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Blakeslee AF, 1927, BOT GAZ, V84, P27, DOI 10.1086/333757; Blakeslee AF, 1904, SCIENCE, V19, P0864, DOI 10.1126/science.19.492.864; Blakeslee AF, 1921, BOT GAZ, V72, P162, DOI 10.1086/332909; BROWN J, 2005, AM J HEALTH-SYST PH, V25, P215; Burt A, 1996, P NATL ACAD SCI USA, V93, P770, DOI 10.1073/pnas.93.2.770; CONSTANDSEWESTE.TS, 1972, COEFFICIENTS BIOL DI; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; CUTTER VM, 1942, B TORREY BOT CLUB, V69, P592; Domsch K.H., 1980, COMPENDIUM SOIL FUNG; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Douhan GW, 2005, NEW PHYTOL, V166, P263, DOI 10.1111/j.1469-8137.2004.01305.x; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; ELLIS JJ, 1985, MYCOLOGIA, V77, P243, DOI 10.2307/3793074; Faeth SH, 2002, OIKOS, V98, P25, DOI 10.1034/j.1600-0706.2002.980103.x; Fiore-Donno AM, 2001, NEW PHYTOL, V152, P533, DOI 10.1046/j.0028-646X.2001.00271.x; FISHER A, 1892, PHYCOMYCETES MUCORIN, V1, P161; FRYE CB, 1993, MYCOPATHOLOGIA, V124, P139, DOI 10.1007/BF01103730; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; GAUGER W, 1965, MYCOLOGIA, V57, P634, DOI 10.2307/3756739; GAUGER WL, 1961, AM J BOT, V48, P427, DOI 10.2307/2439336; GAUGER WL, 1977, J GEN MICROBIOL, V101, P211, DOI 10.1099/00221287-101-2-211; GEIDUSCHEK E, 1961, ARCH BIOCHEM BIOPHYS, V95, P114, DOI 10.1016/0003-9861(61)90116-3; Glenn TC, 2005, METHOD ENZYMOL, V395, P202, DOI 10.1016/S0076-6879(05)95013-1; Harrington TC, 1999, STRUCTURE DYNAMICS F, V43, P71, DOI DOI 10.1007/978-94-011-4423-0_3; HAWKER LE, 1971, PHILOS T ROY SOC B, V263, P71, DOI 10.1098/rstb.1971.0110; HAWKER LE, 1968, ANN BOT-LONDON, V32, P137, DOI 10.1093/oxfordjournals.aob.a084188; HESSELTINE C, 1961, MYCOLOGIA, V53, P406, DOI 10.2307/3756584; HESSELTINE CW, 1987, MYCOLOGIA, V79, P289, DOI 10.2307/3807661; Ibrahim AS, 2003, ANTIMICROB AGENTS CH, V47, P3343, DOI 10.1128/AAC.47.10.3343-3344.2003; IDNURM A, 2007, SEX FUNGI; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; INUI T, 1965, J GEN APPL MICROBIOL, VS 11, P1, DOI 10.2323/jgam.11.Supplement_1; Keller A, 2009, GENE, V430, P50, DOI 10.1016/j.gene.2008.10.012; Kirk PM., 2008, DICT FUNGI, V10th ed; Kito H, 2009, BIOSCI BIOTECH BIOCH, V73, P861, DOI 10.1271/bbb.80773; Koetschan C, 2010, NUCLEIC ACIDS RES, V38, pD275, DOI 10.1093/nar/gkp966; KWONCHUNG KJ, 1992, INFECT IMMUN, V60, P602, DOI 10.1128/IAI.60.2.602-605.1992; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Liou Guey-Yuh, 2001, Nova Hedwigia, V72, P231; Liu XY, 2007, SYDOWIA, V59, P235; Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354; Maddison W.P., MESQUITE MODULAR SYS; MILKO AA, 1974, IDENTIFICATION GUIDE; Nielsen K, 2005, GENETICS, V171, P975, DOI 10.1534/genetics.105.045039; Oda Y, 2003, FOOD MICROBIOL, V20, P371, DOI 10.1016/S0740-0020(02)00131-4; Ogawa Yoshio, 2004, Mycoscience, V45, P271, DOI 10.1007/s10267-004-0180-1; Perez G, 2010, MOL ECOL, V19, P1801, DOI 10.1111/j.1365-294X.2010.04584.x; PETRIKKOS GL, 2008, MYCOL NEWSL, V1, P31; Pidoplichko N.M., 1971, ATLAS MUCORALEAN FUN; Ramirez-Prado JH, 2008, FUNGAL GENET BIOL, V45, P1292, DOI 10.1016/j.fgb.2008.06.007; REHNER SA, 1994, MYCOL RES, V98, P625, DOI 10.1016/S0953-7562(09)80409-7; Ribes JA, 2000, CLIN MICROBIOL REV, V13, P236, DOI 10.1128/CMR.13.2.236-301.2000; Rozen S, 2000, BIOINFORMATICS METHO; Sabouraud R., 1896, TRICHOPHYTIES HUMAIN, P49; Saito K, 2004, ARCH MICROBIOL, V182, P30, DOI 10.1007/s00203-004-0691-3; Schipper MAA, 1996, J MED VET MYCOL, V34, P199; SCHIPPER MAA, 1984, STUD MYCOL, P1; SCHIPPER MAA, 1985, J GEN MICROBIOL, V131, P2359; SCHOLER HJ, 1983, FUNGI PATHOGENIC HUM; Schwarz P, 2006, J CLIN MICROBIOL, V44, P340, DOI 10.1128/JCM.44.2.340-349.2006; Seidl V, 2009, P NATL ACAD SCI USA, V106, P13909, DOI 10.1073/pnas.0904936106; Singh N, 2009, J INFECT DIS, V200, P1002, DOI 10.1086/605445; Skory CD, 2007, CURR GENET, V52, P23, DOI 10.1007/s00294-007-0135-0; Skory CD, 2009, ENZYME MICROB TECH, V44, P242, DOI 10.1016/j.enzmictec.2008.10.009; Sneath P.H.A., 1973, NUMERICAL TAXONOMY P; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor JW, 2000, FUNGAL GENET BIOL, V31, P21, DOI 10.1006/fgbi.2000.1228; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WOLF M, 2005, IN SILICO BIOL, V5; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Zoller S, 1999, LICHENOLOGIST, V31, P511	82	56	60	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15273	10.1371/journal.pone.0015273	http://dx.doi.org/10.1371/journal.pone.0015273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151560	Green Published, gold			2022-12-27	WOS:000285135800020
J	Head, ML; Wong, BBM; Brooks, R				Head, Megan L.; Wong, Bob B. M.; Brooks, Robert			Sexual Display and Mate Choice in an Energetically Costly Environment	PLOS ONE			English	Article							GUPPY POECILIA-RETICULATA; PREDATION RISK; SWIMMING PERFORMANCE; MATING-BEHAVIOR; GEOGRAPHIC-VARIATION; COURTSHIP BEHAVIOR; FEMALE GUPPIES; MALE TRAITS; SELECTION; AVAILABILITY	Sexual displays and mate choice often take place under the same set of environmental conditions and, as a consequence, may be exposed to the same set of environmental constraints. Surprisingly, however, very few studies consider the effects of environmental costs on sexual displays and mate choice simultaneously. We conducted an experiment, manipulating water flow in large flume tanks, to examine how an energetically costly environment might affect the sexual display and mate choice behavior of male and female guppies, Poecilia reticulata. We found that male guppies performed fewer sexual displays and became less choosy, with respect to female size, in the presence of a water current compared to those tested in still water. In contrast to males, female responsive to male displays did not differ between the water current treatments and females exhibited no mate preferences with respect to male size or coloration in either treatment. The results of our study underscore the importance of considering the simultaneous effects of environmental costs on the sexual behaviors of both sexes.	[Head, Megan L.; Brooks, Robert] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Wong, Bob B. M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	University of New South Wales Sydney; Australian National University		M.L.Head@exeter.ac.uk	Head, Megan/D-2551-2010; Brooks, Robert/A-1251-2008	Brooks, Robert/0000-0001-6926-0781; Head, Megan/0000-0002-8123-7661; Wong, Bob/0000-0001-9352-6500	Australian Research Council	Australian Research Council(Australian Research Council)	This work was funded by an Australian Research Council grant to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booksmythe I, 2008, ANIM BEHAV, V76, P1775, DOI 10.1016/j.anbehav.2008.07.022; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Brooks R, 2002, GENETICA, V116, P343, DOI 10.1023/A:1021228308636; Brooks R, 2001, EVOLUTION, V55, P1002, DOI 10.1554/0014-3820(2001)055[1002:DAISSA]2.0.CO;2; CROWLEY PH, 1991, AM NAT, V137, P567, DOI 10.1086/285184; Dosen LD, 2004, ETHOLOGY, V110, P245, DOI 10.1111/j.1439-0310.2004.00965.x; Dunn AM, 2008, ANIM BEHAV, V76, P1289, DOI 10.1016/j.anbehav.2008.06.013; ENDLER JA, 1995, EVOLUTION, V49, P456, DOI [10.2307/2410270, 10.1111/j.1558-5646.1995.tb02278.x]; ESHEL I, 1979, THEOR POPUL BIOL, V16, P301, DOI 10.1016/0040-5809(79)90019-4; Evans JP, 2002, BEHAV ECOL SOCIOBIOL, V52, P496, DOI 10.1007/s00265-002-0535-6; FORSGREN E, 1992, AM NAT, V140, P1041, DOI 10.1086/285455; Fuller R, 1996, BEHAV ECOL, V7, P69, DOI 10.1093/beheco/7.1.69; Gamble S, 2003, ECOL LETT, V6, P463, DOI 10.1046/j.1461-0248.2003.00449.x; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Hebets EA, 2008, ANIM BEHAV, V76, P355, DOI 10.1016/j.anbehav.2007.12.021; Herdman EJE, 2004, ETHOLOGY, V110, P97, DOI 10.1111/j.1439-0310.2003.00960.x; Houde A.E., 1997, SEX COLOR MATE CHOIC; HOUDE AE, 1992, BEHAV ECOL, V3, P346, DOI 10.1093/beheco/3.4.346; Hunt J, 2004, NATURE, V432, P1024, DOI 10.1038/nature03084; Hunt J, 2005, AM NAT, V166, P79, DOI 10.1086/430672; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Karino K, 2006, ZOOL SCI, V23, P255, DOI 10.2108/zsj.23.255; Katvala M, 2001, ANIM BEHAV, V62, P133, DOI 10.1006/anbe.2001.1737; Kodric-Brown A, 2005, ENVIRON BIOL FISH, V73, P299, DOI 10.1007/s10641-005-1598-9; Koga T, 1998, P ROY SOC B-BIOL SCI, V265, P1385, DOI 10.1098/rspb.1998.0446; Kokko H, 2002, P ROY SOC B-BIOL SCI, V269, P1331, DOI 10.1098/rspb.2002.2020; Kolluru GR, 2005, BEHAV ECOL, V16, P294, DOI 10.1093/beheco/arh161; Kotiaho JS, 2000, BEHAV ECOL SOCIOBIOL, V48, P188, DOI 10.1007/s002650000221; Kotiaho JS, 2001, BIOL REV, V76, P365, DOI 10.1017/S1464793101005711; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Lopez S, 1999, ANIM BEHAV, V57, P1129, DOI 10.1006/anbe.1998.1064; Magellan K, 2006, ANIM BEHAV, V72, P75, DOI 10.1016/j.anbehav.2005.09.022; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V258, P89, DOI 10.1098/rspb.1994.0147; MILINSKI M, 1992, P ROY SOC B-BIOL SCI, V250, P229, DOI 10.1098/rspb.1992.0153; Nicoletto PF, 1996, BEHAV ECOL, V7, P272, DOI 10.1093/beheco/7.3.272; Nicoletto PF, 1999, ENVIRON BIOL FISH, V55, P227, DOI 10.1023/A:1007587809618; POULIN R, 1994, P ROY SOC B-BIOL SCI, V256, P183, DOI 10.1098/rspb.1994.0068; REAL L, 1990, AM NAT, V136, P376, DOI 10.1086/285103; SIH A, 1990, AM NAT, V135, P284, DOI 10.1086/285044; Standen EM, 2002, CAN J FISH AQUAT SCI, V59, P1809, DOI 10.1139/F02-151; STONER G, 1988, BEHAV ECOL SOCIOBIOL, V22, P285, DOI 10.1007/BF00299844; Swan T., 2006, THESIS U SO QUEENSLA; Syriatowicz Alexandra, 2004, BMC Ecology, V4, P5, DOI 10.1186/1472-6785-4-5; TUTTLE MD, 1982, ANIM BEHAV, V30, P393, DOI 10.1016/S0003-3472(82)80050-X; Wong BBM, 2003, P ROY SOC B-BIOL SCI, V270, pS36, DOI 10.1098/rsbl.2003.0003; ZAHAVI A, 1975, J THEOR BIOL, V53, P205, DOI 10.1016/0022-5193(75)90111-3	49	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15279	10.1371/journal.pone.0015279	http://dx.doi.org/10.1371/journal.pone.0015279			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151610	Green Submitted, Green Published, gold			2022-12-27	WOS:000285135800022
J	Pan, XF; Liao, YH; Liu, YM; Chang, P; Liao, LN; Yang, L; Li, HQ				Pan, Xuefeng; Liao, Yuanhong; Liu, Yunmeng; Chang, Peng; Liao, Lingni; Yang, Li; Li, Hongquan			Transcription of AAT.ATT Triplet Repeats in Escherichia coli Is Silenced by H-NS and IS1E Transposition	PLOS ONE			English	Article							CANNABINOID RECEPTOR GENE; TRINUCLEOTIDE REPEATS; MOLECULAR-BASIS; DNA; BINDING; PROTEIN; STRAND; SITES; POLYMORPHISM; ASSOCIATION	Background: The trinucleotide repeats AAT.ATT are simple DNA sequences that potentially form different types of non-B DNA secondary structures and cause genomic instabilities in vivo. Methodology and Principal Findings: The molecular mechanism underlying the maintenance of a 24-triplet AAT.ATT repeat was examined in E. coli by cloning the repeats into the EcoRI site in plasmid pUC18 and into the attB site on the E. coli genome. Either the AAT or the ATT strand acted as lagging strand template in a replication fork. Propagations of the repeats in either orientation on plasmids did not affect colony morphology when triplet repeat transcription using the lacZ promoter was repressed either by supplementing LacI(Q) in trans or by adding glucose into the medium. In contrast, transparent colonies were formed by inducing transcription of the repeats, suggesting that transcription of AAT.ATT repeats was toxic to cell growth. Meanwhile, significant IS1E transposition events were observed both into the triplet repeats region proximal to the promoter side, the promoter region of the lacZ gene, and into the AAT.ATT region itself. Transposition reversed the transparent colony phenotype back into healthy, convex colonies. In contrast, transcription of an 8-triplet AAT.ATT repeat in either orientation on plasmids did not produce significant changes in cell morphology and did not promote IS1E transposition events. We further found that a role of IS1E transposition into plasmids was to inhibit transcription through the repeats, which was influenced by the presence of the H-NS protein, but not of its paralogue StpA. Conclusions and Significance: Our findings thus suggest that the longer AAT.ATT triplet repeats in E. coli become vulnerable after transcription. H-NS and its facilitated IS1E transposition can silence long triplet repeats transcription and preserve cell growth and survival.	[Pan, Xuefeng; Liao, Yuanhong; Liu, Yunmeng; Chang, Peng; Liao, Lingni; Yang, Li] Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China; [Pan, Xuefeng] Univ Edinburgh, Inst Cell & Mol Biol, Edinburgh, Midlothian, Scotland; [Pan, Xuefeng; Li, Hongquan] Hebei Univ, Hlth Sci Ctr, Baoding, Peoples R China	Beijing Institute of Technology; University of Edinburgh; Hebei University	Pan, XF (corresponding author), Beijing Inst Technol, Sch Life Sci, Beijing 100081, Peoples R China.	xuefengpancam@yahoo.com.cn		Pan, Xuefeng/0000-0002-7660-659X; Chang, Peng/0000-0003-0890-2685	Natural Science Foundation of the Beijing Institute of Technology, China [1060050320804]; Medical Science foundation of Hebei University, China [2007Z02]; Medical Research Council of the United Kingdom	Natural Science Foundation of the Beijing Institute of Technology, China; Medical Science foundation of Hebei University, China; Medical Research Council of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Natural Science Foundation of the Beijing Institute of Technology (1060050320804), China, and the Medical Science foundation of Hebei University(2007Z02), China. And it has also been supported by a grant from Medical Research Council of the United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLON N, 2006, PHARMACOGENOMICS J, V6, P126; Amit R, 2003, BIOPHYS J, V84, P2467, DOI 10.1016/S0006-3495(03)75051-6; Astolfi P, 2003, GENE, V317, P117, DOI 10.1016/S0378-1119(03)00659-0; Barrero FJ, 2005, PHARMACOGENOMICS J, V5, P135, DOI 10.1038/sj.tpj.6500301; BIEL SW, 1984, GENETICS, V108, P319; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; CHEN J, 2001, BIOTECHNOLOGY, V11, P6; Cox R, 1997, P NATL ACAD SCI USA, V94, P5237, DOI 10.1073/pnas.94.10.5237; Dame RT, 2001, BIOCHIMIE, V83, P231; DAYN A, 1992, P NATL ACAD SCI USA, V89, P11406, DOI 10.1073/pnas.89.23.11406; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; ESCOUBAS JM, 1994, J BACTERIOL, V176, P5864, DOI 10.1128/JB.176.18.5864-5867.1994; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; Gur-Arie R, 2000, GENOME RES, V10, P62; Hubacek JA, 1999, VASA-J VASCULAR DIS, V28, P169, DOI 10.1024/0301-1526.28.3.169; Kappen LS, 2003, BIOCHEMISTRY-US, V42, P2166, DOI 10.1021/bi020650a; Kosmider B, 2006, NUCLEIC ACIDS RES, V34, P5369, DOI 10.1093/nar/gkl612; LANE D, 1994, J MOL BIOL, V242, P339, DOI 10.1006/jmbi.1994.1585; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Leung TF, 2005, CLIN EXP ALLERGY, V35, P1288, DOI 10.1111/j.1365-2222.2005.02342.x; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lyons-Darden T, 1999, J BIOL CHEM, V274, P25975, DOI 10.1074/jbc.274.37.25975; Lyons-Darden T, 1999, NUCLEIC ACIDS RES, V27, P2235, DOI 10.1093/nar/27.11.2235; Mancuso M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011121; Martinez-Gras I, 2006, EUR ARCH PSY CLIN N, V256, P437, DOI 10.1007/s00406-006-0665-3; Matsutani S, 1997, J MOL BIOL, V267, P548, DOI 10.1006/jmbi.1996.0894; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Ohshima K, 1996, J BIOL CHEM, V271, P16784, DOI 10.1074/jbc.271.28.16784; Oshima T, 2006, DNA RES, V13, P141, DOI 10.1093/dnares/dsl009; OTTA E, 2003, EUR J BIOCHEM, V270, P4755; PAN X, 2006, J GENET GENOMICS, V33, P373; PAN X, 2006, J GENET GENOMICS, V33, P1; Pan XF, 2000, NUCLEIC ACIDS RES, V28, P3178, DOI 10.1093/nar/28.16.3178; Pan XF, 2009, DNA REPAIR, V8, P1321, DOI 10.1016/j.dnarep.2009.08.001; Rocha EPC, 2002, NUCLEIC ACIDS RES, V30, P1886, DOI 10.1093/nar/30.9.1886; Rouquette C, 2004, J BACTERIOL, V186, P2091, DOI 10.1128/JB.186.7.2091-2098.2004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; Shiga Y, 2001, J BACTERIOL, V183, P2476, DOI 10.1128/JB.183.8.2476-2484.2001; Subramanian S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r13; Swingle B, 2004, MOL MICROBIOL, V52, P1055, DOI 10.1111/j.1365-2958.2004.04051.x; TODD J, 2009, FEMS MICROBIOL REV, P1; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Trotta E, 2000, BIOCHEMISTRY-US, V39, P6799, DOI 10.1021/bi0001473; Ujike H, 2002, MOL PSYCHIATR, V7, P515, DOI 10.1038/sj.mp.4001029; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; YASUZAWA K, 1992, GENE, V122, P9	49	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14271	10.1371/journal.pone.0014271	http://dx.doi.org/10.1371/journal.pone.0014271			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151567	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800007
J	Exil, VJ; Avila, DS; Benedetto, A; Exil, EA; Adams, MR; Au, C; Aschner, M				Exil, Vernat J.; Avila, Daiana Silva; Benedetto, Alexandre; Exil, Elizabeth A.; Adams, Margaret R.; Au, Catherine; Aschner, Michael			Stressed-Induced TMEM135 Protein Is Part of a Conserved Genetic Network Involved in Fat Storage and Longevity Regulation in Caenorhabditis elegans	PLOS ONE			English	Article							ACYL-COA DEHYDROGENASE; COENZYME-A DEHYDROGENASE; LIFE-SPAN; C-ELEGANS; ACID OXIDATION; MOLECULAR HETEROGENEITY; TRANSCRIPTION FACTOR; MUTATION ANALYSIS; SUDDEN-DEATH; DEFICIENCY	Disorders of mitochondrial fat metabolism lead to sudden death in infants and children. Although survival is possible, the underlying molecular mechanisms which enable this outcome have not yet been clearly identified. Here we describe a conserved genetic network linking disorders of mitochondrial fat metabolism in mice to mechanisms of fat storage and survival in Caenorhabditis elegans (C. elegans). We have previously documented a mouse model of mitochondrial very-long chain acyl-CoA dehydrogenase (VLCAD) deficiency.[1] We originally reported that the mice survived birth, but, upon exposure to cold and fasting stresses, these mice developed cardiac dysfunction, which greatly reduced survival. We used cDNA microarrays[2,3,4] to outline the induction of several markers of lipid metabolism in the heart at birth in surviving mice. We hypothesized that the induction of fat metabolism genes in the heart at birth is part of a regulatory feedback circuit that plays a critical role in survival.[1] The present study uses a dual approach employing both C57BL/6 mice and the nematode, C. elegans, to focus on TMEM135, a conserved protein which we have found to be upregulated 4.3 (+/- 0.14)-fold in VLCAD-deficient mice at birth. Our studies have demonstrated that TMEM135 is highly expressed in mitochondria and in fat-loaded tissues in the mouse. Further, when fasting and cold stresses were introduced to mice, we observed 3.25 (+/- 0.03)- and 8.2 (+/- 0.31)-fold increases in TMEM135 expression in the heart, respectively. Additionally, we found that deletion of the tmem135 orthologue in C. elegans caused a 41.8% (+/- 2.8%) reduction in fat stores, a reduction in mitochondrial action potential and decreased longevity of the worm. In stark contrast, C. elegans transgenic animals overexpressing TMEM-135 exhibited increased longevity upon exposure to cold stress. Based on these results, we propose that TMEM135 integrates biological processes involving fat metabolism and energy expenditure in both the worm (invertebrates) and in mammalian organisms. The data obtained from our experiments suggest that TMEM135 is part of a regulatory circuit that plays a critical role in the survival of VLCAD-deficient mice and perhaps in other mitochondrial genetic defects of fat metabolism as well.	[Exil, Vernat J.] Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Thomas P Graham Div Pediat Cardiol, Nashville, TN 37240 USA; [Avila, Daiana Silva; Benedetto, Alexandre; Exil, Elizabeth A.; Adams, Margaret R.; Au, Catherine; Aschner, Michael] Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Ctr Mol Toxicol, Nashville, TN USA; [Benedetto, Alexandre; Au, Catherine] UCL, London Ctr Nanotechnol, London, England	Vanderbilt University; Vanderbilt University; University of London; University College London	Exil, VJ (corresponding author), Vanderbilt Univ, Dept Pediat, Monroe Carell Jr Childrens Hosp, Thomas P Graham Div Pediat Cardiol, Nashville, TN 37240 USA.	Vernat.exil@vanderbilt.edu	Avila, Daiana S/I-6617-2012; Benedetto, Alexandre/A-5766-2014; Exil, Vernat/GYD-7777-2022; Benedetto, Alexandre/W-5930-2019	Avila, Daiana S/0000-0002-8673-1909; Benedetto, Alexandre/0000-0002-4593-2114; Benedetto, Alexandre/0000-0002-4593-2114; Au, Catherine/0000-0002-1923-9121; Exil, Vernat/0000-0001-5935-4039	Vanderbilt Physician Scientific Development, American Heart Association (South East Affiliates, AHA) [0355278B]; National Institute of Environmental Health Sciences [ES07731, ES10563]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010563] Funding Source: NIH RePORTER	Vanderbilt Physician Scientific Development, American Heart Association (South East Affiliates, AHA)(American Heart Association); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Vanderbilt Physician Scientific Development, American Heart Association f(South East Affiliates, AHA Number 0355278B) (Vernat Exil) and National Institute of Environmental Health Sciences, ES07731 and ES10563 (Michael Aschner). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen BS, 1999, AM J HUM GENET, V64, P479, DOI 10.1086/302261; Antebi A, 1998, DEVELOPMENT, V125, P1191; AOYAMA T, 1995, AM J HUM GENET, V57, P273; AOYAMA T, 1993, BIOCHEM BIOPH RES CO, V191, P1369, DOI 10.1006/bbrc.1993.1368; BARSTEAD RJ, 1991, CELL MOTIL CYTOSKEL, V20, P69, DOI 10.1002/cm.970200108; Bastie CC, 2005, J BIOL CHEM, V280, P14222, DOI 10.1074/jbc.M413625200; BELL J, 1999, NATURE, P71; BERTRAND C, 1993, BIOCHIM BIOPHYS ACTA, V1180, P327, DOI 10.1016/0925-4439(93)90058-9; BRENNER S, 1974, GENETICS, V77, P71; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Exil VJ, 2005, PROG PEDIATR CARDIOL, V20, P143, DOI 10.1016/j.ppedcard.2005.04.005; Exil VJ, 2006, AM J PHYSIOL-HEART C, V290, pH1289, DOI 10.1152/ajpheart.00811.2005; Exil VJ, 2003, CIRC RES, V93, P448, DOI 10.1161/01.RES.0000088786.19197.E4; GOTTLIEB S, 1994, GENETICS, V137, P107; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gregersen N, 2001, HUM MUTAT, V18, P169, DOI 10.1002/humu.1174.abs; Hedge P., 2000, BIOTECHNIQUES, V29, P548; Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Liu Fangli, 2007, Journal of Genetics and Genomics, V34, P189, DOI 10.1016/S1673-8527(07)60020-4; Mathur A, 1999, CIRCULATION, V99, P1337, DOI 10.1161/01.CIR.99.10.1337; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; McKay SJ, 2003, COLD SPRING HARB SYM, V68, P159, DOI 10.1101/sqb.2003.68.159; MITCHELL DH, 1979, J GERONTOL, V34, P28, DOI 10.1093/geronj/34.1.28; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pons R, 2000, PEDIATR NEUROL, V22, P98, DOI 10.1016/S0887-8994(99)00132-0; Rohas LM, 2007, P NATL ACAD SCI USA, V104, P7933, DOI 10.1073/pnas.0702683104; Scheideler M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-340; Souri M, 1996, AM J HUM GENET, V58, P97; Spiekerkoetter U, 2004, EUR J CLIN INVEST, V34, P191, DOI 10.1111/j.1365-2362.2004.01308.x; STRAUSS AW, 1995, P NATL ACAD SCI USA, V92, P10496, DOI 10.1073/pnas.92.23.10496; Werdich AA, 2007, AM J PHYSIOL-HEART C, V292, pH2202, DOI 10.1152/ajpheart.00382.2006; Yanase S, 2002, MECH AGEING DEV, V123, P1579, DOI 10.1016/S0047-6374(02)00093-3	43	26	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14228	10.1371/journal.pone.0014228	http://dx.doi.org/10.1371/journal.pone.0014228			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151927	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600020
J	Allen, AE; Cameron, MA; Brown, TM; Vugler, AA; Lucas, RJ				Allen, Annette E.; Cameron, Morven A.; Brown, Timothy M.; Vugler, Anthony A.; Lucas, Robert J.			Visual Responses in Mice Lacking Critical Components of All Known Retinal Phototransduction Cascades	PLOS ONE			English	Article							SIGNALING PATHWAY; CONE TRANSDUCIN; ROD TRANSDUCIN; MELANOPSIN; PHOTORECEPTORS; ANTAGONIST; MUTATION	The mammalian visual system relies upon light detection by outer-retinal rod/cone photoreceptors and melanopsin-expressing retinal ganglion cells. Gnat1(-/-); Cnga3(-/-); Opn4(-/-) mice lack critical elements of each of these photoreceptive mechanisms via targeted disruption of genes encoding rod alpha transducin (Gnat1); the cone-specific alpha 3 cyclic nucleotide gated channel subunit (Cnga3); and melanopsin (Opn4). Although assumed blind, we show here that these mice retain sufficiently widespread retinal photoreception to drive a reproducible flash electroretinogram (ERG). The threshold sensitivity of this ERG is similar to that of cone-based responses, however it is lost under light adapted conditions. Its spectral efficiency is consistent with that of rod opsin, but not cone opsins or melanopsin, indicating that it originates with light absorption by the rod pigment. The TKO light response survives intravitreal injection of U73122 (a phospholipase C antagonist), but is inhibited by a missense mutation of cone alpha transducin (Gnat2(cpfl3)), suggesting Gnat2-dependence. Visual responses in TKO mice extend beyond the retina to encompass the lateral margins of the lateral geniculate nucleus and components of the visual cortex. Our data thus suggest that a Gnat1-independent phototransduction mechanism downstream of rod opsin can support relatively widespread responses in the mammalian visual system. This anomalous rod opsin-based vision should be considered in experiments relying upon Gnat1 knockout to silence rod phototransduction.	[Allen, Annette E.; Cameron, Morven A.; Brown, Timothy M.; Lucas, Robert J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Vugler, Anthony A.] UCL, Inst Ophthalmol, Dept Ocular Biol & Therapeut, London, England	University of Manchester; University of London; University College London	Allen, AE (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	robert.lucas@manchester.ac.uk	Cameron, Morven/B-4128-2012	Lucas, Robert/0000-0002-1088-8029; Allen, Annette/0000-0003-0214-7076; Cameron, Morven/0000-0002-2277-7035; Brown, Timothy/0000-0002-5625-4750	Wellcome Trust; Biotechnology and Biological Sciences Research Council; Your Manchester Fund; Lincy Foundation; London Project to Cure Blindness	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Your Manchester Fund; Lincy Foundation; London Project to Cure Blindness	This work was supported by the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, and the Your Manchester Fund (to RJL), and The Lincy Foundation and The London Project to Cure Blindness (to AAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnard AR, 2006, CURR BIOL, V16, P389, DOI 10.1016/j.cub.2005.12.045; Biel M, 1999, P NATL ACAD SCI USA, V96, P7553, DOI 10.1073/pnas.96.13.7553; Brockerhoff SE, 2003, J NEUROSCI, V23, P470, DOI 10.1523/JNEUROSCI.23-02-00470.2003; BROWN KT, 1964, NATURE, V201, P626, DOI 10.1038/201626a0; Brown TM, 2011, VISION RES, V51, P280, DOI 10.1016/j.visres.2010.08.010; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Deng WT, 2009, P NATL ACAD SCI USA, V106, P17681, DOI 10.1073/pnas.0901382106; Dryja TP, 1996, NAT GENET, V13, P358, DOI 10.1038/ng0796-358; Dyka FM, 2004, J NEUROCHEM, V90, P190, DOI 10.1111/j.1471-4159.2004.02474.x; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; Grubb MS, 2003, J NEUROPHYSIOL, V90, P3594, DOI 10.1152/jn.00699.2003; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Kohara A, 2005, J PHARMACOL EXP THER, V315, P163, DOI 10.1124/jpet.105.087171; KOJIMA D, 1992, P NATL ACAD SCI USA, V89, P6841, DOI 10.1073/pnas.89.15.6841; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lucas RJ, 2001, NAT NEUROSCI, V4, P621, DOI 10.1038/88443; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lucas RJ, 1999, SCIENCE, V284, P505, DOI 10.1126/science.284.5413.505; Lyubarsky AL, 2004, VISION RES, V44, P3235, DOI 10.1016/j.visres.2004.09.019; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng YW, 1997, P NATL ACAD SCI USA, V94, P1995, DOI 10.1073/pnas.94.5.1995; Porter RHP, 2005, J PHARMACOL EXP THER, V315, P711, DOI 10.1124/jpet.105.089839; Semo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015009; Soucy E, 1998, NEURON, V21, P481, DOI 10.1016/S0896-6273(00)80560-7; SZEL A, 1988, VISION RES, V28, P1297, DOI 10.1016/0042-6989(88)90060-0; Umino Y, 2008, J NEUROSCI, V28, P189, DOI 10.1523/JNEUROSCI.3551-07.2008; Van der Gucht E, 2007, CEREB CORTEX, V17, P2805, DOI 10.1093/cercor/bhm012; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ying SX, 2000, MOL VIS, V6, P101	33	46	46	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15063	10.1371/journal.pone.0015063	http://dx.doi.org/10.1371/journal.pone.0015063			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124780	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500030
J	Shenoy, C; Boura, J; Orshaw, P; Harjai, KJ				Shenoy, Chetan; Boura, Judy; Orshaw, Pamela; Harjai, Kishore J.			Drug-Eluting Stents in Patients with Chronic Kidney Disease: A Prospective Registry Study	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MODERATE RENAL-INSUFFICIENCY; RANDOMIZED CLINICAL-TRIALS; BARE-METAL STENTS; MYOCARDIAL-INFARCTION; ANGIOGRAPHIC OUTCOMES; DIALYSIS PATIENTS; THROMBOSIS; IMPACT; IMPLANTATION	Background: Chronic kidney disease (CKD) is strongly associated with adverse outcomes after percutaneous coronary intervention (PCI). There are limited data on the effectiveness of drug-eluting stents (DES) in patients with CKD. Methodology/Principal Findings: Of 3,752 consecutive patients enrolled in the Guthrie PCI Registry between 2001 and 2006, 436 patients with CKD - defined as a creatinine clearance <60 mL/min - were included in this study. Patients who received DES were compared to those who received bare metal stents (BMS). Patients were followed for a mean duration of 3 years after the index PCI to determine the prognostic impact of stent type. Study end-points were all-cause death, myocardial infarction (MI), target vessel revascularization (TVR), stent thrombosis (ST) and the composite of major adverse cardiovascular events (MACE), defined as death, MI or TVR. Patients receiving DES in our study, by virtue of physician selection, had more stable coronary artery disease and had lower baseline risk of thrombotic or restenotic events. Kaplan-Meier estimates of proportions of patients reaching the end-points were significantly lower for DES vs. BMS for all-cause death (p = 0.0008), TVR (p = 0.029) and MACE (p = 0.0015), but not MI (p = 0.945) or ST (p = 0.88). Multivariable analysis with propensity adjustment demonstrated that DES implantation was an independent predictor of lower rates of all-cause death (hazard ratio [HR] 0.48, 95% confidence interval [CI] 0.25-0.92), TVR (HR 0.50, 95% CI 0.27-0.94) and MACE (HR 0.62, 95% CI 0.41-0.94). Conclusions: In a contemporary PCI registry, selective use of DES in patients with CKD was safe and effective in the long term, with lower risk of all-cause death, TVR and MACE and similar risk of MI and ST as compared with BMS. The mortality benefit may be a result of selection bias and residual confounding, or represent a true finding; a hypothesis that warrants clarification by randomized clinical trials.	[Shenoy, Chetan; Orshaw, Pamela; Harjai, Kishore J.] Guthrie Clin, Sayre, PA USA; [Boura, Judy] William Beaumont Hosp, Royal Oak, MI 48072 USA	Beaumont Health	Shenoy, C (corresponding author), Guthrie Clin, Sayre, PA USA.	harjai_kishore@guthrie.org	Shenoy, Chetan/AAF-9363-2020	Shenoy, Chetan/0000-0001-8877-4999				Appleby CE, 2009, CIRC-CARDIOVASC INTE, V2, P309, DOI 10.1161/CIRCINTERVENTIONS.108.828954; Bavry AA, 2006, AM J MED, V119, P1056, DOI 10.1016/j.amjmed.2006.01.023; Bhatt DL, 2007, J AM COLL CARDIOL, V49, P1982, DOI 10.1016/j.jacc.2007.03.025; Coca SG, 2006, JAMA-J AM MED ASSOC, V296, P1377, DOI 10.1001/jama.296.11.1377; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Hage FG, 2009, J AM COLL CARDIOL, V53, P2129, DOI 10.1016/j.jacc.2009.02.047; Halkin A, 2005, AM HEART J, V150, P1163, DOI 10.1016/j.ahj.2005.01.032; Harjai KJ, 2009, HEART, V95, P1579, DOI 10.1136/hrt.2009.169896; Himmelfarb J, 2007, JAMA-J AM MED ASSOC, V297, P2630, DOI 10.1001/jama.297.23.2630; Iakovou I, 2005, JAMA-J AM MED ASSOC, V293, P2126, DOI 10.1001/jama.293.17.2126; Ishio N, 2007, CIRC J, V71, P1525, DOI 10.1253/circj.71.1525; Jensen LO, 2007, J AM COLL CARDIOL, V50, P463, DOI 10.1016/j.jacc.2007.06.002; King SB, 2008, CIRCULATION, V117, P261, DOI 10.1161/CIRCULATIONAHA.107.188208; Kirtane AJ, 2009, CIRCULATION, V119, P3198, DOI 10.1161/CIRCULATIONAHA.108.826479; Kuchulakanti PK, 2006, CIRCULATION, V113, P1108, DOI 10.1161/CIRCULATIONAHA.105.600155; Lasala JM, 2009, CIRC-CARDIOVASC INTE, V2, P285, DOI 10.1161/CIRCINTERVENTIONS.109.852178.109.852178; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Mellord C, 2008, J AM COLL CARDIOL, V51, P991, DOI 10.1016/j.jacc.2007.11.045; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Nakazawa G, 2007, CATHETER CARDIO INTE, V69, P808, DOI 10.1002/ccd.21016; *NAT CARD DAT REG, TECHN DOWNL RISK ADJ; Novak JE, 2008, J AM SOC NEPHROL, V19, P2, DOI 10.1681/ASN.2007101136; Okada T, 2008, CIRC J, V72, P1430, DOI 10.1253/circj.CJ-08-0010; Pfisterer M, 2006, J AM COLL CARDIOL, V48, P2584, DOI 10.1016/j.jacc.2006.10.026; Shenoy C, 2009, J INTERV CARDIOL, V22, P156, DOI 10.1111/j.1540-8183.2009.00424.x; Spaulding C, 2010, HEART, V96, P1073, DOI 10.1136/hrt.2008.161422; Stettler C, 2007, LANCET, V370, P937, DOI 10.1016/S0140-6736(07)61444-5; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; US Renal Data System: USRDS, 2009, ANN DAT REP ATL CHRO; Widimsky P, 2010, HEART, V96, P86, DOI 10.1136/hrt.2008.161034; Zhang RY, 2006, CHINESE MED J-PEKING, V119, P1176, DOI 10.1097/00029330-200607020-00007	33	27	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15070	10.1371/journal.pone.0015070	http://dx.doi.org/10.1371/journal.pone.0015070			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124771	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500033
J	Waddell, JN; Zhang, PJ; Wen, YF; Gupta, SK; Yevtodiyenko, A; Schmidt, JV; Bidwell, CA; Kumar, A; Kuang, SH				Waddell, Jolena N.; Zhang, Peijing; Wen, Yefei; Gupta, Sanjay K.; Yevtodiyenko, Aleksey; Schmidt, Jennifer V.; Bidwell, Christopher A.; Kumar, Ashok; Kuang, Shihuan			Dlk1 Is Necessary for Proper Skeletal Muscle Development and Regeneration	PLOS ONE			English	Article							SATELLITE CELL-DIFFERENTIATION; FACTOR-KAPPA-B; MYOGENIC DIFFERENTIATION; IMPRINTED GENES; SELF-RENEWAL; STEM-CELLS; INFLAMMATORY CYTOKINES; CALLIPYGE REGION; PROGENITOR CELLS; EXPRESSION	Delta-like 1homolog (Dlk1) is an imprinted gene encoding a transmembrane protein whose increased expression has been associated with muscle hypertrophy in animal models. However, the mechanisms by which Dlk1 regulates skeletal muscle plasticity remain unknown. Here we combine conditional gene knockout and over-expression analyses to investigate the role of Dlk1 in mouse muscle development, regeneration and myogenic stem cells (satellite cells). Genetic ablation of Dlk1 in the myogenic lineage resulted in reduced body weight and skeletal muscle mass due to reductions in myofiber numbers and myosin heavy chain IIB gene expression. In addition, muscle-specific Dlk1 ablation led to postnatal growth retardation and impaired muscle regeneration, associated with augmented myogenic inhibitory signaling mediated by NF-kappa B and inflammatory cytokines. To examine the role of Dlk1 in satellite cells, we analyzed the proliferation, self-renewal and differentiation of satellite cells cultured on their native host myofibers. We showed that ablation of Dlk1 inhibits the expression of the myogenic regulatory transcription factor MyoD, and facilitated the self-renewal of activated satellite cells. Conversely, Dlk1 over-expression inhibited the proliferation and enhanced differentiation of cultured myoblasts. As Dlk1 is expressed at low levels in satellite cells but its expression rapidly increases upon myogenic differentiation in vitro and in regenerating muscles in vivo, our results suggest a model in which Dlk1 expressed by nascent or regenerating myofibers non-cell autonomously promotes the differentiation of their neighbor satellite cells and therefore leads to muscle hypertrophy.	[Waddell, Jolena N.; Zhang, Peijing; Wen, Yefei; Bidwell, Christopher A.; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Gupta, Sanjay K.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40292 USA; [Yevtodiyenko, Aleksey] Stanford Univ, Sch Med, Div Oncol, Stanford, CA 94305 USA; [Schmidt, Jennifer V.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Kuang, Shihuan] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Louisville; Stanford University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Waddell, JN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	skuang@purdue.edu	Gupta/ABE-4368-2020; liang, yan/H-3894-2011	Kumar, Ashok/0000-0001-8571-2848; Wen, Yefei/0000-0002-2121-7538; Kuang, Shihuan/0000-0001-9180-3180; Zhang, Peijing/0000-0003-1586-8710	National Institutes of Health [1R01AR060652-01A1, HD042013]; Muscular Dystrophy Association [92478]; United States Department of Agriculture - National Research Initiative [2009-35206-05218]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD042013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); United States Department of Agriculture - National Research Initiative(United States Department of Agriculture (USDA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The work was funded by National Institutes of Health grant # 1R01AR060652-01A1 to SK and grant # HD042013 to JVS; Muscular Dystrophy Association grant # 92478 to SK; United States Department of Agriculture - National Research Initiative Grant # 2009-35206-05218 to SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah BM, 2007, J BIOL CHEM, V282, P7339, DOI 10.1074/jbc.M607530200; Andersen DC, 2009, STEM CELLS, V27, P898, DOI 10.1634/stemcells.2008-0826; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bakkar N, 2010, PHYSIOL REV, V90, P495, DOI 10.1152/physrev.00040.2009; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; BRAUN T, 1989, EMBO J, V8, P701, DOI 10.1002/j.1460-2075.1989.tb03429.x; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Brennan K, 1999, CURR BIOL, V9, P707, DOI 10.1016/S0960-9822(99)80313-3; Carpenter E, 1996, J ANIM SCI, V74, P388; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Charge SBP, 2002, AM J PHYSIOL-CELL PH, V283, pC1228, DOI 10.1152/ajpcell.00206.2002; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; CORBIN V, 1991, CELL, V67, P311, DOI 10.1016/0092-8674(91)90183-Y; da Rocha ST, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000392; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; Espina AG, 2009, MOL BIOL CELL, V20, P3353, DOI 10.1091/mbc.E08-09-0965; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Fleming-Waddell JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007399; Floridon C, 2000, DIFFERENTIATION, V66, P49, DOI 10.1046/j.1432-0436.2000.066001049.x; Freking BA, 1998, J ANIM SCI, V76, P2549; Halevy O, 2004, DEV DYNAM, V231, P489, DOI 10.1002/dvdy.20151; Jackson SP, 1997, J ANIM SCI, V75, P133; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Khoury H, 2010, BLOOD, V115, P2260, DOI 10.1182/blood-2009-03-212746; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Kumar A, 2004, J MOL MED, V82, P434, DOI 10.1007/s00109-004-0555-y; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Kuroda K, 1999, J BIOL CHEM, V274, P7238, DOI 10.1074/jbc.274.11.7238; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; LABORDA J, 1993, J BIOL CHEM, V268, P3817; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; Li H, 2008, J MOL MED, V86, P1113, DOI 10.1007/s00109-008-0373-8; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Monsalve E, 2009, EUR J IMMUNOL, V39, P2556, DOI 10.1002/eji.200838722; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Moon YS, 2002, MOL CELL BIOL, V22, P5585, DOI 10.1128/MCB.22.15.5585-5592.2002; Moresi V, 2008, STEM CELLS, V26, P997, DOI 10.1634/stemcells.2007-0493; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nofziger D, 1999, DEVELOPMENT, V126, P1689; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Ordentlich P, 1998, MOL CELL BIOL, V18, P2230, DOI 10.1128/MCB.18.4.2230; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Raghunandan R, 2008, STEM CELLS DEV, V17, P495, DOI 10.1089/scd.2007.0102; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Rusconi JC, 1998, MECH DEVELOP, V79, P39, DOI 10.1016/S0925-4773(98)00170-1; Sabourin LA, 2000, CLIN GENET, V57, P16, DOI 10.1034/j.1399-0004.2000.570103.x; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schmidt JV, 2000, GENE DEV, V14, P1997; Schuster-Gossler K, 2007, P NATL ACAD SCI USA, V104, P537, DOI 10.1073/pnas.0608281104; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Song LL, 2008, ONCOGENE, V27, P5833, DOI 10.1038/onc.2008.190; Sprinzak D, 2010, NATURE, V465, P86, DOI 10.1038/nature08959; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takeda H, 2006, P NATL ACAD SCI USA, V103, P8119, DOI 10.1073/pnas.0602844103; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Thaloor D, 1999, AM J PHYSIOL-CELL PH, V277, pC320, DOI 10.1152/ajpcell.1999.277.2.C320; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vasyutina E, 2007, CELL CYCLE, V6, P1451; Vasyutina E, 2007, P NATL ACAD SCI USA, V104, P4443, DOI 10.1073/pnas.0610647104; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Wang YH, 2010, MOL CELL BIOL, V30, P3480, DOI 10.1128/MCB.00057-10; Wang YH, 2009, CELL METAB, V9, P287, DOI 10.1016/j.cmet.2009.01.013; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; WIGSTON DJ, 1992, J NEUROBIOL, V23, P61, DOI 10.1002/neu.480230107; YANAI H, 2010, J BIOCH; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	88	92	97	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15055	10.1371/journal.pone.0015055	http://dx.doi.org/10.1371/journal.pone.0015055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124733	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500027
J	Geng, EH; Bwana, MB; Kabakyenga, J; Muyindike, W; Emenyonu, NI; Musinguzi, N; Mugyenyi, P; Martin, JN; Bangsberg, DR				Geng, Elvin H.; Bwana, Mwebesa B.; Kabakyenga, Jerome; Muyindike, Winnie; Emenyonu, Nneka I.; Musinguzi, Nicholas; Mugyenyi, Peter; Martin, Jeffrey N.; Bangsberg, David R.			Diminishing Availability of Publicly Funded Slots for Antiretroviral Initiation among HIV-Infected ART-Eligible Patients in Uganda	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ADHERENCE; IMPACT	Background: The impact of flat-line funding in the global scale up of antiretroviral therapy (ART) for HIV-infected patients in Africa has not yet been well described. Methods: We evaluated ART-eligible patients and patients starting ART at a prototypical scale up ART clinic in Mbarara, Uganda between April 1, 2009 and May 14, 2010 where four stakeholders sponsor treatment - two PEPFAR implementing organizations, the Ugandan Ministry of Health - Global Fund (MOH-GF) and a private foundation named the Family Treatment Fund (FTF). We assessed temporal trends in the number of eligible patients, the number starting ART and tabulated the distribution of the stakeholders supporting ART initiation by month and quartile of time during this interval. We used survival analyses to assess changes in the rate of ART initiation over calendar time. Findings: A total of 1309 patients who were eligible for ART made visits over the 14 month period of the study and of these 819 started ART. The median number of ART eligible patients each month was 88 (IQR: 74 to 115). By quartile of calendar time, PEPFAR and MOH sponsored 290, 192, 180, and 49 ART initiations whereas the FTF started 1, 2, 1 and 104 patients respectively. By May of 2010 (the last calendar month of observation) FTF sponsored 88% of all ART initiations. Becoming eligible for ART in the 3(rd) (HR = 0.58, 95% 0.45-0.74) and 4(th) quartiles (HR = 0.49, 95% CI: 0.36-0.65) was associated with delay in ART initiation compared to the first quartile in multivariable analyses. Interpretation: During a period of flat line funding from multinational donors for ART programs, reductions in the number of ART initiations by public programs (i.e., PEPFAR and MOH-GF) and delays in ART initiation became apparent at the a large prototypical scale-up ART clinic in Uganda.	[Geng, Elvin H.; Martin, Jeffrey N.] San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94110 USA; [Martin, Jeffrey N.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Bwana, Mwebesa B.; Kabakyenga, Jerome; Muyindike, Winnie; Emenyonu, Nneka I.; Musinguzi, Nicholas; Mugyenyi, Peter; Bangsberg, David R.] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Emenyonu, Nneka I.; Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ragon Inst,Massachusetts Inst Technol & Harvard,C, Boston, MA USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Mbarara University of Science & Technology; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Geng, EH (corresponding author), San Francisco Gen Hosp, Dept Med, Div HIV AIDS, San Francisco, CA 94110 USA.	dbangsberg@partners.org	Muyindike, Winnie/W-2892-2019		National Institutes of Health [K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763, K24 MH87227]; Mark and Lisa Schwartz Family Foundation; United States President's Emergency Plan for AIDS Relief (PEPFAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, U01AI069911, K23AI084544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227, R01MH054907] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mark and Lisa Schwartz Family Foundation; United States President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	National Institutes of Health (K23 AI084544, U01 AI069911, R01 MH054907, P30 AI027763, K24 MH87227), The Mark and Lisa Schwartz Family Foundation, and the United States President's Emergency Plan for AIDS Relief (PEPFAR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	FOX M, 2010, TIME EFFICIENCY FIGH; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; KATABIRA ET, 2009, HLTH MO; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Mills EJ, 2006, JAMA-J AM MED ASSOC, V296, P679, DOI 10.1001/jama.296.6.679; MWAGOMBA B, PLOS ONE, V5; Nguyen VK, 2007, AIDS, V21, pS31, DOI 10.1097/01.aids.0000298100.48990.58; *OFF US GLOB AIDS, POW PARTN PRES EM PL; Rosen S, 2007, PLOS MED, V4, P1691, DOI 10.1371/journal.pmed.0040298; Soni A, 2009, HEALTH AFFAIR, V28, P1617, DOI 10.1377/hlthaff.28.6.1617; Thirumurthy H, 2008, J HUM RESOUR, V43, P511, DOI 10.3368/jhr.43.3.511; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; PEPFAR UGANDA ART HA; NO TIME QUITE HIV AI	14	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14098	10.1371/journal.pone.0014098	http://dx.doi.org/10.1371/journal.pone.0014098			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124842	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000004
J	Redon, CE; Nakamura, AJ; Gouliaeva, K; Rahman, A; Blakely, WF; Bonner, WM				Redon, Christophe E.; Nakamura, Asako J.; Gouliaeva, Ksenia; Rahman, Arifur; Blakely, William F.; Bonner, William M.			The Use of Gamma-H2AX as a Biodosimeter for Total-Body Radiation Exposure in Non-Human Primates	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PERIPHERAL-BLOOD LYMPHOCYTES; IONIZING-RADIATION; DNA-DAMAGE; IN-VIVO; HAIR-FOLLICLES; FOCI; BIOMARKER; SKIN; FRAGMENTATION	Background: There is a crucial shortage of methods capable of determining the extent of accidental exposures of human beings to ionizing radiation. However, knowledge of individual exposures is essential for early triage during radiological incidents to provide optimum possible life-sparing medical procedures to each person. Methods and Findings: We evaluated immunocytofluorescence-based quantitation of gamma-H2AX foci as a biodosimeter of total-body radiation exposure (Co-60 gamma-rays) in a rhesus macaque (Macaca mulatta) model. Peripheral blood lymphocytes and plucked hairs were collected from 4 cohorts of macaques receiving total body irradiation doses ranging from 1 Gy to 8.5 Gy. Each cohort consisted of 6 experimental and 2 control animals. Numbers of residual gamma-H2AX foci were proportional to initial irradiation doses and statistically significant responses were obtained until 1 day after 1 Gy, 4 days after 3.5 and 6.5 Gy, and 14 days after 8.5 Gy in lymphocytes and until 1 day after 1 Gy, at least 2 days after 3.5 and 6.5 Gy, and 9 days after 8.5 Gy in plucked hairs. Conclusion: These findings indicate that quantitation of gamma-H2AX foci may make a robust biodosimeter for analyzing total-body exposure to ionizing radiation in humans. This tool would help clinicians prescribe appropriate types of medical intervention for optimal individual outcome. These results also demonstrate that the use of a high throughput gamma-H2AX biodosimeter would be useful for days post-exposure in applications like large-scale radiological events or radiation therapy. In addition, this study validates a possibility to use plucked hair in future clinical trials investigating genotoxic effects of drugs and radiation treatments.	[Redon, Christophe E.; Nakamura, Asako J.; Gouliaeva, Ksenia; Bonner, William M.] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Rahman, Arifur; Blakely, William F.] Uniformed Serv Univ Hlth Sci, Armed Forces Radiobiol Res Inst, Bethesda, MD 20814 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Uniformed Services University of the Health Sciences - USA; United States Department of Defense	Redon, CE (corresponding author), NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	redonc@mail.nih.gov			NIAID; National Cancer Institute, Center for Cancer Research, NIH; Armed Forces Radiobiology Research Institute [BD-13 (RBB4AR)]; NATIONAL CANCER INSTITUTE [ZIABC006140] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Armed Forces Radiobiology Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the NIAID Radiation/Nuclear Countermeasures Program, the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH and under Armed Forces Radiobiology Research Institute under research work unit number BD-13 (RBB4AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Belyaev IY, 2010, MUTAT RES-REV MUTAT, V704, P132, DOI 10.1016/j.mrrev.2010.01.011; Bhogal N, 2010, RADIAT RES, V173, P1, DOI 10.1667/RR1851.1; Blakely WF, 2010, HEALTH PHYS, V98, P153, DOI 10.1097/HP.0b013e3181b0306d; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Boxman ILA, 1999, J CLIN MICROBIOL, V37, P2270, DOI 10.1128/JCM.37.7.2270-2273.1999; Cai ZL, 2009, INT J RADIAT BIOL, V85, P262, DOI 10.1080/09553000902748757; Camidge DR, 2005, BRIT J CANCER, V92, P1837, DOI 10.1038/sj.bjc.6602558; Conklin WC, 2005, HEALTH PHYS, V89, P457, DOI 10.1097/01.HP.0000178546.37526.c8; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Garty G, 2010, HEALTH PHYS, V98, P209, DOI 10.1097/HP.0b013e3181ab3cb6; Geisel D, 2008, RADIOLOGY, V248, P852, DOI 10.1148/radiol.2483071686; Goans RE, 1997, HEALTH PHYS, V72, P513, DOI 10.1097/00004032-199704000-00001; Gonzalez AJ, 2005, HEALTH PHYS, V89, P418, DOI 10.1097/01.HP.0000179340.57348.26; GREEN MR, 1986, J INVEST DERMATOL, V87, P768, DOI 10.1111/1523-1747.ep12457348; Hou YN, 2009, RADIAT RES, V171, P360, DOI 10.1667/RR1349.1; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Kyoizumi S, 1998, RADIAT RES, V149, P11, DOI 10.2307/3579676; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Martin PR, 2007, RADIAT MEAS, V42, P1119, DOI 10.1016/j.radmeas.2007.05.021; Mukherjee B, 2006, DNA REPAIR, V5, P575, DOI 10.1016/j.dnarep.2006.01.011; Nakamura AJ, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-6; Ohnishi T, 2009, BIOCHEM BIOPH RES CO, V390, P485, DOI 10.1016/j.bbrc.2009.09.114; Porcedda P, 2006, DNA REPAIR, V5, P904, DOI 10.1016/j.dnarep.2006.05.002; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 2000, J BIOL CHEM, V275, P9390, DOI 10.1074/jbc.275.13.9390; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rothkamm K, 2007, RADIOLOGY, V242, P244, DOI 10.1148/radiol.2421060171; Rothkamm K, 2009, ANN I SUPER SANITA, V45, P265; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; SIEBER VK, 1992, BRIT J RADIOL, V65, P148, DOI 10.1259/0007-1285-65-770-148; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015	33	106	112	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15544	10.1371/journal.pone.0015544	http://dx.doi.org/10.1371/journal.pone.0015544			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124906	Green Submitted, Green Published, gold			2022-12-27	WOS:000284527900027
J	Yin, TY; Zhang, XY; Gunter, L; Priya, R; Sykes, R; Davis, M; Wullschleger, SD; Tuskan, GA				Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Sykes, Robert; Davis, Mark; Wullschleger, Stan D.; Tuskan, Gerald A.			Differential Detection of Genetic Loci Underlying Stem and Root Lignin Content in Populus	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; QUANTITATIVE TRAIT LOCI; DUPLICATED GENES; WOOD CHEMISTRY; GENOME; TRICHOCARPA; SEQUENCE; BIOMASS; SYSTEMS; GROWTH	In this study, we established a comprehensive genetic map with a large number of progeny from a three-generation hybrid Populus intercross, and phenotyped the lignin content, S/G ratio and 28 cell wall subcomponents both in stems and roots for the mapping individuals. Phenotypic analysis revealed that lignin content and syringyl-to-guaiacyl (S/G) ratio using pyrolysis molecular beam mass spectroscopy (pyMBMS) varied among mapping individuals. Phenotypic analysis revealed that stem lignin content is significantly higher than that in root and the quantified traits can be classified into four distinct groups, with strong correlations observed among components within organs. Altogether, 179 coordinating QTLs were detected, and they were co-localized into 49 genetic loci, 27 of which appear to be pleiotropic. Many of the detected genetic loci were detected differentially in stem and root. This is the first report of separate genetic loci controlling cell wall phenotypes above and below ground. These results suggest that it may be possible to modify lignin content and composition via breed and/or engineer as a means of simultaneously improving Populus for cellulosic ethanol production and carbon sequestration.	[Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Wullschleger, Stan D.; Tuskan, Gerald A.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA; [Yin, Tongming; Zhang, Xinye; Gunter, Lee; Priya, Ranjan; Sykes, Robert; Davis, Mark; Tuskan, Gerald A.] Bioenergy Sci Ctr, Oak Ridge, TN USA; [Yin, Tongming] Nanjing Forestry Univ, Key Lab Forest Genet & Gene Engn, Nanjing, Peoples R China; [Sykes, Robert; Davis, Mark] Natl Bioenergy Ctr, Natl Renewable Energy Lab, Golden, CO USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); Nanjing Forestry University; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Yin, TY (corresponding author), Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA.	gtk@ornl.gov	Tuskan, Gerald/A-6225-2011; Wullschleger, Stan D/B-8297-2012; Gunter, Lee E/L-3480-2016; Davis, Mark/F-7341-2017	Tuskan, Gerald/0000-0003-0106-1289; Wullschleger, Stan D/0000-0002-9869-0446; Gunter, Lee E/0000-0003-1211-7532; Ranjan, Priya/0000-0002-0357-1939; Davis, Mark/0000-0003-4541-9852	Oak Ridge National Laboratory (ORNL); U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center; US Department of Energy [DE-AC05-00OR22725]	Oak Ridge National Laboratory (ORNL); U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center(United States Department of Energy (DOE)); US Department of Energy(United States Department of Energy (DOE))	Funding for this research was provided by the Laboratory Directed Research and Development Program of Oak Ridge National Laboratory (ORNL) and the U.S. Department of Energy, Office of Science, Biological and Environmental Research Carbon Sequestration Program and Bioenergy Science Center. ORNL is managed by UT-Battelle, LLC for the US Department of Energy under contract no. DE-AC05-00OR22725. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Adams KL, 2004, GENETICS, V168, P2217, DOI 10.1534/genetics.104.033522; Baucher M, 1996, PLANT PHYSIOL, V112, P1479, DOI 10.1104/pp.112.4.1479; Blanc G, 2004, PLANT CELL, V16, P1679, DOI 10.1105/tpc.021410; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Boudet AM, 2003, TRENDS PLANT SCI, V8, P576, DOI 10.1016/j.tplants.2003.10.001; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; CHOW P, 1989, WOOD FIBER SCI, V21, P30; Coleman HD, 2008, PLANT PHYSIOL, V148, P1229, DOI 10.1104/pp.108.125500; Davin LB, 2005, CURR OPIN BIOTECH, V16, P407, DOI 10.1016/j.copbio.2005.06.011; Davis MF, 2006, TREE PHYSIOL, V26, P557, DOI 10.1093/treephys/26.5.557; Dinus RJ, 2001, APPL BIOCHEM BIOTECH, V91-3, P23, DOI 10.1385/ABAB:91-93:1-9:23; Dinus RJ, 2001, CRIT REV PLANT SCI, V20, P51, DOI 10.1016/S0735-2689(01)80012-5; Elberse IAM, 2004, HEREDITY, V93, P22, DOI 10.1038/sj.hdy.6800467; Foust TD, 2008, BIOMASS RECALCITRANC, P7; Frewen BE, 2000, GENETICS, V154, P837; Hu WJ, 1998, P NATL ACAD SCI USA, V95, P5407, DOI 10.1073/pnas.95.9.5407; Islam-Faridi MN, 2009, CYTOGENET GENOME RES, V125, P74, DOI 10.1159/000218749; Kelleher CT, 2007, PLANT J, V50, P1063, DOI 10.1111/j.1365-313X.2007.03112.x; Keurentjes JJB, 2007, GENETICS, V175, P891, DOI 10.1534/genetics.106.066423; Lapierre C, 1999, PLANT PHYSIOL, V119, P153, DOI 10.1104/pp.119.1.153; Li L, 2003, P NATL ACAD SCI USA, V100, P4939, DOI 10.1073/pnas.0831166100; Li X, 2008, PLANT J, V54, P569, DOI 10.1111/j.1365-313X.2008.03457.x; Novaes E, 2009, NEW PHYTOL, V182, P878, DOI 10.1111/j.1469-8137.2009.02785.x; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F; Sjostrom E., 1993, WOOD CHEM, V2nd, P1, DOI [DOI 10.1016/B978-0-08-092589-9.50005-X, 10.1016/B978-0-08-092589-9.50005-X]; Smith E. Chalmers, 1943, JOUR ARNOLD ARBORETUM, V24, P275; Sticklen MB, 2008, NAT REV GENET, V9, P433, DOI 10.1038/nrg2336; Sykes R, 2008, WOOD SCI TECHNOL, V42, P649, DOI 10.1007/s00226-008-0199-0; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan G, 1999, APPL BIOCHEM BIOTECH, V77-9, P55, DOI 10.1385/ABAB:77:1-3:55; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Tuskan GA, 2004, CAN J FOREST RES, V34, P85, DOI [10.1139/x03-283, 10.1139/X03-283]; Tuskan GA, 2001, FOREST CHRON, V77, P259, DOI 10.5558/tfc77259-2; Tuskan GA, 1998, BIOMASS BIOENERG, V14, P307, DOI 10.1016/S0961-9534(97)10065-4; Van Ooijen J.W., 2004, MAPQTL 6 SOFTWARE MA; van Ooijen J.W., 2001, JOINMAP 3 0 SOFTWARE; Vanholme R, 2008, CURR OPIN PLANT BIOL, V11, P278, DOI 10.1016/j.pbi.2008.03.005; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P407; Yang B, 2008, BIOFUEL BIOPROD BIOR, V2, P26, DOI 10.1002/bbb.49; Yin TM, 2004, THEOR APPL GENET, V109, P451, DOI 10.1007/s00122-004-1653-5; Yin T, 2008, GENOME RES, V18, P422, DOI 10.1101/gr.7076308	45	18	21	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14021	10.1371/journal.pone.0014021	http://dx.doi.org/10.1371/journal.pone.0014021			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21151641	Green Published, gold			2022-12-27	WOS:000284467200002
J	Yao, QO; Zhang, DW; Tang, B; Chen, J; Chen, J; Lu, LA; Zhang, WQ				Yao, Qiong; Zhang, Daowei; Tang, Bin; Chen, Jie; Chen, Jing; Lu, Liang; Zhang, Wenqing			Identification of 20-Hydroxyecdysone Late-Response Genes in the Chitin Biosynthesis Pathway	PLOS ONE			English	Article							ECDYSONE RECEPTOR ISOFORMS; STAGE-SPECIFIC EXPRESSION; DROSOPHILA-MELANOGASTER; MOLECULAR-CLONING; SYNTHASE GENE; PUFF CONTAINS; POLYTENE CHROMOSOMES; TREHALASE ACTIVITY; SPODOPTERA-EXIGUA; MATRIX FORMATION	Background: 20-hydroxyecdysone (20E) and its receptor complex ecdysone receptor (EcR) and ultraspiracle (USP) play a crucial role in controlling development, metamorphosis, reproduction and diapause. The ligand-receptor complex 20E-EcR/USP directly activates a small set of early-response genes and a much larger set of late-response genes. However, ecdysone-responsive genes have not been previously characterized in the context of insect chitin biosynthesis. Principal Findings: Here, we show that injection-based RNA interference (RNAi) directed towards a common region of the two isoforms of SeEcR in a lepidopteron insect Spodoptera exigua was effective, with phenotypes including a high mortality prior to pupation and developmental defects. After gene specific RNAi, chitin contents in the cuticle of an abnormal larva significantly decreased. The expression levels of five genes in the chitin biosynthesis pathway, SeTre-1, SeG6PI, SeUAP, SeCHSA and SeCHSB, were significantly reduced, while there was no difference in the expression of SeTre-2 prior to 72 hr after injection of EcR dsRNA. Meanwhile, injection of 20E in vivo induced the expression of the five genes mentioned above. Moreover, the SeTre-1, SeG6PI, SeUAP and SeCHSB genes showed late responses to the hormone and the induction of SeTre1, SeG6PI, SeUAP and SeCHSB genes by 20E were able to be inhibited by the protein synthesis inhibitor cycloheximide in vitro indicating these genes are 20E late-response genes. Conclusions: We conclude that SeTre-1, SeG6PI, SeUAP and SeCHSB in the chitin biosynthesis pathway are 20E late-response genes and 20E and its specific receptors plays a key role in the regulation of chitin biosynthesis via inducing their expression.	[Yao, Qiong; Zhang, Daowei; Tang, Bin; Chen, Jie; Chen, Jing; Lu, Liang; Zhang, Wenqing] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Tang, Bin] Hangzhou Normal Univ, Hangzhou Key Lab Anim Adaptat & Evolut, Hangzhou, Zhejiang, Peoples R China	Sun Yat Sen University; Hangzhou Normal University	Yao, QO (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	Lsszwq@mail.sysu.edu.cn	zhang, wenqing/GYA-0786-2022		National Natural Science Foundation of China [30871634]; National Basic Research Program of China [2006CB102001]; Science Foundation of the State Key Laboratory of Biocontrol [SKLBC 10A 01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Science Foundation of the State Key Laboratory of Biocontrol	This work was supported by National Natural Science Foundation of China (30871634), National Basic Research Program of China (2006CB102001) and Science Foundation of the State Key Laboratory of Biocontrol (SKLBC 10A 01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1992, TRENDS GENET, V8, P132, DOI 10.1016/0168-9525(92)90079-J; ANDRES AJ, 1995, DEVELOPMENT, V121, P2667; APPLE RT, 1991, DEV BIOL, V146, P569, DOI 10.1016/0012-1606(91)90257-4; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; ASHBURNER M, 1976, DEV BIOL, V54, P241, DOI 10.1016/0012-1606(76)90302-X; ASHBURNER M, 1990, CELL, V61, P1, DOI 10.1016/0092-8674(90)90205-S; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; Basso LR, 2006, GENESIS, V44, P505, DOI 10.1002/dvg.20239; Basso LR, 2002, MECH DEVELOP, V110, P15, DOI 10.1016/S0925-4773(01)00589-5; Bender M, 1997, CELL, V91, P777, DOI 10.1016/S0092-8674(00)80466-3; BINNINGTON KC, 1985, TISSUE CELL, V17, P131, DOI 10.1016/0040-8166(85)90021-7; Braquart C, 1996, EUR J BIOCHEM, V240, P336, DOI 10.1111/j.1432-1033.1996.0336h.x; BURTIS KC, 1990, CELL, V61, P85, DOI 10.1016/0092-8674(90)90217-3; Chen X, 2008, B ENTOMOL RES, V98, P613, DOI 10.1017/S0007485308005932; Chen XF, 2007, INSECT BIOCHEM MOLEC, V37, P409, DOI 10.1016/j.ibmb.2007.01.006; Davis MB, 2005, DEV BIOL, V282, P385, DOI 10.1016/j.ydbio.2005.03.019; Dubrovsky EB, 2005, TRENDS ENDOCRIN MET, V16, P6, DOI 10.1016/j.tem.2004.11.003; Gagou ME, 2002, INSECT BIOCHEM MOLEC, V32, P141, DOI 10.1016/S0965-1748(01)00101-1; Gariou-Papalexiou A, 2001, GENOME, V44, P752, DOI 10.1139/gen-44-5-752; HUET F, 1993, DEVELOPMENT, V118, P613; HUET F, 1995, DEVELOPMENT, V121, P1195; Kamimura M, 1997, EUR J BIOCHEM, V248, P786, DOI 10.1111/j.1432-1033.1997.t01-1-00786.x; Kapitskaya MZ, 2000, MOL CELL ENDOCRINOL, V160, P25, DOI 10.1016/S0303-7207(99)00253-1; Kato N, 2006, INSECT BIOCHEM MOLEC, V36, P1, DOI 10.1016/j.ibmb.2005.09.003; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kumar NS, 2008, COMP BIOCHEM PHYS B, V149, P447, DOI 10.1016/j.cbpb.2007.11.005; Lam G, 2000, CURR BIOL, V10, P957, DOI 10.1016/S0960-9822(00)00631-X; Li TR, 2000, DEVELOPMENT, V127, P2897; Martin D, 2001, MOL CELL ENDOCRINOL, V173, P75, DOI 10.1016/S0303-7207(00)00413-5; Minakuchi C, 2002, INSECT BIOCHEM MOLEC, V32, P999, DOI 10.1016/S0965-1748(02)00036-X; Perera SC, 1999, MOL CELL ENDOCRINOL, V152, P73, DOI 10.1016/S0303-7207(99)00058-1; PORCHERON P, 1991, ARCH INSECT BIOCHEM, V16, P257, DOI 10.1002/arch.940160405; Schubiger M, 1998, DEVELOPMENT, V125, P2053; Singtripop T, 2002, J INSECT PHYSIOL, V48, P817, DOI 10.1016/S0022-1910(02)00104-X; Song QS, 1997, INSECT BIOCHEM MOLEC, V27, P973, DOI 10.1016/S0965-1748(97)00080-5; Stowers RS, 2000, DEV BIOL, V221, P23, DOI 10.1006/dbio.2000.9685; Stowers RS, 1999, DEV BIOL, V213, P116, DOI 10.1006/dbio.1999.9358; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tang B, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-51; Tatun N, 2008, INSECT BIOCHEM MOLEC, V38, P788, DOI 10.1016/j.ibmb.2008.05.003; Tatun N, 2008, J INSECT PHYSIOL, V54, P351, DOI 10.1016/j.jinsphys.2007.10.006; Thummel CS, 2002, INSECT BIOCHEM MOLEC, V32, P113, DOI 10.1016/S0965-1748(01)00112-6; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tonning A, 2006, DEVELOPMENT, V133, P331, DOI 10.1242/dev.02206; Wright LG, 1996, J MOL BIOL, V255, P387, DOI 10.1006/jmbi.1996.0032; YAMAMOTO KR, 1976, ANNU REV BIOCHEM, V45, P721, DOI 10.1146/annurev.bi.45.070176.003445; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Zimoch L, 2005, INSECT BIOCHEM MOLEC, V35, P515, DOI 10.1016/j.ibmb.2005.01.008	49	73	86	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14058	10.1371/journal.pone.0014058	http://dx.doi.org/10.1371/journal.pone.0014058			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124981	Green Submitted, gold, Green Published			2022-12-27	WOS:000284356900015
J	Monecke, S; Kanig, H; Rudolph, W; Muller, E; Coombs, G; Hotzel, H; Slickers, P; Ehricht, R				Monecke, Stefan; Kanig, Hanna; Rudolph, Wolfram; Mueller, Elke; Coombs, Geoffrey; Hotzel, Helmut; Slickers, Peter; Ehricht, Ralf			Characterisation of Australian MRSA Strains ST75-and ST883-MRSA-IV and Analysis of Their Accessory Gene Regulator Locus	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PANTON-VALENTINE LEUKOCIDIN; RNASE-P RNA; METHICILLIN-RESISTANT; VIRULENCE FACTORS; PHYLOGENETIC-RELATIONSHIPS; SEQUENCE DETERMINATION; COMPARATIVE GENOMICS; EVOLUTION; RNPB	Background: Community-acquired methicillin-resistant Staphylococcus aureus have become a major problem in Australia. These strains have now been isolated throughout Australia including remote Indigenous communities that have had minimal exposure to healthcare facilities. Some of these strains, belonging to sequence types ST75 and ST883, have previously been reported to harbour highly divergent alleles of the housekeeping genes used in multilocus sequence typing. Methodology/Principal Findings: ST75-MRSA-IV and ST883-MRSA-IV isolates were characterised in detail. Morphological features as well as 16S sequences were identical to other S. aureus strains. Although a partial rnpB gene sequence was not identical to previously known S. aureus sequences, it was found to be more closely related to S. aureus than to other staphylococci. Isolates also were screened using diagnostic DNA microarrays. These isolates yielded hybridisation results atypical for S. aureus. Primer directed amplification assays failed to detect species markers (femA, katA, sbi, spa). However, arbitrarily primed amplification indicated the presence of unknown alleles of these genes. Isolates could not be assigned to capsule types 1, 5 or 8. The allelic group of the accessory gene regulator (agr) locus was not determinable. Sequencing of a region of agrB, agrC and agrD (approximately 2,100 bp) revealed a divergent sequence. However, this sequence is more related to S. aureus agr alleles I and IV than to agr sequences from other Staphylococcus species. The predicted auto-inducing peptide (AIP) sequence of ST75 was identical to that of agr group I, while the predicted AIP sequence of ST883 was identical to agr group IV. Conclusions/Significance: The genetic properties of ST75/ST883-MRSA may be due to a series of evolutionary events in ancient insulated S. aureus strains including a convergent evolution leading to agr group I- or IV-like AIP sequences and a recent acquisition of SCCmec IV elements.	[Monecke, Stefan; Rudolph, Wolfram] Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany; [Kanig, Hanna] Tech Univ Dresden, Dept Appl Microbiol, Inst Microbiol, Dresden, Germany; [Mueller, Elke; Slickers, Peter; Ehricht, Ralf] Alere Technol GmbH, Jena, Germany; [Coombs, Geoffrey] Royal Perth Hosp, PathW Lab Med WA, Perth, WA, Australia; [Hotzel, Helmut] Inst Bacterial Infect & Zoonoses, Friedrich Loffler Inst, Jena, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Alere; Royal Perth Hospital; University of Western Australia; Friedrich Loeffler Institute	Monecke, S (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Inst Med Microbiol & Hyg, Dresden, Germany.	monecke@rocketmail.com	Wolfram, W. Rudolph/AAE-6287-2020; Rudolph, Wolfram W/O-8970-2018	Wolfram, W. Rudolph/0000-0002-6300-4717; Coombs, Geoffrey/0000-0003-1635-6506				BOHLANDER SK, 1992, GENOMICS, V13, P1322, DOI 10.1016/0888-7543(92)90057-Y; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; Ehricht Ralf, 2009, V509, P85, DOI 10.1007/978-1-59745-372-1_6; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Feng Y, 2008, FEMS MICROBIOL REV, V32, P23, DOI 10.1111/j.1574-6976.2007.00086.x; Ghebremedhin B, 2009, J CLIN MICROBIOL, V47, P2975, DOI 10.1128/JCM.00648-09; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Herrmann B, 2000, INT J SYST EVOL MICR, V50, P149, DOI 10.1099/00207713-50-1-149; Hotelling H, 1929, ECON J, V39, P41, DOI 10.2307/2224214; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Ji GY, 1997, SCIENCE, V276, P2027, DOI 10.1126/science.276.5321.2027; Korczak B, 2005, J CLIN MICROBIOL, V43, P1024, DOI 10.1128/JCM.43.3.1024-1031.2005; Korem M, 2005, INFECT IMMUN, V73, P6220, DOI 10.1128/IAI.73.10.6220-6228.2005; LUCK CP, 2009, INT J SYST EVOL MICR; McDonald M, 2006, J CLIN MICROBIOL, V44, P3720, DOI 10.1128/JCM.00836-06; Monecke S, 2008, CLIN MICROBIOL INFEC, V14, P534, DOI 10.1111/j.1469-0691.2008.01986.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P1157, DOI 10.1111/j.1469-0691.2007.01833.x; Monecke S, 2007, CLIN MICROBIOL INFEC, V13, P236, DOI 10.1111/j.1469-0691.2006.01635.x; Monecke S, 2006, CLIN MICROBIOL INFEC, V12, P718, DOI 10.1111/j.1469-0691.2006.01420.x; Monecke S, 2005, CLIN MICROBIOL INFEC, V11, P825, DOI 10.1111/j.1469-0691.2005.01243.x; Monecke S, 2003, GENOME LETT, V2, P106; Monecke S, 2008, FEMS IMMUNOL MED MIC, V53, P237, DOI 10.1111/j.1574-695X.2008.00426.x; Munckhof Wendy J., 2003, International Journal of Infectious Diseases, V7, P259, DOI 10.1016/S1201-9712(03)90104-4; Ng JWS, 2009, J CLIN MICROBIOL, V47, P2295, DOI 10.1128/JCM.00122-09; Nimmo GR, 2008, INT J ANTIMICROB AG, V31, P401, DOI 10.1016/j.ijantimicag.2007.08.011; NODA M, 1988, METHOD ENZYMOL, V165, P22; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; NOVICK RP, 1993, EMBO J, V12, P3967, DOI 10.1002/j.1460-2075.1993.tb06074.x; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; O'Brien FG, 2006, NAT PROTOC, V1, P3028, DOI 10.1038/nprot.2006.382; Robinson DA, 2005, J BACTERIOL, V187, P8312, DOI 10.1128/JB.187.24.8312-8321.2005; Rubin CJ, 2005, INT J SYST EVOL MICR, V55, P2039, DOI 10.1099/ijs.0.63656-0; Schefold Joerg C, 2007, J Med Case Rep, V1, P165; Tapp J, 2003, INT J SYST EVOL MICR, V53, P1861, DOI 10.1099/ijs.0.02639-0; Vorobieva V, 2008, APMIS, V116, P877, DOI 10.1111/j.1600-0463.2008.01092.x; Watanabe S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005714	37	16	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14025	10.1371/journal.pone.0014025	http://dx.doi.org/10.1371/journal.pone.0014025			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103340	Green Published, gold, Green Submitted			2022-12-27	WOS:000284327800011
J	Parachikova, A; Green, KN; Hendrix, C; LaFerla, FM				Parachikova, Anna; Green, Kim N.; Hendrix, Curt; LaFerla, Frank M.			Formulation of a Medical Food Cocktail for Alzheimer's Disease: Beneficial Effects on Cognition and Neuropathology in a Mouse Model of the Disease	PLOS ONE			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TAU-PATHOLOGY; TRANSGENIC MODEL; MEMORY DEFICITS; AMYLOID-BETA; RECOGNITION MEMORY; MICE; PIPERINE; RATS; CURCUMIN	Background: Dietary supplements have been extensively studied for their beneficial effects on cognition and AD neuropathology. The current study examines the effect of a medical food cocktail consisting of the dietary supplements curcumin, piperine, epigallocatechin gallate, alpha-lipoic acid, N-acetylcysteine, B vitaminsvitamin C, and folate on cognitive functioning and the AD hallmark features and amyloid-beta (A beta) in the Tg2576 mouse model of the disease. Principal Findings: The study found that administering the medical food cocktail for 6 months improved cortical- and hippocampal- dependent learning in the transgenic mice, rendering their performance indistinguishable from non-transgenic controls. Coinciding with this improvement in learning and memory, we found that treatment resulted in decreased soluble A beta, including A beta oligomers, previously found to be linked to cognitive functioning. Conclusion: In conclusion, the current study demonstrates that combination diet consisting of natural dietary supplements improves cognitive functioning while decreasing AD neuropathology and may thus represent a safe, natural treatment for AD.	[Parachikova, Anna; Green, Kim N.; LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA; [Hendrix, Curt] Akeso Hlth Sci LLC, Westlake Village, CA USA	University of California System; University of California Irvine	Parachikova, A (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Inst Memory Impairments & Neurol Disorders, Irvine, CA 92717 USA.	laferla@uci.edu			National Institutes of Health [AG-021982, R43AT003025-1]; NATIONAL INSTITUTE ON AGING [R01AG021982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institutes of Health (AG-021982 to FML, and Small Business Innovation Research grant R43AT003025-1 to CH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adair JC, 2001, NEUROLOGY, V57, P1515, DOI 10.1212/WNL.57.8.1515; Aggleton JP, 1997, BRAIN RES BULL, V43, P279, DOI 10.1016/S0361-9230(97)00007-5; Billings LM, 2007, J NEUROSCI, V27, P751, DOI 10.1523/JNEUROSCI.4800-06.2007; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Frautschy SA, 2001, NEUROBIOL AGING, V22, P993, DOI 10.1016/S0197-4580(01)00300-1; Green KN, 2008, J NEUROSCI, V28, P11500, DOI 10.1523/JNEUROSCI.3203-08.2008; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Green KN, 2006, J NEUROSCI, V26, P9047, DOI 10.1523/JNEUROSCI.2797-06.2006; Hager K, 2001, ARCH GERONTOL GERIAT, V32, P275, DOI 10.1016/S0167-4943(01)00104-2; HENSLEY K, 1995, J NEUROCHEM, V65, P2146; Horie K, 1997, BIOCHEM BIOPH RES CO, V236, P327, DOI 10.1006/bbrc.1997.6944; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hsiao KK, 1997, J NEURAL TRANSM-SUPP, P135; Kayed R, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-18; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Lambert JD, 2004, J NUTR, V134, P1948, DOI 10.1093/jn/134.8.1948; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lim GP, 2001, J NEUROSCI, V21, P8370, DOI 10.1523/JNEUROSCI.21-21-08370.2001; Mandel S, 2004, J NEUROCHEM, V88, P1555, DOI 10.1046/j.1471-4159.2003.02291.x; MEDA L, 1995, NATURE, V374, P647, DOI 10.1038/374647a0; Mumby DG, 1996, BEHAV NEUROSCI, V110, P266, DOI 10.1037/0735-7044.110.2.266; MYHRER T, 1988, BEHAV NEUROSCI, V102, P356, DOI 10.1037/0735-7044.102.3.356; Oddo S, 2005, P NATL ACAD SCI USA, V102, P3046, DOI 10.1073/pnas.0408500102; Oddo S, 2003, NEUROBIOL AGING, V24, P1063, DOI 10.1016/j.neurobiolaging.2003.08.012; Ono K, 2004, J NEUROSCI RES, V75, P742, DOI 10.1002/jnr.20025; PHILLIPS RR, 1988, BEHAV BRAIN RES, V27, P99, DOI 10.1016/0166-4328(88)90035-6; Rocchi A, 2003, BRAIN RES BULL, V61, P1, DOI 10.1016/S0361-9230(03)00067-4; Selvendiran K, 2004, BIOMED PHARMACOTHER, V58, P264, DOI 10.1016/j.biopha.2003.08.027; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Sunila ES, 2004, J ETHNOPHARMACOL, V90, P339, DOI 10.1016/j.jep.2003.10.016; SUTHERLAND RJ, 1990, BEHAV BRAIN RES, V37, P57, DOI 10.1016/0166-4328(90)90072-M; Vaucher E, 2002, EXP NEUROL, V175, P398, DOI 10.1006/exnr.2002.7915; Vijayakumar RS, 2004, REDOX REP, V9, P105, DOI 10.1179/135100004225004742; Wan HM, 1999, J NEUROSCI, V19, P1142	38	66	72	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14015	10.1371/journal.pone.0014015	http://dx.doi.org/10.1371/journal.pone.0014015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103342	Green Published, gold			2022-12-27	WOS:000284327800007
J	Turse, JE; Marshall, MJ; Fredrickson, JK; Lipton, MS; Callister, SJ				Turse, Joshua E.; Marshall, Matthew J.; Fredrickson, James K.; Lipton, Mary S.; Callister, Stephen J.			An Empirical Strategy for Characterizing Bacterial Proteomes across Species in the Absence of Genomic Sequences	PLOS ONE			English	Article							SHEWANELLA-ONEIDENSIS MR-1; OUTER-MEMBRANE CYTOCHROMES; MASS-SPECTROMETRY; PROTEIN IDENTIFICATION; PUTREFACIENS MR-1; REDUCTION; TANDEM; CONSERVATION; DIVERGENCE; METABOLISM	Global protein identification through current proteomics methods typically depends on the availability of sequenced genomes. In spite of increasingly high throughput sequencing technologies, this information is not available for every microorganism and rarely available for entire microbial communities. Nevertheless, the protein-level homology that exists between related bacteria makes it possible to extract biological information from the proteome of an organism or microbial community by using the genomic sequences of a near neighbor organism. Here, we demonstrate a trans-organism search strategy for determining the extent to which near-neighbor genome sequences can be applied to identify proteins in unsequenced environmental isolates. In proof of concept testing, we found that within a CLUSTAL W distance of 0.089, near-neighbor genomes successfully identified a high percentage of proteins within an organism. Application of this strategy to characterize environmental bacterial isolates lacking sequenced genomes, but having 16S rDNA sequence similarity to Shewanella resulted in the identification of 300-500 proteins in each strain. The majority of identified pathways mapped to core processes, as well as to processes unique to the Shewanellae, in particular to the presence of c-type cytochromes. Examples of core functional categories include energy metabolism, protein and nucleotide synthesis and cofactor biosynthesis, allowing classification of bacteria by observation of conserved processes. Additionally, within these core functionalities, we observed proteins involved in the alternative lactate utilization pathway, recently described in Shewanella.	[Turse, Joshua E.; Marshall, Matthew J.; Fredrickson, James K.; Lipton, Mary S.; Callister, Stephen J.] Pacific NW Natl Lab, Biol Sci & Computat Sci & Math Div, Richland, WA 99352 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory	Turse, JE (corresponding author), Washington State Univ, Coll Vet Med, Pullman, WA 99164 USA.	stephen.callister@pnl.gov	Lipton, Mary S/H-3913-2012; , 0000-0001-7041-1823/B-9144-2014; Marshall, Matthew J./M-4120-2017	, 0000-0001-7041-1823/0000-0001-7041-1823; Marshall, Matthew J./0000-0002-2402-8003	Department of Energy Office of Biological and Environmental Research (DOE/BER) [ER63232-1018220-0007203]; National Institute of Allergy and Infectious Diseases (NIH/DHHS) [Y1-AI-4894-01]; NIH National Center for Research Resources [RR18522]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018522] Funding Source: NIH RePORTER	Department of Energy Office of Biological and Environmental Research (DOE/BER)(United States Department of Energy (DOE)); National Institute of Allergy and Infectious Diseases (NIH/DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Department of Energy Office of Biological and Environmental Research (DOE/BER; ER63232-1018220-0007203), the National Institute of Allergy and Infectious Diseases (NIH/DHHS through interagency agreement Y1-AI-4894-01), and the NIH National Center for Research Resources (RR18522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; Beliaev Alex S., 2002, OMICS A Journal of Integrative Biology, V6, P39, DOI 10.1089/15362310252780834; Beliaev AS, 1998, J BACTERIOL, V180, P6292; Beliaev AS, 2001, MOL MICROBIOL, V39, P722, DOI 10.1046/j.1365-2958.2001.02257.x; Callister SJ, 2006, J MICROBIOL METH, V67, P424, DOI 10.1016/j.mimet.2006.04.021; Callister SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001542; Carpentier W, 2005, J BACTERIOL, V187, P3293, DOI 10.1128/JB.187.10.3293-3301.2005; Chain PSG, 2005, INFECT IMMUN, V73, P8353, DOI 10.1128/IAI.73.12.8353-8361.2005; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Craig R, 2006, J PROTEOME RES, V5, P1843, DOI 10.1021/pr0602085; Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Daraselia N., 2003, OMICS A Journal of Integrative Biology, V7, P171, DOI 10.1089/153623103322246566; den Hartigh AB, 2004, INFECT IMMUN, V72, P5143, DOI 10.1128/IAI.72.9.5143-5149.2004; Denef VJ, 2007, J PROTEOME RES, V6, P3152, DOI 10.1021/pr0701005; Dennis PC, 2003, CAN J MICROBIOL, V49, P15, DOI [10.1139/w03-008, 10.1139/W03-008]; Espariz M, 2007, MICROBIOL-SGM, V153, P2989, DOI 10.1099/mic.0.2007/006536-0; Ferguson PL, 2003, ANNU REV BIOPH BIOM, V32, P399, DOI 10.1146/annurev.biophys.32.110601.141854; Fredrickson JK, 2008, NAT REV MICROBIOL, V6, P592, DOI 10.1038/nrmicro1947; Fredrickson JK, 1998, GEOCHIM COSMOCHIM AC, V62, P3239, DOI 10.1016/S0016-7037(98)00243-9; Gascuel O, 2006, MOL BIOL EVOL, V23, P1997, DOI 10.1093/molbev/msl072; Grosse C, 1999, J BACTERIOL, V181, P2385; Guha H, 2003, CHEMOSPHERE, V52, P175, DOI 10.1016/S0045-6535(03)00104-8; Habermann B, 2004, MOL CELL PROTEOMICS, V3, P238, DOI 10.1074/mcp.M300073-MCP200; HAN SJ, J GEN VIROL; Heidelberg JF, 2002, NAT BIOTECHNOL, V20, P1118, DOI 10.1038/nbt749; HUGHES C, METHODS MOL BIOL, V604, P105; Jungblut PR, 2008, CHEM CENT J, V2, DOI 10.1186/1752-153X-2-16; KIEBEL GR, 2006, PROTEOMICS; Lipton Mary S, 2006, Methods Biochem Anal, V49, P113; Lipton MS, 2002, P NATL ACAD SCI USA, V99, P11049, DOI 10.1073/pnas.172170199; Liska AJ, 2005, PROTEOMICS, V5, P4118, DOI 10.1002/pmic.200401262; LIU P, MOL BIOL EVOL; Lo I, 2007, NATURE, V446, P537, DOI 10.1038/nature05624; Maddocks SE, 2008, MICROBIOL-SGM, V154, P3609, DOI 10.1099/mic.0.2008/022772-0; Maier TM, 2003, J BASIC MICROB, V43, P312, DOI 10.1002/jobm.200390034; Marshall MJ, 2008, ENVIRON MICROBIOL, V10, P125, DOI 10.1111/j.1462-2920.2007.01438.x; Masselon C, 2005, ANAL CHEM, V77, P400, DOI 10.1021/ac049043e; Mertens B, 2007, CHEMOSPHERE, V66, P99, DOI 10.1016/j.chemosphere.2006.05.018; Meyer TE, 2004, OMICS, V8, P57, DOI 10.1089/153623104773547499; Miller J.H., 1972, EXPT MOL GENETICS; Myers CR, 2003, LETT APPL MICROBIOL, V37, P254, DOI 10.1046/j.1472-765X.2003.01389.x; Myers JM, 2003, LETT APPL MICROBIOL, V37, P21, DOI 10.1046/j.1472-765X.2003.01338.x; Myers JM, 2001, APPL ENVIRON MICROB, V67, P260, DOI 10.1128/AEM.67.1.260-269.2001; Nealson KH, 2002, ANTON LEEUW INT J G, V81, P215, DOI 10.1023/A:1020518818647; Pandhal J, 2008, PROTEOMICS, V8, P2266, DOI 10.1002/pmic.200700398; PASATOLIC L, 2002, GENE EXPRESSION, V37, P1185; Pinchuk GE, 2009, P NATL ACAD SCI USA, V106, P2874, DOI 10.1073/pnas.0806798106; Popa R, 2009, J MICROBIOL METH, V78, P111, DOI 10.1016/j.mimet.2009.06.005; REARDON CL, GEOBIOLOGY, V8, P56; SAINI G, 2007, BIOTECHNOL BIOENG; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sanchez-Perez G, 2008, TRENDS GENET, V24, P154, DOI 10.1016/j.tig.2008.01.002; Sauro Herbert M., 2003, OMICS A Journal of Integrative Biology, V7, P355, DOI 10.1089/153623103322637670; Serres MH, 2006, J BACTERIOL, V188, P4601, DOI 10.1128/JB.01787-05; Shen YF, 2008, ANAL CHEM, V80, P1871, DOI 10.1021/ac702328x; Shevchenko A, 2001, ANAL CHEM, V73, P1917, DOI 10.1021/ac0013709; Subramaniam S, 1998, PROTEINS, V32, P1; Sunyaev S, 2003, ANAL CHEM, V75, P1307, DOI 10.1021/ac026199a; Tabb DL, 2003, ANAL CHEM, V75, P6415, DOI 10.1021/ac0347462; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toes ACM, 2008, MICROBIOL-SGM, V154, P2709, DOI 10.1099/mic.0.2008/016857-0; Villafane R, 2005, ARCH VIROL, V150, P2609, DOI 10.1007/s00705-005-0597-7; Wang ZM, 2008, APPL ENVIRON MICROB, V74, P6746, DOI 10.1128/AEM.01454-08; Wilkins MJ, 2009, APPL ENVIRON MICROB, V75, P6591, DOI 10.1128/AEM.01064-09; Xu CX, 2006, DRUG DISCOV TODAY, V11, P595, DOI 10.1016/j.drudis.2006.05.011	66	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13968	10.1371/journal.pone.0013968	http://dx.doi.org/10.1371/journal.pone.0013968			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103051	Green Submitted, Green Published, gold			2022-12-27	WOS:000284147700016
J	Matrajt, L; Longini, IM				Matrajt, Laura; Longini, Ira M., Jr.			Optimizing Vaccine Allocation at Different Points in Time during an Epidemic	PLOS ONE			English	Article							INFLUENZA VACCINE; CHILDREN; SCHOOLCHILDREN; STRATEGIES; SPREAD; MODELS; TRIAL; RISK; AGE	Background: Pandemic influenza A(H1N1) 2009 began spreading around the globe in April of 2009 and vaccination started in October of 2009. In most countries, by the time vaccination started, the second wave of pandemic H1N1 2009 was already under way. With limited supplies of vaccine, we are left to question whether it may be a good strategy to vaccinate the high-transmission groups earlier in the epidemic, but it might be a better use of resources to protect instead the high-risk groups later in the epidemic. To answer this question, we develop a deterministic epidemic model with two age-groups (children and adults) and further subdivide each age group in low and high risk. Methods and Findings: We compare optimal vaccination strategies started at various points in time in two different settings: a population in a developed country where children account for 24% of the population, and a population in a less developed country where children make up the majority of the population, 55%. For each of these populations, we minimize mortality or hospitalizations and we find an optimal vaccination strategy that gives the best vaccine allocation given a starting vaccination time and vaccine coverage level. We find that population structure is an important factor in determining the optimal vaccine distribution. Moreover, the optimal policy is dynamic as there is a switch in the optimal vaccination strategy at some time point just before the peak of the epidemic. For instance, with 25% vaccine coverage, it is better to protect the high-transmission groups before this point, but it is optimal to protect the most vulnerable groups afterward. Conclusions: Choosing the optimal strategy before or early in the epidemic makes an important difference in minimizing the number of influenza infections, and consequently the number of influenza deaths or hospitalizations, but the optimal strategy makes little difference after the peak.	[Matrajt, Laura] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Longini, Ira M., Jr.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Ctr Stat & Quantitat Infect Dis, Seattle, WA 98104 USA; [Longini, Ira M., Jr.] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Matrajt, L (corresponding author), Univ Washington, Dept Appl Math, Seattle, WA 98195 USA.	longini@scharp.org	Matrajt, Laura/AAV-5216-2020		National Institute of General Medical Sciences [U01-GM070749]; National Institute of Allergy and Infectious Diseases [R01-AI32042]; Consejo Nacional de Ciencia y Tecnologia, Mexico [196221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070749] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Consejo Nacional de Ciencia y Tecnologia, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by the National Institute of General Medical Sciences MIDAS grant U01-GM070749 and the National Institute of Allergy and Infectious Diseases grant R01-AI32042. LM is partially supported by Consejo Nacional de Ciencia y Tecnologia, Mexico, fellowship 196221. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], WORLD DEV INDICATORS; Balcan D, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-45; Bansal S, 2006, PLOS MED, V3, P1816, DOI 10.1371/journal.pmed.0030387; Brauer F., 2008, LECT NOTES MATH, V1945; *CDCP, 2010, MMWR-MORBID MORTAL W, V58, P1009; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; *GLAXOSMITHKLINE, 2009, GLAXOSMITHKLINE UPD; Gojovic MZ, 2009, CAN MED ASSOC J, V181, P673, DOI 10.1503/cmaj.091641; Goldstein E, 2010, J R SOC INTERFACE, V7, P755, DOI 10.1098/rsif.2009.0393; Halloran ME, 1997, AM J EPIDEMIOL, V146, P789; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; MEDLOCK J, 2009, PLOS CURR INFLUENZA; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Mylius SD, 2008, VACCINE, V26, P3742, DOI 10.1016/j.vaccine.2008.04.043; *NAT I ALL INF DIS, 2009, EARL RES CHILDR 2009; *NAT I ALL INF DIS, 2009, UPD RES YOUNG CHILDR; Nolan T, 2010, JAMA-J AM MED ASSOC, V303, P37, DOI 10.1001/jama.2009.1911; Piedra PA, 2005, PEDIATRICS, V116, pE397, DOI 10.1542/peds.2004-2258; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, WORLD POP PROSP 2008; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Sypsa V, 2009, EUROSURVEILLANCE, V14, P2; Tennenbaum S, 2008, J THEOR BIOL, V250, P673, DOI 10.1016/j.jtbi.2007.10.021; TUITE A, 2010, PLOS CURR INFLUENZA; *US DEP HHS, HHS 2009 H1N1 VACC D; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; Wallinga J, 2010, P NATL ACAD SCI USA, V107, P923, DOI 10.1073/pnas.0908491107; *WHO, 2009, PROD AV PAND INFL A; *WHO, 2010, WHO TAK ACT PAND H1N; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; [No title captured]	34	33	33	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13767	10.1371/journal.pone.0013767	http://dx.doi.org/10.1371/journal.pone.0013767			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085686	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800002
J	Xiong, JH; Liu, JA; Rayner, S; Tian, Z; Li, YH; Chen, SG				Xiong, Jianghui; Liu, Juan; Rayner, Simon; Tian, Ze; Li, Yinghui; Chen, Shanguang			Pre-Clinical Drug Prioritization via Prognosis-Guided Genetic Interaction Networks	PLOS ONE			English	Article							CELL LUNG-CANCER; BREAST-CANCER; TARGETED THERAPIES; IDENTIFICATION; PHARMACOLOGY; GEMCITABINE; ROBUSTNESS; MODULARITY; INHIBITORS; SIGNATURES	The high rates of failure in oncology drug clinical trials highlight the problems of using pre-clinical data to predict the clinical effects of drugs. Patient population heterogeneity and unpredictable physiology complicate pre-clinical cancer modeling efforts. We hypothesize that gene networks associated with cancer outcome in heterogeneous patient populations could serve as a reference for identifying drug effects. Here we propose a novel in vivo genetic interaction which we call 'synergistic outcome determination' (SOD), a concept similar to 'Synthetic Lethality'. SOD is defined as the synergy of a gene pair with respect to cancer patients' outcome, whose correlation with outcome is due to cooperative, rather than independent, contributions of genes. The method combines microarray gene expression data with cancer prognostic information to identify synergistic gene-gene interactions that are then used to construct interaction networks based on gene modules (a group of genes which share similar function). In this way, we identified a cluster of important epigenetically regulated gene modules. By projecting drug sensitivity-associated genes on to the cancer-specific intermodule network, we defined a perturbation index for each drug based upon its characteristic perturbation pattern on the inter-module network. Finally, by calculating this index for compounds in the NCI Standard Agent Database, we significantly discriminated successful drugs from a broad set of test compounds, and further revealed the mechanisms of drug combinations. Thus, prognosis-guided synergistic gene-gene interaction networks could serve as an efficient in silico tool for pre-clinical drug prioritization and rational design of combinatorial therapies.	[Xiong, Jianghui; Liu, Juan] Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China; [Xiong, Jianghui; Li, Yinghui; Chen, Shanguang] China Astronaut Res & Training Ctr, State Key Lab Space Med Fundamentals & Applicat, Bioinformat Syst Biol & Translat Med Grp, Beijing, Peoples R China; [Rayner, Simon] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Bioinformat Grp, Wuhan, Peoples R China; [Tian, Ze] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Wuhan University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Xiong, JH (corresponding author), Wuhan Univ, Sch Comp Sci, Wuhan 430072, Peoples R China.	laserxiong@gmail.com; liujuan@whu.edu.cn	rayner, simon/N-7715-2013; tian, ze/HDM-4308-2022	rayner, simon/0000-0001-8703-9140; XIONG, JIANGHUI/0000-0002-3198-5303	National Natural Science Foundation of China [30600759, 60773010, 60970063]; State Key Lab of Space Medicine Fundamentals and Application [SMFA09A07]; Advanced Space Medico-Engineering Research Project of China [01105015, 01104099]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Lab of Space Medicine Fundamentals and Application; Advanced Space Medico-Engineering Research Project of China	This work was partly supported by the National Natural Science Foundation of China to J.X. (30600759) and J.L. (60773010 and 60970063), grant from State Key Lab of Space Medicine Fundamentals and Application to J.X. (SMFA09A07), and Advanced Space Medico-Engineering Research Project of China to J.X. (01105015, 01104099). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastassiou D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100124; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brock A, 2009, NAT REV GENET, V10, P336, DOI 10.1038/nrg2556; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clegg A, 2002, THORAX, V57, P20, DOI 10.1136/thorax.57.1.20; Csermely P, 2005, TRENDS PHARMACOL SCI, V26, P178, DOI 10.1016/j.tips.2005.02.007; Davies AM, 2009, J THORAC ONCOL, V4, P87, DOI 10.1097/JTO.0b013e3181915052; DEVITA VT, 1989, CANC PRINCIPLES PRAC, V1; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FONG PC, 2009, N ENGL J MED; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Hoeller D, 2009, NATURE, V458, P438, DOI 10.1038/nature07960; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Janne PA, 2009, NAT REV DRUG DISCOV, V8, P709, DOI 10.1038/nrd2871; Jones D, 2009, NAT BIOTECHNOL, V27, P108, DOI 10.1038/nbt0209-108; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kamat AM, 2004, MOL CANCER THER, V3, P279; Kamb A, 2005, NAT REV DRUG DISCOV, V4, P161, DOI 10.1038/nrd1635; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Kitano H, 2007, NAT REV DRUG DISCOV, V6, P202, DOI 10.1038/nrd2195; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lauss M, 2008, BRIT J CANCER, V98, P816, DOI 10.1038/sj.bjc.6604219; Markiewski MM, 2008, NAT IMMUNOL, V9, P1225, DOI 10.1038/ni.1655; Metzeler KH, 2008, BLOOD, V112, P4193, DOI 10.1182/blood-2008-02-134411; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Nalepa G, 2006, NAT REV DRUG DISCOV, V5, P596, DOI 10.1038/nrd2056; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Provencio M, 2010, CLIN LUNG CANCER, V11, P91, DOI 10.3816/CLC.2010.n.012; Radiloff Daniel R, 2008, Drug Discov Today Dis Models, V4, P83; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Watkinson J, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-10; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	49	6	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13937	10.1371/journal.pone.0013937	http://dx.doi.org/10.1371/journal.pone.0013937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085674	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800024
J	Chkonia, E; Roinishvili, M; Makhatadze, N; Tsverava, L; Stroux, A; Neumann, K; Herzog, MH; Brand, A				Chkonia, Eka; Roinishvili, Maya; Makhatadze, Natia; Tsverava, Lidia; Stroux, Andrea; Neumann, Konrad; Herzog, Michael H.; Brand, Andreas			The Shine-Through Masking Paradigm Is a Potential Endophenotype of Schizophrenia	PLOS ONE			English	Article							BACKWARD-MASKING; CONTEXTUAL SUPPRESSION; 1ST-DEGREE RELATIVES; UNAFFECTED SIBLINGS; ADOLESCENTS; PERFORMANCE	Background: To understand the genetics of schizophrenia, a hunt for so-called intermediate phenotypes or endophenotypes is ongoing. Visual masking has been proposed to be such an endophenotype. However, no systematic study has been conducted yet to prove this claim. Here, we present the first study showing that masking meets the most important criteria for an endophenotype. Methodology/Principal Findings: We tested 62 schizophrenic patients, 39 non-affected first-degree relatives, and 38 healthy controls in the shine-through masking paradigm and, in addition, in the Continuous Performance Test (CPT) and the Wisconsin Card Sorting Test (WCST). Most importantly, masking performance of relatives was significantly in between the one of patients and controls in the shine-through paradigm. Moreover, deficits were stable throughout one year. Using receiver operating characteristics (ROC) methods, we show that the shine-through paradigm distinguishes with high sensitivity and specificity between schizophrenic patients, first-order relatives and healthy controls. Conclusions/Significance: The shine-through paradigm is a potential endophenotype.	[Chkonia, Eka; Tsverava, Lidia] Tbilisi State Med Univ, Dept Psychiat, Tbilisi, Georgia; [Roinishvili, Maya] I Beritashvili Inst Physiol, Dept Behav & Cognit Funct, Tbilisi, Georgia; [Makhatadze, Natia] Gotsiridze Psychoneurol Dispensary, Tbilisi, Georgia; [Stroux, Andrea; Neumann, Konrad] Charite, CCM, Inst Biometry & Clin Epidemiol, Berlin, Germany; [Herzog, Michael H.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Lab Psychophys, Lausanne, Switzerland; [Brand, Andreas] Klinikum Bremen Ost, Ctr Psychiat & Psychotherapy, Bremen, Germany	Tbilisi State Medical University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Klinikum Bremen-Ost	Chkonia, E (corresponding author), Tbilisi State Med Univ, Dept Psychiat, Tbilisi, Georgia.	echkonia@yahoo.ca	Chkonia, Eka/GQQ-1751-2022; Chkonia, Eka/F-4517-2014	Chkonia, Eka/0000-0002-8817-9679; Chkonia, Eka/0000-0002-8817-9679	Volkswagen Foundation [1/80 096]	Volkswagen Foundation(Volkswagen)	Funding for this study was provided by the Volkswagen Foundation project between Europe and the Orient - A Focus on Research and Higher Education in/on Central Asia and the Caucasus (1/80 096). Volkswagen Foundation had no further role in the study design, in the data collection, data analysis, interpretation, in the writing of the manuscript, and in the decision to submit the paper for publication.	Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen NC, 1983, SCALE ASSESSMENT NEG; AUKES MF, 2008, BIOL PSYCHOL; Bedwell JS, 2003, SCHIZOPHR RES, V63, P273, DOI 10.1016/S0920-9964(02)00356-0; Birkett P, 2008, AM J MED GENET B, V147B, P285, DOI 10.1002/ajmg.b.30594; BRAFF DL, 1981, AM J PSYCHIAT, V138, P1051; Brand A, 2004, EUR ARCH PSY CLIN N, V254, P281, DOI 10.1007/s00406-004-0493-2; BRODY D, 1980, J ABNORM PSYCHOL, V89, P617, DOI 10.1037/0021-843X.89.5.617; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green MF, 1997, ARCH GEN PSYCHIAT, V54, P465; Green MF, 2006, BIOL PSYCHIAT, V59, P446, DOI 10.1016/j.biopsych.2005.06.035; Green MF, 1997, ARCH GEN PSYCHIAT, V54, P846; Grimsen C, 2007, PSYCHIAT RES, V150, P237, DOI 10.1016/j.psychres.2006.03.021; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hermens F, 2008, PSYCHOL REV, V115, P83, DOI 10.1037/0033-295X.115.1.83; Herzog MH, 2004, PSYCHIAT RES, V129, P55, DOI 10.1016/j.psychres.2004.06.008; Herzog MH, 2003, NEURAL COMPUT, V15, P2091, DOI 10.1162/089976603322297304; Herzog MH, 2001, VISION RES, V41, P2325, DOI 10.1016/S0042-6989(01)00122-5; Holzer L, 2009, J CLIN EXP NEUROPSYC, V31, P641, DOI 10.1080/13803390802438454; Horn W, 1983, LEISTUNGSPRUEFSYSTEM; Keri S, 2005, PSYCHOL MED, V35, P1043, DOI 10.1017/S0033291705004381; Keri S, 2004, NEUROPSYCHOLOGY, V18, P537, DOI 10.1037/0894-4105.18.3.537; Keri S, 2001, PSYCHOL MED, V31, P915, DOI 10.1017/S0033291701004068; LEE J, 2008, SCHIZ RES; Lieb K, 1996, SCHIZOPHR RES, V21, P171, DOI 10.1016/0920-9964(96)00025-4; Macmillan N. A., 1991, DETECTION THEORY USE; MERRITT RD, 1990, J NERV MENT DIS, V178, P186, DOI 10.1097/00005053-199003000-00006; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; PARKOSADZE K, 2009, EUR C VIS PERC ECVP; Roinishvili M, 2008, EUR ARCH PSY CLIN N, V258, P210, DOI 10.1007/s00406-007-0780-9; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; RUND BR, 1993, J NERV MENT DIS, V181, P233, DOI 10.1097/00005053-199304000-00004; Rund BR, 1996, AM J PSYCHIAT, V153, P1154; SACCUZZO DP, 1981, J ABNORM PSYCHOL, V90, P305, DOI 10.1037/0021-843X.90.4.305; Sanders AR, 2008, AM J PSYCHIAT, V165, P497, DOI 10.1176/appi.ajp.2007.07101573; Snitz BE, 2006, SCHIZOPHRENIA BULL, V32, P179, DOI 10.1093/schbul/sbi048; Szoke A, 2005, PSYCHOL MED, V35, P771, DOI 10.1017/S0033291704003460; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Ueland T, 2004, PSYCHIAT RES, V126, P229, DOI 10.1016/j.psychres.2004.02.014	40	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14268	10.1371/journal.pone.0014268	http://dx.doi.org/10.1371/journal.pone.0014268			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692ES	21151559	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800005
J	El-Armouche, A; Schwoerer, AP; Neuber, C; Emmons, J; Biermann, D; Christalla, T; Grundhoff, A; Eschenhagen, T; Zimmermann, WH; Ehmke, H				El-Armouche, Ali; Schwoerer, Alexander Peter; Neuber, Christiane; Emmons, Julius; Biermann, Daniel; Christalla, Thomas; Grundhoff, Adam; Eschenhagen, Thomas; Zimmermann, Wolfram Hubertus; Ehmke, Heimo			Common MicroRNA Signatures in Cardiac Hypertrophic and Atrophic Remodeling Induced by Changes in Hemodynamic Load	PLOS ONE			English	Article							FETAL GENE PROGRAM; HEART-FAILURE; RAT HEARTS; EXPRESSION; FIBROSIS; DISEASE; STRESS; REPOLARIZATION; AUTOPHAGY; PROTECTS	Background: Mechanical overload leads to cardiac hypertrophy and mechanical unloading to cardiac atrophy. Both conditions produce similar transcriptional changes including a re-expression of fetal genes, despite obvious differences in phenotype. MicroRNAs (miRNAs) are discussed as superordinate regulators of global gene networks acting mainly at the translational level. Here, we hypothesized that defined sets of miRNAs may determine the direction of cardiomyocyte plasticity responses. Methodology/Principal Findings: We employed ascending aortic stenosis (AS) and heterotopic heart transplantation (HTX) in syngenic Lewis rats to induce mechanical overloading and unloading, respectively. Heart weight was 26 +/- 3% higher in AS (n = 7) and 33 +/- 2% lower in HTX (n = 7) as compared to sham-operated (n = 6) and healthy controls (n = 7). Small RNAs were enriched from the left ventricles and subjected to quantitative stem-loop specific RT-PCR targeting a panel of 351 miRNAs. In total, 153 miRNAs could be unambiguously detected. Out of 72 miRNAs previously implicated in the cardiovascular system, 40 miRNAs were regulated in AS and/or HTX. Overall, HTX displayed a slightly broader activation pattern for moderately regulated miRNAs. Surprisingly, however, the regulation of individual miRNA expression was strikingly similar in direction and amplitude in AS and HTX with no miRNA being regulated in opposite direction. In contrast, fetal hearts from Lewis rats at embryonic day 18 exhibited an entirely different miRNA expression pattern. Conclusions: Taken together, our findings demonstrate that opposite changes in cardiac workload induce a common miRNA expression pattern which is markedly different from the fetal miRNA expression pattern. The direction of postnatal adaptive cardiac growth does, therefore, not appear to be determined at the level of single miRNAs or a specific set of miRNAs. Moreover, miRNAs themselves are not reprogrammed to a fetal program in response to changes in hemodynamic load.	[El-Armouche, Ali; Emmons, Julius; Zimmermann, Wolfram Hubertus] Univ Med Ctr Goettingen UMG, Dept Pharmacol, Gottingen, Germany; [El-Armouche, Ali; Neuber, Christiane; Biermann, Daniel; Eschenhagen, Thomas; Zimmermann, Wolfram Hubertus] Univ Med Ctr Hamburg Eppendorf, Dept Expt & Clin Pharmacol & Toxicol, Hamburg, Germany; [Schwoerer, Alexander Peter; Ehmke, Heimo] Univ Med Ctr Hamburg Eppendorf, Dept Vegetat Physiol & Pathophysiol, Hamburg, Germany; [Christalla, Thomas; Grundhoff, Adam] Univ Hamburg, Heinrich Pette Inst Expt Virol & Immunol, D-2000 Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Heinrich Pette Institute; University of Hamburg	El-Armouche, A (corresponding author), Univ Med Ctr Goettingen UMG, Dept Pharmacol, Gottingen, Germany.	ali.el-armouche@med.uni-goettingen.de; schwoerer@uke.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; El-Armouche, Ali/H-3161-2018	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; El-Armouche, Ali/0000-0003-2514-9429; Grundhoff, Adam/0000-0003-0940-7045	Deutsche Forschungsgemeinschaft [DFG-FOR 604]; European Union; German Foundation of Heart Research	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission); German Foundation of Heart Research	This study was supported by the Deutsche Forschungsgemeinschaft (DFG-FOR 604 to AEA, TE, WHZ and HE), by the European Union (EUGene Heart to AEA and TE) and by the German Foundation of Heart Research (to AEA, APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Busk PK, 2010, BIOCHEM BIOPH RES CO, V396, P989, DOI 10.1016/j.bbrc.2010.05.039; Callis TE, 2009, J CLIN INVEST, V119, P2772, DOI 10.1172/JCI36154; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Cheng YH, 2007, AM J PATHOL, V170, P1831, DOI 10.2353/ajpath.2007.061170; Depre C, 1998, NAT MED, V4, P1269, DOI 10.1038/3253; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Dorn GW, 2007, HYPERTENSION, V49, P962, DOI 10.1161/HYPERTENSIONAHA.106.079426; El-Armouche A, 2008, CARDIOVASC RES, V80, P396, DOI 10.1093/cvr/cvn208; Ferdous A, 2010, J CARDIOVASC TRANSL, V3, P355, DOI 10.1007/s12265-010-9200-z; Gottlieb RA, 2010, ANNU REV PHYSIOL, V72, P45, DOI 10.1146/annurev-physiol-021909-135757; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Khan R, 2006, IMMUNOLOGY, V118, P10, DOI 10.1111/j.1365-2567.2006.02336.x; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Latronico MVG, 2009, NAT REV CARDIOL, V6, P418, DOI 10.1038/nrcardio.2009.56; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Nakai A, 2007, NAT MED, V13, P619, DOI 10.1038/nm1574; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225, DOI 10.1016/S0022-5223(19)42744-X; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Razeghi P, 2006, ANN NY ACAD SCI, V1080, P110, DOI 10.1196/annals.1380.011; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P846, DOI 10.1016/j.yjmcc.2008.09.003; Schwoerer AP, 2008, J MOL CELL CARDIOL, V45, P633, DOI 10.1016/j.yjmcc.2008.02.271; SONG XW, 2010, J CELL PHYSL; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Taegtmeyer H, 2010, ANN NY ACAD SCI, V1188, P191, DOI 10.1111/j.1749-6632.2009.05100.x; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Thum T, 2007, CIRCULATION, V116, P258, DOI 10.1161/CIRCULATIONAHA.107.687947; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; van Rooij E, 2006, P NATL ACAD SCI USA, V103, P18255, DOI 10.1073/pnas.0608791103; Wagner M, 2007, PFLUG ARCH EUR J PHY, V454, P595, DOI 10.1007/s00424-007-0227-1; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Watanabe T, 2007, METHOD ENZYMOL, V427, P155, DOI 10.1016/S0076-6879(07)27009-0; Wiesner RJ, 1997, CIRCULATION, V95, P1253	39	20	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14263	10.1371/journal.pone.0014263	http://dx.doi.org/10.1371/journal.pone.0014263			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151612	gold, Green Published, Green Submitted			2022-12-27	WOS:000285135800004
J	Rosti, V; Bonetti, E; Bergamaschi, G; Campanelli, R; Guglielmelli, P; Maestri, M; Magrini, U; Massa, M; Tinelli, C; Viarengo, G; Villani, L; Primignani, M; Vannucchi, AM; Frassoni, F; Barosi, G				Rosti, Vittorio; Bonetti, Elisa; Bergamaschi, Gaetano; Campanelli, Rita; Guglielmelli, Paola; Maestri, Marcello; Magrini, Umberto; Massa, Margherita; Tinelli, Carmine; Viarengo, Gianluca; Villani, Laura; Primignani, Massimo; Vannucchi, Alessandro M.; Frassoni, Francesco; Barosi, Giovanni		AGIMM Investigators	High Frequency of Endothelial Colony Forming Cells Marks a Non-Active Myeloproliferative Neoplasm with High Risk of Splanchnic Vein Thrombosis	PLOS ONE			English	Article							JAK2 V617F MUTATION; PROGENITOR CELLS; CIRCULATING CD34(+); MYELOFIBROSIS; DIAGNOSIS; BLOOD	Increased mobilization of circulating endothelial progenitor cells may represent a new biological hallmark of myeloproliferative neoplasms. We measured circulating endothelial colony forming cells (ECFCs) in 106 patients with primary myelofibrosis, fibrotic stage, 49 with prefibrotic myelofibrosis, 59 with essential thrombocythemia or polycythemia vera, and 43 normal controls. Levels of ECFC frequency for patient's characteristics were estimated by using logistic regression in univariate and multivariate setting. The sensitivity, specificity, likelihood ratios, and positive predictive value of increased ECFC frequency were calculated for the significantly associated characteristics. Increased frequency of ECFCs resulted independently associated with history of splanchnic vein thrombosis (adjusted odds ratio = 6.61, 95% CI = 2.54-17.16), and a summary measure of non-active disease, i.e. hemoglobin of 13.8 g/dL or lower, white blood cells count of 7.8 x 10(9)/L or lower, and platelet count of 400 x 10(9)/L or lower (adjusted odds ratio = 4.43, 95% CI = 1.45-13.49) Thirteen patients with splanchnic vein thrombosis non associated with myeloproliferative neoplasms were recruited as controls. We excluded a causal role of splanchnic vein thrombosis in ECFCs increase, since no control had elevated ECFCs. We concluded that increased frequency of ECFCs represents the biological hallmark of a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. The recognition of this disease category copes with the phenotypic mimicry of myeloproliferative neoplasms. Due to inherent performance limitations of ECFCs assay, there is an urgent need to arrive to an acceptable standardization of ECFC assessment.	[Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Magrini, Umberto; Villani, Laura; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy; [Rosti, Vittorio; Bonetti, Elisa; Campanelli, Rita; Magrini, Umberto; Villani, Laura; Barosi, Giovanni] IRCCS Policlin S Matteo Fdn, Ctr Study Myelofibrosis, Pavia, Italy; [Bergamaschi, Gaetano] IRCCS Policlin S Matteo Fdn, Dept Internal Med, Unit Clin Med 1, Pavia, Italy; [Guglielmelli, Paola; Vannucchi, Alessandro M.] Univ Florence, Dept Crit Care, Hematol Unit, Florence, Italy; [Guglielmelli, Paola; Vannucchi, Alessandro M.] Ist Toscano Tumori, Florence, Italy; [Maestri, Marcello] IRCCS Policlin S Matteo Fdn, Dept Surg, Pavia, Italy; [Massa, Margherita] IRCCS Policlin S Matteo Fdn, Biotechnol Lab, Pavia, Italy; [Tinelli, Carmine] Fdn IRCCS Policlin S Matteo Fdn, Biometr Unit, Pavia, Italy; [Viarengo, Gianluca] IRCCS Policlin S Matteo Fdn, Unit Clin Immunol Immunohematol & Transfus Serv, Pavia, Italy; [Primignani, Massimo] IRCCS Ca Granda Osped Maggiore Policlin Fdn, Gastroenterol Unit 3, Milan, Italy; [Frassoni, Francesco] Osped San Martino Genova, Ctr Cellule Staminali & Terapia Cellulare, Genoa, Italy	IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; University of Pavia; University of Florence; ISPRO Istituto per lo studio, la prevenzione e la rete oncologica; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Fondazione San Matteo; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Genoa; IRCCS AOU San Martino IST	Rosti, V (corresponding author), IRCCS Policlin S Matteo Fdn, Clin Epidemiol Unit, Pavia, Italy.	barosig@smatteo.pv.it	Barosi, Giovanni/AAI-1714-2019; Frassoni, Francesco/K-3971-2018; Villani, Laura/K-1794-2018; Pietra, Daniela/F-3931-2016; maestri, marcello/Q-3503-2016; Zini, Roberta/I-6734-2012; Rumi, Elisa/J-7424-2016; Campanelli, Rita/K-4686-2016; Bonetti, Elisa/D-4478-2016; Pieri, Lisa/K-1762-2016; Guglielmelli, Paola/K-7509-2016; Vannucchi, Alessandro M./K-7499-2016; Salati, Simona/J-2344-2012; Rosti, Vittorio/K-1743-2018; Massa, Margherita/K-4682-2016; Carolei, Adriana/AAQ-7656-2021; Bortoluzzi, Stefania/G-8211-2011	Frassoni, Francesco/0000-0003-1262-0648; Villani, Laura/0000-0003-4199-5633; Pietra, Daniela/0000-0002-6575-8766; maestri, marcello/0000-0002-5693-9151; Zini, Roberta/0000-0001-6657-0864; Rumi, Elisa/0000-0002-7572-9504; Campanelli, Rita/0000-0003-4923-2761; Bonetti, Elisa/0000-0002-8406-5252; Pieri, Lisa/0000-0003-1812-8072; Guglielmelli, Paola/0000-0003-1809-284X; Vannucchi, Alessandro M./0000-0001-5755-0730; Salati, Simona/0000-0002-8072-1128; Rosti, Vittorio/0000-0003-4195-2289; Massa, Margherita/0000-0001-8037-0439; Bartalucci, Niccolo/0000-0002-9328-3948; Passamonti, Francesco/0000-0001-8068-5289; Carolei, Adriana/0000-0002-5254-8532; DEJANA, ELISABETTA/0000-0002-0007-0426; Bergamaschi, Gaetano/0000-0002-2796-9765; TENEDINI, Elena/0000-0003-0285-765X; Bortoluzzi, Stefania/0000-0001-8240-3070; Tinelli, Carmine/0000-0002-8749-1978; Arruga, Francesca/0000-0001-5298-9314; PANCRAZZI, ALESSANDRO/0000-0002-6943-6924; Corada, Monica/0000-0001-8220-0871	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)	Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano)(Fondazione AIRC per la ricerca sul cancro)	The study was funded by a grant from Associazione Italiana per la Ricerca sul Cancro (AIRC, Milano) "Special Program Molecular Clinical Oncology 5 x 1000" to AGIMM (AIRC-Gruppo Italiano Malattie Mieloproliferative). A detailed description of the AGIMM project is available at http://www.progettoagimm.it. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegra A, 2009, ACTA HAEMATOL-BASEL, V121, P218, DOI 10.1159/000221962; Barosi G, 1999, BRIT J HAEMATOL, V104, P730, DOI 10.1046/j.1365-2141.1999.01262.x; BAROSI G, 1991, CANCER, V68, P2310, DOI 10.1002/1097-0142(19911115)68:10<2310::AID-CNCR2820681034>3.0.CO;2-2; Barosi G, 2001, BLOOD, V98, P3249, DOI 10.1182/blood.V98.12.3249; BAROSI G, 2007, BLOOD CELL MOL DIS, V38, P280; Barosi G, 2007, BLOOD, V110, P4030, DOI 10.1182/blood-2007-07-099184; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; De Stefano V, 2007, J THROMB HAEMOST, V5, P708, DOI 10.1111/j.1538-7836.2007.02424.x; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jaffe E.S., 2001, PATHOLOGY GENETICS T, VVolume 3; Leibundgut EO, 2006, HAEMATOLOGICA, V91, P1465; Massa M, 2005, J CLIN ONCOL, V23, P5688, DOI 10.1200/JCO.2005.09.021; Mesa RA, 2000, BLOOD, V96, P3374; Orr DW, 2010, ALIMENT PHARM THER, V31, P1330, DOI 10.1111/j.1365-2036.2010.04299.x; PAGLIUCA A, 1990, Q J MED, V76, P981; Passamonti F, 2006, BLOOD, V107, P3676, DOI 10.1182/blood-2005-09-3826; Passamonti F, 2010, BLOOD, V115, P1703, DOI 10.1182/blood-2009-09-245837; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Primignani M, 2006, HEPATOLOGY, V44, P1528, DOI 10.1002/hep.21435; Rohde E, 2006, STEM CELLS, V24, P357, DOI 10.1634/stemcells.2005-0072; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Sozer S, 2008, BLOOD CELL MOL DIS, V41, P284, DOI 10.1016/j.bcmd.2008.06.008; Swerdlow SH., 2008, WHO CLASSIFICATION T, P40; Thiele J, 2005, HAEMATOLOGICA, V90, P1128; Tonon L, 1998, BRIT J HAEMATOL, V102, P996, DOI 10.1046/j.1365-2141.1998.00867.x; Vannucchi AM, 2009, CA-CANCER J CLIN, V59, P171, DOI 10.3322/caac.20009; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	30	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15277	10.1371/journal.pone.0015277	http://dx.doi.org/10.1371/journal.pone.0015277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151606	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800021
J	Peng, QH; Wu, JG; Zhang, Y; Liu, Y; Kong, RR; Hu, LL; Du, XJ; Ke, Y				Peng, Qunhui; Wu, Jianguo; Zhang, Ying; Liu, Yun; Kong, Ruirui; Hu, Lelin; Du, Xiaojuan; Ke, Yang			1A6/DRIM, a Novel t-UTP, Activates RNA Polymerase I Transcription and Promotes Cell Proliferation	PLOS ONE			English	Article							PRE-RIBOSOMAL-RNA; TATA-BINDING PROTEIN; FACTOR UBF; RDNA TRANSCRIPTION; GENE-EXPRESSION; PHOSPHORYLATION; COMPLEX; P53; ACETYLATION; RECRUITMENT	Background: Ribosome biogenesis is required for protein synthesis and cell proliferation. Ribosome subunits are assembled in the nucleolus following transcription of a 47S ribosome RNA precursor by RNA polymerase I and rRNA processing to produce mature 18S, 28S and 5.8S rRNAs. The 18S rRNA is incorporated into the ribosomal small subunit, whereas the 28S and 5.8S rRNAs are incorporated into the ribosomal large subunit. Pol I transcription and rRNA processing are coordinated processes and this coordination has been demonstrated to be mediated by a subset of U3 proteins known as t-UTPs. Up to date, five t-UTPs have been identified in humans but the mechanism(s) that function in the t-UTP(s) activation of Pol I remain unknown. In this study we have identified 1A6/DRIM, which was identified as UTP20 in our previous study, as a t-UTP. In the present study, we investigated the function and mechanism of 1A6/DRIM in Pol I transcription. Methodology/Principal Findings: Knockdown of 1A6/DRIM by siRNA resulted in a decreased 47S pre-rRNA level as determined by Northern blotting. Ectopic expression of 1A6/DRIM activated and knockdown of 1A6/DRIM inhibited the human rDNA promoter as evaluated with luciferase reporter. Chromatin immunoprecipitation (ChIP) experiments showed that 1A6/DRIM bound UBF and the rDNA promoter. Re-ChIP assay showed that 1A6/DRIM interacts with UBF at the rDNA promoter. Immunoprecipitation confirmed the interaction between 1A6/DRIM and the nucleolar acetyl-transferase hALP. It is of note that knockdown of 1A6/DRIM dramatically inhibited UBF acetylation. A finding of significance was that 1A6/DRIM depletion, as a kind of nucleolar stress, caused an increase in p53 level and inhibited cell proliferation by arresting cells at G1. Conclusions: We identify 1A6/DRIM as a novel t-UTP. Our results suggest that 1A6/DRIM activates Pol I transcription most likely by associating with both hALP and UBF and thereby affecting the acetylation of UBF.	[Peng, Qunhui; Wu, Jianguo; Kong, Ruirui; Ke, Yang] Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China; [Zhang, Ying; Liu, Yun; Hu, Lelin; Du, Xiaojuan] Peking Univ, Hlth Sci Ctr, Dept Cell Biol, Beijing 100871, Peoples R China; [Peng, Qunhui; Wu, Jianguo; Zhang, Ying; Liu, Yun; Kong, Ruirui; Hu, Lelin; Du, Xiaojuan; Ke, Yang] Peking Univ, Hlth Sci Ctr, Canc Res Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Peng, QH (corresponding author), Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res Minist Educ, Beijing 100871, Peoples R China.	duxiaojuan100@hsc.pku.edu.cn; keyang@hsc.pku.edu.cn	Wu, Jian/AAU-5221-2020; Du, Xiaojuan/AAY-1186-2021; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507	National Ministry of Science and Technology [2008AA02Z131, 2006AA02A402]; National Natural Science Foundation of China [30771224]; Ministry of Education [985-2-016-24]; National Basic Research Program of China (973 program) [2010CB529303]	National Ministry of Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education; National Basic Research Program of China (973 program)(National Basic Research Program of China)	This work was supported by grants from the China key project of National Ministry of Science and Technology grant 2008AA02Z131 and 2006AA02A402, National Natural Science Foundation of China (30771224), the Ministry of Education 985 project of China (No. 985-2-016-24) and by grants from the National Basic Research Program of China (973 program) (Grant No. 2010CB529303). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; COMAI L, 1992, CELL, V68, P965, DOI 10.1016/0092-8674(92)90039-F; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; EBERHARD D, 1993, NUCLEIC ACIDS RES, V21, P4180, DOI 10.1093/nar/21.18.4180; Gallagher JEG, 2004, GENE DEV, V18, P2506, DOI 10.1101/gad.1226604; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001; HADJIOLOVA KV, 1993, EUR J BIOCHEM, V212, P211, DOI 10.1111/j.1432-1033.1993.tb17652.x; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hublitz P, 2005, GENE DEV, V19, P2912, DOI 10.1101/gad.351205; JANTZEN HM, 1992, GENE DEV, V6, P1950, DOI 10.1101/gad.6.10.1950; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; Kinoshita Y, 2001, J BIOL CHEM, V276, P6656, DOI 10.1074/jbc.M008536200; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kopp K, 2007, MOL BIOL CELL, V18, P394, DOI 10.1091/mbc.E06-03-0249; Lapik YR, 2004, MOL CELL, V15, P17, DOI 10.1016/j.molcel.2004.05.020; LEARNED RM, 1986, CELL, V45, P847, DOI 10.1016/0092-8674(86)90559-3; LEARNED RM, 1985, MOL CELL BIOL, V5, P1358, DOI 10.1128/MCB.5.6.1358; Lv JJ, 2003, BIOCHEM BIOPH RES CO, V311, P506, DOI 10.1016/j.bbrc.2003.09.235; Mais C, 2005, GENE DEV, V19, P50, DOI 10.1101/gad.310705; Meraner J, 2006, NUCLEIC ACIDS RES, V34, P1798, DOI 10.1093/nar/gkl101; Milkereit P, 2003, NUCLEIC ACIDS RES, V31, P799, DOI 10.1093/nar/gkg165; MILLER OL, 1969, SCIENCE, V164, P955, DOI 10.1126/science.164.3882.955; MOUGEY EB, 1993, MOL CELL BIOL, V13, P5990, DOI 10.1128/MCB.13.10.5990; OMAHONY DJ, 1991, P NATL ACAD SCI USA, V88, P3180, DOI 10.1073/pnas.88.8.3180; OMAHONY DJ, 1992, J BIOL CHEM, V267, P35; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Pelletier G, 2000, MOL CELL, V6, P1059, DOI 10.1016/S1097-2765(00)00104-0; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Shang YF, 2002, MOL CELL, V9, P601, DOI 10.1016/S1097-2765(02)00471-9; Shen Q, 2009, EXP CELL RES, V315, P1653, DOI 10.1016/j.yexcr.2009.03.007; Sheng Z, 2005, MOL CELL BIOL, V25, P9419, DOI 10.1128/MCB.25.21.9419-9426.2005; Stefanovsky VY, 2008, NUCLEIC ACIDS RES, V36, P5093, DOI 10.1093/nar/gkn484; Tuan JC, 1999, MOL CELL BIOL, V19, P2872; VOIT R, 1992, EMBO J, V11, P2211, DOI 10.1002/j.1460-2075.1992.tb05280.x; Voit R, 2001, P NATL ACAD SCI USA, V98, P13631, DOI 10.1073/pnas.231071698; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Zhang YP, 2009, CANCER CELL, V16, P369, DOI 10.1016/j.ccr.2009.09.024	43	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14244	10.1371/journal.pone.0014244	http://dx.doi.org/10.1371/journal.pone.0014244			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151873	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800004
J	Dawson, K; Thorpe, RS; Malhotra, A				Dawson, Karen; Thorpe, Roger S.; Malhotra, Anita			Estimating Genetic Variability in Non-Model Taxa: A General Procedure for Discriminating Sequence Errors from Actual Variation	PLOS ONE			English	Article							MULTIGENE FAMILIES; POSITIVE SELECTION; EVOLUTION; PCR; DNA; AMPLIFICATION; POLYMORPHISM; DIVERSITY; ARTIFACTS; SNAKE	Genetic variation is the driving force of evolution and as such is of central interest for biologists. However, inadequate discrimination of errors from true genetic variation could lead to incorrect estimates of gene copy number, population genetic parameters, phylogenetic relationships and the deposition of gene and protein sequences in databases that are not actually present in any organism. Misincorporation errors in multi-template PCR cloning methods, still commonly used for obtaining novel gene sequences in non-model species, are difficult to detect, as no previous information may be available about the number of expected copies of genes belonging to multi-gene families. However, studies employing these techniques rarely describe in any great detail how errors arising in the amplification process were detected and accounted for. Here, we estimated the rate of base misincorporation of a widely-used PCR-cloning method, using a single copy mitochondrial gene from a single individual to minimise variation in the template DNA, as 1.62x10(-3) errors per site, or 9.26x10(-5) per site per duplication. The distribution of errors among sequences closely matched that predicted by a binomial distribution function. The empirically estimated error rate was applied to data, obtained using the same methods, from the Phospholipase A(2) toxin family from the pitviper Ovophis monticola. The distribution of differences detected closely matched the expected distribution of errors and we conclude that, when undertaking gene discovery or assessment of genetic diversity using this error-prone method, it will be informative to empirically determine the rate of base misincorporation.	[Dawson, Karen; Thorpe, Roger S.; Malhotra, Anita] Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales	Bangor University	Dawson, K (corresponding author), Bangor Univ, Sch Biol Sci, Coll Nat Sci, Bangor, Gwynedd, Wales.	a.malhotra@bangor.ac.uk		Malhotra, Anita/0000-0002-1738-9046	Natural Environment Research Council [NER/S/A/2005/13423, NER/A/S/2001/01217]	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by a studentship from the Natural Environment Research Council (studentship numberNER/S/A/2005/13423) to KD and a Natural Environment Research Council grant (grant number NER/A/S/2001/01217) to AM and RST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acinas SG, 2004, NATURE, V430, P551, DOI 10.1038/nature02649; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Cummings SM, 2010, CONSERV GENET, V11, P1095, DOI 10.1007/s10592-009-9864-6; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Gibbs HL, 2008, J MOL EVOL, V66, P151, DOI 10.1007/s00239-008-9067-7; Hayes W, 1965, GENETICS BACTERIA TH; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Ikeda N, 2010, GENE, V461, P15, DOI 10.1016/j.gene.2010.04.001; Jan VM, 2007, TOXICON, V50, P1140, DOI 10.1016/j.toxicon.2007.07.024; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; Kobayashi N, 1999, BIOCHEM GENET, V37, P317, DOI 10.1023/A:1018759210666; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Pook CE, 2009, MOL PHYLOGENET EVOL, V53, P792, DOI 10.1016/j.ympev.2009.08.002; Randi Ettore, 2000, P136; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Richly E, 2004, MOL BIOL EVOL, V21, P1081, DOI 10.1093/molbev/msh110; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Siddle HV, 2010, P ROY SOC B-BIOL SCI, V277, P2001, DOI 10.1098/rspb.2009.2362; Speksnijder AGCL, 2001, APPL ENVIRON MICROB, V67, P469, DOI 10.1128/AEM.67.1.469-472.2001; van Oosterhout C, 2006, HEREDITY, V97, P111, DOI 10.1038/sj.hdy.6800843; Weinberger H, 2010, MOL BIOL EVOL, V27, P1025, DOI 10.1093/molbev/msp310; WERLE E, 1994, NUCLEIC ACIDS RES, V22, P4354, DOI 10.1093/nar/22.20.4354; Ziemert N, 2010, APPL ENVIRON MICROB, V76, P3568, DOI 10.1128/AEM.02858-09; Zylstra P, 1998, IMMUNOL CELL BIOL, V76, P395, DOI 10.1046/j.1440-1711.1998.00772.x	28	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15204	10.1371/journal.pone.0015204	http://dx.doi.org/10.1371/journal.pone.0015204			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151906	Green Submitted, Green Published, gold			2022-12-27	WOS:000284995300021
J	Plett, D; Toubia, J; Garnett, T; Tester, M; Kaiser, BN; Baumann, U				Plett, Darren; Toubia, John; Garnett, Trevor; Tester, Mark; Kaiser, Brent N.; Baumann, Ute			Dichotomy in the NRT Gene Families of Dicots and Grass Species	PLOS ONE			English	Article							AFFINITY NITRATE TRANSPORTER; NITROGEN-USE EFFICIENCY; ARABIDOPSIS NITRATE; RICE GENOME; FUNCTIONAL-CHARACTERIZATION; DRAFT SEQUENCE; UPTAKE SYSTEM; CHL1; CLONING; EXPRESSION	A large proportion of the nitrate (NO32-) acquired by plants from soil is actively transported via members of the NRT families of NO32- transporters. In Arabidopsis, the NRT1 family has eight functionally characterised members and predominantly comprises low-affinity transporters; the NRT2 family contains seven members which appear to be high-affinity transporters; and there are two NRT3 (NAR2) family members which are known to participate in high-affinity transport. A modified reciprocal best hit (RBH) approach was used to identify putative orthologues of the Arabidopsis NRT genes in the four fully sequenced grass genomes (maize, rice, sorghum, Brachypodium). We also included the poplar genome in our analysis to establish whether differences between Arabidopsis and the grasses may be generally applicable to monocots and dicots. Our analysis reveals fundamental differences between Arabidopsis and the grass species in the gene number and family structure of all three families of NRT transporters. All grass species possessed additional NRT1.1 orthologues and appear to lack NRT1.6/NRT1.7 orthologues. There is significant separation in the NRT2 phylogenetic tree between NRT2 genes from dicots and grass species. This indicates that determination of function of NRT2 genes in grass species will not be possible in cereals based simply on sequence homology to functionally characterised Arabidopsis NRT2 genes and that proper functional analysis will be required. Arabidopsis has a unique NRT3.2 gene which may be a fusion of the NRT3.1 and NRT3.2 genes present in all other species examined here. This work provides a framework for future analysis of NO32- transporters and NO32- transport in grass crop species.	[Plett, Darren; Toubia, John; Garnett, Trevor; Tester, Mark; Baumann, Ute] Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia; [Kaiser, Brent N.] Univ Adelaide, Waite Res Inst, Sch Agr Food & Wine, Adelaide, SA, Australia	University of Adelaide; University of Adelaide	Plett, D (corresponding author), Univ Adelaide, Waite Res Inst, Australian Ctr Plant Funct Genom, Adelaide, SA, Australia.	brent.kaiser@adelaide.edu.au	Garnett, Trevor/AAJ-7474-2021; Kaiser, Brent/L-6092-2019; Garnett, Trevor P/G-5023-2011; Kaiser, Brent N/O-7458-2015; Tester, Mark/J-2368-2017	Garnett, Trevor/0000-0003-1664-9659; Kaiser, Brent/0000-0001-6167-2423; Kaiser, Brent N/0000-0001-6167-2423; Tester, Mark/0000-0002-5085-8801; Plett, Darren/0000-0002-9551-8755; Toubia, John/0000-0002-5135-6504	DuPont Pioneer; Australian Research Council [LP0776635]	DuPont Pioneer; Australian Research Council(Australian Research Council)	Funding for this research was obtained from both DuPont Pioneer and from an Australian Research Council (www.arc.gov.au) Linkage Grant (LP0776635) to BNK and MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro A, 2008, PLANT CELL, V20, P3289, DOI 10.1105/tpc.107.056788; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; Chen F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000383; Chiu CC, 2004, PLANT CELL PHYSIOL, V45, P1139, DOI 10.1093/pcp/pch143; Chopin F, 2007, PLANT CELL, V19, P1590, DOI 10.1105/tpc.107.050542; Fan SC, 2009, PLANT CELL, V21, P2750, DOI 10.1105/tpc.109.067603; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Ho CH, 2009, CELL, V138, P1184, DOI 10.1016/j.cell.2009.07.004; Huang NC, 1999, PLANT CELL, V11, P1381, DOI 10.1105/tpc.11.8.1381; Koski LB, 2001, J MOL EVOL, V52, P540, DOI 10.1007/s002390010184; LI J, 2010, PLANT CELL; Li WB, 2007, PLANT PHYSIOL, V143, P425, DOI 10.1104/pp.106.091223; Lin CM, 2000, PLANT PHYSIOL, V122, P379, DOI 10.1104/pp.122.2.379; Lin SH, 2008, PLANT CELL, V20, P2514, DOI 10.1105/tpc.108.060244; Liu JX, 2009, J PLANT NUTR SOIL SC, V172, P230, DOI 10.1002/jpln.200800028; Liu KH, 2003, EMBO J, V22, P1005, DOI 10.1093/emboj/cdg118; Liu KH, 1999, PLANT CELL, V11, P865, DOI 10.1105/tpc.11.5.865; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Okamoto M, 2006, PLANT PHYSIOL, V140, P1036, DOI 10.1104/pp.105.074385; Okamoto M, 2003, PLANT CELL PHYSIOL, V44, P304, DOI 10.1093/pcp/pcg036; Orsel M, 2002, PLANT PHYSIOL, V129, P886, DOI 10.1104/pp.005280; Orsel M, 2006, PLANT PHYSIOL, V142, P1304, DOI 10.1104/pp.106.085209; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Poptsova MS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-120; Posada D, 2009, METHODS MOL BIOL, V537, P93, DOI 10.1007/978-1-59745-251-9_5; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; Sylvester-Bradley R, 2009, J EXP BOT, V60, P1939, DOI 10.1093/jxb/erp116; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tong Y, 2005, PLANT J, V41, P442, DOI 10.1111/j.1365-313X.2004.02310.x; Trueman LJ, 1996, GENE, V175, P223, DOI 10.1016/0378-1119(96)00154-0; Tsay YF, 2007, FEBS LETT, V581, P2290, DOI 10.1016/j.febslet.2007.04.047; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Veerassamy S, 2003, J COMPUT BIOL, V10, P997, DOI 10.1089/106652703322756195; Vidmar JJ, 2000, PLANT PHYSIOL, V122, P783, DOI 10.1104/pp.122.3.783; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Wang RC, 1998, P NATL ACAD SCI USA, V95, P15134, DOI 10.1073/pnas.95.25.15134; Wirth J, 2007, J BIOL CHEM, V282, P23541, DOI 10.1074/jbc.M700901200; Yu J, 2002, SCIENCE, V296, P79, DOI 10.1126/science.1068037	43	103	114	6	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15289	10.1371/journal.pone.0015289	http://dx.doi.org/10.1371/journal.pone.0015289			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151904	Green Published, gold			2022-12-27	WOS:000284995300027
J	Filone, CM; Hanna, SL; Caino, MC; Bambina, S; Doms, RW; Cherry, S				Filone, Claire Marie; Hanna, Sheri L.; Caino, M. Cecilia; Bambina, Shelly; Doms, Robert W.; Cherry, Sara			Rift Valley Fever Virus Infection of Human Cells and Insect Hosts Is Promoted by Protein Kinase C Epsilon	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; GENE-EXPRESSION; GENOME; ENTRY; INHIBITION; MACROPINOCYTOSIS; MOSQUITO; REVEALS; PKC; PHOSPHORYLATION	As an arthropod-borne human pathogen, Rift Valley fever virus (RVFV) cycles between an insect vector and mammalian hosts. Little is known about the cellular requirements for infection in either host. Here we developed a tissue culture model for RVFV infection of human and insect cells that is amenable to high-throughput screening. Using this approach we screened a library of 1280 small molecules with pharmacologically defined activities and identified 59 drugs that inhibited RVFV infection with 15 inhibiting RVFV replication in both human and insect cells. Amongst the 15 inhibitors that blocked infection in both hosts was a subset that inhibits protein kinase C. Further studies found that infection is dependent upon the novel protein kinase C isozyme epsilon (PKC epsilon) in both human and insect cells as well as in adult flies. Altogether, these data show that inhibition of cellular factors required for early steps in the infection cycle including PKC epsilon can block RVFV infection, and may represent a starting point for the development of anti-RVFV therapeutics.	[Filone, Claire Marie; Hanna, Sheri L.; Bambina, Shelly; Doms, Robert W.; Cherry, Sara] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Cherry, Sara] Univ Penn, Sch Med, Penn Genome Frontiers Inst, Philadelphia, PA 19104 USA; [Caino, M. Cecilia] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Filone, CM (corresponding author), USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.	cherrys@mail.med.upenn.edu		Filone, Claire Marie/0000-0002-4041-3948; cherry, sara/0000-0003-3956-6610; Caino, M. Cecilia/0000-0001-8294-8070	MARCE [U54 AI 057168]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	MARCE; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the MARCE U54 AI 057168 to RD and SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Amstutz B, 2008, EMBO J, V27, P956, DOI 10.1038/emboj.2008.38; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broughton SJ, 1996, J CELL BIOCHEM, V60, P584, DOI 10.1002/(SICI)1097-4644(19960315)60:4<584::AID-JCB14>3.0.CO;2-H; CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Chu JJH, 2006, VIROLOGY, V349, P463, DOI 10.1016/j.virol.2006.01.022; Conkright MD, 2003, MOL CELL, V11, P1101, DOI 10.1016/S1097-2765(03)00134-5; Coyne CB, 2007, EMBO J, V26, P4016, DOI 10.1038/sj.emboj.7601831; Coyne CB, 2007, CELL HOST MICROBE, V2, P181, DOI 10.1016/j.chom.2007.07.003; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; ELLIS DS, 1988, J MED VIROL, V24, P161, DOI 10.1002/jmv.1890240205; Ennaciri J, 2007, J LEUKOCYTE BIOL, V81, P625, DOI 10.1189/jlb.0806507; FIERING S, 1990, GENE DEV, V4, P1823, DOI 10.1101/gad.4.10.1823; Flick R, 2005, CURR MOL MED, V5, P827, DOI 10.2174/156652405774962263; GAD AM, 1987, T ROY SOC TROP MED H, V81, P694, DOI 10.1016/0035-9203(87)90460-3; Garcia S, 2001, J CLIN MICROBIOL, V39, P4456, DOI 10.1128/JCM.39.12.4456-4461.2001; Gerrard SR, 2002, J VIROL, V76, P12200, DOI 10.1128/JVI.76.23.12200-12210.2002; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; JUPP PG, 1988, J AM MOSQUITO CONTR, V4, P4; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Meier O, 2002, J CELL BIOL, V158, P1119, DOI 10.1083/jcb.200112067; Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Perrimon N, 1998, P NATL ACAD SCI USA, V95, P9716, DOI 10.1073/pnas.95.17.9716; PETERS CJ, 1986, ANTIVIR RES, V6, P285, DOI 10.1016/0166-3542(86)90024-0; Pinheiro VB, 2006, CELL MICROBIOL, V8, P545, DOI 10.1111/j.1462-5822.2006.00693.x; Prekeris R, 1998, J BIOL CHEM, V273, P26790, DOI 10.1074/jbc.273.41.26790; Ramanathan HN, 2008, VIROLOGY, V374, P138, DOI 10.1016/j.virol.2007.12.030; Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; Schmaljohn C.S., 2001, FIELDS VIROLOGY; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; Vialat P, 1997, VIRUS RES, V52, P43, DOI 10.1016/S0168-1702(97)00097-X; Volmer R, 2006, PLOS PATHOG, V2, P195, DOI 10.1371/journal.ppat.0020019; WASMOEN TL, 1988, VIROLOGY, V166, P275, DOI 10.1016/0042-6822(88)90174-2; White KP, 1999, SCIENCE, V286, P2179, DOI 10.1126/science.286.5447.2179; Zhang XHD, 2006, PHARMACOGENOMICS, V7, P299, DOI 10.2217/14622416.7.3.299	44	39	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15483	10.1371/journal.pone.0015483	http://dx.doi.org/10.1371/journal.pone.0015483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124804	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000028
J	Morris, M; Epstein, H; Wawer, M				Morris, Martina; Epstein, Helen; Wawer, Maria			Timing Is Everything: International Variations in Historical Sexual Partnership Concurrency and HIV Prevalence	PLOS ONE			English	Article							RACIAL DISPARITIES; BEHAVIOR PATTERNS; PUBLIC-HEALTH; UNITED-STATES; SOUTH-AFRICA; RISK-FACTORS; INFECTION; TRANSMISSION; YOUNG; MEN	Background: Higher prevalence of concurrent partnerships is one hypothesis for the severity of the HIV epidemic in the countries of Southern Africa. But measures of the prevalence of concurrency alone do not adequately capture the impact concurrency will have on transmission dynamics. The importance of overlap duration and coital exposure are examined here. Methodology/Principal Findings: We conducted a comparison of data from three studies of sexual behavior carried out in the early 1990s in Uganda, Thailand and the US. Using cumulative concurrency measures, the three countries appeared somewhat similar. Over 50% of both Thai and Ugandan men reported a concurrency within the last three partnerships and over 20% reported a concurrency in the last year, the corresponding rates among US men were nearly 20% for Blacks and Hispanics, and about 10% for other racial/ethnic groups. Concurrency measures that were more sensitive to overlap duration, however, showed large differences. The point prevalence of concurrency on the day of interview was over 10% among Ugandan men compared to 1% for Thai men. Ugandan concurrencies were much longer duration - a median of about two years - than either the Thai (1 day) or US concurrencies (4-9 months across all groups), and involved 5-10 times more coital risk exposure with the less frequent partner. In the US, Blacks and Hispanics reported higher prevalence, longer duration and greater coital exposure than Whites, but were lower than Ugandans on nearly every measure. Together, the differences in the prevalence, duration and coital exposure of concurrent partnerships observed align with the HIV prevalence differentials seen in these populations at the time the data were collected. Conclusions/Significance: There were substantial variations in the patterns of concurrent partnerships within and between populations. More long-term overlapping partnerships, with regular coital exposure, were found in populations with greater HIV epidemic severity.	[Morris, Martina] Univ Washington, Dept Stat, Seattle, WA 98195 USA; [Morris, Martina] Univ Washington, Dept Sociol, Seattle, WA 98195 USA; [Wawer, Maria] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Morris, M (corresponding author), Univ Washington, Dept Stat, Seattle, WA 98195 USA.	morris@stat.washington.edu	Franzeck, Fabian C/B-5055-2011; Morris, Martina/I-7510-2012		National Institutes of Health (NIH) [R01DA12831, R01HD41877, R24 HD056799, P30 AI027757]; Robert Wood Johnson Foundation; Henry J. Kaiser Family Foundation; Rockefeller Foundation; Andrew Mellon Foundation; John D. and Catherine T. MacArthur Foundation; New York Community Trust; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD042828] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041877, R24HD056799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083034, P30AI027757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012831] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Henry J. Kaiser Family Foundation; Rockefeller Foundation; Andrew Mellon Foundation; John D. and Catherine T. MacArthur Foundation; New York Community Trust; American Foundation for AIDS Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health (NIH) grants R01DA12831, R01HD41877, R24 HD056799 and P30 AI027757 (www.nih.gov); Robert Wood Johnson Foundation (http://www.rwjf.org/); The Henry J. Kaiser Family Foundation (http://www.kff.org/); The Rockefeller Foundation (http://www.rockefellerfoundation.org/); Andrew Mellon Foundation (http://www.mellon.org/); The John D. and Catherine T. MacArthur Foundation (http://www.macfound.org); The New York Community Trust (www.nycommunitytrust.org); and The American Foundation for AIDS Research (http://www.amfar.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adimora AA, 2002, EPIDEMIOLOGY, V13, P320, DOI 10.1097/00001648-200205000-00013; Adimora AA, 2007, AM J PUBLIC HEALTH, V97, P2230, DOI 10.2105/AJPH.2006.099069; Bohl DD, 2009, SEX TRANSM INFECT, V85, P367, DOI 10.1136/sti.2009.036723; CARAEL M, 1995, SOC AS AIDS, P75; *CDCP, 2004, STD SURV 2004 STDS R; *CDCP, 1994, HIV AIDS SURV REP CD; Celum C, 2010, NEW ENGL J MED, V362, P427, DOI 10.1056/NEJMoa0904849; *DISTR COL DEP HLT, 2009, DISTR COL HIV AIDS E; Durant T., 2007, Morbidity and Mortality Weekly Report, V56, P189; Eaton JW, 2011, AIDS BEHAV, V15, P687, DOI 10.1007/s10461-010-9787-8; Epstein H, 2010, AIDS BEHAV, V14, P29, DOI 10.1007/s10461-009-9627-x; Gregson S., 2010, INT J EPIDEMIOL; Guwatudde D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004145; Hallfors DD, 2007, AM J PUBLIC HEALTH, V97, P125, DOI 10.2105/AJPH.2005.075747; HAMILTON D, 2009, CONSISTENCY SELF REP; HUDSON CP, 1993, INT J STD AIDS, V4, P249, DOI 10.1177/095646249300400501; Hudson CP, 1996, INT J STD AIDS, V7, P236, DOI 10.1258/0956462961917906; Hugonnet S, 2002, J ACQ IMMUN DEF SYND, V30, P73, DOI 10.1097/00042560-200205010-00010; Jewkes R, 2006, INT J EPIDEMIOL, V35, P1455, DOI 10.1093/ije/dyl217; Johnson KM, 2003, AIDS, V17, P605, DOI 10.1097/00002030-200303070-00016; Johnson LF, 2009, DEMOGR RES, V21, P289, DOI 10.4054/DemRes.2009.21.11; KELLY R, 2000, CONCURRENT NONCONCUR; Kirby D, 2008, SEX TRANSM INFECT, V84, pII35, DOI 10.1136/sti.2008.029892; Koumans EH, 2001, SEX TRANSM DIS, V28, P497, DOI 10.1097/00007435-200109000-00004; Lagarde E, 2001, AIDS, V15, P877, DOI 10.1097/00002030-200105040-00008; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Lurie MN, 2010, AIDS BEHAV, V14, P34, DOI 10.1007/s10461-009-9640-0; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mattson CL, 2007, SEX TRANSM DIS, V34, P731, DOI 10.1097/01.olq.0000261335.42480.89; Mermin J, 2008, JAMA-J AM MED ASSOC, V300, P540, DOI 10.1001/jama.300.5.540; Mills S, 1997, AIDS, V11, pS43; MISHRA V, 2009, CONCURRENT SEXUAL PA; MORRIS M, 1993, NATURE, V365, P437, DOI 10.1038/365437a0; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; MORRIS M, 1995, SOC NETWORKS, V17, P299, DOI 10.1016/0378-8733(95)00268-S; Morris M, 2001, SEX TRANSM DIS, V28, P504, DOI 10.1097/00007435-200109000-00005; Morris M, 2004, NETWORK EPIDEMIOLOGY; MORRIS M, 2010, INT J EPIDEMIOL; MORRIS M, 1994, CONNECTIONS, V17, P31; Morris M, 2006, AM J PUBLIC HEALTH, V96, P1091, DOI 10.2105/AJPH.2004.054759; Morris M, 2010, AIDS BEHAV, V14, P31, DOI 10.1007/s10461-009-9639-6; Morris M, 2009, AM J PUBLIC HEALTH, V99, P1023, DOI 10.2105/AJPH.2008.147835; Nunn AJ, 1997, BRIT MED J, V315, P767, DOI 10.1136/bmj.315.7111.767; Pettifor AE, 2005, AIDS, V19, P1525, DOI 10.1097/01.aids.0000183129.16830.06; Potterat JJ, 1999, AM J EPIDEMIOL, V150, P1331, DOI 10.1093/oxfordjournals.aje.a009965; Potts M, 2008, SCIENCE, V320, P749, DOI 10.1126/science.1153843; Reniers G, 2010, AIDS, V24, P299, DOI 10.1097/QAD.0b013e328333af03; Sawers L, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-34; SEWANKAMBO NK, 1994, AIDS, V8, P1707, DOI 10.1097/00002030-199412000-00011; Shisana O., 2009, S AFRICAN NATL HIV P; Stoneburner RL, 2004, SCIENCE, V304, P714, DOI 10.1126/science.1093166; UNAIDS, 2007, ANN REP KNOW YOUR EP; UNAIDS Reference Grp Estimates Mod, 2010, LANCET, V375, P621, DOI 10.1016/S0140-6736(09)62040-7; WATTS CH, 1992, MATH BIOSCI, V108, P89, DOI 10.1016/0025-5564(92)90006-I; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8	55	97	97	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14092	10.1371/journal.pone.0014092	http://dx.doi.org/10.1371/journal.pone.0014092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124829	Green Published, gold			2022-12-27	WOS:000284572000003
J	Fernagut, PO; Li, Q; Dovero, S; Chan, P; Wu, T; Ravenscroft, P; Hill, M; Chen, ZW; Bezard, E				Fernagut, Pierre-Olivier; Li, Qin; Dovero, Sandra; Chan, Piu; Wu, Tao; Ravenscroft, Paula; Hill, Michael; Chen, Zhenwen; Bezard, Erwan			Dopamine Transporter Binding Is Unaffected by L-DOPA Administration in Normal and MPTP-Treated Monkeys	PLOS ONE			English	Article							PARKINSONS-DISEASE PROGRESSION; LEVODOPA-INDUCED DYSKINESIA; IN-VIVO BINDING; MACAQUE MODEL; NIGROSTRIATAL DEGENERATION; RAT STRIATUM; REAL-PET; BETA-CIT; SPECT; AVAILABILITY	Background: Radiotracer imaging of the presynaptic nigrostriatal dopaminergic system is used to assess disease progression in Parkinson's disease (PD) and may provide a useful adjunct to clinical assessment during therapeutic trials of potential neuroprotective agents. Several clinical trials comparing dopamine agonists to L-DOPA or early vs. late L-DOPA have revealed differences between clinical assessment and imaging of the presynaptic dopaminergic system, hence questioning the comparability of these measures as neuroprotection outcome variables. Thus, results of these studies may have been affected by factors other than the primary biological process investigated. Methodology/Principal Findings: We tested the possibility that L-DOPA might interfere with DAT binding. Post-mortem DAT binding was conducted in normal and MPTP-treated macaque monkeys that were administered L-DOPA, acutely or chronically. In parallel, DAT SPECT was conducted in MPTP-treated animals that were administered chronic L-DOPA. [99mTc]TRODAT-1 SPECT binding was similarly reduced in all MPTP monkeys regardless of L-DOPA treatment. L-DOPA had no significant effect on post-mortem DAT binding either in saline or in MPTP-lesioned animals. Conclusions/Significance: These data indicate that L-DOPA does not induce modifications of DAT expression detectable by SPECT of by DAT binding autoradiography, suggesting that differences between clinical assessment and radiotracer imaging in clinical trials may not be specifically related to L-DOPA treatment.	[Fernagut, Pierre-Olivier; Dovero, Sandra; Bezard, Erwan] Univ Bordeaux 2, CNRS, UMR 5227, Bordeaux Inst Neurosci, F-33076 Bordeaux, France; [Li, Qin; Ravenscroft, Paula] Motac Neurosci Ltd, Manchester, Lancs, England; [Li, Qin; Bezard, Erwan] China Acad Med Sci, Inst Lab Anim Sci, Beijing, Peoples R China; [Chan, Piu; Wu, Tao] Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China; [Chen, Zhenwen] Capital Med Univ, Dept Lab Anim Sci, Beijing, Peoples R China	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Capital Medical University; Capital Medical University	Fernagut, PO (corresponding author), Univ Bordeaux 2, CNRS, UMR 5227, Bordeaux Inst Neurosci, F-33076 Bordeaux, France.	pierre-olivier.fernagut@u-bordeaux2.fr	Bezard, Erwan/A-8173-2008; Chan, Piu/I-4580-2016; Bezard, Erwan/ABD-5153-2021; Wu, Tao/S-4505-2019	Chan, Piu/0000-0003-1346-881X; Bezard, Erwan/0000-0002-0410-4638; DOVERO, Sandra/0000-0002-5781-1328; Fernagut, Pierre-Olivier/0000-0002-7737-5439	Agence Nationale de la Recherche [ANR-07-JCJC-0090, ANR-08-MNP-018, ANR-07-MNP-Trafinlid]; National High Technology Research and Development Program of China [2006AA02A116]; Motac Neuroscience Ltd	Agence Nationale de la Recherche(French National Research Agency (ANR)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Motac Neuroscience Ltd	This work was supported by Agence Nationale de la Recherche grants (ANR-07-JCJC-0090; ANR-08-MNP-018; ANR-07-MNP-Trafinlid) and the National High Technology Research and Development Program of China, No. 2006AA02A116. Funding for the research was provided by Motac Neuroscience Ltd to MH and PR who are employees of Motac Neuroscience. The funders had a role in study design, data collection and analysis.	Ahlskog JE, 2003, NEUROLOGY, V60, P381, DOI 10.1212/01.WNL.0000044047.58984.2F; AHMED MR, SCI TRANSL MED, V2; Bezard E, 1997, BRAIN RES, V766, P107, DOI 10.1016/S0006-8993(97)00531-3; Bezard E, 2001, J NEUROSCI, V21, P6853, DOI 10.1523/JNEUROSCI.21-17-06853.2001; Bezard E, 2003, NAT MED, V9, P762, DOI 10.1038/nm875; Bezard E, 2006, NEUROBIOL DIS, V23, P77, DOI 10.1016/j.nbd.2006.02.003; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Brotchie JM, 1999, MOVEMENT DISORD, V14, P40; Chen PS, 2008, NEUROIMAGE, V40, P275, DOI 10.1016/j.neuroimage.2007.11.007; Dresel SHJ, 1998, EUR J NUCL MED, V25, P31; Emond P, 1997, J MED CHEM, V40, P1366, DOI 10.1021/jm960795d; Fahn S, 2004, NEW ENGL J MED, V351, P2498; Francois C, 1996, BRAIN RES BULL, V41, P151, DOI 10.1016/0361-9230(96)00161-X; GNANALINGHAM KK, 1994, BRAIN RES, V640, P185, DOI 10.1016/0006-8993(94)91872-4; Gold SJ, 2007, J NEUROSCI, V27, P14338, DOI 10.1523/JNEUROSCI.4223-07.2007; Gordon I, 1996, EUR J PHARMACOL, V298, P27, DOI 10.1016/0014-2999(95)00770-9; Guigoni C, 2005, EUR J NEUROSCI, V22, P283, DOI 10.1111/j.1460-9568.2005.04196.x; Hall H, 1999, NEUROIMAGE, V9, P108, DOI 10.1006/nimg.1998.0366; Hill MP, 2004, J PHARMACOL EXP THER, V310, P386, DOI 10.1124/jpet.104.066191; IKAWA K, 1993, EUR J PHARMACOL, V250, P261, DOI 10.1016/0014-2999(93)90390-4; Imbert C, 2000, J NEUROSCI METH, V96, P71, DOI 10.1016/S0165-0270(99)00184-3; Innis RB, 1999, MOVEMENT DISORD, V14, P436, DOI 10.1002/1531-8257(199905)14:3<436::AID-MDS1008>3.0.CO;2-J; LARUELLE M, 1993, SYNAPSE, V13, P295, DOI 10.1002/syn.890130402; Marek K, 2002, EUR J NEUROL, V9, P15, DOI 10.1046/j.1468-1331.9.s3.2.x; Marek K, 2001, NEUROLOGY, V57, P2089, DOI 10.1212/WNL.57.11.2089; Meissner W, 2003, MOL NEUROBIOL, V28, P209, DOI 10.1385/MN:28:3:209; Miller Rupert G., 1981, SIMULTANEOUS STAT IN, V2nd, DOI [DOI 10.1007/978-1-4613-8122-8, 10.1007/978-1-4613-8122-8_1]; Montgomery EB, 2003, NEUROLOGY, V61, P1462, DOI 10.1212/WNL.61.10.1462; Moody CA, 1996, NEUROSCI LETT, V217, P55; Morrish PK, 2003, ANN NEUROL, V54, P692, DOI 10.1002/ana.10774; Morrish PK, 2003, MOVEMENT DISORD, V18, pS63, DOI 10.1002/mds.10581; Morrish PK, 2003, MOVEMENT DISORD, V18, P839, DOI 10.1002/mds.10448; Morrish PK, 1998, J NEUROL NEUROSUR PS, V64, P314, DOI 10.1136/jnnp.64.3.314; Morrish PK, 1996, BRAIN, V119, P585, DOI 10.1093/brain/119.2.585; Newberg A, 2007, CLIN NUCL MED, V32, P452, DOI 10.1097/01.rlu.0000262980.98342.dd; Nurmi E, 2000, ANN NEUROL, V47, P804, DOI 10.1002/1531-8249(200006)47:6<804::AID-ANA14>3.0.CO;2-F; Parish CL, 2002, EUR J NEUROSCI, V16, P787, DOI 10.1046/j.1460-9568.2002.02132.x; PARKINSON, 2002, JAMA-J AM MED ASSOC, V287, P1653; Pearce RKB, 1995, MOVEMENT DISORD, V10, P731, DOI 10.1002/mds.870100606; Pirker W, 2002, MOVEMENT DISORD, V17, P45, DOI 10.1002/mds.1265; Prunier C, 2003, NEUROIMAGE, V19, P810, DOI 10.1016/S1053-8119(03)00163-0; Ravina B, 2005, NEUROLOGY, V64, P208, DOI 10.1212/01.WNL.0000149403.14458.7F; Rioux L, 1997, MOVEMENT DISORD, V12, P148, DOI 10.1002/mds.870120204; Scheller D, 2007, EXP NEUROL, V203, P415, DOI 10.1016/j.expneurol.2006.08.026; Scherfler C, 2002, NEUROIMAGE, V17, P128, DOI 10.1006/nimg.2002.1158; Schillaci O, 2005, EUR J NUCL MED MOL I, V32, P1452, DOI 10.1007/s00259-005-1922-9; Stanic D, 2003, J NEUROCHEM, V86, P329, DOI 10.1046/j.1471-4159.2003.01843.x; Thibaut F, 1996, NEUROSCI LETT, V205, P145, DOI 10.1016/0304-3940(96)12399-5; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; van de Giessen EM, 2009, J NUCL MED, V50, P45, DOI 10.2967/jnumed.108.053652; van Dyck CH, 2005, J NUCL MED, V46, P745; Weintraub D, 2005, J NUCL MED, V46, P227; Whone AL, 2003, ANN NEUROL, V54, P93, DOI 10.1002/ana.10609; Winogrodzka A, 2005, PARKINSONISM RELAT D, V11, P475, DOI 10.1016/j.parkreldis.2005.08.001; Winogrodzka A, 2001, J NEURAL TRANSM, V108, P1011, DOI 10.1007/s007020170019; Zigmond MJ, 1997, NEUROBIOL DIS, V4, P247, DOI 10.1006/nbdi.1997.0157	56	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14053	10.1371/journal.pone.0014053	http://dx.doi.org/10.1371/journal.pone.0014053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124922	Green Published, gold, Green Submitted			2022-12-27	WOS:000284467200003
J	Nodari, LR; Ferrari, D; Giani, F; Bossi, M; Rodriguez-Menendez, V; Tredici, G; Delia, D; Vescovi, AL; De Filippis, L				Nodari, Laura Rota; Ferrari, Daniela; Giani, Fabrizio; Bossi, Mario; Rodriguez-Menendez, Virginia; Tredici, Giovanni; Delia, Domenico; Vescovi, Angelo Luigi; De Filippis, Lidia			Long-Term Survival of Human Neural Stem Cells in the Ischemic Rat Brain upon Transient Immunosuppression	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NEURONAL DAMAGE; ADULT BRAIN; HUMAN CNS; TRANSPLANTATION; MODEL; NEUROPROTECTION; NEUROGENESIS	Understanding the physiology of human neural stem cells (hNSCs) in the context of cell therapy for neurodegenerative disorders is of paramount importance, yet large-scale studies are hampered by the slow-expansion rate of these cells. To overcome this issue, we previously established immortal, non-transformed, telencephalic-diencephalic hNSCs (IhNSCs) from the fetal brain. Here, we investigated the fate of these IhNSC's immediate progeny (i.e. neural progenitors; IhNSC-Ps) upon unilateral implantation into the corpus callosum or the hippocampal fissure of adult rat brain, 3 days after global ischemic injury. One month after grafting, approximately one fifth of the IhNSC-Ps had survived and migrated through the corpus callosum, into the cortex or throughout the dentate gyrus of the hippocampus. By the fourth month, they had reached the ipsilateral subventricular zone, CA1-3 hippocampal layers and the controlateral hemisphere. Notably, these results could be accomplished using transient immunosuppression, i.e administering cyclosporine for 15 days following the ischemic event. Furthermore, a concomitant reduction of reactive microglia (Iba1+ cells) and of glial, GFAP+ cells was also observed in the ipsilateral hemisphere as compared to the controlateral one. IhNSC-Ps were not tumorigenic and, upon in vivo engraftment, underwent differentiation into GFAP+ astrocytes, and beta-tubulinIII+ or MAP2+ neurons, which displayed GABAergic and GLUTAmatergic markers. Electron microscopy analysis pointed to the formation of mature synaptic contacts between host and donor-derived neurons, showing the full maturation of the IhNSC-P-derived neurons and their likely functional integration into the host tissue. Thus, IhNSC-Ps possess long-term survival and engraftment capacity upon transplantation into the globally injured ischemic brain, into which they can integrate and mature into neurons, even under mild, transient immunosuppressive conditions. Most notably, transplanted IhNSC-P can significantly dampen the inflammatory response in the lesioned host brain. This work further supports hNSCs as a reliable and safe source of cells for transplantation therapy in neurodegenerative disorders.	[Nodari, Laura Rota; Ferrari, Daniela; Giani, Fabrizio; Vescovi, Angelo Luigi; De Filippis, Lidia] Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy; [Bossi, Mario; Rodriguez-Menendez, Virginia; Tredici, Giovanni] Univ Milano Bicocca, Dept Neurosci & Biomed Technol, Milan, Italy; [Delia, Domenico] Fdn IRCSS Ist Nazl Tumori, Dept Expt Oncol, Milan, Italy; [Vescovi, Angelo Luigi] IRCCS Casa Sollievo Sofferenza, San Giovanni Rotondo, Italy	University of Milano-Bicocca; University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Casa Sollievo Della Sofferenza	Nodari, LR (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Milan, Italy.	angelo.vescovi@unimib.it; lidia.defilippis@unimib.it	Vescovi, Angelo Luigi/A-4919-2015; Ferrari, Daniela/AHE-7647-2022; De Filippis, Lidia/H-3098-2017	Vescovi, Angelo Luigi/0000-0002-1742-4112; Ferrari, Daniela/0000-0001-7251-9854; De Filippis, Lidia/0000-0002-2196-9430; Giani, Fabrizio/0000-0003-0031-3157	CARIPLO Foundation; Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC); Italian Ministry of Health Ricerca Finalizzata	CARIPLO Foundation(Fondazione Cariplo); Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health Ricerca Finalizzata(Ministry of Health, Italy)	This work was supported by CARIPLO Foundation; Neurothon ONLUS Foundation; Italian Association for Cancer Research (AIRC); Italian Ministry of Health Ricerca Finalizzata. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1946, ANAT REC, V94, P239, DOI 10.1002/ar.1090940210; Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Amendola M, 2005, NAT BIOTECHNOL, V23, P108, DOI 10.1038/nbt1049; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bacigaluppi M, 2009, BRAIN, V132, P2239, DOI 10.1093/brain/awp174; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Bendel O, 2005, BRAIN RES, V1033, P135, DOI 10.1016/j.brainres.2004.11.033; Bjorklund A, 2003, LANCET NEUROL, V2, P437, DOI 10.1016/S1474-4422(03)00442-3; Boockvar J, 2005, NEUROSURGERY, V56, pN6; Bueters T, 2008, EXP NEUROL, V209, P114, DOI 10.1016/j.expneurol.2007.09.005; Chu K, 2003, NEUROSCI LETT, V343, P129, DOI 10.1016/S0304-3940(03)00174-5; Craig CG, 1996, J NEUROSCI, V16, P2649; DAADI MM, 2010, STROKE; De Filippis L, 2007, STEM CELLS, V25, P2312, DOI 10.1634/stemcells.2007-0040; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Domanska-Janik K, 2004, MOL BRAIN RES, V121, P50, DOI 10.1016/j.molbrainres.2003.11.006; Englund U, 2002, DEV BRAIN RES, V134, P123, DOI 10.1016/S0165-3806(01)00330-3; Fagel DM, 2006, EXP NEUROL, V199, P77, DOI 10.1016/j.expneurol.2005.04.006; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Givogri MI, 2008, DEV NEUROSCI-BASEL, V30, P340, DOI 10.1159/000150127; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GRITTI A, 1995, NEUROSCI LETT, V185, P151, DOI 10.1016/0304-3940(95)11247-T; Gritti A, 1996, J NEUROSCI, V16, P1091; GU W, 2009, STEM CELL RES; Hurelbrink CB, 2002, EUR J NEUROSCI, V15, P1255, DOI 10.1046/j.1460-9568.2002.01959.x; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Le Belle JE, 2004, J NEUROSCI RES, V76, P174, DOI 10.1002/jnr.20035; Lee ST, 2008, BRAIN, V131, P616, DOI 10.1093/brain/awm306; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Modo M, 2002, BRAIN RES, V958, P70, DOI 10.1016/S0006-8993(02)03463-7; Neri M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010145; Ohira K, 2010, NAT NEUROSCI, V13, P173, DOI 10.1038/nn.2473; Olstorn H, 2007, NEUROSURGERY, V60, P1089, DOI 10.1227/01.NEU.0000255461.91892.0D; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Pluchino S, 2005, NATURE, V436, P266, DOI 10.1038/nature03889; Pluchino S, 2003, NATURE, V422, P688, DOI 10.1038/nature01552; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; POPAWAGNER A, 2009, AGEING RES REV; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; Vescovi AL, 1999, EXP NEUROL, V156, P71, DOI 10.1006/exnr.1998.6998; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Wennersten A, 2006, EXP NEUROL, V199, P339, DOI 10.1016/j.expneurol.2005.12.035; Wong AM, 2005, BRAIN RES, V1063, P140, DOI 10.1016/j.brainres.2005.09.049	53	41	41	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14035	10.1371/journal.pone.0014035	http://dx.doi.org/10.1371/journal.pone.0014035			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124963	gold, Green Published, Green Submitted			2022-12-27	WOS:000284400100004
J	Fortibuoni, T; Libralato, S; Raicevich, S; Giovanardi, O; Solidoro, C				Fortibuoni, Tomaso; Libralato, Simone; Raicevich, Sasa; Giovanardi, Otello; Solidoro, Cosimo			Coding Early Naturalists' Accounts into Long-Term Fish Community Changes in the Adriatic Sea (1800-2000)	PLOS ONE			English	Article							BASE-LINES; RESOURCES; ANECDOTES; DEPLETION	The understanding of fish communities' changes over the past centuries has important implications for conservation policy and marine resource management. However, reconstructing these changes is difficult because information on marine communities before the second half of the 20(th) century is, in most cases, anecdotal and merely qualitative. Therefore, historical qualitative records and modern quantitative data are not directly comparable, and their integration for long-term analyses is not straightforward. We developed a methodology that allows the coding of qualitative information provided by early naturalists into semi-quantitative information through an intercalibration with landing proportions. This approach allowed us to reconstruct and quantitatively analyze a 200-year-long time series of fish community structure indicators in the Northern Adriatic Sea (Mediterranean Sea). Our analysis provides evidence of long-term changes in fish community structure, including the decline of Chondrichthyes, large-sized and late-maturing species. This work highlights the importance of broadening the time-frame through which we look at marine ecosystem changes and provides a methodology to exploit, in a quantitative framework, historical qualitative sources. To the purpose, naturalists' eyewitness accounts proved to be useful for extending the analysis on fish community back in the past, well before the onset of field-based monitoring programs.	[Fortibuoni, Tomaso; Libralato, Simone; Solidoro, Cosimo] Ist Nazl Oceanog & Geofis Sperimentale, Dept Oceanog, Sgonico, Italy; [Fortibuoni, Tomaso; Raicevich, Sasa; Giovanardi, Otello] Ist Super Prot & Ric Ambientale, Chioggia, Italy	Istituto Nazionale di Oceanografia e di Geofisica Sperimentale; Italian Institute for Environmental Protection & Research (ISPRA)	Fortibuoni, T (corresponding author), Ist Nazl Oceanog & Geofis Sperimentale, Dept Oceanog, Sgonico, Italy.	tfortibuoni@ogs.trieste.it	Fortibuoni, Tomaso/L-1362-2019; Solidoro, Cosimo/A-3997-2009; Libralato, Simone/N-5668-2015; Libralato, Simone/AAR-2198-2020	Fortibuoni, Tomaso/0000-0003-3449-3475; Libralato, Simone/0000-0001-8112-1274; Libralato, Simone/0000-0001-8112-1274; Raicevich, Sasa/0000-0002-9323-031X; solidoro, cosimo/0000-0003-2354-4302; Giovanardi, Otello/0000-0002-3171-9099	Alfred P. Sloan Foundation; "Regione Veneto" administration; "Tegnue di Chioggia onlus" association; EC [GOCE-036949]; Sixth Framework Programme; Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia)	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); "Regione Veneto" administration; "Tegnue di Chioggia onlus" association; EC(European CommissionEuropean Commission Joint Research Centre); Sixth Framework Programme(European Commission); Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia)	TF was supported by the Alfred P. Sloan Foundation, History of Marine Animal Populations project(HMAP), the "Regione Veneto" administration and the "Tegnue di Chioggia onlus" association in the framework of the project "La pesca in Alto Adriatico e Laguna di Venezia dalla caduta della Serenissima ad oggi: unanalisi storica ed ecologica". This work was partially funded by the projects SESAME (EC Contract No. GOCE-036949, funded by the Sixth Framework Programme) and VECTOR (VulnErabilita delle Coste e degli ecosistemi marini italiani ai cambiamenti climaTici e loro ruolO nel ciclo del caRbonio mediterraneo) and by the Centro Euro-Mediterraneo per i Cambiamenti Climatici and ISPRA (Istituto Superiore per la Protezione e la Ricerca Ambientale, STS Chioggia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth CH, 2008, BIOL CONSERV, V141, P848, DOI 10.1016/j.biocon.2008.01.006; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; BARMAWIDJAJA DM, 1995, MAR GEOL, V122, P367, DOI 10.1016/0025-3227(94)00121-Z; Botter L, 2006, J MEDITERR STUD, V16, P27; Cardinale M, 2009, MAR ECOL PROG SER, V386, P197, DOI 10.3354/meps08076; CROWLEY PH, 1992, ANNU REV ECOL SYST, V23, P405, DOI 10.1146/annurev.es.23.110192.002201; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; DANCONA U, 1926, COMITATO TALASSOGRAF, V126, P5; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; EDMONDS M, 2005, HIST ECOLOGY HDB RES, P72; Ferretti F, 2008, CONSERV BIOL, V22, P952, DOI 10.1111/j.1523-1739.2008.00938.x; Froese R., 2021, FISHBASE WORLD WIDE; Holm P, 2005, HELGOLAND MAR RES, V59, P39, DOI 10.1007/s10152-004-0205-3; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Jennings S, 1999, J ANIM ECOL, V68, P617, DOI 10.1046/j.1365-2656.1999.00312.x; Jukic-Peladic S, 2001, FISH RES, V53, P95, DOI 10.1016/S0165-7836(00)00232-0; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Lotze HK, 2009, TRENDS ECOL EVOL, V24, P254, DOI 10.1016/j.tree.2008.12.004; Mackinson S, 2001, ENVIRON MANAGE, V27, P533, DOI 10.1007/s002670010168; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; NARDO GD, 1924, MED ARTI, V7, P222; PALOMARES MLD, 2005, ENV HIST, V11, P835; Pandolfi JM, 2003, SCIENCE, V301, P955, DOI 10.1126/science.1085706; Pauly D, 2005, B MAR SCI, V76, P197; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; PAULY D, 1995, TRENDS ECOL EVOL, V10, P430, DOI 10.1016/S0169-5347(00)89171-5; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; Pinnegar JK, 2008, REV FISH BIOL FISHER, V18, P1, DOI 10.1007/s11160-007-9058-6; Pitcher TJ, 2001, ECOL APPL, V11, P601; Rosenberg AA, 2005, FRONT ECOL ENVIRON, V3, P84, DOI 10.2307/3868514; Saenz-Arroyo A, 2005, FISH FISH, V6, P121, DOI 10.1111/j.1467-2979.2005.00185.x; Saenz-Arroyo A, 2005, P ROY SOC B-BIOL SCI, V272, P1957, DOI 10.1098/rspb.2005.3175; SAEZARROYO A, 2006, FISH FISH, V7, P128; Schrope M, 2006, NATURE, V443, P622, DOI 10.1038/443622a; SENNEBOGEN E, 1997, NEPTUNIA, V12, P137; Vrgo N., 2004, ADRIAMED TECH DOC, V12, P91	38	84	85	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e15502	10.1371/journal.pone.0015502	http://dx.doi.org/10.1371/journal.pone.0015502			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103349	Green Published, Green Submitted, gold			2022-12-27	WOS:000284327800023
J	Vitry, AI; Roughead, EE; Preiss, AK; Ryan, P; Ramsay, EN; Gilbert, AL; Caughey, GE; Shakib, S; Esterman, A; Zhang, Y; McDermott, RA				Vitry, Agnes I.; Roughead, Elizabeth E.; Preiss, Adrian K.; Ryan, Philip; Ramsay, Emmae N.; Gilbert, Andrew L.; Caughey, Gillian E.; Shakib, Sepehr; Esterman, Adrian; Zhang, Ying; McDermott, Robyn A.			Influence of Comorbidities on Therapeutic Progression of Diabetes Treatment in Australian Veterans: A Cohort Study	PLOS ONE			English	Article							CLINICAL INERTIA; GLYCEMIC CONTROL; CARE; INTENSIFICATION; IMPACT	Background: This study assessed whether the number of comorbid conditions unrelated to diabetes was associated with a delay in therapeutic progression of diabetes treatment in Australian veterans. Methodology/Principal Findings: A retrospective cohort study was undertaken using data from the Australian Department of Veterans' Affairs (DVA) claims database between July 2000 and June 2008. The study included new users of metformin or sulfonylurea medicines. The outcome was the time to addition or switch to another antidiabetic treatment. The total number of comorbid conditions unrelated to diabetes was identified using the pharmaceutical-based comorbidity index, Rx-Risk-V. Competing risk regression analyses were conducted, with adjustments for a number of covariates that included age, gender, residential status, use of endocrinology service, number of hospitalisation episodes and adherence to diabetes medicines. Overall, 20134 veterans were included in the study. At one year, 23.5% of patients with diabetes had a second medicine added or had switched to another medicine, with 41.4% progressing by 4 years. The number of unrelated comorbidities was significantly associated with the time to addition of an antidiabetic medicine or switch to insulin (subhazard ratio [SHR] 0.87 [95% CI 0.84-0.91], P<0.001). Depression, cancer, chronic obstructive pulmonary disease, dementia, and Parkinson's disease were individually associated with a decreased likelihood of therapeutic progression. Age, residential status, number of hospitalisations and adherence to anti-diabetic medicines delayed therapeutic progression. Conclusions/Significance: Increasing numbers of unrelated conditions decreased the likelihood of therapeutic progression in veterans with diabetes. These results have implications for the development of quality measures, clinical guidelines and the construction of models of care for management of diabetes in elderly people with comorbidities.	[Vitry, Agnes I.; Roughead, Elizabeth E.; Preiss, Adrian K.; Gilbert, Andrew L.; Caughey, Gillian E.] Univ S Australia, Qual Use Med & Pharm Res Ctr, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Ryan, Philip; Ramsay, Emmae N.; Zhang, Ying] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA, Australia; [Shakib, Sepehr] Royal Adelaide Hosp, Dept Clin Pharmacol, Adelaide, SA 5000, Australia; [Esterman, Adrian] Univ S Australia, Sch Nursing & Midwifery, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [McDermott, Robyn A.] Univ S Australia, SA NT Datalink, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia	University of South Australia; University of Adelaide; Royal Adelaide Hospital; Flinders University South Australia; University of South Australia; University of South Australia	Vitry, AI (corresponding author), Univ S Australia, Qual Use Med & Pharm Res Ctr, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia.	agnes.vitry@unisa.edu.au	Esterman, Adrian J/D-1042-2009; Gilbert, Andrew L/C-6892-2009; McDermott, Robyn A/C-5824-2008; Roughead, Elizabeth E/G-4431-2010; Vitry, Agnes I/G-2822-2010; Ramsay, Emmae N/F-4494-2013; Preiss, Adrian K/A-4691-2011; Caughey, Gillian E/A-3041-2011; Zhang, Ying/ABE-2275-2021	Roughead, Elizabeth E/0000-0002-6811-8991; Vitry, Agnes I/0000-0003-1091-6453; Ramsay, Emmae N/0000-0002-8708-5910; Zhang, Ying/0000-0001-6214-2440; Esterman, Adrian/0000-0001-7324-9171; Caughey, Gillian/0000-0003-1192-4121	National Health and Medical Research Council/Australian Research Council [APP ID 401832]	National Health and Medical Research Council/Australian Research Council(Australian Research CouncilNational Health and Medical Research Council (NHMRC) of Australia)	This study was supported by funding from a National Health and Medical Research Council/Australian Research Council Ageing Well Ageing Productively (AWAP) Program grant (APP ID 401832) http://www.nhmrc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	*AIHW, 2002, HLTH CAR US COSTS CO, P1; Boccuzzi SJ, 2001, DIABETES CARE, V24, P1411, DOI 10.2337/diacare.24.8.1411; Brown AF, 2003, J AM GERIATR SOC, V51, P665, DOI 10.1034/j.1600-0579.2003.00211.x; Chaudhry SI, 2005, J AM GERIATR SOC, V53, P1214, DOI 10.1111/j.1532-5415.2005.53370.x; Colagiuri S, 2009, NATL EVIDENCE BASED; Dailey G, 2002, J INT MED RES, V30, P71, DOI 10.1177/147323000203000111; Davis TME, 2006, MED J AUSTRALIA, V184, P325, DOI 10.5694/j.1326-5377.2006.tb00264.x; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gardarsdottir H, 2010, J CLIN EPIDEMIOL, V63, P422, DOI 10.1016/j.jclinepi.2009.07.001; Grant RW, 2004, DIABETIC MED, V21, P150, DOI 10.1111/j.1464-5491.2004.01095.x; Greenfield S, 2009, ANN INTERN MED, V151, P854, DOI 10.7326/0003-4819-151-12-200912150-00005; Hooper L, 2004, BRIT MED J, V329, P948, DOI 10.1136/bmj.38232.680567.EB; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Lagu T, 2008, J GEN INTERN MED, V23, P1208, DOI 10.1007/s11606-008-0647-4; McEwen LN, 2009, DIABETES CARE, V32, P971, DOI 10.2337/dc08-1911; Nichols Gregory A, 2007, Endocr Pract, V13, P37; Parchman ML, 2007, ANN FAM MED, V5, P196, DOI 10.1370/afm.679; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Plat A, 2009, PHARM WORLD SCI, V31, P622, DOI 10.1007/s11096-009-9321-0; *ROYAL AUSTR COLL, 2009, DIAB MAN GEN PRACT G; Sales AE, 2009, J GEN INTERN MED, V24, P1205, DOI 10.1007/s11606-009-1096-4; Selbly JV, 2009, MED CARE, V47, P395, DOI 10.1097/MLR.0b013e31818d775c; Shah BR, 2005, DIABETES CARE, V28, P600, DOI 10.2337/diacare.28.3.600; Turner BJ, 2008, ANN INTERN MED, V148, P578, DOI 10.7326/0003-4819-148-8-200804150-00002; Vitry A, 2009, AUST NZ J PUBL HEAL, V33, P126, DOI 10.1111/j.1753-6405.2009.00357.x; Wetzler HP, 2000, DIABETES CARE, V23, P1637, DOI 10.2337/diacare.23.11.1637	26	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14024	10.1371/journal.pone.0014024	http://dx.doi.org/10.1371/journal.pone.0014024			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103337	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000284327800010
J	Ma, L; Han, SZ; Yang, J; Da, Y				Ma, Li; Han, Shizhong; Yang, Jing; Da, Yang			Multi-locus Test Conditional on Confirmed Effects Leads to Increased Power in Genome-wide Association Studies	PLOS ONE			English	Article							LOCI	Complex diseases or phenotypes may involve multiple genetic variants and interactions between genetic, environmental and other factors. Current genome-wide association studies (GWAS) mostly used single-locus analysis and had identified genetic effects with multiple confirmations. Such confirmed single-nucleotide polymorphism (SNP) effects were likely to be true genetic effects and ignoring this information in testing new effects of the same phenotype results in decreased statistical power due to increased residual variance that has a component of the omitted effects. In this study, a multi-locus association test (MLT) was proposed for GWAS analysis conditional on SNPs with confirmed effects to improve statistical power. Analytical formulae for statistical power were derived and were verified by simulation for MLT accounting for confirmed SNPs and for single-locus test (SLT) without accounting for confirmed SNPs. Statistical power of the two methods was compared by case studies with simulated and the Framingham Heart Study (FHS) GWAS data. Results showed that the MLT method had increased statistical power over SLT. In the GWAS case study on four cholesterol phenotypes and serum metabolites, the MLT method improved statistical power by 5% to 38% depending on the number and effect sizes of the conditional SNPs. For the analysis of HDL cholesterol (HDL-C) and total cholesterol (TC) of the FHS data, the MLT method conditional on confirmed SNPs from GWAS catalog and NCBI had considerably more significant results than SLT.	[Ma, Li; Yang, Jing; Da, Yang] Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA; [Ma, Li] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Han, Shizhong] Yale Univ, Sch Med, Dept Psychiat, Div Human Genet, New Haven, CT USA	University of Minnesota System; University of Minnesota Twin Cities; Cornell University; Yale University	Ma, L (corresponding author), Univ Minnesota, Dept Anim Sci, St Paul, MN 55108 USA.	maxxx131@umn.edu; yda@umn.edu	Han, Shizhong/H-5785-2011; Ma, Li/B-1844-2010	Han, Shizhong/0000-0002-5114-6742	Agricultural Experiment Station at the University of Minnesota [MN-16-043]; National Heart, Lung, and Blood Institute (NHLBI); Boston University	Agricultural Experiment Station at the University of Minnesota(University of Minnesota System); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University	This research was supported in part by project MN-16-043 of the Agricultural Experiment Station at the University of Minnesota. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University. This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or the NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; JANSEN RC, 1994, GENETICS, V136, P1447; Li Y, 2006, AM J HUM GENET S, VS79, P2290; MA L, 2008, PLANT AN GEN 16 C JA; Ma L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-315; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Development Core Team, 2020, R LANGUAGE ENV STAT; Roeder K, 2006, AM J HUM GENET, V78, P243, DOI 10.1086/500026; Saccone NL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001053; Sandhu MS, 2008, LANCET, V371, P483, DOI 10.1016/S0140-6736(08)60208-1; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; ZENG ZB, 1994, GENETICS, V136, P1457	16	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15006	10.1371/journal.pone.0015006	http://dx.doi.org/10.1371/journal.pone.0015006			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103364	Green Submitted, Green Published, gold			2022-12-27	WOS:000284257400020
J	Grujic, J; Fosco, C; Araujo, L; Cuesta, JA; Sanchez, A				Grujic, Jelena; Fosco, Constanza; Araujo, Lourdes; Cuesta, Jose A.; Sanchez, Angel			Social Experiments in the Mesoscale: Humans Playing a Spatial Prisoner's Dilemma	PLOS ONE			English	Article							EVOLUTIONARY GAMES; COOPERATION; RULES	Background: The evolutionary origin of cooperation among unrelated individuals remains a key unsolved issue across several disciplines. Prominent among the several mechanisms proposed to explain how cooperation can emerge is the existence of a population structure that determines the interactions among individuals. Many models have explored analytically and by simulation the effects of such a structure, particularly in the framework of the Prisoner's Dilemma, but the results of these models largely depend on details such as the type of spatial structure or the evolutionary dynamics. Therefore, experimental work suitably designed to address this question is needed to probe these issues. Methods and Findings: We have designed an experiment to test the emergence of cooperation when humans play Prisoner's Dilemma on a network whose size is comparable to that of simulations. We find that the cooperation level declines to an asymptotic state with low but nonzero cooperation. Regarding players' behavior, we observe that the population is heterogeneous, consisting of a high percentage of defectors, a smaller one of cooperators, and a large group that shares features of the conditional cooperators of public goods games. We propose an agent-based model based on the coexistence of these different strategies that is in good agreement with all the experimental observations. Conclusions: In our large experimental setup, cooperation was not promoted by the existence of a lattice beyond a residual level (around 20%) typical of public goods experiments. Our findings also indicate that both heterogeneity and a "moody" conditional cooperation strategy, in which the probability of cooperating also depends on the player's previous action, are required to understand the outcome of the experiment. These results could impact the way game theory on graphs is used to model human interactions in structured groups.	[Grujic, Jelena; Fosco, Constanza; Cuesta, Jose A.; Sanchez, Angel] Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain; [Araujo, Lourdes] Univ Nacl Educ Distancia, Dept Lenguajes & Sistemas, Grp Proc Lenguaje Nat NLP & IR, Madrid, Spain; [Sanchez, Angel] CSIC UAM UC3M UCM, Inst Ciencias Matemat, Madrid, Spain; [Sanchez, Angel] Univ Zaragoza, Inst Biocomputac & Fis Sistemas Complejos BIFI, Zaragoza, Spain	Universidad Carlos III de Madrid; Universidad Nacional de Educacion a Distancia (UNED); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); CSIC - Instituto de Ciencias Matematicas (ICMAT); University of Zaragoza	Grujic, J (corresponding author), Univ Carlos III Madrid, Dept Matemat, GISC, Madrid, Spain.	cuesta@math.uc3m.es	Sánchez, Angel/A-9229-2008; Cuesta, Jose A/Z-4696-2019; Fosco, Constanza/C-3143-2011; Araujo, Lourdes/G-6272-2015; Cuesta, Jose A/A-7157-2008	Sánchez, Angel/0000-0003-1874-2881; Araujo, Lourdes/0000-0002-7657-4794; Cuesta, Jose A/0000-0001-9890-9367	Ministerio de Ciencia e Innovacion (Spain); Comunidad de Madrid	Ministerio de Ciencia e Innovacion (Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by Ministerio de Ciencia e Innovacion (Spain) (http://www.micinn.es/portal/site/MICINN/) through grants i-MATH and MOSAICO, and by Comunidad de Madrid (http://www.modelico.es/index.php?lang=en) through grant MODELICO-CM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AXELROD R, 1981, SCIENCE, V211, P1390, DOI 10.1126/science.7466396; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BO PD, 2010, AM EC REV IN PRESS; BUSKENS V, 2000, ANAL KRITIK, V22, P44; Camerer C, 2003, BEHAV GAME THEORY; Cassar A, 2007, GAME ECON BEHAV, V58, P209, DOI 10.1016/j.geb.2006.03.008; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Fischbacher U, 2001, ECON LETT, V71, P397, DOI 10.1016/S0165-1765(01)00394-9; Fischbacher U, 2010, AM ECON REV, V100, P541, DOI 10.1257/aer.100.1.541; Fletcher JA, 2009, P ROY SOC B-BIOL SCI, V276, P13, DOI 10.1098/rspb.2008.0829; FRIEDMAN JW, 1971, REV ECON STUD, V38, P1, DOI 10.2307/2296617; GACHTER S, 2000, PSYCHOL EC PROMISING; HEGSELMANN R, 2000, ANAL KRITIK, V22, P75; Helbing D, 2010, P NATL ACAD SCI USA, V107, P5265, DOI 10.1073/pnas.1000140107; Kirchkamp O, 2007, GAME ECON BEHAV, V58, P269, DOI 10.1016/j.geb.2006.04.002; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Langer P, 2008, J THEOR BIOL, V250, P634, DOI 10.1016/j.jtbi.2007.11.002; Ledyard JO, 1995, HDB EXPT EC, P111, DOI DOI 10.3987/CONTENTS-12-85-7; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Rapoport A, 1965, PRISONERS DILEMMA; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Roca CP, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046106; SPICHTIG M, 2009, MUNICH DISCUSSION PA; Szabo G, 2009, EPL-EUROPHYS LETT, V87, DOI 10.1209/0295-5075/87/18007; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szathmary E, 1995, MAJOR TRANSITIONS EV; Szolnoki A, 2009, EUR PHYS J B, V67, P337, DOI 10.1140/epjb/e2008-00470-8; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107	30	155	156	3	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13749	10.1371/journal.pone.0013749	http://dx.doi.org/10.1371/journal.pone.0013749			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	679FT	21103058	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700001
J	Hein, E; Honore, C; Skjoedt, MO; Munthe-Fog, L; Hummelshoj, T; Garred, P				Hein, Estrid; Honore, Christian; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Hummelshoj, Tina; Garred, Peter			Functional Analysis of Ficolin-3 Mediated Complement Activation	PLOS ONE			English	Article							MANNAN-BINDING LECTIN; FCN2 GENE; H-FICOLIN; RECOGNITION; DEFICIENCY; POLYMORPHISMS; PROPERDIN; MOLECULE; PATHWAY; INFECTIONS	The recognition molecules of the lectin complement pathway are mannose-binding lectin and Ficolin -1, -2 and -3. Recently deficiency of Ficolin-3 was found to be associated with life threatening infections. Thus, we aimed to develop a functional method based on the ELISA platform for evaluating Ficolin-3 mediated complement activation that could be applicable for research and clinical use. Bovine serum albumin (BSA) was acetylated (acBSA) and chosen as a solid phase ligand for Ficolins in microtiter wells. Binding of Ficolins on acBSA was evaluated, as was functional complement activation assessed by C4, C3 and terminal complement complex (TCC) deposition. Serum Ficolin-3 bound to acBSA in a calcium dependent manner, while only minimal binding of Ficolin-2 and no binding of Ficolin-1 were observed. No binding to normal BSA was seen for any of the Ficolins. Serum C4, C3 and TCC deposition on acBSA were dependent only on Ficolin-3 in appropriate serum dilutions. Deposition of down stream complement components correlated highly significantly with the serum concentration of Ficolin-3 but not with Ficolin-2 in healthy donors. To make the assay robust for clinical use a chemical compound was applied to the samples that inhibited interference from the classical pathway due to the presence of anti-BSA antibodies in some sera. We describe a novel functional method for measuring complement activation mediated by Ficolin-3 in human serum up to the formation of TCC. The assay provides the possibility to diagnose functional and genetic defects of Ficolin-3 and down stream components in the lectin complement pathway.	[Hein, Estrid; Honore, Christian; Skjoedt, Mikkel-Ole; Munthe-Fog, Lea; Hummelshoj, Tina; Garred, Peter] Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen	Hein, E (corresponding author), Univ Copenhagen, Fac Hlth Sci, Rigshosp, Lab Mol Med,Dept Clin Immunol, Copenhagen, Denmark.	garred@post5.tele.dk		Munthe-Fog, Lea/0000-0003-1345-176X; Honore, Christian/0000-0003-4846-1319; Skjodt, Mikkel-Ole/0000-0003-1306-6482; Garred, Peter/0000-0002-2876-8586	Rigshospitalet; The Novo Nordisk Foundation; The Lundbeck Foundation; The Svend Andersen Foundation; The Capital Region of Denmark	Rigshospitalet; The Novo Nordisk Foundation(Novo Nordisk Foundation); The Lundbeck Foundation(Lundbeckfonden); The Svend Andersen Foundation; The Capital Region of Denmark	Funding was obtainet from Rigshospitalet, The Novo Nordisk Foundation, The Lundbeck Foundation, The Svend Andersen Foundation and The Capital Region of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DC, 2004, J IMMUNOASS IMMUNOCH, V25, P17, DOI 10.1081/IAS-120027223; Atkinson APM, 2004, CLIN EXP IMMUNOL, V138, P517, DOI 10.1111/j.1365-2249.2004.02634.x; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Cedzynski M, 2004, CLIN EXP IMMUNOL, V136, P304, DOI 10.1111/j.1365-2249.2004.02453.x; Chapman SJ, 2007, MOL IMMUNOL, V44, P3267, DOI 10.1016/j.molimm.2006.04.013; Cruyssen BV, 2007, RHEUMATOLOGY, V46, P1792, DOI 10.1093/rheumatology/kem266; de Messias-Reason I, 2009, J INFECT DIS, V199, P801, DOI 10.1086/597070; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fijen CAP, 1999, MOL IMMUNOL, V36, P863, DOI 10.1016/S0161-5890(99)00107-8; Frederiksen PD, 2005, SCAND J IMMUNOL, V62, P462, DOI 10.1111/j.1365-3083.2005.01685.x; Garcia-Laorden MI, 2006, J ALLERGY CLIN IMMUN, V118, P1383, DOI 10.1016/j.jaci.2006.08.004; Garlatti V, 2007, EMBO J, V26, P623, DOI 10.1038/sj.emboj.7601500; Garred P, 2003, MOL IMMUNOL, V40, P73, DOI 10.1016/S0161-5890(03)00104-4; Garred P, 2010, J INNATE IMMUN, V2, P3, DOI 10.1159/000242419; Honore C, 2008, MOL IMMUNOL, V45, P2782, DOI 10.1016/j.molimm.2008.02.005; Honore C, 2007, ARTHRITIS RHEUM, V56, P1598, DOI 10.1002/art.22564; Honore C, 2010, J LEUKOCYTE BIOL, V88, P145, DOI 10.1189/jlb.1209802; Hummelshoj T, 2005, HUM MOL GENET, V14, P1651, DOI 10.1093/hmg/ddi173; Hummelshoj T, 2008, MOL IMMUNOL, V45, P2508, DOI 10.1016/j.molimm.2008.01.003; Hummelshoj T, 2008, MOL IMMUNOL, V45, P1623, DOI 10.1016/j.molimm.2007.10.006; Hummelshoj T, 2007, MOL IMMUNOL, V44, P401, DOI 10.1016/j.molimm.2006.02.023; Kishore U, 2000, IMMUNOPHARMACOLOGY, V49, P159, DOI 10.1016/S0162-3109(00)80301-X; Krarup A, 2004, J BIOL CHEM, V279, P47513, DOI 10.1074/jbc.M407161200; Kuraya M, 2005, IMMUNOBIOLOGY, V209, P689, DOI 10.1016/j.imbio.2004.11.001; Lacroix M, 2009, J IMMUNOL, V182, P456, DOI 10.4049/jimmunol.182.1.456; Lappegard KT, 2009, P NATL ACAD SCI USA, V106, P15861, DOI 10.1073/pnas.0903613106; Mollnes TE, 2007, MOL IMMUNOL, V44, P3838, DOI 10.1016/j.molimm.2007.06.150; Munthe-Fog L, 2007, SCAND J IMMUNOL, V65, P383, DOI 10.1111/j.1365-3083.2007.01915.x; Munthe-Fog L, 2008, MOL IMMUNOL, V45, P2660, DOI 10.1016/j.molimm.2007.12.012; Munthe-Fog L, 2009, NEW ENGL J MED, V360, P2637, DOI 10.1056/NEJMoa0900381; Olesen HV, 2006, CLIN IMMUNOL, V121, P324, DOI 10.1016/j.clim.2006.08.014; Palarasah Y, 2010, J CLIN MICROBIOL, V48, P908, DOI 10.1128/JCM.01985-09; Roos A, 2003, MOL IMMUNOL, V39, P655, DOI 10.1016/S0161-5890(02)00254-7; Ruskamp JM, 2009, CLIN EXP IMMUNOL, V155, P433, DOI 10.1111/j.1365-2249.2008.03844.x; Schejbel L, 2009, CLIN IMMUNOL, V131, P456, DOI 10.1016/j.clim.2009.02.008; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Sprong T, 2006, BLOOD, V107, P4865, DOI 10.1182/blood-2005-07-2820; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; Thiel S, 2007, MOL IMMUNOL, V44, P3875, DOI 10.1016/j.molimm.2007.06.005; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Wittenborn T, 2010, J INNATE IMMUN, V2, P167, DOI 10.1159/000218324	42	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15443	10.1371/journal.pone.0015443	http://dx.doi.org/10.1371/journal.pone.0015443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085669	gold, Green Published, Green Submitted			2022-12-27	WOS:000284036800031
J	Sirichandra, C; Davanture, M; Turk, BE; Zivy, M; Valot, B; Leung, J; Merlot, S				Sirichandra, Caroline; Davanture, Marlene; Turk, Benjamin E.; Zivy, Michel; Valot, Benoit; Leung, Jeffrey; Merlot, Sylvain			The Arabidopsis ABA-Activated Kinase OST1 Phosphorylates the bZIP Transcription Factor ABF3 and Creates a 14-3-3 Binding Site Involved in Its Turnover	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2C; ABSCISIC-ACID; SIGNAL-TRANSDUCTION; NEGATIVE REGULATOR; GENE-EXPRESSION; STOMATAL RESPONSE; STRESS; IDENTIFICATION; CHANNEL; GROWTH	Background: Genetic evidence in Arabidopsis thaliana indicates that members of the Snf1-Related Kinases 2 family (SnRK2) are essential in mediating various stress-adaptive responses. Recent reports have indeed shown that one particular member, OPEN STOMATA (OST) 1, whose kinase activity is stimulated by the stress hormone abscisic acid (ABA), is a direct target of negative regulation by the core ABA co-receptor complex composed of PYR/PYL/RCAR and clade A Protein Phosphatase 2C (PP2C) proteins. Methodology/Principal Findings: Here, the substrate preference of OST1 was interrogated at a genome-wide scale. We phosphorylated in vitro a bank of semi-degenerate peptides designed to assess the relative phosphorylation efficiency on a positionally fixed serine or threonine caused by systematic changes in the flanking amino acid sequence. Our results designate the ABA-responsive-element Binding Factor 3 (ABF3), which controls part of the ABA-regulated transcriptome, as a genuine OST1 substrate. Bimolecular Fluorescence Complementation experiments indicate that ABF3 interacts directly with OST1 in the nuclei of living plant cells. In vitro, OST1 phosphorylates ABF3 on multiple LXRXXpS/T preferred motifs including T451 located in the midst of a conserved 14-3-3 binding site. Using an antibody sensitive to the phosphorylated state of the preferred motif, we further show that ABF3 is phosphorylated on at least one such motif in response to ABA in vivo and that phospho-T451 is important for stabilization of ABF3. Conclusions/Significance: All together, our results suggest that OST1 phosphorylates ABF3 in vivo on T451 to create a 14-3-3 binding motif. In a wider physiological context, we propose that the long term responses to ABA that require sustained gene expression is, in part, mediated by the stabilization of ABFs driven by ABA-activated SnRK2s.	[Sirichandra, Caroline; Leung, Jeffrey; Merlot, Sylvain] CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France; [Davanture, Marlene; Zivy, Michel; Valot, Benoit] Univ Paris 11, CNRS, INRA,Plate Forme Prote PAPPSO, UMR Genet Vegetale,UMR 0320,UMR 8120, Gif Sur Yvette, France; [Davanture, Marlene] Univ Paris 11, CNRS, INRA, La Plante & Son Environm IFR87, Gif Sur Yvette, France; [Turk, Benjamin E.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; Centre National de la Recherche Scientifique (CNRS); INRAE; UDICE-French Research Universities; Universite Paris Saclay; Yale University	Sirichandra, C (corresponding author), CNRS, Inst Sci Vegetal, UPR 2355, Gif Sur Yvette, France.	jeff.leung@isv.cnrs-gif.fr; sylvain.merlot@ird.fr	Valot, Benoit BV/G-3521-2018	Zivy, Michel/0000-0002-9814-3792; Merlot, Sylvain/0000-0002-9352-1184; Davanture, Marlene/0000-0001-5324-0583	CNRS; French Ministere de l'enseignement superieur et de la recherche; French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA) [18721NB]; US National Institutes of Health [R01 GM079498]; Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE) [IFR87 (FR-W2251)]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079498] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministere de l'enseignement superieur et de la recherche; French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the CNRS (SM, JL), a doctoral fellowship from the French Ministere de l'enseignement superieur et de la recherche (CS), financial support from the French Ministere des affaires etrangeres et europeennes (Partenariat Hubert Curien/SAKURA 18721NB to SM), and the US National Institutes of Health (grant R01 GM079498 to BT). The Imaging and Cell Biology facility of the IFR87 (FR-W2251) "La plante et son environnement'' is supported by Action de Soutien la Technologie et a la Recherche en Essonne (ASTRE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belin C, 2006, PLANT PHYSIOL, V141, P1316, DOI 10.1104/pp.106.079327; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; Chen Y, 2010, PLANT J, V63, P1, DOI 10.1111/j.1365-313X.2010.04218.x; Choi HI, 2005, PLANT PHYSIOL, V139, P1750, DOI 10.1104/pp.105.069757; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Coblitz B, 2006, FEBS LETT, V580, P1531, DOI 10.1016/j.febslet.2006.02.014; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Finkelstein R, 2005, PLANT MOL BIOL, V59, P253, DOI 10.1007/s11103-005-8767-2; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2007, PLANT CELL, V19, P485, DOI 10.1105/tpc.106.048538; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Furihata T, 2006, P NATL ACAD SCI USA, V103, P1988, DOI 10.1073/pnas.0505667103; Garcia ME, 2008, PLANT MOL BIOL, V67, P643, DOI 10.1007/s11103-008-9344-2; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Hundertmark M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-118; Hutti JE, 2004, NAT METHODS, V1, P27, DOI 10.1038/NMETH708; Johnson RR, 2002, PLANT PHYSIOL, V130, P837, DOI 10.1104/pp.001354; Kagaya Y, 2002, PLANT CELL, V14, P3177, DOI 10.1105/tpc.005272; Kim TH, 2010, ANNU REV PLANT BIOL, V61, P561, DOI 10.1146/annurev-arplant-042809-112226; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kline KG, 2010, P NATL ACAD SCI USA, V107, P15986, DOI 10.1073/pnas.1007879107; Kobayashi Y, 2005, PLANT J, V44, P939, DOI 10.1111/j.1365-313X.2005.02583.x; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Kwak JM, 2001, PLANT PHYSIOL, V127, P473, DOI 10.1104/pp.010428; Lee SC, 2009, P NATL ACAD SCI USA, V106, P21419, DOI 10.1073/pnas.0910601106; Leonhardt N, 2004, PLANT CELL, V16, P596, DOI 10.1105/tpc.019000; LEUNG J, 1994, SCIENCE, V264, P1448, DOI 10.1126/science.7910981; Li JX, 2000, SCIENCE, V287, P300, DOI 10.1126/science.287.5451.300; Lopez-Molina L, 2001, P NATL ACAD SCI USA, V98, P4782, DOI 10.1073/pnas.081594298; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lopez-Molina L, 2002, PLANT J, V32, P317, DOI 10.1046/j.1365-313X.2002.01430.x; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Miao YC, 2006, PLANT CELL, V18, P2749, DOI 10.1105/tpc.106.044230; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Negi J, 2008, NATURE, V452, P483, DOI 10.1038/nature06720; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Pandey S, 2002, NEW PHYTOL, V153, P517, DOI 10.1046/j.0028-646X.2001.00329.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saji S, 2008, PLANT CELL PHYSIOL, V49, P2, DOI 10.1093/pcp/pcm174; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schoonheim PJ, 2007, PLANT PHYSIOL, V143, P670, DOI 10.1104/pp.106.090159; Schoonheim PJ, 2007, PLANT J, V49, P289, DOI 10.1111/j.1365-313X.2006.02955.x; Shin R, 2007, P NATL ACAD SCI USA, V104, P6460, DOI 10.1073/pnas.0610208104; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Stone SL, 2006, PLANT CELL, V18, P3415, DOI 10.1105/tpc.106.046532; Takahashi Y, 2007, PLANT CELL PHYSIOL, V48, pS159; Ton J, 2009, TRENDS PLANT SCI, V14, P310, DOI 10.1016/j.tplants.2009.03.006; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Urano K, 2009, PLANT J, V57, P1065, DOI 10.1111/j.1365-313X.2008.03748.x; Vahisalu T, 2008, NATURE, V452, P487, DOI 10.1038/nature06608; Vahisalu T, 2010, PLANT J, V62, P442, DOI 10.1111/j.1365-313X.2010.04159.x; Vlad F, 2008, PLANT J, V55, P104, DOI 10.1111/j.1365-313X.2008.03488.x; Vlad F, 2009, PLANT CELL, V21, P3170, DOI 10.1105/tpc.109.069179; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; WEEKES J, 1993, FEBS LETT, V334, P335, DOI 10.1016/0014-5793(93)80706-Z; Wydro M, 2006, ACTA BIOCHIM POL, V53, P289; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang YZ, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-6; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666	76	150	163	2	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13935	10.1371/journal.pone.0013935	http://dx.doi.org/10.1371/journal.pone.0013935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085673	Green Published, gold, Green Submitted			2022-12-27	WOS:000284036800023
J	Wilson, SK; Depczynski, M; Fisher, R; Holmes, TH; O'Leary, RA; Tinkler, P				Wilson, Shaun K.; Depczynski, Martial; Fisher, Rebecca; Holmes, Thomas H.; O'Leary, Rebecca A.; Tinkler, Paul			Habitat Associations of Juvenile Fish at Ningaloo Reef, Western Australia: The Importance of Coral and Algae	PLOS ONE			English	Article							GREAT-BARRIER-REEF; 2 SPATIAL SCALES; BLEACHING EVENT; CLIMATE-CHANGE; SEAGRASS BEDS; RECRUITMENT; SETTLEMENT; DEGRADATION; COMMUNITIES; PREFERENCES	Habitat specificity plays a pivotal role in forming community patterns in coral reef fishes, yet considerable uncertainty remains as to the extent of this selectivity, particularly among newly settled recruits. Here we quantified habitat specificity of juvenile coral reef fish at three ecological levels; algal meadows vs. coral reefs, live vs. dead coral and among different coral morphologies. In total, 6979 individuals from 11 families and 56 species were censused along Ningaloo Reef, Western Australia. Juvenile fishes exhibited divergence in habitat use and specialization among species and at all study scales. Despite the close proximity of coral reef and algal meadows (10's of metres) 25 species were unique to coral reef habitats, and seven to algal meadows. Of the seven unique to algal meadows, several species are known to occupy coral reef habitat as adults, suggesting possible ontogenetic shifts in habitat use. Selectivity between live and dead coral was found to be species-specific. In particular, juvenile scarids were found predominantly on the skeletons of dead coral whereas many damsel and butterfly fishes were closely associated with live coral habitat. Among the coral dependent species, coral morphology played a key role in juvenile distribution. Corymbose corals supported a disproportionate number of coral species and individuals relative to their availability, whereas less complex shapes (i.e. massive & encrusting) were rarely used by juvenile fish. Habitat specialisation by juvenile species of ecological and fisheries importance, for a variety of habitat types, argues strongly for the careful conservation and management of multiple habitat types within marine parks, and indicates that the current emphasis on planning conservation using representative habitat areas is warranted. Furthermore, the close association of many juvenile fish with corals susceptible to climate change related disturbances suggests that identifying and protecting reefs resilient to this should be a conservation priority.	[Wilson, Shaun K.; Holmes, Thomas H.] Marine Sci Program, Dept Environm & Conservat, Div Sci, Kensington, WA, Australia; [Depczynski, Martial; Fisher, Rebecca; O'Leary, Rebecca A.; Tinkler, Paul] Univ Western Australia, Oceans Inst, Australian Inst Marine Sci, Crawley, WA, Australia	Australian Institute of Marine Science; University of Western Australia	Wilson, SK (corresponding author), Marine Sci Program, Dept Environm & Conservat, Div Sci, Kensington, WA, Australia.	shaun.wilson@dec.wa.gov.au	Fisher, Rebecca/C-5459-2011; Wilson, Shaun/K-8597-2019; depczynski, martial/B-7689-2008	Fisher, Rebecca/0000-0001-5148-6731; Wilson, Shaun/0000-0002-4590-0948; depczynski, martial/0000-0001-8723-0076	Western Australian Marine Science Institute (WAMSI); CReefs project of the Census of Marine Life	Western Australian Marine Science Institute (WAMSI); CReefs project of the Census of Marine Life	This project was funded by the Western Australian Marine Science Institute (WAMSI). RF and RAO were supported by the CReefs project of the Census of Marine Life. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AJ, 2002, MAR ECOL PROG SER, V228, P213, DOI 10.3354/meps228213; Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Bancroft K., 2000, MMSPINMPNSE262000 DE; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Best NG, 1995, CODA CONVERGENCE DIA; BOOTH DJ, 1994, CORAL REEFS, V13, P81, DOI 10.1007/BF00300765; BOOTH DJ, 1992, J EXP MAR BIOL ECOL, V155, P85, DOI 10.1016/0022-0981(92)90029-A; Booth DJ, 2002, MAR ECOL PROG SER, V245, P205, DOI 10.3354/meps245205; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Bruno JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000711; Caselle JE, 1996, ECOLOGY, V77, P2488, DOI 10.2307/2265748; Chittaro PM, 2004, J EXP MAR BIOL ECOL, V308, P169, DOI 10.1016/j.jembe.2004.02.021; DeMartini EE, 2010, MAR FRESHWATER RES, V61, P532, DOI 10.1071/MF09141; DEPCZYNSKI M, 2010, METHODS MONITORING H; Doherty P.J., 1991, P261; Dulvy NK, 2004, ECOL LETT, V7, P410, DOI 10.1111/j.1461-0248.2004.00593.x; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Garpe KC, 2007, AFR J MAR SCI, V29, P187, DOI 10.2989/AJMS.2007.29.2.4.187; Garpe KC, 2006, MAR ECOL PROG SER, V315, P237, DOI 10.3354/meps315237; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Gutierrez L, 1998, OECOLOGIA, V115, P268, DOI 10.1007/s004420050516; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hoegh-Guldberg O, 1999, MAR FRESHWATER RES, V50, P839, DOI 10.1071/MF99078; Ivlev V.S., 1961, EXPT ECOLOGY FEEDING; Jones G.P., 1991, P294; Jones GP, 2004, P NATL ACAD SCI USA, V101, P8251, DOI 10.1073/pnas.0401277101; Lecchini D, 2005, MAR BIOL, V147, P47, DOI 10.1007/s00227-004-1543-z; Lieske E, 1996, CORAL REEF FISHES; Manly B., 1993, RESOURCE SELECTION A; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; Mumby PJ, 2007, NATURE, V450, P98, DOI 10.1038/nature06252; Mumby PJ, 2004, NATURE, V427, P533, DOI 10.1038/nature02286; Munday PL, 1997, MAR ECOL PROG SER, V152, P227, DOI 10.3354/meps152227; Nagelkerken I, 2000, ESTUAR COAST SHELF S, V51, P31, DOI 10.1006/ecss.2000.0617; Nagelkerken I, 2002, MAR ECOL PROG SER, V244, P299, DOI 10.3354/meps244299; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Ohman MC, 1998, J EXP MAR BIOL ECOL, V225, P219, DOI 10.1016/S0022-0981(97)00224-4; Pratchett MS, 2008, CORAL REEFS, V27, P541, DOI 10.1007/s00338-008-0357-8; Pratchett MS, 2008, OCEANOGR MAR BIOL, V46, P251, DOI 10.1201/9781420065756.ch6; Pratchett MS, 2007, PAC SCI, V61, P113, DOI 10.1353/psc.2007.0011; Randall JE, 1990, FISHES GREAT BARRIER; Sale P.F., 1991, P564; SANO M, 1987, MAR ECOL PROG SER, V37, P191, DOI 10.3354/meps037191; Schoepf V, 2010, HYDROBIOLOGIA, V641, P45, DOI 10.1007/s10750-009-0053-x; Shima JS, 2001, ECOLOGY, V82, P2190, DOI 10.2307/2680225; Sumner N.R., 1998, FISHERIES RES REPORT; SWEATMAN HPA, 1985, ECOL MONOGR, V55, P469, DOI 10.2307/2937132; Syms C, 2000, ECOLOGY, V81, P2714, DOI 10.1890/0012-9658(2000)081[2714:DHSATD]2.0.CO;2; TOLIMIERI N, 1995, OECOLOGIA, V102, P52, DOI 10.1007/BF00333310; UNSWORTH KF, 2010, MAR ECOL-PROG SER, V353, P213; Veron J.E.N., 2000, CORALS WORLD, V1-3; Wade PR, 2000, CONSERV BIOL, V14, P1308, DOI 10.1046/j.1523-1739.2000.99415.x; WELLINGTON GM, 1992, OECOLOGIA, V90, P500, DOI 10.1007/BF01875443; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69; Wilson SK, 2007, MAR BIOL, V151, P1069, DOI 10.1007/s00227-006-0538-3; Wilson SK, 2010, ECOL APPL, V20, P442, DOI 10.1890/08-2205.1; Wilson SK, 2010, J EXP BIOL, V213, P894, DOI 10.1242/jeb.037895; Wilson SK, 2009, CORAL REEFS, V28, P3, DOI 10.1007/s00338-008-0431-2; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x	65	89	89	1	80	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15185	10.1371/journal.pone.0015185	http://dx.doi.org/10.1371/journal.pone.0015185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151875	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800009
J	Gao, L; Zhou, F; Li, XW; Yang, Y; Ruan, YH; Jin, Q				Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Ruan, Yuhua; Jin, Qi			Anal HPV Infection in HIV-Positive Men Who Have Sex with Men from China	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; RISK-FACTORS; PREVALENCE; CANCER; ACQUISITION; CELLS	Background: Anal HPV infection, which contributes to the development of anal warts and anal cancer, is well known to be common among men who have sex with men (MSM), especially among those HIV positives. However, HIV and anal HPV co-infection among MSM has not been addressed in China. Methods: A cross-sectional study was conducted in Beijing and Tianjin, China. Study participants were recruited using multiple methods with the collaboration of local volunteer organizations. Blood and anal swabs were collected for HIV-1 serological test and HPV genotyping. Results: A total of 602 MSM were recruited and laboratory data were available for 578 of them (96.0%). HIV and anal HPV prevalence were 8.5% and 62.1%, respectively. And 48 MSM (8.3%) were found to be co-infected. The HPV genotypes identified most frequently were HPV06 (19.6%), HPV16 (13.0%), HPV52 (8.5%) and HPV11 (7.6%). Different modes of HPV genotypes distribution were observed with respect to HIV status. A strong dose-response relationship was found between HIV seropositivity and multiplicity of HPV genotypes (p<0.001), which is consistent with the observation that anal HPV infection was an independent predictor for HIV infection. Conclusions: A high prevalence of HIV and anal HPV co-infection was observed in the MSM community in Beijing and Tianjin, China. Anal HPV infection was found to be independently associated with increased HIV seropositivity, which suggests the application of HPV vaccine might be a potential strategy to reduce the acquisition of HIV infection though controlling the prevalence of HPV.	[Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Jin, Qi] Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China; [Gao, Lei; Zhou, Feng; Li, Xiangwei; Yang, Yu; Jin, Qi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ruan, Yuhua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Gao, L (corresponding author), Chinese Acad Med Sci, State Key Lab Mol Virol & Genet Engn, Inst Pathogen Biol, Beijing 100037, Peoples R China.	gaolei@ipbcams.ac.cn; jinqi@ipbcams.ac.cn	Jin, Qi/B-5379-2009	Yang, Yu/0000-0002-5611-8951	National Natural Sciences Foundation of China [81001272]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	The work was supported by National Natural Sciences Foundation of China (Grant No: 81001272). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas A, 2010, ONCOLOGY-NY, V24, P364; Auvert B, 2010, JAIDS-J ACQ IMM DEF, V53, P111, DOI 10.1097/QAI.0b013e3181b327e7; Chin-Hong PV, 2009, AIDS, V23, P1135, DOI 10.1097/QAD.0b013e32832b4449; Chin-Hong PV, 2004, J INFECT DIS, V190, P2070, DOI 10.1086/425906; Critchlow CW, 1998, AIDS, V12, P1177, DOI 10.1097/00002030-199810000-00010; de Pokomandy A, 2009, J INFECT DIS, V199, P965, DOI 10.1086/597207; Gage JR, 2000, OBSTET GYNECOL, V96, P879, DOI 10.1016/S0029-7844(00)01057-7; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Kim RH, 2008, INT J ONCOL, V33, P777, DOI 10.3892/ijo_00000064; Koutsky Laura, 1997, American Journal of Medicine, V102, P3; Kreuter A, 2009, CURR OPIN INFECT DIS, V22, P109, DOI 10.1097/QCO.0b013e3283229fc8; Mayaud P, 2001, SEX TRANSM INFECT, V77, P248, DOI 10.1136/sti.77.4.248; Nicol AF, 2005, DIAGN MOL PATHOL, V14, P39, DOI 10.1097/01.pas.0000143309.81183.6c; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Palefsky JM, 1998, J INFECT DIS, V177, P361, DOI 10.1086/514194; Palefsky JM, 2000, SEMIN ONCOL, V27, P471; Palefsky JM, 2009, OBSTET GYN CLIN N AM, V36, P187, DOI 10.1016/j.ogc.2009.02.003; Partridge JM, 2006, LANCET INFECT DIS, V6, P21, DOI 10.1016/S1473-3099(05)70323-6; Safaeian M, 2008, SEX TRANSM INFECT, V84, P306, DOI 10.1136/sti.2007.027318; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; Shah KV, 1997, NEW ENGL J MED, V337, P1386, DOI 10.1056/NEJM199711063371911; Simatherai D, 2009, SEX TRANSM INFECT, V85, P148, DOI 10.1136/sti.2008.032581; Smith JS, 2010, J INFECT DIS, V201, P1677, DOI 10.1086/652408; Strickler HD, 2005, J NATL CANCER I, V97, P577, DOI 10.1093/jnci/dji073; Trottier H, 2006, VACCINE, V24, P4, DOI 10.1016/j.vaccine.2005.09.054; Vajdic CM, 2009, SEX TRANSM INFECT, V85, P330, DOI 10.1136/sti.2008.034744; van der Snoek EM, 2003, SEX TRANSM DIS, V30, P639, DOI 10.1097/01.OLQ.0000079520.04451.59; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wong FY, 2009, AIDS EDUC PREV, V21, P430, DOI 10.1521/aeap.2009.21.5.430; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	31	53	55	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15256	10.1371/journal.pone.0015256	http://dx.doi.org/10.1371/journal.pone.0015256			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151900	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300025
J	Mosca, TJ; Schwarz, TL				Mosca, Timothy J.; Schwarz, Thomas L.			Drosophila Importin-alpha 2 Is Involved in Synapse, Axon and Muscle Development	PLOS ONE			English	Article							NUCLEAR-TRANSPORT; NUCLEOCYTOPLASMIC TRANSPORT; NEUROMUSCULAR-JUNCTION; FUNCTIONAL COMPONENTS; PROTEIN-COMPOSITION; GUIDANCE RECEPTORS; GENETIC DISSECTION; FASCICLIN-III; ACTIVE ZONES; ALPHA	Nuclear import is required for communication between the cytoplasm and the nucleus and to enact lasting changes in gene transcription following stimuli. Binding to an Importin-a molecule in the cytoplasm is often required to mediate nuclear entry of a signaling protein. As multiple isoforms of Importin-alpha exist, some may be responsible for the entry of distinct cargoes rather than general nuclear import. Indeed, in neuronal systems, Importin-a isoforms can mediate very specific processes such as axonal tiling and communication of an injury signal. To study nuclear import during development, we examined the expression and function of Importin-alpha 2 in Drosophila melanogaster. We found that Importin-alpha 2 was expressed in the nervous system where it was required for normal active zone density at the NMJ and axonal commissure formation in the central nervous system. Other aspects of synaptic morphology at the NMJ and the localization of other synaptic markers appeared normal in importin-alpha 2 mutants. Importin-alpha 2 also functioned in development of the body wall musculature. Mutants in importin-alpha 2 exhibited errors in muscle patterning and organization that could be alleviated by restoring muscle expression of Importin-alpha 2. Thus, Importin-alpha 2 is needed for some processes in the development of both the nervous system and the larval musculature.	[Mosca, Timothy J.; Schwarz, Thomas L.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Mosca, Timothy J.; Schwarz, Thomas L.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Mosca, TJ (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	thomas.schwarz@childrens.harvard.edu		Mosca, Timothy/0000-0003-3485-0719	Intellectual and Developmental Disabilities Research Center Imaging Core [P30HD18655]; National Institutes of Health [RO1 NS041062, MH075058]; National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH075058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041062] Funding Source: NIH RePORTER	Intellectual and Developmental Disabilities Research Center Imaging Core; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Defense Science and Engineering Graduate Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by support from Intellectual and Developmental Disabilities Research Center Imaging Core (Grant Number P30HD18655), National Institutes of Health Grants RO1 NS041062 and MH075058 (to TLS), and a predoctoral fellowship from the National Defense Science and Engineering Graduate Foundation (to TJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X; Bednenko J, 2003, TRAFFIC, V4, P127, DOI 10.1034/j.1600-0854.2003.00109.x; Belvin MP, 1996, ANNU REV CELL DEV BI, V12, P393, DOI 10.1146/annurev.cellbio.12.1.393; BIER E, 1990, GENE DEV, V4, P190, DOI 10.1101/gad.4.2.190; BRAND AH, 1993, DEVELOPMENT, V118, P401; Broihier HT, 2004, DEVELOPMENT, V131, P5233, DOI 10.1242/dev.01394; CASH S, 1992, J NEUROSCI, V12, P2051; Chan CC, 2008, DEV BIOL, V318, P17, DOI 10.1016/j.ydbio.2008.02.050; CHIBA A, 1995, NATURE, V374, P166, DOI 10.1038/374166a0; Christophe D, 2000, CELL SIGNAL, V12, P337, DOI 10.1016/S0898-6568(00)00077-2; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Crossley AC, 1978, GENETICS BIOL DROS B, V2, P499; D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009; DIANTONIO A, 1993, CELL, V73, P1281, DOI 10.1016/0092-8674(93)90356-U; Evans TA, 2010, CURR OPIN NEUROBIOL, V20, P79, DOI 10.1016/j.conb.2009.12.006; Fang XD, 2001, DEVELOPMENT, V128, P3349; Fritz JL, 2002, DEV BIOL, V252, P46, DOI 10.1006/dbio.2002.0842; Giarre M, 2002, J STRUCT BIOL, V140, P279, DOI 10.1016/S1047-8477(02)00543-9; Goldfarb DS, 2004, TRENDS CELL BIOL, V14, P505, DOI 10.1016/j.tcb.2004.07.016; Gorjanacz M, 2002, DEV BIOL, V251, P271, DOI 10.1006/dbio.2002.0827; Graf ER, 2009, NEURON, V64, P663, DOI 10.1016/j.neuron.2009.11.002; Haines N, 2007, MOL BIOL CELL, V18, P4721, DOI 10.1091/mbc.E07-01-0047; Halfon MS, 1998, DEV BIOL, V199, P164, DOI 10.1006/dbio.1998.8915; Hanz S, 2003, NEURON, V40, P1095, DOI 10.1016/S0896-6273(03)00770-0; Higashi-Kovtun ME, 2010, J NEUROSCI, V30, P5253, DOI 10.1523/JNEUROSCI.3739-09.2010; Hofbauer A, 2009, J NEUROGENET, V23, P78, DOI 10.1080/01677060802471627; HOOPER JE, 1986, EMBO J, V5, P2321, DOI 10.1002/j.1460-2075.1986.tb04500.x; Jeffrey RA, 2009, J NEUROSCI, V29, P15613, DOI 10.1523/JNEUROSCI.3314-09.2009; Jordan BA, 2009, TRENDS NEUROSCI, V32, P392, DOI 10.1016/j.tins.2009.04.001; KESHISHIAN H, 1993, J NEUROBIOL, V24, P757, DOI 10.1002/neu.480240606; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kim YS, 2002, DEV BIOL, V249, P367, DOI 10.1006/dbio.2002.0768; KUSSEL P, 1995, J CELL BIOL, V129, P1491, DOI 10.1083/jcb.129.6.1491; Lai KO, 2008, P NATL ACAD SCI USA, V105, P17175, DOI 10.1073/pnas.0803906105; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Marrus SB, 2004, J NEUROSCI, V24, P1406, DOI 10.1523/JNEUROSCI.1575-03.2004; Mason DA, 2003, GENETICS, V165, P1943; Mason DA, 2002, GENETICS, V161, P157; Mathe E, 2000, DEV BIOL, V223, P307, DOI 10.1006/dbio.2000.9743; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosca TJ, 2010, NAT NEUROSCI, V13, P935, DOI 10.1038/nn.2593; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; PATEL NH, 1987, CELL, V48, P975, DOI 10.1016/0092-8674(87)90706-9; Perlson E, 2005, NEURON, V45, P715, DOI 10.1016/j.neuron.2005.01.023; Qu DB, 2007, J NEUROCHEM, V103, P408, DOI 10.1111/j.1471-4159.2007.04747.x; Ratan R, 2008, GENETICS, V178, P839, DOI 10.1534/genetics.107.081778; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Sun Q, 2000, DEVELOPMENT, V127, P801; Tekotte H, 2002, DEV BIOL, V244, P396, DOI 10.1006/dbio.2002.0612; Thompson KR, 2004, NEURON, V44, P997, DOI 10.1016/j.neuron.2004.11.025; Ting CY, 2007, NEURON, V56, P793, DOI 10.1016/j.neuron.2007.09.033; TOROK I, 1995, J CELL BIOL, V129, P1473, DOI 10.1083/jcb.129.6.1473; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Viquez NM, 2009, J NEUROSCI, V29, P11484, DOI 10.1523/JNEUROSCI.5584-08.2009; Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008; Wairkar YP, 2009, J NEUROSCI, V29, P517, DOI 10.1523/JNEUROSCI.3848-08.2009; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Yasuhara N, 2007, NAT CELL BIOL, V9, P72, DOI 10.1038/ncb1521; ZINSMAIER KE, 1994, SCIENCE, V263, P977, DOI 10.1126/science.8310297	66	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15223	10.1371/journal.pone.0015223	http://dx.doi.org/10.1371/journal.pone.0015223			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151903	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300022
J	Perc, M; Wang, Z				Perc, Matjaz; Wang, Zhen			Heterogeneous Aspirations Promote Cooperation in the Prisoner's Dilemma Game	PLOS ONE			English	Article							EVOLUTIONARY GAMES; ALTRUISM; BEHAVIOR; GRAPHS; RULES	To be the fittest is central to proliferation in evolutionary games. Individuals thus adopt the strategies of better performing players in the hope of successful reproduction. In structured populations the array of those that are eligible to act as strategy sources is bounded to the immediate neighbors of each individual. But which one of these strategy sources should potentially be copied? Previous research dealt with this question either by selecting the fittest or by selecting one player uniformly at random. Here we introduce a parameter u that interpolates between these two extreme options. Setting u equal to zero returns the random selection of the opponent, while positive u favor the fitter players. In addition, we divide the population into two groups. Players from group A select their opponents as dictated by the parameter u, while players from group B do so randomly irrespective of u. We denote the fraction of players contained in groups A and B by v and 1-v, respectively. The two parameters u and v allow us to analyze in detail how aspirations in the context of the prisoner's dilemma game influence the evolution of cooperation. We find that for sufficiently positive values of u there exist a robust intermediate v approximate to 0.5 for which cooperation thrives best. The robustness of this observation is tested against different levels of uncertainty in the strategy adoption process K and for different interaction networks. We also provide complete phase diagrams depicting the dependence of the impact of u and v for different values of K, and contrast the validity of our conclusions by means of an alternative model where individual aspiration levels are subject to evolution as well. Our study indicates that heterogeneity in aspirations may be key for the sustainability of cooperation in structured populations.	[Perc, Matjaz] Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia; [Wang, Zhen] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	University of Maribor; Nankai University	Perc, M (corresponding author), Univ Maribor, Fac Nat Sci & Math, SLO-2000 Maribor, Slovenia.	matjaz.perc@uni-mb.si	Perc, Matjaz/A-5148-2009; Wang, Zhen/H-5017-2011	Perc, Matjaz/0000-0002-3087-541X; Wang, Zhen/0000-0002-8182-2852	Slovenian Research Agency [Z1-2032]; Center for Asia Studies of Nankai University [2010-5]; National Natural Science Foundation of China [10672081]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Center for Asia Studies of Nankai University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	MP acknowledges support from the Slovenian Research Agency (Grant No. Z1-2032). ZW acknowledges support from the Center for Asia Studies of Nankai University (Grant No. 2010-5) and from the National Natural Science Foundation of China (Grant No. 10672081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson G, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.030901; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Assenza S, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.017101; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Chen XJ, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.017103; Doebeli M, 2005, ECOL LETT, V8, P748, DOI 10.1111/j.1461-0248.2005.00773.x; Fehr E, 2004, NATURE, V432, P449, DOI 10.1038/432449a; Grafen A, 2007, J EVOLUTION BIOL, V20, P2278, DOI 10.1111/j.1420-9101.2007.01413.x; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hauert C, 2005, AM J PHYS, V73, P405, DOI 10.1119/1.1848514; Hauert C, 2002, INT J BIFURCAT CHAOS, V12, P1531, DOI 10.1142/S0218127402005273; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Lehmann L, 2006, J EVOLUTION BIOL, V19, P1365, DOI 10.1111/j.1420-9101.2006.01119.x; Lehmann L, 2007, J EVOLUTION BIOL, V20, P2284, DOI 10.1111/j.1420-9101.2007.01414.x; Marshall JAR, 2009, J THEOR BIOL, V260, P386, DOI 10.1016/j.jtbi.2009.07.008; MARSHALL JAR, 2010, BEHAV ECOL IN PRESS; Maynard Smith J., 1982, pi; McNamara JM, 2008, NATURE, V451, P189, DOI 10.1038/nature06455; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; MILINSKI M, 1987, NATURE, V325, P433, DOI 10.1038/325433a0; Moyano LG, 2009, J THEOR BIOL, V259, P84, DOI 10.1016/j.jtbi.2009.03.002; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NOWAK M, 1989, APPL MATH COMPUT, V30, P191, DOI 10.1016/0096-3003(89)90052-0; NOWAK MA, 1994, INT J BIFURCAT CHAOS, V4, P33, DOI 10.1142/S0218127494000046; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Nowak MA, 1993, INT J BIFURCAT CHAOS, V3, P35, DOI 10.1142/S0218127493000040; Ohtsuki H, 2006, P ROY SOC B-BIOL SCI, V273, P2249, DOI 10.1098/rspb.2006.3576; Ohtsuki H, 2006, NATURE, V441, P502, DOI 10.1038/nature04605; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/022; Perc M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/8/142; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Perc M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033027; Poncela J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/184; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Ren J, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045101; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P ROY SOC B-BIOL SCI, V273, P51, DOI 10.1098/rspb.2005.3272; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; Schuster S, 2008, J BIOL PHYS, V34, P1, DOI 10.1007/s10867-008-9101-4; SELTEN R, 1980, J THEOR BIOL, V84, P93, DOI 10.1016/S0022-5193(80)81038-1; SMITH JM, 1976, ANIM BEHAV, V24, P159, DOI 10.1016/S0003-3472(76)80110-8; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2004, J PHYS A-MATH GEN, V37, P2599, DOI 10.1088/0305-4470/37/7/006; Szabo G, 1998, PHYS REV E, V58, P69, DOI 10.1103/PhysRevE.58.69; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szabo G, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051921; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056109; Szolnoki A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/9/093033; Szolnoki A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.021901; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; Tanimoto J, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.041130; Traulsen A, 2007, J THEOR BIOL, V244, P349, DOI 10.1016/j.jtbi.2006.08.008; Van Segbroeck S, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.058105; Vukov J, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.067103; Wang SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001917; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	66	274	277	3	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15117	10.1371/journal.pone.0015117	http://dx.doi.org/10.1371/journal.pone.0015117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151898	gold, Green Published, Green Submitted			2022-12-27	WOS:000284995300016
J	Mokni, W; Keravis, T; Etienne-Selloum, N; Walter, A; Kane, MO; Schini-Kerth, VB; Lugnier, C				Mokni, Walid; Keravis, Therese; Etienne-Selloum, Nelly; Walter, Alison; Kane, Modou O.; Schini-Kerth, Valerie B.; Lugnier, Claire			Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II	PLOS ONE			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; SMOOTH-MUSCLE-CELLS; HEART-FAILURE; GENE-EXPRESSION; PULMONARY-HYPERTENSION; NATRIURETIC-PEPTIDE; PRESSURE-OVERLOAD; IN-VIVO	Left ventricular hypertrophy leads to heart failure and represents a high risk leading to premature death. Cyclic nucleotides (cAMP and cGMP) play a major role in heart contractility and cyclic nucleotide phosphodiesterases (PDEs) are involved in different stages of advanced cardiac diseases. We have investigated their contributions in the very initial stages of left ventricular hypertrophy development. Wistar male rats were treated over two weeks by chronic infusion of angiotensin II using osmotic mini-pumps. Left cardiac ventricles were used as total homogenates for analysis. PDE1 to PDE5 specific activities and protein and mRNA expressions were explored. Rats developed arterial hypertension associated with a slight cardiac hypertrophy (+24%). cAMP-PDE4 activity was specifically increased while cGMP-PDE activities were broadly increased (+130% for PDE1; +76% for PDE2; +113% for PDE5) and associated with increased expressions for PDE1A, PDE1C and PDE5A. The cGMP-PDE1 activation by Ca2+/CaM was reduced. BNP expression was increased by 3.5-fold, while NOX2 expression was reduced by 66% and AMP kinase activation was increased by 64%. In early cardiac hypertrophy induced by angiotensin II, all specific PDE activities in left cardiac ventricles were increased, favoring an increase in cGMP hydrolysis by PDE1, PDE2 and PDE5. Increased cAMP hydrolysis was related to PDE4. We observed the establishment of two cardioprotective mechanisms and we suggest that these mechanisms could lead to increase intracellular cGMP: i) increased expression of BNP could increase "particulate" cGMP pool; ii) increased activation of AMPK, subsequent to increase in PDE4 activity and 5'AMP generation, could elevate "soluble" cGMP pool by enhancing NO bioavailability through NOX2 down-regulation. More studies are needed to support these assumptions. Nevertheless, our results suggest a potential link between PDE4 and AMPK/NOX2 and they point out that cGMP-PDEs, especially PDE1 and PDE2, may be interesting therapeutic targets in preventing cardiac hypertrophy.	[Mokni, Walid; Keravis, Therese; Etienne-Selloum, Nelly; Walter, Alison; Kane, Modou O.; Schini-Kerth, Valerie B.; Lugnier, Claire] Univ Strasbourg, Fac Pharm, CNRS UMR 7213, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mokni, W (corresponding author), Univ Strasbourg, Fac Pharm, CNRS UMR 7213, Illkirch Graffenstaden, France.	claire.lugnier@unistra.fr	lugnier, claire/AAF-3911-2020		CNRS/Universite de Strasbourg	CNRS/Universite de Strasbourg(Centre National de la Recherche Scientifique (CNRS))	Funding from patent sales have supported this work. There was no grant nor specific funder. Claire Lugnier was academic/CNRS co-author to patent deposits made by Neuro3D/CNRS/Universite Louis Pasteur. Following the cessation of Neuro 3D, patents and molecules have been sold by Neuro3D on March 2007 to Via Pharmaceuticals Inc, San Francisco, California, United States of America. The CNRS/Universite de Strasbourg, after renouncing their property rights, got money from this sale and the funding for the research team is part of it. Following are the patents: WO 2004/041258 - UTILISATION D'INHIBITEURS DES PHOSPHODIESTERASES DES NUCLEOTIDES CYCLIQUES, AYANT UNE STRUCTURE BENZODIAZEPINIQUE EN THERAPIE Copropriete UNISTRA/CNRS/Neuro3D/FORENAP. Date de priorite 30/10/2002; phase nationale FR 02/13607; Licence + cession Neuro3D. WO 2004/072078 - DERIVES DE PYRAZOLOTRIAZINE, PROCEDES DE PREPARATION ET UTILISATIONS Copropriete UNISTRA/CNRS/FORENAP Date de priorite 04/02/2003; FR 03/01256; Licence + cession Neuro3D. WO 2002/098865 - INHIBITEURS DES PHOSPHODIESTERASES DES NUCLEOTIDES CYCLIQUES, PREPARATION ET UTILISATIONS DE CES INHIBITEURS Deposant Neuro3D Date de priorite 07/06/2001; FR 01/07458 Licence + cession Neuro3D. This funding was used freely by the research team. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Gerges A, 2009, CIRC RES, V105, P784, DOI 10.1161/CIRCRESAHA.109.197947; Akki A, 2009, J MOL CELL CARDIOL, V47, P15, DOI 10.1016/j.yjmcc.2009.04.004; Ang KL, 2002, J NEUROCHEM, V81, P422, DOI 10.1046/j.1471-4159.2002.00903.x; Anilkumar N, 2009, FRONT BIOSCI-LANDMRK, V14, P3168, DOI 10.2741/3443; Arad M, 2007, CIRC RES, V100, P474, DOI 10.1161/01.RES.0000258446.23525.37; Badenhorst D, 2004, SAMJ S AFR MED J, V94, P833; Baillie GS, 2002, J BIOL CHEM, V277, P28298, DOI 10.1074/jbc.M108353200; BAYESGENIS A, 1995, AM J CARDIOL, V76, pD54, DOI 10.1016/S0002-9149(99)80493-7; BEAVO JA, 1995, PHYSIOL REV, V75, P725, DOI 10.1152/physrev.1995.75.4.725; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; COSTE H, 1995, BIOCHEM PHARMACOL, V50, P1577, DOI 10.1016/0006-2952(95)02031-4; Das DK, 2004, J CELL MOL MED, V8, P144, DOI 10.1111/j.1582-4934.2004.tb00270.x; Ding B, 2005, CIRCULATION, V111, P2469, DOI 10.1161/01.CIR.0000165128.39715.87; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Dolci S, 2006, BIOCHEM BIOPH RES CO, V341, P837, DOI 10.1016/j.bbrc.2006.01.035; Du JH, 2008, BIOCHEM BIOPH RES CO, V368, P402, DOI 10.1016/j.bbrc.2008.01.099; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Evgenov OV, 2006, AM J PHYSIOL-LUNG C, V290, pL723, DOI 10.1152/ajplung.00485.2004; Fischmeister R, 2005, COMP BIOCHEM PHYS A, V142, P136, DOI 10.1016/j.cbpb.2005.04.012; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Forfia PR, 2007, J AM COLL CARDIOL, V49, P1079, DOI 10.1016/j.jacc.2006.08.066; Francis SH, 2001, PROG NUCLEIC ACID RE, V65, P1; Francis Sharron H., 2009, V191, P367, DOI 10.1007/978-3-540-68964-5_16; FUJISAKI H, 1995, J CLIN INVEST, V96, P1059, DOI 10.1172/JCI118092; Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x; Gretarsdottir S, 2003, NAT GENET, V35, P131, DOI 10.1038/ng1245; GUAZZI M, 2008, INT J CARDIOL; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; HASHIMOTO Y, 1989, J BIOL CHEM, V264, P10884; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Hutchinson DS, 2008, PHARMACOL THERAPEUT, V119, P291, DOI 10.1016/j.pharmthera.2008.05.008; Kelly M, 2009, DIABETES, V58, P1953, DOI 10.2337/db08-1293; Keravis T, 2007, J MOL CELL CARDIOL, V42, pS49, DOI 10.1016/j.yjmcc.2007.03.140; Keravis Therese, 2005, V307, P63; Kim D, 2005, J MOL CELL CARDIOL, V38, P175, DOI 10.1016/j.yjmcc.2004.10.013; Kim D, 2001, CIRCULATION, V104, P2338, DOI 10.1161/hc4401.098432; KISSANE JM, 1958, J BIOL CHEM, V233, P184; Kostic MM, 1997, J MOL CELL CARDIOL, V29, P3135, DOI 10.1006/jmcc.1997.0544; Lamberts RR, 2009, CIRCULATION, V120, pS10, DOI 10.1161/CIRCULATIONAHA.108.828426; Laskowski A, 2006, CARDIOVASC RES, V72, P112, DOI 10.1016/j.cardiores.2006.07.006; Lehnart SE, 2005, CELL, V123, P25, DOI 10.1016/j.cell.2005.07.030; Lewis Gregory D, 2006, Curr Heart Fail Rep, V3, P123, DOI 10.1007/s11897-006-0011-0; Li HL, 2007, J CELL BIOCHEM, V100, P1086, DOI 10.1002/jcb.21197; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUGNIER C, 1979, BIOCHEM PHARMACOL, V28, P3581; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lugnier C, 1999, BBA-GEN SUBJECTS, V1472, P431, DOI 10.1016/S0304-4165(99)00145-2; LUGNIER C, 1993, EUR HEART J, V14, P141; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; MERY PF, 1996, HANDB IMMUNOPHARM, P81; Miller CL, 2009, CIRC RES, V105, pE19; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; MULLER B, 1990, J CARDIOVASC PHARM, V15, P444, DOI 10.1097/00005344-199003000-00015; Murray F, 2007, AM J PHYSIOL-LUNG C, V292, pL294, DOI 10.1152/ajplung.00190.2006; Nagel DJ, 2006, CIRC RES, V98, P777, DOI 10.1161/01.RES.0000215576.27615.fd; Nagendran J, 2007, CIRCULATION, V116, P238, DOI 10.1161/CIRCULATIONAHA.106.655266; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; PODZUWEIT T, 1995, CELL SIGNAL, V7, P733, DOI 10.1016/0898-6568(95)00042-N; Pokreisz P, 2009, CIRCULATION, V119, P408, DOI 10.1161/CIRCULATIONAHA.108.822072; Richter W, 2005, BIOCHEM J, V388, P803, DOI 10.1042/BJ20050030; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2002, CIRC RES, V90, P151, DOI 10.1161/hh0202.104108; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Schermuly RT, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-76; Schulz E, 2008, CIRCULATION, V118, P1347, DOI 10.1161/CIRCULATIONAHA.108.784298; Schulz E, 2009, CIRC RES, V104, P422, DOI 10.1161/CIRCRESAHA.109.194274; Serneri GGN, 2001, CIRC RES, V88, P961, DOI 10.1161/hh0901.089882; Shimizu-Albergine M, 2003, J NEUROSCI, V23, P6452; Sirker A, 2007, AM J NEPHROL, V27, P649, DOI 10.1159/000109148; Smith CJ, 1997, CIRCULATION, V96, P3116, DOI 10.1161/01.CIR.96.9.3116; Staton JM, 2006, J NEUROL NEUROSUR PS, V77, P1067, DOI 10.1136/jnnp.2006.092106; Stehlik J, 2009, J CARD FAIL, V15, P31, DOI 10.1016/j.cardfail.2008.09.005; Stuck BJ, 2008, J BIOL CHEM, V283, P32562, DOI 10.1074/jbc.M801904200; Takahashi K, 2002, HEART VESSELS, V16, P249, DOI 10.1007/s003800200032; Takimoto E, 2005, CIRC RES, V96, P100, DOI 10.1161/01.RES.0000152262.22968.72; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Terrenoire C, 2009, J BIOL CHEM, V284, P9140, DOI 10.1074/jbc.M805366200; Touyz RM, 2000, PHARMACOL REV, V52, P639; Vandeput F, 2007, J BIOL CHEM, V282, P32749, DOI 10.1074/jbc.M703173200; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Walter A, 2008, J VASC RES, V45, P386, DOI 10.1159/000121408; Wang SX, 2010, CIRC RES, V106, P1117, DOI 10.1161/CIRCRESAHA.109.212530; WANG Y, 2009, CIRCULATION; WEBER KT, 1993, CLIN CARDIOL, V16, P10, DOI 10.1002/clc.4960161404; Wegener JW, 2002, CIRC RES, V90, P18, DOI 10.1161/hh0102.103222; Wollert KC, 2003, BRIT J PHARMACOL, V140, P1227, DOI 10.1038/sj.bjp.0705567; Yanaka N, 2003, BIOSCI BIOTECH BIOCH, V67, P973, DOI 10.1271/bbb.67.973; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang M, 2008, CELL SIGNAL, V20, P2231, DOI 10.1016/j.cellsig.2008.08.012; Zhang P, 2008, HYPERTENSION, V52, P918, DOI 10.1161/HYPERTENSIONAHA.108.114702	96	47	61	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14227	10.1371/journal.pone.0014227	http://dx.doi.org/10.1371/journal.pone.0014227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151982	gold, Green Submitted, Green Published			2022-12-27	WOS:000284939600019
J	Boyer, M; Madoui, MA; Gimenez, G; La Scola, B; Raoult, D				Boyer, Mickael; Madoui, Mohammed-Amine; Gimenez, Gregory; La Scola, Bernard; Raoult, Didier			Phylogenetic and Phyletic Studies of Informational Genes in Genomes Highlight Existence of a 4(th) Domain of Life Including Giant Viruses	PLOS ONE			English	Article							SEQUENCE; ORIGIN; TREE; REPLICATION; EVOLUTION; DIVERGENT; DATABASE; COMMON; SIRV1	The discovery of Mimivirus, with its very large genome content, made it possible to identify genes common to the three domains of life (Eukarya, Bacteria and Archaea) and to generate controversial phylogenomic trees congruent with that of ribosomal genes, branching Mimivirus at its root. Here we used sequences from metagenomic databases, Marseillevirus and three new viruses extending the Mimiviridae family to generate the phylogenetic trees of eight proteins involved in different steps of DNA processing. Compared to the three ribosomal defined domains, we report a single common origin for Nucleocytoplasmic Large DNA Viruses (NCLDV), DNA processing genes rooted between Archaea and Eukarya, with a topology congruent with that of the ribosomal tree. As for translation, we found in our new viruses, together with Mimivirus, five proteins rooted deeply in the eukaryotic clade. In addition, comparison of informational genes repertoire based on phyletic pattern analysis supports existence of a clade containing NCLDVs clearly distinct from that of Eukarya, Bacteria and Archaea. We hypothesize that the core genome of NCLDV is as ancient as the three currently accepted domains of life.	[Boyer, Mickael; Madoui, Mohammed-Amine; Gimenez, Gregory; La Scola, Bernard; Raoult, Didier] Univ Mediterrane, URMITE, Ctr Natl Rech Sci UMR IRD 6236, Fac Med, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD)	Boyer, M (corresponding author), Univ Mediterrane, URMITE, Ctr Natl Rech Sci UMR IRD 6236, Fac Med, Marseille, France.	didier.raoult@gmail.com	Madoui, Mohammed-Amin/ABC-1017-2020; LA SCOLA, Bernard/P-6477-2016; Madoui, Mohammed-Amin/AAF-3374-2021; RAOULT, Didier/A-8434-2008; Madoui, Mohammed-Amin/GYD-9411-2022; Boyer, Mickaël/F-6608-2013	LA SCOLA, Bernard/0000-0001-8006-7704; Madoui, Mohammed-Amin/0000-0003-4809-2971; RAOULT, Didier/0000-0002-0633-5974; Boyer, Mickaël/0000-0001-5384-1151	Centre National de la Recherche Scientifique (CNRS)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS))	This work was funded by the Centre National de la Recherche Scientifique (CNRS, credits recurrents). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann HW, 2007, ARCH VIROL, V152, P227, DOI 10.1007/s00705-006-0849-1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bell PJL, 2001, J MOL EVOL, V53, P251; Blum H, 2001, VIROLOGY, V281, P6, DOI 10.1006/viro.2000.0776; CAVALIERSMITH T, 1987, ANN NY ACAD SCI, V503, P17, DOI 10.1111/j.1749-6632.1987.tb40596.x; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Filee J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-320; Forterre P, 2006, VIRUS RES, V117, P5, DOI 10.1016/j.virusres.2006.01.010; Forterre P, 2002, CURR OPIN MICROBIOL, V5, P525, DOI 10.1016/S1369-5274(02)00360-0; Forterre P, 2010, INTERVIROLOGY, V53, P362, DOI 10.1159/000312921; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Iyer LA, 2006, VIRUS RES, V117, P156, DOI 10.1016/j.virusres.2006.01.009; Jordan A, 1998, ANNU REV BIOCHEM, V67, P71, DOI 10.1146/annurev.biochem.67.1.71; Keeling PJ, 2004, P NATL ACAD SCI USA, V101, P15380, DOI 10.1073/pnas.0404505101; Koonin EV, 2008, NAT REV MICROBIOL, V6, P925, DOI 10.1038/nrmicro2030; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; La Scola B, 2010, INTERVIROLOGY, V53, P344, DOI 10.1159/000312919; McGeoch D.J., 1995, MOL BASIS VIRUS EVOL, P67; Moliner C, 2009, CLIN MICROBIOL INFEC, V15, P178, DOI 10.1111/j.1469-0691.2008.02216.x; Moreira D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-12; Moreira D, 2009, NAT REV MICROBIOL, V7, P306, DOI 10.1038/nrmicro2108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Peng X, 2001, VIROLOGY, V291, P226, DOI 10.1006/viro.2001.1190; Prangishvili D, 2006, NAT REV MICROBIOL, V4, P837, DOI 10.1038/nrmicro1527; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858; Raoult D, 2010, LANCET, V375, P104, DOI 10.1016/S0140-6736(09)61958-9; Raoult D, 2009, NAT REV MICROBIOL, V7, DOI 10.1038/nrmicro2108-c6; Senju S, 2000, MOL CELL BIOL, V20, P6195, DOI 10.1128/MCB.20.17.6195-6200.2000; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Torrents E, 2002, J MOL EVOL, V55, P138, DOI 10.1007/s00239-002-2311-7; Villarreal LP, 2010, J THEOR BIOL, V262, P698, DOI 10.1016/j.jtbi.2009.10.014; Woese CR, 2000, MICROBIOL MOL BIOL R, V64, P202, DOI 10.1128/MMBR.64.1.202-236.2000; Wolf YI, 2002, TRENDS GENET, V18, P472, DOI 10.1016/S0168-9525(02)02744-0; Yutin N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-223	41	109	112	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e15530	10.1371/journal.pone.0015530	http://dx.doi.org/10.1371/journal.pone.0015530			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151962	Green Published, Green Submitted, gold			2022-12-27	WOS:000284868000035
J	Rizzi, R; Mahata, P; Mathieson, L; Moscato, P				Rizzi, Romeo; Mahata, Pritha; Mathieson, Luke; Moscato, Pablo			Hierarchical Clustering Using the Arithmetic-Harmonic Cut: Complexity and Experiments	PLOS ONE			English	Article							ALGORITHM; CANCER	Clustering, particularly hierarchical clustering, is an important method for understanding and analysing data across a wide variety of knowledge domains with notable utility in systems where the data can be classified in an evolutionary context. This paper introduces a new hierarchical clustering problem defined by a novel objective function we call the arithmetic-harmonic cut. We show that the problem of finding such a cut is NP-hard and APX-hard but is fixed-parameter tractable, which indicates that although the problem is unlikely to have a polynomial time algorithm (even for approximation), exact parameterized and local search based techniques may produce workable algorithms. To this end, we implement a memetic algorithm for the problem and demonstrate the effectiveness of the arithmetic-harmonic cut on a number of datasets including a cancer type dataset and a corona virus dataset. We show favorable performance compared to currently used hierarchical clustering techniques such as k-MEANS, Graclus and NORMALIZED-CUT. The arithmetic-harmonic cut metric overcoming difficulties other hierarchal methods have in representing both intercluster differences and intracluster similarities.	[Rizzi, Romeo] Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy; [Mahata, Pritha] New S Wales Rural Doctors Network, Newcastle, NSW, Australia; [Mathieson, Luke; Moscato, Pablo] Univ Newcastle, Ctr Bioinformat Biomarker Discovery & Informat Ba, Callaghan, NSW 2308, Australia; [Mathieson, Luke; Moscato, Pablo] Hunter Med Res Inst, Informat Based Med Program, Newcastle, NSW, Australia	University of Udine; University of Newcastle; Hunter Medical Research Institute; University of Newcastle	Rizzi, R (corresponding author), Univ Udine, Dipartimento Matemat & Informat, I-33100 Udine, Italy.	luke.mathieson@newcastle.edu.au	Rizzi, Romeo/J-4224-2012; MOSCATO, PABLO ALBERTO/G-7668-2013	Rizzi, Romeo/0000-0002-2387-0952; Mathieson, Luke/0000-0001-6470-2296; Moscato, Pablo/0000-0003-2570-5966	Australian Research Council (ARC) Centre of Excellence in Bioinformatics [CE0348221]; University of Newcastle; ARC [DP0773279]	Australian Research Council (ARC) Centre of Excellence in Bioinformatics(Australian Research Council); University of Newcastle; ARC(Australian Research Council)	We acknowledge the support of the Australian Research Council (ARC) Centre of Excellence in Bioinformatics (CE0348221), The University of Newcastle, and ARC Discovery Project DP0773279 (Application of novel exact combinatorial optimisation techniques and metaheuristic methods for problems in cancer research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ausiello Giorgio, 1999, COMPLEXITY APPROXIMA; Berretta R, 2004, APPL OPTIM, V86, P65; Buriol L, 2004, J HEURISTICS, V10, P483, DOI 10.1023/B:HEUR.0000045321.59202.52; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dhillon IS, 2007, IEEE T PATTERN ANAL, V29, P1944, DOI 10.1109/TP'AMI.2007.1115; FESTA P, 2002, OPTIMIZATION METHODS, V7, P1033; Flum J., 2006, TEXT THEORET COMP S, DOI 10.1007/3-540-29953-X; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hansen P., 2001, ESSAYS SURVEYS METAH, P415; Karp R. M., 1972, P COMPL COMP COMP, P85; MAHAJAN M, 1997, EL C COMP COMPL ECCC; MAHATA P, 2006, EVOWORKSHOPS 2006, P67; Mendes A, 2005, INT CONF PARA PROC, P604, DOI 10.1109/ICPPW.2005.34; Merz P, 2000, EVOL COMPUT, V8, P61, DOI 10.1162/106365600568103; Moscato P, 2004, STUD FUZZ SOFT COMP, V141, P53; MOSCATO P, 2003, HDB METAHEURISTICS, P105; MOSCATO P, 2006, HDB APPROXIMATION AL; Moscato P., 1989, 826 CALTECH CONC COM; *NCI NIH, 2010, DEV THER PROGR; PAPADIMITRIOU CH, 1991, J COMPUT SYST SCI, V43, P425, DOI 10.1016/0022-0000(91)90023-X; Ross DT, 2000, NAT GENET, V24, P227, DOI 10.1038/73432; Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; van der Laan MJ, 2003, J STAT PLAN INFER, V117, P275, DOI 10.1016/S0378-3758(02)00388-9; Wang S, 2003, IEEE T PATTERN ANAL, V25, P675, DOI 10.1109/TPAMI.2003.1201819; WEI YC, 1991, IEEE T COMPUT AID D, V10, P911, DOI 10.1109/43.87601; Wertheimer M., 1938, SOURCE BOOK GESTALT, P71, DOI [10.1037/11496-005, DOI 10.1037/11496-005]; WHITLEY D, 1994, STAT COMPUT, V4, P65, DOI 10.1007/BF00175354; WU Z, 1993, IEEE T PATTERN ANAL, V15, P1101, DOI 10.1109/34.244673; Yap YL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-43; [No title captured]	31	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2010	5	12							e14067	10.1371/journal.pone.0014067	http://dx.doi.org/10.1371/journal.pone.0014067			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	688QY	21151943	Green Published, gold, Green Submitted			2022-12-27	WOS:000284868000001
J	Espinoza, C; Degenkolbe, T; Caldana, C; Zuther, E; Leisse, A; Willmitzer, L; Hincha, DK; Hannah, MA				Espinoza, Carmen; Degenkolbe, Thomas; Caldana, Camila; Zuther, Ellen; Leisse, Andrea; Willmitzer, Lothar; Hincha, Dirk K.; Hannah, Matthew A.			Interaction with Diurnal and Circadian Regulation Results in Dynamic Metabolic and Transcriptional Changes during Cold Acclimation in Arabidopsis	PLOS ONE			English	Article							LOW-TEMPERATURE; FREEZING TOLERANCE; SUBCELLULAR VOLUMES; GENE-EXPRESSION; STRESS; CLOCK; TIME; MALTOSE; RNA; DISRUPTION	In plants, there is a large overlap between cold and circadian regulated genes and in Arabidopsis, we have shown that cold (4 degrees C) affects the expression of clock oscillator genes. However, a broader insight into the significance of diurnal and/or circadian regulation of cold responses, particularly for metabolic pathways, and their physiological relevance is lacking. Here, we performed an integrated analysis of transcripts and primary metabolites using microarrays and gas chromatography-mass spectrometry. As expected, expression of diurnally regulated genes was massively affected during cold acclimation. Our data indicate that disruption of clock function at the transcriptional level extends to metabolic regulation. About 80% of metabolites that showed diurnal cycles maintained these during cold treatment. In particular, maltose content showed a massive night-specific increase in the cold. However, under free-running conditions, maltose was the only metabolite that maintained any oscillations in the cold. Furthermore, although starch accumulates during cold acclimation we show it is still degraded at night, indicating significance beyond the previously demonstrated role of maltose and starch breakdown in the initial phase of cold acclimation. Levels of some conventional cold induced metabolites, such as c-aminobutyric acid, galactinol, raffinose and putrescine, exhibited diurnal and circadian oscillations and transcripts encoding their biosynthetic enzymes often also cycled and preceded their cold-induction, in agreement with transcriptional regulation. However, the accumulation of other cold-responsive metabolites, for instance homoserine, methionine and maltose, did not have consistent transcriptional regulation, implying that metabolic reconfiguration involves complex transcriptional and post-transcriptional mechanisms. These data demonstrate the importance of understanding cold acclimation in the correct day-night context, and are further supported by our demonstration of impaired cold acclimation in a circadian mutant.	[Espinoza, Carmen; Degenkolbe, Thomas; Caldana, Camila; Zuther, Ellen; Leisse, Andrea; Willmitzer, Lothar; Hincha, Dirk K.; Hannah, Matthew A.] Max Planck Inst Mol Plant Physiol, Potsdam, Germany	Max Planck Society	Espinoza, C (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	matthew.hannah@bayer.com	Willmitzer, Lothar/F-7377-2011; Zuther, Ellen/H-9814-2019; Caldana, Camila/C-4660-2012	Caldana, Camila/0000-0003-3639-0621; Hannah, Matthew/0000-0002-4889-490X; Zuther, Ellen/0000-0002-7446-0515; Espinoza, Carmen/0000-0003-1469-9492	Max-Planck Society	Max-Planck Society(Max Planck SocietyFoundation CELLEX)	The work was supported by the Max-Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, ADV PLANAR LIPID BIL, DOI DOI 10.1016/S1554-4516(05)03006-1; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Benkeblia N, 2007, METABOLOMICS, V3, P297, DOI 10.1007/s11306-007-0078-y; Bieniawska Z, 2008, PLANT PHYSIOL, V147, P263, DOI 10.1104/pp.108.118059; Blasing OE, 2005, PLANT CELL, V17, P3257, DOI 10.1105/tpc.105.035261; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P244, DOI 10.1016/0011-2240(88)90032-6; Chinnusamy V, 2007, TRENDS PLANT SCI, V12, P444, DOI 10.1016/j.tplants.2007.07.002; Cook D, 2004, P NATL ACAD SCI USA, V101, P15243, DOI 10.1073/pnas.0406069101; CROWE JH, 1990, CRYOBIOLOGY, V27, P219, DOI 10.1016/0011-2240(90)90023-W; Cuadros-Inostroza A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-428; Curien G, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.29; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2006, PLANT J, V48, P962, DOI 10.1111/j.1365-313X.2006.02933.x; Dong CH, 2009, MOL PLANT, V2, P59, DOI 10.1093/mp/ssn063; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; Doyle MR, 2002, NATURE, V419, P74, DOI 10.1038/nature00954; Fait A, 2008, TRENDS PLANT SCI, V13, P14, DOI 10.1016/j.tplants.2007.10.005; Fowler S, 2002, PLANT CELL, V14, P1675, DOI 10.1105/tpc.003483; Fowler SG, 2005, PLANT PHYSIOL, V137, P961, DOI 10.1104/pp.104.058354; Fukushima A, 2009, P NATL ACAD SCI USA, V106, P7251, DOI 10.1073/pnas.0900952106; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibon Y, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r76; Gilmour SJ, 1998, PLANT J, V16, P433, DOI 10.1046/j.1365-313x.1998.00310.x; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gray GR, 2005, PHYSIOL PLANTARUM, V124, P236, DOI 10.1111/j.1399-3054.2005.00507.x; Gutierez RA, 2008, P NATL ACAD SCI USA, V105, P4939, DOI 10.1073/pnas.0800211105; Guy C, 2008, PHYSIOL PLANTARUM, V132, P220, DOI 10.1111/j.1399-3054.2007.00999.x; Hall A, 2003, PLANT CELL, V15, P2719, DOI 10.1105/tpc.013730; Hannah MA, 2005, PLOS GENET, V1, P179, DOI 10.1371/journal.pgen.0010026; Hannah MA, 2008, NAT BIOTECHNOL, V26, P741, DOI 10.1038/nbt0708-741; Hannah MA, 2006, PLANT PHYSIOL, V142, P98, DOI 10.1104/pp.106.081141; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; HEBER U, 1971, BIOCHIM BIOPHYS ACTA, V241, P578, DOI 10.1016/0005-2736(71)90056-3; Hincha DK, 2002, GLYCOBIOLOGY, V12, P103, DOI 10.1093/glycob/12.2.103; IBANEZ C, 2010, PLANT PHYSIOL; Ibanez C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003567; JONES MGK, 1977, PLANT PHYSIOL, V60, P379, DOI 10.1104/pp.60.3.379; Kaplan F, 2005, PLANT J, V44, P730, DOI 10.1111/j.1365-313X.2005.02565.x; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Kaplan F, 2007, PLANT J, V50, P967, DOI 10.1111/j.1365-313X.2007.03100.x; Knowles SM, 2008, J BIOL RHYTHM, V23, P463, DOI 10.1177/0748730408326749; Lee M, 2005, PLANT J, V41, P685, DOI 10.1111/j.1365-313X.2004.02329.x; LEIDREITER K, 1995, BOT ACTA, V108, P439, DOI 10.1111/j.1438-8677.1995.tb00518.x; Less H, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-14; Lewandowska M, 2008, ACTA BIOCHIM POL, V55, P457, DOI 10.18388/abp.2008_3051; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Lu SX, 2009, PLANT PHYSIOL, V150, P834, DOI 10.1104/pp.108.133272; Lu Y, 2005, PLANT PHYSIOL, V138, P2280, DOI 10.1104/pp.105.061903; Maruyama K, 2009, PLANT PHYSIOL, V150, P1972, DOI 10.1104/pp.109.135327; McClung CR, 2008, CURR OPIN PLANT BIOL, V11, P514, DOI 10.1016/j.pbi.2008.06.010; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mikkelsen MD, 2009, PLANT J, V60, P328, DOI 10.1111/j.1365-313X.2009.03957.x; Nakamichi N, 2009, PLANT CELL PHYSIOL, V50, P447, DOI 10.1093/pcp/pcp004; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Ptitsyn A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S18; Ramos A, 2005, P NATL ACAD SCI USA, V102, P7037, DOI 10.1073/pnas.0408549102; Rohde P, 2004, PLANT J, V38, P790, DOI 10.1111/j.1365-313X.2004.02080.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schafer J, 2006, R NEWS, V6, P50; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sirko A, 2004, J EXP BOT, V55, P1881, DOI 10.1093/jxb/erh151; Smith AM, 2005, ANNU REV PLANT BIOL, V56, P73, DOI 10.1146/annurev.arplant.56.032604.144257; Smith SM, 2004, PLANT PHYSIOL, V136, P2687, DOI 10.1104/pp.104.044347; Stacklies W, 2007, BIOINFORMATICS, V23, P1164, DOI 10.1093/bioinformatics/btm069; Stitt M, 2007, German Patent Application, Patent No. [08146. 0025U1, 081460025]; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; STRAUSS G, 1986, P NATL ACAD SCI USA, V83, P2422, DOI 10.1073/pnas.83.8.2422; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Uemura M, 2003, PLANT PHYSIOL, V131, P1800, DOI 10.1104/pp.102.013227; Verbruggen N, 2008, AMINO ACIDS, V35, P753, DOI 10.1007/s00726-008-0061-6; Wanner LA, 1999, PLANT PHYSIOL, V120, P391, DOI 10.1104/pp.120.2.391; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Weise SE, 2004, PLANTA, V218, P474, DOI 10.1007/s00425-003-1128-y; Wilkins O, 2010, PLANT J, V63, P715, DOI 10.1111/j.1365-313X.2010.04274.x; WINTER H, 1993, PLANTA, V191, P180, DOI 10.1007/BF00199748; WINTER H, 1994, PLANTA, V193, P530, DOI 10.1007/BF02411558; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Xin ZG, 1998, P NATL ACAD SCI USA, V95, P7799, DOI 10.1073/pnas.95.13.7799; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124; Yano R, 2005, PLANT PHYSIOL, V138, P837, DOI 10.1104/pp.104.056374; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393; Zhu JH, 2007, CURR OPIN PLANT BIOL, V10, P290, DOI 10.1016/j.pbi.2007.04.010; Zuther E, 2004, FEBS LETT, V576, P169, DOI 10.1016/j.febslet.2004.09.006; Zuther E, 2004, PLANTA, V218, P759, DOI 10.1007/s00425-003-1148-7	90	120	121	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14101	10.1371/journal.pone.0014101	http://dx.doi.org/10.1371/journal.pone.0014101			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124901	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900013
J	Capmany, A; Damiani, MT				Capmany, Anahi; Teresa Damiani, Maria			Chlamydia trachomatis Intercepts Golgi-Derived Sphingolipids through a Rab14-Mediated Transport Required for Bacterial Development and Replication	PLOS ONE			English	Article							RAB GTPASES; MEMBRANE-PROTEIN; INTRACELLULAR DEVELOPMENT; LIPID DROPLETS; INCLUSION; FUSION; TRAFFICKING; PHAGOSOME; APPARATUS; CELLS	Chlamydia trachomatis are obligate intracellular bacteria that survive and replicate in a bacterial-modified phagosome called inclusion. As other intracellular parasites, these bacteria subvert the phagocytic pathway to avoid degradation in phagolysosomes and exploit trafficking pathways to acquire both energy and nutrients essential for their survival. Rabs are host proteins that control intracellular vesicular trafficking. Rab14, a Golgi-related Rab, controls Golgi to endosomes transport. Since Chlamydia establish a close relationship with the Golgi apparatus, the recruitment and participation of Rab14 on inclusion development and bacteria growth were analyzed. Time course analysis revealed that Rab14 associated with inclusions by 10 h post infection and was maintained throughout the entire developmental cycle. The recruitment was bacterial protein synthesis-dependent but independent of microtubules and Golgi integrity. Overexpression of Rab14 dominant negative mutants delayed inclusion enlargement, and impaired bacteria replication as determined by IFU. Silencing of Rab14 by siRNA also decreased bacteria multiplication and infectivity. By electron microscopy, aberrant bacteria were observed in cells overexpressing the cytosolic negative Rab14 mutant. Our results showed that Rab14 facilitates the delivery of sphingolipids required for bacterial development and replication from the Golgi to chlamydial inclusions. Novel anti-chlamydial therapies could be developed based on the knowledge of how bacteria subvert host vesicular transport events through Rabs manipulation.	[Capmany, Anahi; Teresa Damiani, Maria] Univ Cuyo, Fac Med, Cell Biol Lab, Dept Biochem,IHEM CONICET, Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Capmany, A (corresponding author), Univ Cuyo, Fac Med, Cell Biol Lab, Dept Biochem,IHEM CONICET, Mendoza, Argentina.	tdamiani@fcm.uncu.edu.ar			PICT-ANPCyT; PIP-CONICET; Sepcyt-UNCuyo	PICT-ANPCyT(ANPCyT); PIP-CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Sepcyt-UNCuyo	This work was supported by grants from PICT-ANPCyT, PIP-CONICET and Sepcyt-UNCuyo to M. T. Damiani. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Beatty WL, 2006, J CELL SCI, V119, P350, DOI 10.1242/jcs.02733; BEATTY WL, 1993, P NATL ACAD SCI USA, V90, P3998, DOI 10.1073/pnas.90.9.3998; BEATTY WL, 1994, MICROBIOL REV, V58, P686, DOI 10.1128/MMBR.58.4.686-699.1994; Betts HJ, 2009, CURR OPIN MICROBIOL, V12, P81, DOI 10.1016/j.mib.2008.11.009; Brurnell JH, 2007, MICROBIOL MOL BIOL R, V71, P636, DOI 10.1128/MMBR.00023-07; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Cocchiaro JL, 2008, P NATL ACAD SCI USA, V105, P9379, DOI 10.1073/pnas.0712241105; Cocchiaro JL, 2009, CELL MICROBIOL, V11, P1571, DOI 10.1111/j.1462-5822.2009.01364.x; Cortes C, 2007, INFECT IMMUN, V75, P5586, DOI 10.1128/IAI.01020-07; Dautry-Varsat A, 2004, TRAFFIC, V5, P561, DOI 10.1111/j.1398-9219.2004.00207.x; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Grieshaber SS, 2003, J CELL SCI, V116, P3793, DOI 10.1242/jcs.00695; Haas A, 2007, TRAFFIC, V8, P311, DOI 10.1111/j.1600-0854.2006.00531.x; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hackstadt T, 1996, EMBO J, V15, P964, DOI 10.1002/j.1460-2075.1996.tb00433.x; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Harris E, 2002, J CELL SCI, V115, P3703, DOI 10.1242/jcs.00050; Heuer D, 2009, NATURE, V457, P731, DOI 10.1038/nature07578; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; Kitt KN, 2008, TRAFFIC, V9, P1218, DOI 10.1111/j.1600-0854.2008.00752.x; KRAMER MJ, 1971, INFECT IMMUN, V3, P333, DOI 10.1128/IAI.3.2.333-341.1971; KREIS TE, 1990, CELL MOTIL CYTOSKEL, V15, P67, DOI 10.1002/cm.970150202; Kumar Y, 2006, CURR BIOL, V16, P1646, DOI 10.1016/j.cub.2006.06.060; Kyei GB, 2006, EMBO J, V25, P5250, DOI 10.1038/sj.emboj.7601407; Leiva N, 2006, EXP CELL RES, V312, P1843, DOI 10.1016/j.yexcr.2006.02.015; Linstedt AD, 2004, CELL, V118, P271, DOI 10.1016/j.cell.2004.07.015; Moore ER, 2008, TRAFFIC, V9, P2130, DOI 10.1111/j.1600-0854.2008.00828.x; Moorhead AR, 2007, INFECT IMMUN, V75, P781, DOI 10.1128/IAI.01447-06; Palmer KJ, 2005, BIOCHEM SOC SYMP, V72, P1; Pasqualato S, 2004, J BIOL CHEM, V279, P11480, DOI 10.1074/jbc.M310558200; Paumet F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007375; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Proikas-Cezanne T, 2006, FEBS LETT, V580, P5241, DOI 10.1016/j.febslet.2006.08.053; Rejman L.A., 2009, PLOS PATHOG, V5; Robertson DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000664; Rzomp KA, 2006, INFECT IMMUN, V74, P5362, DOI 10.1128/IAI.00539-06; Rzomp KA, 2003, INFECT IMMUN, V71, P5855, DOI 10.1128/IAI.71.10.5855-5870.2003; Saka HA, 2010, CURR OPIN MICROBIOL, V13, P4, DOI 10.1016/j.mib.2009.11.002; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Scidmore MA, 1996, INFECT IMMUN, V64, P5366, DOI 10.1128/IAI.64.12.5366-5372.1996; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Subtil A, 2004, CURR OPIN MICROBIOL, V7, P85, DOI 10.1016/j.mib.2003.12.012; Valdivia RH, 2008, CURR OPIN MICROBIOL, V11, P53, DOI 10.1016/j.mib.2008.01.003	47	76	78	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14084	10.1371/journal.pone.0014084	http://dx.doi.org/10.1371/journal.pone.0014084			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124879	gold, Green Published, Green Submitted			2022-12-27	WOS:000284467200015
J	Hammond-Martel, I; Pak, H; Yu, H; Rouget, R; Horwitz, AA; Parvin, JD; Drobetsky, EA; Affar, E				Hammond-Martel, Ian; Pak, Helen; Yu, Helen; Rouget, Raphael; Horwitz, Andrew A.; Parvin, Jeffrey D.; Drobetsky, Elliot A.; Affar, El Bachir			PI 3 Kinase Related Kinases-Independent Proteolysis of BRCA1 Regulates Rad51 Recruitment during Genotoxic Stress in Human Cells	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; NUCLEOTIDE EXCISION-REPAIR; S-PHASE CHECKPOINT; HISTONE H2AX; IN-VIVO; PHOSPHORYLATION; ATR; CYCLE; DEGRADATION; REPLICATION	Background: The function of BRCA1 in response to ionizing radiation, which directly generates DNA double strand breaks, has been extensively characterized. However previous investigations have produced conflicting data on mutagens that initially induce other classes of DNA adducts. Because of the fundamental and clinical importance of understanding BRCA1 function, we sought to rigorously evaluate the role of this tumor suppressor in response to diverse forms of genotoxic stress. Methodology/Principal Findings: We investigated BRCA1 stability and localization in various human cells treated with model mutagens that trigger different DNA damage signaling pathways. We established that, unlike ionizing radiation, either UVC or methylmethanesulfonate (MMS) (generating bulky DNA adducts or alkylated bases respectively) induces a transient downregulation of BRCA1 protein which is neither prevented nor enhanced by inhibition of PIKKs. Moreover, we found that the proteasome mediates early degradation of BRCA1, BARD1, BACH1, and Rad52 implying that critical components of the homologous recombinaion machinery need to be functionally abrogated as part of the early response to UV or MMS. Significantly, we found that inhibition of BRCA1/BARD1 downregulation is accompanied by the unscheduled recruitment of both proteins to chromatin along with Rad51. Consistently, treatment of cells with MMS engendered complete disassembly of Rad51 from pre-formed ionizing radiation-induced foci. Following the initial phase of BRCA1/BARD1 downregulation, we found that the recovery of these proteins in foci coincides with the formation of RPA and Rad51 foci. This indicates that homologous recombination is reactivated at later stage of the cellular response to MMS, most likely to repair DSBs generated by replication blocks. Conclusion/Significance: Taken together our results demonstrate that (i) the stabilities of BRCA1/BARD1 complexes are regulated in a mutagen-specific manner, and (ii) indicate the existence of mechanisms that may be required to prevent the simultaneous recruitment of conflicting signaling pathways to sites of DNA damage.	[Hammond-Martel, Ian; Pak, Helen; Yu, Helen; Rouget, Raphael; Drobetsky, Elliot A.; Affar, El Bachir] Univ Montreal, Dept Med, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada; [Horwitz, Andrew A.; Parvin, Jeffrey D.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Horwitz, Andrew A.; Parvin, Jeffrey D.] Brigham & Womens Hosp, Boston, MA 02115 USA	Universite de Montreal; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Hammond-Martel, I (corresponding author), Univ Montreal, Dept Med, Maisonneuve Rosemont Hosp, Montreal, PQ H3C 3J7, Canada.	aelbachir.hmr@ssss.gouv.qc.ca	Parvin, Jeffrey D/C-8955-2009		Terry Fox Foundation [018144]; Cancer Research Society (CRS); Cole foundation; NCI [CA111480]; NATIONAL CANCER INSTITUTE [R01CA111480] Funding Source: NIH RePORTER	Terry Fox Foundation; Cancer Research Society (CRS); Cole foundation; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a grant (018144) to EBA from the Terry Fox Foundation and Cancer Research Society (CRS). EBA is a scholar of Le Fonds de la Recherche en Sante du Quebec (FRSQ). HY is supported by a PhD fellowship from the Cole foundation. JP was supported by NCI award CA111480. AH was a predoctoral fellow with the Department of Defense Breast Cancer Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Affar E, 2006, MOL CELL BIOL, V26, P3565, DOI 10.1128/MCB.26.9.3565-3581.2006; Anderson CW, 2001, RADIAT RES, V156, P2, DOI 10.1667/0033-7587(2001)156[0002:FMIPTG]2.0.CO;2; Au WWY, 2007, CELL SIGNAL, V19, P1879, DOI 10.1016/j.cellsig.2007.04.010; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bennett CB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001448; Bochar DA, 2000, CELL, V102, P257, DOI 10.1016/S0092-8674(00)00030-1; Bolderson E, 2009, CLIN CANCER RES, V15, P6314, DOI 10.1158/1078-0432.CCR-09-0096; Brodie KM, 2010, CELL SIGNAL, V22, P291, DOI 10.1016/j.cellsig.2009.09.034; Burma S, 2001, J BIOL CHEM, V276, P42462, DOI 10.1074/jbc.C100466200; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Clarkin CEK, 2000, CELL MOL LIFE SCI, V57, P1126, DOI 10.1007/PL00000749; Cortez D, 1999, SCIENCE, V286, P1162, DOI 10.1126/science.286.5442.1162; Dent P, 2003, ONCOGENE, V22, P5885, DOI 10.1038/sj.onc.1206701; Dizin E, 2008, APOPTOSIS, V13, P237, DOI 10.1007/s10495-007-0167-4; Drew Y, 2010, CURR OPIN OBSTET GYN, V22, P67, DOI 10.1097/GCO.0b013e328334ff57; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Fan SJ, 1998, INT J CANCER, V77, P600, DOI 10.1002/(SICI)1097-0215(19980812)77:4<600::AID-IJC21>3.0.CO;2-8; Feki A, 2005, ONCOGENE, V24, P3726, DOI 10.1038/sj.onc.1208491; Fitch ME, 2003, DNA REPAIR, V2, P819, DOI 10.1016/S1568-7864(03)00066-1; Gatei M, 2001, J BIOL CHEM, V276, P17276, DOI 10.1074/jbc.M011681200; Harper Jane V., 2004, V296, P157; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Irminger-Finger I, 2001, MOL CELL, V8, P1255, DOI 10.1016/S1097-2765(01)00406-3; Jacquemont C, 2007, CANCER RES, V67, P7395, DOI 10.1158/0008-5472.CAN-07-1015; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Jin Y, 1997, P NATL ACAD SCI USA, V94, P12075, DOI 10.1073/pnas.94.22.12075; Johnson N, 2009, MOL CELL, V35, P327, DOI 10.1016/j.molcel.2009.06.036; Kessler BM, 2001, CHEM BIOL, V8, P913, DOI 10.1016/S1074-5521(01)00069-2; Kranz D, 2008, J CELL BIOL, V182, P197, DOI 10.1083/jcb.200712014; Kuluncsics Z, 1999, J PHOTOCH PHOTOBIO B, V49, P71, DOI 10.1016/S1011-1344(99)00034-2; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Liu JS, 2003, MUTAT RES-FUND MOL M, V532, P215, DOI 10.1016/j.mrfmmm.2003.08.018; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Manthey KC, 2007, J CELL SCI, V120, P4221, DOI 10.1242/jcs.004580; Marti TM, 2006, P NATL ACAD SCI USA, V103, P9891, DOI 10.1073/pnas.0603779103; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; O'Brien KA, 1999, BIOCHEM BIOPH RES CO, V260, P658, DOI 10.1006/bbrc.1999.0892; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Pageau GJ, 2006, J CELL BIOL, V175, P693, DOI 10.1083/jcb.200602055; Panier S, 2009, DNA REPAIR, V8, P436, DOI 10.1016/j.dnarep.2009.01.013; Rapic-Otrin V, 2002, NUCLEIC ACIDS RES, V30, P2588, DOI 10.1093/nar/30.11.2588; Ray A, 2009, MOL CELL BIOL, V29, P6206, DOI 10.1128/MCB.00503-09; Ruffner H, 1999, MOL CELL BIOL, V19, P4843; Rusin M, 2009, MECH AGEING DEV, V130, P528, DOI 10.1016/j.mad.2009.06.005; Sarkaria JN, 1999, CANCER RES, V59, P4375; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shao RG, 1999, EMBO J, V18, P1397, DOI 10.1093/emboj/18.5.1397; Soria G, 2010, DNA REPAIR, V9, P358, DOI 10.1016/j.dnarep.2009.12.003; Staszewski O, 2008, ENVIRON MOL MUTAGEN, V49, P734, DOI 10.1002/em.20430; Sui GC, 2004, CELL, V117, P859, DOI 10.1016/j.cell.2004.06.004; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Tang YT, 1996, MOL CELL BIOL, V16, P1989; Thomas JE, 1997, CELL GROWTH DIFFER, V8, P801; Thornton TM, 2009, INT J BIOL SCI, V5, P44, DOI 10.7150/ijbs.5.44; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Vassin VM, 2009, J CELL SCI, V122, P4070, DOI 10.1242/jcs.053702; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Ward IM, 2004, J BIOL CHEM, V279, P9677, DOI 10.1074/jbc.C300554200; Wei LZ, 2008, MOL CELL BIOL, V28, P7380, DOI 10.1128/MCB.01075-08; WU X, 2000, SCIENCE, V289, pA11; Xu B, 2002, CANCER RES, V62, P4588; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Yan Y, 2008, CANCER RES, V68, P5113, DOI 10.1158/0008-5472.CAN-07-5818; Yang WW, 2007, CELL DEATH DIFFER, V14, P807, DOI 10.1038/sj.cdd.4402062; Yoon JH, 2000, J MOL BIOL, V299, P681, DOI 10.1006/jmbi.2000.3771; Zhan QM, 2002, ONCOGENE, V21, P5335, DOI 10.1038/sj.onc.1205665; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zheng L, 2000, MOL CELL, V6, P757, DOI 10.1016/S1097-2765(00)00075-7	72	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14027	10.1371/journal.pone.0014027	http://dx.doi.org/10.1371/journal.pone.0014027			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103343	Green Submitted, gold, Green Published			2022-12-27	WOS:000284327800013
J	Humphreys, EH; Williams, KT; Adams, DH; Afford, SC				Humphreys, Elizabeth H.; Williams, Kevin T.; Adams, David H.; Afford, Simon C.			Primary and Malignant Cholangiocytes Undergo CD40 Mediated Fas Dependent Apoptosis, but Are Insensitive to Direct Activation with Exogenous Fas Ligand	PLOS ONE			English	Article							PRIMARY BILIARY-CIRRHOSIS; CELL-DEATH; HUMAN-LIVER; ALLOGRAFT-REJECTION; EPITHELIAL-CELLS; CARCINOMA-CELLS; FACTOR RECEPTOR; TUMOR-GROWTH; C VIRUS; CHOLANGIOCARCINOMA	Introduction: Cholangiocarcinoma is a rare malignancy of the biliary tract, the incidence of which is rising, but the pathogenesis of which remains uncertain. No common genetic defects have been described but it is accepted that chronic inflammation is an important contributing factor. We have shown that primary human cholangiocyte and hepatocyte survival is tightly regulated via co-operative interactions between two tumour necrosis family (TNF) receptor family members; CD40 and Fas (CD95). Functional deficiency of CD154, the ligand for CD40, leads to a failure of clearance of biliary tract infections and a predisposition to cholangiocarcinoma implying a direct link between TNF receptor-mediated apoptosis and the development of cholangiocarcinoma. Aims: To determine whether malignant cholangiocytes display defects in CD40 mediated apoptosis. By comparing CD40 and Fas-mediated apoptosis and intracellular signalling in primary human cholangiocytes and three cholangiocyte cell lines. Results: Primary cholangiocytes and cholangiocyte cell lines were relatively insensitive to direct Fas-mediated killing with exogenous FasL when compared with Jurkat cells, which readily underwent Fas-mediated apoptosis, but were extremely sensitive to CD154 stimulation. The sensitivity of cells to CD40 activation was similar in magnitude in both primary and malignant cells and was STAT-3 and AP-1 dependent in both. Conclusions: 1) Both primary and malignant cholangiocytes are relatively resistant to Fas-mediated killing but show exquisite sensitivity to CD154, suggesting that the CD40 pathway is intact and fully functional in both primary and malignant cholangiocytes 2) The relative insensitivity of cholangiocytes to Fas activation demonstrates the importance of CD40 augmentation of Fas dependent death in these cells. Agonistic therapies which target CD40 and associated intracellular signalling pathways may be effective in promoting apoptosis of malignant cholangiocytes.	[Humphreys, Elizabeth H.; Williams, Kevin T.; Adams, David H.; Afford, Simon C.] Univ Birmingham, Liver Res Ctr, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Humphreys, EH (corresponding author), Univ Birmingham, Liver Res Ctr, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England.	s.c.afford@bham.ac.uk	Humphreys, Elizabeth/I-5090-2015; Adams, David H/C-9092-2009	Humphreys, Elizabeth/0000-0002-6742-7485; Adams, David H/0000-0001-6776-0336	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/E017096/1]; BBSRC [BB/E017096/1] Funding Source: UKRI; STFC [ST/H000429/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E017096/1] Funding Source: researchfish; Medical Research Council [G9818340B] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/E017096/1. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abmayr S. M., 2006, CURRENT PROTOCOLS MO, P1211; Afford SC, 2005, GUT, V54, P1518, DOI 10.1136/gut.2005.067801; Afford SC, 1999, J EXP MED, V189, P441, DOI 10.1084/jem.189.2.441; AFFORD SC, 1995, J PATHOL, V176, P373, DOI 10.1002/path.1711760408; Afford SC, 2001, FASEB J, V15, P2345, DOI 10.1096/fj.01-0088com; Ahmed-Choudhury J, 2006, CELL SIGNAL, V18, P456, DOI 10.1016/j.cellsig.2005.05.015; Alabraba EB, 2008, HEPATOLOGY, V47, P552, DOI 10.1002/hep.22011; Alexandroff AB, 2000, MOL IMMUNOL, V37, P515, DOI 10.1016/S0161-5890(00)00079-1; ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; ANSARI B, 1993, J PATHOL, V170, P1, DOI 10.1002/path.1711700102; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Baxendale AJ, 2005, ONCOGENE, V24, P7913, DOI 10.1038/sj.onc.1208929; Bergamo A, 1997, BRIT J HAEMATOL, V97, P652, DOI 10.1046/j.1365-2141.1997.1032919.x; Bonfoco E, 1998, IMMUNITY, V9, P711, DOI 10.1016/S1074-7613(00)80668-8; Broome U, 1996, GUT, V38, P610, DOI 10.1136/gut.38.4.610; Bugajska U, 2002, J NATL CANCER I, V94, P1381; Cascino I, 1996, J IMMUNOL, V156, P13; Chapman RS, 1999, GENE DEV, V13, P2604, DOI 10.1101/gad.13.19.2604; Chu P, 2002, P NATL ACAD SCI USA, V99, P3854, DOI 10.1073/pnas.022604399; CLEARY AM, 1995, J IMMUNOL, V155, P3329; CLEMENT MV, 1994, J EXP MED, V180, P557, DOI 10.1084/jem.180.2.557; Dzojic H, 2006, PROSTATE, V66, P831, DOI 10.1002/pros.20344; Eliopoulos AG, 2000, MOL CELL BIOL, V20, P5503, DOI 10.1128/MCB.20.15.5503-5515.2000; Esche C, 1999, EUR J IMMUNOL, V29, P2148; Fan MY, 2001, CANCER RES, V61, P4450; Ferrant JL, 2004, INT IMMUNOL, V16, P1583, DOI 10.1093/intimm/dxh162; French LE, 1996, J CELL BIOL, V133, P335, DOI 10.1083/jcb.133.2.335; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Harada K, 1997, HEPATOLOGY, V26, P1399; Hayward AR, 1997, J IMMUNOL, V158, P977; Hess S, 1996, J EXP MED, V183, P159, DOI 10.1084/jem.183.1.159; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jakobson E, 1998, INT J CANCER, V77, P849, DOI 10.1002/(SICI)1097-0215(19980911)77:6<849::AID-IJC9>3.0.CO;2-U; JOPLIN R, 1989, IN VITRO CELL DEV B, V25, P1189; Khan SA, 2005, LANCET, V366, P1303, DOI 10.1016/S0140-6736(05)67530-7; Klimp AH, 2002, CRIT REV ONCOL HEMAT, V44, P143, DOI 10.1016/S1040-8428(01)00203-7; KUBO S, 1995, WORLD J SURG, V19, P637, DOI 10.1007/BF00294744; Le-Niculescu H, 1999, MOL CELL BIOL, V19, P751; LIPSETT PA, 1994, ANN SURG, V220, P644, DOI 10.1097/00000658-199411000-00007; Mach F, 1997, P NATL ACAD SCI USA, V94, P1931, DOI 10.1073/pnas.94.5.1931; Maxwell JR, 1999, J IMMUNOL, V162, P2024; Ochs H D, 1994, Semin Immunol, V6, P337, DOI 10.1006/smim.1994.1042; Ohtsuka T, 2001, ENDOSCOPY, V33, P614, DOI 10.1055/s-2001-15324; Ottaiano A, 2002, TUMORI J, V88, P361, DOI 10.1177/030089160208800502; Pan G, 2007, INT J ONCOL, V31, P843; PAULIE S, 1985, CANCER IMMUNOL IMMUN, V20, P23; Pickens A, 1999, J GASTROINTEST SURG, V3, P374, DOI 10.1016/S1091-255X(99)80053-5; Que FG, 1999, HEPATOLOGY, V30, p384A; Rissoan MC, 1996, CLIN EXP IMMUNOL, V106, P481, DOI 10.1046/j.1365-2249.1996.d01-858.x; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; Schuler W, 2004, TRANSPLANTATION, V77, P717, DOI 10.1097/01.TP.0000116563.72763.83; Shimonishi T, 2000, HEPATOLOGY, V32, P761, DOI 10.1053/jhep.2000.18192; Shin HR, 1996, INT J EPIDEMIOL, V25, P933, DOI 10.1093/ije/25.5.933; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Starkel P, 2003, AM J PATHOL, V162, P587, DOI 10.1016/S0002-9440(10)63852-7; STEWART R, 2001, J IMMUNOL, V179, P2705; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Wang DK, 1997, BRIT J HAEMATOL, V97, P409, DOI 10.1046/j.1365-2141.1997.422688.x; Watanapa P, 1996, BRIT J SURG, V83, P1062, DOI 10.1002/bjs.1800830809; Williams KT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000159; Wingett DG, 1998, BREAST CANCER RES TR, V50, P27, DOI 10.1023/A:1006012607452; ZONG YS, 1991, ONCOLOGY-BASEL, V48, P290	63	18	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14037	10.1371/journal.pone.0014037	http://dx.doi.org/10.1371/journal.pone.0014037			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103345	gold, Green Published			2022-12-27	WOS:000284327800018
J	Fourrage, C; Chevalier, S; Houliston, E				Fourrage, Cecile; Chevalier, Sandra; Houliston, Evelyn			A Highly Conserved Poc1 Protein Characterized in Embryos of the Hydrozoan Clytia hemisphaerica: Localization and Functional Studies	PLOS ONE			English	Article							CENTRIOLE DUPLICATION; GERM PLASM; CNIDARIAN; DIFFERENTIATION; COMPONENT; XENOPUS; GENES	Poc1 (Protein of Centriole 1) proteins are highly conserved WD40 domain-containing centriole components, well characterized in the alga Chlamydomonas, the ciliated protazoan Tetrahymena, the insect Drosophila and in vertebrate cells including Xenopus and zebrafish embryos. Functions and localizations related to the centriole and ciliary axoneme have been demonstrated for Poc1 in a range of species. The vertebrate Poc1 protein has also been reported to show an additional association with mitochondria, including enrichment in the specialized "germ plasm" region of Xenopus oocytes. We have identified and characterized a highly conserved Poc1 protein in the cnidarian Clytia hemisphaerica. Clytia Poc1 mRNA was found to be strongly expressed in eggs and early embryos, showing a punctate perinuclear localization in young oocytes. Fluorescence-tagged Poc1 proteins expressed in developing embryos showed strong localization to centrioles, including basal bodies. Anti-human Poc1 antibodies decorated mitochondria in Clytia, as reported in human cells, but failed to recognise endogenous or fluorescent-tagged Clytia Poc1. Injection of specific morpholino oligonucleotides into Clytia eggs prior to fertilization to repress Poc1 mRNA translation interfered with cell division from the blastula stage, likely corresponding to when neosynthesis normally takes over from maternally supplied protein. Cell cycle lengthening and arrest were observed, phenotypes consistent with an impaired centriolar biogenesis or function. The specificity of the defects could be demonstrated by injection of synthetic Poc1 mRNA, which restored normal development. We conclude that in Clytia embryos, Poc1 has an essentially centriolar localization and function.	[Fourrage, Cecile] Univ Paris 06, Villefranche Sur Mer, France; CNRS, Dev Biol Unit, Villefranche Sur Mer, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS)	Fourrage, C (corresponding author), Univ Paris 06, Villefranche Sur Mer, France.	houliston@obs-vlfr.fr		Houliston, Evelyn/0000-0001-9264-2585	Centre National de Recherche Scientifique and Agence National Recherche de la Recherche [ANR-09-BLAN-0236-02]; French Ministere de l'Enseignement Superieur et de la Recherche	Centre National de Recherche Scientifique and Agence National Recherche de la Recherche; French Ministere de l'Enseignement Superieur et de la Recherche	Funding came from the Centre National de Recherche Scientifique and Agence National Recherche de la Recherche [ANR-09-BLAN-0236-02], and a studentship from the French Ministere de l'Enseignement Superieur et de la Recherche to CF. EST sequencing was performed at the Genoscope (Evry). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiel A, 2009, DEV BIOL, V327, P191, DOI 10.1016/j.ydbio.2008.12.007; Amiel A, 2009, CURR BIOL, V19, P305, DOI 10.1016/j.cub.2008.12.054; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Blachon S, 2009, GENETICS, V182, P133, DOI 10.1534/genetics.109.101709; Chevalier S, 2006, DEV GENES EVOL, V216, P709, DOI 10.1007/s00427-006-0103-6; DEBEC A, 2010, CELL MOL LIFE SCI; Denker E, 2008, DEV BIOL, V315, P99, DOI 10.1016/j.ydbio.2007.12.023; EDDY EM, 1975, INT REV CYTOL, V43, P229; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; Houliston E, 2010, TRENDS GENET, V26, P159, DOI 10.1016/j.tig.2010.01.008; Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Liu Q, 2007, MOL CELL PROTEOMICS, V6, P1299, DOI 10.1074/mcp.M700054-MCP200; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Momose T, 2007, PLOS BIOL, V5, P889, DOI 10.1371/journal.pbio.0050070; Murray AW, 2001, SCIENCE, V291, P1499, DOI 10.1126/science.291.5508.1499; Pearson CG, 2009, J CELL BIOL, V187, P904, DOI 10.1083/jcb.200908019; Perez-Mongiovi D, 1998, J CELL SCI, V111, P385; ROOSENRU.EC, 1965, Z ZELLFORSCH MIK ANA, V68, P597, DOI 10.1007/BF00340088; Roure A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000916; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778	24	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13994	10.1371/journal.pone.0013994	http://dx.doi.org/10.1371/journal.pone.0013994			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103375	Green Published, Green Submitted, gold			2022-12-27	WOS:000284257400004
J	Maricic, T; Whitten, M; Paabo, S				Maricic, Tomislav; Whitten, Mark; Paeaebo, Svante			Multiplexed DNA Sequence Capture of Mitochondrial Genomes Using PCR Products	PLOS ONE			English	Article								Background: To utilize the power of high-throughput sequencers, target enrichment methods have been developed. The majority of these require reagents and equipment that are only available from commercial vendors and are not suitable for the targets that are a few kilobases in length. Methodology/Principal Findings: We describe a novel and economical method in which custom made long-range PCR products are used to capture complete human mitochondrial genomes from complex DNA mixtures. We use the method to capture 46 complete mitochondrial genomes in parallel and we sequence them on a single lane of an Illumina GA(II) instrument. Conclusions/Significance: This method is economical and simple and particularly suitable for targets that can be amplified by PCR and do not contain highly repetitive sequences such as mtDNA. It has applications in population genetics and forensics, as well as studies of ancient DNA.	[Maricic, Tomislav; Whitten, Mark; Paeaebo, Svante] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany	Max Planck Society	Maricic, T (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany.	tomislav_maricic@eva.mpg.de		Maricic, Tomislav/0000-0003-3267-0474	Max Planck Society	Max Planck Society(Max Planck Society)	This study was funded by the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; He YP, 2010, NATURE, V464, P610, DOI 10.1038/nature08802; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kircher M, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r83; Krause J, 2010, CURR BIOL, V20, P231, DOI 10.1016/j.cub.2009.11.068; Mamanova L, 2010, NAT METHODS, V7, P111, DOI 10.1038/nmeth.1419; Meyer M., 2010, COLD SPRING HARB PRO; Meyer M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm566; MEYERHANS A, 1990, NUCLEIC ACIDS RES, V18, P1687, DOI 10.1093/nar/18.7.1687; Pakendorf B, 2005, ANNU REV GENOM HUM G, V6, P165, DOI 10.1146/annurev.genom.6.080604.162249; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Porreca GJ, 2007, NAT METHODS, V4, P931, DOI 10.1038/NMETH1110; Tewhey R, 2009, NAT BIOTECHNOL, V27, P1025, DOI 10.1038/nbt.1583	16	357	377	5	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14004	10.1371/journal.pone.0014004	http://dx.doi.org/10.1371/journal.pone.0014004			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103372	Green Published, gold, Green Submitted			2022-12-27	WOS:000284257400008
J	Nunney, L; Yuan, XL; Bromley, R; Hartung, J; Montero-Astua, M; Moreira, L; Ortiz, B; Stouthamer, R				Nunney, Leonard; Yuan, Xiaoli; Bromley, Robin; Hartung, John; Montero-Astua, Mauricio; Moreira, Lisela; Ortiz, Beatriz; Stouthamer, Richard			Population Genomic Analysis of a Bacterial Plant Pathogen: Novel Insight into the Origin of Pierce's Disease of Grapevine in the US	PLOS ONE			English	Article							CITRUS VARIEGATED CHLOROSIS; XYLELLA-FASTIDIOSA STRAINS; LEAF SCORCH; GENETIC DIVERSITY; SEQUENCE; BIOLOGY	Invasive diseases present an increasing problem worldwide; however, genomic techniques are now available to investigate the timing and geographical origin of such introductions. We employed genomic techniques to demonstrate that the bacterial pathogen causing Pierce's disease of grapevine (PD) is not native to the US as previously assumed, but descended from a single genotype introduced from Central America. PD has posed a serious threat to the US wine industry ever since its first outbreak in Anaheim, California in the 1880s and continues to inhibit grape cultivation in a large area of the country. It is caused by infection of xylem vessels by the bacterium Xylella fastidiosa subsp. fastidiosa, a genetically distinct subspecies at least 15,000 years old. We present five independent kinds of evidence that strongly support our invasion hypothesis: 1) a genome-wide lack of genetic variability in X. fastidiosa subsp. fastidiosa found in the US, consistent with a recent common ancestor; 2) evidence for historical allopatry of the North American subspecies X. fastidiosa subsp. multiplex and X. fastidiosa subsp. fastidiosa; 3) evidence that X. fastidiosa subsp. fastidiosa evolved in a more tropical climate than X. fastidiosa subsp. multiplex; 4) much greater genetic variability in the proposed source population in Central America, variation within which the US genotypes are phylogenetically nested; and 5) the circumstantial evidence of importation of known hosts (coffee plants) from Central America directly into southern California just prior to the first known outbreak of the disease. The lack of genetic variation in X. fastidiosa subsp. fastidiosa in the US suggests that preventing additional introductions is important since new genetic variation may undermine PD control measures, or may lead to infection of other crop plants through the creation of novel genotypes via inter-subspecific recombination. In general, geographically mixing of previously isolated subspecies should be avoided.	[Nunney, Leonard; Yuan, Xiaoli] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Bromley, Robin; Stouthamer, Richard] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Hartung, John] USDA ARS, Plant Pathol Lab, Beltsville, MD USA; [Montero-Astua, Mauricio; Moreira, Lisela; Ortiz, Beatriz] Univ Costa Rica, Ctr Invest Biol Celular & Mol, San Jose, Costa Rica	University of California System; University of California Riverside; University of California System; University of California Riverside; United States Department of Agriculture (USDA); Universidad Costa Rica	Nunney, L (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	leonard.nunney@ucr.edu	Moreira, Lisela/Y-8267-2019	Moreira, Lisela/0000-0003-3344-7979; Nunney, Leonard/0000-0002-4315-3694; Bromley, Robin/0000-0003-2738-2603	United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative [2007-55605-17834]	United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative(United States Department of Agriculture (USDA))	This study was supported by a United States Department of Agriculture Cooperative State Research, Education, and Extension Service National Research Initiative Plant Biosecurity grant 2007-55605-17834 to L.N. and R.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Almeida RPP, 2008, APPL ENVIRON MICROB, V74, P3690, DOI 10.1128/AEM.02388-07; Almeida RPP, 2003, APPL ENVIRON MICROB, V69, P7447, DOI 10.1128/AEM.69.12.7447-7452.2003; Berisha B, 1998, EUR J PLANT PATHOL, V104, P427, DOI 10.1023/A:1008655621235; Bhattacharyya A, 2002, P NATL ACAD SCI USA, V99, P12403, DOI 10.1073/pnas.132393999; Brasier CM, 2001, BIOSCIENCE, V51, P123, DOI 10.1641/0006-3568(2001)051[0123:REOIPP]2.0.CO;2; CHANG CJ, 1993, CURR MICROBIOL, V27, P137, DOI 10.1007/BF01576010; Chen J, 2007, PHYTOPATHOLOGY, V97, pS21; CHEN J, 1995, APPL ENVIRON MICROB, V61, P1688, DOI 10.1128/AEM.61.5.1688-1690.1995; GOHEEN AC, 1979, PLANT DIS REP, V63, P788; GUINN JM, 1915, HIST CALIFORNIA EXTE, V1; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hendson M, 2001, APPL ENVIRON MICROB, V67, P895, DOI 10.1128/AEM.67.2.895-903.2001; Hernandez-Martinez R, 2006, PLANT DIS, V90, P1382, DOI 10.1094/PD-90-1382; HERNANDEZMARTIN.R, 2007, SO CALIFORNIA PHYTOP, V97, P857; HEWITT W. B., 1958, PLANT DIS REPORTER, V42, P211; HOPKINS DL, 1989, ANNU REV PHYTOPATHOL, V27, P271, DOI 10.1146/annurev.py.27.090189.001415; Lin H, 2005, APPL ENVIRON MICROB, V71, P4888, DOI 10.1128/AEM.71.8.4888-4892.2005; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Montero-Astua M, 2008, J MICROBIOL, V46, P482, DOI 10.1007/s12275-008-0072-8; MONTEROASTU AM, 2007, UNITED STATES PHYTOP, V97, P1338; Pierce NB., 1892, CALIFORNIA VINE DIS; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Purcell AH, 1996, ANNU REV PHYTOPATHOL, V34, P131, DOI 10.1146/annurev.phyto.34.1.131; Redak RA, 2004, ANNU REV ENTOMOL, V49, P243, DOI 10.1146/annurev.ento.49.061802.123403; RODRIGUEZ CM, 2001, DIS NOTES, V85, P1027; Scally M, 2005, APPL ENVIRON MICROB, V71, P8491, DOI 10.1128/AEM.71.12.8491-8499.2005; Schaad NW, 2004, SYST APPL MICROBIOL, V27, P290, DOI 10.1078/0723-2020-00263; Schuenzel EL, 2005, APPL ENVIRON MICROB, V71, P3832, DOI 10.1128/AEM.71.7.3832-3839.2005; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; STONER WARREN N., 1952, FLORIDA ENT, V35, P62, DOI 10.2307/3492278; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Van Sluys MA, 2003, J BACTERIOL, V185, P1018, DOI 10.1128/JB.185.3.1018-1026.2003; Yuan X, 2010, PHYTOPATHOLOGY, V100, P601, DOI 10.1094/PHYTO-100-6-0601; 1863, T CALIFORNIA AGR SOC, P52	34	76	78	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15488	10.1371/journal.pone.0015488	http://dx.doi.org/10.1371/journal.pone.0015488			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103383	Green Published, Green Submitted, gold			2022-12-27	WOS:000284257400027
J	Chae, HD; Siefring, JE; Hildeman, DA; Gu, Y; Williams, DA				Chae, Hee-Don; Siefring, Jamie E.; Hildeman, David A.; Gu, Yi; Williams, David A.			RhoH Regulates Subcellular Localization of ZAP-70 and Lck in T Cell Receptor Signaling	PLOS ONE			English	Article							HEMATOPOIETIC PROGENITOR CELLS; GTP-BINDING PROTEIN; IMMUNOLOGICAL SYNAPSE; TYROSINE KINASE; ZETA-CHAIN; LYMPHOCYTE-ACTIVATION; ACTIN CYTOSKELETON; ANTIGEN RECEPTOR; GENE-TRANSFER; PHOSPHORYLATION	RhoH is an hematopoietic-specific, GTPase-deficient Rho GTPase that plays a role in T development. We investigated the mechanisms of RhoH function in TCR signaling. We found that the association between Lck and CD3 zeta was impaired in RhoH-deficient T cells, due to defective translocation of both Lck and ZAP-70 to the immunological synapse. RhoH with Lck and ZAP-70 localizes in the detergent-soluble membrane fraction where the complex is associated with CD3 zeta phosphorylation. To determine if impaired translocation of ZAP-70 was a major determinant of defective T cell development, Rhoh(-/-) bone marrow cells were transduced with a chimeric myristoylation-tagged ZAP-70. Myr-ZAP-70 transduced cells partially reversed the in vivo defects of RhoH-associated thymic development and TCR signaling. Together, our results suggest that RhoH regulates TCR signaling via recruitment of ZAP-70 and Lck to CD3 zeta in the immunological synapse. Thus, we define a new function for a RhoH GTPase as an adaptor molecule in TCR signaling pathway.	[Chae, Hee-Don; Siefring, Jamie E.; Gu, Yi; Williams, David A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Res Fdn, Div Expt Hematol, Cincinnati, OH USA; [Chae, Hee-Don; Siefring, Jamie E.; Hildeman, David A.; Gu, Yi; Williams, David A.] Univ Cincinnati, Coll Med, Cincinnati, OH USA; [Hildeman, David A.] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Res Fdn, Div Immunobiol, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University System of Ohio; University of Cincinnati	Chae, HD (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA.	DAWilliams@childrens.harvard.edu	Hildeman, David/I-4884-2015; Chae, Hee-Don/D-2620-2011; Hildeman, David/AAA-1757-2020	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483	National Institutes of Health [R01 CA113969]; NATIONAL CANCER INSTITUTE [R01CA113969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The work in this manuscript was supported by grant R01 CA113969 from the National Institutes of Health to David Williams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe JM, 1999, J EXP MED, V189, P1163, DOI 10.1084/jem.189.7.1163; Aspenstrom P, 2007, EXP CELL RES, V313, P3673, DOI 10.1016/j.yexcr.2007.07.022; Brdicka T, 2005, MOL CELL BIOL, V25, P4924, DOI 10.1128/MCB.25.12.4924-4933.2005; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Chae HD, 2008, BLOOD, V111, P2597, DOI 10.1182/blood-2007-06-093237; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; CLAYTON LK, 1991, P NATL ACAD SCI USA, V88, P5202, DOI 10.1073/pnas.88.12.5202; DALLERY E, 1995, ONCOGENE, V10, P2171; Deindl S, 2007, CELL, V129, P735, DOI 10.1016/j.cell.2007.03.039; DORN T, 2007, THESIS L MAXIMILIANS; Dorn T, 2007, BLOOD, V109, P2346, DOI 10.1182/BLOOD-2006-04-019034; Dumont C, 2002, J IMMUNOL, V169, P1705, DOI 10.4049/jimmunol.169.4.1705; Friedl P, 2005, NAT REV IMMUNOL, V5, P532, DOI 10.1038/nri1647; Gaidano G, 2003, BLOOD, V102, P1833, DOI 10.1182/blood-2002-11-3606; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; GAUEN LKT, 1994, MOL CELL BIOL, V14, P3729, DOI 10.1128/MCB.14.6.3729; Giannini A, 2004, MOL CELL BIOL, V24, P5667, DOI 10.1128/MCB.24.13.5667-5676.2004; Graef IA, 1997, EMBO J, V16, P5618, DOI 10.1093/emboj/16.18.5618; Gu Y, 2005, BLOOD, V105, P1467, DOI 10.1182/blood-2004-04-1604; Gu Y, 2006, NAT IMMUNOL, V7, P1182, DOI 10.1038/ni1396; Hermiston ML, 2002, J CLIN INVEST, V109, P9; Kobune M, 2001, CANCER RES, V61, P5116; Kumaraguru U, 2000, J IMMUNOL, V165, P750, DOI 10.4049/jimmunol.165.2.750; Li XY, 2002, MOL CELL BIOL, V22, P1158, DOI 10.1128/MCB.22.4.1158-1171.2002; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; Nel AE, 2002, J ALLERGY CLIN IMMUN, V109, P901, DOI 10.1067/mai.2002.124965; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Preudhomme C, 2000, ONCOGENE, V19, P2023, DOI 10.1038/sj.onc.1203521; Roumier A, 2001, IMMUNITY, V15, P715, DOI 10.1016/S1074-7613(01)00225-4; Saito T, 2006, CURR OPIN IMMUNOL, V18, P305, DOI 10.1016/j.coi.2006.03.014; Steinberg M, 2004, BLOOD, V104, P760, DOI 10.1182/blood-2003-12-4314; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; Underhill DM, 2007, TRENDS IMMUNOL, V28, P66, DOI 10.1016/j.it.2006.12.004; vanOers NSC, 1996, J EXP MED, V183, P1053, DOI 10.1084/jem.183.3.1053; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wahlers A, 2001, GENE THER, V8, P477, DOI 10.1038/sj.gt.3301426; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; WANGE RL, 1992, J BIOL CHEM, V267, P11685; Xavier R, 2004, J CELL BIOL, V166, P173, DOI 10.1083/jcb.200309044; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Yamasaki S, 1996, MOL CELL BIOL, V16, P7151	45	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13970	10.1371/journal.pone.0013970	http://dx.doi.org/10.1371/journal.pone.0013970			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103055	gold, Green Published, Green Submitted			2022-12-27	WOS:000284147700017
J	Phipps, W; Ssewankambo, F; Nguyen, H; Saracino, M; Wald, A; Corey, L; Orem, J; Kambugu, A; Casper, C				Phipps, Warren; Ssewankambo, Fred; Nguyen, Huong; Saracino, Misty; Wald, Anna; Corey, Lawrence; Orem, Jackson; Kambugu, Andrew; Casper, Corey			Gender Differences in Clinical Presentation and Outcomes of Epidemic Kaposi Sarcoma in Uganda	PLOS ONE			English	Article							HUMAN CHORIONIC-GONADOTROPIN; CANCER INCIDENCE; SOUTH-AFRICA; AIDS; HIV; WOMEN; MEN; DNA; ANTIBODIES; INFECTION	Introduction: The incidence of Kaposi sarcoma (KS) has increased dramatically among women in sub-Saharan Africa since the onset of the HIV pandemic, but data on KS disease in women are limited. To identify gender-related differences in KS presentation and outcomes, we evaluated the clinical manifestations and response in men and women with AIDS-associated KS in Uganda. Methods and Findings: HIV-infected adults with KS attending the Infectious Diseases Institute (IDI) and Uganda Cancer Institute (UCI) in Kampala, Uganda between 2004 and 2006 were included in a retrospective cohort. Evaluation of KS presentation was based on the clinical features described at the initial KS visit. Response was evaluated as the time to "improvement", as defined by any decrease in lesion size, lesion number, or edema. The cohort consisted of 197 adults with HIV and KS: 55% (108/197) were women. At presentation, the median CD4 T-cell count was significantly lower in women (58 cells/mm(3); IQR 11-156 cells/mm(3)) than men (124 cells/mm(3); IQR 22-254 cells/mm(3)) (p = 0.02). Women were more likely than men to present with lesions of the face (OR 2.8, 95% CI, 1.4, 5.7; p = 0.005) and hard palate (OR 2.0, 95% CI, 1.1, 3.7; p = 0.02), and were less likely than men to have lower extremity lesions (OR 0.54, 95% CI, 0.3, 0.99; p = 0.05). Women were less likely than men to demonstrate clinical improvement (HR = 0.52, CI 0.31, 0.88; p = 0.01) in multivariate analysis. Conclusions: The clinical presentation and response of KS differs between men and women in Uganda. These data suggest that gender affects the pathophysiology of KS, which may have implications for the prevention, diagnosis, and treatment of KS in both men and women. Prospective studies are needed to identify predictors of response and evaluate efficacy of treatment in women with KS, particularly in Africa where the disease burden is greatest.	[Phipps, Warren; Nguyen, Huong; Wald, Anna; Corey, Lawrence; Casper, Corey] Univ Washington, Dept Med, Seattle, WA 98195 USA; [Saracino, Misty; Wald, Anna; Corey, Lawrence] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA; [Wald, Anna; Casper, Corey] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Casper, Corey] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Phipps, Warren; Wald, Anna; Corey, Lawrence; Casper, Corey] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Ssewankambo, Fred; Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Orem, Jackson] Uganda Canc Inst, Kampala, Uganda; [Orem, Jackson] Makerere Univ, Coll Hlth Sci, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Makerere University	Phipps, W (corresponding author), Univ Washington, Dept Med, Seattle, WA 98195 USA.	wtphipps@fhcrc.org	Corey, Lawrence/AAE-1796-2020; Wald, Anna/B-6272-2012	Corey, Lawrence/0000-0002-2179-2436; Wald, Anna/0000-0003-3486-6438	Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation; National Institutes of Health [K24 A1071113]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007140] Funding Source: NIH RePORTER	Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Joel Meyers Infectious Disease Scholarship Grant, Fred Hutchinson Cancer Research Center; Doris Duke Charitable Foundation; National Institutes of Health K24 A1071113. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alagiozoglou L, 2003, EPIDEMIOL INFECT, V131, P1125, DOI 10.1017/S0950268803001146; [Anonymous], 2000, TECHN REP SER WHO; BENEDETTI P, 1991, AIDS, V5, P466, DOI 10.1097/00002030-199104000-00025; Casper C, 2004, JAIDS-J ACQ IMM DEF, V35, P233, DOI 10.1097/00126334-200403010-00003; Chokunonga E, 2000, INT J CANCER, V85, P54, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;54::AID-IJC10&gt;3.0.CO;2-D; Cooley TP, 1996, AIDS, V10, P1221, DOI 10.1097/00002030-199609000-00007; Gandhi M, 2004, J DENT RES, V83, P639, DOI 10.1177/154405910408300811; Gill PS, 1996, NEW ENGL J MED, V335, P1261, DOI 10.1056/NEJM199610243351702; Johnston C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004222; Karnofsky D, 1949, EVALUATION CHEMOTHER, P196; Krown SE, 1997, J CLIN ONCOL, V15, P3085, DOI 10.1200/JCO.1997.15.9.3085; KROWN SE, 1989, J CLIN ONCOL, V7, P1201, DOI 10.1200/JCO.1989.7.9.1201; Laney AS, 2007, AIDS, V21, P1541, DOI 10.1097/QAD.0b013e3282202b7d; Laney AS, 2004, AIDS, V18, P1819, DOI 10.1097/00002030-200409030-00011; LASSOUED K, 1991, AIDS, V5, P877, DOI 10.1097/00002030-199107000-00013; LUNARDIISKANDAR Y, 1995, NATURE, V375, P64, DOI 10.1038/375064a0; Mbulaiteye SM, 2006, INT J CANCER, V118, P985, DOI 10.1002/ijc.21443; Meditz AL, 2007, JAIDS-J ACQ IMM DEF, V44, P306, DOI 10.1097/QAI.0b013e31802c83d9; Mosam A, 2008, INT J STD AIDS, V19, P400, DOI 10.1258/ijsa.2008.007301; Mwanda OW, 2005, ANN TROP MED PARASIT, V99, P81, DOI 10.1179/136485905X19928; Nasti G, 1999, J ACQ IMMUN DEF SYND, V20, P337, DOI 10.1097/00042560-199904010-00003; Onyango J F, 2004, East Afr Med J, V81, P120; Parkin DM, 1999, AIDS, V13, P2563, DOI 10.1097/00002030-199912240-00010; RABKIN CS, 1995, NATURE, V377, P21, DOI 10.1038/377021a0; Smith MS, 1997, J INFECT DIS, V176, P84, DOI 10.1086/514043; Stanberry LR, 2002, NEW ENGL J MED, V347, P1652, DOI 10.1056/NEJMoa011915; Tavio M, 1998, EUR J CANCER, V34, P1634, DOI 10.1016/S0959-8049(98)00154-3; Wabinga HR, 2000, BRIT J CANCER, V82, P1585, DOI 10.1054/bjoc.1999.1071; Wang J, 2007, GENDER MED, V4, P266, DOI 10.1016/S1550-8579(07)80045-3; World Health Organization, 2009, RAP ADV ANT THER HIV; Yoo Deok Jong, 2005, Korean Journal of Internal Medicine, V20, P290; Ziegler J, 2003, INT J CANCER, V103, P233, DOI 10.1002/ijc.10818	32	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13936	10.1371/journal.pone.0013936	http://dx.doi.org/10.1371/journal.pone.0013936			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103057	Green Submitted, gold, Green Published			2022-12-27	WOS:000284147700006
J	Sosa-Garcia, B; Gunduz, V; Vazquez-Rivera, V; Cress, WD; Wright, G; Bian, H; Hinds, PW; Santiago-Cardona, PG				Sosa-Garcia, Bernadette; Gunduz, Volkan; Vazquez-Rivera, Viviana; Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo; Hinds, Philip W.; Santiago-Cardona, Pedro G.			A Role for the Retinoblastoma Protein As a Regulator of Mouse Osteoblast Cell Adhesion: Implications for Osteogenesis and Osteosarcoma Formation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; E-CADHERIN; TRANSCRIPTIONAL REPRESSION; P35/CDK5 KINASE; METASTASIS; EXPRESSION; MERLIN; DIFFERENTIATION; CANCER; FAMILY	The retinoblastoma protein (pRb) is a cell cycle regulator inactivated in most human cancers. Loss of pRb function results from mutations in the gene coding for pRb or for any of its upstream regulators. Although pRb is predominantly known as a cell cycle repressor, our data point to additional pRb functions in cell adhesion. Our data show that pRb regulates the expression of a wide repertoire of cell adhesion genes and regulates the assembly of the adherens junctions required for cell adhesion. We conducted our studies in osteoblasts, which depend on both pRb and on cell-to-cell contacts for their differentiation and function. We generated knockout mice in which the RB gene was excised specifically in osteoblasts using the cre-lox P system and found that osteoblasts from pRb knockout mice did not assemble adherens junction at their membranes. pRb depletion in wild type osteoblasts using RNAi also disrupted adherens junctions. Microarrays comparing pRb-expressing and pRb-deficient osteoblasts showed that pRb controls the expression of a number of cell adhesion genes, including cadherins. Furthermore, pRb knockout mice showed bone abnormalities consistent with osteoblast adhesion defects. We also found that pRb controls the function of merlin, a well-known regulator of adherens junction assembly, by repressing Rac1 and its effector Pak1. Using qRT-PCR, immunoblots, co-immunoprecipitation assays, and immunofluorescent labeling, we observed that pRb loss resulted in Rac1 and Pak1 overexpression concomitant with merlin inactivation by Pak1, merlin detachment from the membrane, and adherens junction loss. Our data support a pRb function in cell adhesion while elucidating the mechanism for this function. Our work suggests that in some tumor types pRb inactivation results in both a loss of cell cycle control that promotes initial tumor growth as well as in a loss of cell-to-cell contacts, which contributes to later stages of metastasis.	[Sosa-Garcia, Bernadette; Vazquez-Rivera, Viviana; Santiago-Cardona, Pedro G.] Ponce Sch Med, Dept Biochem, Ponce, PR USA; [Gunduz, Volkan; Hinds, Philip W.] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA USA; [Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL USA; [Cress, W. Douglas; Wright, Gabriela; Bian, Haikuo] H Lee Moffitt Canc Ctr & Res Inst, Thorac Oncol Dept, Tampa, FL USA	Tufts Medical Center; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Sosa-Garcia, B (corresponding author), Ponce Sch Med, Dept Biochem, Ponce, PR USA.				Ponce School of Medicine [G12 RR003050]; American Cancer Society [93-032-13]; National Institutes of Health National Cancer Institute (NIH NCI) [U56CA118809]; NIH National Institute of General Medical Sciences (NIGMS) [R25GM082406]; Florida Department of Health [08BB-05]; NCI [P01CA119997, R01CA90489]; NIH/NIA [AG020208]; NATIONAL CANCER INSTITUTE [R01CA090489, P50CA119997, U56CA118809] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM082406] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020208] Funding Source: NIH RePORTER	Ponce School of Medicine; American Cancer Society(American Cancer Society); National Institutes of Health National Cancer Institute (NIH NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Florida Department of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Ponce School of Medicine institutional funds (RCMI Grant G12 RR003050) and American Cancer Society Institutional Research Grant 93-032-13 to PGSC, and National Institutes of Health National Cancer Institute (NIH NCI) Grant U56CA118809 to PGSC and WDC. BSG is supported by NIH National Institute of General Medical Sciences (NIGMS) MBRS-RISE Grant R25GM082406 (the content herein is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS). WDC is further supported by grants 08BB-05 (Florida Department of Health), P01CA119997 (NCI), R01CA90489 (NCI), and the Moffitt Cancer Center. PWH is supported by NIH/NIA grant AG020208. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander K, 2004, MOL CELL BIOL, V24, P2808, DOI 10.1128/MCB.24.7.2808-2819.2004; Arima Y, 2008, CANCER RES, V68, P5104, DOI 10.1158/0008-5472.CAN-07-5680; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; Braga VMM, 2000, MOL BIOL CELL, V11, P3703, DOI 10.1091/mbc.11.11.3703; Brown DM, 2004, CANCER CELL, V5, P365, DOI 10.1016/S1535-6108(04)00079-0; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Chou MM, 1996, CELL, V85, P573, DOI 10.1016/S0092-8674(00)81257-X; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Gutierrez GM, 2008, P NATL ACAD SCI USA, V105, P18402, DOI 10.1073/pnas.0805925105; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; Hahn WC, 2002, NEW ENGL J MED, V347, P1593, DOI 10.1056/NEJMra021902; Hay E, 2000, J CELL PHYSIOL, V183, P117, DOI 10.1002/(SICI)1097-4652(200004)183:1<117::AID-JCP14>3.0.CO;2-#; HYNES RO, 1992, CELL, V68, P303, DOI 10.1016/0092-8674(92)90472-O; Ito T, 2007, CELL BIOL INT, V31, P1518, DOI 10.1016/j.cellbi.2007.06.017; Kashima T, 1999, AM J PATHOL, V155, P1549, DOI 10.1016/S0002-9440(10)65471-5; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Knudsen ES, 2006, EXP BIOL MED, V231, P1271; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lee EK, 2007, BIOINFORMATION, V1, P423, DOI 10.6026/97320630001423; Marie PJ, 2002, J CELL PHYSIOL, V190, P297, DOI 10.1002/jcp.10073; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; Penuela S, 2007, J CELL SCI, V120, P3772, DOI 10.1242/jcs.009514; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; Rodriguez-Salas N, 2001, HISTOL HISTOPATHOL, V16, P353, DOI 10.14670/HH-16.353; Ross JF, 1999, MOL CELL, V3, P195, DOI 10.1016/S1097-2765(00)80310-X; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Shah CA, 2009, CANCER EPIDEM BIOMAR, V18, P1365, DOI 10.1158/1055-9965.EPI-08-1034; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Stains Joseph P, 2005, Birth Defects Res C Embryo Today, V75, P72, DOI 10.1002/bdrc.20034; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Thomas DM, 2003, CANCER BIOL THER, V2, P2; Van Aken EH, 2002, INVEST OPHTH VIS SCI, V43, P595; VANGELDER RN, 1990, P NATL ACAD SCI USA, V87, P1663, DOI 10.1073/pnas.87.5.1663; Wei Y, 2009, CELL CYCLE, V8, P2132; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; WEINTRAUB SJ, 1995, NATURE, V375, P812, DOI 10.1038/375812a0; Wu GJ, 2008, MOL CANCER RES, V6, P1666, DOI 10.1158/1541-7786.MCR-07-2200; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yang HS, 2003, MOL CELL, V11, P1163, DOI 10.1016/S1097-2765(03)00135-7; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; Zabouo G, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2215	52	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13954	10.1371/journal.pone.0013954	http://dx.doi.org/10.1371/journal.pone.0013954			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085651	gold, Green Published, Green Submitted			2022-12-27	WOS:000284087800018
J	Hamelryck, T; Borg, M; Paluszewski, M; Paulsen, J; Frellsen, J; Andreetta, C; Boomsma, W; Bottaro, S; Ferkinghoff-Borg, J				Hamelryck, Thomas; Borg, Mikael; Paluszewski, Martin; Paulsen, Jonas; Frellsen, Jes; Andreetta, Christian; Boomsma, Wouter; Bottaro, Sandro; Ferkinghoff-Borg, Jesper			Potentials of Mean Force for Protein Structure Prediction Vindicated, Formalized and Generalized	PLOS ONE			English	Article							KNOWLEDGE-BASED POTENTIALS; STATISTICAL POTENTIALS; 3-DIMENSIONAL STRUCTURES; STABILITY CHANGES; SCORING FUNCTION; REFERENCE STATE; FOLD; RECOGNITION; MODEL; MECHANICS	Understanding protein structure is of crucial importance in science, medicine and biotechnology. For about two decades, knowledge-based potentials based on pairwise distances - so-called "potentials of mean force'' (PMFs) - have been center stage in the prediction and design of protein structure and the simulation of protein folding. However, the validity, scope and limitations of these potentials are still vigorously debated and disputed, and the optimal choice of the reference state a necessary component of these potentials - is an unsolved problem. PMFs are loosely justified by analogy to the reversible work theorem in statistical physics, or by a statistical argument based on a likelihood function. Both justifications are insightful but leave many questions unanswered. Here, we show for the first time that PMFs can be seen as approximations to quantities that do have a rigorous probabilistic justification: they naturally arise when probability distributions over different features of proteins need to be combined. We call these quantities "reference ratio distributions'' deriving from the application of the "reference ratio method.'' This new view is not only of theoretical relevance but leads to many insights that are of direct practical use: the reference state is uniquely defined and does not require external physical insights; the approach can be generalized beyond pairwise distances to arbitrary features of protein structure; and it becomes clear for which purposes the use of these quantities is justified. We illustrate these insights with two applications, involving the radius of gyration and hydrogen bonding. In the latter case, we also show how the reference ratio method can be iteratively applied to sculpt an energy funnel. Our results considerably increase the understanding and scope of energy functions derived from known biomolecular structures.	[Hamelryck, Thomas; Borg, Mikael; Paluszewski, Martin; Paulsen, Jonas; Frellsen, Jes; Andreetta, Christian] Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark; [Boomsma, Wouter; Bottaro, Sandro; Ferkinghoff-Borg, Jesper] Tech Univ Denmark, Tech Univ Denmark DTU Elektro, DK-2800 Lyngby, Denmark; [Boomsma, Wouter] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England	University of Copenhagen; Technical University of Denmark; University of Cambridge	Hamelryck, T (corresponding author), Univ Copenhagen, Dept Biol, Bioinformat Ctr, Copenhagen, Denmark.	thamelry@binf.ku.dk; jfb@elektro.dtu.dk	Boomsma, Wouter/K-2903-2014; Bottaro, Sandro/H-5486-2013; Hamelryck, Thomas/A-3923-2012; Frellsen, Jes/K-4337-2014	Boomsma, Wouter/0000-0002-8257-3827; Bottaro, Sandro/0000-0003-1606-890X; Hamelryck, Thomas/0000-0003-2917-3602; Frellsen, Jes/0000-0001-9224-1271; Borg, Mikael/0000-0002-0646-4231	Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT) [2106-06-0009]; Danish Research Council for Technology and Production Sciences (FTP) [274-09-0184]; Danish Council for Independent Research (FNU) [272-08-0315]	Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT); Danish Research Council for Technology and Production Sciences (FTP); Danish Council for Independent Research (FNU)(Det Frie Forskningsrad (DFF)Danish Natural Science Research Council)	The authors acknowledge funding by the Danish Program Commission on Nanoscience, Biotechnology and IT (NaBiIT, project: Simulating proteins on a millisecond time-scale, 2106-06-0009), the Danish Research Council for Technology and Production Sciences (FTP, project: Protein structure ensembles from mathematical models, 274-09-0184) and the Danish Council for Independent Research (FNU, project: A Bayesian approach to protein structure determination, 272-08-0315). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BenNaim A, 1997, J CHEM PHYS, V107, P3698, DOI 10.1063/1.474725; Bernard B, 2009, PROTEINS, V76, P115, DOI 10.1002/prot.22323; Boomsma W, 2008, P NATL ACAD SCI USA, V105, P8932, DOI 10.1073/pnas.0801715105; Borg M., 2009, LASR2009 STAT TOOLS, P65; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Bowman GR, 2009, PROTEINS, V74, P777, DOI 10.1002/prot.22210; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Buchete NV, 2004, CURR OPIN STRUC BIOL, V14, P225, DOI 10.1016/j.sbi.2004.03.002; Chandler D, 2005, NATURE, V437, P640, DOI 10.1038/nature04162; Chandler D., 1987, INTRO MODERN STAT ME; Cheng J, 2007, BIOPHYS J, V92, P3868, DOI 10.1529/biophysj.106.102152; Colubri A, 2006, J MOL BIOL, V363, P835, DOI 10.1016/j.jmb.2006.08.035; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806; Fain B, 2003, P NATL ACAD SCI USA, V100, P10700, DOI 10.1073/pnas.1732312100; Ferkinghoff-Borg J, 2002, EUR PHYS J B, V29, P481, DOI 10.1140/epjb/e2002-00328-1; FINKELSTEIN AV, 1995, PROTEINS, V23, P142, DOI 10.1002/prot.340230204; Gilis D, 2000, PROTEIN ENG, V13, P849, DOI 10.1093/protein/13.12.849; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Gilks WR, 1996, MARKOV CHAIN MONTE C; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Hamelryck T, 2006, PLOS COMPUT BIOL, V2, P1121, DOI 10.1371/journal.pcbi.0020131; Hamelryck T, 2009, STAT METHODS MED RES, V18, P505, DOI 10.1177/0962280208099492; HESSELBO B, 1995, PHYS REV LETT, V74, P2151, DOI 10.1103/PhysRevLett.74.2151; Huang SY, 2006, J COMPUT CHEM, V27, P1866, DOI 10.1002/jcc.20504; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; Kirtay CK, 2005, QSAR COMB SCI, V24, P527, DOI 10.1002/qsar.200430926; KOCHER JPA, 1994, J MOL BIOL, V235, P1598, DOI 10.1006/jmbi.1994.1109; Koppensteiner WA, 1998, BIOCHEMISTRY-MOSCOW+, V63, P247; KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694; Lazaridis T, 2000, CURR OPIN STRUC BIOL, V10, P139, DOI 10.1016/S0959-440X(00)00063-4; LEOPOLD PE, 1992, P NATL ACAD SCI USA, V89, P8721, DOI 10.1073/pnas.89.18.8721; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Majek P, 2009, PROTEINS, V76, P822, DOI 10.1002/prot.22388; McQuarrie DA, 2000, STAT MECH; Miyazawa S, 1999, PROTEINS, V36, P357, DOI 10.1002/(SICI)1097-0134(19990815)36:3<357::AID-PROT10>3.3.CO;2-L; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Moult J, 1997, CURR OPIN STRUC BIOL, V7, P194, DOI 10.1016/S0959-440X(97)80025-5; Muegge I, 2006, J MED CHEM, V49, P5895, DOI 10.1021/jm050038s; PEARL J, 1988, PROBABILISTIC REASON, P108; Reith D, 2003, J COMPUT CHEM, V24, P1624, DOI 10.1002/jcc.10307; ROOMAN MJ, 1991, J MOL BIOL, V221, P961, DOI 10.1016/0022-2836(91)80186-X; Rooman MJ, 1995, PROTEIN ENG, V8, P849, DOI 10.1093/protein/8.9.849; Rykunov D, 2007, PROTEINS, V67, P559, DOI 10.1002/prot.21279; Rykunov D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-128; Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; Shmygelska A, 2009, P NATL ACAD SCI USA, V106, P1415, DOI 10.1073/pnas.0812510106; Shortle D, 2003, PROTEIN SCI, V12, P1298, DOI 10.1110/ps.0306903; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; Simons KT, 1999, PROTEINS, V34, P82, DOI 10.1002/(SICI)1097-0134(19990101)34:1<82::AID-PROT7>3.0.CO;2-A; Sippl MJ, 1996, FOLD DES, V1, P289, DOI 10.1016/S1359-0278(96)00042-9; SIPPL MJ, 1992, PROTEIN SCI, V1, P625, DOI 10.1002/pro.5560010509; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4; Su Y, 2009, PROTEIN SCI, V18, P2550, DOI 10.1002/pro.257; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Thomas PD, 1996, J MOL BIOL, V257, P457, DOI 10.1006/jmbi.1996.0175; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Zhang C, 2004, PROTEIN SCI, V13, P400, DOI 10.1110/ps.03348304; Zhao F, 2010, J COMPUT BIOL, V17, P783, DOI 10.1089/cmb.2009.0235; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	64	48	49	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13714	10.1371/journal.pone.0013714	http://dx.doi.org/10.1371/journal.pone.0013714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21103041	Green Submitted, Green Published, gold			2022-12-27	WOS:000284036800006
J	Larsen, DA; Keating, J; Miller, J; Bennett, A; Changufu, C; Katebe, C; Eisele, TP				Larsen, David A.; Keating, Joseph; Miller, John; Bennett, Adam; Changufu, Cynthia; Katebe, Cecilia; Eisele, Thomas P.			Barriers to Insecticide-Treated Mosquito Net Possession 2 Years after a Mass Free Distribution Campaign in Luangwa District, Zambia	PLOS ONE			English	Article							MALARIA CONTROL	Background and Methods: Roll Back Malaria set the goal of 100% of households in malaria endemic countries in Africa owning an insecticide-treated mosquito net (ITN) by 2010. Zambia has used mass free distribution campaigns and distribution through antenatal care (ANC) clinics to achieve high coverage. Methodology and Principal Findings: We conducted a probability survey of 801 households in 2008 to assess factors associated with households that lacked an ITN after mass distribution. Community perceptions of barriers to ITN access were also obtained from in-depth interviews with household heads that reported not owning an ITN. Nearly 74% of households in Luangwa district reported owning >= 1 ITN. Logistic regression showed households without a child,5 years old during the ITN distribution campaigns were twice as likely to not have an ITN as those with a child,5 during distribution (Adjusted odds ratio (AOR) = 2.43; 95% confidence interval (CI): 1.67-3.55). Households without a woman who attended an ANC in the past 2 years were more likely to be without ITNs compared to households with a woman who attended an ANC in the past 2 years (AOR = 1.52; 95% CI: 1.04-2.21). In-depth interviews with heads of households without an ITN revealed that old age was a perceived barrier to receiving an ITN during distribution, and that ITNs wore out before they could be replaced. Conclusions and Significance: Delivery of a large number of ITNs does not translate directly into 100% household coverage. Due to their design, current ITN distribution strategies may miss households occupied by the elderly and those without children or ANC access. ITN distribution strategies targeting the elderly, those with limited access to distribution points, and others most likely to be missed are necessary if 100% ITN coverage of households is to be achieved.	[Larsen, David A.; Keating, Joseph; Miller, John; Bennett, Adam; Eisele, Thomas P.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA; [Miller, John] Malaria Control & Evaluat Partnership Africa MACE, PATH, Lusaka, Zambia; [Changufu, Cynthia] Soc Family Hlth, Lusaka, Zambia; [Katebe, Cecilia] Minist Hlth, Lusaka, Zambia	Tulane University	Larsen, DA (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Int Hlth & Dev, New Orleans, LA 70118 USA.	teisele@tulane.edu	Larsen, David/D-4027-2016; Eisele, Thom/AAE-8958-2020	Larsen, David/0000-0002-1876-6536; 	Centers for Disease Control and Prevention (CDC) [1R18CK000102-01]	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was funded by a grant to TPE by the Centers for Disease Control and Prevention (CDC) (1R18CK000102-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MAL CHILDR PROGR INT; [Anonymous], 2004, COCHRANE DB SYST REV; [Anonymous], 2009, WORLD MAL REP 2009; [Anonymous], 2005, MMWR MORB MORTAL WKL, V54, P994; Brentlinger PE, 2007, HEALTH POLICY PLANN, V22, P103, DOI 10.1093/heapol/czm002; Chuma J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-137; Eisele TP, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b1598; Grabowsky M, 2005, TROP MED INT HEALTH, V10, P1151, DOI 10.1111/j.1365-3156.2005.01502.x; Keating J, 2009, ACTA TROP, V112, P277, DOI 10.1016/j.actatropica.2009.08.011; Kilian A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-49; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; Lengeler C, 2007, AM J TROP MED HYG, V77, P222, DOI 10.4269/ajtmh.2007.77.222; Lindblade KA, 2005, TROP MED INT HEALTH, V10, P1141, DOI 10.1111/j.1365-3156.2005.01501.x; Macintyre K, 2006, TROP MED INT HEALTH, V11, P824, DOI 10.1111/j.1365-3156.2006.01637.x; Matovu F, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-109; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; RBM Partnership, 2008, GLOB MAL ACT PLAN MA; Rutstein S. O., 2004, DHS WEALTH INDEX; Steketee RW, 2008, AM J TROP MED HYG, V79, P45, DOI 10.4269/ajtmh.2008.79.45; Steketee RW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008409; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; *UNICEF, 2008, WORLD MAL DAY NEW GO; Webster J, 2007, HEALTH POLICY PLANN, V22, P277, DOI 10.1093/heapol/czm021	23	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13129	10.1371/journal.pone.0013129	http://dx.doi.org/10.1371/journal.pone.0013129			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085711	gold, Green Published			2022-12-27	WOS:000284036800002
J	McLaughlin, RL; Phukan, J; McCormack, W; Lynch, DS; Greenway, M; Cronin, S; Saunders, J; Slowik, A; Tomik, B; Andersen, PM; Bradley, DG; Jakeman, P; Hardiman, O				McLaughlin, Russell Lewis; Phukan, Julie; McCormack, William; Lynch, David S.; Greenway, Matthew; Cronin, Simon; Saunders, Jean; Slowik, Agnieska; Tomik, Barbara; Andersen, Peter M.; Bradley, Daniel G.; Jakeman, Phil; Hardiman, Orla			Angiogenin Levels and ANG Genotypes: Dysregulation in Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; SPORADIC ALS; GENOME; MUTATIONS; VEGF; ASSOCIATION; POPULATION; SERUM	Objective: To determine whether 5 single nucleotide polymorphisms (SNPs) associate with ALS in 3 different populations. We also assessed the contribution of genotype to angiogenin levels in plasma and CSF. Methods: Allelic association statistics were calculated for polymorphisms in the ANG gene in 859 patients and 1047 controls from Sweden, Ireland and Poland. Plasma, serum and CSF angiogenin levels were quantified and stratified according to genotypes across the ANG gene. The contribution of SNP genotypes to variance in circulating angiogenin levels was estimated in patients and controls. Results: All SNPs showed association with ALS in the Irish group. The SNP rs17114699 replicated in the Swedish cohort. No SNP associated in the Polish cohort. Age-and sex-corrected circulating angiogenin levels were significantly lower in patients than in controls (p<0.001). An allele dose-dependent regulation of angiogenin levels was observed in controls. This regulation was attenuated in the ALS cohort. A significant positive correlation between CSF plasma angiogenin levels was present in controls and abolished in ALS. Conclusions: ANG variants associate with ALS in the Irish and Swedish populations, but not in the Polish. There is evidence of dysregulation of angiogenin expression in plasma and CSF in sporadic ALS. Angiogenin expression is likely to be important in the pathogenesis of ALS.	[McLaughlin, Russell Lewis; Bradley, Daniel G.] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [McLaughlin, Russell Lewis; Phukan, Julie; Lynch, David S.; Cronin, Simon; Hardiman, Orla] Beaumont Hosp, Dept Neurol, Dublin 9, Ireland; [Phukan, Julie; Hardiman, Orla] Trinity Coll Dublin, Trinity Coll Inst Neurosci, Dublin, Ireland; [McCormack, William; Jakeman, Phil] Univ Limerick, Fac Educ & Hlth Sci, Human Sci Res Unit, Limerick, Ireland; [Lynch, David S.; Greenway, Matthew; Cronin, Simon] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Saunders, Jean] Univ Limerick, Stat Consulting Unit, Limerick, Ireland; [Slowik, Agnieska; Tomik, Barbara] Jagiellonian Univ, Dept Neurol, Krakow, Poland; [Andersen, Peter M.] Umea Univ Hosp, Dept Pharmacol & Clin Neurosci, S-90185 Umea, Sweden	Trinity College Dublin; Trinity College Dublin; University of Limerick; Royal College of Surgeons - Ireland; University of Limerick; Jagiellonian University; Umea University	McLaughlin, RL (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland.	mclaugr@tcd.ie	Hardiman, Orla/Y-3441-2019; Bradley, Daniel G/A-3240-2012; Jakeman, Philip/C-2308-2008	Hardiman, Orla/0000-0003-2610-1291; Jakeman, Philip/0000-0002-1199-080X; McCormack, William/0000-0002-8051-6853; McLaughlin, Russell/0000-0003-3915-2135; Bradley, Daniel G/0000-0001-7335-7092	Irish Health Research Board [HRB CSA 2007/3]; Irish Motor Neurone Disease Research Foundation [IMNDRF 07/01]; Muscular Dystrophy Association (United States of America) [2007/4252]	Irish Health Research Board; Irish Motor Neurone Disease Research Foundation; Muscular Dystrophy Association (United States of America)(Muscular Dystrophy Association)	This work was supported by the Irish Health Research Board (grant number HRB CSA 2007/3); the Irish Motor Neurone Disease Research Foundation (grant number IMNDRF 07/01) and the Muscular Dystrophy Association (United States of America, grant number 2007/4252). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, R LANG ENV STAT COMP; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Cronin S, 2006, NEUROLOGY, V67, P1833, DOI 10.1212/01.wnl.0000244466.46020.47; Cronin S, 2009, EUR J HUM GENET, V17, P213, DOI 10.1038/ejhg.2008.194; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Devos D, 2004, NEUROLOGY, V62, P2127, DOI 10.1212/01.WNL.0000129913.44351.A3; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Greenway MJ, 2006, NAT GENET, V38, P411, DOI 10.1038/ng1742; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Ilzecka J, 2004, CLIN NEUROL NEUROSUR, V106, P289, DOI 10.1016/j.clineuro.2003.12.007; Lambrechts D, 2003, NAT GENET, V34, P383, DOI 10.1038/ng1211; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Nygren I, 2002, NEUROREPORT, V13, P2199, DOI 10.1097/00001756-200212030-00007; Oosthuyse B, 2001, NAT GENET, V28, P131, DOI 10.1038/88842; Pantsulaia I, 2006, CLIN ENDOCRINOL, V64, P271, DOI 10.1111/j.1365-2265.2006.02456.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rosenstein JM, 2004, EXP NEUROL, V187, P246, DOI 10.1016/j.expneurol.2004.01.022; Strong MJ, 2008, AMYOTROPH LATERAL SC, V9, P323, DOI 10.1080/17482960802372371; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221	25	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15402	10.1371/journal.pone.0015402	http://dx.doi.org/10.1371/journal.pone.0015402			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085671	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800027
J	Wang, CL; Lower, S; Thomas, VP; Williamson, VM				Wang, Congli; Lower, Steven; Thomas, Varghese P.; Williamson, Valerie M.			Root-Knot Nematodes Exhibit Strain-Specific Clumping Behavior That Is Inherited as a Simple Genetic Trait	PLOS ONE			English	Article							C-ELEGANS; CAENORHABDITIS-ELEGANS; MELOIDOGYNE-HAPLA; NATURAL VARIATION; SOCIAL-BEHAVIOR; CYANIDE; GENOME; SUPPRESSION; ATTRACTION; SEQUENCE	Root-knot nematodes are obligate parasites of a wide range of plant species and can feed only on the cytoplasm of living plant cells. In the absence of a suitable plant host, infective juveniles of strain VW9 of the Northern root-knot nematode, Meloidogyne hapla, when dispersed in Pluronic F-127 gel, aggregate into tight, spherical clumps containing thousands of worms. Aggregation or clumping behavior has been observed in diverse genera in the phylum Nematoda spanning free-living species such as Caenorhabditis elegans as well as both plant and animal parasites. Clumping behavior differs between strains of M. hapla and occurs with other species within this genus where strain-specific differences in clumping ability are also apparent. Exposure of M. hapla juveniles to a gradient formed using low levels of cyanide promotes formation of clumps at a preferred cyanide level. Analysis of F2 lines from a cross of M. hapla strains that differ in clump-forming behavior reveals that the behavior segregates as a single, major locus that can be positioned on the genetic map of this nematode. Clumping behavior may be a survival strategy whose importance and function depend on the niche of the nematode strain or species.	[Wang, Congli; Lower, Steven; Thomas, Varghese P.; Williamson, Valerie M.] Univ Calif Davis, Dept Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Wang, CL (corresponding author), Univ Calif Davis, Dept Nematol, Davis, CA 95616 USA.	vmwilliamson@ucdavis.edu			National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service [566000756]; National Science Foundation Division of Environmental Biology [DEB-0120169]; National Science Foundation [IOB-07-44857]	National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Science Foundation Division of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); National Science Foundation(National Science Foundation (NSF))	This research was supported by the National Research Initiative of the United States Department of Agriculture Cooperative State Research, Education, and Extension Service (grant number 566000756), the National Science Foundation Division of Environmental Biology (grant number DEB-0120169), and the National Science Foundation award IOB-07-44857. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad P, 2008, NAT BIOTECHNOL, V26, P909, DOI 10.1038/nbt.1482; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Blumer C, 2000, ARCH MICROBIOL, V173, P170, DOI 10.1007/s002039900127; Chang AJ, 2006, PLOS BIOL, V4, P1588, DOI 10.1371/journal.pbio.0040274; Croll N.A., 1970, BEHAV NEMATODES THEI; CROWE JH, 1975, J EXP ZOOL, V193, P323, DOI 10.1002/jez.1401930308; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001; Gheysen G, 1998, RECENT ADV PHYTOCHEM, V32, P95; Gloria-Soria A, 2008, CURR BIOL, V18, P1694, DOI 10.1016/j.cub.2008.09.043; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Liu QL, 2006, J NEMATOL, V38, P158; Liu QLL, 2007, GENETICS, V176, P1483, DOI 10.1534/genetics.107.071134; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Moens M, 2009, ANNU REV PHYTOPATHOL, V47, P313, DOI 10.1146/annurev-phyto-080508-081846; O'Leary SA, 2001, BIOCONTROL, V46, P345, DOI 10.1023/A:1011470021857; Opperman CH, 2008, P NATL ACAD SCI USA, V105, P14802, DOI 10.1073/pnas.0805946105; Park S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002550; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; POULTON JE, 1990, PLANT PHYSIOL, V94, P401, DOI 10.1104/pp.94.2.401; ROBERTS TM, 1977, J PARASITOL, V63, P357, DOI 10.2307/3280078; ROBINSON AF, 1994, J NEMATOL, V26, P46; Rosso MN, 2009, ANNU REV PHYTOPATHOL, V47, P207, DOI 10.1146/annurev.phyto.112408.132605; Siddiqui IA, 2006, WORLD J MICROB BIOT, V22, P641, DOI 10.1007/s11274-005-9084-2; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Wang CL, 2009, J CHEM ECOL, V35, P1242, DOI 10.1007/s10886-009-9703-8; Wang CL, 2009, NEMATOLOGY, V11, P453, DOI 10.1163/156854109X447024; Wharton David A., 2004, P371, DOI 10.1079/9780851998183.0371; Widmer TL, 2002, J NEMATOL, V34, P16; Williamson VM, 2003, CURR OPIN PLANT BIOL, V6, P327, DOI 10.1016/S1369-5266(03)00059-1; Zimmer M, 2009, NEURON, V61, P865, DOI 10.1016/j.neuron.2009.02.013	31	12	13	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15148	10.1371/journal.pone.0015148	http://dx.doi.org/10.1371/journal.pone.0015148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151553	Green Submitted, gold, Green Published			2022-12-27	WOS:000285135800016
J	Chen, ZJ; Chen, AY; Cheng, F; Qiu, JM				Chen, Zhaojun; Chen, Aaron Yun; Cheng, Fang; Qiu, Jianming			Chipmunk Parvovirus Is Distinct from Members in the Genus Erythrovirus of the Family Parvoviridae	PLOS ONE			English	Article							TRANSCRIPTION PROFILE; SIMIAN PARVOVIRUS; AUTONOMOUS PARVOVIRUS; UNIQUE FEATURES; MINUTE VIRUS; PROTEIN; IDENTIFICATION; APOPTOSIS; REVEALS; CELLS	The transcription profile of chipmunk parvovirus (ChpPV), a tentative member of the genus Erythrovirus in the subfamily Parvovirinae of the family Parvoviridae, was characterized by transfecting a nearly full-length genome. We found that it is unique from the profiles of human parvovirus B19 and simian parvovirus, the members in the genus Erythrovirus so far characterized, in that the small RNA transcripts were not processed for encoding small non-structural proteins. However, like the large non-structural protein NS1 of the human parvovirus B19, the ChpPV NS1 is a potent inducer of apoptosis. Further phylogenetic analysis of ChpPV with other parvoviruses in the subfamily Parvovirinae indicates that ChpPV is distinct from the members in genus Erythrovirus. Thus, we conclude that ChpPV may represent a new genus in the family Parvoviridae.	[Chen, Zhaojun] Hangzhou Normal Univ, Dept Clin Lab, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China; [Chen, Zhaojun; Chen, Aaron Yun; Cheng, Fang; Qiu, Jianming] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	Hangzhou Normal University; University of Kansas; University of Kansas Medical Center	Chen, ZJ (corresponding author), Hangzhou Normal Univ, Dept Clin Lab, Affiliated Hosp, Hangzhou, Zhejiang, Peoples R China.	jqiu@kumc.edu			National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI070723]; National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE) [P20 RR016443]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016443] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070723] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by PHS grant RO1 AI070723 from National Institute of Allergy and Infectious Diseases (NIAID) and grant P20 RR016443 from the National Center for Research Resources (NCRR) Centers of Biomedical Research Excellence (COBRE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allander T, 2001, P NATL ACAD SCI USA, V98, P11609, DOI 10.1073/pnas.211424698; BEARD C, 1989, VIROLOGY, V172, P659, DOI 10.1016/0042-6822(89)90211-0; BRANDENBURGER A, 1990, VIROLOGY, V174, P576, DOI 10.1016/0042-6822(90)90110-D; BROWN KE, 1995, VIROLOGY, V210, P314, DOI 10.1006/viro.1995.1348; Brown KE., 2005, PARVOVIRUSES, P25; Chen AY, 2010, J VIROL, V84, P5615, DOI 10.1128/JVI.02094-09; Chen AY, 2010, BLOOD, V115, P1070, DOI 10.1182/blood-2009-04-215756; Chen ZJ, 2009, VIROLOGY, V394, P276, DOI 10.1016/j.virol.2009.08.044; COTMORE SF, 1983, VIROLOGY, V129, P333, DOI 10.1016/0042-6822(83)90172-1; Cotmore SF, 2005, PARVOVIRUSES, P73; Cotmore SF, 2005, PARVOVIRUSES, P171; Di Piazza M, 2007, J VIROL, V81, P4186, DOI 10.1128/JVI.02601-06; FAUQUET CM, 2004, VIRUS TAXONOMY 8 REP; Green SW, 2000, VIROLOGY, V269, P105, DOI 10.1006/viro.2000.0215; Guan WX, 2008, J VIROL, V82, P9951, DOI 10.1128/JVI.01162-08; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Liu ZW, 2004, J VIROL, V78, P12929, DOI 10.1128/JVI.78.23.12929-12939.2004; LUO WX, 1993, VIROLOGY, V195, P448, DOI 10.1006/viro.1993.1395; Moffatt S, 1998, J VIROL, V72, P3018, DOI 10.1128/JVI.72.4.3018-3028.1998; Morita E, 2001, J VIROL, V75, P7555, DOI 10.1128/JVI.75.16.7555-7563.2001; NAEGER LK, 1992, GENE DEV, V6, P1107, DOI 10.1101/gad.6.6.1107; OZAWA K, 1987, J VIROL, V61, P2395, DOI 10.1128/JVI.61.8.2395-2406.1987; PINTEL D, 1983, NUCLEIC ACIDS RES, V11, P1019, DOI 10.1093/nar/11.4.1019; Qiu JM, 2006, J VIROL, V80, P654, DOI 10.1128/JVI.80.2.654-662.2006; Qiu JM, 2000, VIROLOGY, V269, P137, DOI 10.1006/viro.2000.0205; Qiu JM, 2002, MOL CELL BIOL, V22, P3639, DOI 10.1128/MCB.22.11.3639-3652.2002; Qiu JM, 2002, J VIROL, V76, P12435, DOI 10.1128/JVI.76.24.12435-12447.2002; Rayet B, 1998, J VIROL, V72, P8893, DOI 10.1128/JVI.72.11.8893-8903.1998; SCHOBORG RV, 1991, VIROLOGY, V181, P22, DOI 10.1016/0042-6822(91)90466-O; Sol N, 1999, J VIROL, V73, P8762, DOI 10.1128/JVI.73.10.8762-8770.1999; ST AJ, 1991, VIROLOGY, V183, P133; Sun YN, 2009, J VIROL, V83, P3956, DOI 10.1128/JVI.02569-08; Vashisht K, 2004, J VIROL, V78, P10911, DOI 10.1128/JVI.78.20.10911-10919.2004; Yoo BC, 1999, VIROLOGY, V253, P250, DOI 10.1006/viro.1998.9518; Yoto Y, 2006, J VIROL, V80, P1604, DOI 10.1128/JVI.80.3.1604-1609.2006	35	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15113	10.1371/journal.pone.0015113	http://dx.doi.org/10.1371/journal.pone.0015113			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151930	Green Published, gold			2022-12-27	WOS:000284939600027
J	Nelson, CD; Reinhardt, TA; Beitz, DC; Lippolis, JD				Nelson, Corwin D.; Reinhardt, Timothy A.; Beitz, Donald C.; Lippolis, John D.			In Vivo Activation of the Intracrine Vitamin D Pathway in Innate Immune Cells and Mammary Tissue during a Bacterial Infection	PLOS ONE			English	Article							1-ALPHA,25-DIHYDROXYVITAMIN D-3; INTRAMAMMARY INFECTION; BOVINE-MILK; MASTITIS; TUBERCULOSIS; HYDROXYLASE; METABOLITES; MONOCYTES; HEALTH; FARMS	In Numerous in vitro studies have shown that toll-like receptor signaling induces 25-hydroxyvitamin D-3 1 alpha-hydroxylase (1 alpha-OHase; CYP27B1) expression in macrophages from various species. 1 alpha-OHase is the primary enzyme that converts 25-hydroxyvitamin D-3 to 1,25-dihydroxyvitamin D-3 (1,25(OH) D-2(3)). Subsequently, synthesis of 1,25(OH)(2)D-3 by 1 alpha-OHase in macrophages has been shown to modulate innate immune responses of macrophages. Despite the numerous in vitro studies that have shown 1 alpha-OHase expression is induced in macrophages, however, evidence that 1 alpha-OHase expression is induced by pathogens in vivo is limited. The objective of this study was to evaluate 1 alpha-OHase gene expression in macrophages and mammary tissue during an in vivo bacterial infection with Streptococcus uberis. In tissue and secreted cells from the infected mammary glands, 1 alpha-OHase gene expression was significantly increased compared to expression in tissue and cells from the healthy mammary tissue. Separation of the cells by FACS9 revealed that 1 alpha-OHase was predominantly expressed in the CD14(+) cells isolated from the infected mammary tissue. The 24-hydroxylase gene, a gene that is highly upregulated by 1,25(OH)(2)D-3, was significantly more expressed in tissue and cells from the infected mammary tissue than from the healthy uninfected mammary tissue thus indicating significant local 1,25(OH)(2)D-3 production at the infection site. In conclusion, this study provides the first in vivo evidence that 1 alpha-OHase expression is upregulated in macrophages in response to bacterial infection and that 1 alpha-OHase at the site of infection provides 1,25(OH)(2)D-3 for local regulation of vitamin D responsive genes.	[Nelson, Corwin D.; Reinhardt, Timothy A.; Lippolis, John D.] ARS, Dis & Immunol Res Unit, Natl Anim Dis Ctr, USDA, Ames, IA USA; [Nelson, Corwin D.; Beitz, Donald C.] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA USA; [Beitz, Donald C.] Iowa State Univ, Dept Anim Sci, Ames, IA USA	United States Department of Agriculture (USDA); Iowa State University; Iowa State University	Nelson, CD (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	john.lippolis@ars.usda.gov	Reinhardt, Timothy/A-7536-2009	Reinhardt, Timothy/0000-0001-5552-2509; Nelson, Corwin/0000-0003-0195-5610; Lippolis, John/0000-0003-2314-4384	USDA	USDA(United States Department of Agriculture (USDA))	Research was conducted at a USDA research facility and all funding was internal USDA research dollars. This project is an intramural project of the U. S. Department of Agriculture, Agricultural Research Service, National Animal Disease Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Bannerman DD, 2004, VET RES, V35, P681, DOI 10.1051/vetres:2004040; Brodersen R, 1998, VET IMMUNOL IMMUNOP, V64, P1, DOI 10.1016/S0165-2427(98)00117-2; Bruce D, 2010, EXP BIOL MED, V235, P921, DOI 10.1258/ebm.2010.010061; De Schepper S, 2008, VET RES, V39, DOI 10.1051/vetres:2007044; DELUCA HF, 1975, AM J MED, V58, P39, DOI 10.1016/0002-9343(75)90531-8; Endsley JJ, 2009, VET IMMUNOL IMMUNOP, V128, P199, DOI 10.1016/j.vetimm.2008.10.312; ENGSTROM GW, 1987, J DAIRY SCI, V70, P2266, DOI 10.3168/jds.S0022-0302(87)80286-2; Hewison M, 2007, J STEROID BIOCHEM, V103, P316, DOI 10.1016/j.jsbmb.2006.12.078; Hewison M, 2010, MOL CELL ENDOCRINOL, V321, P103, DOI 10.1016/j.mce.2010.02.013; Hogan J, 2003, VET RES, V34, P507, DOI 10.1051/vetres:2003022; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Hollis BW, 2005, J NUTR, V135, P317, DOI 10.1093/jn/135.2.317; HOLLIS BW, 1981, J NUTR, V111, P1240, DOI 10.1093/jn/111.7.1240; Horst RL, 2005, J MAMMARY GLAND BIOL, V10, P141, DOI 10.1007/s10911-005-5397-x; HORST RL, 1983, J DAIRY SCI, V66, P661, DOI 10.3168/jds.S0022-0302(83)81844-X; Horst RL, 2003, ACTA VET SCAND, P35; Krutzik SR, 2008, J IMMUNOL, V181, P7115, DOI 10.4049/jimmunol.181.10.7115; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MCDERMOTT CM, 1985, J DAIRY SCI, V68, P1959, DOI 10.3168/jds.S0022-0302(85)81057-2; Montoya D, 2009, CELL HOST MICROBE, V6, P343, DOI 10.1016/j.chom.2009.09.002; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Nelson CD, 2010, J DAIRY SCI, V93, P1041, DOI 10.3168/jds.2009-2663; Petrovski KR, 2009, NEW ZEAL VET J, V57, P109, DOI 10.1080/00480169.2009.36887; Reinhardt TA, 1999, ARCH BIOCHEM BIOPHYS, V368, P244, DOI 10.1006/abbi.1999.1335; Reinhardt TA, 2006, J DAIRY RES, V73, P406, DOI 10.1017/S0022029906001889; Riekerink RGMO, 2008, J DAIRY SCI, V91, P1366, DOI 10.3168/jds.2007-0757; Riollet C, 2000, ADV EXP MED BIOL, V480, P247; Sampimon O, 2009, J DAIRY RES, V76, P129, DOI 10.1017/S0022029908003762; Stoffels K, 2007, J STEROID BIOCHEM, V103, P567, DOI 10.1016/j.jsbmb.2006.12.091; Stoffels K, 2006, J BONE MINER RES, V21, P37, DOI 10.1359/JBMR.050908; Vaisanen S, 2005, J MOL BIOL, V350, P65, DOI 10.1016/j.jmb.2005.04.057; Van Rhijn I, 2008, MICROBES INFECT, V10, P711, DOI 10.1016/j.micinf.2008.04.005; Wagner CL, 2008, BREASTFEED MED, V3, P239, DOI 10.1089/bfm.2008.9984	35	45	46	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15469	10.1371/journal.pone.0015469	http://dx.doi.org/10.1371/journal.pone.0015469			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124742	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500041
J	Kromrey, S; Maestri, M; Hauffen, K; Bart, E; Hegde, J				Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Bart, Evgeniy; Hegde, Jay			Fragment-Based Learning of Visual Object Categories in Non-Human Primates	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; NEURAL REPRESENTATION; AREA V2; ACUITY; RECOGNITION; INFORMATION; CORTEX; PERCEPTION; FEATURES; MONKEYS	When we perceive a visual object, we implicitly or explicitly associate it with an object category we know. Recent research has shown that the visual system can use local, informative image fragments of a given object, rather than the whole object, to classify it into a familiar category. We have previously reported, using human psychophysical studies, that when subjects learn new object categories using whole objects, they incidentally learn informative fragments, even when not required to do so. However, the neuronal mechanisms by which we acquire and use informative fragments, as well as category knowledge itself, have remained unclear. Here we describe the methods by which we adapted the relevant human psychophysical methods to awake, behaving monkeys and replicated key previous psychophysical results. This establishes awake, behaving monkeys as a useful system for future neurophysiological studies not only of informative fragments in particular, but also of object categorization and category learning in general.	[Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Hegde, Jay] Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA; [Kromrey, Sarah; Maestri, Matthew; Hauffen, Karin; Hegde, Jay] Med Coll Georgia, Vis Discovery Inst, Augusta, GA 30912 USA; [Bart, Evgeniy] Palo Alto Res Ctr PARC, Intelligent Syst Lab, Palo Alto, CA USA; [Hegde, Jay] Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Kromrey, S (corresponding author), Med Coll Georgia, Brain & Behav Discovery Inst, Augusta, GA 30912 USA.	jay@hegde.us						Anstis S, 1998, PERCEPTION, V27, P817, DOI 10.1068/p270817; ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Ashby EG, 2005, ANNU REV PSYCHOL, V56, P149, DOI 10.1146/annurev.psych.56.091103.070217; BART E, 2008, COSYNE, P121; Bart E, 2008, IEEE T PATTERN ANAL, V30, P1618, DOI 10.1109/TPAMI.2007.70818; Brady MJ, 2003, J VISION, V3, P413, DOI 10.1167/3.6.2; COHEN C, 2005, HDB CATEGORIZATION C; COWEY A, 1974, EXP BRAIN RES, V21, P447; DANIEL PM, 1961, J PHYSIOL-LONDON, V159, P203, DOI 10.1113/jphysiol.1961.sp006803; DRASDO N, 1989, VISION RES, V29, P985, DOI 10.1016/0042-6989(89)90113-2; DRASDO N, 1977, NATURE, V266, P554, DOI 10.1038/266554a0; Duda R.O., 2006, PATTERN CLASSIFICATI; Freedman DJ, 2008, NEUROSCI BIOBEHAV R, V32, P311, DOI 10.1016/j.neubiorev.2007.07.011; Freedman DJ, 2006, NATURE, V443, P85, DOI 10.1038/nature05078; Gauthier I, 1998, VISION RES, V38, P2401, DOI 10.1016/S0042-6989(97)00442-2; Grether WF, 1941, J COMP PSYCHOL, V31, P23, DOI 10.1037/h0060652; Grill-Spector K, 2005, PSYCHOL SCI, V16, P152, DOI 10.1111/j.0956-7976.2005.00796.x; Grill-Spector K, 2001, VISION RES, V41, P1409, DOI 10.1016/S0042-6989(01)00073-6; Harel A, 2007, VISION RES, V47, P2010, DOI 10.1016/j.visres.2007.04.004; Harris C., 1988, P ALVEY VISION C, DOI DOI 10.5244/C.2.23; Hegde J, 2005, J NEUROPHYSIOL, V93, P620, DOI 10.1152/jn.00039.2004; Hegde J, 2004, J NEUROPHYSIOL, V92, P3030, DOI 10.1152/jn.00822.2003; Hegde J, 2000, J NEUROSCI, V20, part. no.; Hegde J, 2008, CURR BIOL, V18, P597, DOI 10.1016/j.cub.2008.03.058; Hegde J, 2007, CEREB CORTEX, V17, P1100, DOI 10.1093/cercor/bhl020; Joyce CA, 2006, VISION RES, V46, P800, DOI 10.1016/j.visres.2005.09.016; Kadir T, 2001, INT J COMPUT VISION, V45, P83, DOI 10.1023/A:1012460413855; Kruskal J, 1978, MULTIDIMENSIONAL SCA; Lerner Y, 2008, J COGNITIVE NEUROSCI, V20, P1189, DOI 10.1162/jocn.2008.20082; Markman AB, 2003, PSYCHOL BULL, V129, P592, DOI 10.1037/0033-2909.129.4.592; McGraw PV, 1999, EXP BRAIN RES, V125, P122, DOI 10.1007/s002210050667; MERVIS CB, 1981, ANNU REV PSYCHOL, V32, P89, DOI 10.1146/annurev.ps.32.020181.000513; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Mikolajczyk K, 2002, LECT NOTES COMPUT SC, V2350, P128, DOI 10.1007/3-540-47969-4_9; Murray EA, 2007, ANNU REV NEUROSCI, V30, P99, DOI 10.1146/annurev.neuro.29.051605.113046; Palmeri TJ, 2004, NAT REV NEUROSCI, V5, P291, DOI 10.1038/nrn1364; Palmeri TJ, 1999, PSYCHON B REV, V6, P495, DOI 10.3758/BF03210840; Pitcher D, 2007, CURR BIOL, V17, P1568, DOI 10.1016/j.cub.2007.07.063; ROLLS ET, 1970, EXP BRAIN RES, V10, P298; ROSCH EH, 1973, COGNITIVE PSYCHOL, V4, P328, DOI 10.1016/0010-0285(73)90017-0; SEGER CA, ANN REV NEUROSCI, V33, P203; Smith EE, 1981, CATEGORIES CONCEPTS; Smith ML, 2007, NEUROIMAGE, V37, P974, DOI 10.1016/j.neuroimage.2007.05.030; Suzuki WA, 2009, NEURON, V61, P657, DOI 10.1016/j.neuron.2009.02.008; Suzuki WA, 2009, NEURON, V61, P678, DOI 10.1016/j.neuron.2009.02.009; Ullman S, 2004, NEURAL NETWORKS, V17, P833, DOI 10.1016/j.neunet.2004.01.006; Ullman S, 2002, NAT NEUROSCI, V5, P682, DOI 10.1038/nn870; Ullman S, 2007, TRENDS COGN SCI, V11, P58, DOI 10.1016/j.tics.2006.11.009; WERTHEIM T, 1980, AM J OPTOM PHYS OPT, V57, P915	49	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15444	10.1371/journal.pone.0015444	http://dx.doi.org/10.1371/journal.pone.0015444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124837	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000027
J	Okeke, IN; Wallace-Gadsden, F; Simons, HR; Matthews, N; Labar, AS; Hwang, J; Wain, J				Okeke, Iruka N.; Wallace-Gadsden, Faith; Simons, Hannah R.; Matthews, Nicholas; Labar, Amy S.; Hwang, Jennifer; Wain, John			Multi-Locus Sequence Typing of Enteroaggregative Escherichia coli Isolates from Nigerian Children Uncovers Multiple Lineages	PLOS ONE			English	Article							CLONAL GROUP; ANTIMICROBIAL RESISTANCE; MOLECULAR EPIDEMIOLOGY; PATHOGENICITY ISLAND; SHIGELLA-FLEXNERI; VIRULENCE; STRAINS; ADHERENCE; DIARRHEA; PLASMID	Background: Enteroaggregative Escherichia coli (EAEC) are defined by their stacked-brick adherence pattern to human epithelial cells. There is no all-encompassing genetic marker for EAEC. The category is commonly implicated in diarrhea but research is hampered by perplexing heterogeneity. Methodology/Principal Findings: To identify key EAEC lineages, we applied multilocus sequence typing to 126 E. coli isolates from a Nigerian case-control study that showed aggregative adherence in the HEp-2 adherence assay, and 24 other EAEC strains from diverse locations. EAEC largely belonged to the A, B1 and D phylogenetic groups and only 7 (4.6%) isolates were in the B2 cluster. As many as 96 sequence types (STs) were identified but 60 (40%) of the EAEC strains belong to or are double locus variants of STs 10, 31, and 394. The remainder did not belong to predominant complexes. The most common ST complex, with predicted ancestor ST10, included 32 (21.3%) of the isolates. Significant age-related distribution suggests that weaned children in Nigeria are at risk for diarrhea from of ST10-complex EAEC. Phylogenetic group D EAEC strains, predominantly from ST31- and ST394 complexes, represented 38 (25.3%) of all isolates, include genome-sequenced strain 042, and possessed conserved chromosomal loci. Conclusions/Significance: We have developed a molecular phylogenetic framework, which demonstrates that although grouped by a shared phenotype, the category of 'EAEC' encompasses multiple pathogenic lineages. Principal among isolates from Nigeria were ST10-complex EAEC that were associated with diarrhea in children over one year and ECOR D strains that share horizontally acquired loci.	[Okeke, Iruka N.; Wallace-Gadsden, Faith; Simons, Hannah R.; Labar, Amy S.; Hwang, Jennifer] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Matthews, Nicholas; Wain, John] Wellcome Trust Sanger Inst, Cambridge, England; [Wain, John] Hlth Protect Agcy, London, England	Haverford College; Wellcome Trust Sanger Institute; Health Protection Agency	Okeke, IN (corresponding author), Haverford Coll, Dept Biol, Haverford, PA 19041 USA.	iokeke@haverford.edu	Okeke, Iruka N/N-1595-2019; Wain, John/B-3446-2013	Okeke, Iruka N/0000-0002-1694-7587; Wain, John/0000-0002-1257-1148	National Science Foundation [0516591]; Society of Science; Wellcome Trust; Howard Hughes Medical Institute; Div Of Molecular and Cellular Bioscience [0948460] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Society of Science; Wellcome Trust(Wellcome Trust); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by National Science Foundation (www.nsf.org) grant RUI #0516591, by a Branco Weiss Fellowship from the Society of Science (http://www.society-in-science.ethz.ch/) to INO and by Wellcome Trust (http://www.wellcome.ac.uk/) support to JW and NM. We thank the Howard Hughes Medical Institute for support of Haverford College undergraduate researchers FW-G and ASL (http://www.haverford.edu/kinsc/HHMI/). FW-G is also a Mellon-Mays Undergraduate Research Fellow (www.mmuf.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUDRY B, 1990, J INFECT DIS, V161, P1249, DOI 10.1093/infdis/161.6.1249; Bean DC, 2009, ANTIMICROB AGENTS CH, V53, P1088, DOI 10.1128/AAC.00800-08; Bhargava S, 2009, J BACTERIOL, V191, P4934, DOI 10.1128/JB.01831-08; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Clermont O, 2000, APPL ENVIRON MICROB, V66, P4555, DOI 10.1128/AEM.66.10.4555-4558.2000; Cohen MB, 2005, J PEDIATR-US, V146, P54, DOI 10.1016/j.jpeds.2004.08.059; Czeczulin JR, 1999, INFECT IMMUN, V67, P2692, DOI 10.1128/IAI.67.6.2692-2699.1999; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Donnenberg MS, 2001, J CLIN INVEST, V107, P539, DOI 10.1172/JCI12404; Dudley EG, 2006, MOL MICROBIOL, V61, P1267, DOI 10.1111/j.1365-2958.2006.05281.x; Dudley EG, 2006, INFECT IMMUN, V74, P2102, DOI 10.1128/IAI.74.4.2102-2114.2006; Elias WP, 2002, EPIDEMIOL INFECT, V129, P49, DOI 10.1017/S0950268802007136; Escobar-Paramo P, 2004, MOL BIOL EVOL, V21, P1085, DOI 10.1093/molbev/msh118; Escobar-Paramo P, 2004, APPL ENVIRON MICROB, V70, P5698, DOI 10.1128/AEM.70.9.5698-5700.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Fernandez-Prada C, 1998, INFECT IMMUN, V66, P3918, DOI 10.1128/IAI.66.8.3918-3924.1998; Gassama A, 2004, MICROB DRUG RESIST, V10, P27, DOI 10.1089/107662904323047763; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guerrant RL, 2005, CLIN INFECT DIS, V41, pS524, DOI 10.1086/432946; Harrington SM, 2006, FEMS MICROBIOL LETT, V254, P12, DOI 10.1111/j.1574-6968.2005.00005.x; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Huang DB, 2006, J MED MICROBIOL, V55, P1303, DOI 10.1099/jmm.0.46674-0; Huang DB, 2006, CLIN INFECT DIS, V43, P556, DOI 10.1086/505869; Hwang J, 2010, INFECT IMMUN, V78, P4068, DOI 10.1128/IAI.00014-10; Itoh Y, 1997, J CLIN MICROBIOL, V35, P2546, DOI 10.1128/JCM.35.10.2546-2550.1997; Jenkins C, 2005, FEMS MICROBIOL LETT, V253, P119, DOI 10.1016/j.femsle.2005.09.040; Jenkins C, 2006, J MED MICROBIOL, V55, P1493, DOI 10.1099/jmm.0.46683-0; Jiang ZD, 2003, J INFECT DIS, V188, P506, DOI 10.1086/377102; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Joo LM, 2007, J BACTERIOL, V189, P3793, DOI 10.1128/JB.01764-06; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; Kahali S, 2004, J CLIN MICROBIOL, V42, P4111, DOI 10.1128/JCM.42.9.4111-4120.2004; Lacher DW, 2007, J BACTERIOL, V189, P342, DOI 10.1128/JB.01472-06; Lang P, 2010, APPL ENVIRON MICROB, V76, P1913, DOI 10.1128/AEM.01753-09; Lau SH, 2008, J CLIN MICROBIOL, V46, P1076, DOI 10.1128/JCM.02065-07; Lescat M, 2009, ANTIMICROB AGENTS CH, V53, P2283, DOI 10.1128/AAC.00123-09; Luck SN, 2004, J BACTERIOL, V186, P5551, DOI 10.1128/JB.186.16.5551-5554.2004; MATHEWSON JJ, 1986, J INFECT DIS, V154, P524, DOI 10.1093/infdis/154.3.524; Arancibia EM, 2009, J ANTIMICROB CHEMOTH, V64, P343, DOI 10.1093/jac/dkp178; Mendez-Arancibia E, 2008, AM J TROP MED HYG, V78, P985, DOI 10.4269/ajtmh.2008.78.985; Nataro JP, 2006, EMERG INFECT DIS, V12, P696, DOI 10.3201/eid1204.060125; Nataro JP, 2005, CURR OPIN GASTROEN, V21, P4; NATARO JP, 1987, PEDIATR INFECT DIS J, V6, P829, DOI 10.1097/00006454-198709000-00008; NATARO JP, 1995, J INFECT DIS, V171, P465, DOI 10.1093/infdis/171.2.465; *NCCLS, 1990, M7A4 NCCLS; Okeke I N, 2001, Lancet Infect Dis, V1, P304, DOI 10.1016/S1473-3099(01)00144-X; Okeke IN, 2000, J INFECT DIS, V181, P252, DOI 10.1086/315204; Okeke IN, 2004, J CLIN MICROBIOL, V42, P36, DOI 10.1128/JCM.42.1.36-44.2004; Okeke IN, 2003, J CLIN MICROBIOL, V41, P4525, DOI 10.1128/JCM.41.10.4525-4530.2003; Okeke IN, 2002, J CLIN MICROBIOL, V40, P301, DOI 10.1128/JCM.40.1.301-305.2002; Okeke IN, 2000, J CLIN MICROBIOL, V38, P7; Oteo J, 2009, INT J ANTIMICROB AG, V34, P173, DOI 10.1016/j.ijantimicag.2009.03.006; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Parks AR, 2009, PLASMID, V61, P1, DOI 10.1016/j.plasmid.2008.09.008; Perez-Losada M, 2006, INFECT GENET EVOL, V6, P97, DOI 10.1016/j.meegid.2005.02.003; Peters JE, 2001, NAT REV MOL CELL BIO, V2, P806, DOI 10.1038/35099006; Rasko DA, 2008, J BACTERIOL, V190, P6881, DOI 10.1128/JB.00619-08; Regua-Mangia AH, 2009, J MED MICROBIOL, V58, P414, DOI 10.1099/jmm.0.006502-0; Reid SD, 2000, NATURE, V406, P64, DOI 10.1038/35017546; Robinson DA, 2010, BACTERIAL POPULATION; SAADI S, 1987, J BACTERIOL, V169, P1836, DOI 10.1128/jb.169.5.1836-1846.1987; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609; Sheikh J, 2001, MOL MICROBIOL, V41, P983, DOI 10.1046/j.1365-2958.2001.02512.x; Sheikh J, 2006, MOL MICROBIOL, V61, P338, DOI 10.1111/j.1365-2958.2006.05234.x; SIMONSEN CC, 1983, J BACTERIOL, V155, P1001, DOI 10.1128/JB.155.3.1001-1008.1983; Steinsland H, 2010, J CLIN MICROBIOL, V48, P2916, DOI 10.1128/JCM.02432-09; SUNDSTROM L, 1988, MOL GEN GENET, V213, P191, DOI 10.1007/BF00339581; Tartof SY, 2005, J CLIN MICROBIOL, V43, P5860, DOI 10.1128/JCM.43.12.5860-5864.2005; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; Tompkins D S, 1999, Commun Dis Public Health, V2, P108; Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344; Turner SM, 2006, J CLIN MICROBIOL, V44, P4528, DOI 10.1128/JCM.01474-06; Vila J, 1999, ANTIMICROB AGENTS CH, V43, P3022, DOI 10.1128/AAC.43.12.3022; Wallace-Gadsden F, 2007, EMERG INFECT DIS, V13, P757, DOI 10.3201/eid1305.061057; WEST A, 2005, DNA SEQUENCING OPTIM, pR29; Whittam TS, 1996, REV MICROBIOL, V27, P7; Wirth T, 2007, GENOME RES, V17, P1647, DOI 10.1101/gr.6122607; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; YAMAMOTO T, 1992, J INFECT DIS, V165, P744, DOI 10.1093/infdis/165.4.744	84	64	66	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14093	10.1371/journal.pone.0014093	http://dx.doi.org/10.1371/journal.pone.0014093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124856	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900008
J	Bell, CG; Finer, S; Lindgren, CM; Wilson, GA; Rakyan, VK; Teschendorff, AE; Akan, P; Stupka, E; Down, TA; Prokopenko, I; Morison, IM; Mill, J; Pidsley, R; Deloukas, P; Frayling, TM; Hattersley, AT; McCarthy, MI; Beck, S; Hitman, GA				Bell, Christopher G.; Finer, Sarah; Lindgren, Cecilia M.; Wilson, Gareth A.; Rakyan, Vardhman K.; Teschendorff, Andrew E.; Akan, Pelin; Stupka, Elia; Down, Thomas A.; Prokopenko, Inga; Morison, Ian M.; Mill, Jonathan; Pidsley, Ruth; Deloukas, Panos; Frayling, Timothy M.; Hattersley, Andrew T.; McCarthy, Mark I.; Beck, Stephan; Hitman, Graham A.		Int Type 2 Diabet 1q Consortium	Integrated Genetic and Epigenetic Analysis Identifies Haplotype-Specific Methylation in the FTO Type 2 Diabetes and Obesity Susceptibility Locus	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DNA METHYLATION; HISTONE MODIFICATIONS; TESTING ASSOCIATION; POSITIVE SELECTION; VARIANTS; IMPACT; RISK; EPIGENOMICS; NUCLEOTIDE	Recent multi-dimensional approaches to the study of complex disease have revealed powerful insights into how genetic and epigenetic factors may underlie their aetiopathogenesis. We examined genotype-epigenotype interactions in the context of Type 2 Diabetes (T2D), focussing on known regions of genomic susceptibility. We assayed DNA methylation in 60 females, stratified according to disease susceptibility haplotype using previously identified association loci. CpG methylation was assessed using methylated DNA immunoprecipitation on a targeted array (MeDIP-chip) and absolute methylation values were estimated using a Bayesian algorithm (BATMAN). Absolute methylation levels were quantified across LD blocks, and we identified increased DNA methylation on the FTO obesity susceptibility haplotype, tagged by the rs8050136 risk allele A (p = 9.40 x 10(-4), permutation p = 1.0 x 10(-3)). Further analysis across the 46 kb LD block using sliding windows localised the most significant difference to be within a 7.7 kb region (p = 1.13 x 10(-7)). Sequence level analysis, followed by pyrosequencing validation, revealed that the methylation difference was driven by the co-ordinated phase of CpG-creating SNPs across the risk haplotype. This 7.7 kb region of haplotype-specific methylation (HSM), encapsulates a Highly Conserved Non-Coding Element (HCNE) that has previously been validated as a long-range enhancer, supported by the histone H3K4me1 enhancer signature. This study demonstrates that integration of Genome-Wide Association (GWA) SNP and epigenomic DNA methylation data can identify potential novel genotype-epigenotype interactions within disease-associated loci, thus providing a novel route to aid unravelling common complex diseases.	[Bell, Christopher G.; Wilson, Gareth A.; Teschendorff, Andrew E.; Stupka, Elia; Beck, Stephan] UCL, UCL Canc Inst, London, England; [Finer, Sarah; Rakyan, Vardhman K.; Stupka, Elia; Hitman, Graham A.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst Cell & Mol Sci, London, England; [Lindgren, Cecilia M.; Prokopenko, Inga; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Akan, Pelin; Deloukas, Panos] Wellcome Trust Sanger Inst, Hinxton, Cambs, England; [Down, Thomas A.] Univ Cambridge, Gurdon Inst, Cambridge, England; [Down, Thomas A.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Morison, Ian M.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Mill, Jonathan; Pidsley, Ruth] Kings Coll London, Inst Psychiat, London WC2R 2LS, England; [Frayling, Timothy M.; Hattersley, Andrew T.] Univ Exeter, Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter, Devon, England	University of London; University College London; University of London; Queen Mary University London; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Cambridge; University of Cambridge; University of Otago; University of London; King's College London; University of Exeter	Bell, CG (corresponding author), UCL, UCL Canc Inst, London, England.	christopher.bell@ucl.ac.uk	Stupka, Elia/J-6279-2012; Mill, Jonathan S/B-3276-2010; Mill, Jonathan/B-5678-2014; Bell, Christopher/C-1585-2008; Pidsley, Ruth E/D-8127-2012; Deloukas, Panos/B-2922-2013; Leslie, Richard/AAF-6977-2020; Morison, Ian M/A-1236-2008; Prokopenko, Inga/AAU-9895-2020; Pidsley, Ruth/B-2540-2013; Prokopenko, Inga/H-3241-2014; Sahlen, Pelin/AAJ-1824-2021; McCarthy, Mark/M-3763-2015	Stupka, Elia/0000-0003-3154-4011; Mill, Jonathan S/0000-0003-1115-3224; Mill, Jonathan/0000-0003-1115-3224; Bell, Christopher/0000-0003-4601-1242; Deloukas, Panos/0000-0001-9251-070X; Leslie, Richard/0000-0002-1786-1531; Morison, Ian M/0000-0003-3616-0025; Prokopenko, Inga/0000-0003-1624-7457; McCarthy, Mark/0000-0002-4393-0510; Finer, Sarah/0000-0002-2684-4653; Hattersley, Andrew/0000-0001-5620-473X; Lindgren, Cecilia/0000-0002-4903-9374; Pidsley, Ruth/0000-0002-1386-1374	Wellcome Trust [084071, WT086596/Z/08/Z]; Heller Research Fellowship; Medical Research Council; Barts and the London Charity; NIDDK [DK-073490]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073490] Funding Source: NIH RePORTER; Medical Research Council [G0800441] Funding Source: researchfish; National Institute for Health Research [ACF-2006-19-002] Funding Source: researchfish; MRC [G0800441] Funding Source: UKRI	Wellcome Trust(Wellcome Trust); Heller Research Fellowship; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Barts and the London Charity; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CGB and SB were funded by the Wellcome Trust (084071). AET was supported by a Heller Research Fellowship. CML is funded by WT086596/Z/08/Z (Wellcome Trust Research Career Development Fellowship). SF was funded by the Medical Research Council and Barts and the London Charity. Additional funding was from NIDDK (DK-073490).	Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Arndt PF, 2003, MOL BIOL EVOL, V20, P1887, DOI 10.1093/molbev/msg204; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck-Nielsen H, 2003, BEST PRACT RES CL EN, V17, P445, DOI 10.1016/S1521-690X(03)00041-1; Bhandare R, 2010, GENOME RES, V20, P428, DOI 10.1101/gr.102038.109; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Braun MM, 2003, DEVELOPMENT, V130, P5579, DOI 10.1242/dev.00685; Caqueret A, 2006, DEV BIOL, V298, P95, DOI 10.1016/j.ydbio.2006.06.019; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Church C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000599; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Forsberg EC, 2000, P NATL ACAD SCI USA, V97, P14494, DOI 10.1073/pnas.97.26.14494; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glaser RL, 2006, NUCLEIC ACIDS RES, V34, pD29, DOI 10.1093/nar/gkj101; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Grant SFA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001746; Grunnet LG, 2009, DIABETES, V58, P2402, DOI 10.2337/db09-0205; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Javierre BM, 2010, GENOME RES, V20, P170, DOI 10.1101/gr.100289.109; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Jowett JBM, 2010, DIABETES, V59, P726, DOI 10.2337/db09-1277; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lee JE, 2006, DEVELOPMENT, V133, P4451, DOI 10.1242/dev.02613; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; McCarthy MI, 2008, HUM MOL GENET, V17, pR100, DOI 10.1093/hmg/ddn298; Meyre D, 2010, DIABETES, V59, P311, DOI 10.2337/db09-0703; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murrell A, 2005, HUM MOL GENET, V14, pR3, DOI 10.1093/hmg/ddi110; O'Rahilly S, 2009, NATURE, V462, P307, DOI 10.1038/nature08532; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Ragvin A, 2010, P NATL ACAD SCI USA, V107, P775, DOI 10.1073/pnas.0911591107; Rakyan VK, 2006, CURR OPIN GENET DEV, V16, P573, DOI 10.1016/j.gde.2006.09.002; Rakyan VK, 2010, GENOME RES, V20, P434, DOI 10.1101/gr.103101.109; Richards EJ, 2006, NAT REV GENET, V7, P395, DOI 10.1038/nrg1834; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schalkwyk LC, 2010, AM J HUM GENET, V86, P196, DOI 10.1016/j.ajhg.2010.01.014; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shoemaker R, 2010, GENOME RES, V20, P883, DOI 10.1101/gr.104695.109; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wallace C, 2010, NAT GENET, V42, P68, DOI 10.1038/ng.493; Walser JC, 2008, GENOME RES, V18, P1403, DOI 10.1101/gr.076455.108; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364; Zeggini E, 2006, DIABETES, V55, pA83; Zemojtel T, 2009, TRENDS GENET, V25, P63, DOI 10.1016/j.tig.2008.11.005; Zhang YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r138; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x	79	178	188	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14040	10.1371/journal.pone.0014040	http://dx.doi.org/10.1371/journal.pone.0014040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124985	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000284356900004
J	Thiemann, C; Theis, F; Grady, D; Brune, R; Brockmann, D				Thiemann, Christian; Theis, Fabian; Grady, Daniel; Brune, Rafael; Brockmann, Dirk			The Structure of Borders in a Small World	PLOS ONE			English	Article							COMMUNITY STRUCTURE; DYNAMICS; NETWORK; TECHNOLOGY; EPIDEMICS; INFLUENZA	Territorial subdivisions and geographic borders are essential for understanding phenomena in sociology, political science, history, and economics. They influence the interregional flow of information and cross-border trade and affect the diffusion of innovation and technology. However, it is unclear if existing administrative subdivisions that typically evolved decades ago still reflect the most plausible organizational structure of today. The complexity of modern human communication, the ease of long-distance movement, and increased interaction across political borders complicate the operational definition and assessment of geographic borders that optimally reflect the multi-scale nature of today's human connectivity patterns. What border structures emerge directly from the interplay of scales in human interactions is an open question. Based on a massive proxy dataset, we analyze a multi-scale human mobility network and compute effective geographic borders inherent to human mobility patterns in the United States. We propose two computational techniques for extracting these borders and for quantifying their strength. We find that effective borders only partially overlap with existing administrative borders, and show that some of the strongest mobility borders exist in unexpected regions. We show that the observed structures cannot be generated by gravity models for human traffic. Finally, we introduce the concept of link significance that clarifies the observed structure of effective borders. Our approach represents a novel type of quantitative, comparative analysis framework for spatially embedded multi-scale interaction networks in general and may yield important insight into a multitude of spatiotemporal phenomena generated by human activity.	[Thiemann, Christian; Grady, Daniel; Brune, Rafael; Brockmann, Dirk] Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA; [Thiemann, Christian; Brune, Rafael] Max Planck Inst Dynam & Self Org, Gottingen, Germany; [Theis, Fabian] Helmholtz Ctr Munich, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Theis, Fabian] Univ Technol Munich, Dept Math, Garching, Germany; [Brockmann, Dirk] NW Inst Complex Syst, Evanston, IL USA	Northwestern University; Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Thiemann, C (corresponding author), Northwestern Univ, Dept Engn Sci & Appl Math, Evanston, IL 60208 USA.	brockmann@northwestern.edu	Brockmann, Dirk A/B-7342-2009; Theis, Fabian J/ABD-5212-2021; Grady, Daniel/E-9789-2015	Theis, Fabian J/0000-0002-2419-1943; Grady, Daniel/0000-0002-2446-2096	Helmholtz Alliance on Systems Biology; Volkswagen Foundation; EU	Helmholtz Alliance on Systems Biology; Volkswagen Foundation(Volkswagen); EU(European Commission)	F.T. acknowledges financial support by the Helmholtz Alliance on Systems Biology (project "CoReNe''). D. B. acknowledges support from the Volkswagen Foundation and EU-FP7 grant Epiwork. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON JE, 1979, AM ECON REV, V69, P106; [Anonymous], [No title captured]; Balcan D, 2009, P NATL ACAD SCI USA, V106, P21484, DOI 10.1073/pnas.0906910106; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Brockmann D, 2008, IEEE PERVAS COMPUT, V7, P28, DOI 10.1109/MPRV.2008.77; Buzna L, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056107; COCHRANE RA, 1975, J TRANSP ECON POLICY, V9, P34; Colizza V, 2006, B MATH BIOL, V68, P1893, DOI 10.1007/s11538-006-9077-9; Colizza V, 2007, PLOS MED, V4, P95, DOI 10.1371/journal.pmed.0040013; Danon L, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/09/P09008; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eagle N, 2010, SCIENCE, V328, P1029, DOI 10.1126/science.1186605; Eagle N, 2009, P NATL ACAD SCI USA, V106, P15274, DOI 10.1073/pnas.0900282106; Eaton J, 2002, ECONOMETRICA, V70, P1741, DOI 10.1111/1468-0262.00352; Ernst D, 2002, RES POLICY, V31, P1417, DOI 10.1016/S0048-7333(02)00072-0; Everitt B. S., 2001, CLUSTER ANAL; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Keller W, 2004, J ECON LIT, V42, P752, DOI 10.1257/0022051042177685; Labov W., 2006, PHONOLOGY SOUND CHAN; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Liben-Nowell D, 2005, P NATL ACAD SCI USA, V102, P11623, DOI 10.1073/pnas.0503018102; Lloyd AL, 2004, MATH BIOSCI, V188, P1, DOI 10.1016/j.mbs.2003.09.003; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Xia YC, 2004, AM NAT, V164, P267, DOI 10.1086/422341	34	113	117	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e15422	10.1371/journal.pone.0015422	http://dx.doi.org/10.1371/journal.pone.0015422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681XH	21124970	Green Submitted, Green Published, gold			2022-12-27	WOS:000284356900017
J	Yoshikawa, F; Banno, Y; Otani, Y; Yamaguchi, Y; Nagakura-Takagi, Y; Morita, N; Sato, Y; Saruta, C; Nishibe, H; Sadakata, T; Shinoda, Y; Hayashi, K; Mishima, Y; Baba, H; Furuichi, T				Yoshikawa, Fumio; Banno, Yoshiko; Otani, Yoshinori; Yamaguchi, Yoshihide; Nagakura-Takagi, Yuko; Morita, Noriyuki; Sato, Yumi; Saruta, Chihiro; Nishibe, Hirozumi; Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Baba, Hiroko; Furuichi, Teiichi			Phospholipase D Family Member 4, a Transmembrane Glycoprotein with No Phospholipase D Activity, Expression in Spleen and Early Postnatal Microglia	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; WHITE-MATTER; PLD ACTIVITY; RAT-BRAIN; D DEFINES; MEMBRANE; LOCALIZATION; PROTEIN; CLONING; GENE	Background: Phospholipase D (PLD) catalyzes conversion of phosphatidylcholine into choline and phosphatidic acid, leading to a variety of intracellular signal transduction events. Two classical PLDs, PLD1 and PLD2, contain phosphatidylinositide-binding PX and PH domains and two conserved His-x-Lys-(x)(4)-Asp (HKD) motifs, which are critical for PLD activity. PLD4 officially belongs to the PLD family, because it possesses two HKD motifs. However, it lacks PX and PH domains and has a putative transmembrane domain instead. Nevertheless, little is known regarding expression, structure, and function of PLD4. Methodology/Principal Findings: PLD4 was analyzed in terms of expression, structure, and function. Expression was analyzed in developing mouse brains and non-neuronal tissues using microarray, in situ hybridization, immunohistochemistry, and immunocytochemistry. Structure was evaluated using bioinformatics analysis of protein domains, biochemical analyses of transmembrane property, and enzymatic deglycosylation. PLD activity was examined by choline release and transphosphatidylation assays. Results demonstrated low to modest, but characteristic, PLD4 mRNA expression in a subset of cells preferentially localized around white matter regions, including the corpus callosum and cerebellar white matter, during the first postnatal week. These PLD4 mRNA-expressing cells were identified as Iba1-positive microglia. In non-neuronal tissues, PLD4 mRNA expression was widespread, but predominantly distributed in the spleen. Intense PLD4 expression was detected around the marginal zone of the splenic red pulp, and splenic PLD4 protein recovered from subcellular membrane fractions was highly N-glycosylated. PLD4 was heterologously expressed in cell lines and localized in the endoplasmic reticulum and Golgi apparatus. Moreover, heterologously expressed PLD4 proteins did not exhibit PLD enzymatic activity. Conclusions/Significance: Results showed that PLD4 is a non-PLD, HKD motif-carrying, transmembrane glycoprotein localized in the endoplasmic reticulum and Golgi apparatus. The spatiotemporally restricted expression patterns suggested that PLD4 might play a role in common function(s) among microglia during early postnatal brain development and splenic marginal zone cells.	[Yoshikawa, Fumio; Nagakura-Takagi, Yuko; Morita, Noriyuki; Sato, Yumi; Saruta, Chihiro; Nishibe, Hirozumi; Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Furuichi, Teiichi] RIKEN, Lab Mol Neurogenesis, Brain Sci Inst, Wako, Saitama, Japan; [Banno, Yoshiko] Gifu Univ, Grad Sch Med, Dept Cell Signaling, Gifu, Japan; [Otani, Yoshinori; Yamaguchi, Yoshihide; Baba, Hiroko] Tokyo Univ Pharm & Life Sci, Dept Mol Neurobiol, Tokyo, Japan; [Morita, Noriyuki] Yasuda Womens Univ, Hiroshima, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Hayashi, Kanehiro; Mishima, Yuriko; Furuichi, Teiichi] CREST, JST, Kawaguchi, Saitama, Japan; [Furuichi, Teiichi] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Furuichi, Teiichi] Hiroshima Univ, Grad Sch Biomed Sci, Hiroshima, Japan	RIKEN; Gifu University; Tokyo University of Pharmacy & Life Sciences; Japan Science & Technology Agency (JST); Saitama University; Hiroshima University	Yoshikawa, F (corresponding author), RIKEN, Lab Mol Neurogenesis, Brain Sci Inst, Wako, Saitama, Japan.	tfuruichi@brain.riken.jp	Shinoda, Yo/H-3091-2019; Hayashi, Kanehiro/L-2777-2013; Sadakata, Tetsushi/W-9324-2018; Furuichi, Teiichi/B-5086-2014	Shinoda, Yo/0000-0003-3253-2194; Sadakata, Tetsushi/0000-0003-0276-4162; Furuichi, Teiichi/0000-0002-9676-1888; Yamaguchi, Yoshihide/0000-0002-5686-9325; OTANI, YOSHINORI/0000-0002-3214-4637	Japanese Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science; Japan Science and Technology Agency	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST))	This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Japan Society for the Promotion of Science, and the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki J, 2008, BBA-MOL CELL BIOL L, V1781, P513, DOI 10.1016/j.bbalip.2008.06.005; Banno Y, 1999, J BIOL CHEM, V274, P27385, DOI 10.1074/jbc.274.39.27385; Banno Y, 1997, J BIOL CHEM, V272, P5208, DOI 10.1074/jbc.272.8.5208; Banno Y, 2008, J NEUROCHEM, V104, P1372, DOI 10.1111/j.1471-4159.2007.05085.x; Cao JX, 1997, VIRUS RES, V48, P11, DOI 10.1016/S0168-1702(96)01422-0; Cockcroft S, 2001, CELL MOL LIFE SCI, V58, P1674, DOI 10.1007/PL00000805; Colley WC, 1997, BIOCHEM J, V326, P745, DOI 10.1042/bj3260745; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; Du GW, 2003, J CELL BIOL, V162, P305, DOI 10.1083/jcb.200302033; Earle KL, 1997, J COMP NEUROL, V387, P371, DOI 10.1002/(SICI)1096-9861(19971027)387:3<371::AID-CNE4>3.0.CO;2-Y; Exton JH, 2002, FEBS LETT, V531, P58, DOI 10.1016/S0014-5793(02)03405-1; HAMMOND SM, 1995, J BIOL CHEM, V270, P29640; Hirasawa T, 2005, J NEUROSCI RES, V81, P357, DOI 10.1002/jnr.20480; Hodgkin MN, 2000, CURR BIOL, V10, P43, DOI 10.1016/S0960-9822(99)00264-X; Hristova M, 2010, GLIA, V58, P11, DOI 10.1002/glia.20896; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kanaho Y, 2009, BBA-MOL CELL BIOL L, V1791, P898, DOI 10.1016/j.bbalip.2009.03.010; Klein J, 2005, J NEUROCHEM, V94, P1473, DOI 10.1111/j.1471-4159.2005.03315.x; Kodaki T, 1997, J BIOL CHEM, V272, P11408; Kraal G, 2006, INT REV CYTOL, V250, P175, DOI 10.1016/S0074-7696(06)50005-1; Leiros I, 2000, STRUCTURE, V8, P655, DOI 10.1016/S0969-2126(00)00150-7; Lopez I, 1998, J BIOL CHEM, V273, P12846, DOI 10.1074/jbc.273.21.12846; Munck A, 2005, FEBS J, V272, P1718, DOI 10.1111/j.1742-4658.2005.04601.x; Ogino C, 2007, BBA-PROTEINS PROTEOM, V1774, P671, DOI 10.1016/j.bbapap.2007.04.004; Pedersen KM, 1998, J BIOL CHEM, V273, P31494, DOI 10.1074/jbc.273.47.31494; Ponting CP, 1996, PROTEIN SCI, V5, P914; Riebeling C, 2009, BBA-MOL CELL BIOL L, V1791, P876, DOI 10.1016/j.bbalip.2009.04.003; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Rudge SA, 2009, BBA-MOL CELL BIOL L, V1791, P856, DOI 10.1016/j.bbalip.2009.04.008; Saito S, 2000, DEV BRAIN RES, V120, P41, DOI 10.1016/S0165-3806(99)00189-3; Sato A, 2008, NEURAL NETWORKS, V21, P1056, DOI 10.1016/j.neunet.2008.05.004; Sciorra VA, 2002, J CELL BIOL, V159, P1039, DOI 10.1083/jcb.200205056; Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200; Stuckey JA, 1999, NAT STRUCT BIOL, V6, P278; Sung TC, 1997, EMBO J, V16, P4519, DOI 10.1093/emboj/16.15.4519; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Wu MM, 2001, J BIOL CHEM, V276, P33027, DOI 10.1074/jbc.M103917200; Wu MM, 2000, CHEM BIOL, V7, P197, DOI 10.1016/S1074-5521(00)00088-0; Xie Z, 2000, J BIOL CHEM, V275, P24962, DOI 10.1074/jbc.M909745199; Yoshikawa F, 2008, J BIOL CHEM, V283, P20830, DOI 10.1074/jbc.M801314200	41	43	45	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13932	10.1371/journal.pone.0013932	http://dx.doi.org/10.1371/journal.pone.0013932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085684	Green Submitted, Green Published, gold			2022-12-27	WOS:000284087800006
J	Deshpande, G; Li, ZH; Santhanam, P; Coles, CD; Lynch, ME; Hamann, S; Hu, XP				Deshpande, Gopikrishna; Li, Zhihao; Santhanam, Priya; Coles, Claire D.; Lynch, Mary Ellen; Hamann, Stephan; Hu, Xiaoping			Recursive Cluster Elimination Based Support Vector Machine for Disease State Prediction Using Resting State Functional and Effective Brain Connectivity	PLOS ONE			English	Article							GRANGER CAUSALITY ANALYSIS; PRENATAL COCAINE EXPOSURE; FMRI DATA; DRUG-USE; SYSTEMS; MRI; CLASSIFICATION; ACTIVATION; PREGNANCY; CHILDREN	Background: Brain state classification has been accomplished using features such as voxel intensities, derived from functional magnetic resonance imaging (fMRI) data, as inputs to efficient classifiers such as support vector machines (SVM) and is based on the spatial localization model of brain function. With the advent of the connectionist model of brain function, features from brain networks may provide increased discriminatory power for brain state classification. Methodology/Principal Findings: In this study, we introduce a novel framework where in both functional connectivity (FC) based on instantaneous temporal correlation and effective connectivity (EC) based on causal influence in brain networks are used as features in an SVM classifier. In order to derive those features, we adopt a novel approach recently introduced by us called correlation-purged Granger causality (CPGC) in order to obtain both FC and EC from fMRI data simultaneously without the instantaneous correlation contaminating Granger causality. In addition, statistical learning is accelerated and performance accuracy is enhanced by combining recursive cluster elimination (RCE) algorithm with the SVM classifier. We demonstrate the efficacy of the CPGC-based RCE-SVM approach using a specific instance of brain state classification exemplified by disease state prediction. Accordingly, we show that this approach is capable of predicting with 90.3% accuracy whether any given human subject was prenatally exposed to cocaine or not, even when no significant behavioral differences were found between exposed and healthy subjects. Conclusions/Significance: The framework adopted in this work is quite general in nature with prenatal cocaine exposure being only an illustrative example of the power of this approach. In any brain state classification approach using neuroimaging data, including the directional connectivity information may prove to be a performance enhancer. When brain state classification is used for disease state prediction, our approach may aid the clinicians in performing more accurate diagnosis of diseases in situations where in non-neuroimaging biomarkers may be unable to perform differential diagnosis with certainty.	[Deshpande, Gopikrishna] Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA; [Li, Zhihao; Santhanam, Priya; Hu, Xiaoping] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Coles, Claire D.; Lynch, Mary Ellen] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA; [Hamann, Stephan] Emory Univ, Dept Psychol, Atlanta, GA 30322 USA	Auburn University System; Auburn University; University System of Georgia; Georgia Institute of Technology; Emory University; Emory University	Deshpande, G (corresponding author), Auburn Univ, MRI Res Ctr, Dept Elect & Comp Engn, Auburn, AL 36849 USA.	xhu@bme.gatech.edu	Li, Zhihao/R-4741-2019	Li, Zhihao/0000-0002-6009-7903; Hu, Xiaoping/0000-0001-7014-5983; Deshpande, Gopikrishna/0000-0001-7471-5357	National Institutes of Health [R01 EB002009]; Georgia Research Alliance; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB002009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	The authors acknowledge the support from National Institutes of Health (R01 EB002009 to XH) and Georgia Research Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accornero VH, 2007, J DEV BEHAV PEDIATR, V28, P195, DOI 10.1097/01.DBP.0000268560.72580.f9; [Anonymous], 2005, STUDIES FUZZINESS SO, DOI [DOI 10.1007/B95439, 10.1007/b95439]; Bassett DS, 2008, J NEUROSCI, V28, P9239, DOI 10.1523/JNEUROSCI.1929-08.2008; Bendersky M, 2006, J PEDIATR PSYCHOL, V31, P71, DOI 10.1093/jpepsy/jsj025; Biswal B, 1998, AM J NEURORADIOL, V19, P1509; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Brown JV, 1998, DEV PSYCHOL, V34, P540, DOI 10.1037/0012-1649.34.3.540; CECCHI G, 2009, P NIPS 2009 VANC CAN; COLES CD, 1993, INT J ADDICT, V28, P1393, DOI 10.3109/10826089309062192; COLES CD, 1992, NEUROTOXICOL TERATOL, V14, P23, DOI 10.1016/0892-0362(92)90025-6; Craddock RC, 2009, MAGN RESON MED, V62, P1619, DOI 10.1002/mrm.22159; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; deCharms RC, 2005, P NATL ACAD SCI USA, V102, P18626, DOI 10.1073/pnas.0505210102; DESHPANDE G, 2009, P ISMRM 17 SCI M 200; Deshpande G, 2008, NEUROIMAGE, V40, P1807, DOI 10.1016/j.neuroimage.2008.01.044; Deshpande G, 2010, IEEE T BIO-MED ENG, V57, P1446, DOI 10.1109/TBME.2009.2037808; Deshpande G, 2010, NEUROIMAGE, V49, P1991, DOI 10.1016/j.neuroimage.2009.08.052; Deshpande G, 2009, HUM BRAIN MAPP, V30, P1361, DOI 10.1002/hbm.20606; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; Hurt H, 2008, J PEDIATR, V152, P371, DOI 10.1016/j.jpeds.2007.08.006; Kaminski M, 2001, BIOL CYBERN, V85, P145, DOI 10.1007/s004220000235; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; LaConte SM, 2007, HUM BRAIN MAPP, V28, P1033, DOI 10.1002/hbm.20326; LaGasse LL, 2006, ANN NY ACAD SCI, V1094, P313, DOI 10.1196/annals.1376.041; Li SJ, 2002, RADIOLOGY, V225, P253, DOI 10.1148/radiol.2251011301; Li SJ, 2000, MAGNET RESON MED, V43, P45, DOI 10.1002/(SICI)1522-2594(200001)43:1<45::AID-MRM6>3.0.CO;2-0; LI Z, 2010, HUMAN BRAIN IN PRESS; Li ZH, 2009, NEUROTOXICOL TERATOL, V31, P342, DOI 10.1016/j.ntt.2009.08.005; Loeber R, 2000, DEV PSYCHOPATHOL, V12, P737, DOI 10.1017/S0954579400004107; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Mayes LC, 2002, NEUROTOXICOL TERATOL, V24, P385, DOI 10.1016/S0892-0362(02)00200-3; Mayes LC, 1998, ANN NY ACAD SCI, V846, P126, DOI 10.1111/j.1749-6632.1998.tb09731.x; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Norman KA, 2006, TRENDS COGN SCI, V10, P424, DOI 10.1016/j.tics.2006.07.005; Phelps EA, 2006, ANNU REV PSYCHOL, V57, P27, DOI 10.1146/annurev.psych.56.091103.070234; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seminowicz DA, 2004, NEUROIMAGE, V22, P409, DOI 10.1016/j.neuroimage.2004.01.015; Sitaram R, 2008, IEEE SIGNAL PROC MAG, V25, P95, DOI 10.1109/MSP2007.910456; Sitaram Ranganatha, 2007, Comput Intell Neurosci, P25487, DOI 10.1155/2007/25487; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Stilla R, 2008, J VISION, V8, DOI 10.1167/8.10.13; Talairach J., 1988, COPLANAR STEREOTAXIC; Vapnik V., 2013, NATURE STAT LAERNING; Weiskopf N, 2004, IEEE T BIO-MED ENG, V51, P966, DOI 10.1109/TBME.2004.827063; WENZEL S, 2001, PRENATAL COCAINE EXP; Yang XW, 2003, PROG NAT SCI-MATER, V13, P750, DOI 10.1080/10020070312331344360; Yoo SS, 2004, NEUROREPORT, V15, P1591, DOI 10.1097/01.wnr.0000133296.39160.fe; Yousef M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-144	50	48	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14277	10.1371/journal.pone.0014277	http://dx.doi.org/10.1371/journal.pone.0014277			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151556	gold, Green Published			2022-12-27	WOS:000285135800009
J	Ohara-Imaizumi, M; Yoshida, M; Aoyagi, K; Saito, T; Okamura, T; Takenaka, H; Akimoto, Y; Nakamichi, Y; Takanashi-Yanobu, R; Nishiwaki, C; Kawakami, H; Kato, N; Hisanaga, S; Kakei, M; Nagamatsu, S				Ohara-Imaizumi, Mica; Yoshida, Masashi; Aoyagi, Kyota; Saito, Taro; Okamura, Tadashi; Takenaka, Hitoshi; Akimoto, Yoshihiro; Nakamichi, Yoko; Takanashi-Yanobu, Rieko; Nishiwaki, Chiyono; Kawakami, Hayato; Kato, Norihiro; Hisanaga, Shin-ichi; Kakei, Masafumi; Nagamatsu, Shinya			Deletion of CDKAL1 Affects Mitochondrial ATP Generation and First-Phase Insulin Exocytosis	PLOS ONE			English	Article							PANCREATIC BETA-CELLS; GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM; CROSS-TALK; RISK LOCI; ER STRESS; SECRETION; GLUCOSE; CALCIUM; ACTIVATOR	Background: A variant of the CDKAL1 gene was reported to be associated with type 2 diabetes and reduced insulin release in humans; however, the role of CDKAL1 in beta cells is largely unknown. Therefore, to determine the role of CDKAL1 in insulin release from beta cells, we studied insulin release profiles in CDKAL1 gene knockout (CDKAL1 KO) mice. Principal Findings: Total internal reflection fluorescence imaging of CDKAL1 KO beta cells showed that the number of fusion events during first-phase insulin release was reduced. However, there was no significant difference in the number of fusion events during second-phase release or high K+-induced release between WT and KO cells. CDKAL1 deletion resulted in a delayed and slow increase in cytosolic free Ca2+ concentration during high glucose stimulation. Patch-clamp experiments revealed that the responsiveness of ATP-sensitive K+ (K-ATP) channels to glucose was blunted in KO cells. In addition, glucose-induced ATP generation was impaired. Although CDKAL1 is homologous to cyclin-dependent kinase 5 (CDK5) regulatory subunit-associated protein 1, there was no difference in the kinase activity of CDK5 between WT and CDKAL1 KO islets. Conclusions/Significance: We provide the first report describing the function of CDKAL1 in beta cells. Our results indicate that CDKAL1 controls first-phase insulin exocytosis in beta cells by facilitating ATP generation, K-ATP channel responsiveness and the subsequent activity of Ca2+ channels through pathways other than CDK5-mediated regulation.	[Ohara-Imaizumi, Mica; Aoyagi, Kyota; Takenaka, Hitoshi; Nakamichi, Yoko; Nishiwaki, Chiyono; Nagamatsu, Shinya] Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Yoshida, Masashi; Kakei, Masafumi] Jichi Med Univ, Saitama Med Ctr, Sch Med, Dept Med 1, Saitama, Japan; [Saito, Taro; Hisanaga, Shin-ichi] Tokyo Metropolitan Univ, Dept Biol Sci, Tokyo 158, Japan; [Okamura, Tadashi; Takanashi-Yanobu, Rieko] Natl Ctr Global Hlth & Med, Dept Infect Dis, Res Inst, Tokyo, Japan; [Akimoto, Yoshihiro; Kawakami, Hayato] Kyorin Univ, Dept Anat, Sch Med, Tokyo, Japan; [Kato, Norihiro] Natl Ctr Global Hlth & Med, Dept Gene Diagnost & Therapeut, Tokyo, Japan	Kyorin University; Jichi Medical University; Tokyo Metropolitan University; National Center for Global Health & Medicine - Japan; Kyorin University; National Center for Global Health & Medicine - Japan	Ohara-Imaizumi, M (corresponding author), Kyorin Univ, Dept Biochem, Sch Med, Tokyo, Japan.	shinya@ks.kyorin-u.ac.jp			Japan Society for Promotion of Science; Sumitomo Foundation; Astellas Foundation for Research on Metabolic Disorders; Research Foundation for Opto-Science and Technology; Kyorin University School of Medicine; NOVARTIS Foundation (Japan) for the Promotion of Science; NIBIO (National Institute of Biomedical Innovation Organization)	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Foundation; Astellas Foundation for Research on Metabolic Disorders; Research Foundation for Opto-Science and Technology; Kyorin University School of Medicine; NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); NIBIO (National Institute of Biomedical Innovation Organization)(National Institute of Biomedical Innovation)	This research was supported by grants from the Grants-in-Aid for Scientific Research (KAKENHI), Japan Society for Promotion of Science (http://www.jsps.go.jp), Sumitomo Foundation (http://www.sumitomo.or.jp), Astellas Foundation for Research on Metabolic Disorders (http://www.astellas.com/jp/byoutai), Research Foundation for Opto-Science and Technology (http://www.refost-hq.jp), Kyorin University School of Medicine Collaboration Project (http://www.kyorin-u.ac.jp), NOVARTIS Foundation (Japan) for the Promotion of Science (http://novartisfound.or.jp/), and the Program for Promotion of Fundamental Studies in Health Sciences of NIBIO (National Institute of Biomedical Innovation Organization) (http://www.nibio.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araki K, 1999, CELL MOL BIOL, V45, P737; Arragain S, 2010, J BIOL CHEM, V285, P28425, DOI 10.1074/jbc.M110.106831; Chen LY, 2003, DIABETES, V52, P1723, DOI 10.2337/diabetes.52.7.1723; Ching YP, 2002, J BIOL CHEM, V277, P15237, DOI 10.1074/jbc.C200032200; COOK DL, 1984, NATURE, V311, P271, DOI 10.1038/311271a0; DUCHEN MR, 1993, BIOCHEM J, V294, P35, DOI 10.1042/bj2940035; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; FILIPPONI P, 1983, ENDOCRINOLOGY, V113, P1972, DOI 10.1210/endo-113-6-1972; GIROIX MH, 1993, BIOCHEM MED METAB B, V50, P301, DOI 10.1006/bmmb.1993.1072; Groenewoud MJ, 2008, DIABETOLOGIA, V51, P1659, DOI 10.1007/s00125-008-1083-z; Heart E, 2006, AM J PHYSIOL-ENDOC M, V290, pE143, DOI 10.1152/ajpendo.00216.2005; Hosokawa T, 2006, J NEUROSCI RES, V84, P747, DOI 10.1002/jnr.20975; Hughes E, 2006, ENDOCRINOLOGY, V147, P1396, DOI 10.1210/en.2005-1023; Komatsu M, 1998, ENDOCRINOLOGY, V139, P1172, DOI 10.1210/en.139.3.1172; Lei XY, 2008, J BIOL CHEM, V283, P34819, DOI 10.1074/jbc.M807409200; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Nakazaki M, 2002, J PHYSIOL-LONDON, V540, P781; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; OHNOSHOSAKU T, 1987, PFLUG ARCH EUR J PHY, V408, P133, DOI 10.1007/BF00581342; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Saito T, 2003, J NEUROSCI, V23, P1189, DOI 10.1523/JNEUROSCI.23-04-01189.2003; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Stancakova A, 2008, J CLIN ENDOCR METAB, V93, P1924, DOI 10.1210/jc.2007-2218; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Takeuchi F, 2009, DIABETES, V58, P1690, DOI 10.2337/db08-1494; Taniwaki T, 2005, DEV GROWTH DIFFER, V47, P163; Ubeda M, 2004, ENDOCRINOLOGY, V145, P3023, DOI 10.1210/en.2003-1522; Ubeda M, 2006, J BIOL CHEM, V281, P28858, DOI 10.1074/jbc.M604690200; Walter L, 2005, J BIOENERG BIOMEMBR, V37, P191, DOI 10.1007/s10863-005-6600-x; Wei FY, 2005, NAT MED, V11, P1104, DOI 10.1038/nm1299; YAGI T, 1993, ANAL BIOCHEM, V214, P70, DOI 10.1006/abio.1993.1458; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	36	53	61	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15553	10.1371/journal.pone.0015553	http://dx.doi.org/10.1371/journal.pone.0015553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151568	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800029
J	Daniels, TF; Wu, XL; Pan, ZX; Michal, JJ; Wright, RW; Killinger, KM; MacNeil, MD; Jiang, ZH				Daniels, Tyler F.; Wu, Xiao-Lin; Pan, Zengxiang; Michal, Jennifer J.; Wright, Raymond W., Jr.; Killinger, Karen M.; MacNeil, Michael D.; Jiang, Zhihua			The Reverse Cholesterol Transport Pathway Improves Understanding of Genetic Networks for Fat Deposition and Muscle Growth in Beef Cattle	PLOS ONE			English	Article							PHOSPHOLIPID TRANSFER PROTEIN; APOLIPOPROTEIN-E; LIPOPROTEIN METABOLISM; DENSITY-LIPOPROTEIN; LIPASE; HDL; HYPERCHOLESTEROLEMIA; POLYMORPHISMS; MECHANISMS; RECEPTOR	In the present study, thirteen genes involved in the reverse cholesterol transport (RCT) pathway were investigated for their associations with three fat depositions, eight fatty acid compositions and two growth-related phenotypes in a Wagyu x Limousin reference population, including 6 F-1 bulls, 113 F-1 dams, and 246 F-2 progeny. A total of 37 amplicons were used to screen single nucleotide polymorphisms (SNPs) on 6 F-1 bulls. Among 36 SNPs detected in 11 of these 13 genes, 19 were selected for genotyping by the Sequenom assay design on all F-2 progeny. Single-marker analysis revealed seven SNPs in ATP binding cassette A1, apolipoproteins A1, B and E, phospholipid transfer protein and paraoxinase 1 genes significantly associated with nine phenotypes (P < 0.05). Previously, we reported genetic networks associated with 19 complex phenotypes based on a total of 138 genetic polymorphisms derived from 71 known functional genes. Therefore, after Bonferroni correction, these significant (adjusted P < 0.05) and suggestive (adjusted P < 0.10) associations were then used to identify genetic networks related to the RCT pathway. Multiple-marker analysis suggested possible genetic networks involving the RCT pathway for kidney-pelvic-heart fat percentage, rib-eye area, and subcutaneous fat depth phenotypes with markers derived from paraoxinase 1, apolipoproteins A1 and E, respectively. The present study confirmed that genes involved in cholesterol homeostasis are useful targets for investigating obesity in humans as well as for improving meat quality phenotypes in a livestock production.	[Daniels, Tyler F.; Pan, Zengxiang; Michal, Jennifer J.; Wright, Raymond W., Jr.; Jiang, Zhihua] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA; [Wu, Xiao-Lin] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Killinger, Karen M.] Washington State Univ, Sch Food Sci, Pullman, WA 99164 USA; [MacNeil, Michael D.] USDA ARS, Ft Keogh Livestock & Range Res Lab, Miles City, MT 59301 USA	Washington State University; University of Wisconsin System; University of Wisconsin Madison; Washington State University; United States Department of Agriculture (USDA)	Daniels, TF (corresponding author), Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA.	jiangz@wsu.edu	Jiang, Zhihua/A-3378-2008; MacNeil, Michael D/A-6772-2009	Jiang, Zhihua/0000-0003-1986-088X; 	Merial Ltd.; Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center	Merial Ltd.; Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center	This work was supported by Merial Ltd. Animal Genomics Research Fund to Z.J. This activity was also funded, in part, with an Emerging Research Issues Internal Competitive Grant from the Washington State University, College of Agricultural, Human, and Natural Resource Sciences, Agricultural Research Center. Montana Agricultural Experiment Station was responsible for maintaining the cattle; USDA Agricultural Research Service supported collection of phenotypic data and provided DNA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alexander LJ, 2007, ANIM GENET, V38, P506, DOI 10.1111/j.1365-2052.2007.01643.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Boekholdt SM, 2006, CLIN GENET, V69, P263, DOI 10.1111/j.1399-0004.2006.00578.x; Boes E, 2009, EXP GERONTOL, V44, P136, DOI 10.1016/j.exger.2008.11.003; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Daniels TF, 2009, INT J BIOL SCI, V5, P474; FIELDING CJ, 1995, J LIPID RES, V36, P211; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Goldberg IJ, 1996, J LIPID RES, V37, P693; GROSSER J, 1981, J LIPID RES, V22, P437; Hebbachi AM, 2001, J LIPID RES, V42, P1609; Holleboom AG, 2008, CURR OPIN LIPIDOL, V19, P385, DOI 10.1097/MOL.0b013e328306a043; Hui DY, 2005, SEMIN CELL DEV BIOL, V16, P183, DOI 10.1016/j.semcdb.2005.01.003; Jiang ZH, 2005, BIOCHEM BIOPH RES CO, V334, P516, DOI 10.1016/j.bbrc.2005.06.120; Jiang Z, 2008, INT J BIOL SCI, V4, P96; Jiang ZH, 2009, INT J BIOL SCI, V5, P528; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; McCoy MG, 2002, J LIPID RES, V43, P921; Mustad VA, 1997, J LIPID RES, V38, P459; Navab M, 1996, ARTERIOSCL THROM VAS, V16, P831, DOI 10.1161/01.ATV.16.7.831; Nishida HI, 1997, J BIOL CHEM, V272, P6959, DOI 10.1074/jbc.272.11.6959; NORO A, 1995, J VET MED SCI, V57, P737, DOI 10.1292/jvms.57.737; OSCAI LB, 1982, J APPL PHYSIOL, V52, P1059, DOI 10.1152/jappl.1982.52.4.1059; Rader DJ, 2009, J LIPID RES, V50, pS189, DOI 10.1194/jlr.R800088-JLR200; Rao R, 1997, BIOCHEMISTRY-US, V36, P3645, DOI 10.1021/bi962776b; Rigotti A, 1997, CURR OPIN LIPIDOL, V8, P181, DOI 10.1097/00041433-199706000-00009; Rozen S, 2000, Methods Mol Biol, V132, P365; Rule DC, 2002, J ANIM SCI, V80, P1202; Salkind N., 2007, ENCY MEASUREMENT STA; Soutar AK, 2007, NAT CLIN PRACT CARD, V4, P214, DOI 10.1038/ncpcardio0836; Teltathum T, 2009, INT J BIOL SCI, V5, P679; Wang N, 2008, FASEB J, V22, P1073, DOI 10.1096/fj.07-9944com; WOOLLETT LA, 1992, J LIPID RES, V33, P77; Wu K, 2007, EUR HEART J, V28, P2930, DOI 10.1093/eurheartj/ehm482; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15203	10.1371/journal.pone.0015203	http://dx.doi.org/10.1371/journal.pone.0015203			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151936	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600033
J	Rahelinirina, S; Leon, A; Harstskeerl, RA; Sertour, N; Ahmed, A; Raharimanana, C; Ferquel, E; Garnier, M; Chartier, L; Duplantier, JM; Rahalison, L; Cornet, M				Rahelinirina, Soanandrasana; Leon, Albertine; Harstskeerl, Rudy A.; Sertour, Natacha; Ahmed, Ahmed; Raharimanana, Claudine; Ferquel, Elisabeth; Garnier, Martine; Chartier, Loic; Duplantier, Jean-Marc; Rahalison, Lila; Cornet, Muriel			First Isolation and Direct Evidence for the Existence of Large Small-Mammal Reservoirs of Leptospira sp in Madagascar	PLOS ONE			English	Article							WEILS DISEASE; INTERROGANS; ANTIBODIES; CARRIAGE; ASSAY; RATS	Background: Leptospirosis has long been a major public health concern in the southwestern Indian Ocean. However, in Madagascar, only a few, old studies have provided indirect serological evidence of the disease in humans or animals. Methodology/Principal Findings: We conducted a large animal study focusing on small-mammal populations. Five field trapping surveys were carried out at five sites, from April 2008 to August 2009. Captures consisted of Rattus norvegicus (35.8%), R. rattus (35.1%), Mus musculus (20.5%) and Suncus murinus (8.6%). We used microbiological culture, serodiagnosis tests (MAT) and real-time PCR to assess Leptospira infection. Leptospira carriage was detected by PCR in 91 (33.9%) of the 268 small mammals, by MAT in 17 of the 151 (11.3%) animals for which serum samples were available and by culture in 9 of the 268 animals (3.3%). Rates of infection based on positive PCR results were significantly higher in Moramanga (54%), Toliara (48%) and Mahajanga (47.4%) than in Antsiranana (8.5%) and Toamasina (14%) (p = 0.001). The prevalence of Leptospira carriage was significantly higher in R. norvegicus (48.9%), S. murinus (43.5%) and R. rattus (30.8%) than in M. musculus (9.1%) (p < 0.001). The MAT detected antibodies against the serogroups Canicola and Icterohaemorrhagiae. Isolates were characterized by serology, secY sequence-based phylogeny, partial sequencing of rrs, multi-locus VNTR analysis and pulsed field gel electrophoresis. The 10 isolates obtained from nine rats were all identified as species L. interrogans serogroup Canicola serovar Kuwait and all had identical partial rrs and secY sequences. Conclusions/Significance: We present here the first direct evidence of widespread leptospiral carriage in small mammals in Madagascar. Our results strongly suggest a high level of environmental contamination, consistent with probable transmission of the infection to humans. This first isolation of pathogenic Leptospira strains in this country may significantly improve the detection of specific antibodies in human cases.	[Rahelinirina, Soanandrasana; Raharimanana, Claudine; Rahalison, Lila] Inst Pasteur, Plague Unit, Antananarivo, Madagascar; [Leon, Albertine] IFR 146 ICORE, Frank Duncombe Lab, Caen, France; [Harstskeerl, Rudy A.; Ahmed, Ahmed] WHO FAO OIE, Amsterdam, Netherlands; [Harstskeerl, Rudy A.; Ahmed, Ahmed] KIT Biomed Res, Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Sertour, Natacha; Ferquel, Elisabeth; Garnier, Martine; Cornet, Muriel] Inst Pasteur, Natl Reference Ctr Borrelia, Paris, France; [Chartier, Loic] Inst Pasteur, Epidemiol Unit, Paris, France; [Duplantier, Jean-Marc] UMR CBGP INRA IRD Cirad Montpellier SupAgro, IRD, Montferrier Sur Lez, France; [Cornet, Muriel] Univ Grenoble 1, Parasitol Mycol Lab, CHU Grenoble, Grenoble, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Madagascar; Food & Agriculture Organization of the United Nations (FAO); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); CHU Grenoble Alpes; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Rahelinirina, S (corresponding author), Inst Pasteur, Plague Unit, Antananarivo, Madagascar.	MCornet@chu-grenoble.fr	Cornet, Muriel/M-6563-2014	Cornet, Muriel/0000-0003-4155-3675	Reseau International des Instituts Pasteur; ANR	Reseau International des Instituts Pasteur; ANR(French National Research Agency (ANR))	This work was supported by a grant from the Reseau International des Instituts Pasteur (Actions Concertees Inter Pasteuriennes, 2007). Some of the surveys in the field were financed by the ANR-SEST project "DiffusPeste". The funders played no role in study design, data collection and analysis, the decision to publish, or preparation of the manuscript.	Ahmed A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007093; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Berlioz-Arthaud A, 2007, T ROY SOC TROP MED H, V101, P714, DOI 10.1016/j.trstmh.2007.02.022; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Boisier P, 2002, EMERG INFECT DIS, V8, P311, DOI 10.3201/eid0803.010250; Bourhy P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000724; Branger C, 2005, FEMS MICROBIOL LETT, V243, P437, DOI 10.1016/j.femsle.2005.01.007; BRYGOO E. R., 1966, Arch. Inst. Pasteur Madagascar, V35, P9; BRYGOO E R, 1956, Bull Soc Pathol Exot Filiales, V49, P686; Cerqueira GM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015335; Collares-Pereira M, 1997, Cent Afr J Med, V43, P234; de Faria MT, 2008, ACTA TROP, V108, P1, DOI 10.1016/j.actatropica.2008.07.005; Duplantier J.-M., 2003, P158; Duval P, 1999, LANCET, V353, P2068, DOI 10.1016/S0140-6736(99)00103-8; Faine S., 1982, Guidelines for the control of leptospirosis.; GEAR J, 1958, S Afr Med J, V32, P94; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; HEATH CW, 1965, NEW ENGL J MED, V273, P857, DOI 10.1056/NEJM196510142731606; Henrmann-Storck C, 2005, W INDIAN MED J, V54, P42; Herrmann-Storck C, 2010, EMERG INFECT DIS, V16, P331, DOI 10.3201/eid1602.090139; Johnson MAS, 2004, EMERG INFECT DIS, V10, P1016, DOI 10.3201/eid1006.030660; KMETY D, 1978, METHOD MICROBIOL, P260; Koizumi N, 2008, JPN J INFECT DIS, V61, P465; KOTEESWARAN A, 2006, INDIAN J MICROBIOL, V27, P329; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; LHUILLIER M, 1978, Archives de l'Institut Pasteur de Madagascar, V46, P429; Matthias MA, 2002, W INDIAN MED J, V51, P10; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; *NAT REF CTR LEPT, 2008, EP LEPT FRANC; PAGANIN F, 2007, INTENS CARE MED, V17, P17; Postic D, 2000, BIOL DIAGNOSIS LEPTO, P181; Priya CG, 2007, J POSTGRAD MED, V53, P236; Ralaiarijaona R. L., 2001, Archives de l'Institut Pasteur de Madagascar, V67, P34; Salaun L, 2006, J CLIN MICROBIOL, V44, P3954, DOI 10.1128/JCM.00336-06; Salles P, 1955, ARCH I PASTEUR MADAG, V19, P23; SEEDAT YK, 1974, S AFR MED J, V48, P2012; SILVERIE R, 1968, Bulletin de la Societe de Pathologie Exotique, V61, P346; Sunbul M, 2001, SCAND J INFECT DIS, V33, P896, DOI 10.1080/00365540110076796; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TAYLOR P, 2007, 10 INT S SMALL MAMM; TERPSTRA WJ, 1987, ZBL BAKT-INT J MED M, V266, P412; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; Vinetz JM, 1996, ANN INTERN MED, V125, P794, DOI 10.7326/0003-4819-125-10-199611150-00002; WILES WA, 1979, CENT AFR J MED, V25, P261; Yersin C, 1998, AM J TROP MED HYG, V59, P933, DOI 10.4269/ajtmh.1998.59.933; Yersin C, 1999, TROP MED INT HEALTH, V4, P38, DOI 10.1046/j.1365-3156.1999.00352.x	46	44	45	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14111	10.1371/journal.pone.0014111	http://dx.doi.org/10.1371/journal.pone.0014111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124843	Green Published, gold			2022-12-27	WOS:000284572000012
J	Dobrovolny, HM; Baron, MJ; Gieschke, R; Davies, BE; Jumbe, NL; Beauchemin, CAA				Dobrovolny, Hana M.; Baron, Marc J.; Gieschke, Ronald; Davies, Brian E.; Jumbe, Nelson L.; Beauchemin, Catherine A. A.			Exploring Cell Tropism as a Possible Contributor to Influenza Infection Severity	PLOS ONE			English	Article							A VIRUS-INFECTION; ADAPTIVE IMMUNE-RESPONSE; HEPATITIS-B-VIRUS; DYNAMICS IN-VIVO; VIRAL DYNAMICS; H5N1 VIRUSES; CYTOKINE RESPONSES; EPITHELIAL-CELLS; MODEL; HEMAGGLUTININ	Several mechanisms have been proposed to account for the marked increase in severity of human infections with avian compared to human influenza strains, including increased cytokine expression, poor immune response, and differences in target cell receptor affinity. Here, the potential effect of target cell tropism on disease severity is studied using a mathematical model for in-host influenza viral infection in a cell population consisting of two different cell types. The two cell types differ only in their susceptibility to infection and rate of virus production. We show the existence of a parameter regime which is characterized by high viral loads sustained long after the onset of infection. This finding suggests that differences in cell tropism between influenza strains could be sufficient to cause significant differences in viral titer profiles, similar to those observed in infections with certain strains of influenza A virus. The two target cell mathematical model offers good agreement with experimental data from severe influenza infections, as does the usual, single target cell model albeit with biologically unrealistic parameters. Both models predict that while neuraminidase inhibitors and adamantanes are only effective when administered early to treat an uncomplicated seasonal infection, they can be effective against more severe influenza infections even when administered late.	[Dobrovolny, Hana M.; Baron, Marc J.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Gieschke, Ronald; Jumbe, Nelson L.] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland; [Davies, Brian E.] F Hoffmann La Roche Inc, Nutley, NJ USA	Toronto Metropolitan University; Roche Holding; Roche Holding	Dobrovolny, HM (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.	cbeau@ryerson.ca	Dobrovolny, Hana M./A-2447-2013; Beauchemin, Catherine AA/G-4619-2011	Dobrovolny, Hana M./0000-0003-3592-6770; Beauchemin, Catherine AA/0000-0003-0599-0069; Tripp, Ralph/0000-0002-2924-9956	Natural Sciences and Engineering Research Council of Canada; F. Hoffmann-La Roche Ltd	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); F. Hoffmann-La Roche Ltd(Hoffmann-La Roche)	This work was supported in part by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (CAAB), with additional support provided by F. Hoffmann-La Roche Ltd. The project was developed jointly by F. Hoffmann-La Roche Ltd and Dr. Beauchemin's research group. However, F. Hoffmann-La Roche Ltd had no role in data collection and analysis. F. Hoffmann-La Roche Ltd was involved in the decision to publish and in the preparation of the manuscript.	Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Bajaria SH, 2002, J ACQ IMMUN DEF SYND, V30, P41, DOI 10.1097/00042560-200205010-00006; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BOCHAROV GA, 1994, J THEOR BIOL, V167, P323, DOI 10.1006/jtbi.1994.1074; Chan MCW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-135; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Coombes R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3092; Crystal RJ, 1991, LUNG SCI FDN; Dahari H, 2005, J HEPATOL, V42, P491, DOI 10.1016/j.jhep.2004.12.017; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Jong MD, 2005, NEW ENGL J MED, V352, P686, DOI 10.1056/NEJMoa044307; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; DIEKMANN O, 1990, J MATH BIOL, V28, P365; EATON JW, 2008, GNU OCTAVE VERSION 3; Eizenberg P, 2009, MED J AUSTRALIA, V191, P151, DOI 10.5694/j.1326-5377.2009.tb02725.x; Fritz RS, 1999, J INFECT DIS, V180, P586, DOI 10.1086/314938; Gallaher WR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-51; Ganusov VV, 2002, EVOLUTION, V56, P213, DOI 10.1111/j.0014-3820.2002.tb01332.x; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Hancioglu B, 2007, J THEOR BIOL, V246, P70, DOI 10.1016/j.jtbi.2006.12.015; HANDEL A, 2007, PLOS COMPUT BIOL, V3; Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; HETHCOTE HW, 1987, MATH BIOSCI, V84, P85, DOI 10.1016/0025-5564(87)90044-7; Hindmarsh AC, 1983, IMACS T SCI COMPUTAT, V1, P55; HOLDER BP, 2010, BMC PUBLIC IN PRESS; Hsieh SM, 2006, J IMMUNOL, V176, P4530, DOI 10.4049/jimmunol.176.8.4530; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Kogure T, 2006, GLYCOCONJUGATE J, V23, P101, DOI 10.1007/s10719-006-5442-z; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Lee HY, 2009, J VIROL, V83, P7151, DOI 10.1128/JVI.00098-09; Li IWS, 2009, J CLIN VIROL, V46, P325, DOI 10.1016/j.jcv.2009.09.013; Matrosovich M, 2007, VIROLOGY, V361, P384, DOI 10.1016/j.virol.2006.11.030; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Matrosovich MN, 2004, P NATL ACAD SCI USA, V101, P4620, DOI 10.1073/pnas.0308001101; Miao HY, 2010, J VIROL, V84, P6687, DOI 10.1128/JVI.00266-10; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nicholls JM, 2007, NAT MED, V13, P147, DOI 10.1038/nm1529; Nicholls JM, 2008, TRENDS MICROBIOL, V16, P149, DOI 10.1016/j.tim.2008.01.008; Ning ZY, 2009, VET RES COMMUN, V33, P895, DOI 10.1007/s11259-009-9307-3; Nowak MA, 1996, P NATL ACAD SCI USA, V93, P4398, DOI 10.1073/pnas.93.9.4398; Nowak MA., 2000, VIRUS DYNAMICS MATH; Oh DY, 2008, J CLIN MICROBIOL, V46, P2189, DOI 10.1128/JCM.00398-08; PAYNE RJH, 1994, MATH BIOSCI, V123, P25, DOI 10.1016/0025-5564(94)90017-5; PAYNE RJH, 1992, J THEOR BIOL, V159, P215, DOI 10.1016/S0022-5193(05)80703-9; Pekosz A, 2009, VIROLOGY, V386, P61, DOI 10.1016/j.virol.2009.01.005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Saenz RA, 2010, J VIROL, V84, P3974, DOI 10.1128/JVI.02078-09; Seber G., 1989, NONLINEAR REGRESSION; Seo SH, 2002, J VIROL, V76, P1071, DOI 10.1128/JVI.76.3.1071-1076.2002; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stevens J, 2008, J MOL BIOL, V381, P1382, DOI 10.1016/j.jmb.2008.04.016; Thompson CI, 2006, J VIROL, V80, P8060, DOI 10.1128/JVI.00384-06; van den Driessche P, 2008, LECT NOTES MATH, V1945, P159; van Riel D, 2006, SCIENCE, V312, P399, DOI 10.1126/science.1125548; van Riel D, 2007, AM J PATHOL, V171, P1215, DOI 10.2353/ajpath.2007.070248; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	63	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e13811	10.1371/journal.pone.0013811	http://dx.doi.org/10.1371/journal.pone.0013811			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124892	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900002
J	Hoshida, Y				Hoshida, Yujin			Nearest Template Prediction: A Single-Sample-Based Flexible Class Prediction with Confidence Assessment	PLOS ONE			English	Article							GENE-EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; STATISTICAL-ANALYSIS; PROFILES; MICROARRAYS; SIGNATURE; DISCOVERY; OUTCOMES	Gene-expression signature-based disease classification and clinical outcome prediction has not been widely introduced in clinical medicine as initially expected, mainly due to the lack of extensive validation needed for its clinical deployment. Obstacles include variable measurement in microarray assay, inconsistent assay platform, analytical requirement for comparable pair of training and test datasets, etc. Furthermore, as medical device helping clinical decision making, the prediction needs to be made for each single patient with a measure of its reliability. To address these issues, there is a need for flexible prediction method less sensitive to difference in experimental and analytical conditions, applicable to each single patient, and providing measure of prediction confidence. The nearest template prediction (NTP) method provides a convenient way to make class prediction with assessment of prediction confidence computed in each single patient's gene-expression data using only a list of signature genes and a test dataset. We demonstrate that the method can be flexibly applied to cross-platform, cross-species, and multiclass predictions without any optimization of analysis parameters.	[Hoshida, Yujin] MIT, Broad Inst, Canc Program, Cambridge, MA 02139 USA; [Hoshida, Yujin] Harvard Univ, Cambridge, MA 02138 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Hoshida, Y (corresponding author), MIT, Broad Inst, Canc Program, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	hoshida@broadinstitute.org	Hoshida, Yujin/R-7513-2019		Charles A. King fellowship	Charles A. King fellowship	Yujin Hoshida is supported by a Charles A. King fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bair E, 2004, PLOS BIOL, V2, P511, DOI 10.1371/journal.pbio.0020108; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupuy A, 2007, JNCI-J NATL CANCER I, V99, P147, DOI 10.1093/jnci/djk018; Fan JQ, 2006, CLIN CANCER RES, V12, P4469, DOI 10.1158/1078-0432.CCR-06-1033; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Hoshida Y, 2008, NEW ENGL J MED, V359, P1995, DOI 10.1056/NEJMoa0804525; Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089; Hoshida Y, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001195; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Pittman J, 2004, BIOSTATISTICS, V5, P587, DOI 10.1093/biostatistics/kxh011; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Stegmaier K, 2004, NAT GENET, V36, P257, DOI 10.1038/ng1305; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van 't Veer LJ, 2008, NATURE, V452, P564, DOI 10.1038/nature06915; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xu L, 2008, MOL CANCER RES, V6, P760, DOI 10.1158/1541-7786.MCR-07-0344; Zervakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-53	26	152	159	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15543	10.1371/journal.pone.0015543	http://dx.doi.org/10.1371/journal.pone.0015543			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124904	gold, Green Published, Green Submitted			2022-12-27	WOS:000284527900026
J	Ye, ZQ; Niu, S; Yu, Y; Yu, H; Liu, BH; Li, RX; Xiao, HS; Zeng, R; Li, YX; Wu, JR; Li, YY				Ye, Zhi-Qiang; Niu, Shen; Yu, Yang; Yu, Hui; Liu, Bao-Hong; Li, Rong-Xia; Xiao, Hua-Sheng; Zeng, Rong; Li, Yi-Xue; Wu, Jia-Rui; Li, Yuan-Yuan			Analyses of Copy Number Variation of GK Rat Reveal New Putative Type 2 Diabetes Susceptibility Loci	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; BETA-CELL; ULTRACONSERVED ELEMENTS; EXPRESSION; IDENTIFICATION; GENES	Large efforts have been taken to search for genes responsible for type 2 diabetes (T2D), but have resulted in only about 20 in humans due to its complexity and heterogeneity. The GK rat, a spontanous T2D model, offers us a superior opportunity to search for more diabetic genes. Utilizing array comparative genome hybridization (aCGH) technology, we identifed 137 non-redundant copy number variation (CNV) regions from the GK rats when using normal Wistar rats as control. These CNV regions (CNVRs) covered approximately 36 Mb nucleotides, accounting for about 1% of the whole genome. By integrating information from gene annotations and disease knowledge, we investigated the CNVRs comprehensively for mining new T2D genes. As a result, we prioritized 16 putative protein-coding genes and two microRNA genes (rno-mir-30b and rno-mir-30d) as good candidates. The catalogue of CNVRs between GK and Wistar rats identified in this work served as a repository for mining genes that might play roles in the pathogenesis of T2D. Moreover, our efforts in utilizing bioinformatics methods to prioritize good candidate genes provided a more specific set of putative candidates. These findings would contribute to the research into the genetic basis of T2D, and thus shed light on its pathogenesis.	[Ye, Zhi-Qiang; Niu, Shen; Yu, Yang; Yu, Hui; Li, Rong-Xia; Xiao, Hua-Sheng; Zeng, Rong; Li, Yi-Xue; Wu, Jia-Rui; Li, Yuan-Yuan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Ye, Zhi-Qiang; Yu, Hui; Liu, Bao-Hong; Li, Yi-Xue; Li, Yuan-Yuan] Shanghai Ctr Bioinformat Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences	Ye, ZQ (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	wujr@sibs.ac.cn; yyli@scbit.org	Yu, Hui/A-4131-2011; Ye, Zhi-Qiang/N-8513-2014; Yu, Hui/B-3787-2018	Ye, Zhi-Qiang/0000-0002-8822-6148; 	National '863' Hi-Tech Research and Development Program of China [2009AA022710]; National '973' Basic Research Program [2010CB529206]; National Natural Science Foundation of China [30770497, 30800641]; China Postdoctoral Science Foundation [20090460669]; Chinese Academy of Sciences [KSCX2-YW-R-112]; Shanghai Committee of Science and Technology [2009B105]; SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences)	National '863' Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China); National '973' Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences)	This work was supported by grants from the National '863' Hi-Tech Research and Development Program of China (2009AA022710), the National '973' Basic Research Program (2010CB529206), the National Natural Science Foundation of China (30770497, 30800641), China Postdoctoral Science Foundation (20090460669), the Research Program of Chinese Academy of Sciences (KSCX2-YW-R-112), the Shanghai Committee of Science and Technology (2009B105) and the SA-SIBS (Sanofi Aventis - Shanghai Institutes for Biological Sciences) Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-320; Almon RR, 2009, J ENDOCRINOL, V200, P331, DOI [10.1677/JOE-80-0404, 10.1677/JOE-08-0404]; Awad IAB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-151; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cook EH, 2008, NATURE, V455, P919, DOI 10.1038/nature07458; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Derti A, 2006, NAT GENET, V38, P1216, DOI 10.1038/ng1888; Dopman EB, 2007, P NATL ACAD SCI USA, V104, P19920, DOI 10.1073/pnas.0709888104; Dwinell MR, 2009, NUCLEIC ACIDS RES, V37, pD744, DOI 10.1093/nar/gkn842; Egan CM, 2007, NAT GENET, V39, P1384, DOI 10.1038/ng.2007.19; Elbein SC, 2009, DIABETES, V58, P268, DOI 10.2337/db08-0931; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Galli J, 1996, NAT GENET, V12, P31, DOI 10.1038/ng0196-31; Gauguier D, 1996, NAT GENET, V12, P38, DOI 10.1038/ng0196-38; GOTO Y, 1975, P JPN ACAD, V51, P80, DOI 10.2183/pjab1945.51.80; Granhall C, 2006, GENETICS, V174, P1565, DOI 10.1534/genetics.106.062208; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Herrera BM, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-54; Huang B, 2009, ACTA BIOCH BIOPH SIN, V41, P472, DOI 10.1093/abbs/gmp035; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim SJ, 2007, J BIOL REG HOMEOS AG, V21, P63; Kloting N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004699; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lovis P, 2008, DIABETES, V57, P2728, DOI 10.2337/db07-1252; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; McCarroll SA, 2007, NAT GENET, V39, pS37, DOI 10.1038/ng2080; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; Megarbane A, 2009, GENET MED, V11, P611, DOI 10.1097/GIM.0b013e3181b2e34c; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Movassat J, 2007, DIABETES OBES METAB, V9, P187, DOI 10.1111/j.1463-1326.2007.00786.x; Neuvial P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-264; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Ortega FJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009022; Portha B, 2009, MOL CELL ENDOCRINOL, V297, P73, DOI 10.1016/j.mce.2008.06.013; Prokopenko I, 2008, TRENDS GENET, V24, P613, DOI 10.1016/j.tig.2008.09.004; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Schaschl H, 2009, CLIN EXP IMMUNOL, V156, P12, DOI 10.1111/j.1365-2249.2008.03865.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Smith M.L., 2006, BIOCONDUCTOR; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Stocker R, 2009, CURR OPIN LIPIDOL, V20, P227, DOI 10.1097/MOL.0b013e32832aee68; Stumvoll M, 2005, LANCET, V365, P1333, DOI 10.1016/S0140-6736(05)61032-X; Tang XQ, 2009, RNA, V15, P287, DOI 10.1261/rna.1211209; Teber ET, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S69; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Wain LV, 2009, LANCET, V374, P340, DOI 10.1016/S0140-6736(09)60249-X; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; World Health Organisation, 2008, WHO DIAB FACT SHEET; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	62	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14077	10.1371/journal.pone.0014077	http://dx.doi.org/10.1371/journal.pone.0014077			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124896	Green Submitted, Green Published, gold			2022-12-27	WOS:000284527900003
J	Guibert, F; Richard-Yris, MA; Lumineau, S; Kotrschal, K; Guemene, D; Bertin, A; Mostl, E; Houdelier, C				Guibert, Floriane; Richard-Yris, Marie-Annick; Lumineau, Sophie; Kotrschal, Kurt; Guemene, Daniel; Bertin, Aline; Moestl, Erich; Houdelier, Cecilia			Social Instability in Laying Quail: Consequences on Yolk Steroids and Offspring's Phenotype	PLOS ONE			English	Article							JAPANESE-QUAIL; TESTOSTERONE LEVELS; MATERNAL TESTOSTERONE; PRENATAL STRESS; SEX-DIFFERENCES; EMOTIONAL REACTIVITY; MALE ATTRACTIVENESS; HORMONE DEPOSITION; AGONISTIC BEHAVIOR; ANDROGEN LEVELS	Individual phenotypic characteristics of many species are influenced by non-genetic maternal effects. Female birds can influence the development of their offspring before birth via the yolk steroid content of their eggs. We investigated this prenatal maternal effect by analysing the influence of laying females' social environment on their eggs' hormonal content and on their offspring's development. Social instability was applied to groups of laying Japanese quail females. We evaluated the impact of this procedure on laying females, on yolk steroid levels and on the general development of chicks. Agonistic interactions were more frequent between females kept in an unstable social environment (unstable females) than between females kept in a stable social environment (stable females). Testosterone concentrations were higher in unstable females' eggs than in those of stable females. Unstable females' chicks hatched later and developed more slowly during their first weeks of life than those of stable females. The emotional reactivity of unstable females' chicks was higher than that of stable females' chicks. In conclusion, our study showed that social instability applied to laying females affected, in a non-genetic way, their offspring's development, thus stressing the fact that females' living conditions during laying can have transgenerational effects.	[Guibert, Floriane; Richard-Yris, Marie-Annick; Lumineau, Sophie; Houdelier, Cecilia] Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France; [Kotrschal, Kurt] Univ Vienna, Konrad Lorenz Forsch Stelle, Grunau, Austria; [Guemene, Daniel] INRA, Unite Rech Avicoles, UR83, F-37380 Nouzilly, France; [Guemene, Daniel] INRA Tours Nouzilly, URA UR83, Nouzilly, France; [Bertin, Aline] Univ Tours Haras Nationaux, CNRS, UMR Physiol Reprod & Comportements 85, INRA, Nouzilly, France; [Moestl, Erich] Univ Vet Med, Dept Nat Sci Biochem, Vienna, Austria	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Rennes; University of Vienna; INRAE; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; University of Veterinary Medicine Vienna	Guibert, F (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Rennes, France.	floriane.guibert@univ-rennes1.fr		Lumineau, Sophie/0000-0002-2076-9947	CNRS; French Ministry of Research and Egide association [17289VE]	CNRS(Centre National de la Recherche Scientifique (CNRS)); French Ministry of Research and Egide association	This work was supported by grants from the CNRS, the French Ministry of Research and Egide association (Partenariat Hubert Curien "Amadeus" number 17289VE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archer J., 1976, P231; AUBRAIS O, 1986, Gibier Faune Sauvage, V3, P317; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P2165, DOI 10.1098/rspb.2005.3194; Barbazanges A, 1996, J NEUROSCI, V16, P3943; Bertin A, 2005, J EXP ZOOL PART A, V303A, P792, DOI 10.1002/jez.a.202; Bertin A, 2004, APPL ANIM BEHAV SCI, V89, P215, DOI 10.1016/j.applanim.2004.06.004; Bertin A, 2008, HORM BEHAV, V54, P396, DOI 10.1016/j.yhbeh.2008.04.012; Bertin A, 2009, HORM BEHAV, V56, P416, DOI 10.1016/j.yhbeh.2009.07.008; Braastad BO, 1998, APPL ANIM BEHAV SCI, V61, P159, DOI 10.1016/S0168-1591(98)00188-9; Calatayud F, 2004, PHYSIOL BEHAV, V80, P465, DOI 10.1016/j.physbeh.2003.10.001; Champagne FA, 2008, FRONT NEUROENDOCRIN, V29, P386, DOI 10.1016/j.yfrne.2008.03.003; Daisley JN, 2005, HORM BEHAV, V47, P185, DOI 10.1016/j.yhbeh.2004.09.006; DEMINIERE JM, 1992, BRAIN RES, V586, P135, DOI 10.1016/0006-8993(92)91383-P; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Downing JA, 2008, PHYSIOL BEHAV, V95, P381, DOI 10.1016/j.physbeh.2008.07.001; EDENS FW, 1983, POULTRY SCI, V62, P1647, DOI 10.3382/ps.0621647; EDENS FW, 1987, COMP BIOCHEM PHYS A, V86, P469, DOI 10.1016/0300-9629(87)90527-5; EDENS FW, 1987, COMP BIOCHEM PHYS A, V86, P473, DOI 10.1016/0300-9629(87)90528-7; Eising CM, 2001, P ROY SOC B-BIOL SCI, V268, P839, DOI 10.1098/rspb.2001.1594; Eising CM, 2003, GEN COMP ENDOCR, V132, P241, DOI 10.1016/S0016-6480(03)00090-X; Eising CM, 2003, ANIM BEHAV, V66, P1027, DOI 10.1006/anbe.2003.2287; Eising CM, 2006, BIOL LETTERS, V2, P20, DOI 10.1098/rsbl.2005.0391; ETCHES RJ, 1976, STEROIDS, V28, P763, DOI 10.1016/0039-128X(76)90028-3; Forkman B, 2007, PHYSIOL BEHAV, V92, P340, DOI 10.1016/j.physbeh.2007.03.016; Formanek L, 2008, ETHOLOGY, V114, P817, DOI 10.1111/j.1439-0310.2008.01536.x; Formanek L, 2008, APPL ANIM BEHAV SCI, V112, P174, DOI 10.1016/j.applanim.2007.07.004; Formanek L, 2009, CHRONOBIOL INT, V26, P396, DOI 10.1080/07420520902892433; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Francis DD, 1999, ANN NY ACAD SCI, V896, P66, DOI 10.1111/j.1749-6632.1999.tb08106.x; Gil D, 2004, HORM BEHAV, V45, P64, DOI 10.1016/j.yhbeh.2003.08.005; Gil D, 1999, SCIENCE, V286, P126, DOI 10.1126/science.286.5437.126; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; Groothuis TG, 2002, FUNCT ECOL, V16, P281; Groothuis TGG, 2005, BIOL LETTERS, V1, P78, DOI 10.1098/rsbl.2004.0233; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Groothuis TGG, 2008, PHILOS T R SOC B, V363, P1647, DOI 10.1098/rstb.2007.0007; Guyomarc'h J.C., 1998, BWP UPDATE, V2, P27; GUYOMARCH JC, 1986, BM ONC, V104, P15; Hackl R, 2003, J COMP PHYSIOL B, V173, P327, DOI 10.1007/s00360-003-0339-7; Hayward LS, 2005, PHYSIOL BIOCHEM ZOOL, V78, P1026, DOI 10.1086/432854; Hayward LS, 2004, GEN COMP ENDOCR, V135, P365, DOI 10.1016/j.ygcen.2003.11.002; HAZARD D, 2004, 8 INT S AV END SCOTT; Hegyi G, 2010, J AVIAN BIOL, V41, P258, DOI 10.1111/j.1600-048X.2009.04787.x; HEMON YA, 1988, B MENS ONC, V127, P29; Hirschenhauser K, 2008, PHYSIOL BEHAV, V95, P457, DOI 10.1016/j.physbeh.2008.07.013; Hirschenhauser K, 1999, GEN COMP ENDOCR, V114, P67, DOI 10.1006/gcen.1998.7236; Jablonka E., 2005, EVOLUTION 4 DIMENSIO; Janczak AM, 2006, APPL ANIM BEHAV SCI, V96, P69, DOI 10.1016/j.applanim.2005.04.020; Jones RB, 1996, WORLD POULTRY SCI J, V52, P131, DOI 10.1079/WPS19960013; JONES RB, 1991, J COMP PSYCHOL, V105, P15, DOI 10.1037/0735-7036.105.1.15; JONES RB, 1988, BEHAV PROCESS, V16, P75; JONES RB, 1987, COGNITIVE ASPECTS SO, P40; Kaiser S, 2005, NEUROSCI BIOBEHAV R, V29, P283, DOI 10.1016/j.neubiorev.2004.09.015; Kendrick KM, 2001, HORM BEHAV, V40, P322, DOI 10.1006/hbeh.2001.1672; Kingma SA, 2009, BEHAV ECOL, V20, P172, DOI 10.1093/beheco/arn130; LAUNAY F, 1993, THESIS U RENNES 1 FR; Lipar JL, 1999, GEN COMP ENDOCR, V115, P220, DOI 10.1006/gcen.1999.7296; Lipar JL, 2000, P ROY SOC B-BIOL SCI, V267, P2005, DOI 10.1098/rspb.2000.1242; Liu D, 2000, NAT NEUROSCI, V3, P799, DOI 10.1038/77702; Marshall RC, 2005, J EXP BIOL, V208, P4593, DOI 10.1242/jeb.01949; Martin P., 1993, MEASURING BEHAV, V2nd, DOI [10.1017/CBO9781139168342, DOI 10.1017/CBO9781139168342]; Mazuc J, 2003, ECOL LETT, V6, P1084, DOI 10.1046/j.1461-0248.2003.00535.x; Mills AD, 1997, NEUROSCI BIOBEHAV R, V21, P261, DOI 10.1016/S0149-7634(96)00028-0; MILLS AD, 1986, BIOL BEHAV, V11, P235; MILLS AD, 1993, PHYSIOL BEHAV, V53, P183, DOI 10.1016/0031-9384(93)90029-F; Mostl E, 2001, WIEN TIERARZTL MONAT, V88, P62; Muller W, 2002, P ROY SOC B-BIOL SCI, V269, P2249, DOI 10.1098/rspb.2002.2159; Navara KJ, 2006, FUNCT ECOL, V20, P449, DOI 10.1111/j.1365-2435.2006.01114.x; Navara KJ, 2005, PHYSIOL BIOCHEM ZOOL, V78, P570, DOI 10.1086/430689; NICHOLS CR, 1991, THESIS U BRIT COLUMB; Okuliarova M, 2007, ACTA VET BRNO, V76, P325, DOI 10.2754/avb200776030325; PALME R, 1993, P 5 S AN STER, P111; Pilz KM, 2004, HORM BEHAV, V46, P179, DOI 10.1016/j.yhbeh.2004.03.004; Pilz KM, 2004, FUNCT ECOL, V18, P58, DOI 10.1111/j.1365-2435.2004.00811.x; Pilz KM, 2003, ANIM BEHAV, V65, P841, DOI 10.1006/anbe.2003.2094; Reed WL, 2001, OECOLOGIA, V128, P164, DOI 10.1007/s004420100642; Rettenbacher S, 2009, GEN COMP ENDOCR, V164, P125, DOI 10.1016/j.ygcen.2009.05.019; Romero LM, 2005, COMP BIOCHEM PHYS A, V140, P73, DOI 10.1016/j.cbpb.2004.11.004; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P344, DOI 10.1007/s00265-005-0057-0; Rubolini D, 2006, BEHAV ECOL SOCIOBIOL, V59, P549, DOI 10.1007/s00265-005-0080-1; Saino N, 2005, J EXP ZOOL PART A, V303A, P998, DOI 10.1002/jez.a.224; Sauveur B., 1987, Egg quality - current problems and recent advances., P219; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; Schwabl H, 1997, NATURWISSENSCHAFTEN, V84, P406, DOI 10.1007/s001140050418; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Schweitzer C, 2010, ANIM BEHAV, V79, P571, DOI 10.1016/j.anbehav.2009.11.023; Schweitzer C, 2009, DEV PSYCHOBIOL, V51, P311, DOI 10.1002/dev.20370; Sockman KW, 2000, P ROY SOC B-BIOL SCI, V267, P1451, DOI 10.1098/rspb.2000.1163; Summers CH, 2005, EUR J PHARMACOL, V526, P21, DOI 10.1016/j.ejphar.2005.09.059; Tanvez A, 2008, ANIM BEHAV, V75, P929, DOI 10.1016/j.anbehav.2007.08.006; Tobler M, 2007, HORM BEHAV, V52, P640, DOI 10.1016/j.yhbeh.2007.07.016; Vallee M, 1997, J NEUROSCI, V17, P2626; von Engelhardt N, 2006, P ROY SOC B-BIOL SCI, V273, P65, DOI 10.1098/rspb.2005.3274; von Engelhardt N, 2009, GEN COMP ENDOCR, V163, P175, DOI 10.1016/j.ygcen.2009.04.004; Welberg LAM, 2001, J NEUROENDOCRINOL, V13, P113, DOI 10.1046/j.1365-2826.2001.00601.x; Wewers D, 2005, BEHAV BRAIN RES, V158, P89, DOI 10.1016/j.bbr.2004.08.009; Whittingham LA, 2002, ANIM BEHAV, V63, P63, DOI 10.1006/anbe.2001.1889; Williams TD, 2004, GEN COMP ENDOCR, V136, P346, DOI 10.1016/j.ygcen.2004.01.010; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wingfield John C., 1994, P303	104	44	45	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14069	10.1371/journal.pone.0014069	http://dx.doi.org/10.1371/journal.pone.0014069			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124926	Green Published, gold, Green Submitted			2022-12-27	WOS:000284467200006
J	DiDonato, RJ; Young, ND; Butler, JE; Chin, KJ; Hixson, KK; Mouser, P; Lipton, MS; DeBoy, R; Methe, BA				DiDonato, Raymond J., Jr.; Young, Nelson D.; Butler, Jessica E.; Chin, Kuk-Jeong; Hixson, Kim K.; Mouser, Paula; Lipton, Mary S.; DeBoy, Robert; Methe, Barbara A.			Genome Sequence of the Deltaproteobacterial Strain NaphS2 and Analysis of Differential Gene Expression during Anaerobic Growth on Naphthalene	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; SULFATE-REDUCING BACTERIUM; MARINE HARBOR SEDIMENTS; QUANTIFYING EXPRESSION; DENITRIFYING BACTERIUM; ENRICHMENT CULTURE; INITIAL REACTION; DEGRADATION; GEOBACTERACEAE; TOLUENE	Background: Anaerobic polycyclic hydrocarbon (PAH) degradation coupled to sulfate reduction may be an important mechanism for in situ remediation of contaminated sediments. Steps involved in the anaerobic degradation of 2-methylnaphthalene have been described in the sulfate reducing strains NaphS3, NaphS6 and N47. Evidence from N47 suggests that naphthalene degradation involves 2-methylnaphthalene as an intermediate, whereas evidence in NaphS2, NaphS3 and NaphS6 suggests a mechanism for naphthalene degradation that does not involve 2-methylnaphthalene. To further characterize pathways involved in naphthalene degradation in NaphS2, the draft genome was sequenced, and gene and protein expression examined. Results: Draft genome sequencing, gene expression analysis, and proteomic analysis revealed that NaphS2 degrades naphthoyl-CoA in a manner analogous to benzoyl-CoA degradation. Genes including the previously characterized NmsA, thought to encode an enzyme necessary for 2-methylnaphthalene metabolism, were not upregulated during growth of NaphS2 on naphthalene, nor were the corresponding protein products. NaphS2 may possess a non-classical dearomatizing enzyme for benzoate degradation, similar to one previously characterized in Geobacter metallireducens. Identification of genes involved in toluene degradation in NaphS2 led us to determine that NaphS2 degrades toluene, a previously unreported capacity. The genome sequence also suggests that NaphS2 may degrade other monoaromatic compounds. Conclusion: This study demonstrates that steps leading to the degradation of 2-naphthoyl-CoA are conserved between NaphS2 and N47, however while NaphS2 possesses the capacity to degrade 2-methylnaphthalene, naphthalene degradation likely does not proceed via 2-methylnaphthalene. Instead, carboxylation or another form of activation may serve as the first step in naphthalene degradation. Degradation of toluene and 2-methylnaphthalene, and the presence of at least one bss-like and bbs-like gene cluster in this organism, suggests that NaphS2 degrades both compounds via parallel mechanisms. Elucidation of the key genes necessary for anaerobic naphthalene degradation may provide the ability to track naphthalene degradation through in situ transcript monitoring.	[DiDonato, Raymond J., Jr.; Young, Nelson D.; Butler, Jessica E.; Mouser, Paula] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA; [Chin, Kuk-Jeong] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Hixson, Kim K.; Lipton, Mary S.] Pacific NW Natl Lab, Div Biol Sci, Richland, WA 99352 USA; [DeBoy, Robert; Methe, Barbara A.] J Craig Venter Inst, Rockville, MD USA	University of Massachusetts System; University of Massachusetts Amherst; University System of Georgia; Georgia State University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; J. Craig Venter Institute	DiDonato, RJ (corresponding author), Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA.	rdidonat@hotmail.com	Hixson, Kim/AAJ-7714-2020; Hixson, Kim/AAW-2332-2020; Lipton, Mary S/H-3913-2012	Hixson, Kim/0000-0003-3716-0326; Hixson, Kim/0000-0003-3915-7040; Mouser, Paula/0000-0003-2316-0915	Office of Naval [N000140310315]	Office of Naval(Office of Naval Research)	This research was funded by the Office of Naval Research grant N000140310315. ONR's website is http://www.onr.navy.mil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AECKERSBERG F, 1991, ARCH MICROBIOL, V156, P5, DOI 10.1007/BF00418180; Annweiler E, 2002, APPL ENVIRON MICROB, V68, P852, DOI 10.1128/AEM.68.2.852-858.2002; Bamforth SM, 2005, J CHEM TECHNOL BIOT, V80, P723, DOI 10.1002/jctb.1276; Barragan MJL, 2004, J BACTERIOL, V186, P5762, DOI 10.1128/JB.186.17.5762-5774.2004; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Butler JE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-180; Chin KJ, 2008, MICROB ECOL, V55, P489, DOI 10.1007/s00248-007-9294-2; CLINE JD, 1969, LIMNOL OCEANOGR, V14, P454, DOI 10.4319/lo.1969.14.3.0454; Coates JD, 1996, APPL ENVIRON MICROB, V62, P1099, DOI 10.1128/AEM.62.3.1099-1101.1996; Coates JD, 1997, APPL ENVIRON MICROB, V63, P3589, DOI 10.1128/AEM.63.9.3589-3593.1997; Coates JD, 1996, ENVIRON SCI TECHNOL, V30, P2784, DOI 10.1021/es9600441; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Fouts DE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000141; Freitag TE, 2009, APPL ENVIRON MICROB, V75, P6679, DOI 10.1128/AEM.01021-09; Galushko A, 1999, ENVIRON MICROBIOL, V1, P415; HAFT DH, 2003, NUCLEIC ACIDS RES, V31, P41; Hayes LA, 1999, ORG GEOCHEM, V30, P937, DOI 10.1016/S0146-6380(99)00077-7; Holmes DE, 2004, APPL ENVIRON MICROB, V70, P7251, DOI 10.1128/AEM.70.12.7251-7259.2004; Holmes DE, 2005, APPL ENVIRON MICROB, V71, P6870, DOI 10.1128/AEM.71.11.6870-6877.2005; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kube M, 2004, ARCH MICROBIOL, V181, P182, DOI 10.1007/s00203-003-0627-3; Kuhner S, 2005, J BACTERIOL, V187, P1493, DOI 10.1128/JB.187.4.1493-1503.2005; Kulzer R, 1998, J BIOL CHEM, V273, P4897, DOI 10.1074/jbc.273.9.4897; Lee PKH, 2006, APPL ENVIRON MICROB, V72, P6161, DOI 10.1128/AEM.01070-06; Meckenstock RU, 2000, APPL ENVIRON MICROB, V66, P2743, DOI 10.1128/AEM.66.7.2743-2747.2000; Methe BA, 2005, P NATL ACAD SCI USA, V102, P10913, DOI 10.1073/pnas.0504766102; Musat F, 2009, ENVIRON MICROBIOL, V11, P209, DOI 10.1111/j.1462-2920.2008.01756.x; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; N'Guessan AL, 2010, ISME J, V4, P253, DOI 10.1038/ismej.2009.115; O'Neil RA, 2008, ENVIRON MICROBIOL, V10, P1218, DOI 10.1111/j.1462-2920.2007.01537.x; Postier B, 2008, J MICROBIOL METH, V74, P26, DOI 10.1016/j.mimet.2007.07.004; Rabus R, 1995, ARCH MICROBIOL, V164, P448, DOI 10.1007/BF02529744; RABUS R, 1993, APPL ENVIRON MICROB, V59, P1444, DOI 10.1128/AEM.59.5.1444-1451.1993; Rothermich MM, 2002, ENVIRON SCI TECHNOL, V36, P4811, DOI 10.1021/es0200241; Safinowski M, 2006, ENVIRON MICROBIOL, V8, P347, DOI 10.1111/j.1462-2920.2005.00900.x; Safinowski M, 2004, FEMS MICROBIOL LETT, V240, P99, DOI 10.1016/j.femsle.2004.09.014; Selesi D, 2010, J BACTERIOL, V192, P295, DOI 10.1128/JB.00874-09; Widdel F., 1992, PROKARYOTES, DOI 10.1007/978-1-4757-2191-1_2; Wischgoll S, 2005, MOL MICROBIOL, V58, P1238, DOI 10.1111/j.1365-2958.2005.04909.x; Zhang XM, 1997, APPL ENVIRON MICROB, V63, P4759, DOI 10.1128/AEM.63.12.4759-4764.1997; Zhang XM, 2000, BIODEGRADATION, V11, P117, DOI 10.1023/A:1011128109670	41	69	70	0	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14072	10.1371/journal.pone.0014072	http://dx.doi.org/10.1371/journal.pone.0014072			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124915	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100017
J	Ladouceur, M; Leslie, WD; Dastani, Z; Goltzman, D; Richards, JB				Ladouceur, Martin; Leslie, William D.; Dastani, Zari; Goltzman, David; Richards, J. Brent			An Efficient Paradigm for Genetic Epidemiology Cohort Creation	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; SALIVA; DNA; DENSITY	Development of novel methodologies to efficiently create large genetic epidemiology cohorts is needed. Here we describe a rapid, precise and cost-efficient method for collection of DNA from cases previously experiencing an osteoporotic fracture by identifying cases using and administrative health-care databases. Over the course of 14 months we collected DNA from 1,130 women experiencing an osteoporotic fracture, at a cost of $54 per sample. This cohort is among the larger DNA osteoporotic fracture collections in the world. The novel method described addresses a major unmet health care research need and is widely applicable to any disease that can be identified accurately through administrative data.	[Ladouceur, Martin; Richards, J. Brent] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ladouceur, Martin; Richards, J. Brent] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Leslie, William D.] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Leslie, William D.] Univ Manitoba, Dept Radiol, Winnipeg, MB, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Epidemiol, Montreal, PQ, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Biostat, Montreal, PQ, Canada; [Dastani, Zari; Richards, J. Brent] McGill Univ, Dept Occupat Hlth, Montreal, PQ, Canada; [Goltzman, David] McGill Univ, Dept Med, Montreal, PQ, Canada; [Goltzman, David] McGill Univ Hlth Ctr, Montreal, PQ, Canada; [Richards, J. Brent] Kings Coll London, London WC2R 2LS, England	McGill University; McGill University; University of Manitoba; University of Manitoba; McGill University; McGill University; McGill University; McGill University; McGill University; University of London; King's College London	Ladouceur, M (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.	brent.richards@mcgill.ca	Richards, J Brent/AAF-4225-2019	Richards, J Brent/0000-0002-3746-9086; Leslie, William/0000-0002-1056-1691	Canadian Foundation for Innovation; Canadian Institutes of Health Research (CIHR); Fonds de la recherche en sante du Quebec; Jewish General Hospital	Canadian Foundation for Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Jewish General Hospital(General Electric)	This work was supported by grants from the Canadian Foundation for Innovation, the Canadian Institutes of Health Research (CIHR), Fonds de la recherche en sante du Quebec and the Jewish General Hospital. Drs. Ladouceur, Richards and Dastani are supported by the CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Grymonpre R, 2006, MED CARE, V44, P471, DOI 10.1097/01.mlr.0000207817.32496.cb; Johnell O, 2004, OSTEOPOROSIS INT, V15, P38, DOI 10.1007/s00198-003-1490-4; Kreiger N, 1999, CAN J AGING, V18, P376, DOI 10.1017/S0714980800009934; LESLIE WD, 2009, OSTEOPOROS INT; Leslie WD, 2007, J CLIN ENDOCR METAB, V92, P77, DOI 10.1210/jc.2006-1415; Ng DPK, 2006, CLIN CHIM ACTA, V367, P81, DOI 10.1016/j.cca.2005.11.024; Nishita DM, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-71; Richards JB, 2008, LANCET, V371, P1505, DOI 10.1016/S0140-6736(08)60599-1; Rogers NL, 2007, AM J HUM BIOL, V19, P319, DOI 10.1002/ajhb.20586; Rylander-Rudqvist T, 2006, CANCER EPIDEM BIOMAR, V15, P1742, DOI 10.1158/1055-9965.EPI-05-0706; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646	11	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14045	10.1371/journal.pone.0014045	http://dx.doi.org/10.1371/journal.pone.0014045			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124974	gold, Green Published, Green Submitted			2022-12-27	WOS:000284356900008
J	Harrigan, RJ; Thomassen, HA; Buermann, W; Cummings, RF; Kahn, ME; Smith, TB				Harrigan, Ryan J.; Thomassen, Henri A.; Buermann, Wolfgang; Cummings, Robert F.; Kahn, Matthew E.; Smith, Thomas B.			Economic Conditions Predict Prevalence of West Nile Virus	PLOS ONE			English	Article							LOUIS ENCEPHALITIS-VIRUS; INFECTIOUS-DISEASE; UNITED-STATES; TRANSMISSION; ASSOCIATIONS; CULICIDAE; MOSQUITOS; VECTORS; DIPTERA; HOST	Understanding the conditions underlying the proliferation of infectious diseases is crucial for mitigating future outbreaks. Since its arrival in North America in 1999, West Nile virus (WNV) has led to population-wide declines of bird species, morbidity and mortality of humans, and expenditures of millions of dollars on treatment and control. To understand the environmental conditions that best explain and predict WNV prevalence, we employed recently developed spatial modeling techniques in a recognized WNV hotspot, Orange County, California. Our models explained 85-95% of the variation of WNV prevalence in mosquito vectors, and WNV presence in secondary human hosts. Prevalence in both vectors and humans was best explained by economic variables, specifically per capita income, and by anthropogenic characteristics of the environment, particularly human population and neglected swimming pool density. While previous studies have shown associations between anthropogenic change and pathogen presence, results show that poorer economic conditions may act as a direct surrogate for environmental characteristics related to WNV prevalence. Low-income areas may be associated with higher prevalence for a number of reasons, including variations in property upkeep, microhabitat conditions conducive to viral amplification in both vectors and hosts, host community composition, and human behavioral responses related to differences in education or political participation. Results emphasize the importance and utility of including economic variables in mapping spatial risk assessments of disease.	[Harrigan, Ryan J.; Thomassen, Henri A.; Smith, Thomas B.] Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90024 USA; [Cummings, Robert F.] Orange Cty Vector Control Dist, Garden Grove, CA USA; [Smith, Thomas B.] Univ Calif Los Angeles, Dept Ecol & Evolut Biol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Harrigan, RJ (corresponding author), Univ Calif Los Angeles, Inst Environm, Ctr Trop Res, Los Angeles, CA 90024 USA.	iluvsa@ucla.edu			US Environmental Protection Agency [R 833778]; United States Environmental Protection Agency [R 833778]; Orange County Vector Control District	US Environmental Protection Agency(United States Environmental Protection Agency); United States Environmental Protection Agency(United States Environmental Protection Agency); Orange County Vector Control District	This work was supported by the Orange County Vector Control District and a US Environmental Protection Agency grant (R 833778). Although the research described in this article has been funded wholly or partially by the United States Environmental Protection Agency through grant/cooperative agreement R 833778, it has not been subjected to the Agency's required peer and policy review and therefore does not necessarily reflect the views of the Agency and no official endorsement should be inferred. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], POOLEDINFRATE VERSIO; Bataille A, 2009, P ROY SOC B-BIOL SCI, V276, P3769, DOI 10.1098/rspb.2009.0998; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2001, STAT SCI, V16, P199, DOI 10.1214/ss/1009213726; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Breiman L., 2017, CLASSIFICATION REGRE; Brown HE, 2008, EMERG INFECT DIS, V14, P1539, DOI 10.3201/eid1410.071396; Calhoun LM, 2007, AM J TROP MED HYG, V77, P478, DOI 10.4269/ajtmh.2007.77.478; Causey D, 2003, SCIENCE, V299, P821; Cummings R.C., 1992, P MOSQ VECTOR CONTRO, V60, P170; CUMMINGS RF, 2009, P CALIF MOSQ VECTOR, V77, P116; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Enserink M, 2000, SCIENCE, V290, P1482, DOI 10.1126/science.290.5496.1482; Enserink M, 2002, SCIENCE, V297, P1988, DOI 10.1126/science.297.5589.1988; Epstein P.R., 2001, GLOBAL CHANGE HUMAN, V2, P105, DOI DOI 10.1023/A:1015089901425; Ezenwa VO, 2007, VECTOR-BORNE ZOONOT, V7, P173, DOI 10.1089/vbz.2006.0584; Ezenwa VO, 2006, P ROY SOC B-BIOL SCI, V273, P109, DOI 10.1098/rspb.2005.3284; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; Kilpatrick AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000092; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Kramer LD, 2001, CURR OPIN INFECT DIS, V14, P519, DOI 10.1097/00001432-200110000-00004; LaDeau SL, 2007, NATURE, V447, P710, DOI 10.1038/nature05829; Landesman WJ, 2007, VECTOR-BORNE ZOONOT, V7, P337, DOI 10.1089/vbz.2006.0590; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; MCBRATNEY AB, 1986, J SOIL SCI, V37, P617, DOI 10.1111/j.1365-2389.1986.tb00392.x; Milligan K, 2004, J PUBLIC ECON, V88, P1667, DOI 10.1016/j.jpubeco.2003.10.005; Miramontes R, 2006, AM J PREV MED, V30, P160, DOI 10.1016/j.amepre.2005.10.008; MOLAEI G, 2010, AM J TROP M IN PRESS; Newhouse V. F., 1966, Mosquito News, V26, P30; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, P313, DOI 10.1080/02693799008941549; PANITZER CB, 2009, EMERG INFECT DIS, V15, P1668; Patnaik JL, 2007, EMERG INFECT DIS, V13, P1788, DOI 10.3201/eid1311.070506; Pecoraro HL, 2007, J VECTOR ECOL, V32, P22, DOI 10.3376/1081-1710(2007)32[22:CALCFP]2.0.CO;2; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; Reisen WK, 2008, EMERG INFECT DIS, V14, P1747, DOI 10.3201/eid1411.080719; Reisen WK, 2008, J MED ENTOMOL, V45, P494, DOI 10.1603/0022-2585(2008)45[494:PWNVTA]2.0.CO;2; Reisen WK, 2005, J MED ENTOMOL, V42, P367, DOI 10.1603/0022-2585(2005)042[0367:AHAMDC]2.0.CO;2; REISEN WK, 1991, J MED ENTOMOL, V28, P357, DOI 10.1093/jmedent/28.3.357; Ripley B. D., 1996, PATTERN RECOGNITION; Ruiz MO, 2007, INT J HEALTH GEOGR, V6, DOI 10.1186/1476-072X-6-10; Shaman J, 2005, J MED ENTOMOL, V42, P134, DOI 10.1603/0022-2585(2005)042[0134:DAAETO]2.0.CO;2; Smith KF, 2007, ECOLOGY, V88, P1903, DOI 10.1890/06-1052.1; Su TY, 2003, J VECTOR ECOL, V28, P79; Swaddle JP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002488; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; Wimberly MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003744; Zohrabian A, 2006, EMERG INFECT DIS, V12, P375, DOI 10.3201/eid1203.050782	55	41	41	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15437	10.1371/journal.pone.0015437	http://dx.doi.org/10.1371/journal.pone.0015437			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103053	Green Submitted, gold, Green Published			2022-12-27	WOS:000284147700026
J	Joshi, R; Tawfik, A; Edeh, N; McCloud, V; Looney, S; Lewis, J; Hsu, S; Ogbureke, KUE				Joshi, Rajeshree; Tawfik, Amany; Edeh, Nneka; McCloud, Veronica; Looney, Stephen; Lewis, Jill; Hsu, Stephen; Ogbureke, Kalu U. E.			Dentin Sialophosphoprotein (DSPP) Gene-Silencing Inhibits Key Tumorigenic Activities in Human Oral Cancer Cell Line, OSC2	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES MMPS; LINKED GLYCOPROTEINS SIBLINGS; GROWTH-FACTOR VEGF; CARCINOMA-CELLS; EXPRESSION; PROTEINS; INTEGRIN; FAMILY; PHOSPHOPROTEIN; PROGRESSION	Background: We determined recently that dentin sialophosphoprotein (DSPP), a member of the SIBLING (Small integrin-binding ligand N-linked glycoproteins) family of phosphoglycoproteins, is highly upregulated in human oral squamous cell carcinomas (OSCCs) where upregulation is associated with tumor aggressiveness. To investigate the effects of DSPP-silencing on the tumorigenic profiles of the oral cancer cell line, OSC2, short-hairpin RNA (shRNA) interference was employed to silence DSPP in OSC2 cells. Methodology/Principal Findings: Multiple regions of DSPP transcript were targeted for shRNA interference using hDSP-shRNA lentiviral particles designed to silence DSPP gene expression. Control shRNA plasmid encoding a scrambled sequence incapable of degrading any known cellular mRNA was used for negative control. Following puromycin selection of stable lines of DSSP-silenced OSC2 cells, phenotypic hallmarks of oral carcinogenesis were assayed by western blot and RT-PCR analyses, MTT (cell-viability), colony-formation, modified Boyden-Chamber (migration and invasion), and flow cytometry (cell-cycle and apoptosis) analyses. DSPP-silenced OSC2 cells showed altered cell morphology, reduced viability, decreased colony-formation ability, decreased migration and invasion, G0/G1 cell-cycle arrest, and increased tumor cell sensitivity to cisplatin-induced apoptosis. Furthermore, MMP-2, MMP-3, MMP-9, VEGF, Ki-67, p53, and EGFR were down-regulated. There was a direct correlation between the degree of DSPP-silencing and MMP suppression, as indicated by least squares regression: MMP-2 {(y = 0.850x, p<0.001) (y = 1.156x, p<0.001)}, MMP-3 {(y = 0.994x, p<0.001) (y = 1.324x, p = 0.004)}, and MMP-9 {(y = 1.248x, p = 0.005, y = 0.809, p = 0.013)}. Conclusions/Significance: DSPP-silencing in OSC2 cell decreased salient hallmarks of oral tumorigenesis and provides the first functional evidence of a potential key role for DSPP in oral cancer biology. The down-regulation of MMP-2, MMP-3, MMP-9, p53 and VEGF in DSPP-silenced OSC2 cells provides a significant functional/molecular framework for deciphering the mechanisms of DSPP activities in oral cancer biology.	[Joshi, Rajeshree; Tawfik, Amany; Edeh, Nneka; McCloud, Veronica; Lewis, Jill; Hsu, Stephen; Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA; [Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Med, Dept Pathol, Augusta, GA 30912 USA; [Looney, Stephen; Ogbureke, Kalu U. E.] Med Coll Georgia, Sch Dent, Dept Oral Hlth & Diagnost Sci, Augusta, GA 30912 USA; [Looney, Stephen] Med Coll Georgia, Dept Biostat, Sch Grad Studies, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	Joshi, R (corresponding author), Med Coll Georgia, Sch Dent, Dept Oral Biol, Augusta, GA 30912 USA.	kogbureke@mail.mcg.edu	Ogbureke, Kalu/AAI-9904-2020; Tawfik, Amany/AAN-9902-2020	Tawfik, Amany/0000-0002-0245-8256; Ogbureke, Kalu/0000-0001-9227-0718	National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH) [K23DE017791-01A1]; Medical College of Georgia Research Institute (MCGRI), Inc. [STP00105W005]; Wendy Will Case Cancer Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [K23DE017791] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical College of Georgia Research Institute (MCGRI), Inc.; Wendy Will Case Cancer Foundation; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by the National Institute of Dental and Craniofacial Research (NIDCR)/National Institutes of Health (NIH) Grant # K23DE017791-01A1 (KUEO); Medical College of Georgia Research Institute (MCGRI), Inc. Grant # STP00105W005 (KUEO); and by Wendy Will Case Cancer Foundation (KUEO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora S, 2005, CLIN CANCER RES, V11, P2272, DOI 10.1158/1078-0432.CCR-04-0572; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; CHANG SE, 1992, INT J CANCER, V52, P896, DOI 10.1002/ijc.2910520612; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Dang DM, 2004, BIOCHEM BIOPH RES CO, V316, P937, DOI 10.1016/j.bbrc.2004.02.143; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Fedarko NS, 2004, FASEB J, V18, P734, DOI 10.1096/fj.03-0966fje; Fisher LW, 2004, CLIN CANCER RES, V10, P8501, DOI 10.1158/1078-0432.CCR-04-1072; Fisher LW, 2003, CONNECT TISSUE RES, V44, P33, DOI 10.1080/03008200390152061; GEORGE A, 1993, J BIOL CHEM, V268, P12624; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Hiraishi Y, 2008, PATHOL ONCOL RES, V14, P39, DOI 10.1007/s12253-008-9020-5; Hsu S, 2005, ANTICANCER RES, V25, P63; Hunter GK, 1996, BIOCHEM J, V317, P59, DOI 10.1042/bj3170059; Jain A, 2009, CLIN CANCER RES, V15, P5199, DOI 10.1158/1078-0432.CCR-09-0783; Johnstone S, 2006, ORAL ONCOL, V42, P337, DOI 10.1016/j.oraloncology.2005.06.020; Karadag A, 2004, JNCI-J NATL CANCER I, V96, P956, DOI 10.1093/jnci/djh169; Kim SH, 2006, J SURG ONCOL, V93, P330, DOI 10.1002/jso.20461; Ogbureke KUE, 2007, ORAL ONCOL, V43, P920, DOI 10.1016/j.oraloncology.2006.11.011; Ogbureke KUE, 2007, J HISTOCHEM CYTOCHEM, V55, P403, DOI 10.1369/jhc.6A7075.2007; Ogbureke KUE, 2010, CANCER-AM CANCER SOC, V116, P1709, DOI 10.1002/cncr.24938; Ogbureke KUE, 2005, KIDNEY INT, V68, P155, DOI 10.1111/j.1523-1755.2005.00389.x; Ogbureke KUE, 2004, J DENT RES, V83, P664, DOI 10.1177/154405910408300902; OSAKI T, 1994, ORAL ONCOL, V30B, P296, DOI 10.1016/0964-1955(94)90028-0; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Tandon S, 2010, CANCER EPIDEM BIOMAR, V19, P574, DOI 10.1158/1055-9965.EPI-09-0981; VEIS A, 1967, BIOCHEMISTRY-US, V6, P2409, DOI 10.1021/bi00860a017; von Marschall Z, 2010, MATRIX BIOL, V29, P295, DOI 10.1016/j.matbio.2010.01.002; Yoneda K, 1999, EUR J CANCER, V35, P278, DOI 10.1016/S0959-8049(98)00291-3; Zhou XJ, 2009, INT J CANCER, V124, P483, DOI 10.1002/ijc.23964	30	18	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13974	10.1371/journal.pone.0013974	http://dx.doi.org/10.1371/journal.pone.0013974			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103065	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700019
J	Kalappa, BI; Gusev, AG; Uteshev, VV				Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.			Activation of Functional alpha 7-Containing nAChRs in Hippocampal CA1 Pyramidal Neurons by Physiological Levels of Choline in the Presence of PNU-120596	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; TRANSIENT FOREBRAIN ISCHEMIA; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; COGNITIVE IMPROVEMENT; ALPHA-7 RECEPTORS; RAT HIPPOCAMPUS; SPATIAL MEMORY; ACH RECEPTORS; INTERNEURONS	Background: The level of expression of functional alpha 7-containing nicotinic acetylcholine receptors (nAChRs) in hippocampal CA1 pyramidal neurons is believed to be very low compared to hippocampal CA1 interneurons, and for many years this expression was largely overlooked. However, high densities of expression of functional alpha 7-containing nAChRs in CA1 pyramidal neurons may not be necessary for triggering important cellular and network functions, especially if activation of alpha 7-containing nAChRs occurs in the presence of positive allosteric modulators such as PNU-120596. Methodology/Principal Findings: An approach previously developed for alpha 7-containing nAChRs expressed in tuberomammillary neurons was applied to investigate functional CA1 pyramidal alpha 7-containing nAChRs using rat coronal hippocampal slices and patch-clamp electrophysiology. The majority (similar to 71%) of tested CA1 pyramidal neurons expressed low densities of functional alpha 7-containing nAChRs as evidenced by small whole-cell responses to choline, a selective endogenous agonist of alpha 7 nAChRs. These responses were potentiated by PNU-120596, a novel positive allosteric modulator of alpha 7 nAChRs. The density of functional alpha 7-containing nAChRs expressed in CA1 pyramidal neurons (and thus, the normalized net effect of activation, i.e., response net charge per unit of membrane capacitance per unit of time) was estimated to be similar to 5% of the density observed in CA1 interneurons. The results of this study demonstrate that despite low levels of expression of functional pyramidal alpha 7-containing nAChRs, physiological levels of choline (similar to 10 mM) are sufficient to activate these receptors and transiently depolarize and even excite CA1 pyramidal neurons in the presence of PNU-120596. The observed effects are possible because in the presence of 10 mM choline and 1-5 mM PNU-120596, a single opening of an individual pyramidal alpha 7-containing nAChR ion channel appears to transiently depolarize (similar to 4 mV) the entire pyramidal neuron and occasionally trigger action potentials. Conclusions: 1) The majority of hippocampal CA1 pyramidal neurons express functional alpha 7-containing nAChRs. In the absence of PNU-120596, a positive allosteric modulator of alpha 7 nAChRs, a lack of responsiveness of some hippocampal CA1 pyramidal neurons to focal application of 0.5-1 mM choline does not imply a lack of expression of functional alpha 7-containing nAChRs in these neurons. Rather, it may indicate a lack of detection of alpha 7-containing nAChR-mediated currents by patch-clamp electrophysiology. 2) PNU-120596 can serve as a powerful tool for detection and enhancement of responsiveness of low densities of functional alpha 7-containing nAChRs such as those present in hippocampal CA1 pyramidal neurons. 3) In the presence of PNU-120596, physiological concentrations of choline activate functional CA1 pyramidal alpha 7-containing nAChRs and produce step-like currents that cause repetitive step-like depolarizations, occasionally triggering bursts of action potentials in CA1 pyramidal neurons. Therefore, the results of this study suggest that in the presence of PNU-120596 and possibly other positive allosteric modulators, endogenous choline may persistently activate CA1 pyramidal alpha 7-containing nAChRs, enhance the excitability of CA1 pyramidal neurons and thus act as a potent therapeutic agent with potential neuroprotective and cognition-enhancing properties.	[Kalappa, Bopanna I.; Gusev, Alexander G.; Uteshev, Victor V.] So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA	Southern Illinois University System; Southern Illinois University	Kalappa, BI (corresponding author), So Illinois Univ, Sch Med, Dept Pharmacol, Springfield, IL 62794 USA.	vuteshev@siumed.edu			NIH [DA021216, DK082625]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082625] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA021216] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by the NIH grants DA021216 (http://www.nida.nih.gov/) and DK082625 (http://www2.niddk.nih.gov/) to VU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CE, 2002, DEV BRAIN RES, V139, P175, DOI 10.1016/S0165-3806(02)00547-3; AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Albuquerque EX, 1997, J PHARMACOL EXP THER, V280, P1117; ALKONDON M, 1994, J PHARMACOL EXP THER, V271, P494; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; ARENDASH GW, 1995, PHARMACOL BIOCHEM BE, V52, P517, DOI 10.1016/0091-3057(95)00119-H; BARRON SC, 2009, MOL PHARM; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Bobinski M, 1998, BRAIN RES, V805, P267, DOI 10.1016/S0006-8993(98)00759-8; Buccafusco J, 2004, MOL INTERV, V4, P285, DOI 10.1124/mi.4.5.8; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; Buccafusco JJ, 2004, J ALZHEIMERS DIS, V6, pS85; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Disterhoft JF, 2007, AGING CELL, V6, P327, DOI 10.1111/j.1474-9726.2007.00297.x; Disterhoft JF, 2006, TRENDS NEUROSCI, V29, P587, DOI 10.1016/j.tins.2006.08.005; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Faghih Ramin, 2007, Recent Pat CNS Drug Discov, V2, P99; Frazier CJ, 1998, J NEUROSCI, V18, P8228; Frazier CJ, 1998, J NEUROSCI, V18, P1187; Grimm D, 1998, HUM GENE THER, V9, P2745, DOI 10.1089/hum.1998.9.18-2745; Gronlien JH, 2007, MOL PHARMACOL, V72, P715, DOI 10.1124/mol.107.035410; Grybko M, 2010, J MOL NEUROSCI, V40, P114, DOI 10.1007/s12031-009-9266-8; GUSEV AG, 2009, J PHARM EXP THER; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Ji D, 2001, NEURON, V31, P131, DOI 10.1016/S0896-6273(01)00332-4; Ji DY, 2000, J NEUROPHYSIOL, V83, P2682, DOI 10.1152/jn.2000.83.5.2682; Jiang Z, 2010, J NEUROSCI, V30, P2582, DOI 10.1523/JNEUROSCI.3971-09.2010; Jones S, 1997, J PHYSIOL-LONDON, V504, P603, DOI 10.1111/j.1469-7793.1997.603bd.x; JOPE RS, 1991, NEUROCHEM RES, V16, P1219, DOI 10.1007/BF00966699; Kaczorowski CC, 2009, LEARN MEMORY, V16, P362, DOI 10.1101/lm.1365609; Kandel ER, 2009, J NEUROSCI, V29, P12748, DOI 10.1523/JNEUROSCI.3958-09.2009; Kem WR, 2000, BEHAV BRAIN RES, V113, P169, DOI 10.1016/S0166-4328(00)00211-4; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; LOPEZHERNANDEZ GY, 2009, NEUROPHARMACOLOGY; McQuiston AR, 1999, J NEUROSCI, V19, P2887; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V287, P918; Mielke JG, 2009, NEUROSCI RES, V65, P296, DOI 10.1016/j.neures.2009.08.003; Mike A, 2000, BRAIN RES, V882, P155, DOI 10.1016/S0006-8993(00)02863-8; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parikh V, 2006, J NEUROCHEM, V97, P488, DOI 10.1111/j.1471-4159.2006.03766.x; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Roncarati R, 2008, ASSAY DRUG DEV TECHN, V6, P181, DOI 10.1089/adt.2007.120; Ross RG, 2010, J CHILD PSYCHOL PSYC, V51, P535, DOI 10.1111/j.1469-7610.2009.02187.x; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Son JH, 2008, J COMP NEUROL, V511, P286, DOI 10.1002/cne.21828; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Verbois SL, 2003, NEUROPHARMACOLOGY, V44, P224, DOI 10.1016/S0028-3908(02)00366-0; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105; Zapata A, 1998, J NEUROSCI, V18, P3597	71	33	33	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13964	10.1371/journal.pone.0013964	http://dx.doi.org/10.1371/journal.pone.0013964			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103043	Green Submitted, Green Published, gold			2022-12-27	WOS:000284147700014
J	Bettencourt, LMA; Lobo, J; Strumsky, D; West, GB				Bettencourt, Luis M. A.; Lobo, Jose; Strumsky, Deborah; West, Geoffrey B.			Urban Scaling and Its Deviations: Revealing the Structure of Wealth, Innovation and Crime across Cities	PLOS ONE			English	Article							INCREASING RETURNS; CITY; PRODUCTIVITY; GROWTH; LIFE	With urban population increasing dramatically worldwide, cities are playing an increasingly critical role in human societies and the sustainability of the planet. An obstacle to effective policy is the lack of meaningful urban metrics based on a quantitative understanding of cities. Typically, linear per capita indicators are used to characterize and rank cities. However, these implicitly ignore the fundamental role of nonlinear agglomeration integral to the life history of cities. As such, per capita indicators conflate general nonlinear effects, common to all cities, with local dynamics, specific to each city, failing to provide direct measures of the impact of local events and policy. Agglomeration nonlinearities are explicitly manifested by the superlinear power law scaling of most urban socioeconomic indicators with population size, all with similar exponents (similar to 1.15). As a result larger cities are disproportionally the centers of innovation, wealth and crime, all to approximately the same degree. We use these general urban laws to develop new urban metrics that disentangle dynamics at different scales and provide true measures of local urban performance. New rankings of cities and a novel and simpler perspective on urban systems emerge. We find that local urban dynamics display long-term memory, so cities under or outperforming their size expectation maintain such (dis)advantage for decades. Spatiotemporal correlation analyses reveal a novel functional taxonomy of U. S. metropolitan areas that is generally not organized geographically but based instead on common local economic models, innovation strategies and patterns of crime.	[Bettencourt, Luis M. A.; West, Geoffrey B.] Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Los Alamos Natl Lab, CNLS, Los Alamos, NM USA; [Bettencourt, Luis M. A.; West, Geoffrey B.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Lobo, Jose] Arizona State Univ, Sch Human Evolut & Social Change, Tempe, AZ USA; [Lobo, Jose] Arizona State Univ, WP Carey Sch Business, Tempe, AZ USA; [Strumsky, Deborah] Univ N Carolina, Dept Geog & Earth Sci, Charlotte, NC 28223 USA	United States Department of Energy (DOE); Los Alamos National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; The Santa Fe Institute; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Charlotte	Bettencourt, LMA (corresponding author), Los Alamos Natl Lab, Div Theoret, Los Alamos, NM USA.	lmbett@lanl.gov	Bettencourt, Luis/R-9861-2019; Strumsky, Deborah/F-5795-2013; Lobo, Jose/AAG-2746-2021	Lobo, Jose/0000-0002-0814-7168	James S. McDonnell Foundation 21st Century Science Initiative; Rockefeller Foundation; National Science Foundation [CBET-0939958, PHY 0202180]; Los Alamos National Laboratory	James S. McDonnell Foundation 21st Century Science Initiative; Rockefeller Foundation; National Science Foundation(National Science Foundation (NSF)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory)	This work was partially supported by a James S. McDonnell Foundation 21st Century Science Initiative in Studying Complex Systems Research Award (http://www.jsmf.org/programs/cs/), the Rockefeller Foundation (http://www.rockefellerfoundation.org/), the National Science Foundation grants CBET-0939958 and PHY 0202180, and the Los Alamos National Laboratory Laboratory Directed Research and Development (LDRD) program (http://www.lanl.gov/science/ldrd/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 1998, EC CITIES SUBURBS; [Anonymous], [No title captured], DOI DOI 10.5198/JFIU.V1I1.29; [Anonymous], 1999, NETWORKS GLOBAL VILL; Arbesman S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.016115; Ash C, 2008, SCIENCE, V319, P739, DOI 10.1126/science.319.5864.739; Bairoch P., 1991, CITIES EC DEV DAWN H, DOI [10.5744/bi.2019.1010, DOI 10.5744/BI.2019.1010]; Batty M., 2007, CITIES COMPLEXITY UN; BATTY M, 2009, ENVIRON PLANN A, V8, P189; Batty M, 2008, SCIENCE, V319, P769, DOI 10.1126/science.1151419; Batty M, 2006, NATURE, V444, P592, DOI 10.1038/nature05302; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2007, RES POLICY, V36, P107, DOI 10.1016/j.respol.2006.09.026; Breschi S., 2001, IND CORP CHANGE, V10, P975, DOI DOI 10.1093/ICC/10.4.975; Carneiro RL, 2000, P NATL ACAD SCI USA, V97, P12926, DOI 10.1073/pnas.240462397; CHOWELL G, 1999, PHYS REV E, V68; CHRISTALLER W, 1933, ZENTRALEN ORTE DDEUT; DURANTON G, 2009, AM ECON REV, V97, P197; Enquist BJ, 2009, P NATL ACAD SCI USA, V106, P7046, DOI 10.1073/pnas.0812303106; *FBI, FBIS UN CRIM REP; Feldman MP, 1999, EUR ECON REV, V43, P409, DOI 10.1016/S0014-2921(98)00047-6; FISCHER CS, 1992, DWELL FRIENDS PERSON; Florida R., 2004, CITIES CREATIVE CLAS, P1, DOI [10.4324/9780203997673, DOI 10.4324/9780203997673]; Fujita M., 2001, SPATIAL EC CITIES RE; Glaeser EL, 2009, J ECON LIT, V47, P983, DOI 10.1257/jel.47.4.983; Glaeser EL, 1999, J POLIT ECON, V107, pS225, DOI 10.1086/250109; GLAESER EL, 2007, 13710 NBER; Gottdiener Mark, 2010, NEW URBAN SOCIOLOGY; Hall P., 1998, CITIES CIVILIZATION; Henderson JV, 2007, REG SCI URBAN ECON, V37, P497, DOI 10.1016/j.regsciurbeco.2006.11.010; Henderson JV, 1988, URBAN DEV THEORY FAC; Hou C, 2010, P NATL ACAD SCI USA, V107, P3634, DOI 10.1073/pnas.0908071107; Jacobs J., 1961, DEATH LIFE GREAT AM; KRUGMAN P, 1991, J POLIT ECON, V99, P483, DOI 10.1086/261763; Losch A., 1954, EC LOCATION; May RM, 2000, SCIENCE, V290, P2084, DOI 10.1126/science.290.5499.2084; MOOMAW RL, 1981, Q J ECON, V96, P675, DOI 10.2307/1880747; Mumford L., 1961, CITY HIST ITS ORIGIN, DOI DOI 10.1016/j.jaa.2011.06.005; *NAT RES COUNC NAT, 2008, UND CRIM TRENDS WORK; Newman M., 2005, STRUCTURE DYNAMICS N; SEGAL D, 1976, REV ECON STAT, V58, P339, DOI 10.2307/1924956; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; SVEIKAUSKAS L, 1975, Q J ECON, V89, P393, DOI 10.2307/1885259; Thisse, 2004, HDB REGIONAL URBAN E, P2063, DOI [10.1016/S1574-0080(04)80005-1, DOI 10.1016/S1574-0080(04)80005-1]; UN-HABITAT, 2009, STAT WORLDS CIT 2008; *US BUR EC AN, GMP INC WAG; Waters JS, 2010, AM NAT, V176, P501, DOI 10.1086/656266; West GB, 1999, SCIENCE, V284, P1677, DOI 10.1126/science.284.5420.1677; Wirth L, 1938, AM J SOCIOL, V44, P1, DOI 10.1086/217913	50	286	293	21	130	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13541	10.1371/journal.pone.0013541	http://dx.doi.org/10.1371/journal.pone.0013541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZN	21085659	gold, Green Submitted, Green Published			2022-12-27	WOS:000284036800004
J	Edwards, LA; Nistala, K; Mills, DC; Stephenson, HN; Zilbauer, M; Wren, BW; Dorrell, N; Lindley, KJ; Wedderburn, LR; Bajaj-Elliott, M				Edwards, Lindsey A.; Nistala, Kiran; Mills, Dominic C.; Stephenson, Holly N.; Zilbauer, Matthias; Wren, Brendan W.; Dorrell, Nick; Lindley, Keith J.; Wedderburn, Lucy R.; Bajaj-Elliott, Mona			Delineation of the Innate and Adaptive T-Cell Immune Outcome in the Human Host in Response to Campylobacter jejuni Infection	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; NATURAL-KILLER-CELLS; DENDRITIC CELLS; CYTOKINE PRODUCTION; INTESTINAL-MUCOSA; ESCHERICHIA-COLI; INTERLEUKIN 22; IN-VITRO; PATHOGENESIS; BETA-DEFENSIN-2	Background: Campylobacter jejuni is the most prevalent cause of bacterial gastroenteritis worldwide. Despite the significant health burden this infection presents, molecular understanding of C. jejuni-mediated disease pathogenesis remains poorly defined. Here, we report the characterisation of the early, innate immune response to C. jejuni using an ex-vivo human gut model of infection. Secondly, impact of bacterial-driven dendritic cell activation on T-cell mediated immunity was also sought. Methodology: Healthy, control paediatric terminal ileum or colonic biopsy tissue was infected with C. jejuni for 8-12 hours. Bacterial colonisation was followed by confocal microscopy and mucosal innate immune responses measured by ELISA. Marked induction of IFN gamma with modest increase in IL-22 and IL-17A was noted. Increased mucosal IL-12, IL-23, IL-1 beta and IL-6 were indicative of a cytokine milieu that may modulate subsequent T-cell mediated immunity. C. jejuni-driven human monocyte-derived dendritic cell activation was followed by analyses of T cell immune responses utilising flow cytometry and ELISA. Significant increase in Th-17, Th-1 and Th-17/Th-1 double-positive cells and corresponding cytokines was observed. The ability of IFN gamma, IL-22 and IL-17 cytokines to exert host defence via modulation of C. jejuni adhesion and invasion to intestinal epithelia was measured by standard gentamicin protection assay. Conclusions: Both innate and adaptive T cell-immunity to C. jejuni infection led to the release of IFN gamma, IL-22 and IL-17A; suggesting a critical role for this cytokine triad in establishing host anti-microbial immunity during the acute and effectors phase of infection. In addition, to their known anti-microbial functions; IL-17A and IL-17F reduced the number of intracellular C. jejuni in intestinal epithelia, highlighting a novel aspect of how IL-17 family members may contribute to protective immunity against C. jejuni.	[Edwards, Lindsey A.; Lindley, Keith J.] Inst Child Hlth, Autoimmun Unit, London, England; [Mills, Dominic C.; Wren, Brendan W.; Dorrell, Nick] London Sch Hyg & Trop Med, Pathogen Mol Biol Dept, London WC1, England; [Zilbauer, Matthias] Addenbrookes Hosp, Cambridge, England; [Lindley, Keith J.] Inst Child Hlth, Surg Unit, London, England	University of London; University College London; University of London; London School of Hygiene & Tropical Medicine; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of London; University College London	Edwards, LA (corresponding author), Inst Child Hlth, Autoimmun Unit, London, England.	m.bajaj-elliott@ich.ucl.ac.uk	Edwards, Lindsey Ann/AAC-1156-2020; Zilbauer, Matthias/AAZ-2740-2020; Edwards, Lindsey/L-8536-2015	Edwards, Lindsey Ann/0000-0002-8222-4555; Zilbauer, Matthias/0000-0002-7272-0547; Edwards, Lindsey/0000-0002-8222-4555; Dorrell, Nick/0000-0003-1144-6502; Wedderburn, Lucy/0000-0002-7495-1429; Bajaj-Elliott, Mona/0000-0002-5234-576X	Institute of Child Health/Great Ormond Street Hospital Special Trustees [05ID04]; Bloomsbury Colleges; Biomedical Research Centre; MRC	Institute of Child Health/Great Ormond Street Hospital Special Trustees; Bloomsbury Colleges; Biomedical Research Centre; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by the Institute of Child Health/Great Ormond Street Hospital Special Trustees 05ID04 (to MB-E and KJL). KN is an Arthritis Research Campaign Clinical Fellow (ref 17998). The following were supported by PhD studentships: DCM (Bloomsbury Colleges), HNS (Biomedical Research Centre) and MZ (MRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awasthi A, 2009, INT IMMUNOL, V21, P489, DOI 10.1093/intimm/dxp021; Beaurepaire C, 2009, J INTERF CYTOK RES, V29, P133, DOI 10.1089/jir.2008.0057; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Ciccia F, 2009, ARTHRITIS RHEUM-US, V60, P955, DOI 10.1002/art.24389; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Dixon GLJ, 2001, INFECT IMMUN, V69, P4351, DOI 10.1128/IAI.69.7.4351-4357.2001; Dorrell N, 2007, CURR OPIN INFECT DIS, V20, P514, DOI 10.1097/QCO.0b013e3282a56b15; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Gurney AL, 2004, INT IMMUNOPHARMACOL, V4, P669, DOI 10.1016/j.intimp.2004.01.016; HADDOCK G, 2010, MICROBIOLOGY    0708; Hicks S, 1996, INFECT IMMUN, V64, P4751, DOI 10.1128/IAI.64.11.4751-4760.1996; Hu L, 2006, INFECT IMMUN, V74, P2697, DOI 10.1128/IAI.74.5.2697-2705.2006; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Karlyshev AV, 2001, INFECT IMMUN, V69, P5921, DOI 10.1128/IAI.69.9.5921-5924.2001; Kubota K, 2010, SCAND J IMMUNOL, V71, P199, DOI 10.1111/j.1365-3083.2009.02366.x; Kuijf ML, 2010, J IMMUNOL, V185, P748, DOI 10.4049/jimmunol.0903014; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2007, J IMMUNOL, V179, P7791, DOI 10.4049/jimmunol.179.11.7791; Lippert E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007413; Luangtongkum T, 2009, FUTURE MICROBIOL, V4, P189, DOI 10.2217/17460913.4.2.189; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; MacCallum AJ, 2006, MICROBIOL-SGM, V152, P3661, DOI 10.1099/mic.0.29234-0; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Moe KK, 2010, J VET MED SCI, V72, P411, DOI 10.1292/jvms.09-0339; Monteiro MA, 2009, INFECT IMMUN, V77, P1128, DOI 10.1128/IAI.01056-08; Nistala K, 2008, ARTHRITIS RHEUM-US, V58, P875, DOI 10.1002/art.23291; Nistala K, 2010, P NATL ACAD SCI USA, V107, P14751, DOI 10.1073/pnas.1003852107; Oberhelman RA, 2003, J INFECT DIS, V187, P260, DOI 10.1086/367676; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Poly F, 2008, CURR OPIN GASTROEN, V24, P27, DOI 10.1097/MOG.0b013e3282f1dcb1; Rathinam VAK, 2009, INFECT IMMUN, V77, P2499, DOI 10.1128/IAI.01562-08; Rescigno M, 2009, J CLIN INVEST, V119, P2441, DOI 10.1172/JCI39134; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Schuller S, 2009, CELL MICROBIOL, V11, P521, DOI 10.1111/j.1462-5822.2008.01275.x; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033; Watson RO, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040014; Wolk K, 2010, SEMIN IMMUNOPATHOL, V32, P17, DOI 10.1007/s00281-009-0188-x; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Zilbauer M, 2005, INFECT IMMUN, V73, P7281, DOI 10.1128/IAI.73.11.7281-7289.2005; Zilbauer M, 2007, CELL MICROBIOL, V9, P2404, DOI 10.1111/j.1462-5822.2007.00969.x	49	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15398	10.1371/journal.pone.0015398	http://dx.doi.org/10.1371/journal.pone.0015398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085698	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000284035900027
J	Cerqueira, GM; McBride, AJA; Hartskeerl, RA; Ahmed, N; Dellagostin, OA; Eslabao, MR; Nascimento, ALTO				Cerqueira, Gustavo M.; McBride, Alan J. A.; Hartskeerl, Rudy A.; Ahmed, Niyaz; Dellagostin, Odir A.; Eslabao, Marcus R.; Nascimento, Ana L. T. O.			Bioinformatics Describes Novel Loci for High Resolution Discrimination of Leptospira Isolates	PLOS ONE			English	Article							SP NOV.; IDENTIFICATION; PROTEINS; SEROVARS	Background: Leptospirosis is one of the most widespread zoonoses in the world and with over 260 pathogenic serovars there is an urgent need for a molecular system of classification. The development of multilocus sequence typing (MLST) schemes for Leptospira spp. is addressing this issue. The aim of this study was to identify loci with potential to enhance Leptospira strain discrimination by sequencing-based methods. Methodology and Principal Findings: We used bioinformatics to evaluate pre-existing loci with the potential to increase the discrimination of outbreak strains. Previously deposited sequence data were evaluated by phylogenetic analyses using either single or concatenated sequences. We identified and evaluated the applicability of the ligB, secY, rpoB and lipL41 loci, individually and in combination, to discriminate between 38 pathogenic Leptospira strains and to cluster them according to the species they belonged to. Pairwise identity among the loci ranged from 82.0-92.0%, while interspecies identity was 97.7-98.5%. Using the ligB-secY-rpoB-lipL41 superlocus it was possible to discriminate 34/38 strains, which belong to six pathogenic Leptospira species. In addition, the sequences were concatenated with the superloci from 16 sequence types from a previous MLST scheme employed to study the association of a leptospiral clone with an outbreak of human leptospirosis in Thailand. Their use enhanced the discriminative power of the existing scheme. The lipL41 and rpoB loci raised the resolution from 81.0-100%, but the enhanced scheme still remains limited to the L. interrogans and L. kirschneri species. Conclusions: As the first aim of our study, the ligB-secY-rpoB-lipL41 superlocus demonstrated a satisfactory level of discrimination among the strains evaluated. Second, the inclusion of the rpoB and lipL41 loci to a MLST scheme provided high resolution for discrimination of strains within L. interrogans and L. kirschneri and might be useful in future epidemiological studies.	[Cerqueira, Gustavo M.; Nascimento, Ana L. T. O.] Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil; [McBride, Alan J. A.] Fundacao Oswaldo Cruz, Goncalo Moniz Inst, Salvador, BA, Brazil; [Hartskeerl, Rudy A.] World Org Anim Hlth WHO FAO OIE, Royal Trop Inst, Dept Biomed Res, Food & Agr Org,UN,WHO, Amsterdam, Netherlands; [Hartskeerl, Rudy A.] Natl Leptospirosis Reference Ctr, Amsterdam, Netherlands; [Ahmed, Niyaz] Univ Hyderabad, Dept Biotechnol, Pathogen Biol Lab, Hyderabad 500134, Andhra Pradesh, India; [Dellagostin, Odir A.; Eslabao, Marcus R.] Univ Fed Pelotas, Ctr Biotecnol, Pelotas, Brazil; [Nascimento, Ana L. T. O.] Univ Sao Paulo, Inst Ciencias Biomed, Interunidades Biotecnol, BR-09500900 Sao Paulo, Brazil	Instituto Butantan; Fundacao Oswaldo Cruz; Food & Agriculture Organization of the United Nations (FAO); World Health Organization; University of Hyderabad; Universidade Federal de Pelotas; Universidade de Sao Paulo	Cerqueira, GM (corresponding author), Inst Butantan, Ctr Biotecnol, Sao Paulo, Brazil.	cerqueiragm@yahoo.com.br	Dellagostin, Odir/C-2331-2009; Cerqueira, Gustavo/B-7180-2015; Ahmed, Niyaz/D-2589-2010; Nascimento, Ana L. T. O./E-8488-2012; McBride, Alan/D-4106-2012	Dellagostin, Odir/0000-0003-2803-4088; Cerqueira, Gustavo/0000-0002-3029-6899; Ahmed, Niyaz/0000-0001-6425-7583; Nascimento, Ana L. T. O./0000-0003-4851-0870; McBride, Alan/0000-0001-9682-540X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Research Support Foundation for the State of Bahia (FAPESB) [PES-0092/2008]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao Butantan	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Research Support Foundation for the State of Bahia (FAPESB); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Butantan	This study did not receive any designated funding. Gustavo M. Cerqueira holds a postdoctoral fellowship from the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP). Alan J.A. McBride would like to acknowledge the support from the Research Support Foundation for the State of Bahia (FAPESB), grant PES-0092/2008. Ana L.T.O. Nascimento would like to acknowledge the support from the FAPESP, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Fundacao Butantan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aanensen DM, 2005, NUCLEIC ACIDS RES, V33, pW728, DOI 10.1093/nar/gki415; Ahmed Niyaz, 2006, Ann Clin Microbiol Antimicrob, V5, P28, DOI 10.1186/1476-0711-5-28; Bharti AR, 2003, LANCET INFECT DIS, V3, P757, DOI 10.1016/S1473-3099(03)00830-2; Brenner DJ, 1999, INT J SYST BACTERIOL, V49, P839, DOI 10.1099/00207713-49-2-839; Bulach DM, 2006, P NATL ACAD SCI USA, V103, P14560, DOI 10.1073/pnas.0603979103; Cerqueira GM, 2009, J MED MICROBIOL, V58, P1173, DOI 10.1099/jmm.0.009175-0; Cerqueira GM, 2009, INFECT GENET EVOL, V9, P760, DOI 10.1016/j.meegid.2009.06.009; DRUMMOND AJ, 2007, GENEIOUS V 3 5; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Eslabao MR, 2010, INFECT GENET EVOL, V10, P586, DOI 10.1016/j.meegid.2010.02.014; Faine S., 1999, LEPTOSPIRA LEPTOSPIR; Gouvela EL, 2008, EMERG INFECT DIS, V14, P505, DOI 10.3201/eid1403.071064; Haake DA, 2004, J BACTERIOL, V186, P2818, DOI 10.1128/JB.186.9.2818-2828.2004; Haake DA, 2002, CLIN INFECT DIS, V34, pE40, DOI 10.1086/339942; Jolley KA, 2007, FEMS MICROBIOL REV, V31, P89, DOI 10.1111/j.1574-6976.2006.00057.x; KMETY E, 1993, CLASSIFICATION SPECI, P17; La Scola B, 2006, FEMS MICROBIOL LETT, V263, P142, DOI 10.1111/j.1574-6968.2006.00377.x; Levett PN, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000120; Levett PN, 2006, INT J SYST EVOL MICR, V56, P671, DOI 10.1099/ijs.0.63783-0; Levett PN, 2001, CLIN MICROBIOL REV, V14, P296, DOI 10.1128/CMR.14.2.296-326.2001; Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Matsunaga J, 2003, MOL MICROBIOL, V49, P929, DOI 10.1046/j.1365-2958.2003.03619.x; Matthias MA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000213; McBride AJA, 2005, CURR OPIN INFECT DIS, V18, P376, DOI 10.1097/01.qco.0000178824.05715.2c; McBride AJA, 2009, INFECT GENET EVOL, V9, P196, DOI 10.1016/j.meegid.2008.10.012; Morey RE, 2006, J CLIN MICROBIOL, V44, P3510, DOI 10.1128/JCM.00670-06; Nascimento ALTO, 2004, J BACTERIOL, V186, P2164, DOI 10.1128/JB.186.7.2164-2172.2004; Pavon ABI, 2009, METHODS MOL BIOL, V551, P129, DOI 10.1007/978-1-60327-999-4_11; Ren SX, 2003, NATURE, V422, P888, DOI 10.1038/nature01597; Segura ER, 2005, CLIN INFECT DIS, V40, P343, DOI 10.1086/427110; SILVA EF, 2009, EMERG INFECT DIS, V15, P3; Slack AT, 2009, INT J SYST EVOL MICR, V59, P705, DOI 10.1099/ijs.0.002766-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thaipadungpanit J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000056; Victoria B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002752; YASUDA PH, 1987, INT J SYST BACTERIOL, V37, P407, DOI 10.1099/00207713-37-4-407	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2010	5	10							e15335	10.1371/journal.pone.0015335	http://dx.doi.org/10.1371/journal.pone.0015335			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	665NX	21124728	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000283043700030
J	Parise, E; Friederici, AD; Striano, T				Parise, Eugenio; Friederici, Angela D.; Striano, Tricia			"Did You Call Me?" 5-Month-Old Infants Own Name Guides Their Attention	PLOS ONE			English	Article							EYE CONTACT INFLUENCES; JOINT ATTENTION; BRAIN RESPONSES; VOCAL CUES; RECOGNITION; EXPRESSIONS; OBJECTS; AUTISM; MEMORY; WORDS	An infant's own name is a unique social cue. Infants are sensitive to their own name by 4 months of age, but whether they use their names as a social cue is unknown. Electroencephalogram (EEG) was measured as infants heard their own name or stranger's names and while looking at novel objects. Event related brain potentials (ERPs) in response to names revealed that infants differentiate their own name from stranger names from the first phoneme. The amplitude of the ERPs to objects indicated that infants attended more to objects after hearing their own names compared to another name. Thus, by 5 months of age infants not only detect their name, but also use it as a social cue to guide their attention to events and objects in the world.	[Parise, Eugenio; Friederici, Angela D.; Striano, Tricia] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Parise, Eugenio] Cent European Univ, Cognit Dev Ctr, Budapest, Hungary; [Striano, Tricia] CUNY Hunter Coll, Dept Psychol, New York, NY 10021 USA	Max Planck Society; Central European University; City University of New York (CUNY) System; Hunter College (CUNY)	Parise, E (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	eugenioparise@tiscali.it; tstriano@hunter.cuny.edu	Parise, Eugenio/ABC-3974-2021; Parise, Eugenio/ABD-9940-2021	Parise, Eugenio/0000-0003-4836-6370; Parise, Eugenio/0000-0003-4836-6370	Alexander von Humboldt Foundation; German Federal Ministry of Education and Research; Humboldt Research Fellowship; Calabria Region, Italy	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Humboldt Research Fellowship(Alexander von Humboldt Foundation); Calabria Region, Italy(Regione Calabria)	This research was supported by the Sofja Kovalevskaja Award granted by the Alexander von Humboldt Foundation, donated by the German Federal Ministry of Education and Research, to T. Striano (http://www.humboldt-foundation.de/web/start.html). In addition, E. Parise was funded by a Humboldt Research Fellowship and by a grant from Calabria Region, Italy (http://www.regione.calabria.it/ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bortfeld H, 2005, PSYCHOL SCI, V16, P298, DOI 10.1111/j.0956-7976.2005.01531.x; Carmody DP, 2006, BRAIN RES, V1116, P153, DOI 10.1016/j.brainres.2006.07.121; Cleveland A, 2007, INFANT BEHAV DEV, V30, P499, DOI 10.1016/j.infbeh.2006.10.009; Csibra G, 2009, TRENDS COGN SCI, V13, P148, DOI 10.1016/j.tics.2009.01.005; de Haan M, 1999, DEV PSYCHOL, V35, P1113, DOI 10.1037/0012-1649.35.4.1113; de Haan M, 2003, INT J PSYCHOPHYSIOL, V51, P45, DOI 10.1016/S0167-8760(03)00152-1; deHaan M, 1997, CHILD DEV, V68, P187, DOI 10.2307/1131845; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Fernald A., 1992, ADAPTED MIND EVOLUTI, P391, DOI DOI 10.1007/BF00852474; Folmer RL, 1997, BRAIN LANG, V56, P306, DOI 10.1006/brln.1997.1828; FRIEDERICI AD, 2008, HDB DEV COGNITIVE NE, P117; Friederici AD, 2007, CURR BIOL, V17, P1208, DOI 10.1016/j.cub.2007.06.011; Friedrich M, 2005, J COGNITIVE NEUROSCI, V17, P1785, DOI 10.1162/089892905774589172; Friedrich M, 2005, NEUROREPORT, V16, P653, DOI 10.1097/00001756-200504250-00028; Grossmann T, 2007, SOC COGN AFFECT NEUR, V2, P284, DOI 10.1093/scan/nsm025; Grossmann T, 2007, EUR J NEUROSCI, V25, P909, DOI 10.1111/j.1460-9568.2007.05379.x; Grossmann T, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00201; Grossmann T, 2010, BIOL LETTERS, V6, P540, DOI 10.1098/rsbl.2009.1069; Hoehl S, 2008, DEVELOPMENTAL SCI, V11, P10, DOI 10.1111/j.1467-7687.2007.00643.x; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Hoehl S, 2009, CHILD DEV, V80, P968, DOI 10.1111/j.1467-8624.2009.01311.x; Hoehl S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002389; HOLCOMB PJ, 1990, LANG COGNITIVE PROC, V5, P281, DOI 10.1080/01690969008407065; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; Holeckova I, 2006, BRAIN RES, V1082, P142, DOI 10.1016/j.brainres.2006.01.089; Holeckova I, 2008, BRAIN RES, V1189, P152, DOI 10.1016/j.brainres.2007.10.091; Kampe KKW, 2003, J NEUROSCI, V23, P5258; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; MAENNEL G, 2010, J COGNITIVE NEUROS S, P291; MANDEL DR, 1995, PSYCHOL SCI, V6, P314, DOI 10.1111/j.1467-9280.1995.tb00517.x; MANDELEMER D, 2003, WHATS NAME INFANTS R; Naatanen R, 2002, NEUROSCI LETT, V318, P49, DOI 10.1016/S0304-3940(01)02438-7; Nelson C.A., 1997, BIOLOGICAL NEUROPSYC; OSTERLING J, 1994, J AUTISM DEV DISORD, V24, P247, DOI 10.1007/BF02172225; Parise E, 2008, SOC NEUROSCI-UK, V3, P141, DOI 10.1080/17470910701865458; Parise E, 2007, INFANT BEHAV DEV, V30, P380, DOI 10.1016/j.infbeh.2006.10.006; Reid VM, 2004, NEUROREPORT, V15, P2553, DOI 10.1097/00001756-200411150-00025; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Richards JE, 2003, DEVELOPMENTAL SCI, V6, P312, DOI 10.1111/1467-7687.00287; Sheehan EA, 2008, TRENDS LANG ACQUIS R, V5, P161; Stahl D, 2010, BRAIN DEV-JPN, V32, P305, DOI 10.1016/j.braindev.2009.04.001; Striano T., 2008, SOCIAL COGNITION DEV; Striano T, 2006, SOC COGN AFFECT NEUR, V1, P87, DOI 10.1093/scan/nsl008; Striano T, 2006, EUR J NEUROSCI, V23, P2819, DOI 10.1111/j.1460-9568.2006.04822.x; Thierry G, 2003, NEUROREPORT, V14, P2307, DOI 10.1097/00001756-200312190-00004; Vaish A, 2004, DEVELOPMENTAL SCI, V7, P261, DOI 10.1111/j.1467-7687.2004.00344.x; WALKERANDREWS AS, 1983, INFANT BEHAV DEV, V6, P491, DOI 10.1016/S0163-6383(83)90331-4; Weber C, 2004, COGNITIVE BRAIN RES, V18, P149, DOI 10.1016/j.cogbrainres.2003.10.001; Werner E, 2000, J AUTISM DEV DISORD, V30, P157, DOI 10.1023/A:1005463707029	50	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14208	10.1371/journal.pone.0014208	http://dx.doi.org/10.1371/journal.pone.0014208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	689PF	21151971	Green Published, Green Accepted, gold			2022-12-27	WOS:000284939600005
J	Tsang, SM; Liu, L; Teh, MT; Wheeler, A; Grose, R; Hart, IR; Garrod, DR; Fortune, F; Wan, H				Tsang, Siu Man; Liu, Li; Teh, Muy-Teck; Wheeler, Ann; Grose, Richard; Hart, Ian R.; Garrod, David R.; Fortune, Farida; Wan, Hong			Desmoglein 3, via an Interaction with E-cadherin, Is Associated with Activation of Src	PLOS ONE			English	Article							PEMPHIGUS-VULGARIS-IGG; CELL-CELL ADHESION; GROWTH-FACTOR RECEPTOR; PROTEIN-KINASE-C; CULTURED KERATINOCYTES; IMMUNOELECTRON MICROSCOPY; TYROSINE PHOSPHORYLATION; FAMILY KINASES; DESMOSOMES; PLAKOGLOBIN	Background: Desmoglein 3 (Dsg3), a desmosomal adhesion protein, is expressed in basal and immediate suprabasal layers of skin and across the entire stratified squamous epithelium of oral mucosa. However, increasing evidence suggests that the role of Dsg3 may involve more than just cell-cell adhesion. Methodology/Principal Findings: To determine possible additional roles of Dsg3 during epithelial cell adhesion we used overexpression of full-length human Dsg3 cDNA, and RNAi-mediated knockdown of this molecule in various epithelial cell types. Overexpression of Dsg3 resulted in a reduced level of E-cadherin but a colocalisation with the E-cadherin-catenin complex of the adherens junctions. Concomitantly these transfected cells exhibited marked migratory capacity and the formation of filopodial protrusions. These latter events are consistent with Src activation and, indeed, Src-specific inhibition reversed these phenotypes. Moreover Dsg3 knockdown, which also reversed the decreased level of E-cadherin, partially blocked Src phosphorylation. Conclusions/Significance: Our data are consistent with the possibility that Dsg3, as an up-stream regulator of Src activity, helps regulate adherens junction formation.	[Tsang, Siu Man; Teh, Muy-Teck; Fortune, Farida; Wan, Hong] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England; [Liu, Li] Queen Mary Univ London, Barts & London Sch Med & Dent, Ctr Infect Dis, London, England; [Wheeler, Ann] Queen Mary Univ London, Barts & London Sch Med & Dent, Imaging Facil, Blizard Inst Cell & Mol Sci, London, England; [Grose, Richard; Hart, Ian R.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Canc, Tumor Biol Ctr, London, England; [Garrod, David R.] King Saud Univ, Riyadh, Saudi Arabia; [Garrod, David R.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; University of London; Queen Mary University London; King Saud University; University of Manchester	Tsang, SM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, Ctr Clin & Diagnost Oral Sci, London, England.	h.wan@qmul.ac.uk	Teh, Muy-Teck/B-9284-2016	Teh, Muy-Teck/0000-0002-7725-8355; Garrod, David/0000-0003-0300-3947; Grose, Richard/0000-0002-4738-0173; Wheeler, Ann/0000-0001-8617-827X	Medical Research Council; Institute of Dentistry; Medical Research Council [G113/32, G0700074] Funding Source: researchfish; MRC [G113/32, G0700074] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Dentistry; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Medical Research Council Career Development Fellowship to HW and by the Institute of Dentistry. Siu Man Tsang is supported by a Medical Research Council funded studentship to Barts and London School of Medicine and Dentistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1996, J INVEST DERMATOL, V106, P351, DOI 10.1111/1523-1747.ep12343081; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Bedane C, 1996, ARCH DERMATOL RES, V288, P343, DOI 10.1007/s004030050061; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Borrmann CM, 2006, EUR J CELL BIOL, V85, P469, DOI 10.1016/j.ejcb.2006.02.009; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Chen YJ, 2007, ONCOGENE, V26, P467, DOI 10.1038/sj.onc.1209802; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Elias PM, 2001, J CELL BIOL, V153, P243, DOI 10.1083/jcb.153.2.243; Ezaki T, 2007, AM J PHYSIOL-GASTR L, V293, pG54, DOI 10.1152/ajpgi.00533.2006; Fukuoka J, 2007, HUM PATHOL, V38, P276, DOI 10.1016/j.humpath.2006.08.006; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Garrod DR, 2002, CURR OPIN CELL BIOL, V14, P537, DOI 10.1016/S0955-0674(02)00366-6; Getsios S, 2004, NAT REV MOL CELL BIO, V5, P271, DOI 10.1038/nrm1356; Green KJ, 2000, NAT REV MOL CELL BIO, V1, P208, DOI 10.1038/35043032; Grosheva I, 2001, J CELL SCI, V114, P695; GUMBINER B, 1988, J CELL BIOL, V107, P1575, DOI 10.1083/jcb.107.4.1575; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Heupel WM, 2009, AM J PATHOL, V174, P475, DOI 10.2353/ajpath.2009.080392; HUANG CC, 2009, LARYNGOSCOPE; Kanno M, 2008, EXP CELL RES, V314, P1683, DOI 10.1016/j.yexcr.2008.01.031; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Koch PJ, 1998, J CELL SCI, V111, P2529; Koch PJ, 1997, J CELL BIOL, V137, P1091, DOI 10.1083/jcb.137.5.1091; Koster MI, 2005, J INVEST DERM SYMP P, V10, P118, DOI 10.1111/j.1087-0024.2005.200416.x; Lewis JE, 1997, J CELL BIOL, V136, P919, DOI 10.1083/jcb.136.4.919; Liu Zhong-Qi, 2007, Zhonghua Yi Xue Za Zhi, V87, P2541; McLachlan RW, 2007, MOL BIOL CELL, V18, P3214, DOI 10.1091/mbc.E06-12-1154; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Merritt AJ, 2002, MOL CELL BIOL, V22, P5846, DOI 10.1128/MCB.22.16.5846-5858.2002; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Osada K, 1997, J INVEST DERMATOL, V108, P482, DOI 10.1111/1523-1747.ep12289726; Owens DW, 2000, MOL BIOL CELL, V11, P51, DOI 10.1091/mbc.11.1.51; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Pittella F, 2001, PATHOL RES PRACT, V197, P85, DOI 10.1078/0344-0338-00014; PLOTT RT, 1994, J INVEST DERMATOL, V103, P168, DOI 10.1111/1523-1747.ep12392642; Pulkkinen L, 2002, J INVEST DERMATOL, V119, P1237, DOI 10.1046/j.1523-1747.2002.19645.x; ROH JY, 1995, J INVEST DERMATOL, V104, P720, DOI 10.1111/1523-1747.ep12606963; Sato M, 2000, LAB INVEST, V80, P1583, DOI 10.1038/labinvest.3780168; Savci-Heijink CD, 2009, AM J PATHOL, V174, P1629, DOI 10.2353/ajpath.2009.080778; Setzer SV, 2004, J INVEST DERMATOL, V123, P426, DOI 10.1111/j.0022-202X.2004.23319.x; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Shimizu A, 2002, ARCH DERMATOL RES, V294, P318, DOI 10.1007/s00403-002-0341-z; Shinohara M, 1998, J PATHOL, V184, P369, DOI 10.1002/(SICI)1096-9896(199804)184:4<369::AID-PATH1236>3.0.CO;2-L; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; SUTER MM, 1990, AM J VET RES, V51, P507; Takahashi Hidetoshi, 1995, Journal of Dermatology (Tokyo), V22, P576; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Wan H, 2003, J CELL SCI, V116, P4239, DOI 10.1242/jcs.00701; Wan H, 2007, EXP CELL RES, V313, P2336, DOI 10.1016/j.yexcr.2007.01.010; Wan H, 2007, STEM CELLS, V25, P1286, DOI 10.1634/stemcells.2006-0304; Williamson L, 2006, EMBO J, V25, P3298, DOI 10.1038/sj.emboj.7601224; Yin TF, 2005, P NATL ACAD SCI USA, V102, P5420, DOI 10.1073/pnas.0501676102; Yin TF, 2004, SEMIN CELL DEV BIOL, V15, P665, DOI 10.1016/j.semcdb.2004.09.005	61	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14211	10.1371/journal.pone.0014211	http://dx.doi.org/10.1371/journal.pone.0014211			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151980	Green Published, gold, Green Submitted			2022-12-27	WOS:000284939600006
J	Lin, JC; Chang, FY; Fung, CP; Yeh, KM; Chen, CT; Tsai, YK; Siu, LK				Lin, Jung-Chung; Chang, Feng-Yee; Fung, Chang-Phone; Yeh, Kuo-Ming; Chen, Chiung-Tong; Tsai, Yu-Kuo; Siu, L. Kristopher			Do Neutrophils Play a Role in Establishing Liver Abscesses and Distant Metastases Caused by Klebsiella pneumoniae?	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; CAPSULAR SEROTYPE K1; DIABETES-MELLITUS; SEPTIC ENDOPHTHALMITIS; POLYMORPHONUCLEAR LEUKOCYTES; NECROTIZING FASCIITIS; NOSOCOMIAL PATHOGENS; EMERGING DISEASE; HIGH PREVALENCE; PHAGOCYTOSIS	Serotype K1 Klebsiella pneumoniae is a major cause of liver abscesses and endophthalmitis. This study was designed to identify the role of neutrophils in the development of distant metastatic complications that were caused by serotype K1 K. pneumoniae. An in vitro cellular model was used to assess serum resistance and neutrophil-mediated killing. BALB/c mice were injected with neutrophils containing phagocytosed K. pneumoniae. Serotype K1 K. pneumoniae was significantly more resistant to serum killing, neutrophil-mediated phagocytosis and intra-cellular killing than non-K1 isolates (p < 0.01). Electron microscopic examination had similar findings as in the bioassay findings. Intraperitoneal injection of neutrophils containing phagocytosed serotype K1 K. pneumoniae led to abscess formation in multiple sites including the subcutaneous tissue, lung, and liver, whereas no abscess formation was observed in mice injected with non-K1 isolates. The resistance of serotype K1 K. pneumoniae to complement- and neutrophil-mediated intracellular killing results in the dissemination of K. pneumoniae via the bloodstream. Escape from neutrophil intracellular killing may contribute to the dissemination and establishment of distant metastases. Thus, neutrophils play a role as a vehicle for helping K. pneumoniae and contributing to the establishment of liver abscess and distant metastatic complications.	[Lin, Jung-Chung; Chang, Feng-Yee; Yeh, Kuo-Ming; Siu, L. Kristopher] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Fung, Chang-Phone] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chen, Chiung-Tong] Natl Hlth Res Inst, Div Biotechnol & Pharmaceut Res, Taipei, Taiwan; [Tsai, Yu-Kuo; Siu, L. Kristopher] Natl Hlth Res Inst, Div Infect Dis, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Yang Ming Chiao Tung University; National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	lksiu@nhri.org.tw	Siu, Leung-Kei/C-1368-2010		National Science Council [NSC93-2314-B-016-018, NSC94-2314-B-016-004, NSC95-2314-B-016-001, NSC96-2314-B-016-006-MY12]; Tri-Service General Hospital [DOD96-22, DOD96-32]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	This work was supported by grants from National Science Council (NSC93-2314-B-016-018, NSC94-2314-B-016-004, NSC95-2314-B-016-001, NSC96-2314-B-016-006-MY1&2), Tri-Service General Hospital (DOD96-22 & 96-32) and from National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agapova O V, 1999, Zh Mikrobiol Epidemiol Immunobiol, P5; BRAYTON RG, 1970, NEW ENGL J MED, V282, P123, DOI 10.1056/NEJM197001152820303; CASANOVA C, 1989, ARCH INTERN MED, V149, P1467, DOI 10.1001/archinte.1989.00390060171048; Chang Feng-Yee, 1995, Journal of the Formosan Medical Association, V94, P232; CHENG D-L, 1991, Archives of Internal Medicine, V151, P1557, DOI 10.1001/archinte.151.8.1557; Chou FF, 1997, WORLD J SURG, V21, P384, DOI 10.1007/PL00012258; CRYZ SJ, 1986, J CLIN MICROBIOL, V23, P687, DOI 10.1128/JCM.23.4.687-690.1986; D'Agata EMC, 2001, INFECT CONT HOSP EP, V22, P550, DOI 10.1086/501950; DUGGER KO, 1989, DIAGN MICR INFEC DIS, V12, P199, DOI 10.1016/0732-8893(89)90015-1; Dylewski JS, 1998, CLIN INFECT DIS, V27, P1561, DOI 10.1086/517760; Fung CP, 2000, J INFECT DIS, V181, P2075, DOI 10.1086/315488; Fung CP, 2002, GUT, V50, P420, DOI 10.1136/gut.50.3.420; Gauger EJ, 2007, INFECT IMMUN, V75, P3315, DOI 10.1128/IAI.00052-07; Gregory SH, 1996, J IMMUNOL, V157, P2514; HAN SHB, 1995, WESTERN J MED, V162, P220; Higashi T, 1995, Kansenshogaku Zasshi, V69, P1017; HIGHSMITH AK, 1985, INFECT CONT HOSP EP, V6, P75, DOI 10.1017/S0195941700062640; Ho PL, 2000, CLIN INFECT DIS, V30, P989, DOI 10.1086/313791; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; Lederman ER, 2005, AM J GASTROENTEROL, V100, P322, DOI 10.1111/j.1572-0241.2005.40310.x; Lin JC, 2004, MICROBES INFECT, V6, P1191, DOI 10.1016/j.micinf.2004.06.003; Lin JC, 2006, J CLIN ENDOCR METAB, V91, P3084, DOI 10.1210/jc.2005-2749; LIU YC, 1986, ARCH INTERN MED, V146, P1913, DOI 10.1001/archinte.146.10.1913; MOLENAAR DM, 1976, DIABETES, V25, P880; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; MOWAT AG, 1971, NEW ENGL J MED, V284, P621, DOI 10.1056/NEJM197103252841201; Nielsen SL, 1999, J ANTIMICROB CHEMOTH, V43, P407, DOI 10.1093/jac/43.3.407; PODSCHUN R, 1991, ZBL HYG UMWELTMED, V192, P279; Podschun R, 1998, CLIN MICROBIOL REV, V11, P589, DOI 10.1128/CMR.11.4.589; PODSCHUN R, 1992, J MED MICROBIOL, V36, P250, DOI 10.1099/00222615-36-4-250; Rahimian J, 2004, CLIN INFECT DIS, V39, P1654, DOI 10.1086/425616; Rhen M, 2003, TRENDS MICROBIOL, V11, P80, DOI 10.1016/S0966-842X(02)00038-0; Saccente M, 1999, CLIN INFECT DIS, V29, P1570, DOI 10.1086/313539; Sawyer D W, 1989, Rev Infect Dis, V11 Suppl 7, pS1532; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Tsay RW, 2002, ARCH INTERN MED, V162, P1021, DOI 10.1001/archinte.162.9.1021; WANG JJ, 1994, J GEN VIROL, V75, P2607, DOI 10.1099/0022-1317-75-10-2607; Yarng SS, 1997, OPHTHALMIC SURG LAS, V28, P147; Yeh KM, 2007, J CLIN MICROBIOL, V45, P466, DOI 10.1128/JCM.01150-06; Yoon YH, 2003, RETINA-J RET VIT DIS, V23, P366, DOI 10.1097/00006982-200306000-00013	40	29	39	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15005	10.1371/journal.pone.0015005	http://dx.doi.org/10.1371/journal.pone.0015005			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151499	gold, Green Published, Green Submitted			2022-12-27	WOS:000284755100051
J	Nelson, PA; Khodadoust, M; Prodhomme, T; Spencer, C; Patarroyo, JC; Varrin-Doyer, M; Ho, JD; Stroud, RM; Zamvil, SS				Nelson, Patricia A.; Khodadoust, Mojgan; Prodhomme, Thomas; Spencer, Collin; Patarroyo, Juan Carlos; Varrin-Doyer, Michel; Ho, Joseph D.; Stroud, Robert M.; Zamvil, Scott S.			Immunodominant T Cell Determinants of Aquaporin-4, the Autoantigen Associated with Neuromyelitis Optica	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; CHROMOSOMAL LOCALIZATION; WATER CHANNEL; B-CELLS; ANTIGEN; ENCEPHALOMYELITIS; PATHOGENESIS; ANTIBODIES; DISEASE; EPITOPE	Autoantibodies that target the water channel aquaporin-4 (AQP4) in neuromyelitis optica (NMO) are IgG1, a T cell-dependent Ig subclass. However, a role for AQP4-specific T cells in this CNS inflammatory disease is not known. To evaluate their potential role in CNS autoimmunity, we have identified and characterized T cells that respond to AQP4 in C57BL/6 and SJL/J mice, two strains that are commonly studied in models of CNS inflammatory diseases. Mice were immunized with either overlapping peptides or intact hAQP4 protein encompassing the entire 323 amino acid sequence. T cell determinants identified from examination of the AQP4 peptide (p) library were located within AQP4 p21-40, p91-110, p101-120, p166-180, p231-250 and p261-280 in C57BL/6 mice, and within p11-30, p21-40, p101-120, p126-140 and p261-280 in SJL/J mice. AQP4-specific T cells were CD4(+) and MHC II-restricted. In recall responses to immunization with intact AQP4, T cells responded primarily to p21-40, indicating this region contains the immunodominant T cell epitope(s) for both strains. AQP4 p21-40-primed T cells secreted both IFN-gamma and IL-17. The core immunodominant AQP4 21-40 T cell determinant was mapped to residues 24-35 in C57BL/6 mice and 23-35 in SJL/J mice. Our identification of the AQP4 T cell determinants and characterization of its immunodominant determinant should permit investigators to evaluate the role of AQP4-specific T cells in vivo and to develop AQP4-targeted murine NMO models.	[Nelson, Patricia A.; Khodadoust, Mojgan; Prodhomme, Thomas; Spencer, Collin; Patarroyo, Juan Carlos; Varrin-Doyer, Michel; Zamvil, Scott S.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Ho, Joseph D.; Stroud, Robert M.] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Nelson, PA (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	zamvil@ucsf.neuroimmunol.org			Guthy Jackson Charitable Foundation; National Institutes of Health (NIH) [RO1 AI073737, RO1 AI059709, RO1 NS063008, 2P50 GM073210]; NMSS [RG 3622, 3913]; Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059709, R01AI073737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210, R37GM024485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063008] Funding Source: NIH RePORTER	Guthy Jackson Charitable Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NMSS(National Multiple Sclerosis Society); Maisin Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	P.A.N., M.K., C.S., M.V.-D. and S.S.Z. were supported by a research grant from the Guthy Jackson Charitable Foundation. T. P. is a fellow of the National Multiple Sclerosis Society (NMSS). S.S.Z. was supported by the National Institutes of Health (NIH) (RO1 AI073737, RO1 AI059709, and RO1 NS063008), the NMSS (RG 3622 and 3913) and the Maisin Foundation. R. M. S. was supported by NIH 2P50 GM073210. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett JL, 2009, ANN NEUROL, V66, P617, DOI 10.1002/ana.21802; Bettelli E, 2006, J CLIN INVEST, V116, P2393, DOI 10.1172/JCI28334; Bradl M, 2009, ANN NEUROL, V66, P630, DOI 10.1002/ana.21837; Crane JM, 2009, J CELL SCI, V122, P813, DOI 10.1242/jcs.042341; GERMAIN RN, 1994, CELL, V76, P287, DOI 10.1016/0092-8674(94)90336-0; Graber DJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-22; Guan Pingping, 2006, Appl Bioinformatics, V5, P55, DOI 10.2165/00822942-200605010-00008; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; HEDRICK SM, 1982, CELL, V30, P141, DOI 10.1016/0092-8674(82)90020-4; Ho JD, 2009, P NATL ACAD SCI USA, V106, P7437, DOI 10.1073/pnas.0902725106; HU X, 2010, NUCL ACIDS RES; Illarionova NB, 2010, NEUROSCIENCE, V168, P915, DOI 10.1016/j.neuroscience.2009.11.062; ISAKSON PC, 1982, J EXP MED, V155, P734, DOI 10.1084/jem.155.3.734; Jarius S, 2010, NAT REV NEUROL, V6, P383, DOI 10.1038/nrneurol.2010.72; KISHIMOTO T, 1978, NATURE, V271, P756, DOI 10.1038/271756a0; Krishnamoorthy G, 2006, J CLIN INVEST, V116, P2385, DOI 10.1172/JCI28330; Lennon VA, 2004, LANCET, V364, P2106, DOI 10.1016/S0140-6736(04)17551-X; Lennon VA, 2005, J EXP MED, V202, P473, DOI 10.1084/jem.20050304; Lucchinetti CF, 2002, BRAIN, V125, P1450, DOI 10.1093/brain/awf151; Maurer M, 2002, CURR OPIN NEUROL, V15, P617, DOI 10.1097/00019052-200210000-00013; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Pennesi Giuseppina, 2002, Int Rev Immunol, V21, P67, DOI 10.1080/08830180212059; Saadoun S, 2010, BRAIN, V133, P349, DOI 10.1093/brain/awp309; Saigo H, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-246; Salomon J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-501; Slavin AJ, 2001, J CLIN INVEST, V108, P1133, DOI 10.1172/JCI200113360; Stuve O, 2002, J IMMUNOL, V169, P6720, DOI 10.4049/jimmunol.169.12.6720; Takahashi T, 2007, BRAIN, V130, P1235, DOI 10.1093/brain/awm062; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; Tani T, 2009, J NEUROIMMUNOL, V211, P110, DOI 10.1016/j.jneuroim.2009.04.001; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Turtzo LC, 1997, GENOMICS, V41, P267, DOI 10.1006/geno.1997.4641; Warabi Y, 2006, J NEUROL SCI, V249, P145, DOI 10.1016/j.jns.2006.06.011; YANG BX, 1995, J BIOL CHEM, V270, P22907, DOI 10.1074/jbc.270.39.22907; ZAMVIL SS, 1990, ANNU REV IMMUNOL, V8, P579, DOI 10.1146/annurev.iy.08.040190.003051; ZAMVIL SS, 1986, NATURE, V324, P258, DOI 10.1038/324258a0; Zhang Q, 2008, NUCLEIC ACIDS RES, V36, pW513, DOI 10.1093/nar/gkn254	38	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15050	10.1371/journal.pone.0015050	http://dx.doi.org/10.1371/journal.pone.0015050			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151500	Green Published, gold			2022-12-27	WOS:000284755100055
J	Mares, CA; Sharma, J; Ojeda, SS; Li, Q; Campos, JA; Morris, EG; Coalson, JJ; Teale, JM				Mares, Chris A.; Sharma, Jyotika; Ojeda, Sandra S.; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Coalson, Jacqueline J.; Teale, Judy M.			Attenuated Response of Aged Mice to Respiratory Francisella novicida Is Characterized by Reduced Cell Death and Absence of Subsequent Hypercytokinemia	PLOS ONE			English	Article							INNATE IMMUNITY; SEVERE SEPSIS; OLD MICE; TULARENSIS; INFECTION; TULAREMIA; ADULT; IMMUNOSENESCENCE; TUBERCULOSIS; RESISTANCE	Background: Pneumonia and pulmonary infections are major causes of mortality among the growing elderly population. Age associated attenuations of various immune parameters, involved with both innate and adaptive responses are collectively known as immune senescence. These changes are likely to be involved with differences in host susceptibility to disease between young and aged individuals. Methodology/Principal Findings: The objective of this study was to assess potential age related differences in the pulmonary host response in mice to the Gram-negative respiratory pathogen, Francisella novicida. We intranasally infected mice with F. novicida and compared various immune and pathological parameters of the pulmonary host response in both young and aged mice. Conclusions/Significance: We observed that 20% of aged mice were able to survive an intranasal challenge with F. novicida while all of their younger cohorts died consistently within 4 to 6 days post infection. Further experiments revealed that all of the aged mice tested were initially able to control bacterial replication in the lungs as well as at distal sites of replication compared with young mice. In addition, the small cohort of aged survivors did not progress to a severe sepsis syndrome with hypercytokinemia, as did all of the young adult mice. Finally, a lack of widespread cell death in potential aged survivors coupled with a difference in cell types recruited to sites of infection within the lung confirmed an altered host response to Francisella in aged mice.	[Mares, Chris A.; Ojeda, Sandra S.; Teale, Judy M.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Sharma, Jyotika; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Teale, Judy M.] Univ Texas San Antonio, S Texas Ctr Emerging Infect Dis, San Antonio, TX USA; [Sharma, Jyotika; Li, Qun; Campos, Jocelyn A.; Morris, Elizabeth G.; Teale, Judy M.] Univ Texas San Antonio, Dept Biol, San Antonio, TX USA; [Coalson, Jacqueline J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Pathol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas at San Antonio (UTSA); University of Texas System; University of Texas Health San Antonio	Mares, CA (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	judy.teale@utsa.edu		Mares, Chris/0000-0002-5160-7326	National Institutes of Health (NIH) [AI 59703, 1P01A10157986, NS35974, T32AI7271]; National Institute of Aging [1R36AG033400-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007271, R01AI059703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R36AG033400] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported by awards AI 59703, 1P01A10157986, NS35974, from the National Institutes of Health (NIH). C.A.M. was also supported through departmental training grant T32AI7271 from the NIH and 1R36AG033400-01 from the National Institute of Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bantel H, 2009, CRIT CARE, V13, DOI 10.1186/cc7966; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Butcher S, 2000, IMMUNOLOGY, V100, P411, DOI 10.1046/j.1365-2567.2000.00079.x; Christova I, 2004, SCAND J INFECT DIS, V36, P785, DOI 10.1080/00365540410021199; COALSON JJ, 1983, ANAT REC, V205, P233, DOI 10.1002/ar.1092050214; COOPER AM, 1995, INFECT IMMUN, V63, P3259, DOI 10.1128/IAI.63.9.3259-3265.1995; Ehrchen J, 2004, INFECT IMMUN, V72, P5106, DOI 10.1128/IAI.72.9.5106-5114.2004; EVANS ME, 1985, MEDICINE, V64, P251, DOI 10.1097/00005792-198507000-00006; Gavazzi G, 2002, LANCET INFECT DIS, V2, P659, DOI 10.1016/S1473-3099(02)00437-1; Ginaldi L, 2000, GERONTOLOGY, V46, P242, DOI 10.1159/000022167; Ginaldi L, 2001, MICROBES INFECT, V3, P851, DOI 10.1016/S1286-4579(01)01443-5; Gomez CR, 2008, EXP GERONTOL, V43, P718, DOI 10.1016/j.exger.2008.05.016; Gomez CR, 2005, CURR OPIN IMMUNOL, V17, P457, DOI 10.1016/j.coi.2005.07.013; High KP, 2007, BIOGERONTOLOGY, V8, P583, DOI 10.1007/s10522-007-9106-6; High KP, 2004, AGEING RES REV, V3, P1, DOI 10.1016/j.arr.2003.08.001; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Kaplan V, 2003, CRIT CARE CLIN, V19, P729, DOI 10.1016/S0749-0704(03)00057-5; Kellum JA, 2007, ARCH INTERN MED, V167, P1655, DOI 10.1001/archinte.167.15.1655; Kieffer TL, 2003, MICROBES INFECT, V5, P397, DOI 10.1016/S1286-4579(03)00052-2; MARES CA, 2009, EXP GERONTOL; Mares CA, 2008, INFECT IMMUN, V76, P3001, DOI 10.1128/IAI.00215-08; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; McClelland RS, 1999, ARCH INTERN MED, V159, P1244, DOI 10.1001/archinte.159.11.1244; Meyer Keith C, 2005, Proc Am Thorac Soc, V2, P433, DOI 10.1513/pats.200508-081JS; Ojeda SS, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-215; Opal SM, 2005, CLIN INFECT DIS, V41, pS504, DOI 10.1086/432007; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Pawelec G, 2004, TRENDS IMMUNOL, V25, P406, DOI 10.1016/j.it.2004.05.006; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; Remick DG, 2007, AM J PATHOL, V170, P1435, DOI 10.2353/ajpath.2007.060872; Sebastian C, 2005, IMMUNOBIOLOGY, V210, P121, DOI 10.1016/j.imbio.2005.05.006; Sharma J, 2009, INFECT IMMUN, V77, P4314, DOI 10.1128/IAI.00654-09; Sharma J, 2009, J LEUKOCYTE BIOL, V86, P491, DOI 10.1189/jlb.1208728; Sjostedt A, 2006, MICROBES INFECT, V8, P561, DOI 10.1016/j.micinf.2005.08.001; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; TAYLOR JP, 1991, AM J EPIDEMIOL, V133, P1032, DOI 10.1093/oxfordjournals.aje.a115812; Turner J, 2002, INFECT IMMUN, V70, P4628, DOI 10.1128/IAI.70.8.4628-4637.2002; Ulloa L, 2005, TRENDS MOL MED, V11, P56, DOI 10.1016/j.molmed.2004.12.007	39	20	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14088	10.1371/journal.pone.0014088	http://dx.doi.org/10.1371/journal.pone.0014088			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124895	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900006
J	Hutson, SL; Mui, E; Kinsley, K; Witola, WH; Behnke, MS; El Bissati, K; Muench, SP; Rohrman, B; Liu, SR; Wollmann, R; Ogata, Y; Sarkeshik, A; Yates, JR; McLeod, R				Hutson, Samuel L.; Mui, Ernest; Kinsley, Karen; Witola, William H.; Behnke, Michael S.; El Bissati, Kamal; Muench, Stephen P.; Rohrman, Brittany; Liu, Susan R.; Wollmann, Robert; Ogata, Yuko; Sarkeshik, Ali; Yates, John R., III; McLeod, Rima			T. gondii RP Promoters & Knockdown Reveal Molecular Pathways Associated with Proliferation and Cell-Cycle Arrest	PLOS ONE			English	Article							PARASITE TOXOPLASMA-GONDII; ACTIVATED PROTEIN PHOSPHATASE; TRANSCRIPTION FACTORS; SACCHAROMYCES-CEREVISIAE; GENE-EXPRESSION; RIBOSOME BIOGENESIS; G(1) ARREST; DNA-BINDING; STAGE; MECHANISM	Molecular pathways regulating rapid proliferation and persistence are fundamental for pathogens but are not elucidated fully in Toxoplasma gondii. Promoters of T. gondii ribosomal proteins (RPs) were analyzed by EMSAs and ChIP. One RP promoter domain, known to bind an Apetela 2, bound to nuclear extract proteins. Promoter domains appeared to associate with histone acetyl transferases. To study effects of a RP gene's regulation in T. gondii, mutant parasites (Delta rps13) were engineered with integration of tetracycline repressor (TetR) response elements in a critical location in the rps13 promoter and transfection of a yellow fluorescent-tetracycline repressor (YFP-TetR). This permitted conditional knockdown of rps13 expression in a tightly regulated manner. Delta rps13 parasites were studied in the presence (+ATc) or absence of anhydrotetracycline (-ATc) in culture. -ATc, transcription of the rps13 gene and expression of RPS13 protein were markedly diminished, with concomitant cessation of parasite replication. Study of Delta rps13 expressing Myc-tagged RPL22, -ATc, showed RPL22 diminished but at a slower rate. Quantitation of RNA showed diminution of 18S RNA. Depletion of RPS13 caused arrest of parasites in the G1 cell cycle phase, thereby stopping parasite proliferation. Transcriptional differences +/- ATc implicate molecules likely to function in regulation of these processes. In vitro, -ATc, Delta rps13 persists for months and the proliferation phenotype can be rescued with ATc. In vivo, however, Delta rps13 could only be rescued when ATc was given simultaneously and not at any time after 1 week, even when L-NAME and ATc were administered. Immunization with Delta rps13 parasites protects mice completely against subsequent challenge with wildtype clonal Type 1 parasites, and robustly protects mice against wildtype clonal Type 2 parasites. Our results demonstrate that G1 arrest by ribosomal protein depletion is associated with persistence of T. gondii in a model system in vitro and immunization with Delta rps13 protects mice against subsequent challenge with wildtype parasites.	[Hutson, Samuel L.; Mui, Ernest; Kinsley, Karen; Witola, William H.; El Bissati, Kamal; Rohrman, Brittany; Liu, Susan R.; McLeod, Rima] Univ Chicago, Dept Surg Ophthalmol, Chicago, IL 60637 USA; [Behnke, Michael S.] Montana State Univ, Dept Vet Mol Biol, Bozeman, MT 59717 USA; [Muench, Stephen P.] Univ Leeds, Inst Membrane & Syst Biol, Leeds, W Yorkshire, England; [Wollmann, Robert] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Ogata, Yuko] Seattle Biomed Res Inst, Seattle, WA 98109 USA; [Sarkeshik, Ali; Yates, John R., III] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [McLeod, Rima] Univ Chicago, Dept Pediat Infect Dis, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Immunol, The Coll, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Mol Med, The Coll, Chicago, IL 60637 USA; [McLeod, Rima] Univ Chicago, Inst Genom & Syst Biol, Comm Genet, The Coll, Chicago, IL 60637 USA	University of Chicago; Montana State University System; Montana State University Bozeman; University of Leeds; University of Chicago; Center for Infectious Disease Research; Scripps Research Institute; University of Chicago; University of Chicago; University of Chicago; University of Chicago	Hutson, SL (corresponding author), Univ Chicago, Dept Surg Ophthalmol, Chicago, IL 60637 USA.	rmcleod@midway.uchicago.edu	Witola, WIlliam Harold/AAD-6647-2020; Behnke, Michael S/R-8839-2016; Muench, Stephen/AAI-9529-2020	Behnke, Michael S/0000-0002-4668-8109; Muench, Stephen/0000-0001-6869-4414; EL BISSATI, KAMAL/0000-0001-9341-4162	Fin Charity Trust; Rooney Aldens, Peter Mann and Dominique Cornwell Family Trust; Intervet/Schering Plough; Toxoplasmosis Research Institute; Research to Prevent Blindness Foundation; Howard Hughes Foundation; National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R01AI043228, U01 AI082180-01, U01 AI 77887, R01 AI071319-01, NIH P41RR0118232]; Morel family; Jackson family; Orlinsky family; Goldberg family; Taub family; Kapnick family; Schilling family; Kiewit family; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043228, R01AI071319, U01AI077887, U01AI082180] Funding Source: NIH RePORTER	Fin Charity Trust; Rooney Aldens, Peter Mann and Dominique Cornwell Family Trust; Intervet/Schering Plough(Merck & CompanySchering Plough Corporation); Toxoplasmosis Research Institute; Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Howard Hughes Foundation(Howard Hughes Medical Institute); National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Morel family; Jackson family; Orlinsky family; Goldberg family; Taub family; Kapnick family; Schilling family; Kiewit family; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors gratefully acknowledge support of this work by gifts from the Fin Charity Trust, the Rooney Aldens, the Peter Mann and Dominique Cornwell Family Trust, the Morel, Jackson, Orlinsky, Goldberg, Taub, Kapnick, Schilling, and Kiewit families, Intervet/Schering Plough, Toxoplasmosis Research Institute, The Research to Prevent Blindness Foundation, The Howard Hughes Foundation Undergraduate Summer Research Program in Neurosciences (BR), and National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases R01AI043228, U01 AI082180-01, U01 AI 77887, R01 AI071319-01 (RM), NIH P41RR0118232 (JY). The funders had no role in study design, data collection and analysis, or decision to publish.	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709; Ball HL, 2009, HUM MOL GENET, V18, P3684, DOI 10.1093/hmg/ddp316; Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Behnke MS, 2008, MOL MICROBIOL, V68, P1502, DOI 10.1111/j.1365-2958.2008.06249.x; Behnke MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012354; Bernstein KA, 2007, MOL BIOL CELL, V18, P953, DOI 10.1091/mbc.E06-06-0512; Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Cech TR, 2000, SCIENCE, V289, P878, DOI 10.1126/science.289.5481.878; COCIORVA D, 2006, CURRENT PROTOCOLS S, V16; Connolly LE, 2009, CELL HOST MICROBE, V6, P1, DOI 10.1016/j.chom.2009.07.001; De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105; Deitsch K, 2007, AM J TROP MED HYG, V77, P201; Diaz-Martin J, 2005, PLANT PHYSIOL, V139, P1483, DOI 10.1104/pp.105.069963; Diop SB, 2008, EMBO REP, V9, P260, DOI 10.1038/embor.2008.8; Donald RGK, 1998, MOL BIOCHEM PARASIT, V91, P295, DOI 10.1016/S0166-6851(97)00210-7; Eaton MS, 2006, INT J PARASITOL, V36, P107, DOI 10.1016/j.ijpara.2005.08.014; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ferguson DJP, 2005, EUKARYOT CELL, V4, P814, DOI 10.1128/EC.4.4.814-826.2005; Ferreira-Cerca S, 2005, MOL CELL, V20, P263, DOI 10.1016/j.molcel.2005.09.005; Ferreira-Cerca S, 2007, MOL CELL, V28, P446, DOI 10.1016/j.molcel.2007.09.029; Ferreira-Cerca S, 2009, NATURE, V459, P46, DOI 10.1038/459046a; Flueck C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000784; Fumagalli S, 2009, NAT CELL BIOL, V11, P501, DOI 10.1038/ncb1858; GOSSEN M, 1993, NUCLEIC ACIDS RES, V21, P4411, DOI 10.1093/nar/21.18.4411; Grandbastien M, 2005, CYTOGENET GENOME RES, V110, P229, DOI 10.1159/000084957; Gubbels MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040036; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Ito T, 2000, PLANT J, V22, P257, DOI 10.1046/j.1365-313x.2000.00728.x; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kasper DC, 2009, DIAGN MICR INFEC DIS, V63, P10, DOI 10.1016/j.diagmicrobio.2008.09.009; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kibe MK, 2005, NUCLEIC ACIDS RES, V33, P1722, DOI 10.1093/nar/gki314; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; LINDNER SE, 2009, J MOL BIOL; MACK DG, 1984, ANTIMICROB AGENTS CH, V26, P26, DOI 10.1128/AAC.26.1.26; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; McCourt PC, 2009, J BIOL CHEM, V284, P11930, DOI 10.1074/jbc.M900857200; MCLEOD R, 1988, J IMMUNOL, V140, P1632; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; MESSINA M, 1995, GENE, V165, P213, DOI 10.1016/0378-1119(95)00548-K; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Mui EJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000190; Mullapudi N, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r34; Nagamune K, 2008, NATURE, V451, P207, DOI 10.1038/nature06478; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Opferman JT, 2006, CELL DEATH DIFFER, V13, P898, DOI 10.1038/sj.cdd.4401923; Radke JR, 2003, MOL BIOCHEM PARASIT, V131, P119, DOI 10.1016/S0166-6851(03)00198-1; Radke JR, 2001, MOL BIOCHEM PARASIT, V115, P165, DOI 10.1016/S0166-6851(01)00284-5; Radke JR, 1998, MOL BIOCHEM PARASIT, V94, P237, DOI 10.1016/S0166-6851(98)00074-7; Reid JL, 2000, MOL CELL, V6, P1297, DOI 10.1016/S1097-2765(00)00128-3; Roberts F, 2000, PARASITE IMMUNOL, V22, P1, DOI 10.1046/j.1365-3024.2000.00259.x; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Rushton PJ, 2008, PLANT PHYSIOL, V147, P280, DOI 10.1104/pp.107.114041; Saksouk N, 2005, MOL CELL BIOL, V25, P10301, DOI 10.1128/MCB.25.23.10301-10314.2005; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schaap D, 2005, MOL BIOCHEM PARASIT, V139, P239, DOI 10.1016/j.molbiopara.2004.11.011; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Seidelt B, 2009, SCIENCE, V326, P1412, DOI 10.1126/science.1177662; Smith AT, 2005, EUKARYOT CELL, V4, P2057, DOI 10.1128/EC.4.12.2057-2065.2005; Stockinger EJ, 2001, NUCLEIC ACIDS RES, V29, P1524, DOI 10.1093/nar/29.7.1524; Sullivan WJ, 2009, MEM I OSWALDO CRUZ, V104, P155, DOI 10.1590/S0074-02762009000200005; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0; Van Poppel NFJ, 2006, PARASITOLOGY, V133, P19, DOI 10.1017/S0031182006009954; van Poppel NFJ, 2006, INT J PARASITOL, V36, P443, DOI 10.1016/j.ijpara.2006.01.005; VANPOPPEL NF, 2005, TRANSCRIPTIONAL REGU, P110; Vonlaufen N, 2008, CELL MICROBIOL, V10, P2387, DOI 10.1111/j.1462-5822.2008.01210.x; Vonlaufen N, 2010, J BIOL CHEM, V285, P11154, DOI 10.1074/jbc.M109.066134; Yonath A, 2006, NATURE, V444, P435, DOI 10.1038/444435a; Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	77	23	23	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14057	10.1371/journal.pone.0014057	http://dx.doi.org/10.1371/journal.pone.0014057			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124925	Green Submitted, Green Published, gold			2022-12-27	WOS:000284467200004
J	Lee, C; Mayfield, RD; Harris, RA				Lee, Changhoon; Mayfield, R. Dayne; Harris, R. Adron			Intron 4 Containing Novel GABAB1 Isoforms Impair GABAB Receptor Function	PLOS ONE			English	Article							N-TERMINAL VARIANT; AMINOBUTYRIC-ACID RECEPTOR; GENE-EXPRESSION; ALTERNATIVE PROMOTERS; FRONTAL-CORTEX; SUBUNIT; PROTEIN; IDENTIFICATION; MEMBRANE; PATTERNS	Background: Gamma-aminobutyric acid type B (GABAB) receptors decrease neural activity through G protein signaling. There are two subunits, GABAB1 and GABAB2. Alternative splicing provides GABAB1 with structural and functional diversity. cDNA microarrays showed strong signals from human brain RNA using GABAB1 intron 4 region probes. Therefore, we predicted the existence of novel splice variants. Methodology/Principal Findings: Based on the probe sequence analysis, we proposed two possible splice variants, GABAB1j and GABAB1k. The existence of human GABAB1j was verified by quantitative real-time PCR, and mouse GABAB1j was found from a microarray probe set based on human GABAB1j sequence. GABAB1j open reading frames (ORF) and expression patterns are not conserved across species, and they do not have any important functional domains except sushi domains. Thus, we focused on another possible splice variant, GABAB1k. After obtaining PCR evidence for GABAB1k existence from human, mouse, and rat, it was cloned from human and mouse by PCR along with three additional isoforms, GABAB1l, GABAB1m, and GABAB1n. Their expression levels by quantitative real-time PCR are relatively low in brain although they may be expressed in specific cell types. GABAB1l and GABAB1m inhibit GABAB receptor-induced G protein-activated inwardly rectifying K(+) channel (GIRK) currents at Xenopus oocyte two-electrode voltage clamp system. Conclusions/Significance: This study supports previous suggestions that intron 4 of GABAB1 gene is a frequent splicing spot across species. Like GABAB1e, GABAB1l and GABAB1m do not have transmembrane domains but have a dimerization motif. So, they also could be secreted and bind GABAB2 dominantly instead of GABAB1a. However, only GABAB1l and GABAB1m are N- and C-terminal truncated splicing variants and impair receptor function. This suggests that the intron 4 containing N-terminal truncation is necessary for the inhibitory action of the new splice variants.	[Lee, Changhoon] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Neurobiol Sect, Austin, TX 78712 USA; Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Inst Cellular & Mol Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lee, C (corresponding author), Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Neurobiol Sect, Austin, TX 78712 USA.	ninolee00@mail.utexas.edu		Lee, Chang Hoon/0000-0002-4031-3795	National Institute on Alcohol Abuse and Alcoholism (NIAAA) [AA06399]; NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA006399, R01AA006399, R01AA012404, R28AA012725] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)Instituto de Investigacion Agropecuaria (INIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant AA06399 and by the NIAAA Integrative Neuroscience Initiative on Alcoholism (INIA)-West consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Billinton A, 2001, TRENDS NEUROSCI, V24, P277, DOI 10.1016/S0166-2236(00)01815-4; Bulanova E, 2007, J BIOL CHEM, V282, P13167, DOI 10.1074/jbc.M610036200; Calver AR, 2000, NEUROSCIENCE, V100, P155, DOI 10.1016/S0306-4522(00)00262-1; Chang WH, 2007, J BIOL CHEM, V282, P25030, DOI 10.1074/jbc.M700924200; Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908; Crofts LA, 1998, P NATL ACAD SCI USA, V95, P10529, DOI 10.1073/pnas.95.18.10529; Ezzat S, 2001, BIOCHEM BIOPH RES CO, V287, P60, DOI 10.1006/bbrc.2001.5546; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Flatscher-Bader T, 2005, J NEUROCHEM, V93, P359, DOI 10.1111/j.1471-4159.2004.03021.x; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Holter J, 2005, J MOL NEUROSCI, V26, P99, DOI 10.1385/JMN:26:1:099; Huang JM, 2009, EXP CELL RES, V315, P1200, DOI 10.1016/j.yexcr.2009.01.004; LAMOND AI, 1985, CELL, V40, P319, DOI 10.1016/0092-8674(85)90146-1; Lareau LF, 2004, CURR OPIN STRUC BIOL, V14, P273, DOI 10.1016/j.sbi.2004.05.002; Lewohl JM, 1999, NAT NEUROSCI, V2, P1084, DOI 10.1038/16012; Liu JW, 2006, NEUROPSYCHOPHARMACOL, V31, P1574, DOI 10.1038/sj.npp.1300947; Liu JW, 2004, J NEUROCHEM, V90, P1050, DOI 10.1111/j.1471-4159.2004.02570.x; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; MOSLEY B, 1989, CELL, V59, P335, DOI 10.1016/0092-8674(89)90295-X; Park H, 2005, J NEUROSCI, V25, P9037, DOI 10.1523/JNEUROSCI.1989-05.2005; Ponomarev I, 2006, J NEUROSCI, V26, P5673, DOI 10.1523/JNEUROSCI.0860-06.2006; Schwarz DA, 2000, J BIOL CHEM, V275, P32174, DOI 10.1074/jbc.M005333200; Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004; Sunn KL, 2001, MOL ENDOCRINOL, V15, P1599, DOI 10.1210/me.15.9.1599; Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200; Travers MT, 2003, BBA-MOL CELL BIOL L, V1634, P97, DOI 10.1016/j.bbalip.2003.09.005; Uezono Y, 2006, AM J PHYSIOL-CELL PH, V290, pC200, DOI 10.1152/ajpcell.00269.2005; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; VOLIVA CF, 1992, MOL CELL BIOL, V12, P2383, DOI 10.1128/MCB.12.5.2383; Wang Z, 1996, J BIOL CHEM, V271, P7835, DOI 10.1074/jbc.271.13.7835; Wei KR, 2001, MOL BRAIN RES, V89, P103, DOI 10.1016/S0169-328X(01)00068-7	32	15	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14044	10.1371/journal.pone.0014044	http://dx.doi.org/10.1371/journal.pone.0014044			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124972	Green Published, Green Submitted, gold			2022-12-27	WOS:000284356900007
J	Papaconstantinou, M; Pepper, AN; Wu, Y; Kasimer, D; Westwood, T; Campos, AR; Bedard, PA				Papaconstantinou, Maria; Pepper, Alicia N.; Wu, Ying; Kasimer, Dahlia; Westwood, Tim; Campos, Ana Regina; Bedard, Pierre-Andre			Menin Links the Stress Response to Genome Stability in Drosophila melanogaster	PLOS ONE			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; HISTONE METHYLTRANSFERASE COMPLEX; TUMOR-SUPPRESSOR PROTEIN; DNA-DAMAGE; HEAT-SHOCK; GENE-EXPRESSION; TYPE-1; TRANSCRIPTION; INTERACTS; REPAIR	Background: The multiple endocrine neoplasia type I gene functions as a tumor suppressor gene in humans and mouse models. In Drosophila melanogaster, mutants of the menin gene (Mnn1) are hypersensitive to mutagens or gamma irradiation and have profound defects in the response to several stresses including heat shock, hypoxia, hyperosmolarity and oxidative stress. However, it is not known if the function of menin in the stress response contributes to genome stability. The objective of this study was to examine the role of menin in the control of the stress response and genome stability. Methodology/Principal Findings: Using a test of loss-of-heterozygosity, we show that Drosophila strains lacking a functional Mnn1 gene or expressing a Mnn1 dsRNA display increased genome instability in response to non-lethal heat shock or hypoxia treatments. This is also true for strains lacking all Hsp70 genes, implying that a precise control of the stress response is required for genome stability. While menin is required for Hsp70 expression, the results of epistatic studies indicate that the increase in genome instability observed in Mnn1 lack-of-function mutants cannot be accounted for by mis-expression of Hsp70. Therefore, menin may promote genome stability by controlling the expression of other stress-responsive genes. In agreement with this notion, gene profiling reveals that Mnn1 is required for sustained expression of all heat shock protein genes but is dispensable for early induction of the heat shock response. Conclusions/Significance: Mutants of the Mnn1 gene are hypersensitive to several stresses and display increased genome instability when subjected to conditions, such as heat shock, generally regarded as non-genotoxic. In this report, we describe a role for menin as a global regulator of heat shock gene expression and critical factor in the maintenance of genome integrity. Therefore, menin links the stress response to the control of genome stability in Drosophila melanogaster.	[Papaconstantinou, Maria; Pepper, Alicia N.; Wu, Ying; Campos, Ana Regina; Bedard, Pierre-Andre] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Kasimer, Dahlia; Westwood, Tim] Univ Toronto, Dept Cell & Syst Biol, Mississauga, ON L5L 1C6, Canada; [Kasimer, Dahlia; Westwood, Tim] Univ Toronto, Canadian Drosophila Microarray Ctr, Mississauga, ON L5L 1C6, Canada	McMaster University; University of Toronto; University Toronto Mississauga; University of Toronto; University Toronto Mississauga	Papaconstantinou, M (corresponding author), McMaster Univ, Dept Biol, Hamilton, ON, Canada.	abedard@mcmaster.ca			Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research [MOP-84359]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	JTW and DK were supported by Discovery and Major Facility Access grants from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca). This work was funded by a grant from the Canadian Institutes of Health Research to PAB and ARC (MOP-84359; www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal SK, 1999, CELL, V96, P143, DOI 10.1016/S0092-8674(00)80967-8; Agarwal SK, 2005, HORM METAB RES, V37, P369, DOI 10.1055/s-2005-870139; BAKER BS, 1978, GENETICS, V90, P531; Bertolino P, 2003, MOL ENDOCRINOL, V17, P1880, DOI 10.1210/me.2003-0154; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brodsky MH, 2000, CELL, V101, P103, DOI 10.1016/S0092-8674(00)80627-3; Brodsky MH, 2000, GENE DEV, V14, P666; Busygina V, 2004, HUM MOL GENET, V13, P2399, DOI 10.1093/hmg/ddh271; Busygina V, 2006, CANCER RES, V66, P8397, DOI 10.1158/0008-5472.CAN-06-0061; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gong WJ, 2006, GENETICS, V172, P275, DOI 10.1534/genetics.105.048793; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GUSTAVSON KH, 1983, CLIN GENET, V23, P143; Heppner C, 2001, ONCOGENE, V20, P4917, DOI 10.1038/sj.onc.1204529; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Hunt CR, 2004, MOL CELL BIOL, V24, P899, DOI 10.1128/MCB.24.2.899-911.2004; Jedlicka P, 1997, EMBO J, V16, P2452, DOI 10.1093/emboj/16.9.2452; Jin SH, 2003, CANCER RES, V63, P4204; Kaji H, 2001, P NATL ACAD SCI USA, V98, P3837, DOI 10.1073/pnas.061358098; Kim H, 2003, CANCER RES, V63, P6135; Krebs RA, 1998, J INSECT PHYSIOL, V44, P1091, DOI 10.1016/S0022-1910(98)00059-6; Krebs RA, 1997, CELL STRESS CHAPERON, V2, P60, DOI 10.1379/1466-1268(1997)002<0060:DCOHOI>2.3.CO;2; Lemmens I, 1997, HUM MOL GENET, V6, P1177, DOI 10.1093/hmg/6.7.1177; Marek LR, 2008, DNA REPAIR, V7, P476, DOI 10.1016/j.dnarep.2007.12.009; Neal SJ, 2003, GENOME, V46, P879, DOI 10.1139/G03-056; Papaconstantinou M, 2005, MOL CELL BIOL, V25, P9960, DOI 10.1128/MCB.25.22.9960-9972.2005; Peters M, 2002, P NATL ACAD SCI USA, V99, P11305, DOI 10.1073/pnas.172382899; SCAPPATICCI S, 1991, CANCER GENET CYTOGEN, V52, P85, DOI 10.1016/0165-4608(91)90057-2; Semotok JL, 2008, METHOD ENZYMOL, V448, P299, DOI 10.1016/S0076-6879(08)02616-5; Smith ST, 2004, NAT CELL BIOL, V6, P162, DOI 10.1038/ncb1088; Sogame N, 2003, P NATL ACAD SCI USA, V100, P4696, DOI 10.1073/pnas.0736384100; Sukhodolets KE, 2003, MOL CELL BIOL, V23, P493, DOI 10.1128/MCB.23.2.493-509.2003; TOMASSETTI P, 1995, CANCER GENET CYTOGEN, V79, P123, DOI 10.1016/0165-4608(95)98126-J; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004; Yokoyama A, 2005, CELL, V123, P207, DOI 10.1016/j.cell.2005.09.025	39	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14049	10.1371/journal.pone.0014049	http://dx.doi.org/10.1371/journal.pone.0014049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124979	gold, Green Published, Green Submitted			2022-12-27	WOS:000284356900012
J	Margolis, EB; Coker, AR; Driscoll, JR; Lemaitre, AI; Fields, HL				Margolis, Elyssa B.; Coker, Allison R.; Driscoll, Joseph R.; Lemaitre, Anne-Iris; Fields, Howard L.			Reliability in the Identification of Midbrain Dopamine Neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PHOSPHORYLATION; OPIOIDS	Brain regions typically contain intermixed subpopulations of neurons with different connectivity and neurotransmitters. This complicates identification of neuronal phenotypes in electrophysiological experiments without using direct detection of unique molecular markers. A prime example of this difficulty is the identification of dopamine (DA) neurons in the midbrain ventral tegmental area (VTA). Although immunocytochemistry (ICC) against tyrosine hydroxylase (TH) is widely used to identify DA neurons, a high false negative rate for TH ICC following ex vivo electrophysiology experiments was recently reported, calling into question the validity of comparing DA and non-DA VTA neurons based on post-hoc ICC. However, in whole cell recordings from randomly selected rat VTA neurons we have found that TH labeling is consistently detected in similar to 55% of neurons even after long recording durations (range: 2.5-150 min). This is consistent with our prior anatomical finding that 55% of VTA neurons are TH(+). To directly estimate a false negative rate for our ICC method we recorded VTA neurons from mice in which EGFP production is driven by the TH promoter. All 12 EGFP(+) neurons recorded with a K-gluconate internal solution (as used in our rat recordings) were strongly labeled by TH ICC (recording duration 16.6 +/- 1.8 min). However, using recording electrodes with an internal solution with high Cl(-) concentration reduced the intensity of TH co-labeling, in some cases to background (recording duration 16.7 +/- 0.9 min; n = 10). Thus TH is a highly reliable molecular marker for DA neurons in VTA patch clamp recordings provided compatible microelectrode solutions are used.	[Margolis, Elyssa B.; Coker, Allison R.; Driscoll, Joseph R.; Lemaitre, Anne-Iris; Fields, Howard L.] Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA; [Margolis, Elyssa B.; Fields, Howard L.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Fields, Howard L.] Univ Calif San Francisco, Wheeler Ctr Neurobiol Addict, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Ernest Gallo Clinic & Research Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Margolis, EB (corresponding author), Univ Calif San Francisco, Ernest Gallo Clin & Res Ctr, Emeryville, CA USA.	elyssam@gallo.ucsf.edu	Fields, Howard/ABG-9073-2020		State of California through University of California San Francisco	State of California through University of California San Francisco	This work was supported by funding from the State of California for medical research on alcohol and substance abuse through the University of California San Francisco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KC, 2010, J NEUROSCI, V30, P6689, DOI 10.1523/JNEUROSCI.4453-09.2010; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Iniguez SD, 2010, J NEUROSCI, V30, P7652, DOI 10.1523/JNEUROSCI.0951-10.2010; Lammel S, 2008, NEURON, V57, P760, DOI 10.1016/j.neuron.2008.01.022; Lindgren N, 2002, EUR J NEUROSCI, V15, P769, DOI 10.1046/j.1460-9568.2002.01901.x; Luo AH, 2008, EUR J NEUROSCI, V27, P408, DOI 10.1111/j.1460-9568.2007.05985.x; Margolis EB, 2006, P NATL ACAD SCI USA, V103, P2938, DOI 10.1073/pnas.0511159103; Margolis EB, 2003, J NEUROSCI, V23, P9981; Margolis EB, 2008, J NEUROSCI, V28, P8908, DOI 10.1523/JNEUROSCI.1526-08.2008; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Roesch MR, 2007, NAT NEUROSCI, V10, P1615, DOI 10.1038/nn2013; Wertheimer EV, 2008, J BIOL CHEM, V283, P35539, DOI 10.1074/jbc.M804586200; YIM CY, 1980, BRAIN RES, V181, P301; Zhang TA, 2010, NEUROPHARMACOLOGY, V59, P431, DOI 10.1016/j.neuropharm.2010.06.004	14	53	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15222	10.1371/journal.pone.0015222	http://dx.doi.org/10.1371/journal.pone.0015222			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151605	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800019
J	Martens, S; Kandula, M; Duncan, J				Martens, Sander; Kandula, Manasa; Duncan, John			Restricted Attentional Capacity within but Not between Sensory Modalities: An Individual Differences Approach	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; DIVIDED ATTENTION; WITHIN-MODALITY; BLINK; TASK; LIMITATIONS; SELECTION; DEFICITS; DISCRIMINATION; IDENTIFICATION	Background: Most people show a remarkable deficit to report the second of two targets when presented in close temporal succession, reflecting an attentional blink (AB). An aspect of the AB that is often ignored is that there are large individual differences in the magnitude of the effect. Here we exploit these individual differences to address a long-standing question: does attention to a visual target come at a cost for attention to an auditory target (and vice versa)? More specifically, the goal of the current study was to investigate a) whether individuals with a large within-modality AB also show a large cross-modal AB, and b) whether individual differences in AB magnitude within different modalities correlate or are completely separate. Methodology/Principal Findings: While minimizing differential task difficulty and chances for a task-switch to occur, a significant AB was observed when targets were both presented within the auditory or visual modality, and a positive correlation was found between individual within-modality AB magnitudes. However, neither a cross-modal AB nor a correlation between cross-modal and within-modality AB magnitudes was found. Conclusion/Significance: The results provide strong evidence that a major source of attentional restriction must lie in modality-specific sensory systems rather than a central amodal system, effectively settling a long-standing debate. Individuals with a large within-modality AB may be especially committed or focused in their processing of the first target, and to some extent that tendency to focus could cross modalities, reflected in the within-modality correlation. However, what they are focusing (resource allocation, blocking of processing) is strictly within-modality as it only affects the second target on within-modality trials. The findings show that individual differences in AB magnitude can provide important information about the modular structure of human cognition.	[Martens, Sander; Kandula, Manasa] Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands; [Martens, Sander; Kandula, Manasa] Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Duncan, John] MRC Cognit & Brain Sci Unit, Cambridge, England	University of Groningen; University of Groningen	Martens, S (corresponding author), Univ Groningen, Neuroimaging Ctr, Groningen, Netherlands.	s.martens@med.umcg.nl		Martens, Sander/0000-0001-8237-7984; Duncan, John/0000-0002-9695-2764	Behavioural and Cognitive Neurosciences (BCN) Research School; Medical Research Council [MC_U105580448] Funding Source: researchfish; MRC [MC_U105580448] Funding Source: UKRI	Behavioural and Cognitive Neurosciences (BCN) Research School; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This research was supported by a grant of the Behavioural and Cognitive Neurosciences (BCN) Research School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2006, P R SOC B, V273, P1339, DOI 10.1098/rspb.2005.3420; ALLPORT DA, 1972, Q J EXP PSYCHOL, V24, P225, DOI 10.1080/00335557243000102; Arnell KM, 2006, PERCEPT PSYCHOPHYS, V68, P447, DOI 10.3758/BF03193689; Arnell KM, 2004, PERCEPT PSYCHOPHYS, V66, P1147, DOI 10.3758/BF03196842; Arnell KM, 2002, PSYCHON B REV, V9, P497, DOI 10.3758/BF03196305; Arnell KM, 2002, COGNITIVE PSYCHOL, V44, P105, DOI 10.1006/cogp.2001.0762; Arnell KM, 1999, J EXP PSYCHOL HUMAN, V25, P630, DOI 10.1037/0096-1523.25.3.630; Bonnel AM, 1998, PERCEPT PSYCHOPHYS, V60, P179, DOI 10.3758/BF03206027; CHUN MM, 1995, J EXP PSYCHOL HUMAN, V21, P109; Dell'Acqua R, 2003, PSYCHOPHYSIOLOGY, V40, P629, DOI 10.1111/1469-8986.00064; Duncan J, 1997, NATURE, V387, P808, DOI 10.1038/42947; EGETH HE, 1977, PERCEPT PSYCHOPHYS, V22, P77, DOI 10.3758/BF03206083; Evans KK, 2005, J EXP PSYCHOL HUMAN, V31, P1476, DOI 10.1037/0096-1523.31.6.1476; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Hein G, 2006, PERCEPT PSYCHOPHYS, V68, P54, DOI 10.3758/BF03193655; Hillstrom AP, 2002, PERCEPT PSYCHOPHYS, V64, P1068, DOI 10.3758/BF03194757; Jolicoeur P, 1999, PSYCHON B REV, V6, P87, DOI 10.3758/BF03210813; Larsen A, 2003, PERCEPT PSYCHOPHYS, V65, P568, DOI 10.3758/BF03194583; LONG J, 1975, Q J EXP PSYCHOL, V27, P599, DOI 10.1080/14640747508400523; Luck SJ, 1996, NATURE, V383, P616, DOI 10.1038/383616a0; Martens S, 2009, EXP BRAIN RES, V192, P43, DOI 10.1007/s00221-008-1551-1; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2010, NEUROSCI BIOBEHAV R, V34, P947, DOI 10.1016/j.neubiorev.2009.12.005; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; Martens S, 2009, EXP PSYCHOL, V56, P18, DOI 10.1027/1618-3169.56.1.18; MASSARO DW, 1977, PERCEPT PSYCHOPHYS, V21, P569, DOI 10.3758/BF03198739; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Potter MC, 2002, J EXP PSYCHOL HUMAN, V28, P1149, DOI 10.1037//0096-1523.28.5.1149; Potter MC, 1998, J EXP PSYCHOL LEARN, V24, P979, DOI 10.1037/0278-7393.24.4.979; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Schneider W., 2002, E PRIME USERS GUIDE; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; SHIFFRIN RM, 1974, PERCEPT PSYCHOPHYS, V15, P460, DOI 10.3758/BF03199286; Soto-Faraco S, 2002, Q J EXP PSYCHOL-A, V55, P23, DOI 10.1080/02724980143000136; SWETS JA, 1970, ANNU REV PSYCHOL, V21, P339, DOI 10.1146/annurev.ps.21.020170.002011; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; TAYLOR MM, 1967, ACTA PSYCHOL, V27, P223, DOI 10.1016/0001-6918(67)99000-2; Treisman A. M., 1973, ATTENTION PERFORM, P101; TULVING E, 1967, ACTA PSYCHOL, V27, P101, DOI 10.1016/0001-6918(67)90050-9; Van der Burg E, 2007, PERCEPT PSYCHOPHYS, V69, P1230, DOI 10.3758/BF03193958; Wickens C.D., 1980, ATTENTION PERFORM, VVIII, P239	41	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15280	10.1371/journal.pone.0015280	http://dx.doi.org/10.1371/journal.pone.0015280			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	690XB	21151865	Green Published, gold			2022-12-27	WOS:000285041800015
J	Alloatti, A; Gupta, S; Gualdron-Lopez, M; Igoillo-Esteve, M; Nguewa, PA; Deumer, G; Wallemacq, P; Altabe, SG; Michels, PAM; Uttaro, AD				Alloatti, Andres; Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Deumer, Gladys; Wallemacq, Pierre; Altabe, Silvia G.; Michels, Paul A. M.; Uttaro, Antonio D.			Genetic and Chemical Evaluation of Trypanosoma brucei Oleate Desaturase as a Candidate Drug Target	PLOS ONE			English	Article							FATTY-ACID SYNTHESIS; STEARIC-ACID; BIOSYNTHESIS; ELONGATION; EXPRESSION; PROTOZOAN; ANALOGS; GROWTH; LIPIDS	Background: Trypanosomes can synthesize polyunsaturated fatty acids. Previously, we have shown that they possess stearoyl-CoA desaturase (SCD) and oleate desaturase (OD) to convert stearate (C18) into oleate (C18: 1) and linoleate (C18: 2), respectively. Here we examine if OD is essential to these parasites. Methodology: Cultured procyclic (insect-stage) form (PCF) and bloodstream-form (BSF) Trypanosoma brucei cells were treated with 12- and 13-thiastearic acid (12-TS and 13-TS), inhibitors of OD, and the expression of the enzyme was knocked down by RNA interference. The phenotype of these cells was studied. Principal Findings: Growth of PCF T. brucei was totally inhibited by 100 mu M of 12-TS and 13-TS, with EC50 values of 40 +/- 2 and 30 +/- 2 mu M, respectively. The BSF was more sensitive, with EC50 values of 7 +/- 3 and 2 +/- 1 mu M, respectively. This growth phenotype was due to the inhibitory effect of thiastearates on OD and, to a lesser extent, on SCD. The enzyme inhibition caused a drop in total unsaturated fatty-acid level of the cells, with a slight increase in oleate but a drastic decrease in linoleate level, most probably affecting membrane fluidity. After knocking down OD expression in PCF, the linoleate content was notably reduced, whereas that of oleate drastically increased, maintaining the total unsaturated fatty-acid level unchanged. Interestingly, the growth phenotype of the RNAi-induced cells was similar to that found for thiastearate-treated trypanosomes, with the former cells growing twofold slower than the latter ones, indicating that the linoleate content itself and not only fluidity could be essential for normal membrane functionality. A similar deleterious effect was found after RNAi in BSF, even with a mere 8% reduction of OD activity, indicating that its full activity is essential. Conclusions/Significance: As OD is essential for trypanosomes and is not present in mammalian cells, it is a promising target for chemotherapy of African trypanosomiasis.	[Alloatti, Andres; Altabe, Silvia G.; Uttaro, Antonio D.] Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Michels, Paul A. M.] Catholic Univ Louvain, Trop Dis Res Unit, Biochem Lab, B-1200 Brussels, Belgium; [Gupta, Shreedhara; Gualdron-Lopez, Melisa; Igoillo-Esteve, Mariana; Nguewa, Paul A.; Michels, Paul A. M.] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium; [Deumer, Gladys; Wallemacq, Pierre] Catholic Univ Louvain, Dept Clin Chem, Clin Univ St Luc, LTAP, B-1200 Brussels, Belgium	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Alloatti, A (corresponding author), Univ Nacl Rosario, CONICET, Fac Ciencias Bioquim & Farmaceut, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina.	toniuttaro@yahoo.com.ar	Nguewa, Paul/T-6982-2017; Alloatti, Andres/P-3021-2016; Gualdrón-López, Melisa/A-4438-2016; Michels, Paul A/A-5637-2009	Nguewa, Paul/0000-0002-2193-7316; Alloatti, Andres/0000-0003-0555-0653; Gualdrón-López, Melisa/0000-0002-8202-6751; Michels, Paul A/0000-0003-3726-6104; Igoillo-Esteve, Mariana/0000-0002-3264-7912	CONICET, Argentina; "de Duve Institute" postdoctoral fellowship; CONICET; FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica) [5492, 1-13842]	CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); "de Duve Institute" postdoctoral fellowship; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica)(FONCyT)	ADU and SGA are members of the Carrera del Investigador Cienti-fico, CONICET (Consejo Nacional de Investigaciones Cientificas y Tecnicas), Argentina. AA has a fellowship from CONICET, Argentina and SG has a "de Duve Institute" postdoctoral fellowship. This work was supported by CONICET and FONCyT (Fondo Nacional para la Investigacion Cientifica y Tecnologica), through Grants PIP 2005 No. 5492 and PICT 2003 No. 1-13842, respectively. Collaboration between the Argentine and Belgian teams was supported through an exchange grant to ADU and PAMM, based on an Agreement for Scientific Cooperation between CONICET (Argentina) and F.N.R.S. (French Community of Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alloatti A, 2009, INT J PARASITOL, V39, P985, DOI 10.1016/j.ijpara.2009.01.011; BEACH DH, 1989, MOL BIOCHEM PARASIT, V35, P57, DOI 10.1016/0166-6851(89)90142-4; Berge RK, 2002, CURR OPIN LIPIDOL, V13, P295, DOI 10.1097/00041433-200206000-00010; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRUN R, 1979, ACTA TROP, V36, P289; FlorinChristensen M, 1997, MOL BIOCHEM PARASIT, V88, P25, DOI 10.1016/S0166-6851(97)00056-X; Haughan P.A., 1991, P312; Hovik KE, 1997, BBA-LIPID LIPID MET, V1349, P251, DOI 10.1016/S0005-2760(97)00135-5; Krazy H, 2006, BBA-MOL CELL RES, V1763, P6, DOI 10.1016/j.bbamcr.2005.11.002; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Livore VI, 2007, FEBS J, V274, P264, DOI 10.1111/j.1742-4658.2006.05581.x; Matthews KR, 2005, J CELL SCI, V118, P283, DOI 10.1242/jcs.01649; MORRIS LJ, 1966, J LIPID RES, V7, P717; PASCAL RA, 1986, J LIPID RES, V27, P221; Paul KS, 2001, TRENDS PARASITOL, V17, P381, DOI 10.1016/S1471-4922(01)01984-5; Petrini GA, 2004, EUR J BIOCHEM, V271, P1079, DOI 10.1111/j.1432-1033.2004.04005.x; Pettersen RJ, 2008, J CARDIOVASC PHARM, V51, P410, DOI 10.1097/FJC.0b013e3181673be0; RAHMAN MD, 1988, J MED CHEM, V31, P1656, DOI 10.1021/jm00403a029; Stephens JL, 2007, J BIOL CHEM, V282, P4427, DOI 10.1074/jbc.M609037200; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Tehlivets O, 2007, BBA-MOL CELL BIOL L, V1771, P255, DOI 10.1016/j.bbalip.2006.07.004; Tripodi KEJ, 2006, FEBS J, V273, P271, DOI 10.1111/j.1742-4658.2005.05049.x; Uttaro AD, 2006, IUBMB LIFE, V58, P563, DOI 10.1080/15216540600920899; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	27	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14239	10.1371/journal.pone.0014239	http://dx.doi.org/10.1371/journal.pone.0014239			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151902	Green Published, Green Submitted, gold			2022-12-27	WOS:000284995300011
J	Calisto, KL; Carvalho, BD; Ropelle, ER; Mittestainer, FC; Camacho, ACA; Guadagnini, D; Carvalheira, JBC; Saad, MJA				Calisto, Kelly Lima; Carvalho, Bruno de Melo; Ropelle, Eduardo Rochete; Mittestainer, Francine Cappa; Aranha Camacho, Angelica Costa; Guadagnini, Dioze; Campelo Carvalheira, Jose Barreto; Abdalla Saad, Mario Jose			RETRACTED: Atorvastatin Improves Survival in Septic Rats: Effect on Tissue Inflammatory Pathway and on Insulin Signaling (Retracted article. See vol. 11, e0159283, 2016)	PLOS ONE			English	Article; Retracted Publication							ENDOPLASMIC-RETICULUM STRESS; COA REDUCTASE INHIBITOR; NF-KAPPA-B; HOMEOSTASIS MODEL ASSESSMENT; TERMINAL KINASE JNK; STATIN THERAPY; LIPOPOLYSACCHARIDE ACTIVATION; RECEPTOR SUBSTRATE-1; ORGAN DYSFUNCTION; MURINE MODEL	The aim of the present study was to investigate whether the survival-improving effect of atorvastatin in sepsis is accompanied by a reduction in tissue activation of inflammatory pathways and, in parallel, an improvement in tissue insulin signaling in rats. Diffuse sepsis was induced by cecal ligation and puncture surgery ( CLP) in male Wistar rats. Serum glucose and inflammatory cytokines levels were assessed 24 h after CLP. The effect of atorvastatin on survival of septic animals was investigated in parallel with insulin signaling and its modulators in liver, muscle and adipose tissue. Atorvastatin improves survival in septic rats and this improvement is accompanied by a marked improvement in insulin sensitivity, characterized by an increase in glucose disappearance rate during the insulin tolerance test. Sepsis induced an increase in the expression/activation of TLR4 and its downstream signaling JNK and IKK/NF-kappa B activation, and blunted insulin-induced insulin signaling in liver, muscle and adipose tissue; atorvastatin reversed all these alterations in parallel with a decrease in circulating levels of TNF-alpha and IL-6. In summary, this study demonstrates that atorvastatin treatment increased survival, with a significant effect upon insulin sensitivity, improving insulin signaling in peripheral tissues of rats during peritoneal-induced sepsis. The effect of atorvastatin on the suppression of the TLR-dependent inflammatory pathway may play a central role in regulation of insulin signaling and survival in sepsis insult.	[Calisto, Kelly Lima; Carvalho, Bruno de Melo; Ropelle, Eduardo Rochete; Mittestainer, Francine Cappa; Aranha Camacho, Angelica Costa; Guadagnini, Dioze; Campelo Carvalheira, Jose Barreto; Abdalla Saad, Mario Jose] Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Sao Paulo, Brazil	Universidade Estadual de Campinas	Calisto, KL (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Internal Med, FCM, Sao Paulo, Brazil.	msaad@fcm.unicamp.br	Carvalheira, Jose B/H-8405-2012; Saad, Mario/ABD-8262-2020; Camacho, Alessandra Conceição Leite Funchal/V-5489-2019; Calisto, Kelly/J-9681-2016; Ropelle, Eduardo R/C-3977-2012	Camacho, Alessandra Conceição Leite Funchal/0000-0001-6600-6630; Ropelle, Eduardo R/0000-0003-1655-9557	CAPES	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	K.L.C. holds a graduate fellowship from CAPES, www.capes.gov.br. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Almog Y, 2003, CHEST, V124, P740, DOI 10.1378/chest.124.2.740; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Breder I, 2010, ATHEROSCLEROSIS, V212, P30, DOI 10.1016/j.atherosclerosis.2010.04.036; Brix-Christensen V, 2004, ANESTHESIOLOGY, V100, P861, DOI 10.1097/00000542-200404000-00016; BRIXCHRISTENSEN V, 2005, INFLAMMATORY RESPONS, P991; Bultinck J, 2006, CYTOKINE, V36, P160, DOI 10.1016/j.cyto.2006.11.010; Carvalho MA, 2005, DIABETES, V54, P959, DOI 10.2337/diabetes.54.4.959; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Clarke RM, 2007, NEUROPHARMACOLOGY, V52, P136, DOI 10.1016/j.neuropharm.2006.07.031; Coleman CI, 2007, CURR MED RES OPIN, V23, P1783, DOI 10.1185/030079907X210570; Copps KD, 2010, CELL METAB, V11, P84, DOI 10.1016/j.cmet.2009.11.003; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Davis RJ, 1999, BIOCHEM SOC SYMP, P1; Dostal LA, 1996, FUND APPL TOXICOL, V32, P285, DOI 10.1006/faat.1996.0132; Fernandez R, 2006, INTENS CARE MED, V32, P160, DOI 10.1007/s00134-005-2743-9; Frost FJ, 2007, CHEST, V131, P1006, DOI 10.1378/chest.06-1997; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gao ZG, 2003, J BIOL CHEM, V278, P24944, DOI 10.1074/jbc.M300423200; Guha M, 2001, CELL SIGNAL, V13, P85, DOI 10.1016/S0898-6568(00)00149-2; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Guha M, 2001, BLOOD, V98, P1429, DOI 10.1182/blood.V98.5.1429; Gupta R, 2007, JAMA-J AM MED ASSOC, V297, P1455, DOI 10.1001/jama.297.13.1455; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Hatherill M, 2000, CRIT CARE MED, V28, P2591, DOI 10.1097/00003246-200007000-00068; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Herschkovitz A, 2007, J BIOL CHEM, V282, P18018, DOI 10.1074/jbc.M610949200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; Jeschke MG, 2004, ENDOCRINOLOGY, V145, P4084, DOI 10.1210/en.2004-0592; Jeschke MG, 2005, J HEPATOL, V42, P870, DOI 10.1016/j.jhep.2004.12.036; Kidd LB, 2008, J PHARMACOL EXP THER, V326, P348, DOI 10.1124/jpet.108.138891; Kruger P, 2006, INTENS CARE MED, V32, P75, DOI 10.1007/s00134-005-2859-y; Kyle UG, 2010, INTENS CARE MED, V36, P312, DOI 10.1007/s00134-009-1703-1; Langouche L, 2005, J CLIN INVEST, V115, P2277, DOI 10.1172/JCI25385; Lee YH, 2003, J BIOL CHEM, V278, P2896, DOI 10.1074/jbc.M208359200; Li CF, 1999, AM J PHYSIOL-HEART C, V276, pH543, DOI 10.1152/ajpheart.1999.276.2.H543; Liappis AP, 2001, CLIN INFECT DIS, V33, P1352, DOI 10.1086/323334; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Maitra SR, 2000, SHOCK, V13, P379, DOI 10.1097/00024382-200005000-00006; Major CD, 2001, DIABETES, V50, P2721, DOI 10.2337/diabetes.50.12.2721; Majumdar SR, 2006, BMJ-BRIT MED J, V333, P999, DOI 10.1136/BMJ.38992.565972.7C; Marik PE, 2004, INTENS CARE MED, V30, P748, DOI 10.1007/s00134-004-2167-y; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; McGown CC, 2007, BRIT J ANAESTH, V98, P163, DOI 10.1093/bja/ael358; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Merx MW, 2004, CIRCULATION, V109, P2560, DOI 10.1161/01.CIR.0000129774.09737.5B; Mortensen EM, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-82; Mortensen EM, 2007, PHARMACOTHERAPY, V27, P1619, DOI 10.1592/phco.27.12.1619; Niessner A, 2006, ATHEROSCLEROSIS, V189, P408, DOI 10.1016/j.atherosclerosis.2005.12.022; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Prada PO, 2005, ENDOCRINOLOGY, V146, P1576, DOI 10.1210/en.2004-0767; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Schabbauer G, 2004, ARTERIOSCL THROM VAS, V24, pE3; Schlienger RG, 2007, PHARMACOTHERAPY, V27, P325, DOI 10.1592/phco.27.3.325; Schmidt H, 2006, INTENS CARE MED, V32, P1248, DOI 10.1007/s00134-006-0246-y; Shapiro NI, 2006, CRIT CARE MED, V34, P1025, DOI 10.1097/01.CCM.0000206104.18647.A8; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Spitzer AL, 2006, SURGERY, V139, P283, DOI 10.1016/j.surg.2005.08.029; Terblanche M, 2006, LANCET INFECT DIS, V6, P242, DOI 10.1016/S1473-3099(06)70439-X; Thirone ACP, 2004, ENDOCRINOLOGY, V145, P281, DOI 10.1210/en.2003-0575; Thomsen RW, 2006, CRIT CARE MED, V34, P1080, DOI 10.1097/01.CCM.0000207345.92928.E4; Tian B, 2003, RECENT PROG HORM RES, V58, P95, DOI 10.1210/rp.58.1.95; Tleyjeh IM, 2009, ARCH INTERN MED, V169, P1658, DOI 10.1001/archinternmed.2009.286; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Van den Berghe G, 2004, J CLIN INVEST, V114, P1187, DOI 10.1172/JCI200423506; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Williams DL, 2004, J IMMUNOL, V172, P449, DOI 10.4049/jimmunol.172.1.449	79	30	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14232	10.1371/journal.pone.0014232	http://dx.doi.org/10.1371/journal.pone.0014232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151908	Green Published, gold			2022-12-27	WOS:000284995300004
J	Luo, Y; Wang, Y; Kuang, SY; Chiang, YH; Hoffer, B				Luo, Yu; Wang, Yun; Kuang, Serena Y.; Chiang, Yung-Hsiao; Hoffer, Barry			Decreased Level of Nurr1 in Heterozygous Young Adult Mice Leads to Exacerbated Acute and Long-Term Toxicity after Repeated Methamphetamine Exposure	PLOS ONE			English	Article							PARKINSONS-DISEASE; DOPAMINE SYNTHESIS; NEURONS; EXPRESSION; BRAIN; GENE; CELLS; RATS	The abuse of psychostimulants, such as methamphetamine (METH), is prevalent in young adults and could lead to long-term adaptations in the midbrain dopamine system in abstinent human METH abusers. Nurr1 is a gene that is critical for the survival and maintenance of dopaminergic neurons and has been implicated in dopaminergic neuron related disorders. In this study, we examined the synergistic effects of repeated early exposure to methamphetamine in adolescence and reduction in Nurr1 gene levels. METH binge exposure in adolescence led to greater damage in the nigrostrial dopaminergic system when mice were exposed to METH binge later in life, suggesting a long-term adverse effect on the dopaminergic system. Compared to naive mice that received METH binge treatment for the first time, mice pretreated with METH in adolescence showed a greater loss of tyrosine hydroxylase (TH) immunoreactivity in striatum, loss of THir fibers in the substantia nigra reticulata (SNr) as well as decreased dopamine transporter (DAT) level and compromised DA clearance in striatum. These effects were further exacerbated in Nurr1 heterozygous mice. Our data suggest that a prolonged adverse effect exists following adolescent METH binge exposure which may lead to greater damage to the dopaminergic system when exposed to repeated METH later in life. Furthermore, our data support that Nurr1 mutations or deficiency could be a potential genetic predisposition which may lead to higher vulnerability in some individuals.	[Luo, Yu; Wang, Yun; Kuang, Serena Y.; Hoffer, Barry] NIDA, Intramural Res Program, Baltimore, MD 21224 USA; [Chiang, Yung-Hsiao] Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan Authorit, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Dept Surg, Coll Med, Taipei, Taiwan Authorit, Taiwan	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University	Luo, Y (corresponding author), NIDA, Intramural Res Program, Baltimore, MD 21224 USA.	luoy@mail.nih.gov		Luo, Yu/0000-0002-7939-5505	National Institute on Drug Abuse, National Institutes of Health; Taiwan Authority NSC [98-2314-B-038-011-MY3]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS070825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000429, ZIADA000461, ZIADA000576] Funding Source: NIH RePORTER	National Institute on Drug Abuse, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Taiwan Authority NSC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Funding for this study was provided by the Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, and by Taiwan Authority NSC grant 98-2314-B-038-011-MY3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman C, 2003, BEHAV BRAIN RES, V143, P95, DOI 10.1016/S0166-4328(03)00029-9; Boger HA, 2007, J NEUROSCI, V27, P8816, DOI 10.1523/JNEUROSCI.1067-07.2007; Cadet JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007812; Cass WA, 1999, J NEUROSCI, V19, P7653, DOI 10.1523/JNEUROSCI.19-17-07653.1999; Chou J, 2008, NEUROSCIENCE, V151, P92, DOI 10.1016/j.neuroscience.2007.10.044; ELLISON G, 1978, SCIENCE, V201, P276, DOI 10.1126/science.26975; Franklin K. B. J., 2008, PAXINOS FRANKLINS MO; Grimes DA, 2006, MOVEMENT DISORD, V21, P906, DOI 10.1002/mds.20820; Hermanson E, 2003, EXP CELL RES, V288, P324, DOI 10.1016/S0014-4827(03)00216-7; HOTCHKISS AJ, 1980, J PHARMACOL EXP THER, V214, P257; Imam SZ, 2005, FASEB J, V19, P1441, DOI 10.1096/fj.04-3362com; Kadkhodaei B, 2009, J NEUROSCI, V29, P15923, DOI 10.1523/JNEUROSCI.3910-09.2009; Larsen KE, 2002, J NEUROSCI, V22, P8951; LaVoie MJ, 1999, J NEUROSCI, V19, P1484, DOI 10.1523/jneurosci.19-04-01484.1999; Le W, 1999, J NEUROCHEM, V73, P2218; Le WD, 2003, NAT GENET, V33, P85, DOI 10.1038/ng1066; Le WD, 2008, J NEUROL SCI, V273, P29, DOI 10.1016/j.jns.2008.06.007; Luo Y, 2007, EXP NEUROL, V203, P221, DOI 10.1016/j.expneurol.2006.08.005; Mark KA, 2004, J NEUROSCI, V24, P11449, DOI 10.1523/JNEUROSCI.3597-04.2004; PRESTON KL, 1985, BRAIN RES, V338, P243, DOI 10.1016/0006-8993(85)90153-2; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Xu PY, 2002, NEUROLOGY, V58, P881, DOI 10.1212/WNL.58.6.881; Zetterstrom RH, 1996, MOL BRAIN RES, V41, P111, DOI 10.1016/0169-328X(96)00074-5; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248	25	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15193	10.1371/journal.pone.0015193	http://dx.doi.org/10.1371/journal.pone.0015193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151937	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600031
J	Blood, AJ; Iosifescu, DV; Makris, N; Perlis, RH; Kennedy, DN; Dougherty, DD; Kim, BW; Lee, MJ; Wu, S; Lee, S; Calhoun, J; Hodge, SM; Fava, M; Rosen, BR; Smoller, JW; Gasic, GP; Breiter, HC				Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Kennedy, David N.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Rosen, Bruce R.; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.		Phenotype Genotype Project Addicti	Microstructural Abnormalities in Subcortical Reward Circuitry of Subjects with Major Depressive Disorder	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; LATE-LIFE DEPRESSION; WHITE-MATTER MICROSTRUCTURE; ANTERIOR CINGULATE; DIFFUSION ANISOTROPY; EXPECTANCY BIAS; 1ST EPISODE; RESPONSES; AMYGDALA; NEUROBIOLOGY	Background: Previous studies of major depressive disorder (MDD) have focused on abnormalities in the prefrontal cortex and medial temporal regions. There has been little investigation in MDD of midbrain and subcortical regions central to reward/aversion function, such as the ventral tegmental area/substantia nigra (VTA/SN), and medial forebrain bundle (MFB). Methodology/Principal Findings: We investigated the microstructural integrity of this circuitry using diffusion tensor imaging (DTI) in 22 MDD subjects and compared them with 22 matched healthy control subjects. Fractional anisotropy (FA) values were increased in the right VT and reduced in dorsolateral prefrontal white matter in MDD subjects. Follow-up analysis suggested two distinct subgroups of MDD patients, which exhibited non-overlapping abnormalities in reward/aversion circuitry. The MDD subgroup with abnormal FA values in VT exhibited significantly greater trait anxiety than the subgroup with normal FA values in VT, but the subgroups did not differ in levels of anhedonia, sadness, or overall depression severity. Conclusions/Significance: These findings suggest that MDD may be associated with abnormal microstructure in brain reward/aversion regions, and that there may be at least two subtypes of microstructural abnormalities which each impact core symptoms of depression.	[Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Depress Clin & Res Program, Boston, MA 02114 USA; [Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Mood & Motor Control Lab,Addict Res Program, Boston, MA 02114 USA; [Blood, Anne J.; Iosifescu, Dan V.; Makris, Nikos; Perlis, Roy H.; Kennedy, David N.; Dougherty, Darin D.; Kim, Byoung Woo; Lee, Myung Joo; Wu, Shirley; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Fava, Maurizio; Rosen, Bruce R.; Smoller, Jordan W.; Gasic, Gregory P.; Breiter, Hans C.] Harvard Univ, Sch Med, Boston, MA USA; [Perlis, Roy H.; Fava, Maurizio; Smoller, Jordan W.] Massachusetts Gen Hosp, Psychiat & Neurodevelopmental Genet Unit, Boston, MA 02114 USA; [Perlis, Roy H.; Fava, Maurizio; Smoller, Jordan W.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Blood, Anne J.; Kim, Byoung Woo; Lee, Myung Joo; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Rosen, Bruce R.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, MENC, Boston, MA 02114 USA; [Blood, Anne J.; Kim, Byoung Woo; Lee, Myung Joo; Lee, Sang; Calhoun, Jesse; Hodge, Steven M.; Rosen, Bruce R.; Gasic, Gregory P.; Breiter, Hans C.] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Makris, Nikos; Kennedy, David N.; Hodge, Steven M.] Massachusetts Gen Hosp, Ctr Morphometr Anal, Boston, MA 02114 USA; [Makris, Nikos; Kennedy, David N.; Hodge, Steven M.] Massachusetts Gen Hosp, Ctr Integrat Informat, Boston, MA 02114 USA; [Blood, Anne J.; Kennedy, David N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Iosifescu, Dan V.] Mt Sinai Sch Med, New York, NY USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai	Blood, AJ (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Lab Neuroimaging & Genet, Depress Clin & Res Program, Boston, MA 02114 USA.	hbreiter@partners.org	Dougherty, Darin D./G-9896-2012; Iosifescu, Dan Vlad/L-3305-2019; Fava, Maurizio/AAH-3548-2020; Kennedy, David N/H-3627-2012	Iosifescu, Dan Vlad/0000-0002-2512-2835; Lee, Myungjoo/0000-0003-3722-9565	NIDA, Bethesda, MD [R01 14118, R21 026104, P20 026002]; Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington, [DABK39-03-C-0098]; NINDS [R01 NS052368]; NCRR [P41RR14075]; Mental Illness and Neuroscience Discovery (MIND) Institute; MGH Department of Radiology; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR001066, P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA027804, R33DA026104, P20DA026002] Funding Source: NIH RePORTER	NIDA, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington,; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Mental Illness and Neuroscience Discovery (MIND) Institute; MGH Department of Radiology; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant to H.C.B. (R01 14118, R21 026104, P20 026002) from NIDA, Bethesda, MD, and a grant (DABK39-03-C-0098; The Phenotype Genotype Project in Addiction and Depression) from the Office of National Drug Control Policy - Counterdrug Technology Assessment Center (ONDCP-CTAC), Washington, D.C. Further support was provided by a grant to A.J.B. (R01 NS052368) from NINDS, by the MGH Department of Radiology to H.C.B., by NCRR (P41RR14075), and by the Mental Illness and Neuroscience Discovery (MIND) Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abercrombie HC, 1998, NEUROREPORT, V9, P3301, DOI 10.1097/00001756-199810050-00028; Aharon I, 2001, NEURON, V32, P537, DOI 10.1016/S0896-6273(01)00491-3; Alexopoulos GS, 2002, AM J PSYCHIAT, V159, P1929, DOI 10.1176/appi.ajp.159.11.1929; Bae JN, 2006, BIOL PSYCHIAT, V60, P1356, DOI 10.1016/j.biopsych.2006.03.052; BAINS JS, 2007, TRENDS NEUROSCI M; Ballmaier M, 2004, AM J PSYCHIAT, V161, P99, DOI 10.1176/appi.ajp.161.1.99; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Blood AJ, 1999, NAT NEUROSCI, V2, P382, DOI 10.1038/7299; Blood AJ, 2006, NEUROREPORT, V17, P1251, DOI 10.1097/01.wnr.0000230500.03330.01; Blood Anne J, 2008, Biosci Hypotheses, V1, P14, DOI 10.1016/j.bihy.2008.01.006; Bogdan R, 2006, BIOL PSYCHIAT, V60, P1147, DOI 10.1016/j.biopsych.2006.03.037; Boska MD, 2007, NEUROBIOL DIS, V26, P590, DOI 10.1016/j.nbd.2007.02.010; Botteron KN, 2002, BIOL PSYCHIAT, V51, P342, DOI 10.1016/S0006-3223(01)01280-X; Breiter HC, 2004, COGNITIVE NEUROSCIENCES III, THIRD EDITION, P1043; Breiter Hans C., 2006, P763; Breiter HC, 2001, NEURON, V30, P619, DOI 10.1016/S0896-6273(01)00303-8; Breiter HC, 1996, NEURON, V17, P875, DOI 10.1016/S0896-6273(00)80219-6; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Breiter HC, 1999, ANN NY ACAD SCI, V877, P523, DOI 10.1111/j.1749-6632.1999.tb09287.x; Bremner JD, 2000, AM J PSYCHIAT, V157, P115, DOI 10.1176/ajp.157.1.115; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Chan CKY, 1996, J ABNORM PSYCHOL, V105, P637, DOI 10.1037/0021-843X.105.4.637; Chan LL, 2007, J NEUROL NEUROSUR PS, V78, P1383, DOI 10.1136/jnnp.2007.121525; COMPTON RJ, 2007, BRAIN COGN; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Delgado MR, 2000, J NEUROPHYSIOL, V84, P3072, DOI 10.1152/jn.2000.84.6.3072; Diaconescu AO, 2010, BRAIN RES, V1313, P143, DOI 10.1016/j.brainres.2009.11.064; Dougherty DD, 2003, J NEUROSURG, V99, P1010, DOI 10.3171/jns.2003.99.6.1010; Drevets WC, 1998, MOL PSYCHIATR, V3, P220, DOI 10.1038/sj.mp.4000370; Drevets WC, 2002, PHARMACOL BIOCHEM BE, V71, P431, DOI 10.1016/S0091-3057(01)00687-6; Drevets WC, 1997, NATURE, V386, P824, DOI 10.1038/386824a0; EDWARDS E, 1992, NEUROCHEM INT, V21, P29, DOI 10.1016/0197-0186(92)90065-Y; Fava M, 1997, BIOL PSYCHIAT, V42, P568, DOI 10.1016/S0006-3223(96)00440-4; Fava M, 2008, AM J PSYCHIAT, V165, P342, DOI 10.1176/appi.ajp.2007.06111868; Fava Maurizio, 2007, Ann Clin Psychiatry, V19, P187, DOI 10.1080/10401230701465178; First M. B., 1997, STRUCTURED CLIN INTE; Forbes EE, 2009, BIOL PSYCHIAT, V66, P199, DOI 10.1016/j.biopsych.2009.05.001; Frodl T, 2002, BIOL PSYCHIAT, V51, P708, DOI 10.1016/S0006-3223(01)01359-2; Frodl T, 2002, AM J PSYCHIAT, V159, P1112, DOI 10.1176/appi.ajp.159.7.1112; Grimm S, 2008, BIOL PSYCHIAT, V63, P369, DOI 10.1016/j.biopsych.2007.05.033; GUIARD BP, 2009, CURR DRUG TARGETS; Guimaraes AR, 1998, HUM BRAIN MAPP, V6, P33, DOI 10.1002/(SICI)1097-0193(1998)6:1<33::AID-HBM3>3.0.CO;2-M; Haber SN, 2000, J NEUROSCI, V20, P2369; Hamilton M., 1967, BRIT J SOC CLIN PSYC, V6, P278, DOI [10.1111/j.2044-8260.1967.tb00530.x, DOI 10.1111/J.2044-8260.1967.TB00530.X]; Harsan LA, 2007, J NEUROSCI RES, V85, P935, DOI 10.1002/jnr.21201; JANSEN JF, 2008, NEUROBIOL DIS; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jensen J, 2003, NEURON, V40, P1251, DOI 10.1016/S0896-6273(03)00724-4; Keedwell PA, 2005, BIOL PSYCHIAT, V58, P843, DOI 10.1016/j.biopsych.2005.05.019; Kim BW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010613; Langguth B, 2007, NEUROENDOCRINOL LETT, V28, P633; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Levita L, 2009, NEUROIMAGE, V44, P1178, DOI 10.1016/j.neuroimage.2008.09.039; Makris N, 2008, NEURON, V60, P174, DOI 10.1016/j.neuron.2008.08.011; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manji HK, 2001, NAT MED, V7, P541, DOI 10.1038/87865; Matsumoto M, 2009, NATURE, V459, P837, DOI 10.1038/nature08028; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; McCabe C, 2009, PSYCHOPHARMACOLOGY, V205, P667, DOI 10.1007/s00213-009-1573-9; Menon M, 2007, BIOL PSYCHIAT, V62, P765, DOI 10.1016/j.biopsych.2006.10.020; Milak MS, 2009, PSYCHIAT RES-NEUROIM, V173, P63, DOI 10.1016/j.pscychresns.2008.09.004; Mintun MA, 2004, BIOL PSYCHIAT, V55, P217, DOI 10.1016/j.biopsych.2003.08.015; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; Nobre MJ, 2004, BRAIN RES, V999, P124, DOI 10.1016/j.brainres.2003.12.001; Nobuhara K, 2006, J NEUROL NEUROSUR PS, V77, P120, DOI 10.1136/jnnp.2004.055129; OLDS J, 1954, J COMP PHYSIOL PSYCH, V47, P419, DOI 10.1037/h0058775; Ongur D, 1998, P NATL ACAD SCI USA, V95, P13290, DOI 10.1073/pnas.95.22.13290; Phillips ML, 2003, BIOL PSYCHIAT, V54, P515, DOI 10.1016/S0006-3223(03)00171-9; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Pizzagalli DA, 2009, AM J PSYCHIAT, V166, P702, DOI 10.1176/appi.ajp.2008.08081201; Roitman MF, 2005, NEURON, V45, P587, DOI 10.1016/j.neuron.2004.12.055; Russo SJ, 2007, NAT NEUROSCI, V10, P93, DOI 10.1038/nn1812; Salat DH, 2005, NEUROBIOL AGING, V26, P1215, DOI 10.1016/j.neurobiolaging.2004.09.017; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxena S, 2001, BIOL PSYCHIAT, V50, P159, DOI 10.1016/S0006-3223(01)01123-4; SCHLAEPFER TE, 2007, NEUROPSYCHOPHARMACOL; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Sheline YI, 1996, P NATL ACAD SCI USA, V93, P3908, DOI 10.1073/pnas.93.9.3908; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Surguladze S, 2005, BIOL PSYCHIAT, V57, P201, DOI 10.1016/j.biopsych.2004.10.028; Taylor WD, 2004, AM J PSYCHIAT, V161, P1293, DOI 10.1176/appi.ajp.161.7.1293; Treadway MT, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0004887, 10.1371/journal.pone.0006598]; Tremblay LK, 2005, ARCH GEN PSYCHIAT, V62, P1228, DOI 10.1001/archpsyc.62.11.1228; Tuch DS, 2005, P NATL ACAD SCI USA, V102, P12212, DOI 10.1073/pnas.0407259102; Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657; van der Kouwe AJW, 2005, NEUROIMAGE, V27, P222, DOI 10.1016/j.neuroimage.2005.03.035; Wacker J, 2009, NEUROIMAGE, V46, P327, DOI 10.1016/j.neuroimage.2009.01.058; WAINER H, 1978, PSYCHOMETRIKA, V43, P203, DOI 10.1007/BF02293863; Wiedemann G, 2001, J ANXIETY DISORD, V15, P401, DOI 10.1016/S0887-6185(01)00072-X; Wise R A, 1985, Psychiatr Med, V3, P445; WISE RA, 1978, BRAIN RES, V152, P215, DOI 10.1016/0006-8993(78)90253-6; Wise RA, 2009, TRENDS NEUROSCI, V32, P517, DOI 10.1016/j.tins.2009.06.004	95	98	100	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e13945	10.1371/journal.pone.0013945	http://dx.doi.org/10.1371/journal.pone.0013945			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124764	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500001
J	Galletti, C; Breveglieri, R; Lappe, M; Bosco, A; Ciavarro, M; Fattori, P				Galletti, Claudio; Breveglieri, Rossella; Lappe, Markus; Bosco, Annalisa; Ciavarro, Marco; Fattori, Patrizia			Covert Shift of Attention Modulates the Ongoing Neural Activity in a Reaching Area of the Macaque Dorsomedial Visual Stream	PLOS ONE			English	Article							FRONTAL EYE FIELD; MEDIAL PARIETOOCCIPITAL CORTEX; LATERAL INTRAPARIETAL AREA; POSTERIOR PARIETAL CORTEX; SPATIAL ATTENTION; SUPERIOR COLLICULUS; NEURONAL RESPONSES; COGNITIVE CONTROL; MONKEY; V6A	Background: Attention is used to enhance neural processing of selected parts of a visual scene. It increases neural responses to stimuli near target locations and is usually coupled to eye movements. Covert attention shifts, however, decouple the attentional focus from gaze, allowing to direct the attention to a peripheral location without moving the eyes. We tested whether covert attention shifts modulate ongoing neuronal activity in cortical area V6A, an area that provides a bridge between visual signals and arm-motor control. Methodology/Principal Findings: We performed single cell recordings from 3 Macaca Fascicularis trained to fixate straight-head, while shifting attention outward to a peripheral cue and inward again to the fixation point. We found that neurons in V6A are influenced by spatial attention. The attentional modulation occurs without gaze shifts and cannot be explained by visual stimulations. Visual, motor, and attentional responses can occur in combination in single neurons. Conclusions/Significance: This modulation in an area primarily involved in visuo-motor transformation for reaching may form a neural basis for coupling attention to the preparation of reaching movements. Our results show that cortical processes of attention are related not only to eye-movements, as many studies have shown, but also to arm movements, a finding that has been suggested by some previous behavioral findings. Therefore, the widely-held view that spatial attention is tightly intertwined with-and perhaps directly derived from-motor preparatory processes should be extended to a broader spectrum of motor processes than just eye movements.	[Galletti, Claudio; Breveglieri, Rossella; Bosco, Annalisa; Ciavarro, Marco; Fattori, Patrizia] Univ Bologna, Dipartimento Fisiol Umana & Gen, Bologna, Italy; [Lappe, Markus] Univ Munster, Dept Psychol, Munster, Germany; [Lappe, Markus] Univ Munster, Otto Creutzfeldt Ctr Cognit & Behav Neurosci, Munster, Germany	University of Bologna; University of Munster; University of Munster	Galletti, C (corresponding author), Univ Bologna, Dipartimento Fisiol Umana & Gen, Bologna, Italy.	patrizia.fattori@unibo.it	Ciavarro, Marco/AAA-7142-2022; Fattori, Patrizia/Q-8947-2017; breveglieri, rossella/C-2014-2014	Ciavarro, Marco/0000-0001-6611-6266; Fattori, Patrizia/0000-0002-0079-3755; breveglieri, rossella/0000-0001-5059-1441; BOSCO, ANNALISA/0000-0003-3032-9571; GALLETTI, CLAUDIO/0000-0001-8927-3408	European Union [FP7-ICT-217077-EYESHOTS]; Ministero dell'Universita e della Ricerca; Fondazione del Monte di Bologna e Ravenna, Italy	European Union(European Commission); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Fondazione del Monte di Bologna e Ravenna, Italy(Fondazione del Monte di Bologna e Ravenna)	This research was supported by European Union FP7-ICT-217077-EYESHOTS (http://www.eyeshots.it/), Ministero dell'Universita e della Ricerca (www.miur.it), and Fondazione del Monte di Bologna e Ravenna, Italy (http://www.fondazionedelmonte.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awh E, 2006, TRENDS COGN SCI, V10, P124, DOI 10.1016/j.tics.2006.01.001; BISLEY JW, 2010, ANN REV NEUROSCI; BOWMAN EM, 1993, J NEUROPHYSIOL, V70, P431, DOI 10.1152/jn.1993.70.1.431; Bremmer F, 1998, EUR J NEUROSCI, V10, P153; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; BUSHNELL MC, 1981, J NEUROPHYSIOL, V46, P755, DOI 10.1152/jn.1981.46.4.755; Castiello U, 1996, J EXP PSYCHOL HUMAN, V22, P582, DOI 10.1037/0096-1523.22.3.582; Cavanaugh J, 2004, J NEUROSCI, V24, P11236, DOI 10.1523/JNEUROSCI.3724-04.2004; Chiu YC, 2009, J NEUROSCI, V29, P3930, DOI 10.1523/JNEUROSCI.5737-08.2009; Colby CL, 1996, J NEUROPHYSIOL, V76, P2841, DOI 10.1152/jn.1996.76.5.2841; Conner CE, 1997, J NEUROSCI, V17, P3201; Constantinidis C, 2001, CEREB CORTEX, V11, P581, DOI 10.1093/cercor/11.7.581; Constantinidis C, 2006, REV NEUROSCIENCE, V17, P415; Cook EP, 2002, J NEUROSCI, V22, P1994, DOI 10.1523/JNEUROSCI.22-05-01994.2002; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Deubel H, 1998, VIS COGN, V5, P81, DOI 10.1080/713756776; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; Esterman M, 2009, P NATL ACAD SCI USA, V106, P17974, DOI 10.1073/pnas.0903593106; Fattori P, 2005, EUR J NEUROSCI, V22, P956, DOI 10.1111/j.1460-9568.2005.04288.x; FISCHER B, 1985, BRAIN RES, V345, P111, DOI 10.1016/0006-8993(85)90841-8; Galletti C, 2003, EXP BRAIN RES, V153, P158, DOI 10.1007/s00221-003-1589-z; Galletti C, 1999, EUR J NEUROSCI, V11, P575, DOI 10.1046/j.1460-9568.1999.00467.x; Galletti C, 1995, EUR J NEUROSCI, V7, P2486, DOI 10.1111/j.1460-9568.1995.tb01047.x; GALLETTI C, 1979, ARCH ITAL BIOL, V117, P231; GOLDBERG ME, 2006, PROG BRAIN RES, P155; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Hamker FH, 2005, CEREB CORTEX, V15, P431, DOI 10.1093/cercor/bhh146; Herrington TM, 2010, J NEUROSCI, V30, P3287, DOI 10.1523/JNEUROSCI.6025-09.2010; HOFFMAN JE, 1995, PERCEPT PSYCHOPHYS, V57, P787, DOI 10.3758/BF03206794; Ignashchenkova A, 2004, NAT NEUROSCI, V7, P56, DOI 10.1038/nn1169; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Kodaka Y, 1997, NEUROSCI RES, V28, P291, DOI 10.1016/S0168-0102(97)00055-2; KOWLER E, 1995, VISION RES, V35, P1897, DOI 10.1016/0042-6989(94)00279-U; Kutz DF, 2005, J NEUROPHYSIOL, V93, P3674, DOI 10.1152/jn.01292.2004; Kutz DF, 2003, EXP BRAIN RES, V149, P83, DOI 10.1007/s00221-002-1337-9; LUI Y, 2010, NAT NEUROSCI, V13, P495; Luppino G, 2005, EUR J NEUROSCI, V21, P3056, DOI 10.1111/j.1460-9568.2005.04149.x; Marzocchi N, 2008, EUR J NEUROSCI, V27, P775, DOI 10.1111/j.1460-9568.2008.06021.x; Moore T, 2003, NEURON, V40, P671, DOI 10.1016/S0896-6273(03)00716-5; Mountcastle VB, 1981, BRAIN MECH PERCEPTUA, P67; Muller JR, 2005, P NATL ACAD SCI USA, V102, P524, DOI 10.1073/pnas.0408311101; Pitzalis S, 2006, J NEUROSCI, V26, P7962, DOI 10.1523/JNEUROSCI.0178-06.2006; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; POSNER MI, 1984, ATTENTION PERFORM, P531; Raffi M, 2005, J NEUROSCI, V25, P5171, DOI 10.1523/JNEUROSCI.5201-04.2005; Rawley JB, 2010, J VISION, V10, DOI 10.1167/10.1.12; SPITZER H, 1988, SCIENCE, V240, P338, DOI 10.1126/science.3353728; Thompson KG, 2005, J NEUROSCI, V25, P9479, DOI 10.1523/JNEUROSCI.0741-05.2005; von Helmholtz H., 1867, HDB PHYSL OPTIK, VVol. 9, DOI 10.1007/BF01708548; Wardak C, 2006, J NEUROSCI, V26, P4228, DOI 10.1523/JNEUROSCI.3336-05.2006	50	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15078	10.1371/journal.pone.0015078	http://dx.doi.org/10.1371/journal.pone.0015078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124734	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500035
J	Agot, KE; Stoep, AV; Tracy, M; Obare, BA; Bukusi, EA; Ndinya-Achola, JO; Moses, S; Weiss, NS				Agot, Kawango E.; Stoep, Ann Vander; Tracy, Melissa; Obare, Billy A.; Bukusi, Elizabeth A.; Ndinya-Achola, Jeckoniah O.; Moses, Stephen; Weiss, Noel S.			Widow Inheritance and HIV Prevalence in Bondo District, Kenya: Baseline Results from a Prospective Cohort Study	PLOS ONE			English	Article							HIV/AIDS	Background: Widow Inheritance is a widespread cultural practice in sub-Saharan Africa that has been postulated as contributing to risk of HIV transmission. We present baseline results from a study designed to investigate the association between widow inheritance and HIV acquisition. Methods and Findings: We performed a cross-sectional analysis of baseline data from a prospective cohort study to investigate if widow inheritance is a risk practice for HIV infection. Study participants were 1,987 widows who were interviewed regarding their inheritance status and sexual behavior profile and tested for HIV. Of these widows, 56.3% were inherited. HIV prevalence, at 63%, was similar among non-inherited and inherited widows. We stratified exposure status by the relationship of the widow to the inheritor and the reason for inheritance, and reexamined the HIV status of four subgroups of inherited women relative to the HIV status of non-inherited women. When adjusting for age and level of formal education, widows who were inherited by non-relatives for sexual ritual were significantly more likely to be infected than widows who were not inherited (OR = 2.07; 95% CI 1.49-2.86); widows who were inherited by relatives for sexual ritual also had elevated odds of HIV infection (OR = 1.34; 95% CI = 1.07-1.70). Widows who were inherited by relatives for companionship were less likely than women who were not inherited to be infected with HIV (OR = 0.85; 95% CI 0.63-1.14). Conclusions: HIV prevalence among inherited widows varied depending upon why and by whom they were inherited. The cohort study will determine the risk for HIV acquisition among the HIV seronegative widows in this sample.	[Agot, Kawango E.; Obare, Billy A.] Dept Res Impact Res & Dev Org, Kisumu, Kenya; [Stoep, Ann Vander; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA; [Tracy, Melissa] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Bukusi, Elizabeth A.] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Ndinya-Achola, Jeckoniah O.] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya; [Moses, Stephen] Univ Manitoba, Dept Community Hlth Sci & Med Microbiol, Winnipeg, MB, Canada	University of Washington; University of Washington Seattle; University of Michigan System; University of Michigan; Kenya Medical Research Institute; University of Nairobi; University of Manitoba	Agot, KE (corresponding author), Dept Res Impact Res & Dev Org, Kisumu, Kenya.	mamagifto@yahoo.com			Fogarty International Center, National Institutes of Health (NIH) [TW06230]; FOGARTY INTERNATIONAL CENTER [R01TW006230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	Fogarty International Center, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by the Fogarty International Center, National Institutes of Health (NIH), Research Grant # TW06230. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Hence the opinions expressed herein are those of the authors and do not necessarily reflect the views of the NIH or the Fogarty International Center.	AGOT EK, 2005, COMPANION FEMINIST G, P363; Agot KE, 2008, ROUTL RES GEND SOC, V14, P287; Agot KE, 2004, EPIDEMIOLOGY, V15, P157, DOI 10.1097/01.ede.0000112220.16977.82; Ambasa-Shisanya C R, 2007, SAHARA J, V4, P606; Amornkul PN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006470; Ayikukwei R, 2008, CULT HEALTH SEX, V10, P587, DOI 10.1080/13691050802012601; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; *GOV NETW, 1997, 4 GOV NETW; GUNGA SO, 2009, J PHILOS ASS KENYA, V1, P161; Gwako ELM, 1998, J ANTHROPOL RES, V54, P173; *INT REG INF NETW, 2007, SAT WIF INH WID CLEA; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, AIDS EP UPD 2009; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Lopman BA, 2009, SEX TRANSM INFECT, V85, pI41, DOI 10.1136/sti.2008.033043; Luginaah I, 2005, SOC SCI MED, V60, P1219, DOI 10.1016/j.socscimed.2004.07.010; Mabumba ED, 2007, TROP DOCT, V37, P229, DOI 10.1258/004947507782332955; Mboya Paul, 1997, LUO KITGI GI TIMBEGI; *MIN HLTH CENTR BU, 2004, KEN DEM HLTH SURV; *NASCOP, 2007, KEN AIDS IND SURV FI; Ntozi J P, 1997, Health Transit Rev, V7 Suppl, P125; Nyanzi S, 2009, CAN J AFR STUDIES, V43, P12, DOI 10.1080/00083968.2010.9707581; Okeyo T M, 1994, Afr J Med Pract, V1, P20; Stover J, 2004, SEX TRANSM INFECT, V80, DOI 10.1136/sti.2004.010157; *UN HIGH COMM REF, 2000, ZIMB WID INH MEMB DE; *UN HIGH COMM REF, 2008, KEN WID INH KIS SUBT	25	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14028	10.1371/journal.pone.0014028	http://dx.doi.org/10.1371/journal.pone.0014028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103347	Green Submitted, Green Published, gold			2022-12-27	WOS:000284327800014
J	Bittner, T; Fuhrmann, M; Burgold, S; Ochs, SM; Hoffmann, N; Mitteregger, G; Kretzschmar, H; LaFerla, FM; Herms, J				Bittner, Tobias; Fuhrmann, Martin; Burgold, Steffen; Ochs, Simon M.; Hoffmann, Nadine; Mitteregger, Gerda; Kretzschmar, Hans; LaFerla, Frank M.; Herms, Jochen			Multiple Events Lead to Dendritic Spine Loss in Triple Transgenic Alzheimer's Disease Mice	PLOS ONE			English	Article							AMYLOID-PRECURSOR-PROTEIN; NEOCORTEX IN-VIVO; A-BETA; SYNAPSE LOSS; LONG-TERM; NEUROFIBRILLARY TANGLES; MOUSE MODEL; COGNITIVE IMPAIRMENT; SENILE PLAQUES; ADULT CORTEX	The pathology of Alzheimer's disease (AD) is characterized by the accumulation of amyloid-beta (A beta) peptide, hyperphosphorylated tau protein, neuronal death, and synaptic loss. By means of long-term two-photon in vivo imaging and confocal imaging, we characterized the spatio-temporal pattern of dendritic spine loss for the first time in 3xTg-AD mice. These mice exhibit an early loss of layer III neurons at 4 months of age, at a time when only soluble A beta is abundant. Later on, dendritic spines are lost around amyloid plaques once they appear at 13 months of age. At the same age, we observed spine loss also in areas apart from amyloid plaques. This plaque independent spine loss manifests exclusively at dystrophic dendrites that accumulate both soluble A beta and hyperphosphorylated tau intracellularly. Collectively, our data shows that three spatio-temporally independent events contribute to a net loss of dendritic spines. These events coincided either with the occurrence of intracellular soluble or extracellular fibrillar A beta alone, or the combination of intracellular soluble A beta and hyperphosphorylated tau.	[Bittner, Tobias; Fuhrmann, Martin; Burgold, Steffen; Ochs, Simon M.; Hoffmann, Nadine; Mitteregger, Gerda; Kretzschmar, Hans; Herms, Jochen] Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany; [LaFerla, Frank M.] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA USA	University of Munich; University of California System; University of California Irvine	Bittner, T (corresponding author), Univ Munich, Ctr Neuropathol & Pr Res, Munich, Germany.	jochen.herms@med.uni-muenchen.de	Fuhrmann, Martin/J-2707-2018; Fuhrmann, Martin/E-4565-2011; Herms, Jochen/D-3518-2011	Fuhrmann, Martin/0000-0001-7672-2913; 	Deutsche Forschungsgemeinschaft [SFB 596, A13]; Bavarian State Ministry for Science, Research and Arts (ForNeuroCell); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung) [01GZ0713, 13N10644]; German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie) [16IN0675]; European Union [Neuro.GSK3, FP-7-223276]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bavarian State Ministry for Science, Research and Arts (ForNeuroCell); German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie)(Federal Ministry for Economic Affairs and Energy (BMWi)); European Union(European Commission)	This work was supported by grants to JH from the Deutsche Forschungsgemeinschaft (SFB 596, A13), the Bavarian State Ministry for Science, Research and Arts (ForNeuroCell), the German Federal Ministry of Education and Research (Bundesministerium fur Bildung und Forschung, 01GZ0713, 13N10644), the German Federal Ministry of Economics and Technology (Bundesministerium fur Wirtschaft und Technologie, 16IN0675), and the European Union (Neuro.GSK3, FP-7-223276). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akram A, 2008, NEUROBIOL AGING, V29, P1296, DOI 10.1016/j.neurobiolaging.2007.03.007; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bittner T, 2009, J NEUROSCI, V29, P10405, DOI 10.1523/JNEUROSCI.2288-09.2009; Blennow K, 1996, J NEURAL TRANSM, V103, P603, DOI 10.1007/BF01273157; BRION JP, 1985, J SUBMICR CYTOL PATH, V17, P89; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuhrmann M, 2007, J NEUROSCI, V27, P6224, DOI 10.1523/JNEUROSCI.5062-06.2007; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; GOEDERT M, 1988, P NATL ACAD SCI USA, V85, P4051, DOI 10.1073/pnas.85.11.4051; Gogolla N, 2006, NAT PROTOC, V1, P2452, DOI 10.1038/nprot.2006.180; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Grutzendler J, 2002, NATURE, V420, P812, DOI 10.1038/nature01276; Grutzendler J, 2007, ANN NY ACAD SCI, V1097, P30, DOI 10.1196/annals.1379.003; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Holcomb L, 1998, NAT MED, V4, P97, DOI 10.1038/nm0198-097; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; HORN G, 1985, J NEUROSCI, V5, P3161; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Knafo S, 2009, CEREB CORTEX, V19, P586, DOI 10.1093/cercor/bhn111; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; Lanz TA, 2003, NEUROBIOL DIS, V13, P246, DOI 10.1016/S0969-9961(03)00079-2; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Segal M, 2002, PROG BRAIN RES, V138, P53, DOI 10.1016/S0079-6123(02)38070-1; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Spires-Jones TL, 2007, AM J PATHOL, V171, P1304, DOI 10.2353/ajpath.2007.070055; Sze CI, 1997, J NEUROPATH EXP NEUR, V56, P933, DOI 10.1097/00005072-199708000-00011; TERRY RD, 1981, ANN NEUROL, V10, P184, DOI 10.1002/ana.410100209; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Tsai J, 2004, NAT NEUROSCI, V7, P1181, DOI 10.1038/nn1335; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Wei W, 2010, NAT NEUROSCI, V13, P190, DOI 10.1038/nn.2476; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715	54	113	116	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15477	10.1371/journal.pone.0015477	http://dx.doi.org/10.1371/journal.pone.0015477			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103384	gold, Green Published			2022-12-27	WOS:000284257400026
J	Rusciani, A; Duca, L; Sartelet, H; Chatron-Colliet, A; Bobichon, H; Ploton, D; Le Naour, R; Blaise, S; Martiny, L; Debelle, L				Rusciani, Anthony; Duca, Laurent; Sartelet, Herve; Chatron-Colliet, Aurore; Bobichon, Helene; Ploton, Dominique; Le Naour, Richard; Blaise, Sebastien; Martiny, Laurent; Debelle, Laurent			Elastin Peptides Signaling Relies on Neuraminidase-1-Dependent Lactosylceramide Generation	PLOS ONE			English	Article							CULTURED FIBROBLASTS; ENDOTHELIAL-CELLS; LIPID DOMAINS; UP-REGULATION; RECEPTOR; RAFTS; PROTEIN; MATRIX; GROWTH; PROLIFERATION	The sialidase activity of neuraminidase-1 (Neu-1) is responsible for ERK 1/2 pathway activation following binding of elastin peptide on the elastin receptor complex. In this work, we demonstrate that the receptor and lipid rafts colocalize at the plasma membrane. We also show that the disruption of these microdomains as well as their depletion in glycolipids blocks the receptor signaling. Following elastin peptide treatment, the cellular GM(3) level decreases while lactosylceramide (LacCer) content increases consistently with a GM(3)/LacCer conversion. The use of lactose or Neu-1 siRNA blocks this process suggesting that the elastin receptor complex is responsible for this lipid conversion. Flow cytometry analysis confirms this elastin peptide-driven LacCer generation. Further, the use of a monoclonal anti-GM(3) blocking antibody shows that GM(3) is required for signaling. In conclusion, our data strongly suggest that Neu-1-dependent GM(3)/LacCer conversion is the key event leading to signaling by the elastin receptor complex. As a consequence, we propose that LacCer is an early messenger for this receptor.	[Rusciani, Anthony; Duca, Laurent; Sartelet, Herve; Blaise, Sebastien; Martiny, Laurent; Debelle, Laurent] Univ Reims, Fac Sci, UMR CNRS 6237, Lab Signalisat & Recepteurs Matriciels SiRMa, Reims, France; [Chatron-Colliet, Aurore; Bobichon, Helene; Ploton, Dominique] Univ Reims, Fac Pharm, UMR CNRS 6237, Lab Medicament Dynam Intracellulaire Architecture, Reims, France; [Le Naour, Richard] Fac Pharm, EA Inflammat & Immun Appareil Resp 4303, Lab Immunol & Microbiol, Reims, France	Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne; Universite de Reims Champagne-Ardenne	Rusciani, A (corresponding author), Univ Reims, Fac Sci, UMR CNRS 6237, Lab Signalisat & Recepteurs Matriciels SiRMa, Reims, France.	laurent.duca@univ-reims.fr	Ploton, Dominique DP/W-7169-2018; MARTINY, Laurent/ABI-5531-2020; BLAISE, Sebastien/AAS-1022-2020	Ploton, Dominique DP/0000-0002-4541-3146; BLAISE, Sebastien/0000-0003-3012-1500; DUCA, Laurent/0000-0002-6035-4906; LE NAOUR, Richard/0000-0003-1925-6041	Fond National pour la Sante ACI; Ligue contre le Cancer (comit departemental de l'Aube), CNRS; Ministere de l'Enseignement Superieur et de la Recherche	Fond National pour la Sante ACI; Ligue contre le Cancer (comit departemental de l'Aube), CNRS(Centre National de la Recherche Scientifique (CNRS)); Ministere de l'Enseignement Superieur et de la Recherche	This work was supported by grants from the Fond National pour la Sante ACI 2007 (Cancerop'le Grand-Est Project), the Ligue contre le Cancer (comit departemental de l'Aube), CNRS and the Ministere de l'Enseignement Superieur et de la Recherche. Anthony Rusciani is a fellow of the Ministere de l'Enseignement Superieur et de la Recherche. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achyuthan KE, 2001, COMP BIOCHEM PHYS B, V129, P29, DOI 10.1016/S1096-4959(01)00372-4; Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Antonicelli F, 2007, CURR TOP DEV BIOL, V79, P99, DOI 10.1016/S0070-2153(06)79005-6; Bhunia AK, 1998, J BIOL CHEM, V273, P34349, DOI 10.1074/jbc.273.51.34349; Brassart B, 1998, CLIN EXP METASTAS, V16, P489, DOI 10.1023/A:1006550503612; Brassart B, 2001, J BIOL CHEM, V276, P5222, DOI 10.1074/jbc.M003642200; Callahan JW, 1999, BBA-MOL BASIS DIS, V1455, P85, DOI 10.1016/S0925-4439(99)00075-7; Chatterjee S, 1998, ARTERIOSCL THROM VAS, V18, P1523, DOI 10.1161/01.ATV.18.10.1523; Chigorno V, 2006, GLYCOCONJUGATE J, V23, P159, DOI 10.1007/s10719-006-7921-7; Cremesti AE, 2002, FEBS LETT, V531, P47, DOI 10.1016/S0014-5793(02)03489-0; DEBELLE L, 1995, J BIOL CHEM, V270, P26099, DOI 10.1074/jbc.270.44.26099; Duca L, 2005, MOL PHARMACOL, V67, P1315, DOI 10.1124/mol.104.002725; Duca L, 2004, CRIT REV ONCOL HEMAT, V49, P235, DOI 10.1016/j.critrevonc.2003.09.007; Duca L, 2007, J BIOL CHEM, V282, P12484, DOI 10.1074/jbc.M609505200; GHUYSENITARD AF, 1992, CR ACAD SCI III-VIE, V315, P473; Gillery P, 1996, BIOCHEM BIOPH RES CO, V228, P94, DOI 10.1006/bbrc.1996.1621; Iwamoto T, 2001, J BIOL CHEM, V276, P46031, DOI 10.1074/jbc.M104464200; Kielty CM, 2002, J CELL SCI, V115, P2817; Kolter T, 2002, J BIOL CHEM, V277, P25859, DOI 10.1074/jbc.R200001200; Korade Z, 2008, NEUROPHARMACOLOGY, V55, P1265, DOI 10.1016/j.neuropharm.2008.02.019; Makino A, 2006, BIOCHEMISTRY-US, V45, P4530, DOI 10.1021/bi052104y; Marks DL, 2005, METHODS, V36, P186, DOI 10.1016/j.ymeth.2004.12.001; MASTICK CC, 1995, J CELL BIOL, V129, P1523, DOI 10.1083/jcb.129.6.1523; MECHAM RP, 1989, J BIOL CHEM, V264, P16652; Mochizuki S, 2002, J BIOL CHEM, V277, P44854, DOI 10.1074/jbc.M205630200; OGURA K, 1992, EXP CELL RES, V199, P169, DOI 10.1016/0014-4827(92)90475-N; ONO K, 1988, CANCER RES, V48, P2730; OOYAMA T, 1987, ARTERIOSCLEROSIS, V7, P593, DOI 10.1161/01.ATV.7.6.593; Pocza P, 2008, INT J CANCER, V122, P1972, DOI 10.1002/ijc.23296; Rajesh M, 2005, CIRC RES, V97, P796, DOI 10.1161/01.RES.0000185327.45463.A8; RIBONI L, 1992, EUR J BIOCHEM, V203, P107, DOI 10.1111/j.1432-1033.1992.tb19834.x; ROBERT L, 2009, ARCH GERONTOL GERIAT; Robinet A, 2005, J CELL SCI, V118, P343, DOI 10.1242/jcs.01613; Seyrantepe V, 2003, HUM MUTAT, V22, P343, DOI 10.1002/humu.10268; Sharma DK, 2005, CANCER RES, V65, P8233, DOI 10.1158/0008-5472.CAN-05-0803; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; Waugh MG, 1999, BIOCHEM J, V337, P591, DOI 10.1042/0264-6021:3370591; Yuyama K, 2007, J BIOL CHEM, V282, P26392, DOI 10.1074/jbc.M705046200	40	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14010	10.1371/journal.pone.0014010	http://dx.doi.org/10.1371/journal.pone.0014010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103358	gold, Green Published, Green Submitted			2022-12-27	WOS:000284257400014
J	Sawada, T; Miyoshi, H; Shimada, K; Suzuki, A; Okamatsu-Ogura, Y; Perfield, JW; Kondo, T; Nagai, S; Shimizu, C; Yoshioka, N; Greenberg, AS; Kimura, K; Koike, T				Sawada, Takashi; Miyoshi, Hideaki; Shimada, Kohei; Suzuki, Akira; Okamatsu-Ogura, Yuko; Perfield, James W., II; Kondo, Takuma; Nagai, So; Shimizu, Chikara; Yoshioka, Narihito; Greenberg, Andrew S.; Kimura, Kazuhiro; Koike, Takao			Perilipin Overexpression in White Adipose Tissue Induces a Brown Fat-Like Phenotype	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLET PROTEIN; ADIPOCYTE LIPOLYSIS; KINASE; OBESITY; STORAGE	Background: Perilipin A (PeriA) exclusively locates on adipocyte lipid droplets and is essential for lipid storage and lipolysis. Previously, we reported that adipocyte specific overexpression of PeriA caused resistance to diet-induced obesity and resulted in improved insulin sensitivity. In order to better understand the biological basis for this observed phenotype, we performed additional studies in this transgenic mouse model. Methodology and Principal Findings: When compared to control animals, whole body energy expenditure was increased in the transgenic mice. Subsequently, we performed DNA microarray analysis and real-time PCR on white adipose tissue. Consistent with the metabolic chamber data, we observed increased expression of genes associated with fatty acid beta-oxidation and heat production, and a decrease in the genes associated with lipid synthesis. Gene expression of Pgc1a, a regulator of fatty acid oxidation and Ucp1, a brown adipocyte specific protein, was increased in the white adipose tissue of the transgenic mice. This observation was subsequently verified by both Western blotting and histological examination. Expression of RIP140, a regulator of white adipocyte differentiation, and the lipid droplet protein FSP27 was decreased in the transgenic mice. Importantly, FSP27 has been shown to control gene expression of these crucial metabolic regulators. Overexpression of PeriA in 3T3-L1 adipocytes also reduced FSP27 expression and diminished lipid droplet size. Conclusions: These findings demonstrate that overexpression of PeriA in white adipocytes reduces lipid droplet size by decreasing FSP27 expression and thereby inducing a brown adipose tissue-like phenotype. Our data suggest that modulation of lipid droplet proteins in white adipocytes is a potential therapeutic strategy for the treatment of obesity and its related disorders.	[Sawada, Takashi; Miyoshi, Hideaki; Kondo, Takuma; Nagai, So; Shimizu, Chikara; Yoshioka, Narihito; Koike, Takao] Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan; [Shimada, Kohei; Okamatsu-Ogura, Yuko; Kimura, Kazuhiro] Hokkaido Univ, Grad Sch Vet Med, Dept Biomed Sci, Sapporo, Hokkaido, Japan; [Suzuki, Akira] KKR Sapporo Med Ctr, Dept Pathol, Sapporo, Hokkaido, Japan; [Perfield, James W., II] Univ Missouri, Dept Nutr & Exercise Physiol & Food Sci, Columbia, MO USA; [Greenberg, Andrew S.] Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Hokkaido University; Hokkaido University; University of Missouri System; University of Missouri Columbia; Tufts University	Sawada, T (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Internal Med 2, Sapporo, Hokkaido, Japan.	hmiyoshi@med.hokudai.ac.jp	Okamatsu-Ogura, Yuko/AAI-5602-2020; MIYOSHI, HIDEAKI/G-3971-2012		Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation; Takeda Science Foundation; Kanae Foundation for the Promotion of Medical Science; Kissei Pharmaceutical Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kanae Foundation for the Promotion of Medical Science; Kissei Pharmaceutical Foundation(Kissei Pharmaceutical Co LtdMukai Science and Technology FoundationInoue Research Award for Young ScientistsKayamori Foundation of Informational Science AdvancementInoue Foundation for ScienceKayamori FoundationSENSHIN Medical Research FoundationFukuda Foundation for Medical Technology)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology Foundation (http://www.mext.go.jp/), Takeda Science Foundation (http://www.takeda-sci.or.jp/), Kanae Foundation for the Promotion of Medical Science (http://kanae.sanofi-aventis.co.jp/), and Kissei Pharmaceutical Foundation (http://www.kissei.co.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bickel PE, 2009, BBA-MOL CELL BIOL L, V1791, P419, DOI 10.1016/j.bbalip.2009.04.002; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; DeFronzo RA, 2004, INT J CLIN PRACT, V58, P9, DOI 10.1111/j.1368-504X.2004.00389.x; Gauthier MS, 2008, J BIOL CHEM, V283, P16514, DOI 10.1074/jbc.M708177200; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Hallberg M, 2008, MOL CELL BIOL, V28, P6785, DOI 10.1128/MCB.00504-08; Kahn CR, 2008, SCIENCE, V322, P542, DOI 10.1126/science.1165667; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Lazar MA, 2008, SCIENCE, V321, P1048, DOI 10.1126/science.1164094; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Londos C, 2005, BIOCHIMIE, V87, P45, DOI 10.1016/j.biochi.2004.12.010; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Miyoshi H, 2010, J LIPID RES, V51, P975, DOI 10.1194/jlr.M002352; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Morganstein DL, 2008, J LIPID RES, V49, P679, DOI 10.1194/jlr.D700029-JLR200; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nishino N, 2008, J CLIN INVEST, V118, P2808, DOI 10.1172/JCI34090; Okamatsu-Ogura Y, 2007, AM J PHYSIOL-ENDOC M, V292, pE1135, DOI 10.1152/ajpendo.00425.2006; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Souza SC, 2002, J BIOL CHEM, V277, P8267, DOI 10.1074/jbc.M108329200; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Toh SY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002890; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Yoshida T, 1999, INT J OBESITY, V23, P570, DOI 10.1038/sj.ijo.0800870	28	69	70	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14006	10.1371/journal.pone.0014006	http://dx.doi.org/10.1371/journal.pone.0014006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103377	gold, Green Published			2022-12-27	WOS:000284257400010
J	Lees, J; Nudds, R; Stokkan, KA; Folkow, L; Codd, J				Lees, John; Nudds, Robert; Stokkan, Karl-Arne; Folkow, Lars; Codd, Jonathan			Reduced Metabolic Cost of Locomotion in Svalbard Rock Ptarmigan (Lagopus muta hyperborea) during Winter	PLOS ONE			English	Article							GENERATING MUSCULAR FORCE; TERRESTRIAL LOCOMOTION; ENERGETIC COST; BODY-MASS; SEASONAL-CHANGES; PREDATION RISK; FOOD-INTAKE; KINEMATIC PARAMETERS; BIPEDAL LOCOMOTION; PREFERRED SPEED	The Svalbard rock ptarmigan, Lagopus muta hyperborea experiences extreme photoperiodic and climatic conditions on the Arctic archipelago of Svalbard. This species, however, is highly adapted to live in this harsh environment. One of the most striking adaptations found in these birds is the deposition, prior to onset of winter, of fat stores which may comprise up to 32% of body mass and are located primarily around the sternum and abdominal region. This fat, while crucial to the birds' survival, also presents a challenge in that the bird must maintain normal physiological function with this additional mass. In particular these stores are likely to constrain the respiratory system, as the sternum and pelvic region must be moved during ventilation and carrying this extra load may also impact upon the energetic cost of locomotion. Here we demonstrate that winter birds have a reduced cost of locomotion when compared to summer birds. A remarkable finding given that during winter these birds have almost twice the body mass of those in summer. These results suggest that Svalbard ptarmigan are able to carry the additional winter fat without incurring any energetic cost. As energy conservation is paramount to these birds, minimising the costs of moving around when resources are limited would appear to be a key adaptation crucial for their survival in the barren Arctic environment.	[Lees, John; Nudds, Robert; Codd, Jonathan] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Stokkan, Karl-Arne; Folkow, Lars] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway	University of Manchester; UiT The Arctic University of Tromso	Lees, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	jonathan.codd@manchester.ac.uk		Lees, John/0000-0002-9627-1790; Codd, Jonathan/0000-0003-0211-1786	Biotechnology and Biological Science Research Council (BBSRC) [G01138/1]; British Pharmacological Society; Higher Education Funding Council for Englan; Medical Research Council, UK; Natural Environment Research Council; BBSRC [BB/G011338/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G011338/1] Funding Source: researchfish	Biotechnology and Biological Science Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Pharmacological Society; Higher Education Funding Council for Englan(UK Research & Innovation (UKRI)Higher Education Funding Council for England (HEFCE)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was funded by the Biotechnology and Biological Science Research Council (BBSRC) (G01138/1) and also supported by a capacity building award in Integrative Biology awarded to the University of Manchester funded by the BBSRC, British Pharmacological Society, Higher Education Funding Council for Englan and the Medical Research Council, UK. JJL is supported by a Natural Environment Research Council DTA award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourachid A, 2000, IBIS, V142, P538, DOI 10.1111/j.1474-919X.2000.tb04455.x; Abourachid A, 2001, COMP BIOCHEM PHYS A, V131, P113, DOI 10.1016/S1095-6433(01)00471-8; BAMFORD OS, 1980, J APPL PHYSIOL, V49, P491, DOI 10.1152/jappl.1980.49.3.491; Bastien GJ, 2005, SCIENCE, V308, P1755, DOI 10.1126/science.1111513; BAUDINETTE RV, 1992, AM J PHYSIOL, V262, pR771, DOI 10.1152/ajpregu.1992.262.5.R771; Baudinette RV, 1998, NATURE, V395, P653, DOI 10.1038/27111; Bechtold DA, 2007, ENDOCRINOLOGY, V148, P3605, DOI 10.1210/en.2007-0596; BIEWENER AA, 1989, BIOSCIENCE, V39, P776, DOI 10.2307/1311183; Biewener AA, 2006, J EXP ZOOL PART A, V305A, P899, DOI 10.1002/jez.a.334; Blem Charles R., 1990, V7, P59; BLEM CR, 1976, AM ZOOL, V16, P671; Blix A.S., 1989, P117; Blix A.S., 2007, POLAR RES-SWEDEN, V26, DOI [10.3402/polar.v26i1.6209, DOI 10.3402/POLAR.V26I1.6209]; BRACKENBURY JH, 1981, J EXP BIOL, V93, P317; Brody S., 1945, BIOENERGETICS GROWTH; Browning RC, 2006, J APPL PHYSIOL, V100, P390, DOI 10.1152/japplphysiol.00767.2005; Browning RC, 2005, OBES RES, V13, P891, DOI 10.1038/oby.2005.103; Bruinzeel LW, 1999, ARDEA, V87, P199; CAVAGNA GA, 1977, AM J PHYSIOL, V233, pR243, DOI 10.1152/ajpregu.1977.233.5.R243; Chappell MA, 2004, J EXP BIOL, V207, P3839, DOI 10.1242/jeb.01213; Claessens LPAM, 2009, J EXP ZOOL PART A, V311A, P586, DOI 10.1002/jez.501; FEDAK MA, 1981, J APPL PHYSIOL, V51, P772, DOI 10.1152/jappl.1981.51.3.772; FEDAK MA, 1982, J EXP BIOL, V97, P23; FEDAK MA, 1979, NATURE, V282, P713, DOI 10.1038/282713a0; Fuglei E, 1999, J COMP PHYSIOL B, V169, P361, DOI 10.1007/s003600050232; Fuglesteg BN, 2006, POLAR BIOL, V29, P308, DOI 10.1007/s00300-005-0054-9; Fujita M, 2004, COMP BIOCHEM PHYS A, V139, P117, DOI 10.1016/j.cbpb.2004.07.005; Gatesy SM, 1999, J MORPHOL, V240, P115, DOI 10.1002/(SICI)1097-4687(199905)240:2<115::AID-JMOR3>3.0.CO;2-Y; GATESY SM, 1991, J ZOOL, V224, P127, DOI 10.1111/j.1469-7998.1991.tb04794.x; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 1998, CLIN EXP PHARMACOL P, V25, P736, DOI 10.1111/j.1440-1681.1998.tb02287.x; GOLDSTEIN DL, 1988, AM ZOOL, V28, P829; Griffin TM, 2000, NATURE, V408, P929, DOI 10.1038/35050167; Griffin TM, 2003, J APPL PHYSIOL, V95, P172, DOI 10.1152/japplphysiol.00944.2002; Hancock JA, 2007, IBIS, V149, P605, DOI 10.1111/j.1474-919X.2007.00688.x; HEGLUND NC, 1995, NATURE, V375, P52, DOI 10.1038/375052a0; HERREID CF, 1967, COMP BIOCHEM PHYSIOL, V21, P405, DOI 10.1016/0010-406X(67)90802-X; Houston AI, 1997, OIKOS, V78, P331, DOI 10.2307/3546301; Hoyt DF, 2000, J EXP BIOL, V203, P221; Hoyt DF, 2006, J EXP ZOOL PART A, V305A, P912, DOI 10.1002/jez.a.335; Hutchinson JR, 2006, J EXP BIOL, V209, P3812, DOI 10.1242/jeb.02443; Iriarte-Diaz J, 2006, J EXP BIOL, V209, P4061, DOI 10.1242/jeb.02473; Kram R, 1996, J EXP BIOL, V199, P609; KRAM R, 1990, NATURE, V346, P265, DOI 10.1038/346265a0; Kullberg C, 1996, P ROY SOC B-BIOL SCI, V263, P1671, DOI 10.1098/rspb.1996.0244; Landis WJ, 2002, COMP BIOCHEM PHYS A, V133, P1135, DOI 10.1016/S1095-6433(02)00248-9; Lighton JRB, 2019, MEASURING METABOLIC RATES: A MANUAL FOR SCIENTISTS, 2ND EDITION, DOI 10.1093/oso/9780198830399.001.0001; LIMA SL, 1986, ECOLOGY, V67, P377, DOI 10.2307/1938580; LINDGARD K, 1989, ORNIS SCAND, V20, P176, DOI 10.2307/3676910; MALOIY GMO, 1986, NATURE, V319, P668, DOI 10.1038/319668a0; Marsh RL, 2006, J EXP BIOL, V209, P2050, DOI 10.1242/jeb.02226; McGowan CP, 2006, J APPL PHYSIOL, V101, P1060, DOI 10.1152/japplphysiol.01538.2005; McKechnie AE, 2002, CONDOR, V104, P705, DOI 10.1650/0010-5422(2002)104[0705:AFHRAR]2.0.CO;2; METCALFE NB, 1995, P ROY SOC B-BIOL SCI, V261, P395, DOI 10.1098/rspb.1995.0165; MORTENSEN A, 1983, ORNIS SCAND, V14, P144, DOI 10.2307/3676018; MORTENSEN A, 1989, ORNIS SCAND, V20, P22, DOI 10.2307/3676703; MORTENSEN A, 1986, ORNIS SCAND, V17, P8, DOI 10.2307/3676746; NILSSEN KJ, 1984, AM J PHYSIOL, V247, pR837, DOI 10.1152/ajpregu.1984.247.5.R837; Nudds RL, 2010, COMP BIOCHEM PHYS A, V156, P318, DOI 10.1016/j.cbpa.2010.01.023; Odum E. P., 1958, Bird-Banding, V29, P105; ODUM EP, 1951, PHYSIOL ZOOL, V24, P216, DOI 10.1086/physzool.24.3.30152115; Pedersen AO, 2006, ARCTIC, V59, P61; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; Peyrot N, 2009, J APPL PHYSIOL, V106, P1763, DOI 10.1152/japplphysiol.91240.2008; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; POHL H, 1973, COMP BIOCHEM PHYSIOL, V45, P851, DOI 10.1016/0300-9629(73)90088-1; POND CM, 1978, ANNU REV ECOL SYST, V9, P519, DOI 10.1146/annurev.es.09.110178.002511; Reierth E, 1998, J BIOL RHYTHM, V13, P393, DOI 10.1177/074873098129000219; Reierth E, 1998, CAN J ZOOL, V76, P2031, DOI 10.1139/cjz-76-11-2031; Reierth E, 1999, J BIOL RHYTHM, V14, P314, DOI 10.1177/074873099129000731; REIMERS E, 1983, ACTA ZOOL FENN, V175, P69; Roberts TJ, 1998, J EXP BIOL, V201, P2745; ROGERS CM, 1987, ECOLOGY, V68, P1051, DOI 10.2307/1938377; Rubenson J, 2004, P ROY SOC B-BIOL SCI, V271, P1091, DOI 10.1098/rspb.2004.2702; SCHOLANDER PF, 1950, BIOL BULL, V99, P237, DOI 10.2307/1538741; SCOTT I, 1994, P NUTR SOC, V53, P521, DOI 10.1079/PNS19940062; Silver FH, 2000, BIOMACROMOLECULES, V1, P180, DOI 10.1021/bm9900139; STOKKAN KA, 1992, ORNIS SCAND, V23, P366, DOI 10.2307/3676662; STOKKAN KA, 1995, J COMP PHYSIOL B, V165, P359, DOI 10.1007/BF00387306; STOKKAN KA, 1986, AM J PHYSIOL, V251, pR264, DOI 10.1152/ajpregu.1986.251.2.R264; STOKKAN KA, 1985, GEN COMP ENDOCR, V58, P76, DOI 10.1016/0016-6480(85)90137-6; TAYLOR CR, 1980, J EXP BIOL, V86, P9; TAYLOR CR, 1974, AM J PHYSIOL, V227, P848, DOI 10.1152/ajplegacy.1974.227.4.848; TAYLOR CR, 1971, AM J PHYSIOL, V221, P597, DOI 10.1152/ajplegacy.1971.221.2.597; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Tickle P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005667; Tickle PG, 2007, J EXP BIOL, V210, P3955, DOI 10.1242/jeb.008953; TICKLE PG, 2010, COMP BIOCH PHYSL A; Tolkamp BJ, 2002, ANIM BEHAV, V64, P945, DOI 10.1006/anbe.2002.2008; Usherwood J, 2008, J EXP BIOL, V211, DOI 10.1242/jeb.010769; Veasey JS, 1998, ANIM BEHAV, V56, P883, DOI 10.1006/anbe.1998.0880; White CR, 2008, J COMP PHYSIOL B, V178, P745, DOI 10.1007/s00360-008-0265-9; Withers PC, 2001, AUST J ZOOL, V49, P445, DOI 10.1071/ZO00057; WITTER MS, 1993, PHILOS T R SOC B, V340, P73, DOI 10.1098/rstb.1993.0050; WUNDER AB, 1969, COMP BIOCH PHYSL, V33, P821	95	17	17	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e15490	10.1371/journal.pone.0015490	http://dx.doi.org/10.1371/journal.pone.0015490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125015	Green Published, Green Submitted, gold			2022-12-27	WOS:000284231800037
J	Awad, O; Yustein, JT; Shah, P; Gul, N; Katuri, V; O'Neill, A; Kong, YL; Brown, ML; Toretsky, JA; Loeb, DM				Awad, Ola; Yustein, Jason T.; Shah, Preeti; Gul, Naheed; Katuri, Varalakshmi; O'Neill, Alison; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.; Loeb, David M.			High ALDH Activity Identifies Chemotherapy-Resistant Ewing's Sarcoma Stem Cells That Retain Sensitivity to EWS-FLI1 Inhibition	PLOS ONE			English	Article							PRIMITIVE NEUROECTODERMAL TUMOR; ALDEHYDE DEHYDROGENASE 1; BREAST-CANCER CELLS; PANCREATIC-CANCER; SIDE POPULATION; RNA HELICASE; IN-VITRO; BONE; MARKER; PROLIFERATION	Background: Cancer stem cells are a chemotherapy-resistant population capable of self-renewal and of regenerating the bulk tumor, thereby causing relapse and patient death. Ewing's sarcoma, the second most common form of bone tumor in adolescents and young adults, follows a clinical pattern consistent with the Cancer Stem Cell model - remission is easily achieved, even for patients with metastatic disease, but relapse remains frequent and is usually fatal. Methodology/Principal Findings: We have isolated a subpopulation of Ewing's sarcoma cells, from both human cell lines and human xenografts grown in immune deficient mice, which express high aldehyde dehydrogenase (ALDH(high)) activity and are enriched for clonogenicity, sphere-formation, and tumor initiation. The ALDH(high) cells are resistant to chemotherapy in vitro, but this can be overcome by the ATP binding cassette transport protein inhibitor, verapamil. Importantly, these cells are not resistant to YK-4-279, a small molecule inhibitor of EWS-FLI1 that is selectively toxic to Ewing's sarcoma cells both in vitro and in vivo. Conclusions/Significance: Ewing's sarcoma contains an ALDH(high) stem-like population of chemotherapy-resistant cells that retain sensitivity to EWS-FLI1 inhibition. Inhibiting the EWS-FLI1 oncoprotein may prove to be an effective means of improving patient outcomes by targeting Ewing's sarcoma stem cells that survive standard chemotherapy.	[Awad, Ola; Yustein, Jason T.; Shah, Preeti; Gul, Naheed; Katuri, Varalakshmi; Loeb, David M.] Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Div Pediat Oncol, Baltimore, MD USA; [O'Neill, Alison; Kong, Yali; Brown, Milton L.; Toretsky, Jeffrey A.] Georgetown Univ, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC USA; [O'Neill, Alison; Toretsky, Jeffrey A.] Georgetown Univ, Dept Pediat, Lombardi Comprehens Canc Ctr, Washington, DC 20057 USA	Johns Hopkins University; Johns Hopkins Medicine; Georgetown University; Georgetown University	Awad, O (corresponding author), Suez Canal Univ, Sch Med, Dept Histol & Genet, Ismailia, Egypt.	loebda@jhmi.edu		O'Neill, Alison Brianna/0000-0003-2369-2655	Liddy Shriver Sarcoma Initiative; Children's Cancer Foundation of Baltimore; Amschwand Sarcoma Cancer Foundation; Go4theGoal Foundation; Dani's Foundation of Denver, CO; Burroughs-Wellcome Clinical Scientist Award; National Institutes of Health (NIH) [R01CA138212, R01CA133662, P30 CA051008]; Ruth L. Kirschstein National Research Service Award (NRSA); Institutional Research Training Grant [5T32CA060441-15]; Maryland Stem Cell Research Foundation; Georgetown University Medical Center; NATIONAL CANCER INSTITUTE [R01CA133662, T32CA060441, P30CA051008, R01CA138212] Funding Source: NIH RePORTER	Liddy Shriver Sarcoma Initiative; Children's Cancer Foundation of Baltimore; Amschwand Sarcoma Cancer Foundation; Go4theGoal Foundation; Dani's Foundation of Denver, CO; Burroughs-Wellcome Clinical Scientist Award(Burroughs Wellcome Fund); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institutional Research Training Grant; Maryland Stem Cell Research Foundation; Georgetown University Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was generously supported by grants from the Liddy Shriver Sarcoma Initiative to J.T. and D. M. L., grants from the Children's Cancer Foundation of Baltimore, MD to J.T. and to J.T.Y., the Amschwand Sarcoma Cancer Foundation (J.T.), Go4theGoal Foundation (J.T.), Dani's Foundation of Denver, CO (J.T.), Burroughs-Wellcome Clinical Scientist Award in Translational Research (J.T.), National Institutes of Health (NIH) R01CA138212 (J.T. and D. M. L.), R01CA133662 (J.T.), the Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (T32), #5T32CA060441-15 (J.T.Y.), the Maryland Stem Cell Research Foundation (D. M. L.), and the Georgetown University Medical Center Drug Discovery Program. NIH support through the following grants Cancer Center Support Grant P30 CA051008 for use of Flow Cytometry Core. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Cironi L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002634; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; DENG S, PLOS ONE, V5; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Erkizan HV, 2009, NAT MED, V15, P750, DOI 10.1038/nm.1983; Feldmann G, 2008, MOL CANCER THER, V7, P2725, DOI 10.1158/1535-7163.MCT-08-0573; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grier HE, 2003, NEW ENGL J MED, V348, P694, DOI 10.1056/NEJMoa020890; GULATI SC, 1989, CANCER INVEST, V7, P411; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jiang X, BMC CANC, V10, P116; Kovar H, 1996, CELL GROWTH DIFFER, V7, P429; LADENSTEIN R, J CLIN ONCOL, V28, P3284; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Mahadevan D, 2004, BLOOD, V104, P1940, DOI 10.1182/blood-2003-07-2490; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; Miser JS, 2007, PEDIATR BLOOD CANCER, V49, P894, DOI 10.1002/pbc.21233; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; OUCHIDA M, 1995, ONCOGENE, V11, P1049; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riggi N, 2005, CANCER RES, V65, P11459, DOI 10.1158/0008-5472.CAN-05-1696; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2003, CANCER RES, V63, P5821; SOHN EJ, CANC RES, V70, P1154; Suva ML, 2009, CANCER RES, V69, P1776, DOI 10.1158/0008-5472.CAN-08-2242; Tanaka K, 1997, J CLIN INVEST, V99, P239, DOI 10.1172/JCI119152; Toretsky JA, 2006, CANCER RES, V66, P5574, DOI 10.1158/0008-5472.CAN-05-3293; Vasiliou V, 2004, DRUG METAB REV, V36, P279, DOI 10.1081/DMR-120034001; VONEITZEN U, 1994, CANCER LETT, V76, P45, DOI 10.1016/0304-3835(94)90132-5; Wakahara K, 2008, MOL CANCER RES, V6, P1937, DOI 10.1158/1541-7786.MCR-08-0054; Yajima T, 2009, INT J ONCOL, V35, P273, DOI 10.3892/ijo_00000337	40	102	106	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13943	10.1371/journal.pone.0013943	http://dx.doi.org/10.1371/journal.pone.0013943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085683	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800010
J	Iovino, M; Patani, R; Watts, C; Chandran, S; Spillantini, MG				Iovino, Mariangela; Patani, Rickie; Watts, Colin; Chandran, Siddharthan; Spillantini, Maria Grazia			Human Stem Cell-Derived Neurons: A System to Study Human Tau Function and Dysfunction	PLOS ONE			English	Article							FRONTOTEMPORAL DEMENTIA; ISOFORMS; PROTEIN; AGGREGATION; MATURATION; GENE; MICE	Background: Intracellular filamentous deposits containing microtubule-associated protein tau constitute a defining characteristic of many neurodegenerative disorders. Current experimental models to study tau pathology in vitro do not usually recapitulate the tau expression pattern characteristic of adult human brain. In this study, we have investigated whether human embryonic stem cell-derived neurons could be a good model to study human tau distribution, function and dysfunction. Methodology/Principal Findings: Using RT-PCR, immunohistochemistry, western blotting and cell transfections we have investigated whether all 6 adult human brain tau isoforms are expressed in neurons derived from human embryonic and fetal stem cells and whether 4 repeat tau over-expression alone, or with the F3 tau repeat fragment, (amino acid 258-380 of the 2N4R tau isoform with the Delta K280 mutation) affects tau distribution. We found that the shortest 3 repeat tau isoform, similarly to human brain, is the first to be expressed during neuronal differentiation while the other 5 tau isoforms are expressed later. Over expression of tau with 4 repeats affects tau cellular distribution and the short tau F3 fragment appears to increase tau phosphorylation but this effect does not appear to be toxic for the cell. Conclusions: Our results indicate that human embryonic stem cell-derived neurons express all 6 tau isoforms and are a good model in which to study tau physiology and pathology.	[Iovino, Mariangela; Patani, Rickie; Watts, Colin; Chandran, Siddharthan; Spillantini, Maria Grazia] Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England; [Patani, Rickie; Chandran, Siddharthan] Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England; [Chandran, Siddharthan] Univ Edinburgh, MRC, Ctr Clin Brain Sci, Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	University of Cambridge; University of Cambridge; University of Edinburgh	Iovino, M (corresponding author), Univ Cambridge, Cambridge Ctr Brain Repair, Dept Clin Neurosci, Cambridge, England.	mgs11@cam.ac.uk	Patani, R/J-3107-2018	Patani, R/0000-0002-3825-7675	Alzheimer's Research Trust; NIHR Biomedical Research Centre; Wellcome Trust; Sir David Walker Trust; Beverley and Raymond Sackler Scholarship; Alzheimers Research UK [ART-PPG2008A-6] Funding Source: researchfish; Medical Research Council [G0800784, G0700711B, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Alzheimer's Research Trust; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); Sir David Walker Trust; Beverley and Raymond Sackler Scholarship; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a pilot grant of the Alzheimer's Research Trust (MI, MGS), NIHR Biomedical Research Centre (SC) and Wellcome Trust Clinical Research Training Fellowship, Sir David Walker Trust Scholarship and Beverley and Raymond Sackler Scholarship (RP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Dawson HN, 2001, J CELL SCI, V114, P1179; Gasparini L, 2007, NEURODEGENER DIS, V4, P236, DOI 10.1159/000101848; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Joannides AJ, 2007, BRAIN, V130, P1263, DOI 10.1093/brain/awm070; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Patani R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007327; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104	13	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13947	10.1371/journal.pone.0013947	http://dx.doi.org/10.1371/journal.pone.0013947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085657	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800013
J	Hashimoto, K; Ishima, T				Hashimoto, Kenji; Ishima, Tamaki			A Novel Target of Action of Minocycline in NGF-Induced Neurite Outgrowth in PC12 Cells: Translation Initiator Factor eIF4AI	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; RECEPTORS; MODEL; NEUROPROTECTION; TETRACYCLINE; POTENTIATION; ANTAGONIST; MECHANISMS; INHIBITOR; PATHWAYS	Background: Minocycline, a second-generation tetracycline antibiotic, has potential activity for the treatment of several neurodegenerative and psychiatric disorders. However, its mechanisms of action remain to be determined. Methodology/Principal Findings: We found that minocycline, but not tetracycline, significantly potentiated nerve growth factor (NGF)-induced neurite outgrowth in PC12 cells, in a concentration dependent manner. Furthermore, we found that the endoplasmic reticulum protein inositol 1,4,5-triphosphate (IP3) receptors and several common signaling molecules (PLC-gamma, PI3K, Akt, p38 MAPK, c-Jun N-terminal kinase (JNK), mammalian target of rapamycin (mTOR), and Ras/Raf/ERK/MAPK pathways) might be involved in the active mechanism of minocycline. Moreover, we found that a marked increase of the eukaryotic translation initiation factor eIF4AI protein by minocycline, but not tetracycline, might be involved in the active mechanism for NGF-induced neurite outgrowth. Conclusions/Significance: These findings suggest that eIF4AI might play a role in the novel mechanism of minocycline. Therefore, agents that can increase eIF4AI protein would be novel therapeutic drugs for certain neurodegenerative and psychiatric diseases.	[Hashimoto, Kenji; Ishima, Tamaki] Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan	Chiba University	Hashimoto, K (corresponding author), Chiba Univ Ctr Forens Mental Hlth, Div Clin Neurosci, Chiba, Japan.	hashimoto@faculty.chiba-u.jp	Hashimoto, Kenji/I-5800-2015	Hashimoto, Kenji/0000-0002-8892-0439	National Center of Neurology and Psychiatry (NCNP), Japan [19-2]	National Center of Neurology and Psychiatry (NCNP), Japan	This is supported by a grant for Intramural Research Grant (19-2) for Neurological and Psychiatric Disorders of National Center of Neurology and Psychiatry (NCNP), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CM, 2004, TRENDS BIOCHEM SCI, V29, P25, DOI 10.1016/j.tibs.2003.11.006; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Berman RM, 2000, BIOL PSYCHIAT, V47, P351, DOI 10.1016/S0006-3223(99)00230-9; Blum D, 2004, NEUROBIOL DIS, V17, P359, DOI 10.1016/j.nbd.2004.07.012; Bolsover SR, 2005, CELL CALCIUM, V37, P395, DOI 10.1016/j.ceca.2005.01.007; Bruno MA, 2009, J NEUROPATH EXP NEUR, V68, P857, DOI 10.1097/NEN.0b013e3181aed9e6; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen CYA, 2009, MOL CELL, V36, P920, DOI 10.1016/j.molcel.2009.12.013; Choi Y, 2007, NEUROPSYCHOPHARMACOL, V32, P2393, DOI 10.1038/sj.npp.1301377; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; Domercq M, 2004, TRENDS PHARMACOL SCI, V25, P609, DOI 10.1016/j.tips.2004.10.001; Du YS, 2001, P NATL ACAD SCI USA, V98, P14669, DOI 10.1073/pnas.251341998; Ferrer I, 2002, NEUROPATH APPL NEURO, V28, P441, DOI 10.1046/j.1365-2990.2002.t01-1-00410.x; FUJITA Y, 2006, PROG NEUROPSYCHOPHAR, V32, P336; Fukao A, 2009, MOL CELL, V36, P1007, DOI 10.1016/j.molcel.2009.11.013; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; HASHIMOTO K, 2010, PROG NEUROP IN PRESS; Hashimoto K, 2007, BIOL PSYCHIAT, V61, P577, DOI 10.1016/j.biopsych.2006.03.019; Hashimoto K, 2009, BRAIN RES REV, V61, P105, DOI 10.1016/j.brainresrev.2009.05.005; Henley J, 2004, TRENDS CELL BIOL, V14, P320, DOI 10.1016/j.tcb.2004.04.006; Hernandez G, 2005, MECH DEVELOP, V122, P865, DOI 10.1016/j.mod.2005.04.002; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Hu W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004151; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Ishima T, 2008, PROG NEURO-PSYCHOPH, V32, P1656, DOI 10.1016/j.pnpbp.2008.06.011; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; KIMURA K, 1994, J BIOL CHEM, V269, P18961; Kriz J, 2002, NEUROBIOL DIS, V10, P268, DOI 10.1006/nbdi.2002.0487; Levine J, 1996, AM J PSYCHIAT, V153, P582; Levkovitz Y, 2007, BRAIN RES, V1154, P154, DOI 10.1016/j.brainres.2007.03.080; Levkovitz Y, 2010, J CLIN PSYCHIAT, V71, P138, DOI 10.4088/JCP.08m04666yel; Li NX, 2010, SCIENCE, V329, P959, DOI 10.1126/science.1190287; Menalled LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009793; Minase T, 2010, EUR J PHARMACOL, V648, P67, DOI 10.1016/j.ejphar.2010.09.007; Miyaoka T, 2008, CNS NEUROL DISORD-DR, V7, P376, DOI 10.2174/187152708786441858; Nishimura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002558; Orsucci D, 2009, CNS NEUROL DISORD-DR, V8, P222; Pae CU, 2008, BIOMED PHARMACOTHER, V62, P308, DOI 10.1016/j.biopha.2007.12.005; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Read DE, 2009, CELL MOL LIFE SCI, V66, P2975, DOI 10.1007/s00018-009-0057-8; Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4; Sanacora G, 2008, NAT REV DRUG DISCOV, V7, P426, DOI 10.1038/nrd2462; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; SOFUOGLU M, 2010, PHARM BIOCH BEHAV, V92, P135; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song Y, 2006, BRAIN RES, V1085, P57, DOI 10.1016/j.brainres.2006.02.042; STEPHENS RM, 1994, NEURON, V12, P691, DOI 10.1016/0896-6273(94)90223-2; Szeto GL, 2010, J INFECT DIS, V201, P1132, DOI 10.1086/651277; Takei K, 1998, SCIENCE, V282, P1705, DOI 10.1126/science.282.5394.1705; TANIBUCHI Y, 2010, GEN HOSP PS IN PRESS; Teng YD, 2004, P NATL ACAD SCI USA, V101, P3071, DOI 10.1073/pnas.0306239101; Thomas M, 2004, CURR PHARM DESIGN, V10, P679, DOI 10.2174/1381612043453162; Wang X, 2003, P NATL ACAD SCI USA, V100, P10483, DOI 10.1073/pnas.1832501100; Yrjanheikki J, 1999, P NATL ACAD SCI USA, V96, P13496, DOI 10.1073/pnas.96.23.13496; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang L, 2007, NEUROPSYCHOPHARMACOL, V32, P2004, DOI 10.1038/sj.npp.1301313; Zhang L, 2006, PROG NEURO-PSYCHOPH, V30, P1381, DOI 10.1016/j.pnpbp.2006.05.015	60	42	45	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2010	5	11							e15430	10.1371/journal.pone.0015430	http://dx.doi.org/10.1371/journal.pone.0015430			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	676NU	21151481	gold, Green Submitted, Green Published			2022-12-27	WOS:000283920000024
J	Martens, GA; Jiang, L; Verhaeghen, K; Connolly, JB; Geromanos, SG; Stange, G; Van Oudenhove, L; Devreese, B; Hellemans, KH; Ling, ZD; Van Schravendijk, C; Pipeleers, DG; Vissers, JPC; Gorus, FK				Martens, Geert A.; Jiang, Lei; Verhaeghen, Katrijn; Connolly, Joanne B.; Geromanos, Scott G.; Stange, Geert; Van Oudenhove, Laurence; Devreese, Bart; Hellemans, Karine H.; Ling, Zhidong; Van Schravendijk, Christiaan; Pipeleers, Daniel G.; Vissers, Johannes P. C.; Gorus, Frans K.			Protein Markers for Insulin-Producing Beta Cells with Higher Glucose Sensitivity	PLOS ONE			English	Article							QUANTITATIVE PROTEOMIC ANALYSIS; RAT PANCREATIC-ISLETS; NADH SHUTTLE SYSTEM; GENE-EXPRESSION; SHORT-CHAIN; DEHYDROGENASE COMPLEX; B-CELLS; SECRETION; GLUCOKINASE; HETEROGENEITY	Background and Methodology: Pancreatic beta cells show intercellular differences in their metabolic glucose sensitivity and associated activation of insulin production. To identify protein markers for these variations in functional glucose sensitivity, rat beta cell subpopulations were flow-sorted for their level of glucose-induced NAD(P) H and their proteomes were quantified by label-free data independent alternate scanning LC-MS. Beta cell-selective proteins were also identified through comparison with rat brain and liver tissue and with purified islet alpha cells, after geometrical normalization using 6 stably expressed reference proteins. Principal Findings: All tissues combined, 943 proteins were reliably quantified. In beta cells, 93 out of 467 quantifiable proteins were uniquely detected in this cell type; several other proteins presented a high molar abundance in beta cells. The proteome of the beta cell subpopulation with high metabolic and biosynthetic responsiveness to 7.5 mM glucose was characterized by (i) an on average 50% higher expression of protein biosynthesis regulators such as 40S and 60S ribosomal constituents, NADPH-dependent protein folding factors and translation elongation factors; (ii) 50% higher levels of enzymes involved in glycolysis and in the cytosolic arm of the malate/aspartate-NADH-shuttle. No differences were noticed in mitochondrial enzymes of the Krebs cycle, beta-oxidation or respiratory chain. Conclusions: Quantification of subtle variations in the proteome using alternate scanning LC-MS shows that beta cell metabolic glucose responsiveness is mostly associated with higher levels of glycolytic but not of mitochondrial enzymes.	[Martens, Geert A.; Jiang, Lei; Stange, Geert; Hellemans, Karine H.; Ling, Zhidong; Van Schravendijk, Christiaan; Pipeleers, Daniel G.; Gorus, Frans K.] Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium; [Martens, Geert A.; Verhaeghen, Katrijn; Gorus, Frans K.] UZ Brussel, Univ Hosp Brussels, Brussels, Belgium; [Connolly, Joanne B.; Geromanos, Scott G.; Vissers, Johannes P. C.] Waters Corp, Manchester, Lancs, England; [Van Oudenhove, Laurence; Devreese, Bart] Univ Ghent, Lab Prot Biochem & Biomol Engn L ProBE, B-9000 Ghent, Belgium	Vrije Universiteit Brussel; University Hospital Brussels; Waters UK; Ghent University	Martens, GA (corresponding author), Brussels Free Univ VUB, Diabet Res Ctr, Brussels, Belgium.	geert.martens@vub.ac.be	Devreese, Bart/B-2011-2009; Martens, Geert/ABA-6297-2020; Hellemans, Karine/B-7573-2013; Martens, Geert A./F-6920-2015; Devreese, Bart/K-2841-2019; stange, geert m/C-1092-2009	Devreese, Bart/0000-0002-9764-2581; Martens, Geert/0000-0003-1208-6289; Hellemans, Karine/0000-0001-9306-4369; Martens, Geert A./0000-0003-1208-6289; Devreese, Bart/0000-0002-9764-2581; stange, geert m/0000-0003-3148-1372; Pipeleers, Daniel/0000-0002-6440-2485; Gorus, Frans/0000-0002-9007-6177; Verhaeghen, Katrijn/0000-0001-5099-8962	Research Foundation Flanders [G.0374.08, G.0428.09]; Interuniversity Attraction Poles Programme of the Belgian Science Policy [IUAP P6/40]; Agency for Innovation by Science and Technology [IWT 40084]; Juvenile Diabetes Research Foundation [4-2005-1327]; European Union [241883]	Research Foundation Flanders(FWO); Interuniversity Attraction Poles Programme of the Belgian Science Policy; Agency for Innovation by Science and Technology; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Union(European Commission)	This study benefited from support by the Research Foundation Flanders (www.fwo.be Grants G.0374.08 and G.0428.09), by the Interuniversity Attraction Poles Programme of the Belgian Science Policy (www.belspo.be Grant IUAP P6/40), by the Agency for Innovation by Science and Technology (www.iwt.be Grant IWT 40084), by the Juvenile Diabetes Research Foundation (Center grant 4-2005-1327) and the European Union (FP7-project 241883). These funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Brautigam CA, 2009, J BIOL CHEM, V284, P13086, DOI 10.1074/jbc.M806563200; Dannies PS, 1999, ENDOCR REV, V20, P3, DOI 10.1210/er.20.1.3; DEVOS A, 1995, J CLIN INVEST, V96, P2489, DOI 10.1172/JCI118308; Dowling P, 2006, PROTEOMICS, V6, P6578, DOI 10.1002/pmic.200600298; Elouil H, 2007, DIABETOLOGIA, V50, P1442, DOI 10.1007/s00125-007-0674-4; Eto K, 1999, SCIENCE, V283, P981, DOI 10.1126/science.283.5404.981; Eto K, 1999, J BIOL CHEM, V274, P25386, DOI 10.1074/jbc.274.36.25386; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; GERMAN MS, 1993, P NATL ACAD SCI USA, V90, P1781, DOI 10.1073/pnas.90.5.1781; GIORDANO E, 1993, AM J PHYSIOL, V265, pC358, DOI 10.1152/ajpcell.1993.265.2.C358; Hardy OT, 2007, MOL ENDOCRINOL, V21, P765, DOI 10.1210/me.2006-0411; HEIMBERG H, 1993, EMBO J, V12, P2873, DOI 10.1002/j.1460-2075.1993.tb05949.x; JETTON TL, 1992, P NATL ACAD SCI USA, V89, P2619, DOI 10.1073/pnas.89.7.2619; Khaldi MZ, 2004, AM J PHYSIOL-ENDOC M, V287, pE207, DOI 10.1152/ajpendo.00426.2003; KIEKENS R, 1992, J CLIN INVEST, V89, P117, DOI 10.1172/JCI115551; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Ling ZD, 1996, DIABETES, V45, P1774, DOI 10.2337/diabetes.45.12.1774; Ling ZD, 2006, DIABETES, V55, P78, DOI 10.2337/diabetes.55.01.06.db05-0820; Lingohr MK, 2002, TRENDS MOL MED, V8, P375, DOI 10.1016/S1471-4914(02)02377-8; Lu HF, 2008, MOL CELL PROTEOMICS, V7, P1434, DOI 10.1074/mcp.M700478-MCP200; Lu HF, 2010, DIABETES, V59, P448, DOI 10.2337/db09-0129; MacDonald MJ, 2007, J BIOL CHEM, V282, P30596, DOI 10.1074/jbc.M702732200; MACDONALD MJ, 1995, J BIOL CHEM, V270, P20051; Maechler P, 2000, J PHYSIOL-LONDON, V529, P49, DOI 10.1111/j.1469-7793.2000.00049.x; Martens GA, 2006, ENDOCRINOLOGY, V147, P5196, DOI 10.1210/en.2006-0580; Martens GA, 2005, J BIOL CHEM, V280, P20389, DOI 10.1074/jbc.M411869200; Martens GA, 2007, J BIOL CHEM, V282, P21134, DOI 10.1074/jbc.M700083200; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; O'Driscoll L, 2006, J ENDOCRINOL, V191, P665, DOI 10.1677/joe.1.06894; PETTIT FH, 1978, P NATL ACAD SCI USA, V75, P4881, DOI 10.1073/pnas.75.10.4881; PIPELEERS D, 1986, P NATL ACAD SCI USA, V83, P5267, DOI 10.1073/pnas.83.14.5267; PIPELEERS D, 1994, DIABETOLOGIA, V37, pS57, DOI 10.1007/BF00400827; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Stange Geert, 2003, Methods Mol Med, V83, P15; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; VANSCHRAVENDIJK CFH, 1992, J BIOL CHEM, V267, P21344; Vissers JPC, 2007, MOL CELL PROTEOMICS, V6, P755, DOI 10.1074/mcp.M600303-MCP200; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106	43	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14214	10.1371/journal.pone.0014214	http://dx.doi.org/10.1371/journal.pone.0014214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151894	Green Published, Green Submitted, gold			2022-12-27	WOS:000284995300001
J	Meek, S; Buehr, M; Sutherland, L; Thomson, A; Mullins, JJ; Smith, AJ; Burdon, T				Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Mullins, John J.; Smith, Andrew J.; Burdon, Tom			Efficient Gene Targeting by Homologous Recombination in Rat Embryonic Stem Cells	PLOS ONE			English	Article							HPRT GENE; MICE; BLASTOCYSTS; EXPRESSION; LOCUS; INTEGRATION; PROMOTER; STRATEGY; GENOME	The rat is the preferred experimental animal in many biological studies. With the recent derivation of authentic rat embryonic stem (ES) cells it is now feasible to apply state-of-the art genetic engineering in this species using homologous recombination. To establish whether rat ES cells are amenable to in vivo recombination, we tested targeted disruption of the hypoxanthine phosphoribosyltransferase (hprt) locus in ES cells derived from both inbred and outbred strains of rats. Targeting vectors that replace exons 7 and 8 of the hprt gene with neomycinR/thymidine kinase selection cassettes were electroporated into male Fisher F344 and Sprague Dawley rat ES cells. Approximately 2% of the G418 resistant colonies also tolerated selection with 6-thioguanine, indicating inactivation of the hprt gene. PCR and Southern blot analysis confirmed correct site-specific targeting of the hprt locus in these clones. Embryoid body and monolayer differentiation of targeted cell lines established that they retained differentiation potential following targeting and selection. This report demonstrates that gene modification via homologous recombination in rat ES cells is efficient, and should facilitate implementation of targeted, genetic manipulation in the rat.	[Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Burdon, Tom] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; [Meek, Stephen; Buehr, Mia; Sutherland, Linda; Thomson, Alison; Burdon, Tom] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland; [Mullins, John J.] Univ Edinburgh, Queens Med Res Inst, Ctr Cardiovasc Sci, Mol Physiol Lab, Edinburgh, Midlothian, Scotland; [Smith, Andrew J.] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC Ctr Regenerat Med, Edinburgh, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh	Meek, S (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	tom.burdon@roslin.ed.ac.uk			Biological and Biotechnological Science Research Council; Roslin Foundation; Wellcome Trust; BBSRC [BBS/E/R/00001627, BB/H012478/1, BBS/E/R/00001601] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001601, BB/H012478/1, BBS/E/R/00001627] Funding Source: researchfish; Medical Research Council [G0700711B] Funding Source: researchfish	Biological and Biotechnological Science Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Roslin Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Biological and Biotechnological Science Research Council and the Roslin Foundation (SM, MB, LS, AT, TB). JJM was the recipient of a Wellcome Trust Principal Research Fellowship and his contribution here was supported by the EURATOOLS programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer A, 2001, CURR OPIN BIOTECH, V12, P473, DOI 10.1016/S0958-1669(00)00248-2; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Buehr M, 2003, BIOL REPROD, V68, P222, DOI 10.1095/biolreprod.102.006197; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; DOETSCHMAN T, 1988, P NATL ACAD SCI USA, V85, P8583, DOI 10.1073/pnas.85.22.8583; DOETSCHMAN T, 1987, NATURE, V330, P576, DOI 10.1038/330576a0; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; KUEHN MR, 1987, NATURE, V326, P295, DOI 10.1038/326295a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Palais G, 2009, PHYSIOL GENOMICS, V37, P140, DOI 10.1152/physiolgenomics.90328.2008; RAMIREZSOLIS R, 1995, NATURE, V378, P720, DOI 10.1038/378720a0; RATHJEN PD, 1990, CELL, V62, P1105, DOI 10.1016/0092-8674(90)90387-T; Samuel MS, 2009, GENESIS, V47, P440, DOI 10.1002/dvg.20519; SMITH AJH, 1995, NAT GENET, V9, P376, DOI 10.1038/ng0495-376; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; VALANCIUS V, 1991, MOL CELL BIOL, V11, P1402, DOI 10.1128/MCB.11.3.1402; Wallace HAC, 2007, CELL, V128, P197, DOI 10.1016/j.cell.2006.11.044; Yang GS, 2009, GENOMICS, V93, P196, DOI 10.1016/j.ygeno.2008.09.014; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	22	36	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14225	10.1371/journal.pone.0014225	http://dx.doi.org/10.1371/journal.pone.0014225			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151976	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600017
J	Knecht, DA; LaFleur, RA; Kahsai, AW; Argueta, CE; Beshir, AB; Fenteany, G				Knecht, David A.; LaFleur, Rebecca A.; Kahsai, Alem W.; Argueta, Christian E.; Beshir, Anwar B.; Fenteany, Gabriel			Cucurbitacin I Inhibits Cell Motility by Indirectly Interfering with Actin Dynamics	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; BREAST-CANCER CELLS; DICTYOSTELIUM-DISCOIDEUM; F-ACTIN; GLIOBLASTOMA-MULTIFORME; COLLAGEN PRODUCTION; CARCINOMA-CELLS; MONOMERIC RED; CYCLE ARREST; APOPTOSIS	Background: Cucurbitacins are plant natural products that inhibit activation of the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway by an unknown mechanism. They are also known to cause changes in the organization of the actin cytoskeleton. Methodology/Principal Findings: We show that cucurbitacin I potently inhibits the migration of Madin-Darby canine kidney (MDCK) cell sheets during wound closure, as well as the random motility of B16-F1 mouse melanoma cells, but has no effect on movement of Dictyostelium discoideum amoebae. Upon treatment of MDCK or B16-F1 cells with cucurbitacin I, there is a very rapid cessation of motility and gradual accumulation of filamentous actin aggregates. The cellular effect of the compound is similar to that observed when cells are treated with the actin filament-stabilizing agent jasplakinolide. However, we found that, unlike jasplakinolide or phallacidin, cucurbitacin I does not directly stabilize actin filaments. In in vitro actin depolymerization experiments, cucurbitacin I had no effect on the rate of actin filament disassembly at the nanomolar concentrations that inhibit cell migration. At elevated concentrations, the depolymerization rate was also unaffected, although there was a delay in the initiation of depolymerization. Therefore, cucurbitacin I targets some factor involved in cellular actin dynamics other than actin itself. Two candidate proteins that play roles in actin depolymerization are the actin-severing proteins cofilin and gelsolin. Cucurbitacin I possesses electrophilic reactivity that may lead to chemical modification of its target protein, as suggested by structure-activity relationship data. However, mass spectrometry revealed no evidence for modification of purified cofilin or gelsolin by cucurbitacin I. Conclusions/Significance: Cucurbitacin I results in accumulation of actin filaments in cells by a unique indirect mechanism. Furthermore, the proximal target of cucurbitacin I relevant to cell migration is unlikely to be the same one involved in activation of the JAK2/STAT3 pathway.	[Knecht, David A.; LaFleur, Rebecca A.] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA; [Kahsai, Alem W.; Argueta, Christian E.; Beshir, Anwar B.; Fenteany, Gabriel] Univ Connecticut, Dept Chem, Storrs, CT 06269 USA	University of Connecticut; University of Connecticut	Knecht, DA (corresponding author), Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.	david.knecht@uconn.edu; gabriel.fenteany@uconn.edu	Fenteany, Gabriel/F-4944-2018	Fenteany, Gabriel/0000-0001-7407-2195; Knecht, David/0000-0001-6103-4296; Fenteany, Gabriel/0000-0003-0335-4587	American Cancer Society [RSG-02-250-01-DDC]; U.S. National Institutes of Health (NIH) [GM077622]; NIH [GM040599]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040599, R01GM077622] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Cancer Society grant RSG-02-250-01-DDC and U.S. National Institutes of Health (NIH) grant GM077622 to GF and NIH grant GM040599 to DAK. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; Blaskovich MA, 2003, CANCER RES, V63, P1270; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Christine R, 2005, CANCER RES, V65, P195; COOPER JA, 1983, J MUSCLE RES CELL M, V4, P253, DOI 10.1007/BF00712034; Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3; Dinan L, 1997, BIOCHEM J, V327, P643, DOI 10.1042/bj3270643; Duncan KLK, 1996, BIOCHEM PHARMACOL, V52, P1553, DOI 10.1016/S0006-2952(96)00557-6; Duncan MD, 1997, J SURG RES, V69, P55, DOI 10.1006/jsre.1997.5028; Escandell JM, 2008, BIOCHEM PHARMACOL, V76, P198, DOI 10.1016/j.bcp.2008.05.004; Fenteany G, 2003, CURR TOP MED CHEM, V3, P593, DOI 10.2174/1568026033452348; Graness A, 2006, BIOCHEM PHARMACOL, V72, P32, DOI 10.1016/j.bcp.2006.04.001; Haritunians T, 2008, LEUKEMIA RES, V32, P1366, DOI 10.1016/j.leukres.2008.01.019; KNECHT DA, 1987, DEV BIOL, V121, P277, DOI 10.1016/0012-1606(87)90160-6; Knetsch MLW, 2002, J MUSCLE RES CELL M, V23, P605, DOI 10.1023/A:1024498805771; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lazaro-Dieguez F, 2008, J CELL SCI, V121, P1415, DOI 10.1242/jcs.017665; Lee DH, 2010, THESCIENTIFICWORLDJO, V10, P413, DOI 10.1100/tsw.2010.44; Lee E, 1998, CELL MOTIL CYTOSKEL, V39, P122, DOI 10.1002/(SICI)1097-0169(1998)39:2<122::AID-CM3>3.0.CO;2-8; Lim CP, 2006, ONCOGENE, V25, P5416, DOI 10.1038/sj.onc.1209531; Maloney KN, 2008, J NAT PROD, V71, P1927, DOI 10.1021/np8005259; Mc Henry KT, 2002, CHEMBIOCHEM, V3, P1105, DOI 10.1002/1439-7633(20021104)3:11<1105::AID-CBIC1105>3.0.CO;2-S; Momma K, 2008, CYTOTECHNOLOGY, V56, P33, DOI 10.1007/s10616-007-9100-5; MUSZA LL, 1994, J NAT PRODUCTS, V57, P1498, DOI 10.1021/np50113a004; Nakashima S, 2010, BIOORG MED CHEM LETT, V20, P2994, DOI 10.1016/j.bmcl.2010.02.062; Ono S, 2007, INT REV CYTOL, V258, P1, DOI 10.1016/S0074-7696(07)58001-0; Oser M, 2009, J CELL BIOCHEM, V108, P1252, DOI 10.1002/jcb.22372; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Park CS, 2004, J PHARMACOL EXP THER, V309, P705, DOI 10.1124/jpet.103.063693; Park G, 2008, J INVEST DERMATOL, V128, P2429, DOI 10.1038/jid.2008.103; Peters RR, 1997, PLANTA MED, V63, P525, DOI 10.1055/s-2006-957755; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Recio MC, 2004, PLANTA MED, V70, P414, DOI 10.1055/s-2004-818968; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shi XZ, 2006, BRIT J HAEMATOL, V135, P26, DOI 10.1111/j.1365-2141.2006.06259.x; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Su YH, 2008, CANCER BIOL THER, V7, P1243, DOI 10.4161/cbt.7.8.6263; SUSSMAN R, 1967, BIOCHEM BIOPH RES CO, V29, P53, DOI 10.1016/0006-291X(67)90539-6; Tannin-Spitz T, 2007, BIOCHEM PHARMACOL, V73, P56, DOI 10.1016/j.bcp.2006.09.012; Thoennissen NH, 2009, CANCER RES, V69, P5876, DOI 10.1158/0008-5472.CAN-09-0536; van Kester MS, 2008, J INVEST DERMATOL, V128, P1691, DOI 10.1038/sj.jid.5701246; Wakimoto N, 2008, CANCER SCI, V99, P1793, DOI 10.1111/j.1349-7006.2008.00899.x; Washington RW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-10; YESILADA E, 1988, J NAT PROD, V51, P504, DOI 10.1021/np50057a008; Yin D, 2008, INT J CANCER, V123, P1364, DOI 10.1002/ijc.23648; Zhang MX, 2009, CANCER CHEMOTH PHARM, V63, P635, DOI 10.1007/s00280-008-0780-0	46	41	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14039	10.1371/journal.pone.0014039	http://dx.doi.org/10.1371/journal.pone.0014039			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124831	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000001
J	Ehnert, S; Baur, J; Schmitt, A; Neumaier, M; Lucke, M; Dooley, S; Vester, H; Wildemann, B; Stockle, U; Nussler, AK				Ehnert, Sabrina; Baur, Johannes; Schmitt, Andreas; Neumaier, Markus; Lucke, Martin; Dooley, Steven; Vester, Helen; Wildemann, Britt; Stoeckle, Ulrich; Nussler, Andreas K.			TGF-beta(1) As Possible Link between Loss of Bone Mineral Density and Chronic Inflammation	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; IGF-I; MORPHOGENETIC PROTEIN-2; OSTEOBLAST ADHESION; EXPRESSION; STIMULATION; CELLS; POLY(D,L-LACTIDE); MECHANISMS	Background: The TGF family plays a key role in bone homeostasis. Systemic or topic application of proteins of this family apparently positively affects bone healing in vivo. However, patients with chronic inflammation, having increased TGF-beta(1) serum-levels, often show reduced bone mineral content and disturbed bone healing. Therefore, we wanted to identify intracellular mechanisms induced by chronic presence of TGF-beta(1) and their possible role in bone homeostasis in primary human osteoblasts. Methodology/Principal Findings: Osteoblasts were isolated from femur heads of patients undergoing total hip replacement. Adenoviral reporter assays showed that in primary human osteoblasts TGF-beta(1) mediates its signal via Smad2/3 and not Smad1/5/8. It induces proliferation as an intermediate response but decreases AP-activity and inorganic matrix production as a late response. In addition, expression levels of osteoblastic markers were strongly regulated (AP down arrow; Osteocalcin down arrow; Osteopontin up arrow; MGP down arrow; BMP 2 down arrow; BSP2 down arrow; OSF2 down arrow; Osteoprotegerin down arrow; RANKL up arrow) towards an osteoclast recruiting phenotype. All effects were blocked by inhibition of Smad2/3 signaling with the Alk5-Inhibitor (SB431542). Interestingly, a rescue experiment showed that reduced AP-activities did not recover to base line levels, even 8 days after stopping the TGF-beta(1) application. Conclusions/Significance: In spite of the initial positive effects on cell proliferation, it is questionable if continuous Smad2/3 phosphorylation is beneficial for bone healing, because decreased AP-activity and BMP2 levels indicate a loss of function of the osteoblasts. Thus, inhibition of Smad2/3 phosphorylation might positively influence functional activity of osteoblasts in patients with chronically elevated TGF-beta(1) levels and thus, could lead to an improved bone healing in vivo.	[Ehnert, Sabrina; Baur, Johannes; Schmitt, Andreas; Neumaier, Markus; Lucke, Martin; Vester, Helen; Stoeckle, Ulrich; Nussler, Andreas K.] Tech Univ Munich, Dept Traumatol, MRI, Munich, Germany; [Dooley, Steven] Heidelberg Univ, Dept Med 2, Univ Hosp Mannheim, Heidelberg, Germany; [Wildemann, Britt] Charite, Julius Wolff Inst, Berlin Brandenburg Ctr Regenerat Therapies, D-13353 Berlin, Germany	Technical University of Munich; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Ehnert, S (corresponding author), Tech Univ Munich, Dept Traumatol, MRI, Munich, Germany.	ehnert@uchir.me.tum.de	Dooley, Steven/T-6491-2018; Wildemann, Britt/G-7732-2012; Nussler, Andreas/H-3557-2019; Ehnert, Sabrina/AAE-8163-2019	Dooley, Steven/0000-0002-4840-6240; Wildemann, Britt/0000-0002-8365-1188; Nussler, Andreas/0000-0002-6666-6791; Ehnert, Sabrina/0000-0003-4347-1702	Fresenius Foundation; Freunde der TU Munchen	Fresenius Foundation; Freunde der TU Munchen	This work was partially supported by the Fresenius Foundation and 'Freunde der TU Munchen'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advincula MC, 2006, BIOMATERIALS, V27, P2201, DOI 10.1016/j.biomaterials.2005.11.014; Boden SD, 2002, SPINE, V27, P2662, DOI 10.1097/00007632-200212010-00005; BONEWALD LF, 1994, J CELL BIOCHEM, V55, P350, DOI 10.1002/jcb.240550312; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; DIEUDONNE SC, 1991, J BONE MINER RES, V6, P479; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; El-Amin SF, 2006, J BIOMED MATER RES A, V76A, P439, DOI 10.1002/jbm.a.30411; Erlebacher A, 1998, MOL BIOL CELL, V9, P1903, DOI 10.1091/mbc.9.7.1903; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Fedulov AV, 2005, IMMUNOL INVEST, V34, P143, DOI 10.1081/IMM-200055807; Filvaroff E, 1999, DEVELOPMENT, V126, P4267; Geiser AG, 1998, BONE, V23, P87, DOI 10.1016/S8756-3282(98)00078-7; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Harbers GM, 2005, J BIOMED MATER RES A, V75A, P855, DOI 10.1002/jbm.a.30482; HARRIS SE, 1994, J BONE MINER RES, V9, P855; HATTERSLEY G, 1991, J BONE MINER RES, V6, P165; IGNOTZ RA, 1987, CELL, V51, P189, DOI 10.1016/0092-8674(87)90146-2; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JOYCE ME, 1990, ORTHOP CLIN N AM, V21, P199; Kaneda T, 2000, J IMMUNOL, V165, P4254, DOI 10.4049/jimmunol.165.8.4254; Kanzler S, 2001, J VIRAL HEPATITIS, V8, P430, DOI 10.1046/j.1365-2893.2001.00314.x; Lai CF, 2002, J BIOL CHEM, V277, P15514, DOI 10.1074/jbc.M200794200; Lamberts SWJ, 1997, SCIENCE, V278, P419, DOI 10.1126/science.278.5337.419; Leask A, 2007, CARDIOVASC RES, V74, P207, DOI 10.1016/j.cardiores.2006.07.012; Lind M, 1998, ACTA ORTHOP SCAND, V69, P2; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Mohammad KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005275; NODA M, 1989, ENDOCRINOLOGY, V124, P2991, DOI 10.1210/endo-124-6-2991; PFEILSCHIFTER J, 1987, P NATL ACAD SCI USA, V84, P2024, DOI 10.1073/pnas.84.7.2024; PFEILSCHIFTER J, 1990, J BONE MINER RES, V5, P49, DOI 10.1002/jbmr.5650050109; Piek E, 1999, FASEB J, V13, P2105, DOI 10.1096/fasebj.13.15.2105; Reddi AH, 1998, NAT BIOTECHNOL, V16, P247, DOI 10.1038/nbt0398-247; ROBEY PG, 1987, J CELL BIOL, V105, P457, DOI 10.1083/jcb.105.1.457; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; ROSEN CJ, 1994, J CELL BIOCHEM, V56, P348, DOI 10.1002/jcb.240560311; ROSEN D, 1994, BONE, V15, P355, DOI 10.1016/8756-3282(94)90300-X; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Schmidmaier Gerhard, 2006, J Long Term Eff Med Implants, V16, P61; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Thirunavukkarasu K, 2001, J BIOL CHEM, V276, P36241, DOI 10.1074/jbc.M104319200; Wildemann B, 2004, CALCIFIED TISSUE INT, V74, P388, DOI 10.1007/s00223-003-0117-2; Wildemann B, 2004, BIOMATERIALS, V25, P3639, DOI 10.1016/j.biomaterials.2003.10.058; WRANA JL, 1988, J CELL BIOL, V106, P915, DOI 10.1083/jcb.106.3.915	49	65	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14073	10.1371/journal.pone.0014073	http://dx.doi.org/10.1371/journal.pone.0014073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124921	Green Submitted, gold, Green Published			2022-12-27	WOS:000284467200008
J	Verguet, S; Holt, BY; Szeri, AJ				Verguet, Stephane; Holt, Bethany Young; Szeri, Andrew J.			Increasing the Effectiveness of Vaginal Microbicides: A Biophysical Framework to Rethink Behavioral Acceptability	PLOS ONE			English	Article							PHASE-I TRIAL; HIV PREVENTION; TOPICAL MICROBICIDES; SEXUAL PLEASURE; WOMEN; GEL; SAFETY; PREFERENCES; EXPERIENCES; CHALLENGES	Background: Microbicide candidates delivered via gel vehicles are intended to coat the vaginal epithelium after application. The coating process depends on intrinsic biophysical properties of the gel texture, which restricts the potential choices for an effective product: the gel first must be physically synthesizable, then acceptable to the user, and finally applied in a manner promoting timely adequate coating, so that the user adherence is optimized. We present a conceptual framework anchoring microbicide behavioral acceptability within the fulfillment of the product biophysical requirements. Methods: We conducted a semi-qualitative/quantitative study targeting women aged 18-55 in Northern California to assess user preferences for microbicide gel attributes. Attributes included: (i) the wait time between application and intercourse, (ii) the gel texture and (iii) the trade-off between wait time and gel texture. Wait times were assessed using a mathematical model determining coating rates depending upon the gel's physical attributes. Results: 71 women participated. Results suggest that women would independently prefer a gel spreading rapidly, in 2 to 15 minutes (P<0.0001), as well as one that is thick or slippery (P<0.02). Clearly, thick gels do not spread rapidly; hence the motivation to study the trade-off. When asked the same question 'constrained' by the biophysical reality, women indicated no significant preference for a particular gel thickness (and therefore waiting time) (P>0.10) for use with a steady partner, a preference for a watery gel spreading rapidly rather than one having intermediate properties for use with a casual partner (P=0.024). Conclusions: Biophysical constraints alter women's preferences regarding acceptable microbicide attributes. Product developers should offer a range of formulations in order to address all preferences. We designed a conceptual framework to rethink behavioral acceptability in terms of biophysical requirements that can help improve adherence in microbicide use ultimately enhancing microbicide effectiveness.	[Verguet, Stephane] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Holt, Bethany Young] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Holt, Bethany Young] Inst Publ Hlth, Coalit Adv Multipurpose Innovat, Folsom, CA USA; [Szeri, Andrew J.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; Public Health Institute; University of California System; University of California Berkeley	Verguet, S (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.	verguet@uw.edu		Szeri, Andrew/0000-0003-0407-2645	California HIV/AIDS Research Program	California HIV/AIDS Research Program	Support for the project was provided by the California HIV/AIDS Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5; Barnhart K, 2009, CONTRACEPTION, V79, P297, DOI 10.1016/j.contraception.2008.11.001; Bentley ME, 2004, AM J PUBLIC HEALTH, V94, P1159, DOI 10.2105/AJPH.94.7.1159; Coggins C, 2000, SEX TRANSM INFECT, V76, P480, DOI 10.1136/sti.76.6.480; Darroch JE, 1999, FAM PLANN PERSPECT, V31, P16, DOI 10.2307/2991552; El-Sadr WM, 2006, AIDS, V20, P1109, DOI 10.1097/01.aids.0000226950.72223.5f; Garg Anita B, 2009, Antivir Chem Chemother, V19, P143; Grant RM, 2008, SCIENCE, V321, P532, DOI 10.1126/science.1160355; Gupta KM, 2007, J PHARM SCI-US, V96, P670, DOI 10.1002/jps.20752; Hardy E, 1998, CONTRACEPTION, V58, P245, DOI 10.1016/S0010-7824(98)00104-8; Hendrix CW, 2009, ANNU REV PHARMACOL, V49, P349, DOI 10.1146/annurev.pharmtox.48.113006.094906; Holt BY, 2006, J WOMENS HEALTH, V15, P281, DOI 10.1089/jwh.2006.15.281; Holt BY, 2010, CONTRACEPTION, V81, P177, DOI 10.1016/j.contraception.2009.11.009; Joint United Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO) 2009, 2009, AIDS EP UPD DEC 2009; Jones HE, 2009, J WOMENS HEALTH, V18, P1003, DOI 10.1089/jwh.2008.0862; Karim QA, 2010, SCI EXPRESS; Kieweg SL, 2006, J BIOMECH ENG-T ASME, V128, P540, DOI 10.1115/1.2206198; Koo HP, 2005, J SOC ISSUES, V61, P67, DOI 10.1111/j.0022-4537.2005.00394.x; Masse PJ, 2008, ANNU REV MED, V59, P455, DOI 10.1146/annurev.med.59.061206.112737; McGowan I, 2010, CURR OPIN INFECT DIS, V23, P26, DOI 10.1097/QCO.0b013e328334fe70; Morrow K, 2003, J WOMENS HEALTH, V12, P655, DOI 10.1089/154099903322404302; MORROW K, 2010, MICR 2010 PITTSB MAY; Morrow KM, 2008, AIDS BEHAV, V12, P272, DOI 10.1007/s10461-007-9266-z; Morrow KM, 2007, JAIDS-J ACQ IMM DEF, V45, P93, DOI 10.1097/QAI.0b013e3180415ded; Nuttall J, 2007, INFECT DIS CLIN N AM, V21, P219, DOI 10.1016/j.idc.2007.01.009; Owen DH, 2007, J PHARM SCI-US, V96, P661, DOI 10.1002/jps.20736; Padian NS, 2010, AIDS, V24, P621, DOI 10.1097/QAD.0b013e328337798a; Ramjee G, 2001, INT FAM PLAN PERSPEC, V27, P164, DOI 10.2307/2673851; Ramjee G, 2010, CURR OPIN HIV AIDS, V5, P316, DOI 10.1097/COH.0b013e32833a9f66; Romano J, 2008, CURR OPIN HIV AIDS, V3, P558, DOI 10.1097/COH.0b013e328305b96e; Rosen RK, 2008, J WOMENS HEALTH, V17, P383, DOI 10.1089/jwh.2006.0325; Severy LJ, 2005, AIDS BEHAV, V9, P121, DOI 10.1007/s10461-005-1687-y; Short MB, 2007, SEX TRANSM DIS, V34, P362, DOI 10.1097/01.olq.0000243619.51895.bd; Stone A, 2002, NAT REV DRUG DISCOV, V1, P977, DOI 10.1038/nrd959; Stone A., 2010, MICROBICIDES WAYS FO; Szeri AJ, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2973188; Tanner AE, 2008, J ADOLESCENT HEALTH, V43, P349, DOI 10.1016/j.jadohealth.2008.02.017; Tanner A, 2009, J SEX RES, V46, P15, DOI 10.1080/00224490802398407; Ventuneac A, 2010, AIDS BEHAV, V14, P618, DOI 10.1007/s10461-009-9611-5; Weeks MR, 2004, SEX TRANSM DIS, V31, P682, DOI 10.1097/01.olq.0000143113.04524.a5; Weiss HA, 2008, EMERG THEMES EPIDEMI, V5, DOI 10.1186/1742-7622-5-8; Woodsong C, 2008, AIDS EDUC PREV, V20, P171, DOI 10.1521/aeap.2008.20.2.171; Zubowicz EA, 2006, J WOMENS HEALTH, V15, P952, DOI 10.1089/jwh.2006.15.952	43	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15501	10.1371/journal.pone.0015501	http://dx.doi.org/10.1371/journal.pone.0015501			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	683HW	21124931	Green Submitted, Green Published, gold			2022-12-27	WOS:000284467200019
J	Fischer, E; De Vlas, S; Meima, A; Habbema, D; Richardus, J				Fischer, Egil; De Vlas, Sake; Meima, Abraham; Habbema, Dik; Richardus, Jan			Different Mechanisms for Heterogeneity in Leprosy Susceptibility Can Explain Disease Clustering within Households	PLOS ONE			English	Article							RISK-FACTORS; EPIDEMIOLOGY; CONTACTS; MODEL; BCG	The epidemiology of leprosy is characterized by heterogeneity in susceptibility and clustering of disease within households. We aim to assess the extent to which different mechanisms for heterogeneity in leprosy susceptibility can explain household clustering as observed in a large study among contacts of leprosy patients. We used a microsimulation model, parameterizing it with data from over 20,000 contacts of leprosy patients in Bangladesh. We simulated six mechanisms producing heterogeneity in susceptibility: (1) susceptibility was allocated at random to persons (i.e. no additional mechanism), (2) a household factor, (3, 4) a genetic factor (dominant or recessive), or (5, 6) half a household factor and half genetic. We further assumed that a fraction of 5%, 10%, and 20% of the population was susceptible, leading to a total of 18 scenarios to be fitted to the data. We obtained an acceptable fit for each of the six mechanisms, thereby excluding none of the possible underlying mechanisms for heterogeneity of susceptibility to leprosy. However, the distribution of leprosy among contacts did differ between mechanisms, and predicted trends in the declining leprosy case detection were dependent on the assumed mechanism, with genetic-based susceptibility showing the slowest decline. Clustering of leprosy within households is partially caused by an increased transmission within households independent of the leprosy susceptibility mechanism. Even a large and detailed data set on contacts of leprosy patients could not unequivocally reveal the mechanism most likely responsible for heterogeneity in leprosy susceptibility.	[Fischer, Egil; De Vlas, Sake; Meima, Abraham; Habbema, Dik; Richardus, Jan] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Fischer, E (corresponding author), Cent Vet Inst WUR, Dept Epidemiol Crisis Management & Diagnost, Lelystad, Netherlands.	j.richardus@erasmusmc.nl	Fischer, Egil A.J./A-1913-2010; Fischer, Egil Andreas Joor/F-6125-2010; Richardus, Jan Hendrik/AAE-1278-2021	Fischer, Egil A.J./0000-0002-0599-701X; Fischer, Egil Andreas Joor/0000-0002-0599-701X; Richardus, Jan Hendrik/0000-0003-0564-6313; de Vlas, Sake J./0000-0002-1830-5668	Netherlands Leprosy Relief	Netherlands Leprosy Relief	EF, AM and JR were supported by a grant from the Netherlands Leprosy Relief (www.leprastichting.nl). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; BAGSHAWE A, 1989, B WORLD HEALTH ORGAN, V67, P389; Bakker MI, 2005, BMC MED GENET, V6, DOI 10.1186/1471-2350-6-40; Bakker MI, 2002, TROP MED INT HEALTH, V7, P780, DOI 10.1046/j.1365-3156.2002.00931.x; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; de Oliveira MLW, 1998, WHO TECH REP SER, V874, P1; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fine PEM, 1997, AM J EPIDEMIOL, V146, P91, DOI 10.1093/oxfordjournals.aje.a009195; FINE PEM, 1982, EPIDEMIOL REV, V4, P161, DOI 10.1093/oxfordjournals.epirev.a036245; Fischer EAJ, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-125; Fischer EAJ, 2005, PREV VET MED, V67, P283, DOI 10.1016/j.prevetmed.2004.12.002; FISCHER EAJ, 2008, COMPUTER METHODS PRO; Hiebeler DE, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.022901; Kerr-Pontes LRS, 2004, INT J EPIDEMIOL, V33, P262, DOI 10.1093/ije/dyh002; Korenromp EL, 2000, AIDS, V14, P573, DOI 10.1097/00002030-200003310-00013; LAW AM, 2000, EXPT DESIGN SENSITIV, P622; Meima A, 2004, B WORLD HEALTH ORGAN, V82, P373; Mira MT, 2003, NAT GENET, V33, P412, DOI 10.1038/ng1096; MIRA MT, 2004, NATURE; Moet FJ, 2008, BMJ-BRIT MED J, V336, P761, DOI 10.1136/bmj.39500.885752.BE; Moet FJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000198; Moet FJ, 2006, J INFECT DIS, V193, P346, DOI 10.1086/499278; Nicholls PG, 2003, LEPROSY REV, V74, P349; NOORDEEN SK, 1985, LEPROSY; SCHURING RP, 2009, VACCINE; Setia MS, 2006, LANCET INFECT DIS, V6, P162, DOI 10.1016/S1473-3099(06)70412-1; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Smith T, 2006, AM J TROP MED HYG, V75, P1; Stolk WA, 2003, J INFECT DIS, V188, P1371, DOI 10.1086/378354; *UNSTATS, 2000, MILL DEV GOAL IND; van Beers SM, 1999, INT J LEPROSY, V67, P119; Van der Ploeg CPB, 1998, INTERFACES, V28, P84, DOI 10.1287/inte.28.3.84; WADE H. W., 1952, INTERNATL JOUR LEPROSY, V20, P1; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P333; *WHO, 2007, WHO UNICEF REV NAT I; 2002, INT J LEPROSY OTH S, V70, pS1	36	25	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14061	10.1371/journal.pone.0014061	http://dx.doi.org/10.1371/journal.pone.0014061			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124916	gold, Green Submitted, Green Published			2022-12-27	WOS:000284400100010
J	Zong, ZY; Lu, XJ				Zong, Zhiyong; Lue, Xiaoju			Characterization of a New SCCmec Element in Staphylococcus cohnii	PLOS ONE			English	Article							CASSETTE-CHROMOSOME-MEC; COAGULASE-NEGATIVE STAPHYLOCOCCI; GENETIC DIVERSITY; RESISTANT; AUREUS; EPIDERMIDIS; SAPROPHYTICUS; STRAINS; CLASSIFICATION; HAEMOLYTICUS	Background: Many SCCmec elements of coagulase-negative staphylococci (CoNS) could not be typed using multiplex PCR. Such a 'non-typable' SCCmec was encountered in a Staphylococcus cohnii isolate. Methodology/Principal Findings: The SCCmec type of methicillin-resistant S. cohnii clinical isolate WC28 could not be assigned using multiplex PCR. Newly-designed primers were used to amplify ccrA and ccrB genes. The whole SCCmec was obtained by three overlapping long-range PCR, targeting regions from left-hand inverted repeat (IRL) to ccrA/B, from ccrA/B to mecA and from mecA to orfX. The region abutting IRL was identified using inverse PCR with self-ligated enzyme-restricted WC28 fragments as the template. WC28 SCCmec had a class A mec gene complex (mecI-mecR1-mecA). The ccrA and ccrB genes were closest (89.7% identity) to ccrA(SHP) of Staphylococcus haemolyticus strain H9 and to ccrB3 (90% identity) of Staphylococcus pseudintermedius strain KM241, respectively. Two new genes potentially encoding AAA-type ATPase were found in J1 region and a psi Tn554 transposon was present in J2 region, while J3 region was the same as many SCCmec of Staphylococcus aureus. WC28 SCCmec abutted an incomplete SCC element with a novel allotype of ccrC, which was closest (82% identity) to ccrC1 allele 9 in Staphylococcus saprophyticus strain ATCC 15305. Only two direct target repeat sequences, one close to the 3'-end of orfX and the other abutting the left end of WC28 SCCmec, could be detected. Conclusions/Significance: A new 35-kb SCCmec was characterized in a S. cohnii isolate, carrying a class A mec gene complex, new variants of ccrA5 and ccrB3 and two novel genes in the J1 region. This element is flanked by 8-bp perfect inverted repeats and is similar to type III SCCmec in S. aureus and a SCCmec in S. pseudintermedius but with different J1 and J3 regions. WC28 SCCmec was arranged in tandem with an additional SCC element with ccrC, SCC(WC28), but the two elements might have integrated independently rather than constituted a composite. This study adds new evidence of the diversity of SCCmec in CoNS and highlights the need for characterizing the 'non-typable' SCCmec to reveal the gene pool associated with mecA.	[Zong, Zhiyong; Lue, Xiaoju] Sichuan Univ, Ctr Infect Dis, W China Hosp, Chengdu 610064, Peoples R China; [Zong, Zhiyong] Div Infect Dis, State Key Lab Biotherapy, Chengdu, Peoples R China	Sichuan University	Zong, ZY (corresponding author), Sichuan Univ, Ctr Infect Dis, W China Hosp, Chengdu 610064, Peoples R China.	zongzhiyong@gmail.com	Zong, Zhiyong/C-6142-2013	ZONG, ZHIYONG/0000-0002-7675-260X	National Natural Science Foundation of China [30900052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by a grant (no. 30900052) from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Descloux S, 2008, J CLIN MICROBIOL, V46, P1818, DOI 10.1128/JCM.02255-07; Diekema DJ, 2001, CLIN INFECT DIS, V32, pS114, DOI 10.1086/320184; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; Higashide M, 2008, ANTIMICROB AGENTS CH, V52, P2061, DOI 10.1128/AAC.01150-07; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Ibrahem S, 2008, CLIN MICROBIOL INFEC, V14, P1020, DOI 10.1111/j.1469-0691.2008.02080.x; Ito T, 2004, ANTIMICROB AGENTS CH, V48, P2637, DOI 10.1128/AAC.48.7.2637-2651.2004; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; Jamaluddin TZMT, 2008, J CLIN MICROBIOL, V46, P3778, DOI 10.1128/JCM.02262-07; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kuroda M, 2005, P NATL ACAD SCI USA, V102, P13272, DOI 10.1073/pnas.0502950102; Kwon NH, 2005, J ANTIMICROB CHEMOTH, V56, P624, DOI 10.1093/jac/dki306; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li M, 2009, J MED MICROBIOL, V58, P456, DOI 10.1099/jmm.0.007567-0; MATSUHASHI M, 1986, J BACTERIOL, V167, P975, DOI 10.1128/jb.167.3.975-980.1986; Miragaia M, 2007, J BACTERIOL, V189, P2540, DOI 10.1128/JB.01484-06; Miragaia M, 2005, MICROB DRUG RESIST, V11, P83, DOI 10.1089/mdr.2005.11.83; Machado ABP, 2007, J MED MICROBIOL, V56, P1328, DOI 10.1099/jmm.0.47294-0; Oliveira DC, 2000, ANTIMICROB AGENTS CH, V44, P1906, DOI 10.1128/AAC.44.7.1906-1910.2000; Pi BR, 2009, J MED MICROBIOL, V58, P731, DOI 10.1099/jmm.0.007351-0; Ruppe E, 2009, ANTIMICROB AGENTS CH, V53, P442, DOI 10.1128/AAC.00724-08; Soderquist B, 2009, CLIN MICROBIOL INFEC, V15, P1176, DOI 10.1111/j.1469-0691.2009.02771.x; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang Y, 2009, J APPL MICROBIOL, V107, P1375, DOI 10.1111/j.1365-2672.2009.04322.x	27	27	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14016	10.1371/journal.pone.0014016	http://dx.doi.org/10.1371/journal.pone.0014016			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103346	Green Published, gold, Green Submitted			2022-12-27	WOS:000284327800008
J	Cox, JL; Mallanna, SK; Luo, X; Rizzino, A				Cox, Jesse L.; Mallanna, Sunil K.; Luo, Xu; Rizzino, Angie			Sox2 Uses Multiple Domains to Associate with Proteins Present in Sox2-Protein Complexes	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INTERACTION NETWORK; TRANSCRIPTION FACTORS; CARCINOMA-CELLS; DIFFERENTIATION; EXPRESSION; OCT4; GENE; PLURIPOTENCY; BINDING	Master regulators, such as Sox2, Oct4 and Nanog, control complex gene networks necessary for the self-renewal and pluripotency of embryonic stem cells (ESC). These master regulators associate with co-activators and co-repressors to precisely control their gene targets. Recent studies using proteomic analysis have identified a large, diverse group of coactivators and co-repressors that associate with master regulators, including Sox2. In this report, we examined the size distribution of nuclear protein complexes containing Sox2 and its associated proteins HDAC1, Sall4 and Lin28. Interestingly, we determined that Sox2 and HDAC1 associate with protein complexes that vary greatly in size; whereas, Lin28 primarily associates with smaller complexes, and Sall4 primarily associates with larger complexes. Additionally, we examined the domains of Sox2 necessary to mediate its association with its partner proteins Sall4, HDAC1 and HDAC2. We determined that Sox2 uses multiple and distinct domains to associate with its partner proteins. We also examined the domains of Sox2 necessary to mediate its self-association, and we determined that Sox2 self-association is mediated through multiple domains. Collectively, these studies provide novel insights into how Sox2 is able to associate with a wide array of nuclear proteins that control gene transcription.	[Cox, Jesse L.; Mallanna, Sunil K.; Luo, Xu; Rizzino, Angie] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Rizzino, Angie] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Cox, JL (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA.	arizzino@unmc.edu			National Institutes of Health [GM080751]; National Cancer Institute Cancer Center [CA009476]; NATIONAL CANCER INSTITUTE [T32CA009476] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080751] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institutes of Health (GM080751). Core facilities of the Eppley Institute were supported in part by an National Cancer Institute Cancer Center Support Grant (CA009476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Baltus GA, 2009, STEM CELLS, V27, P2175, DOI 10.1002/stem.168; Bernard P, 2003, HUM MOL GENET, V12, P1755, DOI 10.1093/hmg/ddg182; Boer B, 2007, NUCLEIC ACIDS RES, V35, P1773, DOI 10.1093/nar/gkm059; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; CHAKRAVARTHY H, 2010, FASEB J IN PRESS; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Han Y, 2008, MOL CELL BIOL, V28, P4999, DOI 10.1128/MCB.00695-08; KELLY D, 1995, MOL REPROD DEV, V40, P135, DOI 10.1002/mrd.1080400202; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kopp JL, 2007, J BIOL CHEM, V282, P3027, DOI 10.1074/jbc.M609907200; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lamb K, 1996, MOL REPROD DEV, V44, P460; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MALLANNA SK, 2010, STEM CELLS      0804; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Peirano RI, 2000, NUCLEIC ACIDS RES, V28, P3047, DOI 10.1093/nar/28.16.3047; Ramirez J, 2009, EPIGENETICS-US, V4, P532, DOI 10.4161/epi.4.8.10108; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Rizzino A, 2009, WIRES SYST BIOL MED, V1, P228, DOI 10.1002/wsbm.12; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	37	40	41	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15486	10.1371/journal.pone.0015486	http://dx.doi.org/10.1371/journal.pone.0015486			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103394	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700034
J	Widgren, K; Nielsen, J; Molbak, K				Widgren, Katarina; Nielsen, Jens; Molbak, Kare			Registry-Based Surveillance of Influenza-Associated Hospitalisations during the 2009 Influenza Pandemic in Denmark: The Hidden Burden on the Young	PLOS ONE			English	Article								Background: To follow the impact of the 2009 influenza pandemic in Denmark, influenza surveillance was extended with a system monitoring potentially influenza-associated hospitalisations. Methodology/Principal Findings: National administrative data from 2004-2010 from the automatic reporting of all hospital visits and admissions in Denmark (population 5.5 million) were used. In-patient hospitalisations linked to ICD-10 codes for potentially influenza-associated conditions (influenza, viral and bacterial pneumonia, respiratory distress, and febrile convulsion) were aggregated by week and age groups; <5 years, 5-24 years, 25-64 years and >= 65 years. Weekly numbers of influenza-associated hospitalisations were plotted to follow the course of the pandemic. We calculated the total numbers of influenza-associated hospitalisations in each influenza season (week 30 to week 15, the following year). Risk ratios of being admitted with an influenza-associated condition in this season (2009/2010) compared to the previous five seasons (2004/2005-2008/2009) were calculated using binary regression. During the pandemic season, influenza-associated hospitalisations peaked in week 47, 2009. The total number of influenza-associated hospitalisations was 38,273 compared to the median of previous seasons of 35,662 (p = 0.28). The risk ratio of influenza-associated hospitalisations during the pandemic season compared to previous seasons was 1.63 (95% CI 1.49-1.78) for 5-24 year-olds and ranged between 0.98 and 1.08 for the other three age groups. Conclusions: The 2009 pandemic influenza did not lead to an overall increase in the number of influenza-associated hospitalisations in Denmark in the 2009/2010 season and could be managed within existing hospital capacity. However, there was a disproportionally large impact on the age group 5-24 years. The influenza-associated hospitalisations during the 2009/2010 pandemic influenza	[Widgren, Katarina; Nielsen, Jens; Molbak, Kare] Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark; [Widgren, Katarina] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden	Statens Serum Institut; European Centre for Disease Prevention & Control	Widgren, K (corresponding author), Statens Serum Inst, Dept Epidemiol, DK-2300 Copenhagen, Denmark.	widgren.katarina@gmail.com		Molbak, Kare/0000-0002-3100-4990				Ahmed R, 2007, NAT IMMUNOL, V8, P1188, DOI 10.1038/ni1530; Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; *CDCP, 2010, EM INF PROGR; *CDCP, 2010, FLUVIEW; CHAN M, 2010, WORLD NOW START 2009; CULLEN G, 2009, EURO SURVEILL, V14; *DANM STAT, 2010, POP COUNTS; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; *EUR CTR DIS PREV, 2010, INFL SURV NETW EISN; *EURO MOMO, 2010, EUR MON EXC MORT PUB; GLISMANN S, 2010, INFLUENZA SEASON 200; Ikonen N, 2010, EURO SURVEILL, V15; Mazick A, 2010, EURO SURVEILL, V15; Miller MA, 2009, NEW ENGL J MED, V360, P2595, DOI 10.1056/NEJMp0903906; Millichap JG, 2006, PEDIATR NEUROL, V35, P165, DOI 10.1016/j.pediatrneurol.2006.06.004; MOLBAK K, EPINEWS, V49; *NEW S WAL PUBL HL, 2009, EURO SURVEILL, V14; Nickelsen T N, 2001, Ugeskr Laeger, V164, P33; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2000, J INFECT DIS, V181, P831, DOI 10.1086/315320; *STATACORP LP, 2010, STAT DAT AN STAT SOF; *SUNDH, 2010, NAT PAT REG; *SUNDH, 2006, PREP PAND INFL; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Van 't Klooster TM, 2010, EUROSURVEILLANCE, V15; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P173; Wilson N, 2009, EUROSURVEILLANCE, V14; World Health Organization, 2010, INT CLASS DIS ICD	29	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13939	10.1371/journal.pone.0013939	http://dx.doi.org/10.1371/journal.pone.0013939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085646	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800009
J	van der Sluis, S; Verhage, M; Posthuma, D; Dolan, CV				van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle; Dolan, Conor V.			Phenotypic Complexity, Measurement Bias, and Poor Phenotypic Resolution Contribute to the Missing Heritability Problem in Genetic Association Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MEASUREMENT INVARIANCE; RISK; POLYMORPHISMS; INTELLIGENCE; METAANALYSIS; CHILDHOOD; DISORDER; CANCER; MODEL	Background: The variance explained by genetic variants as identified in (genome-wide) genetic association studies is typically small compared to family-based heritability estimates. Explanations of this 'missing heritability' have been mainly genetic, such as genetic heterogeneity and complex (epi-) genetic mechanisms. Methodology: We used comprehensive simulation studies to show that three phenotypic measurement issues also provide viable explanations of the missing heritability: phenotypic complexity, measurement bias, and phenotypic resolution. We identify the circumstances in which the use of phenotypic sum-scores and the presence of measurement bias lower the power to detect genetic variants. In addition, we show how the differential resolution of psychometric instruments (i.e., whether the instrument includes items that resolve individual differences in the normal range or in the clinical range of a phenotype) affects the power to detect genetic variants. Conclusion: We conclude that careful phenotypic data modelling can improve the genetic signal, and thus the statistical power to identify genetic variants by 20-99%.	[van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Funct Genom Sect, Amsterdam, Netherlands; [van der Sluis, Sophie; Verhage, Matthijs; Posthuma, Danielle] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands; [Posthuma, Danielle] Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Med Genom Sect, Amsterdam, Netherlands; [Dolan, Conor V.] Univ Amsterdam, Fac Social & Behav Sci FMG, Dept Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; University of Amsterdam	van der Sluis, S (corresponding author), Vrije Univ Amsterdam, CNCR, Dept Clin Genet, Funct Genom Sect, Amsterdam, Netherlands.	sophie.van.der.sluis@cncr.vu.nl		Posthuma, Danielle/0000-0001-7582-2365; verhage, matthijs/0000-0002-6085-7503; van der Sluis, Sophie/0000-0001-9958-7216	Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW) [NWO/MaGW VENI-451-08-025, NWO/MaGW VIDI-016-065-318]	Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW)(Netherlands Organization for Scientific Research (NWO))	SvdS (NWO/MaGW VENI-451-08-025) and DP (NWO/MaGW VIDI-016-065-318) are financially supported by the Netherlands Scientific Organization (Nederlandse Organisatie voor Wetenschappelijk Onderzoek, gebied Maatschappij-en Gedragswetenschappen: NWO/MaGW: http://www.nwo.nl/). The funders had no role in study design, data simulation and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1991, MANUAL CHILD BEHAV C; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bartholomew DJ, 2009, PSYCHOL REV, V116, P567, DOI 10.1037/a0016262; BOLLEN K, 1991, PSYCHOL BULL, V110, P305, DOI 10.1037/0033-2909.110.2.305; Borsboom D, 2003, PSYCHOL REV, V110, P203, DOI 10.1037/0033-295X.110.2.203; Borsboom D, 2008, MEAS-INTERDISCIP RES, V6, P25, DOI 10.1080/15366360802035497; CASTO SD, 1995, BEHAV GENET, V25, P25, DOI 10.1007/BF02197239; Craddock N, 2009, BRIT J PSYCHIAT, V195, P97, DOI 10.1192/bjp.bp.108.063156; Cramer A, 2010, BEHAV BRAIN IN PRESS; Embretson S, 2000, MULTIVARIATE APPL BO; Faraone SV, 2005, BIOL PSYCHIAT, V57, P1313, DOI 10.1016/j.biopsych.2004.11.024; Franke B, 2009, HUM GENET, V126, P13, DOI 10.1007/s00439-009-0663-4; Galvan A, 2010, TRENDS GENET, V26, P132, DOI 10.1016/j.tig.2009.12.008; Hoekstra RA, 2007, LEARN INDIVID DIFFER, V17, P97, DOI 10.1016/j.lindif.2007.05.005; Holmans P, 2009, AM J HUM GENET, V85, P13, DOI 10.1016/j.ajhg.2009.05.011; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Larsson H, 2006, J AM ACAD CHILD PSY, V45, P973, DOI 10.1097/01.chi.0000222787.57100.d8; Li J, 2010, AM J EPIDEMIOL, V171, P1, DOI 10.1093/aje/kwp318; Lubke GH, 2004, TWIN RES, V7, P292, DOI 10.1375/136905204774200578; LUX V, 2010, PSYCH MED; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McDonald RP, 1999, TEST THEORY UNIFIED; McLoughlin G, 2007, J ABNORM CHILD PSYCH, V35, P999, DOI 10.1007/s10802-007-9149-9; Medland S, 2010, EUR J HUM GENET, V18, P233, DOI 10.1038/ejhg.2009.133; Mellenbergh G.J., 1989, INT J EDUC RES, V13, P127, DOI [10.1016/0883-0355(89)90002-5, DOI 10.1016/0883-0355(89)90002-5]; Mellenbergh GJ, 1996, PSYCHOL METHODS, V1, P293, DOI 10.1037/1082-989X.1.3.293; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Neale M. C, 2003, MX STAT MODELING, V6th; Neale MC, 2005, TWIN RES HUM GENET, V8, P553, DOI 10.1375/183242705774860231; Peng B, 2010, MUTAGENESIS, V25, P41, DOI 10.1093/mutage/gep041; Plomin R, 2002, TRENDS COGN SCI, V6, P169, DOI 10.1016/S1364-6613(00)01853-2; Polderman TJC, 2007, J CHILD PSYCHOL PSYC, V48, P1080, DOI 10.1111/j.1469-7610.2007.01783.x; Posthuma D, 2001, BEHAV GENET, V31, P593, DOI 10.1023/A:1013349512683; Price TS, 2000, CHILD DEV, V71, P948, DOI 10.1111/1467-8624.00201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Core Team, 2018, R LANG ENV STAT COMP; Rasch G., 1980, PROBABILISTIC MODELS; Rijsdijk FV, 2002, BEHAV GENET, V32, P199, DOI 10.1023/A:1016021128949; Ruano D, 2010, AM J HUM GENET, V86, P113, DOI 10.1016/j.ajhg.2009.12.006; Sebastiani P, 2009, AM J HEMATOL, V84, P504, DOI 10.1002/ajh.21440; SORBOM D, 1989, PSYCHOMETRIKA, V54, P371, DOI 10.1007/BF02294623; Sullivan PF, 2009, MOL PSYCHIATR, V14, P359, DOI 10.1038/mp.2008.125; Tian Y, 2010, INT J COLORECTAL DIS, V25, P161, DOI 10.1007/s00384-009-0809-9; van den Berg SM, 2007, BEHAV GENET, V37, P604, DOI 10.1007/s10519-007-9156-1; van der Maas HLJ, 2006, PSYCHOL REV, V113, P842, DOI 10.1037/0033-295X.113.4.842; van der Sluis S, 2008, BEHAV GENET, V38, P202, DOI 10.1007/s10519-007-9184-x; Wechsler D., 2012, WAIS 4 KASIKIRJA; Wicherts JM, 2009, P R SOC B, V276, P2675, DOI 10.1098/rspb.2009.0238; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zhang HF, 2009, HUM GENET, V125, P627, DOI 10.1007/s00439-009-0660-7; Zondervan KT, 2007, NAT PROTOC, V2, P2492, DOI 10.1038/nprot.2007.366	54	81	83	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13929	10.1371/journal.pone.0013929	http://dx.doi.org/10.1371/journal.pone.0013929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085666	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800020
J	Kronik, N; Kogan, Y; Elishmereni, M; Halevi-Tobias, K; Vuk-Pavlovic, S; Agur, Z				Kronik, Natalie; Kogan, Yuri; Elishmereni, Moran; Halevi-Tobias, Karin; Vuk-Pavlovic, Stanimir; Agur, Zvia			Predicting Outcomes of Prostate Cancer Immunotherapy by Personalized Mathematical Models	PLOS ONE			English	Article							APOPTOTIC TUMOR-CELLS; DENDRITIC CELLS; T-CELLS; CHEMOTHERAPY; GROWTH; VACCINATION; STRATEGIES; INDUCTION; DOCETAXEL; INTERVAL	Background: Therapeutic vaccination against disseminated prostate cancer (PCa) is partially effective in some PCa patients. We hypothesized that the efficacy of treatment will be enhanced by individualized vaccination regimens tailored by simple mathematical models. Methodology/Principal Findings: We developed a general mathematical model encompassing the basic interactions of a vaccine, immune system and PCa cells, and validated it by the results of a clinical trial testing an allogeneic PCa whole-cell vaccine. For model validation in the absence of any other pertinent marker, we used the clinically measured changes in prostate-specific antigen (PSA) levels as a correlate of tumor burden. Up to 26 PSA levels measured per patient were divided into each patient's training set and his validation set. The training set, used for model personalization, contained the patient's initial sequence of PSA levels; the validation set contained his subsequent PSA data points. Personalized models were simulated to predict changes in tumor burden and PSA levels and predictions were compared to the validation set. The model accurately predicted PSA levels over the entire measured period in 12 of the 15 vaccination-responsive patients (the coefficient of determination between the predicted and observed PSA values was R-2 = 0.972). The model could not account for the inconsistent changes in PSA levels in 3 of the 15 responsive patients at the end of treatment. Each validated personalized model was simulated under many hypothetical immunotherapy protocols to suggest alternative vaccination regimens. Personalized regimens predicted to enhance the effects of therapy differed among the patients. Conclusions/Significance: Using a few initial measurements, we constructed robust patient-specific models of PCa immunotherapy, which were retrospectively validated by clinical trial results. Our results emphasize the potential value and feasibility of individualized model-suggested immunotherapy protocols.	[Kronik, Natalie; Kogan, Yuri; Elishmereni, Moran; Halevi-Tobias, Karin; Agur, Zvia] Inst Med BioMath, Bene Ataroth, Israel; [Vuk-Pavlovic, Stanimir] Mayo Clin, Coll Med, Rochester, MN USA	Mayo Clinic	Kronik, N (corresponding author), Holon Inst Technol, Dept Appl Math, Fac Exact Sci, Holon, Israel.	agur@imbm.org			Chai Foundation; NIH [P50CA91956]; NATIONAL CANCER INSTITUTE [P50CA091956] Funding Source: NIH RePORTER	Chai Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	N.K., Y.K., M.E., K.H.T., and Z.A. thank the Chai Foundation for support of this work. S.V.P. gratefully acknowledges the support by Mrs. Adelyn L. Luther, Mayo Clinic Cancer Center, and NIH Grant P50CA91956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalamian-Matheis M, 2007, ADV EXP MED BIOL, V601, P173; ACHARYA RS, 1984, INT J BIOMED COMPUT, V15, P139, DOI 10.1016/0020-7101(84)90026-6; Agur Z., 1994, Random and Computational Dynamics, V2, P279; Agur Z, 2004, DISCRETE CONT DYN-B, V4, P29; AGUR Z, 1992, EUR J CANCER, V28A, P1085, DOI 10.1016/0959-8049(92)90463-C; Agur Z, 2006, OPER RES, V54, P829, DOI 10.1287/opre.1060.0320; Arakelyan L, 2005, EUR J CANCER, V41, P159, DOI 10.1016/j.ejca.2004.09.012; Arakelyan L., 2002, Angiogenesis, V5, P203, DOI 10.1023/A:1023841921971; Bajzer Z, 2005, BIOSYSTEMS, V80, P1, DOI 10.1016/j.biosystems.2004.09.025; BAJZER Z, 1984, SCIENCE, V225, P930, DOI 10.1126/science.6382606; BAJZER Z, 1990, Critical Reviews in Oncogenesis, V2, P53; Brandacher G, 2006, CURR DRUG METAB, V7, P599, DOI 10.2174/138920006778017768; Brill TH, 2009, HUM GENE THER, V20, P1641, DOI 10.1089/hum.2009.101; Bunimovich-Mendrazitsky S, 2008, B MATH BIOL, V70, P2055, DOI 10.1007/s11538-008-9344-z; Cappuccio A, 2007, J THEOR BIOL, V248, P259, DOI 10.1016/j.jtbi.2007.05.015; Cappuccio A, 2006, CANCER RES, V66, P7293, DOI 10.1158/0008-5472.CAN-06-0241; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; COJOCARU L, 1992, MATH BIOSCI, V109, P85, DOI 10.1016/0025-5564(92)90053-Y; Collins C, 2007, CANCER BIOL THER, V6, P1360; Damber JE, 2008, LANCET, V371, P1710, DOI 10.1016/S0140-6736(08)60729-1; de Pillis LG, 2006, J THEOR BIOL, V238, P841, DOI 10.1016/j.jtbi.2005.06.037; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; De Vleeschouwer S, 2005, CANCER IMMUNOL IMMUN, V54, P372, DOI 10.1007/s00262-004-0615-8; DEPILLIS LG, 2001, COMP MATH MATH PHYS, V3, P1748; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; ELISHMERENI M, 2008, AACR INT C ADV CANC; Georger TC, 2003, EUR J IMMUNOL, V33, P502, DOI 10.1002/immu.200310026; GOLDIE JH, 1979, CANCER TREAT REP, V63, P1727; Gorelik B, 2008, CANCER RES, V68, P9033, DOI 10.1158/0008-5472.CAN-08-1723; HARNEVO LE, 1992, CANCER CHEMOTH PHARM, V30, P469, DOI 10.1007/BF00685599; Harzstark AL, 2009, ONCOLOGIST, V14, P391, DOI 10.1634/theoncologist.2008-0240; Healy CG, 1998, CYTOMETRY, V32, P109, DOI 10.1002/(SICI)1097-0320(19980601)32:2<109::AID-CYTO6>3.0.CO;2-G; Higano CS, 2009, CANCER-AM CANCER SOC, V115, P3670, DOI 10.1002/cncr.24429; Kiessling A, 2008, EUR UROL, V53, P694, DOI 10.1016/j.eururo.2007.11.043; Kirschner D, 1998, J MATH BIOL, V37, P235, DOI 10.1007/s002850050127; Kokhaei P, 2004, LEUKEMIA, V18, P1810, DOI 10.1038/sj.leu.2403517; Kokhaei P, 2003, LEUKEMIA, V17, P894, DOI 10.1038/sj.leu.2402913; Kronik N, 2008, CANCER IMMUNOL IMMUN, V57, P425, DOI 10.1007/s00262-007-0387-z; Kulprathipanja NV, 2004, J NEUROIMMUNOL, V153, P76, DOI 10.1016/j.jneuroim.2004.04.011; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Leon K, 2007, J IMMUNOL, V179, P5659, DOI 10.4049/jimmunol.179.9.5659; Louzoun Y, 2007, IMMUNOL REV, V216, P9; Machiels JP, 2008, J CLIN ONCOL, V26, P5261, DOI 10.1200/JCO.2008.16.9524; Marrari A, 2007, CANCER IMMUNOL IMMUN, V56, P429, DOI 10.1007/s00262-006-0233-8; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Michael A, 2005, CLIN CANCER RES, V11, P4469, DOI 10.1158/1078-0432.CCR-04-2337; Min WP, 2003, J IMMUNOL, V170, P1304, DOI 10.4049/jimmunol.170.3.1304; Nani F, 2000, MATH BIOSCI, V163, P159, DOI 10.1016/S0025-5564(99)00058-9; Olson WC, 2007, REV RECENT CLIN TRIA, V2, P182, DOI 10.2174/157488707781662724; Pawelec G, 2004, FEBS LETT, V567, P63, DOI 10.1016/j.febslet.2004.02.091; Peshwa MV, 1998, PROSTATE, V36, P129, DOI 10.1002/(SICI)1097-0045(19980701)36:2<129::AID-PROS8>3.0.CO;2-D; SCHELLHAMMER PF, 2009, ANN M AM UR ASS APR; Street D, 1997, GYNECOL ONCOL, V65, P265, DOI 10.1006/gyno.1997.4667; Swanson KR, 2003, J NEUROL SCI, V216, P1, DOI 10.1016/j.jns.2003.06.001; Vuk-Pavlovic S, 2008, BLOOD CELL MOL DIS, V40, P94, DOI 10.1016/j.bcmd.2007.06.025; Vukmanovic-Stejic M, 2006, J CLIN INVEST, V116, P2423, DOI 10.1172/JCI28941; Weiner LM, 2008, NEW ENGL J MED, V358, P2664, DOI 10.1056/NEJMp0803663; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; YOUNGA D, 2009, SYSTEMS BIOMEDICINE, pCH15	59	78	81	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15482	10.1371/journal.pone.0015482	http://dx.doi.org/10.1371/journal.pone.0015482			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21151630	gold, Green Published, Green Submitted			2022-12-27	WOS:000285084100037
J	Bouffi, C; Bony, C; Courties, G; Jorgensen, C; Noel, D				Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele			IL-6-Dependent PGE2 Secretion by Mesenchymal Stem Cells Inhibits Local Inflammation in Experimental Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; PROSTAGLANDIN E-2; CYTOKINE PRODUCTION; PROLIFERATION; GENERATION; MACROPHAGES; LYMPHOCYTE; IMMUNOSUPPRESSION	Background: Based on their capacity to suppress immune responses, multipotent mesenchymal stromal cells (MSC) are intensively studied for various clinical applications. Although it has been shown in vitro that the immunomodulatory effect of MSCs mainly occurs through the secretion of soluble mediators, the mechanism is still not completely understood. The aim of the present study was to better understand the mechanisms underlying the suppressive effect of MSCs in vivo, using cells isolated from mice deficient in the production of inducible nitric oxide synthase (iNOS) or interleukin (IL)-6 in the murine model of collagen-induced arthritis. Principal Findings: In the present study, we show that primary murine MSCs from various strains of mice or isolated from mice deficient for iNOS or IL-6 exhibit different immunosuppressive potential. The immunomodulatory function of MSCs was mainly attributed to IL-6-dependent secretion of prostaglandin E2 (PGE2) with a minor role for NO. To address the role of these molecules in vivo, we used the collagen-induced arthritis as an experimental model of immune-mediated disorder. MSCs effectively inhibited collagen-induced inflammation during a narrow therapeutic window. In contrast to wild type MSCs, IL-6-deficient MSCs and to a lesser extent iNOS-deficient MSCs were not able to reduce the clinical signs of arthritis. Finally, we show that, independently of NO or IL-6 secretion or Treg cell induction, MSCs modulate the host response by inducing a switch to a Th2 immune response. Significance: Our data indicate that MSCs mediate their immunosuppressive effect via two modes of action: locally, they reduce inflammation through the secretion of anti-proliferative mediators, such as NO and mainly PGE2, and systemically they switch the host response from a Th1/Th17 towards a Th2 immune profile.	[Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele] INSERM, Unite 844, Montpellier, France; [Bouffi, Carine; Bony, Claire; Courties, Gabriel; Jorgensen, Christian; Noel, Daniele] Univ Montpellier I, Montpellier, France; [Jorgensen, Christian] Hop Lapeyronie, Serv Immunorhumatol Therapeut, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier	Bouffi, C (corresponding author), INSERM, Unite 844, Montpellier, France.	daniele.noel@inserm.fr	Noel, Daniele/E-5719-2016	Courties, Gabriel/0000-0002-0003-7407; Noel, Daniele/0000-0002-3498-3776	Inserm Institute, the University of Montpellier I; Agence Nationale de la Recherche	Inserm Institute, the University of Montpellier I(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Work in the laboratory Inserm U844 is supported by the Inserm Institute, the University of Montpellier I and a grant from the "Agence Nationale de la Recherche" (project ANR Physio 2006 "Immunostem"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparailly F, 1998, J IMMUNOL, V160, P5213; Armaka M, 2008, J EXP MED, V205, P331, DOI 10.1084/jem.20070906; Augello A, 2007, ARTHRITIS RHEUM-US, V56, P1175, DOI 10.1002/art.22511; Bartholomew A, 2001, HUM GENE THER, V12, P1527, DOI 10.1089/10430340152480258; Bour AMJJ, 2000, EXP GERONTOL, V35, P1017, DOI 10.1016/S0531-5565(00)00128-5; Chabannes D, 2007, BLOOD, V110, P3691, DOI 10.1182/blood-2007-02-075481; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Charbonnier LM, 2006, J IMMUNOL, V177, P3806, DOI 10.4049/jimmunol.177.6.3806; Chen B, 2010, CLIN EXP IMMUNOL, V159, P292, DOI 10.1111/j.1365-2249.2009.04069.x; Choi JJ, 2008, CLIN EXP IMMUNOL, V153, P269, DOI 10.1111/j.1365-2249.2008.03683.x; Daubener W, 1999, INFECT IMMUN, V67, P5615; Djouad F, 2005, ARTHRITIS RES THER, V7, pR1304, DOI 10.1186/ar1827; Djouad F, 2005, ARTHRITIS RHEUM-US, V52, P1595, DOI 10.1002/art.21012; Djouad F, 2009, NAT REV RHEUMATOL, V5, P392, DOI 10.1038/nrrheum.2009.104; Ghannam S, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt2; Gonzalez MA, 2009, ARTHRITIS RHEUM-US, V60, P1006, DOI 10.1002/art.24405; GONZALEZREY E, 2009, ANN RHEUM DIS; Hematti Peiman, 2008, Transplant Rev (Orlando), V22, P262, DOI 10.1016/j.trre.2008.05.002; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Lee RH, 2006, P NATL ACAD SCI USA, V103, P17438, DOI 10.1073/pnas.0608249103; Marinova-Mutafchieva L, 2006, CLIN EXP IMMUNOL, V146, P287, DOI 10.1111/j.1365-2249.2006.03204.x; Marinova-Mutafchieva L, 2002, ARTHRITIS RHEUM, V46, P507, DOI 10.1002/art.10126; Miranda KM, 2001, NITRIC OXIDE-BIOL CH, V5, P62, DOI 10.1006/niox.2000.0319; Morgan ME, 2005, ARTHRITIS RHEUM-US, V52, P2212, DOI 10.1002/art.21195; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Noel D, 2007, LEUKEMIA LYMPHOMA, V48, P1283, DOI 10.1080/10428190701361869; Parekkadan B, 2008, STEM CELLS, V26, P1913, DOI 10.1634/stemcells.2007-0790; Perez N, 2002, HUM GENE THER, V13, P2161, DOI 10.1089/104303402320987851; Poggi A, 2008, HUM IMMUNOL, V69, P755, DOI 10.1016/j.humimm.2008.08.278; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Prevosto C, 2007, HAEMATOLOGICA, V92, P881, DOI 10.3324/haematol.11240; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sawada T, 1997, J IMMUNOL, V158, P5267; Schurgers E, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2939; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Shibata Y, 2005, J LEUKOCYTE BIOL, V78, P1281, DOI 10.1189/jlb.0605321; Son Y, 2006, IMMUNOLOGY, V119, P36, DOI 10.1111/j.1365-2567.2006.02402.x; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Sudres M, 2006, J IMMUNOL, V176, P7761, DOI 10.4049/jimmunol.176.12.7761; Takaoka Y, 1999, J BIOCHEM-TOKYO, V126, P553, DOI 10.1093/oxfordjournals.jbchem.a022485; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Vinatier C, 2009, TRENDS BIOTECHNOL, V27, P307, DOI 10.1016/j.tibtech.2009.02.005; Vuolteenaho K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/345838; Waterman RS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010088; Woolard MD, 2007, J IMMUNOL, V178, P2065, DOI 10.4049/jimmunol.178.4.2065; Zappia E, 2005, BLOOD, V106, P1755, DOI 10.1182/blood-2005-04-1496	51	278	289	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14247	10.1371/journal.pone.0014247	http://dx.doi.org/10.1371/journal.pone.0014247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151872	Green Submitted, Green Published, gold			2022-12-27	WOS:000285041800006
J	Chakarov, N; Kruger, O				Chakarov, Nayden; Krueger, Oliver			Mesopredator Release by an Emergent Superpredator: A Natural Experiment of Predation in a Three Level Guild	PLOS ONE			English	Article							GOSHAWK ACCIPITER-GENTILIS; LIFETIME REPRODUCTIVE SUCCESS; BUZZARD BUTEO-BUTEO; INTRAGUILD PREDATION; COMMON BUZZARD; TOP PREDATORS; RAPTORS; FITNESS; OWL; BIODIVERSITY	Background: Intraguild predation (IGP) is widespread but it is often neglected that guilds commonly include many layers of dominance within. This could obscure the effects of IGP making unclear whether the intermediate or the bottom mesopredator will bear higher costs from the emergence of a new top predator. Methodology/Principal Findings: In one of the most extensive datasets of avian IGP, we analyse the impact of recolonization of a superpredator, the eagle owl Bubo bubo on breeding success, territorial dynamics and population densities of two mesopredators, the northern goshawk Accipiter gentilis and its IG prey, the common buzzard Buteo buteo. The data covers more than two decades and encompass three adjacent plots. Eagle owls only recolonized the central plot during the second decade, thereby providing a natural experiment. Both species showed a decrease in standardized reproductive success and an increase in brood failure within 1.5 km of the superpredator. During the second decade, territory dynamics of goshawks was significantly higher in the central plot compared to both other plots. No such pattern existed in buzzards. Goshawk density in the second decade decreased in the central plot, while it increased in both other plots. Buzzard density in the second decade rapidly increased in the north, remained unchanged in the south and increased moderately in the center in a probable case of mesopredator release. Conclusions/Significance: Our study finds support for top-down control on the intermediate mesopredator and both top-down and bottom-up control of the bottom mesopredator. In the face of considerable costs of IGP, both species probably compete to breed in predator-free refugia, which get mostly occupied by the dominant raptor. Therefore for mesopredators the outcome of IGP might depend directly on the number of dominance levels which supersede them.	[Chakarov, Nayden; Krueger, Oliver] Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany	University of Bielefeld	Chakarov, N (corresponding author), Univ Bielefeld, Dept Anim Behav, Bielefeld, Germany.	az.nayden@gmail.com			Volkswagen Foundation [I/84 196]; German Science Foundation (DFG) [KR 2089/2-1]	Volkswagen Foundation(Volkswagen); German Science Foundation (DFG)(German Research Foundation (DFG))	NC was supported by the Volkswagen Foundation within its Evolutionary Biology initiative, grant I/84 196. OK holds a Heisenberg Professorship of the German Science Foundation (DFG) (KR 2089/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger KM, 2008, ECOL APPL, V18, P599, DOI 10.1890/07-0308.1; Boerner M, 2009, BEHAV ECOL, V20, P180, DOI 10.1093/beheco/arn132; BRAUNEIS W, 2010, CHARADRIUS, V46, P28; Brommer JE, 1998, J ANIM ECOL, V67, P359, DOI 10.1046/j.1365-2656.1998.00201.x; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [10.1007/b97636, DOI 10.1007/B97636]; Busche Guenther, 2004, Vogelwarte, V42, P169; Chakarov N, 2008, FUNCT ECOL, V22, P1062, DOI 10.1111/j.1365-2435.2008.01460.x; Cramp S., 1980, HDB BIRDS EUROPE MID; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; DIAMOND JM, 1983, NATURE, V304, P586, DOI 10.1038/304586a0; Elliott A., 1992, HDB BIRDS WORLD ALIV; Elmhagen B, 2010, J ANIM ECOL, V79, P785, DOI 10.1111/j.1365-2656.2010.01678.x; Fedriani JM, 2000, OECOLOGIA, V125, P258, DOI 10.1007/s004420000448; Hakkarainen H, 2004, OECOLOGIA, V141, P420, DOI 10.1007/s00442-004-1656-6; Hakkarainen H, 1996, ECOLOGY, V77, P1134, DOI 10.2307/2265582; KORPIMAKI E, 1992, J ANIM ECOL, V61, P103, DOI 10.2307/5513; Kruger O, 2005, EVOL ECOL, V19, P467, DOI 10.1007/s10682-005-0293-9; Kruger O, 2002, OIKOS, V96, P441, DOI 10.1034/j.1600-0706.2002.960306.x; Kruger O, 2002, ECOGRAPHY, V25, P523, DOI 10.1034/j.1600-0587.2002.250502.x; Kruger O, 2001, OIKOS, V93, P260, DOI 10.1034/j.1600-0706.2001.930209.x; Kruger O, 2001, J ANIM ECOL, V70, P173, DOI 10.1046/j.1365-2656.2001.00481.x; Kruger O, 2007, OECOLOGIA, V152, P459, DOI 10.1007/s00442-007-0677-3; Kruger Oliver, 1996, Vogelwelt, V117, P1; LOURENCO R, 2010, POPULATION ECOLOGY, P1, DOI DOI 10.1007/S10144-10010-10199-10144; Mccleery RA, 2009, LANDSCAPE ECOL, V24, P483, DOI 10.1007/s10980-009-9323-2; McDonald RA, 2007, DIVERS DISTRIB, V13, P92, DOI 10.1111/j.1366-9516.2006.00303.x; MEBS TH, 1964, J ORNITHOL, V105, P247, DOI 10.1007/BF01672243; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Mylius SD, 2001, AM NAT, V158, P259, DOI 10.1086/321321; Petty SJ, 2003, IBIS, V145, P472, DOI 10.1046/j.1474-919X.2003.00191.x; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2003, J ANIM ECOL, V72, P232, DOI 10.1046/j.1365-2656.2003.00693.x; Sergio F, 2007, ANIM BEHAV, V74, P1607, DOI 10.1016/j.anbehav.2006.10.022; Sergio F, 2008, IBIS, V150, P132, DOI 10.1111/j.1474-919X.2008.00786.x; Thompson CM, 2007, ECOLOGY, V88, P334, DOI 10.1890/0012-9658(2007)88[334:FWAIPC]2.0.CO;2; VONBLOTZEIM UG, 1971, HDB VOGEL MITTELEURO; WALTER B, 2008, BERICHTE NATURWISSEN, V48, P28	39	32	32	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15229	10.1371/journal.pone.0015229	http://dx.doi.org/10.1371/journal.pone.0015229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151912	gold, Green Published			2022-12-27	WOS:000284995300023
J	Ersoz, ES; Wright, MH; Gonzalez-Martinez, SC; Langley, CH; Neale, DB				Ersoz, Elhan S.; Wright, Mark H.; Gonzalez-Martinez, Santiago C.; Langley, Charles H.; Neale, David B.			Evolution of Disease Response Genes in Loblolly Pine: Insights from Candidate Genes	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; BALANCING SELECTION; TAEDA L.; DIVERSITY; RESISTANCE; LOCUS; HITCHHIKING; EXPRESSION; MUTATION; HISTORY	Background: Host-pathogen interactions that may lead to a competitive co-evolution of virulence and resistance mechanisms present an attractive system to study molecular evolution because strong, recent (or even current) selective pressure is expected at many genomic loci. However, it is unclear whether these selective forces would act to preserve existing diversity, promote novel diversity, or reduce linked neutral diversity during rapid fixation of advantageous alleles. In plants, the lack of adaptive immunity places a larger burden on genetic diversity to ensure survival of plant populations. This burden is even greater if the generation time of the plant is much longer than the generation time of the pathogen. Methodology/Principal Findings: Here, we present nucleotide polymorphism and substitution data for 41 candidate genes from the long-lived forest tree loblolly pine, selected primarily for their prospective influences on host-pathogen interactions. This dataset is analyzed together with 15 drought-tolerance and 13 wood-quality genes from previous studies. A wide range of neutrality tests were performed and tested against expectations from realistic demographic models. Conclusions/Significance: Collectively, our analyses found that axr (auxin response factor), caf1 (chromatin assembly factor) and gatabp1 (gata binding protein 1) candidate genes carry patterns consistent with directional selection and erd3 (early response to drought 3) displays patterns suggestive of a selective sweep, both of which are consistent with the arm-race model of disease response evolution. Furthermore, we have identified patterns consistent with diversifying selection at erf1-like (ethylene responsive factor 1), ccoaoemt (caffeoyl-CoA-O-methyltransferase), cyp450-like (cytochrome p450-like) and pr4.3 (pathogen response 4.3), expected under the trench-warfare evolution model. Finally, a drought-tolerance candidate related to the plant cell wall, lp5, displayed patterns consistent with balancing selection. In conclusion, both arms-race and trench-warfare models seem compatible with patterns of polymorphism found in different disease-response candidate genes, indicating a mixed strategy of disease tolerance evolution for loblolly pine, a major tree crop in southeastern United States.	[Ersoz, Elhan S.; Gonzalez-Martinez, Santiago C.; Neale, David B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Wright, Mark H.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Gonzalez-Martinez, Santiago C.] Inst Nacl Invest & Tecnol Agr & Alimentaria CIFOR, Dept Forest Syst & Resources, Ctr Forest Res, Ctr Invest Forestal, Madrid, Spain; [Langley, Charles H.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Neale, David B.] US Forest Serv, Inst Forest Genet, USDA, Davis, CA USA	University of California System; University of California Davis; Cornell University; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service	Ersoz, ES (corresponding author), Syngenta Biotechnol Inc, Stanton, MN USA.	dbneale@ucdavis.edu	Gonzalez-Martinez, Santiago C/H-2014-2012	Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Wright, Mark/0000-0001-8036-1161	University of California; 'Similar toRamon y Cajal' fellowship [RC02-2941]; Cornell Presidential Genomics Initiative Fellowship; NSF [0606461]; USDA/IFAFS [2001-52100-11315]	University of California(University of California System); 'Similar toRamon y Cajal' fellowship; Cornell Presidential Genomics Initiative Fellowship; NSF(National Science Foundation (NSF)); USDA/IFAFS(United States Department of Agriculture (USDA))	The work of Santiago C. Gonzalez-Martinez was supported by a Fulbright/MECD scholarship at University of California (Davis) and the 'similar to Ramon y Cajal' fellowship RC02-2941. The work of Mark Wright was supported by the Cornell Presidential Genomics Initiative Fellowship and NSF #0606461. Funding for this research was provided by ADEPT project USDA/IFAFS grant # 2001-52100-11315 (http://dendrome.ucdavis.edu/adept). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown GR, 2004, P NATL ACAD SCI USA, V101, P15255, DOI 10.1073/pnas.0404231101; Brown GR, 2003, GENETICS, V164, P1537; Bustamante CD, 2002, NATURE, V416, P531, DOI 10.1038/416531a; Clark AG, 1997, P NATL ACAD SCI USA, V94, P7730, DOI 10.1073/pnas.94.15.7730; de Meaux J, 2003, HEREDITY, V91, P345, DOI 10.1038/sj.hdy.6800342; Eckert AJ, 2009, TREE GENET GENOMES, V5, P225, DOI 10.1007/s11295-008-0183-8; Emrich SJ, 2007, GENETICS, V175, P429, DOI 10.1534/genetics.106.064006; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FLOR HH, 1956, ADV GENET, V8, P29, DOI 10.1016/S0065-2660(08)60498-8; FU YX, 1993, GENETICS, V133, P693; Gernandt DS, 2008, INT J PLANT SCI, V169, P1086, DOI 10.1086/590472; Gill GP, 2003, PLANT BIOTECHNOL J, V1, P253, DOI 10.1046/j.1467-7652.2003.00024.x; Gonzalez-Martinez SC, 2006, GENETICS, V172, P1915, DOI 10.1534/genetics.105.047126; Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195; Hudson RR, 1997, P NATL ACAD SCI USA, V94, P7725, DOI 10.1073/pnas.94.15.7725; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Kim Y, 2000, GENETICS, V155, P1415; Kliebenstein DJ, 2002, GENETICS, V161, P1685; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McVean G, 2002, GENETICS, V160, P1231; Moeller DA, 2005, MOL BIOL EVOL, V22, P2480, DOI 10.1093/molbev/msi247; Morse AM, 2004, THEOR APPL GENET, V109, P922, DOI 10.1007/s00122-004-1719-4; Myburg H, 2006, PHYSIOL MOL PLANT P, V68, P79, DOI 10.1016/j.pmpp.2006.07.002; Pyhajarvi T, 2007, GENETICS, V177, P1713, DOI 10.1534/genetics.107.077099; Rose LE, 2007, GENETICS, V175, P1307, DOI 10.1534/genetics.106.063602; Rossi M, 1998, P NATL ACAD SCI USA, V95, P9750, DOI 10.1073/pnas.95.17.9750; Schmidtling RC, 1999, SILVAE GENET, V48, P35; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; TAJIMA F, 1989, GENETICS, V123, P585; Tian DC, 2002, P NATL ACAD SCI USA, V99, P11525, DOI 10.1073/pnas.172203599; Tiffin P, 2006, TRENDS GENET, V22, P662, DOI 10.1016/j.tig.2006.09.011; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; Verrelli BC, 2002, AM J HUM GENET, V71, P1112, DOI 10.1086/344345; Wakeley J, 1997, GENETICS, V145, P847; Warren JA, 2004, APPL ENVIRON MICROB, V70, P441, DOI 10.1128/AEM.70.1.441-451.2004; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wilson IW, 2001, GENETICS, V158, P1301	39	19	20	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14234	10.1371/journal.pone.0014234	http://dx.doi.org/10.1371/journal.pone.0014234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151911	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300006
J	Stapleton, JA; Swartz, JR				Stapleton, James A.; Swartz, James R.			Development of an In Vitro Compartmentalization Screen for High-Throughput Directed Evolution of [FeFe] Hydrogenases	PLOS ONE			English	Article							SINGLE-COPY DNA; ENZYME LIBRARIES; DOUBLE EMULSIONS; SELECTION; PROTEINS; DISPLAY; PCR; AMPLIFICATION; EXPRESSION; SURFACE	Background: [FeFe] hydrogenase enzymes catalyze the formation and dissociation of molecular hydrogen with the help of a complex prosthetic group composed of common elements. The development of energy conversion technologies based on these renewable catalysts has been hindered by their extreme oxygen sensitivity. Attempts to improve the enzymes by directed evolution have failed for want of a screening platform capable of throughputs high enough to adequately sample heavily mutated DNA libraries. In vitro compartmentalization (IVC) is a powerful method capable of screening for multiple-turnover enzymatic activity at very high throughputs. Recent advances have allowed [FeFe] hydrogenases to be expressed and activated in the cell-free protein synthesis reactions on which IVC is based; however, IVC is a demanding technique with which many enzymes have proven incompatible. Methodology/Principal Findings: Here we describe an extremely high-throughput IVC screen for oxygen-tolerant [FeFe] hydrogenases. We demonstrate that the [FeFe] hydrogenase CpI can be expressed and activated within emulsion droplets, and identify a fluorogenic substrate that links activity after oxygen exposure to the generation of a fluorescent signal. We present a screening protocol in which attachment of mutant genes and the proteins they encode to the surfaces of microbeads is followed by three separate emulsion steps for amplification, expression, and evaluation of hydrogenase mutants. We show that beads displaying active hydrogenase can be isolated by fluorescence-activated cell-sorting, and we use the method to enrich such beads from a mock library. Conclusions/Significance: [FeFe] hydrogenases are the most complex enzymes to be produced by cell-free protein synthesis, and the most challenging targets to which IVC has yet been applied. The technique described here is an enabling step towards the development of biocatalysts for a biological hydrogen economy.	[Stapleton, James A.; Swartz, James R.] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Swartz, James R.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA	Stanford University; Stanford University	Stapleton, JA (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180	Stanford University; National Defense Science and Engineering (NDSEG)	Stanford University(Stanford University); National Defense Science and Engineering (NDSEG)	This work was funded by the Global Climate and Energy Project (GCEP) at Stanford University (http://gcep.stanford.edu/), as well as a National Defense Science and Engineering (NDSEG) Fellowship (http://ndseg.asee.org/) to JAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Agresti JJ, 2010, P NATL ACAD SCI USA, V107, P4004, DOI 10.1073/pnas.0910781107; Agresti JJ, 2005, P NATL ACAD SCI USA, V102, P16170, DOI 10.1073/pnas.0503733102; Aharoni A, 2005, CHEM BIOL, V12, P1281, DOI 10.1016/j.chembiol.2005.09.012; Anna SL, 2003, APPL PHYS LETT, V82, P364, DOI 10.1063/1.1537519; Bernath K, 2005, J MOL BIOL, V345, P1015, DOI 10.1016/j.jmb.2004.11.017; Bernath K, 2004, ANAL BIOCHEM, V325, P151, DOI 10.1016/j.ab.2003.10.005; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brouzes E, 2009, P NATL ACAD SCI USA, V106, P14195, DOI 10.1073/pnas.0903542106; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Cohen J, 2005, BIOCHEM SOC T, V33, P80, DOI 10.1042/BST0330080; Davidson Eric A, 2009, Curr Protoc Mol Biol, VChapter 24, DOI 10.1002/0471142727.mb2406s87; Diehl F, 2006, NAT METHODS, V3, P551, DOI 10.1038/NMETH898; Edd JF, 2008, LAB CHIP, V8, P1262, DOI 10.1039/b805456h; Frenz L, 2008, LANGMUIR, V24, P12073, DOI 10.1021/la801954w; GAN R, 2008, BIOTECHNOL PROGR, V24, P3; Georgiou G, 1997, NAT BIOTECHNOL, V15, P29, DOI 10.1038/nbt0197-29; Ghadessy FJ, 2004, PROTEIN ENG DES SEL, V17, P201, DOI 10.1093/protein/gzh025; Griffiths AD, 2003, EMBO J, V22, P24, DOI 10.1093/emboj/cdg014; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Holtze C, 2008, LAB CHIP, V8, P1632, DOI 10.1039/b806706f; Kelly BT, 2007, CHEM COMMUN, P1773, DOI 10.1039/b616252e; Kuchenreuther JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007565; Kumaresan P, 2008, ANAL CHEM, V80, P3522, DOI 10.1021/ac800327d; Leamon JH, 2006, NAT METHODS, V3, P541, DOI 10.1038/nmeth0706-541; Link DR, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.054503; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mastrobattista E, 2005, CHEM BIOL, V12, P1291, DOI 10.1016/j.chembiol.2005.09.016; PECK HD, 1956, J BACTERIOL, V71, P70, DOI 10.1128/JB.71.1.70-80.1956; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pirrung MC, 1996, BIOCONJUGATE CHEM, V7, P317, DOI 10.1021/bc960013v; Pohl G, 2004, EXPERT REV MOL DIAGN, V4, P41, DOI 10.1586/14737159.4.1.41; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Pushkarev D, 2009, NAT BIOTECHNOL, V27, P847, DOI 10.1038/nbt.1561; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rungpragayphan S, 2002, J MOL BIOL, V318, P395, DOI 10.1016/S0022-2836(02)00094-3; Schaerli Y, 2009, ANAL CHEM, V81, P302, DOI 10.1021/ac802038c; Sepp A, 2002, FEBS LETT, V532, P455, DOI 10.1016/S0014-5793(02)03740-7; Shah RK, 2008, MATER TODAY, V11, P18, DOI 10.1016/S1369-7021(08)70053-1; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Stapleton JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010554; Tawfik DS, 1998, NAT BIOTECHNOL, V16, P652, DOI 10.1038/nbt0798-652	43	52	54	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15275	10.1371/journal.pone.0015275	http://dx.doi.org/10.1371/journal.pone.0015275			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151915	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300026
J	Bento, CF; Fernandes, R; Ramalho, J; Marques, C; Shang, F; Taylor, A; Pereira, P				Bento, Carla Figueira; Fernandes, Rosa; Ramalho, Jose; Marques, Carla; Shang, Fu; Taylor, Allen; Pereira, Paulo			The Chaperone-Dependent Ubiquitin Ligase CHIP Targets HIF-1 alpha for Degradation in the Presence of Methylglyoxal	PLOS ONE			English	Article							INDUCIBLE FACTOR 1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; COILED-COIL DOMAIN; E3 LIGASE; DIABETES-MELLITUS; HIF-ALPHA; HYPOXIA; PROTEIN; ANGIOGENESIS	Hypoxia-inducible factor-1 (HIF-1) plays a key role in cell adaptation to low oxygen and stabilization of HIF-1 is vital to ensure cell survival under hypoxia. Diabetes has been associated with impairment of the cell response to hypoxia and downregulation of HIF-1 is most likely the event that transduces hyperglycemia into increased cell death in diabetes-associated hypoxia. In this study, we aimed at identifying the molecular mechanism implicated in destabilization of HIF-1 by high glucose. In this work, we identified a new molecular mechanism whereby methylglyoxal (MGO), which accumulates in high-glucose conditions, led to a rapid proteasome-dependent degradation of HIF-1 alpha under hypoxia. Significantly, MGO-induced degradation of HIF-1 alpha did not require the recruitment of the ubiquitin ligase pVHL nor did it require hydroxylation of the proline residues P402/P564 of HIF-1 alpha. Moreover, we identified CHIP (Carboxy terminus of Hsp70-Interacting Protein) as the E3 ligase that ubiquitinated HIF-1 alpha in the presence of MGO. Consistently, silencing of endogenous CHIP and overexpression of glyoxalase I both stabilized HIF-1 alpha under hypoxia in the presence of MGO. Data shows that increased association of Hsp40/70 with HIF-1 alpha led to recruitment of CHIP, which promoted polyubiquitination and degradation of HIF-1 alpha. Moreover, MGO-induced destabilization of HIF-1 alpha led to a dramatic decrease in HIF-1 transcriptional activity. Altogether, data is consistent with a new pathway for degradation of HIF-1 alpha in response to intracellular accumulation of MGO. Moreover, we suggest that accumulation of MGO is likely to be the link between high glucose and the loss of cell response to hypoxia in diabetes.	[Bento, Carla Figueira; Fernandes, Rosa; Ramalho, Jose; Marques, Carla; Pereira, Paulo] Univ Coimbra, Fac Med, Ctr Ophthalmol & Vis Sci COCV, Inst Biomed Res Light & Image IBILI, Coimbra, Portugal; [Bento, Carla Figueira] Univ Coimbra, PhD Programme, Ctr Neurosci & Cell Biol CNC, Coimbra, Portugal; [Shang, Fu; Taylor, Allen] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA	Universidade de Coimbra; Universidade de Coimbra; Tufts University; United States Department of Agriculture (USDA)	Bento, CF (corresponding author), Univ Coimbra, Fac Med, Ctr Ophthalmol & Vis Sci COCV, Inst Biomed Res Light & Image IBILI, Coimbra, Portugal.	ppereira@ibili.uc.pt	Pereira, Paulo/AAD-8375-2022; Fernandes, Rosa/P-1102-2014; Ramalho, Jose/M-6415-2015; Marques, Carla/AAC-9838-2019	Pereira, Paulo/0000-0002-9908-2290; Fernandes, Rosa/0000-0001-7828-2296; Ramalho, Jose/0000-0002-1927-164X; Marques, Carla/0000-0002-1817-4813; Bento, Carla F./0000-0001-8377-4543	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal [POCTI/SAU-OBS/57772/2004, PDTC/SAU-OSM/67498/2006];  [SFRH/BD/15229/2004]	FCT - Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); 	This work was supported by the PhD fellowship SFRH/BD/15229/2004 (Carla F. Bento) and by the grants POCTI/SAU-OBS/57772/2004 and PDTC/SAU-OSM/67498/2006 (FCT - Fundacao para a Ciencia e a Tecnologia, Portugal). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaci A, 1999, CIRCULATION, V99, P2239, DOI 10.1161/01.CIR.99.17.2239; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Beisswenger PJ, 1999, DIABETES, V48, P198, DOI 10.2337/diabetes.48.1.198; Bento CF, 2010, EXP PHYSIOL, V95, P955, DOI 10.1113/expphysiol.2010.053561; Bulteau AL, 2001, J BIOL CHEM, V276, P45662, DOI 10.1074/jbc.M105374200; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Ceradini DJ, 2008, J BIOL CHEM, V283, P10930, DOI 10.1074/jbc.M707451200; Coffe V, 2006, NEUROCHEM RES, V31, P103, DOI 10.1007/s11064-005-9236-7; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dobler D, 2006, DIABETES, V55, P1961, DOI 10.2337/db05-1634; Du J, 2006, INT J BIOCHEM CELL B, V38, P1084, DOI 10.1016/j.biocel.2005.10.019; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Han Y, 2007, MOL CELL BIOCHEM, V305, P123, DOI 10.1007/s11010-007-9535-1; Hansson LO, 2002, P NATL ACAD SCI USA, V99, P10305, DOI 10.1073/pnas.122347199; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hume AN, 2006, MOL BIOL CELL, V17, P4720, DOI 10.1091/mbc.E06-05-0457; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kalapos MP, 1999, TOXICOL LETT, V110, P145, DOI 10.1016/S0378-4274(99)00160-5; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kimura H, 2001, J BIOL CHEM, V276, P2292, DOI 10.1074/jbc.M008398200; Koh MY, 2008, MOL CELL BIOL, V28, P7081, DOI 10.1128/MCB.00773-08; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180; Laga M, 2007, BIOCHEM PHARMACOL, V74, P579, DOI 10.1016/j.bcp.2007.05.026; Larger E, 2004, DIABETES, V53, P752, DOI 10.2337/diabetes.53.3.752; Lee HK, 2009, J NEUROCHEM, V108, P273, DOI 10.1111/j.1471-4159.2008.05764.x; Liu LX, 2008, J CELL PHYSIOL, V217, P319, DOI 10.1002/jcp.21503; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Lopes VS, 2007, TRAFFIC, V8, P486, DOI 10.1111/j.1600-0854.2007.00548.x; Luo WB, 2010, J BIOL CHEM, V285, P3651, DOI 10.1074/jbc.M109.068577; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Malmberg K, 1999, CIRCULATION, V99, P2626, DOI 10.1161/01.CIR.99.20.2626; Marques C, 2006, FASEB J, V20, P741, DOI 10.1096/fj.05-5080fje; Miller AG, 2006, J BIOL CHEM, V281, P11864, DOI 10.1074/jbc.M513813200; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murata S, 2003, INT J BIOCHEM CELL B, V35, P572, DOI 10.1016/S1357-2725(02)00394-1; Nikolay R, 2004, J BIOL CHEM, V279, P2673, DOI 10.1074/jbc.M311112200; Portero-Otin M, 2002, DIABETES, V51, P1535, DOI 10.2337/diabetes.51.5.1535; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Ravi R, 2000, GENE DEV, V14, P34; Riboulet-Chavey A, 2006, DIABETES, V55, P1289, DOI 10.2337/db05-0857; Schalkwijk CG, 1999, PERITON DIALYSIS INT, V19, P325; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2009, PHYSIOLOGY, V24, P97, DOI 10.1152/physiol.00045.2008; Slomiany MG, 2004, AM J PHYSIOL-CELL PH, V287, pC746, DOI 10.1152/ajpcell.00568.2003; Sohn SY, 2006, J GEN VIROL, V87, P1883, DOI 10.1099/vir.0.81684-0; Stitt AW, 2005, DIABETES, V54, P785, DOI 10.2337/diabetes.54.3.785; Takeshita T, 2009, CANCER CHEMOTH PHARM, V64, P1039, DOI 10.1007/s00280-009-0961-5; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; THANGARAJAH H, 2009, P NATL ACAD SCI US; Thornalley Paul J., 2008, Drug Metabolism and Drug Interactions, V23, P125; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Yao D, 2007, J BIOL CHEM, V282, P31038, DOI 10.1074/jbc.M704703200; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018	55	86	92	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15062	10.1371/journal.pone.0015062	http://dx.doi.org/10.1371/journal.pone.0015062			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124777	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500029
J	Durand, N; Carot-Sans, G; Chertemps, T; Bozzolan, F; Party, V; Renou, M; Debernard, S; Rosell, G; Maibeche-Coisne, M				Durand, Nicolas; Carot-Sans, Gerard; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Rosell, Gloria; Maibeche-Coisne, Martine			Characterization of an Antennal Carboxylesterase from the Pest Moth Spodoptera littoralis Degrading a Host Plant Odorant	PLOS ONE			English	Article							PHEROMONE-BINDING PROTEIN; SEX-PHEROMONE; DETOXIFICATION ENZYMES; INSECTICIDE RESISTANCE; RECEPTOR NEURONS; ESTERASE CDNAS; CLONING; FEMALE; INACTIVATION; EXPRESSION	Background: Carboxyl/cholinesterases (CCEs) are highly diversified in insects. These enzymes have a broad range of proposed functions, in neuro/developmental processes, dietary detoxification, insecticide resistance or hormone/pheromone degradation. As few functional data are available on purified or recombinant CCEs, the physiological role of most of these enzymes is unknown. Concerning their role in olfaction, only two CCEs able to metabolize sex pheromones have been functionally characterized in insects. These enzymes are only expressed in the male antennae, and secreted into the lumen of the pheromone-sensitive sensilla. CCEs able to hydrolyze other odorants than sex pheromones, such as plant volatiles, have not been identified. Methodology: In Spodoptera littoralis, a major crop pest, a diversity of antennal CCEs has been previously identified. We have employed here a combination of molecular biology, biochemistry and electrophysiology approaches to functionally characterize an intracellular CCE, SlCXE10, whose predominant expression in the olfactory sensilla suggested a role in olfaction. A recombinant protein was produced using the baculovirus system and we tested its catabolic properties towards a plant volatile and the sex pheromone components. Conclusion: We showed that SlCXE10 could efficiently hydrolyze a green leaf volatile and to a lesser extent the sex pheromone components. The transcript level in male antennae was also strongly induced by exposure to this plant odorant. In antennae, SlCXE10 expression was associated with sensilla responding to the sex pheromones and to plant odours. These results suggest that a CCE-based intracellular metabolism of odorants could occur in insect antennae, in addition to the extracellular metabolism occurring within the sensillar lumen. This is the first functional characterization of an Odorant-Degrading Enzyme active towards a host plant volatile.	[Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Paris, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] INRA, Paris, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Versailles, France; [Durand, Nicolas; Chertemps, Thomas; Bozzolan, Francoise; Party, Virginie; Renou, Michel; Debernard, Stephane; Maibeche-Coisne, Martine] INRA, F-78026 Versailles, France; [Carot-Sans, Gerard] Inst Adv Chem Catalonia IQAC CSIC, Dept Biol Chem & Mol Modelling, Barcelona, Spain; [Rosell, Gloria] Univ Barcelona, Unit Med Chem, CSIC, Fac Pharm, Barcelona, Spain	INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; INRAE; UDICE-French Research Universities; Sorbonne Universite; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC); Consejo Superior de Investigaciones Cientificas (CSIC); University of Barcelona	Durand, N (corresponding author), Univ Paris 06, UMR 1272, UPMC INRA Physiol Insecte, Paris, France.	martine.maibeche@snv.jussieu.fr	Durand, Nicolas F./D-3035-2011; RENOU, Michel/AAT-7340-2021	Durand, Nicolas F./0000-0002-3613-2609; RENOU, Michel/0000-0001-6172-0210	Universite Pierre et Marie Curie (UPMC), INRA [ANR-07-NEURO-037-01]; Research Ministry	Universite Pierre et Marie Curie (UPMC), INRA; Research Ministry	This work was supported by Universite Pierre et Marie Curie (UPMC), INRA, ANR-07-NEURO-037-01 funding and a fellowship from the Research Ministry to N. Durand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON P, 1995, PHYSIOL ENTOMOL, V20, P189, DOI 10.1111/j.1365-3032.1995.tb00001.x; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Biswas S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009133; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Despres L, 2007, TRENDS ECOL EVOL, V22, P298, DOI 10.1016/j.tree.2007.02.010; Devonshire AL, 2007, INSECT BIOCHEM MOLEC, V37, P891, DOI 10.1016/j.ibmb.2007.04.011; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Feyereisen R, 1999, ANNU REV ENTOMOL, V44, P507, DOI 10.1146/annurev.ento.44.1.507; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; GYORGYI TK, 1988, P NATL ACAD SCI USA, V85, P9851, DOI 10.1073/pnas.85.24.9851; Hildebrand J.G., 1980, RECEPTORS NEUROTRANS, P261; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Ishida Y, 2002, INSECT BIOCHEM MOLEC, V32, P1775, DOI 10.1016/S0965-1748(02)00136-4; Ishida Y, 2008, P NATL ACAD SCI USA, V105, P9076, DOI 10.1073/pnas.0802610105; Jonsson M, 1999, PHYSIOL ENTOMOL, V24, P377, DOI 10.1046/j.1365-3032.1999.00154.x; Kamita SG, 2003, INSECT BIOCHEM MOLEC, V33, P1261, DOI 10.1016/j.ibmb.2003.08.004; Laue M, 2000, ARTHROPOD STRUCT DEV, V29, P57, DOI 10.1016/S1467-8039(00)00013-X; Lee SH, 2010, INSECT MOL BIOL, V19, P599, DOI 10.1111/j.1365-2583.2010.01024.x; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; Maibeche-Coisne M, 2004, CHEM SENSES, V29, P381, DOI 10.1093/chemse/bjh039; Marion-Poll F., 1995, J NEUROSCI METH, V63, P591, DOI [10.1016/0165-0270(95)00110-7, DOI 10.1016/0165-0270(95)00110-7]; Merlin C, 2007, INSECT MOL BIOL, V16, P73, DOI [10.1111/j.1365-2583.2006.00702.x, 10.1111/1365-2583.2006.00702.x]; Newcomb RD, 1997, P NATL ACAD SCI USA, V94, P7464, DOI 10.1073/pnas.94.14.7464; Oakeshott JG, 2010, INSECT MOL BIOL, V19, P147, DOI 10.1111/j.1365-2583.2009.00961.x; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Oakeshott JG, 1999, BIOESSAYS, V21, P1031; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Quero C, 2003, BIOORGAN MED CHEM, V11, P1047, DOI 10.1016/S0968-0896(02)00467-4; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Rogers ME, 1999, J EXP BIOL, V202, P1625; RYBCZYNSKI R, 1990, J BIOL CHEM, V265, P19712; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Small GJ, 2000, INSECT MOL BIOL, V9, P647, DOI 10.1046/j.1365-2583.2000.00229.x; Steinbrecht R.A., 1987, P353; STEINBRECHT RA, 1992, CELL TISSUE RES, V270, P287, DOI 10.1007/BF00328015; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Teese MG, 2010, INSECT BIOCHEM MOLEC, V40, P1, DOI 10.1016/j.ibmb.2009.12.002; Tsubota T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-377; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; VOGT RG, 1989, J NEUROSCI, V9, P3332; VOGT RG, 1985, P NATL ACAD SCI USA, V82, P8827, DOI 10.1073/pnas.82.24.8827; VOGT RG, 2005, COMPREHENSIVE INSECT, V3, P753, DOI DOI 10.1016/B0-44-451924-6/00047-8; Wojtasek H, 1999, FEBS LETT, V458, P333, DOI 10.1016/S0014-5793(99)01178-3; YU Q, 2009, BMC GENOMICS, V40, P100	46	68	75	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15026	10.1371/journal.pone.0015026	http://dx.doi.org/10.1371/journal.pone.0015026			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124773	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500018
J	Song, XM; Wang, Y; Zhu, Z; Li, CY				Song, Xue-Mei; Wang, Ye; Zhu, Zhao; Li, Chao-Yi			Morphological Bases of Suppressive and Facilitative Spatial Summation in the Striate Cortex of the Cat	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; CLASSICAL RECEPTIVE-FIELD; MACAQUE V1 NEURONS; DENDRITIC SPINES; CORTICAL-NEURONS; ORIENTATION SELECTIVITY; FUNCTIONAL ARCHITECTURE; HORIZONTAL CONNECTIONS; CONTEXTUAL MODULATION; INTEGRATION FIELD	In V1 of cats and monkeys, activity of neurons evoked by stimuli within the receptive field can be modulated by stimuli in the extra-receptive field (ERF). This modulating effect can be suppressive (S-ERF) or facilitatory (F-ERF) and plays different roles in visual information processing. Little is known about the cellular bases underlying the different types of ERF modulating effects. Here, we focus on the morphological differences between the S-ERF and F-ERF neurons. Single unit activities were recorded from V1 of the cat. The ERF properties of each neuron were assessed by area-response functions using sinusoidal grating stimuli. On completion of the functional tests, the cells were injected intracellularly with biocytin. The labeled cells were reconstructed and morphologically characterized in terms of the ERF modulation effects. We show that the vast majority of S-ERF neurons and F-ERF neurons are pyramidal cells and that the two types of cells clearly differ in the size of the soma, in complexity of dendrite branching, in spine size and density, and in the range of innervations of the axon collaterals. We propose that different pyramidal cell phenotypes reflect a high degree of specificity of neuronal connections associated with different types of spatial modulation.	[Song, Xue-Mei; Wang, Ye; Zhu, Zhao; Li, Chao-Yi] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Li, Chao-Yi] Univ Elect Sci & Technol China, Key Lab Neuroinformat, Minist Educ China, Chengdu 610054, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Ministry of Education, China; University of Electronic Science & Technology of China	Song, XM (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai, Peoples R China.	cyli@sibs.ac.cn	Song, Xue-Mei/O-5409-2014	Song, Xue-Mei/0000-0001-9062-5829; Wang, Ye/0000-0001-9131-9014	Major State Basic Research Program [2007CB311001]; Natural Science Foundations of China [90820301, 60835005]; Shanghai Municipal Committee of Science and Technology [088014158, 098014026]	Major State Basic Research Program(National Basic Research Program of China); Natural Science Foundations of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Committee of Science and Technology(Shanghai Science & Technology Committee)	This work was supported by the Major State Basic Research Program (2007CB311001 to CYL), the Natural Science Foundations of China (90820301 and 60835005 to CYL), and Shanghai Municipal Committee of Science and Technology (088014158 and 098014026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaki T, 2002, NEUROSCI RES, V43, P207, DOI 10.1016/S0168-0102(02)00038-X; ALBRIGHT TD, 1992, SCIENCE, V255, P1141, DOI 10.1126/science.1546317; ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; Angelucci A, 2002, J NEUROSCI, V22, P8633; Arellano JI, 2007, FRONT NEUROSCI-SWITZ, V1, P131, DOI 10.3389/neuro.01.1.1.010.2007; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Chen G, 2005, J PHYSIOL-LONDON, V564, P233, DOI 10.1113/jphysiol.2004.080051; Chisum HJ, 2003, J NEUROSCI, V23, P2947; COLONNIER MARC, 1968, BRAIN RES, V9, P268, DOI 10.1016/0006-8993(68)90234-5; Das A, 1999, NATURE, V399, P655, DOI 10.1038/21371; DEANGELIS GC, 1992, J NEUROPHYSIOL, V68, P144, DOI 10.1152/jn.1992.68.1.144; DEANGELIS GC, 1994, J NEUROPHYSIOL, V71, P347, DOI 10.1152/jn.1994.71.1.347; DEHAY C, 1991, J PHYSIOL-LONDON, V440, P723, DOI 10.1113/jphysiol.1991.sp018732; DOBBINS A, 1987, NATURE, V329, P438, DOI 10.1038/329438a0; Dorph-Petersen KA, 2001, J MICROSC-OXFORD, V204, P232, DOI 10.1046/j.1365-2818.2001.00958.x; Duan H, 2002, NEUROSCIENCE, V114, P349, DOI 10.1016/S0306-4522(02)00305-6; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GILBERT CD, 1992, NEURON, V9, P1, DOI 10.1016/0896-6273(92)90215-Y; Gilbert CD, 1996, P NATL ACAD SCI USA, V93, P615, DOI 10.1073/pnas.93.2.615; GILBERT CD, 1990, VISION RES, V30, P1689, DOI 10.1016/0042-6989(90)90153-C; HARRIS KM, 1989, J NEUROSCI, V9, P2982; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; HORIKAWA K, 1988, J NEUROSCI METH, V25, P1, DOI 10.1016/0165-0270(88)90114-8; HUBEL DH, 1965, J NEUROPHYSIOL, V28, P1041, DOI 10.1152/jn.1965.28.6.1041; Jones HE, 2002, J NEUROPHYSIOL, V88, P2796, DOI 10.1152/jn.00403.2001; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Jones HE, 2000, EXP BRAIN RES, V135, P279, DOI 10.1007/s002210000574; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KNIERIM JJ, 1992, J NEUROPHYSIOL, V67, P961, DOI 10.1152/jn.1992.67.4.961; KOCH C, 1993, J NEUROSCI, V13, P413; LAMME VAF, 1995, J NEUROSCI, V15, P1605; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Levitt JB, 1997, NATURE, V387, P73, DOI 10.1038/387073a0; Li CY, 1996, NEWS PHYSIOL SCI, V11, P181; LI CY, 1994, VISION RES, V34, P2337, DOI 10.1016/0042-6989(94)90280-1; Li CY, 1999, P NATL ACAD SCI USA, V96, P4052, DOI 10.1073/pnas.96.7.4052; MAFFEI L, 1976, VISION RES, V16, P1131, DOI 10.1016/0042-6989(76)90253-4; MALACH R, 1993, P NATL ACAD SCI USA, V90, P10469, DOI 10.1073/pnas.90.22.10469; Matsubara JA, 1996, J COMP NEUROL, V366, P93; MCGUIRE BA, 1991, J COMP NEUROL, V305, P370, DOI 10.1002/cne.903050303; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Nusser Z, 1998, NEURON, V21, P545, DOI 10.1016/S0896-6273(00)80565-6; Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781; Rossi AF, 2001, J NEUROSCI, V21, P1698, DOI 10.1523/JNEUROSCI.21-05-01698.2001; SARY G, 1993, SCIENCE, V260, P995, DOI 10.1126/science.8493538; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; Sengpiel F, 1997, EXP BRAIN RES, V116, P216, DOI 10.1007/PL00005751; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Shen ZM, 2007, J PHYSIOL-LONDON, V583, P581, DOI 10.1113/jphysiol.2007.130294; SHOLL DA, 1953, J ANAT, V87, P387; Shushruth S, 2009, J NEUROPHYSIOL, V102, P2069, DOI 10.1152/jn.00512.2009; SILLITO AM, 1995, NATURE, V378, P492, DOI 10.1038/378492a0; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; Stettler DD, 2002, NEURON, V36, P739, DOI 10.1016/S0896-6273(02)01029-2; TSO DY, 1986, J NEUROSCI, V6, P1160; VONDERHEYDT R, 1989, J NEUROSCI, V9, P1731; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Xu WF, 2005, CEREB CORTEX, V15, P1697, DOI 10.1093/cercor/bhi046; Yao HS, 2002, NEURON, V35, P547, DOI 10.1016/S0896-6273(02)00782-1; Zhu Z, 2002, CEREB CORTEX, V12, P585, DOI 10.1093/cercor/12.6.585; Zipser K, 1996, J NEUROSCI, V16, P7376	66	4	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15025	10.1371/journal.pone.0015025	http://dx.doi.org/10.1371/journal.pone.0015025			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21151335	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500017
J	Del Bianco, C; Vedenko, A; Choi, SH; Berger, MF; Shokri, L; Bulyk, ML; Blacklow, SC				Del Bianco, Cristina; Vedenko, Anastasia; Choi, Sung Hee; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.; Blacklow, Stephen C.			Notch and MAML-1 Complexation Do Not Detectably Alter the DNA Binding Specificity of the Transcription Factor CSL	PLOS ONE			English	Article							C. ELEGANS; IN-VITRO; MICROARRAYS; MASTERMIND; SEQUENCE; COACTIVATOR; RECOGNITION; ACTIVATION; REPRESSOR; NETWORK	Background: Canonical Notch signaling is initiated when ligand binding induces proteolytic release of the intracellular part of Notch (ICN) from the cell membrane. ICN then travels into the nucleus where it drives the assembly of a transcriptional activation complex containing the DNA-binding transcription factor CSL, ICN, and a specialized co-activator of the Mastermind family. A consensus DNA binding site motif for the CSL protein was previously defined using selection-based methods, but whether subsequent association of Notch and Mastermind-like proteins affects the DNA binding preferences of CSL has not previously been examined. Principal Findings: Here, we utilized protein-binding microarrays (PBMs) to compare the binding site preferences of isolated CSL with the preferred binding sites of CSL when bound to the CSL-binding domains of all four different human Notch receptors. Measurements were taken both in the absence and in the presence of Mastermind-like-1 (MAML1). Our data show no detectable difference in the DNA binding site preferences of CSL before and after loading of Notch and MAML1 proteins. Conclusions/Significance: These findings support the conclusion that accrual of Notch and MAML1 promote transcriptional activation without dramatically altering the preferred sites of DNA binding, and illustrate the potential of PBMs to analyze the binding site preferences of multiprotein-DNA complexes.	[Del Bianco, Cristina; Choi, Sung Hee; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Del Bianco, Cristina; Choi, Sung Hee; Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Vedenko, Anastasia; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Vedenko, Anastasia; Berger, Michael F.; Shokri, Leila; Bulyk, Martha L.; Blacklow, Stephen C.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Berger, Michael F.; Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; [Bulyk, Martha L.; Blacklow, Stephen C.] Harvard Univ, Sch Med, Div Hlth Sci & Technol, Boston, MA USA; [Blacklow, Stephen C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Del Bianco, C (corresponding author), Univ Trent, Cibio Ctr Interdipartimentale Biol Integrata, Trento, Italy.	mlbulyk@receptor.med.harvard.edu; sblacklow@partners.org	Del Bianco, Cristina/J-4665-2012		National Institutes of Health/National Human Genome Research Institute [R01 HG003985, R01 CA092433]; NATIONAL CANCER INSTITUTE [R01CA092433] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003985] Funding Source: NIH RePORTER	National Institutes of Health/National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by grant # R01 HG003985 from National Institutes of Health/National Human Genome Research Institute to M. L. B. and grant # R01 CA092433 to S. C. B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALIBES A, 2010, NUCL ACIDS IN PRESS; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berger Michael F., 2006, V338, P245; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berger MF, 2009, NAT PROTOC, V4, P393, DOI 10.1038/nprot.2008.195; Bulyk ML, 2001, P NATL ACAD SCI USA, V98, P7158, DOI 10.1073/pnas.111163698; Bulyk ML, 1999, NAT BIOTECHNOL, V17, P573, DOI 10.1038/9878; Del Bianco C, 2008, J MOL BIOL, V376, P131, DOI 10.1016/j.jmb.2007.11.061; DOU SB, 1994, MOL CELL BIOL, V14, P3310, DOI 10.1128/MCB.14.5.3310; Dudley AM, 2002, P NATL ACAD SCI USA, V99, P7554, DOI 10.1073/pnas.112683499; Friedmann DR, 2010, PROTEIN SCI, V19, P34, DOI 10.1002/pro.280; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Grove CA, 2009, CELL, V138, P314, DOI 10.1016/j.cell.2009.04.058; Kao HY, 1998, GENE DEV, V12, P2269, DOI 10.1101/gad.12.15.2269; Krejci A, 2007, GENE DEV, V21, P1322, DOI 10.1101/gad.424607; Krejci A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000140; Lesch BJ, 2009, GENE DEV, V23, P345, DOI 10.1101/gad.1763509; Liefke R, 2010, GENE DEV, V24, P590, DOI 10.1101/gad.563210; Mukherjee S, 2004, NAT GENET, V36, P1331, DOI 10.1038/ng1473; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Oswald F, 2001, MOL CELL BIOL, V21, P7761, DOI 10.1128/MCB.21.22.7761-7774.2001; Petcherski AG, 2000, NATURE, V405, P364, DOI 10.1038/35012645; Petcherski AG, 2000, CURR BIOL, V10, pR471, DOI 10.1016/S0960-9822(00)00577-7; Scharer CD, 2009, CANCER RES, V69, P709, DOI 10.1158/0008-5472.CAN-08-3415; TUN T, 1994, NUCLEIC ACIDS RES, V22, P965, DOI 10.1093/nar/22.6.965; Wallberg AE, 2002, MOL CELL BIOL, V22, P7812, DOI 10.1128/MCB.22.22.7812-7819.2002; Wei GH, 2010, EMBO J, V29, P2147, DOI 10.1038/emboj.2010.106; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108	31	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15034	10.1371/journal.pone.0015034	http://dx.doi.org/10.1371/journal.pone.0015034			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124806	Green Submitted, gold, Green Published			2022-12-27	WOS:000284572000021
J	Oida, T; Weiner, HL				Oida, Takatoku; Weiner, Howard L.			TGF-beta Induces Surface LAP Expression on Murine CD4 T Cells Independent of Foxp3 Induction	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; LATENCY-ASSOCIATED PEPTIDE; RECEPTOR; GENE; BINDING; MICE; GARP	Background: It has been reported that human FOXP3(+) CD4 Tregs express GARP-anchored surface latency-associated peptide (LAP) after activation, based on the use of an anti-human LAP mAb. Murine CD4 Foxp3(+) Tregs have also been reported to express surface LAP, but these studies have been hampered by the lack of suitable anti-mouse LAP mAbs. Methodology/Principal Findings: We generated anti-mouse LAP mAbs by immunizing TGF-beta(-/-) animals with a mouse Tgfb1-transduced P3U1 cell line. Using these antibodies, we demonstrated that murine Foxp3(+) CD4 Tregs express LAP on their surface. In addition, retroviral transduction of Foxp3 into mouse CD4(+)CD25(-) T cells induced surface LAP expression. We then examined surface LAP expression after treating CD4(+)CD25(-) T cells with TGF-beta and found that TGF-beta induced surface LAP not only on T cells that became Foxp3(+) but also on T cells that remained Foxp3(-) after TGF-beta treatment. GARP expression correlated with the surface LAP expression, suggesting that surface LAP is GARP-anchored also in murine T cells. Conclusions/Significance: Unlike human CD4 T cells, surface LAP expression on mouse CD4 T cells is controlled by Foxp3 and TGF-beta. Our newly described anti-mouse LAP mAbs will provide a useful tool for the investigation and functional analysis of T cells that express LAP on their surface.	[Oida, Takatoku; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Oida, T (corresponding author), BioLegend Inc, San Diego, CA USA.	hweiner@rics.bwh.harvard.edu			National Institutes of Health [AI435801, NS38037]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS038037] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health Grants AI435801 and NS38037. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; CHRIST M, 1994, J IMMUNOL, V153, P1936; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Docagne F, 2001, J BIOL CHEM, V276, P46243, DOI 10.1074/jbc.M010915200; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; KULKARNI AB, 1993, P NATL ACAD SCI USA, V90, P770, DOI 10.1073/pnas.90.2.770; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MIYAZONO K, 1993, GROWTH FACTORS, V8, P11, DOI 10.3109/08977199309029130; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Ochi H, 2006, NAT MED, V12, P627, DOI 10.1038/nm1408; Oida T, 2003, J IMMUNOL, V170, P2516, DOI 10.4049/jimmunol.170.5.2516; Oida T, 2010, J IMMUNOL, V185, P3529, DOI 10.4049/jimmunol.0904121; Piccirillo CA, 2002, J EXP MED, V196, P237, DOI 10.1084/jem.20020590; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Stockis J, 2009, EUR J IMMUNOL, V39, P3315, DOI 10.1002/eji.200939684; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Tran DQ, 2009, BLOOD, V113, P5125, DOI 10.1182/blood-2009-01-199950; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	20	50	58	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15523	10.1371/journal.pone.0015523	http://dx.doi.org/10.1371/journal.pone.0015523			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124798	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000036
J	Hall, C; Welch, J; Kowbel, DJ; Glass, NL				Hall, Charles; Welch, Juliet; Kowbel, David J.; Glass, N. Louise			Evolution and Diversity of a Fungal Self/Nonself Recognition Locus	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; HETEROKARYON INCOMPATIBILITY LOCUS; HET-C LOCUS; VEGETATIVE INCOMPATIBILITY; NONSELF RECOGNITION; NEUROSPORA-CRASSA; BALANCING SELECTION; VIRUS TRANSMISSION; PODOSPORA-ANSERINA; ALLELIC DIVERSITY	Background: Self/nonself discrimination is an essential feature for pathogen recognition and graft rejection and is a ubiquitous phenomenon in many organisms. Filamentous fungi, such as Neurospora crassa, provide a model for analyses of population genetics/evolution of self/nonself recognition loci due to their haploid nature, small genomes and excellent genetic/genomic resources. In N. crassa, nonself discrimination during vegetative growth is determined by 11 heterokaryon incompatibility (het) loci. Cell fusion between strains that differ in allelic specificity at any of these het loci triggers a rapid programmed cell death response. Methodology/Principal Findings: In this study, we evaluated the evolution, population genetics and selective mechanisms operating at a nonself recognition complex consisting of two closely linked loci, het-c (NCU03493) and pin-c (NCU03494). The genomic position of pin-c next to het-c is unique to Neurospora/Sordaria species, and originated by gene duplication after divergence from other species within the Sordariaceae. The het-c pin-c alleles in N. crassa are in severe linkage disequilibrium and consist of three haplotypes, het-c1/pin-c1, het-c2/pin-c2 and het-c3/pin-c3, which are equally frequent in population samples and exhibit trans-species polymorphisms. The absence of recombinant haplotypes is correlated with divergence of the het-c/pin-c intergenic sequence. Tests for positive and balancing selection at het-c and pin-c support the conclusion that both of these loci are under non-neutral balancing selection; other regions of both genes appear to be under positive selection. Our data show that the het-c2/pin-c2 haplotype emerged by a recombination event between the het-c1/pin-c1 and het-c3/pin-c3 approximately 3-12 million years ago. Conclusions/Significance: These results support models by which loci that confer nonself discrimination form by the association of polymorphic genes with genes containing HET domains. Distinct allele classes can emerge by recombination and positive selection and are subsequently maintained by balancing selection and divergence of intergenic sequence resulting in recombination blocks between haplotypes.	[Hall, Charles; Welch, Juliet; Kowbel, David J.; Glass, N. Louise] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hall, C (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.	Lglass@berkeley.edu	Glass, N. Louise/ABA-7303-2021		National Institutes of Health [GM60468, GM081597]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM081597, R01GM060468] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this work is supported by an R01 grant from the National Institutes of Health to N.L.G. (GM60468) and a collaborative R24 grant from the National Institutes of Health to Drs. John W. Taylor, Rachel Brem (UCB) and N.L.G. (GM081597). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; AKAIKE H, 1974, IEEE T AUTOMATIC CON, V19; ANWAR MM, 1993, J GEN MICROBIOL, V139, P1599, DOI 10.1099/00221287-139-7-1599; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biella S, 2002, P ROY SOC B-BIOL SCI, V269, P2269, DOI 10.1098/rspb.2002.2148; Browne KA, 2002, J AM CHEM SOC, V124, P7950, DOI 10.1021/ja017746x; CAMBARERI EB, 1993, FUNGAL GENET NEWSL, V40, P22; CHARLESWORTH D, 1995, BIOESSAYS, V17, P31, DOI 10.1002/bies.950170108; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Chevanne D, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-134; Chevanne D, 2009, CURR GENET, V55, P93, DOI 10.1007/s00294-008-0227-5; Cortesi P, 1998, APPL ENVIRON MICROB, V64, P2988; Cortesi P, 2001, GENETICS, V159, P107; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Debets AJM, 1998, MYCOL RES, V102, P1343, DOI 10.1017/S095375629800639X; DEBETS F, 1994, CURR GENET, V26, P113, DOI 10.1007/BF00313797; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; Dishaw LJ, 2009, CURR BIOL, V19, pR286, DOI 10.1016/j.cub.2009.02.035; DOBZHANSKY T, 1948, P NATL ACAD SCI USA, V34, P137, DOI 10.1073/pnas.34.4.137; Edh K, 2009, GENETICS, V181, P977, DOI 10.1534/genetics.108.090837; Espagne E, 2002, GENETICS, V161, P71; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Fedorova ND, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000046; Fedorova ND, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-177; FIGUEROA F, 1988, NATURE, V335, P265, DOI 10.1038/335265a0; FISHER R, 1961, J THEOR BIOL, V4, P411; Fleissner A, 2009, P NATL ACAD SCI USA, V106, P19393, DOI 10.1073/pnas.0907039106; GAFF DF, 1971, J EXP BOT, V22, P756, DOI 10.1093/jxb/22.3.756; Galagan JE, 2004, TRENDS GENET, V20, P417, DOI 10.1016/j.tig.2004.07.007; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Glass NL, 2006, CURR OPIN MICROBIOL, V9, P553, DOI 10.1016/j.mib.2006.09.001; Glass NL, 2003, EUKARYOT CELL, V2, P1, DOI 10.1128/EC.2.1.1-8.2003; GOLDMAN N, 1994, MOL BIOL EVOL, V11, P725; Grosberg RK, 2000, SCIENCE, V289, P2111, DOI 10.1126/science.289.5487.2111; HASEGAWA M, 1991, J MOL EVOL, V32, P443, DOI 10.1007/BF02101285; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOWLETT BJ, 1993, FUNGAL GENET NEWSL, V40, P40; Hutchison E, 2009, MICROBIOL-SGM, V155, P3957, DOI 10.1099/mic.0.032284-0; Jacobson DJ, 1998, FUNGAL GENET BIOL, V23, P45, DOI 10.1006/fgbi.1997.1020; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; Kamau E, 2005, CURR BIOL, V15, P1773, DOI 10.1016/j.cub.2005.08.062; Kaneko I, 2006, GENETICS, V172, P1545, DOI 10.1534/genetics.105.051490; Kerenyi Z, 2006, APPL ENVIRON MICROB, V72, P6527, DOI 10.1128/AEM.01543-06; Kusaba M, 1997, P NATL ACAD SCI USA, V94, P7673, DOI 10.1073/pnas.94.14.7673; LANGLEY CH, 1974, J MOL EVOL, V3, P161, DOI 10.1007/BF01797451; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Marek SM, 2003, FUNGAL GENET BIOL, V40, P126, DOI 10.1016/S1087-1845(03)00086-0; Menkis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000030; Metzenberg RL., 2004, FUNGAL GENET REP, V51, P19, DOI [10.4148/1941-4765.1138, DOI 10.4148/1941-4765.1138]; Micali CO, 2006, GENETICS, V173, P1991, DOI 10.1534/genetics.106.057562; Mir-Rashed N, 2000, FUNGAL GENET BIOL, V30, P197, DOI 10.1006/fgbi.2000.1218; Muirhead CA, 2002, GENETICS, V161, P633; Nasrallah JB, 2002, SCIENCE, V296, P305, DOI 10.1126/science.296.5566.305; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; NEWHOUSE JR, 1991, CAN J BOT, V69, P602, DOI 10.1139/b91-082; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nowrousian M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000891; Pal K, 2007, STUD MYCOL, P19, DOI 10.3114/sim.2007.59.03; Paoletti M, 2007, EUKARYOT CELL, V6, P2001, DOI 10.1128/EC.00129-07; Paoletti M, 2009, BIOESSAYS, V31, P1201, DOI 10.1002/bies.200900085; Pel HJ, 2007, NAT BIOTECHNOL, V25, P221, DOI 10.1038/nbt1282; PERKINS DD, 1976, EVOLUTION, V30, P281, DOI 10.1111/j.1558-5646.1976.tb00910.x; Perkins DD, 1988, FUNGAL GENET NEWSL, V35, P44, DOI DOI 10.4148/1941-4765.1546; Pond SLK, 2006, BIOINFORMATICS, V22, P3096, DOI 10.1093/bioinformatics/btl474; Pond SLK, 2005, BIOINFORMATICS, V21, P2531, DOI 10.1093/bioinformatics/bti320; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Powell AJ, 2001, J MOL EVOL, V52, P94, DOI 10.1007/s002390010138; Powell AJ, 2007, FUNGAL GENET BIOL, V44, P896, DOI 10.1016/j.fgb.2007.04.010; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sarkar S, 2002, EMBO J, V21, P4841, DOI 10.1093/emboj/cdf479; SAUPE S, 1995, CURR GENET, V27, P466, DOI 10.1007/BF00311217; Saupe SJ, 2000, MICROBIOL MOL BIOL R, V64, P489, DOI 10.1128/MMBR.64.3.489-502.2000; Saupe SJ, 1997, GENETICS, V146, P1299; Saupe SJ, 2000, CURR GENET, V38, P39, DOI 10.1007/s002940000130; Saupe SJ, 1996, GENETICS, V143, P1589; Shiu PKT, 1999, GENETICS, V151, P545; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Swofford D.L., 1999, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Takuno S, 2007, GENETICS, V177, P949, DOI 10.1534/genetics.107.073825; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tavare S., 1986, SOME PROBABILISTIC S; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Van Diepeningen AD, 2009, MYCOL RES, V113, P222, DOI 10.1016/j.mycres.2008.10.003; Vogel H.J., 1956, MICROBIAL GENET B, V13, P42; Wang X, 2001, PLANT PHYSIOL, V125, P1012, DOI 10.1104/pp.125.2.1012; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wu J, 1998, P NATL ACAD SCI USA, V95, P12398, DOI 10.1073/pnas.95.21.12398; Wu J, 2001, MOL CELL BIOL, V21, P1045, DOI 10.1128/MCB.21.4.1045-1057.2001	91	38	39	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14055	10.1371/journal.pone.0014055	http://dx.doi.org/10.1371/journal.pone.0014055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124910	Green Published, Green Submitted, gold			2022-12-27	WOS:000284400100007
J	Dogruman-Al, F; Simsek, Z; Boorom, K; Ekici, E; Sahin, M; Tuncer, C; Kustimur, S; Altinbas, A				Dogruman-Al, Funda; Simsek, Zahide; Boorom, Kenneth; Ekici, Eyup; Sahin, Memduh; Tuncer, Candan; Kustimur, Semra; Altinbas, Akif			Comparison of Methods for Detection of Blastocystis Infection in Routinely Submitted Stool Samples, and also in IBS/IBD Patients in Ankara, Turkey	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; SERINE-PROTEASE ACTIVITY; NECROSIS-FACTOR-ALPHA; INTESTINAL PROTOZOA; ENTAMOEBA-HISTOLYTICA; MICROSCOPIC DIAGNOSIS; CLINICAL-SIGNIFICANCE; HOMINIS INFECTION; PREVALENCE; DISEASE	Background: This study compared diagnostic methods for identifying Blastocystis in stool samples, and evaluated the frequency of detection of Blastocystis in patients with irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD). Results and Discussion: From a set of 105 stool specimens submitted for routine parasitological analysis, 30 were identified as positive for Blastocystis by the culture method. From that group of 30 positives, Lugol's stain, trichrome staining, and an immunofluorescence assay identified 11, 15, and 26 samples as positive respectively. Using culture as a standard, the sensitivity of Lugol's stain was 36.7%, trichrome staining was 50%, and the IFA stain was 86.7%. The specificity of Lugol's stain was 91%, trichrome staining was 100%, and the IFA stain was 97.3%. In the group of 27 IBS and IBD patients, using all methods combined, we detected Blastocystis in 67% (18/27) of the patients. Blastocystis was detected in 33% (2/6) of IBD patients and 76% (16/21) of IBS patients. For comparison, trichrome staining alone, the method most frequently used in many countries, would have only identified Blastocystis infection in 29% (6/21) of the IBS patients. No parasitic co-infections were identified in the IBS/IBD patients. Most Blastocystis-positive IBS/IBD patients were over 36 with an average length of illness of 4.9 years. Conclusions: Most IBS patients in this study were infected with Blastocystis. IFA staining may be a useful alternative to stool culture, especially if stool specimens have been chemically preserved.	[Dogruman-Al, Funda; Kustimur, Semra] Gazi Univ, Sch Med, Dept Med Microbiol, Ankara, Turkey; [Simsek, Zahide; Altinbas, Akif] Yildirim Beyazit Educ & Res Hosp, Dept Gastroenterol, Ankara, Turkey; [Boorom, Kenneth] Blastocystis Res Fdn, Corvallis, OR USA; [Ekici, Eyup; Sahin, Memduh; Tuncer, Candan] Gazi Univ, Sch Med, Dept Internal Med, Gastroenterol Sect, Ankara, Turkey	Gazi University; Diskapi Yildirim Beyazit Training & Research Hospital; Gazi University	Dogruman-Al, F (corresponding author), Gazi Univ, Sch Med, Dept Med Microbiol, Ankara, Turkey.	kboorom@bhomcenter.org	simsek, zahide/ABH-8874-2020					Al Funda Dogruman, 2009, Turkiye Parazitoloji Dergisi, V33, P136; ALLES AJ, 1995, J CLIN MICROBIOL, V33, P1632, DOI 10.1128/JCM.33.6.1632-1634.1995; ALTAWIL YS, 1994, ARCH PEDIAT ADOL MED, V148, P882, DOI 10.1001/archpedi.1994.02170080112026; AMIN O, 2005, RES J PARASITOLOGY, V2006, P1; Amin OM, 2002, AM J TROP MED HYG, V66, P799, DOI 10.4269/ajtmh.2002.66.799; Blessmann J, 2002, J CLIN MICROBIOL, V40, P4413, DOI 10.1128/JCM.40.12.4413-4417.2002; Bogoch II, 2006, EUR J CLIN MICROBIOL, V25, P344, DOI 10.1007/s10096-006-0135-x; Boorom KF, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-40; Cenac N, 2007, J CLIN INVEST, V117, P636, DOI 10.1172/JCI29255; Dogruman-Al F, 2009, MEM I OSWALDO CRUZ, V104, P724, DOI 10.1590/S0074-02762009000500011; DOYLE PW, 1990, J CLIN MICROBIOL, V28, P116, DOI 10.1128/JCM.28.1.116-121.1990; Elwakil HS, 2010, PARASITOL RES, V107, P685, DOI 10.1007/s00436-010-1922-y; EVERHART JE, 1991, GASTROENTEROLOGY, V100, P998, DOI 10.1016/0016-5085(91)90275-P; Franchimont D, 2004, GUT, V53, P987, DOI 10.1136/gut.2003.030205; Frolova L, 2008, J HISTOCHEM CYTOCHEM, V56, P267, DOI 10.1369/jhc.7A7303.2007; GARCIA LS, 1992, J CLIN MICROBIOL, V30, P3255, DOI 10.1128/JCM.30.12.3255-3257.1992; Garcia LS, 2000, J CLIN MICROBIOL, V38, P3337, DOI 10.1128/JCM.38.9.3337-3340.2000; Gecse K, 2008, GUT, V57, P591, DOI 10.1136/gut.2007.140210; Giacometti A, 1999, EUR J CLIN MICROBIOL, V18, P436, DOI 10.1007/s100960050314; Guo X, 2008, MUCOSAL IMMUNOL, V1, P139, DOI 10.1038/mi.2007.18; Hussein EM, 2009, PARASITOL RES, V105, P1053, DOI 10.1007/s00436-009-1515-9; Jones MS, 2009, PARASITOL RES, V104, P341, DOI 10.1007/s00436-008-1198-7; Kamda JD, 2009, INFECT IMMUN, V77, P685, DOI 10.1128/IAI.00718-08; Langhorst J, 2009, AM J GASTROENTEROL, V104, P404, DOI 10.1038/ajg.2008.86; Leelayoova S, 2002, ANN TROP MED PARASIT, V96, P803, DOI 10.1179/000349802125002275; MARKELL EK, 1986, AM J TROP MED HYG, V35, P1023, DOI 10.4269/ajtmh.1986.35.1023; Marshall JK, 2006, GASTROENTEROLOGY, V131, P445, DOI 10.1053/j.gastro.2006.05.053; MCMAHON LA, 2009, VET IMMUNOL IMMUNOPA; Moe KT, 1997, PARASITOL RES, V83, P319, DOI 10.1007/s004360050256; NAGLER J, 1993, J CLIN GASTROENTEROL, V16, P109, DOI 10.1097/00004836-199303000-00006; NIMRI LF, 1993, J CLIN MICROBIOL, V31, P2706, DOI 10.1128/JCM.31.10.2706-2708.1993; Parkar U, 2007, PARASITOLOGY, V134, P359, DOI 10.1017/S0031182006001582; Parkar U, 2010, VET PARASITOL, V169, P8, DOI 10.1016/j.vetpar.2009.12.032; Penrose AS, 2007, WORLD J GASTROENTERO, V13, P4574, DOI 10.3748/wjg.v13.i34.4574; QADRI SMH, 1989, J CLIN MICROBIOL, V27, P2407, DOI 10.1128/JCM.27.11.2407-2409.1989; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Seguin R, 1995, P NATL ACAD SCI USA, V92, P12175, DOI 10.1073/pnas.92.26.12175; Sostek MB, 1996, AM J GASTROENTEROL, V91, P2494; SOUPPART L, 2009, PARASITOL RES; Stark D, 2007, INT J PARASITOL, V37, P11, DOI 10.1016/j.ijpara.2006.09.009; Stensvold CR, 2007, DIAGN MICR INFEC DIS, V59, P303, DOI 10.1016/j.diagmicrobio.2007.06.003; Stensvold CR, 2009, TRENDS PARASITOL, V25, P23, DOI 10.1016/j.pt.2008.09.010; Stensvold CR, 2010, J CLIN GASTROENTEROL, V44, P85, DOI 10.1097/MCG.0b013e3181bb86ba; SU C, 2006, SLEISENGER FORDTRANS, P2499; Suresh K, 2004, EUR J CLIN MICROBIOL, V23, P509, DOI 10.1007/s10096-004-1123-7; Talley NJ, 2006, INTERN MED J, V36, P724, DOI 10.1111/j.1445-5994.2006.01217.x; Thabane M, 2010, AM J GASTROENTEROL, V105, P933, DOI 10.1038/ajg.2010.74; Tuteja AK, 2008, DIGEST DIS SCI, V53, P271, DOI 10.1007/s10620-007-9853-x; Utzinger J, 2010, CLIN MICROBIOL INFEC, V16, P267, DOI 10.1111/j.1469-0691.2009.02782.x; van der Veek PPJ, 2005, AM J GASTROENTEROL, V100, P2510, DOI 10.1111/j.1572-0241.2005.00257.x; WHEATLEY WB, 1951, AM J CLIN PATHOL, V21, P990, DOI 10.1093/ajcp/21.10_ts.990; Wilson S, 2004, BRIT J GEN PRACT, V54, P495; Windsor JJ, 2005, AM J TROP MED HYG, V72, P501, DOI 10.4269/ajtmh.2005.72.5.0720501; Windsor JJ, 2002, BRIT J BIOMED SCI, V59, P154, DOI 10.1080/09674845.2002.11783653; Windsor JJ, 2001, BRIT J BIOMED SCI, V58, P129; WINDSOR JJ, 2007, BIOMEDICAL SCI, P524; Wong-Baeza I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/254521; Yakoob J, 2004, AM J TROP MED HYG, V70, P383, DOI 10.4269/ajtmh.2004.70.383; Yakoob J, 2010, PARASITOL RES, V107, P679, DOI 10.1007/s00436-010-1918-7; Yakoob J, 2010, PARASITOL RES, V106, P1033, DOI 10.1007/s00436-010-1761-x; Yamamoto-Furusho JK, 2010, DIGESTION, V82, P18, DOI 10.1159/000273871; Youn S, 2009, J CLIN MICROBIOL, V47, P451, DOI 10.1128/JCM.01736-08; Zhou XB, 2010, PARASITOL RES, V106, P1315, DOI 10.1007/s00436-010-1801-6; ZIERDT CH, 1991, CLIN MICROBIOL REV, V4, P61, DOI 10.1128/CMR.4.1.61-79.1991	64	61	74	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e15484	10.1371/journal.pone.0015484	http://dx.doi.org/10.1371/journal.pone.0015484			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124983	Green Submitted, Green Published, gold			2022-12-27	WOS:000284356900018
J	Neumuller, KG; Elsayad, K; Reisecker, JM; Waxham, MN; Heinze, KG				Neumueller, Klaus G.; Elsayad, Kareem; Reisecker, Johannes M.; Waxham, M. Neal; Heinze, Katrin G.			Photounbinding of Calmodulin from a Family of CaM Binding Peptides	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIGHT; MECHANISM; PROTEINS; DYNAMICS; DYES	Background: Recent studies have shown that fluorescently labeled antibodies can be dissociated from their antigen by illumination with laser light. The mechanism responsible for the photounbinding effect, however, remains elusive. Here, we give important insights into the mechanism of photounbinding and show that the effect is not restricted to antibody/antigen binding. Methodology/Principal Findings: We present studies of the photounbinding of labeled calmodulin (CaM) from a set of CaM-binding peptides with different affinities to CaM after one- and two-photon excitation. We found that the photounbinding effect becomes stronger with increasing binding affinity. Our observation that photounbinding can be influenced by using free radical scavengers, that it does not occur with either unlabeled protein or non-fluorescent quencher dyes, and that it becomes evident shortly after or with photobleaching suggest that photounbinding and photobleaching are closely linked. Conclusions/Significance: The experimental results exclude surface effects, or heating by laser irradiation as potential causes of photounbinding. Our data suggest that free radicals formed through photobleaching may cause a conformational change of the CaM which lowers their binding affinity with the peptide or its respective binding partner.	[Neumueller, Klaus G.; Elsayad, Kareem; Reisecker, Johannes M.; Heinze, Katrin G.] Res Inst Mol Pathol, Dept Opt Engn, A-1030 Vienna, Austria; [Waxham, M. Neal] Univ Texas Hlth Sci Ctr, Dept Neurobiol & Anat, Houston, TX USA	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); University of Texas System; University of Texas Health Science Center Houston	Neumuller, KG (corresponding author), DSM Biotechnol Ctr, Dept Appl Biochem, Delft, Netherlands.	katrin.heinze@imp.ac.at		Elsayad, Kareem/0000-0003-1642-2905; Waxham, M. Neal/0000-0003-4801-1190	Research Institute of Molecular Pathology, Vienna, Austria; Austrian Science Fund (FWF); NIH/NINDS [R01-NS026086]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS026086] Funding Source: NIH RePORTER	Research Institute of Molecular Pathology, Vienna, Austria; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Research was funded by the Research Institute of Molecular Pathology, Vienna, Austria and the Austrian Science Fund (FWF). MNW would like to acknowledge financial support from the NIH/NINDS, grant #R01-NS026086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; BarcellosHoff MH, 1996, MOL ENDOCRINOL, V10, P1077, DOI 10.1210/me.10.9.1077; BARDEN JA, 1987, EUR J BIOCHEM, V162, P583, DOI 10.1111/j.1432-1033.1987.tb10679.x; Beutler M, 2008, EUR BIOPHYS J BIOPHY, V38, P69, DOI 10.1007/s00249-008-0361-5; Bingaman S, 2003, MICROCIRCULATION, V10, P221, DOI 10.1038/sj.mn.7800186; Bulina ME, 2006, NAT PROTOC, V1, P947, DOI 10.1038/nprot.2006.89; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Dittrich PS, 2001, APPL PHYS B-LASERS O, V73, P829, DOI 10.1007/sO03400100737; Dobrucki JW, 2007, BIOPHYS J, V93, P1778, DOI 10.1529/biophysj.106.096636; FAULSTICH H, 1997, HOPPESEYLERS Z PHYSL, V358, P181; Fureder-Kitzmuller E, 2005, CHEM PHYS LETT, V404, P13, DOI 10.1016/j.cplett.2005.01.053; Gaertner TR, 2004, J BIOL CHEM, V279, P39374, DOI 10.1074/jbc.M405352200; Gsponer J, 2008, STRUCTURE, V16, P736, DOI 10.1016/j.str.2008.02.017; Hancock JT, 2001, BIOCHEM SOC T, V29, P345, DOI 10.1042/BST0290345; Heinze KG, 2009, J PHYS CHEM B, V113, P5225, DOI 10.1021/jp8060152; Hoebe RA, 2008, J MICROSC-OXFORD, V231, P9, DOI 10.1111/j.1365-2818.2008.02009.x; Hoogenboom JP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.097401; Junker JP, 2009, SCIENCE, V323, P633, DOI 10.1126/science.1166191; KASCHE V, 1964, J PHYS CHEM-US, V68, P817, DOI 10.1021/j100786a019; Kim SA, 2004, P NATL ACAD SCI USA, V101, P105, DOI 10.1073/pnas.2436461100; Koizumi M, 1972, MOL PHOTOCHEM, V4, P57; Kuno M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.125304; LINDQVIST L, 1961, ARK KEMI, V16, P79; Luschtinetz F, 2009, BIOCONJUGATE CHEM, V20, P576, DOI 10.1021/bc800497v; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Putkey JA, 1996, J BIOL CHEM, V271, P29619, DOI 10.1074/jbc.271.47.29619; Remington SJ, 2006, CURR OPIN STRUC BIOL, V16, P714, DOI 10.1016/j.sbi.2006.10.001; USUI Y, 1965, B CHEM SOC JPN, V38, P1015, DOI 10.1246/bcsj.38.1015; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; Waxham MN, 1998, J BIOL CHEM, V273, P17579, DOI 10.1074/jbc.273.28.17579; Yeow EKL, 2006, J PHYS CHEM A, V110, P1726, DOI 10.1021/jp055496r	32	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14050	10.1371/journal.pone.0014050	http://dx.doi.org/10.1371/journal.pone.0014050			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124984	Green Submitted, Green Published, gold			2022-12-27	WOS:000284356900013
J	Pelechano, V; Chavez, S; Perez-Ortin, JE				Pelechano, Vicent; Chavez, Sebastian; Perez-Ortin, Jose E.			A Complete Set of Nascent Transcription Rates for Yeast Genes	PLOS ONE			English	Article							RNA-POLYMERASE-II; POSTTRANSCRIPTIONAL CONTROL; INITIATION; ELONGATION; EXPRESSION; STABILITY; CHROMATIN; STRESS; NUMBER	The amount of mRNA in a cell is the result of two opposite reactions: transcription and mRNA degradation. These reactions are governed by kinetics laws, and the most regulated step for many genes is the transcription rate. The transcription rate, which is assumed to be exercised mainly at the RNA polymerase recruitment level, can be calculated using the RNA polymerase densities determined either by run-on or immunoprecipitation using specific antibodies. The yeast Saccharomyces cerevisiae is the ideal model organism to generate a complete set of nascent transcription rates that will prove useful for many gene regulation studies. By combining genomic data from both the GRO (Genomic Run-on) and the RNA pol ChIP-on-chip methods we generated a new, more accurate nascent transcription rate dataset. By comparing this dataset with the indirect ones obtained from the mRNA stabilities and mRNA amount datasets, we are able to obtain biological information about posttranscriptional regulation processes and a genomic snapshot of the location of the active transcriptional machinery. We have obtained nascent transcription rates for 4,670 yeast genes. The median RNA polymerase II density in the genes is 0.078 molecules/kb, which corresponds to an average of 0.096 molecules/gene. Most genes have transcription rates of between 2 and 30 mRNAs/hour and less than 1% of yeast genes have > 1 RNA polymerase molecule/gene. Histone and ribosomal protein genes are the highest transcribed groups of genes and other than these exceptions the transcription of genes is an infrequent phenomenon in a yeast cell.	[Pelechano, Vicent; Perez-Ortin, Jose E.] Univ Valencia, Fac Ciencias Biol, Dept Bioquim & Biol Mol, E-46100 Burjassot, Spain; [Chavez, Sebastian] Univ Seville, Fac Biol, Dept Genet, Seville, Spain	University of Valencia; University of Sevilla	Pelechano, V (corresponding author), EMBL, Heidelberg, Germany.	jose.e.perez@uv.es	Pérez-Ortín, José E./K-8582-2014; Pelechano, Vicent/ABF-2597-2020; Pelechano, Vicent/A-8431-2011; Chavez, Sebastian S/F-7574-2011; Chávez, Sebastián/GXF-7069-2022; IBIS, GENICA/O-1906-2015	Pérez-Ortín, José E./0000-0002-1992-513X; Pelechano, Vicent/0000-0002-9415-788X; Pelechano, Vicent/0000-0002-9415-788X; Chavez, Sebastian S/0000-0002-8064-4839; 	Generalitat Valenciana (Regional Valencian Government); Spanish Ministry of Science and Innovation; Spanish Ministry of Education and Science [BFU2007-67575-CO3-02/BMC, BFU2007-67575-CO3-01/BMC]; Regional Andalusian Government [P07-CVI02623]; Generalitat Valenciana [ACOMP/2009/368]	Generalitat Valenciana (Regional Valencian Government)(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Spanish Ministry of Education and Science(Spanish Government); Regional Andalusian Government; Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission)	VP was partially covered by a Formacion del Personal Investigador (F.P.I.) fellowship from the Generalitat Valenciana (Regional Valencian Government) and by an Especializacion en Organismos Internacionales (E.O.I.) fellowship from Spanish Ministry of Science and Innovation. This work was supported by grants from the Spanish Ministry of Education and Science BFU2007-67575-CO3-02/BMC to SC and BFU2007-67575-CO3-01/BMC to JEP-O; P07-CVI02623 from Regional Andalusian Government to SC and ACOMP/2009/368 from Generalitat Valenciana to JEP-O. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bon M, 2006, FASEB J, V20, P1721, DOI 10.1096/fj.06-6087fje; Borggrefe T, 2001, J BIOL CHEM, V276, P47150, DOI 10.1074/jbc.M109581200; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Fan JS, 2002, P NATL ACAD SCI USA, V99, P10611, DOI 10.1073/pnas.162212399; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Garcia-Martinez J, 2004, MOL CELL, V15, P303, DOI 10.1016/j.molcel.2004.06.004; Garcia-Martinez J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r222; GARCIAMARTINEZ J, 2010, YEAST GENET IN PRESS; Ginsburg DS, 2009, MOL CELL BIOL, V29, P6473, DOI 10.1128/MCB.01033-09; Grigull J, 2004, MOL CELL BIOL, V24, P5534, DOI 10.1128/MCB.24.12.5534-5547.2004; HEREFORD LM, 1977, CELL, V10, P453, DOI 10.1016/0092-8674(77)90032-0; Hirayoshi K, 1999, METHOD ENZYMOL, V304, P351; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; Iyer V, 1996, P NATL ACAD SCI USA, V93, P5208, DOI 10.1073/pnas.93.11.5208; Jasiak AJ, 2008, J BIOL CHEM, V283, P26423, DOI 10.1074/jbc.M803237200; Koerber RT, 2009, MOL CELL, V35, P889, DOI 10.1016/j.molcel.2009.09.011; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kulaeva OI, 2007, MUTAT RES-FUND MOL M, V618, P116, DOI 10.1016/j.mrfmmm.2006.05.040; Lee CK, 2004, NAT GENET, V36, P900, DOI 10.1038/ng1400; LEWIN B, 2007, GENES, V9; Liu CL, 2005, PLOS BIOL, V3, P1753, DOI 10.1371/journal.pbio.0030328; Lucchini R, 1998, TRANSCRIPTION RIBOSO, P255; Marin A, 2003, YEAST, V20, P703, DOI 10.1002/yea.992; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mata J, 2005, TRENDS BIOCHEM SCI, V30, P506, DOI 10.1016/j.tibs.2005.07.005; Miura F, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-574; Molina-Navarro MM, 2008, J BIOL CHEM, V283, P17908, DOI 10.1074/jbc.M800295200; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Niemisto A, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/46150; Pelechano V, 2010, YEAST, V27, P413, DOI 10.1002/yea.1768; Pelechano V, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000614; Perez-Ortin JE, 2002, J BIOTECHNOL, V98, P227, DOI 10.1016/S0168-1656(02)00134-7; Perez-Ortin JE, 2007, TRENDS GENET, V23, P250, DOI 10.1016/j.tig.2007.03.006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Romero-Santacreu L, 2009, RNA, V15, P1110, DOI 10.1261/rna.1435709; Rosaleny LE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r119; Schwabish MA, 2004, MOL CELL BIOL, V24, P10111, DOI 10.1128/MCB.24.23.10111-10117.2004; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Singh J, 2009, NAT STRUCT MOL BIOL, V16, P1128, DOI 10.1038/nsmb.1666; Sprouse RO, 2008, P NATL ACAD SCI USA, V105, P13304, DOI 10.1073/pnas.0801901105; Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023; Struhl K, 2007, NAT STRUCT MOL BIOL, V14, P103, DOI 10.1038/nsmb0207-103; VAN BH, 2010, PLOS BIOL, V8; Venters BJ, 2009, GENOME RES, V19, P360, DOI 10.1101/gr.084970.108; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514	52	108	109	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15442	10.1371/journal.pone.0015442	http://dx.doi.org/10.1371/journal.pone.0015442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103382	Green Published, Green Submitted, gold			2022-12-27	WOS:000284257400023
J	Ling, KKY; Lin, MY; Zingg, B; Feng, ZH; Ko, CP				Ling, Karen K. Y.; Lin, Ming-Yi; Zingg, Brian; Feng, Zhihua; Ko, Chien-Ping			Synaptic Defects in the Spinal and Neuromuscular Circuitry in a Mouse Model of Spinal Muscular Atrophy	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; WERDNIG-HOFFMANN DISEASE; ANTERIOR HORN; AXONAL NEUROPATHY; SENSORY NEURONS; END-PLATE; MOTONEURONS; PROTEIN; MICE	Spinal muscular atrophy (SMA) is a major genetic cause of death in childhood characterized by marked muscle weakness. To investigate mechanisms underlying motor impairment in SMA, we examined the spinal and neuromuscular circuitry governing hindlimb ambulatory behavior in SMA model mice (SMN Delta 7). In the neuromuscular circuitry, we found that nearly all neuromuscular junctions (NMJs) in hindlimb muscles of SMN Delta 7 mice remained fully innervated at the disease end stage and were capable of eliciting muscle contraction, despite a modest reduction in quantal content. In the spinal circuitry, we observed a similar to 28% loss of synapses onto spinal motoneurons in the lateral column of lumbar segments 3-5, and a significant reduction in proprioceptive sensory neurons, which may contribute to the 50% reduction in vesicular glutamate transporter 1(VGLUT1)-positive synapses onto SMN Delta 7 motoneurons. In addition, there was an increase in the association of activated microglia with SMN Delta 7 motoneurons. Together, our results present a novel concept that synaptic defects occur at multiple levels of the spinal and neuromuscular circuitry in SMN Delta 7 mice, and that proprioceptive spinal synapses could be a potential target for SMA therapy.	[Ling, Karen K. Y.; Lin, Ming-Yi; Zingg, Brian; Feng, Zhihua; Ko, Chien-Ping] Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA	University of Southern California	Ling, KKY (corresponding author), Univ So Calif, Dept Biol Sci, Neurobiol Sect, Los Angeles, CA 90089 USA.	cko@college.usc.edu	Ko, Chien-Ping/AAN-2314-2020		NIH [NS063296]; Muscular Dystrophy Association; Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS063296] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association(Muscular Dystrophy Association); Spinal Muscular Atrophy Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grant NS063296, Muscular Dystrophy Association, http://www.mdausa.org/ and Spinal Muscular Atrophy Foundation, http://www.smafoundation.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez FJ, 2010, ANN NY ACAD SCI, V1198, P231, DOI 10.1111/j.1749-6632.2010.05459.x; Anagnostou E, 2005, J CHILD NEUROL, V20, P147, DOI 10.1177/08830738050200022101; Bessis A, 2007, GLIA, V55, P233, DOI 10.1002/glia.20459; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Butchbach MER, 2007, NEUROBIOL DIS, V27, P207, DOI 10.1016/j.nbd.2007.04.009; Chang Q, 2009, AM J PATHOL, V174, P574, DOI 10.2353/ajpath.2009.080557; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; CRUZ LJ, 1985, J BIOL CHEM, V260, P9280; DEL CASTILLO J, 1954, J Physiol, V123, P7; Dubowitz V, 1978, Major Probl Clin Pediatr, V16, piii; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Feng ZH, 2007, CURR OPIN PHARMACOL, V7, P316, DOI 10.1016/j.coph.2006.12.003; Foran E, 2009, ANTIOXID REDOX SIGN, V11, P1587, DOI 10.1089/ars.2009.2444; Friese A, 2009, P NATL ACAD SCI USA, V106, P13588, DOI 10.1073/pnas.0906809106; FYFFE REW, 2001, SPINAL MOTONEURONS S; Graeber MB, 2010, ACTA NEUROPATHOL, V119, P89, DOI 10.1007/s00401-009-0622-0; GRAEBER MB, 1993, ACTA NEUROPATHOL, V86, P179, DOI 10.1007/BF00334886; HARDING AE, 1983, J NEUROL SCI, V59, P69, DOI 10.1016/0022-510X(83)90082-5; HONDA CN, 1995, NEUROSCIENCE, V68, P883, DOI 10.1016/0306-4522(95)00180-Q; Ikemoto A, 2002, ACTA NEUROPATHOL, V103, P179, DOI 10.1007/s004010100449; Ikemoto A, 1996, J NEUROL SCI, V136, P94, DOI 10.1016/0022-510X(95)00297-F; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Jablonka S, 2006, HUM MOL GENET, V15, P511, DOI 10.1093/hmg/ddi467; Jiang MC, 2009, J NEUROSCI, V29, P15031, DOI 10.1523/JNEUROSCI.0574-09.2009; Juttner R, 2005, NEURON, V46, P233, DOI 10.1016/j.neuron.2005.02.027; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; KERNS JM, 1973, J COMP NEUROL, V151, P237, DOI 10.1002/cne.901510303; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; LINDA H, 1992, J COMP NEUROL, V318, P188, DOI 10.1002/cne.903180205; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MENDELL LM, 1971, J NEUROPHYSIOL, V34, P171, DOI 10.1152/jn.1971.34.1.171; Michaud M, 2010, NEUROBIOL DIS, V38, P125, DOI 10.1016/j.nbd.2010.01.006; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Murray LM, 2010, NEUROPATH APPL NEURO, V36, P133, DOI [10.1111/j.1365-2990.2009.01061.x, 10.1111/j.1365-2990.2010.01061.x]; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Nagao M, 1998, J NEUROPATH EXP NEUR, V57, P329, DOI 10.1097/00005072-199804000-00004; NICOLOPOULOSSTOURNARAS S, 1983, J COMP NEUROL, V217, P75, DOI 10.1002/cne.902170107; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Omran H, 1998, J CHILD NEUROL, V13, P327, DOI 10.1177/088307389801300704; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Park GH, 2010, CURR NEUROL NEUROSCI, V10, P108, DOI 10.1007/s11910-010-0095-5; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Renault F, 1983, Rev Electroencephalogr Neurophysiol Clin, V13, P301, DOI 10.1016/S0370-4475(83)80042-2; Rudnik-Schoneborn S, 2003, NEUROLOGY, V60, P983, DOI 10.1212/01.WNL.0000052788.39340.45; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SASAKI S, 1994, ACTA NEUROPATHOL, V88, P222; Schutz B, 2005, NEUROBIOL DIS, V20, P131, DOI 10.1016/j.nbd.2005.02.006; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; SOLIVEN B, 1992, MUSCLE NERVE, V15, P656, DOI 10.1002/mus.880150604; SUMNER BEH, 1975, EXP NEUROL, V49, P406, DOI 10.1016/0014-4886(75)90097-7; Sumner CJ, 2007, J CHILD NEUROL, V22, P979, DOI 10.1177/0883073807305787; Trapp BD, 2007, GLIA, V55, P360, DOI 10.1002/glia.20462; VAUGHN JE, 1977, J COMP NEUROL, V175, P79, DOI 10.1002/cne.901750106; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Wood SJ, 2001, PROG NEUROBIOL, V64, P393, DOI 10.1016/S0301-0082(00)00055-1; Yamanouchi Y, 1996, PEDIATR NEUROL, V15, P32, DOI 10.1016/0887-8994(96)00123-3; Zang DW, 2005, J NEUROSCI RES, V79, P694, DOI 10.1002/jnr.20379; Zhang HM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011696; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	67	145	145	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15457	10.1371/journal.pone.0015457	http://dx.doi.org/10.1371/journal.pone.0015457			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085654	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800025
J	Lindhagen-Persson, M; Brannstrom, K; Vestling, M; Steinitz, M; Olofsson, A				Lindhagen-Persson, Malin; Brannstrom, Kristoffer; Vestling, Monika; Steinitz, Michael; Olofsson, Anders			Amyloid-beta Oligomer Specificity Mediated by the IgM Isotype - Implications for a Specific Protective Mechanism Exerted by Endogenous Auto-Antibodies	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; A-BETA; PROTEIN-PRECURSOR; MOUSE MODEL; MONOCLONAL-ANTIBODIES; TRANSGENIC MICE; MEMORY LOSS; PEPTIDE	Background: Alzheimers disease (AD) has been strongly linked to an anomalous self-assembly of the amyloid-beta peptide (A beta). The correlation between clinical symptoms of AD and A beta depositions is, however, weak. Instead small and soluble A beta oligomers are suggested to exert the major pathological effects. In strong support of this notion, immunological targeting of A beta oligomers in AD mice-models shows that memory impairments can be restored without affecting the total burden of A beta deposits. Consequently a specific immunological targeting of A beta oligomers is of high therapeutic interest. Methodology/Principal Findings: Previously the generation of conformational-dependent oligomer specific anti-A beta antibodies has been described. However, to avoid the difficult task of identifying a molecular architecture only present on oligomers, we have focused on a more general approach based on the hypothesis that all oligomers expose multiple identical epitopes and therefore would have an increased binding to a multivalent receptor. Using the polyvalent IgM immunoglobulin we have developed a monoclonal anti-A beta antibody (OMAB). OMAB only demonstrates a weak interaction with A beta monomers and dimers having fast on and off-rate kinetics. However, as an effect of avidity, its interaction with A beta-oligomers results in a strong complex with an exceptionally slow off-rate. Through this mechanism a selectivity towards A beta oligomers is acquired and OMAB fully inhibits the cytotoxic effect exerted by A beta(1-42) at highly substoichiometric ratios. Anti-A beta auto-antibodies of IgM isotype are frequently present in the sera of humans. Through a screen of endogenous anti-A beta IgM auto-antibodies from a group of healthy individuals we show that all displays a preference for oligomeric A beta. Conclusions/Significance: Taken together we provide a simple and general mechanism for targeting of oligomers without the requirement of conformational-dependent epitopes. In addition, our results suggest that IgM anti-A beta auto-antibodies may exert a more specific protective mechanism in vivo than previously anticipated.	[Lindhagen-Persson, Malin; Brannstrom, Kristoffer; Vestling, Monika; Olofsson, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Steinitz, Michael] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Pathol, IL-91010 Jerusalem, Israel	Umea University; Hebrew University of Jerusalem	Lindhagen-Persson, M (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.olofsson@medchem.umu.se	Brännström, Kristoffer/AAC-1204-2020; Brännström, Kristoffer/D-3648-2009		Ernst and Lili Rosenhain fund, Bruxelles, Belgium; J. C. Kempe; Swedish research council; Socialstyrelsen; FAMY; Medical Faculty of Umea University	Ernst and Lili Rosenhain fund, Bruxelles, Belgium; J. C. Kempe; Swedish research council(Swedish Research CouncilEuropean Commission); Socialstyrelsen; FAMY; Medical Faculty of Umea University	This work was supported by Ernst and Lili Rosenhain fund, Bruxelles, Belgium, J. C. Kempe, the Swedish research council, Socialstyrelsen, FAMY and the Medical Faculty of Umea University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asami-Odaka A, 2005, NEURODEGENER DIS, V2, P36, DOI 10.1159/000086429; Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Chauhan NB, 2003, J NEUROSCI RES, V74, P142, DOI 10.1002/jnr.10721; DaSilva KA, 2009, VACCINE, V27, P1365, DOI 10.1016/j.vaccine.2008.12.044; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; Dodel R, 2010, DRUGS, V70, P513, DOI 10.2165/11533070-000000000-00000; Geylis V, 2005, NEUROBIOL AGING, V26, P597, DOI 10.1016/j.neurobiolaging.2004.06.008; Giuffrida ML, 2009, J NEUROSCI, V29, P10582, DOI 10.1523/JNEUROSCI.1736-09.2009; Hartley DM, 2008, J BIOL CHEM, V283, P16790, DOI 10.1074/jbc.M802215200; Hasegawa K, 2002, BIOCHEMISTRY-US, V41, P13489, DOI 10.1021/bi020369w; Hoshi M, 2003, P NATL ACAD SCI USA, V100, P6370, DOI 10.1073/pnas.1237107100; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; KATZMAN R, 1986, NEUROL CLIN, V4, P329, DOI 10.1016/S0733-8619(18)30972-1; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kim HJ, 2002, FASEB J, V16, P118, DOI 10.1096/fj.01-0987fje; Kotilinek LA, 2002, J NEUROSCI, V22, P6331; Kuo YM, 1996, J BIOL CHEM, V271, P4077; Lambert MP, 2007, J NEUROCHEM, V100, P23, DOI 10.1111/j.1471-4159.2006.04157.x; Lambert MP, 2001, J NEUROCHEM, V79, P595, DOI 10.1046/j.1471-4159.2001.00592.x; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; MARCELLO A, 2009, NEUROBIOL AGING; Marcello A, 2009, J NEURAL TRANSM, V116, P913, DOI 10.1007/s00702-009-0224-y; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morgan D, 2000, NATURE, V408, P982, DOI 10.1038/35050116; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Munch G, 2002, J NEURAL TRANSM, V109, P1081, DOI 10.1007/s007020200091; Myagkova MA, 2001, B EXP BIOL MED+, V131, P127, DOI 10.1023/A:1017527508878; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; O'Nuallain B, 2008, BIOCHEMISTRY-US, V47, P12254, DOI 10.1021/bi801767k; Olofsson A, 2007, BIOCHEM J, V404, P63, DOI 10.1042/BJ20061561; Olofsson A, 2009, ANAL BIOCHEM, V385, P374, DOI 10.1016/j.ab.2008.10.034; ONUALLAIN B, J CLIN IMMUNOL S1, V30, pS37; PAUL S, J CLIN IMMUNOL S1, V30, pS43; Raby CA, 1998, J NEUROCHEM, V71, P2505; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; ROCH JM, 1994, P NATL ACAD SCI USA, V91, P7450, DOI 10.1073/pnas.91.16.7450; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shankar GM, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-48; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sudol KL, 2009, MOL THER, V17, P2031, DOI 10.1038/mt.2009.174; Szabo P, 2008, AUTOIMMUN REV, V7, P415, DOI 10.1016/j.autrev.2008.03.007; Taguchi H, 2008, J BIOL CHEM, V283, P4714, DOI 10.1074/jbc.M707983200; Wang QW, 2004, J NEUROSCI, V24, P3370, DOI 10.1523/JNEUROSCI.1633-03.2004; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilcock DM, 2003, J NEUROSCI, V23, P3745, DOI 10.1523/jneurosci.23-09-03745.2003; Younkin SG, 2001, NAT MED, V7, P18, DOI 10.1038/83292	55	50	54	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13928	10.1371/journal.pone.0013928	http://dx.doi.org/10.1371/journal.pone.0013928			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085663	Green Submitted, Green Published, gold			2022-12-27	WOS:000284036800019
J	BasuRay, S; Mukherjee, S; Romero, E; Wilson, MC; Wandinger-Ness, A				BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wilson, Michael C.; Wandinger-Ness, Angela			Rab7 Mutants Associated with Charcot-Marie-Tooth Disease Exhibit Enhanced NGF-Stimulated Signaling	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FUNCTIONAL ANALYSES; PROTEIN-KINASE; ACTIVATION; CELLS; NEUROPATHIES; ERK; 2B; COMPARTMENT; MECHANISMS	Missense mutants in the late endosomal Rab7 GTPase cause the autosomal dominant peripheral neuropathy Charcot-Marie-Tooth disease type 2B (CMT2B). As yet, the pathological mechanisms connecting mutant Rab7 protein expression to altered neuronal function are undefined. Here, we analyze the effects Rab7 CMT2B mutants on nerve growth factor (NGF) dependent intracellular signaling in PC12 cells. The nerve growth factor receptor TrkA interacted similarly with Rab7 wildtype and CMT2B mutant proteins, but the mutant proteins significantly enhanced TrkA phosphorylation in response to brief NGF stimulation. Two downstream signaling pathways (Erk1/2 and Akt) that are directly activated in response to phospho-TrkA were differentially affected. Akt signaling, arising in response to activated TrkA at the plasma membrane was unaffected. However Erk1/2 phosphorylation, triggered on signaling endosomes, was increased. Cytoplasmic phospho-Erk1/2 persisted at elevated levels relative to control samples for up to 24 h following NGF stimulation. Nuclear shuttling of phospho Erk1/2, which is required to induce MAPK phosphatase expression and down regulate signaling, was greatly reduced by the Rab7 CMT2B mutants and explains the previously reported inhibition in PC12 neurite outgrowth. In conclusion, the data demonstrate a mechanistic link between Rab7 CMT2B mutants and altered TrkA and Erk1/2 signaling from endosomes.	[BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [BasuRay, Soumik; Mukherjee, Sanchita; Romero, Elsa; Wandinger-Ness, Angela] Univ New Mexico, Canc Res & Treatment Ctr, Hlth Sci Ctr, Albuquerque, NM 87131 USA; [Wilson, Michael C.] Univ New Mexico, Dept Neurosci, Hlth Sci Ctr, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center; University of New Mexico; University of New Mexico's Health Sciences Center	BasuRay, S (corresponding author), Univ New Mexico, Dept Pathol, Hlth Sci Ctr, Albuquerque, NM 87131 USA.	wness@unm.edu	Wandinger-Ness, Angela/J-9104-2012	Wandinger-Ness, Angela/0000-0003-0613-3157	National Science Foundation [MCB 0446179, MCB 0956027]; National Institutes of Health [R01 MH48989]; University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048989] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of New Mexico; Cancer Center Fluorescence Microscopy Shared Resource; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was generously supported by the National Science Foundation (MCB 0446179 and MCB 0956027 to AWN); and by the National Institutes of Health (R01 MH48989 to MCW). Any opinions, findings, and conclusions or recommendations expressed in this manuscript are those of the author(s) and do not necessarily reflect the views of the National Science Foundation or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bermudez O, 2008, ONCOGENE, V27, P3685, DOI 10.1038/sj.onc.1211040; BERND P, 1984, J BIOL CHEM, V259, P5509; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; Camps M, 1998, SCIENCE, V280, P1262, DOI 10.1126/science.280.5367.1262; CHAVRIER P, 1990, MOL CELL BIOL, V10, P6578, DOI 10.1128/MCB.10.12.6578; COGLI L, 2010, ACTA NEUROPATHOL; Colucci-D'Amato L, 2003, BIOESSAYS, V25, P1085, DOI 10.1002/bies.10355; De Luca A, 2008, BIOCHEM BIOPH RES CO, V372, P283, DOI 10.1016/j.bbrc.2008.05.060; Dong JB, 2004, J BIOL CHEM, V279, P21334, DOI 10.1074/jbc.M401022200; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Feng Y, 2001, METHOD ENZYMOL, V329, P175; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; FUKUDA M, 1995, ONCOGENE, V11, P239; Gama Lucio, 2002, Methods Mol Biol, V182, P77; Houlden H, 2004, ANN NEUROL, V56, P586, DOI 10.1002/ana.20281; McCray BA, 2010, HUM MOL GENET, V19, P1033, DOI 10.1093/hmg/ddp567; Meggouh F, 2006, NEUROLOGY, V67, P1476, DOI 10.1212/01.wnl.0000240068.21499.f5; MERESSE S, 1995, J CELL SCI, V108, P3349; Mukherjee S, 2005, METHOD ENZYMOL, V403, P650, DOI 10.1016/S0076-6879(05)03056-9; Nave KA, 2007, NAT CLIN PRACT NEURO, V3, P453, DOI 10.1038/ncpneuro0583; Niemann A, 2006, NEUROMOL MED, V8, P217, DOI 10.1385/NMM:8:1:217; Parman Y, 2007, CURR OPIN NEUROL, V20, P542, DOI 10.1097/WCO.0b013e32826fbcb7; Press B, 1998, J CELL BIOL, V140, P1075, DOI 10.1083/jcb.140.5.1075; Sasaki K, 2003, J BIOL CHEM, V278, P30945, DOI 10.1074/jbc.M212167200; Saxena S, 2005, J NEUROSCI, V25, P10930, DOI 10.1523/JNEUROSCI.2029-05.2005; Spinosa MR, 2008, J NEUROSCI, V28, P1640, DOI 10.1523/JNEUROSCI.3677-07.2008; Stein MP, 2005, METHOD ENZYMOL, V403, P628, DOI 10.1016/S0076-6879(05)03055-7; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Tohgo AK, 2002, J BIOL CHEM, V277, P9429, DOI 10.1074/jbc.M106457200; Verhoeven K, 2003, AM J HUM GENET, V72, P722, DOI 10.1086/367847; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Xue LZ, 1998, CELL SIGNAL, V10, P339, DOI 10.1016/S0898-6568(98)00011-4; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000; Zuchner S, 2006, NAT CLIN PRACT NEURO, V2, P45, DOI 10.1038/ncpneuro0071	34	37	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15351	10.1371/journal.pone.0015351	http://dx.doi.org/10.1371/journal.pone.0015351			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151572	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800027
J	Kraft, P; Benz, PM; Austinat, M; Brede, ME; Schuh, K; Walter, U; Stoll, G; Kleinschnitz, C				Kraft, Peter; Benz, Peter Michael; Austinat, Madeleine; Brede, Marc Elmar; Schuh, Kai; Walter, Ulrich; Stoll, Guido; Kleinschnitz, Christoph			Deficiency of Vasodilator-Stimulated Phosphoprotein (VASP) Increases Blood-Brain-Barrier Damage and Edema Formation after Ischemic Stroke in Mice	PLOS ONE			English	Article							VASCULAR-ENDOTHELIAL-CADHERIN; CEREBRAL-ARTERY OCCLUSION; ENA/VASP PROTEINS; INJURY; ACTIN; INHIBITION; MODEL; HIF-1-ALPHA; ACTIVATION; REGULATORS	Background: Stroke-induced brain edema formation is a frequent cause of secondary infarct growth and deterioration of neurological function. The molecular mechanisms underlying edema formation after stroke are largely unknown. Vasodilator-stimulated phosphoprotein (VASP) is an important regulator of actin dynamics and stabilizes endothelial barriers through interaction with cell-cell contacts and focal adhesion sites. Hypoxia has been shown to foster vascular leakage by downregulation of VASP in vitro but the significance of VASP for regulating vascular permeability in the hypoxic brain in vivo awaits clarification. Methodology/Principal Findings: Focal cerebral ischemia was induced in Vasp(-/-) mice and wild-type (WT) littermates by transient middle cerebral artery occlusion (tMCAO). Evan's Blue tracer was applied to visualize the extent of blood-brain-barrier (BBB) damage. Brain edema formation and infarct volumes were calculated from 2,3,5-triphenyltetrazolium chloride (TTC)-stained brain slices. Both mouse groups were carefully controlled for anatomical and physiological parameters relevant for edema formation and stroke outcome. BBB damage (p < 0.05) and edema volumes (1.7 mm(3) +/- 0.5 mm(3) versus 0.8 mm(3) +/- 0.4 mm(3); p < 0.0001) were significantly enhanced in Vasp(-/-) mice compared to controls on day 1 after tMCAO. This was accompanied by a significant increase in infarct size (56.1 mm(3) +/- 17.3 mm(3) versus 39.3 mm(3) +/- 10.7 mm(3), respectively; p < 0.01) and a non significant trend (p > 0.05) towards worse neurological outcomes. Conclusion: Our study identifies VASP as critical regulator of BBB maintenance during acute ischemic stroke. Therapeutic modulation of VASP or VASP-dependent signalling pathways could become a novel strategy to combat excessive edema formation in ischemic brain damage.	[Kraft, Peter; Austinat, Madeleine; Stoll, Guido; Kleinschnitz, Christoph] Univ Wurzburg, Dept Neurol, D-8700 Wurzburg, Germany; [Benz, Peter Michael; Schuh, Kai; Walter, Ulrich] Univ Wurzburg, Inst Clin Biochem & Pathobiochem, Wurzburg, Germany; [Benz, Peter Michael; Schuh, Kai] Univ Wurzburg, Dept Physiol, D-8700 Wurzburg, Germany; [Brede, Marc Elmar] Univ Wurzburg, Dept Anesthesiol, Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Kraft, P (corresponding author), Univ Wurzburg, Dept Neurol, Josef Schneider Str 11, D-8700 Wurzburg, Germany.	christoph.kleinschnitz@mail.uni-wuerzburg.de	Walter, ulrich/W-2478-2017	Walter, ulrich/0000-0001-6784-2307	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany [SFB 688, TP A2, A13, B1]; Wilhelm Sander-Stiftung, Munchen, Germany [2009.017.1]	Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany(German Research Foundation (DFG)); Wilhelm Sander-Stiftung, Munchen, Germany	This work was supported by the Deutsche Forschungsgemeinschaft (DFG), Bonn, Germany, SFB 688, TP A2 (to UW), A13 (to CK), and B1 (to GS) and Wilhelm Sander-Stiftung, Munchen, Germany (2009.017.1 to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austinat M, 2009, STROKE, V40, P285, DOI 10.1161/STROKEAHA.108.526673; Ayata C, 2002, J CLIN NEUROSCI, V9, P113, DOI 10.1054/jocn.2001.1031; Bardutzky J, 2007, STROKE, V38, P3084, DOI 10.1161/STROKEAHA.107.490193; BARONE FC, 1993, J CEREBR BLOOD F MET, V13, P683, DOI 10.1038/jcbfm.1993.87; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Benz PM, 2008, J CELL BIOL, V180, P205, DOI 10.1083/jcb.200709181; BERECZKI D, 2007, COCHRANE DB SYST REV, V183; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; Chen CH, 2009, NEUROBIOL DIS, V33, P509, DOI 10.1016/j.nbd.2008.12.010; Chen WQ, 2008, NEUROBIOL DIS, V31, P433, DOI 10.1016/j.nbd.2008.05.020; Clark WM, 1997, NEUROL RES, V19, P641; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Connolly ES, 1996, NEUROSURGERY, V38, P523, DOI 10.1097/00006123-199603000-00021; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Crossley NA, 2008, STROKE, V39, P929, DOI 10.1161/STROKEAHA.107.498725; Davis B, 2010, INT J DEV NEUROSCI, V28, P423, DOI 10.1016/j.ijdevneu.2010.06.010; Dejana E, 2004, NAT REV MOL CELL BIO, V5, P261, DOI 10.1038/nrm1357; Dirnagl U, 2006, J CEREBR BLOOD F MET, V26, P1465, DOI 10.1038/sj.jcbfm.9600298; Durukan A, 2007, PHARMACOL BIOCHEM BE, V87, P179, DOI 10.1016/j.pbb.2007.04.015; Filiano AJ, 2008, FASEB J, V22, P2662, DOI 10.1096/fj.07-097709; Furman C, 2007, J CELL BIOL, V179, P761, DOI 10.1083/jcb.200705002; Green AR, 2003, TRENDS PHARMACOL SCI, V24, P402, DOI 10.1016/S0165-6147(03)00192-5; Groger M, 2005, J CEREBR BLOOD F MET, V25, P978, DOI 10.1038/sj.jcbfm.9600096; Hauser W, 1999, P NATL ACAD SCI USA, V96, P8120, DOI 10.1073/pnas.96.14.8120; Henes J, 2009, FASEB J, V23, P4244, DOI 10.1096/fj.09-138693; Hicks K, 2010, AM J PHYSIOL-CELL PH, V298, pC1583, DOI 10.1152/ajpcell.00458.2009; Hordijk PL, 1999, J CELL SCI, V112, P1915; Kawamata T, 1996, J CEREBR BLOOD F MET, V16, P542, DOI 10.1097/00004647-199607000-00003; Kayyali US, 2002, J BIOL CHEM, V277, P42596, DOI 10.1074/jbc.M205863200; Kleinschnitz C, 2010, BLOOD, V115, P3835, DOI 10.1182/blood-2009-10-249078; Kris AS, 2008, BIOCHEM BIOPH RES CO, V375, P134, DOI 10.1016/j.bbrc.2008.07.132; Lai CH, 2005, BRAIN RES REV, V50, P7, DOI 10.1016/j.brainresrev.2005.03.007; Matter K, 2003, NAT REV MOL CELL BIO, V4, P225, DOI 10.1038/nrm1055; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Murakami K, 1997, STROKE, V28, P1797, DOI 10.1161/01.STR.28.9.1797; QIZILBASH N, 2002, COCHRANE DB SYST REV, V2; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Righetti E, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000096.pub2, DOI 10.1002/14651858.CD000096.PUB2]; Rosenberger P, 2007, FASEB J, V21, P2613, DOI 10.1096/fj.06-8004com; Schlegel N, 2008, AM J PHYSIOL-CELL PH, V294, pC178, DOI 10.1152/ajpcell.00273.2007; Schlegel N, 2009, AM J PHYSIOL-CELL PH, V296, pC453, DOI 10.1152/ajpcell.00360.2008; Scott JA, 2006, MOL BIOL CELL, V17, P1085, DOI 10.1091/mbc.e05-07-0644; Sechi AS, 2004, FRONT BIOSCI, V9, P1294, DOI 10.2741/1324; Sporbert A, 1999, MOL BRAIN RES, V67, P258, DOI 10.1016/S0169-328X(99)00067-4; van der Worp HB, 2005, J NEUROL, V252, P1108, DOI 10.1007/s00415-005-0802-3; Wojciak-Stothard B, 2006, AM J PHYSIOL-LUNG C, V290, pL1173, DOI 10.1152/ajplung.00309.2005; Wojciak-Stothard B, 2005, AM J PHYSIOL-LUNG C, V288, pL749, DOI 10.1152/ajplung.00361.2004; Wu MH, 2005, J PHYSIOL-LONDON, V569, P359, DOI 10.1113/jphysiol.2005.096537; YAMAGUCHI T, 1995, BRAIN RES, V669, P107, DOI 10.1016/0006-8993(94)01268-M	52	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15106	10.1371/journal.pone.0015106	http://dx.doi.org/10.1371/journal.pone.0015106			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151938	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600026
J	Macdonald, J; Glover, JD; Taylor, L; Sang, HM; McGrew, MJ				Macdonald, Joni; Glover, James D.; Taylor, Lorna; Sang, Helen M.; McGrew, Michael J.			Characterisation and Germline Transmission of Cultured Avian Primordial Germ Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CHICK-EMBRYO; C-KIT; IN-VITRO; MOUSE; EXPRESSION; GENE; HOMOLOG; PATHWAY; ORIGIN	Background: Avian primordial germ cells (PGCs) have significant potential to be used as a cell-based system for the study and preservation of avian germplasm, and the genetic modification of the avian genome. It was previously reported that PGCs from chicken embryos can be propagated in culture and contribute to the germ cell lineage of host birds. Principal Findings: We confirm these results by demonstrating that PGCs from a different layer breed of chickens can be propagated for extended periods in vitro. We demonstrate that intracellular signalling through PI3K and MEK is necessary for PGC growth. We carried out an initial characterisation of these cells. We find that cultured PGCs contain large lipid vacuoles, are glycogen rich, and express the stem cell marker, SSEA-1. These cells also express the germ cell-specific proteins CVH and CDH. Unexpectedly, using RT-PCR we show that cultured PGCs express the pluripotency genes c-Myc, cKlf4, cPouV, cSox2, and cNanog. Finally, we demonstrate that the cultured PGCs will migrate to and colonise the forming gonad of host embryos. Male PGCs will colonise the female gonad and enter meiosis, but are lost from the gonad during sexual development. In male hosts, cultured PGCs form functional gametes as demonstrated by the generation of viable offspring. Conclusions: The establishment of in vitro cultures of germline competent avian PGCs offers a unique system for the study of early germ cell differentiation and also a comparative system for mammalian germ cell development. Primary PGC lines will form the basis of an alternative technique for the preservation of avian germplasm and will be a valuable tool for transgenic technology, with both research and industrial applications.	[Macdonald, Joni] Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland; Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin, Midlothian, Scotland	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Macdonald, J (corresponding author), Univ Edinburgh, Roslin Inst, Roslin, Midlothian, Scotland.	mike.mcgrew@roslin.ed.ac.uk		Glover, James/0000-0003-4678-5643	Biotechnology and Biological Sciences Research Council, U.K.; BBSRC [BB/H023593/1, BBS/E/R/00001607] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/R/00001607, BB/H023593/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, U.K.(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Biotechnology and Biological Sciences Research Council, U.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antin PB, 2010, DEV DYNAM, V239, P1879, DOI 10.1002/dvdy.22318; Aramaki S, 2009, J REPROD DEVELOP, V55, P214, DOI 10.1262/jrd.20154; Aravin AA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000764; Bielanska-Osuchowska Zofia, 2006, Reprod Biol, V6, P161; Blesbois E, 2007, POULTRY SCI, V86, P555, DOI 10.1093/ps/86.3.555; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; De Felici M, 2004, HUM REPROD UPDATE, V10, P197, DOI 10.1093/humupd/dmh020; De Miguel MP, 2002, P NATL ACAD SCI USA, V99, P10458, DOI 10.1073/pnas.122249399; DOLCI S, 1991, NATURE, V352, P807; Donovan PJ, 1998, INT J DEV BIOL, V42, P1043; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; DURCOVAHILLS G, 2008, CURR PROTOC STEM CEL, V20, pCH1; Ehlermann JL, 2003, ANAT REC PART A, V273A, P677, DOI 10.1002/ar.a.10089; Farini D, 2005, DEV BIOL, V285, P49, DOI 10.1016/j.ydbio.2005.06.036; Feng HL, 1998, MOL REPROD DEV, V49, P317, DOI 10.1002/(SICI)1098-2795(199803)49:3&lt;317::AID-MRD12&gt;3.0.CO;2-T; FORD CE, 1975, PROC R SOC SER B-BIO, V190, P187, DOI 10.1098/rspb.1975.0086; FUJIMOTO T, 1977, ANAT REC, V188, P315, DOI 10.1002/ar.1091880305; FUJIMOTO T, 1976, DEV BIOL, V49, P278, DOI 10.1016/0012-1606(76)90273-6; Fulton JE, 2006, POULTRY SCI, V85, P227, DOI 10.1093/ps/85.2.227; GODIN I, 1991, NATURE, V352, P809; Goel S, 2009, REPROD FERT DEVELOP, V21, P696, DOI 10.1071/RD08176; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HAY B, 1988, CELL, V55, P577, DOI 10.1016/0092-8674(88)90216-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HILL DJ, 1985, ENDOCRINOLOGY, V117, P2061, DOI 10.1210/endo-117-5-2061; HIRNING U, 1991, MECH DEVELOP, V33, P119, DOI 10.1016/0925-4773(91)90078-K; Jung JS, 2005, STEM CELLS, V23, P689, DOI 10.1634/stemcells.2004-0208; Karagenc L, 1996, DEV GENET, V19, P290, DOI 10.1002/(SICI)1520-6408(1996)19:4<290::AID-DVG2>3.3.CO;2-S; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Kimura T, 2008, DEVELOPMENT, V135, P869, DOI 10.1242/dev.013474; Kocer A, 2009, MOL HUM REPROD, V15, P205, DOI 10.1093/molehr/gap008; Kuramochi-Miyagawa S, 2010, GENE DEV, V24, P887, DOI 10.1101/gad.1902110; Lavial F, 2007, DEVELOPMENT, V134, P3549, DOI 10.1242/dev.006569; MARANI E, 1986, ACTA MORPHOL NEER SC, V24, P103; MATSUI Y, 1991, NATURE, V353, P750, DOI 10.1038/353750a0; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; MCGREW MJ, 2010, ENCY SUSTAI IN PRESS; Mozdziak PE, 2005, POULTRY SCI, V84, P594, DOI 10.1093/ps/84.4.594; Naito M, 1999, J REPROD FERTIL, V117, P291, DOI 10.1530/jrf.0.1170291; NIEUWKOOP P. D., 1979, PRIMORDAL GERM CELLS; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Pain B, 1996, DEVELOPMENT, V122, P2339; PALMER SJ, 1991, DEVELOPMENT, V112, P265; Park TS, 2000, MOL REPROD DEV, V56, P475, DOI 10.1002/1098-2795(200008)56:4&lt;475::AID-MRD5&gt;3.0.CO;2-M; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Petitte J.N., 2004, HDB STEM CELLS, P471; Petitte JN, 1997, POULTRY SCI, V76, P1084, DOI 10.1093/ps/76.8.1084; Petitte JN, 2004, MECH DEVELOP, V121, P1159, DOI 10.1016/j.mod.2004.05.003; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Sang H, 2006, NAT BIOTECHNOL, V24, P955, DOI 10.1038/nbt0806-955; Slanchev K, 2009, MECH DEVELOP, V126, P270, DOI 10.1016/j.mod.2008.10.006; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SPIEGELMAN M, 1973, J EMBRYOL EXP MORPH, V30, P97; Surani MA, 2008, COLD SH Q B, V73, P9, DOI 10.1101/sqb.2008.73.015; Takeuchi Y, 2005, DEVELOPMENT, V132, P5399, DOI 10.1242/dev.02080; Thompson N, 2005, CURR OPIN PHARMACOL, V5, P350, DOI 10.1016/j.coph.2005.04.007; Tsunekawa N, 2000, DEVELOPMENT, V127, P2741; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; van de Lavoir MC, 2006, MECH DEVELOP, V123, P31, DOI 10.1016/j.mod.2005.10.002; Wandzioch E, 2004, BLOOD, V104, P51, DOI 10.1182/blood-2003-07-2554; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Youngren KK, 2005, NATURE, V435, P360, DOI 10.1038/nature03595; ZSEBO KM, 1990, CELL, V63, P195, DOI 10.1016/0092-8674(90)90300-4	67	94	110	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15518	10.1371/journal.pone.0015518	http://dx.doi.org/10.1371/journal.pone.0015518			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124737	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500044
J	Pinton, G; Thomas, W; Bellini, P; Manente, AG; Favoni, RE; Harvey, BJ; Mutti, L; Moro, L				Pinton, Giulia; Thomas, Warren; Bellini, Paolo; Manente, Arcangela Gabriella; Favoni, Roberto E.; Harvey, Brian J.; Mutti, Luciano; Moro, Laura			Estrogen Receptor beta Exerts Tumor Repressive Functions in Human Malignant Pleural Mesothelioma via EGFR Inactivation and Affects Response to Gefitinib	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ENDOCRINE THERAPY RESISTANCE; FACTOR SIGNALING PATHWAYS; PROSTATE-CANCER CELLS; MOLECULAR-MECHANISM; LUNG-CANCER; PHASE-II; TYROSINE KINASE; BREAST-CANCER; CROSS-TALK	Background: The role of estrogen and estrogen receptors in oncogenesis has been investigated in various malignancies. Recently our group identified estrogen receptor beta (ER beta) expression as an independent prognostic factor in the progression of human Malignant Pleural Mesothelioma (MMe), but the underlying mechanism by which ER beta expression in tumors determines clinical outcome remains largely unknown. This study is aimed at investigating the molecular mechanisms of ER beta action in MMe cells and disclosing the potential translational implications of these results. Methods: We modulated ER beta expression in REN and MSTO-211H MMe cell lines and evaluated cell proliferation and EGF receptor (EGFR) activation. Results: Our data indicate that ER beta knockdown in ER positive cells confers a more invasive phenotype, increases anchorage independent proliferation and elevates the constitutive activation of EGFR-coupled signal transduction pathways. Conversely, re-expression of ER beta in ER negative cells confers a more epithelioid phenotype, decreases their capacity for anchorage independent growth and down-modulates proliferative signal transduction pathways. We identify a physical interaction between ER beta, EGFR and caveolin 1 that results in an altered internalization and in a selective reduced activation of EGFR-coupled signaling, when ER beta is over-expressed. We also demonstrate that differential expression of ER beta influences MMe tumor cell responsiveness to the therapeutic agent: Gefitinib. Conclusions: This study describes a role for ER beta in the modulation of cell proliferation and EGFR activation and provides a rationale to facilitate the targeting of a subgroup of MMe patients who would benefit most from therapy with Gefitinib alone or in combination with Akt inhibitors.	[Pinton, Giulia; Bellini, Paolo; Manente, Arcangela Gabriella; Moro, Laura] Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Dept Chem Food Pharmaceut & Pharmacol Sci, Novara, Italy; [Thomas, Warren; Harvey, Brian J.] Royal Coll Surgeons Ireland, Dept Mol Med, Dublin 2, Ireland; [Thomas, Warren; Harvey, Brian J.] Beaumont Hosp, Educ & Res Ctr, Dublin 9, Ireland; [Favoni, Roberto E.] Natl Canc Inst, Lab Expt Pharmacol, Genoa, Italy; [Mutti, Luciano] Dept Med, Local Hlth Unit 11, Vercelli, Italy	University of Eastern Piedmont Amedeo Avogadro; Royal College of Surgeons - Ireland	Pinton, G (corresponding author), Univ Piemonte Orientale, Drug & Food Biotechnol Ctr, Dept Chem Food Pharmaceut & Pharmacol Sci, Novara, Italy.	moro@pharm.unipmn.it	Harvey, Brian/AAJ-4085-2020; Moro, Laura/ABF-2175-2020; Pinton, Giulia/ABF-2199-2020; Thomas, Warren/A-5477-2010; Mutti, Luciano/A-3545-2011; Harvey, Brian J/A-5120-2010	Harvey, Brian/0000-0002-7388-8034; Harvey, Brian J/0000-0002-7388-8034; Pinton, Giulia/0000-0003-0496-0378; Thomas, Warren/0000-0003-2706-1770; Moro, Laura/0000-0003-3421-2522; Mutti, Luciano/0000-0002-1578-2637	MARF (Mesothelioma Applied Research Foundation); Fondazione Buzzi Unicem; Higher Education Authority of Ireland [PRTLI4]; Progetto Lagrange (Cassa di Risparmio di Torino)	MARF (Mesothelioma Applied Research Foundation); Fondazione Buzzi Unicem; Higher Education Authority of Ireland; Progetto Lagrange (Cassa di Risparmio di Torino)	This work was supported by MARF (Mesothelioma Applied Research Foundation), Fondazione Buzzi Unicem and Higher Education Authority of Ireland (PRTLI4) through the National Biophotonics and Imaging Platform. G. Pinton was supported by a PhD fellowship from Progetto Lagrange (Cassa di Risparmio di Torino). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar RC, 2005, P NATL ACAD SCI USA, V102, P2679, DOI 10.1073/pnas.0500213102; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Arteaga CL, 2003, EXP CELL RES, V284, P122, DOI 10.1016/S0014-4827(02)00104-0; Ascenzi Paolo, 2006, Molecular Aspects of Medicine, V27, P299, DOI 10.1016/j.mam.2006.07.001; BEPLER G, 1988, DIFFERENTIATION, V37, P158, DOI 10.1111/j.1432-0436.1988.tb00806.x; Bonaccorsi L, 2004, INT J CANCER, V112, P78, DOI 10.1002/ijc.20362; Cortese JF, 2006, INT J CANCER, V118, P521, DOI 10.1002/ijc.21271; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Destro A, 2006, LUNG CANCER, V51, P207, DOI 10.1016/j.lungcan.2005.10.016; Edwards JG, 2006, LUNG CANCER, V54, P399, DOI 10.1016/j.lungcan.2006.08.012; Erlandsson MC, 2001, IMMUNOLOGY, V103, P17, DOI 10.1046/j.1365-2567.2001.01212.x; Fagan D, 2008, J MAMMARY GLAND BIOL, V13, P423, DOI 10.1007/s10911-008-9098-0; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Garland LL, 2007, J CLIN ONCOL, V25, P2406, DOI 10.1200/JCO.2006.09.7634; Govindan R, 2005, CLIN CANCER RES, V11, P2300, DOI 10.1158/1078-0432.CCR-04-1940; Hartman J, 2009, CANCER RES, V69, P6100, DOI 10.1158/0008-5472.CAN-09-0506; Kato S, 1998, ONCOLOGY-BASEL, V55, P5, DOI 10.1159/000055253; Kato S, 2000, GENES CELLS, V5, P593, DOI 10.1046/j.1365-2443.2000.00354.x; Levin ER, 2003, MOL ENDOCRINOL, V17, P309, DOI 10.1210/me.2002-0368; Lewis JD, 2007, MOL CANCER RES, V5, P133, DOI 10.1158/1541-7786.MCR-06-0245; Marino M, 2006, STEROIDS, V71, P298, DOI 10.1016/j.steroids.2005.09.011; Marino M, 2008, STEROIDS, V73, P853, DOI 10.1016/j.steroids.2007.12.003; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2006, ANN NY ACAD SCI, V1089, P194, DOI 10.1196/annals.1386.006; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pass HI, 2009, SEMIN THORAC CARDIOV, V21, P97, DOI 10.1053/j.semtcvs.2009.06.007; Pettersson K, 2001, ANNU REV PHYSIOL, V63, P165, DOI 10.1146/annurev.physiol.63.1.165; Pinton G, 2009, CANCER RES, V69, P4598, DOI 10.1158/0008-5472.CAN-08-4523; Richards WG, 2009, SEMIN THORAC CARDIOV, V21, P105, DOI 10.1053/j.semtcvs.2009.07.002; Sanchez M, 2010, TRENDS ENDOCRIN MET, V21, P104, DOI 10.1016/j.tem.2009.09.007; SMYTHE WR, 1994, ANN THORAC SURG, V57, P1395, DOI 10.1016/0003-4975(94)90090-6; Steele JPC, 2005, HEMATOL ONCOL CLIN N, V19, P1041, DOI 10.1016/j.hoc.2005.09.009; Wada-Hiraike O, 2006, P NATL ACAD SCI USA, V103, P2959, DOI 10.1073/pnas.0511271103; Wang L, 2001, P NATL ACAD SCI USA, V98, P2792, DOI 10.1073/pnas.041617498; Weihua Zhang, 2001, Proceedings of the National Academy of Sciences of the United States of America, V98, P6330, DOI 10.1073/pnas.111150898; Yang HC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-196; Zhao Chunyan, 2008, Nucl Recept Signal, V6, pe003, DOI 10.1621/nrs.06003	40	49	49	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14110	10.1371/journal.pone.0014110	http://dx.doi.org/10.1371/journal.pone.0014110			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124760	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500005
J	Touw, DS; Patel, DR; van den Berg, B				Touw, Debra S.; Patel, Dimki R.; van den Berg, Bert			The Crystal Structure of OprG from Pseudomonas aeruginosa, a Potential Channel for Transport of Hydrophobic Molecules across the Outer Membrane	PLOS ONE			English	Article							ESCHERICHIA-COLI; VIBRIO-CHOLERAE; DNA-SEQUENCE; BETA-BARREL; PROTEIN; OMPW; NAPHTHALENE; PLASMID; IDENTIFICATION; RESISTANCE	Background: The outer membrane (OM) of Gram-negative bacteria provides a barrier to the passage of hydrophobic and hydrophilic compounds into the cell. The OM has embedded proteins that serve important functions in signal transduction and in the transport of molecules into the periplasm. The OmpW family of OM proteins, of which P. aeruginosa OprG is a member, is widespread in Gram-negative bacteria. The biological functions of OprG and other OmpW family members are still unclear. Methodology/Principal Findings: In order to obtain more information about possible functions of OmpW family members we have solved the X-ray crystal structure of P. aeruginosa OprG at 2.4 angstrom resolution. OprG forms an eight-stranded beta-barrel with a hydrophobic channel that leads from the extracellular surface to a lateral opening in the barrel wall. The OprG barrel is closed off from the periplasm by interacting polar and charged residues on opposite sides of the barrel wall. Conclusions/Significance: The crystal structure, together with recent biochemical data, suggests that OprG and other OmpW family members form channels that mediate the diffusion of small hydrophobic molecules across the OM by a lateral diffusion mechanism similar to that of E. coli FadL.	[Touw, Debra S.; Patel, Dimki R.; van den Berg, Bert] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Touw, DS (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	bert.vandenberg@umassmed.edu		van den Berg, Bert/0000-0003-1966-8804	National Institutes of Health, (NIGMS) [5R01GM085785]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085785] Funding Source: NIH RePORTER	National Institutes of Health, (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work has been supported by National Institutes of Health grant 5R01GM085785 (NIGMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold T, 2009, J BIOL CHEM, V284, P6403, DOI 10.1074/jbc.M808504200; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; BUEHLER LK, 1991, J BIOL CHEM, V266, P24446; COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0; Das M, 1998, FEMS IMMUNOL MED MIC, V22, P303, DOI 10.1111/j.1574-695X.1998.tb01219.x; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DENOME SA, 1993, J BACTERIOL, V175, P6890, DOI 10.1128/jb.175.21.6890-6901.1993; EATON RW, 1994, J BACTERIOL, V176, P7757, DOI 10.1128/JB.176.24.7757-7762.1994; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gensberg K, 1999, J ANTIMICROB CHEMOTH, V43, P607, DOI 10.1093/jac/43.4.607; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hancock REW, 2002, ANNU REV MICROBIOL, V56, P17, DOI 10.1146/annurev.micro.56.012302.160310; Hearn EM, 2009, NATURE, V458, P367, DOI 10.1038/nature07678; Hong HD, 2006, J BIOL CHEM, V281, P7568, DOI 10.1074/jbc.M512365200; Hong H, 2006, NAT CHEM BIOL, V2, P627, DOI 10.1038/nchembio827; JALAJAKUMARI MB, 1990, NUCLEIC ACIDS RES, V18, P2180, DOI 10.1093/nar/18.8.2180; McPhee JB, 2009, FEMS MICROBIOL LETT, V296, P241, DOI 10.1111/j.1574-6968.2009.01651.x; Mesaros N, 2007, CLIN MICROBIOL INFEC, V13, P560, DOI 10.1111/j.1469-0691.2007.01681.x; Neher TM, 2009, CAN J MICROBIOL, V55, P553, DOI [10.1139/w09-002, 10.1139/W09-002]; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pautsch A, 1998, NAT STRUCT BIOL, V5, P1013, DOI 10.1038/2983; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Peng XX, 2005, J PROTEOME RES, V4, P2257, DOI 10.1021/pr050159g; Soderblom T, 2005, CELL MICROBIOL, V7, P779, DOI 10.1111/j.1462-5822.2005.00510.x; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524; VANBEILEN JB, 1992, MOL MICROBIOL, V6, P3121; Walzer G, 2009, J MICROBIOL METH, V76, P52, DOI 10.1016/j.mimet.2008.09.012; Wu LN, 2006, J PROTEOME RES, V5, P2250, DOI 10.1021/pr060046c; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	32	46	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15016	10.1371/journal.pone.0015016	http://dx.doi.org/10.1371/journal.pone.0015016			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124774	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500015
J	Wright, AK; Wishart, TM; Ingham, CA; Gillingwater, TH				Wright, Ann K.; Wishart, Thomas M.; Ingham, Cali A.; Gillingwater, Thomas H.			Synaptic Protection in the Brain of Wld(S) Mice Occurs Independently of Age but Is Sensitive to Gene-Dose	PLOS ONE			English	Article							WALLERIAN DEGENERATION WLD(S); SPINAL MUSCULAR-ATROPHY; AXONAL DEGENERATION; TRANSGENIC MICE; IN-VIVO; NEUROMUSCULAR-JUNCTIONS; PARKINSON-DISEASE; MOUSE MODELS; MUTANT MICE; PROTEIN	Background: Disruption of synaptic connectivity is a significant early event in many neurodegenerative conditions affecting the aging CNS, including Alzheimer's disease and Parkinson's disease. Therapeutic approaches that protect synapses from degeneration in the aging brain offer the potential to slow or halt the progression of such conditions. A range of animal models expressing the slow Wallerian Degeneration (Wld(S)) gene show robust neuroprotection of synapses and axons from a wide variety of traumatic and genetic neurodegenerative stimuli in both the central and peripheral nervous systems, raising that possibility that Wld(S) may be useful as a neuroprotective agent in diseases with synaptic pathology. However, previous studies of neuromuscular junctions revealed significant negative effects of increasing age and positive effects of gene-dose on Wld(S)-mediated synaptic protection in the peripheral nervous system, raising doubts as to whether Wld(S) is capable of directly conferring synapse protection in the aging brain. Methodology/Principal Findings: We examined the influence of age and gene-dose on synaptic protection in the brain of mice expressing the Wld(S) gene using an established cortical lesion model to induce synaptic degeneration in the striatum. Synaptic protection was found to be sensitive to Wld(S) gene-dose, with heterozygous Wld(S) mice showing approximately half the level of protection observed in homozygous Wld(S) mice. Increasing age had no influence on levels of synaptic protection. In contrast to previous findings in the periphery, synapses in the brain of old Wld(S) mice were just as strongly protected as those in young mice. Conclusions/Significance: Our study demonstrates that Wld(S)-mediated synaptic protection in the CNS occurs independently of age, but is sensitive to gene dose. This suggests that the Wld(S) gene, and in particular its downstream endogenous effector pathways, may be potentially useful therapeutic agents for conferring synaptic protection in the aging brain.	[Wright, Ann K.; Wishart, Thomas M.; Gillingwater, Thomas H.] Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland; [Wright, Ann K.; Wishart, Thomas M.; Gillingwater, Thomas H.] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland; [Ingham, Cali A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH9 1QH, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Wright, AK (corresponding author), Univ Edinburgh, Euan MacDonald Ctr Motor Neurone Dis Res, Edinburgh, Midlothian, Scotland.	T.Gillingwater@ed.ac.uk	Gillingwater, Thomas/G-2880-2011	wishart, thomas/0000-0002-1973-6654; Gillingwater, Thomas/0000-0002-0306-5577	Wellcome Trust [WT084151AIA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a grant from the Wellcome Trust (grant WT084151AIA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adalbert R, 2005, EUR J NEUROSCI, V21, P271, DOI 10.1111/j.1460-9568.2004.03833.x; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Beirowski B, 2010, NEUROSCIENCE, V166, P201, DOI 10.1016/j.neuroscience.2009.12.024; Beirowski B, 2008, EUR J NEUROSCI, V28, P1166, DOI 10.1111/j.1460-9568.2008.06426.x; Beirowski B, 2009, J NEUROSCI, V29, P653, DOI 10.1523/JNEUROSCI.3814-08.2009; CHEN S, 1990, BRAIN RES, V520, P103, DOI 10.1016/0006-8993(90)91695-D; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2007, CELL DEATH DIFFER, V14, P116, DOI 10.1038/sj.cdd.4401944; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Conforti L, 2009, J CELL BIOL, V184, P491, DOI 10.1083/jcb.200807175; CRAWFORD TO, 1995, J NEUROCYTOL, V24, P333, DOI 10.1007/BF01189060; Ferri A, 2003, CURR BIOL, V13, P669, DOI 10.1016/S0960-9822(03)00206-9; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, pR22; Gillingwater TH, 2004, J CEREBR BLOOD F MET, V24, P62, DOI 10.1097/01.WCB.0000095798.98378.34; Gillingwater TH, 2006, HUM MOL GENET, V15, P625, DOI 10.1093/hmg/ddi478; Gillingwater TH, 2003, J NEUROCYTOL, V32, P863, DOI 10.1023/B:NEUR.0000020629.51673.f5; Gillingwater TH, 2003, J ANAT, V203, P265, DOI 10.1046/j.1469-7580.2003.00214.x; Gillingwater TH, 2002, J PHYSIOL-LONDON, V543, P739, DOI 10.1113/jphysiol.2002.022343; Gillingwater TH, 2006, BRAIN, V129, P1546, DOI 10.1093/brain/awl101; Hasbani DM, 2006, EXP NEUROL, V202, P93, DOI 10.1016/j.expneurol.2006.05.017; Jeffrey M, 2000, NEUROPATH APPL NEURO, V26, P41, DOI 10.1046/j.1365-2990.2000.00216.x; KEMP JM, 1971, PHILOS T R SOC B, V262, P413, DOI 10.1098/rstb.1971.0104; Kielar C, 2009, HUM MOL GENET, V18, P4066, DOI 10.1093/hmg/ddp355; Kim SJ, 2008, J CLIN INVEST, V118, P3075, DOI 10.1172/JCI33482; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; LYON MF, 1993, P NATL ACAD SCI USA, V90, P9717, DOI 10.1073/pnas.90.20.9717; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; MI W, 2002, FENS FOR; Mi WQ, 2003, MUTAT RES-FUND MOL M, V526, P33, DOI 10.1016/S0027-5107(03)00011-3; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Murray LM, 2010, HUM MOL GENET, V19, P420, DOI 10.1093/hmg/ddp506; Murray LM, 2008, J ANAT, V213, P633, DOI 10.1111/j.1469-7580.2008.01007.x; Olanow CW, 2009, NEUROLOGY, V72, pS1, DOI 10.1212/WNL.0b013e3181a1d44c; Press C, 2008, J NEUROSCI, V28, P4861, DOI 10.1523/JNEUROSCI.0525-08.2008; Sajadi A, 2004, CURR BIOL, V14, P326, DOI 10.1016//j.cub.2004.01.053; Samsam M, 2003, J NEUROSCI, V23, P2833; Sasaki Y, 2009, J NEUROSCI, V29, P6526, DOI 10.1523/JNEUROSCI.1429-09.2009; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Siskova Z, 2009, AM J PATHOL, V175, P1610, DOI 10.2353/ajpath.2009.090372; SOMOGYI P, 1981, J COMP NEUROL, V195, P567, DOI 10.1002/cne.901950403; Wang MS, 2001, ANN NEUROL, V50, P773, DOI 10.1002/ana.10039; Wishart TM, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-21; Wishart TM, 2007, MOL CELL PROTEOMICS, V6, P1318, DOI 10.1074/mcp.M600457-MCP200; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; Wishart TM, 2010, HUM MOL GENET, V19, P4216, DOI 10.1093/hmg/ddq340; Wishart TM, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-148; Wishart TM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r101; Wong F, 2009, MOL CELL NEUROSCI, V42, P296, DOI 10.1016/j.mcn.2009.08.002; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009	54	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15108	10.1371/journal.pone.0015108	http://dx.doi.org/10.1371/journal.pone.0015108			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124744	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500039
J	Matsumoto, L; Takuma, H; Tamaoka, A; Kurisaki, H; Date, H; Tsuji, S; Iwata, A				Matsumoto, Lumine; Takuma, Hiroshi; Tamaoka, Akira; Kurisaki, Hiroshi; Date, Hidetoshi; Tsuji, Shoji; Iwata, Atsushi			CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's Disease	PLOS ONE			English	Article							NEUROBLASTOMA SH-SY5Y CELLS; LEWY BODIES; DNA METHYLATION; TRANSCRIPTIONAL REGULATION; MESSENGER-RNA; UP-REGULATION; DEMENTIA; GENE; CANCER; BRAIN	Background: Alpha-synuclein (SNCA) gene expression is an important factor in the pathogenesis of Parkinson's disease (PD). Gene multiplication can cause inherited PD, and promoter polymorphisms that increase SNCA expression are associated with sporadic PD. CpG methylation in the promoter region may also influence SNCA expression. Methodology/Principal Findings: By using cultured cells, we identified a region of the SNCA CpG island in which the methylation status altered along with increased SNCA expression. Postmortem brain analysis revealed regional non-specific methylation differences in this CpG region in the anterior cingulate and putamen among controls and PD; however, in the substantia nigra of PD, methylation was significantly decreased. Conclusions/Significance: This CpG region may function as an intronic regulatory element for SNCA gene. Our findings suggest that a novel epigenetic regulatory mechanism controlling SNCA expression influences PD pathogenesis.	[Matsumoto, Lumine; Date, Hidetoshi; Tsuji, Shoji; Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan; [Iwata, Atsushi] Univ Tokyo, Grad Sch Med, Dept Mol Neurosci Neurodegenerat, Bunkyo Ku, Tokyo, Japan; [Takuma, Hiroshi; Tamaoka, Akira] Univ Tsukuba, Dept Neurol, Tsukuba, Ibaraki, Japan; [Kurisaki, Hiroshi] Tokyo Hosp, Natl Hosp Org, Dept Neurol, Tokyo, Japan; [Iwata, Atsushi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	University of Tokyo; University of Tokyo; University of Tsukuba; Japan Science & Technology Agency (JST)	Matsumoto, L (corresponding author), Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo, Japan.	iwata-tky@umin.ac.jp	Iwata, Atsushi/AAH-8924-2019; Iwata, Atsushi/A-9598-2013	Iwata, Atsushi/0000-0001-7308-5314; Iwata, Atsushi/0000-0001-7308-5314	JSPS (Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology; JST; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation; Janssen Pharmaceuticals	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	This study was supported by KAKENHI from JSPS (Japan Society for the Promotion of Science); Japan Ministry of Education, Culture, Sports, Science and Technology; PRESTO from JST; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Brain Science Foundation, the Cell Science Research Foundation and Janssen Pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrachina M, 2009, J NEUROPATH EXP NEUR, V68, P880, DOI 10.1097/NEN.0b013e3181af2e46; Beyer K, 2004, NEUROPATH APPL NEURO, V30, P601, DOI 10.1111/j.1365-2990.2004.00572.x; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Clough RL, 2007, FASEB J, V21, P596, DOI 10.1096/fj.06-7111com; Clough RL, 2009, J NEUROCHEM, V110, P1479, DOI 10.1111/j.1471-4159.2009.06250.x; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8; DRINKWATER RD, 1989, MUTAT RES, V219, P29, DOI 10.1016/0921-8734(89)90038-6; Fraga MF, 2007, TRENDS GENET, V23, P413, DOI 10.1016/j.tig.2007.05.008; Gomez-Santos C, 2003, J NEUROSCI RES, V73, P341, DOI 10.1002/jnr.10663; Gomez-Santos C, 2002, BRAIN RES, V935, P32, DOI 10.1016/S0006-8993(02)02422-8; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iwata A, 2003, HUM MOL GENET, V12, P2625, DOI 10.1093/hmg/ddg283; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Ladd-Acosta C, 2007, AM J HUM GENET, V81, P1304, DOI 10.1086/524110; Lu AP, 2001, ONCOGENE, V20, P5173, DOI 10.1038/sj.onc.1204668; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; McKeith IG, 1996, NEUROLOGY, V47, P1113, DOI 10.1212/WNL.47.5.1113; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mrak RE, 2004, J NEUROPATH EXP NEUR, V63, P679, DOI 10.1093/jnen/63.7.679; Rauch T, 2005, LAB INVEST, V85, P1172, DOI 10.1038/labinvest.3700311; Rideout HJ, 2003, J NEUROCHEM, V84, P803, DOI 10.1046/j.1471-4159.2003.01574.x; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Scherzer CR, 2008, P NATL ACAD SCI USA, V105, P10907, DOI 10.1073/pnas.0802437105; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Takeda A, 2000, ACTA NEUROPATHOL, V99, P296, DOI 10.1007/PL00007441; Tanji K, 2002, PATHOL INT, V52, P572, DOI 10.1046/j.1440-1827.2002.01385.x; Tanji K, 2001, NEUROREPORT, V12, P1909, DOI 10.1097/00001756-200107030-00028; Terada S, 2000, ACTA NEUROPATHOL, V100, P464, DOI 10.1007/s004010000213; Terada S, 2003, ACTA NEUROPATHOL, V105, P163, DOI 10.1007/s00401-002-0622-9; Toyota M, 1999, SEMIN CANCER BIOL, V9, P349, DOI 10.1006/scbi.1999.0135; Urdinguio RG, 2009, LANCET NEUROL, V8, P1056, DOI 10.1016/S1474-4422(09)70262-5; Wakabayashi K, 2000, ACTA NEUROPATHOL, V99, P14, DOI 10.1007/PL00007400; WILSON VL, 1987, J BIOL CHEM, V262, P9948; Yao L, 2008, MOL PHARMACOL, V73, P1105, DOI 10.1124/mol.107.042580	40	209	220	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15522	10.1371/journal.pone.0015522	http://dx.doi.org/10.1371/journal.pone.0015522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124796	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000035
J	Chun, JT; Puppo, A; Vasilev, F; Gragnaniello, G; Garante, E; Santella, L				Chun, Jong T.; Puppo, Agostina; Vasilev, Filip; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia			The Biphasic Increase of PIP2 in the Fertilized Eggs of Starfish: New Roles in Actin Polymerization and Ca2+ Signaling	PLOS ONE			English	Article							SEA-URCHIN EGGS; PLECKSTRIN HOMOLOGY DOMAIN; CORTICAL GRANULE TRANSLOCATION; PLASMA-MEMBRANE PTDINS(4,5)P-2; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INOSITOL 1,4,5-TRISPHOSPHATE; EXTRACELLULAR-MATRIX; IN-VIVO; CALCIUM; CYTOSKELETON	Background: Fertilization of echinoderm eggs is accompanied by dynamic changes of the actin cytoskeleton and by a drastic increase of cytosolic Ca2+. Since the plasma membrane-enriched phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) serves as the precursor of inositol 1,4,5 trisphosphate (InsP(3)) and also regulates actin-binding proteins, PIP2 might be involved in these two processes. Methodology/Principal Findings: In this report, we have studied the roles of PIP2 at fertilization of starfish eggs by using fluorescently tagged pleckstrin homology (PH) domain of PLC-delta 1, which has specific binding affinity to PIP2, in combination with Ca2+ and F-actin imaging techniques and transmission electron microscopy. During fertilization, PIP2 increased at the plasma membrane in two phases rather than continually decreasing. The first increase was quickly followed by a decrease about 40 seconds after sperm-egg contact. However, these changes took place only after the Ca2+ wave had already initiated and propagated. The fertilized eggs then displayed a prolonged increase of PIP2 that was accompanied by the appearance of numerous spikes in the perivitelline space during the elevation of the fertilization envelope (FE). These spikes, protruding from the plasma membrane, were filled with microfilaments. Sequestration of PIP2 by RFP-PH at higher doses resulted in changes of subplasmalemmal actin networks which significantly delayed the intracellular Ca2+ signaling, impaired elevation of FE, and increased occurrences of polyspermic fertilization. Conclusions/Significance: Our results suggest that PIP2 plays comprehensive roles in shaping Ca2+ waves and guiding structural and functional changes required for successful fertilization. We propose that the PIP2 increase and the subsequent formation of actin spikes not only provide the mechanical supports for the elevating FE, but also accommodate increased membrane surfaces during cortical granule exocytosis.	[Chun, Jong T.; Puppo, Agostina; Vasilev, Filip; Gragnaniello, Giovanni; Garante, Ezio; Santella, Luigia] Staz Zool Anton Dohrn, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli	Chun, JT (corresponding author), Staz Zool Anton Dohrn, Villa Comunale, Naples, Italy.	chun@szn.it	Chun, Jong Tai/AAM-3394-2020; Santella, Luigia/AAM-3524-2020	Chun, Jong Tai/0000-0002-6070-4953; Santella, Luigia/0000-0001-7159-0499	Regione Campania Research [2213/B6]	Regione Campania Research	This work was partly supported by Regione Campania Research Grant 2213/B6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; BURGESS DR, 1977, J CELL BIOL, V74, P1032, DOI 10.1083/jcb.74.3.1032; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; CARRON CP, 1982, DEV BIOL, V89, P128, DOI 10.1016/0012-1606(82)90301-3; CHANDLER DE, 1980, J CELL BIOL, V84, P618, DOI 10.1083/jcb.84.3.618; Chun JT, 2009, ACTA PHYSIOL, V195, P61, DOI 10.1111/j.1748-1716.2008.01921.x; Churchill GC, 2003, CURR BIOL, V13, P125, DOI 10.1016/S0960-9822(03)00002-2; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; FORSCHER P, 1989, TRENDS NEUROSCI, V12, P468, DOI 10.1016/0166-2236(89)90098-2; Galione A, 2005, MOL INTERV, V5, P73, DOI 10.1124/mi.5.2.4; Halet G, 2002, J CELL SCI, V115, P2139; HARTWIG JH, 1989, J CELL BIOL, V109, P1571, DOI 10.1083/jcb.109.4.1571; Holz RW, 2000, J BIOL CHEM, V275, P17878, DOI 10.1074/jbc.M000925200; JANMEY PA, 1994, ANNU REV PHYSIOL, V56, P169, DOI 10.1146/annurev.ph.56.030194.001125; Kimata T, 2006, HEPATOLOGY, V44, P140, DOI 10.1002/hep.21215; Kuroda R, 2001, DEVELOPMENT, V128, P4405; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Kyozuka K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006296; Lange K, 2006, J CELL PHYSIOL, V209, P270, DOI 10.1002/jcp.20717; LASSING I, 1985, NATURE, V314, P472, DOI 10.1038/314472a0; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lenart P, 2005, NATURE, V436, P812, DOI 10.1038/nature03810; Lim D, 2003, J BIOL CHEM, V278, P42505, DOI 10.1074/jbc.M301851200; Lim D, 2002, FASEB J, V16, P1050, DOI 10.1096/fj.02-0021com; Lim D, 2001, FASEB J, V15, P2257, DOI 10.1096/fj.01-0157com; Lupu VD, 1998, J BIOL CHEM, V273, P14067, DOI 10.1074/jbc.273.23.14067; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Matese JC, 1997, DEV BIOL, V186, P16, DOI 10.1016/S0012-1606(97)98585-7; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moccia F, 2003, FASEB J, V17, P1907, DOI 10.1096/fj.03-0178fje; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Nusco GA, 2006, BIOCHEM BIOPH RES CO, V348, P109, DOI 10.1016/j.bbrc.2006.07.023; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Puppo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003588; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Santella L, 2005, MOL INTERV, V5, P70, DOI 10.1124/mi.5.2.3; Santella L, 2004, TRENDS BIOCHEM SCI, V29, P400, DOI 10.1016/j.tibs.2004.06.009; Santella L, 1999, EXP CELL RES, V248, P567, DOI 10.1006/excr.1999.4425; Santella L, 2008, INT J DEV BIOL, V52, P571, DOI 10.1387/ijdb.072560ls; SCHROEDER TE, 1983, DEV BIOL, V98, P373, DOI 10.1016/0012-1606(83)90366-4; Sechi AS, 2000, J CELL SCI, V113, P3685; Shibasaki Y, 1997, J BIOL CHEM, V272, P7578, DOI 10.1074/jbc.272.12.7578; Smith RM, 2000, J CELL BIOL, V148, P755, DOI 10.1083/jcb.148.4.755; Snow P, 1996, DEV BIOL, V180, P108, DOI 10.1006/dbio.1996.0288; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Stricker SA, 1999, DEV BIOL, V211, P157, DOI 10.1006/dbio.1999.9340; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; SWANN K, 1986, J CELL BIOL, V103, P2333, DOI 10.1083/jcb.103.6.2333; Thaler CD, 2004, DEV GROWTH DIFFER, V46, P413, DOI 10.1111/j.1440-169x.2004.00758.x; TILNEY LG, 1973, J CELL BIOL, V59, P109, DOI 10.1083/jcb.59.1.109; TILNEY LG, 1989, J CELL BIOL, V109, P1597, DOI 10.1083/jcb.109.4.1597; TILNEY LG, 1980, J CELL BIOL, V87, pA217; Toker A, 1998, CURR OPIN CELL BIOL, V10, P254, DOI 10.1016/S0955-0674(98)80148-8; TURNER PR, 1984, NATURE, V310, P414, DOI 10.1038/310414a0; VACQUIER VD, 1972, NATURE, V240, P352, DOI 10.1038/240352a0; VACQUIER VD, 1975, DEV BIOL, V43, P62, DOI 10.1016/0012-1606(75)90131-1; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; VITALE ML, 1995, NEURON, V14, P353, DOI 10.1016/0896-6273(95)90291-0; Watt SA, 2002, BIOCHEM J, V363, P657, DOI 10.1042/0264-6021:3630657; WEHLAND J, 1977, P NATL ACAD SCI USA, V74, P5613, DOI 10.1073/pnas.74.12.5613; Wessel GM, 2001, INT REV CYTOL, V209, P117; Wessel GM, 2002, DEVELOPMENT, V129, P4315; YAGISAWA H, 1994, J BIOL CHEM, V269, P20179; Yamamoto M, 2001, J CELL BIOL, V152, P867, DOI 10.1083/jcb.152.5.867; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; Yin HL, 2003, ANNU REV PHYSIOL, V65, P761, DOI 10.1146/annurev.physiol.65.092101.142517; Yozuka K, 2008, DEV BIOL, V320, P426, DOI 10.1016/j.ydbio.2008.05.549	67	35	36	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14100	10.1371/journal.pone.0014100	http://dx.doi.org/10.1371/journal.pone.0014100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124897	Green Submitted, Green Published, gold			2022-12-27	WOS:000284527900012
J	King, ONF; Li, XS; Sakurai, M; Kawamura, A; Rose, NR; Ng, SS; Quinn, AM; Rai, G; Mott, BT; Beswick, P; Klose, RJ; Oppermann, U; Jadhav, A; Heightman, TD; Maloney, DJ; Schofield, CJ; Simeonov, A				King, Oliver N. F.; Li, Xuan Shirley; Sakurai, Masaaki; Kawamura, Akane; Rose, Nathan R.; Ng, Stanley S.; Quinn, Amy M.; Rai, Ganesha; Mott, Bryan T.; Beswick, Paul; Klose, Robert J.; Oppermann, Udo; Jadhav, Ajit; Heightman, Tom D.; Maloney, David J.; Schofield, Christopher J.; Simeonov, Anton			Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE-FACTOR; PROLYL 4-HYDROXYLASES; LYSINE DEMETHYLASES; GENE-EXPRESSION; HIF FIH; HYDROXYLASE; METHYLATION; 2-OXOGLUTARATE; SPECIFICITY; LIBRARIES	Background: Small molecule modulators of epigenetic processes are currently sought as basic probes for biochemical mechanisms, and as starting points for development of therapeutic agents. N-e-Methylation of lysine residues on histone tails is one of a number of post-translational modifications that together enable transcriptional regulation. Histone lysine demethylases antagonize the action of histone methyltransferases in a site-and methylation state-specific manner. N-e-Methyllysine demethylases that use 2-oxoglutarate as co-factor are associated with diverse human diseases, including cancer, inflammation and X-linked mental retardation; they are proposed as targets for the therapeutic modulation of transcription. There are few reports on the identification of templates that are amenable to development as potent inhibitors in vivo and large diverse collections have yet to be exploited for the discovery of demethylase inhibitors. Principal Findings: High-throughput screening of a similar to 236,000-member collection of diverse molecules arrayed as dilution series was used to identify inhibitors of the JMJD2 (KDM4) family of 2-oxoglutarate-dependent histone demethylases. Initial screening hits were prioritized by a combination of cheminformatics, counterscreening using a coupled assay enzyme, and orthogonal confirmatory detection of inhibition by mass spectrometric assays. Follow-up studies were carried out on one of the series identified, 8-hydroxyquinolines, which were shown by crystallographic analyses to inhibit by binding to the active site Fe(II) and to modulate demethylation at the H3K9 locus in a cell-based assay. Conclusions: These studies demonstrate that diverse compound screening can yield novel inhibitors of 2OG dependent histone demethylases and provide starting points for the development of potent and selective agents to interrogate epigenetic regulation.	[King, Oliver N. F.; Ng, Stanley S.; Beswick, Paul; Oppermann, Udo; Heightman, Tom D.] Univ Oxford, Struct Genom Consortium, Headington, England; [Li, Xuan Shirley; Klose, Robert J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Sakurai, Masaaki; Quinn, Amy M.; Rai, Ganesha; Mott, Bryan T.; Jadhav, Ajit; Maloney, David J.; Simeonov, Anton] NHGRI, Chem Genom Ctr, NIH, Bethesda, MD 20892 USA; [Kawamura, Akane; Rose, Nathan R.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford OX1 3QU, England; [Kawamura, Akane; Rose, Nathan R.; Schofield, Christopher J.] Univ Oxford, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; University of Oxford; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Oxford; University of Oxford	King, ONF (corresponding author), Univ Oxford, Struct Genom Consortium, Headington, England.	asimeono@mail.nih.gov	Rose, Nathan R/A-9270-2013; Kawamura, Akane/I-4047-2018	Rose, Nathan R/0000-0002-1871-1156; Kawamura, Akane/0000-0003-1169-5082; Jadhav, Ajit/0000-0001-7955-1451; King, Oliver/0000-0002-6152-7207; Mott, Bryan/0000-0002-1912-6362; Schofield, Christopher/0000-0002-0290-6565	Molecular Libraries Initiative of the National Institutes of Health (NIH); NHGRI; NIH; Wellcome Trust; Commonwealth Scholarship Commission in the United Kingdom; Biotechnology and Biological Research Council (U.K.); Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation; Genome Canada through the Ontario Genomics Institute; GlaxoSmithKline; Karolinska Institutet; Knut and Alice Wallenberg Foundation; Ontario Innovation Trust; Ontario Ministry for Research and Innovation; Merck Co., Inc.; Novartis Research Foundation; Swedish Agency for Innovation Systems; Swedish Foundation for Strategic Research; BBSRC [BB/D020190/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D020190/1] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER	Molecular Libraries Initiative of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Commonwealth Scholarship Commission in the United Kingdom; Biotechnology and Biological Research Council (U.K.)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); Genome Canada through the Ontario Genomics Institute(Genome Canada); GlaxoSmithKline(GlaxoSmithKline); Karolinska Institutet(Karolinska Institutet); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Ontario Innovation Trust; Ontario Ministry for Research and Innovation(Ministry of Research and Innovation, Ontario); Merck Co., Inc.(Merck & Company); Novartis Research Foundation; Swedish Agency for Innovation Systems(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported in part by the Molecular Libraries Initiative of the National Institutes of Health (NIH) Roadmap for Medical Research and the Intramural Research Program of NHGRI, NIH, The Wellcome Trust, The Commonwealth Scholarship Commission in the United Kingdom, and the Biotechnology and Biological Research Council (U.K.). The Structural Genomics Consortium is a registered charity (number 1097737) that receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck & Co., Inc., the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research and the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine PV, 2005, CCP4 NEWSL, V42; Archer TK, 2008, EXPERT OPIN THER TAR, V12, P1457, DOI [10.1517/14728222.12.10.1301 , 10.1517/14728220802384047, 10.1517/14728222.12.11.1457 , 10.1517/14728220802384013]; Bleijlevens B, 2008, EMBO REP, V9, P872, DOI 10.1038/embor.2008.120; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chowdhury R, 2008, CHEM SOC REV, V37, P1308, DOI 10.1039/b701676j; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Couture JF, 2007, NAT STRUCT MOL BIOL, V14, P689, DOI 10.1038/nsmb1273; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Flashman E, 2008, J BIOL CHEM, V283, P3808, DOI 10.1074/jbc.M707411200; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Hamada S, 2010, J MED CHEM, V53, P5629, DOI 10.1021/jm1003655; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; Hewitson KS, 2008, J BIOL CHEM, V283, P25971, DOI 10.1074/jbc.M804999200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jensen LR, 2005, AM J HUM GENET, V76, P227, DOI 10.1086/427563; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Koivunen P, 2004, J BIOL CHEM, V279, P9899, DOI 10.1074/jbc.M312254200; Lizcano JM, 2000, ANAL BIOCHEM, V286, P75, DOI 10.1006/abio.2000.4782; MAJAMAA K, 1985, BIOCHEM J, V229, P127, DOI 10.1042/bj2290127; MAJAMAA K, 1984, EUR J BIOCHEM, V138, P239, DOI 10.1111/j.1432-1033.1984.tb07907.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael S, 2008, ASSAY DRUG DEV TECHN, V6, P637, DOI 10.1089/adt.2008.150; Moon H, 2010, MOL CELLS, V29, P471, DOI 10.1007/s10059-010-0058-3; Mosammaparast N, 2010, ANNU REV BIOCHEM, V79, P155, DOI 10.1146/annurev.biochem.78.070907.103946; Ng SS, 2009, CELL MOL LIFE SCI, V66, P407, DOI 10.1007/s00018-008-8303-z; Ng SS, 2007, NATURE, V448, P87, DOI 10.1038/nature05971; POWELL H, 2007, CCP4 NEWSLETTER PROT; Rose NR, 2008, J MED CHEM, V51, P7053, DOI 10.1021/jm800936s; Rose NR, 2010, J MED CHEM, V53, P1810, DOI 10.1021/jm901680b; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakurai M, 2010, MOL BIOSYST, V6, P357, DOI 10.1039/b912993f; Sekirnik R, 2009, CHEM COMMUN, P6376, DOI 10.1039/b916357c; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Smirnova NA, 2010, CHEM BIOL, V17, P380, DOI 10.1016/j.chembiol.2010.03.008; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; TSCHANK G, 1991, BIOCHEM J, V275, P469, DOI 10.1042/bj2750469; Warshakoon NC, 2006, BIOORG MED CHEM LETT, V16, P5517, DOI 10.1016/j.bmcl.2006.08.040; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Yasgar Adam, 2008, JALA Charlottesv Va, V13, P79, DOI 10.1016/j.jala.2007.12.004	48	167	175	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15535	10.1371/journal.pone.0015535	http://dx.doi.org/10.1371/journal.pone.0015535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124847	Green Submitted, Green Published, gold			2022-12-27	WOS:000284527900023
J	Usenik, A; Legisa, M				Usenik, Aleksandra; Legisa, Matic			Evolution of Allosteric Citrate Binding Sites on 6-phosphofructo-1-kinase	PLOS ONE			English	Article							MUSCLE PHOSPHOFRUCTOKINASE; REGULATORY PROPERTIES; ASPERGILLUS-NIGER; GROWTH; GLYCOLYSIS; FLUX; PHOSPHOFRUCTO-1-KINASE; PURIFICATION; QUANTITATION; INHIBITION	As an important part of metabolism, metabolic flux through the glycolytic pathway is tightly regulated. The most complex control is exerted on 6-phosphofructo-1-kinase (PFK1) level; this control overrules the regulatory role of other allosteric enzymes. Among other effectors, citrate has been reported to play a vital role in the suppression of this enzyme's activity. In eukaryotes, amino acid residues forming the allosteric binding site for citrate are found both on the N- and the C-terminal region of the enzyme. These site has evolved from the phosphoenolpyruvate/ADP binding site of bacterial PFK1 due to the processes of duplication and tandem fusion of prokaryotic ancestor gene followed by the divergence of the catalytic and effector binding sites. Stricter inhibition of the PFK1 enzyme was needed during the evolution of multi-cellular organisms, and the most stringent control of PFK1 by citrate occurs in vertebrates. By substituting a single amino acid (K557R or K617A) as a component of the allosteric binding site in the C-terminal region of human muscle type PFK-M with a residue found in the corresponding site of a fungal enzyme, the inhibitory effect of citrate was attenuated. Moreover, the proteins carrying these single mutations enabled growth of E. coli transformants encoding mutated human PFK-M in a glucose-containing medium that did not support the growth of E. coli transformed with native human PFK-M. Substitution of another residue at the citrate-binding site (D591V) of human PFK-M resulted in the complete loss of activity. Detailed analyses revealed that the mutated PFK-M subunits formed dimers but were unable to associate into the active tetrameric holoenzyme. These results suggest that stricter control over glycolytic flux developed in metazoans, whose somatic cells are largely characterized by slow proliferation.	[Usenik, Aleksandra; Legisa, Matic] Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Usenik, A (corresponding author), Natl Inst Chem, Dept Biotechnol, Ljubljana, Slovenia.	matic.legisa@ki.si		Usenik, Aleksandra/0000-0003-2366-2886	Slovenian Research Agency [1000-05-310165]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was funded by the Slovenian Research Agency (Contract No. 1000-05-310165; http://www.arrs.gov.si/sl/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer DE, 2005, ONCOGENE, V24, P6314, DOI 10.1038/sj.onc.1208773; Bennett BD, 2008, NAT PROTOC, V3, P1299, DOI 10.1038/nprot.2008.107; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burgstaller W, 2006, MICROBIOL-SGM, V152, P887, DOI 10.1099/mic.0.28454-0; Canelas AB, 2009, ANAL CHEM, V81, P7379, DOI 10.1021/ac900999t; Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482; Costello LC, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-59; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; EVANS PR, 1981, PHILOS T ROY SOC B, V293, P53, DOI 10.1098/rstb.1981.0059; Ferreras C, 2009, J BIOL CHEM, V284, P9124, DOI 10.1074/jbc.M807737200; HABISON A, 1983, BIOCHEM J, V209, P669, DOI 10.1042/bj2090669; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; KEMP RG, 1983, MOL CELL BIOCHEM, V57, P147, DOI 10.1007/BF00849191; Kemp RG, 2002, BIOCHEMISTRY-US, V41, P9426, DOI 10.1021/bi020110d; KEMP RG, 1987, BIOCHEMISTRY-US, V26, P3443, DOI 10.1021/bi00386a029; Li YL, 1999, BIOCHEMISTRY-US, V38, P16407, DOI 10.1021/bi991761l; Lovingshimer MR, 2006, PROTEIN EXPRES PURIF, V46, P475, DOI 10.1016/j.pep.2005.09.015; Marin-Hernandez A, 2006, FEBS J, V273, P1975, DOI 10.1111/j.1742-4658.2006.05214.x; Martinez-Oyanedel J, 2007, J MOL BIOL, V366, P1185, DOI 10.1016/j.jmb.2006.10.019; MERTENS E, 1991, FEBS LETT, V285, P1, DOI 10.1016/0014-5793(91)80711-B; Mlakar T, 2006, APPL ENVIRON MICROB, V72, P4515, DOI 10.1128/AEM.00539-06; NEWSHOLME EA, 1977, BIOCHEM J, V166, P123, DOI 10.1042/bj1660123; Paricharttanakul NM, 2005, BIOCHEMISTRY-US, V44, P15280, DOI 10.1021/bi051283g; PETERS SJ, 1995, J APPL PHYSIOL, V78, P1853, DOI 10.1152/jappl.1995.78.5.1853; POORMAN RA, 1984, NATURE, V309, P467, DOI 10.1038/309467a0; Ruijter GJG, 1997, BBA-GEN SUBJECTS, V1334, P317, DOI 10.1016/S0304-4165(96)00110-9; SAMBROOK J, 2001, MOL CLONING LABOLATO; STAAL GEJ, 1987, CANCER RES, V47, P5047; Suarez RK, 1997, P NATL ACAD SCI USA, V94, P7065, DOI 10.1073/pnas.94.13.7065; Swiegers JH, 2006, CURR GENET, V50, P161, DOI 10.1007/s00294-006-0084-z; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VORA S, 1985, BIOCHEM J, V229, P333, DOI 10.1042/bj2290333; YAMASAKI T, 1991, GENE, V104, P277, DOI 10.1016/0378-1119(91)90262-A	34	44	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15447	10.1371/journal.pone.0015447	http://dx.doi.org/10.1371/journal.pone.0015447			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124851	gold, Green Published, Green Submitted			2022-12-27	WOS:000284527900019
J	Waseh, S; Hanifi-Moghaddam, P; Coleman, R; Masotti, M; Ryan, S; Foss, M; MacKenzie, R; Henry, M; Szymanski, CM; Tanha, J				Waseh, Shakeeba; Hanifi-Moghaddam, Pejman; Coleman, Russell; Masotti, Michael; Ryan, Shannon; Foss, Mary; MacKenzie, Roger; Henry, Matthew; Szymanski, Christine M.; Tanha, Jamshid			Orally Administered P22 Phage Tailspike Protein Reduces Salmonella Colonization in Chickens: Prospects of a Novel Therapy against Bacterial Infections	PLOS ONE			English	Article							HEAD-BINDING DOMAIN; O-ANTIGEN; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; IN-VITRO; GASTROINTESTINAL-TRACT; CLOSTRIDIUM-DIFFICILE; BACTERIOPHAGE THERAPY; PASSIVE-IMMUNIZATION; INTESTINAL-DISEASES	One of the major causes of morbidity and mortality in man and economically important animals is bacterial infections of the gastrointestinal (GI) tract. The emergence of difficult-to-treat infections, primarily caused by antibiotic resistant bacteria, demands for alternatives to antibiotic therapy. Currently, one of the emerging therapeutic alternatives is the use of lytic bacteriophages. In an effort to exploit the target specificity and therapeutic potential of bacteriophages, we examined the utility of bacteriophage tailspike proteins (Tsps). Among the best-characterized Tsps is that from the Podoviridae P22 bacteriophage, which recognizes the lipopolysaccharides of Salmonella enterica serovar Typhimurium. In this study, we utilized a truncated, functionally equivalent version of the P22 tailspike protein, P22sTsp, as a prototype to demonstrate the therapeutic potential of Tsps in the GI tract of chickens. Bacterial agglutination assays showed that P22sTsp was capable of agglutinating S. Typhimurium at levels similar to antibodies and incubating the Tsp with chicken GI fluids showed no proteolytic activity against the Tsp. Testing P22sTsp against the three major GI proteases showed that P22sTsp was resistant to trypsin and partially to chymotrypsin, but sensitive to pepsin. However, in formulated form for oral administration, P22sTsp was resistant to all three proteases. When administered orally to chickens, P22sTsp significantly reduced Salmonella colonization in the gut and its further penetration into internal organs. In in vitro assays, P22sTsp effectively retarded Salmonella motility, a factor implicated in bacterial colonization and invasion, suggesting that the in vivo decolonization ability of P22sTsp may, at least in part, be due to its ability to interfere with motility... Our findings show promise in terms of opening novel Tsp-based oral therapeutic approaches against bacterial infections in production animals and potentially in humans.	[Waseh, Shakeeba; Hanifi-Moghaddam, Pejman; Coleman, Russell; Masotti, Michael; Ryan, Shannon; Foss, Mary; MacKenzie, Roger; Szymanski, Christine M.; Tanha, Jamshid] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [MacKenzie, Roger; Tanha, Jamshid] Univ Guelph, Dept Environm Biol, Ontario Agr Coll, Guelph, ON N1G 2W1, Canada; [Henry, Matthew] Dow AgroSci, Dept Discovery Res, Indianapolis, IN USA; [Tanha, Jamshid] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada	National Research Council Canada; University of Guelph; Dow Chemical Company; University of Ottawa	Waseh, S (corresponding author), Natl Res Council Canada, Inst Biol Sci, 100 Sussex Dr, Ottawa, ON K1A 0R6, Canada.	cszymans@ualberta.ca; jamshid.tanha@nrc-cnrc.gc.ca			National Research Council of Canada; Dow AgroSciences Inc.	National Research Council of Canada; Dow AgroSciences Inc.	The financial support for this work was provided by National Research Council of Canada and Dow AgroSciences Inc. and resulted in a patent which is co-owned by both organizations. The funders played a role in study design and data collection and analysis.	Alisky J, 1998, J INFECTION, V36, P5, DOI 10.1016/S0163-4453(98)92874-2; Atterbury RJ, 2007, APPL ENVIRON MICROB, V73, P4543, DOI 10.1128/AEM.00049-07; Bar-Shira E, 2006, DEV COMP IMMUNOL, V30, P930, DOI 10.1016/j.dci.2005.12.002; Barbirz S, 2008, MOL MICROBIOL, V69, P303, DOI 10.1111/j.1365-2958.2008.06311.x; Barbirz S, 2009, MACROMOL BIOSCI, V9, P169, DOI 10.1002/mabi.200800278; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; BARROW PA, 1994, INFECT IMMUN, V62, P4602, DOI 10.1128/IAI.62.10.4602-4610.1994; Barrow PA, 1997, TRENDS MICROBIOL, V5, P268, DOI 10.1016/S0966-842X(97)01054-8; Baxa U, 1996, BIOPHYS J, V71, P2040, DOI 10.1016/S0006-3495(96)79402-X; BERCHIERI A, 1991, RES MICROBIOL, V142, P541, DOI 10.1016/0923-2508(91)90187-F; Bjerrum L, 2005, AVIAN DIS, V49, P9, DOI 10.1637/7223-061504R; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; BRYAN FL, 1995, J FOOD PROTECT, V58, P326, DOI 10.4315/0362-028X-58.3.326; Carrillo CL, 2005, APPL ENVIRON MICROB, V71, P6554, DOI 10.1128/AEM.71.11.6554-6563.2005; Carroll P, 2004, VET MICROBIOL, V102, P73, DOI 10.1016/j.vetmic.2004.05.003; CARTER PB, 1974, J EXP MED, V139, P1189, DOI 10.1084/jem.139.5.1189; CHEN BL, 1991, BIOCHEMISTRY-US, V30, P6260, DOI 10.1021/bi00239a026; Clark JR, 2006, TRENDS BIOTECHNOL, V24, P212, DOI 10.1016/j.tibtech.2006.03.003; CRAVEN SE, 1993, AVIAN DIS, V37, P339, DOI 10.2307/1591657; CRAVEN SE, 1994, AVIAN DIS, V38, P401, DOI 10.2307/1592059; DANNER M, 1993, EUR J BIOCHEM, V215, P653, DOI 10.1111/j.1432-1033.1993.tb18076.x; de Geus B, 1998, VET QUART, V20, pS87; DUCHETSUCHAUX M, 1992, INFECT IMMUN, V60, P2828, DOI 10.1128/IAI.60.7.2828-2834.1992; Fischetti VA, 2005, TRENDS MICROBIOL, V13, P491, DOI 10.1016/j.tim.2005.08.007; Forbes SJ, 2008, INFECT IMMUN, V76, P4137, DOI 10.1128/IAI.00416-08; Freiberg A, 2003, J BIOL CHEM, V278, P1542, DOI 10.1074/jbc.M205294200; Harmsen MM, 2005, VET MICROBIOL, V111, P89, DOI 10.1016/j.vetmic.2005.09.005; Huff WE, 2006, POULTRY SCI, V85, P1373, DOI 10.1093/ps/85.8.1373; ISRAEL JV, 1967, P NATL ACAD SCI USA, V57, P284, DOI 10.1073/pnas.57.2.284; ISRAEL V, 1978, J GEN VIROL, V40, P669, DOI 10.1099/0022-1317-40-3-669; IWASHITA S, 1976, EUR J BIOCHEM, V65, P87, DOI 10.1111/j.1432-1033.1976.tb10392.x; Kaiser MG, 2001, POULTRY SCI, V80, P1105, DOI 10.1093/ps/80.8.1105; Khan MI, 2003, J APPL MICROBIOL, V95, P142, DOI 10.1046/j.1365-2672.2003.01953.x; Kramer J, 2001, VET IMMUNOL IMMUNOP, V79, P219, DOI 10.1016/S0165-2427(01)00261-6; Kreisberg JF, 2002, PROTEIN SCI, V11, P820, DOI 10.1110/ps.3440102; Kropinski Andrew M, 2006, Can J Infect Dis Med Microbiol, V17, P297; Kurtz CB, 2001, ANTIMICROB AGENTS CH, V45, P2340, DOI 10.1128/AAC.45.8.2340-2347.2001; LYERLY DM, 1991, INFECT IMMUN, V59, P2215, DOI 10.1128/IAI.59.6.2215-2218.1991; MA JKC, 1990, INFECT IMMUN, V58, P3407, DOI 10.1128/IAI.58.10.3407-3414.1990; Marco ML, 2006, CURR OPIN BIOTECH, V17, P204, DOI 10.1016/j.copbio.2006.02.005; Marcos LA, 2007, J INFECTION, V55, P385, DOI 10.1016/j.jinf.2007.07.016; Miller S, 1998, PROTEIN SCI, V7, P2223, DOI 10.1002/pro.5560071021; Morgavi DP, 2000, ENZYME MICROB TECH, V26, P171, DOI 10.1016/S0141-0229(99)00133-7; Muller JJ, 2008, STRUCTURE, V16, P766, DOI 10.1016/j.str.2008.01.019; NEVOLA JJ, 1985, INFECT IMMUN, V50, P152, DOI 10.1128/IAI.50.1.152-159.1985; Northrop JH, 1920, J GEN PHYSIOL, V2, P465, DOI 10.1085/jgp.2.5.465; Oliveira A, 2009, BRIT POULTRY SCI, V50, P558, DOI 10.1080/00071660903141013; Parisien A, 2008, J APPL MICROBIOL, V104, P1, DOI 10.1111/j.1365-2672.2007.03498.x; Ryan S, 2009, BIOCONJUGATE CHEM, V20, P1966, DOI 10.1021/bc900332r; SCHMIDT P, 1989, J VET MED B, V36, P619, DOI 10.1111/j.1439-0450.1989.tb00653.x; Shea JE, 1999, INFECT IMMUN, V67, P213, DOI 10.1128/IAI.67.1.213-219.1999; SHIMIZU M, 1993, BIOSCI BIOTECH BIOCH, V57, P1445, DOI 10.1271/bbb.57.1445; SIGURSKJOLD BW, 1991, EUR J BIOCHEM, V197, P239, DOI 10.1111/j.1432-1033.1991.tb15904.x; SIITONEN A, 1992, INFECT IMMUN, V60, P3918, DOI 10.1128/IAI.60.9.3918-3920.1992; SMITH HW, 1987, J GEN MICROBIOL, V133, P1111; Steinbacher S, 1997, BIOL CHEM, V378, P337, DOI 10.1515/bchm.1997.378.3-4.337; Steinbacher S, 1996, P NATL ACAD SCI USA, V93, P10584, DOI 10.1073/pnas.93.20.10584; Steinbacher S, 1997, J MOL BIOL, V267, P865, DOI 10.1006/jmbi.1997.0922; Tanji Y, 2005, J BIOSCI BIOENG, V100, P280, DOI 10.1263/jbb.100.280; Toguchi A, 2000, J BACTERIOL, V182, P6308, DOI 10.1128/JB.182.22.6308-6321.2000; Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07; Wang W, 2008, CLIN PHARMACOL THER, V84, P548, DOI 10.1038/clpt.2008.170; WIEDEMANN V, 1990, J VET MED B, V37, P163, DOI 10.1111/j.1439-0450.1990.tb01041.x; Worledge KL, 2000, DIGEST DIS SCI, V45, P2298, DOI 10.1023/A:1005554900286	65	72	77	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e13904	10.1371/journal.pone.0013904	http://dx.doi.org/10.1371/journal.pone.0013904			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124920	Green Published, Green Submitted, gold			2022-12-27	WOS:000284467200001
J	Greving, MP; Belcher, PE; Diehnelt, CW; Gonzalez-Moa, MJ; Emery, J; Fu, JL; Johnston, SA; Woodbury, NW				Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.			Thermodynamic Additivity of Sequence Variations: An Algorithm for Creating High Affinity Peptides Without Large Libraries or Structural Information	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; TNF-ALPHA; COMPUTATIONAL DESIGN; BINDING INTERFACES; BINARY-CODE; RECEPTOR; GENERATION; TARGET; ENERGY; RECOGNITION	Background: There is a significant need for affinity reagents with high target affinity/specificity that can be developed rapidly and inexpensively. Existing affinity reagent development approaches, including protein mutagenesis, directed evolution, and fragment-based design utilize large libraries and/or require structural information thereby adding time and expense. Until now, no systematic approach to affinity reagent development existed that could produce nanomolar affinity from small chemically synthesized peptide libraries without the aid of structural information. Methodology/Principal Findings: Based on the principle of additivity, we have developed an algorithm for generating high affinity peptide ligands. In this algorithm, point-variations in a lead sequence are screened and combined in a systematic manner to achieve additive binding energies. To demonstrate this approach, low-affinity lead peptides for multiple protein targets were identified from sparse random sequence space and optimized to high affinity in just two chemical steps. In one example, a TNF-alpha binding peptide with K-d = 90 nM and high target specificity was generated. The changes in binding energy associated with each variation were generally additive upon combining variations, validating the basis of the algorithm. Interestingly, cooperativity between point-variations was not observed, and in a few specific cases, combinations were less than energetically additive. Conclusions/Significance: By using this additivity algorithm, peptide ligands with high affinity for protein targets were generated. With this algorithm, one of the highest affinity TNF-alpha binding peptides reported to date was produced. Most importantly, high affinity was achieved from small, chemically-synthesized libraries without the need for structural information at any time during the process. This is significantly different than protein mutagenesis, directed evolution, or fragment-based design approaches, which rely on large libraries and/or structural guidance. With this algorithm, high affinity/specificity peptide ligands can be developed rapidly, inexpensively, and in an entirely chemical manner.	[Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.] Arizona State Univ, Ctr BioOpt Nanotechnol, Tempe, AZ USA; [Greving, Matthew P.; Belcher, Paul E.; Diehnelt, Chris W.; Gonzalez-Moa, Maria J.; Emery, Jack; Fu, Jinglin; Johnston, Stephen Albert; Woodbury, Neal W.] Arizona State Univ, Ctr Innovat Med, Biodesign Inst, Tempe, AZ USA; [Johnston, Stephen Albert] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Woodbury, Neal W.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Greving, MP (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.	nwoodbury@asu.edu	Diehnelt, Chris/AAT-9271-2020; Fu, Jinglin/F-3589-2012; Moa, Maria Gonzalez/AAB-6368-2019		Arizona Technology Research Initiative; National Science Foundation	Arizona Technology Research Initiative; National Science Foundation(National Science Foundation (NSF))	This work was supported by start-up funds to S.A.J., including from the Arizona Technology Research Initiative Fund. M. P. G. was supported by a National Science Foundation Integrative Graduate Education and Research Traineeship (IGERT) Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; Blow N, 2007, NATURE, V447, P741, DOI 10.1038/447741a; Carothers JM, 2006, J AM CHEM SOC, V128, P7929, DOI 10.1021/ja060952q; Chirinos-Rojas CL, 1998, J IMMUNOL, V161, P5621; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; DEVLIN JJ, 1990, SCIENCE, V249, P404, DOI 10.1126/science.2143033; Diehnelt CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010728; Dill KA, 1997, J BIOL CHEM, V272, P701, DOI 10.1074/jbc.272.2.701; Fellouse FA, 2005, J MOL BIOL, V348, P1153, DOI 10.1016/j.jmb.2005.03.041; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; GREGORET LM, 1993, P NATL ACAD SCI USA, V90, P4246, DOI 10.1073/pnas.90.9.4246; Greving MP, 2010, ANAL BIOCHEM, V402, P93, DOI 10.1016/j.ab.2010.03.002; Hajduk PJ, 2007, NAT REV DRUG DISCOV, V6, P211, DOI 10.1038/nrd2220; He MM, 2005, SCIENCE, V310, P1022, DOI 10.1126/science.1116304; Jackel C, 2008, ANNU REV BIOPHYS, V37, P153, DOI 10.1146/annurev.biophys.37.032807.125832; Janin J, 1996, PROTEINS, V25, pR1, DOI 10.1002/prot.340250302; JENCKS WP, 1981, P NATL ACAD SCI-BIOL, V78, P4046, DOI 10.1073/pnas.78.7.4046; Karanicolas J, 2009, CURR OPIN STRUC BIOL, V19, P458, DOI 10.1016/j.sbi.2009.07.005; Koide A, 2007, P NATL ACAD SCI USA, V104, P6632, DOI 10.1073/pnas.0700149104; Kortemme T, 2004, CURR OPIN CHEM BIOL, V8, P91, DOI 10.1016/j.cbpa.2003.12.008; Kossiakoff AA, 2008, CURR OPIN STRUC BIOL, V18, P499, DOI 10.1016/j.sbi.2008.06.004; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAM KS, 1991, NATURE, V354, P82, DOI 10.1038/354082a0; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Looger LL, 2003, NATURE, V423, P185, DOI 10.1038/nature01556; Pal G, 2006, J BIOL CHEM, V281, P22378, DOI 10.1074/jbc.M603826200; Palladino MA, 2003, NAT REV DRUG DISCOV, V2, P736, DOI 10.1038/nrd1175; Papoian GA, 2003, BIOPOLYMERS, V68, P333, DOI 10.1002/bip.10286; Pluckthun A, 2007, CURR OPIN STRUC BIOL, V17, P451, DOI 10.1016/j.sbi.2007.08.020; Reichmann D, 2005, P NATL ACAD SCI USA, V102, P57, DOI 10.1073/pnas.0407280102; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; SCHREIER B, 2009, P NATL ACAD SCI US, P1; Sidhu SS, 2007, CURR OPIN CHEM BIOL, V11, P347, DOI 10.1016/j.cbpa.2007.05.001; Smith GP, 1997, CHEM REV, V97, P391, DOI 10.1021/cr960065d; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Takasaki W, 1997, NAT BIOTECHNOL, V15, P1266, DOI 10.1038/nbt1197-1266; Taussig MJ, 2007, NAT METHODS, V4, P13, DOI 10.1038/nmeth0107-13; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Uhlen M, 2009, J MOL RECOGNIT, V22, P57, DOI 10.1002/jmr.891; WELLS JA, 1990, BIOCHEMISTRY-US, V29, P8509, DOI 10.1021/bi00489a001; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; Williams BAR, 2009, J AM CHEM SOC, V131, P17233, DOI 10.1021/ja9051735; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhang J, 2003, BIOCHEM BIOPH RES CO, V310, P1181, DOI 10.1016/j.bbrc.2003.09.141; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	46	10	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15432	10.1371/journal.pone.0015432	http://dx.doi.org/10.1371/journal.pone.0015432			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085650	gold, Green Published, Green Submitted			2022-12-27	WOS:000284087800022
J	Suhre, K; Meisinger, C; Doring, A; Altmaier, E; Belcredi, P; Gieger, C; Chang, D; Milburn, MV; Gall, WE; Weinberger, KM; Mewes, HW; de Angelis, MH; Wichmann, HE; Kronenberg, F; Adamski, J; Illig, T				Suhre, Karsten; Meisinger, Christa; Doering, Angela; Altmaier, Elisabeth; Belcredi, Petra; Gieger, Christian; Chang, David; Milburn, Michael V.; Gall, Walter E.; Weinberger, Klaus M.; Mewes, Hans-Werner; de Angelis, Martin Hrabe; Wichmann, H. -Erich; Kronenberg, Florian; Adamski, Jerzy; Illig, Thomas			Metabolic Footprint of Diabetes: A Multiplatform Metabolomics Study in an Epidemiological Setting	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; TARGETED METABOLOMICS; QUANTITATIVE-ANALYSIS; ACID CONCENTRATIONS; BIOLOGICAL-SYSTEMS; RENAL-FAILURE; AMINO-ACIDS; PLASMA; MELLITUS; METABONOMICS	Background: Metabolomics is the rapidly evolving field of the comprehensive measurement of ideally all endogenous metabolites in a biological fluid. However, no single analytic technique covers the entire spectrum of the human metabolome. Here we present results from a multiplatform study, in which we investigate what kind of results can presently be obtained in the field of diabetes research when combining metabolomics data collected on a complementary set of analytical platforms in the framework of an epidemiological study. Methodology/Principal Findings: 40 individuals with self-reported diabetes and 60 controls (male, over 54 years) were randomly selected from the participants of the population-based KORA (Cooperative Health Research in the Region of Augsburg) study, representing an extensively phenotyped sample of the general German population. Concentrations of over 420 unique small molecules were determined in overnight-fasting blood using three different techniques, covering nuclear magnetic resonance and tandem mass spectrometry. Known biomarkers of diabetes could be replicated by this multiple metabolomic platform approach, including sugar metabolites (1,5-anhydroglucoitol), ketone bodies (3-hydroxybutyrate), and branched chain amino acids. In some cases, diabetes-related medication can be detected (pioglitazone, salicylic acid). Conclusions/Significance: Our study depicts the promising potential of metabolomics in diabetes research by identification of a series of known and also novel, deregulated metabolites that associate with diabetes. Key observations include perturbations of metabolic pathways linked to kidney dysfunction (3-indoxyl sulfate), lipid metabolism (glycerophospholipids, free fatty acids), and interaction with the gut microflora (bile acids). Our study suggests that metabolic markers hold the potential to detect diabetes-related complications already under sub-clinical conditions in the general population.	[Suhre, Karsten; Altmaier, Elisabeth; Mewes, Hans-Werner] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany; [Suhre, Karsten] Univ Munich, Fac Biol, Planegg Martinsried, Germany; [Meisinger, Christa; Doering, Angela; Belcredi, Petra; Gieger, Christian; Wichmann, H. -Erich; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Chang, David] Chenomx, Edmonton, AB, Canada; [Milburn, Michael V.; Gall, Walter E.] Metabolon Inc, Durham, NC USA; [Weinberger, Klaus M.] Biocrates Life Sci AG, Innsbruck, Austria; [Mewes, Hans-Werner] Tech Univ Munich, Dept Genome Oriented Bioinformat, Life & Food Sci Ctr Weihenstephan, D-8050 Freising Weihenstephan, Germany; [de Angelis, Martin Hrabe; Adamski, Jerzy] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Expt Genet, Genome Anal Ctr, Neuherberg, Germany; [de Angelis, Martin Hrabe; Adamski, Jerzy] Tech Univ Munich, Life & Food Sci Ctr Weihenstephan, Inst Expt Genet, D-8050 Freising Weihenstephan, Germany; [Wichmann, H. -Erich] Ludwig Maximilians Univ Munchen, Inst Med Informat Biometry & Epidemiol, Munich, Germany; [Wichmann, H. -Erich] Univ Munich, Klinikum Grosshadern, D-8000 Munich, Germany; [Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Med Genet Mol & Clin Pharmacol, Innsbruck, Austria	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Metabolon; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; University of Munich; University of Munich; Medical University of Innsbruck	Suhre, K (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Bioinformat & Syst Biol, Neuherberg, Germany.	karsten.suhre@helmholtz-muenchen.de	Meisinger, Christine/B-5358-2014; de Angelis, Martin Hrabe/F-5531-2012; Suhre, Karsten/AAF-1778-2020; Kronenberg, Florian/B-1736-2008; Wichmann, Heinz Erich/AAA-5695-2022; Mewes, Hans-Werner/A-8204-2019	de Angelis, Martin Hrabe/0000-0002-7898-2353; Suhre, Karsten/0000-0001-9638-3912; Kronenberg, Florian/0000-0003-2229-1120; Meisinger, Christa/0000-0002-9026-6544; Adamski, Jerzy/0000-0001-9259-0199; Weinberger, Klaus/0000-0002-8947-5306; Gieger, Christian/0000-0001-6986-9554; Mewes, Hans-Werner/0000-0002-9713-6398	German Federal Ministry of Education, Science, Research and Technology [NGFNPlus: 01GS0823]; State of Bavaria; German National Genome Research Network [01GS0823]; Austrian Genome Research Programme GEN-AU; Munich Center of Health Sciences (MC Health); German Federal Ministry of Education and Research (BMBF) [0315494A]; German Center Diabetes Research (DZD e.V.)	German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German National Genome Research Network; Austrian Genome Research Programme GEN-AU; Munich Center of Health Sciences (MC Health); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Center Diabetes Research (DZD e.V.)	The Kooperative Gesundheitsforschung in der Region Augsburg (KORA) research platform and the Monitoring trends and determinants on cardiovascular diseases (MONICA) Augsburg studies were initiated and financed by the Helmholtz Zentrum Munchen - National Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFNPlus: 01GS0823) and by grants from the Genomics of Lipid-associated Disorders "GOLD" of the "Austrian Genome Research Programme GEN-AU". Part of this research was supported within the Munich Center of Health Sciences (MC Health) as part of LMUinnovativ. This study was also supported in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center Diabetes Research (DZD e.V.). E. Altmaier is supported by project SysMBo under BMBF MedSys grant No. 0315494A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADROGUE HJ, 1982, NEW ENGL J MED, V307, P1603, DOI 10.1056/NEJM198212233072603; Altmaier E, 2008, ENDOCRINOLOGY, V149, P3478, DOI 10.1210/en.2007-1747; Altmaier E, 2009, MOL NUTR FOOD RES, V53, P1357, DOI 10.1002/mnfr.200900116; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; BORGHI L, 1985, DIABETES, V34, P812, DOI 10.2337/diabetes.34.8.812; Buse John B, 2003, Diabetes Technol Ther, V5, P355, DOI 10.1089/152091503765691839; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Doring A, 2008, NAT GENET, V40, P430, DOI 10.1038/ng.107; Dumas ME, 2007, NAT GENET, V39, P666, DOI 10.1038/ng2026; Dumas ME, 2006, ANAL CHEM, V78, P2199, DOI 10.1021/ac0517085; Dungan KM, 2006, DIABETES CARE, V29, P1214, DOI 10.2337/dc06-1910; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Fujimoto Wilfred Y., 2000, American Journal of Medicine, V108, p9S; Gall WE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010883; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; GLANVILLE NT, 1985, CAN J PHYSIOL PHARM, V63, P487, DOI 10.1139/y85-084; GOLAY A, 1988, DIABETES METAB REV, V4, P727, DOI 10.1002/dmr.5610040803; Griffin JL, 2006, PHILOS T R SOC B, V361, P147, DOI 10.1098/rstb.2005.1734; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Holmes E, 2007, ANAL CHEM, V79, P2629, DOI 10.1021/ac062305n; ILLIG T, 2009, NAT GENET; Jankowski J, 2003, J CLIN INVEST, V112, P256, DOI 10.1172/JCI200315524; Lanza IR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010538; Lawton KA, 2008, PHARMACOGENOMICS, V9, P383, DOI 10.2217/14622416.9.4.383; Layman DK, 2003, J NUTR, V133, p261S, DOI 10.1093/jn/133.1.261S; Layman DK, 2006, J NUTR, V136, p319S, DOI 10.1093/jn/136.1.319S; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Li X, 2009, ANAL CHIM ACTA, V633, P257, DOI 10.1016/j.aca.2008.11.058; Lindon JC, 2007, FEBS J, V274, P1140, DOI 10.1111/j.1742-4658.2007.05673.x; Madsen R, 2010, ANAL CHIM ACTA, V659, P23, DOI 10.1016/j.aca.2009.11.042; Maier EM, 2009, CLIN GENET, V76, P179, DOI 10.1111/j.1399-0004.2009.01217.x; McGill JRB, 2004, DIABETES CARE, V27, P1859, DOI 10.2337/diacare.27.8.1859; Mooradian AD, 2009, NAT CLIN PRACT ENDOC, V5, P150, DOI 10.1038/ncpendmet1066; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Niwa T, 1996, SEMIN NEPHROL, V16, P167; NIWA T, 1994, J LAB CLIN MED, V124, P96; Norlund L, 1998, CLIN CHEM LAB MED, V36, P175, DOI 10.1515/CCLM.1998.032; PAULING L, 1971, P NATL ACAD SCI USA, V68, P2374, DOI 10.1073/pnas.68.10.2374; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; Roschinger W, 2003, EUR J PEDIATR, V162, pS67, DOI 10.1007/s00431-003-1356-y; RUDERMAN NB, 1975, ANNU REV MED, V26, P245, DOI 10.1146/annurev.me.26.020175.001333; SMITH EB, 1995, EUR HEART J, V16, P11, DOI 10.1093/eurheartj/16.suppl_A.11; SMITH EB, 1992, EUR J EPIDEMIOL, V8, P83, DOI 10.1007/BF00145356; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; VANNINI P, 1982, DIABETOLOGIA, V22, P217, DOI 10.1007/BF00283757; VINAYAVEKHIN N, 2009, ACS CHEM BIOL; Wang-Sattler R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003863; Watson AD, 2006, J LIPID RES, V47, P2101, DOI 10.1194/jlr.R600022-JLR200; Weljie AM, 2006, ANAL CHEM, V78, P4430, DOI 10.1021/ac060209g; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; Wichmann HE, 2005, GESUNDHEITSWESEN, V67, pS2; Wiesner P, 2009, J LIPID RES, V50, P574, DOI 10.1194/jlr.D800028-JLR200; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wollesen F, 1999, KIDNEY INT, V55, P1028, DOI 10.1046/j.1523-1755.1999.0550031028.x; Yared Z, 2003, Minerva Med, V94, P409	60	418	426	1	143	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13953	10.1371/journal.pone.0013953	http://dx.doi.org/10.1371/journal.pone.0013953			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085649	Green Published, Green Submitted, gold			2022-12-27	WOS:000284087800017
J	Li, MJ; Ma, FW; Liang, D; Li, JA; Wang, YL				Li, Mingjun; Ma, Fengwang; Liang, Dong; Li, Juan; Wang, Yanlei			Ascorbate Biosynthesis during Early Fruit Development Is the Main Reason for Its Accumulation in Kiwi	PLOS ONE			English	Article							GAMMA-LACTONE DEHYDROGENASE; VITAMIN-C; ARABIDOPSIS-THALIANA; MONODEHYDROASCORBATE REDUCTASE; ACID BIOSYNTHESIS; GDP-MANNOSE; PLANT; EXPRESSION; GENES; L-GALACTONO-1,4-LACTONE	Background: Ascorbic acid (AsA) is a unique antioxidant as well as an enzyme cofactor. Although it has multiple roles in plants, it is unclear how its accumulation is controlled at the expression level, especially in sink tissues. Kiwifruit (Actinidia) is well-known for its high ascorbate content. Our objective was to determine whether AsA accumulates in the fruits primarily through biosynthesis or because it is imported from the foliage. Methodology/Principal Findings: We systematically investigated AsA levels, biosynthetic capacity, and mRNA expression of genes involved in AsA biosynthesis in kiwi (A. deliciosa cv. Qinmei). Recycling and AsA localization were also monitored during fruit development and among different tissue types. Over time, the amount of AsA, with its capacity for higher biosynthesis and lower recycling, peaked at 30 days after anthesis (DAA), and then decreased markedly up to 60 DAA before declining more slowly. Expression of key genes showed similar patterns of change, except for L-galactono-1,4-lactone dehydrogenase and L-galactose-1-phosphate phosphatase (GPP). However, GPP had good correlation with the rate of AsA accumulation. The expression of these genes could be detected in phloem of stem as well as petiole of leaf and fruit. Additionally, fruit petioles had greater ascorbate amounts, although that was the site of lowest expression by most genes. Fruit microtubule tissues also had higher AsA. However, exogenous applications of AsA to those petioles did not lead to its transport into fruits, and distribution of ascorbate was cell-specific in the fruits, with more accumulation occurring in larger cells. Conclusions: These results suggest that AsA biosynthesis in kiwi during early fruit development is the main reason for its accumulation in the fruits. We also postulate here that GPP is a good candidate for regulating AsA biosynthesis whereas GDP-L-galactose-1-phosphate phosphorylase is not.	[Li, Mingjun; Ma, Fengwang; Liang, Dong; Li, Juan; Wang, Yanlei] NW A&F Univ, Coll Hort, Yangling, Peoples R China	Northwest A&F University - China	Li, MJ (corresponding author), NW A&F Univ, Coll Hort, Yangling, Peoples R China.	fwm64@sina.com	Li, Mingjun/D-4705-2011	Li, Mingjun/0000-0001-5508-895X	National Natural Science Foundation of China [30871700]; Research Fund for the Doctoral Program of Higher Education [20090204110009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education(Research Fund for the Doctoral Program of Higher Education of China (RFDP))	This work was supported by the National Natural Science Foundation of China (30871700) and The Research Fund for the Doctoral Program of Higher Education (20090204110009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alhagdow M, 2007, PLANT PHYSIOL, V145, P1408, DOI 10.1104/pp.107.106500; Badejo AA, 2009, J PLANT PHYSIOL, V166, P652, DOI 10.1016/j.jplph.2008.09.004; Badejo AA, 2009, PLANT CELL PHYSIOL, V50, P423, DOI 10.1093/pcp/pcn206; Bartoli CG, 2005, PLANT CELL ENVIRON, V28, P1073, DOI 10.1111/j.1365-3040.2005.01338.x; Bermudez L, 2008, J EXP BOT, V59, P2875, DOI 10.1093/jxb/ern146; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bulley SM, 2009, J EXP BOT, V60, P765, DOI 10.1093/jxb/ern327; CHATTERJEE IB, 1960, BIOCHEM J, V74, P193, DOI 10.1042/bj0740193; Chen Z, 2003, P NATL ACAD SCI USA, V100, P3525, DOI 10.1073/pnas.0635176100; CHINOY NJ, 1969, HISTOCHEMISTRY, V20, P105, DOI 10.1007/BF00268703; Conklin PL, 2006, J BIOL CHEM, V281, P15662, DOI 10.1074/jbc.M601409200; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; DIMATTEO A, 2003, COMP BIOCH PHYSL A, V134, pS155; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Eltayeb AE, 2007, PLANTA, V225, P1255, DOI 10.1007/s00425-006-0417-7; Franceschi VR, 2002, PLANT PHYSIOL, V130, P649, DOI 10.1104/pp.007062; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Gatzek S, 2002, PLANT J, V30, P541, DOI 10.1046/j.1365-313X.2002.01315.x; Gilbert L, 2009, PLANT J, V60, P499, DOI 10.1111/j.1365-313X.2009.03972.x; Hancock RD, 2005, CRIT REV PLANT SCI, V24, P167, DOI 10.1080/07352680591002165; Hancock RD, 2008, PHYTOCHEMISTRY, V69, P1850, DOI 10.1016/j.phytochem.2008.03.022; Hancock RD, 2007, FUNCT PLANT BIOL, V34, P1080, DOI 10.1071/FP07221; Hancock Robert D., 2003, BMC Plant Biology, V3, P7, DOI 10.1186/1471-2229-3-7; Imai T, 2009, PHYSIOL PLANTARUM, V136, P139, DOI 10.1111/j.1399-3054.2009.01213.x; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; Ishikawa T, 2006, PHYSIOL PLANTARUM, V126, P343, DOI 10.1111/j.1399-3054.2006.00640.x; KING RW, 1974, PLANT PHYSIOL, V53, P96, DOI 10.1104/pp.53.1.96; Laing WA, 2004, P NATL ACAD SCI USA, V101, P16976, DOI 10.1073/pnas.0407453101; Leferink NGH, 2008, FEBS J, V275, P713, DOI 10.1111/j.1742-4658.2007.06233.x; Li MJ, 2008, PLANT SCI, V174, P606, DOI 10.1016/j.plantsci.2008.03.008; Li MJ, 2010, PLANT PHYSIOL BIOCH, V48, P216, DOI 10.1016/j.plaphy.2010.01.015; Li Y, 2007, J NUTR, V137, P2171, DOI 10.1093/jn/137.10.2171; Linster CL, 2007, J BIOL CHEM, V282, P18879, DOI 10.1074/jbc.M702094200; Linster CL, 2008, TRENDS PLANT SCI, V13, P567, DOI 10.1016/j.tplants.2008.08.005; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Loscos J, 2008, PLANT PHYSIOL, V146, P1282, DOI 10.1104/pp.107.114066; Ma FW, 2003, PLANT SCI, V165, P819, DOI 10.1016/S0168-9452(03)00277-2; Maruta T, 2008, J BIOL CHEM, V283, P28842, DOI 10.1074/jbc.M805538200; Maurino VG, 2006, PLANT CELL PHYSIOL, V47, P1381, DOI 10.1093/pcp/pcl011; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; OBA K, 1995, J BIOCHEM, V117, P120, DOI 10.1093/oxfordjournals.jbchem.a124697; Pallanca JE, 1999, PLANT PHYSIOL, V120, P453, DOI 10.1104/pp.120.2.453; Petersen LN, 2010, PLANT PHYSIOL, V152, P1186, DOI 10.1104/pp.109.150805; Rokni Zadeh H, 2007, Commun Agric Appl Biol Sci, V72, P269; Stevens R, 2008, PLANT CELL ENVIRON, V31, P1086, DOI 10.1111/j.1365-3040.2008.01824.x; Tedone Luigi, 2004, BMC Plant Biology, V4, P16, DOI 10.1186/1471-2229-4-16; Torabinejad J, 2009, PLANT PHYSIOL, V150, P951, DOI 10.1104/pp.108.135129; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Zhang W, 2008, PLANT PHYSIOL, V146, P431, DOI 10.1104/pp.107.109934	51	51	62	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14281	10.1371/journal.pone.0014281	http://dx.doi.org/10.1371/journal.pone.0014281			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151561	Green Submitted, Green Published, gold			2022-12-27	WOS:000285135800012
J	Ruhe, ZC; Hayes, CS				Ruhe, Zachary C.; Hayes, Christopher S.			The N-Terminus of GalE Induces tmRNA Activity in Escherichia coli	PLOS ONE			English	Article							MESSENGER-RNA CLEAVAGE; MEDIATED TRANS-TRANSLATION; PEPTIDE-TAGGING ACTIVITY; A-SITE; STOP CODONS; BACILLUS-SUBTILIS; PROTEIN-SYNTHESIS; NASCENT-PEPTIDE; TAGGED PROTEINS; QUALITY-CONTROL	Background: The tmRNA quality control system recognizes stalled translation complexes and facilitates ribosome recycling in a process termed 'ribosome rescue'. During ribosome rescue, nascent chains are tagged with the tmRNA-encoded SsrA peptide, which targets tagged proteins for degradation. In Escherichia coli, tmRNA rescues ribosomes arrested on truncated messages, as well as ribosomes that are paused during elongation and termination. Methodology/Principal Findings: Here, we describe a new translational pausing determinant that leads to SsrA peptide tagging of the E. coli GalE protein (UDP-galactose 4-epimerase). GalE chains are tagged at more than 150 sites, primarily within distinct clusters throughout the C-terminal domain. These tagging sites do not correspond to rare codon clusters and synonymous recoding of the galE gene had little effect on tagging. Moreover, tagging was largely unaffected by perturbations that either stabilize or destabilize the galE transcript. Examination of GalE-thioredoxin (TrxA) fusion proteins showed that the GalE C-terminal domain is no longer tagged when fused to an N-terminal TrxA domain. Conversely, the N-terminus of GalE induced tagging within the fused C-terminal TrxA domain. Conclusions/Significance: These findings suggest that translation of the GalE N-terminus induces subsequent tagging of the C-terminal domain. We propose that co-translational maturation of the GalE N-terminal domain influences ribosome pausing and subsequent tmRNA activity.	[Ruhe, Zachary C.; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Ruhe, ZC (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu	Hayes, Christopher/A-5505-2009		National Institutes of Health (NIH) [GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported by an award from the National Institutes of Health (NIH)(GM078634). The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abo T, 2000, EMBO J, V19, P3762, DOI 10.1093/emboj/19.14.3762; ALIX JH, 1993, P NATL ACAD SCI USA, V90, P9725, DOI 10.1073/pnas.90.20.9725; Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BABITZKE P, 1991, P NATL ACAD SCI USA, V88, P1, DOI 10.1073/pnas.88.1.1; BABITZKE P, 1993, J BACTERIOL, V175, P229, DOI 10.1128/JB.175.1.229-239.1993; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Christensen SK, 2004, MOL MICROBIOL, V51, P1705, DOI 10.1046/j.1365-2958.2003.03941.x; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen T, 2009, PROTEIN SCI, V18, P1377, DOI 10.1002/pro.157; Christensen-Dalsgaard M, 2010, MOL MICROBIOL, V75, P333, DOI 10.1111/j.1365-2958.2009.06969.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Collier J, 2002, MOL MICROBIOL, V45, P745, DOI 10.1046/j.1365-2958.2002.03045.x; Cruz-Vera LR, 2005, MOL CELL, V19, P333, DOI 10.1016/j.molcel.2005.06.013; Deuerling E, 1999, NATURE, V400, P693, DOI 10.1038/23301; Du T, 2004, CURRENT PROTOCOLS MO; Fujihara A, 2002, GENES CELLS, V7, P343, DOI 10.1046/j.1365-2443.2002.00523.x; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gong F, 2002, SCIENCE, V297, P1864, DOI 10.1126/science.1073997; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jourdan SS, 2008, MOL MICROBIOL, V67, P102, DOI 10.1111/j.1365-2958.2007.06028.x; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kobayashi K, 2008, MICROBIOL-SGM, V154, P54, DOI 10.1099/mic.0.2007/011783-0; Komar AA, 2009, TRENDS BIOCHEM SCI, V34, P16, DOI 10.1016/j.tibs.2008.10.002; Kramer G, 2002, NATURE, V419, P171, DOI 10.1038/nature01047; LAVALLIE ER, 1993, BIO-TECHNOL, V11, P187, DOI 10.1038/nbt0293-187; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Lin-Chao S, 1999, P NATL ACAD SCI USA, V96, P12406, DOI 10.1073/pnas.96.22.12406; Maki JA, 2002, MOL CELL, V10, P129, DOI 10.1016/S1097-2765(02)00562-2; MUDD EA, 1990, MOL MICROBIOL, V4, P2127, DOI 10.1111/j.1365-2958.1990.tb00574.x; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Nakatogawa H, 2001, MOL CELL, V7, P185, DOI 10.1016/S1097-2765(01)00166-6; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; REGNIER P, 1990, BIOCHIMIE, V72, P825, DOI 10.1016/0300-9084(90)90192-J; REGNIER P, 1989, J MOL BIOL, V210, P293, DOI 10.1016/0022-2836(89)90331-8; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Roche ED, 2001, J BIOL CHEM, V276, P28509, DOI 10.1074/jbc.M103864200; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; SORENSEN MA, 1989, J MOL BIOL, V207, P365, DOI 10.1016/0022-2836(89)90260-X; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Thoden JB, 1996, PROTEIN SCI, V5, P2149, DOI 10.1002/pro.5560051102; Thoden JB, 1996, BIOCHEMISTRY-US, V35, P2557, DOI 10.1021/bi952715y; Tsai CJ, 2008, J MOL BIOL, V383, P281, DOI 10.1016/j.jmb.2008.08.012; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200	65	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15207	10.1371/journal.pone.0015207	http://dx.doi.org/10.1371/journal.pone.0015207			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151867	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800010
J	He, M; Su, HR; Gao, WW; Johansson, SM; Liu, Q; Wu, XY; Liao, JY; Young, AA; Bartfai, T; Wang, MW				He, Min; Su, Haoran; Gao, Weiwei; Johansson, Stina M.; Liu, Qing; Wu, Xiaoyan; Liao, Jiayu; Young, Andrew A.; Bartfai, Tamas; Wang, Ming-Wei			Reversal of Obesity and Insulin Resistance by a Non-Peptidic Glucagon-Like Peptide-1 Receptor Agonist in Diet-Induced Obese Mice	PLOS ONE			English	Article							BETA-CELL; GLUCOSE-TRANSPORT; LIPID-METABOLISM; BODY-WEIGHT; HIGH-FAT; EXENATIDE EXENDIN-4; ENERGY HOMEOSTASIS; HEPATIC BIOMARKERS; DIABETES-MELLITUS; HDL CHOLESTEROL	Background: Glucagon-like peptide-1 (GLP-1) is recognized as an important regulator of glucose homeostasis. Efforts to utilize GLP-1 mimetics in the treatment of diabetes have yielded clinical benefits. A major hurdle for an effective oral therapy has been the difficulty of finding a non-peptidic GLP-1 receptor (GLP-1R) agonist. While its oral bioavailability still poses significant challenges, Boc5, one of the first such compounds, has demonstrated the attainment of GLP-1R agonism in diabetic mice. The present work was to investigate whether subchronic Boc5 treatment can restore glycemic control and induce sustainable weight loss in diet-induced obese (DIO) mice, an animal model of human obesity and insulin resistance. Methodology/Principal Findings: DIO mice were treated three times a week with Boc5 (0.3, 1 and 3 mg) for 12 weeks. Body weight, body mass index (BMI), food intake, fasting glucose, intraperitoneal glucose tolerance and insulin induced glucose clearance were monitored regularly throughout the treatment. Glucose-stimulated insulin secretion, beta-cell mass, islet size, body composition, serum metabolic profiles, lipogenesis, lipolysis, adipose hypertrophy and lipid deposition in the liver and muscle were also measured after 12 weeks of dosing. Boc5 dose-dependently reduced body weight, BMI and food intake in DIO mice. These changes were associated with significant decreases in fat mass, adipocyte hypertrophy and peripheral tissue lipid accumulation. Boc5 treatment also restored glycemic control through marked improvement of insulin sensitivity and normalization of beta-cell mass. Administration of Boc5 (3 mg) reduced basal but enhanced insulin-mediated glucose incorporation and noradrenaline-stimulated lipolysis in isolated adipocytes from obese mice. Furthermore, circulating leptin, adiponectin, triglyceride, total cholesterol, nonesterified fatty acid and high-density lipoprotein/low-density lipoprotein ratio were normalized to various extents by Boc5 treatment. Conclusions/Significance: Boc5 may produce metabolic benefits via multiple synergistic mechanisms and may represent an attractive tool for therapeutic intervention of obesity and diabetes, by means of non-peptidic GLP-1R agonism.	[He, Min; Su, Haoran; Gao, Weiwei; Johansson, Stina M.; Liu, Qing; Wu, Xiaoyan; Liao, Jiayu; Young, Andrew A.; Wang, Ming-Wei] Natl Ctr Drug Screening, Shanghai, Peoples R China; [He, Min; Liu, Qing; Wu, Xiaoyan; Wang, Ming-Wei] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China; [Bartfai, Tamas; Wang, Ming-Wei] Scripps Res Inst, Mol & Integrat Neurosci Dept, La Jolla, CA 92037 USA	Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Scripps Research Institute	He, M (corresponding author), Natl Ctr Drug Screening, Shanghai, Peoples R China.	wangmw@mail.shcnc.ac.cn	Liu, Qing/AAO-8151-2020	Liu, Qing/0000-0003-1825-6760	Ministry of Science and Technology of China [2009ZX09302-001]; Chinese Academy of Sciences [KSCX1-YW-02-2, KSCX2-YW-R-17]; Natural Science Foundation of China [30628024, 30623008]; Shanghai Science and Technology Development Fund [08DZ2291300, 09DZ2291200, 074319114]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Development Fund	This work was supported in part by grants from the Ministry of Science and Technology of China (2009ZX09302-001), the Chinese Academy of Sciences (KSCX1-YW-02-2 and KSCX2-YW-R-17), the Natural Science Foundation of China (30628024 and 30623008), Shanghai Science and Technology Development Fund (08DZ2291300, 09DZ2291200 and 074319114) and the CAS-Novo Nordisk Research Fund. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2007, REGUL PEPTIDES, V143, P97, DOI 10.1016/j.regpep.2007.03.008; Amori RE, 2007, JAMA-J AM MED ASSOC, V298, P194, DOI 10.1001/jama.298.2.194; Arner P, 2005, BEST PRACT RES CL EN, V19, P471, DOI 10.1016/j.beem.2005.07.004; ARNER P, 1987, AM J PHYSIOL, V253, pE193, DOI 10.1152/ajpendo.1987.253.2.E193; Badman MK, 2005, SCIENCE, V307, P1909, DOI 10.1126/science.1109951; Bays HE, 2004, OBES RES, V12, P1197, DOI 10.1038/oby.2004.151; Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; Bray GA, 2004, J CLIN ENDOCR METAB, V89, P2583, DOI 10.1210/jc.2004-0535; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Buse JB, 2007, DIABETES CARE, V30, P162, DOI 10.2337/dc07-9917; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Colagiuri S, 2010, DIABETES OBES METAB, V12, P463, DOI 10.1111/j.1463-1326.2009.01182.x; Crowe S, 2008, ENDOCRINOLOGY, V149, P2546, DOI 10.1210/en.2007-1447; Dietz WH, 1998, J PEDIATR-US, V132, P191; Ding XK, 2006, HEPATOLOGY, V43, P173, DOI 10.1002/hep.21006; Field BCT, 2008, DRUGS, V68, P147, DOI 10.2165/00003495-200868020-00002; Flint A, 1998, J CLIN INVEST, V101, P515, DOI 10.1172/JCI990; FOLCH J, 1957, J BIOL CHEM, V226, P497; FREDHOLM BB, 1985, METHOD PHARMACOL, P337; Gale SM, 2004, J NUTR, V134, P295, DOI 10.1093/jn/134.2.295; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Gedulin BR, 2005, ENDOCRINOLOGY, V146, P2069, DOI 10.1210/en.2004-1349; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; HARRIS RBS, 1984, AM J PHYSIOL, V247, pR380, DOI 10.1152/ajpregu.1984.247.2.R380; HAYEK T, 1993, J CLIN INVEST, V91, P1665, DOI 10.1172/JCI116375; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Imeryuz N, 1997, AM J PHYSIOL-GASTR L, V273, pG920, DOI 10.1152/ajpgi.1997.273.4.G920; Inuwa IM, 2005, J ANAT, V206, P185, DOI 10.1111/j.1469-7580.2005.00367.x; Johansson SM, 2007, ACTA PHYSIOL, V190, P87, DOI 10.1111/j.1365-201X.2007.01692.x; JohanssonA SM, 2008, EUR J PHARMACOL, V597, P92, DOI 10.1016/j.ejphar.2008.08.022; JOHNSON PR, 1972, J LIPID RES, V13, P2; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Kobayashi-Hattori K, 2005, BIOSCI BIOTECH BIOCH, V69, P2219, DOI 10.1271/bbb.69.2219; Kopelman PG, 2000, NATURE, V404, P635, DOI 10.1038/35007508; Langin D, 2005, DIABETES, V54, P3190, DOI 10.2337/diabetes.54.11.3190; Large V, 2004, DIABETES METAB, V30, P294, DOI 10.1016/S1262-3636(07)70121-0; LAURELL S, 1966, CLIN CHIM ACTA, V13, P317, DOI 10.1016/0009-8981(66)90210-5; Li LX, 2006, ENDOCRINOLOGY, V147, P3318, DOI 10.1210/en.2006-0155; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MacGregor RR, 2006, AM J PHYSIOL-ENDOC M, V290, pE771, DOI 10.1152/ajpendo.00097.2005; Mack CM, 2006, INT J OBESITY, V30, P1332, DOI 10.1038/sj.ijo.0803284; Maggio CA, 2003, ENDOCRIN METAB CLIN, V32, P805, DOI 10.1016/S0889-8529(03)00071-9; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Meier Juris J, 2004, Curr Opin Investig Drugs, V5, P402; MERIDA E, 1993, J CLIN ENDOCR METAB, V77, P1654, DOI 10.1210/jc.77.6.1654; Mizuno A, 1997, METABOLISM, V46, P745, DOI 10.1016/S0026-0495(97)90117-7; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Murphy KG, 2007, P NATL ACAD SCI USA, V104, P689, DOI 10.1073/pnas.0610679104; Olleros ML, 2008, CYTOKINE, V44, P118, DOI 10.1016/j.cyto.2008.07.001; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Pajvani Utpal B, 2003, Curr Diab Rep, V3, P207, DOI 10.1007/s11892-003-0065-2; Parekh PI, 1998, METABOLISM, V47, P1089, DOI 10.1016/S0026-0495(98)90283-9; Parkes D, 2001, DRUG DEVELOP RES, V53, P260, DOI 10.1002/ddr.1195; Petro AE, 2004, METABOLISM, V53, P454, DOI 10.1016/j.metabol.2003.11.018; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Raun K, 2007, DIABETES, V56, P8, DOI 10.2337/db06-0565; REYNISDOTTIR S, 1994, DIABETOLOGIA, V37, P428, DOI 10.1007/s001250050128; RODBELL M, 1964, J BIOL CHEM, V239, P375; Ryysy L, 2000, DIABETES, V49, P749, DOI 10.2337/diabetes.49.5.749; Sancho V, 2005, J MOL ENDOCRINOL, V35, P27, DOI 10.1677/jme.1.01747; Sancho V, 2006, INT J MOL MED, V17, P1133; Schreyer SA, 1998, ATHEROSCLEROSIS, V136, P17, DOI 10.1016/S0021-9150(97)00165-2; Severinsen T, 1999, ACTA PHYSIOL SCAND, V165, P299, DOI 10.1046/j.1365-201x.1999.00488.x; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Spiegelman BM, 1996, CELL, V87, P377, DOI 10.1016/S0092-8674(00)81359-8; Stone NJ, 2000, MED CLIN N AM, V84, P95, DOI 10.1016/S0025-7125(05)70209-1; Su HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002892; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Talior I, 2003, AM J PHYSIOL-ENDOC M, V285, pE295, DOI 10.1152/ajpendo.00044.2003; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Tiessen RG, 2008, INT J CLIN PHARM TH, V46, P443; Villanueva-Penacarrillo ML, 2001, HORM METAB RES, V33, P73, DOI 10.1055/s-2001-12428; Wadden TA, 2000, MED CLIN N AM, V84, P441, DOI 10.1016/j.psc.2004.09.008; WEST DB, 1992, AM J PHYSIOL, V262, pR1025, DOI 10.1152/ajpregu.1992.262.6.R1025; Winzell MS, 2004, DIABETES, V53, pA359; Wolf G, 1996, NUTR REV, V54, P34; Wren AM, 2008, FRONT HORM RES, V36, P165, DOI 10.1159/000115364; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yki-Jarvinen H, 2005, CURR MOL MED, V5, P287, DOI 10.2174/1566524053766031; Young AA, 2002, FRONT ANIM DIAB RES, V5, P235; Zimmermann R, 2003, J LIPID RES, V44, P2089, DOI 10.1194/jlr.M300190-JLR200	97	45	50	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14205	10.1371/journal.pone.0014205	http://dx.doi.org/10.1371/journal.pone.0014205			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151924	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600002
J	Najafi, I; Attari, F; Islami, F; Shakeri, R; Malekzadeh, F; Salahi, R; Gharavi, MY; Hosseini, M; Broumand, B; Haghighi, AN; Larijani, B; Malekzadeh, R				Najafi, Iraj; Attari, Fatemeh; Islami, Farhad; Shakeri, Ramin; Malekzadeh, Fatemeh; Salahi, Rasool; Gharavi, Mina Yapan; Hosseini, Mostafa; Broumand, Behrooz; Haghighi, Ali Nobakht; Larijani, Bagher; Malekzadeh, Reza			Renal Function and Risk Factors of Moderate to Severe Chronic Kidney Disease in Golestan Province, Northeast of Iran	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; GLOMERULAR-FILTRATION-RATE; 3RD NATIONAL-HEALTH; UNITED-STATES; SERUM CREATININE; PREVALENCE; POPULATION; ADULTS; EPIDEMIOLOGY; HYPERTENSION	Introduction: The incidence of end-stage renal disease is increasing worldwide. Earlier studies reported high prevalence rates of obesity and hypertension, two major risk factors of chronic kidney disease (CKD), in Golestan Province, Iran. We aimed to investigate prevalence of moderate to severe CKD and its risk factors in the region. Methods: Questionnaire data and blood samples were collected from 3591 participants (>= 18 years old) from the general population. Based on serum creatinine levels, glomerular filtration rate (GFR) was estimated. Results: High body mass index (BMI) was common: 35.0% of participants were overweight (BMI 25-29.9) and 24.5% were obese (BMI >= 30). Prevalence of CKD stages 3 to 5 (CKD-S3-5), i.e., GFR,60 mL/min/1.73 m(2), was 4.6%. The odds ratio (OR) and 95% confidence interval (95% CI) for the risk of CKD-S3-5 associated with every year increase in age was 1.13 (1.11-1.15). Men were at lower risk of CKD-S3-5 than women (OR = 0.28; 95% CI 0.18-0.45). Obesity (OR = 1.78; 95% CI 1.04-3.05) and self-reported diabetes (OR = 1.70; 95% CI 1.00-2.86), hypertension (OR = 3.16; 95% CI 2.02-4.95), ischemic heart disease (OR = 2.73; 95% CI 1.55-4.81), and myocardial infarction (OR = 2.69; 95% CI 1.14-6.32) were associated with increased risk of CKD-S3-5 in the models adjusted for age and sex. The association persisted for self-reported hypertension even after adjustments for BMI and history of diabetes (OR = 2.85; 95% CI 1.77-4.59). Conclusion: A considerable proportion of inhabitants in Golestan have CKD-S3-5. Screening of individuals with major risk factors of CKD, in order to early detection and treatment of impaired renal function, may be plausible. Further studies on optimal risk prediction of future end-stage renal disease and effectiveness of any screening program are warranted.	[Najafi, Iraj; Attari, Fatemeh] Univ Tehran Med Sci, Shariati Hosp, Nephrol Res Ctr, Tehran, Iran; [Islami, Farhad; Shakeri, Ramin; Malekzadeh, Fatemeh; Gharavi, Mina Yapan; Malekzadeh, Reza] Univ Tehran Med Sci, Shariati Hosp, Digest Dis Res Ctr, Tehran, Iran; [Islami, Farhad] Int Agcy Res Canc, F-69372 Lyon, France; [Salahi, Rasool] Golestan Univ Med Sci, Golestan Res Ctr Gastroenterol & Hepatol, Gorgan, Iran; [Hosseini, Mostafa] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Broumand, Behrooz; Haghighi, Ali Nobakht] IR Iran Acad Med Sci, Clin Sci Study Grp Iran, Tehran, Iran; [Larijani, Bagher] Univ Tehran Med Sci, Shariati Hosp, Endocrinol & Metab Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; World Health Organization; International Agency for Research on Cancer (IARC); Golestan University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Najafi, I (corresponding author), Univ Tehran Med Sci, Shariati Hosp, Nephrol Res Ctr, Tehran, Iran.	rshakeri@gmail.com	larijani, Bagher/ABE-3315-2020; Malekzadeh, Reza/U-1382-2017	larijani, Bagher/0000-0001-5386-7597; Malekzadeh, Reza/0000-0002-9820-6335; Malekzadeh, Reza/0000-0003-1043-3814; Islami, Farhad/0000-0002-7357-5994; , Ramin/0000-0003-0487-3629; hosseini, mostafa/0000-0002-1334-246X	Iranian Academy of Medical Sciences [1/3152]	Iranian Academy of Medical Sciences	The study was funded by the Iranian Academy of Medical Sciences. The grant number is 1/3152. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami H, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-158; Barsoum RS, 2006, NEW ENGL J MED, V354, P997, DOI 10.1056/NEJMp058318; Brosnahan G, 2010, SOUTH MED J, V103, P140, DOI 10.1097/SMJ.0b013e3181c99438; Brown WW, 2003, AM J KIDNEY DIS, V42, P22, DOI 10.1016/S0272-6386(03)00405-0; Chadban SJ, 2003, J AM SOC NEPHROL, V14, pS131, DOI 10.1097/01.ASN.0000070152.11927.4A; Chambers John C, 2002, Semin Vasc Med, V2, P199, DOI 10.1055/s-2002-32043; Chen J, 2005, KIDNEY INT, V68, P2837, DOI 10.1111/j.1523-1755.2005.00757.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2003, AM J KIDNEY DIS, V41, P1, DOI 10.1053/ajkd.2003.50007; Coresh J, 2001, ARCH INTERN MED, V161, P1207, DOI 10.1001/archinte.161.9.1207; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; DUBIOS D, 1916, ANN INTERN MED, V17, P9; Ebrahimi M, 2010, J HYPERTENS, V28, P1620, DOI 10.1097/HJH.0b013e32833a38f2; Eknoyan G, 2001, POSTGRAD MED, V110, P23, DOI 10.3810/pgm.2001.09.1024; Goolsby Mary Jo, 2002, J Am Acad Nurse Pract, V14, P238, DOI 10.1111/j.1745-7599.2002.tb00119.x; Guarnieri G, 2010, J RENAL NUTR, V20, pS19, DOI 10.1053/j.jrn.2010.05.006; Hallan SI, 2010, J NEPHROL, V23, P147; Hosseinpanah F, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-44; Imai Enyu, 2007, Clin Exp Nephrol, V11, P156, DOI 10.1007/s10157-007-0463-x; Islami F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b929; Itoh K, 2003, ANN NUCL MED, V17, P561, DOI 10.1007/BF03006669; Kausz AT, 2001, J AM SOC NEPHROL, V12, P1501, DOI 10.1681/ASN.V1271501; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; MAHDAVIMAZDEH M, REN FAIL, V32, P62; Malekzadeh F, 2010, INT J CLIN PRACT, V64, P1220, DOI 10.1111/j.1742-1241.2010.02412.x; McClellan WM, 1997, AM J KIDNEY DIS, V29, P368, DOI 10.1016/S0272-6386(97)90197-9; Minino A M, 2001, Natl Vital Stat Rep, V49, P1; Nomura I, 2009, VASC HEALTH RISK MAN, V5, P315; Ong-Ajyooth L, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-35; PERRONE RD, 1992, CLIN CHEM, V38, P1933; Pourshams A, 2010, INT J EPIDEMIOL, V39, P52, DOI 10.1093/ije/dyp161; Ramirez SPB, 2002, J AM SOC NEPHROL, V13, P1907, DOI 10.1097/01.ASN.0000018406.20282.C8; Safarinejad MR, 2009, J NEPHROL, V22, P99; Saydah S., 2007, Morbidity and Mortality Weekly Report, V56, P161; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Singh RB, 2000, J HUM HYPERTENS, V14, P749, DOI 10.1038/sj.jhh.1001057; VARMA PP, 2010, NEPHROL DIAL TRANSPL; Zhang LX, 2008, AM J KIDNEY DIS, V51, P373, DOI 10.1053/j.ajkd.2007.11.009; Zhang QL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-117	40	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14216	10.1371/journal.pone.0014216	http://dx.doi.org/10.1371/journal.pone.0014216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151983	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600009
J	van Herpen, TWJM; Cankar, K; Nogueira, M; Bosch, D; Bouwmeester, HJ; Beekwilder, J				van Herpen, Teun W. J. M.; Cankar, Katarina; Nogueira, Marilise; Bosch, Dirk; Bouwmeester, Harro J.; Beekwilder, Jules			Nicotiana benthamiana as a Production Platform for Artemisinin Precursors	PLOS ONE			English	Article							ANTIMALARIAL-DRUG ARTEMISININ; EXPRESSION SYSTEM; MOLECULAR-CLONING; PLANTS; BIOSYNTHESIS; ANNUA; REDUCTASE; TOBACCO; YIELD; ACID	Background: Production of pharmaceuticals in plants provides an alternative for chemical synthesis, fermentation or natural sources. Nicotiana benthamiana is deployed at commercial scale for production of therapeutic proteins. Here the potential of this plant is explored for rapid production of precursors of artemisinin, a sesquiterpenoid compound that is used for malaria treatment. Methodology/Principal Findings: Biosynthetic genes leading to artemisinic acid, a precursor of artemisinin, were combined and expressed in N. benthamiana by agro-infiltration. The first committed precursor of artemisinin, amorpha-4,11-diene, was produced upon infiltration of a construct containing amorpha-4,11-diene synthase, accompanied by 3-hydroxy-3-methylglutaryl-CoA reductase and farnesyl diphosphate synthase. Amorpha-4,11-diene was detected both in extracts and in the headspace of the N. benthamiana leaves. When the amorphadiene oxidase CYP71AV1 was co-infiltrated with the amorphadiene-synthesizing construct, the amorpha-4,11-diene levels strongly decreased, suggesting it was oxidized. Surprisingly, no anticipated oxidation products, such as artemisinic acid, were detected upon GC-MS analysis. However, analysis of leaf extracts with a non-targeted metabolomics approach, using LC-QTOF-MS, revealed the presence of another compound, which was identified as artemisinic acid-12-beta-diglucoside. This compound accumulated to 39.5 mg.kg(-1) fwt. Apparently the product of the heterologous pathway that was introduced, artemisinic acid, is further metabolized efficiently by glycosyl transferases that are endogenous to N. benthamiana. Conclusion/Significance: This work shows that agroinfiltration of N. bentamiana can be used as a model to study the production of sesquiterpenoid pharmaceutical compounds. The interaction between the ectopically introduced pathway and the endogenous metabolism of the plant is discussed.	[van Herpen, Teun W. J. M.; Cankar, Katarina; Nogueira, Marilise; Bouwmeester, Harro J.; Beekwilder, Jules] Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands; [Bosch, Dirk; Beekwilder, Jules] Plant Res Int, Wageningen, Netherlands; [Bosch, Dirk] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands	Wageningen University & Research; Utrecht University	van Herpen, TWJM (corresponding author), Wageningen Univ, Lab Plant Physiol, Wageningen, Netherlands.	jules.beekwilder@wur.nl	Beekwilder, Jules/A-6802-2011; Bouwmeester, Harro J/C-1414-2008	Beekwilder, Jules/0000-0003-3238-4427; Bouwmeester, Harro/0000-0003-0907-2732; Cankar, Katarina/0000-0001-5149-4192	Dutch science foundation NWO [053.63.305]; Dafra Pharma RD	Dutch science foundation NWO(Netherlands Organization for Scientific Research (NWO)); Dafra Pharma RD	This work has been supported by grant 053.63.305 of the IBOS (Integration of Biosynthesis and Organic Synthesis) program of the ACTS (Advanced Chemical Technologies for Sustainability) platform, funded by the Dutch science foundation NWO. Additional support was supplied by Dafra Pharma R&D. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharoni A, 2005, TRENDS PLANT SCI, V10, P594, DOI 10.1016/j.tplants.2005.10.005; [Anonymous], 2008, WORLD MAL REP 2008; Bartholomew DM, 2002, PLANT PHYSIOL, V130, P1562, DOI 10.1104/pp.008334; Beale MH, 2006, P NATL ACAD SCI USA, V103, P10509, DOI 10.1073/pnas.0603998103; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; CHAPPELL J, 1995, PLANT PHYSIOL, V109, P1337, DOI 10.1104/pp.109.4.1337; Cui LW, 2009, EXPERT REV ANTI-INFE, V7, P999, DOI [10.1586/eri.09.68, 10.1586/ERI.09.68]; Cunillera N, 1997, J BIOL CHEM, V272, P15381, DOI 10.1074/jbc.272.24.15381; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Fraissinet-Tachet L, 1998, FEBS LETT, V437, P319, DOI 10.1016/S0014-5793(98)01257-5; Geu-Flores F, 2009, PLANTA, V229, P261, DOI 10.1007/s00425-008-0825-y; Geu-Flores F, 2009, NAT CHEM BIOL, V5, P575, DOI 10.1038/nchembio.185; Gils M, 2005, PLANT BIOTECHNOL J, V3, P613, DOI 10.1111/j.1467-7652.2005.00154.x; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Graham IA, 2010, SCIENCE, V327, P328, DOI 10.1126/science.1182612; Harker M, 2003, PLANT BIOTECHNOL J, V1, P113, DOI 10.1046/j.1467-7652.2003.00011.x; Hellens R, 2000, TRENDS PLANT SCI, V5, P446, DOI 10.1016/S1360-1385(00)01740-4; Kappers IF, 2005, SCIENCE, V309, P2070, DOI 10.1126/science.1116232; Loreto F, 2010, TRENDS PLANT SCI, V15, P154, DOI 10.1016/j.tplants.2009.12.006; Lucker J, 2004, PLANT J, V39, P135, DOI 10.1111/j.1365-313X.2004.02113.x; Moglia A, 2010, METAB ENG, V12, P223, DOI 10.1016/j.ymben.2009.11.003; Ralley L, 2004, PLANT J, V39, P477, DOI 10.1111/j.1365-313X.2004.02151.x; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Teoh KH, 2009, BOTANY, V87, P635, DOI 10.1139/B09-032; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Twyman RM, 2003, TRENDS BIOTECHNOL, V21, P570, DOI 10.1016/j.tibtech.2003.10.002; van Leeuwen W, 2001, J EXP BOT, V52, P949, DOI 10.1093/jexbot/52.358.949; VANENGELEN FA, 1995, TRANSGENIC RES, V4, P288, DOI 10.1007/BF01969123; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; Wallaart TE, 2001, PLANTA, V212, P460, DOI 10.1007/s004250000428; Whitty C, 2008, TROP DOCT, V38, P1, DOI 10.1258/td.2008.080013; Wu SQ, 2006, NAT BIOTECHNOL, V24, P1441, DOI 10.1038/nbt1251; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	35	116	121	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14222	10.1371/journal.pone.0014222	http://dx.doi.org/10.1371/journal.pone.0014222			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151979	Green Published, gold			2022-12-27	WOS:000284939600015
J	Cole, AM; Patton, DL; Rohan, LC; Cole, AL; Cosgrove-Sweeney, Y; Rogers, NA; Ratner, D; Sassi, AB; Lackman-Smith, C; Tarwater, P; Ramratnam, B; Ruchala, P; Lehrer, RI; Waring, AJ; Gupta, P				Cole, Alexander M.; Patton, Dorothy L.; Rohan, Lisa C.; Cole, Amy L.; Cosgrove-Sweeney, Yvonne; Rogers, Nicole A.; Ratner, Deena; Sassi, Alexandra B.; Lackman-Smith, Carol; Tarwater, Patrick; Ramratnam, Bharat; Ruchala, Piotr; Lehrer, Robert I.; Waring, Alan J.; Gupta, Phalguni			The Formulated Microbicide RC-101 Was Safe and Antivirally Active Following Intravaginal Application in Pigtailed Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FUSION INHIBITOR T-20; TOPICAL MICROBICIDE; MACACA-NEMESTRINA; EFFICACY EVALUATIONS; VAGINAL MICROFLORA; HIV-1 TRANSMISSION; THETA-DEFENSINS; COITAL ACT; MODEL	Background: RC-101 is a congener of the antiretroviral peptide retrocyclin, which we and others have reported is active against clinical HIV-1 isolates from all major clades, does not hemagglutinate, and is non-toxic and non-inflammatory in cervicovaginal cell culture. Herein, film-formulated RC-101 was assessed for its antiviral activity in vitro, safety in vivo, retention in the cervix and vagina, and ability to remain active against HIV-1 and SHIV after intravaginal application in macaques. Methodology/Principal Findings: RC-101 was formulated as a quick-dissolving film (2000 mu g/film), retained complete activity in vitro as compared to unformulated peptide, and was applied intravaginally in six pigtailed macaques daily for four days. At one and four days following the final application, the presence of RC-101 was assessed in peripheral blood, cervicovaginal lavage, cytobrushed cervicovaginal cells, and biopsied cervical and vaginal tissues by quantitative western blots. One day following the last film application, cervical biopsies from RC-101-exposed and placebo-controlled macaques were collected and were subjected to challenge with RT-SHIV in an ex vivo organ culture model. RC-101 peptide was detected primarily in the cytobrush and biopsied cervical and vaginal tissues, with little to no peptide detected in lavage samples, suggesting that the peptide was associated with the cervicovaginal epithelia. RC-101 remained in the tissues and cytobrush samples up to four days post-application, yet was not detected in any sera or plasma samples. RC-101, extracted from cytobrushes obtained one day post-application, remained active against HIV-1 BaL. Importantly, cervical biopsies from RC-101-treated animals reduced RT-SHIV replication in ex vivo organ culture as compared to placebo-treated animals. Conclusions/Significance: Formulated RC-101 was stable in vivo and was retained in the mucosa. The presence of antivirally active RC-101 after five days in vivo suggests that RC-101 would be an important molecule to develop further as a topical microbicide to prevent HIV-1 transmission.	[Cole, Alexander M.; Cole, Amy L.; Rogers, Nicole A.] Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Patton, Dorothy L.; Cosgrove-Sweeney, Yvonne] Univ Washington, Sch Med, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Rohan, Lisa C.; Sassi, Alexandra B.] Univ Pittsburgh, Magee Womens Res Inst, Sch Pharm, Pittsburgh, PA USA; [Rohan, Lisa C.; Sassi, Alexandra B.] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA; [Ratner, Deena] Univ Pittsburgh, Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA; [Lackman-Smith, Carol] So Res Inst, Dept Infect Dis Res, Frederick, MD USA; [Tarwater, Patrick] Texas Tech Univ, Hlth Sci Ctr, Dept Biostat, El Paso, TX USA; [Ramratnam, Bharat] Brown Univ, Div Biol & Med, Providence, RI 02912 USA; [Ruchala, Piotr; Lehrer, Robert I.; Waring, Alan J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA	State University System of Florida; University of Central Florida; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Texas Tech University System; Texas Tech University; Brown University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Cole, AM (corresponding author), Univ Cent Florida, Coll Med, Dept Mol Biol & Microbiol, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	acole@mail.ucf.edu		RUCHALA, PIOTR/0000-0002-5574-2779	National Institutes of Health [U19 AI065430, R01 AI052017]; Washington National Primate Research Center [RR00166]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000166] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI065430, R01AI052017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Washington National Primate Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant U19 AI065430 (to P. G., A. M. C., D. L. P., L. C. R., P. T., and B. R.) and R01 AI052017 (to A. M. C.) from the National Institutes of Health, as well as grant RR00166 from the Washington National Primate Research Center (to D. L. P.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cole AM, 2002, P NATL ACAD SCI USA, V99, P1813, DOI 10.1073/pnas.052706399; Cole AL, 2007, IMMUNOLOGY, V121, P140, DOI 10.1111/j.1365-2567.2006.02553.x; Cole AL, 2006, J IMMUNOL, V176, P6900, DOI 10.4049/jimmunol.176.11.6900; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Eckert Linda O, 2003, Infect Dis Obstet Gynecol, V11, P11, DOI 10.1155/S1064744903000024; FIELDS C G, 1991, Peptide Research, V4, P95; Fuhrman CA, 2007, FEBS J, V274, P6477, DOI 10.1111/j.1742-4658.2007.06165.x; Gallo SA, 2006, J BIOL CHEM, V281, P18787, DOI 10.1074/jbc.M602422200; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Lichtenwalner AB, 2000, J MED PRIMATOL, V29, P36; LUSSO P, 1995, J VIROL, V69, P3712, DOI 10.1128/JVI.69.6.3712-3720.1995; Munk C, 2003, AIDS RES HUM RETROV, V19, P875, DOI 10.1089/088922203322493049; Nguyen TX, 2003, PEPTIDES, V24, P1647, DOI 10.1016/j.peptides.2003.07.023; Owen SM, 2004, AIDS RES HUM RETROV, V20, P1157, DOI 10.1089/aid.2004.20.1157; Owen SM, 2004, J PEPT RES, V63, P469, DOI 10.1111/j.1399-3011.2004.00155.x; Patton DL, 1996, SEX TRANSM DIS, V23, P461, DOI 10.1097/00007435-199611000-00004; Patton DL, 1999, AM J OBSTET GYNECOL, V180, P1080, DOI 10.1016/S0002-9378(99)70598-3; Patton DL, 2004, SEX TRANSM DIS, V31, P290, DOI 10.1097/01.OLQ.0000124614.91448.D4; Patton DL, 2004, J MED PRIMATOL, V33, P105, DOI 10.1111/j.1600-0684.2004.00059.x; Patton DL, 2003, SEX TRANSM DIS, V30, P568, DOI 10.1097/00007435-200307000-00007; Patton DL, 1998, SEX TRANSM DIS, V25, P421, DOI 10.1097/00007435-199809000-00007; Patton DL, 1996, SEX TRANSM DIS, V23, P489, DOI 10.1097/00007435-199611000-00009; Patton DL, 2008, SEX TRANSM DIS, V35, P889, DOI 10.1097/OLQ.0b013e31817dfdb8; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; SASSI AS, 2010, ANTIMICROB AGE UNPUB; Takeuchi Y, 2008, J VIROL, V82, P12585, DOI 10.1128/JVI.01726-08; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002	32	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15111	10.1371/journal.pone.0015111	http://dx.doi.org/10.1371/journal.pone.0015111			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124745	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500040
J	Sangare, LR; Stergachis, A; Brentlinger, PE; Richardson, BA; Staedke, SG; Kiwuwa, MS; Weiss, NS				Sangare, Laura R.; Stergachis, Andy; Brentlinger, Paula E.; Richardson, Barbra A.; Staedke, Sarah G.; Kiwuwa, Mpungu S.; Weiss, Noel S.			Determinants of Use of Intermittent Preventive Treatment of Malaria in Pregnancy: Jinja, Uganda	PLOS ONE			English	Article							PRESUMPTIVE TREATMENT; SULFADOXINE-PYRIMETHAMINE; WESTERN KENYA; WOMEN; TANZANIA; DISTRICT; BURDEN; FEVER; NETS	Background: Maternal malaria is associated with serious adverse pregnancy outcomes. One recommended means of preventing malaria during pregnancy is intermittent preventive therapy (IPTp) with sulfadoxine/pyrimethamine (SP). We sought to identify determinants of preventive use of SP during pregnancy among recently pregnant women in Uganda. Additionally, we characterized the timing of and indications for the administration of SP at antenatal care (ANC) visits and missed opportunities for SP administration. Methodology/Principal Findings: Utilizing a population-based random sample, we interviewed 500 women living in Jinja, Uganda who had been pregnant in the past year. Thirty-eight percent (192/500) of women received SP for the treatment of malaria and were excluded from the analysis of IPTp-SP. Of the remaining women, 275 (89.3%) reported at least two ANC visits after the first trimester and had an opportunity to receive IPTp-SP according to the Ugandan guidelines, but only 86 (31.3%) of these women received a full two-dose course of IPTp. The remaining 189 (68.7%) women missed one or more doses of IPTp-SP. Among the 168 women that were offered IPTp, 164 (97.6%) of them took the dose of SP. Conclusions/Significance: Use of IPTp in Uganda was found to be far below target levels. Our results suggest that women will take SP for IPTp if it is offered during an ANC visit. Missed opportunities to administer IPTp-SP during ANC were common in our study, suggesting provider-level improvements are needed.	[Sangare, Laura R.; Stergachis, Andy; Brentlinger, Paula E.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Stergachis, Andy; Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Richardson, Barbra A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Staedke, Sarah G.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Staedke, Sarah G.] Infect Dis Res Collaborat, Kampala, Uganda; [Kiwuwa, Mpungu S.] Makerere Univ, Coll Hlth Sci, Sch Med, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of London; London School of Hygiene & Tropical Medicine; Makerere University	Sangare, LR (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	lsangare@u.washington.edu		Brentlinger, Paula/0000-0002-4865-8915	National Institutes of Health [TL1RR025016]; Department of Epidemiology; School of Public Health, University of Washington; Washington Global Health Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025016] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Epidemiology; School of Public Health, University of Washington(University of Washington); Washington Global Health Alliance; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the National Institutes of Health [TL1RR025016] and the Department of Epidemiology, small grants program at the School of Public Health, University of Washington, and the Washington Global Health Alliance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkadi HO, 2007, CHEMOTHERAPY, V53, P385, DOI 10.1159/000109767; Anders K, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-79; [Anonymous], 2004, STRATEGIC FRAMEWORK; Bardaji A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-27; Barros Aluisio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; Brentlinger PE, 2007, B WORLD HEALTH ORGAN, V85, P873, DOI 10.2471/BLT.06.033381; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Garner P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000169.pub2; Gikandi PW, 2008, TROP MED INT HEALTH, V13, P208, DOI 10.1111/j.1365-3156.2007.01992.x; Guyatt HL, 2004, TROP MED INT HEALTH, V9, P255, DOI 10.1046/j.1365-3156.2003.01193.x; Holtz TH, 2004, TROP MED INT HEALTH, V9, P77, DOI 10.1046/j.1365-3156.2003.01170.x; Kachur SP, 2006, TROP MED INT HEALTH, V11, P441, DOI 10.1111/j.1365-3156.2006.01588.x; Kemble SK, 2006, AM J TROP MED HYG, V74, P999, DOI 10.4269/ajtmh.2006.74.999; Kiwuwa MS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-44; Lumley T, 2006, UW BIOSTATISTICS WOR, V293; Marchant T, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-260; Mbonye AK, 2007, HEALTH POLICY, V81, P228, DOI 10.1016/j.healthpol.2006.05.018; MENENDEZ C, 1995, PARASITOL TODAY, V11, P178, DOI 10.1016/0169-4758(95)80151-0; Mubyazi GM, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-135; Ndyomugyenyi R, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-39; Ndyomugyenyi R, 2010, T ROY SOC TROP MED H, V104, P536, DOI 10.1016/j.trstmh.2010.02.003; Nganda RY, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-42; Njama-Meya D, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-7; Okello PE, 2006, AM J TROP MED HYG, V75, P219, DOI 10.4269/ajtmh.2006.75.219; Olliaro PL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-234; Ouma PO, 2007, TROP MED INT HEALTH, V12, P953, DOI 10.1111/j.1365-3156.2007.01876.x; *PRES MAL I, 2007, UG MAL OP PLAN MOP; *PRES MAL I, 2009, UG MAL OP PLAN MOP; *PRES MAL I, 2008, UG MAL OP PLAN MOP; *REP UG, 2005, FLOW CHART MAL PREG; *REP UG, 2005, MAN UNC MAL PRACT GU; Ribera JM, 2007, PLOS MED, V4, P631, DOI 10.1371/journal.pmed.0040092; Rutstein S.O., 2004, DHS COMP REPORTS; Sirima SB, 2006, AM J TROP MED HYG, V75, P205, DOI 10.4269/ajtmh.2006.75.205; ter Kuile FO, 2007, JAMA-J AM MED ASSOC, V297, P2603, DOI 10.1001/jama.297.23.2603; Uganda Bureau of Statistics Macro International Inc, 2007, UG DEM HLTH SURV 200; Vallely A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-16; van Eijk AM, 2004, TROP MED INT HEALTH, V9, P630, DOI 10.1111/j.1365-3156.2004.01242.x; White NJ, 2005, PLOS MED, V2, P28, DOI 10.1371/journal.pmed.0020003; World Health Organization, 2009, WHOHTMGMP20091	41	28	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15066	10.1371/journal.pone.0015066	http://dx.doi.org/10.1371/journal.pone.0015066			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124732	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000284686500031
J	Zhang, MJ; He, LH; Li, Q; Sun, HH; Gu, YX; You, YH; Meng, FL; Zhang, JZ				Zhang, Maojun; He, Lihua; Li, Qun; Sun, Honghe; Gu, Yixin; You, Yuanhai; Meng, Fanliang; Zhang, Jianzhong			Genomic Characterization of the Guillain-Barre Syndrome-Associated Campylobacter jejuni ICDCCJ07001 Isolate	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; MOLECULAR MIMICRY; SEQUENCE; REVEALS; LIPOPOLYSACCHARIDES; OUTBREAK; STRAINS; BIOSYNTHESIS; MICROARRAY; DIVERSITY	Campylobacter jejuni ICDCCJ07001 (HS:41, ST2993) was isolated from a Guillain-Barre syndrome (GBS) patient during a 36-case GBS outbreak triggered by C. jejuni infections in north China in 2007. Sequence analysis revealed that the ICDCCJ07001 genome consisted of 1,664,840 base pairs (bp) and one tetracycline resistance plasmid of 44,084 bp. The GC content was 59.29% and 1,579 and 37 CDSs were identified on the chromosome and plasmid, respectively. The ICDCCJ07001 genome was compared to C. jejuni subsp. jejuni strains 81-176, 81116, NCTC11168, RM1221 and C. jejuni subsp. doylei 269.97. The length and organization of ICDCCJ07001 was similar to that of NCTC11168, 81-176 and 81-116 except that CMLP1 had a reverse orientation in strain ICDCCJ07001. Comparative genomic analyses were also carried out between GBS-associated C. jejuni strains. Thirteen common genes were present in four GBS-associated strains and 9 genes mapped to the LOS cluster and the ICDCCJ07001_pTet (44 kb) plasmid was mosaic in structure. Thirty-seven predicted CDS in ICDCCJ07001_pTet were homologous to genes present in three virulence-associated plasmids in Campylobacter: 81-176_pTet, pCC31 and 81-176_pVir. Comparative analysis of virulence loci and virulence-associated genes indicated that the LOS biosynthesis loci of ICDCCJ07001 belonged to type A, previously reported to be associated with cases of GBS. The polysaccharide capsular biosynthesis (CPS) loci and the flagella modification (FM) loci of ICDCCJ07001 were similar to corresponding sequences of strain 260.94 of similar serotype as strain ICDCCJ07001. Other virulence-associated genes including cadF, peb1, jlpA, cdt and ciaB were conserved between the C. jejuni strains examined.	[Zhang, Maojun; He, Lihua; Gu, Yixin; You, Yuanhai; Meng, Fanliang; Zhang, Jianzhong] Chinese Ctr Dis Control & Prevent, Natl Inst Commun Dis Control & Prevent, DCDD, Beijing, Peoples R China; [Li, Qun] Chinese Ctr Dis Control & Prevent, Off Dis Control & Emergency Response, Beijing, Peoples R China; [Sun, Honghe] BGI, Dept Appl sci Med, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Communicable Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; Beijing Genomics Institute (BGI)	Zhang, MJ (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Commun Dis Control & Prevent, DCDD, Beijing, Peoples R China.	zhangjianzhong@icdc.cn	Zhang, Jianzhong/AAM-6179-2021	Zhang, Jianzhong/0000-0001-7056-8206	National Key Program for Infectious Disease of China [2008ZX10004-002, 2008ZX10004-008, 2008ZX10004-009]; Young Scholar Scientific Research Foundation of China CDC [2009A102]	National Key Program for Infectious Disease of China; Young Scholar Scientific Research Foundation of China CDC	This work was supported by grants from the National Key Program for Infectious Disease of China (2008ZX10004-002, 2008ZX10004-008 and 2008ZX10004-009) and the Young Scholar Scientific Research Foundation of China CDC (2009A102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacon DJ, 2001, MOL MICROBIOL, V40, P769, DOI 10.1046/j.1365-2958.2001.02431.x; Barton C, 2007, J CLIN MICROBIOL, V45, P386, DOI 10.1128/JCM.01513-06; Batchelor RA, 2004, MICROBIOL-SGM, V150, P3507, DOI 10.1099/mic.0.27112-0; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Clark CG, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-49; Dorrell N, 2001, GENOME RES, V11, P1706, DOI 10.1101/gr.185801; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Gilbert M, 2007, CHEMBIOCHEM, V8, P625, DOI 10.1002/cbic.200600508; Godschalk PCR, 2006, MICROBES INFECT, V8, P248, DOI 10.1016/j.micinf.2005.06.022; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Leonard EE, 2003, J INFECT DIS, V187, P691, DOI 10.1086/368268; May BJ, 2001, P NATL ACAD SCI USA, V98, P3460, DOI 10.1073/pnas.051634598; Moran AP, 1998, J INFECT DIS, V178, P1549, DOI 10.1086/314462; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; Poly F, 2005, J CLIN MICROBIOL, V43, P2330, DOI 10.1128/JCM.43.5.2330-2338.2005; Poly F, 2007, INFECT IMMUN, V75, P3859, DOI 10.1128/IAI.00159-07; Poly F, 2007, INFECT IMMUN, V75, P3425, DOI 10.1128/IAI.00050-07; Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998; Qian W, 2005, GENOME RES, V15, P757, DOI 10.1101/gr.3378705; Sheikh KA, 1998, NEUROLOGY, V51, P371, DOI 10.1212/WNL.51.2.371; Tang JQ, 2006, PLOS MED, V3, P668, DOI 10.1371/journal.pmed.0030151; Zhang MJ, 2010, FOODBORNE PATHOG DIS, V7, P913, DOI 10.1089/fpd.2009.0493	34	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15060	10.1371/journal.pone.0015060	http://dx.doi.org/10.1371/journal.pone.0015060			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124772	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500028
J	Saito, M; Kumamoto, K; Robles, AI; Horikawa, I; Furusato, B; Okamura, S; Goto, A; Yamashita, T; Nagashima, M; Lee, TL; Baxendale, VJ; Rennert, OM; Takenoshita, S; Yokota, J; Sesterhenn, IA; Trivers, GE; Hussain, SP; Harris, CC				Saito, Motonobu; Kumamoto, Kensuke; Robles, Ana I.; Horikawa, Izumi; Furusato, Bungo; Okamura, Shu; Goto, Akiteru; Yamashita, Taro; Nagashima, Makoto; Lee, Tin-Lap; Baxendale, Vanessa J.; Rennert, Owen M.; Takenoshita, Seiichi; Yokota, Jun; Sesterhenn, Isabell A.; Trivers, Glenwood E.; Hussain, S. Perwez; Harris, Curtis C.			Targeted Disruption of Ing2 Results in Defective Spermatogenesis and Development of Soft-Tissue Sarcomas	PLOS ONE			English	Article							HISTONE-DEACETYLASE INHIBITOR; CHROMOSOME LONG ARM; TUMOR-SUPPRESSOR; GERM-CELL; CHROMATIN MODIFICATION; TESTICULAR CANCER; EPIGENETIC EVENTS; MEIOTIC PROPHASE; MALE-INFERTILITY; GENE-EXPRESSION	ING2 (inhibitor of growth family, member 2) is a member of the plant homeodomain (PHD)-containing ING family of putative tumor suppressors. As part of mSin3A HDAC corepressor complexes, ING2 binds to tri-methylated lysine 4 of histone H3 (H3K4me3) to regulate chromatin modification and gene expression. ING2 also functionally interacts with the tumor suppressor protein p53 to regulate cellular senescence, apoptosis and DNA damage response in vitro, and is thus expected to modulate carcinogenesis and aging. Here we investigate the developmental and physiological functions of Ing2 through targeted germline disruption. Consistent with its abundant expression in mouse and human testes, male mice deficient for Ing2 showed abnormal spermatogenesis and were infertile. Numbers of mature sperm and sperm motility were significantly reduced in Ing2(-/-) mice (similar to 2% of wild type, P<0.0001 and similar to 10% of wild type, P<0.0001, respectively). Their testes showed degeneration of seminiferous tubules, meiotic arrest before pachytene stage with incomplete meiotic recombination, induction of p53, and enhanced apoptosis. This phenotype was only partially abrogated by concomitant loss of p53 in the germline. The arrested spermatocytes in Ing2(-/-) testes were characterized by lack of specific HDAC1 accumulation and deregulated chromatin acetylation. The role of Ing2 in germ cell maturation may extend to human ING2 as well. Using publicly available gene expression datasets, low expression of ING2 was found in teratozoospermic sperm (>3-fold reduction) and in testes from patients with defective spermatogenesis (>7-fold reduction in Sertoli-cell only Syndrome). This study establishes ING2 as a novel regulator of spermatogenesis functioning through both p53- and chromatin-mediated mechanisms, suggests that an HDAC1/ING2/H3K4me3-regulated, stage-specific coordination of chromatin modifications is essential to normal spermatogenesis, and provides an animal model to study idiopathic and iatrogenic infertility in men. In addition, a bona fide tumor suppressive role of Ing2 is demonstrated by increased incidence of soft-tissue sarcomas in Ing2(-/-) mice.	[Saito, Motonobu; Kumamoto, Kensuke; Robles, Ana I.; Horikawa, Izumi; Okamura, Shu; Goto, Akiteru; Yamashita, Taro; Nagashima, Makoto; Trivers, Glenwood E.; Hussain, S. Perwez; Harris, Curtis C.] NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Furusato, Bungo; Sesterhenn, Isabell A.] Armed Forces Inst Pathol, Dept Genitourinary Pathol, Washington, DC 20306 USA; [Saito, Motonobu; Kumamoto, Kensuke; Takenoshita, Seiichi] Fukushima Med Univ, Sch Med, Dept Organ Regulatory Surg, Fukushima, Japan; [Lee, Tin-Lap; Baxendale, Vanessa J.; Rennert, Owen M.] NICHHD, Lab Clin & Dev Genom, Program Reprod & Adult Endocrinol, NIH, Bethesda, MD 20892 USA; [Yokota, Jun] Natl Canc Ctr, Div Biol, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Defense; Fukushima Medical University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Cancer Center - Japan	Saito, M (corresponding author), NCI, Human Carcinogenesis Lab, Ctr Canc Res, NIH, Bldg 37, Bethesda, MD 20892 USA.	curtis_harris@nih.gov	Rennert, owen/AAI-7374-2020; Saito, Motonobu/AAQ-3633-2021; Lee, Tin-Lap/W-6595-2019; Lee, Tin-Lap/A-7853-2009; Goto, Akiteru/P-5775-2014	Saito, Motonobu/0000-0001-5072-3520; Lee, Tin-Lap/0000-0002-6654-0988; Lee, Tin-Lap/0000-0002-6654-0988; Robles, Ana/0000-0001-5019-4374; Furusato, Bungo/0000-0003-4614-9882; Hussain, S. Perwez/0000-0002-2294-522X; Goto, Akiteru/0000-0001-8776-9004	National Cancer Institute, National Institutes of Health; JA-Fukushima, Japan; NATIONAL CANCER INSTITUTE [ZIABC010875] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); JA-Fukushima, Japan; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the Intramural Research Program of the National Cancer Institute, National Institutes of Health. MS was supported by a scholarship from the JA-Fukushima, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad M, 2007, J BIOL CHEM, V282, P31060, DOI 10.1074/jbc.M701639200; Beumer TL, 1998, CELL DEATH DIFFER, V5, P669, DOI 10.1038/sj.cdd.4400396; Binda O, 2008, ONCOGENE, V27, P3384, DOI 10.1038/sj.onc.1211014; Brydoy M, 2007, ACTA ONCOL, V46, P480, DOI 10.1080/02841860601166958; Carmell MA, 2007, DEV CELL, V12, P503, DOI 10.1016/j.devcel.2007.03.001; Coles AH, 2007, CANCER RES, V67, P2054, DOI 10.1158/0008-5472.CAN-06-3558; Cooke HJ, 2002, NAT REV GENET, V3, P790, DOI 10.1038/nrg911; Coussens M, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0001571, 10.1371/journal.pone.0002640]; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Feig C, 2007, MOL HUM REPROD, V13, P33, DOI 10.1093/molehr/gal097; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; GALLI M, 2009, ANN HEMATOL; Gattiker A, 2007, NUCLEIC ACIDS RES, V35, pD457, DOI 10.1093/nar/gkl957; Godmann M, 2007, BIOL REPROD, V77, P754, DOI 10.1095/biolreprod.107.062265; Goto A, 2005, CANCER SCI, V96, P480, DOI 10.1111/j.1349-7006.2005.00075.x; Gromley A, 2009, P NATL ACAD SCI USA, V106, P6285, DOI 10.1073/pnas.0902310106; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Hussain SP, 2004, CANCER RES, V64, P6849, DOI 10.1158/0008-5472.CAN-04-2201; JOHNSEN S G, 1970, Hormones (Basel), V1, P2, DOI 10.1159/000178170; Kelly WK, 2005, J CLIN ONCOL, V23, P3923, DOI 10.1200/JCO.2005.14.167; Khoo CM, 2007, P NATL ACAD SCI USA, V104, P3931, DOI 10.1073/pnas.0700093104; Kichina JV, 2006, ONCOGENE, V25, P857, DOI 10.1038/sj.onc.1209118; Kim SK, 2008, MOL CELLS, V25, P317; Kumamoto K, 2008, CANCER RES, V68, P3193, DOI 10.1158/0008-5472.CAN-07-2780; Kumamoto K, 2009, INT J CANCER, V125, P1306, DOI 10.1002/ijc.24437; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li XJ, 2008, DEV CELL, V15, P547, DOI 10.1016/j.devcel.2008.08.014; Magelssen H, 2006, NAT CLIN PRACT UROL, V3, P312, DOI 10.1038/ncpuro0508; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; MEIROW D, 1995, HUM REPROD, V10, P2017, DOI 10.1093/oxfordjournals.humrep.a136228; Nagashima M, 2001, P NATL ACAD SCI USA, V98, P9671, DOI 10.1073/pnas.161151798; Netzel-Arnett S, 2009, BIOL REPROD, V81, P921, DOI 10.1095/biolreprod.109.076273; Okada H, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040026; Pedeux R, 2005, MOL CELL BIOL, V25, P6639, DOI 10.1128/MCB.25.15.6639-6648.2005; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Raman JD, 2005, J UROLOGY, V174, P1819, DOI 10.1097/01.ju.0000177491.98461.aa; ROTTER V, 1993, P NATL ACAD SCI USA, V90, P9075, DOI 10.1073/pnas.90.19.9075; Salazar G, 2005, DEV DYNAM, V234, P114, DOI 10.1002/dvdy.20533; Sargeant AM, 2008, CANCER RES, V68, P3999, DOI 10.1158/0008-5472.CAN-08-0203; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Schwartz D, 1999, CELL GROWTH DIFFER, V10, P665; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shimada Y, 1998, CYTOGENET CELL GENET, V83, P232, DOI 10.1159/000015188; SIRONEN A, 2009, BIOL REPROD; Smith KT, 2010, CHEM BIOL, V17, P65, DOI 10.1016/j.chembiol.2009.12.010; Soliman MA, 2007, TRENDS BIOCHEM SCI, V32, P509, DOI 10.1016/j.tibs.2007.08.006; Spiess AN, 2003, BIOL REPROD, V68, P2044, DOI 10.1095/biolreprod.102.011593; Spiess AN, 2007, HUM REPROD, V22, P2936, DOI 10.1093/humrep/dem292; Szemes M, 2006, NEUROCHEM RES, V31, P237, DOI 10.1007/s11064-005-9012-8; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Takano N, 2004, BIOL REPROD, V71, P1785, DOI 10.1095/biolreprod.104.030452; Toure A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r102; Toure A, 2004, GENETICS, V166, P901, DOI 10.1534/genetics.166.2.901; Unoki M, 2009, CURR DRUG TARGETS, V10, P442, DOI 10.2174/138945009788185059; Yang X, 1998, P NATL ACAD SCI USA, V95, P3667, DOI 10.1073/pnas.95.7.3667; Yin YZ, 1998, DEV BIOL, V204, P165, DOI 10.1006/dbio.1998.9074	68	38	39	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e15541	10.1371/journal.pone.0015541	http://dx.doi.org/10.1371/journal.pone.0015541			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124965	Green Published, gold, Green Submitted			2022-12-27	WOS:000284400100019
J	Idro, R; Gwer, S; Williams, TN; Otieno, T; Uyoga, S; Fegan, G; Kager, PA; Maitland, K; Kirkham, F; Neville, BGR; Newton, CRJ				Idro, Richard; Gwer, Samson; Williams, Thomas N.; Otieno, Tuda; Uyoga, Sophie; Fegan, Gregory; Kager, Piet A.; Maitland, Kathryn; Kirkham, Fenella; Neville, Brian G. R.; Newton, Charles R. J.			Iron Deficiency and Acute Seizures: Results from Children Living in Rural Kenya and a Meta-Analysis	PLOS ONE			English	Article							SOLUBLE TRANSFERRIN RECEPTOR; FEBRILE CONVULSIONS; MALARIA; ANEMIA	Background: There are conflicting reports on whether iron deficiency changes susceptibility to seizures. We examined the hypothesis that iron deficiency is associated with an increased risk of acute seizures in children in a malaria endemic area. Methods: We recruited 133 children, aged 3-156 months, who presented to a district hospital on the Kenyan coast with acute seizures and frequency-matched these to children of similar ages but without seizures. We defined iron deficiency according to the presence of malarial infection and evidence of inflammation. In patients with malaria, we defined iron deficiency as plasma ferritin<30 mu g/ml if plasma C-reactive protein (CRP) was<50mg/ml or ferritin<273 mu g/ml if CRP >= 50mg/ ml, and in those without malaria, as ferritin, 12 mu g/ml if CRP<10mg/ml or ferritin<30 mu g/ml if CRP >= 10mg/ml. In addition, we performed a meta-analysis of case-control studies published in English between January 1966 and December 2009 and available through PUBMED that have examined the relationship between iron deficiency and febrile seizures in children. Results: In our Kenyan case control study, cases and controls were similar, except more cases reported past seizures. Malaria was associated with two-thirds of all seizures. Eighty one (30.5%) children had iron deficiency. Iron deficiency was neither associated with an increased risk of acute seizures (45/133[33.8%] cases were iron deficient compared to 36/133[27.1%] controls, p=0.230) nor status epilepticus and it did not affect seizure semiology. Similar results were obtained when children with malaria, known to cause acute symptomatic seizures in addition to febrile seizures were excluded. However, in a meta-analysis that combined all eight case-control studies that have examined the association between iron deficiency and acute/febrile seizures to-date, iron deficiency, described in 310/1,018(30.5%) cases and in 230/1,049(21.9%) controls, was associated with a significantly increased risk of seizures, weighted OR 1.79(95%CI 1.03-3.09). Conclusions: Iron deficiency is not associated with an increased risk of all acute seizures in children but of febrile seizures. Further studies should examine mechanisms involved and the implications for public health.	[Idro, Richard] Makerere Univ, Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda; [Idro, Richard; Gwer, Samson; Williams, Thomas N.; Otieno, Tuda; Uyoga, Sophie; Fegan, Gregory; Maitland, Kathryn; Newton, Charles R. J.] Kenya Govt Med Res Ctr, Ctr Geog Med Res Coast, Kilifi, Kenya; [Williams, Thomas N.] John Radcliffe Hosp, Dept Paediat, Oxford OX3 9DU, England; [Fegan, Gregory] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1, England; [Kager, Piet A.] Univ Amsterdam, Acad Med Ctr, Dept Infect Dis Trop Med & AIDS, NL-1105 AZ Amsterdam, Netherlands; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Paediat, London, England; [Maitland, Kathryn] Univ London Imperial Coll Sci Technol & Med, Fac Med, Wellcome Trust Ctr Clin Trop Med, London, England; [Kirkham, Fenella] Southampton Gen Hosp, Dept Paediat Neurol, Southampton SO9 4XY, Hants, England; [Kirkham, Fenella; Neville, Brian G. R.; Newton, Charles R. J.] UCL, Inst Child Hlth, Wolfson Ctr, Neurosci Unit, London, England; [Newton, Charles R. J.] London Sch Hyg & Trop Med, Clin Res Unit, London WC1, England	Makerere University; Mulago National Referral Hospital; Kenya Medical Research Institute; University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam; Imperial College London; Imperial College London; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Idro, R (corresponding author), Makerere Univ, Mulago Hosp, Dept Paediat & Child Hlth, Kampala, Uganda.	ridro1@gmail.com	Newton, Charles/V-7872-2019; , Ridro/ABD-3556-2020; Newton, Charles RJC/B-7578-2014; Kirkham, Fenella/C-2442-2009; Fegan, Greg W/O-8079-2018	Newton, Charles/0000-0002-6999-5507; Newton, Charles RJC/0000-0002-6999-5507; Kirkham, Fenella/0000-0002-2443-7958; Fegan, Greg W/0000-0002-2663-2765; Uyoga, Sophie/0000-0003-1746-7873; Maitland, Kathryn/0000-0002-0007-0645; Idro, Richard/0000-0003-4728-4605	Wellcome Trust [070114]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by the Wellcome Trust through a fellowship to Prof. Newton (070114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The study is published with the permission of the Director of KEMRI.	AKPEDE GO, 1993, J TROP PEDIATRICS, V39, P350, DOI 10.1093/tropej/39.6.350; BARZIDEH O, 1995, PSYCHOL REP, V76, P971, DOI 10.2466/pr0.1995.76.3.971; Beales PF, 2000, T ROY SOC TROP MED H, V94, pS1; Berkley JA, 2005, NEW ENGL J MED, V352, P39, DOI 10.1056/NEJMoa040275; Bidabadi E, 2009, SEIZURE-EUR J EPILEP, V18, P347, DOI 10.1016/j.seizure.2009.01.008; Daoud AS, 2002, EPILEPSIA, V43, P740, DOI 10.1046/j.1528-1157.2002.32501.x; Das BS, 1997, BRIT J NUTR, V78, P751, DOI 10.1079/BJN19970192; Hartfield DS, 2009, CLIN PEDIATR, V48, P420, DOI 10.1177/0009922809331800; Idro R, 2008, BMC PEDIATR, V8, DOI 10.1186/1471-2431-8-5; Idro R, 2008, EPILEPSY RES, V81, P114, DOI 10.1016/j.eplepsyres.2008.04.021; Idro R, 2007, JAMA-J AM MED ASSOC, V297, P2232, DOI 10.1001/jama.297.20.2232; Kivibidila S, 1999, J TROP PEDIATRICS, V45, P166, DOI 10.1093/tropej/45.3.166; KOBRINSKY NL, 1995, J CHILD NEUROL, V10, P105, DOI 10.1177/088307389501000207; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Macdonald CE, 1996, BRIT MED J, V313, P1205, DOI 10.1136/bmj.313.7066.1205a; Menendez C, 2001, AM J TROP MED HYG, V65, P138, DOI 10.4269/ajtmh.2001.65.138; Mwaniki M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-16; NAVEEDUR R, 2005, JCPSP-J COLL PHYSICI, V15, P338; Newton CRJC, 1997, TROP MED INT HEALTH, V2, P165, DOI 10.1046/j.1365-3156.1997.d01-238.x; OSKI FA, 1992, DIFFERENTIAL DIAGNOS, P346; PARKS YA, 1989, ACTA PAEDIATR SCAND, P71; Phiri KS, 2009, J CLIN PATHOL, V62, P1103, DOI 10.1136/jcp.2009.066498; Pisacane A, 1996, BMJ-BRIT MED J, V313, P343, DOI 10.1136/bmj.313.7053.343; Sadlier LG, 2007, BMJ-BRIT MED J, V334, P307, DOI 10.1136/bmj.39087.691817.AE; Sazawal S, 2006, LANCET, V367, P133, DOI 10.1016/S0140-6736(06)67962-2; SKIKNE BS, 1990, BLOOD, V75, P1870; Smith H.J., COCHRANE DB SYST REV, V2, P2003, DOI [10.1002/14651858.CD001474, DOI 10.1002/14651858.CD001474]; Vaswani RK, 2010, INDIAN PEDIATR, V47, P437, DOI 10.1007/s13312-010-0080-8; Wambua S, 2006, BRIT J HAEMATOL, V133, P206, DOI 10.1111/j.1365-2141.2006.06006.x; Wang XS, 2004, J NEUROL SCI, V220, P59, DOI 10.1016/j.jns.2004.02.004; Waruiru CM, 1996, T ROY SOC TROP MED H, V90, P152, DOI 10.1016/S0035-9203(96)90120-0; Wike WM, 1996, BRIT MED J, V313, P1205, DOI 10.1136/bmj.313.7066.1205; World Health Organization (WHO), 2005, POCK BOOK HOSP CAR C; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615; 2000, ZHONGGUO JI SHENG CH, V18, P129	35	63	64	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14001	10.1371/journal.pone.0014001	http://dx.doi.org/10.1371/journal.pone.0014001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103365	Green Published, gold, Green Submitted			2022-12-27	WOS:000284257400006
J	Eakin, CM; Morgan, JA; Heron, SF; Smith, TB; Liu, G; Alvarez-Filip, L; Baca, B; Bartels, E; Bastidas, C; Bouchon, C; Brandt, M; Bruckner, AW; Bunkley-Williams, L; Cameron, A; Causey, BD; Chiappone, M; Christensen, TRL; Crabbe, MJC; Day, O; de la Guardia, E; Diaz-Pulido, G; DiResta, D; Gil-Agudelo, DL; Gilliam, DS; Ginsburg, RN; Gore, S; Guzman, HM; Hendee, JC; Hernandez-Delgado, EA; Husain, E; Jeffrey, CFG; Jones, RJ; Jordan-Dahlgren, E; Kaufman, LS; Kline, DI; Kramer, PA; Lang, JC; Lirman, D; Mallela, J; Manfrino, C; Marechal, JP; Marks, K; Mihaly, J; Miller, WJ; Mueller, EM; Muller, EM; Toro, CAO; Oxenford, HA; Ponce-Taylor, D; Quinn, N; Ritchie, KB; Rodriguez, S; Ramirez, AR; Romano, S; Samhouri, JF; Sanchez, JA; Schmahl, GP; Shank, BV; Skirving, WJ; Steiner, SCC; Villamizar, E; Walsh, SM; Walter, C; Weil, E; Williams, EH; Roberson, KW; Yusuf, Y				Eakin, C. Mark; Morgan, Jessica A.; Heron, Scott F.; Smith, Tyler B.; Liu, Gang; Alvarez-Filip, Lorenzo; Baca, Bart; Bartels, Erich; Bastidas, Carolina; Bouchon, Claude; Brandt, Marilyn; Bruckner, Andrew W.; Bunkley-Williams, Lucy; Cameron, Andrew; Causey, Billy D.; Chiappone, Mark; Christensen, Tyler R. L.; Crabbe, M. James C.; Day, Owen; de la Guardia, Elena; Diaz-Pulido, Guillermo; DiResta, Daniel; Gil-Agudelo, Diego L.; Gilliam, David S.; Ginsburg, Robert N.; Gore, Shannon; Guzman, Hector M.; Hendee, James C.; Hernandez-Delgado, Edwin A.; Husain, Ellen; Jeffrey, Christopher F. G.; Jones, Ross J.; Jordan-Dahlgren, Eric; Kaufman, Les S.; Kline, David I.; Kramer, Philip A.; Lang, Judith C.; Lirman, Diego; Mallela, Jennie; Manfrino, Carrie; Marechal, Jean-Philippe; Marks, Ken; Mihaly, Jennifer; Miller, W. Jeff; Mueller, Erich M.; Muller, Erinn M.; Orozco Toro, Carlos A.; Oxenford, Hazel A.; Ponce-Taylor, Daniel; Quinn, Norman; Ritchie, Kim B.; Rodriguez, Sebastian; Rodriguez Ramirez, Alberto; Romano, Sandra; Samhouri, Jameal F.; Sanchez, Juan A.; Schmahl, George P.; Shank, Burton V.; Skirving, William J.; Steiner, Sascha C. C.; Villamizar, Estrella; Walsh, Sheila M.; Walter, Cory; Weil, Ernesto; Williams, Ernest H.; Roberson, Kimberly Woody; Yusuf, Yusri			Caribbean Corals in Crisis: Record Thermal Stress, Bleaching, and Mortality in 2005	PLOS ONE			English	Article							CLIMATE-CHANGE; REEF; EVENTS; TEMPERATURE; HURRICANES; SEVERITY; DISEASE; ISLAND	Background: The rising temperature of the world's oceans has become a major threat to coral reefs globally as the severity and frequency of mass coral bleaching and mortality events increase. In 2005, high ocean temperatures in the tropical Atlantic and Caribbean resulted in the most severe bleaching event ever recorded in the basin. Methodology/Principal Findings: Satellite-based tools provided warnings for coral reef managers and scientists, guiding both the timing and location of researchers' field observations as anomalously warm conditions developed and spread across the greater Caribbean region from June to October 2005. Field surveys of bleaching and mortality exceeded prior efforts in detail and extent, and provided a new standard for documenting the effects of bleaching and for testing nowcast and forecast products. Collaborators from 22 countries undertook the most comprehensive documentation of basin-scale bleaching to date and found that over 80% of corals bleached and over 40% died at many sites. The most severe bleaching coincided with waters nearest a western Atlantic warm pool that was centered off the northern end of the Lesser Antilles. Conclusions/Significance: Thermal stress during the 2005 event exceeded any observed from the Caribbean in the prior 20 years, and regionally-averaged temperatures were the warmest in over 150 years. Comparison of satellite data against field surveys demonstrated a significant predictive relationship between accumulated heat stress (measured using NOAA Coral Reef Watch's Degree Heating Weeks) and bleaching intensity. This severe, widespread bleaching and mortality will undoubtedly have long-term consequences for reef ecosystems and suggests a troubled future for tropical marine ecosystems under a warming climate.	[Eakin, C. Mark; Jeffrey, Christopher F. G.; Roberson, Kimberly Woody] Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA; [Morgan, Jessica A.; Liu, Gang; Christensen, Tyler R. L.] NOAA Coral Reef Watch, IM Syst Grp, Silver Spring, MD USA; [Heron, Scott F.; Skirving, William J.] ReefSense Pty Ltd, NOAA Coral Reef Watch, Townsville, Qld, Australia; [Heron, Scott F.] James Cook Univ, Sch Engn & Phys Sci, Townsville, Qld, Australia; [Smith, Tyler B.; Brandt, Marilyn; Romano, Sandra] Univ Virgin Isl, Ctr Marine & Environm Studies, St Thomas, VI USA; [Alvarez-Filip, Lorenzo] Parque Nacl Arrecifes Cozumel, Cozumel, Mexico; [Alvarez-Filip, Lorenzo] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Baca, Bart] CSA S Inc, Dania, FL USA; [Bartels, Erich; Ritchie, Kim B.; Walter, Cory] Mote Marine Lab, Ctr Coral Reef Res, Summerland Key, FL USA; [Bastidas, Carolina; Rodriguez, Sebastian] Univ Simon Bolivar, Inst Tecnol & Ciencias Marinas, Caracas, Venezuela; [Bouchon, Claude] Univ Antilles Guyane, Biol Marine Lab, Pointe A Pitre, Guadeloupe, France; [Bruckner, Andrew W.] Khaled bin Sultan Living Oceans Fdn, Landover, MD USA; [Bunkley-Williams, Lucy; Weil, Ernesto; Williams, Ernest H.] Univ Puerto Rico, Dept Biol, Mayaguez, PR USA; [Cameron, Andrew; Ponce-Taylor, Daniel] Global Vis Int & Amigos Sian Kaan Asociac Civil, Playa Del Carmen, Quintana Roo, Mexico; [Causey, Billy D.] Natl Ocean & Atmospher Adm, Off Natl Marine Sanctuaries, Key West, FL USA; [Chiappone, Mark] Univ N Carolina Wilmington, Ctr Marine Sci, Key Largo, FL USA; [Crabbe, M. James C.] Univ Bedfordshire, Luton Inst Res Appl Nat Sci, Luton, Beds, England; [Day, Owen] Buccoo Reef Trust, Carnbee, Trinidad Tobago; [de la Guardia, Elena] Univ La Habana, Ctr Invest Marinas, Havana, Cuba; [Diaz-Pulido, Guillermo] Univ Magdalena, Santa Marta, Colombia; [Diaz-Pulido, Guillermo] Griffith Univ, Griffith Sch Environm, Nathan, Qld 4111, Australia; [Diaz-Pulido, Guillermo] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [DiResta, Daniel] Univ Miami, Marine & Atmospher Sci Program, Coral Gables, FL 33124 USA; [Gil-Agudelo, Diego L.; Rodriguez Ramirez, Alberto] Inst Invest Marinas & Costeras INVEMAR, Santa Marta, Colombia; [Gilliam, David S.] Nova SE Univ, Natl Coral Reef Inst, Dania, FL USA; [Ginsburg, Robert N.; Lirman, Diego] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Virginia Key, FL USA; [Guzman, Hector M.; Kline, David I.] Smithsonian Trop Res Inst, Balboa, Panama; [Hendee, James C.] NOAA, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA; [Hernandez-Delgado, Edwin A.] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, San Juan, PR 00936 USA; [Husain, Ellen] Univ Exeter, Marine Spatial Ecol Lab, Exeter, Devon, England; [Jones, Ross J.] Bermuda Inst Ocean Sci, St Georges, Bermuda; [Jordan-Dahlgren, Eric] Univ Nacl Autonoma Mexico, Inst Ciencias Mar & Limnol, Cancun, Quintana Roo, Mexico; [Kaufman, Les S.] Boston Univ, Dept Biol, Boston, MA 02215 USA; [Kline, David I.] Univ Queensland, Global Change Inst, Brisbane, Qld, Australia; [Kramer, Philip A.] Nature Conservancy, Sugarloaf Key, FL USA; [Lang, Judith C.; Marks, Ken] Ocean Res & Educ Fdn Inc, Coral Gables, FL USA; [Mallela, Jennie] Univ W Indies, Dept Life Sci, St Augustine, Trinidad Tobago; [Mallela, Jennie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT, Australia; [Manfrino, Carrie] Cent Caribbean Marine Inst, Union, NJ USA; [Manfrino, Carrie] Kean Univ, Union, NJ USA; [Marechal, Jean-Philippe] Observ Milieu Marin Martiniquais, Fort De France, Martinique, France; [Mihaly, Jennifer] Reef Check, Pacific Palisades, CA USA; [Miller, W. Jeff] S Florida Caribbean Network, St John, VI USA; [Mueller, Erich M.] Perry Inst Marine Sci, Jupiter, FL USA; [Muller, Erinn M.] Florida Inst Technol, Dept Biol Sci, Melbourne, FL 32901 USA; [Orozco Toro, Carlos A.] Corp Desarrollo Sostenible Archipielago San Andre, San Andres Isla, Colombia; [Oxenford, Hazel A.] Univ W Indies, Ctr Resource Management & Environm Studies, Cave Hill, Barbados; [Quinn, Norman] Dept Planning & Nat Resources, Christiansted, VI USA; [Samhouri, Jameal F.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA; [Sanchez, Juan A.] Univ Los Andes, Dept Ciencias Biol, Bogota, Colombia; [Schmahl, George P.] Natl Ocean & Atmospher Adm, Galveston, TX USA; [Shank, Burton V.] Natl Ocean & Atmospher Adm, NE Fisheries Sci Ctr, Woods Hole, MA USA; [Steiner, Sascha C. C.] Inst Trop Marine Ecol Inc, Roseau, Dominica; [Villamizar, Estrella] Cent Univ Venezuela, Inst Zool Trop, Caracas, Venezuela; [Walsh, Sheila M.] Brown Univ, Environm Change Initiat, Providence, RI 02912 USA; [Yusuf, Yusri] Univ Malaysia Terengganu, Inst Oceanog, Kuala Terengganu, Malaysia; [Yusuf, Yusri] Univ Malaysia Terengganu, ReefBase, Kuala Terengganu, Malaysia	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; James Cook University; University of the Virgin Islands; University of East Anglia; Mote Marine Laboratory & Aquarium; Simon Bolivar University; Universite des Antilles; University of Puerto Rico; University of Puerto Rico Mayaguez; National Oceanic Atmospheric Admin (NOAA) - USA; University of North Carolina; University of North Carolina Wilmington; University of Bedfordshire; Universidad de la Habana; Universidad del Magdalena; Griffith University; Griffith University; University of Miami; Nova Southeastern University; Smithsonian Institution; Smithsonian Tropical Research Institute; National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML); University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Exeter; Bermuda Institute of Ocean Sciences; Universidad Nacional Autonoma de Mexico; Boston University; University of Queensland; University West Indies Mona Jamaica; University West Indies Saint Augustine; Australian National University; Florida Institute of Technology; University West Indies Mona Jamaica; University West Indies Cave Hill Campus; University of California System; University of California Los Angeles; Universidad de los Andes (Colombia); National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; University of Central Venezuela; Brown University; Universiti Malaysia Terengganu; Universiti Malaysia Terengganu	Eakin, CM (corresponding author), Natl Ocean & Atmospher Adm, Ctr Coastal Monitoring & Assessment, Silver Spring, MD USA.	coralreefwatch@noaa.gov	Alvarez-Filip, Lorenzo/C-9552-2011; Jones, Ross/N-4651-2013; Christensen, Tyler/E-7922-2011; Weil, Ernesto/ABF-1290-2020; Hendee, James C/E-6358-2010; Yusuf, Yusri/A-5366-2019; Manfrino, Carrie/F-7588-2013; Morgan, Jessica/E-7926-2011; Heron, Scott F/E-7928-2011; Rinaldi2, Carlos/D-4479-2011; sanchez, juan/GSD-8167-2022; Weil, Ernesto/AAI-3591-2020; Diaz-Pulido, Guillermo/B-3648-2013; Manfrino, Carrie/AAZ-9126-2021; Eakin, C. Mark/F-5585-2010; Liu, Gang/E-7921-2011; Skirving, William/E-7927-2011	Alvarez-Filip, Lorenzo/0000-0002-5726-7238; Jones, Ross/0000-0003-1661-4149; Weil, Ernesto/0000-0001-5275-1584; Hendee, James C/0000-0002-4799-5354; Yusuf, Yusri/0000-0003-2876-0987; Eakin, C. Mark/0000-0002-5987-0858; Guzman, Hector M./0000-0001-9928-8523; Christensen, Tyler/0000-0002-9744-5270; Rodriguez-Ramirez, Alberto/0000-0003-4855-7345; Diaz-Pulido, Guillermo/0000-0002-0901-3727; Kline, David/0000-0001-5128-9439; Liu, Gang/0000-0001-8369-6805; Mallela, Jennie/0000-0002-7811-6850; Heron, Scott/0000-0001-5262-6978; Sanchez, Juan Armando/0000-0001-7149-8369; Manfrino, Carrie/0000-0002-3129-9629; Skirving, William/0000-0003-0167-6427	NOAA	NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	This work was partially supported by salaries from the NOAA Coral Reef Conservation Program to the NOAA Coral Reef Conservation Program authors. NOAA provided funding to Caribbean ReefCheck investigators to undertake surveys of bleaching and mortality. Otherwise, no funding from outside authors' institutions was necessary for the undertaking of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Berkelmans R, 2004, CORAL REEFS, V23, P74, DOI 10.1007/s00338-003-0353-y; Brandt ME, 2009, ECOLOGY, V90, P2859, DOI 10.1890/08-0445.1; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Bruno JF, 2003, ECOL LETT, V6, P1056, DOI 10.1046/j.1461-0248.2003.00544.x; Bruno JF, 2007, PLOS BIOL, V5, P1220, DOI 10.1371/journal.pbio.0050124; Carilli JE, 2010, GLOBAL CHANGE BIOL, V16, P1247, DOI 10.1111/j.1365-2486.2009.02043.x; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; COLES SL, 1978, MAR BIOL, V49, P187, DOI 10.1007/BF00391130; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Eakin C. M., 2009, V205, P41; Eakin CM, 2001, B MAR SCI, V69, P171; Glynn P.W., 1990, Elsevier Oceanography Series, V52, P55; GLYNN PW, 1990, CORAL REEFS, V8, P181, DOI 10.1007/BF00265009; Graham NAJ, 2006, P NATL ACAD SCI USA, V103, P8425, DOI 10.1073/pnas.0600693103; Heron SF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012210; Hill JJ, 2004, METHODS ECOLOGICAL M; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEGHGULDBERG O, 2005, UNDERSTANDING STRESS, P107; Isaaks EH, 1989, APPL GEOSTATISTICS; Kramer Philip A., 2003, Atoll Research Bulletin, V496, P1; Lesser MP, 2007, J EXP MAR BIOL ECOL, V346, P36, DOI 10.1016/j.jembe.2007.02.015; Leujak W, 2007, J EXP MAR BIOL ECOL, V351, P168, DOI 10.1016/j.jembe.2007.06.028; Liu G., 2006, P 10 INT CORAL REEF, Vvol. 1793, P1783; Mallela J, 2009, MAR ENVIRON RES, V68, P158, DOI 10.1016/j.marenvres.2009.06.001; Manzello DP, 2007, P NATL ACAD SCI USA, V104, P12035, DOI 10.1073/pnas.0701194104; Marshall PA, 2006, REEF MANAGERS GUIDE; Miller J, 2009, CORAL REEFS, V28, P925, DOI 10.1007/s00338-009-0531-7; Mora C, 2008, P R SOC B, V275, P767, DOI 10.1098/rspb.2007.1472; Muller EM, 2008, CORAL REEFS, V27, P191, DOI 10.1007/s00338-007-0310-2; Mumby PJ, 2001, MAR ECOL PROG SER, V222, P209, DOI 10.3354/meps222209; *NOAA NAT CLIM DAT, 2009, NOAA EXT REC SEA SUR; *NOAA NAT OC DAT C, 2009, NODC 4 KM PATHF VERS; Oxenford H. A., 2010, P 11 INT COR REEF S, P505; Oxenford HA, 2008, CLIMATIC CHANGE, V87, P435, DOI 10.1007/s10584-007-9311-y; Pandolfi JM, 2005, SCIENCE, V307, P1725, DOI 10.1126/science.1104258; Pandolfi JM, 2006, ECOL LETT, V9, P818, DOI 10.1111/j.1461-0248.2006.00933.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rodriguez S, 2010, REV BIOL TROP, V58, P189; Shein KA, 2006, B AM METEOROL SOC, V87, pS6, DOI 10.1175/BAMS-87-6-shein; Smith TM, 2004, J CLIMATE, V17, P2466, DOI 10.1175/1520-0442(2004)017<2466:IEROS>2.0.CO;2; Solomon S., 2007, PHYS SCI BASIS WORKI; Trenberth KE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026894; Whelan KRT, 2007, CORAL REEFS, V26, P689, DOI 10.1007/s00338-007-0241-y; Wilkinson C, 2000, STATUS CORAL REEFS W; Wilkinson C, 2008, STATUS CARIBBEAN COR; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013	48	402	417	20	311	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2010	5	11							e13969	10.1371/journal.pone.0013969	http://dx.doi.org/10.1371/journal.pone.0013969			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680KW	21125021	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000284231800007
J	Keramari, M; Razavi, J; Ingman, KA; Patsch, C; Edenhofer, F; Ward, CM; Kimber, SJ				Keramari, Maria; Razavi, Janet; Ingman, Karen A.; Patsch, Christoph; Edenhofer, Frank; Ward, Christopher M.; Kimber, Susan J.			Sox2 Is Essential for Formation of Trophectoderm in the Preimplantation Embryo	PLOS ONE			English	Article							CELL SELF-RENEWAL; PLURIPOTENT STEM-CELLS; DOUBLE-STRANDED-RNA; TRANSCRIPTIONAL REGULATION; PROTEIN TRANSDUCTION; GENE-EXPRESSION; TROPHOBLAST DEVELOPMENT; PRIMITIVE ENDODERM; MOUSE EMBRYO; NANOG	Background: In preimplantation mammalian development the transcription factor Sox2 (SRY-related HMG-box gene 2) forms a complex with Oct4 and functions in maintenance of self-renewal of the pluripotent inner cell mass (ICM). Previously it was shown that Sox2-/- embryos die soon after implantation. However, maternal Sox2 transcripts may mask an earlier phenotype. We investigated whether Sox2 is involved in controlling cell fate decisions at an earlier stage. Methods and Findings: We addressed the question of an earlier role for Sox2 using RNAi, which removes both maternal and embryonic Sox2 mRNA present during the preimplantation period. By depleting both maternal and embryonic Sox2 mRNA at the 2-cell stage and monitoring embryo development in vitro we show that, in the absence of Sox2, embryos arrest at the morula stage and fail to form trophectoderm (TE) or cavitate. Following knock-down of Sox2 via three different short interfering RNA (siRNA) constructs in 2-cell stage mouse embryos, we have shown that the majority of embryos (76%) arrest at the morula stage or slightly earlier and only 18.7-21% form blastocysts compared to 76.2-83% in control groups. In Sox2 siRNA-treated embryos expression of pluripotency associated markers Oct4 and Nanog remained unaffected, whereas TE associated markers Tead4, Yap, Cdx2, Eomes, Fgfr2, as well as Fgf4, were downregulated in the absence of Sox2. Apoptosis was also increased in Sox2 knock-down embryos. Rescue experiments using cell-permeant Sox2 protein resulted in increased blastocyst formation from 18.7% to 62.6% and restoration of Sox2, Oct4, Cdx2 and Yap protein levels in the rescued Sox2-siRNA blastocysts. Conclusion and Significance: We conclude that the first essential function of Sox2 in the preimplantation mouse embryo is to facilitate establishment of the trophectoderm lineage. Our findings provide a novel insight into the first differentiation event within the preimplantation embryo, namely the segregation of the ICM and TE lineages.	[Keramari, Maria; Razavi, Janet; Ingman, Karen A.; Kimber, Susan J.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Patsch, Christoph; Edenhofer, Frank] Univ Bonn, Life & Brain Ctr, Stem Cell Engn Grp, Inst Reconstruct Neurobiol, D-5300 Bonn, Germany; [Patsch, Christoph; Edenhofer, Frank] Hertie Fdn, Bonn, Germany; [Ward, Christopher M.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England	University of Manchester; University of Bonn; University of Manchester	Keramari, M (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	sue.kimber@manchester.ac.uk	Edenhofer, Frank/ABG-9458-2020	Edenhofer, Frank/0000-0002-6489-714X; Keramari, Maria/0000-0001-5545-1763; Ward, Christopher/0000-0001-7389-4488; Kimber, Susan/0000-0002-0568-6342	Greek State's Scholarship Foundation (IKY-Greece); Infertility Research Trust (UK); Medical Research Council (MRC/UK) [R107358]; Deutsche Forschungsgemeinschaft (DFG) [ED79/1-1]; Biotechnology and Biological Sciences Research Council [BB/E527239/1] Funding Source: researchfish; Medical Research Council [G0300484, G0801057, G0700092] Funding Source: researchfish; BBSRC [BB/E527239/1] Funding Source: UKRI; MRC [G0801057, G0300484, G0700092] Funding Source: UKRI	Greek State's Scholarship Foundation (IKY-Greece); Infertility Research Trust (UK); Medical Research Council (MRC/UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Greek State's Scholarship Foundation (IKY-Greece), Infertility Research Trust (UK), Medical Research Council (MRC/UK, R107358) and Deutsche Forschungsgemeinschaft (DFG, ED79/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Arman E, 1998, P NATL ACAD SCI USA, V95, P5082, DOI 10.1073/pnas.95.9.5082; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Batchu RB, 2005, CANCER RES, V65, P10041, DOI 10.1158/0008-5472.CAN-05-1383; Becker-Hapak M, 2001, METHODS, V24, P247, DOI 10.1006/meth.2001.1186; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bosnali M, 2008, BIOL CHEM, V389, P851, DOI 10.1515/BC.2008.106; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Brooks H, 2005, ADV DRUG DELIVER REV, V57, P559, DOI 10.1016/j.addr.2004.12.001; Chai N, 1998, DEV BIOL, V198, P105, DOI 10.1016/S0012-1606(98)80031-6; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Collignon J, 1996, DEVELOPMENT, V122, P509; Dominguez-Bendala J, 2005, DIABETES, V54, P720, DOI 10.2337/diabetes.54.3.720; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Episkopou V, 2005, TRENDS NEUROSCI, V28, P219, DOI 10.1016/j.tins.2005.03.003; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FELDMAN B, 1995, SCIENCE, V267, P246, DOI 10.1126/science.7809630; FLEMING TP, 1994, HISTOCHEMISTRY, V101, P1, DOI 10.1007/BF00315824; Grabarek JB, 2002, GENESIS, V32, P269, DOI 10.1002/gene.10076; Griffin KJP, 1998, DEVELOPMENT, V125, P3379; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Haffner-Krausz R, 1999, MECH DEVELOP, V85, P167, DOI 10.1016/S0925-4773(99)00082-9; Hardy K, 1997, MOL HUM REPROD, V3, P919, DOI 10.1093/molehr/3.10.919; Hardy K, 2003, BIOL REPROD, V68, P1165, DOI 10.1095/biolreprod.102.010090; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1982, DEV BIOL, V91, P431, DOI 10.1016/0012-1606(82)90049-5; KAMACHI Y, 1995, EMBO J, V14, P3510, DOI 10.1002/j.1460-2075.1995.tb07357.x; Kamjoo M, 2002, MOL REPROD DEV, V61, P67, DOI 10.1002/mrd.1132; Keenan ID, 2006, DEV BIOL, V299, P478, DOI 10.1016/j.ydbio.2006.08.040; Kelberman D, 2006, J CLIN INVEST, V116, P2442, DOI 10.1172/JCI28658; Kiernan AE, 2005, NATURE, V434, P1031, DOI 10.1038/nature03487; Kim MH, 2002, BIOCHEM BIOPH RES CO, V296, P1372, DOI 10.1016/S0006-291X(02)02070-3; KIMBER SJ, 1990, INT REV CYTOL, V120, P53; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2004, PLACENTA, V25, pS32, DOI 10.1016/j.placenta.2004.01.015; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li J, 2007, J BIOL CHEM, V282, P19481, DOI 10.1074/jbc.M702056200; Li XP, 2005, MOL REPROD DEV, V72, P152, DOI 10.1002/mrd.20346; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Luster TA, 2000, MOL REPROD DEV, V57, P4, DOI 10.1002/1098-2795(200009)57:1<4::AID-MRD3>3.0.CO;2-I; Luster TA, 2003, GENE, V323, P163, DOI 10.1016/j.gene.2003.09.019; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Nishioka N, 2008, MECH DEVELOP, V125, P270, DOI 10.1016/j.mod.2007.11.002; NISWANDER L, 1992, DEVELOPMENT, V114, P755; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Okubo T, 2006, GENE DEV, V20, P2654, DOI 10.1101/gad.1457106; Okumura-Nakanishi S, 2005, J BIOL CHEM, V280, P5307, DOI 10.1074/jbc.m410015200; Pevny LH, 1997, CURR OPIN GENET DEV, V7, P338, DOI 10.1016/S0959-437X(97)80147-5; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; Pownall ME, 1998, CURR BIOL, V8, P673, DOI 10.1016/S0960-9822(98)70257-X; Que J, 2007, DEVELOPMENT, V134, P2521, DOI 10.1242/dev.003855; Ragge NK, 2005, AM J MED GENET A, V135A, P1, DOI 10.1002/ajmg.a.30642; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Ralston A, 2010, DEVELOPMENT, V137, P395, DOI 10.1242/dev.038828; RAPPOLEE DA, 1994, DEVELOPMENT, V120, P2259; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Scaffidi P, 2001, J BIOL CHEM, V276, P47296, DOI 10.1074/jbc.M107619200; SENNER CE, 2010, PLACENTA, P1; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Shi WJ, 2006, J BIOL CHEM, V281, P23319, DOI 10.1074/jbc.M601811200; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Stein P, 2005, DEV BIOL, V286, P464, DOI 10.1016/j.ydbio.2005.08.015; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Sun Y, 2006, CRIT REV EUKAR GENE, V16, P211, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.20; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tatematsu M, 2003, CANCER SCI, V94, P135, DOI 10.1111/j.1349-7006.2003.tb01409.x; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tokuzawa Y, 2003, MOL CELL BIOL, V23, P2699, DOI 10.1128/MCB.23.8.2699-2708.2003; Tsukamoto T, 2004, J CANCER RES CLIN, V130, P135, DOI 10.1007/s00432-003-0519-6; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wianny F, 2000, NAT CELL BIOL, V2, P70, DOI 10.1038/35000016; Wiebe MS, 2000, GENE, V246, P383, DOI 10.1016/S0378-1119(00)00086-X; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	90	141	147	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13952	10.1371/journal.pone.0013952	http://dx.doi.org/10.1371/journal.pone.0013952			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103067	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700007
J	Sirbu, A; Ruskin, HJ; Crane, M				Sirbu, Alina; Ruskin, Heather J.; Crane, Martin			Cross-Platform Microarray Data Normalisation for Regulatory Network Inference	PLOS ONE			English	Article							TRANSCRIPTION; EXPRESSION; GENES; PHASE	Background: Inferring Gene Regulatory Networks (GRNs) from time course microarray data suffers from the dimensionality problem created by the short length of available time series compared to the large number of genes in the network. To overcome this, data integration from diverse sources is mandatory. Microarray data from different sources and platforms are publicly available, but integration is not straightforward, due to platform and experimental differences. Methods: We analyse here different normalisation approaches for microarray data integration, in the context of reverse engineering of GRN quantitative models. We introduce two preprocessing approaches based on existing normalisation techniques and provide a comprehensive comparison of normalised datasets. Conclusions: Results identify a method based on a combination of Loess normalisation and iterative K-means as best for time series normalisation for this problem.	[Sirbu, Alina; Ruskin, Heather J.; Crane, Martin] Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland	Dublin City University	Sirbu, A (corresponding author), Dublin City Univ, Ctr Sci Comp & Complex Syst Modelling, Dublin 9, Ireland.	asirbu@computing.dcu.ie	Sirbu, Alina/I-3288-2014; Crane, Martin/V-6823-2019	Sirbu, Alina/0000-0002-3947-7143; Crane, Martin/0000-0001-7598-3126	Irish Research Council for Science, Engineering and Technology	Irish Research Council for Science, Engineering and Technology(Irish Research Council for Science, Engineering and Technology)	This work was supported by the Irish Research Council for Science, Engineering and Technology (http://www.ircset.ie/), under the Embark Scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alterovitz G, 2010, BRIEF BIOINFORM, V11, P80, DOI 10.1093/bib/bbp054; Aoki-Kinoshita Kiyoko F., 2007, V396, P71; BOSLAUGH S, STAT NUTSHELL; Do JH, 2006, MOL CELLS, V22, P254; DONOHO D, 1995, WAVELAB REPRODUCIBLE; Fomekong-Nanfack Y, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-94; Hecker M, 2009, BIOSYSTEMS, V96, P86, DOI 10.1016/j.biosystems.2008.12.004; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaiser G., 1994, FRIENDLY GUIDE WAVEL; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lim WK, 2007, BIOINFORMATICS, V23, pI282, DOI 10.1093/bioinformatics/btm201; Noman N, 2006, GECCO 2006: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P263; Noman N, 2007, IEEE ACM T COMPUT BI, V4, P634, DOI 10.1109/TCBB.2007.1058; Orlando DA, 2008, NATURE, V453, P944, DOI 10.1038/nature06955; Pramila T, 2002, GENE DEV, V16, P3034, DOI 10.1101/gad.1034302; Pramila T, 2006, GENE DEV, V20, P2266, DOI 10.1101/gad.1450606; Przytycka TM, 2010, BRIEF BIOINFORM, V11, P15, DOI 10.1093/bib/bbp057; SAVAGEAU MA, 1988, MATH COMPUT MODEL, V11, P546, DOI 10.1016/0895-7177(88)90553-5; Shabalin AA, 2008, BIOINFORMATICS, V24, P1154, DOI 10.1093/bioinformatics/btn083; SHAKYA K, 2009, ADV COMPUTA IN PRESS; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spieth C, 2005, IEEE C EVOL COMPUTAT, P660; Wang Y, 2006, BIOINFORMATICS, V22, P2413, DOI 10.1093/bioinformatics/btl396; Xulvi-Brunet R, 2010, BIOINFORMATICS, V26, P205, DOI 10.1093/bioinformatics/btp632	25	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13822	10.1371/journal.pone.0013822	http://dx.doi.org/10.1371/journal.pone.0013822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103045	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700004
J	Marko, AJ; Miller, RA; Kelman, A; Frauwirth, KA				Marko, Aimee J.; Miller, Rebecca A.; Kelman, Alina; Frauwirth, Kenneth A.			Induction of Glucose Metabolism in Stimulated T Lymphocytes Is Regulated by Mitogen-Activated Protein Kinase Signaling	PLOS ONE			English	Article							HUMAN PERIPHERAL LYMPHOCYTES; CELL-ACTIVATION; PHYTOHEMAGGLUTININ STIMULATION; PHOSPHATIDYLINOSITOL 3-KINASE; CARBOHYDRATE METABOLISM; GLUTAMINE-METABOLISM; CANCER-CELLS; GLYCOLYSIS; AKT; TRANSLOCATION	T lymphocytes play a critical role in cell-mediated immune responses. During activation, extracellular and intracellular signals alter T cell metabolism in order to meet the energetic and biosynthetic needs of a proliferating, active cell, but control of these phenomena is not well defined. Previous studies have demonstrated that signaling from the costimulatory receptor CD28 enhances glucose utilization via the phosphatidylinositol-3-kinase ( PI3K) pathway. However, since CD28 ligation alone does not induce glucose metabolism in resting T cells, contributions from T cell receptor-initiated signaling pathways must also be important. We therefore investigated the role of mitogen-activated protein kinase (MAPK) signaling in the regulation of mouse T cell glucose metabolism. T cell stimulation strongly induces glucose uptake and glycolysis, both of which are severely impaired by inhibition of extracellular signal-regulated kinase (ERK), whereas p38 inhibition had a much smaller effect. Activation also induced hexokinase activity and expression in T cells, and both were similarly dependent on ERK signaling. Thus, the ERK signaling pathway cooperates with PI3K to induce glucose utilization in activated T cells, with hexokinase serving as a potential point for coordinated regulation.	[Marko, Aimee J.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; Univ Maryland, Maryland Pathogen Res Inst, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Marko, AJ (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	kfrauwir@umd.edu			National Cancer Institute [K01 CA092156]; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [K01CA092156] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by a Howard Temin K01 Career Development Award (grant number K01 CA092156) from the National Cancer Institute (www.cancer.gov) and a New Investigator Grant from the Leukemia Research Foundation (www.leukemia-research.org) to K.A.F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ARDAWI MSM, 1983, BIOCHEM J, V212, P835, DOI 10.1042/bj2120835; ARDAWI MSM, 1988, METABOLISM, V37, P99, DOI 10.1016/0026-0495(88)90036-4; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; BRAND K, 1989, METABOLISM, V38, P29, DOI 10.1016/0026-0495(89)90136-4; BRAND K, 1984, BIOCHEM J, V221, P471, DOI 10.1042/bj2210471; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; COOPER EH, 1963, BRIT J HAEMATOL, V9, P101, DOI 10.1111/j.1365-2141.1963.tb05446.x; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; CULVENOR JG, 1976, BIOCHIM BIOPHYS ACTA, V437, P354, DOI 10.1016/0304-4165(76)90005-2; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Deng HB, 2008, J BIOL CHEM, V283, P20754, DOI 10.1074/jbc.M800024200; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franchi-Gazzola R, 1999, J BIOL CHEM, V274, P28922, DOI 10.1074/jbc.274.41.28922; Frauwirth KA, 2002, FASEB J, V16, pA711; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; HEDESKOV CJ, 1968, BIOCHEM J, V110, P373, DOI 10.1042/bj1100373; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Hyde R, 2007, J BIOL CHEM, V282, P19788, DOI 10.1074/jbc.M611520200; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; KOCH B, 1990, J CELL PHYSIOL, V143, P94, DOI 10.1002/jcp.1041430112; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Lopez-Fontanals M, 2003, J GEN PHYSIOL, V122, P5, DOI 10.1085/jgp.200308800; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Parry RV, 1997, EUR J IMMUNOL, V27, P2495, DOI 10.1002/eji.1830271006; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rathmell JC, 2001, J IMMUNOL, V167, P6869, DOI 10.4049/jimmunol.167.12.6869; Rathmell JC, 2000, MOL CELL, V6, P683, DOI 10.1016/S1097-2765(00)00066-6; Robey RB, 1999, AM J PHYSIOL-RENAL, V277, pF742, DOI 10.1152/ajprenal.1999.277.5.F742; ROOS D, 1970, BIOCHIM BIOPHYS ACTA, V222, P565, DOI 10.1016/0304-4165(70)90182-0; ROOS D, 1973, EXP CELL RES, V77, P127, DOI 10.1016/0014-4827(73)90561-2; SAGONE AL, 1974, CELL IMMUNOL, V14, P443, DOI 10.1016/0008-8749(74)90195-6; Taha C, 1999, J BIOL CHEM, V274, P33085, DOI 10.1074/jbc.274.46.33085; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang QH, 1999, MOL CELL BIOL, V19, P4008; WARBURG O, 1956, SCIENCE, V124, P269; Zhou Q, 2008, J NEUROCHEM, V104, P325, DOI 10.1111/j.1471-4159.2007.04957.x	45	68	69	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e15425	10.1371/journal.pone.0015425	http://dx.doi.org/10.1371/journal.pone.0015425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085672	Green Submitted, Green Published, gold			2022-12-27	WOS:000284036800028
J	deWaard, JR; Mitchell, A; Keena, MA; Gopurenko, D; Boykin, LM; Armstrong, KF; Pogue, MG; Lima, J; Floyd, R; Hanner, RH; Humble, LM				deWaard, Jeremy R.; Mitchell, Andrew; Keena, Melody A.; Gopurenko, David; Boykin, Laura M.; Armstrong, Karen F.; Pogue, Michael G.; Lima, Joao; Floyd, Robin; Hanner, Robert H.; Humble, Leland M.			Towards a Global Barcode Library for Lymantria (Lepidoptera: Lymantriinae) Tussock Moths of Biosecurity Concern	PLOS ONE			English	Article							DNA BARCODES; GYPSY MOTHS; UNITED-STATES; IDENTIFICATION; POPULATIONS; INVASIONS; GENETICS; DIPTERA; MODEL; LIFE	Background: Detecting and controlling the movements of invasive species, such as insect pests, relies upon rapid and accurate species identification in order to initiate containment procedures by the appropriate authorities. Many species in the tussock moth genus Lymantria are significant forestry pests, including the gypsy moth Lymantria dispar L., and consequently have been a focus for the development of molecular diagnostic tools to assist in identifying species and source populations. In this study we expand the taxonomic and geographic coverage of the DNA barcode reference library, and further test the utility of this diagnostic method, both for species/subspecies assignment and for determination of geographic provenance of populations. Methodology/Principal Findings: Cytochrome oxidase I (COI) barcodes were obtained from 518 individuals and 36 species of Lymantria, including sequences assembled and generated from previous studies, vouchered material in public collections, and intercepted specimens obtained from surveillance programs in Canada. A maximum likelihood tree was constructed, revealing high bootstrap support for 90% of species clusters. Bayesian species assignment was also tested, and resulted in correct assignment to species and subspecies in all instances. The performance of barcoding was also compared against the commonly employed NB restriction digest system (also based on COI); while the latter is informative for discriminating gypsy moth subspecies, COI barcode sequences provide greater resolution and generality by encompassing a greater number of haplotypes across all Lymantria species, none shared between species. Conclusions/Significance: This study demonstrates the efficacy of DNA barcodes for diagnosing species of Lymantria and reinforces the view that the approach is an under-utilized resource with substantial potential for biosecurity and surveillance. Biomonitoring agencies currently employing the NB restriction digest system would gather more information by transitioning to the use of DNA barcoding, a change which could be made relatively seamlessly as the same gene region underlies both protocols.	[deWaard, Jeremy R.; Humble, Leland M.] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada; [deWaard, Jeremy R.] Royal British Columbia Museum, Victoria, BC, Canada; [Mitchell, Andrew] Australian Museum, Sydney, NSW 2000, Australia; [Keena, Melody A.] USDA, No Res Stn, Hamden, CT USA; [Gopurenko, David] Wagga Wagga Agr Inst, Wagga Wagga, NSW, Australia; [Boykin, Laura M.; Armstrong, Karen F.] Lincoln Univ, Bioprotect Res Ctr, Christchurch, New Zealand; [Pogue, Michael G.] USDA, Systemat Entomol Lab, Washington, DC 20250 USA; [Lima, Joao; Floyd, Robin; Hanner, Robert H.] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Humble, Leland M.] Nat Resources Canada, Canadian Forest Serv, Victoria, BC, Canada	University of British Columbia; Australian Museum; United States Department of Agriculture (USDA); Lincoln University - New Zealand; Smithsonian Institution; United States Department of Agriculture (USDA); University of Guelph; Natural Resources Canada; Canadian Forest Service	deWaard, JR (corresponding author), Univ British Columbia, Vancouver, BC V5Z 1M9, Canada.	jdewaard@interchange.ubc.ca	Armstrong, Karen F/J-3460-2013; Keena, Melody A./W-7124-2019; Boykin, Laura/H-8876-2014; Gopurenko, David/H-3341-2014; Mitchell, Andrew/B-7018-2008; deWaard, Jeremy R/G-8112-2014	Armstrong, Karen F/0000-0003-4973-2651; Keena, Melody A./0000-0003-3099-6243; Boykin, Laura/0000-0002-6101-1921; Gopurenko, David/0000-0003-2886-1614; Mitchell, Andrew/0000-0001-5022-5898; 	Forest Investment Account - Forest Science Program; NSERC; Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC; New Zealand Tertiary Education Commission; Australian Department of Agriculture, Food and Fisheries; NSW Agricultural Genomics Centre	Forest Investment Account - Forest Science Program; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)Genome Canada); New Zealand Tertiary Education Commission; Australian Department of Agriculture, Food and Fisheries(Australian GovernmentDepartment of Agriculture and Water Resources); NSW Agricultural Genomics Centre	Funding was provided by a Forest Investment Account - Forest Science Program Student Grant and an NSERC Graduate Scholarship (to JRD); the Canadian Barcode of Life Network from Genome Canada through the Ontario Genomics Institute, NSERC (to LMH and RHH), and other sponsors listed at www.BOLNET.ca; the New Zealand Tertiary Education Commission (to LB and KFA); the Australian Department of Agriculture, Food and Fisheries (to AM); and the NSW Agricultural Genomics Centre (to AM and DG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Allen EA, 2002, CAN J PLANT PATHOL, V24, P103, DOI 10.1080/07060660309506983; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 2003, N Z PLANT PROTECT-SE, V56, P16, DOI 10.30843/nzpp.2003.56.6025; Ball SL, 2006, CAN J FOREST RES, V36, P337, DOI 10.1139/X05-276; Barr NB, 2009, J ECON ENTOMOL, V102, P401, DOI 10.1603/029.102.0153; Bogdanowicz SM, 1997, ANN ENTOMOL SOC AM, V90, P768, DOI 10.1093/aesa/90.6.768; Bogdanowicz SM, 2000, MOL PHYLOGENET EVOL, V15, P487, DOI 10.1006/mpev.1999.0744; BOGDANOWICZ SM, 1993, ANN ENTOMOL SOC AM, V86, P710, DOI 10.1093/aesa/86.6.710; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Brockerhoff EG, 2010, NEW ZEAL J ECOL, V34, P158; Cho S, 2008, SYST ENTOMOL, V33, P581, DOI 10.1111/j.1365-3113.2008.00427.x; deWaard JR, 2009, BIODIVERS CONSERV, V18, P3825, DOI 10.1007/s10531-009-9682-7; DeWaard Jeremy R., 2008, V410, P275; *FAO, 2006, INT STAND PHYT MEAS, V27, P11; Floyd R, 2010, BIOL INVASIONS, V12, P2947, DOI 10.1007/s10530-010-9709-8; Garner KJ, 1996, INSECT MOL BIOL, V5, P81, DOI 10.1111/j.1365-2583.1996.tb00043.x; Gilligan TM, 2009, LBAM ID TOOLS DIAGNO; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Haack RA, 2006, CAN J FOREST RES, V36, P269, DOI 10.1139/x05-249; Hajibabaei M, 2005, PHILOS T R SOC B, V360, P1959, DOI 10.1098/rstb.2005.1727; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2010, BIOL LETTERS, V6, P359, DOI 10.1098/rsbl.2009.0848; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Humble LM, 2006, CAN J PLANT PATHOL, V28, pS256, DOI 10.1080/07060660609507383; Humble Leland M., 2009, Journal of the Entomological Society of British Columbia, V106, P61; Keena MA, 2008, ENVIRON ENTOMOL, V37, P636, DOI 10.1603/0046-225X(2008)37[636:WDOFFA]2.0.CO;2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Koshio C, 2002, APPL ENTOMOL ZOOL, V37, P309, DOI 10.1303/aez.2002.309; Le Roux J, 2009, ANN APPL BIOL, V154, P1, DOI 10.1111/j.1744-7348.2008.00280.x; Liebhold A., 1989, Bulletin of the Entomological Society of America, V35, P20; Liebhold A. M., 1995, FOREST SCI MONOGR, V41, pa0001; Lou M, 2010, MOL PHYLOGENET EVOL, V56, P187, DOI 10.1016/j.ympev.2010.01.002; Lovett GM, 2006, BIOSCIENCE, V56, P395, DOI 10.1641/0006-3568(2006)056[0395:FERTEP]2.0.CO;2; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Nadel RL, 2010, BIOL INVASIONS, V12, P1067, DOI 10.1007/s10530-009-9524-2; PFEIFER TA, 1995, CAN ENTOMOL, V127, P49, DOI 10.4039/Ent12749-1; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pogue MG, 2007, PUBLICATION USDA; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reineke A, 1999, ANN ENTOMOL SOC AM, V92, P737, DOI 10.1093/aesa/92.5.737; Ross MG, 2005, RESPONSE GYPSY MOTH; Scheffer SJ, 2006, ANN ENTOMOL SOC AM, V99, P204, DOI 10.1603/0013-8746(2006)099[0204:DBATIL]2.0.CO;2; Schintlmeister A., 2004, Quadrifina, V7, P1; Siddall ME, 2005, CONSERV GENET, V6, P467, DOI 10.1007/s10592-005-4986-y; Simonsen TJ, 2008, ANN ENTOMOL SOC AM, V101, P899, DOI 10.1603/0013-8746(2008)101[899:TAIPOC]2.0.CO;2; Smith MA, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-31; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; WALLNER WE, 1995, J ECON ENTOMOL, V88, P337, DOI 10.1093/jee/88.2.337; Weese DA, 2009, ANIM CONSERV, V12, P13, DOI 10.1111/j.1469-1795.2008.00215.x; Wilson A. D., 2010, Journal of Entomology, V7, P60, DOI 10.3923/je.2010.60.79; Zwickl D. J, 2006, GENETIC ALGORITHM AP	54	55	62	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14280	10.1371/journal.pone.0014280	http://dx.doi.org/10.1371/journal.pone.0014280			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151562	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800011
J	Kato, T; Kasai, A; Mizuno, M; Liang, FY; Shintani, N; Maeda, S; Yokoyama, M; Ozaki, M; Nawa, H				Kato, Taisuke; Kasai, Atsushi; Mizuno, Makoto; Liang Fengyi; Shintani, Norihito; Maeda, Sadaaki; Yokoyama, Minesuke; Ozaki, Miwako; Nawa, Hiroyuki			Phenotypic Characterization of Transgenic Mice Overexpressing Neuregulin-1	PLOS ONE			English	Article							RISK GENE NEUREGULIN-1; MUTANT MICE; DOPAMINERGIC-NEURONS; PREFRONTAL CORTEX; SOCIAL-BEHAVIOR; NERVOUS-SYSTEM; MESSENGER-RNA; KNOCKOUT MICE; SCHIZOPHRENIA; EXPRESSION	Background: Neuregulin-1 (NRG1) is one of the susceptibility genes for schizophrenia and implicated in the neurotrophic regulation of GABAergic and dopaminergic neurons, myelination, and NMDA receptor function. Postmortem studies often indicate a pathologic association of increased NRG1 expression or signaling with this illness. However, the psychobehavioral implication of NRG1 signaling has mainly been investigated using hypomorphic mutant mice for individual NRG1 splice variants. Methodology/Principal Findings: To assess the behavioral impact of hyper NRG1 signaling, we generated and analyzed two independent mouse transgenic (Tg) lines carrying the transgene of green fluorescent protein (GFP)-tagged type-1 NRG1 cDNA. The promoter of elongation-factor 1 alpha gene drove ubiquitous expression of GFP-tagged NRG1 in the whole brain. As compared to control littermates, both heterozygous NRG1-Tg lines showed increased locomotor activity, a nonsignificant trend toward decreasing prepulse inhibition, and decreased context-dependent fear learning but exhibited normal levels of tone-dependent learning. In addition, social interaction scores in both Tg lines were reduced in an isolation-induced resident-intruder test. There were also phenotypic increases in a GABAergic marker (parvalbumin) as well as in myelination markers (myelin basic protein and 2',3'-cyclic nucleotide 3'-phosphodiesterase) in their frontal cortex, indicating the authenticity of NRG1 hyper-signaling, although there were marked decreases in tyrosine hydroxylase levels and dopamine content in the hippocampus. Conclusions: These findings suggest that aberrant hyper-signals of NRG1 also disrupt various cognitive and behavioral processes. Thus, neuropathological implication of hyper NRG1 signaling in psychiatric diseases should be evaluated with further experimentation.	[Kato, Taisuke; Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan; [Kasai, Atsushi; Maeda, Sadaaki] Setsunan Univ, Fac Pharmaceut Sci, Dept Pharmacotherapeut, Osaka, Japan; [Mizuno, Makoto; Nawa, Hiroyuki] Niigata Univ, Ctr Transdisciplinary Res, Niigata, Japan; [Liang Fengyi] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Anat, Singapore 117595, Singapore; [Shintani, Norihito] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Neuropharmacol, Osaka, Japan; [Yokoyama, Minesuke] Niigata Univ, Brain Res Inst, Ctr Bioresource Based Res, Niigata, Japan; [Ozaki, Miwako] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Tokyo, Japan; [Ozaki, Miwako] Waseda Bioscience Inst Singapore WABIOS, Neurosci & Neuroengn Grp, Helios, Singapore	Niigata University; Setsunan University; Niigata University; National University of Singapore; Osaka University; Niigata University; Waseda University	Kato, T (corresponding author), Niigata Univ, Brain Res Inst, Dept Mol Neurobiol, Niigata, Japan.	hnawa@bri.niigata-u.ac.jp	Kasai, Atsushi/C-8073-2011; Liang, Fengyi/A-7521-2018; Shintani, Norihito/N-1600-2019; Shintani, Norihito/D-5860-2014	Kasai, Atsushi/0000-0002-1612-3078; Liang, Fengyi/0000-0003-1162-6212; Shintani, Norihito/0000-0002-7850-9064; Shintani, Norihito/0000-0002-7850-9064; Kato, Taisuke/0000-0001-5696-7104	Health and Labor Sciences Research Grants; Japan Science and Technology Agency; Ministry of Health, Labour and Welfare of Japan; Astrazeneca Pharmaceutical; Astrazeneca Pharmaceutical, Inc.	Health and Labor Sciences Research Grants(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Astrazeneca Pharmaceutical(AstraZeneca); Astrazeneca Pharmaceutical, Inc.(AstraZeneca)	This work was supported by Health and Labor Sciences Research Grants, a grant for Promotion of Nigata University Research Projects, Core Research for Evolutional Science and Technology from the Japan Science and Technology Agency, and a grant-in-aid from the Ministry of Health, Labour and Welfare of Japan. Hiroyuki Nawa was a recipient of research grants from Astrazeneca Pharmaceutical. No funders had a role in either the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; HN was a recipient of the research grants from Astrazeneca Pharmaceutical, Inc. This does not alter the authors' adherence to the PLoS ONE policies on sharing data and materials.	Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Akbarian S, 2006, BRAIN RES REV, V52, P293, DOI 10.1016/j.brainresrev.2006.04.001; Arguello PA, 2006, NEURON, V52, P179, DOI 10.1016/j.neuron.2006.09.023; Brinkmann BG, 2008, NEURON, V59, P581, DOI 10.1016/j.neuron.2008.06.028; Chen YJJ, 2008, J NEUROSCI, V28, P6872, DOI 10.1523/JNEUROSCI.1815-08.2008; Chong VZ, 2008, SCHIZOPHR RES, V100, P270, DOI 10.1016/j.schres.2007.12.474; Clemens KJ, 2004, PSYCHOPHARMACOLOGY, V173, P318, DOI 10.1007/s00213-004-1786-x; Davis KL, 2003, ARCH GEN PSYCHIAT, V60, P443, DOI 10.1001/archpsyc.60.5.443; Deakin IH, 2009, NEUROREPORT, V20, P1523, DOI 10.1097/WNR.0b013e328330f6e7; Dickerson JW, 2009, NEUROSCIENCE, V163, P482, DOI 10.1016/j.neuroscience.2009.06.008; Ehrlichman RS, 2009, BRAIN RES, V1294, P116, DOI 10.1016/j.brainres.2009.07.065; Eyles DW, 2002, SCHIZOPHR RES, V57, P27, DOI 10.1016/S0920-9964(01)00299-7; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; Frankland PW, 2004, HIPPOCAMPUS, V14, P557, DOI 10.1002/hipo.10208; Fumagalli F, 1998, J NEUROSCI, V18, P4861; Gerlai R, 2000, BEHAV BRAIN RES, V109, P219, DOI 10.1016/S0166-4328(99)00175-8; Golub MS, 2004, BEHAV BRAIN RES, V153, P159, DOI 10.1016/j.bbr.2003.11.010; Hahn CG, 2006, NAT MED, V12, P824, DOI 10.1038/nm1418; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Hashimoto R, 2004, MOL PSYCHIATR, V9, P299, DOI 10.1038/sj.mp.4001434; Karl T, 2007, GENES BRAIN BEHAV, V6, P677, DOI 10.1111/j.1601-183X.2006.00298.x; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kasai Atsushi, 2007, Folia Pharmacologica Japonica, V130, P281, DOI 10.1254/fpj.130.281; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Krivosheya D, 2008, J BIOL CHEM, V283, P32944, DOI 10.1074/jbc.M800073200; Lachman HM, 2006, AM J MED GENET B, V141B, P102, DOI 10.1002/ajmg.b.30242; Law AJ, 2006, P NATL ACAD SCI USA, V103, P6747, DOI 10.1073/pnas.0602002103; Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028; Li DW, 2006, HUM MOL GENET, V15, P1995, DOI 10.1093/hmg/ddl122; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Meuer S, 2001, RAPID CYCLE REAL TIM, P21, DOI 10.1007/978-3-642-59524-0; Mizuno M, 2007, J NEUROSCI, V27, P10116, DOI 10.1523/JNEUROSCI.2368-07.2007; Mohn AR, 1999, CELL, V98, P427, DOI 10.1016/S0092-8674(00)81972-8; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; O'Tuathaigh CMP, 2007, NEUROSCIENCE, V147, P18, DOI 10.1016/j.neuroscience.2007.03.051; O'Tuathaigh CM, 2006, NEUROREPORT, V17, P79, DOI 10.1097/01.wnr.0000192738.31029.0a; O'Tuathaigh CMP, 2008, PROG NEURO-PSYCHOPH, V32, P462, DOI 10.1016/j.pnpbp.2007.09.018; O'Tuathaigh CMP, 2007, NEUROSCI BIOBEHAV R, V31, P60, DOI 10.1016/j.neubiorev.2006.04.002; Ozaki M, 2004, J NEUROCHEM, V91, P176, DOI 10.1111/j.1471-4159.2004.02719.x; Ozaki M, 2000, J NEUROSCI RES, V59, P612; Ozaki M, 1997, NATURE, V390, P691, DOI 10.1038/37795; Petryshen TL, 2005, MOL PSYCHIATR, V10, P366, DOI 10.1038/sj.mp.4001608; Prevot V, 2003, J NEUROSCI, V23, P230; Rimer M, 2005, NEUROREPORT, V16, P271, DOI 10.1097/00001756-200502280-00014; Rogers DC, 1997, MAMM GENOME, V8, P711, DOI 10.1007/s003359900551; Rossato JI, 2009, SCIENCE, V325, P1017, DOI 10.1126/science.1172545; Roy K, 2007, P NATL ACAD SCI USA, V104, P8131, DOI 10.1073/pnas.0702157104; SamsDodd F, 1996, BEHAV PHARMACOL, V7, P3; SAMSDODD F, 1995, BEHAV PHARMACOL, V6, P55; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; van den Buuse M, 2009, INT J NEUROPSYCHOPH, V29, P1; Volkow ND, 2001, J NEUROSCI, V21, pU1; Yurek DM, 2004, BRAIN RES, V1028, P116, DOI 10.1016/j.brainres.2004.08.066; Zhang LX, 2004, J NEUROCHEM, V91, P1358, DOI 10.1111/j.1471-4159.2004.02817.x; Zheng YJ, 2009, PROG NEURO-PSYCHOPH, V33, P701, DOI 10.1016/j.pnpbp.2009.03.021	57	88	91	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14185	10.1371/journal.pone.0014185	http://dx.doi.org/10.1371/journal.pone.0014185			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151609	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800001
J	Ishiguro, M; Mishiro, K; Fujiwara, Y; Chen, HY; Izuta, H; Tsuruma, K; Shimazawa, M; Yoshimura, S; Satoh, M; Iwama, T; Hara, H				Ishiguro, Mitsunori; Mishiro, Keisuke; Fujiwara, Yasuyuki; Chen, Huayue; Izuta, Hiroshi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Yoshimura, Shinichi; Satoh, Masahiko; Iwama, Toru; Hara, Hideaki			Phosphodiesterase-III Inhibitor Prevents Hemorrhagic Transformation Induced by Focal Cerebral Ischemia in Mice Treated with tPA	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; NITRIC-OXIDE SYNTHASE; BLOOD-BRAIN-BARRIER; ENDOTHELIAL-CELLS; CILOSTAZOL PROTECTS; NEURONAL DAMAGE; RAT-BRAIN; STROKE; THROMBOLYSIS; PHOSPHORYLATION	The purpose of the present study was to investigate whether cilostazol, a phosphodiesterase-III inhibitor and antiplatelet drug, would prevent tPA-associated hemorrhagic transformation. Mice subjected to 6-h middle cerebral artery occlusion were treated with delayed tPA alone at 6 h, with combined tPA plus cilostazol at 6 h, or with vehicle at 6 h. We used multiple imaging (electron microscopy, spectroscopy), histological and neurobehavioral measures to assess the effects of the treatment at 18 h and 7 days after the reperfusion. To further investigate the mechanism of cilostazol to beneficial effect, we also performed an in vitro study with tPA and a phosphodiesterase-III inhibitor in human brain microvascular endothelial cells, pericytes, and astrocytes. Combination therapy with tPA plus cilostazol prevented development of hemorrhagic transformation, reduced brain edema, prevented endothelial injury via reduction MMP-9 activity, and prevented the blood-brain barrier opening by inhibiting decreased claudin-5 expression. These changes significantly reduced the morbidity and mortality at 18 h and 7 days after the reperfusion. Also, the administration of both drugs prevented injury to brain human endothelial cells and human brain pericytes. The present study indicates that a phosphodiesterase-III inhibitor prevents the hemorrhagic transformation induced by focal cerebral ischemia in mice treated with tPA.	[Ishiguro, Mitsunori; Mishiro, Keisuke; Izuta, Hiroshi; Tsuruma, Kazuhiro; Shimazawa, Masamitsu; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Ishiguro, Mitsunori; Yoshimura, Shinichi; Iwama, Toru] Gifu Univ, Grad Sch Med, Dept Neurosurg, Gifu, Japan; [Fujiwara, Yasuyuki; Satoh, Masahiko] Aichi Gakuin Univ, Sch Pharm, Lab Pharmaceut Hlth Sci, Aichi, Japan; [Chen, Huayue] Gifu Univ, Grad Sch Med, Dept Anat, Gifu, Japan	Gifu Pharmaceutical University; Gifu University; Aichi Gakuin University; Gifu University	Ishiguro, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Fujiwara, Yasuyuki/AAB-8775-2020	Fujiwara, Yasuyuki/0000-0003-0028-0658; Iwama, Toru/0000-0002-9426-284X; Chen, Huayue/0000-0001-6758-1995	Gifu Pharmaceutical University	Gifu Pharmaceutical University	Funding was provided by the Gifu Pharmaceutical University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKIYAMA H, 1985, ARZNEIMITTEL-FORSCH, V35-2, P1124; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016; Brott T, 1997, STROKE, V28, P2109, DOI 10.1161/01.STR.28.11.2109; Choi JM, 2002, J PHARMACOL EXP THER, V300, P787, DOI 10.1124/jpet.300.3.787; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; HARA H, 1990, STROKE, V21, P102; Hara H, 1997, P NATL ACAD SCI USA, V94, P2007, DOI 10.1073/pnas.94.5.2007; Hara H, 1996, J CEREBR BLOOD F MET, V16, P605, DOI 10.1097/00004647-199607000-00010; Hashimoto A, 2006, ATHEROSCLEROSIS, V189, P350, DOI 10.1016/j.atherosclerosis.2006.01.022; Huang YI, 2008, LANCET NEUROL, V7, P494, DOI 10.1016/S1474-4422(08)70094-2; Ishizaki T, 2003, EXP CELL RES, V290, P275, DOI 10.1016/S0014-4827(03)00354-9; Jin G, 2009, EXP NEUROL, V217, P165, DOI 10.1016/j.expneurol.2009.02.004; Kim KY, 2002, J PHARMACOL EXP THER, V300, P709, DOI 10.1124/jpet.300.2.709; Koto T, 2007, AM J PATHOL, V170, P1389, DOI 10.2353/ajpath.2007.060693; Lee JH, 2003, BRAIN RES, V994, P91, DOI 10.1016/j.brainres.2003.09.021; Liu D, 2004, NAT MED, V10, P1379, DOI 10.1038/nm1122; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Matsumoto M, 2005, ATHEROSCLEROSIS SUPP, V6, P33, DOI 10.1016/j.atherosclerosissup.2005.09.003; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; Nonaka Y, 2009, J PHARMACOL EXP THER, V330, P13, DOI 10.1124/jpet.109.151548; Nonaka Y, 2009, NEUROSCI LETT, V452, P156, DOI 10.1016/j.neulet.2009.01.039; Noshita N, 2001, J CEREBR BLOOD F MET, V21, P1442, DOI 10.1097/00004647-200112000-00009; Ota H, 2008, ARTERIOSCL THROM VAS, V28, P1634, DOI 10.1161/ATVBAHA.108.164368; Qin ZY, 2007, STROKE, V38, P1362, DOI 10.1161/01.STR.0000259660.62865.eb; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; STELZNER TJ, 1989, J CELL PHYSIOL, V139, P157, DOI 10.1002/jcp.1041390122; Sumii T, 2002, STROKE, V33, P831, DOI 10.1161/hs0302.104542; TANAKA K, 1989, STROKE, V20, P668, DOI 10.1161/01.STR.20.5.668; Valable S, 2005, J CEREBR BLOOD F MET, V25, P1491, DOI 10.1038/sj.jcbfm.9600148; Wakida K, 2006, BRAIN RES, V1116, P187, DOI 10.1016/j.brainres.2006.07.125; Wang JJ, 2010, AM J PHYSIOL-HEART C, V298, pH1146, DOI 10.1152/ajpheart.00252.2009; Wilhite DB, 2003, J VASC SURG, V38, P710, DOI 10.1016/S0741-5214(03)01029-2; Yagi K, 2009, STROKE, V40, P626, DOI 10.1161/STROKEAHA.108.520262; Yamashita T, 2009, J CEREBR BLOOD F MET, V29, P715, DOI 10.1038/jcbfm.2008.164; Yoeruek E, 2008, INVEST OPHTH VIS SCI, V49, P1392, DOI 10.1167/iovs.07-1079; Yoshimoto T, 2009, NEUROL MED-CHIR, V49, P235, DOI 10.2176/nmc.49.235; Zhang WR, 2004, NEUROL RES, V26, P342, DOI 10.1179/016164104225014058; ZHAO Y, 2009, NEUROL RES      0805	39	69	71	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15178	10.1371/journal.pone.0015178	http://dx.doi.org/10.1371/journal.pone.0015178			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151895	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300020
J	Job, B; Bernheim, A; Beau-Faller, M; Camilleri-Broet, S; Girard, P; Hofman, P; Mazieres, J; Toujani, S; Lacroix, L; Laffaire, J; Dessen, P; Fouret, P				Job, Bastien; Bernheim, Alain; Beau-Faller, Michele; Camilleri-Broet, Sophie; Girard, Philippe; Hofman, Paul; Mazieres, Julien; Toujani, Saloua; Lacroix, Ludovic; Laffaire, Julien; Dessen, Philippe; Fouret, Pierre		LG Investigators	Genomic Aberrations in Lung Adenocarcinoma in Never Smokers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; HUMAN CANCER; CHROMOSOMAL-ABERRATIONS; SOMATIC MUTATIONS; TOBACCO EXPOSURE; ARRAY-CGH; GENE; NONSMOKERS; GEFITINIB; ERLOTINIB	Background: Lung cancer in never smokers would rank as the seventh most common cause of cancer death worldwide. Methods and Findings: We performed high-resolution array comparative genomic hybridization analysis of lung adenocarcinoma in sixty never smokers and identified fourteen new minimal common regions (MCR) of gain or loss, of which five contained a single gene (MOCS2, NSUN3, KHDRBS2, SNTG1 and ST18). One larger MCR of gain contained NSD1. One focal amplification and nine gains contained FUS. NSD1 and FUS are oncogenes hitherto not known to be associated with lung cancer. FISH showed that the amplicon containing FUS was joined to the next telomeric amplicon at 16p11.2. FUS was over-expressed in 10 tumors with gain of 16p11.2 compared to 30 tumors without that gain. Other cancer genes present in aberrations included ARNT, BCL9, CDK4, CDKN2B, EGFR, ERBB2, MDM2, MDM4, MET, MYC and KRAS. Unsupervised hierarchical clustering with adjustment for false-discovery rate revealed clusters differing by the level and pattern of aberrations and displaying particular tumor characteristics. One cluster was strongly associated with gain of MYC. Another cluster was characterized by extensive losses containing tumor suppressor genes of which RB1 and WRN. Tumors in that cluster frequently harbored a central scar-like fibrosis. A third cluster was associated with gains on 7p and 7q, containing ETV1 and BRAF, and displayed the highest rate of EGFR mutations. SNP array analysis validated copy-number aberrations and revealed that RB1 and WRN were altered by recurrent copy-neutral loss of heterozygosity. Conclusions: The present study has uncovered new aberrations containing cancer genes. The oncogene FUS is a candidate gene in the 16p region that is frequently gained in never smokers. Multiple genetic pathways defined by gains of MYC, deletions of RB1 and WRN or gains on 7p and 7q are involved in lung adenocarcinoma in never smokers.	[Job, Bastien] Inst Rech Integree Cancerol Villejuif, Villejuif, France; [Bernheim, Alain; Toujani, Saloua; Dessen, Philippe; Fouret, Pierre] INSERM, INSERM Genet Tumeurs U985, Villejuif, France; [Beau-Faller, Michele] CHU Strasbourg, Hop Hautepierre, Lab Biochim & Biol Mol, F-67000 Strasbourg, France; [Camilleri-Broet, Sophie] INSERM, INSERM JE2492, Le Kremlin Bicetre, France; [Camilleri-Broet, Sophie; Dessen, Philippe] Univ Paris Sud, Le Kremlin Bicetre, France; [Girard, Philippe] Inst Mutualiste Montsouris, Dept Thorac, Paris, France; [Hofman, Paul] CHU Nice, Hop Pasteur, Lab Pathol Clin & Expt, Nice, France; [Mazieres, Julien] CHU Toulouse, Hop Larrey, Unite Cancerol Cervico Thorac, Toulouse, France; [Lacroix, Ludovic] Inst Cancerol Gustave Roussy, Lab Rech Translat, Villejuif, France; [Laffaire, Julien] Ligue Natl Canc, Paris, France; [Fouret, Pierre] Univ Paris 06, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute Mutualiste Montsouris; UDICE-French Research Universities; Universite Paris Cite; CHU Nice; CHU de Toulouse; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Sorbonne Universite	Job, B (corresponding author), Inst Rech Integree Cancerol Villejuif, Villejuif, France.	pierre.fouret@psl.aphp.fr	Hofman, Paul/P-7654-2018; Beau-Faller, Michèle/R-3052-2016; MAZIERES, JULIEN/M-3986-2014	Hofman, Paul/0000-0003-0431-9353; MAZIERES, JULIEN/0000-0002-5921-7613; RICHON, Catherine/0000-0002-3556-3941	Institut National du Cancer; Ligue Nationale contre le cancer	Institut National du Cancer(Institut National du Cancer (INCA) France); Ligue Nationale contre le cancer(Ligue nationale contre le cancer)	This work is part of the Programme National d'Excellence Specialise Poumon funded by the Institut National du Cancer and of the Programme Cartes d'Identite des Tumeurs funded by the Ligue Nationale contre le cancer (grants to Pierre Fouret). The Institut National du Cancer has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ligue Nationale contre le Cancer conducted the hybridization experiments to SNP arrays as part of its program Carte d'Identite des tumeurs. JL is employed by the Ligue Nationale contre le Cancer and analyzed the SNP array data.	Agrelo R, 2006, P NATL ACAD SCI USA, V103, P8822, DOI 10.1073/pnas.0600645103; Balsara BR, 2002, ONCOGENE, V21, P6877, DOI 10.1038/sj.onc.1205836; CAVENEE WK, 1983, NATURE, V305, P779, DOI 10.1038/305779a0; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garnis C, 2006, INT J CANCER, V118, P1556, DOI 10.1002/ijc.21491; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Gazdar AF, 2007, J CLIN ONCOL, V25, P469, DOI 10.1200/JCO.2006.09.4623; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Horn L, 2009, J CLIN ONCOL, V27, P4232, DOI 10.1200/JCO.2009.23.6661; Hsu DS, 2009, P NATL ACAD SCI USA, V106, P5312, DOI 10.1073/pnas.0900827106; International Federation of Red Cross and Red Crescent Societies, 2007, WORLD DISASTERS REPO, P97; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Kang JU, 2008, CANCER GENET CYTOGEN, V182, P1, DOI 10.1016/j.cancergencyto.2007.12.004; Kanoe H, 1999, ONCOGENE, V18, P721, DOI 10.1038/sj.onc.1202364; Kim TM, 2005, CLIN CANCER RES, V11, P8235, DOI 10.1158/1078-0432.CCR-05-1157; LaFramboise T, 2009, NUCLEIC ACIDS RES, V37, P4181, DOI 10.1093/nar/gkp552; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peiffer DA, 2006, GENOME RES, V16, P1136, DOI 10.1101/gr.5402306; Pham DK, 2006, J CLIN ONCOL, V24, P1700, DOI 10.1200/JCO.2005.04.3224; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Riely GJ, 2008, CLIN CANCER RES, V14, P5731, DOI 10.1158/1078-0432.CCR-08-0646; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Rudin CM, 2009, CLIN CANCER RES, V15, P5646, DOI 10.1158/1078-0432.CCR-09-0377; Rudin CM, 2009, CLIN CANCER RES, V15, P5622, DOI 10.1158/1078-0432.CCR-09-0373; Sanchez-Cespedes M, 2001, CANCER RES, V61, P1309; Scott KL, 2009, NATURE, V459, P1085, DOI 10.1038/nature08109; Shaw AT, 2009, J CLIN ONCOL, V27, P4247, DOI 10.1200/JCO.2009.22.6993; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shigematsu H, 2005, CANCER RES, V65, P1642, DOI 10.1158/0008-5472.CAN-04-4235; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tam IYS, 2006, CLIN CANCER RES, V12, P1647, DOI 10.1158/1078-0432.CCR-05-1981; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Tanaka H, 2009, NAT REV CANCER, V9, P215, DOI 10.1038/nrc2591; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Toh CK, 2007, J CLIN PATHOL, V60, P337, DOI 10.1136/jcp.2006.040576; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Toyooka S, 2006, CANCER RES, V66, P1371, DOI 10.1158/0008-5472.CAN-05-2625; Tsao MS, 2005, NEW ENGL J MED, V353, P133, DOI 10.1056/NEJMoa050736; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wong MP, 2003, CANCER, V97, P1263, DOI 10.1002/cncr.11183; Wong MP, 2002, CANCER RES, V62, P4464; Zhao XJ, 2005, CANCER RES, V65, P5561, DOI 10.1158/0008-5472.CAN-04-4603	50	47	47	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15145	10.1371/journal.pone.0015145	http://dx.doi.org/10.1371/journal.pone.0015145			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151896	Green Submitted, gold, Green Published			2022-12-27	WOS:000284995300018
J	Lu, D; Lian, H; Zhang, XJ; Shao, HT; Huang, L; Qin, CA; Zhang, LF				Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Huang, Lan; Qin, Chuan; Zhang, Lianfeng			LMNA E82K Mutation Activates FAS and Mitochondrial Pathways of Apoptosis in Heart Tissue Specific Transgenic Mice	PLOS ONE			English	Article							LAMIN-A/C GENE; RAT VENTRICULAR MYOCYTES; A-TYPE LAMINS; DILATED CARDIOMYOPATHY; MUSCULAR-DYSTROPHY; NATRIURETIC PEPTIDE; NUCLEAR-ENVELOPE; DISEASE; EXPRESSION; PHENOTYPE	The lamin A/C (LMNA), nuclear intermediate filament proteins, is a basic component of the nuclear lamina. Mutations in LMNA are associated with a broad range of laminopathies, congenital diseases affecting tissue regeneration and homeostasis. Heart tissue specific transgenic mice of human LMNA E82K, a mutation causing dilated cardiomyopathy, were generated. Lmna(E82K) transgenic mouse lines exhibited thin-walled, dilated left and right ventricles, a progressive decrease of contractile function assessed by echocardiography. Abnormalities of the conduction system, myocytes disarray, collagen accumulation and increased levels of B-type natriuretic peptide (BNP), procollagen type III alpha 1 (Col3 alpha 1) and skeletal muscle actin alpha 1 (Act alpha 1) were detected in the hearts of Lmna(E82K) transgenic mice. The LMNA E82K mutation caused mislocation of LMNA in the nucleus and swollen mitochondria with loss of critae, together with the loss of nuclear envelope integrity. Most interestingly, we found that the level of apoptosis was 8.5-fold higher in the Lmna(E82K) transgenic mice than that of non-transgenic (NTG) mice. In the presence of the LMNA E82K, both of FAS and mitochondrial pathways of apoptosis were activated consistent with the increase of FAS expression, the release of cytochrome c from mitochondria to cytosol and activation of caspase-8, -9 and -3. Our results suggested that the apoptosis, at least for the LMNA E82K or the mutations in the rod region of Lamin A/C, might be an important mechanism causing continuous loss of myocytes and lead to myocardial dysfunction. It could be a potential therapeutic means to suppress and/or prevent inappropriate cardiac cell death in patients carrying LMNA mutation.	[Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100037, Peoples R China; [Lu, Dan; Lian, Hong; Zhang, Xiaojuan; Shao, Haitao; Huang, Lan; Qin, Chuan; Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Huang, Lan; Qin, Chuan; Zhang, Lianfeng] Chinese Acad Med Sci, Key Lab Human Dis Anim Model, State Adm Tradit Chinese Med, Inst Lab Anim Sci, Beijing 100037, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS	Lu, D (corresponding author), Chinese Acad Med Sci, Key Lab Human Dis Comparat Med, Minist Hlth, Inst Lab Anim Sci, Beijing 100037, Peoples R China.	Zhanglf@cnilas.org		LU, Dan/0000-0002-5204-2574	Ministry of Health Foundation [200802036]; National Science and Technology Major Projects [2009ZX09501-026]	Ministry of Health Foundation; National Science and Technology Major Projects	This work was supported in part by the Ministry of Health Foundation (200802036) and the National Science and Technology Major Projects (2009ZX09501-026). The funders had no role in study design, date collection and analysis, decision to publish, or preparation of the manuscript.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Anselmi A, 2008, J CARDIOVASC MED, V9, P227, DOI 10.2459/JCM.0b013e328277f1d7; Arimura T, 2005, HUM MOL GENET, V14, P155, DOI 10.1093/hmg/ddi017; Barac YD, 2005, CARDIOVASC RES, V68, P75, DOI 10.1016/j.cardiores.2005.05.015; BELTRAMI CA, 1995, J MOL CELL CARDIOL, V27, P291, DOI 10.1016/S0022-2828(08)80028-4; Bishopric Nanette H., 2001, Current Opinion in Pharmacology, V1, P141, DOI 10.1016/S1471-4892(01)00032-7; Botto N, 2010, CARDIOVASC ULTRASOUN, V8, DOI 10.1186/1476-7120-8-9; Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295; Brower GL, 2006, EUR J CARDIO-THORAC, V30, P604, DOI 10.1016/j.ejcts.2006.07.006; Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Eichhorn EJ, 1996, CIRCULATION, V94, P2285, DOI 10.1161/01.CIR.94.9.2285; Feng JJ, 2009, NEUROMUSCULAR DISORD, V19, P6, DOI 10.1016/j.nmd.2008.09.005; Genschel J, 2000, HUM MUTAT, V16, P451, DOI 10.1002/1098-1004(200012)16:6<451::AID-HUMU1>3.0.CO;2-9; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupta S, 2001, LIFE SCI, V69, P2957, DOI 10.1016/S0024-3205(01)01404-7; Henriques-Pons A, 2009, J CARDIOVASC PHARM, V53, P94, DOI 10.1097/FJC.0b013e318198fe46; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Hutchison CJ, 2001, J CELL SCI, V114, P9; Juan F, 2008, INT J CARDIOL, V128, P83, DOI 10.1016/j.ijcard.2008.03.006; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Lammerding J, 2004, J CLIN INVEST, V113, P370, DOI 10.1172/JCI200419670; Lanfear DE, 2007, CARDIOVASC DRUG THER, V21, P55, DOI 10.1007/s10557-007-6007-5; Lee SD, 2007, OBESITY, V15, P2407, DOI 10.1038/oby.2007.286; Mestroni L, 2008, J AM COLL CARDIOL, V52, P1261, DOI 10.1016/j.jacc.2008.07.021; Meune C, 2006, NEW ENGL J MED, V354, P209, DOI 10.1056/NEJMc052632; Mounkes L, 2004, CURR TOP DEV BIOL, V61, P191, DOI 10.1016/S0070-2153(04)61008-8; Mounkes LC, 2005, HUM MOL GENET, V14, P2167, DOI 10.1093/hmg/ddi221; Narula J, 1999, P NATL ACAD SCI USA, V96, P8144, DOI 10.1073/pnas.96.14.8144; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Rottman JN, 2003, J AM SOC ECHOCARDIOG, V16, P1150, DOI 10.1067/S0894-7317(03)00471-1; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Sebillon P, 2003, J MED GENET, V40, P560, DOI 10.1136/jmg.40.8.560; Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; Tsybouleva N, 2004, CIRCULATION, V109, P1284, DOI 10.1161/01.CIR.0000121426.43044.2B; van der Kooi AJ, 2002, NEUROLOGY, V59, P620, DOI 10.1212/WNL.59.4.620; Wang H, 2006, BIOCHEM BIOPH RES CO, V344, P17, DOI 10.1016/j.bbrc.2006.03.149; Wang YX, 2006, HUM MOL GENET, V15, P2479, DOI 10.1093/hmg/ddl170; Wolf CM, 2008, J MOL CELL CARDIOL, V44, P293, DOI 10.1016/j.yjmcc.2007.11.008; Wollert KC, 2000, CIRCULATION, V101, P1172, DOI 10.1161/01.CIR.101.10.1172; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Yaniv G, 2002, CARDIOVASC RES, V54, P611, DOI 10.1016/S0008-6363(02)00264-X	45	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15167	10.1371/journal.pone.0015167	http://dx.doi.org/10.1371/journal.pone.0015167			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151901	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300019
J	Jana, S; Campbell, H; Woodliff, J; Waukau, J; Jailwala, P; Ghorai, J; Ghosh, S; Glisic, S				Jana, Srikanta; Campbell, Hope; Woodliff, Jeffrey; Waukau, Jill; Jailwala, Parthav; Ghorai, Jugal; Ghosh, Soumitra; Glisic, Sanja			The Type of Responder T-Cell Has a Significant Impact in a Human In Vitro Suppression Assay	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; REGULATORY CELLS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; PERIPHERAL-BLOOD; DISEASE-ACTIVITY; MEDIATED SUPPRESSION; CUTTING EDGE; ACTIVATION; IL-2	Background: In type 1 diabetes (T1D), a prototypic autoimmune disease, effector T cells destroy beta cells. Normally, CD4(+)CD25(+high), or natural regulatory T cells (Tregs), counter this assault. In autoimmunity, the failure to suppress CD4(+)CD25(low) T cells is important for disease development. However, both Treg dysfunction and hyperactive responder T-cell proliferation contribute to disease. Methods/Principal Findings: We investigated human CD4(+)CD25(low) T cells and compared them to CD4(+)CD25(-) T cells in otherwise equivalent in vitro proliferative conditions. We then asked whether these differences in suppression are exacerbated in T1D. In both single and co-culture with Tregs, the CD4(+)CD25(low) T cells divided more rapidly than CD4(+)CD25 T cells, which manifests as increased proliferation/reduced suppression. Time-course experiments showed that this difference could be explained by higher IL-2 production from CD4+CD25(low) compared to CD4+CD25- T cells. There was also a significant increase in CD4+CD25(low) T-cell proliferation compared to CD4+CD25- T cells during suppression assays from RO T1D and at-risk subjects (n = 28, p = 0.015 and p = 0.024 respectively). Conclusions/Significance: The in vitro dual suppression assays proposed here could highlight the impaired sensitivity of certain responder T cells to the suppressive effect of Tregs in human autoimmune diseases.	[Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Med Coll Wisconsin, Dept Pediat, Max McGee Natl Res Ctr Juvenile Diabet & Human, Milwaukee, WI 53226 USA; [Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Med Coll Wisconsin, Ctr Mol Genet, Milwaukee, WI 53226 USA; [Jana, Srikanta; Waukau, Jill; Jailwala, Parthav; Ghosh, Soumitra; Glisic, Sanja] Childrens Hosp Wisconsin, Milwaukee, WI 53201 USA; [Ghorai, Jugal] Univ Wisconsin, Dept Math Sci, Milwaukee, WI 53201 USA; [Campbell, Hope] Blood Res Inst, Milwaukee, WI USA	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; University of Wisconsin System; University of Wisconsin Milwaukee; Versiti Blood Center of Wisconsin	Jana, S (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	sglisic@mcw.edu			Max McGee Fund; Children's Research Institute; National Institutes of Health [GCRC MO1-RR00058]; RAC MCW [409-1]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000058] Funding Source: NIH RePORTER	Max McGee Fund; Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RAC MCW; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by Max McGee Fund, Children's Research Institute, a grant from GCRC MO1-RR00058 from the National Institutes of Health and RAC MCW grant (409-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMASAKI Y, 1995, CLIN EXP IMMUNOL, V99, P245; Baecher-Allan C, 2002, J IMMUNOL, V169, P6210, DOI 10.4049/jimmunol.169.11.6210; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Bijl M, 2001, LUPUS, V10, P866, DOI 10.1191/096120301701548517; Black APB, 2002, ARTHRITIS RES, V4, P177, DOI 10.1186/ar403; Busse D, 2010, P NATL ACAD SCI USA, V107, P3058, DOI 10.1073/pnas.0812851107; CANTRELL DA, 1984, SCIENCE, V224, P1312, DOI 10.1126/science.6427923; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Crispin JC, 2003, J AUTOIMMUN, V21, P273, DOI 10.1016/S0896-8411(03)00121-5; CROFT M, 1994, J IMMUNOL, V152, P2675; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; De Boer RJ, 2005, J COMPUT APPL MATH, V184, P140, DOI 10.1016/j.cam.2004.08.020; Dieckmann D, 2001, J EXP MED, V193, P1303, DOI 10.1084/jem.193.11.1303; Ehst BD, 2003, AM J TRANSPLANT, V3, P1355, DOI 10.1046/j.1600-6135.2003.00246.x; Glisic-Milosavljevic S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000146; Gondek DC, 2005, J IMMUNOL, V174, P1783, DOI 10.4049/jimmunol.174.4.1783; Hansen JD, 2009, MOL IMMUNOL, V46, P457, DOI 10.1016/j.molimm.2008.10.007; Herman AE, 2004, J EXP MED, V199, P1479, DOI 10.1084/jem.20040179; Hidaka T, 1999, Ther Apher, V3, P178, DOI 10.1046/j.1526-0968.1999.00136.x; Hoffmann P, 2006, BLOOD, V108, P4260, DOI 10.1182/blood-2006-06-027409; Jailwala P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006527; Jensen J, 2004, J NEUROIMMUNOL, V149, P202, DOI 10.1016/j.jneuroim.2003.12.019; Jin Y, 2009, CLIN IMMUNOL, V130, P272, DOI 10.1016/j.clim.2008.10.005; Jonuleit H, 2003, J IMMUNOL, V171, P6323, DOI 10.4049/jimmunol.171.12.6323; Khoury SJ, 2000, ARCH NEUROL-CHICAGO, V57, P1183, DOI 10.1001/archneur.57.8.1183; Klein S, 2010, J INVEST DERMATOL, V130, P492, DOI 10.1038/jid.2009.313; Kumanogoh A, 2001, J IMMUNOL, V166, P353, DOI 10.4049/jimmunol.166.1.353; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Lezzi G, 1998, IMMUNITY, V8, P89, DOI 10.1016/S1074-7613(00)80461-6; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu MF, 2004, SCAND J IMMUNOL, V59, P198, DOI 10.1111/j.0300-9475.2004.01370.x; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Long SA, 2010, DIABETES, V59, P407, DOI 10.2337/db09-0694; Lundgren A, 2003, INFECT IMMUN, V71, P1755, DOI 10.1128/IAI.71.4.1755-1762.2003; May T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002372; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Peakman M, 1996, DIABETES CARE, V19, P1177, DOI 10.2337/diacare.19.11.1177; Podtschaske M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000935; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Salazar-Fontana LI, 2001, CLIN IMMUNOL, V99, P253, DOI 10.1006/clim.2001.5003; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Setoguchi R, 2005, J EXP MED, V201, P723, DOI 10.1084/jem.20041982; Shevach EM, 2001, IMMUNOL REV, V182, P58, DOI 10.1034/j.1600-065X.2001.1820104.x; Strauss L, 2009, J IMMUNOL, V182, P1469, DOI 10.4049/jimmunol.182.3.1469; Suri-Payer E, 1998, J IMMUNOL, V160, P1212; Thornton AM, 2004, J IMMUNOL, V172, P6519, DOI 10.4049/jimmunol.172.11.6519; Tran DQ, 2009, J IMMUNOL, V182, P2929, DOI 10.4049/jimmunol.0803827; van Amelsfort JM, 2004, ARTHRITIS RHEUM-US, V50, pS526; Venigalla RKC, 2008, ARTHRITIS RHEUM-US, V58, P2120, DOI 10.1002/art.23556; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579	51	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15154	10.1371/journal.pone.0015154	http://dx.doi.org/10.1371/journal.pone.0015154			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151941	Green Published, Green Submitted, gold			2022-12-27	WOS:000284939600028
J	Tang, Y; Xiang, W; Terry, L; Kretzschmar, HA; Windl, O				Tang, Yue; Xiang, Wei; Terry, Linda; Kretzschmar, Hans A.; Windl, Otto			Transcriptional Analysis Implicates Endoplasmic Reticulum Stress in Bovine Spongiform Encephalopathy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CREUTZFELDT-JAKOB-DISEASE; ABNORMAL PRION PROTEIN; ER STRESS; GENE-EXPRESSION; CELL-DEATH; ARABIDOPSIS-THALIANA; CEREBROSPINAL-FLUID; VARIANT CJD; SCRAPIE	Bovine spongiform encephalopathy (BSE) is a fatal, transmissible, neurodegenerative disease of cattle. To date, the disease process is still poorly understood. In this study, brain tissue samples from animals naturally infected with BSE were analysed to identify differentially regulated genes using Affymetrix GeneChip Bovine Genome Arrays. A total of 230 genes were shown to be differentially regulated and many of these genes encode proteins involved in immune response, apoptosis, cell adhesion, stress response and transcription. Seventeen genes are associated with the endoplasmic reticulum (ER) and 10 of these 17 genes are involved in stress related responses including ER chaperones, Grp94 and Grp170. Western blotting analysis showed that another ER chaperone, Grp78, was up-regulated in BSE. Up-regulation of these three chaperones strongly suggests the presence of ER stress and the activation of the unfolded protein response (UPR) in BSE. The occurrence of ER stress was also supported by changes in gene expression for cytosolic proteins, such as the chaperone pair of Hsp70 and DnaJ. Many genes associated with the ubiquitin-proteasome pathway and the autophagy-lysosome system were differentially regulated, indicating that both pathways might be activated in response to ER stress. A model is presented to explain the mechanisms of prion neurotoxicity using these ER stress related responses. Clustering analysis showed that the differently regulated genes found from the naturally infected BSE cases could be used to predict the infectious status of the samples experimentally infected with BSE from the previous study and vice versa. Proof-of-principle gene expression biomarkers were found to represent BSE using 10 genes with 94% sensitivity and 87% specificity.	[Tang, Yue; Terry, Linda; Windl, Otto] Vet Labs Agcy, Dept Mol Pathogenesis & Genet, Surrey, England; [Xiang, Wei] Univ Erlangen Nurnberg, Inst Biochem, Emil Fischer Ctr, Erlangen, Germany; [Kretzschmar, Hans A.] Univ Munich, Inst Neuropathol, D-8000 Munich, Germany	Veterinary Laboratories Agency; University of Erlangen Nuremberg; University of Munich	Tang, Y (corresponding author), Vet Labs Agcy, Dept Mol Pathogenesis & Genet, Surrey, England.	y.tang@vla.defra.gsi.gov.uk; o.windl@vla.defra.gsi.gov.uk	Windl, Otto/C-6760-2011; Xiang, Wei/Y-3171-2019; Tang, Yue/C-7094-2011; Terry, Linda A/C-2338-2011		Veterinary Laboratories Agency UK	Veterinary Laboratories Agency UK	This work was supported by a development grant of Veterinary Laboratories Agency UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Bates PW, 1999, PLANT J, V20, P183, DOI 10.1046/j.1365-313x.1999.00590.x; Booth S, 2004, BIOCHEM BIOPH RES CO, V325, P1339, DOI 10.1016/j.bbrc.2004.10.150; Borovecki F, 2005, P NATL ACAD SCI USA, V102, P11023, DOI 10.1073/pnas.0504921102; Brown AR, 2005, BIOCHEM BIOPH RES CO, V334, P86, DOI 10.1016/j.bbrc.2005.06.060; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Chin LS, 2010, BIOCHEM SOC T, V38, P144, DOI 10.1042/BST0380144; Collins S, 2000, J CLIN NEUROSCI, V7, P203, DOI 10.1054/jocn.1999.0193; Doh-ura K, 2000, J NEUROPATH EXP NEUR, V59, P774, DOI 10.1093/jnen/59.9.774; Dron M, 2005, EUR J NEUROSCI, V22, P133, DOI 10.1111/j.1460-9568.2005.04172.x; Ersdal C, 2009, NEUROPATH APPL NEURO, V35, P259, DOI 10.1111/j.1365-2990.2008.00988.x; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; Fazi B, 2009, ONCOGENE, V28, P3814, DOI 10.1038/onc.2009.233; Ferreiro E, 2008, J NEUROCHEM, V104, P766, DOI 10.1111/j.1471-4159.2007.05048.x; Gavier-Widen D, 2005, J VET DIAGN INVEST, V17, P509, DOI 10.1177/104063870501700601; Groenendyk J, 2005, ACTA BIOCHIM POL, V52, P381; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Hetz C, 2005, J NEUROSCI, V25, P2793, DOI 10.1523/JNEUROSCI.4090-04.2005; Hetz C, 2003, EMBO J, V22, P5435, DOI 10.1093/emboj/cdg537; Holgado-Madruga M, 2003, MOL CELL BIOL, V23, P4471, DOI 10.1128/MCB.23.13.4471-4484.2003; Ironside JW, 1998, FEMS IMMUNOL MED MIC, V21, P91, DOI 10.1111/j.1574-695X.1998.tb01153.x; Jeffrey M, 2006, J PATHOL, V209, P4, DOI 10.1002/path.1962; JEFFREY M, 1992, ACTA NEUROPATHOL, V84, P559, DOI 10.1007/BF00304476; Jin JK, 2007, NEUROSCI LETT, V420, P138, DOI 10.1016/j.neulet.2007.04.069; Kamauchi S, 2005, FEBS J, V272, P3461, DOI 10.1111/j.1742-4658.2005.04770.x; Keith RJ, 2009, CHEM-BIOL INTERACT, V178, P242, DOI 10.1016/j.cbi.2008.10.055; Kristiansen M, 2005, J BIOL CHEM, V280, P38851, DOI 10.1074/jbc.M506600200; Kuang E, 2006, EXP CELL RES, V312, P1983, DOI 10.1016/j.yexcr.2006.02.024; Kuo TH, 1997, CELL CALCIUM, V21, P399, DOI 10.1016/S0143-4160(97)90051-8; Lai ED, 2007, PHYSIOLOGY, V22, P193, DOI 10.1152/physiol.00050.2006; Lehman NL, 2009, ACTA NEUROPATHOL, V118, P329, DOI 10.1007/s00401-009-0560-x; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Lindholm D, 2006, CELL DEATH DIFFER, V13, P385, DOI 10.1038/sj.cdd.4401778; Lisbona F, 2009, CELL CYCLE, V8, P1643; Lloyd SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000383; Marteijn JAF, 2007, BLOOD, V110, P3128, DOI 10.1182/blood-2006-11-058602; Ngoh GA, 2009, AM J PHYSIOL-HEART C, V297, pH1711, DOI 10.1152/ajpheart.00553.2009; Okushima Y, 2002, PLANT CELL PHYSIOL, V43, P532, DOI 10.1093/pcp/pcf063; Patschan S, 2008, AM J PHYSIOL-HEART C, V294, pH1119, DOI 10.1152/ajpheart.00713.2007; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Rajan SS, 2007, INDIAN J MED RES, V125, P411; Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito T, 2007, J NEUROCHEM, V102, P133, DOI 10.1111/j.1471-4159.2007.04540.x; Sanchez JC, 2004, PROTEOMICS, V4, P2229, DOI 10.1002/pmic.200300799; Sasaki K, 2006, J PATHOL, V209, P484, DOI 10.1002/path.2009; Sawiris GP, 2007, J GEN VIROL, V88, P1356, DOI 10.1099/vir.0.82387-0; Sharma NK, 2008, J CLIN ENDOCR METAB, V93, P4532, DOI 10.1210/jc.2008-1001; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Skinner PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-114; Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699; Tan SX, 2009, MOL BIOL CELL, V20, P1493, DOI 10.1091/mbc.E08-07-0697; Tang Y, 2009, J VIROL, V83, P9464, DOI 10.1128/JVI.00352-09; Theil D, 1999, J COMP PATHOL, V121, P357, DOI 10.1053/jcpa.1999.0333; Vonk LA, 2010, BIOCHEM CELL BIOL, V88, P539, DOI [10.1139/O09-174, 10.1139/o09-174]; WADA I, 1991, J BIOL CHEM, V266, P19599; Wan QW, 2007, APOPTOSIS, V12, P319, DOI 10.1007/s10495-006-0574-y; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells Gerald A. H., 2004, VVolume 41, P595; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Winklhofer KF, 2003, J BIOL CHEM, V278, P14961, DOI 10.1074/jbc.M209942200; Xiang W, 2004, J VIROL, V78, P11051, DOI 10.1128/JVI.78.20.11051-11060.2004; Xiang W, 2007, J NEUROCHEM, V102, P834, DOI 10.1111/j.1471-4159.2007.04566.x	66	28	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14207	10.1371/journal.pone.0014207	http://dx.doi.org/10.1371/journal.pone.0014207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151970	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600004
J	Wang, Y; Abarbanell, AM; Herrmann, JL; Weil, BR; Manukyan, MC; Poynter, JA; Meldrum, DR				Wang, Yue; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Weil, Brent R.; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Meldrum, Daniel R.			TLR4 Inhibits Mesenchymal Stem Cell (MSC) STAT3 Activation and Thereby Exerts Deleterious Effects on MSC-Mediated Cardioprotection	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOLL-LIKE RECEPTORS; BONE-MARROW; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; CARDIAC REPAIR; ISCHEMIA/REPERFUSION INJURY; CD34 EXPRESSION; CXC CHEMOKINES; STROMAL CELLS	Background: Bone marrow-derived mesenchymal stem cells (MSC) improve myocardial recovery after ischemia/reperfusion (I/R) injury. These effects are mediated in part by the paracrine secretion of angiogenic and tissue growth-promoting factors. Toll-like receptor 4 (TLR4) is expressed by MSC and induces apoptosis and inhibits proliferation in neuronal progenitors as well as many other cell types. It is unknown whether knock-out (KO) of TLR4 will change the paracrine properties of MSC and in turn improve MSC-associated myocardial protection. Methodology/Principal Findings: This study explored the effect of MSC TLR4 on the secretion of angiogenic factors and chemokines in vitro by using ELISA and cytokine array assays and investigated the role of TLR4 on MSC-mediated myocardial recovery after I/R injury in an isolated rat heart model. We observed that MSC isolated from TLR4 KO mice exhibited a greater degree of cardioprotection in a rat model of myocardial I/R injury. This enhanced protection was associated with increased angiogenic factor production, proliferation and differentiation. TLR4-dificiency was also associated with decreased phosphorylation of PI-3K and AKT, but increased activation of STAT3. siRNA targeting of STAT3 resulted in attenuation of the enhanced cardioprotection of TLR4-deficient MSC. Conclusions/Significance: This study indicates that TLR4 exerts deleterious effects on MSC-derived cardioprotection following I/R by a STAT3 inhibitory mechanism.	[Wang, Yue; Abarbanell, Aaron M.; Herrmann, Jeremy L.; Weil, Brent R.; Manukyan, Mariuxi C.; Poynter, Jeffrey A.; Meldrum, Daniel R.] Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA; [Meldrum, Daniel R.] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN USA; [Meldrum, Daniel R.] Indiana Univ Sch Med, Ctr Immunobiol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Wang, Y (corresponding author), Indiana Univ Sch Med, Dept Surg, Indianapolis, IN 46202 USA.	dmeldrum@iupui.edu		Herrmann, Jeremy/0000-0001-7818-0548; Abarbanell, Aaron/0000-0003-0694-8081	NIH [R01GM070628, R01HL085595, F32 HL092718, F32 HL092719, F32 HL093987]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL092718, F32HL093987, R01HL085595, F32HL092719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070628] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the following NIH grants: R01GM070628, R01HL085595, F32 HL092718, F32 HL092719 and F32 HL093987. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arminan A, 2010, J AM COLL CARDIOL, V55, P2244, DOI 10.1016/j.jacc.2009.08.092; Assmus B, 2002, CIRCULATION, V106, P3009, DOI 10.1161/01.CIR.0000043246.74879.CD; Assmus B, 2006, NEW ENGL J MED, V355, P1222, DOI 10.1056/NEJMoa051779; Belo AV, 2005, MICROCIRCULATION, V12, P597, DOI 10.1080/10739680500253535; Belperio JA, 2000, J LEUKOCYTE BIOL, V68, P1; Boyle AJ, 2010, METHODS MOL BIOL, V660, P65, DOI 10.1007/978-1-60761-705-1_5; Copland I, 2008, EXP HEMATOL, V36, P93, DOI 10.1016/j.exphem.2007.08.032; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dill T, 2009, AM HEART J, V157, P541, DOI 10.1016/j.ahj.2008.11.011; Edman LC, 2008, EXP CELL RES, V314, P2123, DOI 10.1016/j.yexcr.2008.02.019; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; Frangogiannis NG, 2004, CIRCULATION, V110, P1341, DOI 10.1161/01.CIR.0000141560.18364.63; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gosse SG, 2005, CELL SIGNAL, V17, P1352, DOI 10.1016/j.cellsig.2005.02.002; Guedez L, 1998, BLOOD, V92, P1342, DOI 10.1182/blood.V92.4.1342.416k22_1342_1349; Haider HK, 2005, AM J PHYSIOL-HEART C, V288, pH2557, DOI 10.1152/ajpheart.01215.2004; Hossain M, 2005, BIOMATERIALS, V26, P2595, DOI 10.1016/j.biomaterials.2004.07.051; Hua F, 2009, BRAIN RES, V1262, P100, DOI 10.1016/j.brainres.2009.01.018; Huang J, 2010, CIRC RES, V106, P1753, DOI 10.1161/CIRCRESAHA.109.196030; Imai Y, 2008, CELL, V133, P235, DOI 10.1016/j.cell.2008.02.043; Jung DY, 2005, J IMMUNOL, V174, P6467, DOI 10.4049/jimmunol.174.10.6467; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kudo M, 2003, J MOL CELL CARDIOL, V35, P1113, DOI 10.1016/S0022-2828(03)00211-6; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Markel TA, 2008, AM J PHYSIOL-REG I, V295, pR1124, DOI 10.1152/ajpregu.90508.2008; Min JK, 2005, CIRC RES, V96, P300, DOI 10.1161/01.RES.0000155330.07887.EE; Nesselmann C, 2008, J CELL MOL MED, V12, P1795, DOI 10.1111/j.1582-4934.2008.00457.x; Nourse MB, ARTERIOSCLER THROMB, V30, P80; Osada-Oka M, 2008, J ATHEROSCLER THROMB, V15, P26, DOI 10.5551/jat.E533; Pevsner-Fischer M, 2007, BLOOD, V109, P1422, DOI 10.1182/blood-2006-06-028704; Rho SB, 2007, J CELL BIOCHEM, V101, P57, DOI 10.1002/jcb.21127; Rolls A, 2007, NAT CELL BIOL, V9, P1081, DOI 10.1038/ncb1629; Romagnani P, 2004, TRENDS IMMUNOL, V25, P201, DOI 10.1016/j.it.2004.02.006; Sanchez-Tillo E, 2006, EUR J IMMUNOL, V36, P2515, DOI 10.1002/eji.200535270; Shechter R, 2008, J CELL BIOL, V183, P393, DOI 10.1083/jcb.200804010; SIMMONS PJ, 1991, BLOOD, V78, P2848; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi Y, 2005, J BIOL CHEM, V280, P24195, DOI 10.1074/jbc.M411913200; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tomchuck SL, 2008, STEM CELLS, V26, P99, DOI 10.1634/stemcells.2007-0563; Trivedi P, 2010, STEM CELLS DEV, V19, P1109, DOI 10.1089/scd.2009.0465; Tsung A, 2005, J IMMUNOL, V175, P7661, DOI 10.4049/jimmunol.175.11.7661; WALLER EK, 1995, BLOOD, V86, P710, DOI 10.1182/blood.V86.2.710.bloodjournal862710; Wang MJ, 2007, J MOL CELL CARDIOL, V42, P1009, DOI 10.1016/j.yjmcc.2007.04.010; Wang MJ, 2009, P NATL ACAD SCI USA, V106, P17499, DOI 10.1073/pnas.0908924106; Wang MJ, 2009, J THORAC CARDIOV SUR, V138, P163, DOI 10.1016/j.jtcvs.2009.03.010; Wang Y, 2008, AM J PHYSIOL-REG I, V295, pR1115, DOI 10.1152/ajpregu.90383.2008; Wang Y, 2009, AM J PHYSIOL-CELL PH, V297, pC1284, DOI 10.1152/ajpcell.00183.2009; Wang Y, 2009, SURGERY, V146, P198, DOI 10.1016/j.surg.2009.04.013; Weil BR, 2009, AM J PHYSIOL-REG I, V296, pR1735, DOI 10.1152/ajpregu.90876.2008; Weimar IS, 1998, LEUKEMIA, V12, P1195, DOI 10.1038/sj.leu.2401080; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Zeller CN, 2009, ANN THORAC SURG, V87, P812, DOI 10.1016/j.athoracsur.2008.12.033	57	6	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14206	10.1371/journal.pone.0014206	http://dx.doi.org/10.1371/journal.pone.0014206			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151968	Green Published, gold, Green Submitted			2022-12-27	WOS:000284939600003
J	Roongapinun, S; Oh, SY; Wu, F; Panthong, A; Zheng, T; Zhu, Z				Roongapinun, Sukit; Oh, Sun-Young; Wu, Fan; Panthong, Ampai; Zheng, Tao; Zhu, Zhou			Role of SHIP-1 in the Adaptive Immune Responses to Aeroallergen in the Airway	PLOS ONE			English	Article							INOSITOL PHOSPHATASE SHIP; PHOSPHOINOSITIDE 3-KINASE; ALLERGIC INFLAMMATION; NEGATIVE REGULATOR; ASTHMA MODEL; IN-VIVO; ACTIVATION; SURVIVAL; HYPERRESPONSIVENESS; P110-DELTA	Background: Th2-dominated inflammatory response in the airway is an integral component in the pathogenesis of allergic asthma. Accumulating evidence supports the notion that the phosphoinositide 3-kinase (PI3K) pathway is involved in the process. We previously reported that SHIP-1, a negative regulator of the PI3K pathway, is essential in maintaining lung immunohomeostasis, potentially through regulation of innate immune cells. However, the function of SHIP-1 in adaptive immune response in the lung has not been defined. We sought to determine the role of SHIP-1 in adaptive immunity in response to aeroallergen stimulation in the airway. Methodology/Principal Findings: SHIP-1 knockout (SHIP-1(-/-)) mice on BALB/c background were immunized with ovalbumin (OVA) plus aluminum hydroxide, a strong Th2-inducing immunization, and challenged with OVA. Airway and lung inflammation, immunoglobulin response, Th2 cytokine production and lymphocyte response were analyzed and compared with wild type mice. Even though there was mild spontaneous inflammation in the lung at baseline, SHIP-1(-/-) mice showed altered responses, including less cell infiltration around the airways but more in the parenchyma, less mucus production, decreased Th2 cytokine production, and diminished serum OVA-specific IgE, IgG1, but not IgG2a. Naive and OVA sensitized SHIP-1(-/-) T cells produced a lower amount of IL-4. In vitro differentiated SHIP-1(-/-) Th2 cells produced less IL-4 compared to wild type Th2 cells upon T cell receptor stimulation. Conclusions/Significance: These findings indicate that, in contrast to its role as a negative regulator in the innate immune cells, SHIP-1 acts as a positive regulator in Th2 cells in the adaptive immune response to aeroallergen. Thus any potential manipulation of SHIP-1 activity should be adjusted according to the specific immune response.	[Roongapinun, Sukit; Oh, Sun-Young; Wu, Fan; Zheng, Tao; Zhu, Zhou] Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA; [Roongapinun, Sukit; Panthong, Ampai] Chiang Mai Univ, Dept Pharmacol, Fac Med, Chiang Mai 50000, Thailand	Johns Hopkins University; Johns Hopkins Medicine; Chiang Mai University	Roongapinun, S (corresponding author), Johns Hopkins Univ, Sch Med, Johns Hopkins Asthma & Allergy Ctr, Div Allergy & Clin Immunol, Baltimore, MD 21218 USA.	zzhu@jhmi.edu	Roongapinun, Sukit/O-1577-2018	Roongapinun, Sukit/0000-0003-2062-610X	National Institutes of Health (NIH) [HL079349, AI075025]; Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075025] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program(Thailand Research Fund (TRF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants HL079349 to Z.Z. and AI075025 and the AAAAI Women's Award to T.Z. S.R. is a recipient of a training grant from the Thailand Research Fund for the Royal Golden Jubilee Ph.D. Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOCHNER BS, 1994, ANNU REV IMMUNOL, V12, P295; Cohn L, 1999, J EXP MED, V190, P1309, DOI 10.1084/jem.190.9.1309; CUTZ E, 1978, HISTOPATHOLOGY, V2, P407, DOI 10.1111/j.1365-2559.1978.tb01735.x; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Duan W, 2005, INT IMMUNOPHARMACOL, V5, P495, DOI 10.1016/j.intimp.2004.10.015; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Haddon DJ, 2009, J IMMUNOL, V183, P228, DOI 10.4049/jimmunol.0900427; Helgason CD, 1998, GENE DEV, V12, P1610, DOI 10.1101/gad.12.11.1610; Lee KS, 2006, FASEB J, V20, P455, DOI 10.1096/fj.05-5045com; Liu QR, 1998, J EXP MED, V188, P1333, DOI 10.1084/jem.188.7.1333; Liu QR, 1999, GENE DEV, V13, P786, DOI 10.1101/gad.13.7.786; MacDonald SM, 2002, MOL IMMUNOL, V38, P1323, DOI 10.1016/S0161-5890(02)00082-2; Myou S, 2003, J EXP MED, V198, P1573, DOI 10.1084/jem.20030298; Nashed BF, 2007, EUR J IMMUNOL, V37, P416, DOI 10.1002/eji.200636401; Oh SY, 2007, J ALLERGY CLIN IMMUN, V119, P123, DOI 10.1016/j.jaci.2006.08.029; Okkenhaug K, 2004, BIOCHEM SOC T, V32, P332, DOI 10.1042/BST0320332; Ono M, 1996, NATURE, V383, P263, DOI 10.1038/383263a0; Pinho V, 2005, J LEUKOCYTE BIOL, V77, P800, DOI 10.1189/jlb.0704386; Rohrschneider LR, 2000, GENE DEV, V14, P505; Tarasenko T, 2007, P NATL ACAD SCI USA, V104, P11382, DOI 10.1073/pnas.0704853104; Zhang TT, 2008, J ALLERGY CLIN IMMUN, V122, P811, DOI 10.1016/j.jaci.2008.08.008; Zhou Z, 1999, J CLIN INVEST, V103, P779, DOI 10.1172/JCI5909; Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336	23	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e14174	10.1371/journal.pone.0014174	http://dx.doi.org/10.1371/journal.pone.0014174			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151496	Green Submitted, Green Published, gold			2022-12-27	WOS:000284755100050
J	Della Bella, S; Taddeo, A; Colombo, E; Brambilla, L; Bellinvia, M; Pregliasco, F; Cappelletti, M; Calabro, ML; Villa, ML				Della Bella, Silvia; Taddeo, Adriano; Colombo, Elena; Brambilla, Lucia; Bellinvia, Monica; Pregliasco, Fabrizio; Cappelletti, Monica; Calabro, Maria Luisa; Villa, Maria Luisa			Human Herpesvirus-8 Infection Leads to Expansion of the Preimmune/Natural Effector B Cell Compartment	PLOS ONE			English	Article							CLASSIC KAPOSIS-SARCOMA; EFFUSION LYMPHOMA; PERIPHERAL-BLOOD; DENDRITIC CELLS; DC-SIGN; MEMORY; LYMPHOCYTES; NAIVE; VIRUS; EXPRESSION	Background: Human herpesvirus-8 (HHV-8) is the etiological agent of Kaposi's sarcoma (KS) and of some lymphoproliferative disorders of B cells. Most malignancies develop after long-lasting viral dormancy, and a preventing role for both humoral and cellular immune control is suggested by the high frequency of these pathologies in immunosuppressed patients. B cells, macrophages and dendritic cells of peripheral lymphoid organs and blood represent the major reservoir of HHV-8. Due to the dual role of B cells in HHV-8 infection, both as virus reservoir and as agents of humoral immune control, we analyzed the subset distribution and the functional state of peripheral blood B cells in HHV-8-infected individuals with and without cKS. Methodology/Principal Findings: Circulating B cells and their subsets were analyzed by 6-color flow cytometry in the following groups: 1- patients HHV-8 positive with classic KS (cKS) (n = 47); 2- subjects HHV-8 positive and cKS negative (HSP) (n = 10); 3- healthy controls, HHV-8 negative and cKS negative (HC) (n = 43). The number of B cells belonging to the preimmune/natural effector compartment, including transitional, pre-naive, naive and MZ-like subsets, was significantly higher among HHV-8 positive subjects, with or without cKS, while was comparable to healthy controls in the antigen-experienced T-cell dependent compartment. The increased number of preimmune/natural effector B cells was associated with increased resistance to spontaneous apoptosis, while it did not correlate with HHV-8 viral load. Conclusions/Significance: Our results indicate that long-lasting HHV-8 infection promotes an imbalance in peripheral B cell subsets, perturbing the equilibrium between earlier and later steps of maturation and activation processes. This observation may broaden our understanding of the complex interplay between viral and immune factors leading HHV-8-infected individuals to develop HHV-8-associated malignancies.	[Della Bella, Silvia; Taddeo, Adriano; Colombo, Elena; Cappelletti, Monica; Villa, Maria Luisa] Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy; [Brambilla, Lucia; Bellinvia, Monica] Fdn IRCCS Osped Maggiore Policlin, Inst Dermatol Sci, Milan, Italy; [Pregliasco, Fabrizio] Univ Milan, Dept Publ Hlth Microbiol & Virol, Milan, Italy; [Calabro, Maria Luisa] IRCCS, IOV, Padua, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Istituto Oncologico Veneto (IOV)	Della Bella, S (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20133 Milan, Italy.	silvia.dellabella@unimi.it	Pregliasco, Fabrizio Ernesto/D-1642-2012; pregliasco, fabrizio/AAD-7499-2022; Calabrò, Maria Luisa/H-6015-2016; Bella, Silvia Della/AAB-7904-2019; Taddeo, Adriano/AAW-3861-2021	Pregliasco, Fabrizio Ernesto/0000-0002-3919-0679; Calabrò, Maria Luisa/0000-0001-9401-6182; Taddeo, Adriano/0000-0003-3281-1548; Della Bella, Silvia/0000-0003-0818-5049	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) [2006065944-002, 2008A3E9WM]; Doctorate School of Molecular Medicine, University of Milan	Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); Doctorate School of Molecular Medicine, University of Milan	This work was supported by grants from Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) 2006065944-002 (to SDB) and 2008A3E9WM (to MLV and SDB). AT, EC and MC were supported by a fellowship of the Doctorate School of Molecular Medicine, University of Milan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JB, 2002, BLOOD, V99, P649, DOI 10.1182/blood.V99.2.649; Anolik J, 2003, EUR J IMMUNOL, V33, P2398, DOI 10.1002/eji.200323515; Antman K, 2000, NEW ENGL J MED, V342, P1027, DOI 10.1056/NEJM200004063421407; Avery DT, 2010, J EXP MED, V207, P155, DOI 10.1084/jem.20091706; Barozzi P, 2007, AUTOIMMUN REV, V7, P132, DOI 10.1016/j.autrev.2007.02.018; Boulanger E, 2004, AM J HEMATOL, V76, P88, DOI 10.1002/ajh.20048; Brambilla L, 2003, EUR J DERMATOL, V13, P83; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Calabro M L, 1998, J Hum Virol, V1, P207; Carroll PA, 2004, VIROLOGY, V328, P7, DOI 10.1016/j.virol.2004.07.008; Chaganti S, 2008, BLOOD, V112, P672, DOI 10.1182/blood-2007-10-116269; Chaganti S, 2009, BLOOD, V113, P6372, DOI 10.1182/blood-2008-08-175828; Chandriani S, 2010, J VIROL, V84, P5565, DOI 10.1128/JVI.02723-09; Charles ED, 2008, BLOOD, V111, P1344, DOI 10.1182/blood-2007-07-101717; Chong Y, 2005, INT IMMUNOL, V17, P383, DOI 10.1093/intimm/dxh218; Colonna-Romano G, 2009, MECH AGEING DEV, V130, P681, DOI 10.1016/j.mad.2009.08.003; Crowley JE, 2005, SEMIN IMMUNOL, V17, P193, DOI 10.1016/j.smim.2005.02.001; Dagklis A, 2009, BLOOD, V114, P26, DOI 10.1182/blood-2008-09-176933; Dagna L, 2005, NEW ENGL J MED, V353, P156, DOI 10.1056/NEJMoa042850; Della Bella S, 2006, CLIN IMMUNOL, V119, P317, DOI 10.1016/j.clim.2006.01.011; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Della Bella S, 2008, J IMMUNOL METHODS, V339, P153, DOI 10.1016/j.jim.2008.09.009; Frasca D, 2008, J IMMUNOL, V180, P5283, DOI 10.4049/jimmunol.180.8.5283; Ganem D, 2010, J CLIN INVEST, V120, P939, DOI 10.1172/JCI40567; Gasperini P, 2005, J CLIN MICROBIOL, V43, P2866, DOI 10.1128/JCM.43.6.2866-2875.2005; Ghia P, 2004, BLOOD, V103, P2337, DOI 10.1182/blood-2003-09-3277; Ginaldi L, 2001, AM J HEMATOL, V67, P63, DOI 10.1002/ajh.1082; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Hengge UR, 2002, LANCET INFECT DIS, V2, P344, DOI 10.1016/S1473-3099(02)00288-8; HIRANO T, 1986, NATURE, V324, P73, DOI 10.1038/324073a0; Horikawa K, 2006, IMMUNOLOGY, V118, P497, DOI 10.1111/j.1365-2567.2006.02382.x; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Lanzavecchia A, 2009, CURR OPIN IMMUNOL, V21, P298, DOI 10.1016/j.coi.2009.05.019; LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071; Lee J, 2009, J IMMUNOL, V182, P4116, DOI 10.4049/jimmunol.0803391; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Monini P, 1999, BLOOD, V93, P4044; Ni JH, 2003, J IMMUNOL, V170, P3429, DOI 10.4049/jimmunol.170.6.3429; Palestro G, 1999, Adv Clin Path, V3, P11; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; Pillai S, 2009, NAT REV IMMUNOL, V9, P767, DOI 10.1038/nri2656; Racanelli V, 2006, J VIROL, V80, P3923, DOI 10.1128/JVI.80.8.3923-3934.2006; Rappocciolo G, 2006, J IMMUNOL, V176, P1741, DOI 10.4049/jimmunol.176.3.1741; Rappocciolo G, 2008, J VIROL, V82, P4793, DOI 10.1128/JVI.01587-07; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Sato S, 2004, ARTHRITIS RHEUM-US, V50, P1918, DOI 10.1002/art.20274; Schulz TF, 1998, J GEN VIROL, V79, P1573, DOI 10.1099/0022-1317-79-7-1573; Taddeo A, 2008, J INVEST DERMATOL, V128, P2125, DOI 10.1038/jid.2008.23; Thomsen AR, 1996, J IMMUNOL, V157, P3074; Toubi E, 2004, J VIROL, V78, P11379, DOI 10.1128/JVI.78.20.11379-11384.2004; VALENTINE MA, 1987, P NATL ACAD SCI USA, V84, P8085, DOI 10.1073/pnas.84.22.8085; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Wirths S, 2005, EUR J IMMUNOL, V35, P3433, DOI 10.1002/eji.200535364; Xu GW, 2007, BIOCHEM BIOPH RES CO, V361, P745, DOI 10.1016/j.bbrc.2007.07.052	57	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15029	10.1371/journal.pone.0015029	http://dx.doi.org/10.1371/journal.pone.0015029			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124778	Green Published, gold			2022-12-27	WOS:000284686500019
J	Kersulyte, D; Kalia, A; Gilman, RH; Mendez, M; Herrera, P; Cabrera, L; Velapatino, B; Balqui, J; de la Vega, FPP; Ulloa, CAR; Cok, J; Hooper, CC; Dailide, G; Tamma, S; Berg, DE				Kersulyte, Dangeruta; Kalia, Awdhesh; Gilman, Robert H.; Mendez, Melissa; Herrera, Phabiola; Cabrera, Lilia; Velapatino, Billie; Balqui, Jacqueline; Puente de la Vega, Freddy Paredes; Rodriguez Ulloa, Carlos A.; Cok, Jaime; Hooper, Catherine C.; Dailide, Giedrius; Tamma, Sravya; Berg, Douglas E.			Helicobacter pylori from Peruvian Amerindians: Traces of Human Migrations in Strains from Remote Amazon, and Genome Sequence of an Amerind Strain	PLOS ONE			English	Article							INSERTION SPECIFICITY; FUNCTIONAL-ORGANIZATION; TRANSPOSABLE ELEMENT; INFECTION; CAGA; INFLAMMATION; DISEASES; TRANSMISSION; ASSOCIATION; POPULATIONS	Background: The gastric pathogen Helicobacter pylori is extraordinary in its genetic diversity, the differences between strains from well-separated human populations, and the range of diseases that infection promotes. Principal Findings: Housekeeping gene sequences from H. pylori from residents of an Amerindian village in the Peruvian Amazon, Shimaa, were related to, but not intermingled with, those from Asia. This suggests descent of Shimaa strains from H. pylori that had infected the people who migrated from Asia into The Americas some 15,000+ years ago. In contrast, European type sequences predominated in strains from Amerindian Lima shantytown residents, but with some 12% Amerindian or East Asian-like admixture, which indicates displacement of ancestral purely Amerindian strains by those of hybrid or European ancestry. The genome of one Shimaa village strain, Shi470, was sequenced completely. Its SNP pattern was more Asian-than European-like genome-wide, indicating a purely Amerind ancestry. Among its unusual features were two cagA virulence genes, each distinct from those known from elsewhere; and a novel allele of gene hp0519, whose encoded protein is postulated to interact with host tissue. More generally, however, the Shi470 genome is similar in gene content and organization to those of strains from industrialized countries. Conclusions: Our data indicate that Shimaa village H. pylori descend from Asian strains brought to The Americas many millennia ago; and that Amerind strains are less fit than, and were substantially displaced by, hybrid or European strains in less isolated communities. Genome comparisons of H. pylori from Amerindian and other communities should help elucidate evolutionary forces that have shaped pathogen populations in The Americas and worldwide.	[Kersulyte, Dangeruta; Mendez, Melissa; Velapatino, Billie; Dailide, Giedrius; Tamma, Sravya; Berg, Douglas E.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Kalia, Awdhesh] Univ Louisville, Dept Biol, Louisville, KY 40292 USA; [Gilman, Robert H.; Mendez, Melissa; Herrera, Phabiola; Velapatino, Billie; Balqui, Jacqueline; Hooper, Catherine C.] Univ Peruana Cayetano Heredia, Dept Microbiol, Lima, Peru; [Gilman, Robert H.; Cabrera, Lilia] Asociac Benef PRISMA, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Puente de la Vega, Freddy Paredes] Ctr Salud, Kepashiato, Cusco, Peru; [Rodriguez Ulloa, Carlos A.; Cok, Jaime] Policlin Peruano Japones, Lima, Peru; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Berg, Douglas E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Washington University (WUSTL); University of Louisville; Universidad Peruana Cayetano Heredia; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Washington University (WUSTL); Washington University (WUSTL)	Kersulyte, D (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.	berg@borcim.wustl.edu	Herrera, Phabiola/AAL-7992-2021; Méndez, Melissa M/E-2833-2017	Méndez, Melissa M/0000-0001-8061-5002; Kalia, Awdhesh/0000-0001-5365-1702; Velapatino, Billie/0000-0003-3791-8395	US National Institutes of Health (NIH) [RO1 DK63041, R21 AI078237, R21 AI088337, 5R24 TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI088337, R21AI078237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063041] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grants from the US National Institutes of Health (NIH) RO1 DK63041, R21 AI078237, R21 AI088337 and 5R24 TW007988. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amieva MR, 2008, GASTROENTEROLOGY, V134, P306, DOI 10.1053/j.gastro.2007.11.009; Aspholm-Hurtig M, 2004, SCIENCE, V305, P519, DOI 10.1126/science.1098801; Backert S, 2010, HELICOBACTER, V15, P163, DOI 10.1111/j.1523-5378.2010.00759.x; Barbujani G, 2010, TRENDS GENET, V26, P285, DOI 10.1016/j.tig.2010.04.002; BIANCHINE PJ, 2002, ALLERGY PROC, V13, P225; Carnoy C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006531; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Cover TL, 2005, NAT REV MICROBIOL, V3, P320, DOI 10.1038/nrmicro1095; D'Elios MM, 2009, HELICOBACTER, V14, P21, DOI 10.1111/j.1523-5378.2009.00698.x; Devi SM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-191; Diamond J., 2010, RUZHYA MIKROBY STALI; Dominguez-Bello MG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003307; Dorer MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000544; Dumrese C, 2009, FEBS LETT, V583, P1637, DOI 10.1016/j.febslet.2009.04.027; Falush D, 2003, SCIENCE, V299, P1582, DOI 10.1126/science.1080857; FISCHER W, 2010, NUCL ACIDS RES; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Frenck RW, 2003, MICROBES INFECT, V5, P705, DOI 10.1016/S1286-4579(03)00112-6; Graham DY, 2007, HELICOBACTER, V12, P64, DOI 10.1111/j.1523-5378.2007.00566.x; Herrera PM, 2008, J CLIN MICROBIOL, V46, P3912, DOI 10.1128/JCM.01453-08; Hunefeldt Christine, 2004, BRIEF HIST PERU; Hussein NR, 2010, EUR J CLIN MICROBIOL, V29, P817, DOI 10.1007/s10096-010-0933-z; Jeong JY, 2001, J BACTERIOL, V183, P5155, DOI 10.1128/JB.183.17.5155-5162.2001; Karnholz A, 2006, J BACTERIOL, V188, P882, DOI 10.1128/JB.188.3.882-893.2006; Kersulyte D, 1998, GENE, V223, P175, DOI 10.1016/S0378-1119(98)00164-4; Kersulyte D, 2000, J BACTERIOL, V182, P3210, DOI 10.1128/JB.182.11.3210-3218.2000; Kersulyte D, 2004, J BACTERIOL, V186, P7521, DOI 10.1128/JB.186.22.7521-7528.2004; Kersulyte D, 2002, J BACTERIOL, V184, P992, DOI 10.1128/jb.184.4.992-1002.2002; Kersulyte D, 2000, J BACTERIOL, V182, P5300, DOI 10.1128/JB.182.19.5300-5308.2000; Kersulyte D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006859; Linz B, 2007, NATURE, V445, P915, DOI 10.1038/nature05562; Lu HS, 2008, CANCER SCI, V99, P2004, DOI 10.1111/j.1349-7006.2008.00950.x; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Mahdavi J, 2002, SCIENCE, V297, P573, DOI 10.1126/science.1069076; Makola D, 2007, J CLIN GASTROENTEROL, V41, P548, DOI 10.1097/MCG.0b013e318030e3c3; Malaty HM, 2007, BEST PRACT RES CL GA, V21, P205, DOI 10.1016/j.bpg.2006.10.005; Mane SP, 2010, J BACTERIOL, V192, P3078, DOI 10.1128/JB.00063-10; Masterson D. M., 2003, JAPANESE LATIN AM; Matic I, 2000, J BACTERIOL, V182, P5922, DOI 10.1128/JB.182.20.5922-5924.2000; Meagher Arnold J., 2008, COOLIE TRADE TRAFFIC; Mittl PRE, 2007, CELL SIGNAL, V19, P20, DOI 10.1016/j.cellsig.2006.05.034; Nei M., 2000, MOL EVOLUTION PHYLOG; O'Rourke DH, 2009, CURR BIOL, V19, pR203, DOI 10.1016/j.cub.2009.01.021; Ogura M, 2007, PLOS COMPUT BIOL, V3, P1455, DOI 10.1371/journal.pcbi.0030151; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Oleastro M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-248; Peck A, 2010, INFECT IMMUN, V78, P32, DOI 10.1128/IAI.00929-09; Peck B, 1999, NUCLEIC ACIDS RES, V27, P3325, DOI 10.1093/nar/27.16.3325; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; RecavarrenArce S, 1997, CLIN INFECT DIS, V25, P1006, DOI 10.1086/516080; Robinson K, 2007, BEST PRACT RES CL GA, V21, P237, DOI 10.1016/j.bpg.2007.01.001; Schwarz S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000180; Soto G, 2003, J INFECT DIS, V188, P1263, DOI 10.1086/379046; Suerbaum S, 1998, P NATL ACAD SCI USA, V95, P12619, DOI 10.1073/pnas.95.21.12619; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Tegtmeyer N, 2009, CELL MICROBIOL, V11, P488, DOI 10.1111/j.1462-5822.2008.01269.x; Templeton AR, 2005, YEARB PHYS ANTHROPOL, V48, P33, DOI 10.1002/ajpa.20351; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang G, 1999, TRENDS MICROBIOL, V7, P488, DOI 10.1016/S0966-842X(99)01632-7; Wirth T, 2005, MOL ECOL, V14, P3289, DOI 10.1111/j.1365-294X.2005.02687.x; Xia YL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007736; Yamaoka Y, 2009, CLIN MICROBIOL INFEC, V15, P829, DOI 10.1111/j.1469-0691.2009.02967.x; Yamaoka Y, 2008, J MED MICROBIOL, V57, P545, DOI 10.1099/jmm.0.2008/000570-0	66	62	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15076	10.1371/journal.pone.0015076	http://dx.doi.org/10.1371/journal.pone.0015076			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124785	Green Published, gold			2022-12-27	WOS:000284686500034
J	de Vries, HS; Morsche, RHMT; van Oijen, MGH; Nagtegaal, ID; Peters, WHM; de Jong, DJ				de Vries, Hilbert S.; Morsche, Rene H. M. Te; van Oijen, Martijn G. H.; Nagtegaal, Iris D.; Peters, Wilbert H. M.; de Jong, Dirk J.			The Functional-765G -> C Polymorphism of the COX-2 Gene May Reduce the Risk of Developing Crohn's Disease	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CYCLOOXYGENASE 2; MESSENGER-RNA; EXPRESSION; ASSOCIATION; COLITIS; CANCER; PREVALENCE; INHIBITORS; RELAPSE	Background: Cyclooxygenase-2 (COX-2) is a key enzyme involved in the conversion of arachidonic acid into prostaglandins. COX-2 is mainly induced at sites of inflammation in response to proinflammatory cytokines such as interleukin-1 alpha/beta, interferon-gamma and tumor necrosis factor-alpha produced by inflammatory cells. Aim: The aim of this study was to investigate the possible modulating effect of the functional COX-2 polymorphisms -1195 A -> G and -765G -> C on the risk for development of inflammatory bowel disease (IBD) in a Dutch population. Methods: Genomic DNA of 525 patients with Crohn's disease (CD), 211 patients with ulcerative colitis (UC) and 973 healthy controls was genotyped for the -1195 A -> G (rs689466) and -765G -> C (rs20417) polymorphisms. Distribution of genotypes in patients and controls were compared and genotype-phenotype interactions were investigated. Results: The genotype distribution of the -1195A -> G polymorphism was not different between the patients with CD or UC and the control group. The -765GC genotype was more prevalent in CD patients compared to controls with an OR of 1.33 (95% CI 1.04-1.69, p < 0.05). The -765GC and -765CC genotype carriers showed a tendency to be less frequent in patients with CD compared to controls, with ORs of 0.78 (95% CI: 0.61-1.00) and 0.49 (95% CI 0.22-1.08), respectively. Combining homozygous and heterozygous patients with the -765C allele showed a reduced risk for developing CD, with an OR of 0.75 (95% CI: 0.59-0.96). In the context of this, the G(-1195)G(-765)/A(-1195)C(-765) diplotype was significantly less common in patients with CD compared to controls, with an OR of 0.62 (95% CI: 0.39-0.98). For UC however, such an effect was not observed. No correlation was found between COX-2 diplotypes and clinical characteristics of IBD. Conclusions: The -765G -> C polymorphism was associated with a reduced risk for developing Crohn's disease in a Dutch population.	[de Vries, Hilbert S.; Morsche, Rene H. M. Te; van Oijen, Martijn G. H.; Peters, Wilbert H. M.; de Jong, Dirk J.] Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [Nagtegaal, Iris D.] Radboud Univ Nijmegen, Dept Pathol, Med Ctr, NL-6525 ED Nijmegen, Netherlands; [van Oijen, Martijn G. H.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	de Vries, HS (corresponding author), Radboud Univ Nijmegen, Dept Gastroenterol & Hepatol, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	h.devries@mdl.umcn.nl	Nagtegaal, Iris D/A-2448-2014; de Jong, D.J./L-4417-2015; te Morsche, R/P-9143-2015; Peters, W.H.M./L-4572-2015	Nagtegaal, Iris D/0000-0003-0887-4127; de Vries, Hilbert/0000-0003-4058-6459				Agoff SN, 2000, AM J PATHOL, V157, P737, DOI 10.1016/S0002-9440(10)64587-7; ANDERSEN V, INFLAMM BOW IN PRESS; Biancone L, 2004, ALIMENT PHARM THER, V19, P755, DOI 10.1111/j.1365-2036.2004.01907.x; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Carty E, 2000, GUT, V46, P487, DOI 10.1136/gut.46.4.487; Casparie M, 2007, CELL ONCOL, V29, P19; Courivaud C, 2009, AM J TRANSPLANT, V9, P2752, DOI 10.1111/j.1600-6143.2009.02830.x; Cox DG, 2005, WORLD J GASTROENTERO, V11, P6003, DOI 10.3748/wjg.v11.i38.6003; Fornai M, 2010, PHARMACOL THERAPEUT, V125, P62, DOI 10.1016/j.pharmthera.2009.09.007; Gasche C, 2000, INFLAMM BOWEL DIS, V6, P8, DOI 10.1097/00054725-200002000-00002; Hasegawa K, 2001, EUR J CANCER, V37, P1469, DOI 10.1016/S0959-8049(01)00137-X; Hendel J, 1997, AM J GASTROENTEROL, V92, P1170; Hoff JH, 2009, WORLD J GASTROENTERO, V15, P4561, DOI 10.3748/wjg.15.4561; Hugot JP, 2007, AM J GASTROENTEROL, V102, P1259, DOI 10.1111/j.1572-0241.2007.01149.x; Jiang GL, 2007, J PHARMACOL EXP THER, V320, P22, DOI 10.1124/jpet.106.111146; Mariani F, 2009, CANCER LETT, V279, P221, DOI 10.1016/j.canlet.2009.02.001; Martin GR, 2006, EXP BIOL MED, V231, P130; Matuk R, 2004, INFLAMM BOWEL DIS, V10, P352, DOI 10.1097/00054725-200407000-00005; Ostergaard M, 2009, SCAND J GASTROENTERO, V44, P65, DOI 10.1080/00365520802400826; Papafili A, 2002, ARTERIOSCL THROM VAS, V22, P1631, DOI 10.1161/01.ATV.0000030340.80207.C5; Peters WHM, 2009, HEAD NECK-J SCI SPEC, V31, P938, DOI 10.1002/hed.21058; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Roberts PJ, 2001, GUT, V48, P468, DOI 10.1136/gut.48.4.468; Rudock ME, 2009, ATHEROSCLEROSIS, V203, P459, DOI 10.1016/j.atherosclerosis.2008.07.018; Sanak M, 2005, J ALLERGY CLIN IMMUN, V116, P221, DOI 10.1016/j.jaci.2005.03.010; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Sheibanie AF, 2007, J IMMUNOL, V178, P8138, DOI 10.4049/jimmunol.178.12.8138; Silverberg MS, 2005, CAN J GASTROENTEROL, V19, p5A, DOI 10.1155/2005/269076; Singer II, 1998, GASTROENTEROLOGY, V115, P297, DOI 10.1016/S0016-5085(98)70196-9; Szczeklik W, 2004, J ALLERGY CLIN IMMUN, V114, P248, DOI 10.1016/j.jaci.2004.05.030; Tabernero A, 2003, CIRCULATION, V107, P1407, DOI 10.1161/01.CIR.0000055321.13957.17; Takeuchi K, 2006, CLIN GASTROENTEROL H, V4, P196, DOI 10.1016/S1542-3565(05)00980-8; Tan W, 2007, CARCINOGENESIS, V28, P1197, DOI 10.1093/carcin/bgl242; Trifan OC, 2003, J CELL MOL MED, V7, P207, DOI 10.1111/j.1582-4934.2003.tb00222.x; Wallace JL, 2006, THESCIENTIFICWORLDJO, V6, P577, DOI 10.1100/tsw.2006.122; Warner TD, 2004, FASEB J, V18, P790, DOI 10.1096/fj.03-0645rev; Westbrook AM, 2010, MUTAT RES-REV MUTAT, V705, P40, DOI 10.1016/j.mrrev.2010.03.001; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhao D, 2009, GASTROENTEROLOGY, V136, P1659, DOI 10.1053/j.gastro.2009.01.071	40	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15011	10.1371/journal.pone.0015011	http://dx.doi.org/10.1371/journal.pone.0015011			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124790	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000016
J	Hickey, C; Chelazzi, L; Theeuwes, J				Hickey, Clayton; Chelazzi, Leonardo; Theeuwes, Jan			Reward Guides Vision when It's Your Thing: Trait Reward-Seeking in Reward-Mediated Visual Priming	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS; INDIVIDUAL-DIFFERENCES; ATTENTIONAL CAPTURE; LATENT INHIBITION; DOPAMINE; PUNISHMENT; RESPONSES; EMOTION; ANXIETY; SEARCH	Reward-related mesolimbic dopamine is thought to play an important role in guiding animal behaviour, biasing approach towards potentially beneficial environmental stimuli and away from objects unlikely to garner positive outcome. This is considered to result in part from an impact on perceptual and attentional processes: dopamine initiates a series of cognitive events that result in the priming of reward-associated perceptual features. We have provided behavioural and electrophysiological evidence that this mechanism guides human vision in search, an effect we refer to as reward priming. We have also demonstrated that there is substantial individual variability in this effect. Here we show that behavioural differences in reward priming are predicted remarkably well by a personality index that captures the degree to which a person's behaviour is driven by reward outcome. Participants with reward-seeking personalities are found to be those who allocate visual resources to objects characterized by reward-associated visual features. These results add to a rapidly developing literature demonstrating the crucial role reward plays in attentional control. They additionally illustrate the striking impact personality traits can have on low-level cognitive processes like perception and selective attention.	[Hickey, Clayton; Theeuwes, Jan] Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands; [Chelazzi, Leonardo] Univ Verona, Dept Neurol & Visual Sci, I-37100 Verona, Italy; [Chelazzi, Leonardo] Natl Inst Neurosci, Verona, Italy	Vrije Universiteit Amsterdam; University of Verona	Hickey, C (corresponding author), Vrije Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	c.hickey@psy.vu.nl	Theeuwes, Jan/B-6862-2008; Theeuwes, Jan/ABF-3771-2020; Chelazzi, Leonardo/B-6084-2011; Hickey, Clayton/ABA-6126-2021	Chelazzi, Leonardo/0000-0001-8566-0611; Hickey, Clayton/0000-0002-4162-5643; Theeuwes, Jan/0000-0002-5849-7721	Fondazione Cariverona	Fondazione Cariverona(Fondazione Cariverona)	L.C. is supported by Fondazione Cariverona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CORRELATION PARAMETR; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Berridge KC, 1998, BRAIN RES REV, V28, P309, DOI 10.1016/S0165-0173(98)00019-8; Boksem MAS, 2006, BRAIN RES, V1101, P92, DOI 10.1016/j.brainres.2006.05.004; Burnham BP, 2007, PSYCHON B REV, V14, P392, DOI 10.3758/BF03194082; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; FOWLES DC, 1994, NEBR SYM MOTIV, V41, P181; Franken IHA, 2005, J PSYCHOPATHOL BEHAV, V27, P25, DOI 10.1007/s10862-005-3262-2; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; GRAY JA, 1982, BEHAV BRAIN SCI, V5, P469, DOI 10.1017/S0140525X00013066; GRAY JA, 1990, COGNITION EMOTION, V4, P269, DOI 10.1080/02699939008410799; Gray JA, 1997, BEHAV BRAIN RES, V88, P27, DOI 10.1016/S0166-4328(97)02313-9; Gray JA, 1995, BEHAV BRAIN RES, V71, P19, DOI 10.1016/0166-4328(95)00154-9; Hickey C, 2006, J COGNITIVE NEUROSCI, V18, P604, DOI 10.1162/jocn.2006.18.4.604; Hickey C, 2011, VIS COGN, V19, P117, DOI 10.1080/13506285.2010.503946; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; Hickey C, 2010, EXP BRAIN RES, V201, P789, DOI 10.1007/s00221-009-2094-9; Horstmann G, 2002, PSYCHOL SCI, V13, P499, DOI 10.1111/1467-9280.00488; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; Luck S.J., 2005, INTRO EVENT RELATED; Ohman A, 2001, J EXP PSYCHOL GEN, V130, P466, DOI 10.1037/0096-3445.130.3.466; Pinto Y, 2005, PERCEPT PSYCHOPHYS, V67, P1354, DOI 10.3758/BF03193640; Poy R, 2004, PERS INDIV DIFFER, V36, P1471, DOI 10.1016/S0191-8869(03)00242-3; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Redgrave P, 1999, TRENDS NEUROSCI, V22, P146, DOI 10.1016/S0166-2236(98)01373-3; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; van Steenbergen H, 2009, PSYCHOL SCI, V20, P1473, DOI 10.1111/j.1467-9280.2009.02470.x; WEINSTEIN AM, 1995, BIOL PSYCHIAT, V37, P847, DOI 10.1016/0006-3223(94)00249-3; WOLFE JM, 1989, J EXP PSYCHOL HUMAN, V15, P419, DOI 10.1037/0096-1523.15.3.419; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95	37	123	126	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14087	10.1371/journal.pone.0014087	http://dx.doi.org/10.1371/journal.pone.0014087			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684DM	21124893	gold, Green Published			2022-12-27	WOS:000284527900005
J	Knirr, S; Gomos-Klein, J; Andino, BE; Harrow, F; Erhard, KF; Kovalovsky, D; Sant'Angelo, DB; Ortiz, BD				Knirr, Stefan; Gomos-Klein, Janette; Andino, Blanca E.; Harrow, Faith; Erhard, Karl F.; Kovalovsky, Damian; Sant'Angelo, Derek B.; Ortiz, Benjamin D.			Ectopic T Cell Receptor-alpha Locus Control Region Activity in B Cells Is Suppressed by Direct Linkage to Two Flanking Genes at Once	PLOS ONE			English	Article							CHAIN CONSTANT-REGION; TCR-ALPHA; ALPHA/DELTA LOCUS; IN-VIVO; TRANSGENIC MICE; TRANSCRIPTION FACTORS; DAD1 GENES; EXPRESSION; ELEMENT; DEATH	The molecular mechanisms regulating the activity of the TCR alpha gene are required for the production of the circulating T cell repertoire. Elements of the mouse TCR alpha locus control region (LCR) play a role in these processes. We previously reported that TCR alpha LCR DNA supports a gene expression pattern that mimics proper thymus-stage, TCR alpha gene-like developmental regulation. It also produces transcription of linked reporter genes in peripheral T cells. However, TCR alpha LCR-driven transgenes display ectopic transcription in B cells in multiple reporter gene systems. The reasons for this important deviation from the normal TCR alpha gene regulation pattern are unclear. In its natural locus, two genes flank the TCR alpha LCR, TCR alpha (upstream) and Dad1 (downstream). We investigated the significance of this gene arrangement to TCR alpha LCR activity by examining transgenic mice bearing a construct where the LCR was flanked by two separate reporter genes. Surprisingly, the presence of a second, distinct, reporter gene downstream of the LCR virtually eliminated the ectopic B cell expression of the upstream reporter observed in earlier studies. Downstream reporter gene activity was unaffected by the presence of a second gene upstream of the LCR. Our findings indicate that a gene arrangement in which the TCR alpha LCR is flanked by two distinct transcription units helps to restrict its activity, selectively, on its 5'-flanking gene, the natural TCR alpha gene position with respect to the LCR. Consistent with these findings, a TCR alpha/Dad1 locus bacterial artificial chromosome dual-reporter construct did not display the ectopic upstream (TCR alpha) reporter expression in B cells previously reported for single TCR alpha transgenes.	[Knirr, Stefan; Gomos-Klein, Janette; Andino, Blanca E.; Harrow, Faith; Erhard, Karl F.; Ortiz, Benjamin D.] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Kovalovsky, Damian; Sant'Angelo, Derek B.] Mem Sloan Kettering Canc Ctr, Div Immunol, New York, NY 10021 USA	City University of New York (CUNY) System; Hunter College (CUNY); Memorial Sloan Kettering Cancer Center	Knirr, S (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	Ortiz@genectr.hunter.cuny.edu			National Institutes of Health (NIH) [AI-053050, GM-007823, GM-060665]; National Science Foundation [MCB-0236964]; Weill-Cornell Clinical Translational Science Center (NIH) [UL1-RR024996]; Hunter College Gene Center (NIH) [RR03037]; Ford Foundation; National Research Council; Hunter College Gene Center; Howard Hughes Medical Institute; National Cancer Institute [P30-CA 08748];  [T32-CA-09149-32]; NATIONAL CANCER INSTITUTE [P30CA008748, T32CA009149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024996, G12RR003037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053050, R21AI053050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T34GM007823, R25GM060665] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Weill-Cornell Clinical Translational Science Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hunter College Gene Center (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation; National Research Council; Hunter College Gene Center; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) grant AI-053050 and National Science Foundation grant MCB-0236964 (to B.D.O.) and completed with the support of the collaborative pilot project program (to B.D.O. and D.B.S.) of the Weill-Cornell Clinical Translational Science Center (NIH grant UL1-RR024996) and the Hunter College Gene Center (NIH grant RR03037). The Hunter College Gene Center is also acknowledged for its support of J.G.K. through its Gene Center Fellows program, and S.K. and B.E.A. through its bridge funding program. B.E. A. was also supported by the Minority Access to Research Careers (MARC) program at Hunter College funded by NIH grant GM-007823. F.H. was supported by the Minority Biomedical Research Support (MBRS) program at Hunter College funded by NIH grant GM-060665 and a Ford Foundation Dissertation Fellowship from the National Research Council. K.F.E. was supported by the Howard Hughes Medical Institute Undergraduate Education Program at Hunter College. National Cancer Institute grant P30-CA 08748 provides partial support for MSKCC's Monoclonal Antibody, Flow Cytometry, Glassware Washing core facilities and the Research Animal Resource Center. D.K. is supported by grant T32-CA-09149-32. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abarrategui I, 2009, ADV EXP MED BIOL, V650, P93; Adlam M, 2003, IMMUNITY, V18, P173, DOI 10.1016/S1074-7613(03)00021-9; Bassing CH, 2003, P NATL ACAD SCI USA, V100, P2598, DOI 10.1073/pnas.0437943100; Brewster JL, 2000, GENESIS, V26, P271, DOI 10.1002/(SICI)1526-968X(200004)26:4<271::AID-GENE90>3.0.CO;2-E; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; DIAZ P, 1994, IMMUNITY, V1, P207, DOI 10.1016/1074-7613(94)90099-X; Gaszner M, 2006, NAT REV GENET, V7, P703, DOI 10.1038/nrg1925; GIESE K, 1995, GENE DEV, V9, P995, DOI 10.1101/gad.9.8.995; Gomos-Klein J, 2007, J IMMUNOL, V179, P1088, DOI 10.4049/jimmunol.179.2.1088; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Harrow F, 2005, J IMMUNOL, V175, P6659, DOI 10.4049/jimmunol.175.10.6659; Harrow F, 2004, J BIOL CHEM, V279, P17842, DOI 10.1074/jbc.M401258200; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hernandez-Munain C, 1998, MOL CELL BIOL, V18, P3223, DOI 10.1128/MCB.18.6.3223; Hong NA, 2000, DEV BIOL, V220, P76, DOI 10.1006/dbio.2000.9615; Hong NA, 1997, MOL CELL BIOL, V17, P2151, DOI 10.1128/MCB.17.4.2151; Hozumi K, 2000, IMMUNOL LETT, V71, P61, DOI 10.1016/S0165-2478(99)00167-4; JONES BK, 1995, MOL CELL BIOL, V15, P7010; Kabra NH, 1999, J IMMUNOL, V162, P2766; KINGSLEY C, 1992, MOL CELL BIOL, V12, P4251, DOI 10.1128/MCB.12.10.4251; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; Kushida MM, 1997, J IMMUNOL, V159, P4913; LANG G, 1991, NUCLEIC ACIDS RES, V19, P5851, DOI 10.1093/nar/19.21.5851; Lee GR, 2003, IMMUNITY, V19, P145, DOI 10.1016/S1074-7613(03)00179-1; LEIDEN JM, 1993, ANNU REV IMMUNOL, V11, P539, DOI 10.1146/annurev.iy.11.040193.002543; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lin O, 2003, DEVELOPMENT, V130, P519, DOI 10.1242/dev.00227; Lobito AA, 2004, EUR J IMMUNOL, V34, P890, DOI 10.1002/eji.200324675; Magdinier F, 2004, J BIOL CHEM, V279, P25381, DOI 10.1074/jbc.M403121200; Melton E, 1996, EUR J IMMUNOL, V26, P2952, DOI 10.1002/eji.1830261222; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Nishii K, 1999, GENES CELLS, V4, P243, DOI 10.1046/j.1365-2443.1999.00256.x; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Ortiz BD, 1999, MOL CELL BIOL, V19, P1901; Ortiz BD, 1997, EMBO J, V16, P5037, DOI 10.1093/emboj/16.16.5037; Ortiz BD, 2001, J IMMUNOL, V167, P3836, DOI 10.4049/jimmunol.167.7.3836; Papapetrou EP, 2009, J CLIN INVEST, V119, P157, DOI 10.1172/JCI37216; Ramirez J, 2010, CURR OPIN IMMUNOL, V22, P177, DOI 10.1016/j.coi.2010.02.003; Sabbattini P, 1999, MOL CELL BIOL, V19, P671; Seidl KJ, 1999, P NATL ACAD SCI USA, V96, P3000, DOI 10.1073/pnas.96.6.3000; SMITH VM, 1995, J BIOL CHEM, V270, P1515, DOI 10.1074/jbc.270.4.1515; Stolzer AL, 2005, EUR J IMMUNOL, V35, P1822, DOI 10.1002/eji.200526123; Wang K, 1997, IMMUNOGENETICS, V46, P376, DOI 10.1007/s002510050291; WIJGERDE M, 1995, NATURE, V377, P209, DOI 10.1038/377209a0; Yang L, 2005, P NATL ACAD SCI USA, V102, P4518, DOI 10.1073/pnas.0500600102; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhong XP, 1999, J IMMUNOL, V163, P295; Zhou JM, 1999, CELL, V99, P567, DOI 10.1016/S0092-8674(00)81546-9	51	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15527	10.1371/journal.pone.0015527	http://dx.doi.org/10.1371/journal.pone.0015527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124935	gold, Green Published			2022-12-27	WOS:000284467200020
J	Kelly, NE; Shea, EK; Metaxas, A; Haedrich, RL; Auster, PJ				Kelly, Noreen E.; Shea, Elizabeth K.; Metaxas, Anna; Haedrich, Richard L.; Auster, Peter J.			Biodiversity of the Deep-Sea Continental Margin Bordering the Gulf of Maine (NW Atlantic): Relationships among Sub-Regions and to Shelf Systems	PLOS ONE			English	Article							WESTERN NORTH-ATLANTIC; WATER GORGONIAN CORALS; NEAR-BOTTOM CURRENTS; NEW-ENGLAND; SPECIES RICHNESS; TAXONOMIC DISTINCTNESS; SUBMARINE-CANYON; UNITED-STATES; NOVA-SCOTIA; SLOPE	Background: In contrast to the well-studied continental shelf region of the Gulf of Maine, fundamental questions regarding the diversity, distribution, and abundance of species living in deep-sea habitats along the adjacent continental margin remain unanswered. Lack of such knowledge precludes a greater understanding of the Gulf of Maine ecosystem and limits development of alternatives for conservation and management. Methodology/Principal Findings: We use data from the published literature, unpublished studies, museum records and online sources, to: (1) assess the current state of knowledge of species diversity in the deep-sea habitats adjacent to the Gulf of Maine (39-43 degrees N, 63-71 degrees W, 150-3000 m depth); (2) compare patterns of taxonomic diversity and distribution of megafaunal and macrofaunal species among six distinct sub-regions and to the continental shelf; and (3) estimate the amount of unknown diversity in the region. Known diversity for the deep-sea region is 1,671 species; most are narrowly distributed and known to occur within only one sub-region. The number of species varies by sub-region and is directly related to sampling effort occurring within each. Fishes, corals, decapod crustaceans, molluscs, and echinoderms are relatively well known, while most other taxonomic groups are poorly known. Taxonomic diversity decreases with increasing distance from the continental shelf and with changes in benthic topography. Low similarity in faunal composition suggests the deep-sea region harbours faunal communities distinct from those of the continental shelf. Non-parametric estimators of species richness suggest a minimum of 50% of the deep-sea species inventory remains to be discovered. Conclusions/Significance: The current state of knowledge of biodiversity in this deep-sea region is rudimentary. Our ability to answer questions is hampered by a lack of sufficient data for many taxonomic groups, which is constrained by sampling biases, life-history characteristics of target species, and the lack of trained taxonomists.	[Kelly, Noreen E.] Bedford Inst Oceanog, Ctr Marine Biodivers, Dartmouth, NS, Canada; [Shea, Elizabeth K.] Delaware Museum Nat Hist, Dept Mollusks, Wilmington, DE USA; [Metaxas, Anna] Dalhousie Univ, Dept Oceanog, Halifax, NS, Canada; [Haedrich, Richard L.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada; [Auster, Peter J.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Auster, Peter J.] Univ Connecticut, NE Underwater Res Technol & Educ Ctr, Groton, CT USA	Bedford Institute of Oceanography; Fisheries & Oceans Canada; Dalhousie University; Memorial University Newfoundland; University of Connecticut; University of Connecticut	Kelly, NE (corresponding author), York Univ, Dept Biol, Toronto, ON M3J 2R7, Canada.	kellyne@yorku.ca	KELLY, NOREEN E/H-7628-2019; Auster, Peter/ABI-3568-2020	KELLY, NOREEN E/0000-0002-5432-5658; Shea, Elizabeth/0000-0002-5379-8410	Alfred P. Sloan Foundation; University of Southern Maine, Portland, Maine; Centre for Marine Biodiversity Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia	Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); University of Southern Maine, Portland, Maine; Centre for Marine Biodiversity Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia	This synthesis was funded by a grant from the Alfred P. Sloan Foundation to the Gulf of Maine Area program of the Census of Marine Life, which is run jointly by scientists at the University of Southern Maine, Portland, Maine (L. S. Incze and S. L. Ellis) and the Centre for Marine Biodiversity, Bedford Institute of Oceanography, Dartmouth, Nova Scotia (P. Lawton). N. Kelly was supported by a post-doctoral fellowship at the Centre for Marine Biodiversity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auster Peter J., 1996, Reviews in Fisheries Science, V4, P185; Auster PJ, 2005, ERLANGEN EARTH C SER, P761, DOI 10.1007/3-540-27673-4_40; BISCAYE PE, 1988, CONT SHELF RES, V8, P855, DOI 10.1016/0278-4343(88)90080-5; BOUCHET P, 2006, EXPLORATION MARINE B, P33; Bryan TL, 2007, MAR ECOL PROG SER, V330, P113, DOI 10.3354/meps330113; Bryan TL, 2006, DEEP-SEA RES PT I, V53, P1865, DOI 10.1016/j.dsr.2006.09.006; Buhl-Mortensen L, 2004, SYMBIOSIS, V37, P33; Buhl-Mortensen L, 2004, J NAT HIST, V38, P1233, DOI 10.1080/0022293031000155205; Cairns SD, 2007, P BIOL SOC WASH, V120, P243, DOI 10.2988/0006-324X(2007)120[243:SOWAOG]2.0.CO;2; CHO WW, 2008, THESIS MIT WHOI; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; Clarke KR, 2001, MAR ECOL PROG SER, V216, P265, DOI 10.3354/meps216265; Cogswell A. T., 2009, 2855 FISH AQ SCI; Colwell R.K., 2006, ESTIMATES STAT ESTIM; COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091; Cooper R. A., 1987, NOAA S SER UNDERSEA, V2, P17; CSANADY GT, 1988, CONT SHELF RES, V8, P653, DOI 10.1016/0278-4343(88)90070-2; Davies AJ, 2007, BIOL CONSERV, V138, P299, DOI 10.1016/j.biocon.2007.05.011; DeVaney SC, 2009, NORTHEAST NAT, V16, P409, DOI 10.1656/045.016.n308; Devine JA, 2006, NATURE, V439, P29, DOI 10.1038/439029a; DUNCAN RA, 1984, J GEOPHYS RES, V89, P9980, DOI 10.1029/JB089iB12p09980; ESSIM Planning Office, 2006, 200601 ESSIM PLANN O; FADER GBJ, 1988, 1692 GEOL SURV CAN; Gage J.D., 1992, DEEP SEA BIOL NATURA; Giere O, 2009, MEIOBENTHOLOGY MICRO, DOI 10.1007/978-3-540-68661-3; Gordon J. D. M., 2003, Journal of Northwest Atlantic Fishery Science, V31, P57; GRASSLE JF, 1992, AM NAT, V139, P313, DOI 10.1086/285329; GREENE CH, 1988, SCIENCE, V241, P359, DOI 10.1126/science.241.4863.359; HAEDRICH RL, 1975, J MAR RES, V33, P191; HAEDRICH RL, 1980, MAR BIOL, V57, P165, DOI 10.1007/BF00390735; Hamilton P., 1996, J MAR ENV ENG, V2, P203; Hartel KE, 2008, NORTHEAST NAT, V15, P317, DOI 10.1656/1092-6194-15.3.317; HECKER B, 1990, DEEP-SEA RES, V37, P37, DOI 10.1016/0198-0149(90)90028-T; Hecker B., 1980, EPIFAUNAL ZONATION C; Hecker B, 1983, CANYON SLOPE PROCESS; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; International Council for the Exploration of the Sea (ICES), 2008, ICES NAFO JOINT WORK; Kendall VJ, 2006, DEEP-SEA RES PT I, V53, P506, DOI 10.1016/j.dsr.2005.12.005; Koslow JA, 2000, ICES J MAR SCI, V57, P548, DOI 10.1006/jmsc.2000.0722; LAMBSHEAD PJD, 1993, OCEANIS S D, V19, P5; Loder JW, 2001, DEEP-SEA RES PT II, V48, P3, DOI 10.1016/S0967-0645(00)00080-1; MACIOLEK N, 1987, STUDY BIOL PROCESSES; Maciolek NJ, 2009, DEEP-SEA RES PT II, V56, P1763, DOI 10.1016/j.dsr2.2009.05.031; MACIOLEKBLAKE NJ, 1985, GEORGES BANK INFAUNA; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Merrett N. R., 1997, FISH FISHERIES SERIE; Metaxas A, 2005, J MAR BIOL ASSOC UK, V85, P1381, DOI 10.1017/S0025315405012567; Metaxas A, 2004, DEEP-SEA RES PT I, V51, P1307, DOI 10.1016/j.dsr.2004.06.001; Moore J. A., 2003, Journal of Northwest Atlantic Fishery Science, V31, P363; Moore JA, 2004, ARCH FISH MAR RES, V51, P241; Moore JA, 2003, NORTHEAST NAT, V10, P159, DOI 10.1656/1092-6194(2003)010[0159:AALODF]2.0.CO;2; Moore JA, 2009, B PEABODY MUS NAT HI, V50, P381, DOI 10.3374/014.050.0205; Moore Jon A., 2008, Bulletin of the Peabody Museum of Natural History, V49, P31, DOI 10.3374/0079-032X(2008)49[31:FBNHIT]2.0.CO;2; Mortensen PB, 2004, MAR BIOL, V144, P1223, DOI 10.1007/s00227-003-1280-8; Mosher CV, 2009, MAR ECOL PROG SER, V397, P81, DOI 10.3354/meps08113; POORE GCB, 1993, NATURE, V361, P597, DOI 10.1038/361597a0; RAMP SR, 1985, J PHYS OCEANOGR, V15, P1790, DOI 10.1175/1520-0485(1985)015<1790:TDFTTN>2.0.CO;2; Rex M.A., 2010, BIOSCIENCE; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROGERS AD, 1994, ADV MAR BIOL, V30, P305, DOI 10.1016/S0065-2881(08)60065-6; ROWE GT, 1982, DEEP-SEA RES, V29, P257, DOI 10.1016/0198-0149(82)90113-3; ROWE GT, 1979, CONTINENTAL SLOPES, P49; Scanlon KM., 1984, GEOMARINE LETT, V4, P1; SCHMITZ WJ, 1987, MARINE ENV US ATLANT, P27; Smith CR, 2003, ECOSY WORLD, V28, P179; Smith Craig R., 2008, P334, DOI 10.1017/CBO9780511751790.030; Sutton TT, 2004, COPEIA, P116; Theroux R. B., 1998, 140 NOAA NMFS US DEP; THISTLE D, 1985, DEEP-SEA RES, V32, P1077, DOI 10.1016/0198-0149(85)90063-9; THISTLE D, 1991, MAR GEOL, V99, P413, DOI 10.1016/0025-3227(91)90053-7; Thoma JN, 2009, MAR ECOL PROG SER, V397, P25, DOI 10.3354/meps08318; UIBLEIN F, 2005, DEEP SEA 2003 C GO 1, P98; UZMANN JR, 1977, MAR FISH REV, V39, P12; VALENTINE P, 1987, US GEOLOGICAL SURVEY, V1782, P1; VALENTINE PC, 1984, J SEDIMENT PETROL, V54, P704; VALENTINE PC, 1980, MAR GEOL, V38, P283, DOI 10.1016/0025-3227(80)90004-3; Vetter EW, 1998, DEEP-SEA RES PT II, V45, P25, DOI 10.1016/S0967-0645(97)00048-9; Wahle RA, 2008, ICES J MAR SCI, V65, P862, DOI 10.1093/icesjms/fsn058; Watanabe S, 2009, DEEP-SEA RES PT I, V56, P2235, DOI 10.1016/j.dsr.2009.09.003; Watling L, 2005, ERLANGEN EARTH C SER, P279, DOI 10.1007/3-540-27673-4_13; Watling L, 1998, CONSERV BIOL, V12, P1180, DOI 10.1046/j.1523-1739.1998.0120061180.x; Watling L, 2007, J MAR BIOL ASSOC UK, V87, P393, DOI 10.1017/S002531540705535X; WILSON RR, 1987, SEAMOUNTS ISLANDS AT, V43, P319; WOLFF N, 2010, HYPSOMETRIC CHARACTE	84	15	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e13832	10.1371/journal.pone.0013832	http://dx.doi.org/10.1371/journal.pone.0013832			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124960	Green Accepted, gold, Green Published			2022-12-27	WOS:000284400100001
J	Gordon, CS; Serino, AS; Krause, MP; Campbell, JE; Cafarelli, E; Adegoke, OAJ; Hawke, TJ; Riddell, MC				Gordon, Carly S.; Serino, Antonio S.; Krause, Matthew P.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Hawke, Thomas J.; Riddell, Michael C.			Impaired Growth and Force Production in Skeletal Muscles of Young Partially Pancreatectomized Rats: A Model of Adolescent Type 1 Diabetic Myopathy?	PLOS ONE			English	Article							PROTEIN-SYNTHESIS; MORPHOLOGICAL ABNORMALITIES; CARBOHYDRATE-METABOLISM; MORPHOMETRIC-ANALYSIS; CONTRACTILE ACTIVITY; CELLULAR MECHANISMS; ENDOCRINE FUNCTION; PHYSICAL-FITNESS; SINGLE-FIBER; FINAL HEIGHT	This present study investigated the temporal effects of type 1 diabetes mellitus (T1DM) on adolescent skeletal muscle growth, morphology and contractile properties using a 90% partial pancreatecomy (Px) model of the disease. Four week-old male Sprague-Dawley rats were randomly assigned to Px (n = 25) or Sham (n = 24) surgery groups and euthanized at 4 or 8 weeks following an in situ assessment of muscle force production. Compared to Shams, Px were hyperglycemic (>15 mM) and displayed attenuated body mass gains by days 2 and 4, respectively (both P<0.05). Absolute maximal force production of the gastrocnemius plantaris soleus complex (GPS) was 30% and 50% lower in Px vs. Shams at 4 and 8 weeks, respectively (P<0.01). GP mass was 35% lower in Px vs Shams at 4 weeks (1.24 +/- 0.06 g vs. 1.93 +/- 0.03 g, P<0.05) and 45% lower at 8 weeks (1.57 +/- 0.12 vs. 2.80 +/- 0.06, P<0.05). GP fiber area was 15-20% lower in Px vs. Shams at 4 weeks in all fiber types. At 8 weeks, GP type I and II fiber areas were similar to 25% and 40% less, respectively, in Px vs. Shams (group by fiber type interactions, P<0.05). Phosphorylation states of 4E-BP1 and S6K1 following leucine gavage increased 2.0- and 3.5-fold, respectively, in Shams but not in Px. Px rats also had impaired rates of muscle protein synthesis in the basal state and in response to gavage. Taken together, these data indicate that exposure of growing skeletal muscle to uncontrolled T1DM significantly impairs muscle growth and function largely as a result of impaired protein synthesis in type II fibers.	[Gordon, Carly S.; Serino, Antonio S.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Riddell, Michael C.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada; [Gordon, Carly S.; Serino, Antonio S.; Krause, Matthew P.; Campbell, Jonathan E.; Cafarelli, Enzo; Adegoke, Olasunkanmi A. J.; Hawke, Thomas J.; Riddell, Michael C.] York Univ, Muscle Hlth Res Ctr, Toronto, ON M3J 2R7, Canada; [Krause, Matthew P.; Hawke, Thomas J.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	York University - Canada; York University - Canada; McMaster University	Gordon, CS (corresponding author), York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 2R7, Canada.	mriddell@yorku.ca		Hawke, Thomas/0000-0003-4974-4820; Campbell, Jonathan/0000-0001-8223-1600	National Science and Engineering Research Council of Canada (NSERC); Canadian Diabetes Association	National Science and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Diabetes Association	This research was supported by grants from National Science and Engineering Research Council of Canada (NSERC) and the Canadian Diabetes Association to MCR. CG is the recipient of the NSERC Canada Graduate Scholarship award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adegoke OAJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE105, DOI 10.1152/ajpendo.90752.2008; Andersen H, 1997, DIABETOLOGIA, V40, P1062, DOI 10.1007/s001250050788; Andersen H, 2004, DIABETES CARE, V27, P2382, DOI 10.2337/diacare.27.10.2382; Andersen H, 1996, DIABETES, V45, P440, DOI 10.2337/diabetes.45.4.440; Andersen H, 1998, DIABETES CARE, V21, P604, DOI 10.2337/diacare.21.4.604; Anthony JC, 2002, DIABETES, V51, P928, DOI 10.2337/diabetes.51.4.928; Anthony JC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1092, DOI 10.1152/ajpendo.00208.2001; ARMSTRONG RB, 1975, CELL TISSUE RES, V162, P387; Attaix D, 2005, ESSAYS BIOCHEM, V41, P173, DOI 10.1042/EB0410173; BARALDI E, 1992, PEDIATR PULM, V13, P155, DOI 10.1002/ppul.1950130306; Bognetti E, 1998, DIABETES CARE, V21, P1226, DOI 10.2337/diacare.21.8.1226; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; BROWN M, 1994, DIABETIC MED, V11, P182, DOI 10.1111/j.1464-5491.1994.tb02017.x; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; CAPRIO S, 1994, AM J PHYSIOL, V266, pE885, DOI 10.1152/ajpendo.1994.266.6.E885; Caso G, 2010, CURR OPIN CLIN NUTR, V13, P93, DOI 10.1097/MCO.0b013e328333294d; Charlton M, 1998, J NUTR, V128, p323S, DOI 10.1093/jn/128.2.323S; Chiarelli F, 2004, EUR J ENDOCRINOL, V151, pU109, DOI 10.1530/eje.0.151U109; Chonkar A, 2006, ANN NY ACAD SCI, V1084, P442, DOI 10.1196/annals.1372.006; COTTER MA, 1993, EXP PHYSIOL, V78, P139, DOI 10.1113/expphysiol.1993.sp003675; Crowther GJ, 2003, AM J PHYSIOL-ENDOC M, V284, pE655, DOI 10.1152/ajpendo.00343.2002; Crozier SJ, 2005, J NUTR, V135, P376, DOI 10.1093/jn/135.3.376; DARR KC, 1989, J APPL PHYSIOL, V67, P1827, DOI 10.1152/jappl.1989.67.5.1827; Donaghue KC, 2009, PEDIATR DIABETES, V10, P195, DOI 10.1111/j.1399-5448.2009.00576.x; DUCAJU MVL, 1995, PEDIATR RES, V38, P607, DOI 10.1203/00006450-199510000-00022; Fahim MA, 1998, ANAT RECORD, V251, P240, DOI 10.1002/(SICI)1097-0185(199806)251:2<240::AID-AR13>3.0.CO;2-O; Fricke O., 2008, Journal of Musculoskeletal & Neuronal Interactions, V8, P188; Fritzsche K, 2008, EXP CLIN ENDOCR DIAB, V116, P606, DOI 10.1055/s-2008-1073126; GARLICK PJ, 1980, BIOCHEM J, V192, P719, DOI 10.1042/bj1920719; GOLDBERG AL, 1979, DIABETES, V28, P18, DOI 10.2337/diab.28.1.S18; Gordon JW, 2001, J APPL PHYSIOL, V90, P389, DOI 10.1152/jappl.2001.90.1.389; Gunczler P, 1999, DIABETES CARE, V22, P1012, DOI 10.2337/diacare.22.6.1012; Gusso S, 2008, DIABETOLOGIA, V51, P1317, DOI 10.1007/s00125-008-1012-1; Hamilton J, 2002, J PEDIATR ENDOCR MET, V15, P115; HUTTUNEN NP, 1984, ANN CLIN RES, V16, P1; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JAKOBSEN J, 1986, CLIN NEUROPATHOL, V5, P73; Johnston APW, 2007, AM J PHYSIOL-CELL PH, V292, pC1033, DOI 10.1152/ajpcell.00338.2006; KLUEBER KM, 1994, ANAT REC, V239, P18, DOI 10.1002/ar.1092390104; Krause MP, 2011, PEDIATR DIABETES, V12, P345, DOI 10.1111/j.1399-5448.2010.00699.x; Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008; LARSSON Y, 1964, J APPL PHYSIOL, V19, P629, DOI 10.1152/jappl.1964.19.4.629; Lesniewski LA, 2003, MUSCLE NERVE, V28, P493, DOI 10.1002/mus.10468; McGuire M, 1999, EXP PHYSIOL, V84, P1051, DOI 10.1111/j.1469-445X.1999.01916.x; Miyazaki M, 2009, J APPL PHYSIOL, V106, P1367, DOI 10.1152/japplphysiol.91355.2008; MIZUMOTO R, 1982, AM J SURG, V143, P237, DOI 10.1016/0002-9610(82)90077-0; Mozdziak PE, 2000, J APPL PHYSIOL, V88, P158, DOI 10.1152/jappl.2000.88.1.158; OERTEL G, 1988, J NEUROL SCI, V88, P303, DOI 10.1016/0022-510X(88)90227-4; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; POORTMANS JR, 1986, INT J SPORTS MED, V7, P232, DOI 10.1055/s-2008-1025765; RESKENIELSEN E, 1970, DIABETOLOGIA, V6, P104, DOI 10.1007/BF00421437; RESKENIELSEN E, 1970, DIABETOLOGIA, V6, P98, DOI 10.1007/BF00421436; RESKENIELSEN E, 1977, ACTA NEUROL SCAND, V55, P345, DOI 10.1111/j.1600-0404.1977.tb05654.x; Riddell MC, 2006, PEDIATR DIABETES, V7, P60, DOI 10.1111/j.1399-543X.2006.00146.x; Rosa JS, 2009, PEDIATR DIABETES, V10, P213, DOI 10.1111/j.1399-5448.2008.00452.x; Sanchez OA, 2005, J APPL PHYSIOL, V99, P472, DOI 10.1152/japplphysiol.01233.2004; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Snow LM, 2006, PATHOBIOLOGY, V73, P244, DOI 10.1159/000098210; SOMMER H, 1987, EUR SURG RES, V19, P318, DOI 10.1159/000128716; Spangenburg EE, 2008, J PHYSIOL-LONDON, V586, P283, DOI 10.1113/jphysiol.2007.141507; STEPHENSON GMM, 1994, DIABETES, V43, P622, DOI 10.2337/diabetes.43.5.622; STERKY G, 1963, ACTA PAEDIATR, V52, P1, DOI 10.1111/j.1651-2227.1963.tb04073.x; SUZUKI O, 1976, ANAL BIOCHEM, V75, P192, DOI 10.1016/0003-2697(76)90070-1; TATTERSALL RB, 1973, LANCET, V2, P1105; VANELLI M, 1992, HORM RES, V37, P65, DOI 10.1159/000182404; Vignaud A, 2007, PATHOBIOLOGY, V74, P291, DOI 10.1159/000105812; YASUGI H, 1976, AM J SURG, V132, P577, DOI 10.1016/0002-9610(76)90346-9	68	17	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14032	10.1371/journal.pone.0014032	http://dx.doi.org/10.1371/journal.pone.0014032			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103335	Green Published, gold, Green Submitted			2022-12-27	WOS:000284327800016
J	Barbagallo, APM; Weldon, R; Tamayev, R; Zhou, DW; Giliberto, L; Foreman, O; D'Adamio, L				Barbagallo, Alessia P. M.; Weldon, Richard; Tamayev, Robert; Zhou, Dawang; Giliberto, Luca; Foreman, Oded; D'Adamio, Luciano			Tyr(682) in the Intracellular Domain of APP Regulates Amyloidogenic APP Processing In Vivo	PLOS ONE			English	Article							BETA PRECURSOR PROTEIN; RECEPTOR-RELATED PROTEIN; C-TERMINAL FRAGMENTS; KINESIN LIGHT-CHAIN; ALZHEIMERS-DISEASE; AXONAL-TRANSPORT; GAMMA-SECRETASE; FE65; PHOSPHORYLATION; TYROSINE	Background: The pathogenesis of Alzheimer's disease is attributed to misfolding of Amyloid-beta (A beta) peptides. A beta is generated during amyloidogenic processing of A beta-precursor protein (APP). Another characteristic of the AD brain is increased phosphorylation of APP amino acid Tyr(682). Tyr(682) is part of the Y-682 ENPTY687 motif, a docking site for interaction with cytosolic proteins that regulate APP metabolism and signaling. For example, normal A beta generation and secretion are dependent upon Tyr(682) in vitro. However, physiological functions of Tyr(682) are unknown. Methodology/Principal Findings: To this end, we have generated an APP Y682G knock-in (KI) mouse to help dissect the role of APP Tyr(682) in vivo. We have analyzed proteolytic products from both the amyloidogenic and non-amyloidogenic processing of APP and measure a profound shift towards non-amyloidogenic processing in APP KI mice. In addition, we demonstrate the essential nature of amino acid Tyr(682) for the APP/Fe65 interaction in vivo. Conclusions/Significance: Together, these observations point to an essential role of APP intracellular domain for normal APP processing and function in vivo, and provide rationale for further studies into physiological functions associated with this important phosphorylation site.	[Barbagallo, Alessia P. M.; Weldon, Richard; Tamayev, Robert; Zhou, Dawang; D'Adamio, Luciano] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Foreman, Oded] Jackson Lab, Dept Lab Anim Hlth, Bar Harbor, ME 04609 USA; [Giliberto, Luca] N Shore LIJ, Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA	Yeshiva University; Albert Einstein College of Medicine; Jackson Laboratory; Northwell Health	Barbagallo, APM (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	luciano.dadamio@einstein.yu.edu		Zhou, Dawang/0000-0002-9053-5249; D'Adamio, Luciano/0000-0002-2204-9441; D'Adamio, Luciano/0000-0002-9820-4882	Alzheimer's Association [IIRG-09-129984]; NIH [R01AG033007]; Training Program in Cellular and Molecular Biology and Genetics [T32 GM007491]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007288, T32GM007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033007] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training Program in Cellular and Molecular Biology and Genetics; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Alzheimer's Association IIRG-09-129984 grant (LD), NIH Grants R01AG033007 (LD) and Training Program in Cellular and Molecular Biology and Genetics T32 GM007491 (RT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando K, 2001, J BIOL CHEM, V276, P40353, DOI 10.1074/jbc.M104059200; AUSTIN SA, 2008, NEUROBIOL AGING; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; Balastik M, 2007, BBA-MOL BASIS DIS, V1772, P422, DOI 10.1016/j.bbadis.2007.01.006; Buxbaum JD, 1998, J NEUROSCI, V18, P9629; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cao XW, 2004, J BIOL CHEM, V279, P24601, DOI 10.1074/jbc.M402248200; Cash AD, 2003, AM J PATHOL, V162, P1623, DOI 10.1016/S0002-9440(10)64296-4; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fiore F, 1995, J BIOL CHEM, V270, P30853, DOI 10.1074/jbc.270.52.30853; Galvan V, 2006, P NATL ACAD SCI USA, V103, P7130, DOI 10.1073/pnas.0509695103; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Giliberto L, 2009, J BIOL CHEM, V284, P9027, DOI 10.1074/jbc.M805685200; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Huttunen HJ, 2009, J MOL NEUROSCI, V37, P6, DOI 10.1007/s12031-008-9088-0; Inomata H, 2003, J BIOL CHEM, V278, P22946, DOI 10.1074/jbc.M212160200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; King GD, 2004, J NEUROCHEM, V88, P971, DOI 10.1046/j.1471-4159.2003.02234.x; Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Lanz TA, 2006, J NEUROSCI METH, V157, P71, DOI 10.1016/j.jneumeth.2006.03.023; Lazarov O, 2005, J NEUROSCI, V25, P2386, DOI 10.1523/JNEUROSCI.3089-04.2005; Lee MS, 2003, J CELL BIOL, V163, P83, DOI 10.1083/jcb.200301115; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Matsuda S, 2003, J BIOL CHEM, V278, P38601, DOI 10.1074/jbc.M304379200; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Minopoli G, 2007, J BIOL CHEM, V282, P831, DOI 10.1074/jbc.C600276200; MORIN PJ, 1993, J NEUROCHEM, V61, P464; MOYA KL, 1994, J NEUROCHEM, V63, P1971; Muresan Z, 2005, J CELL BIOL, V171, P615, DOI 10.1083/jcb.200502043; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Pastorino L, 2006, NATURE, V440, P528, DOI 10.1038/nature04543; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Pietrzik CU, 2004, J NEUROSCI, V24, P4259, DOI 10.1523/JNEUROSCI.5451-03.2004; Praprotnik D, 1996, ACTA NEUROPATHOL, V91, P226, DOI 10.1007/s004010050420; Puzzo D, 2008, J NEUROSCI, V28, P14537, DOI 10.1523/JNEUROSCI.2692-08.2008; Reinhard C, 2005, EMBO J, V24, P3996, DOI 10.1038/sj.emboj.7600860; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Russo C, 2002, J BIOL CHEM, V277, P35282, DOI 10.1074/jbc.M110785200; Russo C, 2001, NEUROBIOL DIS, V8, P173, DOI 10.1006/nbdi.2000.0357; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; Sano Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000051; Scheinfeld MH, 2003, J BIOL CHEM, V278, P42058, DOI 10.1074/jbc.M304853200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Schmidt Stephen D., 2004, V299, P279; Selkoe DJ, 2000, NEUROL CLIN, V18, P903, DOI 10.1016/S0733-8619(05)70232-2; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; SIMONS M, 1995, J NEUROSCI RES, V41, P121, DOI 10.1002/jnr.490410114; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Stokin GB, 2006, J PHYSIOL-PARIS, V99, P193, DOI 10.1016/j.jphysparis.2005.12.085; Stokin GB, 2005, SCIENCE, V307, P1282, DOI 10.1126/science.1105681; Stokin GB, 2006, ANNU REV BIOCHEM, V75, P607, DOI 10.1146/annurev.biochem.75.103004.142637; Tamayev R, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-28; Tarr PE, 2002, J BIOL CHEM, V277, P16798, DOI 10.1074/jbc.M110286200; Terry RD, 1996, J NEUROPATH EXP NEUR, V55, P1023, DOI 10.1097/00005072-199655100-00001; Tienari PJ, 1996, EMBO J, V15, P5218, DOI 10.1002/j.1460-2075.1996.tb00907.x; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556, DOI 10.1074/jbc.273.50.33556; Turner PR, 2003, PROG NEUROBIOL, V70, P1, DOI 10.1016/S0301-0082(03)00089-3; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5; Zhou DW, 2009, J ALZHEIMERS DIS, V16, P301, DOI 10.3233/JAD-2009-0970; Zhou DW, 2004, J BIOL CHEM, V279, P25374, DOI 10.1074/jbc.M400488200	78	48	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15503	10.1371/journal.pone.0015503	http://dx.doi.org/10.1371/journal.pone.0015503			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103325	Green Published, Green Submitted, gold			2022-12-27	WOS:000284257400028
J	Etemadmoghadam, D; George, J; Cowin, PA; Cullinane, C; Kansara, M; Gorringe, KL; Smyth, GK; Bowtell, DDL				Etemadmoghadam, Dariush; George, Joshy; Cowin, Prue A.; Cullinane, Carleen; Kansara, Maya; Gorringe, Kylie L.; Smyth, Gordon K.; Bowtell, David D. L.		Australian Ovarian Canc Study Grp	Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer	PLOS ONE			English	Article							POTENTIAL THERAPEUTIC TARGET; CYCLIN-E; COPY-NUMBER; CELL-CYCLE; GENE AMPLIFICATION; 19Q12 AMPLICON; LUNG; PREDICTOR; LANDSCAPE; STABILITY	Genomic amplification of 19q12 occurs in several cancer types including ovarian cancer where it is associated with primary treatment failure. We systematically attenuated expression of genes within the minimally defined 19q12 region in ovarian cell lines using short-interfering RNAs (siRNA) to identify driver oncogene(s) within the amplicon. Knockdown of CCNE1 resulted in G1/S phase arrest, reduced cell viability and apoptosis only in amplification-carrying cells. Although CCNE1 knockdown increased cisplatin resistance in short-term assays, clonogenic survival was inhibited after treatment. Gain of 20q11 was highly correlated with 19q12 amplification and spanned a 2.5 Mb region including TPX2, a centromeric protein required for mitotic spindle function. Expression of TPX2 was highly correlated with gene amplification and with CCNE1 expression in primary tumors. siRNA inhibition of TPX2 reduced cell viability but this effect was not amplicon-dependent. These findings demonstrate that CCNE1 is a key driver in the 19q12 amplicon required for survival and clonogenicity in cells with locus amplification. Co-amplification at 19q12 and 20q11 implies the presence of a cooperative mutational network. These observations have implications for the application of targeted therapies in CCNE1 dependent ovarian cancers.	[Etemadmoghadam, Dariush; George, Joshy; Cowin, Prue A.; Kansara, Maya; Gorringe, Kylie L.; Bowtell, David D. L.] Peter MacCallum Canc Ctr, Canc Genom Program, Melbourne, Australia; [George, Joshy; Bowtell, David D. L.] Univ Melbourne, Dept Biochem, Parkville, Vic 3052, Australia; [Cullinane, Carleen] Peter MacCallum Canc Ctr, Translat Res Program, Melbourne, Australia; [Gorringe, Kylie L.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Smyth, Gordon K.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic 3050, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center; University of Melbourne; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Etemadmoghadam, D (corresponding author), Peter MacCallum Canc Ctr, Canc Genom Program, Melbourne, Australia.	david.bowtell@petermac.org	Smyth, Gordon/B-5276-2008; Gorringe, Kylie L/H-3264-2019; George, Joshy/K-4841-2019; Bowtell, David/H-1007-2016	Smyth, Gordon/0000-0001-9221-2892; Gorringe, Kylie L/0000-0001-5681-2022; Bowtell, David/0000-0001-9089-7525; George, Joshy/0000-0001-8510-8229; Cullinane, Carleen/0000-0001-5833-6605	National Health and Medical Research Council (NHMRC) [628779]; U.S. Army Medical Research and Materiel Command [DAMD17-01-1-0729]; Cancer Council Victoria; Queensland Cancer Fund; Cancer Council New South Wales; Cancer Council South Australia; Cancer Foundation of Western Australia; Cancer Council Tasmania	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Queensland Cancer Fund; Cancer Council New South Wales(Cancer Council New South Wales); Cancer Council South Australia(Cancer Council South Australia); Cancer Foundation of Western Australia(Cancer Council Western Australia); Cancer Council Tasmania(Cancer Council Tasmania)	This study was funded by a National Health and Medical Research Council (NHMRC) project grant 628779 (www.nhmrc.gov.au). The Australian Ovarian Cancer Study is supported by the U.S. Army Medical Research and Materiel Command under DAMD17-01-1-0729, The Cancer Council Victoria, Queensland Cancer Fund, The Cancer Council New South Wales, The Cancer Council South Australia, The Cancer Foundation of Western Australia, The Cancer Council Tasmania and the NHMRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal R, 2009, CLIN CANCER RES, V15, P3654, DOI 10.1158/1078-0432.CCR-08-3293; AKAMA Y, 1995, JPN J CANCER RES, V86, P617, DOI 10.1111/j.1349-7006.1995.tb02442.x; Akli S, 2003, CANCER BIOL THER, V2, pS38; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Bedrosian I, 2004, ONCOGENE, V23, P2648, DOI 10.1038/sj.onc.1207408; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bredel M, 2009, JAMA-J AM MED ASSOC, V302, P261, DOI 10.1001/jama.2009.997; Chia W, 2008, J CELL BIOL, V180, P267, DOI 10.1083/jcb.200708159; Cui WW, 2007, NUCLEIC ACIDS RES, V35, pD805, DOI 10.1093/nar/gkl767; Djouder N, 2007, MOL CELL, V28, P28, DOI 10.1016/j.molcel.2007.08.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Etemadmoghadam D, 2009, CLIN CANCER RES, V15, P1417, DOI 10.1158/1078-0432.CCR-08-1564; Farley J, 2003, CANCER RES, V63, P1235; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Gorringe KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011408; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Haverty PM, 2008, GENE CHROMOSOME CANC, V47, P530, DOI 10.1002/gcc.20558; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kwek SS, 2009, ONCOGENE, V28, P1892, DOI 10.1038/onc.2009.34; Leung SY, 2006, MODERN PATHOL, V19, P854, DOI 10.1038/modpathol.3800593; Lin L, 2000, CANCER RES, V60, P7021; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marchetti C, 2010, EXPERT REV ANTICANC, V10, P47, DOI 10.1586/ERA.09.167; Mayr D, 2006, AM J CLIN PATHOL, V126, P101, DOI 10.1309/N6X5MB24BP42KP20; Mull BB, 2009, ONCOGENE, V28, P3167, DOI 10.1038/onc.2009.182; Nakayama K, 2007, INT J CANCER, V120, P2613, DOI 10.1002/ijc.22609; Nakayama N, 2010, CANCER-AM CANCER SOC, V116, P2621, DOI 10.1002/cncr.24987; Nikolsky Y, 2008, CANCER RES, V68, P9532, DOI 10.1158/0008-5472.CAN-08-3082; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Ramos AH, 2009, CANCER BIOL THER, V8, P2042, DOI 10.4161/cbt.8.21.9764; Rozen S, 2000, Methods Mol Biol, V132, P365; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; SEHDEV AS, 2010, MOD PATHOL; Shapiro GI, 2006, J CLIN ONCOL, V24, P1770, DOI 10.1200/JCO.2005.03.7689; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Swarbrick A, 2005, ONCOGENE, V24, P381, DOI 10.1038/sj.onc.1208188; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Warner SL, 2009, CLIN CANCER RES, V15, P6519, DOI 10.1158/1078-0432.CCR-09-0077; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; WEIR BA, 2007, NATURE	44	79	82	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15498	10.1371/journal.pone.0015498	http://dx.doi.org/10.1371/journal.pone.0015498			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103391	gold, Green Published			2022-12-27	WOS:000284147700036
J	Ensoli, B; Bellino, S; Tripiciano, A; Longo, O; Francavilla, V; Marcotullio, S; Cafaro, A; Picconi, O; Paniccia, G; Scoglio, A; Arancio, A; Ariola, C; Alvarez, MJR; Campagna, M; Scaramuzzi, D; Iori, C; Esposito, R; Mussini, C; Ghinelli, F; Sighinolfi, L; Palamara, G; Latini, A; Angarano, G; Ladisa, N; Soscia, F; Mercurio, VS; Lazzarin, A; Tambussi, G; Visintini, R; Mazzotta, F; Di Pietro, M; Galli, M; Rusconi, S; Carosi, G; Torti, C; Di Perri, G; Bonora, S; Ensoli, F; Garaci, E				Ensoli, Barbara; Bellino, Stefania; Tripiciano, Antonella; Longo, Olimpia; Francavilla, Vittorio; Marcotullio, Simone; Cafaro, Aurelio; Picconi, Orietta; Paniccia, Giovanni; Scoglio, Arianna; Arancio, Angela; Ariola, Cristina; Alvarez, Maria J. Ruiz; Campagna, Massimo; Scaramuzzi, Donato; Iori, Cristina; Esposito, Roberto; Mussini, Cristina; Ghinelli, Florio; Sighinolfi, Laura; Palamara, Guido; Latini, Alessandra; Angarano, Gioacchino; Ladisa, Nicoletta; Soscia, Fabrizio; Mercurio, Vito S.; Lazzarin, Adriano; Tambussi, Giuseppe; Visintini, Raffaele; Mazzotta, Francesco; Di Pietro, Massimo; Galli, Massimo; Rusconi, Stefano; Carosi, Giampiero; Torti, Carlo; Di Perri, Giovanni; Bonora, Stefano; Ensoli, Fabrizio; Garaci, Enrico			Therapeutic Immunization with HIV-1 Tat Reduces Immune Activation and Loss of Regulatory T-Cells and Improves Immune Function in Subjects on HAART	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENE-EXPRESSION; HLA-DR; ANTIRETROVIRAL THERAPY; CYNOMOLGUS MONKEYS; PERIPHERAL-BLOOD; DENDRITIC CELLS; PROTEIN; INFECTION; AIDS	Although HAART suppresses HIV replication, it is often unable to restore immune homeostasis. Consequently, non-AIDS-defining diseases are increasingly seen in treated individuals. This is attributed to persistent virus expression in reservoirs and to cell activation. Of note, in CD4(+) T cells and monocyte-macrophages of virologically-suppressed individuals, there is continued expression of multi-spliced transcripts encoding HIV regulatory proteins. Among them, Tat is essential for virus gene expression and replication, either in primary infection or for virus reactivation during HAART, when Tat is expressed, released extracellularly and exerts, on both the virus and the immune system, effects that contribute to disease maintenance. Here we report results of an ad hoc exploratory interim analysis (up to 48 weeks) on 87 virologically-suppressed HAART-treated individuals enrolled in a phase II randomized open-label multicentric clinical trial of therapeutic immunization with Tat (ISS T-002). Eighty-eight virologically-suppressed HAART-treated individuals, enrolled in a parallel prospective observational study at the same sites (ISS OBS T-002), served for intergroup comparison. Immunization with Tat was safe, induced durable immune responses, and modified the pattern of CD4(+) and CD8(+) cellular activation (CD38 and HLA-DR) together with reduction of biochemical activation markers and persistent increases of regulatory T cells. This was accompanied by a progressive increment of CD4(+) T cells and B cells with reduction of CD8(+) T cells and NK cells, which were independent from the type of antiretroviral regimen. Increase in central and effector memory and reduction in terminally-differentiated effector memory CD4(+) and CD8(+) T cells were accompanied by increases of CD4(+) and CD8(+) T cell responses against Env and recall antigens. Of note, more immune-compromised individuals experienced greater therapeutic effects. In contrast, these changes were opposite, absent or partial in the OBS population. These findings support the use of Tat immunization to intensify HAART efficacy and to restore immune homeostasis.	[Ensoli, Barbara; Bellino, Stefania; Tripiciano, Antonella; Longo, Olimpia; Francavilla, Vittorio; Marcotullio, Simone; Cafaro, Aurelio; Picconi, Orietta; Paniccia, Giovanni; Scoglio, Arianna; Alvarez, Maria J. Ruiz] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Tripiciano, Antonella; Francavilla, Vittorio; Paniccia, Giovanni; Scoglio, Arianna; Arancio, Angela; Ariola, Cristina; Alvarez, Maria J. Ruiz; Campagna, Massimo; Scaramuzzi, Donato; Iori, Cristina; Ensoli, Fabrizio] San Gallicano Hosp, Ist Fisioterapici Ospetalieri, Core Lab Virol & Immunol, Rome, Italy; [Esposito, Roberto; Mussini, Cristina] Univ Policlin Modena, Div Infect Dis, Modena, Italy; [Ghinelli, Florio; Sighinolfi, Laura] Univ Hosp Ferrara, Infect Dis Unit, Ferrara, Italy; [Palamara, Guido; Latini, Alessandra] San Gallicano Hosp, Dept Infect Dermatol, Rome, Italy; [Angarano, Gioacchino; Ladisa, Nicoletta] Univ Bari, Policlin Hosp, Div Infect Dis, Bari, Italy; [Soscia, Fabrizio; Mercurio, Vito S.] S Maria Goretti Hosp, Dept Infect Dis, Latina, Italy; [Lazzarin, Adriano; Tambussi, Giuseppe; Visintini, Raffaele] Hosp San Raffaele, Div Infect Dis, I-20132 Milan, Italy; [Mazzotta, Francesco; Di Pietro, Massimo] SM Annunziata Hosp, Infect Dis Unit, Florence, Italy; [Galli, Massimo; Rusconi, Stefano] Univ Milan, L Sacco Hosp Vialba, Inst Trop & Infect Dis, Milan, Italy; [Carosi, Giampiero; Torti, Carlo] Spedali Civil Brescia, Div Trop & Infect Dis, I-25125 Brescia, Italy; [Di Perri, Giovanni; Bonora, Stefano] Amedeo di Savoia Hosp, Clin Infect Dis, Turin, Italy	Istituto Superiore di Sanita (ISS); IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; University of Ferrara; Arcispedale Sant'Anna; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Universita degli Studi di Bari Aldo Moro; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Luigi Sacco Hospital; Hospital Spedali Civili Brescia	Ensoli, B (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	barbara.ensoli@iss.it	Rusconi, Stefano/H-9263-2012; Cafaro, Aurelio/K-5314-2016; Tripiciano, Antonella/K-4635-2016; Sighinolfi, Laura/AAH-1426-2020; Paniccia, Giovanni/M-7440-2017; GARACI, ENRICO/AAB-3349-2021; Ensoli, Fabrizio/J-6540-2018; Picconi, Orietta/L-4613-2016; bonora, stefano/AAC-2993-2019; latini, alessandra/J-8186-2018; Di Perri, Giovanni/AAC-1882-2019; Ensoli, Barbara/J-9169-2016; RUIZ ALVAREZ, MARIA JOSEFINA/D-7968-2016; Mussini, Cristina/K-8672-2016; LAZZARIN, Adriano/K-3607-2018; GALLI, MASSIMO/L-7282-2017	Rusconi, Stefano/0000-0002-0375-9990; Tripiciano, Antonella/0000-0001-7814-984X; Paniccia, Giovanni/0000-0002-9850-5802; Ensoli, Fabrizio/0000-0003-4995-3067; Picconi, Orietta/0000-0003-3626-9952; bonora, stefano/0000-0002-7537-3341; Ensoli, Barbara/0000-0002-0545-8737; RUIZ ALVAREZ, MARIA JOSEFINA/0000-0003-1751-780X; Mussini, Cristina/0000-0002-6615-4198; Arancio, Angela/0000-0002-6747-0475; Segala, Daniela/0000-0001-6133-0386; LAZZARIN, Adriano/0000-0003-2551-7754; ANGARANO, Gioacchino/0000-0003-3207-7523; Bellino, Stefania/0000-0003-1149-3835; Latini, Alessandra/0000-0002-9421-6560; Cafaro, Aurelio/0000-0001-9675-6344; Tambussi, Giuseppe/0000-0002-0604-2960; GALLI, MASSIMO/0000-0001-8887-6215	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	This work was funded by the special project for 'The development of clinical trials of vaccines against HIV/AIDS' funded by the Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexaki A, 2008, CURR HIV RES, V6, P388, DOI 10.2174/157016208785861195; Allen TM, 2000, NATURE, V407, P386, DOI 10.1038/35030124; Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Alves NL, 2007, J IMMUNOL, V179, P221, DOI 10.4049/jimmunol.179.1.221; Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; BARILLARI G, 1992, J IMMUNOL, V149, P3727; Bellino S, 2009, REV RECENT CLIN TRIA, V4, P195, DOI 10.2174/157488709789957529; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Borsetti A, 2009, VIRAL IMMUNOL, V22, P117, DOI 10.1089/vim.2008.0082; BUONAGURO L, 1994, J VIROL, V68, P2677, DOI 10.1128/JVI.68.4.2677-2682.1994; BUONAGURO L, 1992, J VIROL, V66, P7159, DOI 10.1128/JVI.66.12.7159-7167.1992; Burtis C.A., 1999, TIETZ TXB CLIN CHEM, P1654; Butto S, 2003, J INFECT DIS, V188, P1171, DOI 10.1086/378412; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2010, J VIROL, V84, P8953, DOI 10.1128/JVI.00377-10; CAGIGI A, 2010, AIDS; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Campbell GR, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-50; Cao JH, 2003, J IMMUNOL, V171, P3837, DOI 10.4049/jimmunol.171.7.3837; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chase AJ, 2008, J VIROL, V82, P8307, DOI 10.1128/JVI.00520-08; Chertova E, 2006, J VIROL, V80, P9039, DOI 10.1128/JVI.01013-06; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Cullen B R, 1995, AIDS, V9 Suppl A, pS19; DAYTON AI, 1986, CELL, V44, P941, DOI 10.1016/0092-8674(86)90017-6; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Deeks Steven G, 2009, Top HIV Med, V17, P118; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; ENSOLI B, 2005, AIDS VACCINE INTEGRA, V9, P38; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Fischer M, 2004, J INFECT DIS, V189, P273, DOI 10.1086/380797; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; GATHE J, 2010, 17 C RETR OPP INF; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; HAUBER J, 1987, P NATL ACAD SCI USA, V84, P6364, DOI 10.1073/pnas.84.18.6364; HO HN, 1993, J IMMUNOL, V150, P3070; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Hunt PW, 2006, AIDS, V20, P691, DOI 10.1097/01.aids.0000216369.30948.18; JACKSON DG, 1990, J IMMUNOL, V144, P2811; Jiao YM, 2009, IMMUNOLOGY, V128, pe366, DOI 10.1111/j.1365-2567.2008.02978.x; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kelly J, 2008, VIROLOGY, V372, P300, DOI 10.1016/j.virol.2007.11.007; Lafrenie RM, 1997, J IMMUNOL, V159, P4077; Lambotte O, 2000, J ACQ IMMUN DEF SYND, V23, P114; Lassen Kara G., 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020068; Lassen KG, 2004, J VIROL, V78, P9105, DOI 10.1128/JVI.78.17.9105-9114.2004; Li CJ, 1997, P NATL ACAD SCI USA, V94, P8116, DOI 10.1073/pnas.94.15.8116; Li JCB, 2010, AIDS, V24, P1609, DOI 10.1097/QAD.0b013e32833ac6a0; Lin X, 2003, J VIROL, V77, P8227, DOI 10.1128/JVI.77.15.8227-8236.2003; Liu ZY, 1997, J ACQ IMMUN DEF SYND, V16, P83, DOI 10.1097/00042560-199710010-00003; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; Nappi F, 2009, J GENE MED, V11, P955, DOI 10.1002/jgm.1381; Natarajan V, 1999, LANCET, V353, P119, DOI 10.1016/S0140-6736(05)76156-0; O'Connor DH, 2002, NAT MED, V8, P493, DOI 10.1038/nm0502-493; Ott M, 1997, SCIENCE, V275, P1481, DOI 10.1126/science.275.5305.1481; Pasternak AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008490; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; PURI RK, 1992, CANCER RES, V52, P3787; RAYNE F, 2010, EMBO J; REISS P, 1991, J ACQ IMMUN DEF SYND, V4, P165; Remoli AL, 2006, BIOCHEM J, V396, P371, DOI 10.1042/BJ20051570; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; SASTRY KJ, 1990, J BIOL CHEM, V265, P20091; Savarino A, 1999, FASEB J, V13, P2265, DOI 10.1096/fasebj.13.15.2265; SCALA G, 1994, J EXP MED, V179, P961, DOI 10.1084/jem.179.3.961; Secchiero P, 1999, J IMMUNOL, V162, P2427; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Speiser DE, 2001, EUR J IMMUNOL, V31, P459, DOI 10.1002/1521-4141(200102)31:2<459::AID-IMMU459>3.0.CO;2-Y; Szabo S E, 2004, Lab Hematol, V10, P109, DOI 10.1532/LH96.04020; TIMOTHY W, 2010, 17 C RETR OPP INF; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Valentin A, 2002, P NATL ACAD SCI USA, V99, P7015, DOI 10.1073/pnas.102672999; vanBaalen CA, 1997, J GEN VIROL, V78, P1913, DOI 10.1099/0022-1317-78-8-1913; Volberding PA, 2010, LANCET, V376, P49, DOI 10.1016/S0140-6736(10)60676-9; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Welles SL, 1996, J INFECT DIS, V174, P696, DOI 10.1093/infdis/174.4.696; Wu YT, 2001, SCIENCE, V293, P1503, DOI 10.1126/science.1061548; Wu YT, 2003, J VIROL, V77, P10376, DOI 10.1128/JVI.77.19.10376-10382.2003; Zauli G, 1996, J IMMUNOL, V157, P2216; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002	103	75	78	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13540	10.1371/journal.pone.0013540	http://dx.doi.org/10.1371/journal.pone.0013540			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085635	Green Published, gold			2022-12-27	WOS:000284087800001
J	Shaltiel-Karyo, R; Frenkel-Pinter, M; Egoz-Matia, N; Frydman-Marom, A; Shalev, DE; Segal, D; Gazit, E				Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Egoz-Matia, Nirit; Frydman-Marom, Anat; Shalev, Deborah E.; Segal, Daniel; Gazit, Ehud			Inhibiting alpha-Synuclein Oligomerization by Stable Cell-Penetrating beta-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies	PLOS ONE			English	Article							AGGREGATION; FIBRILLIZATION; PROTEINS; PATHOGENESIS; STRATEGY; NMR	The intracellular oligomerization of alpha-synuclein is associated with Parkinson's disease and appears to be an important target for disease-modifying treatment. Yet, to date, there is no specific inhibitor for this aggregation process. Using unbiased systematic peptide array analysis, we indentified molecular interaction domains within the beta-synuclein polypeptide that specifically binds alpha-synuclein. Adding such peptide fragments to alpha-synuclein significantly reduced both amyloid fibrils and soluble oligomer formation in vitro. A retro-inverso analogue of the best peptide inhibitor was designed to develop the identified molecular recognition module into a drug candidate. While this peptide shows indistinguishable activity as compared to the native peptide, it is stable in mouse serum and penetrates alpha-synuclein over-expressing cells. The interaction interface between the D-amino acid peptide and alpha-synuclein was mapped by Nuclear Magnetic Resonance spectroscopy. Finally, administering the retro-inverso peptide to a Drosophila model expressing mutant A53T alpha-synuclein in the nervous system, resulted in a significant recovery of the behavioral abnormalities of the treated flies and in a significant reduction in alpha-synuclein accumulation in the brains of the flies. The engineered retro-inverso peptide can serve as a lead for developing a novel class of therapeutic agents to treat Parkinson's disease.	[Shaltiel-Karyo, Ronit; Frenkel-Pinter, Moran; Egoz-Matia, Nirit; Frydman-Marom, Anat; Segal, Daniel; Gazit, Ehud] Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel; [Shalev, Deborah E.] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Tel Aviv University; Hebrew University of Jerusalem	Shaltiel-Karyo, R (corresponding author), Tel Aviv Univ, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel.	vpr@tauex.tau.ac.il	Gazit, Ehud/C-3715-2011; Gazit, Ehud/M-8026-2019; Gazit, Ehud/AHE-9332-2022; Shalev, Deborah E/AAY-2873-2021	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Segal, Daniel/0000-0002-6777-505X	Israeli Science Foundation (ISF); German-Israeli Project Cooperation (DIP)	Israeli Science Foundation (ISF)(Israel Science Foundation); German-Israeli Project Cooperation (DIP)	This work was supported by funding from the Israeli Science Foundation (ISF) and the German-Israeli Project Cooperation (DIP) to UG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashe KH, 2001, LEARN MEMORY, V8, P301, DOI 10.1101/lm.43701; Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009; Biere AL, 2000, J BIOL CHEM, V275, P34574, DOI 10.1074/jbc.M005514200; Chiti F, 2002, P NATL ACAD SCI USA, V99, P16419, DOI 10.1073/pnas.212527999; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cookson MR, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-9; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; El-Agnaf OMA, 2004, FASEB J, V18, P1315, DOI 10.1096/fj.03-1346fje; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Gazit E, 2002, FASEB J, V16, P77, DOI 10.1096/fj.01-0442hyp; GRIFFEY RH, 1985, J BIOL CHEM, V260, P9734; Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701; Hashimoto M, 1999, NEUROREPORT, V10, P717, DOI 10.1097/00001756-199903170-00011; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; JENSEN PH, 1995, BIOCHEM J, V310, P91, DOI 10.1042/bj3100091; Kaytor MD, 1999, J BIOL CHEM, V274, P37507, DOI 10.1074/jbc.274.53.37507; Kessler JC, 2003, BIOCHEMISTRY-US, V42, P672, DOI 10.1021/bi020429y; Klein WL, 2001, TRENDS NEUROSCI, V24, P219, DOI 10.1016/S0166-2236(00)01749-5; KUMAR A, 1980, BIOCHEM BIOPH RES CO, V95, P1, DOI 10.1016/0006-291X(80)90695-6; Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lee HJ, 2008, INT J BIOCHEM CELL B, V40, P1835, DOI 10.1016/j.biocel.2008.01.017; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lev N, 2006, NEUROSCI LETT, V399, P27, DOI 10.1016/j.neulet.2005.09.086; Liu ML, 1998, J MAGN RESON, V132, P125, DOI 10.1006/jmre.1998.1405; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Park JY, 2003, BIOCHEMISTRY-US, V42, P3696, DOI 10.1021/bi020604a; Pawar AP, 2005, J MOL BIOL, V350, P379, DOI 10.1016/j.jmb.2005.04.016; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porat Y, 2004, BIOCHEMISTRY-US, V43, P14454, DOI 10.1021/bi048582a; Porat Y, 2003, BIOCHEMISTRY-US, V42, P10971, DOI 10.1021/bi034889i; Rochet JC, 2000, BIOCHEMISTRY-US, V39, P10619, DOI 10.1021/bi001315u; SACCHETTINI JC, 2002, THERAPEUTIC STRATEGI, P267; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Serpell LC, 2000, P NATL ACAD SCI USA, V97, P4897, DOI 10.1073/pnas.97.9.4897; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tsigelny IF, 2007, FEBS J, V274, P1862, DOI 10.1111/j.1742-4658.2007.05733.x; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2002, J BIOL CHEM, V277, P11970, DOI 10.1074/jbc.M109541200; Volles MJ, 2007, J MOL BIOL, V366, P1510, DOI 10.1016/j.jmb.2006.12.044; WAXMAN EA, 2008, BIOCH BIOPHYS ACTA; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Windisch M, 2004, J MOL NEUROSCI, V24, P155, DOI 10.1385/JMN:24:1:155; Wuthrich K, 1986, NMR PROTEINS NUCL AC	53	73	76	4	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13863	10.1371/journal.pone.0013863	http://dx.doi.org/10.1371/journal.pone.0013863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085664	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800008
J	Kress, WJ; Erickson, DL; Swenson, NG; Thompson, J; Uriarte, M; Zimmerman, JK				Kress, W. John; Erickson, David L.; Swenson, Nathan G.; Thompson, Jill; Uriarte, Maria; Zimmerman, Jess K.			Advances in the Use of DNA Barcodes to Build a Community Phylogeny for Tropical Trees in a Puerto Rican Forest Dynamics Plot	PLOS ONE			English	Article							PLANT DIVERSITY; MECHANISMS; SEQUENCES; ALIGNMENT	Background: Species number, functional traits, and phylogenetic history all contribute to characterizing the biological diversity in plant communities. The phylogenetic component of diversity has been particularly difficult to quantify in species-rich tropical tree assemblages. The compilation of previously published (and often incomplete) data on evolutionary relationships of species into a composite phylogeny of the taxa in a forest, through such programs as Phylomatic, has proven useful in building community phylogenies although often of limited resolution. Recently, DNA barcodes have been used to construct a robust community phylogeny for nearly 300 tree species in a forest dynamics plot in Panama using a supermatrix method. In that study sequence data from three barcode loci were used to generate a well-resolved species-level phylogeny. Methodology/Principal Findings: Here we expand upon this earlier investigation and present results on the use of a phylogenetic constraint tree to generate a community phylogeny for a diverse, tropical forest dynamics plot in Puerto Rico. This enhanced method of phylogenetic reconstruction insures the congruence of the barcode phylogeny with broadly accepted hypotheses on the phylogeny of flowering plants (i.e., APG III) regardless of the number and taxonomic breadth of the taxa sampled. We also compare maximum parsimony versus maximum likelihood estimates of community phylogenetic relationships as well as evaluate the effectiveness of one-versus two-versus three-gene barcodes in resolving community evolutionary history. Conclusions/Significance: As first demonstrated in the Panamanian forest dynamics plot, the results for the Puerto Rican plot illustrate that highly resolved phylogenies derived from DNA barcode sequence data combined with a constraint tree based on APG III are particularly useful in comparative analysis of phylogenetic diversity and will enhance research on the interface between community ecology and evolution.	[Kress, W. John; Erickson, David L.] Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA; [Swenson, Nathan G.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Thompson, Jill; Zimmerman, Jess K.] Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA; [Uriarte, Maria] Columbia Univ, New York, NY USA	Smithsonian Institution; Smithsonian National Museum of Natural History; Michigan State University; University of Puerto Rico; University of Puerto Rico Rio Piedras; Columbia University	Kress, WJ (corresponding author), Smithsonian Inst, Natl Museum Nat Hist, Dept Bot, Washington, DC 20560 USA.	kressj@si.edu	Swenson, Nathan/A-3514-2012; Thompson, Jill/K-2200-2012; Uriarte, Maria/L-8944-2013	Swenson, Nathan/0000-0003-3819-9767; Thompson, Jill/0000-0002-4370-2593; 	Center for Tropical Forest Science; Smithsonian Institution Global Earth Observatories; U.S. Forest Service; University of Puerto Rico; National Science Foundation [DEB-0516066, DEB-0218039, DEB-0620910]; Mellon Foundation; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Institution Global Earth Observatories; U.S. Forest Service(United States Department of Agriculture (USDA)United States Forest Service); University of Puerto Rico; National Science Foundation(National Science Foundation (NSF)); Mellon Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the Center for Tropical Forest Science, the Smithsonian Institution Global Earth Observatories, the U.S. Forest Service, the University of Puerto Rico, the National Science Foundation (DEB-0516066, DEB-0218039 and DEB-0620910), and the Mellon Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bininda-Emonds ORP, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-156; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carolan JC, 2006, ANN BOT-LONDON, V98, P141, DOI 10.1093/aob/mcl079; Cavender-Bares J, 2009, ECOL LETT, V12, P693, DOI 10.1111/j.1461-0248.2009.01314.x; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; Dick CW, 2009, BIOSCIENCE, V59, P745, DOI 10.1525/bio.2009.59.9.6; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ewel J.J., 1973, ITF18 US FOR SERV; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gonzalez MA, 2010, J ECOL, V98, P137, DOI 10.1111/j.1365-2745.2009.01607.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hubbell Stephen P., 2001, V32, pi; Kembel SW, 2006, ECOLOGY, V87, pS86, DOI 10.1890/0012-9658(2006)87[86:TPSOAN]2.0.CO;2; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Losos EC, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P3; Maddison D.R., 2007, MESQUITE 2 MODULAR S; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Swenson NG, 2009, ECOLOGY, V90, P2161, DOI 10.1890/08-1025.1; Swenson NG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004390; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Thompson J, 2002, ECOL APPL, V12, P1344, DOI 10.1890/1051-0761(2002)012[1344:LUHEAT]2.0.CO;2; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809	32	110	123	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15409	10.1371/journal.pone.0015409	http://dx.doi.org/10.1371/journal.pone.0015409			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085700	Green Published, gold			2022-12-27	WOS:000284035900028
J	Panza, G; Luers, L; Stohr, J; Nagel-Steger, L; Weiss, J; Riesner, D; Willbold, D; Birkmann, E				Panza, Giannantonio; Luers, Lars; Stoehr, Jan; Nagel-Steger, Luitgard; Weiss, Juergen; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva			Molecular Interactions between Prions as Seeds and Recombinant Prion Proteins as Substrates Resemble the Biological Interspecies Barrier In Vitro	PLOS ONE			English	Article							MAMMALIAN PRIONS; SCRAPIE; CONVERSION; DISEASE; PRPSC; BSE; MECHANISMS; STRAINS; PATHWAY; FORM	Prion diseases like Creutzfeldt-Jakob disease in humans, Scrapie in sheep or bovine spongiform encephalopathy are fatal neurodegenerative diseases, which can be of sporadic, genetic, or infectious origin. Prion diseases are transmissible between different species, however, with a variable species barrier. The key event of prion amplification is the conversion of the cellular isoform of the prion protein (PrPC) into the pathogenic isoform (PrPSc). We developed a sodiumdodecylsulfate-based PrP conversion system that induces amyloid fibril formation from soluble alpha-helical structured recombinant PrP (recPrP). This approach was extended applying pre-purified PrPSc as seeds which accelerate fibrillization of recPrP. In the present study we investigated the interspecies coherence of prion disease. Therefore we used PrPSc from different species like Syrian hamster, cattle, mouse and sheep and seeded fibrillization of recPrP from the same or other species to mimic in vitro the natural species barrier. We could show that the in vitro system of seeded fibrillization is in accordance with what is known from the naturally occurring species barriers.	[Panza, Giannantonio; Luers, Lars; Stoehr, Jan; Nagel-Steger, Luitgard; Riesner, Detlev; Willbold, Dieter; Birkmann, Eva] Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany; [Weiss, Juergen] Deutsch Diabet Zentrum, Inst Klin Biochem & Pathobiochem, Dusseldorf, Germany; [Willbold, Dieter; Birkmann, Eva] Forschungszentrum Julich, Inst Strukturbiol & Biophys 3, D-52425 Julich, Germany	Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Helmholtz Association; Research Center Julich	Panza, G (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-4000 Dusseldorf, Germany.	e.birkmann@fz-juelich.de	Nagel-Steger, Luitgard/H-6415-2013; Stöhr, Jan/A-9638-2009; Birkmann, Eva/H-6019-2013; Willbold, Dieter/A-6280-2013	Nagel-Steger, Luitgard/0000-0001-5232-2149; Stöhr, Jan/0000-0003-2610-7458; Birkmann, Eva/0000-0002-2069-0630; Willbold, Dieter/0000-0002-0065-7366	European Union [FOOD-CT-2004-506579]; Presidentenfond der Helmholtzgemeinschaft (HGF, "Virtual Institute of Structural Biology"); Food Standards Agency UK [M03R0005/004]; Deutsche Forschungsgemeinschaft (DFG)	European Union(European Commission); Presidentenfond der Helmholtzgemeinschaft (HGF, "Virtual Institute of Structural Biology"); Food Standards Agency UK; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This authors were funded by the European Union: (Network of Excellence "NeuroPrion", FOOD-CT-2004-506579, http://www.neuroprion.org/en/index. html); "Presidentenfond der Helmholtzgemeinschaft" (HGF, "Virtual Institute of Structural Biology"), http://www.vibs-rhine-ruhr.org/; and Food Standards Agency UK (M03R0005/004) http://www.food.gov.uk/. Lars Luers was a fellow of the Graduiertenkolleg 1033. Jan Stohr was supported by a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atarashi R, 2007, NAT METHODS, V4, P645, DOI 10.1038/NMETH1066; Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Beringue V, 2008, VET RES, V39, DOI 10.1051/vetres:2008024; Birkmann E, 2006, BIOL CHEM, V387, P95, DOI 10.1515/BC.2006.013; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; COHEN FE, 1994, SCIENCE, V264, P530, DOI 10.1126/science.7909169; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Colby DW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000736; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Eigen M, 1996, BIOPHYS CHEM, V63, pA1, DOI 10.1016/S0301-4622(96)02250-8; Geoghegan JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000535; Green KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000139; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; Jansen K, 2001, BIOL CHEM, V382, P683, DOI 10.1515/BC.2001.081; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Laurent M, 1997, FEBS LETT, V407, P1, DOI 10.1016/S0014-5793(97)00310-4; Leffers KW, 2005, BIOL CHEM, V386, P569, DOI 10.1515/BC.2005.067; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Li L, 2007, BIOCHEM BIOPH RES CO, V364, P796, DOI 10.1016/j.bbrc.2007.10.087; Mehlhorn I, 1996, BIOCHEMISTRY-US, V35, P5528, DOI 10.1021/bi952965e; Panza G, 2008, BIOCHEM BIOPH RES CO, V373, P493, DOI 10.1016/j.bbrc.2008.06.059; Raymond GJ, 1997, NATURE, V388, P285, DOI 10.1038/40876; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Safar J, 1998, NAT MED, V4, P1157, DOI 10.1038/2654; Stohr J, 2008, P NATL ACAD SCI USA, V105, P2409, DOI 10.1073/pnas.0712036105; Vanik DL, 2004, MOL CELL, V14, P139, DOI 10.1016/S1097-2765(04)00155-8; Watts JC, 2006, PLOS PATHOG, V2, P152, DOI 10.1371/journal.ppat.0020026; Wells GAH, 1991, BRAIN PATHOL, V1, P69, DOI 10.1111/j.1750-3639.1991.tb00642.x; Wong C, 2001, EMBO J, V20, P377, DOI 10.1093/emboj/20.3.377	31	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14283	10.1371/journal.pone.0014283	http://dx.doi.org/10.1371/journal.pone.0014283			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151607	Green Published, gold			2022-12-27	WOS:000285135800013
J	Shimazawa, M; Tanaka, H; Ito, Y; Morimoto, N; Tsuruma, K; Kadokura, M; Tamura, S; Inoue, T; Yamada, M; Takahashi, H; Warita, H; Aoki, M; Hara, H				Shimazawa, Masamitsu; Tanaka, Hirotaka; Ito, Yasushi; Morimoto, Nobutaka; Tsuruma, Kazuhiro; Kadokura, Michinori; Tamura, Shigeki; Inoue, Teruyoshi; Yamada, Mitsunori; Takahashi, Hitoshi; Warita, Hitoshi; Aoki, Masashi; Hara, Hideaki			An Inducer of VGF Protects Cells against ER Stress-Induced Cell Death and Prolongs Survival in the Mutant SOD1 Animal Models of Familial ALS	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ENDOPLASMIC-RETICULUM STRESS; TRANSGENIC MOUSE MODEL; MOTOR-NEURON DISEASE; CSF BIOMARKERS; GENE VGF; PEPTIDE; INDUCTION; PATHWAYS; BRAIN	Amyotrophic lateral sclerosis (ALS) is the most frequent adult-onset motor neuron disease, and recent evidence has suggested that endoplasmic reticulum (ER) stress signaling is involved in the pathogenesis of ALS. Here we identified a small molecule, SUN N8075, which has a marked protective effect on ER stress-induced cell death, in an in vitro cell-based screening, and its protective mechanism was mediated by an induction of VGF nerve growth factor inducible (VGF): VGF knockdown with siRNA completely abolished the protective effect of SUN N8075 against ER-induced cell death, and overexpression of VGF inhibited ER-stress-induced cell death. VGF level was lower in the spinal cords of sporadic ALS patients than in the control patients. Furthermore, SUN N8075 slowed disease progression and prolonged survival in mutant SOD1 transgenic mouse and rat models of ALS, preventing the decrease of VGF expression in the spinal cords of ALS mice. These data suggest that VGF plays a critical role in motor neuron survival and may be a potential new therapeutic target for ALS, and SUN N8075 may become a potential therapeutic candidate for treatment of ALS.	[Shimazawa, Masamitsu; Tanaka, Hirotaka; Ito, Yasushi; Morimoto, Nobutaka; Tsuruma, Kazuhiro; Hara, Hideaki] Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan; [Kadokura, Michinori; Tamura, Shigeki; Inoue, Teruyoshi] Asubio Pharma Co Ltd, Biomed Res Labs, Osaka, Japan; [Yamada, Mitsunori] Saigata Natl Hosp, Natl Hosp Org, Dept Clin Res, Niigata, Japan; [Takahashi, Hitoshi] Niigata Univ, Brain Res Inst, Dept Pathol, Niigata, Japan; [Warita, Hitoshi; Aoki, Masashi] Tohoku Univ, Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	Gifu Pharmaceutical University; Asubio Pharma Co., Ltd.; Niigata University; Tohoku University	Shimazawa, M (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Warita, Hitoshi/T-1970-2019	Warita, Hitoshi/0000-0001-7934-3863; INOUE, TERUYOSHI/0000-0002-1785-6062	Japanese Ministry of Health Labor and Welfare; Takeda Science Foundation	Japanese Ministry of Health Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported in part by the Japanese Ministry of Health Labor and Welfare and Takeda Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alder J, 2003, J NEUROSCI, V23, P10800; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Annoura H, 2000, J MED CHEM, V43, P3372, DOI 10.1021/jm000143w; Atkin JD, 2008, NEUROBIOL DIS, V30, P400, DOI 10.1016/j.nbd.2008.02.009; Atkin JD, 2006, J BIOL CHEM, V281, P30152, DOI 10.1074/jbc.M603393200; Bartolomucci A, 2006, P NATL ACAD SCI USA, V103, P14584, DOI 10.1073/pnas.0606102103; Bozdagi O, 2008, J NEUROSCI, V28, P9857, DOI 10.1523/JNEUROSCI.3145-08.2008; Chiba T, 2006, BIOCHEM BIOPH RES CO, V343, P793, DOI 10.1016/j.bbrc.2006.02.184; Gething MJ, 1999, SEMIN CELL DEV BIOL, V10, P465, DOI 10.1006/scdb.1999.0318; Goodall Emily F., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010854; Gurney ME, 1997, J NEUROL SCI, V152, pS67, DOI 10.1016/S0022-510X(97)00247-5; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; HAWLEY RJ, 1992, J NEUROSCI, V12, P2573; Hitomi J, 2004, NEUROSCI LETT, V357, P127, DOI 10.1016/j.neulet.2003.12.080; Hu P, 2004, J BIOL CHEM, V279, P49420, DOI 10.1074/jbc.M407700200; Hunsberger JG, 2007, NAT MED, V13, P1476, DOI 10.1038/nm1669; Ilieva EV, 2007, BRAIN, V130, P3111, DOI 10.1093/brain/awm190; Jiang YH, 2004, BMC CANCER, V4, DOI 10.1186/1471-2407-4-70; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kleizen B, 2004, CURR OPIN CELL BIOL, V16, P343, DOI 10.1016/j.ceb.2004.06.012; Levi A, 2004, CELL MOL NEUROBIOL, V24, P517, DOI 10.1023/B:CEMN.0000023627.79947.22; LIU JW, 1994, ENDOCRINOLOGY, V135, P2742, DOI 10.1210/en.135.6.2742; Maruyama W, 2002, NEUROTOXICOL TERATOL, V24, P675, DOI 10.1016/S0892-0362(02)00221-0; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagata T, 2007, NEUROL RES, V29, P767, DOI 10.1179/016164107X229803; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; PIORO EP, 1995, CLIN NEUROSCI, V3, P375; POSSENTI R, 1989, EMBO J, V8, P2217, DOI 10.1002/j.1460-2075.1989.tb08345.x; Ruetschi U, 2005, EXP NEUROL, V196, P273, DOI 10.1016/j.expneurol.2005.08.002; Salton SRJ, 2000, FRONT NEUROENDOCRIN, V21, P199, DOI 10.1006/frne.2000.0199; Sasaki S, 2007, J NEUROPATH EXP NEUR, V66, P517, DOI 10.1097/01.jnen.0000263868.84188.3b; Severini C, 2008, J NEUROCHEM, V104, P534, DOI 10.1111/j.1471-4159.2007.05068.x; Succu S, 2005, NEUROPHARMACOLOGY, V49, P1017, DOI 10.1016/j.neuropharm.2005.05.015; Sun W, 2002, J NEUROSCI, V22, P6537; Thakker-Varia S, 2007, J NEUROSCI, V27, P12156, DOI 10.1523/JNEUROSCI.1898-07.2007; Trani E, 2002, J NEUROCHEM, V81, P565, DOI 10.1046/j.1471-4159.2002.00842.x; Wootz H, 2004, BIOCHEM BIOPH RES CO, V322, P281, DOI 10.1016/j.bbrc.2004.07.118; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhao Zhong, 2008, Int J Med Sci, V5, P92	41	44	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15307	10.1371/journal.pone.0015307	http://dx.doi.org/10.1371/journal.pone.0015307			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151573	Green Submitted, Green Published, gold			2022-12-27	WOS:000285135800024
J	Kilpinen, S; Ojala, K; Kallioniemi, O				Kilpinen, Sami; Ojala, Kalle; Kallioniemi, Olli			Analysis of Kinase Gene Expression Patterns across 5681 Human Tissue Samples Reveals Functional Genomic Taxonomy of the Kinome	PLOS ONE			English	Article							VACCINIA-RELATED KINASE-1; PROTEIN-KINASE; MICROARRAY PLATFORMS; MAMMALIAN-CELLS; BREAST-CANCER; DIFFERENTIATION; CHECKPOINT; REGULATORS; ARRAYS; P53	Kinases play key roles in cell signaling and represent major targets for drug development, but the regulation of their activation and their associations with health and disease have not been systematically analyzed. Here, we carried out a bioinformatic analysis of the expression levels of 459 human kinase genes in 5681 samples consisting of 44 healthy and 55 malignant human tissues. Defining the tissues where the kinase genes were transcriptionally active led to a functional genomic taxonomy of the kinome and a classification of human tissues and disease types based on the similarity of their kinome gene expression. The co-expression network around each of the kinase genes was defined in order to determine the functional context, i.e. the biological processes that were active in the cells and tissues where the kinase gene was expressed. Strong associations for individual kinases were found for mitosis (69 genes, including AURKA and BUB1), cell cycle control (73 genes, including PLK1 and AURKB), DNA repair (49 genes, including CHEK1 and ATR), immune response (72 genes, including MATK), neuronal (131 genes, including PRKCE) and muscular (72 genes, including MYLK2) functions. We then analyzed which kinase genes gain or lose transcriptional activity in the development of prostate and lung cancers and elucidated the functional associations of individual cancer associated kinase genes. In summary, we report here a systematic classification of kinases based on the bioinformatic analysis of their expression in human tissues and diseases, as well as grouping of tissues and tumor types according to the similarity of their kinome transcription.	[Kilpinen, Sami; Ojala, Kalle; Kallioniemi, Olli] Univ Helsinki, FIMM, Helsinki, Finland	University of Helsinki	Kilpinen, S (corresponding author), Univ Helsinki, FIMM, Helsinki, Finland.	sami.k.kilpinen@helsinki.fi	Kallioniemi, Olli P/H-5111-2011	Kallioniemi, Olli P/0000-0002-3231-0332; Kilpinen, Sami/0000-0003-3444-2539	Academy of Finland (Centres of Excellence) [213502]; Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University	Academy of Finland (Centres of Excellence)(Academy of Finland); Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University	Academy of Finland (Centres of Excellence funding no. 213502) Cancer Organizations of Finland Sigdrid Juselius Foundation Cancer Organizations of Finland Helsinki University funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed E, 2009, FUTURE ONCOL, V5, P779, DOI [10.2217/fon.09.55, 10.2217/FON.09.55]; Aiuti A, 1998, EXP HEMATOL, V26, P143; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Autio R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S24; Bailey KM, 2008, J BIOL CHEM, V283, P13714, DOI 10.1074/jbc.M709329200; BAKER J, EXP CELL RES, P1856; Brazma A, 2003, NUCLEIC ACIDS RES, V31, P68, DOI 10.1093/nar/gkg091; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Byrne GJ, 2000, J NATL CANCER I, V92, P1329, DOI 10.1093/jnci/92.16.1329; Chan GKT, 1999, J CELL BIOL, V146, P941, DOI 10.1083/jcb.146.5.941; Chan YW, 2009, J CELL BIOL, V185, P859, DOI 10.1083/jcb.200812167; de Carcer G, 2007, CURR MED CHEM, V14, P969, DOI 10.2174/092986707780362925; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Elo LL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni193; Enders GH, 2008, J BIOL CHEM, V283, P17749, DOI 10.1074/jbc.R800021200; Eusebi V, 2000, AM J SURG PATHOL, V24, P223, DOI 10.1097/00000478-200002000-00008; Finetti P, 2008, CANCER RES, V68, P767, DOI 10.1158/0008-5472.CAN-07-5516; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Fry AM, 1998, EMBO J, V17, P470, DOI 10.1093/emboj/17.2.470; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gaudet S, 2000, P NATL ACAD SCI USA, V97, P5167, DOI 10.1073/pnas.090102397; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hallstrom TMKA, 2008, PROSTATE, V68, P902, DOI 10.1002/pros.20746; Hendriks BS, 2005, J BIOL CHEM, V280, P6157, DOI 10.1074/jbc.M410491200; Houreih MA, 2009, INT J SURG PATHOL, V17, P135, DOI 10.1177/1066896908319444; Hu PZ, 2007, NAT REV CANCER, V7, P23, DOI 10.1038/nrc2036; Huang YF, 2009, MOL CELL BIOL, V29, P2935, DOI 10.1128/MCB.01837-08; Hwang KB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-159; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Irizarry RA, 2005, NAT METHODS, V2, P477, DOI 10.1038/nmeth0605-477b; Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004; Jenssen TK, 2001, NAT GENET, V28, P21, DOI 10.1038/88213; Johnson SA, 2005, NAT METHODS, V2, P17, DOI 10.1038/NMETH731; Kalejs M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-4; Kang TH, 2007, MOL CELL BIOL, V27, P8533, DOI 10.1128/MCB.00018-07; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Klebig C, 2009, J CELL BIOL, V185, P841, DOI 10.1083/jcb.200902128; Kunitoku N, 2003, DEV CELL, V5, P853, DOI 10.1016/S1534-5807(03)00364-2; Lacroix M, 2006, ENDOCR-RELAT CANCER, V13, P1033, DOI 10.1677/ERC-06-0001; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Lee BC, 2006, BLOOD, V108, P904, DOI 10.1182/blood-2005-12-4885; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lenz Heinz-Josef, 2006, Oncology (Williston Park), V20, P5; Li JX, 2004, BIOCHEM GENET, V42, P129, DOI 10.1023/B:BIGI.0000020468.96238.54; Liu LL, 2005, MOL CELLS, V19, P39; Liu Y, 2004, J BIOL CHEM, V279, P4507, DOI 10.1074/jbc.M309995200; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Marshall E, 2004, SCIENCE, V306, P630, DOI 10.1126/science.306.5696.630; Martinez-Lara I, 1996, Acta Stomatol Belg, V93, P29; McLean LA, 2004, CLIN CANCER RES, V10, P155, DOI 10.1158/1078-0432.CCR-0784-3; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; O'Regan L, 2009, MOL CELL BIOL, V29, P3975, DOI 10.1128/MCB.01867-08; OHISHI T, 2001, CANCER RES, V70, P2041; Petros TJ, 2006, MOL CELL NEUROSCI, V32, P49, DOI 10.1016/j.mcn.2006.02.002; PHILIPPE E, 1986, DEV BRAIN RES, V27, P275, DOI 10.1016/0165-3806(86)90255-5; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Radzikowska E, 2003, EUR RESPIR J, V21, P552, DOI 10.1183/09031936.03.00035502; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; SCHLUTER C, 1993, J CELL BIOL, V123, P513, DOI 10.1083/jcb.123.3.513; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Serova M, 2006, SEMIN ONCOL, V33, P466, DOI 10.1053/j.seminoncol.2006.04.009; Shmulevich I, 2002, BIOINFORMATICS, V18, P555, DOI 10.1093/bioinformatics/18.4.555; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; TAIRA M, 2005, J ORAL TISSUE ENG, V3, P25; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Wall SJ, 2005, J BIOL CHEM, V280, P40187, DOI 10.1074/jbc.M508226200; Widakowich C, 2007, ONCOLOGIST, V12, P1443, DOI 10.1634/theoncologist.12-12-1443; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wood Kenneth W., 2001, Current Opinion in Pharmacology, V1, P370, DOI 10.1016/S1471-4892(01)00064-9; Zeidman R, 2002, MOL BIOL CELL, V13, P12, DOI 10.1091/mbc.01-04-0210; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102; [No title captured]	82	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15068	10.1371/journal.pone.0015068	http://dx.doi.org/10.1371/journal.pone.0015068			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151926	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600023
J	Pancione, M; Sabatino, L; Fucci, A; Carafa, V; Nebbioso, A; Forte, N; Febbraro, A; Parente, D; Ambrosino, C; Normanno, N; Altucci, L; Colantuoni, V				Pancione, Massimo; Sabatino, Lina; Fucci, Alessandra; Carafa, Vincenzo; Nebbioso, Angela; Forte, Nicola; Febbraro, Antonio; Parente, Domenico; Ambrosino, Concetta; Normanno, Nicola; Altucci, Lucia; Colantuoni, Vittorio			Epigenetic Silencing of Peroxisome Proliferator-Activated Receptor gamma Is a Biomarker for Colorectal Cancer Progression and Adverse Patients' Outcome	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; HISTONE DEACETYLASE; PPAR-GAMMA; NUCLEAR RECEPTORS; GENE; EXPRESSION	The relationship between peroxisome proliferator-activated receptor gamma (PPARG) expression and epigenetic changes occurring in colorectal-cancer pathogenesis is largely unknown. We investigated whether PPARG is epigenetically regulated in colorectal cancer (CRC) progression. PPARG expression was assessed in CRC tissues and paired normal mucosa by western blot and immunohistochemistry and related to patients' clinicopathological parameters and survival. PPARG promoter methylation was analyzed by methylation-specific-PCR and bisulphite sequencing. PPARG expression and promoter methylation were similarly examined also in CRC derived cell lines. Chromatin immunoprecipitation in basal conditions and after epigenetic treatment was performed along with knocking-down experiments of putative regulatory factors. Gene expression was monitored by immunoblotting and functional assays of cell proliferation and invasiveness. Methylation on a specific region of the promoter is strongly correlated with PPARG lack of expression in 30% of primary CRCs and with patients' poor prognosis. Remarkably, the same methylation pattern is found in PPARG-negative CRC cell lines. Epigenetic treatment with 5'-aza-2'-deoxycytidine can revert this condition and, in combination with trichostatin A, dramatically reactivates gene transcription and receptor activity. Transcriptional silencing is due to the recruitment of MeCP2, HDAC1 and EZH2 that impart repressive chromatin signatures determining an increased cell proliferative and invasive potential, features that can experimentally be reverted. Our findings provide a novel mechanistic insight into epigenetic silencing of PPARG in CRC that may be relevant as a prognostic marker of tumor progression.	[Pancione, Massimo; Sabatino, Lina; Fucci, Alessandra; Ambrosino, Concetta; Colantuoni, Vittorio] Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy; [Carafa, Vincenzo; Nebbioso, Angela; Altucci, Lucia] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Altucci, Lucia] CNR IGB, Naples, Italy; [Forte, Nicola; Febbraro, Antonio; Parente, Domenico] Fatebenefratelli Hosp, Dept Med Oncol, Benevento, Italy; [Forte, Nicola; Febbraro, Antonio; Parente, Domenico] Fatebenefratelli Hosp, Dept Clin Pathol, Benevento, Italy; [Ambrosino, Concetta; Colantuoni, Vittorio] Biogem G Salvatore Genet Res Inst, Ariano Irpino, Italy; [Normanno, Nicola] Oncol Res Ctr, Pharmacogen Lab, Mercogliano, Italy	University of Sannio; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR)	Pancione, M (corresponding author), Univ Sannio, Dept Biol & Environm Sci, Benevento, Italy.	colantuoni@unisannio.it	NEBBIOSO, ANGELA/GVS-1294-2022; Pancione, Massimo/AAF-2109-2019; Altucci, Lucia/S-8031-2019; Normanno, Nicola/AAT-1107-2021; ambrosino, concetta/AAB-3452-2019; NEBBIOSO, Angela/C-3566-2016	altucci, lucia/0000-0002-7312-5387; NEBBIOSO, Angela/0000-0001-5374-3527; carafa, vincenzo/0000-0002-8025-3758; Sabatino, Lina/0000-0001-5341-7430; Normanno, Nicola/0000-0002-7158-2605; PANCIONE, Massimo/0000-0003-1728-8816	AIRC (Associazione Italiana per la Ricerca sul Cancro); EU	AIRC (Associazione Italiana per la Ricerca sul Cancro)(Fondazione AIRC per la ricerca sul cancro); EU(European Commission)	This work is supported by grants from AIRC (Associazione Italiana per la Ricerca sul Cancro) to V.C. and L.A.; EU project to L.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barz T, 2006, CANCER RES, V66, P11975, DOI 10.1158/0008-5472.CAN-06-1529; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Capaccio D, 2010, BBA-MOL BASIS DIS, V1802, P572, DOI 10.1016/j.bbadis.2010.01.012; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528; Fujiki K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-38; Gemma C, 2009, OBESITY, V17, P1032, DOI 10.1038/oby.2008.605; Girnun G, 2009, GASTROENTEROLOGY, V136, P1157, DOI 10.1053/j.gastro.2009.02.022; Girnun GD, 2007, CANCER CELL, V11, P395, DOI 10.1016/j.ccr.2007.02.025; Hite KC, 2009, BIOCHEM CELL BIOL, V87, P219, DOI 10.1139/O08-115; Ikezoe T, 2001, CANCER RES, V61, P5307; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Knouff C, 2004, ENDOCR REV, V25, P899, DOI 10.1210/er.2003-0036; Koyama M, 2010, CLIN CANCER RES, V16, P2320, DOI 10.1158/1078-0432.CCR-09-2301; Mann J, 2010, GASTROENTEROLOGY, V138, P705, DOI 10.1053/j.gastro.2009.10.002; Martens JHA, 2010, CANCER CELL, V17, P173, DOI 10.1016/j.ccr.2009.12.042; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Ogino S, 2007, J MOL DIAGN, V9, P305, DOI 10.2353/jmoldx.2007.060170; Ogino S, 2009, GASTROENTEROLOGY, V136, P1242, DOI 10.1053/j.gastro.2008.12.048; Pancione M, 2010, HUM PATHOL, V41, P867, DOI 10.1016/j.humpath.2009.09.019; Pancione M, 2009, HUM PATHOL, V40, P714, DOI 10.1016/j.humpath.2008.08.019; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; Sarraf P, 1999, MOL CELL, V3, P799, DOI 10.1016/S1097-2765(01)80012-5; Suzuki H, 2002, NAT GENET, V31, P141, DOI 10.1038/ng892; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074	31	59	62	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14229	10.1371/journal.pone.0014229	http://dx.doi.org/10.1371/journal.pone.0014229			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151932	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600021
J	Thysell, E; Surowiec, I; Hornberg, E; Crnalic, S; Widmark, A; Johansson, AI; Stattin, P; Bergh, A; Moritz, T; Antti, H; Wikstro, P				Thysell, Elin; Surowiec, Izabella; Hornberg, Emma; Crnalic, Sead; Widmark, Anders; Johansson, Annika I.; Stattin, Paer; Bergh, Anders; Moritz, Thomas; Antti, Henrik; Wikstro, Pernilla			Metabolomic Characterization of Human Prostate Cancer Bone Metastases Reveals Increased Levels of Cholesterol	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; LOWERING DRUGS; LINOLEIC-ACID; SCID MICE; IN-VITRO; RISK; CELLS; SPECTROMETRY; GROWTH; GC/MS	Background: Metastasis to the bone is one clinically important features of prostate cancer (PCa). Current diagnostic methods cannot predict metastatic PCa at a curable stage of the disease. Identification of metabolic pathways involved in the growth of bone metastases therefore has the potential to improve PCa prognostication as well as therapy. Methodology/Principal Findings: Metabolomics was applied for the study of PCa bone metastases (n = 20) in comparison with corresponding normal bone (n = 14), and furthermore of malignant (n = 13) and benign (n = 17) prostate tissue and corresponding plasma samples obtained from patients with (n = 15) and without (n = 13) diagnosed metastases and from men with benign prostate disease (n = 30). This was done using gas chromatography-mass spectrometry for sample characterization, and chemometric bioinformatics for data analysis. Results were verified in a separate test set including metastatic and normal bone tissue from patients with other cancers (n = 7). Significant differences were found between PCa bone metastases, bone metastases of other cancers, and normal bone. Furthermore, we identified metabolites in primary tumor tissue and in plasma which were significantly associated with metastatic disease. Among the metabolites in PCa bone metastases especially cholesterol was noted. In a test set the mean cholesterol level in PCa bone metastases was 127.30 mg/g as compared to 81.06 and 35.85 mg/g in bone metastases of different origin and normal bone, respectively (P = 0.0002 and 0.001). Immunohistochemical staining of PCa bone metastases showed intense staining of the low density lipoprotein receptor and variable levels of the scavenger receptor class B type 1 and 3-hydroxy-3-methylglutaryl-coenzyme reductase in tumor epithelial cells, indicating possibilities for influx and de novo synthesis of cholesterol. Conclusions/Significance: We have identified metabolites associated with PCa metastasis and specifically identified high levels of cholesterol in PCa bone metastases. Based on our findings and the previous literature, this makes cholesterol a possible therapeutic target for advanced PCa.	[Thysell, Elin; Surowiec, Izabella; Antti, Henrik] Umea Univ, Dept Chem, Umea, Sweden; [Hornberg, Emma; Bergh, Anders; Wikstro, Pernilla] Umea Univ, Dept Med Biosci, Umea, Sweden; [Crnalic, Sead; Stattin, Paer] Umea Univ, Dept Pathol Surg & Perioperat Sci, Umea, Sweden; [Widmark, Anders] Umea Univ, Dept Urol & Androl & Orthoped & Radiat Sci, Umea, Sweden; [Johansson, Annika I.; Moritz, Thomas] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden	Umea University; Umea University; Umea University; Umea University; Swedish University of Agricultural Sciences; Umea University	Thysell, E (corresponding author), Umea Univ, Dept Chem, Umea, Sweden.	henrik.antti@chem.umu.se; pernilla.wikstrom@medbio.umu.se	Crnalic, Sead/AAF-3475-2021	Moritz, Thomas/0000-0002-4258-3190; Johansson, Annika/0000-0001-5000-1288	Swedish Cancer Society; Swedish Research Council; Lions Cancer Research foundation; KEMPE foundation; Knut and Alice Wallenberg foundation; Northern Sweden Cancer Foundation	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Research foundation; KEMPE foundation; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Northern Sweden Cancer Foundation	Grant support: the Swedish Cancer Society, the Swedish Research Council, the Lions Cancer Research foundation, KEMPE foundation, Knut and Alice Wallenberg foundation, and the Northern Sweden Cancer Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A J, 2005, ANAL CHEM, V77, P8086, DOI 10.1021/ac051211v; Ali AS, 2009, CANCER TREAT REV, V35, P1, DOI 10.1016/j.ctrv.2008.07.006; Awad AB, 2001, EUR J CANCER PREV, V10, P507, DOI 10.1097/00008469-200112000-00005; Bravi F, 2006, UROLOGY, V67, P1205, DOI 10.1016/j.urology.2006.01.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Catalona WJ, 1998, JAMA-J AM MED ASSOC, V279, P1542, DOI 10.1001/jama.279.19.1542; Cesano A, 1998, ANTICANCER RES, V18, P1429; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; CONNOLLY JM, 1992, PROSTATE, V20, P151, DOI 10.1002/pros.2990200210; Cook LS, 1999, J UROLOGY, V161, P152, DOI 10.1016/S0022-5347(01)62086-X; CORNEL EB, 1993, J UROLOGY, V150, P2019, DOI 10.1016/S0022-5347(17)35957-8; CRNALIC S, ENDOCRINE; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Denkert C, 2006, CANCER RES, V66, P10795, DOI 10.1158/0008-5472.CAN-06-0755; Denkert C, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-72; Dillard PR, 2008, MOL CELL ENDOCRINOL, V295, P115, DOI 10.1016/j.mce.2008.08.013; Flick ED, 2007, CANCER EPIDEM BIOMAR, V16, P2218, DOI 10.1158/1055-9965.EPI-07-0197; FOWLER AH, 1992, MAGN RESON MED, V25, P140, DOI 10.1002/mrm.1910250114; Heemers HV, 2006, MOL ENDOCRINOL, V20, P2265, DOI 10.1210/me.2005-0479; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Issaq HJ, 2008, J UROLOGY, V179, P2422, DOI 10.1016/j.juro.2008.01.084; Jacobs EJ, 2007, CANCER EPIDEM BIOMAR, V16, P2213, DOI 10.1158/1055-9965.EPI-07-0448; Jonsson P, 2005, ANAL CHEM, V77, P5635, DOI 10.1021/ac050601e; Jonsson P, 2006, J PROTEOME RES, V5, P1407, DOI 10.1021/pr0600071; Klotz Laurence, 2006, Curr Treat Options Oncol, V7, P355, DOI 10.1007/s11864-006-0003-z; KURHANEWICZ J, 1993, MAGN RESON MED, V29, P149, DOI 10.1002/mrm.1910290202; Lopergolo A, 2009, CANCER-AM CANCER SOC, V115, P3058, DOI 10.1002/cncr.24346; Magura L, 2008, CANCER CAUSE CONTROL, V19, P1259, DOI 10.1007/s10552-008-9197-7; Montgomery RB, 2008, CANCER RES, V68, P4447, DOI 10.1158/0008-5472.CAN-08-0249; Murtola TJ, 2007, CANCER EPIDEM BIOMAR, V16, P2226, DOI 10.1158/1055-9965.EPI-07-0599; *NIST, NIST MS SEARCH US GU; Parekh DJ, 2007, J UROLOGY, V178, P2252, DOI 10.1016/j.juro.2007.08.055; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Platz EA, 2009, CANCER EPIDEM BIOMAR, V18, P2807, DOI 10.1158/1055-9965.EPI-09-0472; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Schaffner C P, 1981, Prog Clin Biol Res, V75A, P279; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Sivaprasad U, 2006, MOL CANCER THER, V5, P2310, DOI 10.1158/1535-7163.MCT-06-0175; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Solomon KR, 2008, TRENDS ENDOCRIN MET, V19, P113, DOI 10.1016/j.tem.2007.12.004; Solomon KR, 2009, AM J PATHOL, V174, P1017, DOI 10.2353/ajpath.2009.080551; Sreekumar A, 2009, NATURE, V457, P910, DOI 10.1038/nature07762; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Takarada T, 2008, J PHARMACOL SCI, V106, P536, DOI 10.1254/jphs.FM0070243; Tomlins SA, 2007, NAT GENET, V39, P41, DOI 10.1038/ng1935; Vellaichamy A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007075; Zakian KL, 2008, CANCER BIOMARK, V4, P263, DOI 10.3233/CBM-2008-44-508; Zhuang LY, 2005, J CLIN INVEST, V115, P959; Zhuang LY, 2002, CANCER RES, V62, P2227	50	115	120	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14175	10.1371/journal.pone.0014175	http://dx.doi.org/10.1371/journal.pone.0014175			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151972	Green Published, Green Submitted, gold			2022-12-27	WOS:000284939600001
J	Tian, JA; Zhang, XY; Liang, BG; Li, SW; Wu, ZX; Wang, QH; Leng, CX; Dong, JL; Wang, T				Tian, Juan; Zhang, Xueyan; Liang, Benguo; Li, Shanwei; Wu, Zhixia; Wang, Qianhua; Leng, Chunxu; Dong, Jiangli; Wang, Tao			Expression of Baculovirus Anti-Apoptotic Genes p35 and op-iap in Cotton (Gossypium hirsutum L.) Enhances Tolerance to Verticillium Wilt	PLOS ONE			English	Article							PROGRAMMED CELL-DEATH; VACUOLAR PROCESSING ENZYME; HYPERSENSITIVE RESPONSE; CASPASE ACTIVATION; TRANSGENIC COTTON; FUNGAL-INFECTION; ALBO-ATRUM; DAHLIAE; PLANTS; DISEASE	Background: Programmed cell death plays an important role in mediating plant adaptive responses to the environment such as the invasion of pathogens. Verticillium wilt, caused by the necrotrophic pathogen Verticillium dahliae, is a serious vascular disease responsible for great economic losses to cotton, but the molecular mechanisms of verticillium disease and effective, safe methods of resistance to verticillium wilt remain unexplored. Methodology/Principal Findings: In this study, we introduced baculovirus apoptosis inhibitor genes p35 and op-iap into the genome of cotton via Agrobacterium-mediated transformation and analyzed the response of transgenic plants to verticillium wilt. Results showed that p35 and op-iap constructs were stably integrated into the cotton genome, expressed in the transgenic lines, and inherited through the T-3 generation. The transgenic lines had significantly increased tolerance to verticillium wilt throughout the developmental stages. The disease index of T-1-T-3 generation was lower than 19, significantly (P < 0.05) better than the negative control line z99668. After treatment with 250 mg/L VD-toxins for 36 hours, DNA from negative control leaves was fragmented, whereas fragmentation in the transgenic leaf DNA did not occur. The percentage of cell death in transgenic lines increased by 7.11% after 60 mg/L VD-toxin treatment, which was less than that of the negative control lines's 21.27%. This indicates that p35 and op-iap gene expression partially protects cells from VD-toxin induced programmed cell death (PCD). Conclusion/Significance: Verticillium dahliae can trigger plant cells to die through induction of a PCD mechanism involved in pathogenesis. This paper provides a potential strategy for engineering broad-spectrum necrotrophic disease resistance in plants.	[Tian, Juan; Leng, Chunxu; Dong, Jiangli; Wang, Tao] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Zhang, Xueyan; Wu, Zhixia; Wang, Qianhua] Chinese Acad Agr Sci, Inst Cotton Res, Minist Agr, Key Lab Cotton Genet Improvement, Anyang, Peoples R China; [Liang, Benguo] Xinyang Agr Coll, Dept Hort, Xinyang, Peoples R China; [Li, Shanwei] Shandong Agr Univ, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China	China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Tian, JA (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	dongjl@cau.edu.cn			Major projects of genetically modified organisms breeding of China [2008ZX08005-003, 2008ZX08009-002]	Major projects of genetically modified organisms breeding of China	This work was supported by the major projects of genetically modified organisms breeding of China (2008ZX08005-003 and 2008ZX08009-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BejaranoAlcazar J, 1997, PLANT PATHOL, V46, P168, DOI 10.1046/j.1365-3059.1997.d01-221.x; BIRNBAUM MJ, 1994, J VIROL, V68, P2521, DOI 10.1128/JVI.68.4.2521-2528.1994; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bonneau L, 2008, J EXP BOT, V59, P491, DOI 10.1093/jxb/erm352; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUCHNER V, 1982, FEBS LETT, V138, P261, DOI 10.1016/0014-5793(82)80456-0; Chichkova NV, 2010, EMBO J, V29, P1149, DOI 10.1038/emboj.2010.1; Chichkova NV, 2004, PLANT CELL, V16, P157, DOI 10.1105/tpc.017889; Chu ZQ, 1999, ACTA BOT SIN, V41, P972; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; Davidson FF, 1998, NATURE, V391, P587, DOI 10.1038/35385; de Freitas DS, 2007, BIOTECHNOL LETT, V29, P79, DOI 10.1007/s10529-006-9201-9; del Pozo O, 1998, CURR BIOL, V8, P1129, DOI 10.1016/S0960-9822(98)70469-5; Dickman MB, 2001, P NATL ACAD SCI USA, V98, P6957, DOI 10.1073/pnas.091108998; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; GOUR HN, 1985, PHYSIOL PLANT PATHOL, V27, P109, DOI 10.1016/0048-4059(85)90060-8; Hansen G, 2000, MOL PLANT MICROBE IN, V13, P649, DOI 10.1094/MPMI.2000.13.6.649; Hatsugai N, 2004, SCIENCE, V305, P855, DOI 10.1126/science.1099859; Hisahara S, 2000, EMBO J, V19, P341, DOI 10.1093/emboj/19.3.341; HUISMAN OC, 1982, ANNU REV PHYTOPATHOL, V20, P303, DOI 10.1146/annurev.py.20.090182.001511; Khurana SMP, 2005, CURR SCI INDIA, V88, P740; Kim M, 2006, PLANT CELL, V18, P2341, DOI 10.1105/tpc.106.041509; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Kuroyanagi M, 2005, J BIOL CHEM, V280, P32914, DOI 10.1074/jbc.M504476200; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Lincoln JE, 2002, P NATL ACAD SCI USA, V99, P15217, DOI 10.1073/pnas.232579799; Means JC, 2008, FUTURE VIROL, V3, P383, DOI 10.2217/17460794.3.4.383; MEYER R, 1993, FEBS LETT, V335, P203, DOI 10.1016/0014-5793(93)80730-I; MEYER R, 1994, PHYTOCHEMISTRY, V35, P1449, DOI 10.1016/S0031-9422(00)86872-7; Mitsuhara I, 1999, CURR BIOL, V9, P775, DOI 10.1016/S0960-9822(99)80341-8; Mlejnek P, 2002, PLANTA, V215, P158, DOI 10.1007/s00425-002-0733-5; Murray F, 1999, MOL BREEDING, V5, P219, DOI 10.1023/A:1009625801909; Nakaune S, 2005, PLANT CELL, V17, P876, DOI 10.1105/tpc.104.026872; Palmer CS, 2005, PHYSIOL MOL PLANT P, V67, P308, DOI 10.1016/j.pmpp.2006.05.003; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; PEGG GF, 1965, NATURE, V208, P1228, DOI 10.1038/2081228b0; Rajasekaran K, 2005, PLANT BIOTECHNOL J, V3, P545, DOI 10.1111/j.1467-7652.2005.00145.x; Ryerson DE, 1996, PLANT CELL, V8, P393, DOI 10.1105/tpc.8.3.393; Stein JC, 1999, PLANT PHYSIOL, V121, P71, DOI 10.1104/pp.121.1.71; SUGIMOTO A, 1994, EMBO J, V13, P2023, DOI 10.1002/j.1460-2075.1994.tb06475.x; Sun YL, 1999, FEBS LETT, V462, P317, DOI 10.1016/S0014-5793(99)01539-2; Sun YQ, 2004, THEOR APPL GENET, V109, P472, DOI 10.1007/s00122-004-1663-3; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tohidfar M, 2005, PLANT CELL TISS ORG, V83, P83, DOI 10.1007/s11240-004-6155-2; Viswanath V, 2000, P NATL ACAD SCI USA, V97, P2270, DOI 10.1073/pnas.030365297; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Wang W, 1999, ACTA BOT SIN, V41, P1072; Wang YQ, 2004, PLANT BREEDING, V123, P454, DOI 10.1111/j.1439-0523.2004.01005.x; Wang Zhihua, 2008, Sheng Wu Gong Cheng Xue Bao, V24, P1707, DOI 10.1016/S1872-2075(08)60070-9; Wei YB, 2008, ACTA BIOCH BIOPH SIN, V40, P278, DOI 10.1111/j.1745-7270.2008.00407.x; Wijayanto T, 2009, PLANT BIOTECHNOL J, V7, P778, DOI 10.1111/j.1467-7652.2009.00443.x; Zhang Y. S., 1989, Acta Mycologica Sinica, V8, P140; Zhen XH, 2004, J PLANT PHYSIOL, V161, P1367, DOI 10.1016/j.jplph.2004.04.007	53	23	30	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14218	10.1371/journal.pone.0014218	http://dx.doi.org/10.1371/journal.pone.0014218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151969	Green Submitted, gold, Green Published			2022-12-27	WOS:000284939600011
J	Bonaccorsi, I; Cantoni, C; Carrega, P; Oliveri, D; Lui, G; Conte, R; Navarra, M; Cavaliere, R; Traggiai, E; Gattorno, M; Martini, A; Mingari, MC; Moretta, A; Ferlazzo, G				Bonaccorsi, Irene; Cantoni, Claudia; Carrega, Paolo; Oliveri, Daniela; Lui, Gabrielle; Conte, Romana; Navarra, Michele; Cavaliere, Riccardo; Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto; Mingari, Maria Cristina; Moretta, Alessandro; Ferlazzo, Guido			The Immune Inhibitory Receptor LAIR-1 Is Highly Expressed by Plasmacytoid Dendritic Cells and Acts Complementary with NKp44 to Control IFN alpha Production	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; NATURAL-KILLER-CELLS; IMMUNOGLOBULIN SUPERFAMILY; AUTOIMMUNE-DISEASES; I INTERFERONS; T-CELLS; DIFFERENTIATION; ACTIVATION; LYMPHOCYTES; PRECURSORS	Plasmacytoid dendritic cells (pDCs) are a subset of dendritic cells endowed with the capacity of producing large amounts of IFN alpha. Here we show that the Leukocyte-Associated Ig-like Receptor-1 (LAIR-1) is abundantly expressed on pDCs (the highest expression among all leukocytes) and its cross-linking inhibits IFNa production in response to Toll-like receptor ligands. Remarkably, LAIR-1 expression in pDCs is down-regulated in the presence of interleukin (IL)-3, thus indicating coordinated functions with NKp44, another pDC inhibitory receptor, which is conversely induced by IL-3. Nevertheless, the expression of NKp44 in pDCs isolated from secondary lymphoid organs, which is thought to be influenced by IL-3, is not coupled to a decreased expression of LAIR-1. Interestingly, pDCs isolated from peripheral blood of systemic lupus erithematosus (SLE) patients express lower levels of LAIR-1 while displaying slight but consistent expression of NKp44, usually undetectable on pDCs derived from healthy donors. Using sera derived from SLE patients, we show that LAIR-1 and NKp44 display synergistic inhibitory effects on IFNa production by interleukin IL-3 cultured pDCs stimulated with DNA immunocomplexes. In conclusion, our results indicate that the inhibitory function of LAIR-1 may play a relevant role in the mechanisms controlling IFNa production by pDCs both in normal and pathological innate immune responses.	[Bonaccorsi, Irene; Oliveri, Daniela; Cavaliere, Riccardo; Ferlazzo, Guido] Univ Messina, Dept Human Pathol, Lab Immunol & Biotherapy, Messina, Italy; [Cantoni, Claudia; Mingari, Maria Cristina; Moretta, Alessandro] Univ Genoa, Dept Expt Med DIMES, Genoa, Italy; [Cantoni, Claudia; Moretta, Alessandro] Univ Genoa, CERB, Genoa, Italy; [Cantoni, Claudia; Carrega, Paolo; Lui, Gabrielle; Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto] Ist Giannina Gaslini, I-16148 Genoa, Italy; [Conte, Romana; Mingari, Maria Cristina] Ist Nazl Ric Canc, I-16132 Genoa, Italy; [Navarra, Michele] Univ Messina, Pharmaco Biol Dept, Messina, Italy; [Traggiai, Elisabetta; Gattorno, Marco; Martini, Alberto] Univ Genoa, Dept Pediat, Genoa, Italy	University of Messina; University of Genoa; University of Genoa; University of Genoa; IRCCS Istituto Giannina Gaslini; University of Genoa; IRCCS AOU San Martino IST; University of Messina; University of Genoa	Bonaccorsi, I (corresponding author), Univ Messina, Dept Human Pathol, Lab Immunol & Biotherapy, Messina, Italy.	guido.ferlazzo@unime.it	Cantoni, Claudia/J-8732-2018; Gattorno, Marco/AAL-2974-2020; Carrega, Paolo/G-4883-2018; Mingari, Maria Cristina/AAB-1315-2019; Bonaccorsi, Irene/J-7409-2016	Cantoni, Claudia/0000-0001-6471-1424; Gattorno, Marco/0000-0003-0704-1916; Carrega, Paolo/0000-0001-8541-9115; Bonaccorsi, Irene/0000-0002-2893-0117; Ferlazzo, Guido/0000-0002-3874-8554; MARTINI, Alberto/0000-0001-7642-1459; Navarra, Michele/0000-0002-6492-7820	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 5624]; Ministero Italiano della Salute; Regione Sicilia, Ricerca Sanitaria Regionale	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero Italiano della Salute(Ministry of Health, Italy); Regione Sicilia, Ricerca Sanitaria Regionale	Research in the authors' laboratories is supported by: Associazione Italiana per la Ricerca sul Cancro (AIRC) project IG 5624(http://www.airc.it); Ministero Italiano della Salute, Programma Straordinario Ricerca Oncologica (http://www.ministerosalute.it/); Regione Sicilia, Ricerca Sanitaria Regionale 2007 (http://www. regione.sicilia.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albanesi C, 2009, J EXP MED, V206, P249, DOI 10.1084/jem.20080129; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bave U, 2003, J IMMUNOL, V171, P3296, DOI 10.4049/jimmunol.171.6.3296; Bave U, 2000, J IMMUNOL, V165, P3519, DOI 10.4049/jimmunol.165.6.3519; Blanco P, 2001, SCIENCE, V294, P1540, DOI 10.1126/science.1064890; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Campbell KS, 2004, J IMMUNOL, V172, P899, DOI 10.4049/jimmunol.172.2.899; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Carrega P, 2008, CANCER-AM CANCER SOC, V112, P863, DOI 10.1002/cncr.23239; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; de Vries ARV, 1999, EUR J IMMUNOL, V29, P3160; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Fanning SL, 2006, J IMMUNOL, V177, P5829, DOI 10.4049/jimmunol.177.9.5829; Ferlazzo G, 2004, P NATL ACAD SCI USA, V101, P16606, DOI 10.1073/pnas.0407522101; Fuchs A, 2005, BLOOD, V106, P2076, DOI 10.1182/blood-2004-12-4802; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Jansen CA, 2007, EUR J IMMUNOL, V37, P914, DOI 10.1002/eji.200636678; Ju XS, 2008, BLOOD, V112, P1184, DOI 10.1182/blood-2007-12-127951; Kadowaki N, 2001, J IMMUNOL, V166, P2291, DOI 10.4049/jimmunol.166.4.2291; Merlo A, 2005, CLIN DIAGN LAB IMMUN, V12, P705, DOI 10.1128/CDLI.12.6.705-712.2005; Meyaard L, 1997, IMMUNITY, V7, P283, DOI 10.1016/S1074-7613(00)80530-0; Meyaard L, 1999, J IMMUNOL, V162, P5800; Meyaard L, 2008, J LEUKOCYTE BIOL, V83, P799, DOI 10.1189/jlb.0907609; Pascual V, 2006, CURR OPIN IMMUNOL, V18, P676, DOI 10.1016/j.coi.2006.09.014; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; POGGI A, 1995, EUR J IMMUNOL, V25, P369, DOI 10.1002/eji.1830250210; Poggi A, 1998, EUR J IMMUNOL, V28, P2086, DOI 10.1002/(SICI)1521-4141(199807)28:07<2086::AID-IMMU2086>3.0.CO;2-T; Poggi A, 1997, INT IMMUNOL, V9, P1271, DOI 10.1093/intimm/9.9.1271; Ronnblom L, 2008, LUPUS, V17, P394, DOI 10.1177/0961203308090020; Sozzani S, 2010, TRENDS IMMUNOL, V31, P270, DOI 10.1016/j.it.2010.05.004; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2004, SCIENCE, V306, P1517, DOI 10.1126/science.1103478; Wu PP, 2008, CLIN IMMUNOL, V129, P40, DOI 10.1016/j.clim.2008.06.004	35	53	56	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 30	2010	5	11							e15080	10.1371/journal.pone.0015080	http://dx.doi.org/10.1371/journal.pone.0015080			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	687DK	21151495	Green Published, Green Submitted, gold			2022-12-27	WOS:000284755100063
J	Li, MM; Li, P; Song, RT; Xu, ZK				Li, Mangmang; Li, Ping; Song, Rentao; Xu, Zhengkai			An Induced Hypersensitive-Like Response Limits Expression of Foreign Peptides via a Recombinant TMV-Based Vector in a Susceptible Tobacco	PLOS ONE			English	Article							DEFENSE-RELATED GENES; MEMBRANE PROTEIN F; VIRUS COAT PROTEIN; MOSAIC-VIRUS; PSEUDOMONAS-AERUGINOSA; NICOTIANA-SYLVESTRIS; MESSENGER-RNAS; VIRAL VECTORS; RESISTANCE; INFECTION	Background: By using tobacco mosaic virus (TMV)-based vectors, foreign epitopes of the VP1 protein from food-and-month disease virus (FMDV) could be fused near to the C-terminus of the TMV coat protein (CP) and expressed at high levels in susceptible tobacco plants. Previously, we have shown that the recombinant TMV vaccines displaying FMDV VP1 epitopes could generate protection in guinea pigs and swine against the FMDV challenge. Recently, some recombinant TMV, such as TMVFN20 that contains an epitope FN20 from the FMDV VP1, were found to induce local necrotic lesions (LNL) on the inoculated leaves of a susceptible tobacco, Nicotiana tabacum Samsun nn. This hypersensitive-like response (HLR) blocked amplification of recombinant TMVFN20 in tobacco and limited the utility of recombinant TMV vaccines against FMDV. Methodology/ Principal Findings: Here we investigate the molecular mechanism of the HLR in the susceptible Samsun nn. Histochemical staining analyses show that these LNL are similar to those induced in a resistant tobacco Samsun NN inoculated with wild type (wt) TMV. The recombinant CP subunits are specifically related to the HLR. Interestingly, this HLR in Samsun nn (lacking the N/N'-gene) was able to be induced by the recombinant TMV at both 25 degrees C and 33 degrees C, whereas the hypersensitive response (HR) in the resistant tobacco plants induced by wt TMV through the N/N'-gene pathways only at a permissive temperature (below 30 degrees C). Furthermore, we reported for the first time that some of defense response (DR)-related genes in tobacco were transcriptionally upregulated during HLR. Conclusions: Unlike HR, HLR is induced in the susceptible tobacco through N/N'-gene independent pathways. Induction of the HLR is associated with the expression of the recombinant CP subunits and upregulation of the DR-related genes.	[Li, Mangmang; Xu, Zhengkai] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China; [Li, Ping; Song, Rentao; Xu, Zhengkai] Shanghai Univ, Sch Life Sci, Shanghai Key Lab Bioenergy Crops, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Xu, ZK (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China.	zkxu@staff.shu.edu.cn	Song, Rentao/AAG-9107-2021; Song, Rentao/A-6544-2012; LI, MANGMANG/J-1683-2015	Song, Rentao/0000-0003-1810-9875; Song, Rentao/0000-0003-1810-9875; 	National Natural Science Foundation of China [30700525]; Science and Technology Commission of Shanghai [08QA14033]; Shanghai Committee of Science and Technology [06JC14030]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee)	This project was supported by the National Natural Science Foundation of China (No. 30700525), the Science and Technology Commission of Shanghai (No. 08QA14033), and Shanghai Committee of Science and Technology (No. 06JC14030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CJ, 1994, PLANT CELL TISS ORG, V39, P7, DOI 10.1007/BF00037585; BALANDIN T, 1995, PLANT MOL BIOL, V27, P1197, DOI 10.1007/BF00020893; Bendahmane M, 1999, J MOL BIOL, V290, P9, DOI 10.1006/jmbi.1999.2860; BOL JF, 1990, ANNU REV PHYTOPATHOL, V28, P113, DOI 10.1146/annurev.py.28.090190.000553; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; CORNELISSEN BJC, 1986, EMBO J, V5, P37, DOI 10.1002/j.1460-2075.1986.tb04174.x; CULVER JN, 1994, J MOL BIOL, V242, P130, DOI 10.1006/jmbi.1994.1564; CULVER JN, 1989, VIROLOGY, V173, P755, DOI 10.1016/0042-6822(89)90592-8; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; DIETRICH RA, 1994, CELL, V77, P565, DOI 10.1016/0092-8674(94)90218-6; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Erickson FL, 1999, PHILOS T ROY SOC B, V354, P653, DOI 10.1098/rstb.1999.0417; FITCHEN J, 1995, VACCINE, V13, P1051, DOI 10.1016/0264-410X(95)00075-C; Gilleland HE, 2000, FEMS IMMUNOL MED MIC, V27, P291, DOI 10.1111/j.1574-695X.2000.tb01442.x; GONDET L, 1992, BIOCHEM BIOPH RES CO, V186, P888, DOI 10.1016/0006-291X(92)90829-A; Grdzelishvili VZ, 2000, VIROLOGY, V275, P177, DOI 10.1006/viro.2000.0511; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jiang LB, 2006, VACCINE, V24, P109, DOI 10.1016/j.vaccine.2005.09.060; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang MK, 1998, MOL CELLS, V8, P388; Koo M, 1999, P NATL ACAD SCI USA, V96, P7774, DOI 10.1073/pnas.96.14.7774; Lacorte C, 2007, VIRUS RES, V129, P80, DOI 10.1016/j.virusres.2007.06.020; LAWTON K, 1992, PLANT MOL BIOL, V19, P735, DOI 10.1007/BF00027070; Li QL, 2007, J VIROL METHODS, V140, P212, DOI 10.1016/j.jviromet.2006.10.011; Li QL, 2006, VIROLOGY, V348, P253, DOI 10.1016/j.virol.2005.11.013; MATTHEWS REF, 1981, PLANT VIROLOGY; McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33; Murphy AM, 2004, J GEN VIROL, V85, P3777, DOI 10.1099/vir.0.80385-0; NODA M, 1986, NATURE, V320, P188, DOI 10.1038/320188a0; Oh SK, 2006, PLANTA, V223, P1101, DOI 10.1007/s00425-006-0232-1; Palmer KE, 2006, VACCINE, V24, P5516, DOI 10.1016/j.vaccine.2006.04.058; Pontier D, 1999, PLANT MOL BIOL, V39, P1243, DOI 10.1023/A:1006133311402; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; Smith ML, 2007, VIROLOGY, V358, P321, DOI 10.1016/j.virol.2006.08.040; Staczek J, 2000, VACCINE, V18, P2266, DOI 10.1016/S0264-410X(99)00571-X; TAKAMATSU N, 1990, FEBS LETT, V269, P73, DOI 10.1016/0014-5793(90)81121-4; ThordalChristensen H, 1997, PLANT J, V11, P1187, DOI 10.1046/j.1365-313X.1997.11061187.x; Ueda H, 2006, PLANT MOL BIOL, V61, P31, DOI 10.1007/s11103-005-5817-8; VANDENBULCKE M, 1989, P NATL ACAD SCI USA, V86, P2673, DOI 10.1073/pnas.86.8.2673; WARD ER, 1991, PLANT CELL, V3, P1085, DOI 10.1105/tpc.3.10.1085; Wu LG, 2003, VACCINE, V21, P4390, DOI 10.1016/S0264-410X(03)00428-6	42	5	5	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15087	10.1371/journal.pone.0015087	http://dx.doi.org/10.1371/journal.pone.0015087			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124743	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500036
J	Katsikopoulos, KV; King, AJ				Katsikopoulos, Konstantinos V.; King, Andrew J.			Swarm Intelligence in Animal Groups: When Can a Collective Out-Perform an Expert?	PLOS ONE			English	Article							CONSENSUS DECISION-MAKING; LEADERSHIP; INFORMATION; FISH; HEURISTICS; EVOLUTION; ACCURACY	An important potential advantage of group-living that has been mostly neglected by life scientists is that individuals in animal groups may cope more effectively with unfamiliar situations. Social interaction can provide a solution to a cognitive problem that is not available to single individuals via two potential mechanisms: (i) individuals can aggregate information, thus augmenting their `collective cognition', or (ii) interaction with conspecifics can allow individuals to follow specific 'leaders', those experts with information particularly relevant to the decision at hand. However, a-priori, theory-based expectations about which of these decision rules should be preferred are lacking. Using a set of simple models, we present theoretical conditions (involving group size, and diversity of individual information) under which groups should aggregate information, or follow an expert, when faced with a binary choice. We found that, in single-shot decisions, experts are almost always more accurate than the collective across a range of conditions. However, for repeated decisions - where individuals are able to consider the success of previous decision outcomes - the collective's aggregated information is almost always superior. The results improve our understanding of how social animals may process information and make decisions when accuracy is a key component of individual fitness, and provide a solid theoretical framework for future experimental tests where group size, diversity of individual information, and the repeatability of decisions can be measured and manipulated.	[Katsikopoulos, Konstantinos V.; King, Andrew J.] Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany	Max Planck Society	Katsikopoulos, KV (corresponding author), Max Planck Inst Human Dev, Ctr Adapt Behav & Cognit, Berlin, Germany.	ajking@rvc.ac.uk	Katsikopoulos, Konstantinos/B-6356-2012	King, Andy/0000-0003-0955-0191; Katsikopoulos, Konstantinos/0000-0002-9572-1980	AXA Postdoctoral Fellowship	AXA Postdoctoral Fellowship(AXA Research Fund)	This work was supported by an AXA Postdoctoral Fellowship awarded to AJK, http://www.axa-research.org/en/research-funding/postgrants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2003, ANIMAL SIGNALS; Biro D, 2006, CURR BIOL, V16, P2123, DOI 10.1016/j.cub.2006.08.087; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P719, DOI 10.1098/rstb.2008.0276; Couzin I, 2007, NATURE, V445, P715, DOI 10.1038/445715a; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dall SRX, 2005, SCIENCE, V308, P353; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Detrain C, 2008, ADV INSECT PHYSIOL, V35, P123, DOI 10.1016/S0065-2806(08)00002-7; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Faria JJ, 2010, ANIM BEHAV, V79, P895, DOI 10.1016/j.anbehav.2009.12.039; Hutchinson JMC, 2005, BEHAV PROCESS, V69, P97, DOI 10.1016/j.beproc.2005.02.019; Katsikopoulos KV, 2006, J MATH PSYCHOL, V50, P488, DOI 10.1016/j.jmp.2006.06.001; KING AJ, 2009, COMMUNICATIVE INTEGR, P147; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; KRAUSE J, LIVING GROUPS; Krause J, 2010, TRENDS ECOL EVOL, V25, P28, DOI 10.1016/j.tree.2009.06.016; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; Marshall JAR, 2006, J R SOC INTERFACE, V3, P243, DOI 10.1098/rsif.2005.0075; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Reimer T, 2004, COGNITIVE SCI, V28, P1009, DOI 10.1016/j.cogsci.2004.06.004; STEVENS J, 2008, 1 ERNST STRUNGM FOR, P285; STEVENS JR, SIMPLE HEUR IN PRESS; Sumpter DJT, 2008, CURR BIOL, V18, P1773, DOI 10.1016/j.cub.2008.09.064; Trimmer PC, 2008, P ROY SOC B-BIOL SCI, V275, P2353, DOI 10.1098/rspb.2008.0417; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Ward AJW, 2008, P NATL ACAD SCI USA, V105, P6948, DOI 10.1073/pnas.0710344105	32	24	24	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15505	10.1371/journal.pone.0015505	http://dx.doi.org/10.1371/journal.pone.0015505			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124803	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000284572000031
J	Romih, V; Lepej, SZ; Gedike, K; Lukas, D; Begovac, J				Romih, Vanja; Lepej, Snjezana Zidovec; Gedike, Kornelija; Lukas, Davorka; Begovac, Josip			Frequency of HIV-1 Viral Load Monitoring of Patients Initially Successfully Treated with Combination Antiretroviral Therapy	PLOS ONE			English	Article							CROATIA; PREVALENCE; INFECTION; HIV/AIDS; ROUTINE; ZAGREB; STILL	Background: Although considered an essential tool for monitoring the effect of combination antiretroviral treatment (CART), HIV-1 RNA (viral load, VL) testing is greatly influenced by cost and availability of resources. Objectives: To examine whether HIV infected patients who were initially successfully treated with CART have less frequent monitoring of VL over time and whether CART failure and other HIV-disease and sociodemographic characteristics are associated with less frequent VL testing. Methods: The study included patients who started CART in the period 1999-2004, were older than 18 years, CART naive, had two consecutive viral load measurements of <400 copies/ml after 5 months of treatment and had continuous CART during the first 15 months. The time between two consecutive visits (days) was the outcome and associated factors were assessed using linear mixed models. Results: We analyzed a total of 128 patients with 1683 visits through December 2009. CART failure was observed in 31 (24%) patients. When adjusted for the follow-up time, the mean interval between two consecutive VL tests taken in patients before CART failure (155.2 days) was almost identical to the interval taken in patients who did not fail CART (155.3 days). On multivariable analysis, we found that the adjusted estimated time between visits was 150.9 days before 2003 and 177.6 in 2008/2009. A longer time between visits was observed in seafarers compared to non-seafarers; the mean difference was 30.7 days (95% CI, 14.0 to 47.4; p<0.001); and in individuals who lived more than 160 kilometers from the HIV treatment center (mean difference, 16 days, p = 0.010). Conclusions: Less frequent monitoring of VL became common in recent years and was not associated with failure. We identified seafarers as a population with special needs for CART monitoring and delivery.	[Romih, Vanja; Lepej, Snjezana Zidovec; Gedike, Kornelija; Lukas, Davorka; Begovac, Josip] Univ Hosp Infect Dis, Zagreb, Croatia; [Begovac, Josip] Univ Zagreb, Sch Med, Dept Infect Dis, Zagreb 41001, Croatia	University of Zagreb	Romih, V (corresponding author), Univ Hosp Infect Dis, Zagreb, Croatia.	jbegovac@bfm.hr	Begovac, Josip/AAI-5672-2021	Begovac, Josip/0000-0003-2641-4327	Croatian Ministry of Science, Education and Sports [108-1080116-0098, 143-1080116-0097]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This study was supported in part by grants from the Croatian Ministry of Science, Education and Sports to Josip Begovac and Snjezana Zidovec Lepej (Grants 108-1080116-0098 and 143-1080116-0097). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Begovac J, 2006, COLLEGIUM ANTROPOL, V30, P17; Bernays S, 2009, AIDS CARE, V21, P315, DOI 10.1080/09540120802183495; Bozicevic I, 2009, AIDS BEHAV, V13, P303, DOI 10.1007/s10461-008-9436-7; Haubrich RH, 2001, CLIN INFECT DIS, V33, P1060, DOI 10.1086/322636; Kendall MA, 2006, CONTEMP CLIN TRIALS, V27, P287, DOI 10.1016/j.cct.2006.02.001; Laine C, 2002, J ACQ IMMUN DEF SYND, V29, P270, DOI 10.1097/00126334-200203010-00007; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Raboud JM, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-40; Raboud JM, 2005, JAIDS-J ACQ IMM DEF, V39, P327, DOI 10.1097/01.qai.0000143603.94728.b2; Ramirez-Piedad MK, 2009, J MED VIROL, V81, P573, DOI 10.1002/jmv.21433; Reekie J, 2008, AIDS, V22, P2381, DOI 10.1097/QAD.0b013e328317a6eb; Tesic V, 2006, COLLEGIUM ANTROPOL, V30, P89; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	14	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15051	10.1371/journal.pone.0015051	http://dx.doi.org/10.1371/journal.pone.0015051			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124844	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000284572000023
J	Chinappi, M; Via, A; Marcatili, P; Tramontano, A				Chinappi, Mauro; Via, Allegra; Marcatili, Paolo; Tramontano, Anna			On the Mechanism of Chloroquine Resistance in Plasmodium falciparum	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN PFCRT; DIGESTIVE VACUOLE; STRUCTURE PREDICTION; HOMOLOGY DETECTION; DRUG-RESISTANCE; EFFLUX SYSTEM; H+ LEAK; TRANSPORTER; MUTATIONS; PH	Resistance to chloroquine of malaria strains is known to be associated with a parasite protein named PfCRT, the mutated form of which is able to reduce chloroquine accumulation in the digestive vacuole of the pathogen. Whether the protein mediates extrusion of the drug acting as a channel or as a carrier and which is the protonation state of its chloroquine substrate is the subject of a scientific debate. We present here an analytical approach that explores which combination of hypotheses on the mechanism of transport and the protonation state of chloroquine are consistent with available equilibrium experimental data. We show that the available experimental data are not, by themselves, sufficient to conclude whether the protein acts as a channel or as a transporter, which explains the origin of their different interpretation by different authors. Interestingly, though, each of the two models is only consistent with a subset of hypotheses on the protonation state of the transported molecule. The combination of these results with a sequence and structure analysis of PfCRT, which strongly suggests that the molecule is a carrier, indicates that the transported species is either or both the mono and di-protonated forms of chloroquine. We believe that our results, besides shedding light on the mechanism of chloroquine resistance in P. falciparum, have implications for the development of novel therapies against resistant malaria strains and demonstrate the usefulness of an approach combining systems biology strategies with structural bioinformatics and experimental data.	[Chinappi, Mauro; Via, Allegra; Marcatili, Paolo; Tramontano, Anna] Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy; [Tramontano, Anna] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Chinappi, M (corresponding author), Univ Roma La Sapienza, Dept Biochem Sci, Rome, Italy.	Anna.Tramontano@uniroma1.it	Via, Allegra/AAY-7435-2020; Tramontano, anna/D-5378-2009; Marcatili, Paolo/G-9673-2016	Tramontano, anna/0000-0002-5610-3338; Chinappi, Mauro/0000-0002-4509-1247; Marcatili, Paolo/0000-0003-2615-5695	King Abdullah University of Science and Technology (KAUST) [KUK-I1-012-43]; Human Frontier Science Program (HFSP) [RGP0054/2006-C]; Fondazione Roma	King Abdullah University of Science and Technology (KAUST)(King Abdullah University of Science & Technology); Human Frontier Science Program (HFSP)(Human Frontier Science Program); Fondazione Roma(Fondazione RomaEuropean Commission)	This work was supported by King Abdullah University of Science and Technology (KAUST) - Award No. KUK-I1-012-43 (http://www.kaust.edu.sa/), Human Frontier Science Program (HFSP) -RGP0054/2006-C grant (http://www.hfsp.org/), and Fondazione Roma (http://www.fondazioneroma.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernsel A, 2008, PROTEINS, V71, P1387, DOI 10.1002/prot.21825; Biegert A, 2009, P NATL ACAD SCI USA, V106, P3770, DOI 10.1073/pnas.0810767106; Biegert A, 2006, NUCLEIC ACIDS RES, V34, pW335, DOI 10.1093/nar/gkl217; Bray PG, 2006, MOL MICROBIOL, V62, P238, DOI 10.1111/j.1365-2958.2006.05368.x; Bray PG, 2005, MOL MICROBIOL, V56, P323, DOI 10.1111/j.1365-2958.2005.04556.x; BRAY PG, 1992, BIOCHEM PHARMACOL, V44, P1317, DOI 10.1016/0006-2952(92)90532-N; Bray PG, 1998, MOL PHARMACOL, V54, P170, DOI 10.1124/mol.54.1.170; Bray PG, 1999, J CELL BIOL, V145, P363, DOI 10.1083/jcb.145.2.363; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Cooper RA, 2005, ACTA TROP, V94, P170, DOI 10.1016/j.actatropica.2005.04.004; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; Cooper RA, 2007, MOL MICROBIOL, V63, P270, DOI 10.1111/j.1365-2958.2006.05511.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERRARI V, 1991, BIOCHEM PHARMACOL, V41, P23, DOI 10.1016/0006-2952(91)90006-Q; FERRARI V, 1991, BIOCHEM PHARMACOL, V42, pS167, DOI 10.1016/0006-2952(91)90407-V; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; FITCH CD, 1970, SCIENCE, V169, P289, DOI 10.1126/science.169.3942.289; Hayward R, 2006, J CELL SCI, V119, P1016, DOI 10.1242/jcs.02795; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; HOMEWOOD CA, 1972, NATURE, V235, P50, DOI 10.1038/235050a0; Huaman MC, 2004, AM J TROP MED HYG, V71, P40, DOI 10.4269/ajtmh.2004.71.40; Johnson DJ, 2004, MOL CELL, V15, P867, DOI 10.1016/j.molcel.2004.09.012; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Klonis N, 2007, BIOCHEM J, V407, P343, DOI 10.1042/BJ20070934; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; Kuhn Y, 2007, CELL MICROBIOL, V9, P1004, DOI 10.1111/j.1462-5822.2006.00847.x; Lehane AM, 2008, ANTIMICROB AGENTS CH, V52, P4374, DOI 10.1128/AAC.00666-08; Lehane AM, 2008, J CELL SCI, V121, P1624, DOI 10.1242/jcs.016758; Martin RE, 2004, MOL BIOL EVOL, V21, P1938, DOI 10.1093/molbev/msh205; Martin RE, 2009, SCIENCE, V325, P1680, DOI 10.1126/science.1175667; Pagola S, 2000, NATURE, V404, P307, DOI 10.1038/35005132; Perrin DD, 1965, INT UNION PURE APPL; Saliba KJ, 1998, BIOCHEM PHARMACOL, V56, P313, DOI 10.1016/S0006-2952(98)00140-3; Sanchez CP, 2007, TRENDS PARASITOL, V23, P332, DOI 10.1016/j.pt.2007.04.013; Sanchez CP, 2007, MOL MICROBIOL, V64, P407, DOI 10.1111/j.1365-2958.2007.05664.x; Sanchez CP, 2005, BIOCHEMISTRY-US, V44, P9862, DOI 10.1021/bi050061f; Sanchez CP, 2004, BIOCHEMISTRY-US, V43, P16365, DOI 10.1021/bi048241x; Sanchez CP, 2003, BIOCHEMISTRY-US, V42, P9383, DOI 10.1021/bi034269h; SLATER AFG, 1991, P NATL ACAD SCI USA, V88, P325, DOI 10.1073/pnas.88.2.325; SLATER AFG, 1993, PHARMACOL THERAPEUT, V57, P203, DOI 10.1016/0163-7258(93)90056-J; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Sonnhammer ELL, 1997, PROTEINS, V28, P405, DOI 10.1002/(SICI)1097-0134(199707)28:3<405::AID-PROT10>3.0.CO;2-L; Stein W., 2012, TRANSPORT DIFFUSION; SUGIOKA K, 1987, FEBS LETT, V210, P37, DOI 10.1016/0014-5793(87)81293-0; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Wang Y, 2009, BIOINFORMATICS, V25, P2076, DOI 10.1093/bioinformatics/btp346; Warhurst DC, 2002, LANCET, V360, P1527, DOI 10.1016/S0140-6736(02)11577-7; Wellems TE, 2004, NAT MED, V10, P1169, DOI 10.1038/nm1104-1169; Wellems TE, 2003, NEW ENGL J MED, V349, P1496, DOI 10.1056/NEJMp038127; Wellems TE, 2001, J INFECT DIS, V184, P770, DOI 10.1086/322858; YAYON A, 1984, EMBO J, V3, P2695, DOI 10.1002/j.1460-2075.1984.tb02195.x	55	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14064	10.1371/journal.pone.0014064	http://dx.doi.org/10.1371/journal.pone.0014064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124966	Green Published, Green Submitted, gold			2022-12-27	WOS:000284400100013
J	Cronshaw, DG; Nie, YC; Waite, J; Zou, YR				Cronshaw, Darran G.; Nie, Yuchun; Waite, Janelle; Zou, Yong-Rui			An Essential Role of the Cytoplasmic Tail of CXCR4 in G-Protein Signaling and Organogenesis	PLOS ONE			English	Article							CHEMOKINE RECEPTOR CXCR4; COUPLED RECEPTORS; BETA-ARRESTIN; WHIM-SYNDROME; CELL-ADHESION; BONE-MARROW; 7-TRANSMEMBRANE RECEPTORS; INTRACELLULAR DOMAINS; CRYSTAL-STRUCTURE; TYROSINE KINASE	CXCR4 regulates cell proliferation, enhances cell survival and induces chemotaxis, yet molecular mechanisms underlying its signaling remain elusive. Like all other G-protein coupled receptors (GPCRs), CXCR4 delivers signals through G-protein-dependent and -independent pathways, the latter involving its serine-rich cytoplasmic tail. To evaluate the signaling and biological contribution of this G-protein-independent pathway, we generated mutant mice that express cytoplasmic tail-truncated CXCR4 (Delta T) by a gene knock-in approach. We found that Delta T mice exhibited multiple developmental defects, with not only G-protein-independent but also G-protein-dependent signaling events completely abolished, despite Delta's ability to still associate with G-proteins. These results reveal an essential positive regulatory role of the cytoplasmic tail in CXCR4 signaling and suggest the tail is crucial for mediating G-protein activation and initiating crosstalk between G-protein-dependent and G-protein-independent pathways for correct GPCR signaling.	[Cronshaw, Darran G.; Nie, Yuchun; Waite, Janelle; Zou, Yong-Rui] Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA	Northwell Health	Cronshaw, DG (corresponding author), Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY USA.	yzou@nshs.edu			DANA Foundation [CU-51912001]; Sandler Program for Asthma Research [SPAR 04-0179]; Irene Diamond Fund [SHRI 1703]	DANA Foundation; Sandler Program for Asthma Research; Irene Diamond Fund	This work was supported in part by the DANA Foundation (CU-51912001), the Sandler Program for Asthma Research (SPAR 04-0179), and the Irene Diamond Fund (SHRI 1703) to Y.-R. Z. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagri A, 2002, DEVELOPMENT, V129, P4249; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Burger JA, 2006, BLOOD, V107, P1761, DOI 10.1182/blood-2005-08-3182; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Busillo JM, 2010, J BIOL CHEM, V285, P7805, DOI 10.1074/jbc.M109.091173; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cheng ZJ, 2000, J BIOL CHEM, V275, P2479, DOI 10.1074/jbc.275.4.2479; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Colvin RA, 2004, J BIOL CHEM, V279, P30219, DOI 10.1074/jbc.M403595200; de Gorter DJJ, 2007, IMMUNITY, V26, P93, DOI 10.1016/j.immuni.2006.11.012; Diaz GA, 2005, IMMUNOL REV, V203, P235, DOI 10.1111/j.0105-2896.2005.00226.x; Ding Y, 2008, EXP CELL RES, V314, P590, DOI 10.1016/j.yexcr.2007.10.032; DOHLMAN HG, 1991, ANNU REV BIOCHEM, V60, P653, DOI 10.1146/annurev.biochem.60.1.653; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Fong AM, 2002, P NATL ACAD SCI USA, V99, P7478, DOI 10.1073/pnas.112198299; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Gosling J, 1997, P NATL ACAD SCI USA, V94, P5061, DOI 10.1073/pnas.94.10.5061; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hernandez PA, 2003, NAT GENET, V34, P70, DOI 10.1038/ng1149; Kawai T, 2005, EXP HEMATOL, V33, P460, DOI 10.1016/j.exphem.2005.01.001; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; Lagane B, 2008, BLOOD, V112, P34, DOI 10.1182/blood-2007-07-102103; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Lukacs NW, 2002, AM J PATHOL, V160, P1353, DOI 10.1016/S0002-9440(10)62562-X; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; McCormick PJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008102; Meng EC, 2001, TRENDS PHARMACOL SCI, V22, P587, DOI 10.1016/S0165-6147(00)01825-3; Moepps B, 1997, EUR J IMMUNOL, V27, P2102, DOI 10.1002/eji.1830270839; Murdoch C, 2000, IMMUNOL REV, V177, P175, DOI 10.1034/j.1600-065X.2000.17715.x; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Roland J, 2003, BLOOD, V101, P399, DOI 10.1182/blood-2002-03-0978; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; SAVARESE TM, 1992, BIOCHEM J, V283, P1; Signoret N, 1998, J CELL SCI, V111, P2819; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Ueda Y, 2006, CANCER RES, V66, P5665, DOI 10.1158/0008-5472.CAN-05-3579; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Zlotnik A, 2006, INT J CANCER, V119, P2026, DOI 10.1002/ijc.22024; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e15397	10.1371/journal.pone.0015397	http://dx.doi.org/10.1371/journal.pone.0015397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124917	gold, Green Published, Green Submitted			2022-12-27	WOS:000284400100018
J	Li, SL; Quarto, N; Longaker, MT				Li, Shuli; Quarto, Natalina; Longaker, Michael T.			Activation of FGF Signaling Mediates Proliferative and Osteogenic Differences between Neural Crest Derived Frontal and Mesoderm Parietal Derived Bone	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; TRANSCRIPTIONAL CONTROL; MOLECULAR-MECHANISMS; STROMAL CELLS; SELF-RENEWAL; STEM-CELLS; PDGF-BB; DIFFERENTIATION; SURVIVAL; EXPRESSION	Background: As a culmination of efforts over the last years, our knowledge of the embryonic origins of the mammalian frontal and parietal cranial bones is unambiguous. Progenitor cells that subsequently give rise to frontal bone are of neural crest origin, while parietal bone progenitors arise from paraxial mesoderm. Given the unique qualities of neural crest cells and the clear delineation of the embryonic origins of the calvarial bones, we sought to determine whether mouse neural crest derived frontal bone differs in biology from mesoderm derived parietal bone. Methods: BrdU incorporation, immunoblotting and osteogenic differentiation assays were performed to investigate the proliferative rate and osteogenic potential of embryonic and postnatal osteoblasts derived from mouse frontal and parietal bones. Co-culture experiments and treatment with conditioned medium harvested from both types of osteoblasts were performed to investigate potential interactions between the two different tissue origin osteoblasts. Immunoblotting techniques were used to investigate the endogenous level of FGF-2 and the activation of three major FGF signaling pathways. Knockdown of FGF Receptor 1 (FgfR1) was employed to inactivate the FGF signaling. Results: Our results demonstrated that striking differences in cell proliferation and osteogenic differentiation between the frontal and parietal bone can be detected already at embryonic stages. The greater proliferation rate, as well as osteogenic capacity of frontal bone derived osteoblasts, were paralleled by an elevated level of FGF-2 protein synthesis. Moreover, an enhanced activation of FGF-signaling pathways was observed in frontal bone derived osteoblasts. Finally, the greater osteogenic potential of frontal derived osteoblasts was dramatically impaired by knocking down FgfR1. Conclusions: Osteoblasts from mouse neural crest derived frontal bone displayed a greater proliferative and osteogenic potential and endogenous enhanced activation of FGF signaling compared to osteoblasts from mesoderm derived parietal bone. FGF signaling plays a key role in determining biological differences between the two types of osteoblasts.	[Li, Shuli; Quarto, Natalina; Longaker, Michael T.] Stanford Univ, Sch Med, Childrens Surg Res Program, Dept Surg, Stanford, CA 94305 USA; [Quarto, Natalina] Univ Naples Federico II, Dept Struct & Funct Biol, Naples, Italy	Stanford University; University of Naples Federico II	Li, SL (corresponding author), Stanford Univ, Sch Med, Childrens Surg Res Program, Dept Surg, Stanford, CA 94305 USA.	Longaker@stanford.edu			Oak Foundation; National Institutes of Health (NIH) [R01 DE014526, R01 DE13194, 1R01DE019434]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013194] Funding Source: NIH RePORTER	Oak Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This investigation was supported by the Oak Foundation and National Institutes of Health (NIH) grants R01 DE014526, R01 DE13194 and 1R01DE019434 to M. T. L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2000, PHILOS T R SOC B, V355, P953, DOI 10.1098/rstb.2000.0631; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chaudhary LR, 2001, J CELL BIOCHEM, V81, P304, DOI 10.1002/1097-4644(20010501)81:2<304::AID-JCB1045>3.3.CO;2-L; Chaudhary LR, 1997, BIOCHEM BIOPH RES CO, V238, P134, DOI 10.1006/bbrc.1997.7256; Couly G, 1996, DEVELOPMENT, V122, P3393; Cowan CM, 2003, J BIOL CHEM, V278, P32005, DOI 10.1074/jbc.M304698200; Dailey L, 2005, CYTOKINE GROWTH F R, V16, P233, DOI 10.1016/j.cytogfr.2005.01.007; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Debiais F, 2004, EXP CELL RES, V297, P235, DOI 10.1016/j.yexcr.2004.03.032; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Fakhry A, 2005, BONE, V36, P254, DOI 10.1016/j.bone.2004.10.003; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Karsenty G, 2001, ENDOCRINOLOGY, V142, P2731, DOI 10.1210/en.142.7.2731; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kontges G, 1996, DEVELOPMENT, V122, P3229; LaBonne C, 1999, ANNU REV CELL DEV BI, V15, P81, DOI 10.1146/annurev.cellbio.15.1.81; Le Douarin NM, 2008, CELL CYCLE, V7, P1013, DOI 10.4161/cc.7.8.5641; Li S, 2007, AM J PHYSIOL-CELL PH, V293, pC1834, DOI 10.1152/ajpcell.00135.2007; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Morriss-Kay GM, 2001, J ANAT, V199, P143; MUENKE M, 1995, TRENDS GENET, V11, P308, DOI 10.1016/S0168-9525(00)89088-5; Naski M C, 1998, Front Biosci, V3, pd781; Ornitz DM, 2001, GENOME BIOL, V2; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Quarto N, 2008, BONE, V42, P1040, DOI 10.1016/j.bone.2008.01.026; Quarto N, 2006, TISSUE ENG, V12, P1405, DOI 10.1089/ten.2006.12.1405; Quarto N, 2010, J BONE MINER RES, V25, P1680, DOI 10.1359/jbmr.091116; Quarto N, 2009, CELLS TISSUES ORGANS, V190, P158, DOI 10.1159/000202789; Trainor P, 2002, SCIENCE, V297, P781, DOI 10.1126/science.1075454; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; Yang DH, 2006, BONE, V38, P485, DOI 10.1016/j.bone.2005.10.009	37	39	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14033	10.1371/journal.pone.0014033	http://dx.doi.org/10.1371/journal.pone.0014033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124973	Green Published, gold, Green Submitted			2022-12-27	WOS:000284356900002
J	Goto, K; Kurashima, R; Gokan, H; Inoue, N; Ito, I; Watanabe, S				Goto, Kazuhiro; Kurashima, Ryo; Gokan, Hayato; Inoue, Naomi; Ito, Isao; Watanabe, Shigeru			Left-Right Asymmetry Defect in the Hippocampal Circuitry Impairs Spatial Learning and Working Memory in iv Mice	PLOS ONE			English	Article							PERFORMANCE; RECEPTORS; C57BL/6N; INVERSUS; LESIONS; POTENT; BRAIN; TASK; FLOW	Although left-right (L-R) asymmetry is a fundamental feature of higher-order brain function, little is known about how asymmetry defects of the brain affect animal behavior. Previously, we identified structural and functional asymmetries in the circuitry of the mouse hippocampus resulting from the asymmetrical distribution of NMDA receptor GluR epsilon 2 (NR2B) subunits. We further examined the epsilon 2 asymmetry in the inversus viscerum (iv) mouse, which has randomized laterality of internal organs, and found that the iv mouse hippocampus exhibits right isomerism (bilateral right-sidedness) in the synaptic distribution of the epsilon 2 subunit, irrespective of the laterality of visceral organs. To investigate the effects of hippocampal laterality defects on higher-order brain functions, we examined the capacity of reference and working memories of iv mice using a dry maze and a delayed nonmatching-to-position (DNMTP) task, respectively. The iv mice improved dry maze performance more slowly than control mice during acquisition, whereas the asymptotic level of performance was similar between the two groups. In the DNMTP task, the iv mice showed poorer accuracy than control mice as the retention interval became longer. These results suggest that the L-R asymmetry of hippocampal circuitry is critical for the acquisition of reference memory and the retention of working memory.	[Goto, Kazuhiro] Japan Soc Promot Sci, Tokyo, Japan; [Goto, Kazuhiro; Kurashima, Ryo; Gokan, Hayato; Inoue, Naomi; Watanabe, Shigeru] Keio Univ, Fac Letters, Dept Psychol, Tokyo, Japan; [Ito, Isao] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 812, Japan	Japan Society for the Promotion of Science; Keio University; Kyushu University	Goto, K (corresponding author), Kyoto Univ, Human Brain Res Ctr, Kyoto, Japan.	kgoto@psy.flet.keio.ac.jp	Goto, Kazuhiro/E-6456-2011; Goto, Kazuhiro/ABB-3677-2020		Japan Science and Technology Corporation; Ministry of Education, Culture, Sports, Science and Technology of Japan [18/5950, 21300125]; Global Center of Excellence [D029]	Japan Science and Technology Corporation(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Solution Oriented Research or Science and Technology from the Japan Science and Technology Corporation to II, the Global Center of Excellence Program (D029) to Keio University, and Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant No. 18/5950 to KG and No. 21300125 to II). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2005, CURR BIOL, V15, P238, DOI 10.1016/j.cub.2005.01.014; Bailey KR, 2005, BEHAV NEUROSCI, V119, P410, DOI 10.1037/0735-7044.119.2.410; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; BURK JA, 1998, BEHAV NEUROSCI, V112, P2; Chen C, 1997, ANNU REV NEUROSCI, V20, P157, DOI 10.1146/annurev.neuro.20.1.157; Chizh BA, 2001, TRENDS PHARMACOL SCI, V22, P636, DOI 10.1016/S0165-6147(00)01863-0; DAVISON MC, 1978, J EXP ANAL BEHAV, V29, P331, DOI 10.1901/jeab.1978.29-331; Deadwyler SA, 1996, J NEUROSCI, V16, P354; Fischer G, 1997, J PHARMACOL EXP THER, V283, P1285; GESCHWIND N, 1987, CAREBRAL LATERALIZAT; Goto K, 2010, BEHAV PROCESS, V84, P591, DOI 10.1016/j.beproc.2010.02.022; Halpern ME, 2005, J NEUROSCI, V25, P10351, DOI 10.1523/JNEUROSCI.3439-05.2005; Hummel K. P., 1959, Journal of Heredity, V50, P9; JARRARD LE, 1993, BEHAV NEURAL BIOL, V60, P9, DOI 10.1016/0163-1047(93)90664-4; Kawakami R, 2003, SCIENCE, V300, P990, DOI 10.1126/science.1082609; Kawakami R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001945; Kolkman MJM, 2004, BEHAV BRAIN RES, V154, P171, DOI 10.1016/j.bbr.2004.02.006; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Mutel V, 1998, J NEUROCHEM, V70, P2147; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Nonaka S, 2002, NATURE, V418, P96, DOI 10.1038/nature00849; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Okada Y, 1999, MOL CELL, V4, P459, DOI 10.1016/S1097-2765(00)80197-5; Sloan HL, 2006, BEHAV BRAIN RES, V171, P240, DOI 10.1016/j.bbr.2006.03.042; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Supp DM, 1999, DEVELOPMENT, V126, P5495; Supp DM, 1997, NATURE, V389, P963, DOI 10.1038/40140; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Vallortigara G, 2000, BRAIN LANG, V73, P189, DOI 10.1006/brln.2000.2303; White KG, 2001, ANIM LEARN BEHAV, V29, P193, DOI 10.3758/BF03192887; Wu Y, 2005, J NEUROSCI, V25, P9213, DOI 10.1523/JNEUROSCI.2134-05.2005; Yoshida M, 2001, PHYSIOL BEHAV, V73, P37, DOI 10.1016/S0031-9384(01)00419-X	33	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e15468	10.1371/journal.pone.0015468	http://dx.doi.org/10.1371/journal.pone.0015468			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103351	Green Published, gold			2022-12-27	WOS:000284327800020
J	Xu, M; Bi, YF; Xu, Y; Yu, B; Huang, Y; Gu, LN; Wu, YH; Zhu, XL; Li, MA; Wang, TG; Song, AY; Hou, JN; Li, XY; Ning, GA				Xu, Min; Bi, Yufang; Xu, Yu; Yu, Bing; Huang, Yun; Gu, Lina; Wu, Yaohua; Zhu, Xiaolin; Li, Mian; Wang, Tiange; Song, Aiyun; Hou, Jianing; Li, Xiaoying; Ning, Guang			Combined Effects of 19 Common Variations on Type 2 Diabetes in Chinese: Results from Two Community-Based Studies	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; IMPAIRED GLUCOSE-TOLERANCE; SUSCEPTIBILITY LOCI; GENETIC-VARIANTS; FASTING GLUCOSE; PLASMA-GLUCOSE; RISK; HHEX; CDKN2A/B; IGF2BP2	Background: Many susceptible loci for type 2 diabetes mellitus (T2DM) have recently been identified from Caucasians through genome wide association studies (GWAS). We aimed to determine the association of 11 known loci with T2DM and impaired glucose regulation (IGR), individually and in combination, in Chinese. Methods/Principal Findings: Subjects were enrolled in: (1) a case-control study including 1825 subjects with T2DM, 1487 with IGR and 2200 with normal glucose regulation; and (2) a prospective cohort with 734 non-diabetic subjects at baseline. The latter was followed up for 3.5 years, in which 67 subjects developed T2DM. Nineteen single nucleotide polymorphisms (SNPs) were selected to replicate in both studies. We found that CDKAL1 (rs7756992), SLC30A8 (rs13266634, rs2466293), CDKN2A/2B (rs10811661) and KCNQ1 (rs2237892) were associated with T2DM with odds ratio from 1.21 to 1.35. In the prospective study, the fourth quartile of risk scores based on the combined effects of the risk alleles had 3.05 folds (95% CI, 1.31-7.12) higher risk for incident T2DM as compared with the first quartile, after adjustment for age, gender, body mass index and diabetes family history. This combined effect was confirmed in the case-control study after the same adjustments. The addition of the risk scores to the model of clinical risk factors modestly improved discrimination for T2DM by 1.6% in the case-control study and 2.9% in the prospective study. Conclusions/Significance: Our study provided further evidence for these GWAS derived SNPs as the genetic susceptible loci for T2DM in Chinese and extended this association to IGR.	[Xu, Min; Zhu, Xiaolin; Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China; [Xu, Min; Bi, Yufang; Xu, Yu; Huang, Yun; Gu, Lina; Wu, Yaohua; Zhu, Xiaolin; Li, Mian; Wang, Tiange; Song, Aiyun; Hou, Jianing; Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Dept Endocrine & Metab Dis, Shanghai Clin Ctr Endocrine & Metab Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [Yu, Bing] Univ Sydney, Dept Mol & Clin Genet, Royal Prince Alfred Hosp, Sydney, NSW 2006, Australia; [Yu, Bing] Univ Sydney, Cent Clin Sch, Sydney, NSW 2006, Australia; [Li, Xiaoying; Ning, Guang] Shanghai Jiao Tong Univ, Lab Endocrinol & Metab, Shanghai Inst Biol Sci, Chinese Acad Sci, Shanghai 200030, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Sydney; University of Sydney; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University	Xu, M (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Med Genom, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China.	gning@sibs.ac.cn	Li, Mian/HGE-6038-2022; Zhu, Xiaolin/GLV-1533-2022	Zhu, Xiaolin/0000-0002-3221-595X; Yu, Bing/0000-0001-6013-5220; Li, Xiaoying/0000-0002-9383-5757	State Key Laboratory of Medical Genomics; Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health [1994DP131044]; National Key New Drug Creation and Manufacturing Program [2008ZX09312/019]; 863 Project [2006AA02A409]; Nature Science Foundation of China [30800536]; Shanghai Committee for Science and Technology [08DJ1400602, 08ZR141700]; E-Institute of Shanghai Universities, Shanghai Education Commission	State Key Laboratory of Medical Genomics; Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health; National Key New Drug Creation and Manufacturing Program; 863 Project(National High Technology Research and Development Program of China); Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Committee for Science and Technology(Shanghai Science & Technology Committee); E-Institute of Shanghai Universities, Shanghai Education Commission	This study was supported by the grants from State Key Laboratory of Medical Genomics, Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Chinese Public Health (No. 1994DP131044), National Key New Drug Creation and Manufacturing Program (2008ZX09312/019), 863 Project (No. 2006AA02A409), Nature Science Foundation of China (No. 30800536), Shanghai Committee for Science and Technology (No. 08DJ1400602 and 08ZR141700) and E-Institute of Shanghai Universities, Shanghai Education Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balding DJ, 2006, NAT REV GENET, V7, P781, DOI 10.1038/nrg1916; Bouatia-Naji N, 2009, NAT GENET, V41, P89, DOI 10.1038/ng.277; Chen JM, 2009, AM J HUM GENET, V85, P775, DOI 10.1016/j.ajhg.2009.10.016; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Gudmundsson J, 2007, NAT GENET, V39, P977, DOI 10.1038/ng2062; Horikoshi M, 2007, DIABETOLOGIA, V50, P2461, DOI 10.1007/s00125-007-0827-5; Hu C, 2009, DIABETOLOGIA, V52, P1322, DOI 10.1007/s00125-009-1335-6; Kraft P, 2009, NEW ENGL J MED, V360, P1701, DOI 10.1056/NEJMp0810107; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; Li HX, 2008, DIABETES, V57, P264, DOI 10.2337/db07-1130; Li XY, 2009, CLIN ENDOCRINOL, V70, P691, DOI 10.1111/j.1365-2265.2008.03371.x; Lyssenko V, 2008, NEW ENGL J MED, V359, P2220, DOI 10.1056/NEJMoa0801869; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Nicolson TJ, 2009, DIABETES, V58, P2070, DOI 10.2337/db09-0551; Nordman S, 2005, EXP CLIN ENDOCR DIAB, V113, P282, DOI 10.1055/s-2005-865650; Omori S, 2008, DIABETES, V57, pA331; Palmer ND, 2008, DIABETES, V57, P1093, DOI 10.2337/db07-1169; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Prokopenko I, 2009, NAT GENET, V41, P77, DOI 10.1038/ng.290; Qi QB, 2009, HUM MOL GENET, V18, P3508, DOI 10.1093/hmg/ddp294; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; SAAD MF, 1988, NEW ENGL J MED, V319, P1500, DOI 10.1056/NEJM198812083192302; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Saxena R, 2010, NAT GENET, V42, P142, DOI 10.1038/ng.521; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SLAKED R, 2007, NATURE, V445, P828; Staiger H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000832; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wang J, 2007, DIABETOLOGIA, V50, P1192, DOI 10.1007/s00125-007-0656-6; Weedon MN, 2006, PLOS MED, V3, P1877, DOI 10.1371/journal.pmed.0030374; Wijesekara N, 2010, DIABETOLOGIA, V53, P1656, DOI 10.1007/s00125-010-1733-9; Xiang J, 2008, J CLIN ENDOCR METAB, V93, P4107, DOI 10.1210/jc.2008-0161; Xu M, 2009, DIABETOLOGIA, V52, P1511, DOI 10.1007/s00125-009-1386-8; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	42	74	82	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14022	10.1371/journal.pone.0014022	http://dx.doi.org/10.1371/journal.pone.0014022			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103332	Green Published, Green Submitted, gold			2022-12-27	WOS:000284327800009
J	Yang, F; Cheng, Y; An, JY; Kwon, YT; Eckardt, S; Leu, NA; McLaughlin, KJ; Wang, PJ				Yang, Fang; Cheng, Yong; An, Jee Young; Kwon, Yong Tae; Eckardt, Sigrid; Leu, N. Adrian; McLaughlin, K. John; Wang, Peijing Jeremy			The Ubiquitin Ligase Ubr2, a Recognition E3 Component of the N-End Rule Pathway, Stabilizes Tex19.1 during Spermatogenesis	PLOS ONE			English	Article							ROTHMUND-THOMSON; MICE LACKING; PROTEIN; MOUSE; DEGRADATION; EXPRESSION; MUTATIONS; APOPTOSIS; RECQL4; GENES	Ubiquitin E3 ligases target their substrates for ubiquitination, leading to proteasome-mediated degradation or altered biochemical properties. The ubiquitin ligase Ubr2, a recognition E3 component of the N-end rule proteolytic pathway, recognizes proteins with N-terminal destabilizing residues and plays an important role in spermatogenesis. Tex19.1 (also known as Tex19) has been previously identified as a germ cell-specific protein in mouse testis. Here we report that Tex19.1 forms a stable protein complex with Ubr2 in mouse testes. The binding of Tex19.1 to Ubr2 is independent of the second position cysteine of Tex19.1, a putative target for arginylation by the N-end rule pathway R-transferase. The Tex19.1-null mouse mutant phenocopies the Ubr2-deficient mutant in three aspects: heterogeneity of spermatogenic defects, meiotic chromosomal asynapsis, and embryonic lethality preferentially affecting females. In Ubr2-deficient germ cells, Tex19.1 is transcribed, but Tex19.1 protein is absent. Our results suggest that the binding of Ubr2 to Tex19.1 metabolically stabilizes Tex19.1 during spermatogenesis, revealing a new function for Ubr2 outside the conventional N-end rule pathway.	[Yang, Fang; Cheng, Yong; Leu, N. Adrian; Wang, Peijing Jeremy] Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Dept Anim Biol, Philadelphia, PA 19104 USA; [An, Jee Young; Kwon, Yong Tae] Univ Pittsburgh, Ctr Pharmacogenet, Dept Pharmaceut Sci, Pittsburgh, PA USA; [Kwon, Yong Tae] Seoul Natl Univ, Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea; [Eckardt, Sigrid; McLaughlin, K. John] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Seoul National University (SNU); University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Yang, F (corresponding author), Univ Penn, Sch Vet Med, Ctr Anim Transgenesis & Germ Cell Res, Dept Anim Biol, Philadelphia, PA 19104 USA.	pwang@vet.upenn.edu	McLaughlin, Kenneth/E-3648-2011		National Institutes of Health/National Institute of General Medical Sciences [GM089893, GM076327, GM074000, HL083365]; World Class University; NRF (National Research Foundation of Korea); MEST (Ministry of Education, Science and Technology) [R31-2008-000-10103-0]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD064628] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083365] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074000, R01GM076327, R01GM089893] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); World Class University; NRF (National Research Foundation of Korea)(National Research Foundation of Korea); MEST (Ministry of Education, Science and Technology)(Ministry of Education, Science & Technology (MEST), Republic of Korea); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health/National Institute of General Medical Sciences [Grant number GM089893 and GM076327 to P.J.W.; GM074000 and HL083365 to Y.T.K], and World Class University and World Class Institute programs of the NRF (National Research Foundation of Korea) and the MEST (Ministry of Education, Science and Technology) [grant number R31-2008-000-10103-0 to Y.T.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An JY, 2010, P NATL ACAD SCI USA, V107, P1912, DOI 10.1073/pnas.0910267107; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Byrd C, 1998, EMBO J, V17, P269, DOI 10.1093/emboj/17.1.269; de Vries FAT, 2005, GENE DEV, V19, P1376, DOI 10.1101/gad.329705; Ditzel M, 2003, NAT CELL BIOL, V5, P467, DOI 10.1038/ncb984; HARLOW E, 1998, USING ANTIBODIES LAB; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Kitao S, 1999, NAT GENET, V22, P82, DOI 10.1038/8788; Kuntz S, 2008, STEM CELLS, V26, P734, DOI 10.1634/stemcells.2007-0772; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Lee MJ, 2005, P NATL ACAD SCI USA, V102, P15030, DOI 10.1073/pnas.0507533102; Ollinger R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000199; Rao H, 2001, NATURE, V410, P955, DOI 10.1038/35073627; REDDI PP, 1995, BIOL REPROD, V53, P873, DOI 10.1095/biolreprod53.4.873; Sasaki T, 2006, MOL CELL, V24, P63, DOI 10.1016/j.molcel.2006.08.005; Schmekel K, 1996, EXP CELL RES, V226, P20, DOI 10.1006/excr.1996.0198; Siitonen HA, 2003, HUM MOL GENET, V12, P2837, DOI 10.1093/hmg/ddg306; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Tasaki T, 2009, J BIOL CHEM, V284, P1884, DOI 10.1074/jbc.M803641200; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Yang F, 2008, GENE DEV, V22, P682, DOI 10.1101/gad.1613608; Yang F, 2006, J CELL BIOL, V173, P497, DOI 10.1083/jcb.200603063; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; Zenker M, 2005, NAT GENET, V37, P1345, DOI 10.1038/ng1681	27	27	32	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14017	10.1371/journal.pone.0014017	http://dx.doi.org/10.1371/journal.pone.0014017			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103378	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000284257400016
J	Loguercio, S; Overall, RW; Michaelson, JJ; Wiltshire, T; Pletcher, MT; Miller, BH; Walker, JR; Kempermann, G; Su, AI; Beyer, A				Loguercio, Salvatore; Overall, Rupert W.; Michaelson, Jacob J.; Wiltshire, Tim; Pletcher, Mathew T.; Miller, Brooke H.; Walker, John R.; Kempermann, Gerd; Su, Andrew I.; Beyer, Andreas			Integrative Analysis of Low- and High-Resolution eQTL	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION; BIOINFORMATICS TOOLBOX; MICE; DISCOVERY; NETWORKS; STRAINS; LINKAGE; LISTS; BXD	The study of expression quantitative trait loci (eQTL) is a powerful way of detecting transcriptional regulators at a genomic scale and for elucidating how natural genetic variation impacts gene expression. Power and genetic resolution are heavily affected by the study population: whereas recombinant inbred (RI) strains yield greater statistical power with low genetic resolution, using diverse inbred or outbred strains improves genetic resolution at the cost of lower power. In order to overcome the limitations of both individual approaches, we combine data from RI strains with genetically more diverse strains and analyze hippocampus eQTL data obtained from mouse RI strains (BXD) and from a panel of diverse inbred strains (Mouse Diversity Panel, MDP). We perform a systematic analysis of the consistency of eQTL independently obtained from these two populations and demonstrate that a significant fraction of eQTL can be replicated. Based on existing knowledge from pathway databases we assess different approaches for using the high-resolution MDP data for fine mapping BXD eQTL. Finally, we apply this framework to an eQTL hotspot on chromosome 1 (Qrr1), which has been implicated in a range of neurological traits. Here we present the first systematic examination of the consistency between eQTL obtained independently from the BXD and MDP populations. Our analysis of fine-mapping approaches is based on 'real life' data as opposed to simulated data and it allows us to propose a strategy for using MDP data to fine map BXD eQTL. Application of this framework to Qrr1 reveals that this eQTL hotspot is not caused by just one (or few) 'master regulators', but actually by a set of polymorphic genes specific to the central nervous system.	[Loguercio, Salvatore; Michaelson, Jacob J.; Beyer, Andreas] Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany; [Overall, Rupert W.; Kempermann, Gerd; Beyer, Andreas] Tech Univ Dresden, CRTD, Dresden, Germany; [Wiltshire, Tim] Univ N Carolina, Sch Pharm, Div Pharmacotherapy & Expt Therapeut, Chapel Hill, NC USA; [Pletcher, Mathew T.] Pfizer Global Res & Dev, Compound Safety Predict, Groton, CT USA; [Miller, Brooke H.] Scripps Florida, Scripps Res Inst, Dept Neurosci, Jupiter, FL USA; [Walker, John R.; Su, Andrew I.] Novartis Res Fdn, Genom Inst, San Diego, CA USA	Technische Universitat Dresden; Technische Universitat Dresden; University of North Carolina; University of North Carolina Chapel Hill; Pfizer; Scripps Research Institute; State University System of Florida; University of Florida; Novartis	Loguercio, S (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Overall, Rupert W/P-3102-2016; Beyer, Andreas/A-3352-2009; Kempermann, Gerd/F-5416-2010; Beyer, Andreas/AAQ-5519-2020	Overall, Rupert W/0000-0002-3882-6073; Beyer, Andreas/0000-0002-3891-2123; Kempermann, Gerd/0000-0002-5304-4061; Beyer, Andreas/0000-0002-3891-2123; Su, Andrew I./0000-0002-9859-4104; Michaelson, Jacob/0000-0001-9713-0992	Klaus Tschira Foundation; Helmholtz Alliance for Systems Biology; European Community [FP7-223539]	Klaus Tschira Foundation; Helmholtz Alliance for Systems Biology; European Community(European Commission)	This work was funded by the Klaus Tschira Foundation http://www.klaus-tschira-stiftung.de/english/index.html, the Helmholtz Alliance for Systems Biology http://www.helmholtz.de/en/joint_initiative_for_innovation_and_research/initiating_and_networking/helmholtz_alliances/systems_biology/helmholtz_alliance_on_systems_biology/ and the European Community's Seventh Framework Programme (grant no. FP7-223539) http://www.phenoxigen.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000622; Belmont PJ, 2008, J BIOL CHEM, V283, P14012, DOI 10.1074/jbc.M709776200; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; BOEHNKE M, 1994, AM J HUM GENET, V55, P379; Breitling R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000232; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Buck K, 1999, MAMM GENOME, V10, P431, DOI 10.1007/s003359901018; Burgess-Herbert SL, 2008, GENETICS, V180, P2227, DOI 10.1534/genetics.108.090175; Caldarone B, 1997, NAT GENET, V17, P335, DOI 10.1038/ng1197-335; Casley WL, 1999, DRUG METAB DISPOS, V27, P1375; Chan PP, 2009, NUCLEIC ACIDS RES, V37, pD93, DOI 10.1093/nar/gkn787; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chesler EJ, 2005, NAT GENET, V37, P233, DOI 10.1038/ng1518; Crabbe JC, 1996, ADDICT BIOL, V1, P229, DOI 10.1080/1355621961000124846; DEFRIES JC, 1978, BEHAV GENET, V8, P3, DOI 10.1007/BF01067700; DiPetrillo K, 2005, TRENDS GENET, V21, P683, DOI 10.1016/j.tig.2005.09.008; Doss S, 2005, GENOME RES, V15, P681, DOI 10.1101/gr.3216905; Drenan RM, 2005, J CELL BIOL, V169, P623, DOI 10.1083/jcb.200502007; Ferraro TN, 2007, EPILEPSIA, V48, P1667, DOI 10.1111/j.1528-1167.2007.01126.x; FLINT J, 1995, SCIENCE, V269, P1432, DOI 10.1126/science.7660127; Gatti DM, 2009, MAMM GENOME, V20, P437, DOI 10.1007/s00335-009-9199-0; Gershenfeld HK, 1997, BEHAV GENET, V27, P201, DOI 10.1023/A:1025653812535; Ghazalpour A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000149; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HALEY CS, 1992, HEREDITY, V69, P315, DOI 10.1038/hdy.1992.131; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kang HM, 2008, GENETICS, V178, P1709, DOI 10.1534/genetics.107.080101; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Malmanger B, 2006, MAMM GENOME, V17, P1193, DOI 10.1007/s00335-006-0070-2; Matthews DB, 2005, ALCOHOL CLIN EXP RES, V29, p195A; McClurg P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-61; McClurg P, 2007, GENETICS, V176, P675, DOI 10.1534/genetics.106.066241; Michaelson JJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-502; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Mozhui K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000260; Odom DT, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100059; OVERALL R, 2009, FRONTIERS NEUROGENOM, V1, P1; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Patel NV, 1999, BEHAV GENET, V29, P303, DOI 10.1023/A:1021653732147; Peirce JL, 2006, MAMM GENOME, V17, P643, DOI 10.1007/s00335-005-0187-8; Peirce JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001036; Peirce JL, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-7; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schadt EE, 2008, PLOS BIOL, V6, P1020, DOI 10.1371/journal.pbio.0060107; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Taylor BA, 1999, MAMM GENOME, V10, P335, DOI 10.1007/s003359900998; Turri MG, 1999, MAMM GENOME, V10, P1098, DOI 10.1007/s003359901169; Wu CL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000070; Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222; Zhu J, 2008, NAT GENET, V40, P854, DOI 10.1038/ng.167	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13920	10.1371/journal.pone.0013920	http://dx.doi.org/10.1371/journal.pone.0013920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085707	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800013
J	Nguyen, LT; Yen, PH; Nie, J; Liadis, N; Ghazarian, D; Al-Habeeb, A; Easson, A; Leong, W; Lipa, J; McCready, D; Reedijk, M; Hogg, D; Joshua, AM; Quirt, I; Messner, H; Shaw, P; Crump, M; Sharon, E; Ohashi, PS				Nguyen, Linh T.; Yen, Pei Hua; Nie, Jessica; Liadis, Nicole; Ghazarian, Danny; Al-Habeeb, Ayman; Easson, Alexandra; Leong, Wey; Lipa, Joan; McCready, David; Reedijk, Michael; Hogg, David; Joshua, Anthony M.; Quirt, Ian; Messner, Hans; Shaw, Patricia; Crump, Michael; Sharon, Eran; Ohashi, Pamela S.			Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)	PLOS ONE			English	Article							T-CELL RESPONSES; OVERCOMING IMMUNOLOGICAL-TOLERANCE; METASTATIC MELANOMA; ADOPTIVE TRANSFER; PHASE-I; RECOMBINANT INTERLEUKIN-2; MALIGNANT-MELANOMA; TARGETING CTLA-4; TRANSFER THERAPY; HLA-A	Background: Various immunotherapeutic strategies for cancer are aimed at augmenting the T cell response against tumor cells. Adoptive cell therapy (ACT), where T cells are manipulated ex vivo and subsequently re-infused in an autologous manner, has been performed using T cells from various sources. Some of the highest clinical response rates for metastatic melanoma have been reported in trials using tumor-infiltrating lymphocytes (TILs). These protocols still have room for improvement and furthermore are currently only performed at a limited number of institutions. The goal of this work was to develop TILs as a therapeutic product at our institution. Principal Findings: TILs from 40 melanoma tissue specimens were expanded and characterized. Under optimized culture conditions, 72% of specimens yielded rapidly proliferating TILs as defined as at least one culture reaching >= 3x10(7) TILs within 4 weeks. Flow cytometric analyses showed that cultures were predominantly CD3+ T cells, with highly variable CD4+:CD8+ T cell ratios. In total, 148 independent bulk TIL cultures were assayed for tumor reactivity. Thirty-four percent (50/148) exhibited tumor reactivity based on IFN-gamma production and/or cytotoxic activity. Thirteen percent (19/148) showed specific cytotoxic activity but not IFN-gamma production and only 1% (2/148) showed specific IFN-gamma production but not cytotoxic activity. Further expansion of TILs using a 14-day "rapid expansion protocol'' (REP) is required to induce a 500-to 2000-fold expansion of TILs in order to generate sufficient numbers of cells for current ACT protocols. Thirty-eight consecutive test REPs were performed with an average 1865-fold expansion (+/- 1034-fold) after 14 days. Conclusions: TILs generally expanded efficiently and tumor reactivity could be detected in vitro. These preclinical data from melanoma TILs lay the groundwork for clinical trials of ACT.	[Nguyen, Linh T.; Yen, Pei Hua; Nie, Jessica; Liadis, Nicole; Ohashi, Pamela S.] Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Ghazarian, Danny; Al-Habeeb, Ayman; Shaw, Patricia] Univ Hlth Network, Princess Margaret Hosp, Dept Pathol, Toronto, ON, Canada; [Easson, Alexandra; Leong, Wey; Lipa, Joan; McCready, David; Reedijk, Michael; Sharon, Eran] Univ Hlth Network, Princess Margaret Hosp, Dept Surg Oncol, Toronto, ON, Canada; [Hogg, David; Joshua, Anthony M.; Quirt, Ian; Messner, Hans; Crump, Michael] Univ Hlth Network, Princess Margaret Hosp, Dept Med Oncol Hematol, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Immunol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto	Nguyen, LT (corresponding author), Univ Hlth Network, Ontario Canc Inst, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca	; Easson, Alexandra/U-9850-2017	Ghazarian, Danny/0000-0002-3531-1074; Easson, Alexandra/0000-0003-0998-3659; Ohashi, Pamela S./0000-0003-2915-9317; Joshua, Anthony/0000-0001-5159-4580	Campbell Institute for Breast Cancer Research; Canadian Breast Cancer Research Alliance [019361]; Government of Ontario	Campbell Institute for Breast Cancer Research; Canadian Breast Cancer Research Alliance; Government of Ontario	This work was supported by the Campbell Institute for Breast Cancer Research and the Canadian Breast Cancer Research Alliance (grant number 019361; http://www.breast.cancer.ca/). This study was also conducted with the support of the Ontario Institute for Cancer Research through funding provided by the Government of Ontario (ORBiT grant; http://www.oicr.on.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOKI Y, 1991, CANCER RES, V51, P1934; Atkins MB, 2000, CANCER J SCI AM, V6, pS8; BAARS JW, 1992, BIOTHERAPY, V4, P289, DOI 10.1007/BF02172659; Bachmann MF, 1996, EUR J IMMUNOL, V26, P2017, DOI 10.1002/eji.1830260908; Barrow C, 2006, CLIN CANCER RES, V12, P764, DOI 10.1158/1078-0432.CCR-05-1544; Bedikian AY, 2006, J CLIN ONCOL, V24, P4738, DOI 10.1200/JCO.2006.06.0483; BELLDEGRUN A, 1993, J UROLOGY, V150, P1384, DOI 10.1016/S0022-5347(17)35785-3; Berger R, 2008, CLIN CANCER RES, V14, P3044, DOI 10.1158/1078-0432.CCR-07-4079; Besser MJ, 2010, CLIN CANCER RES, V16, P2646, DOI 10.1158/1078-0432.CCR-10-0041; Besser MJ, 2009, J IMMUNOTHER, V32, P415, DOI 10.1097/CJI.0b013e31819c8bda; Blank C, 2005, CANCER IMMUNOL IMMUN, V54, P307, DOI 10.1007/s00262-004-0593-x; Boon T, 2006, ANNU REV IMMUNOL, V24, P175, DOI 10.1146/annurev.immunol.24.021605.090733; Brahmer JR, 2010, J CLIN ONCOL, V28, P3167, DOI 10.1200/JCO.2009.26.7609; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; CLARK WH, 1986, HUM PATHOL, V17, P443, DOI 10.1016/S0046-8177(86)80032-6; DILLMAN RO, 1993, CANCER, V71, P2358, DOI 10.1002/1097-0142(19930401)71:7<2358::AID-CNCR2820710730>3.0.CO;2-M; Dreno B, 2002, CANCER IMMUNOL IMMUN, V51, P539, DOI 10.1007/s00262-002-0315-1; Dudley ME, 2008, J CLIN ONCOL, V26, P5233, DOI 10.1200/JCO.2008.16.5449; Dudley ME, 2005, J CLIN ONCOL, V23, P2346, DOI 10.1200/JCO.2005.00.240; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Dudley ME, 2003, J IMMUNOTHER, V26, P332, DOI 10.1097/00002371-200307000-00005; Dudley ME, 2001, J IMMUNOTHER, V24, P363, DOI 10.1097/00002371-200107000-00012; Dunn GP, 2004, IMMUNITY, V21, P137, DOI 10.1016/j.immuni.2004.07.017; Gardini A, 2004, J SURG ONCOL, V87, P46, DOI 10.1002/jso.20066; GOEDEGEBUURE PS, 1995, J CLIN ONCOL, V13, P1939, DOI 10.1200/JCO.1995.13.8.1939; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Kawakami Y, 2000, J IMMUNOTHER, V23, P17, DOI 10.1097/00002371-200001000-00004; KRADIN RL, 1989, LANCET, V1, P577; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Ohlen C, 2002, J EXP MED, V195, P1407, DOI 10.1084/jem.20011063; Pittet MJ, 2000, J IMMUNOL, V164, P1148, DOI 10.4049/jimmunol.164.3.1148; Pittet MJ, 1999, J EXP MED, V190, P705, DOI 10.1084/jem.190.5.705; Queirolo P, 1999, ANN SURG ONCOL, V6, P272, DOI 10.1007/s10434-999-0272-4; RATTO GB, 1995, J THORAC CARDIOV SUR, V109, P1212, DOI 10.1016/S0022-5223(95)70205-9; RAVAUD A, 1995, BRIT J CANCER, V71, P331, DOI 10.1038/bjc.1995.66; Reali UM, 1998, MELANOMA RES, V8, P77; Ribas A, 2008, ONCOLOGIST, V13, P10, DOI 10.1634/theoncologist.13-S4-10; Romero P, 1998, J EXP MED, V188, P1641, DOI 10.1084/jem.188.9.1641; ROSENBERG SA, 1994, J NATL CANCER I, V86, P1159, DOI 10.1093/jnci/86.15.1159; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; Schwartzentruber DJ, 2009, J CLIN ONCOL, V27, p18s; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Speiser DE, 2005, J CLIN INVEST, V115, P739, DOI 10.1172/JCI200523373; Tran KQ, 2008, J IMMUNOTHER, V31, P742, DOI 10.1097/CJI.0b013e31818403d5; Vignard V, 2005, J IMMUNOL, V175, P4797, DOI 10.4049/jimmunol.175.7.4797; Wallen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004749; Weber J, 2008, ONCOLOGIST, V13, P16, DOI 10.1634/theoncologist.13-S4-16; Yee C, 2002, P NATL ACAD SCI USA, V99, P16168, DOI 10.1073/pnas.242600099	49	32	40	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13940	10.1371/journal.pone.0013940	http://dx.doi.org/10.1371/journal.pone.0013940			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085676	gold, Green Submitted, Green Published			2022-12-27	WOS:000284036800025
J	Erdely, A; Kepka-Lenhart, D; Salmen-Muniz, R; Chapman, R; Hulderman, T; Kashon, M; Simeonova, PP; Morris, SM				Erdely, Aaron; Kepka-Lenhart, Diane; Salmen-Muniz, Rebecca; Chapman, Rebecca; Hulderman, Tracy; Kashon, Michael; Simeonova, Petia P.; Morris, Sidney M., Jr.			Arginase Activities and Global Arginine Bioavailability in Wild-Type and ApoE-Deficient Mice: Responses to High Fat and High Cholesterol Diets	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; OXIDE-MEDIATED DILATION; LIVER-TYPE ARGINASE; UREA CYCLE ENZYMES; NITRIC-OXIDE; ATHEROGENIC DIET; ENDOTHELIAL DYSFUNCTION; GENE-EXPRESSION; ATHEROSCLEROTIC LESIONS; CORONARY ARTERIOLES	Increased catabolism of arginine by arginase is increasingly viewed as an important pathophysiological factor in cardiovascular disease, including atherosclerosis induced by high cholesterol diets. Whereas previous studies have focused primarily on effects of high cholesterol diets on arginase expression and arginine metabolism in specific blood vessels, there is no information regarding the impact of lipid diets on arginase activity or arginine bioavailability at a systemic level. We, therefore, evaluated the effects of high fat (HF) and high fat-high cholesterol (HC) diets on arginase activity in plasma and tissues and on global arginine bioavailability (defined as the ratio of plasma arginine to ornithine + citrulline) in apoE(-/-) and wild-type C57BL/6J mice. HC and HF diets led to reduced global arginine bioavailability in both strains. The HC diet resulted in significantly elevated plasma arginase in both strains, but the HF diet increased plasma arginase only in apoE(-/-) mice. Elevated plasma arginase activity correlated closely with increased alanine aminotransferase levels, indicating that liver damage was primarily responsible for elevated plasma arginase. The HC diet, which promotes atherogenesis, also resulted in increased arginase activity and expression of the type II isozyme of arginase in multiple tissues of apoE(-/-) mice only. These results raise the possibility that systemic changes in arginase activity and global arginine bioavailability may be contributing factors in the initiation and/or progression of cardiovascular disease.	[Erdely, Aaron; Salmen-Muniz, Rebecca; Chapman, Rebecca; Hulderman, Tracy; Simeonova, Petia P.] NIOSH, Toxicol & Mol Biol Branch, Morgantown, WV USA; [Erdely, Aaron; Salmen-Muniz, Rebecca; Hulderman, Tracy] NIOSH, Lab Occupat Cardiovasc Toxicol, Morgantown, WV USA; [Kepka-Lenhart, Diane; Morris, Sidney M., Jr.] NIOSH, Biostat & Epidemiol Branch, Hlth Effects Lab Div, Morgantown, WV USA; [Kashon, Michael] Univ Pittsburgh, Sch Med, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Erdely, A (corresponding author), NIOSH, Toxicol & Mol Biol Branch, Morgantown, WV USA.	efi4@cdc.gov	Erdely, Aaron/A-3518-2013; Morris, Sidney M/I-3440-2015		National Institutes of Health [RO1 GM57384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057384] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by National Institutes of Health grant RO1 GM57384 to SMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Demougeot C, 2005, J HYPERTENS, V23, P971, DOI 10.1097/01.hjh.0000166837.78559.93; Desai MS, 2008, J LEUKOCYTE BIOL, V83, P1336, DOI 10.1189/jlb.0607390; Durante W, 2001, CIRCULATION, V103, P1121, DOI 10.1161/01.CIR.103.8.1121; Durante W, 1997, J BIOL CHEM, V272, P30154, DOI 10.1074/jbc.272.48.30154; Durante W, 2007, CLIN EXP PHARMACOL P, V34, P906, DOI 10.1111/j.1440-1681.2007.04638.x; Erdely A, 2006, AM J PHYSIOL-LUNG C, V290, pL534, DOI 10.1152/ajplung.00326.2005; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Hein TW, 2003, FASEB J, V17, P2328, DOI 10.1096/fj.03-0115fje; Ikemoto M, 2001, CLIN CHEM, V47, P946; Ikemoto M, 1998, CLIN CHIM ACTA, V271, P11, DOI 10.1016/S0009-8981(97)00226-X; Johnson FK, 2005, AM J PHYSIOL-REG I, V288, pR1057, DOI 10.1152/ajpregu.00758.2004; Joyce CW, 2002, P NATL ACAD SCI USA, V99, P407, DOI 10.1073/pnas.012587699; Kyung TW, 2009, J NUTR, V139, P502, DOI 10.3945/jn.108.100032; Li Z, 2007, ENVIRON HEALTH PERSP, V115, P377, DOI 10.1289/ehp.9688; LIAO F, 1993, J CLIN INVEST, V91, P2572, DOI 10.1172/JCI116495; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marathe C, 2006, J BIOL CHEM, V281, P32197, DOI 10.1074/jbc.M605237200; Mori M, 2000, BIOCHEM BIOPH RES CO, V275, P715, DOI 10.1006/bbrc.2000.3169; Morris CR, 2005, JAMA-J AM MED ASSOC, V294, P81, DOI 10.1001/jama.294.1.81; MORRIS SM, 1992, ANNU REV NUTR, V12, P81, DOI 10.1146/annurev.nu.12.070192.000501; Morris SM, 2005, VASC MED, V10, pS83, DOI 10.1191/1358863x05vm601oa; Morris SM, 1998, AM J PHYSIOL-ENDOC M, V275, pE740, DOI 10.1152/ajpendo.1998.275.5.E740; MORRIS SM, 1987, ARCH BIOCHEM BIOPHYS, V256, P343, DOI 10.1016/0003-9861(87)90455-3; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Napoli C, 2009, ARCH PHARM RES, V32, P1103, DOI 10.1007/s12272-009-1801-1; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Preli RB, 2002, ATHEROSCLEROSIS, V162, P1, DOI 10.1016/S0021-9150(01)00717-1; Qureshi AA, 2001, J NUTR, V131, P2606, DOI 10.1093/jn/131.10.2606; Reid KM, 2007, AM J PHYSIOL-GASTR L, V292, pG512, DOI 10.1152/ajpgi.00227.2006; ROTH E, 1994, TRANSPLANTATION, V57, P665, DOI 10.1097/00007890-199403150-00006; Ryoo S, 2008, CIRC RES, V102, P923, DOI 10.1161/CIRCRESAHA.107.169573; Santhanam L, 2007, CIRC RES, V101, P692, DOI 10.1161/CIRCRESAHA.107.157727; SCHIMKE RT, 1962, J BIOL CHEM, V237, P459; Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001; Shockley KR, 2009, PHYSIOL GENOMICS, V39, P172, DOI 10.1152/physiolgenomics.90350.2008; Tang WHW, 2009, J AM COLL CARDIOL, V53, P2061, DOI 10.1016/j.jacc.2009.02.036; Tous M, 2005, MOL CELL BIOCHEM, V268, P53, DOI 10.1007/s11010-005-2997-0; Vergnes L, 2003, J BIOL CHEM, V278, P42774, DOI 10.1074/jbc.M306022200; Wei LH, 2001, P NATL ACAD SCI USA, V98, P9260, DOI 10.1073/pnas.161294898; Wei LH, 2000, AM J PHYSIOL-CELL PH, V279, pC248, DOI 10.1152/ajpcell.2000.279.1.C248; White AR, 2006, HYPERTENSION, V47, P245, DOI 10.1161/01.HYP.0000198543.34502.d7; Wu GY, 1998, BIOCHEM J, V336, P1, DOI 10.1042/bj3360001; Yang ZH, 2006, CURR HYPERTENS REP, V8, P54, DOI 10.1007/s11906-006-0041-8; Zhang CH, 2004, HYPERTENSION, V44, P935, DOI 10.1161/01.HYP.0000146907.82869.f2; ZHANG SH, 1994, J CLIN INVEST, V94, P937, DOI 10.1172/JCI117460; Zheng SQ, 2008, EUR J PHARMACOL, V584, P118, DOI 10.1016/j.ejphar.2008.01.045	47	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15253	10.1371/journal.pone.0015253	http://dx.doi.org/10.1371/journal.pone.0015253			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151916	Green Published, gold, Green Accepted			2022-12-27	WOS:000284995300024
J	Hasan, N; Corbin, D; Hu, CA				Hasan, Nazarul; Corbin, Deborah; Hu, Chuan			Fusogenic Pairings of Vesicle-Associated Membrane Proteins (VAMPs) and Plasma Membrane t-SNAREs-VAMP5 as the Exception	PLOS ONE			English	Article							TRANS-GOLGI NETWORK; 3 SNARE COMPLEXES; EPITHELIAL-CELLS; MEDIATED CLEAVAGE; HUMAN PLATELETS; SYNTAXIN 4; IN-VITRO; FUSION; EXOCYTOSIS; CELLUBREVIN	Background: Intracellular vesicle fusion is mediated by the interactions of SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein receptor) proteins on vesicles (v-SNAREs) and on target membranes (t-SNAREs). The vesicle-associated membrane proteins (VAMPs) are v-SNAREs that reside in various post-Golgi vesicular compartments. To fully understand the specific role of each VAMP in vesicle trafficking, it is important to determine if VAMPs have differential membrane fusion activities. Methodology/Principal Findings: In this study, we developed a cell fusion assay that quantifies SNARE-mediated membrane fusion events by activated expression of beta-galactosidase, and examined fusogenic pairings between the seven VAMPs, i.e., VAMPs 1, 2, 3, 4, 5, 7 and 8, and two plasma membrane t-SNARE complexes, syntaxin1/SNAP-25 and syntaxin4/SNAP-25. VAMPs 1, 2, 3, 4, 7 and 8 drove fusion efficiently, whereas VAMP5 was unable to mediate fusion with the t-SNAREs. By expressing VAMPs 1, 3, 4, 7 and 8 at the same level, we further compared their membrane fusion activities. VAMPs 1 and 3 had comparable and the highest fusion activities, whereas VAMPs 4, 7 and 8 exhibited 30-50% lower fusion activities. Moreover, we determined the dependence of cell fusion activity on VAMP1 expression level. Analysis of the dependence data suggested that there was no cooperativity of VAMP proteins in the cell fusion reaction. Conclusions/Significance: These data indicate that VAMPs have differential membrane fusion capacities, and imply that with the exception of VAMP5, VAMPs are essentially redundant in mediating fusion with plasma membrane t-SNAREs.	[Hasan, Nazarul; Corbin, Deborah; Hu, Chuan] Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA	University of Louisville	Hasan, N (corresponding author), Univ Louisville, Sch Med, Dept Biochem & Mol Biol, Louisville, KY 40292 USA.	chuan.hu@louisville.edu			American Heart Association; University of Louisville School of Medicine; National Institutes of Health [CA135123]; NATIONAL CANCER INSTITUTE [R03CA135123] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); University of Louisville School of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a scientist development grant from the American Heart Association, a startup fund from the University of Louisville School of Medicine and CA135123 from the National Institutes of Health (to C.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani RJ, 1999, J CELL BIOL, V146, P765, DOI 10.1083/jcb.146.4.765; Advani RJ, 1998, J BIOL CHEM, V273, P10317, DOI 10.1074/jbc.273.17.10317; Bock JB, 2001, NATURE, V409, P839, DOI 10.1038/35057024; Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Brandhorst D, 2006, P NATL ACAD SCI USA, V103, P2701, DOI 10.1073/pnas.0511138103; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Danieli T, 1996, J CELL BIOL, V133, P559, DOI 10.1083/jcb.133.3.559; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200; Feng D, 2002, BLOOD, V99, P4006, DOI 10.1182/blood.V99.11.4006; Galli T, 1998, MOL BIOL CELL, V9, P1437, DOI 10.1091/mbc.9.6.1437; GALLI T, 1994, J CELL BIOL, V125, P1015, DOI 10.1083/jcb.125.5.1015; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Hasan N, 2010, EXP CELL RES, V316, P12, DOI 10.1016/j.yexcr.2009.10.007; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hu C, 2007, EXP CELL RES, V313, P3198, DOI 10.1016/j.yexcr.2007.06.008; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; Jagadish MN, 1996, BIOCHEM J, V317, P945, DOI 10.1042/bj3170945; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Karatekin E, 2010, P NATL ACAD SCI USA, V107, P3517, DOI 10.1073/pnas.0914723107; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Li X, 2002, AM J PHYSIOL-RENAL, V283, pF1111, DOI 10.1152/ajprenal.00185.2002; Luftman K, 2009, BIOCHEM BIOPH RES CO, V380, P65, DOI 10.1016/j.bbrc.2009.01.036; Mallard F, 2002, J CELL BIOL, V156, P653, DOI 10.1083/jcb.200110081; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Mayer A, 1996, CELL, V85, P83, DOI 10.1016/S0092-8674(00)81084-3; MCMAHON HT, 1993, NATURE, V364, P346, DOI 10.1038/364346a0; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Morgenthaler FD, 2003, EUR J NEUROSCI, V17, P1365, DOI 10.1046/j.1460-9568.2003.02572.x; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Peden AA, 2001, J BIOL CHEM, V276, P49183, DOI 10.1074/jbc.M106646200; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Pocard T, 2007, J CELL SCI, V120, P3309, DOI 10.1242/jcs.007948; Polgar J, 2002, BLOOD, V100, P1081, DOI 10.1182/blood.V100.3.1081; Procino G, 2008, J CELL SCI, V121, P2097, DOI 10.1242/jcs.022210; Proux-Gillardeaux V, 2005, P NATL ACAD SCI USA, V102, P6362, DOI 10.1073/pnas.0409613102; Randhawa VK, 2000, MOL BIOL CELL, V11, P2403, DOI 10.1091/mbc.11.7.2403; Reed GL, 1999, BLOOD, V93, P2617, DOI 10.1182/blood.V93.8.2617.408k19_2617_2626; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Rowe J, 2001, J CELL SCI, V114, P3323; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Steegmaier M, 1999, MOL BIOL CELL, V10, P1957, DOI 10.1091/mbc.10.6.1957; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Veale KJ, 2010, TRAFFIC, V11, P1370, DOI 10.1111/j.1600-0854.2010.01094.x; Wang CC, 2004, DEV CELL, V7, P359, DOI 10.1016/j.devcel.2004.08.002; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wong SH, 1998, MOL BIOL CELL, V9, P1549, DOI 10.1091/mbc.9.6.1549; Zeng Q, 2003, J BIOL CHEM, V278, P23046, DOI 10.1074/jbc.M303214200; Zeng Q, 1998, MOL BIOL CELL, V9, P2423, DOI 10.1091/mbc.9.9.2423	54	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14238	10.1371/journal.pone.0014238	http://dx.doi.org/10.1371/journal.pone.0014238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151919	gold, Green Submitted, Green Published			2022-12-27	WOS:000284995300010
J	Barnett, A; Abrantes, KG; Stevens, JD; Bruce, BD; Semmens, JM				Barnett, Adam; Abrantes, Katya G.; Stevens, John D.; Bruce, Barry D.; Semmens, Jayson M.			Fine-Scale Movements of the Broadnose Sevengill Shark and Its Main Prey, the Gummy Shark	PLOS ONE			English	Article							PACIFIC SLEEPER SHARK; NOTORYNCHUS-CEPEDIANUS; SOMNIOSUS-MICROCEPHALUS; ACOUSTIC TRACKING; PREDATOR; BEHAVIOR; DIET; ECOLOGY; HABITAT; RISK	Information on the fine-scale movement of predators and their prey is important to interpret foraging behaviours and activity patterns. An understanding of these behaviours will help determine predator-prey relationships and their effects on community dynamics. For instance understanding a predator's movement behaviour may alter pre determined expectations of prey behaviour, as almost any aspect of the prey's decisions from foraging to mating can be influenced by the risk of predation. Acoustic telemetry was used to study the fine-scale movement patterns of the Broadnose Sevengill shark Notorynchus cepedianus and its main prey, the Gummy shark Mustelus antarcticus, in a coastal bay of southeast Tasmania. Notorynchus cepedianus displayed distinct diel differences in activity patterns. During the day they stayed close to the substrate (sea floor) and were frequently inactive. At night, however, their swimming behaviour continually oscillated through the water column from the substrate to near surface. In contrast, M. antarcticus remained close to the substrate for the entire diel cycle, and showed similar movement patterns for day and night. For both species, the possibility that movement is related to foraging behaviour is discussed. For M. antarcticus, movement may possibly be linked to a diet of predominantly slow benthic prey. On several occasions, N. cepedianus carried out a sequence of burst speed events (increased rates of movement) that could be related to chasing prey. All burst speed events during the day were across the substrate, while at night these occurred in the water column. Overall, diel differences in water column use, along with the presence of oscillatory behaviour and burst speed events suggest that N. cepedianus are nocturnal foragers, but may opportunistically attack prey they happen to encounter during the day.	[Barnett, Adam; Abrantes, Katya G.; Semmens, Jayson M.] Univ Tasmania, Marine Res Labs, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia; [Barnett, Adam; Stevens, John D.; Bruce, Barry D.] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Abrantes, Katya G.] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO); James Cook University	Barnett, A (corresponding author), Univ Tasmania, Marine Res Labs, Tasmanian Aquaculture & Fisheries Inst, Hobart, Tas, Australia.	adam.barnett@utas.edu.au		, Adam/0000-0001-7430-8428; abrantes, katya/0000-0001-8648-8817; Semmens, Jayson/0000-0003-1742-6692	Save Our Seas Foundation; Winifred Violet Scott Foundation; Holsworth Wildlife Research Endowment	Save Our Seas Foundation; Winifred Violet Scott Foundation; Holsworth Wildlife Research Endowment	This study was supported by grants from the Save Our Seas Foundation (www.saveourseas.com), Winifred Violet Scott Foundation (no website available) and the Holsworth Wildlife Research Endowment (http://www.anz.com/personal/private-bank-trustees/trustees/apply-grant/named-charitable-trusts/). No grant numbers are available at present due to finance department restructuring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DP, 2005, J WILDLIFE MANAGE, V69, P298, DOI 10.2193/0022-541X(2005)069&lt;0298:SSRSBR&gt;2.0.CO;2; Andrews KS, 2009, ANIM BEHAV, V78, P525, DOI 10.1016/j.anbehav.2009.05.027; Barnett A, 2010, J FISH BIOL, V77, P1688, DOI 10.1111/j.1095-8649.2010.02810.x; Barnett A, 2010, MAR ECOL PROG SER, V416, P189, DOI 10.3354/meps08778; Barnett A, 2010, J EXP MAR BIOL ECOL, V393, P188, DOI 10.1016/j.jembe.2010.07.022; Braccini JM, 2008, MAR ECOL PROG SER, V371, P273, DOI 10.3354/meps07684; Brown JS, 1999, J MAMMAL, V80, P385, DOI 10.2307/1383287; Campana SE, 2009, MAR ECOL PROG SER, V387, P241, DOI 10.3354/meps08109; CAREY FG, 1990, MAR BIOL, V106, P329, DOI 10.1007/BF01344309; CROCKER GE, 2001, J ZOOL LOND, V254, P267; Davis RW, 2007, PHILOS T R SOC B, V362, P2141, DOI 10.1098/rstb.2007.2107; EBERT DA, 1989, CALIF FISH GAME, V75, P102; Ebert DA, 2002, MAR FRESHWATER RES, V53, P517, DOI 10.1071/MF01143; EBERT DA, 1991, S AFR J MARINE SCI, V11, P565, DOI 10.2989/025776191784287547; EBERT DA, 1991, S AFR J MARINE SCI, V11, P455, DOI 10.2989/025776191784287637; Frid A, 2009, OECOLOGIA, V158, P775, DOI 10.1007/s00442-008-1189-5; Gardiner JM, 2010, CURR BIOL, V20, P1187, DOI 10.1016/j.cub.2010.04.053; Gunn JS, 1999, MAR BIOL, V135, P553, DOI 10.1007/s002270050656; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Heithaus MR, 2009, J ANIM ECOL, V78, P556, DOI 10.1111/j.1365-2656.2008.01512.x; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heithaus MR, 2001, MAR ECOL PROG SER, V209, P307, DOI 10.3354/meps209307; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2005, MAR BIOL, V147, P1239, DOI 10.1007/s00227-005-0004-7; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; HOLTS DB, 1993, AUST J MAR FRESH RES, V44, P901; Hulbert LB, 2006, J FISH BIOL, V69, P406, DOI 10.1111/j.1095-8649.2006.01175.x; Jadot C, 2006, ICES J MAR SCI, V63, P128, DOI 10.1016/j.icesjms.2005.06.010; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; Johnson CJ, 2002, ECOL APPL, V12, P1840, DOI 10.1890/1051-0761(2002)012[1840:AMBATU]2.0.CO;2; KLIMLEY AP, 1993, MAR BIOL, V117, P1, DOI 10.1007/BF00346421; Klimley AP, 2002, ENVIRON BIOL FISH, V63, P117; Klimley AP, 2001, MAR BIOL, V138, P429, DOI 10.1007/s002270000394; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Laroche RK, 2008, ANIM BEHAV, V76, P1901, DOI 10.1016/j.anbehav.2008.06.025; Last P. R., 2009, SHARKS RAYS AUSTR, V2; Lima SL, 2002, TRENDS ECOL EVOL, V17, P70, DOI 10.1016/S0169-5347(01)02393-X; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lucifora LO, 2005, MAR ECOL PROG SER, V289, P237, DOI 10.3354/meps289237; Macia A, 2003, J EXP MAR BIOL ECOL, V291, P29, DOI 10.1016/S0022-0981(03)00097-2; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mitchell WA, 2002, OIKOS, V99, P249, DOI 10.1034/j.1600-0706.2002.990205.x; Nakano H, 2003, MAR ECOL PROG SER, V265, P255, DOI 10.3354/meps265255; Nams VO, 2005, OECOLOGIA, V143, P179, DOI 10.1007/s00442-004-1804-z; Nams VO, 1996, LANDSCAPE ECOL, V11, P289, DOI 10.1007/BF02059856; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Sigler MF, 2006, J FISH BIOL, V69, P392, DOI 10.1111/j.1095-8649.2006.01096.x; SIH A, 1980, SCIENCE, V210, P1041, DOI 10.1126/science.210.4473.1041; Stevens J. D., 1997, 93061 CSIRO FISH RES; Stokesbury MJW, 2005, MAR BIOL, V148, P159, DOI 10.1007/s00227-005-0061-y; Strong WR, 1996, GREAT WHITE SHARKS, P229, DOI 10.1016/B978-012415031-7/50022-7; Sundstrom LF, 2002, J FISH BIOL, V61, P834, DOI 10.1006/jfbi.2002.2058; Sundstrom LF, 2001, ENVIRON BIOL FISH, V60, P225, DOI 10.1023/A:1007657505099; TRICAS TC, 1981, COPEIA, P904, DOI 10.2307/1444199; West GJ, 2001, ENVIRON BIOL FISH, V60, P283, DOI 10.1023/A:1007697816642; WILLIAMS H, 1992, AUST J MAR FRESH RES, V43, P237, DOI 10.1071/MF9920237; Wirsing AJ, 2007, ANIM BEHAV, V74, P93, DOI 10.1016/j.anbehav.2006.11.016; Yang MS, 1999, FISH B-NOAA, V97, P406; Yano K, 2007, J FISH BIOL, V70, P374, DOI 10.1111/j.1095-8649.2007.01308.x; YICK J, THESIS U TASMANIA	61	39	39	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15464	10.1371/journal.pone.0015464	http://dx.doi.org/10.1371/journal.pone.0015464			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151925	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000284939600035
J	Aisiku, OR; Runnels, LW; Scarlata, S				Aisiku, Omozuanvbo R.; Runnels, Loren W.; Scarlata, Suzanne			Identification of a Novel Binding Partner of Phospholipase C beta 1: Translin-Associated Factor X	PLOS ONE			English	Article							BETA-GAMMA-SUBUNITS; G-ALPHA-Q; G-PROTEINS; LIVING CELLS; ACTIVATION; G-ALPHA(Q); INOSITIDES; RECEPTORS; EFFECTORS; MEMBRANE	Mammalian phospholipase C beta 1 (PLC beta 1) is activated by the ubiquitous G alpha(q) family of G proteins on the surface of the inner leaflet of plasma membrane where it catalyzes the hydrolysis of phosphatidylinositol 4,5 bisphosphate. In general, PLC beta 1 is mainly localized on the cytosolic plasma membrane surface, although a substantial fraction is also found in the cytosol and, under some conditions, in the nucleus. The factors that localize PLC beta 1 in these other compartments are unknown. Here, we identified a novel binding partner, translin-associated factor X (TRAX). TRAX is a cytosolic protein that can transit into the nucleus. In purified form, PLC beta 1 binds strongly to TRAX with an affinity that is only ten-fold weaker than its affinity for its functional partner, G alpha(q). In solution, TRAX has little effect on the membrane association or the catalytic activity of PLC beta 1. However, TRAX directly competes with G alpha(q) for PLC beta 1 binding, and excess TRAX reverses G alpha(q) activation of PLC beta 1. In C6 glia cells, endogenous PLC beta 1 and TRAX colocalize in the cytosol and the nucleus, but not on the plasma membrane where TRAX is absent. In Neuro2A cells expressing enhanced yellow and cyano fluorescent proteins (i.e., eYFP-PLC beta 1 and eCFP-TRAX), Forster resonance energy transfer (FRET) is observed mostly in the cytosol and a small amount is seen in the nucleus. FRET does not occur at the plasma membrane where TRAX is not found. Our studies show that TRAX, localized in the cytosol and nucleus, competes with plasma-membrane bound G alpha(q) for PLC beta 1 binding thus stabilizing PLC beta 1 in other cellular compartments.	[Aisiku, Omozuanvbo R.; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Runnels, Loren W.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, New Brunswick, NJ USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Rutgers State University New Brunswick; Rutgers State University Medical Center	Aisiku, OR (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	suzanne.scarlata@sunysb.edu		Runnels, Loren/0000-0002-2537-7360	National Institutes of Health [NIH053132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health, NIH053132. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Cocco L, 2002, ADV ENZYME REGUL, V42, P181, DOI 10.1016/S0065-2571(01)00030-9; Cocco L, 2000, ADV ENZYME REGUL, V40, P83, DOI 10.1016/S0065-2571(99)00028-X; Cocco L, 2006, BBA-MOL CELL BIOL L, V1761, P509, DOI 10.1016/j.bbalip.2006.03.001; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Exton JH, 1996, ANNU REV PHARMACOL, V36, P481, DOI 10.1146/annurev.pa.36.040196.002405; Garcia-Hoz C, 2010, J BIOL CHEM, V285, P13480, DOI 10.1074/jbc.M109.098699; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Liu Y, 2009, SCIENCE, V325, P750, DOI 10.1126/science.1176325; Manzoli L, 1997, CANCER RES, V57, P2137; Manzoli L, 1999, ANTICANCER RES, V19, P3753; PARK DG, 1993, J BIOL CHEM, V268, P3710; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Phillips F, 2006, SOCIAL CULTURE AND HIGH-TECH ECONOMIC DEVELOPMENT, P15; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Runnels LW, 1996, BIOCHEMISTRY-US, V35, P16824, DOI 10.1021/bi961606w; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Runnels LW, 2002, NAT CELL BIOL, V4, P329, DOI 10.1038/ncb781; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Singer AU, 2002, NAT STRUCT BIOL, V9, P32, DOI 10.1038/nsb731; Sugiura I, 2004, ACTA CRYSTALLOGR D, V60, P674, DOI 10.1107/S0907444904002549; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Sun CN, 2006, MOL PHARMACOL, V70, P454, DOI 10.1124/mol.105.021261; Wang J, 2004, BIOCHEMISTRY-US, V43, P13424, DOI 10.1021/bi048847l; Wang T, 1999, P NATL ACAD SCI USA, V96, P7843, DOI 10.1073/pnas.96.14.7843; Yang SC, 2004, J BIOL CHEM, V279, P12605, DOI 10.1074/jbc.M313133200	32	31	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15001	10.1371/journal.pone.0015001	http://dx.doi.org/10.1371/journal.pone.0015001			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124736	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500013
J	Sabbatini, F; Bandera, A; Ferrario, G; Trabattoni, D; Marchetti, G; Franzetti, F; Clerici, M; Gori, A				Sabbatini, Francesca; Bandera, Alessandra; Ferrario, Giulio; Trabattoni, Daria; Marchetti, Giulia; Franzetti, Fabio; Clerici, Mario; Gori, Andrea			Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; MYCOBACTERIUM-AVIUM; HUMAN MACROPHAGES; CELL COUNT; IN-VITRO; CD4; RESTORATION; TRIAL; IMMUNOTHERAPY	Background: Treatment of HIV-infected patients with interleukin-2 (IL-2) produces significant increases in CD4 T cell counts; however an associated qualitative improvement in cells function has yet to be conclusively demonstrated. By measuring mycobacterial killing activity, we evaluated IL-2-mediated functional immune enhancement ex vivo in immunological non-responders (INRs). Methods and Findings: PBMC from 12 immunological non-responders (INRs) (CD4+<200/mu l, HIV-RNA<50 cp/ml) on combination antiretroviral treatment (cART) were collected at baseline, and after 3 IL-2 cycles. Eight INRs receiving only cART were studied as controls. After 21 days of PBMC incubation with a virulent M. avium suspension, counts of residual colony forming units (CFUs) and concentrations of TNF-alpha, IL-10 and IFN-gamma were determined. In IL-2 treated patients, a significant reduction in mean residual CFUs of PBMC cultures was observed (p<0.01). Moreover, following IL-2 treatment, significant increases in PBMC's IFN gamma production (p = 0.02) and substantial reductions in IL-10 levels were observed. Conclusions: IL-2 therapy restores the ability of the lympho-monocyte system in eliciting an effective response against mycobacterial infections. Our data indicate the possibility of a clinical role held by IL-2 in enhancing the immune function of subjects unable to achieve immune competence through cART alone.	[Sabbatini, Francesca; Bandera, Alessandra; Gori, Andrea] Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy; [Ferrario, Giulio; Franzetti, Fabio] Univ Milan, Luigi Sacco Hosp, Infect Dis Sect, Dept Clin Sci, Milan, Italy; [Trabattoni, Daria] Univ Milan, Dept Preclin Sci, Chair Immunol, LITA VIALBA, Milan, Italy; [Marchetti, Giulia] Univ Milan, San Paolo Hosp, Clin Infect Dis, Dept Med Surg & Dent, Milan, Italy; [Clerici, Mario] Univ Milan, Sch Med, Chair Immunol, Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn IRCCS, Milan, Italy	San Gerardo Hospital; University of Milano-Bicocca; University of Milan; Luigi Sacco Hospital; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Sabbatini, F (corresponding author), Univ Milano Bicocca, San Gerardo Hosp, Dept Internal Med, Div Infect Dis, Monza, Italy.	f.sabbatini@hsgerardo.org	Trabattoni, Daria/G-7424-2012; franzetti, fabio/AAK-9158-2020; Marchetti, Giulia/GPX-7655-2022; Bandera, Alessandra/AAC-6081-2022; Gori, Andrea/AAC-6078-2022; Bandera, Alessandra/D-6255-2015; MARCHETTI, GIULIA CARLA/K-4384-2018	Trabattoni, Daria/0000-0001-9535-3359; franzetti, fabio/0000-0001-9253-4453; MARCHETTI, GIULIA CARLA/0000-0002-4498-4828; Clerici, Mario/0000-0001-5920-6191; BANDERA, ALESSANDRA/0000-0001-9440-4601; Bandera, Alessandra/0000-0003-1626-0328	Ermenegildo Zegna Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	Ermenegildo Zegna Foundation, Italy; Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy	The present study was funded by a grant from the Ermenegildo Zegna Foundation, Italy, and Angelantoni Heraeus Scientific Instruments (A.H.S.I.) S.p.A., Milan, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Autran B, 1999, IMMUNOL LETT, V66, P207, DOI 10.1016/S0165-2478(98)00159-X; BAGBY GC, 2000, HEMATOLOGY BASIC PRI, P154; Bahr GM, 2003, J ANTIMICROB CHEMOTH, V51, P5, DOI 10.1093/jac/dkg063; BERMUDEZ LEM, 1990, J LEUKOCYTE BIOL, V48, P67, DOI 10.1002/jlb.48.1.67; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; CROWLE AJ, 1992, INFECT IMMUN, V60, P3697, DOI 10.1128/IAI.60.9.3697-3703.1992; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gori A, 2004, ANTIVIR THER, V9, P603; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; JENKINS PA, 1982, BIOL MYCOBACTERIA; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Levy Y, 2003, AIDS, V17, P343, DOI 10.1097/00002030-200302140-00008; Luo Y, 2010, CLIN EXP IMMUNOL, V160, P359, DOI 10.1111/j.1365-2249.2010.04105.x; Marchetti G, 2004, AIDS, V18, P211, DOI 10.1097/00002030-200401230-00010; Marchetti G, 2002, J INFECT DIS, V186, P606, DOI 10.1086/342479; Marchetti G, 2005, J ANTIMICROB CHEMOTH, V55, P401, DOI 10.1093/jac/dkh557; MEYLAN PRA, 1992, J INFECT DIS, V165, P80, DOI 10.1093/infdis/165.1.80; Miller V, 2002, J INFECT DIS, V186, P189, DOI 10.1086/341466; Newman GW, 1997, J INFECT DIS, V175, P891, DOI 10.1086/513987; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Piketty C, 1998, AIDS, V12, P745, DOI 10.1097/00002030-199807000-00011; RELJIC R, 2010, CYTOKINE        0428; Vazquez N, 2006, J LEUKOCYTE BIOL, V80, P1136, DOI 10.1189/jlb.0306206	25	11	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14119	10.1371/journal.pone.0014119	http://dx.doi.org/10.1371/journal.pone.0014119			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124762	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500009
J	Wohlrab, S; Iversen, MH; John, U				Wohlrab, Sylke; Iversen, Morten H.; John, Uwe			A Molecular and Co-Evolutionary Context for Grazer Induced Toxin Production in Alexandrium tamarense	PLOS ONE			English	Article							ATLANTIC RIGHT WHALES; POISONING PSP TOXINS; PLANKTONIC COPEPODS; EUBALAENA-GLACIALIS; MARINE; PHYTOPLANKTON; DIVERSITY; PREY; COMMUNICATION; METABOLITES	Marine dinoflagellates of the genus Alexandrium are the proximal source of neurotoxins associated with Paralytic Shellfish Poisoning. The production of these toxins, the toxin biosynthesis and, thus, the cellular toxicity can be influenced by abiotic and biotic factors. There is, however, a lack of substantial evidence concerning the toxins' ecological function such as grazing defense. Waterborne cues from copepods have been previously found to induce a species-specific increase in toxin content in Alexandrium minutum. However, it remains speculative in which context these species-specific responses evolved and if it occurs in other Alexandrium species as well. In this study we exposed Alexandrium tamarense to three copepod species (Calanus helgolandicus, Acartia clausii, and Oithona similis) and their corresponding cues. We show that the species-specific response towards copepod-cues is not restricted to one Alexandrium species and that co-evolutionary processes might be involved in these responses, thus giving additional evidence for the defensive role of phycotoxins. Through a functional genomic approach we gained insights into the underlying molecular processes which could trigger the different outcomes of these species-specific responses and consequently lead to increased toxin content in Alexandrium tamarense. We propose that the regulation of serine/threonine kinase signaling pathways has a major influence in directing the external stimuli i.e. copepod-cues, into different intracellular cascades and networks in A. tamarense. Our results show that A. tamarense can sense potential predating copepods and respond to the received information by increasing its toxin production. Furthermore, we demonstrate how a functional genomic approach can be used to investigate species interactions within the plankton community.	[Wohlrab, Sylke; John, Uwe] Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany; [Iversen, Morten H.] Univ Bremen, Dept Geosci Marum, Bremen, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Bremen	Wohlrab, S (corresponding author), Alfred Wegener Inst Polar & Marine Res, Dept Ecol Chem, Bremerhaven, Germany.	Sylke.Wohlrab@awi.de	john, uwe/S-3009-2016; Wohlrab, Sylke/R-7435-2016; Iversen, Morten/C-7741-2013; Iversen, Morten Hvitfeldt/Q-3774-2016	john, uwe/0000-0002-1297-4086; Wohlrab, Sylke/0000-0003-3190-0880; Iversen, Morten Hvitfeldt/0000-0002-5287-1110	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU [GOCE-CT-2004-511154]; Marine Genomics [GOCE-CT-2004-505403]	Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; EU(European Commission); Marine Genomics	Financial support was provided by the PACES (Polar regions and Coasts in a changing Earth System) research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment, and by the EU-Project ESTTAL (Expressed Sequence Tags of Toxic Algae, GOCE-CT-2004-511154) and Marine Genomics (GOCE-CT-2004-505403). The Poseidon cruise (P352) was endorsed by the SCOR-IOC (Scientific Committee on Oceanographic Research - Intergovernmental Oceanographic Commission) program GEOHAB (Global Ecology and Oceanography of Harmful Algal Blooms) as a contribution to the Core Research Project on Harmful Algal Blooms in Fjords and Coastal Embayments. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpermann TJ, 2010, J PHYCOL, V46, P18, DOI 10.1111/j.1529-8817.2009.00767.x; Avery DE, 2007, LIMNOL OCEANOGR, V52, P2099, DOI 10.4319/lo.2007.52.5.2099; Bagoien E, 1996, MAR BIOL, V126, P361, DOI 10.1007/BF00354618; Bagoien E, 2005, MAR ECOL PROG SER, V300, P129, DOI 10.3354/meps300129; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Bergkvist J, 2008, OECOLOGIA, V156, P147, DOI 10.1007/s00442-008-0981-6; BOYD CM, 1976, LIMNOL OCEANOGR, V21, P175, DOI 10.4319/lo.1976.21.1.0175; CASTOR G, 2002, MARINE ECOLOGY PROGR, V240, P105; Cembella A, 1998, PHYSL ECOLOGY HARMFU, P381; Cembella AD, 2003, PHYCOLOGIA, V42, P420, DOI 10.2216/i0031-8884-42-4-420.1; Colin SP, 2004, EVOL ECOL, V18, P355, DOI 10.1007/s10682-004-2369-3; Doucette GJ, 2006, MAR ECOL PROG SER, V306, P303, DOI 10.3354/meps306303; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Durbin E, 2002, HARMFUL ALGAE, V1, P243, DOI 10.1016/S1568-9883(02)00046-X; Ferrari MCO, 2008, BEHAV ECOL SOCIOBIOL, V62, P1079, DOI 10.1007/s00265-007-0535-7; Fink P, 2007, MAR FRESHW BEHAV PHY, V40, P155, DOI 10.1080/10236240701602218; Fistarol GO, 2005, AQUAT MICROB ECOL, V41, P153, DOI 10.3354/ame041153; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; Gustafsson S, 2004, AQUAT ECOL, V38, P37, DOI 10.1023/B:AECO.0000020985.47348.5e; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; Hansson LA, 2000, ECOLOGY, V81, P842, DOI 10.2307/177381; HARRIS RP, 1994, MAR BIOL, V119, P431, DOI 10.1007/BF00347540; Iversen MH, 2007, MAR ECOL PROG SER, V350, P79, DOI 10.3354/meps07095; Jasti S, 2005, APPL ENVIRON MICROB, V71, P3483, DOI 10.1128/AEM.71.7.3483-3494.2005; Jenster G, 2004, MOL CELL ENDOCRINOL, V218, P1, DOI 10.1016/j.mce.2004.01.012; KELLER MD, 1987, J PHYCOL, V23, P633; Kiorboe T, 1996, MAR ECOL PROG SER, V143, P65, DOI 10.3354/meps143065; Kiorboe T, 2005, MAR ECOL PROG SER, V300, P117, DOI 10.3354/meps300117; Korth KL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-221; Kozlowsky-Suzuki B, 2009, HARMFUL ALGAE, V8, P395, DOI 10.1016/j.hal.2008.08.025; Krock B, 2007, HARMFUL ALGAE, V6, P734, DOI 10.1016/j.hal.2007.02.005; Laforsch C, 2006, LIMNOL OCEANOGR, V51, P1466, DOI 10.4319/lo.2006.51.3.1466; Liu JW, 2006, PROG NAT SCI-MATER, V16, P671; Maffei ME, 2007, TRENDS PLANT SCI, V12, P310, DOI 10.1016/j.tplants.2007.06.001; Medhekar B, 2007, CURR OPIN MICROBIOL, V10, P388, DOI 10.1016/j.mib.2007.06.004; Mortensen A. M., 1985, TOXIC DINOFLAGELLATE, P163; PAFFENHOFER GA, 1993, J PLANKTON RES, V15, P37, DOI 10.1093/plankt/15.1.37; Pflugmacher S, 1998, BBA-GEN SUBJECTS, V1425, P527, DOI 10.1016/S0304-4165(98)00107-X; Pohnert G, 2007, TRENDS ECOL EVOL, V22, P198, DOI 10.1016/j.tree.2007.01.005; Pohnert G, 2010, J PLANKTON RES, V32, P141, DOI 10.1093/plankt/fbp118; PRAKASH A, 1971, FISH RES BD CAN B, V177, P87; Rausher MD, 2001, NATURE, V411, P857, DOI 10.1038/35081193; Saiz E, 2009, ENVIRON POLLUT, V157, P1219, DOI 10.1016/j.envpol.2008.12.011; SCHANTZ EJ, 1975, J AM CHEM SOC, V97, P1238, DOI 10.1021/ja00838a045; Schwachtje J, 2008, PLANT PHYSIOL, V146, P845, DOI 10.1104/pp.107.112490; Selander E, 2006, P ROY SOC B-BIOL SCI, V273, P1673, DOI 10.1098/rspb.2006.3502; Sivonen K, 1999, TOXIC CYANOBACTERIA, P41, DOI DOI 10.4324/9780203478073; Svensen C, 2000, J PLANKTON RES, V22, P1155, DOI 10.1093/plankt/22.6.1155; Teegarden GJ, 1999, MAR ECOL PROG SER, V181, P163, DOI 10.3354/meps181163; Teegarden GJ, 1996, J EXP MAR BIOL ECOL, V196, P145, DOI 10.1016/0022-0981(95)00128-X; Teegarden GJ, 2003, J PLANKTON RES, V25, P429, DOI 10.1093/plankt/25.4.429; Teegarden GJ, 2008, HARMFUL ALGAE, V7, P33, DOI 10.1016/j.hal.2007.05.010; Tillmann U, 2007, J PLANKTON RES, V29, P527, DOI 10.1093/plankt/fbm034; Tillmann U, 2009, HARMFUL ALGAE, V8, P759, DOI 10.1016/j.hal.2009.03.005; TILLMANNS AR, 2008, METAANALYSIS CYANOBA; Turner Jefferson T., 1998, NATO ASI Series Series G Ecological Sciences, V41, P453; Turner JT, 2000, MAR ECOL PROG SER, V203, P95, DOI 10.3354/meps203095; Turner JT, 1997, LIMNOL OCEANOGR, V42, P1203, DOI 10.4319/lo.1997.42.5_part_2.1203; UYE S-I, 1982, Journal of the Oceanographical Society of Japan, V38, P149, DOI 10.1007/BF02110286; Vardi A, 2002, CURR BIOL, V12, P1767, DOI 10.1016/S0960-9822(02)01217-4; Verret F, 2010, NEW PHYTOL, V187, P23, DOI 10.1111/j.1469-8137.2010.03271.x; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Wootton EC, 2007, ENVIRON MICROBIOL, V9, P216, DOI 10.1111/j.1462-2920.2006.01130.x; Wu JQ, 2007, PLANT CELL, V19, P1096, DOI 10.1105/tpc.106.049353; Wu JQ, 2009, PLANT CELL ENVIRON, V32, P1161, DOI 10.1111/j.1365-3040.2009.01943.x; Wyatt T, 1997, J PLANKTON RES, V19, P551, DOI 10.1093/plankt/19.5.551; Yang I, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-248	67	47	47	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15039	10.1371/journal.pone.0015039	http://dx.doi.org/10.1371/journal.pone.0015039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124775	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500020
J	Monnet, C; Loux, V; Gibrat, JF; Spinnler, E; Barbe, V; Vacherie, B; Gavory, F; Gourbeyre, E; Siguier, P; Chandler, M; Elleuch, R; Irlinger, F; Vallaeys, T				Monnet, Christophe; Loux, Valentin; Gibrat, Jean-Francois; Spinnler, Eric; Barbe, Valerie; Vacherie, Benoit; Gavory, Frederick; Gourbeyre, Edith; Siguier, Patricia; Chandler, Michael; Elleuch, Rayda; Irlinger, Francoise; Vallaeys, Tatiana			The Arthrobacter arilaitensis Re117 Genome Sequence Reveals Its Genetic Adaptation to the Surface of Cheese	PLOS ONE			English	Article							LACTIC-ACID BACTERIA; BREVIBACTERIUM-LINENS; CORYNEBACTERIUM-GLUTAMICUM; AMINO-ACIDS; LISTERIA-MONOCYTOGENES; RIPENED CHEESES; L-TYROSINE; SP NOV.; SMEAR; PURIFICATION	Arthrobacter arilaitensis is one of the major bacterial species found at the surface of cheeses, especially in smear-ripened cheeses, where it contributes to the typical colour, flavour and texture properties of the final product. The A. arilaitensis Re117 genome is composed of a 3,859,257 bp chromosome and two plasmids of 50,407 and 8,528 bp. The chromosome shares large regions of synteny with the chromosomes of three environmental Arthrobacter strains for which genome sequences are available: A. aurescens TC1, A. chlorophenolicus A6 and Arthrobacter sp. FB24. In contrast however, 4.92% of the A. arilaitensis chromosome is composed of ISs elements, a portion that is at least 15 fold higher than for the other Arthrobacter strains. Comparative genomic analyses reveal an extensive loss of genes associated with catabolic activities, presumably as a result of adaptation to the properties of the cheese surface habitat. Like the environmental Arthrobacter strains, A. arilaitensis Re117 is well-equipped with enzymes required for the catabolism of major carbon substrates present at cheese surfaces such as fatty acids, amino acids and lactic acid. However, A. arilaitensis has several specificities which seem to be linked to its adaptation to its particular niche. These include the ability to catabolize D-galactonate, a high number of glycine betaine and related osmolyte transporters, two siderophore biosynthesis gene clusters and a high number of Fe3+/siderophore transport systems. In model cheese experiments, addition of small amounts of iron strongly stimulated the growth of A. arilaitensis, indicating that cheese is a highly iron-restricted medium. We suggest that there is a strong selective pressure at the surface of cheese for strains with efficient iron acquisition and salt-tolerance systems together with abilities to catabolize substrates such as lactic acid, lipids and amino acids.	[Monnet, Christophe; Spinnler, Eric; Irlinger, Francoise] INRA, Genie & Microbiol Procedes Alimentaires UMR782, F-78850 Thiverval Grignon, France; [Monnet, Christophe; Spinnler, Eric; Irlinger, Francoise] AgroParisTech, Genie & Microbiol Procedes Alimentaires UMR782, Thiverval Grignon, France; [Elleuch, Rayda] Univ Sci Sfax, Lab Genie Enzymat & Microbiol, Sfax, Tunisia; [Vallaeys, Tatiana] Univ Montpellier 2, CNRS CC093, Ecosyst Lagunaires UMR5119, Montpellier, France; [Gourbeyre, Edith; Siguier, Patricia; Chandler, Michael] Univ Toulouse 3, Lab Microbiol & Genet Mol, CNRS, UMR5100, F-31062 Toulouse, France; [Barbe, Valerie; Vacherie, Benoit; Gavory, Frederick] CEA DSV IG Genoscope, Evry, France; [Loux, Valentin; Gibrat, Jean-Francois] INRA, Math Informat & Genome UR1077, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; Universite de Sfax; Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CEA; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Monnet, C (corresponding author), INRA, Genie & Microbiol Procedes Alimentaires UMR782, F-78850 Thiverval Grignon, France.	monnet@grignon.inra.fr	Spinnler, Henry-Eric/H-1956-2011; Vallaeys, Tatiana/AAE-5508-2019; PONNERASSERY, Sudheesh/C-4589-2014	Spinnler, Henry-Eric/0000-0002-6778-6736; IRLINGER, Francoise/0000-0001-7883-7589; Siguier, Patricia/0000-0003-1620-6495; Vacherie, Benoit/0000-0002-1564-0575; Gavory, Frederick/0000-0003-1534-5725; Loux, Valentin/0000-0002-8268-915X; Chandler, Michael/0000-0002-0292-6662	AgroParistech;  [UMR782]	AgroParistech; 	The work was partially supported by AgroParistech and internal funds of UMR782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarita F, 2004, APPL ENVIRON MICROB, V70, P7348, DOI 10.1128/AEM.70.12.7348-7354.2004; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P1013, DOI 10.1128/AEM.69.2.1013-1022.2003; ARCHIBALD F, 1983, FEMS MICROBIOL LETT, V19, P29, DOI 10.1111/j.1574-6968.1983.tb00504.x; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; Bentley SD, 2003, LANCET, V361, P637, DOI 10.1016/S0140-6736(03)12597-4; Beresford T., 2004, CHEESE CHEM PHYS MIC, V1, P287, DOI DOI 10.1016/S1874-558X(04)80071-X; BLAKLEY ER, 1977, CAN J MICROBIOL, V23, P1128, DOI 10.1139/m77-169; Bockelmann W, 2001, INT DAIRY J, V11, P307, DOI 10.1016/S0958-6946(01)00060-7; Bott M, 2003, J BIOTECHNOL, V104, P129, DOI 10.1016/S0168-1656(03)00144-5; Bouige P, 2002, CURR PROTEIN PEPT SC, V3, P541, DOI 10.2174/1389203023380486; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Brennan NM, 2002, APPL ENVIRON MICROB, V68, P820, DOI 10.1128/AEM.68.2.820-830.2002; Brocker M, 2009, J BACTERIOL, V191, P3869, DOI 10.1128/JB.00113-09; BRUYNEEL B, 1989, BIOTECHNOL LETT, V11, P401, DOI 10.1007/BF01089472; Bryson K, 2006, NUCLEIC ACIDS RES, V34, P3533, DOI 10.1093/nar/gkl471; Callanan M, 2008, J BACTERIOL, V190, P727, DOI 10.1128/JB.01295-07; Cases I, 2005, NAT REV MICROBIOL, V3, P105, DOI 10.1038/nrmicro1084; CHANG SF, 1985, J DAIRY SCI, V68, P2840, DOI 10.3168/jds.S0022-0302(85)81176-0; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; van de Guchte M, 2006, P NATL ACAD SCI USA, V103, P9274, DOI 10.1073/pnas.0603024103; DEACON J, 1977, FEBS LETT, V77, P201, DOI 10.1016/0014-5793(77)80234-2; Deetae P, 2007, APPL MICROBIOL BIOT, V76, P1161, DOI 10.1007/s00253-007-1095-5; Dias B, 1998, APPL ENVIRON MICROB, V64, P3320; Elshafei AM, 2001, ENZYME MICROB TECH, V29, P76, DOI 10.1016/S0141-0229(01)00346-5; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fan F, 2004, ARCH BIOCHEM BIOPHYS, V421, P149, DOI 10.1016/j.abb.2003.10.003; FERCHICHI M, 1985, J GEN MICROBIOL, V131, P715; Fetherston JD, 1999, MOL MICROBIOL, V32, P289, DOI 10.1046/j.1365-2958.1999.01348.x; Feurer C, 2004, J DAIRY SCI, V87, P3189, DOI 10.3168/jds.S0022-0302(04)73454-2; Feurer C, 2004, J APPL MICROBIOL, V97, P546, DOI 10.1111/j.1365-2672.2004.02333.x; Fox P. E, 2000, FUNDAMENTALS CHEESE; Galaup P, 2007, INNOV FOOD SCI EMERG, V8, P373, DOI 10.1016/j.ifset.2007.03.017; Gaucheron F, 1997, INT DAIRY J, V7, P141, DOI 10.1016/S0958-6946(96)00054-4; Goerges S, 2008, APPL ENVIRON MICROB, V74, P2210, DOI 10.1128/AEM.01663-07; Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Irlinger F, 2005, INT J SYST EVOL MICR, V55, P457, DOI 10.1099/ijs.0.63125-0; ISHIZUKA H, 1993, J GEN MICROBIOL, V139, P425, DOI 10.1099/00221287-139-3-425; JACOBSEN T, 1989, APPL MICROBIOL BIOT, V32, P256; Jenssen H, 2009, BIOCHIMIE, V91, P19, DOI 10.1016/j.biochi.2008.05.015; Jerke K, 2008, PLASMID, V59, P73, DOI 10.1016/j.plasmid.2007.12.003; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; KORMANEC J, 1993, NUCLEIC ACIDS RES, V21, P2512, DOI 10.1093/nar/21.10.2512; Krause I, 1997, LAIT, V77, P101, DOI 10.1051/lait:199716; KRINSKY NI, 1989, FREE RADICAL BIO MED, V7, P617, DOI 10.1016/0891-5849(89)90143-3; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leclercq-Perlat MN, 2004, J DAIRY SCI, V87, P1536, DOI 10.3168/jds.S0022-0302(04)73305-6; Leuschner RGK, 1998, J FOOD PROTECT, V61, P874, DOI 10.4315/0362-028X-61.7.874; LING MF, 1994, J MOL BIOL, V243, P950, DOI 10.1006/jmbi.1994.1696; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lynch D, 2001, J BACTERIOL, V183, P2576, DOI 10.1128/JB.183.8.2576-2585.2001; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Molimard P, 1996, J DAIRY SCI, V79, P169, DOI 10.3168/jds.S0022-0302(96)76348-8; Mongodin EF, 2006, PLOS GENET, V2, P2094, DOI 10.1371/journal.pgen.0020214; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Monnet C, 2010, FOOD MICROBIOL, V27, P302, DOI 10.1016/j.fm.2009.11.009; Mounier J, 2006, J APPL MICROBIOL, V101, P668, DOI 10.1111/j.1365-2672.2006.02922.x; Mounier J, 2005, APPL ENVIRON MICROB, V71, P6489, DOI 10.1128/AEM.71.11.6489-6500.2005; Nomura M, 1998, J DAIRY SCI, V81, P1486, DOI 10.3168/jds.S0022-0302(98)75714-5; Noordman WH, 2006, J APPL MICROBIOL, V101, P637, DOI 10.1111/j.1365-2672.2006.02928.x; ONG SA, 1979, J AGR FOOD CHEM, V27, P990, DOI 10.1021/jf60225a033; Pocsi I, 2008, MOL NUTR FOOD RES, V52, P1434, DOI 10.1002/mnfr.200700467; Pohlmann A, 2006, NAT BIOTECHNOL, V24, P1257, DOI 10.1038/nbt1244; POLYCHRONIADOU A, 1979, LAIT, V59, P234, DOI 10.1051/lait:1979585-58612; Prakash P, 2005, BIOINFORMATICS, V21, P2161, DOI 10.1093/bioinformatics/bti375; Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886; Rattray FP, 1997, INT DAIRY J, V7, P273, DOI 10.1016/S0958-6946(97)00013-7; Rea MC, 2007, J DAIRY SCI, V90, P2200, DOI 10.3168/jds.2006-377; REINSCHEID DJ, 1994, J BACTERIOL, V176, P3474, DOI 10.1128/JB.176.12.3474-3483.1994; Rudolf M, 2001, INT J FOOD MICROBIOL, V63, P91, DOI 10.1016/S0168-1605(00)00413-X; Saier MH, 2000, MICROBIOL MOL BIOL R, V64, P354, DOI 10.1128/MMBR.64.2.354-411.2000; Schadewaldt P, 2004, J CHROMATOGR B, V801, P249, DOI 10.1016/j.jchromb.2003.11.020; Shimizu E, 1997, BIOSCI BIOTECH BIOCH, V61, P501, DOI 10.1271/bbb.61.501; Siguier P, 2009, RES MICROBIOL, V160, P232, DOI 10.1016/j.resmic.2009.02.003; SIMON N, 1995, APPL ENVIRON MICROB, V61, P1643, DOI 10.1128/AEM.61.4.1643-1645.1995; Smacchi E, 1999, FEMS MICROBIOL LETT, V178, P191, DOI 10.1111/j.1574-6968.1999.tb13777.x; Smacchi E, 2000, LAIT, V80, P255, DOI 10.1051/lait:2000124; Smit G, 2005, FEMS MICROBIOL REV, V29, P591, DOI 10.1016/j.femsre.2005.04.002; Soliveri JA, 2000, MICROBIOL-SGM, V146, P333, DOI 10.1099/00221287-146-2-333; SPARNINS VL, 1976, J BACTERIOL, V127, P362, DOI 10.1128/JB.127.1.362-366.1976; STRATTON JE, 1991, J FOOD PROT, V54; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tauch A, 2000, PLASMID, V44, P285, DOI 10.1006/plas.2000.1489; Van Gijsegem F, 2008, MOL PLANT MICROBE IN, V21, P1471, DOI 10.1094/MPMI-21-11-1471; VISCA P, 1994, J BACTERIOL, V176, P1128, DOI 10.1128/JB.176.4.1128-1140.1994; Wang F, 2007, BIOTECHNOL ADV, V25, P211, DOI 10.1016/j.biotechadv.2006.12.001; WAYNE AW, 2010, FEMS MICROB IN PRESS; Weinberg ED, 1997, PERSPECT BIOL MED, V40, P578; Westerberg K, 2000, INT J SYST EVOL MICR, V50, P2083, DOI 10.1099/00207713-50-6-2083; Wiens GD, 2008, J BACTERIOL, V190, P6970, DOI 10.1128/JB.00721-08	94	55	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15489	10.1371/journal.pone.0015489	http://dx.doi.org/10.1371/journal.pone.0015489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124797	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000029
J	Major, JM; Doubeni, CA; Freedman, ND; Park, Y; Lian, M; Hollenbeck, AR; Schatzkin, A; Graubard, BI; Sinha, R				Major, Jacqueline M.; Doubeni, Chyke A.; Freedman, Neal D.; Park, Yikyung; Lian, Min; Hollenbeck, Albert R.; Schatzkin, Arthur; Graubard, Barry I.; Sinha, Rashmi			Neighborhood Socioeconomic Deprivation and Mortality: NIH-AARP Diet and Health Study	PLOS ONE			English	Article							RISK-FACTORS; FOLLOW-UP; WOMEN; AREA; MEN; INEQUALITIES; GENDER; DIFFERENTIALS; RETIREMENT; AMERICAN	Purpose: Residing in deprived areas may increase risk of mortality beyond that explained by a person's own SES-related factors and lifestyle. The aim of this study was to examine the relation between neighborhood socioeconomic deprivation and all-cause, cancer-and cardiovascular disease (CVD)-specific mortality for men and women after accounting for education and other important person-level risk factors. Methods: In the longitudinal NIH-AARP Study, we analyzed data from healthy participants, ages 50-71 years at study baseline (1995-1996). Deaths (n = 33831) were identified through December 2005. Information on census tracts was obtained from the 2000 US Census. Cox models estimated hazard ratios (HRs) and 95% confidence intervals (CIs) for quintiles of neighborhood deprivation. Results: Participants in the highest quintile of deprivation had elevated risks for overall mortality (HRmen = 1.17, 95% CI: 1.10, 1.24; HRwomen = 1.13, 95% CI: 1.05, 1.22) and marginally increased risk for cancer deaths (HRmen = 1.09, 95% CI: 1.00, 1.20; HRwomen = 1.09, 95% CI: 0.99, 1.22). CVD mortality associations appeared stronger in men (HR = 1.33, 95% CI: 1.19, 1.49) than women (HR = 1.18, 95% CI: 1.01, 1.38). There was no evidence of an effect modification by education. Conclusion: Higher neighborhood deprivation was associated with modest increases in all-cause, cancer-and CVD-mortality after accounting for many established risk factors.	[Major, Jacqueline M.; Freedman, Neal D.; Park, Yikyung; Schatzkin, Arthur; Graubard, Barry I.; Sinha, Rashmi] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Doubeni, Chyke A.] Univ Massachusetts, Sch Med, Dept Family Med & Community Hlth, Worcester, MA USA; [Lian, Min] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Hollenbeck, Albert R.] Amer Assoc Retired Persons, Washington, DC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Massachusetts System; University of Massachusetts Worcester; Washington University (WUSTL); American Association of Retired Persons (AARP)	Major, JM (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA.	Jacqueline.major@nih.gov	Freedman, Neal David/B-9741-2015; Doubeni, Chyke A/W-6749-2019; Hollenbeck, Albert/AAG-9461-2020; Sinha, Rashmi/G-7446-2015	Freedman, Neal David/0000-0003-0074-1098; Doubeni, Chyke A/0000-0001-7495-0285; Sinha, Rashmi/0000-0002-2466-7462; Park, Yikyung/0000-0002-6281-489X	National Cancer Institute, National Institute of Health; NATIONAL CANCER INSTITUTE [U01CA151736, R01CA137750, ZIACP010196, K01CA127118] Funding Source: NIH RePORTER	National Cancer Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by the Intramural Research Program of the National Cancer Institute, National Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen PK, 1997, BIOMETRICS, V53, P1475, DOI 10.2307/2533513; Borrell LN, 2004, INT J EPIDEMIOL, V33, P398, DOI 10.1093/ije/dyh063; Bosma H, 2001, AM J EPIDEMIOL, V153, P363, DOI 10.1093/aje/153.4.363; CARSTAIRS V, 1989, COMMUNITY MED, V11, P210, DOI 10.1093/oxfordjournals.pubmed.a042469; Chapman BP, 2010, AM J EPIDEMIOL, V171, P83, DOI 10.1093/aje/kwp323; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Chung RY, 2010, AM J EPIDEMIOL, V171, P345, DOI 10.1093/aje/kwp378; Feinglass J, 2007, J GERONTOL B-PSYCHOL, V62, pS209, DOI 10.1093/geronb/62.4.S209; GOLDBLATT P, 1991, AM J IND MED, V20, P285, DOI 10.1002/ajim.4700200303; KLEIN JP, 1992, BIOMETRICS, V48, P795, DOI 10.2307/2532345; KOSKINEN S, 1994, SOC SCI MED, V38, P1385, DOI 10.1016/0277-9536(94)90276-3; Krieger N, 2007, EPIDEMIOLOGY, V18, P658, DOI 10.1097/EDE.0b013e318156bfcd; Lantz PM, 2010, SOC SCI MED, V70, P1558, DOI 10.1016/j.socscimed.2010.02.003; LeClere FB, 1998, J HEALTH SOC BEHAV, V39, P91, DOI 10.2307/2676393; MacIntire S, 1993, J SOC POLICY, V22, P21; Mackenbach JP, 1999, AM J PUBLIC HEALTH, V89, P1800, DOI 10.2105/AJPH.89.12.1800; MARKIDES KS, 1989, INT J AGING HUM DEV, V29, P95, DOI 10.2190/4LHT-Y4DM-73F6-N75L; Marmot MG, 1996, BRIT MED J, V313, P1177, DOI 10.1136/bmj.313.7066.1177; Martikainen P, 2003, J EPIDEMIOL COMMUN H, V57, P210, DOI 10.1136/jech.57.3.210; McDonough P, 1999, J HEALTH SOC BEHAV, V40, P17, DOI 10.2307/2676376; Messer LC, 2006, J URBAN HEALTH, V83, P1041, DOI 10.1007/s11524-006-9094-x; MILLAR WJ, 1983, CAN J PUBLIC HEALTH, V74, P329; Mustard CA, 2003, J EPIDEMIOL COMMUN H, V57, P974, DOI 10.1136/jech.57.12.974; Roux AVD, 2001, AM J PUBLIC HEALTH, V91, P1783, DOI 10.2105/AJPH.91.11.1783; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Singh GK, 2003, AM J PUBLIC HEALTH, V93, P1137, DOI 10.2105/AJPH.93.7.1137; Sinha R, 2009, ARCH INTERN MED, V169, P562, DOI 10.1001/archinternmed.2009.6; Sloggett A, 1998, J EPIDEMIOL COMMUN H, V52, P228, DOI 10.1136/jech.52.4.228; Smith GD, 1998, J EPIDEMIOL COMMUN H, V52, P399, DOI 10.1136/jech.52.6.399; Therneau T.M., 2000, MODELING SURVIVAL DA; Vagero D, 2000, BRIT MED J, V320, P1286, DOI 10.1136/bmj.320.7245.1286; Waitzman NJ, 1998, AM J PUBLIC HEALTH, V88, P973, DOI 10.2105/AJPH.88.6.973; WEI LJ, 1989, J AM STAT ASSOC, V84, P8; Willett WC, 1997, AM J CLIN NUTR, V65, P1220, DOI 10.1093/ajcn/65.4.1220S; Winkleby MA, 2003, J EPIDEMIOL COMMUN H, V57, P444, DOI 10.1136/jech.57.6.444; Yen IH, 1999, AM J EPIDEMIOL, V149, P898	37	82	82	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15538	10.1371/journal.pone.0015538	http://dx.doi.org/10.1371/journal.pone.0015538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684DM	21124858	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900025
J	Llorente, B; Rodriguez, V; Alonso, GD; Torres, HN; Flawia, MM; Bravo-Almonacid, FF				Llorente, Briardo; Rodriguez, Vanina; Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.; Bravo-Almonacid, Fernando F.			Improvement of Aroma in Transgenic Potato As a Consequence of Impairing Tuber Browning	PLOS ONE			English	Article							NUTRITIONAL-VALUE; EXPRESSION; QUALITY; MOUSE; ENRICHMENT; HEALTH; FLAVOR; MICE	Sensory analysis studies are critical in the development of quality enhanced crops, and may be an important component in the public acceptance of genetically modified foods. It has recently been established that odor preferences are shared between humans and mice, suggesting that odor exploration behavior in mice may be used to predict the effect of odors in humans. We have previously found that mice fed diets supplemented with engineered nonbrowning potatoes (-PPO) consumed more potato than mice fed diets supplemented with wild-type potatoes (WT). This prompted us to explore a possible role of potato odor in mice preference for nonbrowning potatoes. Taking advantage of two well established neuroscience paradigms, the "open field test" and the "nose-poking preference test", we performed experiments where mice exploration behavior was monitored in preference assays on the basis of olfaction alone. No obvious preference was observed towards -PPO or WT lines when fresh potato samples were tested. However, when oxidized samples were tested, mice consistently investigated -PPO potatoes more times and for longer periods than WT potatoes. Congruently, humans discriminated WT from -PPO samples with a considerably better performance when oxidized samples were tested than when fresh samples were tested in blind olfactory experiments. Notably, even though participants ranked all samples with an intermediate level of pleasantness, there was a general consensus that the -PPO samples had a more intense odor and also evoked the sense-impression of a familiar vegetable more often than the WT samples. Taken together, these findings suggest that our previous observations might be influenced, at least in part, by differential odors that are accentuated among the lines once oxidative deterioration takes place. Additionally, our results suggest that nonbrowning potatoes, in addition to their extended shelf life, maintain their odor quality for longer periods of time than WT potatoes. To our knowledge this is the first report on the use of an animal model applied to the sensory analysis of a transgenic crop.	[Llorente, Briardo; Rodriguez, Vanina; Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.; Bravo-Almonacid, Fernando F.] Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ingn Genet & Biol Mol INGEBI, Buenos Aires, DF, Argentina; [Alonso, Guillermo D.; Torres, Hector N.; Flawia, Mirtha M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina; [Bravo-Almonacid, Fernando F.] Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Llorente, B (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Inst Invest Ingn Genet & Biol Mol INGEBI, Buenos Aires, DF, Argentina.	fbravo@dna.uba.ar	Llorente, Briardo/B-1341-2014; Torres, Héctor/GXG-1780-2022; Llorente, Briardo/AAX-2422-2020; Alonso, Guillermo Daniel/AAI-6674-2020	Llorente, Briardo/0000-0002-3727-1395; Llorente, Briardo/0000-0002-3727-1395; Alonso, Guillermo Daniel/0000-0001-9386-9431	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Facultad de Ciencias Exactas y Naturales (FCEyN); Universidad de Buenos Aires (UBA); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Facultad de Ciencias Exactas y Naturales (FCEyN); Universidad de Buenos Aires (UBA)(University of Buenos Aires); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina(ANPCyT)	This work was funded by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), Facultad de Ciencias Exactas y Naturales (FCEyN), Universidad de Buenos Aires (UBA), Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT), Argentina. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluru M, 2008, J EXP BOT, V59, P3551, DOI 10.1093/jxb/ern212; Amiri L, 1998, DEV PSYCHOBIOL, V33, P157, DOI 10.1002/(SICI)1098-2302(199809)33:2<157::AID-DEV6>3.0.CO;2-I; Arab A, 2007, J CHEM ECOL, V33, P1845, DOI 10.1007/s10886-007-9358-2; Baker JM, 2006, PLANT BIOTECHNOL J, V4, P381, DOI 10.1111/j.1467-7652.2006.00197.x; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Davidovich-Rikanati R, 2007, NAT BIOTECHNOL, V25, P899, DOI 10.1038/nbt1312; Diretto G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000350; Dominguez T, 2010, PLANT PHYSIOL, V153, P655, DOI 10.1104/pp.110.154815; Dudareva N, 2008, CURR OPIN BIOTECH, V19, P181, DOI 10.1016/j.copbio.2008.02.011; Friedman M, 1996, J AGR FOOD CHEM, V44, P631, DOI 10.1021/jf950394r; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Graff GD, 2009, NAT BIOTECHNOL, V27, P702, DOI 10.1038/nbt0809-702; Haddad R, 2008, CURR OPIN NEUROBIOL, V18, P438, DOI 10.1016/j.conb.2008.09.007; Khan RM, 2007, J NEUROSCI, V27, P10015, DOI 10.1523/JNEUROSCI.1158-07.2007; Kobayakawa K, 2007, NATURE, V450, P503, DOI 10.1038/nature06281; Koob AO, 2006, J NEUROSCI METH, V157, P330, DOI 10.1016/j.jneumeth.2006.04.020; Larrinaga AR, 2010, ACTA OECOL, V36, P141, DOI 10.1016/j.actao.2009.11.003; LLORENTE B, 2010, PLANT BIOTE IN PRESS, DOI DOI 10.1111/J.1467-7652.2010.00534.X; Mandairon N, 2009, J NEUROSCI METH, V180, P296, DOI 10.1016/j.jneumeth.2009.04.008; Mandairon N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004209; Morris J, 2008, P NATL ACAD SCI USA, V105, P1431, DOI 10.1073/pnas.0709005105; Niu XL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-100; Paine JA, 2005, NAT BIOTECHNOL, V23, P482, DOI 10.1038/nbt1082; PANHUBER H, 1982, PHYSIOL BEHAV, V28, P149, DOI 10.1016/0031-9384(82)90116-0; Park S, 2009, PLANT BIOTECHNOL J, V7, P106, DOI 10.1111/j.1467-7652.2008.00379.x; Peters HC, 2005, NAT NEUROSCI, V8, P51, DOI 10.1038/nn1375; ROESSLER EB, 1978, J FOOD SCI, V43, P940, DOI 10.1111/j.1365-2621.1978.tb02458.x; Schwab W, 2008, PLANT J, V54, P712, DOI 10.1111/j.1365-313X.2008.03446.x; Small DM, 2008, NEURON, V57, P786, DOI 10.1016/j.neuron.2008.01.021; Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7; Smith DR, 2009, BEHAV BRAIN RES, V201, P22, DOI 10.1016/j.bbr.2009.01.024; THYGESEN PW, 1995, PLANT PHYSIOL, V109, P525, DOI 10.1104/pp.109.2.525; Tomas-Barberan F, 2001, J SCI FOOD AGR, V81, P853, DOI 10.1002/jsfa.885; Underwood BA, 2005, PLANT PHYSIOL, V138, P255, DOI 10.1104/pp.104.051144; Veyrac A, 2007, LEARN MEMORY, V14, P847, DOI 10.1101/lm.708807	36	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14030	10.1371/journal.pone.0014030	http://dx.doi.org/10.1371/journal.pone.0014030			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103333	Green Published, gold, Green Submitted			2022-12-27	WOS:000284327800015
J	Takahashi, T; Kurebayashi, Y; Ikeya, K; Mizuno, T; Fukushima, K; Kawamoto, H; Kawaoka, Y; Suzuki, Y; Suzuki, T				Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Kawaoka, Yoshihiro; Suzuki, Yasuo; Suzuki, Takashi			The Low-pH Stability Discovered in Neuraminidase of 1918 Pandemic Influenza A Virus Enhances Virus Replication	PLOS ONE			English	Article							SIALIDASE ACTIVITY; VIRULENCE; INFECTION; CELLS; HEMAGGLUTININ; ENDOCYTOSIS; MECHANISM; CALCIUM; GENES; DUCK	The "Spanish" pandemic influenza A virus, which killed more than 20 million worldwide in 1918-19, is one of the serious pathogens in recorded history. Characterization of the 1918 pandemic virus reconstructed by reverse genetics showed that PB1, hemagglutinin (HA), and neuraminidase (NA) genes contributed to the viral replication and virulence of the 1918 pandemic influenza virus. However, the function of the NA gene has remained unknown. Here we show that the avian-like low-pH stability of sialidase activity discovered in the 1918 pandemic virus NA contributes to the viral replication efficiency. We found that deletion of Thr at position 435 or deletion of Gly at position 455 in the 1918 pandemic virus NA was related to the low-pH stability of the sialidase activity in the 1918 pandemic virus NA by comparison with the sequences of other human N1 NAs and sialidase activity of chimeric constructs. Both amino acids were located in or near the amino acid resides that were important for stabilization of the native tetramer structure in a low-pH condition like the N2 NAs of pandemic viruses that emerged in 1957 and 1968. Two reverse-genetic viruses were generated from a genetic background of A/WSN/33 (H1N1) that included low-pH-unstable N1 NA from A/USSR/92/77 (H1N1) and its counterpart N1 NA in which sialidase activity was converted to a low-pH-stable property by a deletion and substitutions of two amino acid residues at position 435 and 455 related to the low-pH stability of the sialidase activity in 1918 NA. The mutant virus that included "Spanish Flu" like low-pH-stable NA showed remarkable replication in comparison with the mutant virus that included low-pH-unstable N1 NA. Our results suggest that the avian-like low-pH stability of sialidase activity in the 1918 pandemic virus NA contributes to the viral replication efficiency.	[Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Takahashi, Tadanobu; Kurebayashi, Yuuki; Ikeya, Kumiko; Mizuno, Takashi; Fukushima, Keijo; Kawamoto, Hiroko; Suzuki, Takashi] Global COE Program Innovat Human Hlth Sci, Shizuoka, Japan; [Takahashi, Tadanobu; Ikeya, Kumiko; Kawamoto, Hiroko; Kawaoka, Yoshihiro; Suzuki, Yasuo; Suzuki, Takashi] Japan Sci & Technol Agcy, CREST, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Virol, Tokyo, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Suzuki, Yasuo] Chubu Univ, Dept Biomed Sci, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan	University of Shizuoka; Japan Science & Technology Agency (JST); University of Tokyo; University of Wisconsin System; University of Wisconsin Madison; Chubu University	Takahashi, T (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	Suzukit@u-shizuoka-ken.ac.jp		Yasuo, Suzuki/0000-0003-3518-5642	Japan Science and Technology Agency [18390142, 20790357]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Japan Science Society; SRI (Shizuoka Research Institute); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid from the Scientific Research (B 18390142), Young Scientist (B; 20790357), CREST (Japan Science and Technology Agency), The Mochida Memorial Foundation for Medical and Pharmaceutical Research, The Sasakawa Scientific Research Grant from The Japan Science Society, The SRI (Shizuoka Research Institute) academic research grant, and the Gobal COE Program from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chaipan C, 2009, J VIROL, V83, P3200, DOI 10.1128/JVI.02205-08; CHONG AKJ, 1991, BIOCHIM BIOPHYS ACTA, V1077, P65, DOI 10.1016/0167-4838(91)90526-6; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; Gerasimenko JV, 1998, CURR BIOL, V8, P1335, DOI 10.1016/S0960-9822(07)00565-9; Goto H, 1998, P NATL ACAD SCI USA, V95, P10224, DOI 10.1073/pnas.95.17.10224; Gu J, 2007, LANCET, V370, P1137, DOI 10.1016/S0140-6736(07)61515-3; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; Kobasa D, 2001, J VIROL, V75, P11773, DOI 10.1128/JVI.75.23.11773-11780.2001; Matrosovich MN, 2004, J VIROL, V78, P12665, DOI 10.1128/JVI.78.22.12665-12667.2004; Neumann G, 1999, P NATL ACAD SCI USA, V96, P9345, DOI 10.1073/pnas.96.16.9345; Ohuchi M, 2006, MICROBES INFECT, V8, P1287, DOI 10.1016/j.micinf.2005.12.008; Pappas C, 2008, P NATL ACAD SCI USA, V105, P3064, DOI 10.1073/pnas.0711815105; Reid AH, 2000, P NATL ACAD SCI USA, V97, P6785, DOI 10.1073/pnas.100140097; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; Suzuki T, 2005, J VIROL, V79, P11705, DOI 10.1128/JVI.79.18.11705-11715.2005; Suzuki T, 2004, FEBS LETT, V557, P228, DOI 10.1016/S0014-5793(03)01503-5; Takahashi T, 2003, FEBS LETT, V543, P71, DOI 10.1016/S0014-5793(03)00403-4; Takahashi T, 2001, J BIOCHEM-TOKYO, V130, P279, DOI 10.1093/oxfordjournals.jbchem.a002983; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Taubenberger JK, 2006, P AM PHILOS SOC, V150, P86; Tumpey TM, 2004, P NATL ACAD SCI USA, V101, P3166, DOI 10.1073/pnas.0308391100; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; Uhlendorff J, 2009, ARCH VIROL, V154, P945, DOI 10.1007/s00705-009-0393-x	25	17	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15556	10.1371/journal.pone.0015556	http://dx.doi.org/10.1371/journal.pone.0015556			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151571	Green Submitted, Green Published, gold			2022-12-27	WOS:000285135800030
J	Gao, F; Zhou, BJ; Li, GY; Jia, PS; Li, H; Zhao, YL; Zhao, P; Xia, GX; Guo, HS				Gao, Feng; Zhou, Bang-Jun; Li, Guo-Ying; Jia, Pei-Song; Li, Hui; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan			A Glutamic Acid-Rich Protein Identified in Verticillium dahliae from an Insertional Mutagenesis Affects Microsclerotial Formation and Pathogenicity	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; MAGNAPORTHE-ORYZAE; LIPOPOLYSACCHARIDE COMPLEX; BLAST FUNGUS; HYDROPHOBIN GENE; POTATO ISOLATE; COTTON PLANT; ALBO-ATRUM; HOST-RANGE; TUMEFACIENS	Verticillium dahliae Kleb. is a phytopathogenic fungus that causes wilt disease in a wide range of crops, including cotton. The life cycle of V. dahliae includes three vegetative phases: parasitic, saprophytic and dormant. The dormant microsclerotia are the primary infectious propagules, which germinate when they are stimulated by root exudates. In this study, we report the first application of Agrobacterium tumefaciens-mediated transformation (ATMT) for construction of insertional mutants from a virulent defoliating isolate of V. dahliae (V592). Changes in morphology, especially a lack of melanized microsclerotia or pigmentation traits, were observed in mutants. Together with the established laboratory unimpaired root dip-inoculation approach, we found insertional mutants to be affected in their pathogenicities in cotton. One of the genes tagged in a pathogenicity mutant encoded a glutamic acid-rich protein (VdGARP1), which shared no significant similarity to any known annotated gene. The vdgarp1 mutant showed vigorous mycelium growth with a significant delay in melanized microsclerotial formation. The expression of VdGARP1 in the wild type V529 was organ-specific and differentially regulated by different stress agencies and conditions, in addition to being stimulated by cotton root extract in liquid culture medium. Under extreme infertile nutrient conditions, VdGARP1 was not necessary for melanized microsclerotial formation. Taken together, our data suggest that VdGARP1 plays an important role in sensing infertile nutrient conditions in infected cells to promote a transfer from saprophytic to dormant microsclerotia for long-term survival. Overall, our findings indicate that insertional mutagenesis by ATMT is a valuable tool for the genome-wide analysis of gene function and identification of pathogenicity genes in this important cotton pathogen.	[Gao, Feng; Zhou, Bang-Jun; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Gao, Feng; Zhou, Bang-Jun; Li, Hui; Zhao, Yun-Long; Zhao, Pan; Xia, Gui-Xian; Guo, Hui-Shan] Chinese Acad Sci, Natl Ctr Plant Gene Res Beijing, Inst Microbiol, Beijing, Peoples R China; [Gao, Feng; Li, Guo-Ying; Jia, Pei-Song; Li, Hui] Shihezi Univ, Key Lab Prevent & Control Oasis Crop Dis, Shihezi, Peoples R China; [Zhou, Bang-Jun; Zhao, Yun-Long; Zhao, Pan] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Microbiology, CAS; Shihezi University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Gao, F (corresponding author), Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China.	guohs@im.ac.cn	/AAJ-4923-2021; zhou, Bangjun/AAN-7883-2020	Zhou, Bangjun/0000-0003-2986-6310	China Transgenic Research and Commercialization Key Special Project [2009ZX08010-001B]; Ministry of Science and Technology [2011CB100703]	China Transgenic Research and Commercialization Key Special Project; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by grants from China Transgenic Research and Commercialization Key Special Project (grant 2009ZX08010-001B)for construction of V. dahliae insertional mutant library and the Ministry of Science and Technology (grant 2011CB100703) for functional study of V. dahliae genes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; Bhat RG, 1999, PHYTOPATHOLOGY, V89, P1218, DOI 10.1094/PHYTO.1999.89.12.1218; Blaise F, 2007, FUNGAL GENET BIOL, V44, P123, DOI 10.1016/j.fgb.2006.07.006; Bowman D. T., 1999, Journal of Cotton Science, V3, P139; BUCHNER V, 1982, FEBS LETT, V138, P261, DOI 10.1016/0014-5793(82)80456-0; BUNDOCK P, 1995, EMBO J, V14, P3206, DOI 10.1002/j.1460-2075.1995.tb07323.x; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Dobinson KF, 2004, CURR GENET, V45, P104, DOI 10.1007/s00294-003-0464-6; GARBER RH, 1966, PHYTOPATHOLOGY, V56, P1121; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GERIK JS, 1988, PHYTOPATHOLOGY, V78, P1174, DOI 10.1094/Phyto-78-1174; Haber-Pohlmeier S, 2007, BIOPHYS J, V92, P3207, DOI 10.1529/biophysj.106.094847; Huser A, 2009, MOL PLANT MICROBE IN, V22, P143, DOI 10.1094/MPMI-22-2-0143; Jeon J, 2007, NAT GENET, V39, P561, DOI 10.1038/ng2002; KEEN NT, 1972, PHYSIOL PLANT PATHOL, V2, P317, DOI 10.1016/S0048-4059(72)80006-7; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Koroleva OV, 2001, BIOCHEMISTRY-MOSCOW+, V66, P960, DOI 10.1023/A:1012357223083; Li GH, 2007, CURR GENET, V51, P233, DOI 10.1007/s00294-007-0122-5; LI KN, 1994, APPL ENVIRON MICROB, V60, P4324, DOI 10.1128/AEM.60.12.4324-4331.1994; Li L, 2007, MOL PLANT MICROBE IN, V20, P448, DOI 10.1094/MPMI-20-4-0448; LIU YG, 1995, PLANT J, V8, P457, DOI 10.1046/j.1365-313X.1995.08030457.x; Meng Y, 2007, FUNGAL GENET BIOL, V44, P1050, DOI 10.1016/j.fgb.2007.04.002; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Mullins ED, 2001, PHYTOPATHOLOGY, V91, P173, DOI 10.1094/PHYTO.2001.91.2.173; NACHMIAS A, 1982, POTATO RES, V25, P321, DOI 10.1007/BF02357289; NACHMIAS A, 1985, PHYSIOL PLANT PATHOL, V26, P43, DOI 10.1016/0048-4059(85)90029-3; NACHMIAS A, 1987, PHYTOPATHOLOGY, V77, P506, DOI 10.1094/Phyto-77-506; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Rauyaree P, 2005, CURR GENET, V48, P109, DOI 10.1007/s00294-005-0586-0; SCHNATHORST WC, 1966, PHYTOPATHOLOGY, V56, P1155; Schnathorst WC, 1981, COMPENDIUM COTTON DI, P41; Talhinhas P, 2008, MOL BIOTECHNOL, V39, P57, DOI 10.1007/s12033-007-9028-1; Tsuji Gento, 2003, Journal of General Plant Pathology, V69, P230, DOI 10.1007/s10327-003-0040-4; Vallad GE, 2008, PHYTOPATHOLOGY, V98, P871, DOI 10.1094/PHYTO-98-8-0871; Walton FJ, 2005, MOL MICROBIOL, V57, P1381, DOI 10.1111/j.1365-2958.2005.04779.x; Wang JY, 2004, APPL ENVIRON MICROB, V70, P4989, DOI 10.1128/AEM.70.8.4989-4995.2004; Xia ZJ, 1998, EUR J PLANT PATHOL, V104, P871, DOI 10.1023/A:1008628209867; Ying XB, 2010, PLANT CELL, V22, P1358, DOI 10.1105/tpc.109.072058; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x; Zhou ZZ, 2009, MOL PLANT MICROBE IN, V22, P402, DOI 10.1094/MPMI-22-4-0402	43	73	99	4	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15319	10.1371/journal.pone.0015319	http://dx.doi.org/10.1371/journal.pone.0015319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151869	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800016
J	Bereswill, S; Munoz, M; Fischer, A; Plickert, R; Haag, LM; Otto, B; Kuhl, AA; Loddenkemper, C; Gobel, UB; Heimesaat, MM				Bereswill, Stefan; Munoz, Melba; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Kuehl, Anja A.; Loddenkemper, Christoph; Goebel, Ulf B.; Heimesaat, Markus M.			Anti-Inflammatory Effects of Resveratrol, Curcumin and Simvastatin in Acute Small Intestinal Inflammation	PLOS ONE			English	Article							BOWEL-DISEASE; TOXOPLASMA-GONDII; EXPERIMENTAL COLITIS; ORAL INFECTION; RATS; MICE; STATINS; CELLS; PRAVASTATIN; ACTIVATION	Background: The health beneficial effects of Resveratrol, Curcumin and Simvastatin have been demonstrated in various experimental models of inflammation. We investigated the potential anti-inflammatory and immunomodulatory mechanisms of the above mentioned compounds in a murine model of hyper-acute Th1-type ileitis following peroral infection with Toxoplasma gondii. Methodology/Principal Findings: Here we show that after peroral administration of Resveratrol, Curcumin or Simvastatin, mice were protected from ileitis development and survived the acute phase of inflammation whereas all Placebo treated controls died. In particular, Resveratrol treatment resulted in longer-term survival. Resveratrol, Curcumin or Simvastatin treated animals displayed significantly increased numbers of regulatory T cells and augmented intestinal epithelial cell proliferation/regeneration in the ileum mucosa compared to placebo control animals. In contrast, mucosal T lymphocyte and neutrophilic granulocyte numbers in treated mice were reduced. In addition, levels of the anti-inflammatory cytokine IL-10 in ileum, mesenteric lymph nodes and spleen were increased whereas pro-inflammatory cytokine expression (IL-23p19, IFN-gamma, TNF-alpha, IL-6, MCP-1) was found to be significantly lower in the ileum of treated animals as compared to Placebo controls. Furthermore, treated animals displayed not only fewer pro-inflammatory enterobacteria and enterococci but also higher anti-inflammatory lactobacilli and bifidobacteria loads. Most importantly, treatment with all three compounds preserved intestinal barrier functions as indicated by reduced bacterial translocation rates into spleen, liver, kidney and blood. Conclusion/Significance: Oral treatment with Resveratrol, Curcumin or Simvastatin ameliorates acute small intestinal inflammation by down-regulating Th1-type immune responses and prevents bacterial translocation by maintaining gut barrier function. These findings provide novel and potential prophylaxis and treatment options of patients with inflammatory bowel diseases.	[Bereswill, Stefan; Munoz, Melba; Fischer, Andre; Plickert, Rita; Haag, Lea-Maxie; Otto, Bettina; Goebel, Ulf B.; Heimesaat, Markus M.] Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany; [Kuehl, Anja A.; Loddenkemper, Christoph] Charite, Inst Pathol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bereswill, S (corresponding author), Charite, Inst Mikrobiol & Hyg, D-13353 Berlin, Germany.	markus.heimesaat@charite.de	Haag, Lea Maxie/AAP-9001-2020	Kuhl, Anja/0000-0003-2293-5387; Munoz, Melba/0000-0003-3386-4502; Heimesaat, Markus/0000-0001-6399-651X; Haag, Lea-Maxie/0000-0002-3754-5317	German Research Foundation (DFG) [SFB633, TP B6, TP A7, TP Z1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG, SFB633) to MMH and MM (TP B6), AF, SB, and UBG (TP A7), AAK and CL (TP Z1), BO and L-MH (GRACO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, TRENDS PHARMACOL SCI, V30, P85, DOI 10.1016/j.tips.2008.11.002; Ahn J, 2007, BIOCHEM BIOPH RES CO, V364, P972, DOI 10.1016/j.bbrc.2007.10.109; Basset Christelle, 2002, Science Progress, V85, P33, DOI 10.3184/003685002783238861; Baugh MD, 1999, GASTROENTEROLOGY, V117, P814, DOI 10.1016/S0016-5085(99)70339-2; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Calabrese Vittorio, 2003, Ital J Biochem, V52, P177; Camacho-Barquero L, 2007, INT IMMUNOPHARMACOL, V7, P333, DOI 10.1016/j.intimp.2006.11.006; Candela M, 2008, INT J FOOD MICROBIOL, V125, P286, DOI 10.1016/j.ijfoodmicro.2008.04.012; Claramunt RM, 2009, BIOORGAN MED CHEM, V17, P1290, DOI 10.1016/j.bmc.2008.12.029; Diomede L, 2001, ARTERIOSCL THROM VAS, V21, P1327, DOI 10.1161/hq0801.094222; Elmali N, 2007, INFLAMMATION, V30, P1, DOI 10.1007/s10753-006-9012-0; Fooks LJ, 2002, BRIT J NUTR, V88, pS39, DOI [10.1079/BJN2002628, 10.1079/BJNBJN2002591]; GERDES J, 1991, AM J PATHOL, V138, P867; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Jahovic N, 2006, SCAND J GASTROENTERO, V41, P954, DOI 10.1080/00365520600554444; Jain SK, 1994, CIBA F SYMP, V185, P164; Jian YT, 2005, WORLD J GASTROENTERO, V11, P1747, DOI 10.3748/wjg.v11.i12.1747; Jobin C, 1999, J IMMUNOL, V163, P3474; KOBASHIGAWA JA, 1995, NEW ENGL J MED, V333, P621, DOI 10.1056/NEJM199509073331003; Kouri TT, 2000, CLIN CHIM ACTA, V297, P305, DOI 10.1016/S0009-8981(00)00256-4; Larrosa M, 2009, J AGR FOOD CHEM, V57, P2211, DOI 10.1021/jf803638d; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Lubbad A, 2009, MOL CELL BIOCHEM, V322, P127, DOI 10.1007/s11010-008-9949-4; Ma ZH, 2005, INFLAMM RES, V54, P522, DOI 10.1007/s00011-005-1388-z; Maher BM, 2009, J LEUKOCYTE BIOL, V85, P186, DOI 10.1189/jlb.0608382; Martin AR, 2004, BIOCHEM PHARMACOL, V67, P1399, DOI 10.1016/j.bcp.2003.12.024; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Medina C, 2006, J LEUKOCYTE BIOL, V79, P954, DOI 10.1189/jlb.1005544; Munoz M, 2009, J EXP MED, V206, P3047, DOI 10.1084/jem.20090900; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rapin JR, 2010, CLINICS, V65, P635, DOI 10.1590/S1807-59322010000600012; SANCHEZFIDALGO S, EUR J PHARM, V633, P78; Simes J, 2002, EUR HEART J, V23, P207, DOI 10.1053/euhj.2001.2775; Sugimoto K, 2002, GASTROENTEROLOGY, V123, P1912, DOI 10.1053/gast.2002.37050; UNG VY, DIG DIS SCI, V55, P1272; Vossenkamper A, 2004, EUR J IMMUNOL, V34, P3197, DOI 10.1002/eji.200424993	40	198	215	7	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15099	10.1371/journal.pone.0015099	http://dx.doi.org/10.1371/journal.pone.0015099			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151942	gold, Green Submitted, Green Published			2022-12-27	WOS:000284939600024
J	Bottcher, B				Boettcher, Bjoern			Feller Processes: The Next Generation in Modeling. Brownian Motion, Levy Processes and Beyond	PLOS ONE			English	Article							MARKOV; APPROXIMATION; CONSTRUCTION	We present a simple construction method for Feller processes and a framework for the generation of sample paths of Feller processes. The construction is based on state space dependent mixing of Levy processes. Brownian Motion is one of the most frequently used continuous time Markov processes in applications. In recent years also Levy processes, of which Brownian Motion is a special case, have become increasingly popular. Levy processes are spatially homogeneous, but empirical data often suggest the use of spatially inhomogeneous processes. Thus it seems necessary to go to the next level of generalization: Feller processes. These include Levy processes and in particular Brownian motion as special cases but allow spatial inhomogeneities. Many properties of Feller processes are known, but proving the very existence is, in general, very technical. Moreover, an applicable framework for the generation of sample paths of a Feller process was missing. We explain, with practitioners in mind, how to overcome both of these obstacles. In particular our simulation technique allows to apply Monte Carlo methods to Feller processes.	Tech Univ Dresden, Inst Math Stochast, Dresden, Germany	Technische Universitat Dresden	Bottcher, B (corresponding author), Tech Univ Dresden, Inst Math Stochast, Dresden, Germany.	bjoern.boettcher@tu-dresden.de	Böttcher, Björn/AAH-5218-2020	Böttcher, Björn/0000-0002-3045-5829				[Anonymous], 2010, R LANG ENV STAT COMP; Baeumer B, 2005, P AM MATH SOC, V133, P2273, DOI 10.1090/S0002-9939-05-07949-9; BASS RF, 1988, PROBAB THEORY REL, V79, P271, DOI 10.1007/BF00320922; Bottcher B, 2008, J LOND MATH SOC, V78, P605, DOI 10.1112/jlms/jdn043; Bottcher B, 2009, STOCH DYNAM, V9, P71, DOI 10.1142/S0219493709002555; Bottcher B, 2005, MATH NACHR, V278, P1235, DOI 10.1002/mana.200310304; Bottcher B, 2003, PROBABILISTIC METHODS IN FLUIDS, PROCEEDINGS, P35, DOI 10.1142/9789812703989_0003; Cont R., 2004, FINANCIAL MODELLING; COX JC, 1985, ECONOMETRICA, V53, P385, DOI 10.2307/1911242; Ditlevsen PD, 1996, NATURE, V379, P810, DOI 10.1038/379810a0; Doney RA, 2005, ANN APPL PROBAB, V15, P1445, DOI 10.1214/105051605000000016; Feller W., 1951, P 2 BERK S MATH STAT, P227; Gonchar VY, 2003, PLASMA PHYS REP+, V29, P380, DOI 10.1134/1.1575308; GRIGELIONIS B, 2001, LITH MATH J, V41, P239; GRIGELIONIS B, 1999, LITH MATH J, V39, P33, DOI 10.1007/BF02465533; Hoh W, 1998, THESIS U BIELEFELD; IKEDA N, 1989, MATH LIB, V24; Jacob N., 2001, PSEUDODIFFERENTIAL O, V1-3; Jacod J., 2002, LIMIT THEOREMS STOCH, V2nd; Janssen HK, 1999, EUR PHYS J B, V7, P137, DOI 10.1007/s100510050596; KOCHUBEJ A. N, 1989, MATH USSR IZV, V33, P233; Kolokoltsov V, 2000, P LOND MATH SOC, V80, P725, DOI 10.1112/S0024611500012314; Ma ZM, 1998, ANN I H POINCARE-PR, V34, P1, DOI 10.1016/S0246-0203(98)80011-3; Meerschaert MM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.060102; Protter P, 1997, ANN PROBAB, V25, P393; Reeves DM, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006069; Reynolds AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000354; Sato K., 1999, CAMBRIDGE STUDIES AD, V68; Scalas E, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.011107; Schilling RL, 2010, ELECTRON J PROBAB, V15, P1369, DOI 10.1214/EJP.v15-807; Stroock DW., 2003, MARKOV PROCESSES K I; Woyczynski WA, 2001, LEVY PROCESSES: THEORY AND APPLICATIONS, P241; Zhang Y, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004912; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	38	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15102	10.1371/journal.pone.0015102	http://dx.doi.org/10.1371/journal.pone.0015102			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151931	Green Published, Green Submitted, gold			2022-12-27	WOS:000284939600025
J	Carlini, F; Ridolfi, B; Molinari, A; Parisi, C; Bozzuto, G; Toccacieli, L; Formisano, G; De Orsi, D; Paradisi, S; Grober, OMV; Ravo, M; Weisz, A; Arcieri, R; Vella, S; Gaudi, S				Carlini, Francesca; Ridolfi, Barbara; Molinari, Agnese; Parisi, Chiara; Bozzuto, Giuseppina; Toccacieli, Laura; Formisano, Giuseppe; De Orsi, Daniela; Paradisi, Silvia; Grober, Oli Maria Victoria; Ravo, Maria; Weisz, Alessandro; Arcieri, Romano; Vella, Stefano; Gaudi, Simona			The Reverse Transcription Inhibitor Abacavir Shows Anticancer Activity in Prostate Cancer Cell Lines	PLOS ONE			English	Article							TRANSPOSABLE ELEMENTS; L1 RETROTRANSPOSITION; NUCLEOSIDE ANALOG; CARCINOMA-CELLS; IN-VITRO; EXPRESSION; DIFFERENTIATION; PROTEIN; DNA; ANNOTATION	Background: Transposable Elements (TEs) comprise nearly 45% of the entire genome and are part of sophisticated regulatory network systems that control developmental processes in normal and pathological conditions. The retroviral/retrotransposon gene machinery consists mainly of Long Interspersed Nuclear Elements (LINEs-1) and Human Endogenous Retroviruses (HERVs) that code for their own endogenous reverse transcriptase (RT). Interestingly, RT is typically expressed at high levels in cancer cells. Recent studies report that RT inhibition by non-nucleoside reverse transcriptase inhibitors (NNRTIs) induces growth arrest and cell differentiation in vitro and antagonizes growth of human tumors in animal model. In the present study we analyze the anticancer activity of Abacavir (ABC), a nucleoside reverse transcription inhibitor (NRTI), on PC3 and LNCaP prostate cancer cell lines. Principal Findings: ABC significantly reduces cell growth, migration and invasion processes, considerably slows S phase progression, induces senescence and cell death in prostate cancer cells. Consistent with these observations, microarray analysis on PC3 cells shows that ABC induces specific and dose-dependent changes in gene expression, involving multiple cellular pathways. Notably, by quantitative Real-Time PCR we found that LINE-1 ORF1 and ORF2 mRNA levels were significantly up-regulated by ABC treatment. Conclusions: Our results demonstrate the potential of ABC as anticancer agent able to induce antiproliferative activity and trigger senescence in prostate cancer cells. Noteworthy, we show that ABC elicits up-regulation of LINE-1 expression, suggesting the involvement of these elements in the observed cellular modifications.	[Carlini, Francesca; Ridolfi, Barbara; Parisi, Chiara; De Orsi, Daniela; Arcieri, Romano; Vella, Stefano; Gaudi, Simona] Ist Super Sanita, Dept Therapeut Res & Drug Evaluat, I-00161 Rome, Italy; [Molinari, Agnese; Bozzuto, Giuseppina; Toccacieli, Laura; Formisano, Giuseppe] Ist Super Sanita, Dept Technol & Hlth, I-00161 Rome, Italy; [Paradisi, Silvia] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Grober, Oli Maria Victoria; Ravo, Maria; Weisz, Alessandro] Univ Naples 2, Dept Gen Pathol, Naples, Italy; [Weisz, Alessandro] Univ Salerno, Fac Med, Mol Med Lab, I-84100 Salerno, Italy	Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Istituto Superiore di Sanita (ISS); Universita della Campania Vanvitelli; University of Salerno	Carlini, F (corresponding author), Ist Super Sanita, Dept Therapeut Res & Drug Evaluat, Viale Regina Elena 299, I-00161 Rome, Italy.	simona.gaudi@iss.it	Molinari, Agnese/AAC-2918-2021; parisi, Chiara/K-6330-2016; RIDOLFI, BARBARA/D-7967-2016; CARLINI, FRANCESCA/D-7945-2016; Molinari, Agnese/E-7588-2015; Arcieri, Romano/O-4289-2014; Vella, Stefano/GZM-0519-2022; Weisz, Alessandro/A-1317-2014; VELLA, STEFANO/ABI-3368-2020; Bozzuto, Giuseppina/E-9094-2015	Molinari, Agnese/0000-0002-9592-5465; parisi, Chiara/0000-0003-1350-3929; RIDOLFI, BARBARA/0000-0002-6443-5500; Molinari, Agnese/0000-0002-9592-5465; Weisz, Alessandro/0000-0003-0455-2083; Bozzuto, Giuseppina/0000-0002-9761-3326; Carlini, Francesca/0000-0002-2409-6284; Ravo, Maria/0000-0003-1003-2922; Arcieri, Romano/0000-0002-9041-8202	National Institute of Health in Rome (ISS); Ministry of University and Research, Regione Campania; Associazione Italiana per la Ricerca sul Cancro (AIRC); Second University of Naples; University of Cagliari	National Institute of Health in Rome (ISS); Ministry of University and Research, Regione Campania; Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Second University of Naples; University of Cagliari	Funding was provided by from the National Institute of Health in Rome (ISS), Ricerca Finalizzata 2004, Collaboration program ISS/NIH-USA and Ricerca Corrente 2007-2008, ISS. Other fundings are from Ministry of University and Research, Regione Campania, Associazione Italiana per la Ricerca sul Cancro (AIRC) and the PhD programs: "Pathology of Cell Signal Transduction" (OMVG) of the Second University of Naples and "Toxicology, Oncology and Molecular Pathology" of the University of Cagliari (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINI A, 1987, CANCER RES, V47, P3239; Asch HL, 1996, ONCOL RES, V8, P239; Banerjee G, 2005, PHOTODERMATOL PHOTO, V21, P32, DOI 10.1111/j.1600-0781.2005.00136.x; Banerjee S, 2000, BBA-PROTEIN STRUCT M, V1480, P1, DOI 10.1016/S0167-4838(00)00080-7; Belancio VP, 2010, NUCLEIC ACIDS RES, V38, P3909, DOI 10.1093/nar/gkq132; Belgnaoui SM, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-13; BRANCIFORTE D, 1994, MOL CELL BIOL, V14, P2584, DOI 10.1128/MCB.14.4.2584; CAPORALE LH, 2006, IMPLICIT GENOME; Chueh AC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000354; Daluge SM, 1997, ANTIMICROB AGENTS CH, V41, P1082, DOI 10.1128/AAC.41.5.1082; Damm K, 2001, EMBO J, V20, P6958, DOI 10.1093/emboj/20.24.6958; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DERAGON JM, 1990, EMBO J, V9, P3363, DOI 10.1002/j.1460-2075.1990.tb07537.x; El-Sawy M, 2005, J MOL BIOL, V354, P246, DOI 10.1016/j.jmb.2005.09.050; Farkash EA, 2006, NUCLEIC ACIDS RES, V34, P1196, DOI 10.1093/nar/gkj522; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Garcia-Perez JL, 2007, HUM MOL GENET, V16, P1569, DOI 10.1093/hmg/ddm105; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones RB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001547; Jordan IK, 2003, TRENDS GENET, V19, P68, DOI 10.1016/S0168-9525(02)00006-9; Jurka J, 2007, ANNU REV GENOM HUM G, V8, P241, DOI 10.1146/annurev.genom.8.080706.092416; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Landriscina M, 2008, INT J CANCER, V122, P2842, DOI 10.1002/ijc.23197; Landriscina M, 2009, PROSTATE, V69, P744, DOI 10.1002/pros.20923; Li TH, 1999, GENE, V239, P367, DOI 10.1016/S0378-1119(99)00384-4; Li TH, 2001, GENE, V276, P135, DOI 10.1016/S0378-1119(01)00637-0; Mangiacasale R, 2003, ONCOGENE, V22, P2750, DOI 10.1038/sj.onc.1206354; Nangia-Makker P, 1998, BREAST CANCER RES TR, V49, P171, DOI 10.1023/A:1005913810250; Nowacki M, 2009, SCIENCE, V324, P935, DOI 10.1126/science.1170023; ORGEL LE, 1980, NATURE, V284, P604, DOI 10.1038/284604a0; Oricchio E, 2007, ONCOGENE, V26, P4226, DOI 10.1038/sj.onc.1210214; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Perlmutter Mark A, 2007, Rev Urol, V9 Suppl 1, pS3; Pittoggi C, 2003, MOL REPROD DEV, V66, P225, DOI 10.1002/mrd.10349; Ramos KS, 2007, GENOMICS, V90, P176, DOI 10.1016/j.ygeno.2007.04.003; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Sciamanna E, 2005, ONCOGENE, V24, P3923, DOI 10.1038/sj.onc.1208562; Shi X, 2007, MOL CELL BIOL, V27, P1264, DOI 10.1128/MCB.01888-06; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Spadafora C, 2008, SYST BIOL REPROD MED, V54, P11, DOI 10.1080/19396360701876815; Stribinskis V, 2006, CANCER RES, V66, P2616, DOI 10.1158/0008-5472.CAN-05-3478; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Teneng I, 2007, GENES CELLS, V12, P1101, DOI 10.1111/j.1365-2443.2007.01117.x; Thornburg BG, 2006, GENE, V365, P104, DOI 10.1016/j.gene.2005.09.036; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Wallace N, 2008, GENE, V419, P1, DOI 10.1016/j.gene.2008.04.007	51	37	40	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14221	10.1371/journal.pone.0014221	http://dx.doi.org/10.1371/journal.pone.0014221			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151977	Green Submitted, gold, Green Published			2022-12-27	WOS:000284939600014
J	Pallares-Ruiz, N; Philibert, L; Dumont, B; Fabre, A; Cuisset, L; Cointin, E; Rittore, C; Soler, S; Touitou, I				Pallares-Ruiz, Nathalie; Philibert, Laurent; Dumont, Bruno; Fabre, Aurelie; Cuisset, Laurence; Cointin, Elodie; Rittore, Cecile; Soler, Stephan; Touitou, Isabelle			Combined Mutation And Rearrangement Screening by Quantitative PCR High-Resolution Melting: Is It Relevant for Hereditary Recurrent Fever Genes?	PLOS ONE			English	Article							AUTOINFLAMMATORY SYNDROME; GERMLINE MUTATIONS; DELETIONS	The recent identification of genes implicated in hereditary recurrent fevers has allowed their specific diagnosis. So far however, only punctual mutations have been identified and a significant number of patients remain with no genetic confirmation of their disease after routine molecular approaches such as sequencing. The possible involvement of sequence rearrangements in these patients has only been examined in familial Mediterranean fever and was found to be unlikely. To assess the existence of larger genetic alterations in 3 other concerned genes, MVK (Mevalonate kinase), NLRP3 (Nod like receptor family, pyrin domain containing 3) and TNFRSF1A (TNF receptor superfamily 1A), we adapted the qPCR-HRM method to study possible intragenic deletions and duplications. This single-tube approach, combining both qualitative (mutations) and quantitative (rearrangement) screening, has proven effective in Lynch syndrome diagnosis. Using this approach, we studied 113 unselected (prospective group) and 88 selected (retrospective group) patients and identified no intragenic rearrangements in the 3 genes. Only qualitative alterations were found with a sensitivity similar to that obtained using classical molecular techniques for screening punctual mutations. Our results support that deleterious copy number alterations in MVK, NLRP3 and TNFRSF1A are rare or absent from the mutational spectrum of hereditary recurrent fevers, and demonstrate that a routine combined method such as qPCR-HRM provides no further help in genetic diagnosis. However, quantitative approaches such as qPCR or SQF-PCR did prove to be quick and effective and could still be useful after non contributory punctual mutation screening in the presence of clinically evocative signs.	[Pallares-Ruiz, Nathalie; Philibert, Laurent; Dumont, Bruno; Fabre, Aurelie; Cointin, Elodie; Rittore, Cecile; Soler, Stephan; Touitou, Isabelle] Hop A de Villeneuve, Genet Lab, Unite Med Malad Auto Inflammatories, Montpellier, France; [Cuisset, Laurence] Univ Paris 05, Hop Cochin, Assistance Publ Hop Paris, Paris, France; [Cuisset, Laurence] Univ Paris 05, Inst Cochin, INSERM, Paris, France; [Touitou, Isabelle] Univ Montpellier I, Montpellier, France	Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite de Montpellier	Pallares-Ruiz, N (corresponding author), Hop A de Villeneuve, Genet Lab, Unite Med Malad Auto Inflammatories, Montpellier, France.	i-touitou@chu-montpellier.fr			French Ministry of Health; University Hospital of Montpellier; European Community [HEALTH-F2-2008-200923]	French Ministry of Health; University Hospital of Montpellier; European Community(European Commission)	This work was supported by the French Ministry of Health, the University Hospital of Montpellier, and the Coordination Theme 1 (Health) of the European Community's FP7, Grant Agreement Number HEALTH-F2-2008-200923. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chou LS, 2005, AM J CLIN PATHOL, V124, P330, DOI 10.1309/BF3MLJN8J527MWQY; Cuisset L, 2001, EUR J HUM GENET, V9, P260, DOI 10.1038/sj.ejhg.5200614; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Giansily-Blaizot M, 2007, BRIT J HAEMATOL, V138, P359, DOI 10.1111/j.1365-2141.2007.06660.x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Jeru I, 2006, ARTHRITIS RHEUM-US, V54, P508, DOI 10.1002/art.21618; Kalari KR, 2008, BIOINFORMATICS, V24, P1975, DOI 10.1093/bioinformatics/btn370; Laccone F, 2004, HUM MUTAT, V23, P234, DOI 10.1002/humu.20004; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; McDermott MF, 1999, CELL, V97, P133, DOI 10.1016/S0092-8674(00)80721-7; Rouleau E, 2009, HUM MUTAT, V30, P867, DOI 10.1002/humu.20947; Sellner LN, 2004, HUM MUTAT, V23, P413, DOI 10.1002/humu.20035; Simon A, 2007, AM J PHYSIOL-REG I, V292, pR86, DOI 10.1152/ajpregu.00504.2006; STEGER G, 1994, NUCLEIC ACIDS RES, V22, P2760, DOI 10.1093/nar/22.14.2760; van Gijn ME, 2008, EUR J HUM GENET, V16, P1404, DOI 10.1038/ejhg.2008.135; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484	17	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14096	10.1371/journal.pone.0014096	http://dx.doi.org/10.1371/journal.pone.0014096			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124859	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900009
J	Wang, X; Bjorklund, S; Wasik, AM; Grandien, A; Andersson, P; Kimby, E; Dahlman-Wright, K; Zhao, CY; Christensson, B; Sander, B				Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Grandien, Alf; Andersson, Patrik; Kimby, Eva; Dahlman-Wright, Karin; Zhao, Chunyan; Christensson, Birger; Sander, Birgitta			Gene Expression Profiling and Chromatin Immunoprecipitation Identify DBN1, SETMAR and HIG2 as Direct Targets of SOX11 in Mantle Cell Lymphoma	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SOX11; ACTIN-BINDING-PROTEIN; THYMOSIN BETA 15; DIFFERENTIAL EXPRESSION; NEURAL DIFFERENTIATION; NUCLEAR EXPRESSION; ALZHEIMER-DISEASE; TISSUE; MOUSE; BOX	The SRY (sex determining region Y)-box 11 (SOX11) gene, located on chromosome 2p25, encodes for a transcription factor that is involved in tissue remodeling during embryogenesis and is crucial for neurogenesis. The role for SOX11 in hematopoiesis has not yet been defined. Two genes under direct control of SOX11 are the class-III beta-tubulin gene (TUBB3) in neural cells and the transcription factor TEA domain family member 2 (TEAD2) in neural and mesenchymal progenitor cells. Normal, mature lymphocytes lack SOX11 but express SOX4, another member of the same group of SOX transcription factors. We and others recently identified SOX11 as aberrantly expressed in mantle cell lymphoma (MCL). Since SOX11 is variably expressed in MCL it may not be essential for tumorigenesis, but may carry prognostic information. Currently, no specific functional effects have been linked to SOX11 expression in MCL and it is not known which genes are under influence of SOX11 in lymphoma. In this study we found variable expression of SOX11, SOX4 and SOX12 mRNA in mantle cell lymphoma cell lines. Downregulation of SOX11 expression by siRNA verified that SOX11 controlled the expression of the gene TUBB3 in the MCL cell line Granta 519. Furthermore we identified, by global gene expression analysis, 26 new target genes influenced by siRNA SOX11 downmodulation. Among these genes, DBN1, SETMAR and HIG2 were found to be significantly correlated to SOX11 expression in two cohorts of primary mantle cell lymphomas. Chromatin immunoprecipitation (ChIP) analysis showed that these genes are direct targets of the SOX11 protein. In spite of almost complete downregulation of the SOX11 protein no significant effects on Granta 519 cell proliferation or survival in short term in vitro experiments was found. In summary we have identified a number of genes influenced by SOX11 expression in MCL cell lines and primary MCL. Among these genes, DBN1, SETMAR and HIG2 are direct transcriptional targets of the SOX11 protein.	[Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Christensson, Birger; Sander, Birgitta] Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden; [Wang, Xiao; Bjoerklund, Stefan; Wasik, Agata M.; Christensson, Birger; Sander, Birgitta] Karolinska Univ Hosp Huddinge, Stockholm, Sweden; [Grandien, Alf] Karolinska Inst, Ctr Infect Med, Stockholm, Sweden; [Grandien, Alf] Karolinska Inst, Ctr Expt Hematol, Stockholm, Sweden; [Grandien, Alf; Kimby, Eva] Karolinska Inst, Dept Med, Div Hematol, Stockholm, Sweden; [Grandien, Alf; Kimby, Eva] Karolinska Univ Hosp, Stockholm, Sweden; [Andersson, Patrik] Stockholm S Hosp, Dept Hematol, Stockholm, Sweden; [Zhao, Chunyan] Karolinska Inst, Dept Biosci & Nutr, Novum, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Wang, X (corresponding author), Karolinska Inst, Dept Lab Med, Div Pathol, Stockholm, Sweden.	birgitta.sander@ki.se		Kimby, Eva/0000-0003-3078-6131	Swedish Cancer Society; Swedish Research Council; Cancer Society in Stockholm; Karolinska Institutet; Stockholm Country Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancer Society in Stockholm; Karolinska Institutet(Karolinska Institutet); Stockholm Country Council	This work was funded by a grant from the Swedish Cancer Society, the Swedish Research Council, the Cancer Society in Stockholm, the Karolinska Institutet Funds, and the Stockholm Country Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bao L, 1998, CLIN EXP METASTAS, V16, P227, DOI 10.1023/A:1006540824969; Bao L, 2000, GENE, V260, P37, DOI 10.1016/S0378-1119(00)00452-2; Bao LR, 1996, NAT MED, V2, P1322, DOI 10.1038/nm1296-1322; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; BHATTARAM P, NAT COMMUN, V1, P9; BODRUG SE, 1994, EMBO J, V13, P2124, DOI 10.1002/j.1460-2075.1994.tb06488.x; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Chen YH, 2010, MODERN PATHOL, V23, P105, DOI 10.1038/modpathol.2009.140; de Bont JM, 2008, NEURO-ONCOLOGY, V10, P648, DOI 10.1215/15228517-2008-032; Dictor M, 2009, HAEMATOL-HEMATOL J, V94, P1563, DOI 10.3324/haematol.2009.008474; Dun XP, 2010, HISTOL HISTOPATHOL, V25, P533, DOI 10.14670/HH-25.533; Dy P, 2008, NUCLEIC ACIDS RES, V36, P3101, DOI 10.1093/nar/gkn162; Ek S, 2008, BLOOD, V111, P800, DOI 10.1182/blood-2007-06-093401; Fernandez V, 2010, CANCER RES, V70, P1408, DOI 10.1158/0008-5472.CAN-09-3419; Gold JS, 1997, MODERN PATHOL, V10, P1106; Gustafsson K, 2008, INT J CANCER, V123, P1025, DOI 10.1002/ijc.23584; Hargrave M, 1997, DEV DYNAM, V210, P79, DOI 10.1002/(SICI)1097-0177(199710)210:2<79::AID-AJA1>3.0.CO;2-6; Harigaya Y, 1996, J NEUROSCI RES, V43, P87, DOI 10.1002/jnr.490430111; Haslinger A, 2009, EUR J NEUROSCI, V29, P2103, DOI 10.1111/j.1460-9568.2009.06768.x; Hatanpaa K, 1999, J NEUROPATH EXP NEUR, V58, P637, DOI 10.1097/00005072-199906000-00008; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Jankowski MP, 2006, NEUROSCIENCE, V143, P501, DOI 10.1016/j.neuroscience.2006.09.010; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; JAY P, 1995, GENOMICS, V29, P541, DOI 10.1006/geno.1995.9970; Keon BH, 2000, J CELL SCI, V113, P325; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Kojima N, 1988, Brain Res, V464, P207; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Li C, 2006, GLIA, V53, P392, DOI 10.1002/glia.20291; LOVEC H, 1994, EMBO J, V13, P3487, DOI 10.1002/j.1460-2075.1994.tb06655.x; Matthews J, 2006, MOL ENDOCRINOL, V20, P534, DOI 10.1210/me.2005-0140; McDonough WS, 2005, NEOPLASIA, V7, P862, DOI 10.1593/neo.05190; Mozos A, 2009, HAEMATOL-HEMATOL J, V94, P1555, DOI 10.3324/haematol.2009.010264; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Nemeth MJ, 2003, BLOOD, V102, P1298, DOI 10.1182/blood-2002-11-3541; Sander B, 2005, INT J CANCER, V117, P418, DOI 10.1002/ijc.21166; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; SHIRAO T, 1988, MOL BRAIN RES, V4, P71, DOI 10.1016/0169-328X(88)90020-4; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Wang X, 2008, BRIT J HAEMATOL, V143, P248, DOI 10.1111/j.1365-2141.2008.07329.x; Weigle B, 2005, ONCOL REP, V13, P139; Wray J, 2009, BLOOD, V114, P1852, DOI 10.1182/blood-2008-08-175760; Wray J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005323; Yan B, 2009, DEV DYNAM, V238, P1358, DOI 10.1002/dvdy.21885; Yan B, 2009, DEV BIOL, V329, P80, DOI 10.1016/j.ydbio.2009.02.019; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	50	31	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14085	10.1371/journal.pone.0014085	http://dx.doi.org/10.1371/journal.pone.0014085			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124928	Green Submitted, gold, Green Published			2022-12-27	WOS:000284467200016
J	Miller, AK; Print, CG; Nielsen, PMF; Crampin, EJ				Miller, Andrew K.; Print, Cristin G.; Nielsen, Poul M. F.; Crampin, Edmund J.			A Bayesian Search for Transcriptional Motifs	PLOS ONE			English	Article							FACTOR-BINDING SITES; DNA	Identifying transcription factor (TF) binding sites (TFBSs) is an important step towards understanding transcriptional regulation. A common approach is to use gaplessly aligned, experimentally supported TFBSs for a particular TF, and algorithmically search for more occurrences of the same TFBSs. The largest publicly available databases of TF binding specificities contain models which are represented as position weight matrices (PWM). There are other methods using more sophisticated representations, but these have more limited databases, or aren't publicly available. Therefore, this paper focuses on methods that search using one PWM per TF. An algorithm, MATCHTM, for identifying TFBSs corresponding to a particular PWM is available, but is not based on a rigorous statistical model of TF binding, making it difficult to interpret or adjust the parameters and output of the algorithm. Furthermore, there is no public description of the algorithm sufficient to exactly reproduce it. Another algorithm, MAST, computes a p-value for the presence of a TFBS using true probabilities of finding each base at each offset from that position. We developed a statistical model, BaSeTraM, for the binding of TFs to TFBSs, taking into account random variation in the base present at each position within a TFBS. Treating the counts in the matrices and the sequences of sites as random variables, we combine this TFBS composition model with a background model to obtain a Bayesian classifier. We implemented our classifier in a package (SBaSeTraM). We tested SBaSeTraM against a MATCHTM implementation by searching all probes used in an experimental Saccharomyces cerevisiae TF binding dataset, and comparing our predictions to the data. We found no statistically significant differences in sensitivity between the algorithms (at fixed selectivity), indicating that SBaSeTraM's performance is at least comparable to the leading currently available algorithm. Our software is freely available at: http://wiki.github.com/A1kmm/sbasetram/building-the-tools.	[Miller, Andrew K.; Nielsen, Poul M. F.; Crampin, Edmund J.] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, Dept Mol Med, Auckland 1, New Zealand; [Print, Cristin G.] Univ Auckland, NZ Bioinformat Inst, Auckland 1, New Zealand; [Nielsen, Poul M. F.; Crampin, Edmund J.] Univ Auckland, Fac Engn, Dept Engn Sci, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland; University of Auckland	Miller, AK (corresponding author), Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand.	ak.miller@auckland.ac.nz; e.crampin@auckland.ac.nz	Nielsen, Poul M F/A-5814-2009	Nielsen, Poul M F/0000-0002-4704-0179; Print, Cristin/0000-0001-8345-7812	New Zealand Tertiary Education Commission; New Zealand Health Research Council; Breast Cancer Research Trust; New Zealand Foundation for Research, Science and Technology; King Abdullah University of Science and Technology [KUK-C1-013-04]	New Zealand Tertiary Education Commission; New Zealand Health Research Council(Health Research Council of New Zealand); Breast Cancer Research Trust; New Zealand Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	This work was supported by the New Zealand Tertiary Education Commission [Top Achiever's Doctoral Scholarship] to AKM (http://www.tec.govt.nz); the New Zealand Health Research Council International Investment Opportunities Fund (http://www.hrc.govt.nz/) to CGP and EJC; the Breast Cancer Research Trust (http://www.breastcancercure.org.nz/) to CGP and EJC; and the New Zealand Foundation for Research, Science and Technology to CGP and EJC (http://www.frst.govt.nz/). This publication is based on work (by EJC) that was supported in part by award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (http://www.kaust.edu.sa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bailey TL, 1998, BIOINFORMATICS, V14, P48, DOI 10.1093/bioinformatics/14.1.48; Das MK, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S7-S21; Gropp W., 1999, USING MPI 2 ADV FEAT; Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800; HOLM S, 1979, SCAND J STAT, V6, P65; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Lahdesmaki H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001820; Mahony S, 2007, PLOS COMPUT BIOL, V3, P578, DOI 10.1371/journal.pcbi.0030061; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; Olver F. W., 2010, NIST HDB MATH FUNCTI; R Core Team, 2020, R LANG ENV STAT COMP; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Tompa M, 2005, NAT BIOTECHNOL, V23, P137, DOI 10.1038/nbt1053; Weidendorfer J, 2008, TOOLS FOR HIGH PERFORMANCE COMPUTING, P93, DOI 10.1007/978-3-540-68564-7_7; [No title captured]	17	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e13897	10.1371/journal.pone.0013897	http://dx.doi.org/10.1371/journal.pone.0013897			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124986	Green Published, gold			2022-12-27	WOS:000284356900001
J	Bocchino, M; Agnese, S; Fagone, E; Svegliati, S; Grieco, D; Vancheri, C; Gabrielli, A; Sanduzzi, A; Avvedimento, EV				Bocchino, Marialuisa; Agnese, Savina; Fagone, Evelina; Svegliati, Silvia; Grieco, Domenico; Vancheri, Carlo; Gabrielli, Armando; Sanduzzi, Alessandro; Avvedimento, Enrico V.			Reactive Oxygen Species Are Required for Maintenance and Differentiation of Primary Lung Fibroblasts in Idiopathic Pulmonary Fibrosis	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASES; SIGNAL-REGULATED KINASE; SYSTEMIC-SCLEROSIS; OXIDATIVE STRESS; INFLAMMATORY MECHANISMS; MINOR COMPONENT; NADPH OXIDASE; PDGF RECEPTOR; GROWTH-FACTOR; DISEASES	Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal illness whose pathogenesis remains poorly understood. Recent evidence suggests oxidative stress as a key player in the establishment/progression of lung fibrosis in animal models and possibly in human IPF. The aim of the present study was to characterize the cellular phenotype of fibroblasts derived from IPF patients and identify underlying molecular mechanisms. Methodology/Principal Findings: We first analyzed the baseline differentiation features and growth ability of primary lung fibroblasts derived from 7 histology proven IPF patients and 4 control subjects at different culture passages. Then, we focused on the redox state and related molecular pathways of IPF fibroblasts and investigated the impact of oxidative stress in the establishment of the IPF phenotype. IPF fibroblasts were differentiated into alpha-smooth muscle actin (SMA)-positive myofibroblasts, displayed a pro-fibrotic phenotype as expressing type-I collagen, and proliferated lower than controls cells. The IPF phenotype was inducible upon oxidative stress in control cells and was sensitive to ROS scavenging. IPF fibroblasts also contained large excess of reactive oxygen species (ROS) due to the activation of an NADPH oxidase-like system, displayed higher levels of tyrosine phosphorylated proteins and were more resistant to oxidative-stress induced cell death. Interestingly, the IPF traits disappeared with time in culture, indicating a transient effect of the initial trigger. Conclusions/Significance: Robust expression of alpha-SMA and type-I collagen, high and uniformly-distributed ROS levels, resistance to oxidative-stress induced cell death and constitutive activation of tyrosine kinase(s) signalling are distinctive features of the IPF phenotype. We suggest that this phenotype can be used as a model to identify the initial trigger of IPF.	[Bocchino, Marialuisa; Sanduzzi, Alessandro] Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Sez Malattie Apparato Resp, Naples, Italy; [Bocchino, Marialuisa; Agnese, Savina; Grieco, Domenico; Avvedimento, Enrico V.] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol L Calif, Naples, Italy; [Fagone, Evelina; Vancheri, Carlo] Univ Catania, Dipartimento Med Interna & Specialist, Sez Malattie Resp, Catania, Italy; [Svegliati, Silvia; Gabrielli, Armando] Univ Politecn Marche, Dipartimento Sci Med & Chirurg, Sez Clin Med, Ancona, Italy	University of Naples Federico II; University of Naples Federico II; University of Catania; Marche Polytechnic University	Bocchino, M (corresponding author), Univ Naples Federico II, Dipartimento Med Clin & Sperimentale, Sez Malattie Apparato Resp, Naples, Italy.	marialuisa.bocchino@unina.it	Svegliati, Silvia/L-2614-2016; Gabrielli, Armando/AAC-3173-2019; VANCHERI, Carlo/K-9417-2016	Svegliati, Silvia/0000-0001-6863-2600; GRIECO, Domenico/0000-0002-7131-5742; VANCHERI, Carlo/0000-0002-5120-9926; Fagone, Evelina/0000-0001-8413-7300	Associazione Italiana per la Lotta al Cancro (A.I.R.C.); Fondazione Cariverona	Associazione Italiana per la Lotta al Cancro (A.I.R.C.)(Fondazione AIRC per la ricerca sul cancro); Fondazione Cariverona(Fondazione Cariverona)	This work has been supported by Associazione Italiana per la Lotta al Cancro (A.I.R.C.) and by a generous grant from Fondazione Cariverona. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias, 2002, AM J RESP CRIT CARE, V165, P277, DOI [DOI 10.1164/AJRCCM.165.2.ATS01, 10.1164/ajrccm.165.2.ats01]; Babior BM, 2004, CURR OPIN IMMUNOL, V16, P42, DOI 10.1016/j.coi.2003.12.001; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Beeh KM, 2002, EUR RESPIR J, V19, P1119, DOI 10.1183/09031936.02.00262402; CANTIN AM, 1987, J CLIN INVEST, V79, P1665, DOI 10.1172/JCI113005; Chan EC, 2009, PHARMACOL THERAPEUT, V122, P97, DOI 10.1016/j.pharmthera.2009.02.005; Chaudhary NI, 2007, EUR RESPIR J, V29, P976, DOI 10.1183/09031936.00152106; Cong YS, 2006, MECH AGEING DEV, V127, P332, DOI 10.1016/j.mad.2005.12.005; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Das R, 2007, FREE RADICAL BIO MED, V42, P541, DOI 10.1016/j.freeradbiomed.2006.11.020; Escano CS, 2008, J PHARMACOL EXP THER, V324, P34, DOI 10.1124/jpet.107.126300; Flaherty KR, 2003, AM J RESP CRIT CARE, V167, P1410, DOI 10.1164/rccm.200204-373OC; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gabrielli A, 2009, NEW ENGL J MED, V360, P1989, DOI 10.1056/NEJMra0806188; Gauldie J, 2002, AM J RESP CRIT CARE, V165, P1205, DOI 10.1164/rccm.2202054; Goodwin A, 2009, BIOCHEM SOC T, V37, P849, DOI 10.1042/BST0370849; Hardie WD, 2008, AM J PHYSIOL-LUNG C, V294, pL1217, DOI 10.1152/ajplung.00020.2008; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Ingram JL, 2006, CURR MOL MED, V6, P409, DOI 10.2174/156652406777435426; JORDANA M, 1988, AM REV RESPIR DIS, V137, P579, DOI 10.1164/ajrccm/137.3.579; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kinnula VL, 2003, AM J RESP CRIT CARE, V167, P1600, DOI 10.1164/rccm.200212-1479SO; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Lenz AG, 1996, EUR RESPIR J, V9, P307, DOI 10.1183/09031936.96.09020307; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nicholson AG, 2002, AM J RESP CRIT CARE, V166, P173, DOI 10.1164/rccm.2109039; Phan Sem H, 2008, Proc Am Thorac Soc, V5, P334, DOI 10.1513/pats.200708-146DR; Psathakis K, 2006, EUR J CLIN INVEST, V36, P362, DOI 10.1111/j.1365-2362.2006.01636.x; RAGHU G, 1988, AM REV RESPIR DIS, V138, P703, DOI 10.1164/ajrccm/138.3.703; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Rottoli P, 2005, PROTEOMICS, V5, P2612, DOI 10.1002/pmic.200401206; Sambo P, 2001, ARTHRITIS RHEUM-US, V44, P2653, DOI 10.1002/1529-0131(200111)44:11<2653::AID-ART445>3.0.CO;2-1; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Selman M, 2001, RESP RES, V3, DOI 10.1186/rr175; Strieter RM, 2002, AM J RESP CRIT CARE, V165, P1206, DOI 10.1164/rccm.2202055; Sugiura H, 2009, PULM PHARMACOL THER, V22, P487, DOI 10.1016/j.pupt.2009.04.002; Svegliati S, 2005, J BIOL CHEM, V280, P36474, DOI 10.1074/jbc.M502851200; Waghray M, 2005, FASEB J, V19, P854, DOI 10.1096/fj.04-2882fje; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Wu WS, 2006, MOL CANCER RES, V4, P747, DOI 10.1158/1541-7786.MCR-06-0096	42	102	104	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14003	10.1371/journal.pone.0014003	http://dx.doi.org/10.1371/journal.pone.0014003			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103368	Green Published, gold, Green Submitted			2022-12-27	WOS:000284257400007
J	Gosai, SJ; Kwak, JH; Luke, CJ; Long, OS; King, DE; Kovatch, KJ; Johnston, PA; Shun, TY; Lazo, JS; Perlmutter, DH; Silverman, GA; Pak, SC				Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Johnston, Paul A.; Shun, Tong Ying; Lazo, John S.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.			Automated High-Content Live Animal Drug Screening Using C-elegans Expressing the Aggregation Prone Serpin alpha 1-antitrypsin Z	PLOS ONE			English	Article							HIGH-THROUGHPUT SCREEN; CAENORHABDITIS-ELEGANS; PROTEIN AGGREGATION; MK2-EGFP TRANSLOCATION; KINASE INHIBITORS; CELLULAR ASPECTS; ADMET RULES; LIFE-SPAN; AUTOPHAGY; ASSAY	The development of preclinical models amenable to live animal bioactive compound screening is an attractive approach to discovering effective pharmacological therapies for disorders caused by misfolded and aggregation-prone proteins. In general, however, live animal drug screening is labor and resource intensive, and has been hampered by the lack of robust assay designs and high throughput work-flows. Based on their small size, tissue transparency and ease of cultivation, the use of C. elegans should obviate many of the technical impediments associated with live animal drug screening. Moreover, their genetic tractability and accomplished record for providing insights into the molecular and cellular basis of human disease, should make C. elegans an ideal model system for in vivo drug discovery campaigns. The goal of this study was to determine whether C. elegans could be adapted to high-throughput and high-content drug screening strategies analogous to those developed for cell-based systems. Using transgenic animals expressing fluorescently-tagged proteins, we first developed a high-quality, high-throughput work-flow utilizing an automated fluorescence microscopy platform with integrated image acquisition and data analysis modules to qualitatively assess different biological processes including, growth, tissue development, cell viability and autophagy. We next adapted this technology to conduct a small molecule screen and identified compounds that altered the intracellular accumulation of the human aggregation prone mutant that causes liver disease in alpha 1-antitrypsin deficiency. This study provides powerful validation for advancement in preclinical drug discovery campaigns by screening live C. elegans modeling alpha 1-antitrypsin deficiency and other complex disease phenotypes on high-content imaging platforms.	[Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA; [Gosai, Sager J.; Kwak, Joon Hyeok; Luke, Cliff J.; Long, Olivia S.; King, Dale E.; Kovatch, Kevin J.; Perlmutter, David H.; Silverman, Gary A.; Pak, Stephen C.] Magee Womens Hosp, Res Inst, Pittsburgh, PA USA; [Johnston, Paul A.; Shun, Tong Ying; Lazo, John S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Drug Discovery Inst, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Gosai, SJ (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Dept Pediat Cell Biol & Physiol,UPMC, Pittsburgh, PA 15260 USA.	gsilverman@upmc.edu; paksc@upmc.edu	Silverman, Gary/AAJ-1269-2020	Pak, Stephen/0000-0002-8089-3237; Johnston, Paul/0000-0001-5815-3091	Hartwell Foundation; Fiske Drug Discovery Fund; National Institutes of Health [DK079806, DK081422, MH07441]; NIH National Center for Research Resources (NCRR); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK079806, R01DK084512, R01DK076918, R01DK081422] Funding Source: NIH RePORTER	Hartwell Foundation; Fiske Drug Discovery Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from The Hartwell Foundation (GAS), the Fiske Drug Discovery Fund (JSL) and the National Institutes of Health (DK079806 and DK081422 to GAS and MH07441 to JSL). Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH National Center for Research Resources (NCRR). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguzzi A, 2010, NAT REV DRUG DISCOV, V9, P237, DOI 10.1038/nrd3050; Artal-Sanz Marto, 2006, Biotechnology Journal, V1, P1405, DOI 10.1002/biot.200600176; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bartolini M, 2010, CHEMBIOCHEM, V11, P1018, DOI 10.1002/cbic.200900666; Bleicher KH, 2003, NAT REV DRUG DISCOV, V2, P369, DOI 10.1038/nrd1086; Breger J, 2007, PLOS PATHOG, V3, P168, DOI 10.1371/journal.ppat.0030018; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Dantuma NP, 2000, NAT BIOTECHNOL, V18, P538, DOI 10.1038/75406; de Voer G, 2008, BBA-MOL BASIS DIS, V1782, P433, DOI 10.1016/j.bbadis.2008.04.003; DRISCOLL M, 1991, NATURE, V349, P588, DOI 10.1038/349588a0; Ellerbrock BR, 2004, J BIOMOL SCREEN, V9, P147, DOI 10.1177/1087057103261038; Faber PW, 1999, P NATL ACAD SCI USA, V96, P179, DOI 10.1073/pnas.96.1.179; Frearson JA, 2009, DRUG DISCOV TODAY, V14, P1150, DOI 10.1016/j.drudis.2009.09.004; Giacomotto J, 2010, BRIT J PHARMACOL, V160, P204, DOI 10.1111/j.1476-5381.2010.00725.x; Gill MS, 2003, FREE RADICAL BIO MED, V35, P558, DOI 10.1016/S0891-5849(03)00328-9; Giuliano KA, 2006, METHOD ENZYMOL, V414, P601, DOI 10.1016/S0076-6879(06)14031-8; Gleeson MP, 2008, J MED CHEM, V51, P817, DOI 10.1021/jm701122q; Gleeson P, 2009, BIOORGAN MED CHEM, V17, P5906, DOI 10.1016/j.bmc.2009.07.002; Haney SA, 2006, DRUG DISCOV TODAY, V11, P889, DOI 10.1016/j.drudis.2006.08.015; Herczenik E, 2008, FASEB J, V22, P2115, DOI 10.1096/fj.07-099671; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; Hodgson J, 2001, NAT BIOTECHNOL, V19, P722, DOI 10.1038/90761; Johnston PA, 2002, DRUG DISCOV TODAY, V7, P353, DOI 10.1016/S1359-6446(01)02140-7; Johnston PA, 2008, ASSAY DRUG DEV TECHN, V6, P505, DOI 10.1089/adt.2008.151; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P737, DOI 10.1089/adt.2007.101; Johnston PA, 2007, ASSAY DRUG DEV TECHN, V5, P319, DOI 10.1089/adt.2007.066; Johnston PA, 2009, ASSAY DRUG DEV TECHN, V7, P250, DOI 10.1089/adt.2008.186; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Kang C, 2007, GENE DEV, V21, P2161, DOI 10.1101/gad.1573107; Kraemer BC, 2003, P NATL ACAD SCI USA, V100, P9980, DOI 10.1073/pnas.1533448100; Krainc D, 2010, ARCH NEUROL-CHICAGO, V67, P388, DOI 10.1001/archneurol.2010.40; Krebs MP, 2010, J MOL BIOL, V395, P1063, DOI 10.1016/j.jmb.2009.11.015; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Lakso M, 2003, J NEUROCHEM, V86, P165, DOI 10.1046/j.1471-4159.2003.01809.x; Lee S, 2006, METHOD ENZYMOL, V414, P468, DOI 10.1016/S0076-6879(06)14025-2; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; Link CD, 2006, EXP GERONTOL, V41, P1007, DOI 10.1016/j.exger.2006.06.059; Lomas DA, 2005, BIOCHEM SOC T, V33, P321, DOI 10.1042/BST0330321; Luke CJ, 2007, CELL, V130, P1108, DOI 10.1016/j.cell.2007.07.013; Lum JJ, 2005, NAT REV MOL CELL BIO, V6, P439, DOI 10.1038/nrm1660; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Molina G, 2009, NAT CHEM BIOL, V5, P680, DOI 10.1038/nchembio.190; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Moy TI, 2009, ACS CHEM BIOL, V4, P527, DOI 10.1021/cb900084v; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Nehrke K, 2002, J BIOL CHEM, V277, P29036, DOI 10.1074/jbc.M203200200; Nickischer D, 2006, METHOD ENZYMOL, V414, P389, DOI 10.1016/S0076-6879(06)14022-7; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Oeda T, 2001, HUM MOL GENET, V10, P2013, DOI 10.1093/hmg/10.19.2013; Okoli I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007025; Perlmutter DH, 2002, J CLIN INVEST, V110, P1579, DOI 10.1172/JCI200216787; Petrascheck M, 2007, NATURE, V450, P553, DOI 10.1038/nature05991; Picken MM, 2010, ARCH PATHOL LAB MED, V134, P545, DOI 10.1043/1543-2165-134.4.545; Rihel J, 2010, SCIENCE, V327, P348, DOI 10.1126/science.1183090; Royal DC, 2005, J BIOL CHEM, V280, P41976, DOI 10.1074/jbc.M510732200; Silverman GA, 2009, PEDIATR RES, V65, P10, DOI 10.1203/PDR.0b013e31819009b0; Stockwell BR, 2000, NAT REV GENET, V1, P116, DOI 10.1038/35038557; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Tran TC, 2007, CANCER RES, V67, P11386, DOI 10.1158/0008-5472.CAN-07-3126; Trask OJ, 2006, METHOD ENZYMOL, V414, P419, DOI 10.1016/S0076-6879(06)14023-9; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Williams RG, 2006, METHOD ENZYMOL, V414, P364, DOI 10.1016/S0076-6879(06)14021-5; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104	69	128	132	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15460	10.1371/journal.pone.0015460	http://dx.doi.org/10.1371/journal.pone.0015460			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103396	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000284147700030
J	Lan, L; Lin, SY; Zhang, S; Cohen, RS				Lan, Lan; Lin, Shengyin; Zhang, Sui; Cohen, Robert S.			Evidence for a Transport-Trap Mode of Drosophila melanogaster gurken mRNA Localization	PLOS ONE			English	Article							ALPHA-LIKE PROTEIN; TRANSLATIONAL CONTROL; GENE-EXPRESSION; OOGENESIS; OOCYTE; OSKAR; DYNEIN; POLARITY; REVEALS; PATTERN	The Drosophila melanogaster gurken gene encodes a TGF alpha-like signaling molecule that is secreted from the oocyte during two distinct stages of oogenesis to define the coordinate axes of the follicle cell epithelium that surrounds the oocyte and its 15 anterior nurse cells. Because the gurken receptor is expressed throughout the epithelium, axial patterning requires region-specific secretion of Gurken protein, which in turn requires subcellular localization of gurken transcripts. The first stage of Gurken signaling induces anteroposterior pattern in the epithelium and requires the transport of gurken transcripts from nurse cells into the oocyte. The second stage of Gurken signaling induces dorsovental polarity in the epithelium and requires localization of gurken transcripts to the oocyte's anterodorsal corner. Previous studies, relying predominantly on real-time imaging of injected transcripts, indicated that anterodorsal localization involves transport of gurken transcripts to the oocyte's anterior cortex followed by transport to the anterodorsal corner, and anchoring. Such studies further indicated that a single RNA sequence element, the GLS, mediates both transport steps by facilitating association of gurken transcripts with a cytoplasmic dynein motor complex. Finally, it was proposed that the GLS somehow steers the motor complex toward that subset of microtubules that are nucleated around the oocyte nucleus, permitting directed transport to the anterodorsal corner. Here, we re-investigate the role of the GLS using a transgenic fly assay system that includes use of the endogenous gurken promoter and biological rescue as well as RNA localization assays. In contrast to previous reports, our studies indicate that the GLS is sufficient for anterior localization only. Our data support a model in which anterodorsal localization is brought about by repeated rounds of anterior transport, accompanied by specific trapping at the anterodorsal cortex. Our data further indicate that trapping at the anterodorsal corner requires at least one as-yet-unidentified gurken RLE.	[Lan, Lan; Lin, Shengyin; Zhang, Sui; Cohen, Robert S.] Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA	University of Kansas	Lan, L (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	rcohen@ku.edu	LAN, LAN/N-8872-2018		National Institutes of Health [R01GM068022]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068022] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant R01GM068022 awarded to RSC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M., 1989, DROSOPHILA; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; Bastock R, 2008, CURR BIOL, V18, pR1082, DOI 10.1016/j.cub.2008.09.011; Becalska AN, 2009, DEVELOPMENT, V136, P2493, DOI 10.1242/dev.032391; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0; Chekulaeva M, 2006, CELL, V124, P521, DOI 10.1016/j.cell.2006.01.031; CHEUNG HK, 1992, DEVELOPMENT, V114, P653; Clark IE, 1997, DEVELOPMENT, V124, P461; Clouse KN, 2008, DEV BIOL, V313, P713, DOI 10.1016/j.ydbio.2007.11.008; Cohen RS, 2005, RNA, V11, P1017, DOI 10.1261/rna.7218905; Delanoue R, 2007, DEV CELL, V13, P523, DOI 10.1016/j.devcel.2007.08.022; Dollar G, 2002, DEVELOPMENT, V129, P517; Duncan JE, 2002, CURR BIOL, V12, P1982, DOI 10.1016/S0960-9822(02)01303-9; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; Filardo P, 2003, MECH DEVELOP, V120, P289, DOI 10.1016/S0925-4773(02)00454-9; Forrest KM, 2003, CURR BIOL, V13, P1159, DOI 10.1016/S0960-9822(03)00451-2; GONZALEZREYES A, 1995, NATURE, V375, P654, DOI 10.1038/375654a0; Grunert S, 1996, CURR OPIN GENET DEV, V6, P395, DOI 10.1016/S0959-437X(96)80059-1; Heger A, 2007, GENETICS, V177, P1337, DOI 10.1534/genetics.107.070466; Januschke J, 2002, CURR BIOL, V12, P1971, DOI 10.1016/S0960-9822(02)01302-7; Jaramillo AM, 2008, J CELL SCI, V121, P887, DOI 10.1242/jcs.019091; Kugler JM, 2009, FLY, V3, P15, DOI 10.4161/fly.3.1.7751; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044; Meignin C, 2010, CURR OPIN CELL BIOL, V22, P112, DOI 10.1016/j.ceb.2009.11.011; NeumanSilberberg FS, 1996, MECH DEVELOP, V59, P105, DOI 10.1016/0925-4773(96)00567-9; NEUMANSILBERBERG FS, 1993, CELL, V75, P165, DOI 10.1016/S0092-8674(05)80093-5; Nielsen CB, 2010, NAT METHODS, V7, pS5, DOI [10.1038/NMETH.1422, 10.1038/nmeth.1422]; Nilson LA, 1999, CURR TOP DEV BIOL, V44, P203; Norvell A, 1999, GENE DEV, V13, P864, DOI 10.1101/gad.13.7.864; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Pirrotta V, 1988, Biotechnology, V10, P437; Queenan AM, 1999, MECH DEVELOP, V89, P35, DOI 10.1016/S0925-4773(99)00196-3; Rom I, 2007, BBA-MOL CELL RES, V1773, P1526, DOI 10.1016/j.bbamcr.2007.05.005; Roth S, 2003, PHILOS T ROY SOC B, V358, P1317, DOI 10.1098/rstb.2003.1325; ROTH S, 1995, CELL, V81, P967, DOI 10.1016/0092-8674(95)90016-0; Saunders C, 1999, MOL CELL, V3, P43, DOI 10.1016/S1097-2765(00)80173-2; SCHUPBACH T, 1987, CELL, V49, P699, DOI 10.1016/0092-8674(87)90546-0; SERANO T, 1995, DEVELOPMENT, V121, P3809; SERANO TL, 1995, MECH DEVELOP, V51, P183, DOI 10.1016/0925-4773(95)00363-0; SIMON AM, 1992, DEVELOPMENT, V114, P545; St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THEURKAUF WE, 1992, DEVELOPMENT, V115, P923; Van De Bor V, 2005, DEV CELL, V9, P51, DOI 10.1016/j.devcel.2005.04.012; Yan N, 2004, GENETICS, V168, P1433, DOI 10.1534/genetics.104.033985	49	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15448	10.1371/journal.pone.0015448	http://dx.doi.org/10.1371/journal.pone.0015448			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103393	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700027
J	Donegan, S; Williamson, P; Gamble, C; Tudur-Smith, C				Donegan, Sarah; Williamson, Paula; Gamble, Carrol; Tudur-Smith, Catrin			Indirect Comparisons: A Review of Reporting and Methodological Quality	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; DRUG-ELUTING STENTS; MOLECULAR-WEIGHT HEPARINS; COMPARATIVE METAANALYSIS; COST-EFFECTIVENESS; COMPETING INTERVENTIONS; RHEUMATOID-ARTHRITIS; SECONDARY PREVENTION; ECONOMIC-EVALUATION; SYSTEMATIC REVIEWS	Background: The indirect comparison of two interventions can be valuable in many situations. However, the quality of an indirect comparison will depend on several factors including the chosen methodology and validity of underlying assumptions. Published indirect comparisons are increasingly more common in the medical literature, but as yet, there are no published recommendations of how they should be reported. Our aim is to systematically review the quality of published indirect comparisons to add to existing empirical data suggesting that improvements can be made when reporting and applying indirect comparisons. Methodology/Findings: Reviews applying statistical methods to indirectly compare the clinical effectiveness of two interventions using randomised controlled trials were eligible. We searched (1966-2008) Database of Abstracts and Reviews of Effects, The Cochrane library, and Medline. Full review publications were assessed for eligibility. Specific criteria to assess quality were developed and applied. Forty-three reviews were included. Adequate methodology was used to calculate the indirect comparison in 41 reviews. Nineteen reviews assessed the similarity assumption using sensitivity analysis, subgroup analysis, or meta-regression. Eleven reviews compared trial-level characteristics. Twenty-four reviews assessed statistical homogeneity. Twelve reviews investigated causes of heterogeneity. Seventeen reviews included direct and indirect evidence for the same comparison; six reviews assessed consistency. One review combined both evidence types. Twenty-five reviews urged caution in interpretation of results, and 24 reviews indicated when results were from indirect evidence by stating this term with the result. Conclusions: This review shows that the underlying assumptions are not routinely explored or reported when undertaking indirect comparisons. We recommend, therefore, that the quality of indirect comparisons should be improved, in particular, by assessing assumptions and reporting the assessment methods applied. We propose that the quality criteria applied in this article may provide a basis to help review authors carry out indirect comparisons and to aid appropriate interpretation.	[Donegan, Sarah; Williamson, Paula; Gamble, Carrol; Tudur-Smith, Catrin] Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Donegan, S (corresponding author), Univ Liverpool, Ctr Med Stat & Hlth Evaluat, Liverpool L69 3BX, Merseyside, England.	Sarah.Donegan@liverpool.ac.uk	Williamson, Paula R/B-6425-2016; Gamble, Carrol/AAE-9895-2019	Williamson, Paula R/0000-0001-9802-6636; Gamble, Carrol/0000-0002-3021-1955; Tudur Smith, Catrin/0000-0003-3051-1445; Donegan, Sarah/0000-0003-1709-2290	NICE Liverpool Reviews and Implementation Group	NICE Liverpool Reviews and Implementation Group	The research contributes to SD's PhD, funded by the NICE Liverpool Reviews and Implementation Group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Setta AM, 2007, REPROD BIOMED ONLINE, V14, P611, DOI 10.1016/S1472-6483(10)61054-1; Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Berner MM, 2006, INT J IMPOT RES, V18, P229, DOI 10.1038/sj.ijir.3901395; Biondi-Zoccai GL, 2005, INT J CARDIOL, V100, P119, DOI 10.1016/j.ijcard.2004.11.001; Boonen S, 2007, J CLIN ENDOCR METAB, V92, P1415, DOI 10.1210/jc.2006-1404; Brown TJ, 2006, HEALTH TECHNOL ASSES, V10, P1; Bucher HC, 1997, J CLIN EPIDEMIOL, V50, P683, DOI 10.1016/S0895-4356(97)00049-8; Buscemi N, 2007, J GEN INTERN MED, V22, P1335, DOI 10.1007/s11606-007-0251-z; Buttner M, 2004, ANESTHESIOLOGY, V101, P1454; Chou R, 2006, LANCET, V368, P1503, DOI 10.1016/S0140-6736(06)69638-4; Clark W, 2004, HEALTH TECHNOL ASSES, V8, P1; Collins R, 2007, HEALTH TECHNOL ASSES, V11, P1; Coomarasamy A, 2003, BJOG-INT J OBSTET GY, V110, P1045, DOI 10.1016/S1470-0328(03)03971-5; Cooper NJ, 2009, STAT MED, V28, P1861, DOI 10.1002/sim.3594; Costa J, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003633.pub2, 10.1002/14651858.CD0004296.pub2, 10.1002/14651858.CD004312.pub2, 10.1002/14651858.CD004315.pub2, 10.1002/14651858.CD004314.pub2, 10.1002/14651858.CD004900.pub2, 10.1002/14651858.CD004899.pub2]; Dolovich LR, 2000, ARCH INTERN MED, V160, P181, DOI 10.1001/archinte.160.2.181; Eckert L, 2006, CURR MED RES OPIN, V22, P2313, DOI 10.1185/030079906X148625; Edwards SJ, 2009, INT J CLIN PRACT, V63, P841, DOI 10.1111/j.1742-1241.2009.02072.x; Einarson TR, 2000, CLIN THER, V22, P1502, DOI 10.1016/S0149-2918(00)83048-9; Gisbert JP, 2000, ALIMENT PHARM THER, V14, P1141; Glenny AM, 2005, HEALTH TECHNOL ASSES, V9, P1; Habib AS, 2004, CAN J ANAESTH, V51, P311, DOI 10.1007/BF03018234; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Hind D, 2003, BMJ-BRIT MED J, V327, P361, DOI 10.1136/bmj.327.7411.361; Hochberg MC, 2003, ANN RHEUM DIS, V62, P13, DOI 10.1136/ard.62.suppl_2.ii13; Indolfi C, 2005, AM J CARDIOL, V95, P1146, DOI 10.1016/j.amjcard.2005.01.040; Jones L, 2004, HEALTH TECHNOL ASSES, V8, P1; Lim E, 2003, BMJ-BRIT MED J, V327, P1309, DOI 10.1136/bmj.327.7427.1309; LOWENTHAL A, 1994, ACTA NEUROL BELG, V94, P24; Mason Lorna, 2004, BMC Fam Pract, V5, P10, DOI 10.1186/1471-2296-5-10; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; McLeod C, 2007, HEALTH TECHNOL ASSES, V11, pIX; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Mudge MAC, 2005, INT J PSYCHIAT CLIN, V9, P3, DOI 10.1080/13651500510014783; MULROW CD, 1994, BRIT MED J, V309, P597, DOI 10.1136/bmj.309.6954.597; Norris SL, 2007, CURR DIABETES REV, V3, P127, DOI 10.2174/157339907780598216; Otoul C, 2005, CLIN NEUROPHARMACOL, V28, P72, DOI 10.1097/01.wnf.0000159956.87511.67; Otto MW, 2001, AM J PSYCHIAT, V158, P1989, DOI 10.1176/appi.ajp.158.12.1989; Panidou ET, 2004, AIDS, V18, P2153, DOI 10.1097/00002030-200411050-00007; PIGNON JP, 1992, NEW ENGL J MED, V327, P1618, DOI 10.1056/NEJM199212033272302; Po ALW, 1997, BRIT MED J, V315, P1565, DOI 10.1136/bmj.315.7122.1565; Richy F, 2005, CALCIFIED TISSUE INT, V76, P176, DOI 10.1007/s00223-004-0005-4; Rocha E, 2000, HAEMATOLOGICA, V85, P935; SALANTI G, 2009, J CLIN EPID IN PRESS; Sanchez-Ramos L, 2002, OBSTET GYNECOL, V99, P145, DOI 10.1016/S0029-7844(01)01644-1; Sauriol L, 2001, CLIN THER, V23, P942, DOI 10.1016/S0149-2918(01)80082-5; Song F, 2008, J CLIN EPIDEMIOL, V61, P455, DOI 10.1016/j.jclinepi.2007.06.006; Song F, 2003, BMJ-BRIT MED J, V326, P472, DOI 10.1136/bmj.326.7387.472; Song FJ, 2000, CONTROL CLIN TRIALS, V21, P488, DOI 10.1016/S0197-2456(00)00055-6; Song FJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1147; Stettler C, 2006, HEART, V92, P650, DOI 10.1136/hrt.2005.070698; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P45, DOI 10.1007/s00198-006-0204-0; Vis PMJ, 2005, ANN PHARMACOTHER, V39, P1798, DOI 10.1345/aph.1G076; Wu P, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-300; Yazdanpanah Y, 2004, BMJ-BRIT MED J, V328, P249, DOI 10.1136/bmj.37995.435787.A6; Zhou Z, 2006, AM HEART J, V151, P273, DOI 10.1016/j.ahj.2005.04.003	57	87	90	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e11054	10.1371/journal.pone.0011054	http://dx.doi.org/10.1371/journal.pone.0011054			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085712	Green Published, gold, Green Accepted			2022-12-27	WOS:000284036800001
J	Volkow, ND; Fowler, JS; Wang, GJ; Shumay, E; Telang, F; Thanos, PK; Alexoff, D				Volkow, Nora D.; Fowler, Joanna S.; Wang, Gene-Jack; Shumay, Elena; Telang, Frank; Thanos, Peter K.; Alexoff, David			Distribution and Pharmacokinetics of Methamphetamine in the Human Body: Clinical Implications	PLOS ONE			English	Article							AMPHETAMINE; PET; DOPAMINE; SMOKING; COCAINE; BINDING; MICE	Background: Methamphetamine is one of the most toxic of the drugs of abuse, which may reflect its distribution and accumulation in the body. However no studies have measured methamphetamine's organ distribution in the human body. Methods: Positron Emission Tomography (PET) was used in conjunction with [(11)C]d-methamphetamine to measure its whole-body distribution and bioavailability as assessed by peak uptake (% Dose/cc), rate of clearance (time to reach 50% peak-clearance) and accumulation (area under the curve) in healthy participants (9 Caucasians and 10 African Americans). Results: Methamphetamine distributed through most organs. Highest uptake (whole organ) occurred in lungs (22% Dose; weight similar to 1246 g), liver (23%; weight similar to 1677 g) and intermediate in brain (10%; weight similar to 1600 g). Kidneys also showed high uptake (per/cc basis) (7%; weight 305 g). Methamphetamine's clearance was fastest in heart and lungs (7-16 minutes), slowest in brain, liver and stomach (>75 minutes), and intermediate in kidneys, spleen and pancreas (22-50 minutes). Lung accumulation of [(11)C]d-methamphetamine was 30% higher for African Americans than Caucasians (p<0.05) but did not differ in other organs. Conclusions: The high accumulation of methamphetamine, a potent stimulant drug, in most body organs is likely to contribute to the medical complications associated with methamphetamine abuse. In particular, we speculate that methamphetamine's high pulmonary uptake could render this organ vulnerable to infections (tuberculosis) and pathology (pulmonary hypertension). Our preliminary findings of a higher lung accumulation of methamphetamine in African Americans than Caucasians merits further investigation and questions whether it could contribute to the infrequent use of methamphetamine among African Americans.	[Volkow, Nora D.] Natl Inst Drug Abuse, Bethesda, MD 20892 USA; [Volkow, Nora D.; Telang, Frank; Thanos, Peter K.] Natl Inst Alcohol Abuse & Alcoholism, Bethesda, MD USA; [Fowler, Joanna S.; Wang, Gene-Jack; Shumay, Elena; Alexoff, David] Brookhaven Natl Lab, Upton, NY 11973 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); United States Department of Energy (DOE); Brookhaven National Laboratory	Volkow, ND (corresponding author), Natl Inst Drug Abuse, Bethesda, MD 20892 USA.	nvolkow@nida.nih.gov			National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse [K05DA020001]; Department of Energy;  [MO1RR10710]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR010710] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA020001] Funding Source: NIH RePORTER	National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Department of Energy(United States Department of Energy (DOE)); ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the Intramural Research Program of the National Institutes of Health (NIH), National Institute on Alcohol Abuse and Alcoholism, the National Institute on Drug Abuse (K05DA020001) and infrastructure support from the Department of Energy and GCRC grant MO1RR10710. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cadet JL, 2009, INT REV NEUROBIOL, V88, P101, DOI 10.1016/S0074-7742(09)88005-7; CALDWELL J, 1972, BIOCHEM J, V129, P25, DOI 10.1042/bj1290025; Chin KM, 2006, CHEST, V130, P1657, DOI 10.1378/chest.130.6.1657; CITRON B P, 1972, Clinical Research, V20, P236; COOK CE, 1993, DRUG METAB DISPOS, V21, P717; Darke S, 2008, DRUG ALCOHOL REV, V27, P253, DOI 10.1080/09595230801923702; de la Grandmaison GL, 2001, FORENSIC SCI INT, V119, P149, DOI 10.1016/S0379-0738(00)00401-1; DEAN D, 2000, CROSS SECTIONAL HUMA, P8; Desai RI, 2010, J PHARMACOL EXP THER, V333, P834, DOI 10.1124/jpet.110.165746; Eisenhofer G, 2001, PHARMACOL THERAPEUT, V91, P35, DOI 10.1016/S0163-7258(01)00144-9; Fowler JS, 2007, J NUCL MED, V48, P1724, DOI 10.2967/jnumed.107.040279; Fowler JS, 2008, NEUROIMAGE, V43, P756, DOI 10.1016/j.neuroimage.2008.07.020; Gonzales R, 2010, ANNU REV PUBL HEALTH, V31, P385, DOI 10.1146/annurev.publhealth.012809.103600; Ishigami Akiko, 2003, Leg Med (Tokyo), V5, P42, DOI 10.1016/S1344-6223(03)00005-1; ISHIYAMA I, 1987, J FORENSIC SCI, V32, P658; Karch SB, 1999, J FORENSIC SCI, V44, P359; Kaye S, 2007, ADDICTION, V102, P1204, DOI 10.1111/j.1360-0443.2007.01874.x; Kim I, 2004, THER DRUG MONIT, V26, P664, DOI 10.1097/00007691-200412000-00013; KUCZENSKI R, 1995, J NEUROSCI, V15, P1308; Mankatittham W, 2009, SE ASIAN J TROP MED, V40, P93; Martinez LR, 2009, J INFECT DIS, V200, P131, DOI 10.1086/599328; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; Mcketin R, 2008, DRUG ALCOHOL REV, V27, P220, DOI 10.1080/09595230801923710; MCMAHON EM, 1971, SCIENCE, V174, P66, DOI 10.1126/science.174.4004.66; MERKI HS, 1988, GASTROENTEROLOGY, V94, P887, DOI 10.1016/0016-5085(88)90543-4; Mooney LJ, 2009, METHAMPHETAMINE ADDI, P117; Newton TF, 2005, PHARMACOL BIOCHEM BE, V82, P90, DOI 10.1016/j.pbb.2005.07.012; PEVZNER ES, 2010, AM J PUBLIC HLT 0218; Saito M, 2008, EXP ANIM TOKYO, V57, P35, DOI 10.1538/expanim.57.35; Sexton Rocky L, 2005, J Ethn Subst Abuse, V4, P77, DOI 10.1300/J233v04n01_06; SHIUE CY, 1993, NUCL MED BIOL, V20, P973, DOI 10.1016/0969-8051(93)90098-F; Substance Abuse and Mental Health Services Administration Office of Applied Studies, 2007, DAWN SER D, VD-29; Takano A, 2007, ANN NUCL MED, V21, P349, DOI 10.1007/s12149-007-0031-1; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; VOLKOW ND, 1992, J NUCL MED, V33, P521; Wheeler JM, 2009, GENES BRAIN BEHAV, V8, P758, DOI 10.1111/j.1601-183X.2009.00522.x	36	98	100	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15269	10.1371/journal.pone.0015269	http://dx.doi.org/10.1371/journal.pone.0015269			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151866	gold, Green Published, Green Submitted			2022-12-27	WOS:000285041800013
J	Hansel, NN; Sidhaye, V; Rafaels, NM; Gao, L; Gao, PS; Williams, R; Connett, JE; Beaty, TH; Mathias, RA; Wise, RA; King, LS; Barnes, KC				Hansel, Nadia N.; Sidhaye, Venkataramana; Rafaels, Nicholas M.; Gao, Li; Gao, Peisong; Williams, Renaldo; Connett, John E.; Beaty, Terri H.; Mathias, Rasika A.; Wise, Robert A.; King, Landon S.; Barnes, Kathleen C.			Aquaporin 5 Polymorphisms and Rate of Lung Function Decline in Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							EPITHELIAL-CELLS; CYSTIC-FIBROSIS; SMOKING; HEALTH; GENE; SMOKERS; ASTHMA; COPD; SUSCEPTIBILITY; INTERVENTION	Rationale: Aquaporin-5 (AQP5) can cause mucus overproduction and lower lung function. Genetic variants in the AQP5 gene might be associated with rate of lung function decline in chronic obstructive pulmonary disease (COPD). Methods: Five single nucleotide polymorphisms (SNPs) in AQP5 were genotyped in 429 European American individuals with COPD randomly selected from the NHLBI Lung Health Study. Mean annual decline in FEV(1) % predicted, assessed over five years, was calculated as a linear regression slope, adjusting for potential covariates and stratified by smoking status. Constructs containing the wildtype allele and risk allele of the coding SNP N228K were generated using site-directed mutagenesis, and transfected into HBE-16 (human bronchial epithelial cell line). AQP5 abundance and localization were assessed by immunoblots and confocal immunofluoresence under control, shear stress and cigarette smoke extract (CSE 10%) exposed conditions to test for differential expression or localization. Results: Among continuous smokers, three of the five SNPs tested showed significant associations (0.02>P>0.004) with rate of lung function decline; no associations were observed among the group of intermittent or former smokers. Haplotype tests revealed multiple association signals (0.012>P>0.0008) consistent with the single-SNP results. In HBE16 cells, shear stress and CSE led to a decrease in AQP5 abundance in the wild-type, but not in the N228K AQP5 plasmid. Conclusions: Polymorphisms in AQP5 were associated with rate of lung function decline in continuous smokers with COPD. A missense mutation modulates AQP-5 expression in response to cigarette smoke extract and shear stress. These results suggest that AQP5 may be an important candidate gene for COPD.	[Hansel, Nadia N.; Sidhaye, Venkataramana; Rafaels, Nicholas M.; Gao, Li; Gao, Peisong; Williams, Renaldo; Mathias, Rasika A.; Wise, Robert A.; King, Landon S.; Barnes, Kathleen C.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Hansel, Nadia N.; Beaty, Terri H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Connett, John E.] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Minnesota System; University of Minnesota Twin Cities	Hansel, NN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	kbarnes@jhmi.edu	Sidhaye, Venkataramana/AAC-3930-2019	Sidhaye, Venkataramana/0000-0002-4506-8549; Wise, Robert/0000-0002-8353-2349	National Heart, Lung and Blood Institute [HL076322, HL066583, HL010342, N01-HV-48195]; NIA [AG21057]; Flight Attendant Medical Research Institute [HL085763]; Mary Beryl Patch Turnbull Scholar Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL085763, U01HL066583, P01HL010342, K23HL076322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021057, R56AG021057] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Flight Attendant Medical Research Institute; Mary Beryl Patch Turnbull Scholar Program; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Heart, Lung and Blood Institute (HL076322, HL066583, HL010342), NIA (AG21057), Flight Attendant Medical Research Institute Young Clinician Scientist Award and HL085763 (VS). Genotyping services were provided by the Johns Hopkins University under U.S. Federal Government contract number N01-HV-48195 from the NHLBI. KCB was supported in part by the Mary Beryl Patch Turnbull Scholar Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTHONISEN NR, 1989, AM REV RESPIR DIS, V140, P871, DOI 10.1164/ajrccm/140.4.871; ANTHONISEN NR, 1994, JAMA-J AM MED ASSOC, V272, P1497, DOI 10.1001/jama.272.19.1497; Arkwright PD, 2000, THORAX, V55, P459, DOI 10.1136/thorax.55.6.459; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BASCOM R, 1991, PHARMACOGENETICS, V1, P102, DOI 10.1097/00008571-199111000-00008; Becker KG, 2004, MED HYPOTHESES, V62, P309, DOI 10.1016/S0306-9877(03)00332-3; Collaco JM, 2008, JAMA-J AM MED ASSOC, V299, P417, DOI 10.1001/jama.299.4.417; CONNETT JE, 1993, CONTROL CLIN TRIALS, V14, pS1; Eden E, 2010, COPD, V7, P366, DOI 10.3109/15412555.2010.510159; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glader P, 2006, RESP MED, V100, P818, DOI 10.1016/j.rmed.2005.09.008; Hansel NN, 2009, EUR RESPIR J, V34, P103, DOI 10.1183/09031936.00120408; He JQ, 2006, HUM GENET, V119, P365, DOI 10.1007/s00439-006-0143-z; He JQ, 2004, AM J RESP CRIT CARE, V170, P388, DOI 10.1164/rccm.200312-1763OC; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hogg JC, 2004, LANCET, V364, P709, DOI 10.1016/S0140-6736(04)16900-6; Kanner RE, 1999, AM J MED, V106, P410, DOI 10.1016/S0002-9343(99)00056-X; Krane CM, 2009, CYTOKINE, V46, P111, DOI 10.1016/j.cyto.2008.12.018; Krane CM, 2001, P NATL ACAD SCI USA, V98, P14114, DOI 10.1073/pnas.231273398; Lee MD, 1996, J BIOL CHEM, V271, P8599, DOI 10.1074/jbc.271.15.8599; Mannino David M, 2002, Respir Care, V47, P1184; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Ning YY, 2008, SWISS MED WKLY, V138, P573, DOI 2008/39/smw-12240; Ogawa E, 2007, RESP MED, V101, P938, DOI 10.1016/j.rmed.2006.09.008; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sandford AJ, 2002, THORAX, V57, P736, DOI 10.1136/thorax.57.8.736; Seo T, 2008, ANN EPIDEMIOL, V18, P330, DOI 10.1016/j.annepidem.2007.10.002; Serikov VB, 2006, INHAL TOXICOL, V18, P79, DOI 10.1080/08958370500282506; SHEN Y, 2010, J CELL MOL MED, DOI DOI 10.1111/J.1582-4934.2010.01103.X/PDF.; Sidhaye V, 2005, J BIOL CHEM, V280, P3590, DOI 10.1074/jbc.M411038200; Sidhaye VK, 2008, P NATL ACAD SCI USA, V105, P3345, DOI 10.1073/pnas.0712287105; Steinfeld S, 2001, LAB INVEST, V81, P143, DOI 10.1038/labinvest.3780221; Tashkin DP, 1996, AM J RESP CRIT CARE, V153, P1802, DOI 10.1164/ajrccm.153.6.8665038; Tzetis M, 2001, HUM GENET, V108, P216, DOI 10.1007/s004390100467; Verkman AS, 2000, AM J PHYSIOL-LUNG C, V278, pL867, DOI 10.1152/ajplung.2000.278.5.L867; Wang K, 2007, ACTA PHARMACOL SIN, V28, P1166, DOI 10.1111/j.1745-7254.2007.00608.x; Zhang YG, 2010, RESPIROLOGY, V15, P643, DOI 10.1111/j.1440-1843.2010.01748.x	38	28	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14226	10.1371/journal.pone.0014226	http://dx.doi.org/10.1371/journal.pone.0014226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151978	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600018
J	Vagasi, CI; Pap, PL; Barta, Z				Vagasi, Csongor I.; Pap, Peter L.; Barta, Zoltan			Haste Makes Waste: Accelerated Molt Adversely Affects the Expression of Melanin-Based and Depigmented Plumage Ornaments in House Sparrows	PLOS ONE			English	Article							CURRENT REPRODUCTIVE EFFORT; MALE COLLARED FLYCATCHERS; DIET QUALITY AFFECTS; PASSER-DOMESTICUS; BADGE SIZE; TRADE-OFF; PIED FLYCATCHER; FEATHER QUALITY; STATUS SIGNAL; BROOD SIZE	Background: Many animals display colorful signals in their integument which convey information about the quality of their bearer. Theoretically, these ornaments incur differential production and/or maintenance costs that enforce their honesty. However, the proximate mechanisms of production costs are poorly understood and contentious in cases of non-carotenoid-based plumage ornaments like the melanin-based badge and depigmented white wing-bar in house sparrows Passer domesticus. Costly life-history events are adaptively separated in time, thus, when reproduction is extended, the time available for molt is curtailed and, in turn, molt rate is accelerated. Methodology/Principal Findings: We experimentally accelerated the molt rate by shortening the photoperiod in order to test whether this environmental constraint is mirrored in the expression of plumage ornaments. Sparrows which had undergone an accelerated molt developed smaller badges and less bright wing-bars compared to conspecifics that molted at a natural rate being held at natural-like photoperiod. There was no difference in the brightness of the badge or the size of the wing-bar. Conclusions/Significance: These results indicate that the time available for molt and thus the rate at which molt occurs may constrain the expression of melanin-based and depigmented plumage advertisements. This mechanism may lead to the evolution of honest signaling if the onset of molt is condition-dependent through the timing of and/or trade-off between breeding and molt.	[Vagasi, Csongor I.; Pap, Peter L.; Barta, Zoltan] Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary; [Vagasi, Csongor I.; Pap, Peter L.] Univ Babes Bolyai, Dept Taxon & Ecol, R-3400 Cluj Napoca, Romania	University of Debrecen; Babes Bolyai University from Cluj	Vagasi, CI (corresponding author), Univ Debrecen, Dept Evolutionary Zool, Behav Ecol Res Grp, Debrecen, Hungary.	csongor.vagasi@vocs.unideb.hu	Vágási, Csongor I./AAU-4548-2020	Vágási, Csongor I./0000-0002-8736-2391; Barta, Zoltan/0000-0002-7121-9865	Hungarian Ministry of Education and Culture [FNFRDL060701DN 46/2006]; Hungarian Academy of Sciences [2009A00031E]; Romanian Ministry of Education and Research [ET94/2006, PNII-RU TE 291/2010]; OTKA [NF61143]; TAMOP [4.2.1./B-09/1/KONV-2010-0007]; European Social Fund; European Regional Development Fund	Hungarian Ministry of Education and Culture; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Romanian Ministry of Education and Research(Ministry of Education and Research - Romania); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); TAMOP; European Social Fund(European Social Fund (ESF)); European Regional Development Fund(European Commission)	This work was supported by PhD scholarships from the Hungarian Ministry of Education and Culture (#FNFRDL060701DN 46/2006 to CIV) and the Hungarian Academy of Sciences (#2009A00031E to CIV), the CEEX research grant (#ET94/2006) of the Romanian Ministry of Education and Research (to PLP) and an OTKA grant (#NF61143 to ZB), and partially supported by a research grant (CNCSIS-UEFISCSU #PNII-RU TE 291/2010 to PLP and CIV) of the Romanian Ministry of Education and Research and the TAMOP project (# 4.2.1./B-09/1/KONV-2010-0007 to ZB), which is implemented through the New Hungary Development Plan, co-financed by the European Social Fund and the European Regional Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badyaev AV, 2007, J EVOLUTION BIOL, V20, P1277, DOI 10.1111/j.1420-9101.2007.01354.x; Barta Z, 2006, OIKOS, V112, P580, DOI 10.1111/j.0030-1299.2006.14240.x; BENSCH S, 1985, ORNIS SCAND, V16, P151, DOI 10.2307/3676481; Bojarinova JG, 1999, J AVIAN BIOL, V30, P437, DOI 10.2307/3677016; Bokony V, 2008, IBIS, V150, P139; Bokony V, 2006, ETHOLOGY, V112, P947, DOI 10.1111/j.1439-0310.2006.01246.x; Buchanan KL, 2010, J AVIAN BIOL, V41, P445, DOI 10.1111/j.1600-048X.2010.04929.x; Buchanan KL, 2001, P ROY SOC B-BIOL SCI, V268, P1337, DOI 10.1098/rspb.2001.1669; Buchanan KL, 2003, BEHAV ECOL SOCIOBIOL, V55, P50, DOI 10.1007/s00265-003-0682-4; Cramp S.E., 1994, HDB BIRDS EUROPE MID; Dawson A, 2000, P ROY SOC B-BIOL SCI, V267, P2093, DOI 10.1098/rspb.2000.1254; Dawson A, 2008, PHILOS T R SOC B, V363, P1621, DOI 10.1098/rstb.2007.0004; Ducrest AL, 2008, TRENDS ECOL EVOL, V23, P502, DOI 10.1016/j.tree.2008.06.001; Galvan I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003335; Gonzalez G, 1999, J ANIM ECOL, V68, P1225, DOI 10.1046/j.1365-2656.1999.00364.x; Griffith SC, 1999, NATURE, V400, P358, DOI 10.1038/22536; Griffith SC, 2000, P ROY SOC B-BIOL SCI, V267, P1115, DOI 10.1098/rspb.2000.1116; Griggio M, 2009, J EVOLUTION BIOL, V22, P782, DOI 10.1111/j.1420-9101.2009.01700.x; GUSTAFSSON L, 1995, NATURE, V375, P311, DOI 10.1038/375311a0; Hanssen SA, 2006, ANIM BEHAV, V71, P337, DOI 10.1016/j.anbehav.2005.04.021; HEARING VJ, 1991, FASEB J, V5, P2902, DOI 10.1096/fasebj.5.14.1752358; Hemborg C, 1998, BEHAV ECOL SOCIOBIOL, V43, P19, DOI 10.1007/s002650050462; Hill G. E., 2006, BIRD COLORATION, V2; Hill G. E., 2006, BIRD COLORATION, V1; HILL GE, 1991, NATURE, V350, P337, DOI 10.1038/350337a0; Hinsley SA, 2003, IBIS, V145, P337, DOI 10.1046/j.1474-919X.2003.00167.x; Ito S, 2000, PIGM CELL RES, V13, P103, DOI 10.1034/j.1600-0749.13.s8.19.x; Jawor JM, 2003, AUK, V120, P249, DOI 10.1642/0004-8038(2003)120[0249:MOHASS]2.0.CO;2; Jensen H, 2004, J ANIM ECOL, V73, P599, DOI 10.1111/j.0021-8790.2004.00837.x; Johnstone Rufus A., 1997, P155; LESSELLS CM, 1986, J ANIM ECOL, V55, P669, DOI 10.2307/4747; Liker A, 2001, CONDOR, V103, P151, DOI 10.1650/0010-5422(2001)103[0151:MBSPDA]2.0.CO;2; Liker A, 2009, P NATL ACAD SCI USA, V106, P7893, DOI 10.1073/pnas.0900042106; McGlothlin JW, 2007, BEHAV ECOL SOCIOBIOL, V61, P1391, DOI 10.1007/s00265-007-0370-x; McGraw KJ, 2008, PIGM CELL MELANOMA R, V21, P133, DOI 10.1111/j.1755-148X.2008.00454.x; McGraw KJ, 2007, BEHAV ECOL, V18, P137, DOI 10.1093/beheco/arl059; McGraw KJ, 2000, P ROY SOC B-BIOL SCI, V267, P1525, DOI 10.1098/rspb.2000.1174; McGraw KJ., 2006, BIRD COLORATION, P243; MOLLER AP, 1990, ANIM BEHAV, V39, P458, DOI 10.1016/S0003-3472(05)80409-9; MOLLER AP, 1988, BEHAV ECOL SOCIOBIOL, V22, P373; MOLLER AP, 1992, BEHAV ECOL SOCIOBIOL, V31, P271; Moreno-Rueda G, 2005, ARDEA, V93, P109; Moreno-Rueda G, 2010, J AVIAN BIOL, V41, P229, DOI 10.1111/j.1600-048X.2009.04859.x; MORTON GA, 1990, CONDOR, V92, P813, DOI 10.2307/1368717; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Nakagawa S, 2008, BIOL LETTERS, V4, P667, DOI 10.1098/rsbl.2008.0349; Nakagawa S, 2007, BEHAV ECOL, V18, P831, DOI 10.1093/beheco/arm050; NEWTON I, 1966, IBIS, V108, P41, DOI 10.1111/j.1474-919X.1966.tb07251.x; Nilsson JA, 1996, P ROY SOC B-BIOL SCI, V263, P711, DOI 10.1098/rspb.1996.0106; Pap PL, 2008, CAN J ZOOL, V86, P834, DOI 10.1139/Z08-060; Pap PL, 2009, J EXP BIOL, V212, P3228, DOI 10.1242/jeb.031948; Parejo D, 2009, J EXP BIOL, V212, P3576, DOI 10.1242/jeb.033654; Part T, 1997, ANIM BEHAV, V54, P893, DOI 10.1006/anbe.1997.0514; Poston JP, 2005, ANIM BEHAV, V70, P1171, DOI 10.1016/j.anbehav.2005.02.015; Prum RO, 2006, BIRD COLORATION, V1, P295; Qvarnstrom A, 2000, NATURE, V405, P344, DOI 10.1038/35012605; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; Roulin A, 2008, ANIM BEHAV, V75, P1351, DOI 10.1016/j.anbehav.2007.09.007; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; Shawkey MD, 2006, P R SOC B, V273, P2985, DOI 10.1098/rspb.2006.3675; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Shawkey MD, 2003, P ROY SOC B-BIOL SCI, V270, P1455, DOI 10.1098/rspb.2003.2390; SIIKAMAKI P, 1994, FUNCT ECOL, V8, P587, DOI 10.2307/2389919; Stewart IRK, 2010, AUK, V127, P549, DOI 10.1525/auk.2010.10048; Stoehr AM, 2006, FUNCT ECOL, V20, P276, DOI 10.1111/j.1365-2435.2006.01090.x; Svensson E, 1997, BEHAV ECOL, V8, P92, DOI 10.1093/beheco/8.1.92; Torok J, 2003, BEHAV ECOL, V14, P382, DOI 10.1093/beheco/14.3.382; Vaclav R, 2006, ZOOL SCI, V23, P1073, DOI 10.2108/zsj.23.1073; Veiga JP, 1996, P ROY SOC B-BIOL SCI, V263, P229, DOI 10.1098/rspb.1996.0036; Veiga JP, 1996, BEHAV ECOL SOCIOBIOL, V39, P345, DOI 10.1007/s002650050299; VEIGA JP, 1993, EVOLUTION, V47, P1161, DOI 10.1111/j.1558-5646.1993.tb02143.x; VERHULST S, 1995, ECOLOGY, V76, P2392, DOI 10.2307/2265815; Garamszegi LZ, 2006, BEHAV ECOL SOCIOBIOL, V60, P663, DOI 10.1007/s00265-006-0210-4	75	36	36	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14215	10.1371/journal.pone.0014215	http://dx.doi.org/10.1371/journal.pone.0014215			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151981	Green Published, gold, Green Submitted			2022-12-27	WOS:000284939600008
J	Wagner, S; Kufleitner, J; Zensi, A; Dadparvar, M; Wien, S; Bungert, J; Vogel, T; Worek, F; Kreuter, J; von Briesen, H				Wagner, Sylvia; Kufleitner, Juergen; Zensi, Anja; Dadparvar, Miriam; Wien, Sascha; Bungert, Judith; Vogel, Tikva; Worek, Franz; Kreuter, Joerg; von Briesen, Hagen			Nanoparticulate Transport of Oximes over an In Vitro Blood-Brain Barrier Model	PLOS ONE			English	Article							ALBUMIN HSA NANOPARTICLES; APOLIPOPROTEIN-A-I; ORGANOPHOSPHATE PESTICIDES; CHOLINESTERASE INHIBITORS; ENDOTHELIAL-CELLS; DRUG TRANSPORT; ACETYLCHOLINESTERASE; ENTER; WORLD; HI-6	Background: Due to the use of organophosphates (OP) as pesticides and the availability of OP-type nerve agents, an effective medical treatment for OP poisonings is still a challenging problem. The acute toxicity of an OP poisoning is mainly due to the inhibition of acetylcholinesterase (AChE) in the peripheral and central nervous systems (CNS). This results in an increase in the synaptic concentration of the neurotransmitter acetylcholine, overstimulation of cholinergic receptors and disorder of numerous body functions up to death. The standard treatment of OP poisoning includes a combination of a muscarinic antagonist and an AChE reactivator (oxime). However, these oximes can not cross the blood-brain barrier (BBB) sufficiently. Therefore, new strategies are needed to transport oximes over the BBB. Methodology/Principal Findings: In this study, we combined different oximes (obidoxime dichloride and two different HI 6 salts, HI 6 dichloride monohydrate and HI 6 dimethanesulfonate) with human serum albumin nanoparticles and could show an oxime transport over an in vitro BBB model. In general, the nanoparticulate transported oximes achieved a better reactivation of OP-inhibited AChE than free oximes. Conclusions/Significance: With these nanoparticles, for the first time, a tool exists that could enable a transport of oximes over the BBB. This is very important for survival after severe OP intoxication. Therefore, these nanoparticulate formulations are promising formulations for the treatment of the peripheral and the CNS after OP poisoning.	[Wagner, Sylvia; Wien, Sascha; Bungert, Judith; von Briesen, Hagen] Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, Sankt Ingbert, Germany; [Kufleitner, Juergen; Zensi, Anja; Dadparvar, Miriam; Kreuter, Joerg] Goethe Univ Frankfurt, Inst Pharmaceut Technol, Frankfurt, Germany; [Vogel, Tikva] Biotechnol Gen Ltd, Rehovot, Israel; [Worek, Franz] Bundeswehr Inst Pharmacol & Toxicol, Munich, Germany	Fraunhofer Gesellschaft; Goethe University Frankfurt	Wagner, S (corresponding author), Fraunhofer Inst Biomed Engn, Dept Cell Biol & Appl Virol, Sankt Ingbert, Germany.	hagen.briesen@ibmt.fraunhofer.de		Wagner, Sylvia/0000-0001-7922-977X; Worek, Franz/0000-0003-3531-3616	German Bundesamt Wehrtechnik und Beschaffung [U2.3 E/UR3G/5G031/5A802]	German Bundesamt Wehrtechnik und Beschaffung	This work was financially supported by the German Bundesamt Wehrtechnik und Beschaffung (U2.3 E/UR3G/5G031/5A802). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge W. N., 1972, ENZYME INHIBITORS SU; Amr MM, 1999, TOXICOL LETT, V107, P1, DOI 10.1016/S0378-4274(99)00026-0; BROWN SK, 1989, ARCH ENVIRON HEALTH, V44, P34, DOI 10.1080/00039896.1989.9935870; Cocker J, 2002, TOXICOL LETT, V134, P97, DOI 10.1016/S0378-4274(02)00168-6; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; Eddleston M, 2002, QJM-INT J MED, V95, P275, DOI 10.1093/qjmed/95.5.275; Eddleston M, 2002, LANCET, V360, P1163, DOI 10.1016/S0140-6736(02)11204-9; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FIREMARK H, 1964, J PHARMACOL EXP THER, V145, P252; FORGET G, 1991, J TOXICOL ENV HEALTH, V32, P11, DOI 10.1080/15287399109531462; FUKUSHIMA H, 1990, IN VITRO CELL DEV B, V26, P612, DOI 10.1007/BF02624211; Gaillard Pieter J, 2005, Expert Opin Drug Deliv, V2, P299, DOI 10.1517/17425247.2.2.299; Gumbleton M, 2001, J PHARM SCI-US, V90, P1681, DOI 10.1002/jps.1119; Gunnell D, 2003, INT J EPIDEMIOL, V32, P902, DOI 10.1093/ije/dyg307; HOBBIGER F, 1967, BIOCHEM PHARMACOL, V16, P455, DOI 10.1016/0006-2952(67)90093-7; HOLMSTEDT B, 1959, PHARMACOL REV, V11, P567; JEYARATNAM J, 1990, World Health Statistics Quarterly, V43, P139; Kreuter J, 2003, PHARM RES-DORDR, V20, P409, DOI 10.1023/A:1022604120952; Kreuter J, 2002, J DRUG TARGET, V10, P317, DOI 10.1080/10611860290031877; KREUTER J, 1995, BRAIN RES, V674, P171, DOI 10.1016/0006-8993(95)00023-J; Kreuter J, 2007, J CONTROL RELEASE, V118, P54, DOI 10.1016/j.jconrel.2006.12.012; Kwong TC, 2002, THER DRUG MONIT, V24, P144, DOI 10.1097/00007691-200202000-00022; Langer K, 2008, INT J PHARMACEUT, V347, P109, DOI 10.1016/j.ijpharm.2007.06.028; Langer K, 2003, INT J PHARM, V257, P169, DOI 10.1016/S0378-5173(03)00134-0; LIGTENSTEIN DA, 1988, TOXICOL APPL PHARM, V92, P324, DOI 10.1016/0041-008X(88)90392-4; LIGTENSTEIN DA, 1983, TOXICOL APPL PHARM, V71, P177, DOI 10.1016/0041-008X(83)90334-4; LUNDY PM, 1990, ARCH TOXICOL, V64, P377, DOI 10.1007/BF01973459; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; Marrs T. C., 2007, CHEM WARFARE AGENTS; MASSOULIE J, 1993, PROG NEUROBIOL, V41, P31, DOI 10.1016/0301-0082(93)90040-Y; Michaelis K, 2006, J PHARMACOL EXP THER, V317, P1246, DOI 10.1124/jpet.105.097139; Nagao M, 1997, TOXICOL APPL PHARM, V144, P198, DOI 10.1006/taap.1997.8110; Olivier JC, 1999, PHARMACEUT RES, V16, P1836, DOI 10.1023/A:1018947208597; Omidi Y, 2003, BRAIN RES, V990, P95, DOI 10.1016/S0006-8993(03)03443-7; Rhaese S, 2003, J CONTROL RELEASE, V92, P199, DOI 10.1016/S0168-3659(03)00302-X; Sachs L., 1984, ANGEW STAT ANWENDUNG, V6, DOI [10.1007/978-3-662-05748-3, DOI 10.1007/978-3-662-05748-3]; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SU CT, 1986, FUND APPL TOXICOL, V6, P506, DOI 10.1016/0272-0590(86)90224-1; Taylor P, 1995, TOXICOL LETT, V82-3, P453, DOI 10.1016/0378-4274(95)03575-3; Thiermann H, 1999, TOXICOL LETT, V107, P233, DOI 10.1016/S0378-4274(99)00052-1; Worek F, 2004, BIOCHEM PHARMACOL, V68, P2237, DOI 10.1016/j.bcp.2004.07.038; Zenker D, 2003, J PHYSIOL-LONDON, V551, P1023, DOI 10.1113/jphysiol.2003.045880; Zensi A, 2010, J DRUG TARGET, V18, P842, DOI 10.3109/1061186X.2010.513712; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; [No title captured]; [No title captured]	46	56	58	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e14213	10.1371/journal.pone.0014213	http://dx.doi.org/10.1371/journal.pone.0014213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151975	Green Published, gold, Green Submitted			2022-12-27	WOS:000284939600007
J	Adams, EDM; Goss, GG; Leys, SP				Adams, Emily D. M.; Goss, Greg G.; Leys, Sally P.			Freshwater Sponges Have Functional, Sealing Epithelia with High Transepithelial Resistance and Negative Transepithelial Potential	PLOS ONE			English	Article							SEPTATE JUNCTIONS; CELL-ADHESION; EVOLUTION; DEMOSPONGIAE; INSIGHTS; ORGANIZATION; PROTEINS; COLLAGEN; RECEPTOR; POLARITY	Epithelial tissue - the sealed and polarized layer of cells that regulates transport of ions and solutes between the environment and the internal milieu - is a defining characteristic of the Eumetazoa. Sponges, the most ancient metazoan phylum [1,2], are generally believed to lack true epithelia [3,4,5], but their ability to occlude passage of ions has never been tested. Here we show that freshwater sponges (Demospongiae, Haplosclerida) have functional epithelia with high transepithelial electrical resistance (TER), a transepithelial potential (TEP), and low permeability to small-molecule diffusion. Curiously, the Amphimedon queenslandica sponge genome lacks the classical occluding genes [5] considered necessary to regulate sealing and control of ion transport. The fact that freshwater sponge epithelia can seal suggests that either occluding molecules have been lost in some sponge lineages, or demosponges use novel molecular complexes for epithelial occlusion; if the latter, it raises the possibility that mechanisms for occlusion used by sponges may exist in other metazoa. Importantly, our results imply that functional epithelia evolved either several times, or once, in the ancestor of the Metazoa.	[Adams, Emily D. M.; Goss, Greg G.; Leys, Sally P.] Univ Alberta, Dept Biol Sci, Physiol Cell & Dev Biol Grp, Edmonton, AB, Canada	University of Alberta	Adams, EDM (corresponding author), Univ Alberta, Dept Biol Sci, Physiol Cell & Dev Biol Grp, Edmonton, AB, Canada.	sleys@ualberta.ca	Leys, Sally/A-2660-2014; Goss, Greg/D-2723-2015	Leys, Sally/0000-0001-9268-2181; Goss, Greg/0000-0003-0786-8868	National Science and Engineering Research Council of Canada	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by Discovery Grants from the National Science and Engineering Research Council of Canada (G. G. and S. P. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adell T, 2004, J MOL EVOL, V59, P41, DOI 10.1007/s00239-004-2602-2; Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Aouacheria A, 2006, MOL BIOL EVOL, V23, P2288, DOI 10.1093/molbev/msl100; Borchiellini C, 2004, MOL PHYLOGENET EVOL, V32, P823, DOI 10.1016/j.ympev.2004.02.021; Boute N, 1996, BIOL CELL, V88, P37, DOI 10.1016/S0248-4900(97)86829-3; Brower DL, 1997, P NATL ACAD SCI USA, V94, P9182, DOI 10.1073/pnas.94.17.9182; Cereijido M, 2004, PHYSIOL REV, V84, P1229, DOI 10.1152/physrev.00001.2004; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Eerkes-Medrano DI, 2006, INVERTEBR BIOL, V125, P177, DOI 10.1111/j.1744-7410.2006.00051.x; Elliott GRD, 2007, J EXP BIOL, V210, P3736, DOI 10.1242/jeb.003392; Elliott GRD, 2010, J EXP BIOL, V213, P2310, DOI 10.1242/jeb.039859; Fahey B, 2010, EVOL DEV, V12, P601, DOI 10.1111/j.1525-142X.2010.00445.x; Franke WW, 2009, CELL TISSUE RES, V338, P1, DOI 10.1007/s00441-009-0849-z; GREEN CR, 1982, J CELL SCI, V53, P279; Green CR, 1979, C INT CENT NATL RECH, V291, P153; GRELL K G, 1971, Cytobiologie, V4, P216; HAND AR, 1972, J CELL BIOL, V52, P397, DOI 10.1083/jcb.52.2.397; Hyman LH., 1940, INVERTEBRATES; Knust E, 2002, SCIENCE, V298, P1955, DOI 10.1126/science.1072161; LABATROBERT J, 1981, P NATL ACAD SCI-BIOL, V78, P6261, DOI 10.1073/pnas.78.10.6261; LEDGER PW, 1975, TISSUE CELL, V7, P13, DOI 10.1016/S0040-8166(75)80004-8; Leik J, 1970, Tissue cell, V2, P435, DOI 10.1016/S0040-8166(70)80043-X; Leys SP, 2009, INTEGR COMP BIOL, V49, P167, DOI 10.1093/icb/icp038; Leys SP, 1997, NATURE, V387, P29, DOI 10.1038/387029b0; Leys SP, 2006, INTEGR COMP BIOL, V46, P104, DOI 10.1093/icb/icj016; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; Mackie GO., 1984, BIOL INTEGUMENT, P43; Magie CR, 2008, BIOL BULL-US, V214, P218, DOI 10.2307/25470665; Meixner MJ, 2007, MOL PHYLOGENET EVOL, V45, P875, DOI 10.1016/j.ympev.2007.09.007; Muto S, 2010, P NATL ACAD SCI USA, V107, P8011, DOI 10.1073/pnas.0912901107; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; Nickel M, 2010, INVERTEBR BIOL, V129, P1, DOI 10.1111/j.1744-7410.2010.00193.x; PARKER GH, 1910, J EXP ZOOL, V8, P765, DOI DOI 10.1002/JEZ.1400080102; PEASE DC, 1955, J HISTOCHEM CYTOCHEM, V3, P295, DOI 10.1177/3.4.295; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; RASMONT R, 1966, ANN SOC R ZOOL BELG, V91, P147; Revel J. P., 1966, Biological Bulletin Marine Biological Laboratory Woods Hole, V131, P402; SKAER HL, 1987, J CELL SCI, V88, P139; Sperling EA, 2009, MOL BIOL EVOL, V26, P2261, DOI 10.1093/molbev/msp148; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Timpl R, 1996, CURR OPIN CELL BIOL, V8, P618, DOI 10.1016/S0955-0674(96)80102-5; Tyler S, 2003, INTEGR COMP BIOL, V43, P55, DOI 10.1093/icb/43.1.55; Wilson HV, 1910, J EXP ZOOL, V9, P537, DOI 10.1002/jez.1400090305; Wilson HV, 1907, J EXP ZOOL, V5, P245, DOI 10.1002/jez.1400050204	47	49	50	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15040	10.1371/journal.pone.0015040	http://dx.doi.org/10.1371/journal.pone.0015040			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124779	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500021
J	Christensen, D; Lindenstrom, T; van de Wijdeven, G; Andersen, P; Agger, EM				Christensen, Dennis; Lindenstrom, Thomas; van de Wijdeven, Gijsbert; Andersen, Peter; Agger, Else Marie			Syringe Free Vaccination with CAF01 Adjuvated Ag85B-ESAT-6 in Bioneedles Provides Strong and Prolonged Protection Against Tuberculosis	PLOS ONE			English	Article							CATIONIC LIPOSOMES; GLOBAL BURDEN; CORD FACTOR; INJECTIONS; MEMORY	Bioneedles are small hollow sugar based needles administered with a simple compressed air device. In the present study we investigate how incorporation of a subunit vaccine based on TB vaccine hybrid Ag85B-ESAT-6 adjuvated with CAF01 into Bioneedles affects its immunogenicity as well as its ability to protect against TB in a mouse model. The CMI response measured by IFN-gamma and antigen specific CD4+ T-cells was, two weeks after the last vaccination, significantly lower in the group immunized with Bioneedle-incorporated vaccine compared to the conventional vaccine, using syringe and needle. However, at four, nine and 52 weeks after vaccination we observed similar high IFN-gamma levels in the Bioneedle group and the group vaccinated using syringe and needle and comparable levels of antigen specific T-cells. Furthermore, the protective efficacy for the two vaccination methods was comparable and similar to BCG vaccination both six and 52 weeks after vaccination. These results therefore advocate the further development of the Bioneedle devises and applicators for the delivery of human vaccines.	[Christensen, Dennis; Lindenstrom, Thomas; Andersen, Peter; Agger, Else Marie] Statens Serum Inst, Dept Infect Dis Immunol Vaccine Delivery & Formul, DK-2300 Copenhagen, Denmark; [van de Wijdeven, Gijsbert] Bioneedle Technol Grp BV, Eindhoven, Netherlands	Statens Serum Institut	Christensen, D (corresponding author), Statens Serum Inst, Dept Infect Dis Immunol Vaccine Delivery & Formul, DK-2300 Copenhagen, Denmark.	den@ssi.dk	Christensen, Dennis/C-6378-2008; Lindenstrøm, Thomas/ABE-4203-2020	Christensen, Dennis/0000-0003-2382-8639; Lindenstrøm, Thomas/0000-0002-7162-8124; Andersen, Peter/0000-0002-5869-2551	European Commission [LSHP-CT-2003-503367]; Statens Serum Institut	European Commission(European CommissionEuropean Commission Joint Research Centre); Statens Serum Institut	This work was partly funded by the European Commission contract No. LSHP-CT-2003-503367 and partly by core funding from Statens Serum Institut. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116; Agger EM, 2001, VACCINE, V19, P2298, DOI 10.1016/S0264-410X(00)00519-3; ANDERSEN P, 1991, INFECT IMMUN, V59, P1558, DOI 10.1128/IAI.59.4.1558-1563.1991; CANTER J, 1990, ARCH INTERN MED, V150, P1923, DOI 10.1001/archinte.150.9.1923; Davidsen J, 2005, BBA-BIOMEMBRANES, V1718, P22, DOI 10.1016/j.bbamem.2005.10.011; duChatelet IP, 1997, VACCINE, V15, P449, DOI 10.1016/S0264-410X(96)00173-9; Hauri AM, 2004, INT J STD AIDS, V15, P7, DOI 10.1258/095646204322637182; Henriksen-Lacey M, 2010, J CONTROL RELEASE, V142, P180, DOI 10.1016/j.jconrel.2009.10.022; Hirschberg HJHB, 2008, VACCINE, V26, P2389, DOI 10.1016/j.vaccine.2008.02.067; Holten-Andersen L, 2004, INFECT IMMUN, V72, P1608, DOI 10.1128/IAI.72.3.1608-1617.2004; Ishii Y, 2008, J CONTROL RELEASE, V131, P113, DOI 10.1016/j.jconrel.2008.07.025; Kelly K, 2008, VACCINE, V26, P1344, DOI 10.1016/j.vaccine.2007.12.041; Kim YC, 2010, J INFECT DIS, V201, P190, DOI 10.1086/649228; Lindenstrom T, 2009, J IMMUNOL, V182, P8047, DOI 10.4049/jimmunol.0801592; Prausnitz MR, 2009, CURR TOP MICROBIOL, V333, P369, DOI 10.1007/978-3-540-92165-3_18; Pruss-Ustun A, 2005, AM J IND MED, V48, P482, DOI 10.1002/ajim.20230; Rosenkrands I, 2005, INFECT IMMUN, V73, P5817, DOI 10.1128/IAI.73.9.5817-5826.2005; Salehi AS, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-19; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; van de Wijdeven GGP, 2002, J CONTROL RELEASE, V85, P145, DOI 10.1016/S0168-3659(02)00283-3; WEINRICH OA, 2001, INFECT IMMUN, V69, P2773, DOI DOI 10.1128/IAI.69.5.2773-2778.2001	21	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15043	10.1371/journal.pone.0015043	http://dx.doi.org/10.1371/journal.pone.0015043			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124731	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500023
J	Dai, C; Liang, D; Li, HW; Sasaki, M; Dawson, TM; Dawson, VL				Dai, Cheng; Liang, Dong; Li, Huiwu; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.			Functional Identification of Neuroprotective Molecules	PLOS ONE			English	Article							GENE-EXPRESSION; CELL-SURVIVAL; GROWTH; NEURONS; KINASE; PARTHANATOS; MUTATIONS; REGULATOR; MESSENGER; PROTEINS	The central nervous system has the capacity to activate profound neuroprotection following sub-lethal stress in a process termed preconditioning. To gain insight into this potent survival response we developed a functional cloning strategy that identified 31 putative neuroprotective genes of which 28 were confirmed to provide protection against oxygen-glucose deprivation (OGD) or excitotoxic exposure to N-methyl-D-aspartate (NMDA) in primary rat cortical neurons. These results reveal that the brain possesses a wide and diverse repertoire of neuroprotective genes. Further characterization of these and other protective signals could provide new treatment opportunities for neurological injury from ischemia or neurodegenerative disease.	[Dai, Cheng; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Neuroregenerat Program, Baltimore, MD 21218 USA; [Dai, Cheng; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Stem Cell Program, Inst Cell Engn, Baltimore, MD USA; [Dai, Cheng; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Liang, Dong; Li, Huiwu; Sasaki, Masayuki; Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Dawson, Ted M.; Dawson, Valina L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Dai, C (corresponding author), Johns Hopkins Univ, Sch Med, Neuroregenerat Program, Baltimore, MD 21218 USA.	tdawson@jhmi.edu; vdawson@jhmi.edu	Dawson, Valina/Y-9757-2019	Dawson, Valina/0000-0002-2915-3970	American Heart Association; McKnight Foundation; USPHS [NS40809, DA000266]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040809] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); McKnight Foundation; USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by an American Heart Association Predoctoral Award to CD, a McKnight Foundation Neuroscience of Brain Disorders Award to VLD, and USPHS NS40809 DA000266. TMD is the Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CM, 2009, BIOCHEM SOC T, V37, P1293, DOI 10.1042/BST0371293; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Cheng AW, 2003, J BIOL CHEM, V278, P7591, DOI 10.1074/jbc.M207232200; David KK, 2009, FRONT BIOSCI-LANDMRK, V14, P1116, DOI 10.2741/3297; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Gonzalez-Zulueta M, 1998, J NEUROSCI, V18, P2040; Gonzalez-Zulueta M, 2000, P NATL ACAD SCI USA, V97, P436, DOI 10.1073/pnas.97.1.436; Huang YF, 2007, P NATL ACAD SCI USA, V104, P4194, DOI 10.1073/pnas.0611609104; IVEY DM, 1993, J BIOL CHEM, V268, P11296; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jiang HP, 2000, P NATL ACAD SCI USA, V97, P12684, DOI 10.1073/pnas.220431297; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; KURNELLAS MP, 2010, CELL DEATH DIFFER; Lezcano N, 2000, SCIENCE, V287, P1660, DOI 10.1126/science.287.5458.1660; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Liauw J, 2008, J CEREBR BLOOD F MET, V28, P1722, DOI 10.1038/jcbfm.2008.65; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Michiels F, 2000, METHOD ENZYMOL, V325, P295; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Naslavsky N, 2009, J CELL SCI, V122, P389, DOI 10.1242/jcs.037051; Parsadanian AS, 1998, J NEUROSCI, V18, P1009; Pohl U, 2000, GENOMICS, V63, P255, DOI 10.1006/geno.1999.6087; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Talapatra S, 2002, CELL DEATH DIFFER, V9, P856, DOI 10.1038/sj.cdd.4401078; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wahab N, 2007, BIOCHEM J, V406, P131, DOI 10.1042/BJ20061817; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	32	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15008	10.1371/journal.pone.0015008	http://dx.doi.org/10.1371/journal.pone.0015008			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124846	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000015
J	Zhong, J; Chuang, SC; Bianchi, R; Zhao, WF; Paul, G; Thakkar, P; Liu, D; Fenton, AA; Wong, RKS; Tiedge, H				Zhong, Jun; Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Paul, Geet; Thakkar, Punam; Liu, David; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri			Regulatory BC1 RNA and the Fragile X Mental Retardation Protein: Convergent Functionality in Brain	PLOS ONE			English	Article							FMR1 KNOCKOUT MICE; MESSENGER-RNA; EPILEPTIFORM DISCHARGES; TRANSLATIONAL CONTROL; BEHAVIORAL EVIDENCE; HIPPOCAMPAL SLICES; MOUSE MODEL; BC200 RNA; POLYRIBOSOMES; INITIATION	Background: BC RNAs and the fragile X mental retardation protein (FMRP) are translational repressors that have been implicated in the control of local protein synthesis at the synapse. Work with BC1 and Fmr1 animal models has revealed that phenotypical consequences resulting from the absence of either BC1 RNA or FMRP are remarkably similar. To establish functional interactions between BC1 RNA and FMRP is important for our understanding of how local protein synthesis regulates neuronal excitability. Methodology/Principal Findings: We generated BC1(-/-) Fmr1(-/-) double knockout (dKO) mice. We examined such animals, lacking both BC1 RNA and FMRP, in comparison with single knockout (sKO) animals lacking either one repressor. Analysis of neural phenotypical output revealed that at least three attributes of brain functionality are subject to control by both BC1 RNA and FMRP: neuronal network excitability, epileptogenesis, and place learning. The severity of CA3 pyramidal cell hyperexcitability was significantly higher in BC1(-/-) Fmr1(-/-) dKO preparations than in the respective sKO preparations, as was seizure susceptibility of BC1(-/-) Fmr1(-/-) dKO animals in response to auditory stimulation. In place learning, BC1(-/-) Fmr1(-/-) dKO animals were severely impaired, in contrast to BC1(-/-) or Fmr1(-/-) sKO animals which exhibited only mild deficits. Conclusions/Significance: Our data indicate that BC1 RNA and FMRP operate in sequential-independent fashion. They suggest that the molecular interplay between two translational repressors directly impacts brain functionality.	[Zhong, Jun; Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Paul, Geet; Thakkar, Punam; Liu, David; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA; [Chuang, Shih-Chieh; Bianchi, Riccardo; Zhao, Wangfa; Fenton, Andre A.; Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Program Neural & Behav Sci, Brooklyn, NY 11203 USA; [Wong, Robert K. S.; Tiedge, Henri] SUNY Hlth Sci Ctr, Dept Neurol, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Zhong, J (corresponding author), SUNY Hlth Sci Ctr, Dept Physiol & Pharmacol, Robert F Furchgott Ctr Neural & Behav Sci, Brooklyn, NY 11203 USA.	jun.zhong@downstate.edu; henri.tiedge@downstate.edu	Bianchi, Riccardo/GLT-3136-2022; Cabrera, Mariel/GMX-2706-2022	Bianchi, Riccardo/0000-0002-1656-4455; Fenton, Andre/0000-0002-5063-1156	National Institutes of Health [HD43428, NS057839, NS035481, NS046769]; National Science Foundation [IOS-0725001]; FRAXA Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035481, R01NS046769, R43NS057839, R56NS035481] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); FRAXA Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health HD43428, NS057839, NS035481, NS046769; National Science Foundation IOS-0725001; and the FRAXA Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; BAKKER CE, 1994, CELL, V78, P23; Bassell GJ, 2008, NEURON, V60, P201, DOI 10.1016/j.neuron.2008.10.004; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Centonze D, 2008, BIOL PSYCHIAT, V63, P963, DOI 10.1016/j.biopsych.2007.09.008; Chen L, 2001, NEUROSCIENCE, V103, P1043, DOI 10.1016/S0306-4522(01)00036-7; Chuang SC, 2005, J NEUROSCI, V25, P8048, DOI 10.1523/JNEUROSCI.1777-05.2005; Cimadevilla JM, 2001, P NATL ACAD SCI USA, V98, P3531, DOI 10.1073/pnas.051628398; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; DHooge R, 1997, NEUROSCIENCE, V76, P367, DOI 10.1016/S0306-4522(96)00224-2; Grossman AW, 2006, J NEUROSCI, V26, P7151, DOI 10.1523/JNEUROSCI.1790-06.2006; Iacoangeli A, 2010, BRAIN RES, V1338, P36, DOI 10.1016/j.brainres.2010.03.042; Jacquemont S, 2007, LANCET NEUROL, V6, P45, DOI 10.1016/S1474-4422(06)70676-7; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Kindler S, 2005, ANNU REV CELL DEV BI, V21, P223, DOI 10.1146/annurev.cellbio.21.122303.120653; Kondrashov AV, 2005, J MOL BIOL, V353, P88, DOI 10.1016/j.jmb.2005.07.049; Kubik S, 2005, J NEUROSCI, V25, P9205, DOI 10.1523/JNEUROSCI.1707-05.2005; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lee AC, 2002, J NEUROPHYSIOL, V88, P1625, DOI 10.1152/jn.2002.88.4.1625; Lewejohann L, 2004, BEHAV BRAIN RES, V154, P273, DOI 10.1016/j.bbr.2004.02.015; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Lin D, 2008, MOL CELL BIOL, V28, P3008, DOI 10.1128/MCB.01800-07; Maccarrone M, 2010, NEUROPSYCHOPHARMACOL, V35, P1500, DOI 10.1038/npp.2010.19; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P11563, DOI 10.1073/pnas.90.24.11563; MARTIGNETTI JA, 1993, P NATL ACAD SCI USA, V90, P9698, DOI 10.1073/pnas.90.20.9698; Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321; Miyashiro KY, 2009, TRENDS PHARMACOL SCI, V30, P203, DOI 10.1016/j.tips.2009.01.005; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Musumeci SA, 2000, EPILEPSIA, V41, P19, DOI 10.1111/j.1528-1157.2000.tb01499.x; NELSON DL, 1995, SEMIN CELL BIOL, V6, P5, DOI 10.1016/1043-4682(95)90009-8; Olypher AV, 2006, J NEUROSCI, V26, P158, DOI 10.1523/JNEUROSCI.2064-05.2006; Oostra BA, 2009, BBA-GEN SUBJECTS, V1790, P467, DOI 10.1016/j.bbagen.2009.02.007; Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Serrano P, 2008, PLOS BIOL, V6, P2698, DOI 10.1371/journal.pbio.0060318; Skryabin BV, 2003, MOL CELL BIOL, V23, P6435, DOI 10.1128/MCB.23.18.6435-6441.2003; Stefani G, 2004, J NEUROSCI, V24, P7272, DOI 10.1523/JNEUROSCI.2306-04.2004; Sung YJ, 2003, J BIOL CHEM, V278, P15669, DOI 10.1074/jbc.M211117200; Taft RJ, 2007, BIOESSAYS, V29, P288, DOI 10.1002/bies.20544; Volk LJ, 2007, J NEUROSCI, V27, P11624, DOI 10.1523/JNEUROSCI.2266-07.2007; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WANG H, 2009, NEUROSCIENCE, V3, P431; Wang HD, 2005, J CELL BIOL, V171, P811, DOI 10.1083/jcb.200506006; Wang HD, 2002, J NEUROSCI, V22, P10232; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wesierska M, 2005, J NEUROSCI, V25, P2413, DOI 10.1523/JNEUROSCI.3962-04.2005; Yan QJ, 2004, GENES BRAIN BEHAV, V3, P337, DOI 10.1111/j.1601-183X.2004.00087.x; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhong J, 2009, J NEUROSCI, V29, P9977, DOI 10.1523/JNEUROSCI.3893-08.2009	53	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15509	10.1371/journal.pone.0015509	http://dx.doi.org/10.1371/journal.pone.0015509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124905	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900022
J	Chong, P; Chattoraj, P; Biswas, I				Chong, Patrick; Chattoraj, Partho; Biswas, Indranil			Activation of the SMU.1882 Transcription by CovR in Streptococcus mutans	PLOS ONE			English	Article							HYALURONIC-ACID CAPSULE; GROUP-A STREPTOCOCCUS; RESPONSE REGULATOR; VIRULENCE FACTORS; STRESS TOLERANCE; GENOME SEQUENCE; STREPTOLYSIN-S; SIGMA-SUBUNIT; IN-VIVO; EXPRESSION	In Streptococcus mutans, the global response regulator CovR plays an important role in biofilm formation, stress-tolerance response, and caries production. We have previously shown that CovR acts as a transcriptional repressor by binding to the upstream promoter regions of its target genes. Here, we report that in vivo, CovR activates the transcription of SMU. 1882, which encodes a small peptide containing a double-glycine motif. We also show that SMU. 1882 is transcriptionally linked to comA that encodes a putative ABC transporter protein. Several genes from man gene clusters that encode mannose phosphotranferase system flank SMU. 1882 -comA genes. Genomic comparison with other streptococci indicates that SMU. 1882 is uniquely present in S. mutans, while the man operon is conserved among all streptococci, suggesting that a genetic rearrangement might have taken place at this locus. With the use of a transcriptional reporter system and semi-quantitative RT-PCR, we demonstrated the transcriptional regulation of SMU. 1882 by CovR. In vitro gel shift and DNase I foot-printing analyses with purified CovR suggest that CovR binds to a large region surrounding the -10 region of the P-1882. Using this information and comparing with other CovR regulated promoters, we have developed a putative consensus binding sequence for CovR. Although CovR binds to P-1882, in vitro experiments using purified S. mutans RpoD, E. coli RNA polymerase, and CovR did not activate transcription from this promoter. Thus, we speculate that in vivo, CovR may interfere with the binding of a repressor or requires a cofactor.	[Chong, Patrick; Chattoraj, Partho; Biswas, Indranil] Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Chong, P (corresponding author), Univ Kansas, Med Ctr, Dept Microbiol Mol Genet & Immunol, Kansas City, KS 66103 USA.	ibiswas@kumc.edu			National Institute of Dental and Craniofacial Research (NIDCR) [DE016686]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016686] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research (NIDCR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was made possible by a National Institute of Dental and Craniofacial Research (NIDCR) grant (DE016686) to IB. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2005, J CLIN MICROBIOL, V43, P5721, DOI 10.1128/JCM.43.11.5721-5732.2005; Abranches J, 2003, APPL ENVIRON MICROB, V69, P4760, DOI 10.1128/AEM.69.8.4760-4769.2003; Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banerjee A, 2008, APPL ENVIRON MICROB, V74, P2037, DOI 10.1128/AEM.02346-07; Biswas I, 2008, MICROBIOL-SGM, V154, P2275, DOI 10.1099/mic.0.2008/019265-0; Biswas I, 2008, J BACTERIOL, V190, P68, DOI 10.1128/JB.00990-07; Biswas I, 2007, J BACTERIOL, V189, P6521, DOI 10.1128/JB.00825-07; Biswas S, 2006, J BACTERIOL, V188, P988, DOI 10.1128/JB.188.3.988-998.2006; Chong P, 2008, J BACTERIOL, V190, P4478, DOI 10.1128/JB.01961-07; Churchward G, 2007, MOL MICROBIOL, V64, P34, DOI 10.1111/j.1365-2958.2007.05649.x; Dalton TL, 2004, J BACTERIOL, V186, P3928, DOI 10.1128/JB.186.12.3928-3937.2004; Dalton TL, 2006, MICROB PATHOGENESIS, V40, P221, DOI 10.1016/j.micpath.2006.01.005; de Jong A, 2010, NUCLEIC ACIDS RES, V38, pW647, DOI 10.1093/nar/gkq365; Dirix G, 2004, MICROBIOL-SGM, V150, P1121, DOI 10.1099/mic.0.27040-0; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Federle MJ, 2002, MOL MICROBIOL, V43, P1161, DOI 10.1046/j.1365-2958.2002.02810.x; Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398; Frith MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000071; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Gusa AA, 2005, MOL MICROBIOL, V56, P1195, DOI 10.1111/j.1365-2958.2005.04623.x; Gusa AA, 2007, J BACTERIOL, V189, P1407, DOI 10.1128/JB.01036-06; HAMADA S, 1980, MICROBIOL REV, V44, P331, DOI 10.1128/MMBR.44.2.331-384.1980; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; HORAUD T, 1984, EUR HEART J, V5, P39, DOI 10.1093/eurheartj/5.suppl_C.39; Idone V, 2003, INFECT IMMUN, V71, P4351, DOI 10.1128/IAI.71.8.4351-4360.2003; Jiang SM, 2005, J BACTERIOL, V187, P1105, DOI 10.1128/JB.187.3.1105-1113.2005; Kaste LM, 1996, J DENT RES, V75, P631, DOI 10.1177/002203459607502S03; Lamy MC, 2004, MOL MICROBIOL, V54, P1250, DOI 10.1111/j.1365-2958.2004.04365.x; Lemos JA, 2008, MICROBIOL-SGM, V154, P3247, DOI 10.1099/mic.0.2008/023770-0; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MALAKOOTI J, 1995, J BACTERIOL, V177, P6854, DOI 10.1128/jb.177.23.6854-6860.1995; Mouslim C, 2003, J BIOL CHEM, V278, P50588, DOI 10.1074/jbc.M309433200; NICOLAS GG, 2007, MOL GENET GENOMICS, P193; Perez JC, 2008, J BIOL CHEM, V283, P10773, DOI 10.1074/jbc.M709843200; PEREZCASAL J, 1991, J BACTERIOL, V173, P2617, DOI 10.1128/jb.173.8.2617-2624.1991; PETERSON P, 2003, WORLD ORAL HLTH REPO; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pitts NB, 2006, BRIT DENT J, V200, P313, DOI 10.1038/sj.bdj.4813377; Sato Y, 2000, FEMS MICROBIOL LETT, V186, P187, DOI 10.1111/j.1574-6968.2000.tb09102.x; Steffen P, 1997, MOL MICROBIOL, V23, P945, DOI 10.1046/j.1365-2958.1997.2741639.x; Steiner K, 2002, INFECT IMMUN, V70, P3627, DOI 10.1128/IAI.70.7.3627-3636.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; SURZYCKI SJ, 1976, P NATL ACAD SCI USA, V73, P3961, DOI 10.1073/pnas.73.11.3961; Tanzer J M, 2001, J Dent Educ, V65, P1028; Walthers D, 2007, MOL MICROBIOL, V65, P477, DOI 10.1111/j.1365-2958.2007.05800.x; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	49	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15528	10.1371/journal.pone.0015528	http://dx.doi.org/10.1371/journal.pone.0015528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124877	Green Published, Green Submitted, gold			2022-12-27	WOS:000284467200021
J	Myhre, S; Mohammed, H; Tramm, T; Alsner, J; Finak, G; Park, M; Overgaard, J; Borresen-Dale, AL; Frigessi, A; Sorlie, T				Myhre, Simen; Mohammed, Hayat; Tramm, Trine; Alsner, Jan; Finak, Greg; Park, Morag; Overgaard, Jens; Borresen-Dale, Anne-Lise; Frigessi, Arnoldo; Sorlie, Therese			In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome	PLOS ONE			English	Article							POSTMASTECTOMY RADIOTHERAPY; ESTROGEN; PATTERNS; CHEMOTHERAPY; RECURRENCE; SIGNATURE; SURVIVAL; ISOFORM; ASSAY; RISK	Breast tumors consist of several different tissue components. Despite the heterogeneity, most gene expression analyses have traditionally been performed without prior microdissection of the tissue sample. Thus, the gene expression profiles obtained reflect the mRNA contribution from the various tissue components. We utilized histopathological estimations of area fractions of tumor and stromal tissue components in 198 fresh-frozen breast tumor tissue samples for a cell type-associated gene expression analysis associated with distant metastasis. Sets of differentially expressed gene-probes were identified in tumors from patients who developed distant metastasis compared with those who did not, by weighing the contribution from each tumor with the relative content of stromal and tumor epithelial cells in their individual tumor specimen. The analyses were performed under various assumptions of mRNA transcription level from tumor epithelial cells compared with stromal cells. A set of 30 differentially expressed gene-probes was ascribed solely to carcinoma cells. Furthermore, two sets of 38 and five differentially expressed gene-probes were mostly associated to tumor epithelial and stromal cells, respectively. Finally, a set of 26 differentially expressed gene-probes was identified independently of cell type focus. The differentially expressed genes were validated in independent gene expression data from a set of laser capture microdissected invasive ductal carcinomas. We present a method for identifying and ascribing differentially expressed genes to tumor epithelial and/or stromal cells, by utilizing pathologic information and weighted t-statistics. Although a transcriptional contribution from the stromal cell fraction is detectable in microarray experiments performed on bulk tumor, the gene expression differences between the distant metastasis and no distant metastasis group were mostly ascribed to the tumor epithelial cells of the primary breast tumors. However, the gene PIP5K2A was found significantly elevated in stroma cells in distant metastasis group, compared to stroma in no distant metastasis group. These findings were confirmed in gene expression data from the representative compartments from microdissected breast tissue. The method described was also found to be robust to different histopathological procedures.	[Myhre, Simen; Mohammed, Hayat; Borresen-Dale, Anne-Lise; Sorlie, Therese] Oslo Univ Hosp Radiumhosp, Div Surg & Canc, Inst Canc Res, Dept Genet, Oslo, Norway; [Myhre, Simen; Borresen-Dale, Anne-Lise; Sorlie, Therese] Univ Oslo, Inst Clin Med, Fac Med, Oslo, Norway; [Mohammed, Hayat; Frigessi, Arnoldo] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Tramm, Trine; Alsner, Jan; Overgaard, Jens] Aarhus Univ Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Finak, Greg; Park, Morag] McGill Univ, Rosalind & Morris Goodman Canc Ctr, Montreal, PQ, Canada	University of Oslo; University of Oslo; University of Oslo; Aarhus University; McGill University	Myhre, S (corresponding author), Oslo Univ Hosp Radiumhosp, Div Surg & Canc, Inst Canc Res, Dept Genet, Oslo, Norway.	simenmy@rr-research.no	Alsner, Jan/A-3056-2009; Sørlie, Therese/B-1413-2015	Alsner, Jan/0000-0002-5395-3193; Sørlie, Therese/0000-0002-5995-2319; Frigessi, Arnoldo/0000-0001-7103-7589; Finak, Greg/0000-0003-4341-9090; Tramm, Trine/0000-0003-3894-4552	Norwegian Research Council [163027/V40, 175240/S10]; Norwegian Cancer Society [PR-2006-0332, 80108003]; "Foreningen for brystkreftopererte" (FFB); Centre Statistics for Innovation; Danish Cancer Society; Danish Medical Research Council; CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Reseau de Recherche en Cancer du FRSQ; Canadian Institutes of Health Research Team	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society); "Foreningen for brystkreftopererte" (FFB); Centre Statistics for Innovation; Danish Cancer Society(Danish Cancer Society); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology; Reseau de Recherche en Cancer du FRSQ; Canadian Institutes of Health Research Team(Canadian Institutes of Health Research (CIHR))	This study was supported by the Norwegian Research Council (163027/V40 to TS and FUGE II, 175240/S10 to ALB), The Norwegian Cancer Society (PR-2006-0332 to TS and 80108003 to ALB), "Foreningen for brystkreftopererte" (FFB), and the Centre Statistics for Innovation, The Danish Cancer Society, The Danish Medical Research Council and CIRRO - the Lundbeck Foundation Center for Interventional Research in Radiation Oncology, Reseau de Recherche en Cancer du FRSQ, and a Canadian Institutes of Health Research Team Grant to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bissell MJ, 2002, DIFFERENTIATION, V70, P537, DOI 10.1046/j.1432-0436.2002.700907.x; Blake CA, 2005, EXP BIOL MED, V230, P800, DOI 10.1177/153537020523001104; Cardoso F, 2008, J CLIN ONCOL, V26, P2058, DOI 10.1200/JCO.2007.15.6638; Carter CJ, 2007, NEUROCHEM INT, V50, P461, DOI 10.1016/j.neuint.2006.11.009; Cleator SJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1506; Conover WJ., 1999, PRACTICAL NONPARAMET, V3rd; De Souza SE, 2008, INT J ONCOL, V33, P25; Eisen MB, 1999, METHOD ENZYMOL, V303, P179; Farmer P, 2009, NAT MED, V15, P68, DOI 10.1038/nm.1908; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Franzen LE, 2005, MODERN PATHOL, V18, P912, DOI 10.1038/modpathol.3800370; Gonda TJ, 2008, EXPERT OPIN BIOL TH, V8, P713, DOI [10.1517/14712598.8.6.713, 10.1517/14712598.8.6.713 ]; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kyndi M, 2009, RADIOTHER ONCOL, V90, P74, DOI 10.1016/j.radonc.2008.04.014; Miller MM, 1997, J CLIN ENDOCR METAB, V82, P2956, DOI 10.1210/jc.82.9.2956; Nielsen HM, 2006, J CLIN ONCOL, V24, P2268, DOI 10.1200/JCO.2005.02.8738; Noth S, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-307; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Radisky D, 2001, SEMIN CANCER BIOL, V11, P87, DOI 10.1006/scbi.2000.0360; Sakaguchi G, 1995, BIOCHEM BIOPH RES CO, V217, P1053, DOI 10.1006/bbrc.1995.2876; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sparano JA, 2008, J CLIN ONCOL, V26, P721, DOI [10.1200/JCO.2007.15.1068, 10.1200/JCO.2008.16.7528]; Stuart RO, 2004, P NATL ACAD SCI USA, V101, P615, DOI 10.1073/pnas.2536479100; Su LK, 2001, GENOMICS, V71, P142, DOI 10.1006/geno.2000.6428; Sugiyama Y, 2005, GASTROENTEROLOGY, V128, P480, DOI 10.1053/j.gastro.2004.11.010; Tessitore L, 2004, INT J ONCOL, V24, P1529; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wakefield L, 2008, GENE CHROMOSOME CANC, V47, P118, DOI 10.1002/gcc.20512; Wincewicz A, 2007, FOLIA HISTOCHEM CYTO, V45, P81; Yau WL, 2006, INT J CANCER, V119, P2821, DOI 10.1002/ijc.22232	37	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14002	10.1371/journal.pone.0014002	http://dx.doi.org/10.1371/journal.pone.0014002			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124964	Green Submitted, gold, Green Published			2022-12-27	WOS:000284400100002
J	Netherton, SJ; Bonni, S				Netherton, Stuart J.; Bonni, Shirin			Suppression of TGF beta-Induced Epithelial-Mesenchymal Transition Like Phenotype by a PIAS1 Regulated Sumoylation Pathway in NMuMG Epithelial Cells	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; E-CADHERIN; COLORECTAL-CANCER; TUMOR PROGRESSION; GENE-ACTIVATION; SNON; RECEPTOR; CARCINOMA; SNAIL; PHOSPHORYLATION	Epithelial-mesenchymal-transition (EMT) is a fundamental cellular process that is critical for normal development and tumor metastasis. The transforming growth factor beta (TGF beta) is a potent inducer of EMT like effects, but the mechanisms that regulate TGF beta-induced EMT remain incompletely understood. Using the widely employed NMuMG mammary epithelial cells as a model to study TGF beta-induced EMT, we report that TGF beta downregulates the levels of the SUMO E3 ligase PIAS1 in cells undergoing EMT. Gain and loss of function analyses indicate that PIAS1 acts in a SUMO ligase dependent manner to suppress the ability of TGF beta to induce EMT in these cells. We also find that TGF beta inhibits sumoylation of the PIAS1 substrate SnoN, a transcriptional regulator that antagonizes TGF beta-induced EMT. Accordingly, loss of function mutations of SnoN sumoylation impair the ability of SnoN to inhibit TGF beta-induced EMT in NMuMG cells. Collectively, our findings suggest that PIAS1 is a novel negative regulator of EMT and reveal that inhibition of the PIAS1-SnoN sumoylation pathway represents a key mechanism by which TGF beta induces EMT, with important implications in normal development and tumor metastasis.	[Netherton, Stuart J.; Bonni, Shirin] Univ Calgary, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada	University of Calgary	Netherton, SJ (corresponding author), Univ Calgary, Dept Biochem & Mol Biol, So Alberta Canc Res Inst, Calgary, AB, Canada.	sbonni@ucalgary.ca			Alberta Cancer Board (ACB); Canadian Institutes of Health Research	Alberta Cancer Board (ACB); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by grants from the Alberta Cancer Board (ACB), and the Canadian Institutes of Health Research to SB. SJN is an ACB Postdoctoral Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; ATTISANO L, 1994, BBA-MOL CELL RES, V1222, P71, DOI 10.1016/0167-4889(94)90026-4; Barrallo-Gimeno A, 2005, DEVELOPMENT, V132, P3151, DOI 10.1242/dev.01907; Bates RC, 2005, CANCER BIOL THER, V4, P365; Bates RC, 2007, CELLS TISSUES ORGANS, V185, P29, DOI 10.1159/000101300; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410; Deckers M, 2006, CANCER RES, V66, P2202, DOI 10.1158/0008-5472.CAN-05-3560; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Greenhalgh CJ, 2001, J LEUKOCYTE BIOL, V70, P348; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Heiz M, 2004, J BIOL CHEM, V279, P31149, DOI 10.1074/jbc.M403587200; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Johnson ES, 1999, J CELL BIOL, V147, P981, DOI 10.1083/jcb.147.5.981; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kadare G, 2003, J BIOL CHEM, V278, P47434, DOI 10.1074/jbc.M308562200; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kondo M, 2004, CELL DEATH DIFFER, V11, P1092, DOI 10.1038/sj.cdd.4401467; Laping NJ, 2002, MOL PHARMACOL, V62, P58, DOI 10.1124/mol.62.1.58; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Madhavan M, 2001, MODERN PATHOL, V14, P423, DOI 10.1038/modpathol.3880329; MASSAGUE J, 1990, ANNU REV CELL BIOL, V6, P597, DOI 10.1146/annurev.cb.06.110190.003121; Massague Joan, 1994, Trends in Cell Biology, V4, P172, DOI 10.1016/0962-8924(94)90202-X; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Miyazono K, 2009, P JPN ACAD B-PHYS, V85, P314, DOI 10.2183/pjab.85.314; OKA H, 1993, CANCER RES, V53, P1696; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Peng SB, 2005, BIOCHEMISTRY-US, V44, P2293, DOI 10.1021/bi048851x; Pot I, 2008, CURR MOL MED, V8, P319, DOI 10.2174/156652408784533797; ROBERTS AB, 1990, PEPTIDE GROWTH FACTO, P419; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Sarker KP, 2005, J BIOL CHEM, V280, P13037, DOI 10.1074/jbc.M409367200; Sarker KP, 2008, J BIOL CHEM, V283, P13269, DOI 10.1074/jbc.M708834200; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shuai K, 2005, NAT REV IMMUNOL, V5, P593, DOI 10.1038/nri1667; Suzuki T, 1999, J BIOL CHEM, V274, P31131, DOI 10.1074/jbc.274.44.31131; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2003, CURR OPIN CELL BIOL, V15, P740, DOI 10.1016/j.ceb.2003.10.006; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; von Both I, 2004, DEV CELL, V7, P331, DOI 10.1016/j.devcel.2004.07.023; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; WRANA JL, 1992, COLD SPRING HARB SYM, V57, P81, DOI 10.1101/SQB.1992.057.01.011; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Wrighton KH, 2007, J BIOL CHEM, V282, P6517, DOI 10.1074/jbc.M610206200; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou YN, 2002, WORLD J GASTROENTERO, V8, P987, DOI 10.3748/wjg.v8.i6.987; Zhu QW, 2007, MOL CELL BIOL, V27, P324, DOI 10.1128/MCB.01394-06	59	40	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13971	10.1371/journal.pone.0013971	http://dx.doi.org/10.1371/journal.pone.0013971			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103059	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700018
J	Wang, QY; Shinkre, BA; Lee, JG; Weniger, MA; Liu, YF; Chen, WP; Wiestner, A; Trenkle, WC; Ye, YH				Wang, Qiuyan; Shinkre, Bidhan A.; Lee, Jin-gu; Weniger, Marc A.; Liu, Yanfen; Chen, Weiping; Wiestner, Adrian; Trenkle, William C.; Ye, Yihong			The ERAD Inhibitor Eeyarestatin I Is a Bifunctional Compound with a Membrane-Binding Domain and a p97/VCP Inhibitory Group	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; CELL CARCINOMA-CELLS; AAA-ATPASE; PROTEASOME INHIBITORS; RETRO-TRANSLOCATION; MISFOLDED PROTEINS; QUALITY-CONTROL; HEAVY-CHAINS; CANCER-CELLS	Background: Protein homeostasis in the endoplasmic reticulum (ER) has recently emerged as a therapeutic target for cancer treatment. Disruption of ER homeostasis results in ER stress, which is a major cause of cell death in cells exposed to the proteasome inhibitor Bortezomib, an anti-cancer drug approved for treatment of multiple myeloma and Mantle cell lymphoma. We recently reported that the ERAD inhibitor Eeyarestatin I (EerI) also disturbs ER homeostasis and has anticancer activities resembling that of Bortezomib. Methodology and Principal Findings: Here we developed in vitro binding and cell-based functional assays to demonstrate that a nitrofuran-containing (NFC) group in EerI is the functional domain responsible for the cytotoxicity. Using both SPR and pull down assays, we show that EerI directly binds the p97 ATPase, an essential component of the ERAD machinery, via the NFC domain. An aromatic domain in EerI, although not required for p97 interaction, can localize EerI to the ER membrane, which improves its target specificity. Substitution of the aromatic module with another benzene-containing domain that maintains membrane localization generates a structurally distinct compound that nonetheless has similar biologic activities as EerI. Conclusions and Significance: Our findings reveal a class of bifunctional chemical agents that can preferentially inhibit membrane-bound p97 to disrupt ER homeostasis and to induce tumor cell death. These results also suggest that the AAA ATPase p97 may be a potential drug target for cancer therapeutics.	[Wang, Qiuyan; Lee, Jin-gu; Liu, Yanfen; Ye, Yihong] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Weniger, Marc A.; Wiestner, Adrian] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Shinkre, Bidhan A.; Trenkle, William C.] NIDDK, Lab Cell Biochem & Biol, NIH, Bethesda, MD USA; [Chen, Weiping] NIDDK, Genom Core Lab, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Wang, QY (corresponding author), NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	yihongy@mail.nih.gov	Chen, Weiping/C-9550-2011	Lee, Jin-Gu/0000-0001-9477-6990	NIH; National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute, National Institutes of Health; Korean Government [KRF-2008-357-C00103]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK071004] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Korean Government(Korean Government); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The research is supported by the NIH intramural AIDS Targeted Antiviral Program (IATAP), and by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and of the National Heart, Lung, and Blood Institute, National Institutes of Health, and by the Korea Research Foundation Grant funded by the Korean Government [KRF-2008-357-C00103] to J.-G. Lee. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams J, 2004, CANCER CELL, V5, P417, DOI 10.1016/S1535-6108(04)00120-5; Ameri K, 2004, BLOOD, V103, P1876, DOI 10.1182/blood-2003-06-1859; ARMSTRONG JL, 2009, J BIOL CHEM; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Blais JD, 2004, MOL CELL BIOL, V24, P7469, DOI 10.1128/MCB.24.17.7469-7482.2004; Borroto JIG, 2002, MUTAT RES-GEN TOX EN, V519, P179, DOI 10.1016/S1383-5718(02)00133-X; Cross BCS, 2009, J CELL SCI, V122, P4393, DOI 10.1242/jcs.054494; EDER E, 1991, MUTAGENESIS, V6, P261, DOI 10.1093/mutage/6.4.261; Fels DR, 2008, CANCER RES, V68, P9323, DOI 10.1158/0008-5472.CAN-08-2873; Fiebiger E, 2004, MOL BIOL CELL, V15, P1635, DOI 10.1091/mbc.E03-07-0506; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fribley AM, 2006, J BIOL CHEM, V281, P31440, DOI 10.1074/jbc.M604356200; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Kang SW, 2006, CELL, V127, P999, DOI 10.1016/j.cell.2006.10.032; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nilsson IM, 2001, J BIOL CHEM, V276, P41748, DOI 10.1074/jbc.M105823200; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Rizzatti EG, 2008, LEUKEMIA LYMPHOMA, V49, P798, DOI 10.1080/10428190801910912; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shamu CE, 1999, J CELL BIOL, V147, P45, DOI 10.1083/jcb.147.1.45; Szokalska A, 2009, CANCER RES, V69, P4235, DOI 10.1158/0008-5472.CAN-08-3439; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang Q., 2008, J BIOL CHEM; Wang QY, 2006, J CELL BIOL, V174, P963, DOI 10.1083/jcb.200605100; Wang Q, 2009, P NATL ACAD SCI USA, V106, P2200, DOI 10.1073/pnas.0807611106; Wang XZ, 1996, MOL CELL BIOL, V16, P4273; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wilcox AJ, 2009, NAT CELL BIOL, V11, P1481, DOI 10.1038/ncb1997; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2005, ESSAYS BIOCHEM, V41, P99, DOI 10.1042/EB0410099; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	50	146	148	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e15479	10.1371/journal.pone.0015479	http://dx.doi.org/10.1371/journal.pone.0015479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21124757	gold, Green Published, Green Submitted			2022-12-27	WOS:000284147700032
J	Kruh, NA; Troudt, J; Izzo, A; Prenni, J; Dobos, KM				Kruh, Nicole A.; Troudt, Jolynn; Izzo, Angelo; Prenni, Jessica; Dobos, Karen M.			Portrait of a Pathogen: The Mycobacterium tuberculosis Proteome In Vivo	PLOS ONE			English	Article							GENE-EXPRESSION; DIFFERENTIAL EXPRESSION; STATISTICAL-MODEL; MASS-SPECTROMETRY; HYPOXIC RESPONSE; GUINEA-PIGS; GROWTH; MACROPHAGES; VIRULENCE; PROTEINS	Background: Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), is a facultative intracellular pathogen that can persist within the host. The bacteria are thought to be in a state of reduced replication and metabolism as part of the chronic lung infection. Many in vitro studies have dissected the hypothesized environment within the infected lung, defining the bacterial response to pH, starvation and hypoxia. While these experiments have afforded great insight, the picture remains incomplete. The only way to study the combined effects of these environmental factors and the mycobacterial response is to study the bacterial response in vivo. Methodology/Principal Findings: We used the guinea pig model of tuberculosis to examine the bacterial proteome during the early and chronic stages of disease. Lungs were harvested thirty and ninety days after aerosol challenge with Mtb, and analyzed by liquid chromatography-mass spectrometry. To date, in vivo proteomics of the tubercle bacillus has not been described and this work has generated the first large-scale shotgun proteomic data set, comprising over 500 unique protein identifications. Cell wall and cell wall processes, and intermediary metabolism and respiration were the two major functional classes of proteins represented in the infected lung. These classes of proteins displayed the greatest heterogeneity indicating important biological processes for establishment of a productive bacterial infection and its persistence. Proteins necessary for adaptation throughout infection, such as nitrate/nitrite reduction were found at both time points. The PE-PPE protein class, while not well characterized, represented the third most abundant category and showed the most consistent expression during the infection. Conclusions/Significance: Cumulatively, the results of this work may provide the basis for rational drug design - identifying numerous Mtb proteins, from essential kinases to products involved in metal regulation and cell wall remodeling, all present throughout the course of infection.	[Kruh, Nicole A.; Troudt, Jolynn; Izzo, Angelo; Dobos, Karen M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Prenni, Jessica] Colorado State Univ, Prote & Metab Facil, Ft Collins, CO 80523 USA; [Prenni, Jessica] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University	Kruh, NA (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Karen.Dobos@Colostate.edu	Kruh-Garcia, Nicole/D-5853-2017; Dobos, Karen/D-1170-2017; Izzo, Angelo A/F-1229-2017	Kruh-Garcia, Nicole/0000-0002-9896-8380; Dobos, Karen/0000-0001-7115-8524; Izzo, Angelo A/0000-0003-3208-2330; Prenni, Jessica/0000-0002-0337-8450	Bill and Melinda Gates Foundation [42775]; NIH-NIAID [HHSN266200400091c]	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); NIH-NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were performed with funding from the Bill and Melinda Gates Foundation (Grant # 42775, Mycobacterium tuberculosis in vivo) to KMD and AAI (J. Belisle, PI) and funding from the NIH-NIAID (Contract # HHSN266200400091c, Tuberculosis Vaccine Testing and Research Materials) to KMD and AAI (KMD, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Av-Gay Y, 1999, INFECT IMMUN, V67, P5676, DOI 10.1128/IAI.67.11.5676-5682.1999; Bentley-Hibbert SI, 1999, INFECT IMMUN, V67, P581, DOI 10.1128/IAI.67.2.581-588.1999; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Bhatnagar S, 2007, J BIOL CHEM, V282, P25779, DOI 10.1074/jbc.M702277200; Braunstein M, 2003, MOL MICROBIOL, V48, P453, DOI 10.1046/j.1365-2958.2003.03438.x; Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006; Cho SH, 2006, TUBERCULOSIS, V86, P445, DOI 10.1016/j.tube.2005.10.002; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x; Cox JS, 1999, NATURE, V402, P79, DOI 10.1038/47042; Crick DC, 2001, GLYCOBIOLOGY, V11, p107R, DOI 10.1093/glycob/11.9.107R; De Voss JJ, 2000, P NATL ACAD SCI USA, V97, P1252, DOI 10.1073/pnas.97.3.1252; Deb C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006077; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Dubnau E, 2005, INFECT IMMUN, V73, P3754, DOI 10.1128/IAI.73.6.3754-3757.2005; Fenhalls G, 2002, INFECT IMMUN, V70, P6330, DOI 10.1128/IAI.70.11.6330-6338.2002; Fisher MA, 2002, J BACTERIOL, V184, P4025, DOI 10.1128/JB.184.14.4025-4032.2002; Grover A, 2009, INFECT IMMUN, V77, P4837, DOI 10.1128/IAI.00704-09; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hegymegi-Barakonyi B, 2008, CURR MED CHEM, V15, P2760, DOI 10.2174/092986708786242886; Hutter B, 2000, FEMS MICROBIOL LETT, V188, P141, DOI 10.1016/S0378-1097(00)00227-5; Izzo A, 2005, TUBERCULOSIS, V85, P25, DOI 10.1016/j.tube.2004.09.008; Jain SK, 2007, J INFECT DIS, V195, P1634, DOI 10.1086/517526; Kaplan G, 2003, INFECT IMMUN, V71, P7099, DOI 10.1128/IAI.71.12.7099-7108.2003; Kashyap RS, 2005, CLIN DIAGN LAB IMMUN, V12, P752, DOI 10.1128/CDLI.12.6.752-758.2005; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; Lamichhane G, 2005, INFECT IMMUN, V73, P2533, DOI 10.1128/IAI.73.4.2533-2540.2005; Mattow J, 2006, PROTEOMICS, V6, P2485, DOI 10.1002/pmic.200500547; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; MEHAFFY C, PROTEOMICS; Mohammadi T, 2007, MOL MICROBIOL, V65, P1106, DOI 10.1111/j.1365-2958.2007.05851.x; Monahan IM, 2001, MICROBIOL-SGM, V147, P459, DOI 10.1099/00221287-147-2-459; Murphy DJ, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-84; Muttucumaru DGN, 2004, TUBERCULOSIS, V84, P239, DOI 10.1016/j.tube.2003.12.006; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Ojha AK, 2008, MOL MICROBIOL, V69, P164, DOI 10.1111/j.1365-2958.2008.06274.x; Papavinasasundaram KG, 2005, J BACTERIOL, V187, P5751, DOI 10.1128/JB.187.16.5751-5760.2005; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; RAGHU B, 1993, BIOCHEM MOL BIOL INT, V31, P341; Raynaud C, 2002, MOL MICROBIOL, V45, P203, DOI 10.1046/j.1365-2958.2002.03009.x; Rifat D, 2009, J INFECT DIS, V200, P1126, DOI 10.1086/605700; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rosenkrands I, 2002, J BACTERIOL, V184, P3485, DOI 10.1128/JB.184.13.3485-3491.2002; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schwab U, 2009, MICROB PATHOGENESIS, V46, P185, DOI 10.1016/j.micpath.2008.12.006; Searle BC, 2010, PROTEOMICS, V10, P1265, DOI 10.1002/pmic.200900437; SEGAL W, 1956, J BACTERIOL, V72, P132, DOI 10.1128/JB.72.2.132-141.1956; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; SMITH DW, 1991, TUBERCLE, V72, P223, DOI 10.1016/0041-3879(91)90013-I; SMITH DW, 1989, REV INFECT DIS, V11, pS385; Sohaskey CD, 2003, J BACTERIOL, V185, P7247, DOI 10.1128/JB.185.24.7247-7256.2003; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Timm J, 2003, P NATL ACAD SCI USA, V100, P14321, DOI 10.1073/pnas.2436197100; Tundup S, 2006, FEBS LETT, V580, P1285, DOI 10.1016/j.febslet.2006.01.042; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; van Veen HW, 1997, ANTON LEEUW INT J G, V72, P299, DOI 10.1023/A:1000530927928; Voskuil MI, 2004, TUBERCULOSIS, V84, P256, DOI 10.1016/j.tube.2003.12.014; Voskuil MI, 2004, TUBERCULOSIS, V84, P218, DOI 10.1016/j.tube.2004.02.003; Ward SK, 2008, J BACTERIOL, V190, P2939, DOI 10.1128/JB.01847-07; WARD SK, MOL MICROBIOL; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; WHEELER PR, 1990, J GEN MICROBIOL, V136, P211, DOI 10.1099/00221287-136-1-211; Zvi A, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-18	68	152	157	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13938	10.1371/journal.pone.0013938	http://dx.doi.org/10.1371/journal.pone.0013938			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085642	gold, Green Published, Green Submitted			2022-12-27	WOS:000284087800008
J	Kimberley, TJ; Di Fabio, RP				Kimberley, Teresa Jacobson; Di Fabio, Richard P.			Visualizing the Effects of rTMS in a Patient Sample: Small N vs. Group Level Analysis	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; INTERINDIVIDUAL VARIABILITY; HAND DYSTONIA; EXCITABILITY; RELIABILITY; MODULATION; RESPONSES; CURVES	The use of transcranial magnetic stimulation (TMS) to assess changes in cortical excitability is a tool used with increased prevalence in healthy and impaired populations. One factor of concern with this technique is how to achieve adequate statistical power given constraints of a small number of subjects and variability in responses. This paper compares a single pulse excitability measure using traditional group-level statistics vs single subject analyses in a patient population of subjects with focal hand dystonia, pre and post repetitive TMS (rTMS). Results show significant differences in cortical excitability for 4/5 subjects using a split middle line analysis on plots of individual subject data. Group level statistics (ANOVA), however, did not detect any significant findings. The consideration of single subject statistics for TMS excitability measures may assist researchers in describing the variably of rTMS outcome measures.	[Kimberley, Teresa Jacobson; Di Fabio, Richard P.] Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kimberley, TJ (corresponding author), Univ Minnesota, Dept Phys Med & Rehabil, Minneapolis, MN 55455 USA.	tjk@umn.edu	Kimberley, Teresa/AAL-1893-2020	Kimberley, Teresa/0000-0001-6397-4054	Dystonia Medical Research Foundation; National Center for Research Resources (NCRR) in the National Institutes of Health [M01 RR00400]	Dystonia Medical Research Foundation; National Center for Research Resources (NCRR) in the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dystonia Medical Research Foundation (http://www.dystonia-foundation.org/pages/2010_solicitation_for_research_support_from_dod/364.php) and partial support from: National Center for Research Resources (NCRR) M01 RR00400 in the National Institutes of Health (http://www.ncrr.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman CL, 1997, ARCH PHYS MED REHAB, V78, P1145, DOI 10.1016/S0003-9993(97)90142-8; Berardelli A, 1998, EXP BRAIN RES, V122, P79, DOI 10.1007/s002210050493; Borich M, 2009, RESTOR NEUROL NEUROS, V27, P55, DOI 10.3233/RNN-2009-0461; Carey JR, 2010, NEUROSCI LETT, V469, P338, DOI 10.1016/j.neulet.2009.12.023; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Duque J, 2008, CEREB CORTEX, V18, P1395, DOI 10.1093/cercor/bhm173; Fink GR, 1997, J NEUROPHYSIOL, V77, P2164, DOI 10.1152/jn.1997.77.4.2164; FITZGERALD PB, 2002, CLIN NEUROPHYSIOLOGY, V113; Gangitano M, 2002, CLIN NEUROPHYSIOL, V113, P1249, DOI 10.1016/S1388-2457(02)00109-8; HINZE J, 2007, NCSS HELP SYSTEM; Kimberley TJ, 2009, NEUROSCI LETT, V464, P84, DOI 10.1016/j.neulet.2009.08.029; KOH THHG, 1988, ARCH DIS CHILD, V63, P1347, DOI 10.1136/adc.63.11.1347; Maeda F, 2002, CLIN NEUROPHYSIOL, V113, P376, DOI 10.1016/S1388-2457(02)00008-1; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; Moll GH, 1999, EEG CL N SU, P243; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P1002, DOI 10.1016/S1388-2457(00)00284-4; Murase N, 2005, BRAIN, V128, P104, DOI 10.1093/brain/awh315; NOURBAKHSH MR, 1994, PHYS THER, V74, P768, DOI 10.1093/ptj/74.8.768; OTTENBACHER KJ, 1986, AM J OCCUP THER, V40, P464, DOI 10.5014/ajot.40.7.464; Pascual-Leone A, 2000, CURR OPIN NEUROBIOL, V10, P232, DOI 10.1016/S0959-4388(00)00081-7; Portney LG, 2009, FDN CLIN RES APPL PR, V3rd, DOI DOI 10.1016/S0039-6257(02)00362-4; Quartarone A, 2006, TRENDS NEUROSCI, V29, P192, DOI 10.1016/j.tins.2006.02.007; Rossini P M, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P171; Schluter ND, 1998, BRAIN, V121, P785, DOI 10.1093/brain/121.5.785; Sommer M, 2002, CLIN NEUROPHYSIOL, V113, P265, DOI 10.1016/S1388-2457(01)00726-X; Stinear CM, 2004, HUM MOVEMENT SCI, V23, P527, DOI 10.1016/j.humov.2004.08.022; vanderKamp W, 1996, J CLIN NEUROPHYSIOL, V13, P164, DOI 10.1097/00004691-199603000-00007; Wassermann EM, 1998, NEUROSCI LETT, V250, P141, DOI 10.1016/S0304-3940(98)00437-6; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 8	2010	5	12							e15155	10.1371/journal.pone.0015155	http://dx.doi.org/10.1371/journal.pone.0015155			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	691MJ	21151629	gold, Green Published, Green Submitted			2022-12-27	WOS:000285084100023
J	Britzen-Laurent, N; Bauer, M; Berton, V; Fischer, N; Syguda, A; Reipschlager, S; Naschberger, E; Herrmann, C; Sturzl, M				Britzen-Laurent, Nathalie; Bauer, Michael; Berton, Valeria; Fischer, Nicole; Syguda, Adrian; Reipschlaeger, Simone; Naschberger, Elisabeth; Herrmann, Christian; Stuerzl, Michael			Intracellular Trafficking of Guanylate-Binding Proteins Is Regulated by Heterodimerization in a Hierarchical Manner	PLOS ONE			English	Article							NUCLEOTIDE-BINDING; INTERFERON-GAMMA; ENDOTHELIAL-CELLS; VESICLE FORMATION; PLASMA-MEMBRANE; INDUCED GTPASES; GTP HYDROLYSIS; RAS TRAFFICS; PRENYLATION; GOLGI	Guanylate-binding proteins (GBPs) belong to the dynamin family of large GTPases and represent the major IFN-gamma-induced proteins. Here we systematically investigated the mechanisms regulating the subcellular localization of GBPs. Three GBPs (GBP-1, GBP-2 and GBP-5) carry a C-terminal CaaX-prenylation signal, which is typical for small GTPases of the Ras family, and increases the membrane affinity of proteins. In this study, we demonstrated that GBP-1, GBP-2 and GBP-5 are prenylated in vivo and that prenylation is required for the membrane association of GBP-1, GBP-2 and GBP-5. Using co-immunoprecipitation, yeast-two-hybrid analysis and fluorescence complementation assays, we showed for the first time that GBPs are able to homodimerize in vivo and that the membrane association of GBPs is regulated by dimerization similarly to dynamin. Interestingly, GBPs could also heterodimerize. This resulted in hierarchical positioning effects on the intracellular localization of the proteins. Specifically, GBP-1 recruited GBP-5 and GBP-2 into its own cellular compartment and GBP-5 repositioned GBP-2. In addition, GBP-1, GBP-2 and GBP-5 were able to redirect non-prenylated GBPs to their compartment in a prenylation-dependent manner. Overall, these findings prove in vivo the ability of GBPs to dimerize, indicate that heterodimerization regulates sub-cellular localization of GBPs and underscore putative membrane-associated functions of this family of proteins.	[Britzen-Laurent, Nathalie; Bauer, Michael; Berton, Valeria; Fischer, Nicole; Reipschlaeger, Simone; Naschberger, Elisabeth; Stuerzl, Michael] Univ Erlangen Nurnberg, Div Mol & Expt Surg, Univ Med Ctr Erlangen, Erlangen, Germany; [Syguda, Adrian; Herrmann, Christian] Ruhr Univ Bochum, Fac Chem & Biochem, Bochum, Germany	University of Erlangen Nuremberg; Ruhr University Bochum	Britzen-Laurent, N (corresponding author), Univ Erlangen Nurnberg, Div Mol & Expt Surg, Univ Med Ctr Erlangen, Erlangen, Germany.	michael.stuerzl@uk-erlangen.de	Stürzl, Michael/B-3019-2015; Naschberger, Elisabeth/AAV-5289-2021; Britzen-Laurent, Nathalie/M-3982-2013	Stürzl, Michael/0000-0002-9276-2824; Naschberger, Elisabeth/0000-0003-1291-622X; Britzen-Laurent, Nathalie/0000-0002-0494-7117	Deutsche Forschungsgemeinschaft [DFG-GK 1071, DFG 317/2-1]; Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg; German Ministry for Education and Research (BMBF); European commission [FP7]; University of Erlangen-Nuremberg	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg; German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European commission(European CommissionEuropean Commission Joint Research Centre); University of Erlangen-Nuremberg	This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG-GK 1071 and DFG 317/2-1; http://www.dfg.de/), the Interdisciplinary Center for Clinical Research (IZKF) of the University of Erlangen-Nuremberg (http://www.izkf.med.uni-erlangen.de/) and the German Ministry for Education and Research (BMBF; http://www.bmbf.de/) to M.S.; N.B.-L. was supported by an intra-European fellowship of the European commission (Marie-Curie actions, FP7; http://cordis.europa.eu/fp7/home_en.html) and a grant of the ELAN fonds of the University of Erlangen-Nuremberg (http://www.elan.med.unierlangen.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SL, 1999, VIROLOGY, V256, P8, DOI 10.1006/viro.1999.9614; Apolloni A, 2000, MOL CELL BIOL, V20, P2475, DOI 10.1128/MCB.20.7.2475-2487.2000; Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105; CHEN CA, 1988, BIOTECHNIQUES, V6, P632; CHENG YSE, 1983, J BIOL CHEM, V258, P7746; Degrandi D, 2007, J IMMUNOL, V179, P7729, DOI 10.4049/jimmunol.179.11.7729; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Fres JM, 2010, J LIPID RES, V51, P2454, DOI 10.1194/jlr.D005397; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Gomes AQ, 2003, MOL BIOL CELL, V14, P1882, DOI 10.1091/mbc.E02-10-0639; Goodwin JS, 2005, J CELL BIOL, V170, P261, DOI 10.1083/jcb.200502063; Guenzi E, 2003, EMBO J, V22, P3772, DOI 10.1093/emboj/cdg382; Guenzi E, 2001, EMBO J, V20, P5568, DOI 10.1093/emboj/20.20.5568; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hunn JP, 2008, EMBO J, V27, P2495, DOI 10.1038/emboj.2008.176; ITSUI Y, 2009, HEPATOLOGY; Kerppola TK, 2006, NAT REV MOL CELL BIO, V7, P449, DOI 10.1038/nrm1929; Kunzelmann S, 2006, J BIOL CHEM, V281, P28627, DOI 10.1074/jbc.M604911200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lubeseder-Martellato C, 2002, AM J PATHOL, V161, P1749, DOI 10.1016/S0002-9440(10)64452-5; Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619; Maurer-Stroh S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r55; Maurer-Stroh S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r21; Messmer-Blust AF, 2010, MOL BIOL CELL, V21, P2514, DOI 10.1091/mbc.E09-04-0344; Michaelson D, 2002, MOL BIOL CELL, V13, P3294, DOI 10.1091/mbc.E02-02-0095; Modiano N, 2005, P NATL ACAD SCI USA, V102, P8680, DOI 10.1073/pnas.0503227102; Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nantais DE, 1996, J LEUKOCYTE BIOL, V60, P423, DOI 10.1002/jlb.60.3.423; Naschberger E, 2006, AM J PATHOL, V169, P1088, DOI 10.2353/ajpath.2006.060244; Olszewski MA, 2006, J INTERF CYTOK RES, V26, P328, DOI 10.1089/jir.2006.26.328; Praefcke GJK, 2004, J MOL BIOL, V344, P257, DOI 10.1016/j.jmb.2004.09.026; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, EMBO J, V19, P4555, DOI 10.1093/emboj/19.17.4555; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2009, SCIENCE, V325, P1217, DOI 10.1126/science.1171004; Ramachandran R, 2008, EMBO J, V27, P27, DOI 10.1038/sj.emboj.7601961; Remy I, 2007, BIOTECHNIQUES, V42, P137, DOI 10.2144/000112396; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roskoski R, 2003, BIOCHEM BIOPH RES CO, V303, P1, DOI 10.1016/S0006-291X(03)00323-1; Schnoor M, 2009, MUCOSAL IMMUNOL, V2, P33, DOI 10.1038/mi.2008.62; Siderovski DP, 2005, INT J BIOL SCI, V1, P51, DOI 10.7150/ijbs.1.51; Tietzel I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006499; Tripal P, 2007, J INTERF CYTOK RES, V27, P44, DOI 10.1089/jir.2007.0086; Vestal DJ, 2000, J INTERF CYTOK RES, V20, P991, DOI 10.1089/10799900050198435; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogler O, 2008, BBA-BIOMEMBRANES, V1778, P1640, DOI 10.1016/j.bbamem.2008.03.008; VOPEL T, 2010, J MOL BIOL; WEHNER M, 2010, FEBS J; Weinlander K, 2008, FASEB J, V22, P4168, DOI 10.1096/fj.08-107524; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wright LP, 2006, J LIPID RES, V47, P883, DOI 10.1194/jlr.R600004-JLR200	56	81	86	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14246	10.1371/journal.pone.0014246	http://dx.doi.org/10.1371/journal.pone.0014246			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151871	gold, Green Published, Green Submitted			2022-12-27	WOS:000285041800005
J	Opsteegh, L; Soer, R; Reinders-Messelink, HA; Reneman, MF; van der Sluis, CK				Opsteegh, Lonneke; Soer, Remko; Reinders-Messelink, Heleen A.; Reneman, Michiel F.; van der Sluis, Corry K.			Validity of the Dictionary of Occupational Titles for Assessing Upper Extremity Work Demands	PLOS ONE			English	Article							HAND; FRACTURE; TIME	Objectives: The Dictionary of Occupational Titles (DOT) is used in vocational rehabilitation to guide decisions about the ability of a person with activity limitations to perform activities at work. The DOT has categorized physical work demands in five categories. The validity of this categorization is unknown. Aim of this study was to investigate whether the DOT could be used validly to guide decisions for patients with injuries to the upper extremities. Four hypotheses were tested. Methods: A database including 701 healthy workers was used. All subjects filled out the Dutch Musculoskeletal Questionnaire, from which an Upper Extremity Work Demands score (UEWD) was derived. First, relation between the DOT-categories and UEWD-score was analysed using Spearman correlations. Second, variance of the UEWD-score in occupational groups was tested by visually inspecting boxplots and assessing kurtosis of the distribution. Third, it was investigated whether occupations classified in one DOT-category, could significantly differ on UEWD-scores. Fourth, it was investigated whether occupations in different DOT-categories could have similar UEWD-scores using Mann Whitney U-tests (MWU). Results: Relation between the DOT-categories and the UEWD-score was weak (r(sp) = 0.40; p < .01). Overlap between categories was found. Kurtosis exceeded +/- 1.0 in 3 occupational groups, indicating large variance. UEWD-scores were significantly different within one DOT-category (MWU = 1.500; p < .001). UEWD scores between DOT-categories were not significantly different (MWU = 203.000; p = .49). Conclusion: All four hypotheses could not be rejected. The DOT appears to be invalid for assessing upper extremity work demands.	[Opsteegh, Lonneke; Soer, Remko; Reinders-Messelink, Heleen A.; Reneman, Michiel F.; van der Sluis, Corry K.] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands; [Reinders-Messelink, Heleen A.] Ctr Rehabil Revalidatie Friesland, Beetsterzwaag, Netherlands	University of Groningen	Opsteegh, L (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, Ctr Rehabil, Groningen, Netherlands.	l.opsteegh@cvr.umcg.nl		Soer, Remko/0000-0003-4154-1711	Stichting Instituut GAK [2100304]	Stichting Instituut GAK	This work was supported by the Stichting Instituut GAK: www.stichtinginstituutgak.nl, grant number: 2100304. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dale AM, 2010, INT J OCCUP ENV HEAL, V16, P1; Field A, 2002, DISCOVERING STAT USI; Frings-Dresen MHW, 2003, J OCCUP REHABIL, V13, P233, DOI 10.1023/A:1026268620904; HILDEBRANDT VH, 2001, THESIS VRIJE U AMSTE; HILDEBRANDT VH, 2001, PREVENTION WORK RELA, P33; Innes Ev, 1999, Work, V13, P125; KASDAN ML, 1993, J OCCUP ENVIRON MED, V35, P132, DOI 10.1097/00043764-199302000-00013; MacDermid JC, 2007, J OCCUP REHABIL, V17, P47, DOI 10.1007/s10926-007-9069-0; Meiners PM, 2005, DISABIL REHABIL, V27, P617, DOI 10.1080/09638280500030423; Miller A. R., 1980, WORK JOBS OCCUPATION; Pennathur A, 2001, J OCCUP REHABIL, V11, P281, DOI 10.1023/A:1013348609126; Pennathur A, 1999, J OCCUP REHABIL, V9, P227, DOI 10.1023/A:1021327617705; Skov O, 1999, J HAND SURG-BRIT EUR, V24B, P187, DOI 10.1054/jhsb.1998.0180; Soer R, 2006, Work, V26, P273; Soer R, 2009, ARCH PHYS MED REHAB, V90, P1785, DOI 10.1016/j.apmr.2009.05.008; *US EMPL TRAIN ADM, 1991, DICT OCC TITL; Waters T., 1994, APPL MANUAL REVISED, V94	17	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15158	10.1371/journal.pone.0015158	http://dx.doi.org/10.1371/journal.pone.0015158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151934	Green Published, gold			2022-12-27	WOS:000284939600029
J	Bousema, T; Roeffen, W; Meijerink, H; Mwerinde, H; Mwakalinga, S; van Gemert, GJ; van de Vegte-Bolmer, M; Mosha, F; Targett, G; Riley, EM; Sauerwein, R; Drakeley, C				Bousema, Teun; Roeffen, Will; Meijerink, Hinta; Mwerinde, Harry; Mwakalinga, Steve; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Mosha, Frank; Targett, Geoffrey; Riley, Eleanor M.; Sauerwein, Robert; Drakeley, Chris			The Dynamics of Naturally Acquired Immune Responses to Plasmodium falciparum Sexual Stage Antigens Pfs230 & Pfs48/45 in a Low Endemic Area in Tanzania	PLOS ONE			English	Article							TRANSMISSION-BLOCKING IMMUNITY; HUMAN-ANTIBODY RESPONSES; MALARIA TRANSMISSION; SURFACE-ANTIGEN; GAMETOCYTES; AGE; REACTIVITY; REDUCTION; PAPUA; SERA	Background: Naturally acquired immune responses against sexual stages of P. falciparum can reduce the transmission of malaria from humans to mosquitoes. These antigens are candidate transmission-blocking vaccines but little is known about the acquisition of sexual stage immunity after exposure to gametocytes, or their longevity and functionality. We conducted a longitudinal study on functional sexual stage immune responses. Methodology/Principal Findings: Parasitaemic individuals (n = 116) were recruited at a health centre in Lower Moshi, Tanzania. Patients presented with gametocytes (n = 16), developed circulating gametocytes by day 7 (n = 69) or between day 7 and 14 (n = 10) after treatment or did not develop gametocytes (n = 21). Serum samples were collected on the first day of gametocytaemia and 28 and 84 days post-enrolment (or d7, 28, 84 after enrolment from gametocyte-negative individuals). Antibody responses to sexual stage antigens Pfs230 and Pfs48/45 were detected in 20.7% (72/348) and 15.2% (53/348) of the samples, respectively, and were less prevalent than antibodies against asexual stage antigens MSP-1(19) (48.1%; 137/285) and AMA-1 (52.4%; 129/246)(p<0.001). The prevalence of anti-Pfs230 (p = 0.026) and anti-Pfs48/45 antibodies (p = 0.017) increased with longer duration of gametocyte exposure and had an estimated half-life of approximately 3 months. Membrane feeding experiments demonstrated a strong association between the prevalence and concentration of Pfs230 and Pfs48/45 antibodies and transmission reducing activity (TRA, p<0.01). Conclusions/Significance: In a longitudinal study, anti-Pfs230 and Pf48/45 antibodies developed rapidly after exposure to gametocytes and were strongly associated with transmission-reducing activity. Our data indicate that the extent of antigen exposure is important in eliciting functional transmission-reducing immune responses.	[Bousema, Teun; Targett, Geoffrey; Riley, Eleanor M.; Drakeley, Chris] Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, London WC1E 7HT, England; [Bousema, Teun; Mwakalinga, Steve; Mosha, Frank; Drakeley, Chris] Joint Malaria Programme, Moshi, Tanzania; [Roeffen, Will; Meijerink, Hinta; van Gemert, Geert-Jan; van de Vegte-Bolmer, Marga; Sauerwein, Robert] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6525 ED Nijmegen, Netherlands; [Mwerinde, Harry] Tanzania Plantat Co, TPC Dist Designated Hosp, Lower Moshi, Tanzania; [Mwakalinga, Steve] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Mosha, Frank] Kilimanjaro Clin Res Inst, Moshi, Tanzania	University of London; London School of Hygiene & Tropical Medicine; Radboud University Nijmegen; University of Copenhagen	Bousema, T (corresponding author), Univ London London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Immunol & Infect, Keppel St, London WC1E 7HT, England.	chris.drakeley@lshtm.ac.uk	Roeffen, W.F.G./L-4607-2015; Sauerwein, Robert/C-8519-2013; Bousema, Teun/N-3574-2014; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Bousema, Teun/0000-0003-2666-094X; Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Drakeley, Chris/0000-0003-4863-075X	Wellcome Trust [063516] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Baird JK, 1998, J INFECT DIS, V178, P592, DOI 10.1086/517482; BAIRD JK, 1995, PARASITOL TODAY, V11, P105, DOI 10.1016/0169-4758(95)80167-7; Baton LA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-15; Bousema JT, 2007, PARASITE IMMUNOL, V29, P309, DOI 10.1111/j.1365-3024.2007.00948.x; Bousema JT, 2006, J INFECT DIS, V193, P1151, DOI 10.1086/503051; Bousema JT, 2006, AM J TROP MED HYG, V74, P425; Bousema JT, 2006, CURR MOL MED, V6, P223, DOI 10.2174/156652406776055140; Bousema T, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-136; Buckling A, 2001, P ROY SOC B-BIOL SCI, V268, P2325, DOI 10.1098/rspb.2001.1808; CARTER R, 1990, PARASITE IMMUNOL, V12, P587, DOI 10.1111/j.1365-3024.1990.tb00990.x; Carter R, 2000, NAT MED, V6, P241, DOI 10.1038/73062; Cheru L, 2010, VACCINE, V28, P4423, DOI 10.1016/j.vaccine.2010.04.036; Chowdhury DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006352; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; DELGIUDICE G, 1990, B WORLD HEALTH ORGAN, V68, P191; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Drakeley C, 2006, TRENDS PARASITOL, V22, P424, DOI 10.1016/j.pt.2006.07.001; Drakeley CJ, 2006, PARASITE IMMUNOL, V28, P185, DOI 10.1111/j.1365-3024.2005.00818.x; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; Drakeley CJ, 2004, PARASITE IMMUNOL, V26, P159, DOI 10.1111/j.0141-9838.2004.00696.x; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Fonjungo PN, 1999, INFECT IMMUN, V67, P2975, DOI 10.1128/IAI.67.6.2975-2985.1999; Giha HA, 2010, VACCINE, V28, P1732, DOI 10.1016/j.vaccine.2009.12.018; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; GRAVES PM, 1988, PARASITE IMMUNOL, V10, P209, DOI 10.1111/j.1365-3024.1988.tb00215.x; GRAVES PM, 1990, AM J TROP MED HYG, V42, P515, DOI 10.4269/ajtmh.1990.42.515; GRAVES PM, 1980, T ROY SOC TROP MED H, V74, P738, DOI 10.1016/0035-9203(80)90189-3; Healer J, 1997, INFECT IMMUN, V65, P3017, DOI 10.1128/IAI.65.8.3017-3023.1997; Healer J, 1999, PARASITOLOGY, V119, P425, DOI 10.1017/S0031182099005041; Kinyanjui SM, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-82; Lensen A, 1996, T ROY SOC TROP MED H, V90, P20, DOI 10.1016/S0035-9203(96)90464-2; Miura K, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-107; Mulder B, 1999, EXP PARASITOL, V92, P81, DOI 10.1006/expr.1999.4398; Oesterholt MJAM, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-98; Okell LC, 2009, J INFECT DIS, V200, P1509, DOI 10.1086/644781; ONG CSL, 1990, PARASITE IMMUNOL, V12, P447, DOI 10.1111/j.1365-3024.1990.tb00980.x; Ouedraogo AL, 2007, AM J TROP MED HYG, V76, P626, DOI 10.4269/ajtmh.2007.76.626; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Outchkourov NS, 2008, P NATL ACAD SCI USA, V105, P4301, DOI 10.1073/pnas.0800459105; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P812, DOI 10.1016/0035-9203(82)90116-X; PONNUDURAI T, 1989, PARASITOLOGY, V98, P165, DOI 10.1017/S0031182000062065; PREMAWANSA S, 1994, PARASITE IMMUNOL, V16, P35, DOI 10.1111/j.1365-3024.1994.tb00302.x; RILEY EM, 1994, PARASITE IMMUNOL, V16, P55, DOI 10.1111/j.1365-3024.1994.tb00323.x; Roeffen W, 1996, PARASITE IMMUNOL, V18, P103, DOI 10.1046/j.1365-3024.1996.d01-54.x; ROEFFEN W, 1995, AM J TROP MED HYG, V52, P60, DOI 10.4269/ajtmh.1995.52.60; ROEFFEN W, 1994, MEM I OSWALDO CRUZ, V89, P13, DOI 10.1590/S0074-02761994000600004; Sauerwein RW, 2007, MICROBES INFECT, V9, P792, DOI 10.1016/j.micinf.2007.02.011; Schneider P, 2007, AM J TROP MED HYG, V76, P470, DOI 10.4269/ajtmh.2007.76.470; Shekalaghe S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-69; Targett G, 2001, J INFECT DIS, V183, P1254, DOI 10.1086/319689; Targett GA, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S10; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Van Der Kolk M, 2005, PARASITOLOGY, V130, P13, DOI 10.1017/S0031182004006067; van der Kolk M, 2006, INT J PARASITOL, V36, P1091, DOI 10.1016/j.ijpara.2006.05.004; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Wipasa J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000770; Wu YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002636; Yazdanbakhsh M, 2010, NAT REV IMMUNOL, V10, P80, DOI 10.1038/nri2673	60	66	67	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14114	10.1371/journal.pone.0014114	http://dx.doi.org/10.1371/journal.pone.0014114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124765	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000284686500006
J	Gilbert, JA; Field, D; Swift, P; Thomas, S; Cummings, D; Temperton, B; Weynberg, K; Huse, S; Hughes, M; Joint, I; Somerfield, PJ; Muhling, M				Gilbert, Jack A.; Field, Dawn; Swift, Paul; Thomas, Simon; Cummings, Denise; Temperton, Ben; Weynberg, Karen; Huse, Susan; Hughes, Margaret; Joint, Ian; Somerfield, Paul J.; Muehling, Martin			The Taxonomic and Functional Diversity of Microbes at a Temperate Coastal Site: A 'Multi-Omic' Study of Seasonal and Diel Temporal Variation	PLOS ONE			English	Article							WESTERN ENGLISH-CHANNEL; COMMUNITY STRUCTURE; RARE BIOSPHERE; OCEAN; GENOMICS; BACTERIAL; DYNAMICS; WATERS; SEA; METAGENOMICS	How microbial communities change over time in response to the environment is poorly understood. Previously a six-year time series of 16S rRNA V6 data from the Western English Channel demonstrated robust seasonal structure within the bacterial community, with diversity negatively correlated with day-length. Here we determine whether metagenomes and metatranscriptomes follow similar patterns. We generated 16S rRNA datasets, metagenomes (1.2 GB) and metatranscriptomes (157 MB) for eight additional time points sampled in 2008, representing three seasons (Winter, Spring, Summer) and including day and night samples. This is the first microbial 'multi-omic' study to combine 16S rRNA amplicon sequencing with metagenomic and metatranscriptomic profiling. Five main conclusions can be drawn from analysis of these data: 1) Archaea follow the same seasonal patterns as Bacteria, but show lower relative diversity; 2) Higher 16S rRNA diversity also reflects a higher diversity of transcripts; 3) Diversity is highest in winter and at night; 4) Community-level changes in 16S-based diversity and metagenomic profiles are better explained by seasonal patterns (with samples closest in time being most similar), while metatranscriptomic profiles are better explained by diel patterns and shifts in particular categories (i.e., functional groups) of genes; 5) Changes in key genes occur among seasons and between day and night (i.e., photosynthesis); but these samples contain large numbers of orphan genes without known homologues and it is these unknown gene sets that appear to contribute most towards defining the differences observed between times. Despite the huge diversity of these microbial communities, there are clear signs of predictable patterns and detectable stability over time. Renewed and intensified efforts are required to reveal fundamental deterministic patterns in the most complex microbial communities. Further, the presence of a substantial proportion of orphan sequences underscores the need to determine the gene products of sequences with currently unknown function.	[Gilbert, Jack A.; Swift, Paul; Thomas, Simon; Cummings, Denise; Temperton, Ben; Weynberg, Karen; Joint, Ian; Somerfield, Paul J.] Plymouth Marine Lab, Plymouth, Devon, England; [Gilbert, Jack A.] Argonne Natl Lab, Argonne, IL 60439 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Field, Dawn; Swift, Paul] Natl Environm Res Council NERC Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Huse, Susan] Marine Biol Lab, Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Woods Hole, MA 02543 USA; [Hughes, Margaret] Univ Liverpool, Sch Biol Sci, Liverpool L69 3BX, Merseyside, England; [Muehling, Martin] TU Bergakad Freiberg, IOZ Interdisciplinary Ctr Ecol, Freiberg, Germany	Plymouth Marine Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; UK Centre for Ecology & Hydrology (UKCEH); Marine Biological Laboratory - Woods Hole; University of Liverpool; Technical University Freiberg	Gilbert, JA (corresponding author), Plymouth Marine Lab, Plymouth, Devon, England.	gilbertjack@gmail.com	Gilbert, Jack/AAF-3270-2019; Weynberg, Karen/AAW-1657-2020; Weynberg, Karen/P-2526-2017; Temperton, Ben/AAE-2785-2021; Somerfield, Paul J/J-9189-2014; Field, Dawn/C-1653-2010	Weynberg, Karen/0000-0002-9856-2137; Somerfield, Paul J/0000-0002-7581-5621; Thomas, Simon/0000-0002-8474-1230; Temperton, Ben/0000-0002-3667-8302	Natural Environmental Research Council [NE/F00138X/1]; NERC [pml010004, NE/F00138X/1, pml010009] Funding Source: UKRI; Natural Environment Research Council [NE/F00138X/1, pml010004, CEH010021, pml010009] Funding Source: researchfish	Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding for this work was provided by a Natural Environmental Research Council (www.nerc.ac.uk) grant, NE/F00138X/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Saez L, 2008, ENVIRON MICROBIOL, V10, P2444, DOI 10.1111/j.1462-2920.2008.01674.x; Andersson AF, 2010, ISME J, V4, P171, DOI 10.1038/ismej.2009.108; BINDER BJ, 1995, APPL ENVIRON MICROB, V61, P708, DOI 10.1128/AEM.61.2.708-717.1995; Booth T, 2007, BIOTECHNIQUES, V42, P300, DOI 10.2144/000112385; CAPORASO JG, 2010, P NATL ACAD SCI US; Clarke KR, 1999, MAR ECOL PROG SER, V184, P21, DOI 10.3354/meps184021; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; DELONG EF, 2001, ENV DIVERSITY BACTER, V50, P1; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Frias-Lopez J, 2008, P NATL ACAD SCI USA, V105, P3805, DOI 10.1073/pnas.0708897105; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gilbert J., 2010, NAT PRECED; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P3132, DOI 10.1111/j.1462-2920.2009.02017.x; Gilbert JA, 2009, ENVIRON MICROBIOL, V11, P111, DOI 10.1111/j.1462-2920.2008.01745.x; Gilbert JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003042; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; GOOD IJ, 1956, BIOMETRIKA, V43, P45; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Gorley C.K., 2006, GETTING STARTED PRIM; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Huber JA, 2007, SCIENCE, V318, P97, DOI 10.1126/science.1146689; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Mary I, 2006, AQUAT MICROB ECOL, V42, P119, DOI 10.3354/ame042119; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Niu BF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-187; Oremland RS, 2005, NAT REV MICROBIOL, V3, P572, DOI 10.1038/nrmicro1182; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Poretsky RS, 2009, ENVIRON MICROBIOL, V11, P1358, DOI 10.1111/j.1462-2920.2008.01863.x; Rees AP, 1999, DEEP-SEA RES PT I, V46, P483, DOI 10.1016/S0967-0637(98)00073-9; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Sun YJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp285; SWEENEY BM, 1989, J PHYCOL, V25, P183, DOI 10.1111/j.0022-3646.1989.00183.x; VAULOT D, 1995, SCIENCE, V268, P1480, DOI 10.1126/science.268.5216.1480; Wellington EMH, 2003, CURR OPIN MICROBIOL, V6, P295, DOI 10.1016/S1369-5274(03)00066-3; WOESE CR, 1987, MICROBIOL REV, V51, P221, DOI 10.1128/MMBR.51.2.221-271.1987; Yang Q, 2010, SCIENCE, V327, P1522, DOI 10.1126/science.1181759	49	156	160	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15545	10.1371/journal.pone.0015545	http://dx.doi.org/10.1371/journal.pone.0015545			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124740	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000284686500047
J	Hansen, KF; Sakamoto, K; Wayman, GA; Impey, S; Obrietan, K				Hansen, Katelin F.; Sakamoto, Kensuke; Wayman, Gary A.; Impey, Soren; Obrietan, Karl			Transgenic miR132 Alters Neuronal Spine Density and Impairs Novel Object Recognition Memory	PLOS ONE			English	Article							INDUCED MICRORNA; NERVOUS-SYSTEM; C-ELEGANS; IN-VIVO; MECP2; CREB; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; HIPPOCAMPUS	Inducible gene expression plays a central role in neuronal plasticity, learning, and memory, and dysfunction of the underlying molecular events can lead to severe neuronal disorders. In addition to coding transcripts (mRNAs), non-coding microRNAs (miRNAs) appear to play a role in these processes. For instance, the CREB-regulated miRNA miR132 has been shown to affect neuronal structure in an activity-dependent manner, yet the details of its physiological effects and the behavioral consequences in vivo remain unclear. To examine these questions, we employed a transgenic mouse strain that expresses miR132 in forebrain neurons. Morphometric analysis of hippocampal neurons revealed that transgenic miR132 triggers a marked increase in dendritic spine density. Additionally, miR132 transgenic mice exhibited a decrease in the expression of MeCP2, a protein implicated in Rett Syndrome and other disorders of mental retardation. Consistent with these findings, miR132 transgenic mice displayed significant deficits in novel object recognition. Together, these data support a role for miR132 as a regulator of neuronal structure and function, and raise the possibility that dysregulation of miR132 could contribute to an array of cognitive disorders.	[Hansen, Katelin F.; Sakamoto, Kensuke; Obrietan, Karl] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Wayman, Gary A.] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Impey, Soren] Oregon Hlth & Sci Univ, Oregon Stem Cell Ctr, Portland, OR 97201 USA	University System of Ohio; Ohio State University; Washington State University; Oregon Health & Science University	Hansen, KF (corresponding author), Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA.	obrietan.1@osu.edu	Hansen, Katelin/H-3447-2013	Hansen, Katelin/0000-0001-7065-0154	National Institutes of Health [MH62335, MH086032, NS066345, NS067409]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086032, R01MH062335] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067409, R01NS066345] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health Grant numbers: MH62335, MH086032, NS066345 and NS067409. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Cao XW, 2006, ANNU REV NEUROSCI, V29, P77, DOI 10.1146/annurev.neuro.29.051605.112839; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Khudayberdiev Sharof, 2009, Commun Integr Biol, V2, P411; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MORRIS R, 1985, DEV NEUROSCI-BASEL, V7, P133, DOI 10.1159/000112283; Nakazawa T, 2008, J NEUROCHEM, V105, P1384, DOI 10.1111/j.1471-4159.2008.05335.x; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Schule B, 2008, CLIN GENET, V74, P116, DOI 10.1111/j.1399-0004.2008.01005.x; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; Viosca J, 2009, LEARN MEMORY, V16, P198, DOI 10.1101/lm.1220309; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Vuksic M, 2008, HIPPOCAMPUS, V18, P364, DOI 10.1002/hipo.20398; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Wibrand K, 2010, EUR J NEUROSCI, V31, P636, DOI 10.1111/j.1460-9568.2010.07112.x; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102	31	172	178	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15497	10.1371/journal.pone.0015497	http://dx.doi.org/10.1371/journal.pone.0015497			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124738	Green Published, gold, Green Submitted			2022-12-27	WOS:000284686500042
J	Leck, KJ; Zhang, SG; Hauser, CAE				Leck, Kwong-Joo; Zhang, Shuguang; Hauser, Charlotte A. E.			Study of Bioengineered Zebra Fish Olfactory Receptor 131-2: Receptor Purification and Secondary Structure Analysis	PLOS ONE			English	Article							CIRCULAR-DICHROISM SPECTRA; INTEGRAL MEMBRANE-PROTEINS; HIGH-LEVEL EXPRESSION; CRYSTAL-STRUCTURE; GENES; RHODOPSIN; EVOLUTION; SEQUENCE; SYSTEM	How fishes are able to detect trace molecules in large bodies of water is not understood. It is plausible that they use olfactory receptors to detect water-soluble compounds. How the zebra fish Danio Rerio, an organism with only 98 functional olfactory receptors, is able to selectively detect and recognize numerous compounds in water remains a puzzling phenomenon. We are interested in studying the biochemical and molecular mechanisms of olfaction in fish. Here, we report on the study of a bioengineered zebra fish olfactory receptor OR131-2, affinity-purified from a HEK293S tetracycline-inducible system. This receptor was expressed and translocated to the cell plasma membrane as revealed by confocal microscopy. Circular dichroism spectroscopy showed that the purified zebra fish receptor folded into an a-helical structure, as observed for other G-protein coupled receptors (GPCRs). Our study shows that it is possible to produce viable quantities of the zebra fish olfactory receptor. This will not only enable detailed structural and functional analyses, but also aid in the design of biosensor devices in order to detect water-soluble metabolites or its intermediates, which are associated with human health.	[Leck, Kwong-Joo; Zhang, Shuguang; Hauser, Charlotte A. E.] Inst Bioengn & Nanotechnol, Membrane Prot Nanobiotechnol Lab, Singapore, Singapore; [Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Massachusetts Institute of Technology (MIT)	Leck, KJ (corresponding author), Inst Bioengn & Nanotechnol, Membrane Prot Nanobiotechnol Lab, Singapore, Singapore.	chauser@ibn.a-star.edu.sg	Hauser, Charlotte A. E./C-1321-2014; Leck, Kwong Joo/B-2336-2012; Hauser, Charlotte/B-6850-2015	Hauser, Charlotte A. E./0000-0001-8251-7246; Zhang, Shuguang/0000-0002-3856-3752	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)	Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR))	This work is supported by an internal grant provided by the Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ache BW, 2005, NEURON, V48, P417, DOI 10.1016/j.neuron.2005.10.022; Araneda RC, 2000, NAT NEUROSCI, V3, P1248, DOI 10.1038/81774; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fleischer J, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.009.2009; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gilad Y, 2005, GENOME RES, V15, P224, DOI 10.1101/gr.2846405; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Loll PJ, 2003, J STRUCT BIOL, V142, P144, DOI 10.1016/S1047-8477(03)00045-5; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Niimura Y, 2005, P NATL ACAD SCI USA, V102, P6039, DOI 10.1073/pnas.0501922102; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Quignon P, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r80; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Reeves PJ, 1996, P NATL ACAD SCI USA, V93, P11487, DOI 10.1073/pnas.93.21.11487; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 1998, GENOME RES, V8, P449, DOI 10.1101/gr.8.5.449; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; STRADER CD, 1994, ANNU REV BIOCHEM, V63, P101, DOI 10.1146/annurev.bi.63.070194.000533; Wallace BA, 2003, PROTEIN SCI, V12, P875, DOI 10.1110/ps.0229603; Wallin E, 1998, PROTEIN SCI, V7, P1029, DOI 10.1002/pro.5560070420; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Young JM, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r71	34	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 25	2010	5	11							e15027	10.1371/journal.pone.0015027	http://dx.doi.org/10.1371/journal.pone.0015027			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686GM	21124770	Green Submitted, Green Published, gold			2022-12-27	WOS:000284684800001
J	Marshall, J; Ashe, KM; Bangari, D; McEachern, K; Chuang, WL; Pacheco, J; Copeland, DP; Desnick, RJ; Shayman, JA; Scheule, RK; Cheng, SH				Marshall, John; Ashe, Karen M.; Bangari, Dinesh; McEachern, KerryAnne; Chuang, Wei-Lien; Pacheco, Joshua; Copeland, Diane P.; Desnick, Robert J.; Shayman, James A.; Scheule, Ronald K.; Cheng, Seng H.			Substrate Reduction Augments the Efficacy of Enzyme Therapy in a Mouse Model of Fabry Disease	PLOS ONE			English	Article							AGALSIDASE-BETA THERAPY; GAUCHER-DISEASE; REPLACEMENT THERAPY; ALPHA-GALACTOSIDASE; RENAL-FUNCTION; MICE; GLOBOTRIAOSYLCERAMIDE; INVOLVEMENT; MIGLUSTAT; SAFETY	Fabry disease is an X-linked glycosphingolipid storage disorder caused by a deficiency in the activity of the lysosomal hydrolase a-galactosidase A (a-gal). This deficiency results in accumulation of the glycosphingolipid globotriaosylceramide (GL-3) in lysosomes. Endothelial cell storage of GL-3 frequently leads to kidney dysfunction, cardiac and cerebrovascular disease. The current treatment for Fabry disease is through infusions of recombinant a-gal (enzyme-replacement therapy; ERT). Although ERT can markedly reduce the lysosomal burden of GL-3 in endothelial cells, variability is seen in the clearance from several other cell types. This suggests that alternative and adjuvant therapies may be desirable. Use of glucosylceramide synthase inhibitors to abate the biosynthesis of glycosphingolipids (substrate reduction therapy, SRT) has been shown to be effective at reducing substrate levels in the related glycosphingolipidosis, Gaucher disease. Here, we show that such an inhibitor (eliglustat tartrate, Genz-112638) was effective at lowering GL-3 accumulation in a mouse model of Fabry disease. Relative efficacy of SRT and ERT at reducing GL-3 levels in Fabry mouse tissues differed with SRT being more effective in the kidney, and ERT more efficacious in the heart and liver. Combination therapy with ERT and SRT provided the most complete clearance of GL-3 from all the tissues. Furthermore, treatment normalized urine volume and uromodulin levels and significantly delayed the loss of a nociceptive response. The differential efficacies of SRT and ERT in the different tissues indicate that the combination approach is both additive and complementary suggesting the possibility of an improved therapeutic paradigm in the management of Fabry disease.	[Marshall, John; Ashe, Karen M.; Bangari, Dinesh; McEachern, KerryAnne; Chuang, Wei-Lien; Pacheco, Joshua; Copeland, Diane P.; Scheule, Ronald K.; Cheng, Seng H.] Genzyme Corp, Appl Discovery Res, Framingham, MA 01701 USA; [Desnick, Robert J.] Mt Sinai Sch Med, New York, NY USA; [Shayman, James A.] Univ Michigan, Genzyme Corp, Ann Arbor, MI 48109 USA	Sanofi-Aventis; Genzyme Corporation; Icahn School of Medicine at Mount Sinai; Sanofi-Aventis; Genzyme Corporation; University of Michigan System; University of Michigan	Marshall, J (corresponding author), Genzyme Corp, Appl Discovery Res, Framingham, MA 01701 USA.	john.marshall@genzyme.com	Cheng, Seng H/AAC-6564-2022	Marshall, John/0000-0003-1361-2869	NIDDK NIH HHS [R01 DK055823] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055823] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abe A, 2000, J CLIN INVEST, V105, P1563, DOI 10.1172/JCI9711; [Anonymous], 2014, METABOLIC MOL BASES; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Cox TM, 2003, J INHERIT METAB DIS, V26, P513, DOI 10.1023/A:1025902113005; Crosbie TW, 2009, J INHERIT METAB DIS, V32, P745, DOI 10.1007/s10545-009-1254-1; Dutsch M, 2002, J CLIN NEUROPHYSIOL, V19, P575; GADOTH N, 1983, J MED GENET, V20, P309, DOI 10.1136/jmg.20.4.309; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Heare T, 2007, J INHERIT METAB DIS, V30, P79, DOI 10.1007/s10545-006-0473-y; Hoffmann B, 2007, CLIN GASTROENTEROL H, V5, P1447, DOI 10.1016/j.cgh.2007.08.012; Hollak CEM, 2009, PHARMACOEPIDEM DR S, V18, P770, DOI 10.1002/pds.1779; Kobayashi M, 2008, J Inherit Metab Dis, V31 Suppl 3, P483, DOI 10.1007/s10545-007-0740-6; Lidove O, 2007, INT J CLIN PRACT, V61, P293, DOI 10.1111/j.1742-1241.2006.01237.x; Luciano CA, 2002, MUSCLE NERVE, V26, P622, DOI 10.1002/mus.10236; Lukina E, 2010, BLOOD, V116, P893, DOI 10.1182/blood-2010-03-273151; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; McEachern KA, 2007, MOL GENET METAB, V91, P259, DOI 10.1016/j.ymgme.2007.04.001; Moller AT, 2009, PAIN, V145, P237, DOI 10.1016/j.pain.2009.06.032; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Moore DF, 2006, ACTA PAEDIATR, V95, P69, DOI 10.1080/08035320600618932; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Pastores GM, 2005, CLIN THER, V27, P1215, DOI 10.1016/j.clinthera.2005.08.004; Platt FM, 2009, BBA-MOL CELL RES, V1793, P737, DOI 10.1016/j.bbamcr.2008.08.009; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Schiffmann R, 2002, ACTA PAEDIATR, V91, P48, DOI 10.1080/080352502762457923; Schiffmann R, 2006, NEPHROL DIAL TRANSPL, V21, P345, DOI 10.1093/ndt/gfi152; Schiffmann R, 2007, J AM SOC NEPHROL, V18, P1576, DOI 10.1681/ASN.2006111263; Sessa A, 2003, J NEPHROL, V16, P310; Shu L, 2007, J BIOL CHEM, V282, P20960, DOI 10.1074/jbc.M702436200; Shu LM, 2005, J AM SOC NEPHROL, V16, P2636, DOI 10.1681/ASN.2005040383; Thurberg BL, 2009, CIRCULATION, V119, P2561, DOI 10.1161/CIRCULATIONAHA.108.841494; Thurberg BL, 2002, KIDNEY INT, V62, P1933, DOI 10.1046/j.1523-1755.2002.00675.x; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Vylet'al P, 2008, J INHERIT METAB DIS, V31, P508, DOI 10.1007/s10545-008-0900-3; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Wilcox WR, 2008, MOL GENET METAB, V93, P112, DOI 10.1016/j.ymgme.2007.09.013; Wilcox WR, 2004, AM J HUM GENET, V75, P65, DOI 10.1086/422366; Ziegler RJ, 2007, MOL THER, V15, P492, DOI 10.1038/sj.mt.6300066	40	54	57	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15033	10.1371/journal.pone.0015033	http://dx.doi.org/10.1371/journal.pone.0015033			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124789	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000020
J	Res, PCM; Piskin, G; de Boer, OJ; van der Loos, CM; Teeling, P; Bos, JD; Teunissen, MBM				Res, Pieter C. M.; Piskin, Gamze; de Boer, Onno J.; van der Loos, Chris M.; Teeling, Peter; Bos, Jan D.; Teunissen, Marcel B. M.			Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis	PLOS ONE			English	Article							INTERFERON-GAMMA; EPIDERMAL HYPERPLASIA; MONOCLONAL-ANTIBODY; FAMILY CYTOKINES; VULGARIS LESIONS; TYPE-1 CYTOKINES; INTERLEUKIN 22; EXPRESSION; IDENTIFICATION; INFLAMMATION	Background: Although recent studies indicate a crucial role for IL-17A and IL-22 producing T cells in the pathogenesis of psoriasis, limited information is available on their frequency and heterogeneity and their distribution in skin in situ. Methodology/Principal Findings: By spectral imaging analysis of double-stained skin sections we demonstrated that IL-17 was mainly expressed by mast cells and neutrophils and IL-22 by macrophages and dendritic cells. Only an occasional IL-17(pos), but no IL-22(pos) T cell could be detected in psoriatic skin, whereas neither of these cytokines was expressed by T cells in normal skin. However, examination of in vitro-activated T cells by flow cytometry revealed that substantial percentages of skin-derived CD4 and CD8 T cells were able to produce IL-17A alone or together with IL-22 (i.e. Th17 and Tc17, respectively) or to produce IL-22 in absence of IL-17A and IFN-gamma (i.e. Th22 and Tc22, respectively). Remarkably, a significant proportional rise in Tc17 and Tc22 cells, but not in Th17 and Th22 cells, was found in T cells isolated from psoriatic versus normal skin. Interestingly, we found IL-22 single-producers in many skin-derived IL-17A(pos) CD4 and CD8 T cell clones, suggesting that in vivo IL-22 single-producers may arise from IL-17A(pos) T cells as well. Conclusions/Significance: The increased presence of Tc17 and Tc22 cells in lesional psoriatic skin suggests that these types of CD8 T cells play a significant role in the pathogenesis of psoriasis. As part of the skin-derived IL-17A(pos) CD4 and CD8 T clones developed into IL-22 single-producers, this demonstrates plasticity in their cytokine production profile and suggests a developmental relationship between Th17 and Th22 cells and between Tc17 and Tc22 cells.	[Res, Pieter C. M.; Piskin, Gamze; Bos, Jan D.; Teunissen, Marcel B. M.] Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands; [de Boer, Onno J.; van der Loos, Chris M.; Teeling, Peter] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Res, PCM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Dermatol, NL-1105 AZ Amsterdam, Netherlands.	p.c.res@amc.uva.nl; m.b.teunissen@amc.uva.nl	Teunissen, Marcel BM/D-6512-2012	de Boer, Onno/0000-0001-8844-1326				Austin LM, 1999, J INVEST DERMATOL, V113, P752, DOI 10.1046/j.1523-1747.1999.00749.x; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Bos JD, 2007, J AM ACAD DERMATOL, V56, P468, DOI 10.1016/j.jaad.2006.12.006; Bos JD, 2005, BRIT J DERMATOL, V152, P1098, DOI 10.1111/j.1365-2133.2005.06645.x; BOS JD, 1989, ARCH DERMATOL RES, V281, P24, DOI 10.1007/BF00424268; BOS JD, 1983, ARCH DERMATOL RES, V275, P181, DOI 10.1007/BF00510050; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Chan JR, 2006, J EXP MED, V203, P2577, DOI 10.1084/jem.20060244; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; de Boer OJ, 2010, J PATHOL, V220, P499, DOI 10.1002/path.2667; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Fan X, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000038; Friese MA, 2009, ANN NEUROL, V66, P132, DOI 10.1002/ana.21744; Fuschiotti P, 2009, ARTHRITIS RHEUM-US, V60, P1119, DOI 10.1002/art.24432; Gottlieb AB, 2007, CURR MED RES OPIN, V23, P1081, DOI 10.1185/030079907X182112; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ikeda K, 2003, BLOOD, V101, P3594, DOI 10.1182/blood-2002-09-2817; Johnston A, 2004, CLIN EXP IMMUNOL, V138, P83, DOI 10.1111/j.1365-2249.2004.00600.x; Kauffman CL, 2004, J INVEST DERMATOL, V123, P1037, DOI 10.1111/j.0022-202X.2004.23448.x; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Krueger GG, 2007, NEW ENGL J MED, V356, P580, DOI 10.1056/NEJMoa062382; Kryczek I, 2008, J IMMUNOL, V181, P4733, DOI 10.4049/jimmunol.181.7.4733; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee E, 2004, J EXP MED, V199, P125, DOI 10.1084/jem.20030451; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; Nickoloff BJ, 2007, CLIN DERMATOL, V25, P568, DOI 10.1016/j.clindermatol.2007.08.011; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; Nograles KE, 2009, J ALLERGY CLIN IMMUN, V123, P1244, DOI 10.1016/j.jaci.2009.03.041; Piskin G, 2006, J IMMUNOL, V176, P1908, DOI 10.4049/jimmunol.176.3.1908; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Szabo SK, 1998, J INVEST DERMATOL, V111, P1072, DOI 10.1046/j.1523-1747.1998.00419.x; TEUNISSEN MB, 2007, GIORN ITAL DERMAT V, V142, P229; Teunissen MBM, 1998, J INVEST DERMATOL, V111, P645, DOI 10.1046/j.1523-1747.1998.00347.x; Toichi E, 2006, J IMMUNOL, V177, P4917, DOI 10.4049/jimmunol.177.7.4917; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van der Loos CM, 2008, J HISTOCHEM CYTOCHEM, V56, P313, DOI 10.1369/jhc.2007.950170; Vissers WHPM, 2004, BRIT J DERMATOL, V150, P852, DOI 10.1111/j.1365-2133.2004.05863.x; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557; Wiekowski MT, 2001, J IMMUNOL, V166, P7563, DOI 10.4049/jimmunol.166.12.7563; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zaba LC, 2009, J INVEST DERMATOL, V129, P79, DOI 10.1038/jid.2008.194; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Zhou XH, 2003, PHYSIOL GENOMICS, V13, P69, DOI 10.1152/physiolgenomics.00157.2002	53	227	245	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14108	10.1371/journal.pone.0014108	http://dx.doi.org/10.1371/journal.pone.0014108			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124836	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000010
J	Buttstedt, A; Winter, R; Sackewitz, M; Hause, G; Schmid, FX; Schwarz, E				Buttstedt, Anja; Winter, Reno; Sackewitz, Mirko; Hause, Gerd; Schmid, Franz-Xaver; Schwarz, Elisabeth			Influence of the Stability of a Fused Protein and Its Distance to the Amyloidogenic Segment on Fibril Formation	PLOS ONE			English	Article							COLD SHOCK PROTEIN; SINGLE-STRANDED-DNA; OCULOPHARYNGEAL MUSCULAR-DYSTROPHY; N-TERMINAL DOMAIN; BACILLUS-SUBTILIS CSPB; IN-VITRO; NUCLEAR INCLUSIONS; MESSENGER-RNA; MUSCLE-FIBERS; EXPANSIONS	Conversion of native proteins into amyloid fibrils is irreversible and therefore it is difficult to study the interdependence of conformational stability and fibrillation by thermodynamic analyses. Here we approached this problem by fusing amyloidogenic poly-alanine segments derived from the N-terminal domain of the nuclear poly (A) binding protein PABPN1 with a well studied, reversibly unfolding protein, CspB from Bacillus subtilis. Earlier studies had indicated that CspB could maintain its folded structure in fibrils, when it was separated from the amyloidogenic segment by a long linker. When CspB is directly fused with the amyloidogenic segment, it unfolds because its N-terminal chain region becomes integrated into the fibrillar core, as shown by protease mapping experiments. Spacers of either 3 or 16 residues between CspB and the amyloidogenic segment were not sufficient to prevent this loss of CspB structure. Since the low thermodynamic stability of CspB (Delta G(D) = 12.4 kJ/mol) might be responsible for unfolding and integration of CspB into fibrils, fusions with a CspB mutant with enhanced thermodynamic stability (Delta G(D) = 26.9 kJ/mol) were studied. This strongly stabilized CspB remained folded and prevented fibril formation in all fusions. Our data show that the conformational stability of a linked, independently structured protein domain can control fibril formation.	[Buttstedt, Anja; Winter, Reno; Sackewitz, Mirko; Schwarz, Elisabeth] Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany; [Hause, Gerd] Univ Halle Wittenberg, Bioctr, Halle, Germany; [Schmid, Franz-Xaver] Univ Bayreuth, Biochem Lab, D-8580 Bayreuth, Germany	Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg; University of Bayreuth	Buttstedt, A (corresponding author), Univ Halle Wittenberg, Inst Biochem & Biotechnol, Halle, Germany.	elisabeth.schwarz@biochemtech.uni-halle.de	Buttstedt, Anja/B-5281-2012	Buttstedt, Anja/0000-0003-2299-7000	Deutsche Forschungsgemeinschaft (DFG) [1026, GRK 1026, SFB 610]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG) through Graduiertenkolleg 1026 (Conformational transitions in macromolecular interactions) (GRK 1026 and SFB 610) (http://www.biochemtech.uni-halle.de/grk1026/ and http://www.sfb610.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht A, 2005, CURR OPIN GENET DEV, V15, P285, DOI 10.1016/j.gde.2005.04.003; Brais B, 1998, NAT GENET, V18, P164, DOI 10.1038/ng0298-164; Calado A, 2000, HUM MOL GENET, V9, P2321, DOI 10.1093/oxfordjournals.hmg.a018924; Calamai M, 2005, BIOPHYS J, V89, P4201, DOI 10.1529/biophysj.105.068726; Chiti F, 2000, EMBO J, V19, P1441, DOI 10.1093/emboj/19.7.1441; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Espargaro A, 2008, J MOL BIOL, V378, P1116, DOI 10.1016/j.jmb.2008.03.020; Everett CM, 2004, BRAIN, V127, P2385, DOI 10.1093/brain/awh278; Gatchel JR, 2005, NAT REV GENET, V6, P743, DOI 10.1038/nrg1691; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GRAUMANN P, 1994, FEBS LETT, V338, P157, DOI 10.1016/0014-5793(94)80355-2; Lodderstedt G, 2008, BIOCHEMISTRY-US, V47, P2181, DOI 10.1021/bi701322g; Lodderstedt G, 2007, FEBS J, V274, P346, DOI 10.1111/j.1742-4658.2006.05595.x; Lopez MM, 2000, BBA-PROTEIN STRUCT M, V1479, P196, DOI 10.1016/S0167-4838(00)00048-0; Lopez MM, 2001, J BIOL CHEM, V276, P15511, DOI 10.1074/jbc.M010474200; Lopez MM, 1999, J BIOL CHEM, V274, P33601, DOI 10.1074/jbc.274.47.33601; Max KEA, 2007, J MOL BIOL, V369, P1087, DOI 10.1016/j.jmb.2007.04.016; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; MAYR LM, 1993, J MOL BIOL, V231, P897, DOI 10.1006/jmbi.1993.1336; Messaed C, 2009, NEUROBIOL DIS, V34, P397, DOI 10.1016/j.nbd.2009.02.013; Ohnishi S, 2004, CELL MOL LIFE SCI, V61, P511, DOI 10.1007/s00018-003-3264-8; Pace C N, 1986, Methods Enzymol, V131, P266; PAJOT P, 1976, EUR J BIOCHEM, V63, P263, DOI 10.1111/j.1432-1033.1976.tb10228.x; Rohrberg J, 2008, FEBS LETT, V582, P1587, DOI 10.1016/j.febslet.2008.04.002; Sackewitz M, 2008, J AM CHEM SOC, V130, P7172, DOI 10.1021/ja800120s; Sackewitz M, 2008, PROTEIN SCI, V17, P1044, DOI 10.1110/ps.073276308; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Scheuermann T, 2003, PROTEIN SCI, V12, P2685, DOI 10.1110/ps.03214703; Schindler T, 1999, J BIOL CHEM, V274, P3407, DOI 10.1074/jbc.274.6.3407; SCHINDLER T, 1995, NAT STRUCT BIOL, V2, P663, DOI 10.1038/nsb0895-663; Shinchuk LM, 2005, PROTEINS, V61, P579, DOI 10.1002/prot.20536; Tome FMS, 1997, NEUROMUSCULAR DISORD, V7, pS63, DOI 10.1016/S0960-8966(97)00085-0; TOME FMS, 1989, NEUROLOGY, V39, P926, DOI 10.1212/WNL.39.7.926; Uyama E, 1997, NEUROMUSCULAR DISORD, V7, pS41, DOI 10.1016/S0960-8966(97)00081-3; WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J; Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1016/S0168-6445(99)00008-X; WALLACE RB, 1987, METHOD ENZYMOL, V152, P432; Waxman EA, 2009, BBA-MOL BASIS DIS, V1792, P616, DOI 10.1016/j.bbadis.2008.09.013; Wunderlich M, 2005, J MOL BIOL, V347, P1063, DOI 10.1016/j.jmb.2005.02.014; Yankner BA, 2009, J BIOL CHEM, V284, P4754, DOI 10.1074/jbc.R800018200; Zeeb M, 2006, NUCLEIC ACIDS RES, V34, P4561, DOI 10.1093/nar/gkl376	41	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15436	10.1371/journal.pone.0015436	http://dx.doi.org/10.1371/journal.pone.0015436			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124848	gold, Green Published, Green Submitted			2022-12-27	WOS:000284527900018
J	Kudryavtseva, NN; Bondar, NP; Boyarskikh, UA; Filipenko, ML				Kudryavtseva, Natalia N.; Bondar, Natalia P.; Boyarskikh, Ul'yana A.; Filipenko, Maxim L.			Snca and Bdnf Gene Expression in the VTA and Raphe Nuclei of Midbrain in Chronically Victorious and Defeated Male Mice	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; VENTRAL TEGMENTAL AREA; ALPHA-SYNUCLEIN; REPEATED EXPERIENCE; NOREPINEPHRINE TRANSPORTER; SEROTONIN TRANSPORTER; BRAIN; DOPAMINE; COCAINE; BEHAVIOR	Background: Alpha-synuclein (alpha-Syn) is a small neuronal protein that has been found to be expressed throughout the brain. It has been shown that alpha-Syn regulates the homeostasis of monoamine neurotransmitters and is involved in various degenerative and affective disorders. There is indication that alpha-Syn may regulate expression of the brain-derived neurotropic factor (BDNF) which plays an important role in the mood disorders. Methodology/Principal Findings: The study aimed to analyze the mRNA levels of Snca and Bdnf genes in the ventral tegmental area (VTA) and raphe nuclei of the midbrain in male mice that had each won or defeated 20 encounters (20-time winners and 20-time losers, respectively) in daily agonistic interactions. Groups of animals that had the same winning and losing track record followed by a no-fight period for 14 days (no-fighting winners and no-fighting losers) were also studied. Snca mRNA levels were increased in the raphe nuclei in the 20-time losers and in the VTA of the 20-time winners. After no-fight period Snca mRNA levels decreased in both groups. Snca mRNA levels were similar to the control level in the VTA of the 20-time losers and in the raphe nuclei of the 20-time winners. However Snca gene expression increased in these areas in the no-fighting winners and no-fighting losers in comparison with respective mRNA levels in animals before no-fight period. Bdnf mRNA levels increased in VTA of 20-time winners. Significant positive correlations were found between the mRNA levels of Snca and Bdnf genes in the raphe nuclei. Conclusions/Significance: Social experience affects Snca gene expression depending on brain areas and functional activity of monoaminergic systems in chronically victorious or defeated mice. These findings may be useful for understanding the mechanisms of forming different alpha-synucleinopathies.	[Kudryavtseva, Natalia N.; Bondar, Natalia P.] Inst Cytol & Genet SD RAS, Novosibirsk, Russia; [Boyarskikh, Ul'yana A.; Filipenko, Maxim L.] Inst Chem Biol & Basic Med SD RAS, Novosibirsk, Russia	Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Kudryavtseva, NN (corresponding author), Inst Cytol & Genet SD RAS, Novosibirsk, Russia.	natnik@bionet.nsc.ru	Kudryavtseva, Natalia/AAI-1127-2019; Boyarskikh, Ulyana/AAU-9540-2020; Bondar, Natalya/Q-7908-2016	Bondar, Natalya/0000-0002-5602-5149	Russian Academy of Sciences [22.16]	Russian Academy of Sciences(Russian Academy of Sciences)	This work was supported by research grant (22.16) from the Russian Academy of Sciences (Molecular and Cellular Biology Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amstislavskaya TG, 1997, FEBS LETT, V406, P106, DOI 10.1016/S0014-5793(97)00252-4; Avgustinovich D F, 2005, Ross Fiziol Zh Im I M Sechenova, V91, P1454; Avgustinovich D. F., 2004, Uspekhi Fiziologicheskikh Nauk, V35, P19; Azaryan AV, 1998, CAN J PHYSIOL PHARM, V76, P278, DOI 10.1139/cjpp-76-3-278; Bondar NP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004190; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; COCCARO EF, 1992, INT CLIN PSYCHOPHARM, V7, P3, DOI 10.1097/00004850-199200710-00001; COOPER SJ, 1991, MESOLIMBIC DOPAMINE SYSTEM : FROM MOTIVATION TO ACTION, P331; Crespo JA, 2001, NEUROPSYCHOPHARMACOL, V25, P185, DOI 10.1016/S0893-133X(01)00221-4; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; Devoino L V, 1998, Vestn Ross Akad Med Nauk, P19; Filipenko ML, 2001, MOL BRAIN RES, V96, P77, DOI 10.1016/S0169-328X(01)00270-4; Filipenko ML, 2002, BIOCHEMISTRY-MOSCOW+, V67, P451, DOI 10.1023/A:1015238124000; Fish EW, 2002, PSYCHOPHARMACOLOGY, V163, P459, DOI 10.1007/s00213-002-1211-2; Frieling H, 2008, NEUROPSYCHOBIOLOGY, V58, P48, DOI 10.1159/000155991; George JM, 2002, GENOME BIOL, V3; Goloshchapov AV, 2005, MOL BRAIN RES, V135, P290, DOI 10.1016/j.molbrainres.2004.11.009; Greenberg ME, 2009, J NEUROSCI, V29, P12764, DOI 10.1523/JNEUROSCI.3566-09.2009; Groves JO, 2007, MOL PSYCHIATR, V12, P1079, DOI 10.1038/sj.mp.4002075; HAHN MK, 2002, PHARMACOGENOMICS J, V25, P487; Heinz A, 2001, ALCOHOL CLIN EXP RES, V25, P487; Jeannotte AM, 2009, NEUROPSYCHOPHARMACOL, V34, P987, DOI 10.1038/npp.2008.146; Kao AW, 2009, ALZ DIS ASSOC DIS, V23, P365, DOI 10.1097/WAD.0b013e3181b5065d; Kreek MJ, 1996, J ADDICT DIS, V15, P73, DOI 10.1300/J069v15n04_05; Kudryavtseva N.N., 2006, PERSPECTIVES PSYCHOL, P35; Kudryavtseva NN, 1998, AGGRESSIVE BEHAV, V24, P271, DOI 10.1002/(SICI)1098-2337(1998)24:4<271::AID-AB3>3.0.CO;2-M; KUDRYAVTSEVA NN, 1991, ZH VYSSH NERV DEYAT+, V41, P459; Kudryavtseva NN, 2004, RUSS J GENET+, V40, P590, DOI 10.1023/B:RUGE.0000033307.59669.d6; KUDRYAVTSEVA NN, 1991, AGGRESSIVE BEHAV, V17, P285, DOI 10.1002/1098-2337(1991)17:5<285::AID-AB2480170505>3.0.CO;2-P; KULIKOV AV, 1995, PHARMACOL BIOCHEM BE, V50, P431, DOI 10.1016/0091-3057(94)00293-R; Mash DC, 2003, J NEUROSCI, V23, P2564; Mauceli G, 2006, ANN NY ACAD SCI, V1074, P191, DOI 10.1196/annals.1369.019; Miczek K.A., 2007, HDB NEUROCHEMISTRY M, P285, DOI DOI 10.1007/978-0-387-30405-2_7; Miczek KA, 2008, PHARMACOL THERAPEUT, V120, P102, DOI 10.1016/j.pharmthera.2008.07.006; Nichols CD, 2003, MOL BRAIN RES, V111, P182, DOI 10.1016/S0169-328X(03)00029-9; Nikulina EM, 1999, NEUROREPORT, V10, P3015, DOI 10.1097/00001756-199909290-00026; Parain K, 1999, NEUROREPORT, V10, P557, DOI 10.1097/00001756-199902250-00021; Rosen GD, 2000, INT MOUSE GENOME C, V14, P166; Scott J.P., 1971, PHYSL AGGRESSION DEF, P11; Sidhu A, 2004, ANN NY ACAD SCI, V1035, P250, DOI 10.1196/annals.1332.016; Spangler R, 1996, MOL BRAIN RES, V38, P71, DOI 10.1016/0169-328X(95)00319-N; Totterdell S, 2004, BRAIN RES, V1004, P61, DOI 10.1016/j.brainres.2003.10.072; Wersinger C, 2003, NEUROSCI LETT, V340, P189, DOI 10.1016/S0304-3940(03)00097-1; Wersinger C, 2006, EUR J NEUROSCI, V24, P3141, DOI 10.1111/j.1460-9568.2006.05181.x; Wersinger C, 2006, EUR J NEUROSCI, V24, P55, DOI 10.1111/j.1460-9568.2006.04900.x; Yavich L, 2004, J NEUROSCI, V24, P11165, DOI 10.1523/JNEUROSCI.2559-04.2004; YUAN Y, 2010, CELL M IN PRESS 0420	47	15	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14089	10.1371/journal.pone.0014089	http://dx.doi.org/10.1371/journal.pone.0014089			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124898	Green Submitted, gold, Green Published			2022-12-27	WOS:000284527900007
J	Sahaboglu, A; Tanimoto, N; Kaur, J; Sancho-Pelluz, J; Huber, G; Fahl, E; Arango-Gonzalez, B; Zrenner, E; Ekstrom, P; Lowenheim, H; Seeliger, M; Paquet-Durand, F				Sahaboglu, Ayse; Tanimoto, Naoyuki; Kaur, Jasvir; Sancho-Pelluz, Javier; Huber, Gesine; Fahl, Edda; Arango-Gonzalez, Blanca; Zrenner, Eberhart; Ekstrom, Per; Loewenheim, Hubert; Seeliger, Mathias; Paquet-Durand, Francois			PARP1 Gene Knock-Out Increases Resistance to Retinal Degeneration without Affecting Retinal Function	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE GENE; PHOTORECEPTOR CELL-DEATH; CROSS-TALK; GUANOSINE-MONOPHOSPHATE; EXCESSIVE ACTIVATION; MICE LACKING; BETA-SUBUNIT; MOUSE; MITOCHONDRIAL; CONTRIBUTES	Retinitis pigmentosa (RP) is a group of inherited neurodegenerative diseases affecting photoreceptors and causing blindness in humans. Previously, excessive activation of enzymes belonging to the poly-ADP-ribose polymerase (PARP) group was shown to be involved in photoreceptor degeneration in the human homologous rd1 mouse model for RP. Since there are at least 16 different PARP isoforms, we investigated the exact relevance of the predominant isoform - PARP1 - for photoreceptor cell death using PARP1 knock-out (KO) mice. In vivo and ex vivo morphological analysis using optic coherence tomography (OCT) and conventional histology revealed no major alterations of retinal phenotype when compared to wild-type (wt). Likewise, retinal function as assessed by electroretinography (ERG) was normal in PARP1 KO animals. We then used retinal explant cultures derived from wt, rd1, and PARP1 KO animals to test their susceptibility to chemically induced photoreceptor degeneration. Since photoreceptor degeneration in the rd1 retina is triggered by a loss-of-function in phosphodiesterase-6 (PDE6), we used selective PDE6 inhibition to emulate the rd1 situation on non-rd1 genotypes. While wt retina subjected to PDE6 inhibition showed massive photoreceptor degeneration comparable to rd1 retina, in the PARP1 KO situation, cell death was robustly reduced. Together, these findings demonstrate that PARP1 activity is in principle dispensable for normal retinal function, but is of major importance for photoreceptor degeneration under pathological conditions. Moreover, our results suggest that PARP dependent cell death or PARthanatos may play a major role in retinal degeneration and highlight the possibility to use specific PARP inhibitors for the treatment of RP.	[Sahaboglu, Ayse; Kaur, Jasvir; Sancho-Pelluz, Javier; Arango-Gonzalez, Blanca; Zrenner, Eberhart; Paquet-Durand, Francois] Univ Tubingen, Div Expt Ophthalmol, Inst Ophthalm Res, Tubingen, Germany; [Tanimoto, Naoyuki; Huber, Gesine; Fahl, Edda; Seeliger, Mathias] Univ Tubingen, Ctr Ophthalmol, Inst Ophthalm Res, Ocular Neurodegenerat Res Grp, Tubingen, Germany; [Ekstrom, Per] Lund Univ, Dept Ophthalmol, Lund, Sweden; [Loewenheim, Hubert] Univ Tubingen, Dept Otolaryngol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lund University; Eberhard Karls University of Tubingen	Sahaboglu, A (corresponding author), Univ Tubingen, Div Expt Ophthalmol, Inst Ophthalm Res, Tubingen, Germany.	francois.paquet-durand@klinikum.uni-tuebingen.de	Arango-Gonzalez, Blanca/AAR-7427-2021; Paquet-Durand, Francois/G-6709-2015; Sancho-Pelluz, Javier/AAB-2786-2019; Paquet-Durand, Francois/C-6094-2008; Löwenheim, Hubert/GPS-7207-2022	Arango-Gonzalez, Blanca/0000-0002-9045-182X; Paquet-Durand, Francois/0000-0001-7355-5742; Sancho-Pelluz, Javier/0000-0001-5409-5760; Löwenheim, Hubert/0000-0001-8200-8804; Sahaboglu, Ayse/0000-0003-3241-0672	Charlotte and Tistou Kerstan Foundation; European Union [EVI-GENORET: LSHG-CT-2005-512036, NEUROTRAIN: MEST-CT-2005-020235, HEALTH-F2-2008-200234]; Fundacion Oftalmologica del Mediterraneo (FOM); Deutsche Forschungsgemeinschaft (DFG) [PA1751/1-1, Se837/5-2, Se837/6-1, Se837/7-1]; Werner Reichhardt Centre for Integrative Neuroscience (CIN) [PP2009-20]	Charlotte and Tistou Kerstan Foundation; European Union(European Commission); Fundacion Oftalmologica del Mediterraneo (FOM)(FOM (The Netherlands)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Werner Reichhardt Centre for Integrative Neuroscience (CIN)	This work has been supported by grants from the Charlotte and Tistou Kerstan Foundation, the European Union (EVI-GENORET: LSHG-CT-2005-512036, NEUROTRAIN: MEST-CT-2005-020235, HEALTH-F2-2008-200234), Fundacion Oftalmologica del Mediterraneo (FOM), Deutsche Forschungsgemeinschaft (DFG; PA1751/1-1, Se837/5-2, Se837/6-1, Se837/7-1), and the Werner Reichhardt Centre for Integrative Neuroscience (CIN, No. PP2009-20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 1999, J BIOL CHEM, V274, P17860, DOI 10.1074/jbc.274.25.17860; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Andrabi SA, 2008, ANN NY ACAD SCI, V1147, P233, DOI 10.1196/annals.1427.014; Beneke S, 2004, INT J CANCER, V111, P813, DOI 10.1002/ijc.20342; BOWES C, 1990, NATURE, V347, P677, DOI 10.1038/347677a0; Buelow Ben, 2008, J Biol Chem, V283, P24571, DOI 10.1074/jbc.M802673200; Burkart V, 1999, NAT MED, V5, P314, DOI 10.1038/6535; Caffe AR, 2001, J CHEM NEUROANAT, V22, P263; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; de Murcia JMN, 2003, EMBO J, V22, P2255, DOI 10.1093/emboj/cdg206; DEVENTE J, 1987, NEUROSCIENCE, V22, P361, DOI 10.1016/0306-4522(87)90226-0; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Ghezzi D, 2010, AM J HUM GENET, V86, P639, DOI 10.1016/j.ajhg.2010.03.002; Hauck SM, 2006, MOL CELL PROTEOMICS, V5, P324, DOI 10.1074/mcp.M500217-MCP200; Herceg Z, 2001, MUTAT RES-FUND MOL M, V477, P97, DOI 10.1016/S0027-5107(01)00111-7; Herse Peter, 2005, Clin Exp Optom, V88, P335; Hong SJ, 2004, TRENDS PHARMACOL SCI, V25, P259, DOI 10.1016/j.tips.2004.03.005; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kraft R, 2004, AM J PHYSIOL-CELL PH, V286, pC129, DOI 10.1152/ajpcell.00331.2003; MCLAUGHLIN ME, 1995, P NATL ACAD SCI USA, V92, P3249, DOI 10.1073/pnas.92.8.3249; Morin F, 2001, J NEUROCHEM, V78, P88, DOI 10.1046/j.1471-4159.2001.00407.x; Murashita H, 2006, HEARING RES, V214, P1, DOI 10.1016/j.heares.2005.12.008; Nucci C, 2000, BIOCHEM BIOPH RES CO, V278, P360, DOI 10.1006/bbrc.2000.3811; Paquet-Durand F, 2006, J NEUROCHEM, V96, P802, DOI 10.1111/j.1471-4159.2005.03628.x; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Paquet-Durand F, 2009, J NEUROCHEM, V108, P796, DOI 10.1111/j.1471-4159.2008.05822.x; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Sancho-Pelluz J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.4; Sancho-Pelluz J, 2008, MOL NEUROBIOL, V38, P253, DOI 10.1007/s12035-008-8045-9; Sanges D, 2006, APOPTOSIS, V11, P1629, DOI 10.1007/s10495-006-9006-2; SANYAL S, 1973, Z ANAT ENTWICKLUNGS, V142, P219, DOI 10.1007/BF00519723; Schreiber V, 2002, J BIOL CHEM, V277, P23028, DOI 10.1074/jbc.M202390200; Seeliger MW, 2001, NAT GENET, V29, P70, DOI 10.1038/ng712; Shieh WM, 1998, J BIOL CHEM, V273, P30069, DOI 10.1074/jbc.273.46.30069; SIMS JL, 1983, BIOCHEMISTRY-US, V22, P5188, DOI 10.1021/bi00291a019; Smith S, 2001, TRENDS BIOCHEM SCI, V26, P174, DOI 10.1016/S0968-0004(00)01780-1; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Tabuchi K, 2001, ANN OTO RHINOL LARYN, V110, P118; Tanimoto N, 2009, FRONT BIOSCI-LANDMRK, V14, P2730, DOI 10.2741/3409; Vallazza-Deschamps G, 2005, EUR J NEUROSCI, V22, P1013, DOI 10.1111/j.1460-9568.2005.04306.x; Vosler PS, 2009, EXP NEUROL, V218, P213, DOI 10.1016/j.expneurol.2009.04.032; Wang YF, 2009, EXP NEUROL, V218, P193, DOI 10.1016/j.expneurol.2009.03.020; WANG ZQ, 1995, GENE DEV, V9, P509, DOI 10.1101/gad.9.5.509	47	62	65	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15495	10.1371/journal.pone.0015495	http://dx.doi.org/10.1371/journal.pone.0015495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124852	Green Published, gold, Green Submitted			2022-12-27	WOS:000284527900021
J	Manjoo, P; Joseph, L; Pilote, L; Dasgupta, K				Manjoo, Priya; Joseph, Lawrence; Pilote, Louise; Dasgupta, Kaberi			Sex Differences in Step Count-Blood Pressure Association: A Preliminary Study in Type 2 Diabetes	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; EXERCISE; WALKING; MORTALITY; RISK; STEPS/DAY; ACCURACY; PROGRAM; ADULTS	Background: Walking and cardiovascular mortality are inversely associated in type 2 diabetes, but few studies have objectively measured associations of walking with individual cardiovascular risk factors. Such information would be useful for "dosing" daily steps in clinical practice. This study aimed to quantify decrements in blood pressure and glycated hemoglobin (A1C) per 1,000 daily step increments. Methodology/Principal Findings: Two hundred and one subjects with type 2 diabetes underwent assessments of step counts (pedometer-measured), blood pressure, A1C and anthropometric parameters. Due to missing data, the final analysis was conducted on 83 women and 102 men, with a mean age of 60 years. Associations of daily steps with blood pressure and A1C were evaluated using sex-specific multivariate linear regression models (adjusted for age, ethnicity, and BMI). Potential sex differences were confirmed in a combined model (women and men) with interaction terms. Mean values for daily steps, blood pressure, A1C and BMI were 5,357 steps/day; 137/80 mm Hg; 7.7% and 30.4 kg/m(2) respectively. A 1,000 daily step increment among women was associated with a -2.6 (95% CI: -4.1 to -1.1) mm Hg change in systolic and a -1.4 (95% CI: -2.2 to -0.6) mm Hg change in diastolic blood pressure. Among men, corresponding changes were -0.7 (95% CI: -2.1 to 0.7) and -0.6 (95% CI: -1.4 to 0.3) mm Hg, respectively. Sex differences were confirmed in combined models. Step counts and A1C did not demonstrate clinically important associations. Conclusions/Significance: A 1,000 steps/day increment is associated with important blood pressure decrements among women with type 2 diabetes but the data were inconclusive among men. Targeted "dose increments" of 1,000 steps/day in women may lead to measurable blood pressure reductions. This information may be of potential use in the titration or "dosing" of daily steps. No associations were found between step count increments and A1C.	[Manjoo, Priya; Joseph, Lawrence; Pilote, Louise; Dasgupta, Kaberi] McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ, Canada; [Manjoo, Priya] Vancouver Isl Hlth Author, Dept Med, Victoria, BC, Canada	McGill University; Vancouver Island Health Authority	Manjoo, P (corresponding author), McGill Univ, Dept Med, Div Clin Epidemiol, Ctr Hlth, Montreal, PQ, Canada.	kaberi.dasgupta@mcgill.ca		Pilote, Louise/0000-0002-6159-0628	Canadian Institutes of Health Research (CIHR) [MOP-79275]; Fonds de la Recherche en Sante du Quebec	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This study was funded by an operating grant from the Canadian Institutes of Health Research (CIHR, MOP-79275). KD holds a career award from the CIHR (New Investigator Award). LP holds a career award from the Fonds de la Recherche en Sante du Quebec (National Researcher Award). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Canadian Diabetes Association Expert Panel Committee, 2008, CAN J DIABETES, V32, pS168; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Chan CB, 2003, OBES RES, V11, P1563, DOI 10.1038/oby.2003.208; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Cyarto EV, 2004, MED SCI SPORT EXER, V36, P205, DOI 10.1249/01.MSS.0000113476.62469.98; DASGUPTA K, 2009, PRELIMINARY ANAL DEM; Dasgupta K, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-1; Dunn AL, 1998, MED SCI SPORT EXER, V30, P1076, DOI 10.1097/00005768-199807000-00009; Eriksson J, 1997, DIABETOLOGIA, V40, P125; Feinstein A.R., 1996, MULTIVARIABLE ANAL I; Fritz T, 2006, DIABETES RES CLIN PR, V71, P21, DOI 10.1016/j.diabres.2005.06.002; Gregg EW, 2003, ARCH INTERN MED, V163, P1440, DOI 10.1001/archinte.163.12.1440; Hagberg JM, 2000, SPORTS MED, V30, P193, DOI 10.2165/00007256-200030030-00004; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Hu FB, 2001, ANN INTERN MED, V134, P96, DOI 10.7326/0003-4819-134-2-200101160-00009; Lollgen H, 2009, INT J SPORTS MED, V30, P213, DOI 10.1055/s-0028-1128150; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Marshall SJ, 2009, AM J PREV MED, V36, P410, DOI 10.1016/j.amepre.2009.01.021; Praet SFE, 2008, DIABETOLOGIA, V51, P736, DOI 10.1007/s00125-008-0950-y; Schmidt MD, 2009, AM J PREV MED, V37, P278, DOI 10.1016/j.amepre.2009.05.020; Schneider PL, 2004, MED SCI SPORT EXER, V36, P331, DOI 10.1249/01.MSS.0000113486.60548.E9; Shatenstein B, 2005, CAN J DIET PRACT RES, V66, P67, DOI 10.3148/66.2.2005.67; Shepherd EF, 1999, J ORTHOP RES, V17, P703, DOI 10.1002/jor.1100170512; Sisson SB, 2010, AM J PREV MED, V38, P575, DOI 10.1016/j.amepre.2010.02.015; Svacinova H, 2003, Vnitr Lek, V49, P205; Swartz AM, 2007, GERONTOLOGY, V53, P454, DOI 10.1159/000118600; Tanasescu M, 2003, CIRCULATION, V107, P2435, DOI 10.1161/01.CIR.0000066906.11109.1F; Tudor-Locke C, 2004, SPORTS MED, V34, P1, DOI 10.2165/00007256-200434010-00001; Tudor-Locke C, 2004, INT J OBESITY, V28, P113, DOI 10.1038/sj.ijo.0802485; Tudor-Locke C, 2008, MED SCI SPORT EXER, V40, pS537, DOI 10.1249/MSS.0b013e31817c7133; Tudor-Locke C, 2009, MED SCI SPORT EXER, V41, P1384, DOI 10.1249/MSS.0b013e318199885c	33	22	24	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14086	10.1371/journal.pone.0014086	http://dx.doi.org/10.1371/journal.pone.0014086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124929	gold, Green Published			2022-12-27	WOS:000284467200017
J	Waller-Evans, H; Promel, S; Langenhan, T; Dixon, J; Zahn, D; Colledge, WH; Doran, J; Carlton, MBL; Davies, B; Aparicio, SAJR; Grosse, J; Russ, AP				Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Dixon, John; Zahn, Dirk; Colledge, William H.; Doran, Joanne; Carlton, Mark B. L.; Davies, Ben; Aparicio, Samuel A. J. R.; Grosse, Johannes; Russ, Andreas P.			The Orphan Adhesion-GPCR GPR126 Is Required for Embryonic Development in the Mouse	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; CARDIAC NEURAL CREST; NEUREGULIN RECEPTOR; SCHWANN-CELLS; POLARITY; ERBB2; MYELINATION; CLEAVAGE; FATE	Adhesion-GPCRs provide essential cell-cell and cell-matrix interactions in development, and have been implicated in inherited human diseases like Usher Syndrome and bilateral frontoparietal polymicrogyria. They are the second largest subfamily of seven-transmembrane spanning proteins in vertebrates, but the function of most of these receptors is still not understood. The orphan Adhesion-GPCR GPR126 has recently been shown to play an essential role in the myelination of peripheral nerves in zebrafish. In parallel, whole-genome association studies have implicated variation at the GPR126 locus as a determinant of body height in the human population. The physiological function of GPR126 in mammals is still unknown. We describe a targeted mutation of GPR126 in the mouse, and show that GPR126 is required for embryonic viability and cardiovascular development.	[Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Russ, Andreas P.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Waller-Evans, Helen; Proemel, Simone; Langenhan, Tobias; Russ, Andreas P.] Univ Oxford, Magdalen Coll, Oxford OX1 3QU, England; [Dixon, John; Zahn, Dirk; Doran, Joanne; Carlton, Mark B. L.; Grosse, Johannes] Takeda Cambridge Ltd, Cambridge, England; [Colledge, William H.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Davies, Ben] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Aparicio, Samuel A. J. R.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Aparicio, Samuel A. J. R.] Univ British Columbia, BC Canc Res Ctr, Vancouver, BC V5Z 1M9, Canada	University of Oxford; University of Oxford; University of Cambridge; University of Oxford; Wellcome Centre for Human Genetics; University of British Columbia; British Columbia Cancer Agency; University of British Columbia	Waller-Evans, H (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	andreas.russ@bioch.ox.ac.uk	Davies, Ben/GYD-9163-2022; Colledge, William/X-4976-2019; Langenhan, Tobias/AAY-3773-2020	Davies, Ben/0000-0003-3405-507X; Colledge, William/0000-0002-9603-4429; Langenhan, Tobias/0000-0002-9061-3809; Aparicio, Samuel/0000-0002-0487-9599; Davies, Benjamin/0000-0003-3623-600X; Promel, Simone/0000-0001-7800-7323; Waller-Evans, Helen/0000-0003-4133-6064	Environmental Protection Agency Cephalosporin Trust [CF077]; Royal Society; Wellcome Trust [WT075336AIA]; Biotechnology and Biological Sciences Research Council [BB/C504200/1]; Daimler-Benz Foundation	Environmental Protection Agency Cephalosporin Trust; Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Daimler-Benz Foundation	This work was supported by grants from the Environmental Protection Agency Cephalosporin Trust (CF077), the Royal Society, the Wellcome Trust (WT075336AIA), the Biotechnology and Biological Sciences Research Council (BB/C504200/1) to APR, and by DPhil studentships from the BBSRC to HW-E, the Daimler-Benz Foundation to SP, and the Wellcome Trust to TL. The GPR126 mutant mouse strain was generated by Takeda Cambridge Ltd. and made available to the APR lab for analysis under a material transfer agreement for academic research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0; BJARNADOTTIR T, 2007, CELL MOL LIFE SCI; Budi EH, 2008, DEVELOPMENT, V135, P2603, DOI 10.1242/dev.019299; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Chai Y, 2000, DEVELOPMENT, V127, P1671; Conway SJ, 1997, DEVELOPMENT, V124, P505; Creazzo TL, 1998, ANNU REV PHYSIOL, V60, P267, DOI 10.1146/annurev.physiol.60.1.267; GASSMANN M, 1995, NATURE, V378, P390, DOI 10.1038/378390a0; HANCOCK DB, 2009, NAT GENET; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Laisney JAGC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-27; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; LEE KF, 1995, NATURE, V378, P394, DOI 10.1038/378394a0; Lin HH, 2004, J BIOL CHEM, V279, P31823, DOI 10.1074/jbc.M402974200; MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Ozcelik C, 2002, P NATL ACAD SCI USA, V99, P8880, DOI 10.1073/pnas.122249299; Piao XH, 2004, SCIENCE, V303, P2033, DOI 10.1126/science.1092780; Russ AP, 2000, NATURE, V404, P95, DOI 10.1038/35003601; Sherman DL, 2005, NAT REV NEUROSCI, V6, P683, DOI 10.1038/nrn1743; Shimeld SM, 2000, P NATL ACAD SCI USA, V97, P4449, DOI 10.1073/pnas.97.9.4449; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Stehlik C, 2004, FEBS LETT, V569, P149, DOI 10.1016/j.febslet.2004.05.038; Strutt D, 2008, CURR BIOL, V18, pR898, DOI 10.1016/j.cub.2008.07.055; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Weston MD, 2004, AM J HUM GENET, V74, P357, DOI 10.1086/381685; Woldeyesus MT, 1999, GENE DEV, V13, P2538, DOI 10.1101/gad.13.19.2538; Yona S, 2008, TRENDS BIOCHEM SCI, V33, P491, DOI 10.1016/j.tibs.2008.07.005; Zhao JH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-96	32	58	60	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2010	5	11							e14047	10.1371/journal.pone.0014047	http://dx.doi.org/10.1371/journal.pone.0014047			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681XH	21124978	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000284356900010
J	Weiss, MS; Bernabe, BP; Bellis, AD; Broadbelt, LJ; Jeruss, JS; Shea, LD				Weiss, Michael S.; Bernabe, Beatriz Penalver; Bellis, Abigail D.; Broadbelt, Linda J.; Jeruss, Jacqueline S.; Shea, Lonnie D.			Dynamic, Large-Scale Profiling of Transcription Factor Activity from Live Cells in 3D Culture	PLOS ONE			English	Article							BREAST-CANCER CELLS; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; SIGNALING PATHWAY; EXTRACELLULAR-MATRIX; AP-1 TRANSCRIPTION; GROWTH-INHIBITION; ESTROGEN-RECEPTOR; EPITHELIAL-CELLS; MICROARRAY DATA	Background: Extracellular activation of signal transduction pathways and their downstream target transcription factors (TFs) are critical regulators of cellular processes and tissue development. The intracellular signaling network is complex, and techniques that quantify the activities of numerous pathways and connect their activities to the resulting phenotype would identify the signals and mechanisms regulating tissue development. The ability to investigate tissue development should capture the dynamic pathway activity and requires an environment that supports cellular organization into structures that mimic in vivo phenotypes. Taken together, our objective was to develop cellular arrays for dynamic, large-scale quantification of TF activity as cells organized into spherical structures within 3D culture. Methodology/Principal Findings: TF-specific and normalization reporter constructs were delivered in parallel to a cellular array containing a well-established breast cancer cell line cultured in Matrigel. Bioluminescence imaging provided a rapid, non-invasive, and sensitive method to quantify luciferase levels, and was applied repeatedly on each sample to monitor dynamic activity. Arrays measuring 28 TFs identified up to 19 active, with 13 factors changing significantly over time. Stimulation of cells with beta-estradiol or activin A resulted in differential TF activity profiles evolving from initial stimulation of the ligand. Many TFs changed as expected based on previous reports, yet arrays were able to replicate these results in a single experiment. Additionally, arrays identified TFs that had not previously been linked with activin A. Conclusions/Significance: This system provides a method for large-scale, non-invasive, and dynamic quantification of signaling pathway activity as cells organize into structures. The arrays may find utility for investigating mechanisms regulating normal and abnormal tissue growth, biomaterial design, or as a platform for screening therapeutics.	[Weiss, Michael S.; Bernabe, Beatriz Penalver; Bellis, Abigail D.; Broadbelt, Linda J.; Shea, Lonnie D.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Jeruss, Jacqueline S.] Northwestern Univ, Dept Surg, Feinberg Sch Med, Evanston, IL USA; [Jeruss, Jacqueline S.; Shea, Lonnie D.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL USA; [Shea, Lonnie D.] Northwestern Univ, Inst Bionanotechnol Med IBNAM, Evanston, IL USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University	Weiss, MS (corresponding author), Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA.	j-jeruss@md.northwestern.edu; l-shea@northwestern.edu	Broadbelt, Linda/B-7640-2009; Shea, Lonnie D/B-7615-2009		National Institutes of Health [R21CA125285, UL1DE019587, T32GM008449]; Chicago Biomedical Consortium; NATIONAL CANCER INSTITUTE [R21CA125285, K22CA138776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [UL1DE019587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008449] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institutes of Health - R21CA125285, UL1DE019587, T32GM008449 (www.nih.gov). Chicago Biomedical Consortium (http://www.chicagobiomedicalconsortium.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Burdette JE, 2005, CANCER RES, V65, P7968, DOI 10.1158/0008-5472.CAN-04-3553; Chang JH, 1998, MOL CELL BIOL, V18, P4986, DOI 10.1128/MCB.18.9.4986; Cheng C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-116; Cocolakis E, 2001, J BIOL CHEM, V276, P18430, DOI 10.1074/jbc.M010768200; Coleman ML, 2004, NAT REV MOL CELL BIO, V5, P355, DOI 10.1038/nrm1365; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Darnell JE, 2002, NAT REV CANCER, V2, P740, DOI 10.1038/nrc906; de la Iglesia N, 2008, J NEUROSCI, V28, P5870, DOI 10.1523/JNEUROSCI.5385-07.2008; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Dedieu S, 2006, CELL SIGNAL, V18, P889, DOI 10.1016/j.cellsig.2005.08.001; Denhardt DT, 1996, BIOCHEM J, V318, P729, DOI 10.1042/bj3180729; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Dimri M, 2007, CANCER RES, V67, P4164, DOI 10.1158/0008-5472.CAN-06-2580; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Duan RQ, 2002, BIOCHEM BIOPH RES CO, V294, P384, DOI 10.1016/S0006-291X(02)00499-0; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Ho J, 2004, CELL SIGNAL, V16, P693, DOI 10.1016/j.cellsig.2003.11.002; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Huebsch N, 2009, NATURE, V462, P426, DOI 10.1038/nature08601; Ignowski JM, 2004, BIOTECHNOL BIOENG, V86, P827, DOI 10.1002/bit.20059; Ikeda K, 2004, ARCH HISTOL CYTOL, V67, P435, DOI 10.1679/aohc.67.435; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; JIANG SY, 1992, MOL CELL ENDOCRINOL, V90, P77, DOI 10.1016/0303-7207(92)90104-E; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; King KR, 2007, LAB CHIP, V7, P77, DOI 10.1039/b612516f; Kleinman HK, 2005, SEMIN CANCER BIOL, V15, P378, DOI 10.1016/j.semcancer.2005.05.004; Lewis-Wambi JS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2255; Liu JW, 1999, CELL GROWTH DIFFER, V10, P677; Lonnstedt I, 2002, STAT SINICA, V12, P31; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Molchadsky A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003707; Molinari AM, 2000, CANCER RES, V60, P2594; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Pannier AK, 2007, BIOTECHNOL BIOENG, V98, P486, DOI 10.1002/bit.21477; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Peyton SR, 2008, BIOMATERIALS, V29, P2597, DOI 10.1016/j.biomaterials.2008.02.005; PHILIPS A, 1993, J BIOL CHEM, V268, P14103; R. T. eam, 2008, R LANG ENV STAT COMP; Reuter JA, 2009, CANCER CELL, V15, P477, DOI 10.1016/j.ccr.2009.04.002; Romanov S, 2008, NAT METHODS, V5, P253, DOI 10.1038/NMETH.1186; Sabbah M, 1999, P NATL ACAD SCI USA, V96, P11217, DOI 10.1073/pnas.96.20.11217; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen Q, 2008, ONCOGENE, V27, P366, DOI 10.1038/sj.onc.1210643; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Souchelnytskyi S, 2002, J MAMMARY GLAND BIOL, V7, P359, DOI 10.1023/A:1024029930563; Streuli CH, 1999, J MAMMARY GLAND BIOL, V4, P183, DOI 10.1023/A:1018729308878; Varga CM, 2001, MOL THER, V4, P438, DOI 10.1006/mthe.2001.0475; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wieland JA, 2007, J CONTROL RELEASE, V120, P233, DOI 10.1016/j.jconrel.2007.04.015; Woodward TL, 2000, ENDOCRINOLOGY, V141, P2814, DOI 10.1210/en.141.8.2814; Wozniak MA, 2003, J CELL BIOL, V163, P583, DOI 10.1083/jcb.200305010; Yun CH, 2007, DEVELOPMENT, V134, P769, DOI 10.1242/dev.02778; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang YY, 2009, MOL CANCER RES, V7, P498, DOI 10.1158/1541-7786.MCR-08-0415	66	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14026	10.1371/journal.pone.0014026	http://dx.doi.org/10.1371/journal.pone.0014026			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103341	Green Published, Green Submitted, gold			2022-12-27	WOS:000284327800012
J	Brown-Steinke, K; deRonde, K; Yemen, S; Palmer, LA				Brown-Steinke, Kathleen; deRonde, Kimberly; Yemen, Sean; Palmer, Lisa A.			Gender Differences in S-Nitrosoglutathione Reductase Activity in the Lung	PLOS ONE			English	Article							PULMONARY-HYPERTENSION; NATURAL-HISTORY; NITROSOTHIOLS; REGULATOR; ESTROGEN; ANDROGEN; HYPOXIA; ASTHMA; SEX; NITROSOHEMOGLOBIN	S-nitrosothiols have been implicated in the etiology of various pulmonary diseases. Many of these diseases display gender preferences in presentation or altered severity that occurs with puberty, the mechanism by which is unknown. Estrogen has been shown to influence the expression and activity of endothelial nitric oxide synthase (eNOS) which is associated with increased S-nitrosothiol production. The effects of gender hormones on the expression and activity of the de-nitrosylating enzyme S-nitrosoglutathione reductase (GSNO-R) are undefined. This report evaluates the effects of gender hormones on the activity and expression of GSNO-R and its relationship to N-acetyl cysteine (NAC)-induced pulmonary hypertension (PH). GSNO-R activity was elevated in lung homogenates from female compared to male mice. Increased activity was not due to changes in GSNO-R expression, but correlated with GSNO-R S-nitrosylation: females were greater than males. The ability of GSNO-R to be activated by S-nitrosylation was confirmed by: 1) the ability of S-nitrosoglutathione (GSNO) to increase the activity of GSNO-R in murine pulmonary endothelial cells and 2) reduced activity of GSNO-R in lung homogenates from eNOS(-/-) mice. Gender differences in GSNO-R activity appear to explain the difference in the ability of NAC to induce PH: female and castrated male animals are protected from NAC-induced PH. Castration results in elevated GSNO-R activity that is similar to that seen in female animals. The data suggest that GSNO-R activity is modulated by both estrogens and androgens in conjunction with hormonal regulation of eNOS to maintain S-nitrosothiol homeostasis. Moreover, disruption of this eNOS-GSNO-R axis contributes to the development of PH.	[Brown-Steinke, Kathleen; deRonde, Kimberly; Yemen, Sean; Palmer, Lisa A.] Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA	University of Virginia	Brown-Steinke, K (corresponding author), Univ Virginia Hlth Syst, Dept Pediat, Charlottesville, VA USA.	lap5w@virginia.edu			Department of Defense [W81XWH-07-1-0134]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL101871] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Work for this project has been supported by the Peer Reviewed Medical Research Program through the Department of Defense, Award Number W81XWH-07-1-0134 to LAP. The funders had no role in study design, data colletion and analysis, decision to publish or preparation of the manuscript.	Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Bai CX, 2005, CIRCULATION, V112, P1701, DOI 10.1161/CIRCULATIONAHA.104.523217; Baraona E, 2001, ALCOHOL CLIN EXP RES, V25, P502, DOI 10.1097/00000374-200104000-00004; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; Beall CM, 2004, P NATL ACAD SCI USA, V101, P14300, DOI 10.1073/pnas.0405949101; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Benhar M, 2009, NAT REV MOL CELL BIO, V10, P721, DOI 10.1038/nrm2764; BONNER JR, 1984, CLIN CHEST MED, V5, P557; Carey MA, 2007, TRENDS ENDOCRIN MET, V18, P308, DOI 10.1016/j.tem.2007.08.003; Chambliss KL, 2002, ENDOCR REV, V23, P665, DOI 10.1210/er.2001-0045; Chen Z, 1999, J CLIN INVEST, V103, P401, DOI 10.1172/JCI5347; Foster MW, 2009, TRENDS MOL MED, V15, P391, DOI 10.1016/j.molmed.2009.06.007; Funai EF, 1997, BIOCHEM BIOPH RES CO, V239, P875, DOI 10.1006/bbrc.1997.7565; Gaston B, 1998, BIOCHEM BIOPH RES CO, V253, P899, DOI 10.1006/bbrc.1998.9865; Gaston B, 2006, AM J RESP CRIT CARE, V173, P1186, DOI 10.1164/rccm.200510-1584PP; Goetz RM, 1999, P NATL ACAD SCI USA, V96, P2788, DOI 10.1073/pnas.96.6.2788; Haqqani AS, 2003, NITRIC OXIDE-BIOL CH, V9, P172, DOI 10.1016/j.niox.2003.11.003; Ikeda Y, 2009, ENDOCRINOLOGY, V150, P2857, DOI 10.1210/en.2008-1254; Jaffrey SR, 2001, NAT CELL BIOL, V3, P193, DOI 10.1038/35055104; Liu L, 2004, CELL, V116, P617, DOI 10.1016/S0092-8674(04)00131-X; Liu LM, 2001, NATURE, V410, P490, DOI 10.1038/35068596; MARTIN AJ, 1980, BRIT MED J, V280, P1397, DOI 10.1136/bmj.280.6229.1397; McMahon TJ, 2005, P NATL ACAD SCI USA, V102, P14801, DOI 10.1073/pnas.0506957102; MCMURTRY IF, 1973, J APPL PHYSIOL, V35, P459, DOI 10.1152/jappl.1973.35.4.459; MORISHIGE WK, 1978, ENDOCRINOLOGY, V102, P1827, DOI 10.1210/endo-102-6-1827; Palmer LA, 2007, J CLIN INVEST, V117, P2592, DOI 10.1172/JCI29444; Que LG, 2005, SCIENCE, V308, P1618, DOI 10.1126/science.1108228; Que LG, 2009, AM J RESP CRIT CARE, V180, P226, DOI 10.1164/rccm.200901-0158OC; RABINOVITCH M, 1981, AM J PHYSIOL, V240, pH62, DOI 10.1152/ajpheart.1981.240.1.H62; Resta TC, 2001, AM J PHYSIOL-LUNG C, V280, pL88, DOI 10.1152/ajplung.2001.280.1.L88; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Smith A. M., 2006, Current Vascular Pharmacology, V4, P9, DOI 10.2174/157016106775203090; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Wu H, 2007, J ALLERGY CLIN IMMUN, V120, P322, DOI 10.1016/j.jaci.2007.04.022; Zaman K, 2001, BIOCHEM BIOPH RES CO, V284, P65, DOI 10.1006/bbrc.2001.4935; Zaman K, 2006, MOL PHARMACOL, V70, P1435, DOI 10.1124/mol.106.023242	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e14007	10.1371/journal.pone.0014007	http://dx.doi.org/10.1371/journal.pone.0014007			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103380	gold, Green Submitted, Green Published			2022-12-27	WOS:000284257400011
J	Fogarty, AW; Lewis, SA; McKeever, TM; Lowe, GDO; Clark, L; Britton, J				Fogarty, Andrew W.; Lewis, Sarah A.; McKeever, Tricia M.; Lowe, Gordon D. O.; Clark, Lorna; Britton, John			The Association Between Blood Coagulation Activity and Lung Function: A Population-Based Study	PLOS ONE			English	Article							C-REACTIVE PROTEIN; FIBRIN D-DIMER; PULMONARY-FUNCTION; PLASMA-FIBRINOGEN; HEART-DISEASE; AIR-POLLUTION; DECLINE; RISK	Background: Increased in susceptibility to thrombotic disease may be associated with lower lung function. If causal, this association may suggest an area for development of new interventions for lung disease. The aim of this study was to investigate the association between blood coagulation activation as measured by plasma d-dimers and lung function. Methodology/Principal Findings: We conducted a cross-sectional study on 2463 randomly selected adults in 1991 and followed up 1252 of these individuals in 2000. Plasma D-dimer levels, a marker of activity of blood coagulation pathways, were analysed in the baseline 1991 samples. There was an inverse cross-sectional association between plasma D-dimer and Forced Expiratory Volume in one second, with a decrease of 71 ml per mg FEU/ml increment in plasma D-dimer (95% confidence intervals CI: -135 to -6), and a decrease in Forced Vital Capacity (97 ml per mg FEU/ml increase in D-dimer, 95% CI: -170 to -24). These associations were attenuated after adjustment for serum highly sensitive CRP. No association was observed between plasma D-dimer and the decline in lung function between 1991 and 2000. Conclusions/Significance: The cross-sectional findings are consistent with the hypothesis that activation of blood coagulation pathways is associated with decreased lung function, and that systemic inflammation may contribute to this relation. However, the lack of an association with decline in lung function suggests that clotting pathways that involve d-dimers may not be a promising therapeutic target for new interventions for respiratory disease.	[Fogarty, Andrew W.; Lewis, Sarah A.; McKeever, Tricia M.; Britton, John] Univ Nottingham, Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Nottingham NG7 2RD, England; [Lowe, Gordon D. O.] Univ Glasgow, Div Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Clark, Lorna] City Hosp Nottingham, Dept Clin Chem, Nottingham, England	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham; University of Glasgow; Nottingham University Hospital NHS Trust; Nottingham City Hospital	Fogarty, AW (corresponding author), Univ Nottingham, Resp Biomed Res Unit, Div Epidemiol & Publ Hlth, City Hosp, Clin Sci Bldg, Nottingham NG7 2RD, England.	andrew.fogarty@nottingham.ac.uk		McKeever, Tricia/0000-0003-0914-0416	Asthma UK; British Lung Foundation [07/03]	Asthma UK; British Lung Foundation	This work was supported by Asthma UK (http://www.asthma.org.uk/) and the British Lung Foundation (Grant 07/03) (http://www.lunguk.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson D, 2006, AM J RESP CRIT CARE, V174, P626, DOI 10.1164/rccm.200602-243OC; Barnes PJ, 2000, NEW ENGL J MED, V343, P269, DOI 10.1056/NEJM200007273430407; Begbie ME, 2003, POSTGRAD MED J, V79, P18, DOI 10.1136/pmj.79.927.18; BRITTON J, 1994, LANCET, V344, P357, DOI 10.1016/S0140-6736(94)91399-4; Calderon-Garciduenas L, 2001, TOXICOL SCI, V61, P342, DOI 10.1093/toxsci/61.2.342; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Danesh J, 2001, CIRCULATION, V103, P2323; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Fletcher C, 1976, NATURAL HIST CHRONIC, P70; Fogarty AW, 2007, THORAX, V62, P515, DOI 10.1136/thx.2006.066969; Gauderman WJ, 2004, NEW ENGL J MED, V351, P1057, DOI 10.1056/NEJMoa040610; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Juul K, 2005, ARCH INTERN MED, V165, P2032, DOI 10.1001/archinte.165.17.2032; Kony S, 2004, THORAX, V59, P892, DOI 10.1136/thx.2003.015768; Lowe GDO, 2004, ARTERIOSCL THROM VAS, V24, P1957, DOI 10.1161/01.ATV.0000141842.27810.a9; McKeever TM, 2002, AM J RESP CRIT CARE, V165, P1299, DOI 10.1164/rccm.2109030; SEATON A, 1995, LANCET, V345, P176, DOI 10.1016/S0140-6736(95)90173-6; Sin DD, 2005, CHEST, V127, P1952, DOI 10.1378/chest.127.6.1952; Thyagarajan B, 2006, INT J EPIDEMIOL, V35, P1001, DOI 10.1093/ije/dyl049; Torres-Duque Carlos, 2008, Proc Am Thorac Soc, V5, P577, DOI 10.1513/pats.200707-100RP; Tuder RM, 2007, AM J RESP CELL MOL, V37, P130, DOI 10.1165/rcmb.2007-0163TR; WELLS PS, 1995, CIRCULATION, V91, P2184, DOI 10.1161/01.CIR.91.8.2184	22	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15014	10.1371/journal.pone.0015014	http://dx.doi.org/10.1371/journal.pone.0015014			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103357	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000284257400021
J	Weber, KP; De, S; Kozarewa, I; Turner, DJ; Babu, MM; de Bono, M				Weber, Katherine P.; De, Subhajyoti; Kozarewa, Iwanka; Turner, Daniel J.; Babu, M. Madan; de Bono, Mario			Whole Genome Sequencing Highlights Genetic Changes Associated with Laboratory Domestication of C. elegans	PLOS ONE			English	Article							MUS-MUSCULUS-MUSCULUS; CAENORHABDITIS-ELEGANS; NATURAL VARIATION; HOUSE MICE; WILD; EVOLUTION; BEHAVIOR; OXYGEN; POLYMORPHISM; EXPLORATION	Defining the mutational landscape when individuals of a species grow separately and diverge over many generations can provide insights into trait evolution. A specific example of this involves studying changes associated with domestication where different lines of the same wild stock have been cultivated independently in different standard environments. Whole genome sequence comparison of such lines permits estimation of mutation rates, inference of genes' ancestral states and ancestry of existing strains, and correction of sequencing errors in genome databases. Here we study domestication of the C. elegans Bristol strain as a model, and report the genome sequence of LSJ1 (Bristol), a sibling of the standard C. elegans reference wild type N2 (Bristol). The LSJ1 and N2 lines were cultivated separately from shortly after the Bristol strain was isolated until methods to freeze C. elegans were developed. We find that during this time the two strains have accumulated 1208 genetic differences. We describe phenotypic variation between N2 and LSJ1 in the rate at which embryos develop, the rate of production of eggs, the maturity of eggs at laying, and feeding behavior, all the result of post-isolation changes. We infer the ancestral alleles in the original Bristol isolate and highlight 2038 likely sequencing errors in the original N2 reference genome sequence. Many of these changes modify genome annotation. Our study provides a starting point to further investigate genotype-phenotype association and offers insights into the process of selection as a result of laboratory domestication.	[Weber, Katherine P.; De, Subhajyoti; Babu, M. Madan; de Bono, Mario] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Kozarewa, Iwanka; Turner, Daniel J.] Wellcome Trust Sanger Inst, Hinxton, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute	Weber, KP (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	debono@mrc-lmb.cam.ac.uk	Mohan, Babu P./I-7362-2019	de Bono, Mario/0000-0001-8347-0443	Medical Research Council; Wellcome Trust; Marshall Scholarship; National Science Foundation [2008068356]; MRC [MC_U105185859, MC_U105178786] Funding Source: UKRI; Medical Research Council [MC_U105178786, MC_U105185859] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Marshall Scholarship; National Science Foundation(National Science Foundation (NSF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (http://www.mrc.ac.uk/index.htm) and the Wellcome Trust (http://www.wellcome.ac.uk/). K. Weber was supported by a Marshall Scholarship (http://www.marshallscholarship.org/) and a National Science Foundation Graduate Fellowship (Fellow ID: 2008068356; http://www.nsf.gov/funding/pgm_summ.jsp?pims_id = 6201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustsson H, 2004, PHYSIOL BEHAV, V81, P685, DOI 10.1016/j.physbeh.2004.03.014; Bridges CB., 1944, MUTANTS DROSOPHILA M; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Darwin Charles R, 1875, VARIATION ANIMALS PL, Vsecond; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Diamond J, 2002, NATURE, V418, P700, DOI 10.1038/nature01019; DOHM MR, 1994, AM J PHYSIOL-REG I, V267, pR1098, DOI 10.1152/ajpregu.1994.267.4.R1098; Fernandes C, 2004, BEHAV GENET, V34, P621, DOI 10.1007/s10519-004-5589-y; Flint J, 2003, J NEUROBIOL, V54, P46, DOI 10.1002/neu.10161; Gray JM, 2004, NATURE, V430, P317, DOI 10.1038/nature02714; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; HANSEN LE, 1960, NEMATOLOGICA, V5, P27; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Koch R, 2000, GENOME RES, V10, P1690, DOI 10.1101/gr.GR-1471R; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Lindsley D.L., 1968, GENETIC VARIATIONS D; Mackay TFC, 2010, PHILOS T R SOC B, V365, P1229, DOI 10.1098/rstb.2009.0315; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Milloz J, 2008, GENE DEV, V22, P3064, DOI 10.1101/gad.495308; NICHOLAS WL, 1959, ANN NY ACAD SCI, V77, P218, DOI 10.1111/j.1749-6632.1959.tb36902.x; Persson A, 2009, NATURE, V458, P1030, DOI 10.1038/nature07820; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Rockman MV, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000419; Rogers C, 2006, CURR BIOL, V16, P649, DOI 10.1016/j.cub.2006.03.023; Rogers C, 2003, NAT NEUROSCI, V6, P1178, DOI 10.1038/nn1140; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Ruebenbauer A, 2008, CURR BIOL, V18, P1438, DOI 10.1016/j.cub.2008.08.062; Sarin S, 2008, NAT METHODS, V5, P865, DOI 10.1038/NMETH.1249; Seidel HS, 2008, SCIENCE, V319, P589, DOI 10.1126/science.1151107; Silver L.M., 1995, MOUSE GENETICS CONCE; Sulston JHJ, 1988, NEMATODE CAENORHABDI; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878; Witherspoon DJ, 2003, J MOL EVOL, V56, P751, DOI 10.1007/s00239-002-2450-x; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	41	59	59	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e13922	10.1371/journal.pone.0013922	http://dx.doi.org/10.1371/journal.pone.0013922			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21085631	gold, Green Published			2022-12-27	WOS:000284087800005
J	Bostrom, BL; Jones, TT; Hastings, M; Jones, DR				Bostrom, Brian L.; Jones, T. Todd; Hastings, Mervin; Jones, David R.			Behaviour and Physiology: The Thermal Strategy of Leatherback Turtles	PLOS ONE			English	Article							SEA-TURTLES; TEMPERATURES; ENDOTHERMY; EVOLUTION; ECOLOGY; NICHE	Background: Adult leatherback turtles (Dermochelys coriacea) exhibit thermal gradients between their bodies and the environment of >= 8 degrees C in sub-polar waters and <= 4 degrees C in the tropics. There has been no direct evidence for thermoregulation in leatherbacks although modelling and morphological studies have given an indication of how thermoregulation may be achieved. Methodology/Principal Findings: We show for the first time that leatherbacks are indeed capable of thermoregulation from studies on juvenile leatherbacks of 16 and 37 kg. In cold water (< 25 degrees C), flipper stroke frequency increased, heat loss through the plastron, carapace and flippers was minimized, and a positive thermal gradient of up to 2.3 degrees C was maintained between body and environment. In warm water (25 - 31 degrees C), turtles were inactive and heat loss through their plastron, carapace and flippers increased. The thermal gradient was minimized (0.5 degrees C). Using a scaling model, we estimate that a 300 kg adult leatherback is able to maintain a maximum thermal gradient of 18.2 degrees C in cold sub-polar waters. Conclusions/Significance: In juvenile leatherbacks, heat gain is controlled behaviourally by increasing activity while heat flux is regulated physiologically, presumably by regulation of blood flow distribution. Hence, harnessing physiology and behaviour allows leatherbacks to keep warm while foraging in cold sub-polar waters and to prevent overheating in a tropical environment.	[Bostrom, Brian L.; Jones, T. Todd; Jones, David R.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Jones, T. Todd] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Natl Ocean & Atmospher Adm, Kewalo Res Facil, Honolulu, HI 96822 USA	University of British Columbia; National Oceanic Atmospheric Admin (NOAA) - USA; University of Hawaii System; University of Hawaii Manoa	Bostrom, BL (corresponding author), Univ British Columbia, Dept Zool, Vancouver, BC, Canada.	bbostrom@interchange.ubc.ca			NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a NSERC Discovery Grant to David R. Jones (http://www.nserc-crsng.gc.ca/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta MJ, 2002, J THERM BIOL, V27, P249, DOI 10.1016/S0306-4565(01)00094-8; Bernal D, 2001, COMP BIOCHEM PHYS A, V129, P695, DOI 10.1016/S1095-6433(01)00333-6; BLOCK BA, 1993, SCIENCE, V260, P210, DOI 10.1126/science.8469974; Bostrom BL, 2007, COMP BIOCHEM PHYS A, V147, P323, DOI 10.1016/j.cbpa.2006.10.032; BRETT JR, 1971, AM ZOOL, V11, P99; Davenport J, 2009, J EXP BIOL, V212, P2753, DOI 10.1242/jeb.026500; Eckert SA, 2002, J EXP BIOL, V205, P3689; GOFF PG, 1988, COPEIA, V4, P1071; GREER AE, 1973, NATURE, V244, P181, DOI 10.1038/244181a0; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; HEATH ME, 1980, COPEIA, P767; Hochscheid S, 2002, PHYSIOL BIOCHEM ZOOL, V75, P66, DOI 10.1086/339050; HUEY RB, 1979, AM ZOOL, V19, P357; HUTCHISON VH, 1979, AM ZOOL, V19, P367; James MC, 2004, CAN J ZOOL, V82, P1302, DOI 10.1139/z04-110; James MC, 2005, ECOL LETT, V8, P195, DOI 10.1111/j.1461-0248.2004.00710.x; James MC, 2006, J EXP MAR BIOL ECOL, V335, P221, DOI 10.1016/j.jembe.2006.03.013; Kvadsheim PH, 1996, J THERM BIOL, V21, P123, DOI 10.1016/0306-4565(95)00034-8; Moon DY, 1997, J EXP ZOOL, V278, P372; PALADINO FV, 1990, NATURE, V344, P858, DOI 10.1038/344858a0; SATO K, 1994, MAR BIOL, V118, P343, DOI 10.1007/BF00349802; Southwood AL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P285, DOI 10.1086/427048; STANDORA EA, 1982, J THERM BIOL, V7, P159, DOI 10.1016/0306-4565(82)90006-7; Wallace BP, 2008, J EXP MAR BIOL ECOL, V356, P8, DOI 10.1016/j.jembe.2007.12.023	24	41	41	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13925	10.1371/journal.pone.0013925	http://dx.doi.org/10.1371/journal.pone.0013925			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085716	Green Published, gold			2022-12-27	WOS:000284036800016
J	Okello, JBA; Rodriguez, L; Poinar, D; Bos, K; Okwi, AL; Bimenya, GS; Sewankambo, NK; Henry, KR; Kuch, M; Poinar, HN				Okello, John B. A.; Rodriguez, Linda; Poinar, Debi; Bos, Kirsten; Okwi, Andrew L.; Bimenya, Gabriel S.; Sewankambo, Nelson K.; Henry, Kenneth R.; Kuch, Melanie; Poinar, Hendrik N.			Quantitative Assessment of the Sensitivity of Various Commercial Reverse Transcriptases Based on Armored HIV RNA	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VIRUS TYPE-1 RNA; RT-PCR; GENE-EXPRESSION; MESSENGER-RNA; VIRAL-RNA; INHIBITION; ASSAY; CDNA; DNA	Background: The in-vitro reverse transcription of RNA to its complementary DNA, catalyzed by the enzyme reverse transcriptase, is the most fundamental step in the quantitative RNA detection in genomic studies. As such, this step should be as analytically sensitive, efficient and reproducible as possible, especially when dealing with degraded or low copy RNA samples. While there are many reverse transcriptases in the market, all claiming to be highly sensitive, there is need for a systematic independent comparison of their applicability in quantification of rare RNA transcripts or low copy RNA, such as those obtained from archival tissues. Methodology/Principal Findings: We performed RT-qPCR to assess the sensitivity and reproducibility of 11 commercially available reverse transcriptases in cDNA synthesis from low copy number RNA levels. As target RNA, we used a serially known number of Armored HIV-RNA molecules, and observed that 9 enzymes we tested were consistently sensitive to similar to 1000 copies, seven of which were sensitive to similar to 100 copies, while only 5 were sensitive to similar to 10 RNA template copies across all replicates tested. Despite their demonstrated sensitivity, these five best performing enzymes (Accuscript, HIV-RT, M-MLV, Superscript III and Thermoscript) showed considerable variation in their reproducibility as well as their overall amplification efficiency. Accuscript and Superscript III were the most sensitive and consistent within runs, with Accuscript and Superscript II ranking as the most reproducible enzymes between assays. Conclusions/Significance: We therefore recommend the use of Accuscript or Superscript III when dealing with low copy number RNA levels, and suggest purification of the RT reactions prior to downstream applications (eg-qPCR) to augment detection. Although the results presented in this study were based on a viral RNA surrogate, and applied to nucleic acid lysates derived from archival formalin-fixed paraffin embedded tissue, their relative performance on RNA obtained from other tissue types may vary, and needs future evaluation.	[Okello, John B. A.; Rodriguez, Linda; Poinar, Debi; Bos, Kirsten; Kuch, Melanie; Poinar, Hendrik N.] McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON, Canada; [Okwi, Andrew L.; Bimenya, Gabriel S.] Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol, Kampala, Uganda; [Sewankambo, Nelson K.] Makerere Univ, Coll Hlth Sci, Off Principal, Kampala, Uganda; [Henry, Kenneth R.] Case Western Reserve Univ, Div Infect Dis, Cleveland, OH 44106 USA; [Poinar, Hendrik N.] McMaster Univ, Michael DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Poinar, Hendrik N.] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada	McMaster University; Makerere University; Makerere University; Case Western Reserve University; McMaster University; McMaster University	Okello, JBA (corresponding author), McMaster Univ, Dept Anthropol, McMaster Ancient DNA Ctr, Hamilton, ON, Canada.	jokello@mcmaster.ca; poinarh@mcmaster.ca	Okello, John B A/B-5157-2018	Okello, John B A/0000-0002-5889-1905; Sewankambo, Nelson/0000-0001-9362-053X	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This study was funded by the Canadian Institutes of Health Research (CIHR, to HNP). The funders, however, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AREZI B, 2006, STRATEGIES STRATAGEN, V19, P52; Arezi B, 2010, ANAL BIOCHEM, V400, P301, DOI 10.1016/j.ab.2010.01.024; BarraganGonzalez E, 1997, CLIN CHIM ACTA, V260, P73, DOI 10.1016/S0009-8981(96)06509-6; BUSTIN S, 2004, J BIOMOL TECH, V153, P155; Bustin SA, 2005, J MOL ENDOCRINOL, V34, P597, DOI 10.1677/jme.1.01755; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin SA, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290023; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chandler DP, 1998, APPL ENVIRON MICROB, V64, P669; CHUMAKOV KM, 1994, PCR METH APPL, V4, P62; Cikos S, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-113; Cottam EM, 2009, VIRUS RES, V140, P199, DOI 10.1016/j.virusres.2008.10.012; Deprez RHL, 2002, ANAL BIOCHEM, V307, P63, DOI 10.1016/S0003-2697(02)00021-0; FEHLMANN C, 1993, CLIN CHEM, V39, P368; Gal AB, 2006, REPROD FERT DEVELOP, V18, P365, DOI 10.1071/RD05012; Henning TR, 2009, J CLIN VIROL, V46, P309, DOI 10.1016/j.jcv.2009.08.015; Hietala SK, 2006, J CLIN MICROBIOL, V44, P67, DOI 10.1128/JCM.44.1.67-70.2006; Jefferies D, 2002, ANAL BIOCHEM, V308, P192, DOI 10.1016/S0003-2697(02)00204-X; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; KARRER EE, 1995, P NATL ACAD SCI USA, V92, P3814, DOI 10.1073/pnas.92.9.3814; Kawasaki ES, 1990, PCR PROTOCOLS GUIDE; Kermekchiev MB, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1055; King CE, 2009, BIOTECHNIQUES, V47, P941, DOI 10.2144/000113244; Levesque-Sergerie JP, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-93; McKinney MD, 2009, J CLIN VIROL, V44, P39, DOI 10.1016/j.jcv.2008.09.003; MULDER J, 1994, J CLIN MICROBIOL, V32, P292, DOI 10.1128/JCM.32.2.292-300.1994; Okello JBA, 2010, ANAL BIOCHEM, V400, P110, DOI 10.1016/j.ab.2010.01.014; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Pasloske BL, 1998, J CLIN MICROBIOL, V36, P3590, DOI 10.1128/JCM.36.12.3590-3594.1998; Pfaffl M. W., 2004, QUANTIFICATION STRAT; R Development Core Team, 2010, R VERS 2 11 1 LANG E; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Schwarz C, 2009, NUCLEIC ACIDS RES, V37, P3215, DOI 10.1093/nar/gkp159; SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Stahlberg A, 2004, CLIN CHEM, V50, P1678, DOI 10.1373/clinchem.2004.035469; Stahlberg A, 2003, CLIN CHEM, V49, P51, DOI 10.1373/49.1.51; Stangegaard M, 2006, BIOTECHNIQUES, V40, P649, DOI 10.2144/000112153; Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176; Taniguchi K, 2009, NAT METHODS, V6, P503, DOI 10.1038/nmeth.1338; VERMA IM, 1977, BIOCHIM BIOPHYS ACTA, V473, P1, DOI 10.1016/0304-419X(77)90005-1; WalkerPeach CR, 1999, CLIN CHEM, V45, P2079; Wilson IG, 1997, APPL ENVIRON MICROB, V63, P3741, DOI 10.1128/AEM.63.10.3741-3751.1997; Wittwer CT., 2004, MOL MICROBIOLOGY DIA, P71; Wong L, 1998, BIOTECHNOL TECH, V12, P485, DOI 10.1023/A:1008871608947	45	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13931	10.1371/journal.pone.0013931	http://dx.doi.org/10.1371/journal.pone.0013931			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085668	Green Published, gold			2022-12-27	WOS:000284036800022
J	Amin, AD; Chaix, ABH; Mason, RP; Badge, RM; Borts, RH				Amin, Amit Dipak; Chaix, Alexandre B. H.; Mason, Robert P.; Badge, Richard M.; Borts, Rhona H.			The Roles of the Saccharomyces cerevisiae RecQ Helicase SGS1 in Meiotic Genome Surveillance	PLOS ONE			English	Article							MISMATCH REPAIR PROTEINS; DNA TOPOISOMERASE-III; DOUBLE-STRAND BREAKS; WERNERS-SYNDROME GENES; HOMEOLOGOUS RECOMBINATION; CROSSING-OVER; HOMOLOGOUS RECOMBINATION; HETERODUPLEX REJECTION; SALMONELLA-TYPHIMURIUM; MULTIPLE PATHWAYS	Background: The Saccharomyces cerevisiae RecQ helicase Sgs1 is essential for mitotic and meiotic genome stability. The stage at which Sgs1 acts during meiosis is subject to debate. Cytological experiments showed that a deletion of SGS1 leads to an increase in synapsis initiation complexes and axial associations leading to the proposal that it has an early role in unwinding surplus strand invasion events. Physical studies of recombination intermediates implicate it in the dissolution of double Holliday junctions between sister chromatids. Methodology/Principal Findings: In this work, we observed an increase in meiotic recombination between diverged sequences (homeologous recombination) and an increase in unequal sister chromatid events when SGS1 is deleted. The first of these observations is most consistent with an early role of Sgs1 in unwinding inappropriate strand invasion events while the second is consistent with unwinding or dissolution of recombination intermediates in an Mlh1- and Top3-dependent manner. We also provide data that suggest that Sgs1 is involved in the rejection of 'second strand capture' when sequence divergence is present. Finally, we have identified a novel class of tetrads where non-sister spores (pairs of spores where each contains a centromere marker from a different parent) are inviable. We propose a model for this unusual pattern of viability based on the inability of sgs1 mutants to untangle intertwined chromosomes. Our data suggest that this role of Sgs1 is not dependent on its interaction with Top3. We propose that in the absence of SGS1 chromosomes may sometimes remain entangled at the end of pre-meiotic replication. This, combined with reciprocal crossing over, could lead to physical destruction of the recombined and entangled chromosomes. We hypothesise that Sgs1, acting in concert with the topoisomerase Top2, resolves these structures. Conclusions: This work provides evidence that Sgs1 interacts with various partner proteins to maintain genome stability throughout meiosis.	[Amin, Amit Dipak; Chaix, Alexandre B. H.; Mason, Robert P.; Badge, Richard M.; Borts, Rhona H.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England	University of Leicester	Amin, AD (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	rhb7@le.ac.uk		Amin, Amit Dipak/0000-0002-2613-2082; Badge, Richard/0000-0003-3201-336X	Royal Society; Cancer Research UK	Royal Society(Royal Society of London); Cancer Research UK(Cancer Research UK)	This work was supported by the Royal Society http://royalsociety.org/ and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MFF, 2001, P NATL ACAD SCI USA, V98, P14524, DOI 10.1073/pnas.201529598; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RJ, 2000, J BIOL CHEM, V275, P26898; Bennett RJ, 1998, J BIOL CHEM, V273, P9644, DOI 10.1074/jbc.273.16.9644; Bennett RJ, 2001, P NATL ACAD SCI USA, V98, P11108, DOI 10.1073/pnas.201387098; Bernstein KA, 2009, EMBO J, V28, P915, DOI 10.1038/emboj.2009.28; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BRITTEN RJ, 1988, P NATL ACAD SCI USA, V85, P4770, DOI 10.1073/pnas.85.13.4770; Cejka Petr, 2010, J Biol Chem, V285, P8290, DOI 10.1074/jbc.M109.083196; Chakraverty RK, 2001, MOL CELL BIOL, V21, P7150, DOI 10.1128/MCB.21.21.7150-7162.2001; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; CHAMBERS SR, 1999, THESIS U OXFORD; Chang M, 2005, EMBO J, V24, P2024, DOI 10.1038/sj.emboj.7600684; Chen WL, 1999, GENETICS, V151, P1299; Chen WL, 1998, MOL CELL BIOL, V18, P6525, DOI 10.1128/MCB.18.11.6525; Coghlan A, 2005, TRENDS GENET, V21, P673, DOI 10.1016/j.tig.2005.09.009; Cotton VE, 2009, METHODS MOL BIOL, V557, P3, DOI 10.1007/978-1-59745-527-5_1; Dherin C, 2009, MOL CELL BIOL, V29, P907, DOI 10.1128/MCB.00945-08; Duno M, 2000, MOL GEN GENET, V264, P89, DOI 10.1007/s004380000286; EGEL R, 1978, HEREDITY, V41, P233, DOI 10.1038/hdy.1978.92; Frei C, 2000, GENE DEV, V14, P81; Fricke WM, 2001, J BIOL CHEM, V276, P8848, DOI 10.1074/jbc.M009719200; Gangloff S, 2000, NAT GENET, V25, P192, DOI 10.1038/76055; GANGLOFF S, 1994, MOL CELL BIOL, V14, P8391, DOI 10.1128/MCB.14.12.8391; Gellon L, 2002, J BIOL CHEM, V277, P29963, DOI 10.1074/jbc.M202963200; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; HOLM C, 1994, CELL, V77, P955, DOI 10.1016/0092-8674(94)90433-2; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Hunter N, 1996, EMBO J, V15, P1726, DOI 10.1002/j.1460-2075.1996.tb00518.x; Hunter N, 1997, GENE DEV, V11, P1573, DOI 10.1101/gad.11.12.1573; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jessop L, 2008, MOL CELL, V31, P313, DOI 10.1016/j.molcel.2008.05.021; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Keeney S, 1997, CELL, V88, P375, DOI 10.1016/S0092-8674(00)81876-0; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lee BH, 2003, SCIENCE, V300, P482, DOI 10.1126/science.1081846; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; LOUIS EJ, 1990, GENETICS, V124, P533; Lu JA, 1996, NATURE, V383, P678, DOI 10.1038/383678a0; Mankouri HW, 2006, MOL BIOL CELL, V17, P4473, DOI 10.1091/mbc.E06-06-0516; Miyajima A, 2000, MOL CELL BIOL, V20, P6399, DOI 10.1128/MCB.20.17.6399-6409.2000; Miyajima A, 2000, GENES GENET SYST, V75, P319, DOI 10.1266/ggs.75.319; Mullen JR, 2005, MOL CELL BIOL, V25, P4476, DOI 10.1128/MCB.25.11.4476-4487.2005; Mullen JR, 2000, GENETICS, V154, P1101; Myung K, 2001, NATURE, V411, P1073, DOI 10.1038/35082608; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Nicholson A, 2000, GENETICS, V154, P133; Oh SD, 2008, MOL CELL, V31, P324, DOI 10.1016/j.molcel.2008.07.006; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Onoda F, 2000, MUTAT RES-DNA REPAIR, V459, P203, DOI 10.1016/S0921-8777(99)00071-3; Onoda F, 2001, MOL GEN GENET, V264, P702, DOI 10.1007/s004380000358; Ouyang KJ, 2008, MECH AGEING DEV, V129, P425, DOI 10.1016/j.mad.2008.03.003; Page SL, 2003, SCIENCE, V301, P785, DOI 10.1126/science.1086605; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Pedrazzi G, 2003, BIOL CHEM, V384, P1155, DOI 10.1515/BC.2003.128; PERKINS DD, 1949, GENETICS, V34, P607; Putnam CD, 2009, NATURE, V460, P984, DOI 10.1038/nature08217; RADMAN M, 1989, GENOME, V31, P68, DOI 10.1139/g89-014; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; Rieseberg LH, 2003, SCIENCE, V301, P1211, DOI 10.1126/science.1086949; Rockmill B, 2003, CURR BIOL, V13, P1954, DOI 10.1016/j.cub.2003.10.059; Rockmill B, 2006, GENETICS, V174, P1745, DOI 10.1534/genetics.106.058933; Rossetti Liliana C, 2004, Hum Mutat, V24, P440, DOI 10.1002/humu.9288; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHWACHA A, 1995, CELL, V83, P783, DOI 10.1016/0092-8674(95)90191-4; Seki M, 2006, MOL CELL BIOL, V26, P6299, DOI 10.1128/MCB.00702-06; Selva EM, 1997, MOL GEN GENET, V257, P71; SELVA EM, 1995, GENETICS, V139, P1175; Shinohara A, 2004, CYTOGENET GENOME RES, V107, P201, DOI 10.1159/000080598; SINGH DK, 2008, BIOGERONTOLOGY; Spell RM, 2004, GENETICS, V168, P1855, DOI 10.1534/genetics.104.032771; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; SUN H, 1991, CELL, V64, P1155, DOI 10.1016/0092-8674(91)90270-9; Tay Y, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1089; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wang TF, 2002, BIOCHEM BIOPH RES CO, V296, P949, DOI 10.1016/S0006-291X(02)02034-X; Watt PM, 1996, GENETICS, V144, P935; WATT PM, 1995, CELL, V81, P253, DOI 10.1016/0092-8674(95)90335-6; Weinstein J, 2008, DNA REPAIR, V7, P558, DOI 10.1016/j.dnarep.2007.12.010; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Zahrt TC, 1997, P NATL ACAD SCI USA, V94, P9786, DOI 10.1073/pnas.94.18.9786	89	3	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15380	10.1371/journal.pone.0015380	http://dx.doi.org/10.1371/journal.pone.0015380			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085703	Green Submitted, gold, Green Published			2022-12-27	WOS:000284035900025
J	Gonzalez, R; Kerbel, B; Chun, A; Unniappan, S				Gonzalez, Ronald; Kerbel, Brent; Chun, Alexander; Unniappan, Suraj			Molecular, Cellular and Physiological Evidences for the Anorexigenic Actions of Nesfatin-1 in Goldfish	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SATIETY MOLECULE; GENOME DUPLICATION; NEUROPEPTIDE-Y; IMMUNOREACTIVITY; EXPRESSION; PITUITARY; RECEPTOR; NEURONS; FISH	Background: Nesfatin-1 is a recently discovered anorexigen encoded in the precursor peptide, nucleobindin-2 (NUCB2) in mammals. To date, nesfatin-1 has not been described in any non-mammalian species, although some information is available in the sequenced genomes of several species. Our objective was to characterize nesfatin-1 in fish. Methodology/Principal Findings: In the present study, we employed molecular, immunohistochemical, and physiological studies to characterize the structure, distribution, and appetite regulatory effects of nesfatin-1 in a non-mammalian vertebrate. A very high conservation in NUCB2 sequences, especially in the nesfatin-1 region was found in lower vertebrates. Abundant expression of NUCB2 mRNA was detected in several tissues including the brain and liver of goldfish. Nesfatin-1-like immunoreactive cells are present in the feeding regulatory nucleus of the hypothalamus and in the gastrointestinal tract of goldfish. Approximately 6-fold increase in NUCB2 mRNA levels was found in the liver after 7-day food-deprivation, and a similar increase was also found after short-term fasting. This points toward a possible liver specific role for NUCB2 in the control of metabolism during food-deprivation. Meanwhile, similar to 2-fold increase at 1 and 3 h post-feeding and an similar to 3-fold reduction after a 7-day food-deprivation was observed in NUCB2 mRNA in the goldfish hypothalamus. In vivo, a single intraperitoneal injection of the full-length native (goldfish; gf) nesfatin-1 at a dose of 50 ng/g body weight induced a 23% reduction of food intake one hour post-injection in goldfish. Furthermore, intracerebroventricular injection of gfnesfatin-1 at a dose of 5 ng/g body weight resulted in similar to 50% reduction in food intake. Conclusions/Significance: Our results provide molecular, anatomical and functional evidences to support potential anorectic and metabolic roles for endogenous nesfatin-1 in goldfish. Collectively, we provide novel information on NUCB2 in non-mammals and an anorexigenic role for nesfatin-1 in goldfish.	[Gonzalez, Ronald; Kerbel, Brent; Chun, Alexander; Unniappan, Suraj] York Univ, Lab Integrat Neuroendocrinol, Dept Biol, Toronto, ON M3J 2R7, Canada	York University - Canada	Gonzalez, R (corresponding author), York Univ, Lab Integrat Neuroendocrinol, Dept Biol, Toronto, ON M3J 2R7, Canada.	suraju@yorku.ca			Natural Sciences and Engineering Research Council (NSERC) of Canada; Canadian Institutes of Health Research; Ontario Ministry of Research and Innovation; Ontario Graduate Scholarship; NSERC	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the Natural Sciences and Engineering Research Council (NSERC) of Canada through a Discovery Grant, and two Research Tools and Instruments Grants to SU. SU is a recipient of the New Investigator Award from the Canadian Institutes of Health Research and the Early Researcher Award from the Ontario Ministry of Research and Innovation. RG is a recipient of the Ontario Graduate Scholarship. BK is a recipient of the Undergraduate Summer Research Award from the NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahima RS, 2006, OBESITY, V14, p9S, DOI 10.1038/oby.2006.276; ANGLADE I, 1993, CELL TISSUE RES, V273, P345, DOI 10.1007/BF00312837; Brailoiu GC, 2007, ENDOCRINOLOGY, V148, P5088, DOI 10.1210/en.2007-0701; BURNSTOCK G, 1958, J PHYSIOL-LONDON, V141, P35, DOI 10.1113/jphysiol.1958.sp005953; Cerda-Reverter JM, 2003, REGUL PEPTIDES, V115, P101, DOI 10.1016/S0167-0115(03)00144-7; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P2336, DOI 10.1210/en.2002-0213; Cerda-Reverter JM, 2003, ENDOCRINOLOGY, V144, P4552, DOI 10.1210/en.2003-0453; Christoffels A, 2004, MOL BIOL EVOL, V21, P1146, DOI 10.1093/molbev/msh114; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Foo KS, 2008, NEUROSCIENCE, V156, P563, DOI 10.1016/j.neuroscience.2008.07.054; Foo KS, 2010, J ENDOCRINOL, V204, P255, DOI 10.1677/JOE-09-0254; Fort P, 2008, NEUROSCIENCE, V155, P174, DOI 10.1016/j.neuroscience.2008.05.035; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Gonzalez R, 2010, GEN COMP ENDOCR, V166, P273, DOI 10.1016/j.ygcen.2009.09.008; Gonzalez R, 2009, BIOCHEM BIOPH RES CO, V381, P643, DOI 10.1016/j.bbrc.2009.02.104; Hrytsenko O, 2007, BRAIN RES, V1135, P31, DOI 10.1016/j.brainres.2006.12.009; Jaillon O, 2004, NATURE, V431, P946, DOI 10.1038/nature03025; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Li QC, 2010, REGUL PEPTIDES, V159, P72, DOI 10.1016/j.regpep.2009.11.003; Maejima Y, 2009, CELL METAB, V10, P355, DOI 10.1016/j.cmet.2009.09.002; Merali Z, 2008, PSYCHOPHARMACOLOGY, V201, P115, DOI 10.1007/s00213-008-1252-2; Moon Thomas W., 1995, V4, P65; Morash MG, 2009, GEN COMP ENDOCR, V162, P179, DOI 10.1016/j.ygcen.2009.03.013; MORATA P, 1982, COMP BIOCHEM PHYS B, V72, P543, DOI 10.1016/0305-0491(82)90503-X; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pan WH, 2007, PEPTIDES, V28, P2223, DOI 10.1016/j.peptides.2007.09.005; PENG C, 1994, ENDOCRINOLOGY, V134, P1095, DOI 10.1210/en.134.3.1095; PETER RE, 1990, J EXP ZOOL, P84; PETER RE, 1975, J COMP NEUROL, V159, P69, DOI 10.1002/cne.901590106; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; PICKAVANCE LC, 1992, J CHEM NEUROANAT, V5, P221, DOI 10.1016/0891-0618(92)90047-T; Price CJ, 2008, J NEUROENDOCRINOL, V20, P245, DOI 10.1111/j.1365-2826.2007.01641.x; Price CJ, 2008, BRAIN RES, V1230, P99, DOI 10.1016/j.brainres.2008.06.084; Price TO, 2007, PEPTIDES, V28, P2372, DOI 10.1016/j.peptides.2007.10.008; Ramanjaneya M, 2010, ENDOCRINOLOGY, V151, P3169, DOI 10.1210/en.2009-1358; Rao SD, 1996, GEN COMP ENDOCR, V102, P210, DOI 10.1006/gcen.1996.0062; Seidah NG, 1998, ANN NY ACAD SCI, V839, P9, DOI 10.1111/j.1749-6632.1998.tb10727.x; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Stengel A, 2009, ENDOCRINOLOGY, V150, P232, DOI 10.1210/en.2008-0747; Stengel A, 2009, ENDOCRINOLOGY, V150, P4911, DOI 10.1210/en.2009-0578; Su YJ, 2010, BIOCHEM BIOPH RES CO, V391, P1039, DOI 10.1016/j.bbrc.2009.12.014; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Unniappan S, 2004, GEN COMP ENDOCR, V136, P200, DOI 10.1016/j.ygcen.2003.12.010; Unniappan S, 2008, AM J PHYSIOL-REG I, V295, pR51, DOI 10.1152/ajpregu.00234.2007; VANDENTHILLART G, 1984, J COMP PHYSIOL, V154, P477, DOI 10.1007/BF02515152; Yosten GLC, 2010, AM J PHYSIOL-REG I, V298, pR1642, DOI 10.1152/ajpregu.00804.2009	46	95	101	7	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15201	10.1371/journal.pone.0015201	http://dx.doi.org/10.1371/journal.pone.0015201			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151928	gold, Green Published, Green Submitted			2022-12-27	WOS:000284939600032
J	Lusingu, J; Olotu, A; Leach, A; Lievens, M; Vekemans, J; Olivier, A; Benns, S; Olomi, R; Msham, S; Lang, T; Gould, J; Hallez, K; Guerra, Y; Njuguna, P; Awuondo, KO; Malabeja, A; Abdul, O; Gesase, S; Dekker, D; Malle, L; Ismael, S; Mturi, N; Drakeley, CJ; Savarese, B; Villafana, T; Ballou, WR; Cohen, J; Riley, EM; Lemnge, MM; Marsh, K; Bejon, P; von Seidlein, L				Lusingu, John; Olotu, Ally; Leach, Amanda; Lievens, Marc; Vekemans, Johan; Olivier, Aurelie; Benns, Sarah; Olomi, Raimos; Msham, Salum; Lang, Trudie; Gould, Jayne; Hallez, Karin; Guerra, Yolanda; Njuguna, Patricia; Awuondo, Ken O.; Malabeja, Anangisye; Abdul, Omar; Gesase, Samwel; Dekker, Denise; Malle, Lincoln; Ismael, Sadiki; Mturi, Neema; Drakeley, Chris J.; Savarese, Barbara; Villafana, Tonya; Ballou, W. Ripley; Cohen, Joe; Riley, Eleanor M.; Lemnge, Martha M.; Marsh, Kevin; Bejon, Philip; von Seidlein, Lorenz			Safety of the Malaria Vaccine Candidate, RTS,S/AS01(E) in 5 to 17 Month Old Kenyan and Tanzanian Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; IMMUNE ADULT MEN; PHASE 2A TRIAL; NAIVE ADULTS; MOZAMBICAN CHILDREN; DOUBLE-BLIND; EFFICACY; IMMUNOGENICITY; INFANTS; REGION	The malaria vaccine candidate, RTS,S/AS01(E), showed promising protective efficacy in a trial of Kenyan and Tanzanian children aged 5 to 17 months. Here we report on the vaccine's safety and tolerability. The experimental design was a Phase 2b, two-centre, double-blind (observer-and participant-blind), randomised (1: 1 ratio) controlled trial. Three doses of study or control (rabies) vaccines were administered intramuscularly at 1 month intervals. Solicited adverse events (AEs) were collected for 7 days after each vaccination. There was surveillance and reporting for unsolicited adverse events for 30 days after each vaccination. Serious adverse events (SAEs) were recorded throughout the study period which lasted for 14 months after dose 1 in Korogwe, Tanzania and an average of 18 months post-dose 1 in Kilifi, Kenya. Blood samples for safety monitoring of haematological, renal and hepatic functions were taken at baseline, 3, 10 and 14 months after dose 1. A total of 894 children received RTS, S/AS01(E) or rabies vaccine between March and August 2007. Overall, children vaccinated with RTS, S/AS01(E) had fewer SAEs (51/447) than children in the control group (88/447). One SAE episode in a RTS, S/AS01(E) recipient and nine episodes among eight rabies vaccine recipients met the criteria for severe malaria. Unsolicited AEs were reported in 78% of subjects in the RTS, S/AS01(E) group and 74% of subjects in the rabies vaccine group. In both vaccine groups, gastroenteritis and pneumonia were the most frequently reported unsolicited AE. Fever was the most frequently observed solicited AE and was recorded after 11% of RTS, S/AS01(E) doses compared to 31% of doses of rabies vaccine. The candidate vaccine RTS, S/AS01(E) showed an acceptable safety profile in children living in a malaria-endemic area in East Africa. More data on the safety of RTS, S/AS01(E) will become available from the Phase 3 programme.	[Lusingu, John; Msham, Salum; Malabeja, Anangisye; Abdul, Omar; Gesase, Samwel; Malle, Lincoln; Ismael, Sadiki; Lemnge, Martha M.] Natl Inst Med Res, Tanga, Tanzania; [Olotu, Ally; Lang, Trudie; Njuguna, Patricia; Awuondo, Ken O.; Mturi, Neema; Marsh, Kevin; Bejon, Philip] KEMRI, Ctr Geog Med Res Coast, Kilifi, Kenya; [Leach, Amanda; Lievens, Marc; Vekemans, Johan; Olivier, Aurelie; Benns, Sarah; Hallez, Karin; Guerra, Yolanda; Ballou, W. Ripley; Cohen, Joe] GlaxoSmithKline Biol, Rixensart, Belgium; [Olomi, Raimos; Gould, Jayne; von Seidlein, Lorenz] Joint Malaria Programme, Korogwe, Tanzania; [Dekker, Denise; Drakeley, Chris J.; Riley, Eleanor M.] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Savarese, Barbara] PATH Malaria Vaccine Initiat, Bethesda, MD USA; [Villafana, Tonya] MedImmune LLC, Gaithersburg, MD USA; [Marsh, Kevin; Bejon, Philip] Nuffield Dept Med, Oxford, MD USA	GlaxoSmithKline; University of London; London School of Hygiene & Tropical Medicine; AstraZeneca; Medimmune	Lusingu, J (corresponding author), Natl Inst Med Res, Tanga, Tanzania.	lseidlein@gmail.com	Lusingu, John P. A./GSJ-3228-2022; Leach, Amanda/AAS-1120-2020; Riley, Eleanor/AAL-1382-2020; Riley, Eleanor M/C-8960-2013	Leach, Amanda/0000-0002-7114-9967; Riley, Eleanor/0000-0003-3447-3570; Riley, Eleanor M/0000-0003-3447-3570; Lusingu, John P. A./0000-0002-9407-0602	Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative (MVI)	Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative (MVI)	GSK and both study sites received funding to undertake the work described in this report from the Program for Appropriate Technology in Health (PATH) Malaria Vaccine Initiative (MVI), which was involved in all aspects of the study design.	Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Bojang K, 2009, HUM VACCINES, V5, P242, DOI 10.4161/hv.5.4.7050; COHEN J, 2009, HUM VACCIN, P6; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; LANG TA, 2010, J INT HLTH IN PRESS; Lell B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007611; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; *MEDDRA, 2007, MED DICT REG ACT; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Sacarlal J, 2008, VACCINE, V26, P174, DOI 10.1016/j.vaccine.2007.11.003; Sacarlal J, 2009, J INFECT DIS, V200, P329, DOI 10.1086/600119; Stoute JA, 2006, AM J TROP MED HYG, V75, P166, DOI 10.4269/ajtmh.2006.75.166; Vekemans J, 2008, EXPERT REV VACCINES, V7, P223, DOI 10.1586/14760584.7.2.223	22	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14090	10.1371/journal.pone.0014090	http://dx.doi.org/10.1371/journal.pone.0014090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124768	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500004
J	Koerdt, A; Godeke, J; Berger, J; Thormann, KM; Albers, SV				Koerdt, Andrea; Goedeke, Julia; Berger, Juergen; Thormann, Kai M.; Albers, Sonja-Verena			Crenarchaeal Biofilm Formation under Extreme Conditions	PLOS ONE			English	Article							ARCHAEON SULFOLOBUS-SOLFATARICUS; PSEUDOMONAS-AERUGINOSA; BACTERIAL BIOFILMS; PYROCOCCUS-FURIOSUS; GENUS SULFOLOBUS; HOT-SPRINGS; EXOPOLYSACCHARIDE; ENVIRONMENT; MULTIPLE; MATRIX	Background: Biofilm formation has been studied in much detail for a variety of bacterial species, as it plays a major role in the pathogenicity of bacteria. However, only limited information is available for the development of archaeal communities that are frequently found in many natural environments. Methodology: We have analyzed biofilm formation in three closely related hyperthermophilic crenarchaeotes: Sulfolobus acidocaldarius, S. solfataricus and S. tokodaii. We established a microtitre plate assay adapted to high temperatures to determine how pH and temperature influence biofilm formation in these organisms. Biofilm analysis by confocal laser scanning microscopy demonstrated that the three strains form very different communities ranging from simple carpet-like structures in S. solfataricus to high density tower-like structures in S. acidocaldarius in static systems. Lectin staining indicated that all three strains produced extracellular polysaccharides containing glucose, galactose, mannose and N-acetylglucosamine once biofilm formation was initiated. While flagella mutants had no phenotype in two days old static biofilms of S. solfataricus, a UV-induced pili deletion mutant showed decreased attachment of cells. Conclusion: The study gives first insights into formation and development of crenarchaeal biofilms in extreme environments.	[Koerdt, Andrea; Goedeke, Julia; Thormann, Kai M.] Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany; [Berger, Juergen] Max Planck Inst Dev Biol, Tubingen, Germany	Max Planck Society; Max Planck Society	Koerdt, A (corresponding author), Max Planck Inst Terr Microbiol, Dept Ecophysiol, D-35043 Marburg, Germany.	albers@mpi-marburg.mpg.de	Albers, Sonja-Verena/H-8689-2019; Albers, Sonja-Verena/H-1213-2012	Albers, Sonja-Verena/0000-0003-2459-2226; Koerdt, Andrea/0000-0002-9214-6183	Max Planck Society	Max Planck Society(Max Planck Society)	The work was supported by intramural funds of the Max Planck Society to SVA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers SV, 2009, EXTREMOPHILES, V13, P403, DOI 10.1007/s00792-009-0241-7; Allesen-Holm M, 2006, MOL MICROBIOL, V59, P1114, DOI 10.1111/j.1365-2958.2005.05008.x; BAKERAUSTIN C, 2010, EXTREMOPHILES; BROCK TD, 1972, ARCH MIKROBIOL, V84, P54, DOI 10.1007/BF00408082; Chiang P, 2003, J BACTERIOL, V185, P2374, DOI 10.1128/JB.185.7.2374-2378.2003; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Ellen AF, 2009, EXTREMOPHILES, V13, P67, DOI 10.1007/s00792-008-0199-x; Flemming HC, 2007, J BACTERIOL, V189, P7945, DOI 10.1128/JB.00858-07; Froels S, 2008, MOL MICROBIOL, V70, P938, DOI 10.1111/j.1365-2958.2008.06459.x; Grogan DW, 1996, J MICROBIOL METH, V26, P35, DOI 10.1016/0167-7012(96)00840-8; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hall-Stoodley L, 2005, TRENDS MICROBIOL, V13, P7, DOI 10.1016/j.tim.2004.11.004; Inskeep WP, 2004, GEOCHIM COSMOCHIM AC, V68, P3141, DOI 10.1016/j.gca.2003.09.020; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Kruger M, 2008, ENVIRON MICROBIOL, V10, P1934, DOI 10.1111/j.1462-2920.2008.01607.x; LaPaglia C, 1997, APPL ENVIRON MICROB, V63, P3158, DOI 10.1128/AEM.63.8.3158-3163.1997; Macur RE, 2004, GEOBIOLOGY, V2, P163, DOI 10.1111/j.1472-4677.2004.00032.x; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Nather DJ, 2006, J BACTERIOL, V188, P6915, DOI 10.1128/JB.00527-06; NICOLAUS B, 1993, FEMS MICROBIOL LETT, V109, P203, DOI 10.1111/j.1574-6968.1993.tb06168.x; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Rinker KD, 1996, APPL ENVIRON MICROB, V62, P4478, DOI 10.1128/AEM.62.12.4478-4485.1996; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Schelert J, 2004, J BACTERIOL, V186, P427, DOI 10.1128/JB.186.2.427-437.2004; Schopf S, 2008, ARCH MICROBIOL, V190, P371, DOI 10.1007/s00203-008-0371-9; Sutherland IW, 2001, TRENDS MICROBIOL, V9, P222, DOI 10.1016/S0966-842X(01)02012-1; Suzuki T, 2002, EXTREMOPHILES, V6, P39, DOI 10.1007/s007920100221; Szabo Z, 2007, J BACTERIOL, V189, P4305, DOI 10.1128/JB.00042-07; Thoma C, 2008, ENVIRON MICROBIOL, V10, P2785, DOI 10.1111/j.1462-2920.2008.01698.x; Thormann KM, 2004, J BACTERIOL, V186, P8096, DOI 10.1128/JB.186.23.8096-8104.2004; Veith A, 2009, MOL MICROBIOL, V73, P58, DOI 10.1111/j.1365-2958.2009.06746.x; Watnick PI, 1999, MOL MICROBIOL, V34, P586, DOI 10.1046/j.1365-2958.1999.01624.x; Zhang CL, 2008, APPL ENVIRON MICROB, V74, P6417, DOI 10.1128/AEM.00843-08; ZILLIG W, 1994, SYST APPL MICROBIOL, V16, P609; ZILLIG W, 1980, ARCH MICROBIOL, V125, P259, DOI 10.1007/BF00446886; Zolghadr B, 2010, J BACTERIOL, V192, P104, DOI 10.1128/JB.01061-09	37	85	85	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14104	10.1371/journal.pone.0014104	http://dx.doi.org/10.1371/journal.pone.0014104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124788	Green Submitted, Green Published, gold			2022-12-27	WOS:000284572000006
J	Caillaud, D; Crofoot, MC; Scarpino, SV; Jansen, PA; Garzon-Lopez, CX; Winkelhagen, AJS; Bohlman, SA; Walsh, PD				Caillaud, Damien; Crofoot, Margaret C.; Scarpino, Samuel V.; Jansen, Patrick A.; Garzon-Lopez, Carol X.; Winkelhagen, Annemarie J. S.; Bohlman, Stephanie A.; Walsh, Peter D.			Modeling the Spatial Distribution and Fruiting Pattern of a Key Tree Species in a Neotropical Forest: Methodology and Potential Applications	PLOS ONE			English	Article							APPROXIMATE BAYESIAN COMPUTATION; DIPTERYX-PANAMENSIS; HABITAT SELECTION; SEED DISPERSAL; EL-NINO; MOVEMENT; RECRUITMENT; PREDATION; FRAMEWORK; BEHAVIOR	Background: The movement patterns of wild animals depend crucially on the spatial and temporal availability of resources in their habitat. To date, most attempts to model this relationship were forced to rely on simplified assumptions about the spatiotemporal distribution of food resources. Here we demonstrate how advances in statistics permit the combination of sparse ground sampling with remote sensing imagery to generate biological relevant, spatially and temporally explicit distributions of food resources. We illustrate our procedure by creating a detailed simulation model of fruit production patterns for Dipteryx oleifera, a keystone tree species, on Barro Colorado Island (BCI), Panama. Methodology and Principal Findings: Aerial photographs providing GPS positions for large, canopy trees, the complete census of a 50-ha and 25-ha area, diameter at breast height data from haphazardly sampled trees and long-term phenology data from six trees were used to fit 1) a point process model of tree spatial distribution and 2) a generalized linear mixed-effect model of temporal variation of fruit production. The fitted parameters from these models are then used to create a stochastic simulation model which incorporates spatio-temporal variations of D. oleifera fruit availability on BCI. Conclusions and Significance: We present a framework that can provide a statistical characterization of the habitat that can be included in agent-based models of animal movements. When environmental heterogeneity cannot be exhaustively mapped, this approach can be a powerful alternative. The results of our model on the spatio-temporal variation in D. oleifera fruit availability will be used to understand behavioral and movement patterns of several species on BCI.	[Caillaud, Damien; Scarpino, Samuel V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Caillaud, Damien] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Crofoot, Margaret C.; Jansen, Patrick A.] Smithsonian Trop Res Inst, Panama City, Panama; [Crofoot, Margaret C.] Max Planck Inst Ornithol, Dept Migrat & Immunoecol, Radolfzell am Bodensee, Germany; [Crofoot, Margaret C.; Bohlman, Stephanie A.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Jansen, Patrick A.; Winkelhagen, Annemarie J. S.] Wageningen Univ, Forest Ecol & Forest Management Grp, Wageningen, Netherlands; [Jansen, Patrick A.; Garzon-Lopez, Carol X.] Univ Groningen, Community & Conservat Ecol Grp, Haren, Netherlands; [Walsh, Peter D.] VaccinApe, Bethesda, MD USA	University of Texas System; University of Texas Austin; Max Planck Society; Smithsonian Institution; Smithsonian Tropical Research Institute; Max Planck Society; Princeton University; Wageningen University & Research; University of Groningen	Caillaud, D (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	dcaillaud@austin.utexas.edu	Caillaud, Damien/AAH-5850-2019; Jansen, Patrick/G-2545-2015; Garzon-Lopez, Carol/G-6251-2014	Caillaud, Damien/0000-0002-8347-6869; Jansen, Patrick/0000-0002-4660-0314; Garzon-Lopez, Carol/0000-0002-4099-2740	NSF [DEB-0553768, DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, DEB-0749097]; University of California Santa Barbara and the State of California; Center for Tropical Forest Science; Smithsonian Tropical Forest Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Division Of Environmental Biology [0749097] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California Santa Barbara and the State of California(University of California System); Center for Tropical Forest Science(Smithsonian InstitutionSmithsonian Tropical Research Institute); Smithsonian Tropical Forest Research Institute; John D. and Catherine T. MacArthur Foundation; Mellon Foundation; Celera Foundation; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The National Center For Ecological Analysis is supported by NSF Grant DEB-0553768, the University of California Santa Barbara and the State of California. The Forest Dynamics Plots were funded by NSF Grants to Stephen Hubbell DEB-0640386, DEB-0425651, DEB-0346488, DEB-0129874, DEB-00753102, DEB-9909347, DEB-9615226, DEB-9615226, DEB-9405933, DEB-9221033, DEB-9100058, DEB-8906869, DEB-8605042, DEB-8206992, DEB-7922197, and by the Center for Tropical Forest Science, the Smithsonian Tropical Forest Research Institute, The John D. and Catherine T. MacArthur Foundation, the Mellon Foundation and the Celera Foundation. DC is supported by NSF grant DEB-0749097 to L. A. Meyers. SS is supported by an NSF Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2005, ECOLOGY, V86, P3078, DOI 10.1890/04-1806; Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; BARTUMEUS F, 2010, CURR BIOL, P215; Beaumont MA, 2002, GENETICS, V162, P2025; BERMAN M, 1992, J R STAT SOC C-APPL, V41, P31; BONACCORSO FJ, 1980, REV BIOL TROP, V28, P61; BOYER D, P R SOC B IN PRESS; Boyer D, 2006, P ROY SOC B-BIOL SCI, V273, P1743, DOI 10.1098/rspb.2005.3462; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cartar RV, 1997, OECOLOGIA, V112, P430, DOI 10.1007/s004420050329; Ciarniello LM, 2007, ECOL APPL, V17, P1424, DOI 10.1890/06-1100.1; Condit R, 1998, TROPICAL FOREST CENS; Craft ME, 2009, P ROY SOC B-BIOL SCI, V276, P1777, DOI 10.1098/rspb.2008.1636; Crofoot MC, 2008, P NATL ACAD SCI USA, V105, P577, DOI 10.1073/pnas.0707749105; DESTEVEN D, 1984, OIKOS, V43, P207, DOI 10.2307/3544770; Dietrich W.E., 1982, ECOLOGY TROPICAL FOR, P21; Diggle P., 2003, STAT ANAL SPATIAL PO; Forester JD, 2007, ECOL MONOGR, V77, P285, DOI 10.1890/06-0534; FORGET PM, 1993, OECOLOGIA, V94, P255, DOI 10.1007/BF00341325; Foster R. B., 1982, ECOLOGY TROPICAL FOR, P151; Goverde M, 2002, BIOL CONSERV, V104, P293, DOI 10.1016/S0006-3207(01)00194-X; Hadley AS, 2009, BIOL LETTERS, V5, P207, DOI 10.1098/rsbl.2008.0691; Hanson T, 2007, J TROP ECOL, V23, P635, DOI 10.1017/S0266467407004488; Holland RA, 2009, J MAMMAL, V90, P1324, DOI 10.1644/09-MAMM-S-086R2.1; Howe H.F., 1986, P123; Hubbell S.P., 2005, BARRO COLORADO FORES; Hubbell SP, 1999, SCIENCE, V283, P554, DOI 10.1126/science.283.5401.554; Humphries NE, 2010, NATURE, V465, P1066, DOI 10.1038/nature09116; Jansen PA, 2008, ECOGRAPHY, V31, P33, DOI 10.1111/j.2007.0906-7590.05151.x; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; Leigh EG, 1999, TROPICAL FOREST ECOL; LEUENBERGER C, 2010, BAYESIAN COMPUTATION, P243; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; Musiega DE, 2006, ECOL RES, V21, P530, DOI 10.1007/s11284-006-0175-9; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Newton I, 1687, PHILOS NATURALIS PRI; Ovaskainen O, 2004, ECOLOGY, V85, P242, DOI 10.1890/02-0706; Remais J, 2010, J R SOC INTERFACE, V7, P1181, DOI 10.1098/rsif.2009.0523; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Ripley B.D., 1988, STAT INFERENCE SPATI; Russo SE, 2006, ECOLOGY, V87, P3160, DOI 10.1890/0012-9658(2006)87[3160:IABISD]2.0.CO;2; SCHICK RS, 2008, ECOL LETT, P1338; Sims DW, 2008, NATURE, V451, P1098, DOI 10.1038/nature06518; Smythe N., 1970, AM NAT, V104, P25, DOI DOI 10.1086/282638; Stoyan D., 1994, FRACTALS RANDOM SHAP; Toni T, 2009, J R SOC INTERFACE, V6, P187, DOI 10.1098/rsif.2008.0172; Viswanathan GM, 1999, NATURE, V401, P911, DOI 10.1038/44831; Whittington J, 2005, ECOL APPL, V15, P543, DOI 10.1890/03-5317; Wright SJ, 2006, ECOL LETT, V9, P35, DOI 10.1111/j.1461-0248.2005.00851.x; Wright SJ, 1999, ECOLOGY, V80, P1632, DOI 10.2307/176552	50	16	18	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15002	10.1371/journal.pone.0015002	http://dx.doi.org/10.1371/journal.pone.0015002			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124927	Green Published, gold			2022-12-27	WOS:000284467200018
J	Dorum, S; Arntzen, MO; Qiao, SW; Holm, A; Koehler, CJ; Thiede, B; Sollid, LM; Fleckenstein, B				Dorum, Siri; Arntzen, Magnus O.; Qiao, Shuo-Wang; Holm, Anders; Koehler, Christian J.; Thiede, Bernd; Sollid, Ludvig M.; Fleckenstein, Burkhard			The Preferred Substrates for Transglutaminase 2 in a Complex Wheat Gluten Digest Are Peptide Fragments Harboring Celiac Disease T-Cell Epitopes	PLOS ONE			English	Article							TISSUE TRANSGLUTAMINASE; GLIADIN PEPTIDES; BINDING CHARACTERISTICS; ALPHA-GLIADIN; DEAMIDATION; IDENTIFICATION; SPECIFICITY; MOLECULE; SPRUE; RECOGNIZE	Background: Celiac disease is a T-cell mediated chronic inflammatory disorder of the gut that is induced by dietary exposure to gluten proteins. CD4+ T cells of the intestinal lesion recognize gluten peptides in the context of HLA-DQ2.5 or HLA-DQ8 and the gluten derived peptides become better T-cell antigens after deamidation catalyzed by the enzyme transglutaminase 2 (TG2). In this study we aimed to identify the preferred peptide substrates of TG2 in a heterogeneous proteolytic digest of whole wheat gluten. Methods: A method was established to enrich for preferred TG2 substrates in a complex gluten peptide mixture by tagging with 5-biotinamido-pentylamine. Tagged peptides were isolated and then identified by nano-liquid chromatography online-coupled to tandem mass spectrometry, database searching and final manual data validation. Results: We identified 31 different peptides as preferred substrates of TG2. Strikingly, the majority of these peptides were harboring known gluten T-cell epitopes. Five TG2 peptide substrates that were predicted to bind to HLA-DQ2.5 did not contain previously characterized sequences of T-cell epitopes. Two of these peptides elicited T-cell responses when tested for recognition by intestinal T-cell lines of celiac disease patients, and thus they contain novel candidate T-cell epitopes. We also found that the intact 9mer core sequences of the respective epitopes were not present in all peptide substrates. Interestingly, those epitopes that were represented by intact forms were frequently recognized by T cells in celiac disease patients, whereas those that were present in truncated versions were infrequently recognized. Conclusion: TG2 as well as gastrointestinal proteolysis play important roles in the selection of gluten T-cell epitopes in celiac disease.	[Dorum, Siri; Qiao, Shuo-Wang; Sollid, Ludvig M.; Fleckenstein, Burkhard] Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway; [Arntzen, Magnus O.; Koehler, Christian J.; Thiede, Bernd] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway; [Arntzen, Magnus O.; Fleckenstein, Burkhard] Oslo Univ Hosp, Rikshosp, Prote Core Facil, Oslo, Norway; [Arntzen, Magnus O.] Norwegian Univ Life Sci, Prote Core Facil, As, Norway; [Holm, Anders; Sollid, Ludvig M.] Oslo Univ Hosp, Rikshosp, Inst Immunol, Ctr Immune Regulat, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway	Dorum, S (corresponding author), Univ Oslo, Inst Immunol, Ctr Immune Regulat, Oslo, Norway.	siri.dorum@rr-research.no	Sollid, Ludvig/N-9691-2015; Arntzen, Magnus Ø/N-6983-2016; Koehler, Christian/A-5950-2013; Qiao, Shuo-Wang/ABE-8148-2020	Sollid, Ludvig/0000-0001-8860-704X; Arntzen, Magnus Ø/0000-0002-1803-727X; Qiao, Shuo-Wang/0000-0002-0935-8397	Research Council of Norway	Research Council of Norway(Research Council of Norway)	This research was supported by the National Program for Research in Functional Genomics (FUGE and FUGE-Ost) of the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2000, NAT MED, V6, P337, DOI 10.1038/73200; Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Arentz-Hansen H, 2002, GASTROENTEROLOGY, V123, P803, DOI 10.1053/gast.2002.35381; Camarca A, 2009, J IMMUNOL, V182, P4158, DOI 10.4049/jimmunol.0803181; DERITIS G, 1988, GASTROENTEROLOGY, V94, P41, DOI 10.1016/0016-5085(88)90607-5; Dorum S, 2009, J PROTEOME RES, V8, P1748, DOI 10.1021/pr800960n; Fleckenstein B, 2004, J BIOL CHEM, V279, P17607, DOI 10.1074/jbc.M310198200; Fleckenstein B, 2002, J BIOL CHEM, V277, P34109, DOI 10.1074/jbc.M204521200; FOLK JE, 1983, ADV ENZYMOL RAMB, V54, P1; Godkin A, 1997, INT IMMUNOL, V9, P905, DOI 10.1093/intimm/9.6.905; Johansen BH, 1996, INT IMMUNOL, V8, P177, DOI 10.1093/intimm/8.2.177; Kwok WW, 1996, J IMMUNOL, V156, P2171; LUNDIN KEA, 1993, J EXP MED, V178, P187, DOI 10.1084/jem.178.1.187; Marti T, 2005, J PHARMACOL EXP THER, V312, P19, DOI 10.1124/jpet.104.073312; Mazzeo MF, 2003, PROTEIN SCI, V12, P2434, DOI 10.1110/ps.03185903; Molberg O, 2005, GASTROENTEROLOGY, V128, P393, DOI 10.1053/j.gastro.2004.11.003; Molberg O, 1997, SCAND J IMMUNOL, V46, P103, DOI 10.1046/j.1365-3083.1997.d01-93.x; Piper JL, 2002, BIOCHEMISTRY-US, V41, P386, DOI 10.1021/bi011715x; Qiao SW, 2005, J IMMUNOL, V175, P254, DOI 10.4049/jimmunol.175.1.254; Salentijn EMJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-48; Shan L, 2005, J PROTEOME RES, V4, P1732, DOI 10.1021/pr050173t; Shan L, 2002, SCIENCE, V297, P2275, DOI 10.1126/science.1074129; Sjostrom H, 1998, SCAND J IMMUNOL, V48, P111; Sollid LM, 2000, ANNU REV IMMUNOL, V18, P53, DOI 10.1146/annurev.immunol.18.1.53; Sollid LM, 1997, GUT, V41, P851, DOI 10.1136/gut.41.6.851; STAMNAES J, 2008, BIOCH BIOPHYS ACTA; Sulkanen S, 1998, GASTROENTEROLOGY, V115, P1322, DOI 10.1016/S0016-5085(98)70008-3; Tollefsen S, 2006, J CLIN INVEST, V116, P2226, DOI 10.1172/JCI27620; Vader LW, 2002, J EXP MED, V195, P643, DOI 10.1084/jem.20012028; Vader W, 2002, GASTROENTEROLOGY, V122, P1729, DOI 10.1053/gast.2002.33606; van de Wal Y, 1998, P NATL ACAD SCI USA, V95, P10050, DOI 10.1073/pnas.95.17.10050; van de Wal Y, 1999, EUR J IMMUNOL, V29, P3133, DOI 10.1002/(SICI)1521-4141(199910)29:10&lt;3133::AID-IMMU3133&gt;3.0.CO;2-G; vandeWal Y, 1996, IMMUNOGENETICS, V44, P246, DOI 10.1007/s002510050120; Vartdal F, 1996, EUR J IMMUNOL, V26, P2764, DOI 10.1002/eji.1830261132	34	52	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14056	10.1371/journal.pone.0014056	http://dx.doi.org/10.1371/journal.pone.0014056			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124911	Green Submitted, Green Published, gold			2022-12-27	WOS:000284400100008
J	Steffen, R; Menzies, D; Oxlade, O; Pinto, M; de Castro, AZ; Monteiro, P; Trajman, A				Steffen, Ricardo; Menzies, Dick; Oxlade, Olivia; Pinto, Marcia; de Castro, Analia Zuleika; Monteiro, Paula; Trajman, Anete			Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, Brazil	PLOS ONE			English	Article							DIRECTLY OBSERVED THERAPY; COMMUNITY; FAMILY; DIAGNOSIS; ZAMBIA; IMPACT	Background: Costs of tuberculosis diagnosis and treatment may represent a significant burden for the poor and for the health system in resource-poor countries. Objectives: The aim of this study was to analyze patients' costs of tuberculosis care and to estimate the incremental cost-effectiveness ratio (ICER) of the directly observed treatment (DOT) strategy per completed treatment in Rio de Janeiro, Brazil. Methods: We interviewed 218 adult patients with bacteriologically confirmed pulmonary tuberculosis. Information on direct (out-of-pocket expenses) and indirect (hours lost) costs, loss in income and costs with extra help were gathered through a questionnaire. Healthcare system additional costs due to supervision of pill-intake were calculated considering staff salaries. Effectiveness was measured by treatment completion rate. The ICER of DOT compared to self-administered therapy (SAT) was calculated. Principal Findings: DOT increased costs during the treatment phase, while SAT increased costs in the pre-diagnostic phase, for both the patient and the health system. Treatment completion rates were 71% in SAT facilities and 79% in DOT facilities. Costs per completed treatment were US$ 194 for patients and U$ 189 for the health system in SAT facilities, compared to US$ 336 and US$ 726 in DOT facilities. The ICER was US$ 6,616 per completed DOT treatment compared to SAT. Conclusions: Costs incurred by TB patients are high in Rio de Janeiro, especially for those under DOT. The DOT strategy doubles patients' costs and increases by fourfold the health system costs per completed treatment. The additional costs for DOT may be one of the contributing factors to the completion rates below the targeted 85% recommended by WHO.	[Steffen, Ricardo] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Steffen, Ricardo; de Castro, Analia Zuleika; Monteiro, Paula; Trajman, Anete] Rio de Janeiro TB Sci League, Rio De Janeiro, Brazil; [Menzies, Dick; Oxlade, Olivia] McGill Univ, Montreal Chest Inst, Montreal, PQ, Canada; [Pinto, Marcia] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil; [Monteiro, Paula; Trajman, Anete] Univ Gama Filho, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; McGill University; Fundacao Oswaldo Cruz; Universidade Gama Filho	Steffen, R (corresponding author), Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.	atrajman@gmail.com	Trajman, Anete/C-7679-2016	Trajman, Anete/0000-0002-4000-4984	Canadian Institutes of Health Research (CIHR) [PHI-77906]; Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ) [E-26/170.420/2007]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [551497/2007-6]; International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA) [5 U2R TW006883-02]; FOGARTY INTERNATIONAL CENTER [U2RTW006883] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by the Canadian Institutes of Health Research (CIHR, PHI-77906), Fundacao Carlos Chagas de Amparo a Pesquisa do Rio de Janeiro (FAPERJ, grant E-26/170.420/2007) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, grant # 551497/2007-6). RS had a Scientific Initiation scholarship from FAPERJ. AT has financial support from the International Clinical, Operational, and Health Services Research and Training Award (ICOHRTA, Grant # 5 U2R TW006883-02). CIHR, FAPERJ, CNPq and ICOHRTA are not responsible for the statements in this article. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkslip S, 1999, INT J TUBERC LUNG D, V3, P1061; Aspler A, 2008, INT J TUBERC LUNG D, V12, P928; Baltussen R, 2005, BMJ-BRIT MED J, V331, P1364, DOI 10.1136/bmj.38645.660093.68; Burman WJ, 1997, CHEST, V112, P63, DOI 10.1378/chest.112.1.63; Cavalcante SC, 2007, INT J TUBERC LUNG D, V11, P544; Floyd K, 2003, INT J TUBERC LUNG D, V7, pS29; Hill AR, 2002, MEDICINE, V81, P179, DOI 10.1097/00005792-200205000-00002; Jacquet V, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-209; LONNROTH K, 2009, SOC SCI MED; Mohan CI, 2007, INT J TUBERC LUNG D, V11, P27; Muniyandi M, 2006, J Commun Dis, V38, P204; Needham DM, 1998, INT J TUBERC LUNG D, V2, P811; Newell JN, 2006, LANCET, V367, P903, DOI 10.1016/S0140-6736(06)68380-3; Rajeswari R, 1999, INT J TUBERC LUNG D, V3, P869; SOUZA FB, 2007, J BRAS PNEUMOL, V33, P318; *WHO, 2009, TB2009411 WHOHTM	16	55	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e14014	10.1371/journal.pone.0014014	http://dx.doi.org/10.1371/journal.pone.0014014			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	681OY	21103344	Green Submitted, Green Published, gold			2022-12-27	WOS:000284327800006
J	Berg, M; Danielsen, SA; Ahlquist, T; Merok, MA; Agesen, TH; Vatn, MH; Mala, T; Sjo, OH; Bakka, A; Moberg, I; Fetveit, T; Mathisen, O; Husby, A; Sandvik, O; Nesbakken, A; Thiis-Evensen, E; Lothe, RA				Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Vatn, Morten H.; Mala, Tom; Sjo, Ole H.; Bakka, Arne; Moberg, Ingvild; Fetveit, Torunn; Mathisen, Oystein; Husby, Anders; Sandvik, Oddvar; Nesbakken, Arild; Thiis-Evensen, Espen; Lothe, Ragnhild A.			DNA Sequence Profiles of the Colorectal Cancer Critical Gene Set KRAS-BRAF-PIK3CA-PTEN-TP53 Related to Age at Disease Onset	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; PTEN/MMAC1 GENE; MUTATIONS; PTEN; TP53; CETUXIMAB; P53; PANITUMUMAB; CARCINOMAS; IMPACT	The incidence of colorectal cancer (CRC) increases with age and early onset indicates an increased likelihood for genetic predisposition for this disease. The somatic genetics of tumor development in relation to patient age remains mostly unknown. We have examined the mutation status of five known cancer critical genes in relation to age at diagnosis, and compared the genomic complexity of tumors from young patients without known CRC syndromes with those from elderly patients. Among 181 CRC patients, stratified by microsatellite instability status, DNA sequence changes were identified in KRAS (32%), BRAF (16%), PIK3CA (4%), PTEN (14%) and TP53 (51%). In patients younger than 50 years (n = 45), PIK3CA mutations were not observed and TP53 mutations were more frequent than in the older age groups. The total gene mutation index was lowest in tumors from the youngest patients. In contrast, the genome complexity, assessed as copy number aberrations, was highest in tumors from the youngest patients. A comparable number of tumors from young (<50 years) and old patients (>70 years) was quadruple negative for the four predictive gene markers (KRAS-BRAF-PIK3CA-PTEN); however, 16% of young versus only 1% of the old patients had tumor mutations in PTEN/PIK3CA exclusively. This implies that mutation testing for prediction of EGFR treatment response may be restricted to KRAS and BRAF in elderly (>70 years) patients. Distinct genetic differences found in tumors from young and elderly patients, whom are comparable for known clinical and pathological variables, indicate that young patients have a different genetic risk profile for CRC development than older patients.	[Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Lothe, Ragnhild A.] Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo Univ Hosp, Oslo, Norway; [Berg, Marianne; Danielsen, Stine A.; Ahlquist, Terje; Merok, Marianne A.; Agesen, Trude H.; Nesbakken, Arild; Lothe, Ragnhild A.] Univ Oslo, Ctr Canc Biomed, Oslo, Norway; [Merok, Marianne A.; Mala, Tom; Sjo, Ole H.; Nesbakken, Arild] Oslo Univ Hosp, Dept Gastrointestinal Surg, Oslo, Norway; [Vatn, Morten H.; Thiis-Evensen, Espen] Univ Oslo, Rikshosp, Oslo Univ Hosp, Dept Organ Transplantat Gastroenterol & Nephrol, N-0027 Oslo, Norway; [Bakka, Arne; Moberg, Ingvild] Akershus Univ Hosp, Dept Digest Surg, Lorenskog, Norway; [Bakka, Arne; Nesbakken, Arild; Lothe, Ragnhild A.] Univ Oslo, Fac Med, Oslo, Norway; [Fetveit, Torunn] Sorlandet Hosp, Dept Surg, Arendal, Norway; [Mathisen, Oystein] Univ Oslo, Rikshosp, Dept Liver Gastrointestinal & Pediat Surg, N-0027 Oslo, Norway; [Husby, Anders] Diakonhjemmet Hosp, Dept Surg, Oslo, Norway; [Sandvik, Oddvar] Sorlandet Hosp, Dept Gastrointestinal Surg, Kristiansand, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; National Hospital Norway; Diakonhjemmet Hospital	Berg, M (corresponding author), Norwegian Radium Hosp, Inst Canc Res, Dept Canc Prevent, Oslo Univ Hosp, Oslo, Norway.	ragnhild.a.lothe@rr-research.no	Mala, Tom/J-5418-2019	Mala, Tom/0000-0003-3058-4775; Lothe, Ragnhild A./0000-0002-1693-1032	Norwegian Cancer Society [95068/RAL]; Norwegian Foundation for Health and Rehabilitation [HF-52015/002]	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Foundation for Health and Rehabilitation	This study was funded by grants from the Norwegian Cancer Society (http://www.kreftforeningen.no/english) to R. A. L. (grant number 95068/RAL, including PhD grants to S. A. D., M. B. and T. H. A., and Post doc grant to T. A.), and grants from the Norwegian Foundation for Health and Rehabilitation (http://www.helseogrehab.no/) through the EXTRA funds (grant number HF-52015/002) to E. T. E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Boland CR, 2010, GASTROENTEROLOGY, V138, P2073, DOI [10.1053/j.gastro.2009.12.064, 10.1053/j.gastro.2010.04.024]; Boland CR, 1998, CANCER RES, V58, P5248; BOS JL, 1989, CANCER RES, V49, P4682; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cancer Registry of Norway, 2009, CANC NORW 2008 CANC; Chan TL, 2003, CANCER RES, V63, P4878; Chang JG, 1999, EUR J CANCER, V35, P647, DOI 10.1016/S0959-8049(98)00411-0; Danielsen SA, 2008, HUM MUTAT, V29, pE252, DOI 10.1002/humu.20860; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DEJONG UW, 1972, INT J CANCER, V10, P463, DOI 10.1002/ijc.2910100305; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Dicuonzo G, 2001, CLIN CANCER RES, V7, P4049; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; Engstrom PF, 2008, PHARMACOTHERAPY, V28, p18S, DOI 10.1592/phco.28.11-supp.18S; Ericson K, 2010, P NATL ACAD SCI USA, V107, P2598, DOI 10.1073/pnas.0914018107; Forbes S A, 2008, Curr Protoc Hum Genet, VChapter 10, DOI 10.1002/0471142905.hg1011s57; Frizis H, 2004, Tech Coloproctol, V8 Suppl 1, ps147, DOI 10.1007/s10151-004-0139-4; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gonzalez EC, 2001, DIS COLON RECTUM, V44, P251, DOI 10.1007/BF02234301; Gryfe R, 2000, NEW ENGL J MED, V342, P69, DOI 10.1056/NEJM200001133420201; Haglund Kaisa, 2007, Critical Reviews in Oncogenesis, V13, P39; HERREROSVILLANU.M, 2010, MOL BIOL REP; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Karoui M, 2004, BRIT J CANCER, V90, P1230, DOI 10.1038/sj.bjc.6601687; Khan SA, 2008, J SURG ONCOL, V97, P621, DOI 10.1002/jso.20996; LAND H, 1983, SCIENCE, V222, P771, DOI 10.1126/science.6356358; Liang JT, 2003, BRIT J SURG, V90, P205, DOI 10.1002/bjs.4015; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; LOTHE RA, 1993, CANCER RES, V53, P5849; Lothe RA, 1997, MOL MED TODAY, V3, P61, DOI 10.1016/S1357-4310(96)10055-1; Lynch HT, 2003, NEW ENGL J MED, V348, P919, DOI 10.1056/NEJMra012242; McGivern A, 2004, Fam Cancer, V3, P101; Nassif NT, 2004, ONCOGENE, V23, P617, DOI 10.1038/sj.onc.1207059; O'Connell JB, 2004, AM J SURG, V187, P343, DOI 10.1016/j.amjsurg.2003.12.020; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Oikonomou E, 2009, NEOPLASIA, V11, P1116, DOI 10.1593/neo.09514; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Russo A, 2005, J CLIN ONCOL, V23, P7518, DOI 10.1200/JCO.2005.00.471; Samowitz WS, 2009, CANCER CAUSE CONTROL, V20, P1763, DOI 10.1007/s10552-009-9410-3; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Shin KH, 2001, CANCER LETT, V174, P189, DOI 10.1016/S0304-3835(01)00691-7; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; TOL J, 2010, EUR J CANC; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang ZJ, 1998, AM J PATHOL, V153, P363, DOI 10.1016/S0002-9440(10)65579-4; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zbuk K, 2009, SEMIN ONCOL, V36, P439, DOI 10.1053/j.seminoncol.2009.07.008; Zhou XP, 2002, AM J PATHOL, V161, P439, DOI 10.1016/S0002-9440(10)64200-9	61	91	95	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13978	10.1371/journal.pone.0013978	http://dx.doi.org/10.1371/journal.pone.0013978			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103049	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700023
J	de Kroon, MLA; Renders, CM; van Wouwe, JP; van Buuren, S; Hirasing, RA				de Kroon, Marlou L. A.; Renders, Carry M.; van Wouwe, Jacobus P.; van Buuren, Stef; Hirasing, Remy A.			The Terneuzen Birth Cohort: BMI Change between 2 and 6 Years Is Most Predictive of Adult Cardiometabolic Risk	PLOS ONE			English	Article							BODY-MASS INDEX; IMPAIRED GLUCOSE-TOLERANCE; C-REACTIVE PROTEIN; METABOLIC SYNDROME; ADIPOSE-TISSUE; CHILDHOOD GROWTH; YOUNG ADULTHOOD; WEIGHT-GAIN; ADOLESCENCE; OBESITY	Background: We recently reported the age interval 2-6y being the earliest and most critical for adult overweight. We now aim to determine which age intervals are predictive of cardiometabolic risk at young adulthood. Methods and Findings: We analyzed data from 642 18-28 years olds from the Terneuzen Birth Cohort. Individual BMI SDS trajectories were fitted by a piecewise linear model. By multiple regression analyses relationships were assessed between subsequent conditional BMI SDS changes and components of the metabolic syndrome (MetS), skinfold thickness and hsCRP at young adulthood. Results were adjusted for gender and age, and other confounders. Gender was studied as an effect modifier. All BMI SDS changes throughout childhood were related to waist circumference and skinfold thickness. No other significant relationship was found before the age of 2 years, except between the BMI SDS change 0-1y and hsCRP. Fasting blood glucose was not predicted by any BMI SDS change. BMI SDS change 2-6y was strongly related to most outcome variables, especially to waist circumference (beta 0.47, SE 0.02), systolic and diastolic blood pressure (beta 0.20 SE 0.04 and beta 0.19 SE 0.03), and hsCRP (beta 0.16 SE 0.04). The BMI SDS change 10-18y was most strongly related to HDL cholesterol (beta -0.10, SE 0.03), and triglycerides (beta 0.21, SE 0.03). To a lesser degree, the BMI SDS change 6-10y was related to most outcome variables. BMI SDS changes 2-6y and 10-18y were significantly related to MetS: the OR was respectively 3.39 (95% CI 2.33-4.94) and 2.84 (95% CI 1.94-4.15). Conclusion: BMI SDS changes from 2y onwards were related to cardiometabolic risk at young adulthood, the age interval 2-6y being the most predictive. Monitoring and stabilizing the BMI SDS of children as young as 2-6y may not only reverse the progression towards adult overweight, but it may also safeguard cardiometabolic status.	[de Kroon, Marlou L. A.; Hirasing, Remy A.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Renders, Carry M.] Vrije Univ Amsterdam, Dept Hlth Sci, Amsterdam, Netherlands; [van Wouwe, Jacobus P.] TNO Qual Life Prevent & Hlth Care, Netherlands Org Appl Sci Res, Leiden, Netherlands; [van Buuren, Stef] Univ Utrecht, Dept Methodol & Stat, FSS, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Netherlands Organization Applied Science Research; Utrecht University	de Kroon, MLA (corresponding author), Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	top@fms.demon.nl	Van Wouwe, Jacobus P/D-5549-2018; de Kroon, Marlou MLA/M-4040-2014	Van Wouwe, Jacobus P/0000-0001-9273-6258; van Buuren, Stef/0000-0003-1098-2119; Renders, Carry/0000-0001-6688-1312; de Kroon, Marlou/0000-0003-1730-4994	Health Research and Development Council of The Netherlands (ZONMw) [2100.0092]; Community Hospital laboratory in the city of Terneuzen; Municipal Health Service of Terneuzen (GGD Zeeland)	Health Research and Development Council of The Netherlands (ZONMw)(Netherlands Organization for Health Research and Development); Community Hospital laboratory in the city of Terneuzen; Municipal Health Service of Terneuzen (GGD Zeeland)	The study was funded by the Health Research and Development Council of The Netherlands (ZONMw Grants no. 2100.0092). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank all the participants for their time and efforts, the assistants for their contribution to the research work, the Community Hospital laboratory in the city of Terneuzen and especially Ruud Muusze PhD, Municipal Health Service of Terneuzen (GGD Zeeland) for their support and cooperation, especially Dr Victor Slenter, director, and Guus A. de Jonge, PhD, Professor Emeritus, for laying the foundations of this study between 1977-1986. We would like to thank Professor Dr Willem van Mechelen and Dr Mai JM Chin A Paw for their useful comments on an earlier version of this manuscript.	Addo OY, 2010, AM J CLIN NUTR, V91, P635, DOI 10.3945/ajcn.2009.28385; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Baadenhuijsen H, 2005, CLIN CHEM LAB MED, V43, P304, DOI 10.1515/CCLM.2005.052; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; Bhargava SK, 2004, NEW ENGL J MED, V350, P865, DOI 10.1056/NEJMoa035698; Boulat O, 1998, CLIN CHIM ACTA, V272, P127, DOI 10.1016/S0009-8981(98)00017-5; Cole T J, 2004, BMC Pediatr, V4, P6; De Kroon MLA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009155; DEKROON ML, 2008, EUR J PUBLIC HEALTH, V6, P656; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fall CHD, 2008, DIABETES CARE, V31, P2349, DOI 10.2337/dc08-0911; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Gonzalez DA, 2010, INT J OBESITY, V34, P195, DOI 10.1038/ijo.2009.201; HAGER A, 1977, METABOLISM, V26, P607, DOI 10.1016/0026-0495(77)90082-8; Keijzer-Veen MG, 2005, J CLIN EPIDEMIOL, V58, P1320, DOI 10.1016/j.jclinepi.2005.04.004; Khera A, 2005, J AM COLL CARDIOL, V46, P464, DOI 10.1016/j.jacc.2005.04.051; Kindblom JM, 2009, DIABETES, V58, P867, DOI 10.2337/db08-0606; Kvaavik E, 2003, ARCH PEDIAT ADOL MED, V157, P1212, DOI 10.1001/archpedi.157.12.1212; Law CM, 2002, CIRCULATION, V105, P1088, DOI 10.1161/hc0902.104677; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Monteiro POA, 2003, INT J OBESITY, V27, P1274, DOI 10.1038/sj.ijo.0802409; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Oren A, 2003, INT J OBESITY, V27, P1383, DOI 10.1038/sj.ijo.0802404; PARKER LN, 1991, ENDOCRIN METAB CLIN, V20, P71, DOI 10.1016/S0889-8529(18)30282-2; Porter SA, 2009, DIABETES CARE, V32, P1068, DOI 10.2337/dc08-2280; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Scholtens S, 2007, AM J EPIDEMIOL, V165, P919, DOI 10.1093/aje/kwk083; Singhal A, 2007, CIRCULATION, V115, P213, DOI 10.1161/CIRCULATIONAHA.106.617811; Snijders T, 1999, MULTILEVEL ANAL; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Srinivasan SR, 2002, DIABETES, V51, P204, DOI 10.2337/diabetes.51.1.204; St-Onge MP, 2004, DIABETES CARE, V27, P2222, DOI 10.2337/diacare.27.9.2222; Thomas L., 1998, LABOR DIAGNOSE; WIINBERG N, 1995, AM J HYPERTENS, V8, P978, DOI 10.1016/0895-7061(95)00216-2	35	29	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13966	10.1371/journal.pone.0013966	http://dx.doi.org/10.1371/journal.pone.0013966			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103047	Green Published, gold			2022-12-27	WOS:000284147700015
J	Kuper, H; Polack, S; Mathenge, W; Eusebio, C; Wadud, Z; Rashid, M; Foster, A				Kuper, Hannah; Polack, Sarah; Mathenge, Wanjiku; Eusebio, Cristina; Wadud, Zakia; Rashid, Mamunur; Foster, Allen			Does Cataract Surgery Alleviate Poverty? Evidence from a Multi-Centre Intervention Study Conducted in Kenya, the Philippines and Bangladesh	PLOS ONE			English	Article							QUALITY-OF-LIFE; VISUAL IMPAIRMENT; AVOIDABLE BLINDNESS; RAPID ASSESSMENT; SATKHIRA DISTRICT; DISABILITY; HEALTH; IMPACT	Poverty and blindness are believed to be intimately linked, but empirical data supporting this purported relationship are sparse. The objective of this study is to assess whether there is a reduction in poverty after cataract surgery among visually impaired cases. Methodology/Principal Findings: A multi-centre intervention study was conducted in three countries (Kenya, Philippines, Bangladesh). Poverty data (household per capita expenditure -PCE, asset ownership and self-rated wealth) were collected from cases aged >= 50 years who were visually impaired due to cataract (visual acuity, 6/24 in the better eye) and age-sex matched controls with normal vision. Cases were offered free/subsidised cataract surgery. Approximately one year later participants were re-interviewed about poverty. 466 cases and 436 controls were examined at both baseline and follow-up (Follow up rate: 78% for cases, 81% for controls), of which 263 cases had undergone cataract surgery ("operated cases''). At baseline, operated cases were poorer compared to controls in terms of PCE (Kenya: $22 versus 35 pound p = 0.02, Bangladesh: $16 vs $24 p = 0.004, Philippines: $24 vs 32 p = 0.0007), assets and self-rated wealth. By follow-up PCE had increased significantly among operated cases in each of the three settings to the level of controls (Kenya: $30 versus 36 pound p = 0.49, Bangladesh: $23 vs $23 p = 0.20, Philippines: $45 vs $36 p = 0.68). There were smaller increases in self-rated wealth and no changes in assets. Changes in PCE were apparent in different socio-demographic and ocular groups. The largest PCE increases were apparent among the cases that were poorest at baseline. Conclusions/Significance: This study showed that cataract surgery can contribute to poverty alleviation, particularly among the most vulnerable members of society. This study highlights the need for increased provision of cataract surgery to poor people and shows that a focus on blindness may help to alleviate poverty and achieve the Millennium Development Goals.	[Kuper, Hannah] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England; [Polack, Sarah; Mathenge, Wanjiku; Foster, Allen] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Eusebio, Cristina] Cataract Fdn Philippines, Bacolod, Negros Occident, Philippines; [Wadud, Zakia] Child Sight Fdn, Dhaka, Bangladesh; [Rashid, Mamunur] CSS Rawm Hosp, Khulna, Bangladesh	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Kuper, H (corresponding author), London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1, England.	hannah.kuper@lshtm.ac.uk	MATHENGE, WANJIKU/W-3993-2019	Rashid, Mamunur/0000-0003-3862-6554; Foster, Allen/0000-0003-2368-4436	CBM (Christian Blind Mission); SightSavers International; Orbis international	CBM (Christian Blind Mission); SightSavers International; Orbis international	This study was funded by grants from three international eye care charities: CBM (Christian Blind Mission - http://www.cbmi.org/), SightSavers International (http://www.sightsavers.org/default.html) and Orbis international (http://www.orbis.org/). Representatives from these organisations were part of the steering committee for the study, which gave guidance towards conduct of the study. Professor Allen Foster is president of CBM, but other organisations were not involved in preparing the manuscript, the data collection, data analysis or the decision to publish.	Baltussen R, 2004, B WORLD HEALTH ORGAN, V82, P338; Braithwaite J, 2009, ALTER, V3, P219, DOI 10.1016/j.alter.2008.10.002; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Engel E., 1857, Z STAT BUREAUS KONIG, V8-9, P28; Eusebio C, 2007, BRIT J OPHTHALMOL, V91, P1588, DOI 10.1136/bjo.2007.119123; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Gannon B, 2007, SOC SCI MED, V64, P1425, DOI 10.1016/j.socscimed.2006.11.021; Gilbert CE, 2008, BMJ-BRIT MED J, V336, P29, DOI 10.1136/bmj.39395.500046.AE; Grosh M, DESIGNING HOUSEHOLD; JAVITT JC, 1993, DIS CONTROL PRIORITI; Jenkins SP, 2004, J SOC POLICY, V33, P479, DOI 10.1017/S0047279404007780; Kuper H, 2008, PLOS MED, V5, P1716, DOI 10.1371/journal.pmed.0050244; LEWALLEN S, 2000, J COMMUNITY EYE HLTH, V13, P20; Mathenge W, 2007, OPHTHALMOLOGY, V114, P599, DOI 10.1016/j.ophtha.2006.06.057; Polack S, 2008, BRIT J OPHTHALMOL, V92, P1026, DOI 10.1136/bjo.2007.134791; POLACK S, OPHTHALMIC IN PRESS; Polack S, 2007, BRIT J OPHTHALMOL, V91, P927, DOI 10.1136/bjo.2006.110973; Polack S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010913; Polack S, 2008, OPHTHAL EPIDEMIOL, V15, P372, DOI 10.1080/09286580802478716; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Turner AG, 1996, INT J EPIDEMIOL, V25, P198, DOI 10.1093/ije/25.1.198; Wadud Z, 2006, BRIT J OPHTHALMOL, V90, P1225, DOI 10.1136/bjo.2006.101287; Zimmer Z, 2008, SOC SCI MED, V66, P57, DOI 10.1016/j.socscimed.2007.08.032	24	49	49	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15431	10.1371/journal.pone.0015431	http://dx.doi.org/10.1371/journal.pone.0015431			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZE	21085697	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000284035900030
J	Wohlkonig, A; Huet, J; Looze, Y; Wintjens, R				Wohlkonig, Alexandre; Huet, Joelle; Looze, Yvan; Wintjens, Rene			Structural Relationships in the Lysozyme Superfamily: Significant Evidence for Glycoside Hydrolase Signature Motifs	PLOS ONE			English	Article							SITE-DIRECTED MUTAGENESIS; N-ACETYLMURAMIC ACID; PROTEIN FUNCTION; SUBSTRATE-BINDING; CONFORMATIONAL STABILITY; HEVEA-BRASILIENSIS; FUNCTIONAL SITES; CHITINASE; SEQUENCE; IDENTIFICATION	Background: Chitin is a polysaccharide that forms the hard, outer shell of arthropods and the cell walls of fungi and some algae. Peptidoglycan is a polymer of sugars and amino acids constituting the cell walls of most bacteria. Enzymes that are able to hydrolyze these cell membrane polymers generally play important roles for protecting plants and animals against infection with insects and pathogens. A particular group of such glycoside hydrolase enzymes share some common features in their three-dimensional structure and in their molecular mechanism, forming the lysozyme superfamily. Results: Besides having a similar fold, all known catalytic domains of glycoside hydrolase proteins of lysozyme superfamily (families and subfamilies GH19, GH22, GH23, GH24 and GH46) share in common two structural elements: the central helix of the all-alpha domain, which invariably contains the catalytic glutamate residue acting as general-acid catalyst, and a beta-hairpin pointed towards the substrate binding cleft. The invariant beta-hairpin structure is interestingly found to display the highest amino acid conservation in aligned sequences of a given family, thereby allowing to define signature motifs for each GH family. Most of such signature motifs are found to have promising performances for searching sequence databases. Our structural analysis further indicates that the GH motifs participate in enzymatic catalysis essentially by containing the catalytic water positioning residue of inverting mechanism. Conclusions: The seven families and subfamilies of the lysozyme superfamily all have in common a beta-hairpin structure which displays a family-specific sequence motif. These GH beta-hairpin motifs contain potentially important residues for the catalytic activity, thereby suggesting the participation of the GH motif to catalysis and also revealing a common catalytic scheme utilized by enzymes of the lysozyme superfamily.	[Wohlkonig, Alexandre] VIB, Brussels, Belgium; [Huet, Joelle; Looze, Yvan; Wintjens, Rene] Univ Libre Bruxelles, Inst Pharm, Lab Chim Gen, Brussels, Belgium; [Wintjens, Rene] USR 3078 CNRS, Interdisciplinary Res Inst, Villeneuve Dascq, France	Flanders Institute for Biotechnology (VIB); Universite Libre de Bruxelles; Universite de Lille - ISITE; Universite de Lille	Wohlkonig, A (corresponding author), VIB, Brussels, Belgium.	Rene.Wintjens@ulb.ac.be		Wohlkonig, Alexandre/0000-0003-3103-5022	Belgian Fund for Scientific Research (FNRS-FRS)	Belgian Fund for Scientific Research (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Belgian Fund for Scientific Research (FNRS-FRS) (FRFC project). RW is Research Associate at the FNRS-FRC.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen MD, 1997, BIOCHEM J, V322, P815, DOI 10.1042/bj3220815; ATTWOOD TK, 1994, NUCLEIC ACIDS RES, V22, P3590; Ausiello G, 2005, NUCLEIC ACIDS RES, V33, pW133, DOI 10.1093/nar/gki499; Ausiello G, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S2; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Berman Helen M, 2004, Am J Pharmacogenomics, V4, P247, DOI 10.2165/00129785-200404040-00004; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; Bokma E, 1997, FEBS LETT, V411, P161, DOI 10.1016/S0014-5793(97)00682-0; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; Bourne PE, 2004, NUCLEIC ACIDS RES, V32, pD223, DOI 10.1093/nar/gkh096; BOUTONNET NS, 1995, PROTEIN ENG, V8, P647, DOI 10.1093/protein/8.7.647; CANFIELD RE, 1963, J BIOL CHEM, V238, P2698; CHIPMAN DM, 1967, J BIOL CHEM, V242, P4388; COLLINGE DB, 1993, PLANT J, V3, P31, DOI 10.1046/j.1365-313X.1993.t01-1-00999.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Di Gennaro JA, 2001, J STRUCT BIOL, V134, P232, DOI 10.1006/jsbi.2001.4391; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Espadaler J, 2006, BIOINFORMATICS, V22, P2237, DOI 10.1093/bioinformatics/btl382; FELSENSTEIN J, 1995, PHYLIP PHYLOGENY INF; FUKAMIZO T, 1995, BIOCHEM J, V311, P377, DOI 10.1042/bj3110377; Fukamizo T, 2000, CURR PROTEIN PEPT SC, V1, P105, DOI 10.2174/1389203003381450; Funahashi J, 1999, PROTEIN ENG, V12, P841, DOI 10.1093/protein/12.10.841; Garcia-Casado G, 1998, GLYCOBIOLOGY, V8, P1021, DOI 10.1093/glycob/8.10.1021; Golovin A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-312; Hahn M, 2000, ACTA CRYSTALLOGR D, V56, P1096, DOI 10.1107/S090744490000857X; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hashimoto Y, 1996, J BIOCHEM-TOKYO, V119, P145; Helland R, 2009, CELL MOL LIFE SCI, V66, P2585, DOI 10.1007/s00018-009-0063-x; Henikoff JG, 2000, NUCLEIC ACIDS RES, V28, P228, DOI 10.1093/nar/28.1.228; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOLM L, 1994, FEBS LETT, V340, P129, DOI 10.1016/0014-5793(94)80187-8; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Huet J, 2008, BIOCHEMISTRY-US, V47, P8283, DOI 10.1021/bi800655u; Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Iseli B, 1996, FEBS LETT, V382, P186, DOI 10.1016/0014-5793(96)00174-3; JEKEL PA, 1991, EUR J BIOCHEM, V200, P123, DOI 10.1111/j.1432-1033.1991.tb21057.x; JOLLES P, 1984, MOL CELL BIOCHEM, V63, P165; Jones S, 2004, CURR OPIN CHEM BIOL, V8, P3, DOI 10.1016/j.cbpa.2003.11.001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kinoshita K, 2003, CURR OPIN STRUC BIOL, V13, P396, DOI 10.1016/S0959-440X(03)00074-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kuroki R, 1999, P NATL ACAD SCI USA, V96, P8949, DOI 10.1073/pnas.96.16.8949; Lacombe-Harvey ME, 2009, FEBS J, V276, P857, DOI 10.1111/j.1742-4658.2008.06830.x; LANYON SM, 1985, SYST ZOOL, V34, P397, DOI 10.2307/2413204; Laskowski RA, 2005, J MOL BIOL, V351, P614, DOI 10.1016/j.jmb.2005.05.067; Leung AKW, 2001, BIOCHEMISTRY-US, V40, P5665, DOI 10.1021/bi0028035; Loon L. C. van, 1994, Plant Molecular Biology Reporter, V12, P245, DOI 10.1007/BF02668748; Lupyan D, 2005, BIOINFORMATICS, V21, P3255, DOI 10.1093/bioinformatics/bti527; Maenaka K, 1998, BIOCHEM J, V333, P71, DOI 10.1042/bj3330071; MAENAKA K, 1994, J BIOL CHEM, V269, P7070; MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396; Monzingo AF, 1996, NAT STRUCT BIOL, V3, P133, DOI 10.1038/nsb0296-133; MURAKI M, 1992, BIOCHEMISTRY-US, V31, P9212, DOI 10.1021/bi00153a014; Pal D, 2005, STRUCTURE, V13, P121, DOI 10.1016/j.str.2004.10.015; Pazos F, 2004, P NATL ACAD SCI USA, V101, P14754, DOI 10.1073/pnas.0404569101; Pei JM, 2001, BIOINFORMATICS, V17, P700, DOI 10.1093/bioinformatics/17.8.700; RAMBAUT A, 2006, FIGTREE VERSION 1 0; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Stark A, 2003, NUCLEIC ACIDS RES, V31, P3341, DOI 10.1093/nar/gkg506; Takano K, 2001, PROTEINS, V44, P233, DOI 10.1002/prot.1088; Tang CM, 2004, PLANT MOL BIOL, V56, P285, DOI 10.1007/s11103-004-3382-1; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANSCHELTINGA ACT, 1994, STRUCTURE, V2, P1181, DOI 10.1016/S0969-2126(94)00120-0; VERBURG JG, 1993, ARCH BIOCHEM BIOPHYS, V300, P223, DOI 10.1006/abbi.1993.1031; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; Wallace AC, 1997, PROTEIN SCI, V6, P2308; WANG QP, 1994, J AM CHEM SOC, V116, P11594, DOI 10.1021/ja00104a060; Watson JD, 2005, CURR OPIN STRUC BIOL, V15, P275, DOI 10.1016/j.sbi.2005.04.003; WEAVER LH, 1995, J MOL BIOL, V245, P54, DOI 10.1016/S0022-2836(95)80038-7; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901	75	64	69	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15388	10.1371/journal.pone.0015388	http://dx.doi.org/10.1371/journal.pone.0015388			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085702	Green Published, Green Submitted, gold			2022-12-27	WOS:000284035900026
J	Hong, CJ; Tsai, PJ; Cheng, CY; Chou, CK; Jheng, HF; Chuang, YC; Yang, CN; Lin, YT; Hsu, CW; Cheng, IH; Chen, SY; Tsai, SJ; Liou, YJ; Tsai, YS				Hong, Chen-Jee; Tsai, Pei-Jane; Cheng, Chih-Ya; Chou, Chuan-Kai; Jheng, Huei-Fen; Chuang, You-Chung; Yang, Chia-Ning; Lin, Ya-Tzu; Hsu, Chih-Wei; Cheng, Irene H.; Chen, Shiow-Yi; Tsai, Shih-Jen; Liou, Ying-Jay; Tsai, Yau-Sheng			ENU Mutagenesis Identifies Mice with Morbid Obesity and Severe Hyperinsulinemia Caused by a Novel Mutation in Leptin	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; RECEPTOR ACTIVATION; RECOMBINANT HUMAN; BINDING DOMAIN; GENE; COMPLICATIONS; PURIFICATION; INVOLVEMENT; DEFICIENCY; ANTAGONIST	Background: Obesity is a multifactorial disease that arises from complex interactions between genetic predisposition and environmental factors. Leptin is central to the regulation of energy metabolism and control of body weight in mammals. Methodology/Principal Findings: To better recapitulate the complexity of human obesity syndrome, we applied N-ethyl-N-nitrosourea (ENU) mutagenesis in combination with a set of metabolic assays in screening mice for obesity. Mapping revealed linkage to the chromosome 6 within a region containing mouse Leptin gene. Sequencing on the candidate genes identified a novel T-to-A mutation in the third exon of Leptin gene, which translates to a V145E amino acid exchange in the leptin propeptide. Homozygous Leptin(145E/145E) mutant mice exhibited morbid obesity, accompanied by adipose hypertrophy, energy imbalance, and liver steatosis. This was further associated with severe insulin resistance, hyperinsulinemia, dyslipidemia, and hyperleptinemia, characteristics of human obesity syndrome. Hypothalamic leptin actions in inhibition of orexigenic peptides NPY and AgRP and induction of SOCS1 and SOCS3 were attenuated in Leptin(145E/145E) mice. Administration of exogenous wild-type leptin attenuated hyperphagia and body weight increase in Leptin(145E/145E) mice. However, mutant V145E leptin coimmunoprecipitated with leptin receptor, suggesting that the V145E mutation does not affect the binding of leptin to its receptor. Molecular modeling predicted that the mutated residue would form hydrogen bond with the adjacent residues, potentially affecting the structure and formation of an active complex with leptin receptor within that region. Conclusions/Significance: Thus, our evolutionary, structural, and in vivo metabolic information suggests the residue 145 as of special function significance. The mouse model harboring leptin V145E mutation will provide new information on the current understanding of leptin biology and novel mouse model for the study of human obesity syndrome.	[Hong, Chen-Jee; Lin, Ya-Tzu; Hsu, Chih-Wei; Cheng, Irene H.] Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Div Psychiat, Taipei 112, Taiwan; [Hong, Chen-Jee; Tsai, Shih-Jen; Liou, Ying-Jay] Taipei Vet Gen Hosp, Dept Psychiat, Taipei, Taiwan; [Tsai, Pei-Jane] Natl Cheng Kung Univ, Coll Med, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan; [Cheng, Chih-Ya; Liou, Ying-Jay] Natl Yang Ming Univ, Sch Med, Inst Clin Med, Taipei 112, Taiwan; [Chou, Chuan-Kai] Natl Appl Res Labs, Natl Lab Anim Ctr, Taipei, Taiwan; [Jheng, Huei-Fen; Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan; [Chuang, You-Chung; Yang, Chia-Ning] Natl Kaohsiung Univ Appl Sci, Inst Biotechnol, Kaohsiung 807, Taiwan; [Chen, Shiow-Yi] Natl Taiwan Ocean Univ, Inst Biosci & Biotechnol, Chilung, Taiwan; [Tsai, Yau-Sheng] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; National Cheng Kung University; National Yang Ming Chiao Tung University; National Applied Research Laboratories - Taiwan; National Cheng Kung University; National Kaohsiung University of Science & Technology; National Taiwan Ocean University; National Cheng Kung University	Hong, CJ (corresponding author), Natl Yang Ming Univ, Sch Med, Inst Brain Sci, Taipei 112, Taiwan.	yaustsai@mail.ncku.edu.tw	Tsai, Pei-Jane/G-3563-2011; Tsai, Shih-Jen/AAK-7944-2020	Tsai, Shih-Jen/0000-0002-9987-022X	National Health Research Institute [EX98-9823SC]; National Science Council [97-2314-B-075-002-MY3, 98-2320-B-006-009-MY3]	National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by grants from National Health Research Institute to YST (EX98-9823SC) and National Science Council to CJH (97-2314-B-075-002-MY3) and YST (98-2320-B-006-009-MY3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boulanger MJ, 2003, SCIENCE, V300, P2101, DOI 10.1126/science.1083901; Bravo J, 2000, EMBO J, V19, P2399, DOI 10.1093/emboj/19.11.2399; Brunner L, 1999, INT J OBESITY, V23, P463, DOI 10.1038/sj.ijo.0800842; Chow DC, 2001, SCIENCE, V291, P2150, DOI 10.1126/science.1058308; DIGIROLAMO M, 1971, AM J PHYSIOL, V221, P850, DOI 10.1152/ajplegacy.1971.221.3.850; Dummler B, 2006, MOL CELL BIOL, V26, P8042, DOI 10.1128/MCB.00722-06; Echwald SM, 1997, INT J OBESITY, V21, P321, DOI 10.1038/sj.ijo.0800408; Farooqi IS, 2001, NATURE, V414, P34, DOI 10.1038/35102112; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fong TM, 1998, MOL PHARMACOL, V53, P234, DOI 10.1124/mol.53.2.234; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Haluzik M, 2004, PHYSIOL RES, V53, P123; Hinney A, 1998, MOL PSYCHIATR, V3, P539, DOI 10.1038/sj.mp.4000394; Holm L, 1996, SCIENCE, V273, P595, DOI 10.1126/science.273.5275.595; Jurinke Christian, 2002, Adv Biochem Eng Biotechnol, V77, P57; Knobelspies H, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-2; Leiter EH, 2007, OBESITY, V15, P1961, DOI 10.1038/oby.2007.234; Mazen I, 2009, MOL GENET METAB, V97, P305, DOI 10.1016/j.ymgme.2009.04.002; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Moon BC, 1997, GENOMICS, V42, P152, DOI 10.1006/geno.1997.4701; Niv-Spector L, 2005, BIOCHEM J, V391, P221, DOI 10.1042/BJ20050457; Niv-Spector L, 2010, MOL GENET METAB, V100, P193, DOI 10.1016/j.ymgme.2010.02.015; Onions KL, 1998, HYPERTENSION, V31, P1230, DOI 10.1161/01.HYP.31.6.1230; Peelman F, 2004, J BIOL CHEM, V279, P41038, DOI 10.1074/jbc.M404962200; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Sandowski Y, 2002, J BIOL CHEM, V277, P46304, DOI 10.1074/jbc.M207556200; Strobel A, 1998, NAT GENET, V18, P213, DOI 10.1038/ng0398-213; Strosberg AD, 1999, TRENDS PHARMACOL SCI, V20, P227, DOI 10.1016/S0165-6147(99)01313-9; Tsai YS, 2009, MOL ENDOCRINOL, V23, P1787, DOI 10.1210/me.2009-0073; Verploegen SABW, 1997, FEBS LETT, V405, P237, DOI 10.1016/S0014-5793(97)00192-0; Wang Y, 2009, J ENDOCRINOL, V202, P17, DOI 10.1677/JOE-09-0079; Weber JS, 2000, GENESIS, V26, P230, DOI 10.1002/(SICI)1526-968X(200004)26:4<230::AID-GENE20>3.0.CO;2-S; Zabeau L, 2004, MOL ENDOCRINOL, V18, P150, DOI 10.1210/me.2003-0078; Zabeau L, 2003, FEBS LETT, V546, P45, DOI 10.1016/S0014-5793(03)00440-X; Zhang FM, 2005, VITAM HORM, V71, P345, DOI 10.1016/S0083-6729(05)71012-8; Zhang FM, 1997, NATURE, V387, P206, DOI 10.1038/387206a0; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	37	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15333	10.1371/journal.pone.0015333	http://dx.doi.org/10.1371/journal.pone.0015333			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151569	Green Published, gold, Green Submitted			2022-12-27	WOS:000285135800025
J	Aberg, KC; Herzog, MH				Aberg, Kristoffer C.; Herzog, Michael H.			Does Perceptual Learning Suffer from Retrograde Interference?	PLOS ONE			English	Article							SLEEP; DISCRIMINATION; CONSOLIDATION; IMPROVEMENT; MEMORY	In motor learning, training a task B can disrupt improvements of performance of a previously learned task A, indicating that learning needs consolidation. An influential study suggested that this is the case also for visual perceptual learning [1]. Using the same paradigm, we failed to reproduce these results. Further experiments with bisection stimuli also showed no retrograde disruption from task B on task A. Hence, for the tasks tested here, perceptual learning does not suffer from retrograde interference.	[Aberg, Kristoffer C.; Herzog, Michael H.] Ecole Polytech Fed Lausanne, Lab Psychophys, Brain Mind Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Aberg, KC (corresponding author), Ecole Polytech Fed Lausanne, Lab Psychophys, Brain Mind Inst, Lausanne, Switzerland.	kristoffer.aberg@epfl.ch	Aberg, Kristoffer/F-1040-2018	Aberg, Kristoffer/0000-0002-0970-400X	Swiss National Science Foundation (SNF)	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF))	Kristoffer Aberg was supported by the Sinergia project "State representation in reward based learning - from spiking neuron models to psychophysics'' of the Swiss National Science Foundation (SNF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg KC, 2009, VISION RES, V49, P2591, DOI 10.1016/j.visres.2009.07.006; Aberg KC, 2009, VISION RES, V49, P2087, DOI 10.1016/j.visres.2009.05.020; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; KARNI A, 1993, NATURE, V365, P250, DOI 10.1038/365250a0; KARNI A, 1994, SCIENCE, V265, P679, DOI 10.1126/science.8036518; Kuai SG, 2005, NAT NEUROSCI, V8, P1497, DOI 10.1038/nn1546; Matarazzo L, 2008, J VISION, V8, DOI 10.1167/8.4.7; Mednick S, 2003, NAT NEUROSCI, V6, P697, DOI 10.1038/nn1078; Mednick SC, 2008, BEHAV NEUROSCI, V122, P267, DOI 10.1037/0735-7044.122.2.267; Mednick SC, 2002, NAT NEUROSCI, V5, P677, DOI 10.1038/nn864; Miall RC, 2004, EXP BRAIN RES, V154, P201, DOI 10.1007/s00221-003-1630-2; Otto TU, 2006, VISION RES, V46, P3223, DOI 10.1016/j.visres.2006.03.021; Robertson EM, 2004, NAT REV NEUROSCI, V5, P576, DOI 10.1038/nrn1426; Seitzt AR, 2005, P NATL ACAD SCI USA, V102, P14895, DOI 10.1073/pnas.0505765102; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Stickgold R, 2000, NAT NEUROSCI, V3, P1237, DOI 10.1038/81756; Stickgold R, 2000, J COGNITIVE NEUROSCI, V12, P246, DOI 10.1162/089892900562075; Tartaglia EM, 2009, VISION RES, V49, P1420, DOI 10.1016/j.visres.2009.02.013; TAYLOR MM, 1967, J ACOUST SOC AM, V41, P782, DOI 10.1121/1.1910407; Walker MP, 2006, ANNU REV PSYCHOL, V57, P139, DOI 10.1146/annurev.psych.56.091103.070307; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Yotsumoto Y, 2009, VISION RES, V49, P2611, DOI 10.1016/j.visres.2009.08.001; Yu C, 2004, J VISION, V4, P169, DOI 10.1167/4.3.4; Zhang JY, 2008, PLOS BIOL, V6, P1651, DOI 10.1371/journal.pbio.0060197	26	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e14161	10.1371/journal.pone.0014161	http://dx.doi.org/10.1371/journal.pone.0014161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151868	Green Published, gold, Green Submitted			2022-12-27	WOS:000285041800001
J	Xie, C; Tang, XX; Xu, WM; Diao, RY; Cai, ZM; Chan, HC				Xie, Chen; Tang, Xiaoxiao; Xu, Wenming; Diao, Ruiying; Cai, Zhiming; Chan, Hsiao Chang			A Host Defense Mechanism Involving CFTR-Mediated Bicarbonate Secretion in Bacterial Prostatitis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; SOLUBLE ADENYLYL-CYCLASE; CYSTIC-FIBROSIS; FERTILIZING-CAPACITY; CL-/HCO3-EXCHANGE; MESSENGER-RNA; PH; TRACT; FLUID; TRANSLATION	Background: Prostatitis is associated with a characteristic increase in prostatic fluid pH; however, the underlying mechanism and its physiological significance have not been elucidated. Methodology/Principal Findings: In this study a primary culture of rat prostatic epithelial cells and a rat prostatitis model were used. Here we reported the involvement of CFTR, a cAMP-activated anion channel conducting both Cl- and O-3(-), in mediating prostate HCO3- secretion and its possible role in bacterial killing. Upon Escherichia coli (E coli)-LPS challenge, the expression of CFTR and carbonic anhydrase II (CA II), along with several pro-inflammatory cytokines was up-regulated in the primary culture of rat prostate epithelial cells. Inhibiting CFTR function in vitro or in vivo resulted in reduced bacterial killing by prostate epithelial cells or the prostate. High HCO3- content (>50 mM), rather than alkaline pH, was found to be responsible for bacterial killing. The direct action of HCO3- on bacterial killing was confirmed by its ability to increase cAMP production and suppress bacterial initiation factors in E coli. The relevance of the CFTR-mediated HCO3- secretion in humans was demonstrated by the upregulated expression of CFTR and CAII in human prostatitis tissues. Conclusions/Significance: The CFTR and its mediated HCO3- secretion may be up-regulated in prostatitis as a host defense mechanism.	[Xie, Chen; Tang, Xiaoxiao; Chan, Hsiao Chang] Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China; [Xu, Wenming; Chan, Hsiao Chang] Sichuan Univ, W China Univ Hosp 2, Chinese Univ Hong Kong Joint Lab Reprod Med, Hong Kong, Hong Kong, Peoples R China; [Diao, Ruiying; Cai, Zhiming] Peking Univ, Shenzhen Hosp, Guangdong Key Lab Male Reprod & Genet, Shenzhen, Peoples R China	Chinese University of Hong Kong; Sichuan University; Peking University	Xie, C (corresponding author), Chinese Univ Hong Kong, Fac Med, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Hong Kong, Hong Kong, Peoples R China.	hsiaocchan@cuhk.edu.hk	Chan, Hsiao Chang/E-1507-2016		Chinese University of Hong Kong	Chinese University of Hong Kong(Chinese University of Hong Kong)	This work was supported by the Focused Investment Scheme and Li Ka Shing Institute of Health Sciences of The Chinese University of Hong Kong. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajonuma LC, 2008, CELL BIOL INT, V32, P801, DOI 10.1016/j.cellbi.2008.03.010; Alexander RB, 1998, UROLOGY, V52, P744, DOI 10.1016/S0090-4295(98)00390-2; Beeler Jeff A., 2003, V237, P39; BHATTACHARYA A, 1977, BIOCHEM BIOPH RES CO, V77, P1438, DOI 10.1016/S0006-291X(77)80140-X; BLACKLOCK NJ, 1974, BRIT J UROL, V46, P537, DOI 10.1111/j.1464-410X.1974.tb03853.x; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Cafferata EG, 2000, BBA-MOL BASIS DIS, V1500, P241, DOI 10.1016/S0925-4439(99)00105-2; Chan HC, 2006, MOL CELL ENDOCRINOL, V250, P106, DOI 10.1016/j.mce.2005.12.032; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; CHANDIOK S, 1992, INT J STD AIDS, V3, P188, DOI 10.1177/095646249200300306; Chen J, 2007, UROL INT, V78, P230, DOI 10.1159/000099343; Chen MH, 2010, HUM REPROD, V25, P1744, DOI 10.1093/humrep/deq094; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; Choi JY, 2001, NATURE, V410, P94, DOI 10.1038/35065099; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; COHN JA, 1991, BIOCHEM BIOPH RES CO, V181, P36, DOI 10.1016/S0006-291X(05)81378-6; CORRAL LG, 1988, J FOOD SCI, V53, P981, DOI 10.1111/j.1365-2621.1988.tb09005.x; Craig SB, 1999, PLAST RECONSTR SURG, V103, P666, DOI 10.1097/00006534-199902000-00047; CUMMINGS HS, 1994, J BACTERIOL, V176, P198, DOI 10.1128/JB.176.1.198-205.1994; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; DELAROSETTE JJMCH, 1993, UROLOGY, V41, P301, DOI 10.1016/0090-4295(93)90584-W; Dorschner RA, 2006, FASEB J, V20, P35, DOI 10.1096/fj.05-4406com; Drake DR, 1995, AM J DENT, V8, P308; Erdogan S, 2008, RES VET SCI, V84, P18, DOI 10.1016/j.rvsc.2007.02.003; FAIR WR, 1978, J UROLOGY, V120, P695, DOI 10.1016/S0022-5347(17)57333-4; GIAMARELLOU H, 1984, ANDROLOGIA, V16, P417; Grill S, 2001, FEBS LETT, V495, P167, DOI 10.1016/S0014-5793(01)02378-X; GUALERZI CO, 1990, BIOCHEMISTRY-US, V29, P5881, DOI 10.1021/bi00477a001; He LY, 2010, UROLOGY, V75, P654, DOI 10.1016/j.urology.2009.09.061; He Q, 2010, FERTIL STERIL, V93, P2608, DOI 10.1016/j.fertnstert.2010.01.040; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Hoglund P, 1996, NAT GENET, V14, P316, DOI 10.1038/ng1196-316; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Hug MJ, 2003, NEWS PHYSIOL SCI, V18, P38, DOI 10.1152/nips.01412.2002; Ishiguro Hiroshi, 2007, Shengli Xuebao, V59, P465; Jang TL, 2003, WORLD J UROL, V21, P95, DOI 10.1007/s00345-003-0335-2; Jarvis GN, 2001, LETT APPL MICROBIOL, V33, P196, DOI 10.1046/j.1472-765x.2001.00976.x; Johansen TEB, 1998, EUR UROL, V34, P457; KAUL R, 1990, BIOCHIM BIOPHYS ACTA, V1053, P106, DOI 10.1016/0167-4889(90)90032-9; KOPELMAN H, 1988, GASTROENTEROLOGY, V95, P349, DOI 10.1016/0016-5085(88)90490-8; Lee MG, 1999, J BIOL CHEM, V274, P14670, DOI 10.1074/jbc.274.21.14670; LEIB Z, 1994, FERTIL STERIL, V61, P1109; Lipsky BA, 2010, CLIN INFECT DIS, V50, P1641, DOI 10.1086/652861; Mitsumori K, 1999, J INFECT DIS, V180, P1378, DOI 10.1086/314976; PFAU A, 1978, J UROLOGY, V119, P384, DOI 10.1016/S0022-5347(17)57497-2; POULSEN JH, 1994, P NATL ACAD SCI USA, V91, P5340, DOI 10.1073/pnas.91.12.5340; Qiao D, 2008, J CYST FIBROS, V7, P210, DOI 10.1016/j.jcf.2007.07.011; Quinton PM, 2001, NAT MED, V7, P292, DOI 10.1038/85429; Roelofs J, 2002, MOL BIOL EVOL, V19, P2239, DOI 10.1093/oxfordjournals.molbev.a004047; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; SCHAEFFER AJ, 1981, J UROLOGY, V125, P215, DOI 10.1016/S0022-5347(17)54976-9; Shcheynikov N, 2006, J GEN PHYSIOL, V127, P511, DOI 10.1085/jgp.200509392; SNOW DC, 2010, PHARMACOTHERAPY PROS; STRONG TV, 1994, J CLIN INVEST, V93, P347, DOI 10.1172/JCI116966; TAJIMA Y, 1987, BIOCHIM BIOPHYS ACTA, V924, P519; TAKETA S, 1990, PROSTATE, V17, P207, DOI 10.1002/pros.2990170304; Tate S, 2002, THORAX, V57, P926, DOI 10.1136/thorax.57.11.926; THIN RN, 1991, GENITOURIN MED, V67, P279; THOMPSON KD, 1993, J DERMATOL SURG ONC, V19, P216, DOI 10.1111/j.1524-4725.1993.tb00339.x; Trevani AS, 1999, J IMMUNOL, V162, P4849; Wagenlehner FME, 2005, INT J ANTIMICROB AG, V26, P1, DOI 10.1016/j.ijantimicag.2005.04.013; WALKER J, 1995, J CELL SCI, V108, P2433; Wang XF, 2003, NAT CELL BIOL, V5, P902, DOI 10.1038/ncb1047; WEIDNER W, 1992, INFECTION, V20, pS227, DOI 10.1007/BF01704386; WHITE MA, 1975, P ROY SOC MED, V68, P511, DOI 10.1177/003591577506800815; WINNINGHAM DG, 1968, NATURE, V219, P139, DOI 10.1038/219139a0; WOLFF H, 1991, J ANDROL, V12, P331; Xie F, 2006, DEV BIOL, V296, P353, DOI 10.1016/j.ydbio.2006.05.038; Zhou Chen-Xi, 2005, Shengli Xuebao, V57, P115	69	18	21	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15255	10.1371/journal.pone.0015255	http://dx.doi.org/10.1371/journal.pone.0015255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151921	Green Published, Green Submitted, gold			2022-12-27	WOS:000285041800011
J	Ebeling, W; Natoli, RC; Hemmi, JM				Ebeling, Wiebke; Natoli, Riccardo C.; Hemmi, Jan M.			Diversity of Color Vision: Not All Australian Marsupials Are Trichromatic	PLOS ONE			English	Article							CONE VISUAL PIGMENTS; OPSIN GENE DUPLICATION; SMINTHOPSIS-CRASSICAUDATA; MONOCLONAL-ANTIBODIES; SPECTRAL SENSITIVITY; MOLECULAR EVOLUTION; ROD OPSIN; NEW-WORLD; RETINA; RHODOPSIN	Color vision in marsupials has recently emerged as a particularly interesting case among mammals. It appears that there are both dichromats and trichromats among closely related species. In contrast to primates, marsupials seem to have evolved a different type of trichromacy that is not linked to the X-chromosome. Based on microspectrophotometry and retinal whole-mount immunohistochemistry, four trichromatic marsupial species have been described: quokka, quenda, honey possum, and fat-tailed dunnart. It has, however, been impossible to identify the photopigment of the third cone type, and genetically, all evidence so far suggests that all marsupials are dichromatic. The tammar wallaby is the only Australian marsupial to date for which there is no evidence of a third cone type. To clarify whether the wallaby is indeed a dichromat or trichromatic like other Australian marsupials, we analyzed the number of cone types in the "dichromatic" wallaby and the "trichromatic" dunnart. Employing identical immunohistochemical protocols, we confirmed that the wallaby has only two cone types, whereas 20-25% of cones remained unlabeled by S-and LM-opsin antibodies in the dunnart retina. In addition, we found no evidence to support the hypothesis that the rod photopigment (rod opsin) is expressed in cones which would have explained the absence of a third cone opsin gene. Our study is the first comprehensive and quantitative account of color vision in Australian marsupials where we now know that an unexpected diversity of different color vision systems appears to have evolved.	Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia; Australian Natl Univ, Ctr Visual Sci, Res Sch Biol, ANU Coll Med Biol & Environm, Canberra, ACT, Australia	Australian National University; Australian National University	Ebeling, W (corresponding author), Univ Tasmania, Ctr Marine Sci, Hobart, Tas, Australia.	Wiebke.Ebeling@utas.edu.au	Hemmi, Jan M/B-6458-2008	Hemmi, Jan M/0000-0003-4629-9362; Natoli, Riccardo/0000-0002-9350-0439	Australian Research Council through the ARC Centre of Excellence in Vision Science [CE0561903]; Department of Education, Employment and Workplace Relations (DEEWR); Australian National University; ARC Centre of Excellence in Vision Science	Australian Research Council through the ARC Centre of Excellence in Vision Science(Australian Research Council); Department of Education, Employment and Workplace Relations (DEEWR)(Australian GovernmentDepartment of Industry, Innovation and Science); Australian National University(Australian National University); ARC Centre of Excellence in Vision Science(Australian Research Council)	This research was supported by the Australian Research Council through the ARC Centre of Excellence in Vision Science (CE0561903). W. E. was funded through stipends from the Department of Education, Employment and Workplace Relations (DEEWR), the Australian National University, and the ARC Centre of Excellence in Vision Science. These funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNELT PK, 1995, VISUAL NEUROSCI, V12, P793, DOI 10.1017/S0952523800009366; Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; ANDREADIS A, 1987, ANNU REV CELL BIOL, V3, P207, DOI 10.1146/annurev.cellbio.3.1.207; Applebury ML, 2001, TRENDS NEUROSCI, V24, P250, DOI 10.1016/S0166-2236(00)01772-0; Arrese C, 1999, BRAIN BEHAV EVOLUT, V53, P111, DOI 10.1159/000006588; Arrese CA, 2006, CURR BIOL, V16, pR193, DOI 10.1016/j.cub.2006.02.036; Arrese CA, 2005, P ROY SOC B-BIOL SCI, V272, P791, DOI 10.1098/rspb.2004.3009; Arrese CA, 2003, VISUAL NEUROSCI, V20, P307, DOI 10.1017/S0952523803203096; Arrese CA, 2002, CURR BIOL, V12, P657, DOI 10.1016/S0960-9822(02)00772-8; Bennis M, 2005, EXP EYE RES, V80, P623, DOI 10.1016/j.exer.2004.11.004; Collin SP, 2003, CURR BIOL, V13, pR864, DOI 10.1016/j.cub.2003.10.044; Cowing JA, 2008, P ROY SOC B-BIOL SCI, V275, P1491, DOI 10.1098/rspb.2008.0248; Davies WL, 2007, CURR BIOL, V17, pR161, DOI 10.1016/j.cub.2007.01.037; De Araujo MFP, 2006, AM J PRIMATOL, V68, P1129, DOI 10.1002/ajp.20312; Deeb SS, 2003, MOL BIOL EVOL, V20, P1642, DOI 10.1093/molbev/msg181; Dkhissi-Benyabya O, 2006, INVEST OPHTH VIS SCI, V47, P1636, DOI 10.1167/iovs.05-1459; Dulai KS, 1999, GENOME RES, V9, P629; Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8; Fasick JI, 1998, VISUAL NEUROSCI, V15, P643, DOI 10.1017/S0952523898154056; Gamlin PDR, 2007, VISION RES, V47, P946, DOI 10.1016/j.visres.2006.12.015; Glosmann M, 2002, BRAIN RES, V929, P139, DOI 10.1016/S0006-8993(02)02267-9; Granneman JG, 1998, MOL PHARMACOL, V54, P687; Hemmi JM, 1999, J COMP PHYSIOL A, V185, P509, DOI 10.1007/s003590050411; Hemmi JM, 1999, VISUAL NEUROSCI, V16, P291, DOI 10.1017/S0952523899162102; HICKS D, 1987, J HISTOCHEM CYTOCHEM, V35, P1317, DOI 10.1177/35.11.3655327; Hoffmann M, 2007, P ROY SOC B-BIOL SCI, V274, P33, DOI 10.1098/rspb.2006.3707; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Hunt DM, 2009, GENE, V433, P50, DOI 10.1016/j.gene.2008.12.006; Hunt DM, 2003, GENE, V323, P157, DOI 10.1016/j.gene.2003.09.016; Jacobs GH, 2010, J COMP PHYSIOL A, V196, P379, DOI 10.1007/s00359-010-0519-3; Jacobs GH, 2004, VISION RES, V44, P1615, DOI 10.1016/j.visres.2004.01.016; JACOBS GH, 1991, NATURE, V353, P655, DOI 10.1038/353655a0; JACOBS GH, 1993, VISION RES, V33, P1773, DOI 10.1016/0042-6989(93)90168-V; JACOBS GH, 2009, P ROY SOC LOND B BIO, V34, P2957, DOI DOI 10.1098/RSTB.2009.0039; JIANG MS, 1995, EXP EYE RES, V60, P401, DOI 10.1016/S0014-4835(05)80096-X; Kawamura S, 2004, J MOL EVOL, V58, P314, DOI 10.1007/s00239-003-2553-z; Levenson DH, 2006, J COMP PHYSIOL A, V192, P833, DOI 10.1007/s00359-006-0121-x; LIEBMAN PA, 1968, VISION RES, V8, P761, DOI 10.1016/0042-6989(68)90128-4; Ma JX, 2001, NEURON, V32, P451, DOI 10.1016/S0896-6273(01)00482-2; MCDEVITT DS, 1993, ANAT REC, V237, P299, DOI 10.1002/ar.1092370302; MOLDAY RS, 1983, BIOCHEMISTRY-US, V22, P653, DOI 10.1021/bi00272a020; MOLLON JD, 1984, PROC R SOC SER B-BIO, V222, P373, DOI 10.1098/rspb.1984.0071; Muller B, 2007, BRAIN BEHAV EVOLUT, V70, P90, DOI 10.1159/000102971; Muller B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006390; Nilsson MA, 2004, GENE, V340, P189, DOI 10.1016/j.gene.2004.07.040; ODDY AY, 2003, DIRECT SUBMISSION GE; Osorio D, 1996, P ROY SOC B-BIOL SCI, V263, P593, DOI 10.1098/rspb.1996.0089; Palacios AG, 2010, J COMP NEUROL, V518, P1589, DOI 10.1002/cne.22292; Peichl L, 2001, EUR J NEUROSCI, V13, P1520, DOI 10.1046/j.0953-816x.2001.01533.x; Pires SS, 2007, P R SOC B, V274, P2791, DOI 10.1098/rspb.2007.0976; RAYMOND PA, 1993, NEURON, V10, P1161, DOI 10.1016/0896-6273(93)90064-X; Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8; Strachan J, 2004, VISUAL NEUROSCI, V21, P223, DOI 10.1017/S0952523804213281; Sumner P, 2005, J EXP BIOL, V208, pIII, DOI 10.1242/jcb.01646; Wakefield MJ, 2008, VISUAL NEUROSCI, V25, P257, DOI 10.1017/S0952523808080255; Wang DY, 2004, MOL BIOL EVOL, V21, P295, DOI 10.1093/molbev/msh015; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; WIKLER KC, 1990, J NEUROSCI, V10, P3390; Winter Y, 2003, NATURE, V425, P612, DOI 10.1038/nature01971; Xiao M, 2000, J COMP NEUROL, V425, P545; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Zhao HB, 2009, P NATL ACAD SCI USA, V106, P8980, DOI 10.1073/pnas.0813201106	62	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14231	10.1371/journal.pone.0014231	http://dx.doi.org/10.1371/journal.pone.0014231			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151905	Green Published, Green Submitted, gold			2022-12-27	WOS:000284995300003
J	Xue, JA; Bao, YY; Li, BL; Cheng, YB; Peng, ZY; Liu, H; Xu, HJ; Zhu, ZR; Lou, YG; Cheng, JA; Zhang, CX				Xue, Jian; Bao, Yan-Yuan; Li, Bao-ling; Cheng, Yan-Bing; Peng, Zhi-Yu; Liu, Hang; Xu, Hai-Jun; Zhu, Zeng-Rong; Lou, Yong-Gen; Cheng, Jia-An; Zhang, Chuan-Xi			Transcriptome Analysis of the Brown Planthopper Nilaparvata lugens	PLOS ONE			English	Article							WING DIMORPHISM; INSECTICIDE RESISTANCE	Background: The brown planthopper (BPH) Nilaparvata lugens (Stal) is one of the most serious insect pests of rice in Asia. However, little is known about the mechanisms responsible for the development, wing dimorphism and sex difference in this species. Genomic information for BPH is currently unavailable, and, therefore, transcriptome and expression profiling data for this species are needed as an important resource to better understand the biological mechanisms of BPH. Methodology/Principal Findings: In this study, we performed de novo transcriptome assembly and gene expression analysis using short-read sequencing technology (Illumina) combined with a tag-based digital gene expression (DGE) system. The transcriptome analysis assembles the gene information for different developmental stages, sexes and wing forms of BPH. In addition, we constructed six DGE libraries: eggs, second instar nymphs, fifth instar nymphs, brachypterous female adults, macropterous female adults and macropterous male adults. Illumina sequencing revealed 85,526 unigenes, including 13,102 clusters and 72,424 singletons. Transcriptome sequences larger than 350 bp were subjected to Gene Orthology (GO) and KEGG Orthology (KO) annotations. To analyze the DGE profiling, we mainly compared the gene expression variations between eggs and second instar nymphs; second and fifth instar nymphs; fifth instar nymphs and three types of adults; brachypterous and macropterous female adults as well as macropterous female and male adults. Thousands of genes showed significantly different expression levels based on the various comparisons. And we randomly selected some genes to confirm their altered expression levels by quantitative real-time PCR (qRT-PCR). Conclusions/Significance: The obtained BPH transcriptome and DGE profiling data provide comprehensive gene expression information at the transcriptional level that could facilitate our understanding of the molecular mechanisms from various physiological aspects including development, wing dimorphism and sex difference in BPH.	[Xue, Jian; Bao, Yan-Yuan; Li, Bao-ling; Xu, Hai-Jun; Zhu, Zeng-Rong; Lou, Yong-Gen; Cheng, Jia-An; Zhang, Chuan-Xi] Zhejiang Univ, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, State Key Lab Rice Biol,Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China; [Cheng, Yan-Bing; Peng, Zhi-Yu; Liu, Hang] Beijing Genom Inst Shenzhen, Shenzhen, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Beijing Genomics Institute (BGI)	Zhang, CX (corresponding author), Zhejiang Univ, Key Lab Mol Biol Crop Pathogens & Insects, Minist Agr, State Key Lab Rice Biol,Inst Insect Sci, Hangzhou 310003, Zhejiang, Peoples R China.	chxzhang@zju.edu.cn	Peng, Zhiyu/GXV-5301-2022; Zhang, Chuan-Xi/K-7978-2019; Jian, Xue/M-2381-2019	Zhang, Chuan-Xi/0000-0002-7784-1188; Xu, Hai-Jun/0000-0002-7314-377X; Liu, Hang/0000-0003-3012-6061	National Basic Research Program of China (973 Program) [2010CB126200]; National Natural Science Foundation of China [31070136]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The funders include the National Basic Research Program of China (973 Program, No. 2010CB126200) (website: http://www.973.gov.cn/English/Index.aspx), and the National Natural Science Foundation of China (No. 31070136) (website: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bauer H, 2002, J BIOL CHEM, V277, P17457, DOI 10.1074/jbc.M200636200; Braendle C, 2006, HEREDITY, V97, P192, DOI 10.1038/sj.hdy.6800863; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; [程家安 Cheng Jiaan], 2006, [植物保护, Plant Protection], V32, P1; Chicoine J, 2007, DEV CELL, V13, P691, DOI 10.1016/j.devcel.2007.10.002; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Harrison JF, 2000, ANNU REV PHYSIOL, V62, P179, DOI 10.1146/annurev.physiol.62.1.179; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Jansen S, 2001, CELLS TISSUES ORGANS, V168, P82, DOI 10.1159/000016809; Le Goff G, 2003, INSECT BIOCHEM MOLEC, V33, P701, DOI 10.1016/S0965-1748(03)00064-X; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Liu Guang-Jie, 2000, Entomological Knowledge, V37, P186; Matsumura M, 1996, HEREDITY, V76, P229, DOI 10.1038/hdy.1996.36; McIntyre LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-8-r79; Noda H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-117; NOVOTNY V, 1995, ENTOMOL EXP APPL, V76, P233, DOI 10.1007/BF02382989; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Qiu ZH, 2004, CROP PROT, V23, P1131, DOI 10.1016/j.cropro.2004.04.005; ROBERT F, 1986, ECOLOGY, V67, P116; Schoonjans K, 1996, J LIPID RES, V37, P907; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Yan W, 2004, P NATL ACAD SCI USA, V101, P7793, DOI 10.1073/pnas.0308025101	25	183	204	3	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e14233	10.1371/journal.pone.0014233	http://dx.doi.org/10.1371/journal.pone.0014233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151909	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300005
J	Das, P; Lahiri, A; Lahiri, A; Sen, M; Iyer, N; Kapoor, N; Balaji, KN; Chakravortty, D				Das, Priyanka; Lahiri, Amit; Lahiri, Ayan; Sen, Minakshi; Iyer, Namrata; Kapoor, Nisha; Balaji, Kithiganahalli Narayanaswamy; Chakravortty, Dipshikha			Cationic Amino Acid Transporters and Salmonella Typhimurium ArgT Collectively Regulate Arginine Availability towards Intracellular Salmonella Growth	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS BCG; NITRIC-OXIDE PRODUCTION; MURINE MACROPHAGES; ESCHERICHIA-COLI; GENE-EXPRESSION; INFECTION; CELLS; TRAFFICKING; HOMEOSTASIS; METABOLISM	Cationic amino acid transporters (mCAT1 and mCAT2B) regulate the arginine availability in macrophages. How in the infected cell a pathogen can alter the arginine metabolism of the host remains to be understood. We reveal here a novel mechanism by which Salmonella exploit mCAT1 and mCAT2B to acquire host arginine towards its own intracellular growth within antigen presenting cells. We demonstrate that Salmonella infected bone marrow derived macrophages and dendritic cells show enhanced arginine uptake and increased expression of mCAT1 and mCAT2B. We show that the mCAT1 transporter is in close proximity to Salmonella containing vacuole (SCV) specifically by live intracellular Salmonella in order to access the macrophage cytosolic arginine pool. Further, Lysosome associated membrane protein 1, a marker of SCV, also was found to colocalize with mCAT1 in the Salmonella infected cell. The intra vacuolar Salmonella then acquire the host arginine via its own arginine transporter, ArgT for growth. The argT knockout strain was unable to acquire host arginine and was attenuated in growth in both macrophages and in mice model of infection. Together, these data reveal survival strategies by which virulent Salmonella adapt to the harsh conditions prevailing in the infected host cells.	[Das, Priyanka; Lahiri, Amit; Lahiri, Ayan; Sen, Minakshi; Iyer, Namrata; Kapoor, Nisha; Balaji, Kithiganahalli Narayanaswamy; Chakravortty, Dipshikha] Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res & Biosafety Labs, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore	Das, P (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Ctr Infect Dis Res & Biosafety Labs, Bangalore 560012, Karnataka, India.	dipa@mcbl.iisc.ernet.in	Chakravortty, Dipshikha/AAI-4448-2020; Iyer, Namrata/GQO-7833-2022	Chakravortty, Dipshikha/0000-0002-7838-5145; LAHIRI, AMIT/0000-0003-0307-3478; Iyer, Namrata/0000-0002-5263-7092; Lahiri, Ayan/0000-0003-1621-2051	Indian Institute of Science, Bangalore, India [191/MCB]; Department of Biotechnology (DBT), India [197, 172]	Indian Institute of Science, Bangalore, India; Department of Biotechnology (DBT), India(Department of Biotechnology (DBT) India)	This work was supported by the grant, Provision (2A) Tenth Plan (191/MCB) from the Director of Indian Institute of Science, Bangalore, India, and Department of Biotechnology (DBT 197 and DBT 172), India. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ARDESHIR F, 1980, J SUPRAMOL STR CELL, V13, P117, DOI 10.1002/jss.400130111; ARDESHIR F, 1981, J BACTERIOL, V147, P401, DOI 10.1128/JB.147.2.401-409.1981; Bakowski MA, 2008, TRAFFIC, V9, P2022, DOI 10.1111/j.1600-0854.2008.00827.x; Barker LP, 1998, MOL MICROBIOL, V29, P1167, DOI 10.1046/j.1365-2958.1998.00996.x; Chakravortty D, 2002, J EXP MED, V195, P1155, DOI 10.1084/jem.20011547; Das P, PLOS PATHOG, V6; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deves R, 1998, PHYSIOL REV, V78, P487, DOI 10.1152/physrev.1998.78.2.487; Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x; Eswarappa SM, 2008, MICROBIOL-SGM, V154, P666, DOI 10.1099/mic.0.2007/011114-0; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; HIGGINS CF, 1981, P NATL ACAD SCI-BIOL, V78, P6038, DOI 10.1073/pnas.78.10.6038; Holden DW, 2002, TRAFFIC, V3, P161, DOI 10.1034/j.1600-0854.2002.030301.x; KLARSFELD AD, 1994, MOL MICROBIOL, V13, P585, DOI 10.1111/j.1365-2958.1994.tb00453.x; Lahiri A, 2008, MICROBES INFECT, V10, P1166, DOI 10.1016/j.micinf.2008.06.008; Lahiri A, 2008, MICROBIOL-SGM, V154, P2837, DOI 10.1099/mic.0.2008/017574-0; MacLeod CL, 1996, BIOCHEM SOC T, V24, P846, DOI 10.1042/bst0240846; Mori M, 2004, J NUTR, V134, p2820S, DOI 10.1093/jn/134.10.2820S; Munder M, 1999, J IMMUNOL, V163, P3771; Narayana Y, 2008, J BIOL CHEM, V283, P12501, DOI 10.1074/jbc.M709960200; Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200; Peranzoni E, 2007, IMMUNOBIOLOGY, V212, P795, DOI 10.1016/j.imbio.2007.09.008; Peteroy-Kelly M, 2001, INFECT IMMUN, V69, P5823, DOI 10.1128/IAI.69.9.5823-5831.2001; Peteroy-Kelly MA, 2003, INFECT IMMUN, V71, P1011, DOI 10.1128/IAI.71.2.1011-1015.2003; REEVES MW, 1989, J CLIN MICROBIOL, V27, P313, DOI 10.1128/JCM.27.2.313-320.1989; Rogers M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000555; Rothenberg ME, 2006, P NATL ACAD SCI USA, V103, P14895, DOI 10.1073/pnas.0605478103; Simmons WW, 1996, J BIOL CHEM, V271, P11694, DOI 10.1074/jbc.271.20.11694; Stevens BR, 1996, J BIOL CHEM, V271, P24017, DOI 10.1074/jbc.271.39.24017; Talaue MT, 2006, J BACTERIOL, V188, P4830, DOI 10.1128/JB.01687-05; Thompson RW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000023; Verrey F, 2004, PFLUG ARCH EUR J PHY, V447, P532, DOI 10.1007/s00424-003-1086-z; Wanasen N, 2007, INFECT IMMUN, V75, P2802, DOI 10.1128/IAI.00026-07	36	33	33	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15466	10.1371/journal.pone.0015466	http://dx.doi.org/10.1371/journal.pone.0015466			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151933	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600036
J	Hao, PL; Ren, Y; Xie, YM				Hao, Piliang; Ren, Yan; Xie, Yongming			An Improved Protocol for N-Glycosylation Analysis of Gel-Separated Sialylated Glycoproteins by MALDI-TOF/TOF	PLOS ONE			English	Article							FLIGHT MASS-SPECTROMETRY; SAMPLE PURIFICATION; OLIGOSACCHARIDES; PROTEOMICS; DEGLYCOSYLATION; PROTEINS; GLYCANS; CANCER; TIME; ELECTROPHORESIS	Different glycoforms of some proteins have been identified as differential spots for certain diseases in 2-DE, indicating disease-related glycosylation changes. It is routine to determine the site-specific glycosylation of nonsialylated N-glycoproteins from a single gel spot, but some obstacles still exist in analyzing sialylated glycoproteins due to the lability and higher detection limit of acid glycans in MALDI-TOF/TOF analysis. Thus, we present an improved protocol here. Tryptic glycopeptides were separated and subjected to MALDI-TOF/TOF analysis, resulting in the identification of site-specific glycosylation of high-intensity glycopeptides. Sequential deglycosylation and desialylation were used to improve the identification of glycosylation sites and desialylated glycans. The site-specific glycosylation of large glycopeptides and low-intensity glycopeptides was deduced based on the masses of glycopeptides, deglycosylated peptides and desialylated glycans. By applying it to 2-DE separated human serum, the difference of N-glycosylation was successfully determined for alpha 1-antitrypsin between different gel spots.	[Hao, Piliang; Ren, Yan] Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China; [Xie, Yongming] Appl Biosyst Inc China, Shanghai, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Thermo Fisher Scientific; Applied Biosystems	Hao, PL (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing, Peoples R China.	hpiliang@163.com			Beijing Institute of Genomics, Chinese Academy of Sciences	Beijing Institute of Genomics, Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Research Grant from Beijing Institute of Genomics, Chinese Academy of Sciences. It also received instrumental support from Applied Biosystems Inc. (China). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Rahman PS, 2007, ELECTROPHORESIS, V28, P1989, DOI 10.1002/elps.200600629; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen CB, 2008, CLIN CHIM ACTA, V398, P48, DOI 10.1016/j.cca.2008.08.001; Chen Y, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-37; Chen Y, 2008, PROTEOME SCI, V6, DOI 10.1186/1477-5956-6-20; Dube DH, 2005, NAT REV DRUG DISCOV, V4, P477, DOI 10.1038/nrd1751; Ghafouri B, 2006, J PROTEOME RES, V5, P330, DOI 10.1021/pr050341h; Gobom J, 1999, J MASS SPECTROM, V34, P105, DOI 10.1002/(SICI)1096-9888(199902)34:2<105::AID-JMS768>3.0.CO;2-4; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; Graham DRM, 2008, PROTEOMICS, V8, P4919, DOI 10.1002/pmic.200800608; Hagglund P, 2004, J PROTEOME RES, V3, P556, DOI 10.1021/pr034112b; HARVEY DJ, 1993, RAPID COMMUN MASS SP, V7, P614, DOI 10.1002/rcm.1290070712; Herve F, 1998, J CHROMATOGR B, V715, P111, DOI 10.1016/S0378-4347(98)00085-1; Iijima S, 2000, ELECTROPHORESIS, V21, P753, DOI 10.1002/(SICI)1522-2683(20000301)21:4<753::AID-ELPS753>3.0.CO;2-Y; Kuster B, 1997, ANAL BIOCHEM, V250, P82, DOI 10.1006/abio.1997.2199; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P107, DOI 10.1074/mcp.M400068-MCP200; Lee CW, 2007, CLIN CHIM ACTA, V375, P104, DOI 10.1016/j.cca.2006.06.019; Llop E, 2007, PROTEOMICS, V7, P4278, DOI 10.1002/pmic.200700572; Mills PB, 2001, PROTEOMICS, V1, P778, DOI 10.1002/1615-9861(200106)1:6<778::AID-PROT778>3.3.CO;2-8; Morelle W, 2006, PROTEOMICS, V6, P3993, DOI 10.1002/pmic.200600129; MORTEN TA, 2006, AM BIOTECHNOL LAB, P24; Packer NH, 1998, GLYCOCONJUGATE J, V15, P737, DOI 10.1023/A:1006983125913; Papac DI, 1996, ANAL CHEM, V68, P3215, DOI 10.1021/ac960324z; Ren Y, 2007, J PROTEOME RES, V6, P2812, DOI 10.1021/pr070047k; Rohrer JS, 1998, GLYCOBIOLOGY, V8, P35, DOI 10.1093/glycob/8.1.35; Sagil D, 2005, PROTEOMICS, V5, P2689, DOI 10.1002/pmic.200401312; Sparbier Katrin, 2005, J Biomol Tech, V16, P407; Stubiger G, 2005, J SEP SCI, V28, P1764, DOI 10.1002/jssc.200500148; Sung HJ, 2008, BMB REP, V41, P615, DOI 10.5483/BMBRep.2008.41.9.615; Uematsu R, 2005, MOL CELL PROTEOMICS, V4, P1977, DOI 10.1074/mcp.M500203-MCP200; Vanderver A, 2005, CLIN CHEM, V51, P2031, DOI 10.1373/clinchem.2005.055053; von Witzendorff D, 2005, GLYCOBIOLOGY, V15, P475, DOI 10.1093/glycob/cwi022; Wada Y, 2007, GLYCOBIOLOGY, V17, P411, DOI 10.1093/glycob/cwl086; Wuhrer M, 2007, J CHROMATOGR B, V849, P115, DOI 10.1016/j.jchromb.2006.09.041; Zhang XM, 2007, PROTEOMICS, V7, P2340, DOI 10.1002/pmic.200600184	35	7	7	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15096	10.1371/journal.pone.0015096	http://dx.doi.org/10.1371/journal.pone.0015096			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124746	Green Published, Green Submitted, gold			2022-12-27	WOS:000284686500038
J	Imison, M; Chapman, S				Imison, Michelle; Chapman, Simon			'Disease, Disaster and Despair'? The Presentation of Health in Low- and Middle-Income Countries on Australian Television	PLOS ONE			English	Article							INTERNATIONAL NEWS; PUBLIC-HEALTH; COVERAGE	Background: In high-income nations mainstream television news remains an important source of information about both general health issues and low-and middle-income countries (LMICs). However, research on news coverage of health in LMICs is scarce. Principal Findings: The present paper examines the general features of Australian television coverage of LMIC health issues, testing the hypotheses that this coverage conforms to the general patterns of foreign news reporting in high-income countries and, in particular, that LMIC health coverage will largely reflect Australian interests. We analysed relevant items from May 2005 - December 2009 from the largest health-related television dataset of its kind, classifying each story on the basis of the region(s) it covered, principal content relating to health in LMICs and the presence of an Australian reference point. LMICs that are culturally proximate and politically significant to Australia had higher levels of reportage than more distant and unengaged nations. Items concerning communicable diseases, injury and aspects of child health generally consonant with 'disease, disaster and despair' news frames predominated, with relatively little emphasis given to chronic diseases which are increasingly prevalent in many LMICs. Forty-two percent of LMIC stories had explicit Australian content, such as imported medical expertise or health risk to Australians in LMICs. Significance: Media consumers' perceptions of disease burdens in LMICs and of these nations' capacity to identify and manage their own health priorities may be distorted by the major news emphasis on exotic disease, disaster and despair stories. Such perceptions may inhibit the development of appropriate policy emphases in high-income countries. In this context, non-government organisations concerned with international development may find it more difficult to strike a balance between crises and enduring issues in their health programming and fundraising efforts.	[Imison, Michelle; Chapman, Simon] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia	University of Sydney	Imison, M (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW 2006, Australia.	michelle.imison@sydney.edu.au	Chapman, Simon/D-4114-2009		National Health and Medical Research Council [571376]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Capacity Building Grant from the National Health and Medical Research Council (http://www.nhmrc.gov.au) to the Australian Health News Research Collaboration (2009-2013) [571376]. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	*ACFID, 2009, ACFID COD COND NONG; ADAMS WC, 1986, J COMMUN, V36, P113, DOI 10.1111/j.1460-2466.1986.tb01429.x; [Anonymous], 2000, EMERGENCY FUND RAISI, DOI [DOI 10.1108/09653560010361393, 10.1108/09653560010361393]; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], 1994, MEDIA INFORM AUSTR; Bacon W, 2003, AUSTR JOURNALISM REV, V25, P5; Balasegaram M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000234; Bartlett C, 2002, BRIT MED J, V325, P81, DOI 10.1136/bmj.325.7355.81; Beaglehole R, 2008, LANCET, V372, P1988, DOI 10.1016/S0140-6736(08)61558-5; Bennett R, 2002, DISASTER PREVENTION, V11, P33, DOI [10.1108/09653560210421682, DOI 10.1108/09653560210421682]; Brodie M, 2003, J HEALTH POLIT POLIC, V28, P927, DOI 10.1215/03616878-28-5-927; Burman E., 1994, CHANG INT J PSYCHOL, V12, P29; Chapman S, 2009, MED J AUSTRALIA, V191, P620, DOI 10.5694/j.1326-5377.2009.tb03354.x; CONNELL J, 1987, AUSTR GEOGRAPHICAL S, V25, P54; *DFID GLASG MED GR, 2000, VIEW WORLD STUD BRIT; Fleiss J. L., 1981, STAT METHODS RATES P, V2; Holveck JC, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-6; Horton R, 2003, LANCET, V361, P712, DOI 10.1016/S0140-6736(03)12665-7; Hunter-Gault Charlayne, 2006, NEW NEWS OUT AFRICA; Jareg P, 1998, LANCET, V351, P819, DOI 10.1016/S0140-6736(97)11454-4; Lader D., 2007, PUBLIC ATTITUDES DEV; MARTHOZ JP, 2007, MEDIA CONFLICTS CENT, P221; McKie J, 2003, SOC SCI MED, V56, P2407, DOI 10.1016/S0277-9536(02)00244-7; Mitchell RJ, 2009, MED J AUSTRALIA, V191, P648, DOI 10.5694/j.1326-5377.2009.tb03365.x; Moeller SD, 2002, HARV INT J PRESS/POL, V7, P36, DOI 10.1177/1081180X02007001004; MUNGHAM G, 1996, COUR UNESCO, V158; Padania S, 2007, REFLECTING REAL WORL; SCOTT M, 2009, WORLD FOCUS UK AUDIE; Scott M, 2009, MEDIA CULT SOC, V31, P533, DOI 10.1177/0163443709335179; Seale C., 2002, MEDIA HLTH, DOI 10.4135/9781446216286; SHOEMAKER PJ, 1991, JOURNALISM QUART, V68, P781, DOI 10.1177/107769909106800419; Utley G, 1997, FOREIGN AFF, V76, P2, DOI 10.2307/20047932; Voluntary Service Overseas (VSO), 2001, LIV AID LEG DEV WORL; WALLACK L, 1992, AM J PUBLIC HEALTH, V82, P125, DOI 10.2105/AJPH.82.1.125-a; Westwood B, 1999, HEALTH PROMOT INT, V14, P53, DOI 10.1093/heapro/14.1.53; World Health Organization, 2008, GLOB BURD DIS 2004 U; Wu H. Denis, 2003, INT COMMUN GAZ, V65, P9, DOI DOI 10.1177/0016549203065001134; Wu HD, 2000, J COMMUN, V50, P110, DOI 10.1093/joc/50.2.110	38	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14106	10.1371/journal.pone.0014106	http://dx.doi.org/10.1371/journal.pone.0014106			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	684TK	21124795	gold, Green Published, Green Submitted			2022-12-27	WOS:000284572000008
J	Kawaguchi, S; Hsu, CL; Ng, DTW				Kawaguchi, Shinichi; Hsu, Chia-Ling; Ng, Davis T. W.			Interplay of Substrate Retention and Export Signals in Endoplasmic Reticulum Quality Control	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ER-ASSOCIATED DEGRADATION; MISFOLDED PROTEINS; MEMBRANE-PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSPORT VESICLES; INTRACELLULAR-TRANSPORT; UBIQUITIN-LIGASE; PLASMA-MEMBRANE; LUMINAL PROTEIN	Background: Endoplasmic reticulum (ER) quality control mechanisms are part of a comprehensive system to manage cell stress. The flux of molecules is monitored to retain folding intermediates and target misfolded molecules to ER-associated degradation (ERAD) pathways. The mechanisms of sorting remain unclear. While some proteins are retained statically, the classical model substrate CPY* is found in COPII transport vesicles, suggesting a retrieval mechanism for retention. However, its management can be even more dynamic. If ERAD is saturated under stress, excess CPY* traffics to the vacuole for degradation. These observations suggest that misfolded proteins might display different signals for their management. Methodology/Principal Findings: Here, we report the existence of a functional ER exit signal in the pro-domain of CPY*. Compromising its integrity causes ER retention through exclusion from COPII vesicles. The signal co-exists with other signals used for retention and degradation. Physiologically, the export signal is important for stress tolerance. Disabling it converts a benign protein into one that is intrinsically cytotoxic. Conclusions/Significance: These data reveal the remarkable interplay between opposing signals embedded within ERAD substrate molecules and the mechanisms that decipher them. Our findings demonstrate the diversity of mechanisms deployed for protein quality control and maintenance of protein homeostasis.	[Kawaguchi, Shinichi; Hsu, Chia-Ling; Ng, Davis T. W.] Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore; [Ng, Davis T. W.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore; National University of Singapore	Kawaguchi, S (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore 117548, Singapore.	davis@tll.org.sg			Temasek Trust; Singapore Millennium Foundation	Temasek Trust; Singapore Millennium Foundation	Funding was provided by the Temasek Trust and the Singapore Millennium Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708; Ashok A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000479; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4; Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224; Biederer T, 1997, SCIENCE, V278, P1806, DOI 10.1126/science.278.5344.1806; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; Coughlan CM, 2004, J BIOL CHEM, V279, P15289, DOI 10.1074/jbc.M309673200; Dancourt J, 2009, TRAFFIC, V10, P1006, DOI 10.1111/j.1600-0854.2009.00936.x; FINGER A, 1993, EUR J BIOCHEM, V218, P565, DOI 10.1111/j.1432-1033.1993.tb18410.x; Hampton RY, 1996, MOL BIOL CELL, V7, P2029, DOI 10.1091/mbc.7.12.2029; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hirayama H, 2010, J BIOL CHEM, V285, P12390, DOI 10.1074/jbc.M109.082081; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hong E, 1996, J CELL BIOL, V135, P623, DOI 10.1083/jcb.135.3.623; Hoseki J, 2010, J BIOCHEM, V147, P19, DOI 10.1093/jb/mvp194; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Ishida Y, 2009, MOL BIOL CELL, V20, P2744, DOI 10.1091/mbc.E08-11-1092; Jenness DD, 1997, MOL CELL BIOL, V17, P6236, DOI 10.1128/MCB.17.11.6236; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kincaid MM, 2007, MOL BIOL CELL, V18, P455, DOI 10.1091/mbc.E06-08-0696; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Kruse KB, 2006, MOL BIOL CELL, V17, P203, DOI 10.1091/mbc.e04-09-0779; Kuehn MJ, 1996, J CELL BIOL, V135, P585, DOI 10.1083/jcb.135.3.585; Kuehn MJ, 1998, NATURE, V391, P187, DOI 10.1038/34438; Lederkremer GZ, 2009, CURR OPIN STRUC BIOL, V19, P515, DOI 10.1016/j.sbi.2009.06.004; Liu Y, 2006, J BIOL CHEM, V281, P31457, DOI 10.1074/jbc.M606643200; MACHAMER CE, 1988, J BIOL CHEM, V263, P5955; Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Ng DTW, 2000, J CELL BIOL, V150, P77, DOI 10.1083/jcb.150.1.77; Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937; NORMINGTON K, 1989, CELL, V57, P1223, DOI 10.1016/0092-8674(89)90059-7; NUOFFER C, 1991, MOL CELL BIOL, V11, P27, DOI 10.1128/MCB.11.1.27; Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195; Pagant S, 2007, MOL BIOL CELL, V18, P3398, DOI 10.1091/mbc.E07-01-0046; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; ROSE MD, 1989, CELL, V57, P1211, DOI 10.1016/0092-8674(89)90058-5; Sambrook J., 2002, MOL CLONING LAB MANU; SAWANO A, 2000, NUCLEIC ACIDS RES, V28, P78, DOI DOI 10.1093/NAR/28.16.E78; Spear ED, 2003, MOL BIOL CELL, V14, P2756, DOI 10.1091/mbc.E02-11-0717; Spear ED, 2005, J CELL BIOL, V169, P73, DOI 10.1083/jcb.200411136; Suzuki T, 2000, J CELL BIOL, V149, P1039, DOI 10.1083/jcb.149.5.1039; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Taxis C, 2002, MOL BIOL CELL, V13, P1806, DOI 10.1091/mbc.01-08-0399; Thor F, 2009, TRAFFIC, V10, P1819, DOI 10.1111/j.1600-0854.2009.00989.x; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2001, J CELL BIOL, V155, P355, DOI 10.1083/jcb.200106123; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang SY, 2010, MOL BIOL CELL, V21, P1153, DOI 10.1091/mbc.E09-10-0910; Willer M, 2008, J BIOL CHEM, V283, P33883, DOI 10.1074/jbc.M803054200; WINTHER JR, 1991, EUR J BIOCHEM, V197, P681, DOI 10.1111/j.1432-1033.1991.tb15959.x; Xie W, 2009, MOL BIOL CELL, V20, P3317, DOI 10.1091/mbc.E09-03-0231; Yamamoto K, 2001, EMBO J, V20, P3082, DOI 10.1093/emboj/20.12.3082; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4	63	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15532	10.1371/journal.pone.0015532	http://dx.doi.org/10.1371/journal.pone.0015532			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21151492	gold, Green Submitted, Green Published			2022-12-27	WOS:000284572000037
J	Songhet, P; Barthel, M; Rohn, TA; Van Maele, L; Cayet, D; Sirard, JC; Bachmann, M; Kopf, M; Hardt, WD				Songhet, Pascal; Barthel, Manja; Roehn, Till A.; Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude; Bachmann, Martin; Kopf, Manfred; Hardt, Wolf-Dietrich			IL-17A/F-Signaling Does Not Contribute to the Initial Phase of Mucosal Inflammation Triggered by S. Typhimurium	PLOS ONE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; COLONY-STIMULATING FACTOR; SEROVAR TYPHIMURIUM; IL-17 RECEPTOR; NEUTROPHIL RECRUITMENT; KLEBSIELLA-PNEUMONIAE; AIRWAY INFLAMMATION; CUTTING EDGE; HOST-DEFENSE; MOUSE MODEL	Salmonella enterica subspecies 1 serovar Typhimurium ( S. Typhimurium) causes diarrhea and acute inflammation of the intestinal mucosa. The pro-inflammatory cytokines IL-17A and IL-17F are strongly induced in the infected mucosa but their contribution in driving the tissue inflammation is not understood. We have used the streptomycin mouse model to analyze the role of IL-17A and IL-17F and their cognate receptor IL-17RA in S. Typhimurium enterocolitis. Neutralization of IL-17A and IL-17F did not affect mucosal inflammation triggered by infection or spread of S. Typhimurium to systemic sites by 48 h p.i. Similarly, Il17ra(-/-) mice did not display any reduction in infection or inflammation by 12 h p.i. The same results were obtained using S. Typhimurium variants infecting via the TTSS1 type III secretion system, the TTSS1 effector SipA or the TTSS1 effector SopE. Moreover, the expression pattern of 45 genes encoding chemokines/cytokines (including CXCL1, CXCL2, IL-17A, IL-17F, IL-1 alpha, IL-1 beta, IFN gamma, CXCL-10, CXCL-9, IL-6, CCL3, CCL4) and antibacterial molecules was not affected by Il17ra deficiency by 12 h p.i. Thus, in spite of the strong increase in Il17a/Il17f mRNA in the infected mucosa, IL-17RA signaling seems to be dispensable for eliciting the acute disease. Future work will have to address whether this is attributable to redundancy in the cytokine signaling network.	[Songhet, Pascal; Barthel, Manja; Hardt, Wolf-Dietrich] Swiss Fed Inst Technol, Inst Microbiol, D BIOL, Zurich, Switzerland; [Roehn, Till A.; Bachmann, Martin] Cytos Biotechnol AG, Schlieren, Switzerland; [Van Maele, Laurye; Cayet, Delphine; Sirard, Jean-Claude] Univ Lille Nord France, CNRS, Inst Pasteur Lille,Ctr Infect & Immun Lille,U1019, Inst Natl St & Rech Med,UMR 8204, Lille, France; [Kopf, Manfred] Swiss Fed Inst Technol, Inst Integrat Biol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Swiss Federal Institutes of Technology Domain; ETH Zurich	Songhet, P (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, D BIOL, Zurich, Switzerland.	hardt@micro.biol.ethz.ch	Van Maele, Laurye/ABD-3375-2020; Sirard, Jean-Claude/B-5932-2011; Van Maele, Laurye/P-2882-2017; Kopf, Manfred/B-6907-2009	Van Maele, Laurye/0000-0001-9495-5403; Sirard, Jean-Claude/0000-0001-9854-4652; Van Maele, Laurye/0000-0001-9495-5403; Kopf, Manfred/0000-0002-0628-7140; Hardt, Wolf-Dietrich/0000-0002-9892-6420; CAYET, Delphine/0000-0003-1720-0845	Swiss National Science Foundation [310000-113623/1, 310030-132997/1]; KTI; European Union [INCO-CT-2006-032296]; Cytos Biotechnology	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); KTI; European Union(European Commission); Cytos Biotechnology	This work was supported by grants to WDH from the Swiss National Science Foundation (310000-113623/1 and 310030-132997/1), the KTI (to MB and WDH) and a grant to JCS and WDH from the European Union (SavinMucoPath INCO-CT-2006-032296). Funding for the research was also provided by Cytos Biotechnology to MB and TR who are employees of Cytos Biotechnology. However, company policy allows MB and TR to choose and perform their research independently. Thus, the authors would simply like to acknowledge the fact that MB and TR were employed by Cytos Biotechnology and that this funder therefore had no role in the study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Altmeyer M, 2010, INFECT IMMUN, V78, P3420, DOI 10.1128/IAI.00211-10; Barthel M, 2003, INFECT IMMUN, V71, P2839, DOI 10.1128/IAI.71.5.2839-2858.2003; BUONOCORE S, 1923, NATURE, V464, P1371; Claudio E, 2009, J IMMUNOL, V182, P1617, DOI 10.4049/jimmunol.182.3.1617; Coburn B, 2005, INFECT IMMUN, V73, P3219, DOI 10.1128/IAI.73.6.3219-3227.2005; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Godinez I, 2009, INFECT IMMUN, V77, P387, DOI 10.1128/IAI.00933-08; Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008; Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675; Hapfelmeier S, 2004, INFECT IMMUN, V72, P795, DOI 10.1128/IAI.72.2.795-809.2004; Hapfelmeier S, 2008, J EXP MED, V205, P437, DOI 10.1084/jem.20070633; Happel KI, 2005, J EXP MED, V202, P761, DOI 10.1084/jem.20050193; Happel KI, 2003, J IMMUNOL, V170, P4432, DOI 10.4049/jimmunol.170.9.4432; Hornef MW, 2003, J EXP MED, V198, P1225, DOI 10.1084/jem.20022194; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Muller AJ, 2009, CELL HOST MICROBE, V6, P125, DOI 10.1016/j.chom.2009.07.007; NUNES JS, 2010, VET PATHOL; Onishi RM, 2010, IMMUNOLOGY, V129, P311, DOI 10.1111/j.1365-2567.2009.03240.x; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Raffatellu M, 2008, NAT MED, V14, P421, DOI 10.1038/nm1743; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rohn TA, 2006, EUR J IMMUNOL, V36, P2857, DOI 10.1002/eji.200636658; Sonderegger I, 2006, EUR J IMMUNOL, V36, P2849, DOI 10.1002/eji.200636484; Suar M, 2009, INFECT IMMUN, V77, P3569, DOI 10.1128/IAI.00511-09; Uzzau S, 2000, FEMS MICROBIOL LETT, V188, P15, DOI 10.1111/j.1574-6968.2000.tb09161.x; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Wu Q, 2007, MICROBES INFECT, V9, P78, DOI 10.1016/j.micinf.2006.10.012; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Zeng H, 2003, J IMMUNOL, V171, P3668, DOI 10.4049/jimmunol.171.7.3668	38	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e13804	10.1371/journal.pone.0013804	http://dx.doi.org/10.1371/journal.pone.0013804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124903	Green Published, Green Submitted, gold			2022-12-27	WOS:000284527900001
J	Flahou, B; Haesebrouck, F; Pasmans, F; D'Herde, K; Driessen, A; Van Deun, K; Smet, A; Duchateau, L; Chiers, K; Ducatelle, R				Flahou, Bram; Haesebrouck, Freddy; Pasmans, Frank; D'Herde, Katharina; Driessen, Ann; Van Deun, Kim; Smet, Annemieke; Duchateau, Luc; Chiers, Koen; Ducatelle, Richard			Helicobacter suis Causes Severe Gastric Pathology in Mouse and Mongolian Gerbil Models of Human Gastric Disease	PLOS ONE			English	Article							LONG-TERM INFECTION; PYLORI INFECTION; LYMPHOID-TISSUE; MALT LYMPHOMA; INFLAMMATORY RESPONSE; HEILMANNII INFECTION; FELIS INFECTION; IMMUNE-RESPONSE; C57BL/6 MICE; MUCOSA	Background: "Helicobacter (H.) heilmannii type 1 is the most prevalent gastric non-H. pylori Helicobacter species in humans suffering from gastric disease. It has been shown to be identical to H. suis, a bacterium which is mainly associated with pigs. To obtain better insights into the long-term pathogenesis of infections with this micro-organism, experimental infections were carried out in different rodent models. Methodology/Principal Findings: Mongolian gerbils and mice of two strains (BALB/c and C57BL/6) were infected with H. suis and sacrificed at 3 weeks, 9 weeks and 8 months after infection. Gastric tissue samples were collected for PCR analysis, histological and ultrastructural examination. In gerbils, bacteria mainly colonized the antrum and a narrow zone in the fundus near the forestomach/stomach transition zone. In both mice strains, bacteria colonized the entire glandular stomach. Colonization with H. suis was associated with necrosis of parietal cells in all three animal strains. From 9 weeks after infection onwards, an increased proliferation rate of mucosal epithelial cells was detected in the stomach regions colonized with H. suis. Most gerbils showed a marked lymphocytic infiltration in the antrum and in the forestomach/stomach transition zone, becoming more pronounced in the course of time. At 8 months post infection, severe destruction of the normal antral architecture at the inflamed sites and development of mucosa-associated lymphoid tissue (MALT) lymphoma-like lesions were observed in some gerbils. In mice, the inflammatory response was less pronounced than in gerbils, consisting mainly of mononuclear cell infiltration and being most severe in the fundus. Conclusions/Significance: H. suis causes death of parietal cells, epithelial cell hyperproliferation and severe inflammation in mice and Mongolian gerbil models of human gastric disease. Moreover, MALT lymphoma-like lesions were induced in H. suis-infected Mongolian gerbils. Therefore, the possible involvement of this micro-organism in human gastric disease should not be neglected.	[Flahou, Bram; Haesebrouck, Freddy; Pasmans, Frank; Van Deun, Kim; Smet, Annemieke; Chiers, Koen; Ducatelle, Richard] Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium; [D'Herde, Katharina] Univ Ghent, Fac Med & Hlth Sci, Dept Basic Med Sci, B-9000 Ghent, Belgium; [Driessen, Ann] Maastricht Univ, Dept Pathol, Med Ctr, Maastricht, Netherlands; [Duchateau, Luc] Univ Ghent, Fac Vet Med, Dept Comparat Physiol & Biometr, Merelbeke, Belgium	Ghent University; Ghent University; Maastricht University; Ghent University	Flahou, B (corresponding author), Univ Ghent, Fac Vet Med, Dept Pathol Bacteriol & Avian Dis, Merelbeke, Belgium.	bram.flahou@ugent.be	Driessen, Ann/D-3768-2017; D'Herde, Katharina/AAM-4570-2020; Smet, Annemieke/M-9295-2017; Pasmans, Frank/D-3667-2014; Haesebrouck, Freddy/M-3857-2014	Driessen, Ann/0000-0003-4148-610X; D'Herde, Katharina/0000-0001-6591-0476; Smet, Annemieke/0000-0002-1271-6191; Haesebrouck, Freddy/0000-0002-1709-933X	Ghent University, Ghent, Belgium [GOA01G00408]	Ghent University, Ghent, Belgium(Ghent University)	This study was funded by a grant from the Research Fund of Ghent University, Ghent, Belgium (Grant no. GOA01G00408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algood HMS, 2007, FEMS IMMUNOL MED MIC, V51, P577, DOI 10.1111/j.1574-695X.2007.00338.x; Baele M, 2008, INT J SYST EVOL MICR, V58, P1350, DOI 10.1099/ijs.0.65133-0; Baele M, 2009, FEMS IMMUNOL MED MIC, V55, P306, DOI 10.1111/j.1574-695X.2009.00535.x; Cinque SMS, 2006, BRAZ J MED BIOL RES, V39, P253, DOI 10.1590/S0100-879X2006000200012; De Bock M, 2005, J COMP PATHOL, V133, P83, DOI 10.1016/j.jcpa.2005.01.007; De Bock M, 2006, J COMP PATHOL, V135, P226, DOI 10.1016/j.jcpa.2006.08.003; De Groote D, 2005, HELICOBACTER, V10, P398, DOI 10.1111/j.1523-5378.2005.00347.x; De Groote D, 2000, J CLIN MICROBIOL, V38, P1131, DOI 10.1128/JCM.38.3.1131-1135.2000; DEBONGNIE JC, 1995, AM J GASTROENTEROL, V90, P411; Debongnie JC, 1998, EUR J GASTROEN HEPAT, V10, P251, DOI 10.1097/00042737-199803000-00011; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; ENNO A, 1995, AM J PATHOL, V147, P217; Ferrero RL, 2000, J PATHOL, V191, P333; Ferrero RL, 2005, MOL IMMUNOL, V42, P879, DOI 10.1016/j.molimm.2004.12.001; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Flahou B, 2010, HELICOBACTER, V15, P67, DOI 10.1111/j.1523-5378.2009.00736.x; Haesebrouck F, 2009, CLIN MICROBIOL REV, V22, P202, DOI 10.1128/CMR.00041-08; HEINZEL FP, 1989, J EXP MED, V169, P59, DOI 10.1084/jem.169.1.59; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; MARSHALL BJ, 1984, LANCET, V1, P1311; Meyer F, 2000, INFECT IMMUN, V68, P6265, DOI 10.1128/IAI.68.11.6265-6272.2000; Mobley HL, 2001, HELICOBACTER PYLORI; Mohammadi M, 1996, INFECT IMMUN, V64, P238, DOI 10.1128/IAI.64.1.238-245.1996; MORGNER A, 1995, LANCET, V346, P511, DOI 10.1016/S0140-6736(95)91364-5; Morgner A, 2000, GASTROENTEROLOGY, V118, P821, DOI 10.1016/S0016-5085(00)70167-3; MOURA SB, 1993, J MED MICROBIOL, V39, P64, DOI 10.1099/00222615-39-1-64; Mueller R, 1997, LAB INVEST, V76, P117; Nakamura M, 2007, INFECT IMMUN, V75, P1214, DOI 10.1128/IAI.01459-06; Nishikawa K, 2007, FEMS IMMUNOL MED MIC, V50, P268, DOI 10.1111/j.1574-695X.2007.00252.x; O'Rourke JL, 2004, J PATHOL, V203, P896, DOI 10.1002/path.1593; O'Rourke JL, 2003, MICROBES INFECT, V5, P741, DOI 10.1016/S1286-4579(03)00123-0; O'Rourke JL, 2004, INT J SYST EVOL MICR, V54, P2203, DOI 10.1099/ijs.0.63117-0; Park JH, 2003, J COMP PATHOL, V129, P154, DOI 10.1016/S0021-9975(03)00024-0; Park JH, 2008, J COMP PATHOL, V139, P208, DOI 10.1016/j.jcpa.2008.04.005; PARSONNET J, 1994, NEW ENGL J MED, V330, P1267, DOI 10.1056/NEJM199405053301803; PARSONNET J, 1991, NEW ENGL J MED, V325, P1127, DOI 10.1056/NEJM199110173251603; Peterson RA, 2001, VET PATHOL, V38, P173, DOI 10.1354/vp.38-2-173; Rogers AB, 2004, AM J PHYSIOL-GASTR L, V286, pG361, DOI 10.1152/ajpgi.00499.2003; Sakagami T, 1996, GUT, V39, P639, DOI 10.1136/gut.39.5.639; Shiomi S, 2008, HELICOBACTER, V13, P518, DOI 10.1111/j.1523-5378.2008.00629.x; Shirin H, 1998, GUT, V43, P592, DOI 10.1136/gut.43.5.592; Stolte M, 1997, SCAND J GASTROENTERO, V32, P28, DOI 10.3109/00365529709025059; Stolte M, 2002, GUT, V50, P19, DOI 10.1136/gut.50.suppl_3.iii19; Van den Bulck K, 2005, J CLIN MICROBIOL, V43, P2256, DOI 10.1128/JCM.43.5.2256-2260.2005; Wilson KT, 2007, GASTROENTEROLOGY, V133, P288, DOI 10.1053/j.gastro.2007.05.008	45	44	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14083	10.1371/journal.pone.0014083	http://dx.doi.org/10.1371/journal.pone.0014083			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124878	Green Published, gold, Green Submitted			2022-12-27	WOS:000284467200014
J	Simon, AJ; Lev, A; Wolach, B; Gavrieli, R; Amariglio, N; Rosenthal, E; Gazit, E; Eyal, E; Rechavi, G; Somech, R				Simon, Amos J.; Lev, Atar; Wolach, Baruch; Gavrieli, Ronit; Amariglio, Ninette; Rosenthal, Ester; Gazit, Ephraim; Eyal, Eran; Rechavi, Gideon; Somech, Raz			The Effect of Gentamicin-Induced Readthrough on a Novel Premature Termination Codon of CD18 Leukocyte Adhesion Deficiency Patients	PLOS ONE			English	Article							CYSTIC-FIBROSIS; NONSENSE MUTATIONS; ESCHERICHIA-COLI; READ-THROUGH; INTEGRINS; AMINOGLYCOSIDES; TRANSLATION; SUPPRESSION; MODULATION; UAG	Background: Leukocyte adhesion deficiency 1 (LAD1) is an inherited disorder of neutrophil function. Nonsense mutations in the affected CD18 (ITB2) gene have rarely been described. In other genes containing such mutations, treatments with aminoglycoside types of antibiotics (e. g., gentamicin) were reported to partially correct the premature protein termination, by induction of readthrough mechanism. Methodology/Principal Findings: Genetic analysis was performed on 2 LAD1 patients. Expression, functional and immunofluorescence assays of CD18 in the patients were used to determine the in-vivo and in-vitro effects of gentamic-ininduced readthrough. A theoretical modeling of the corrected CD18 protein was developed to predict the protein function. Results: We found a novel premature termination codon, C562T (R188X), in exon 6 of the CD18 gene that caused a severe LAD1 phenotype in two unrelated Palestinian children. In-vivo studies on these patients' cells after gentamicin treatment showed abnormal adhesion and chemotactic functions, while in-vitro studies showed mislocalization of the corrected protein to the cytoplasm and not to the cell surface. A theoretical modeling of the corrected CD18 protein suggested that the replacement of the wild type arginine by gentamicin induced tryptophan at the position of the nonsense mutation, although enabled the expression of the entire CD18 protein, this was not sufficient to stabilize the CD18/11 heterodimer at the cell surface. Conclusion: A novel nonsense mutation in the CD18 gene causing a complete absence of CD18 protein and severe LAD1 clinical phenotype is reported. Both in vivo and in vitro treatments with gentamicin resulted in the expression of a corrected full-length dysfunctional or mislocalized CD18 protein. However, while the use of gentamicin increased the expression of CD18, it did not improve leukocyte adhesion and chemotaxis. Moreover, the integrity of the CD18/CD11 complex at the cell surface was impaired, due to abnormal CD18 protein and possibly lack of CD11a expression.	[Simon, Amos J.; Lev, Atar; Amariglio, Ninette; Eyal, Eran; Rechavi, Gideon; Somech, Raz] Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel; [Simon, Amos J.; Lev, Atar; Wolach, Baruch; Gavrieli, Ronit; Amariglio, Ninette; Rosenthal, Ester; Gazit, Ephraim; Eyal, Eran; Rechavi, Gideon; Somech, Raz] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Simon, Amos J.; Amariglio, Ninette; Rosenthal, Ester] Chaim Sheba Med Ctr, Hematol Lab, IL-52621 Tel Hashomer, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Lab Leukocyte Funct, Kefar Sava, Israel; [Wolach, Baruch; Gavrieli, Ronit] Meir Med Ctr, Dept Pediat, Kefar Sava, Israel; [Gazit, Ephraim] Chaim Sheba Med Ctr, Tissue Typing Lab, IL-52621 Tel Hashomer, Israel; [Somech, Raz] Edmond & Lily Safra Childrens Hosp, Chaim Sheba Med Ctr, Pediat Immunol Serv, Tel Hashomer, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Simon, AJ (corresponding author), Chaim Sheba Med Ctr, Canc Res Ctr, IL-52621 Tel Hashomer, Israel.	raz.somech@sheba.health.gov.il						Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; BACHAR O, 1993, PROTEIN ENG, V6, P279, DOI 10.1093/protein/6.3.279; Bidou L, 2004, GENE THER, V11, P619, DOI 10.1038/sj.gt.3302211; BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77; Brooks DA, 2006, TRENDS MOL MED, V12, P367, DOI 10.1016/j.molmed.2006.06.001; Bunting M, 2002, CURR OPIN HEMATOL, V9, P30, DOI 10.1097/00062752-200201000-00006; Clancy JP, 2007, AM J RESP CELL MOL, V37, P57, DOI 10.1165/rcmb.2006-0173OC; Dinauer Mary C., 2007, V412, P489, DOI 10.1007/978-1-59745-467-4_30; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Fiorini M, 2009, J ALLERGY CLIN IMMUN, V124, P1356, DOI 10.1016/j.jaci.2009.07.058; Guerin K, 2008, EXP EYE RES, V87, P197, DOI 10.1016/j.exer.2008.05.016; Hermann T, 2007, CELL MOL LIFE SCI, V64, P1841, DOI 10.1007/s00018-007-7034-x; Hogg N, 1999, J CLIN INVEST, V103, P97, DOI 10.1172/JCI3312; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Jin YZ, 2004, BLOOD, V104, P4010, DOI 10.1182/blood-2003-05-1592; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Kerem E, 2008, LANCET, V372, P719, DOI 10.1016/S0140-6736(08)61168-X; Lai CH, 2004, P NATL ACAD SCI USA, V101, P15676, DOI 10.1073/pnas.0405155101; LARSON RS, 1989, J CELL BIOL, V108, P703, DOI 10.1083/jcb.108.2.703; Linde L, 2008, TRENDS GENET, V24, P552, DOI 10.1016/j.tig.2008.08.010; Lorusso F, 2006, FERTIL STERIL, V85, DOI 10.1016/j.fertnstert.2005.03.092; Margalit O, 2006, BLOOD, V107, P1599, DOI 10.1182/blood-2005-04-1629; MARTIN R, 1989, MOL GEN GENET, V217, P411, DOI 10.1007/BF02464911; Murphy GJ, 2006, NAT MED, V12, P1093, DOI 10.1038/nm1376; Nilsson M, 2003, BBA-GENE STRUCT EXPR, V1627, P1, DOI 10.1016/S0167-4781(03)00050-2; Nudelman I, 2009, J MED CHEM, V52, P2836, DOI 10.1021/jm801640k; Petersen TK, 1999, VET IMMUNOL IMMUNOP, V68, P283, DOI 10.1016/S0165-2427(99)00016-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinotti M, 2006, J THROMB HAEMOST, V4, P1308, DOI 10.1111/j.1538-7836.2006.01915.x; Roos D, 2002, EXP HEMATOL, V30, P252, DOI 10.1016/S0301-472X(01)00782-2; Rowe SM, 2007, AM J RESP CELL MOL, V37, P347, DOI 10.1165/rcmb.2006-0176OC; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schorry EK, 2008, AM J MED GENET A, V146A, P2512, DOI 10.1002/ajmg.a.32424; Sermet-Gaudelus I, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-5; THOMAS C, 1995, BLOOD, V86, P1629, DOI 10.1182/blood.V86.4.1629.bloodjournal8641629; Wagner KR, 2001, ANN NEUROL, V49, P706, DOI 10.1002/ana.1023.abs; WARDLAW AJ, 1990, J EXP MED, V172, P335, DOI 10.1084/jem.172.1.335; Wilschanski M, 2003, NEW ENGL J MED, V349, P1433, DOI 10.1056/NEJMoa022170; Xi B, 2004, J AM CHEM SOC, V126, P5660, DOI 10.1021/ja0318939	40	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13659	10.1371/journal.pone.0013659	http://dx.doi.org/10.1371/journal.pone.0013659			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103413	Green Submitted, Green Published, gold			2022-12-27	WOS:000284257400001
J	Bisanzio, D; Bertolotti, L; Tomassone, L; Amore, G; Ragagli, C; Mannelli, A; Giacobini, M; Provero, P				Bisanzio, Donal; Bertolotti, Luigi; Tomassone, Laura; Amore, Giusi; Ragagli, Charlotte; Mannelli, Alessandro; Giacobini, Mario; Provero, Paolo			Modeling the Spread of Vector-Borne Diseases on Bipartite Networks	PLOS ONE			English	Article							IXODES-RICINUS ACARI; BORRELIA-LUSITANIAE; TRANSMISSION; IXODIDAE; TUSCANY; PATTERNS; LIZARDS; LARVAE; TICKS; HOSTS	Background: Vector-borne diseases for which transmission occurs exclusively between vectors and hosts can be modeled as spreading on a bipartite network. Methodology/Principal Findings: In such models the spreading of the disease strongly depends on the degree distribution of the two classes of nodes. It is sufficient for one of the classes to have a scale-free degree distribution with a slow enough decay for the network to have asymptotically vanishing epidemic threshold. Data on the distribution of Ixodes ricinus ticks on mice and lizards from two independent studies are well described by a scale-free distribution compatible with an asymptotically vanishing epidemic threshold. The commonly used negative binomial, instead, cannot describe the right tail of the empirical distribution. Conclusions/Significance: The extreme aggregation of vectors on hosts, described by the power-law decay of the degree distribution, makes the epidemic threshold decrease with the size of the network and vanish asymptotically.	[Bisanzio, Donal; Bertolotti, Luigi; Tomassone, Laura; Amore, Giusi; Mannelli, Alessandro; Giacobini, Mario] Univ Turin, Dept Anim Prod Epidemiol & Ecol, Turin, Italy; [Bisanzio, Donal; Bertolotti, Luigi; Giacobini, Mario; Provero, Paolo] Univ Turin, Ctr Mol Biotechnol, Turin, Italy; [Ragagli, Charlotte] Minist Forestry & Agr Polit, State Forestry Dept, Terr Unit Biodivers, Lucca, Italy; [Provero, Paolo] Univ Torino, Dept Genet Biol & Biochem, Turin, Italy	University of Turin; University of Turin; University of Turin	Bisanzio, D (corresponding author), Univ Turin, Dept Anim Prod Epidemiol & Ecol, Turin, Italy.	mario.giacobini@unito.it; paolo.provero@unito.it	Bertolotti, Luigi/F-9236-2013; Tomassone, Laura/J-4524-2012; Provero, Paolo/AAC-1930-2019	Bertolotti, Luigi/0000-0001-7931-4528; Tomassone, Laura/0000-0003-2201-8802; Giacobini, Mario/0000-0002-7647-5649; Bisanzio, Donal/0000-0002-7832-2291; Mannelli, Alessandro/0000-0003-1623-8761	ISI Foundation of Torino, Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy; Associazione Italiana per la Ricerca sul Cancro (AIRC)	ISI Foundation of Torino, Italy; Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro)	The work of D. B. is supported by a Lagrange Fellowship of the ISI Foundation of Torino, Italy. M. G. acknowledges funding by the Ministero dell'Universita e della Ricerca Scientifica e Tecnologica, Italy. P. P. acknowledges funding by the Associazione Italiana per la Ricerca sul Cancro (AIRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amore G, 2007, J MED ENTOMOL, V44, P303, DOI 10.1603/0022-2585(2007)44[303:BLIIIR]2.0.CO;2; ANDERSON RM, 1978, J ANIM ECOL, V47, P219, DOI 10.2307/3933; Barrat A., 2008, DYNAMICAL PROCESSES, DOI 10.1017/cbo9780511791383; BAUWENS D, 1983, HOLARCTIC ECOL, V6, P32; Bertolotti L, 2006, J MED ENTOMOL, V43, P159, DOI 10.1603/0022-2585(2006)043[0159:BLASFG]2.0.CO;2; Bisanzio D, 2008, J MED ENTOMOL, V45, P547, DOI 10.1603/0022-2585(2008)45[547:TVITUO]2.0.CO;2; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Dorogovtsev SN, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.062101; Gern L, 1996, J MED ENTOMOL, V33, P189, DOI 10.1093/jmedent/33.1.189; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Gray J, 2002, LYME BORRELIOSIS BIO; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Matuschka FR, 1998, APPL ENVIRON MICROB, V64, P3089; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; NILSSON A, 1978, OIKOS, V31, P313, DOI 10.2307/3543656; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.035108; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Patrican LA, 1997, J MED ENTOMOL, V34, P52, DOI 10.1093/jmedent/34.1.52; Perkins SE, 2003, INT J PARASITOL, V33, P909, DOI 10.1016/S0020-7519(03)00128-0; Ragagli C, 2011, VECTOR-BORNE ZOONOT, V11, P21, DOI 10.1089/vbz.2008.0195; RANDOLPH SE, 1995, J MED ENTOMOL, V32, P765, DOI 10.1093/jmedent/32.6.765; Randolph SE, 1999, PARASITOLOGY, V118, P177, DOI 10.1017/S0031182098003643; Shaw DJ, 1998, PARASITOLOGY, V117, P597, DOI 10.1017/S0031182098003448; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Zhou T, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.046115	27	23	24	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13796	10.1371/journal.pone.0013796	http://dx.doi.org/10.1371/journal.pone.0013796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103064	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700002
J	Hartholt, KA; van der Velde, N; Looman, CWN; Panneman, MJM; Van Beeck, EF; Patka, P; van der Cammen, TJM				Hartholt, Klaas A.; van der Velde, Nathalie; Looman, Caspar W. N.; Panneman, Martien J. M.; Van Beeck, Ed F.; Patka, Peter; van der Cammen, Tischa J. M.			Adverse Drug Reactions Related Hospital Admissions in Persons Aged 60 Years and over, The Netherlands, 1981-2007: Less Rapid Increase, Different Drugs	PLOS ONE			English	Article							EMERGENCY-DEPARTMENT VISITS; ELDERLY-PEOPLE; THERAPY; EVENTS	Background: Epidemiologic information on time trends of Adverse Drug Reactions (ADR) and ADR-related hospitalizations is scarce. Over time, pharmacotherapy has become increasingly complex. Because of raised awareness of ADR, a decrease in ADR might be expected. The aim of this study was to determine trends in ADR-related hospitalizations in the older Dutch population. Methodology and Principal Findings: Secular trend analysis of ADR-related hospital admissions in patients >= 60 years between 1981 and 2007, using the National Hospital Discharge Registry of the Netherlands. Numbers, age-specific and age-adjusted incidence rates (per 10,000 persons) of ADR-related hospital admissions were used as outcome measures in each year of the study. Between 1981 and 2007, ADR-related hospital admissions in persons >= 60 years increased by 143%. The overall standardized incidence rate increased from 23.3 to 38.3 per 10,000 older persons. The increase was larger in males than in females. Since 1997, the increase in incidence rates of ADR-related hospitalizations flattened (percentage annual change 0.65%), compared to the period 1981-1996 (percentage annual change 2.56%). Conclusion/Significance: ADR-related hospital admissions in older persons have shown a rapidly increasing trend in the Netherlands over the last three decades with a temporization since 1997. Although an encouraging flattening in the increasing trend of ADR-related admissions was found around 1997, the incidence is still rising, which warrants sustained attention to this problem.	[Hartholt, Klaas A.; van der Velde, Nathalie; van der Cammen, Tischa J. M.] Univ Med Ctr, Erasmus MC, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands; [Hartholt, Klaas A.; Patka, Peter] Univ Med Ctr, Erasmus MC, Dept Surg Traumatol, Rotterdam, Netherlands; [Looman, Caspar W. N.; Van Beeck, Ed F.] Univ Med Ctr, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Panneman, Martien J. M.] Consumer & Safety Inst, Amsterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Hartholt, KA (corresponding author), Univ Med Ctr, Erasmus MC, Dept Internal Med, Geriatr Med Sect, Rotterdam, Netherlands.	t.vandercammen@erasmusmc.nl	Hartholt, Klaas A/Q-1782-2016	Hartholt, Klaas A/0000-0001-5019-9239; van der Velde, Nathalie/0000-0002-6477-6209	Netherlands Organization for Health Research and Development (ZonMw) [170.885.607]	Netherlands Organization for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	Klaas Hartholt is a research fellow at the Erasmus MC, appointed on a research grant from The Netherlands Organization for Health Research and Development (ZonMw), project number 170.885.607. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou A, 2008, EUR J INTERN MED, V19, P505, DOI 10.1016/j.ejim.2007.06.030; Barat I, 2001, BRIT J CLIN PHARMACO, V51, P615, DOI 10.1046/j.0306-5251.2001.01401.x; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Brvar Miran, 2009, BMC Clin Pharmacol, V9, P8, DOI 10.1186/1472-6904-9-8; Budnitz DS, 2006, JAMA-J AM MED ASSOC, V296, P1858, DOI 10.1001/jama.296.15.1858; Budnitz DS, 2007, ANN INTERN MED, V147, P755, DOI 10.7326/0003-4819-147-11-200712040-00006; Burgess CL, 2005, MED J AUSTRALIA, V182, P267, DOI 10.5694/j.1326-5377.2005.tb06698.x; CASPERS PWJ, 2004, MEDICATION SAFETY SO, P1; Eguale T, 2008, DRUG SAFETY, V31, P1005, DOI 10.2165/00002018-200831110-00005; *FDN PHARM STAT SF, 2009, PHARMACEUTISCH WEEKB, V144; Fialova D, 2005, JAMA-J AM MED ASSOC, V293, P1348, DOI 10.1001/jama.293.11.1348; Hartholt KA, 2010, ARCH INTERN MED, V170, P905, DOI 10.1001/archinternmed.2010.106; HURWITZ N, 1969, BRIT MED J, V1, P536, DOI 10.1136/bmj.1.5643.536; Khong Teck K, 2002, Expert Opin Pharmacother, V3, P1289; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Langley J, 2006, INJURY PREV, V12, P58, DOI 10.1136/ip.2005.010173; Langley J, 2002, INJ PREV, V8, P332, DOI 10.1136/ip.8.4.332; Leendertse AJ, 2008, ARCH INTERN MED, V168, P1890, DOI 10.1001/archinternmed.2008.3; Mallet L, 2007, LANCET, V370, P185, DOI 10.1016/S0140-6736(07)61092-7; Mannesse CK, 2000, AGE AGEING, V29, P35, DOI 10.1093/ageing/29.1.35; McLean AJ, 2004, PHARMACOL REV, V56, P163, DOI 10.1124/pr.56.2.4; MCNEIL DR, 1977, DEMOGRAPHY, V14, P245, DOI 10.2307/2060581; Meerding Willem Jan, 2006, Eur J Public Health, V16, P272, DOI 10.1093/eurpub/ckl006; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Noble RE, 2003, METABOLISM, V52, P27, DOI 10.1053/S0026-0495(03)00298-1; Onder G, 2010, ARCH INTERN MED, V170, P1142, DOI 10.1001/archinternmed.2010.153; PAAS G, 2002, RELIABLITY LMR DATAB; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; PERENBOOM R, HLTH LIFE EXPECTANCY, P3; Somers A, 2003, EUR J CLIN PHARMACOL, V58, P707, DOI 10.1007/s00228-002-0535-5; Spinewine A, 2007, LANCET, V370, P173, DOI 10.1016/S0140-6736(07)61091-5; *STAT NETH CBS, 2009, HEALTHC US HOSP ADM; *STAT NETH CBS, 2010, US HEALTHC SERV NETH; Swoboda WJ, 1999, PHARMACOEPIDEM DR S, V8, pS47, DOI 10.1002/(SICI)1099-1557(199904)8:1+<S47::AID-PDS408>3.3.CO;2-C; United Nations, 2007, WORLD POP PROSP 2006; *US GAO, 2000, ADV DRUG EV MAGN HLT; van der Hooft CS, 2008, PHARMACOEPIDEM DR S, V17, P365, DOI 10.1002/pds.1565; van der Hooft CS, 2006, DRUG SAFETY, V29, P161, DOI 10.2165/00002018-200629020-00006; VANSIJL M, 2005, CORRECTING MISSING D; Zhang Min, 2009, BMJ, V338, pa2752, DOI 10.1136/bmj.a2752	40	43	43	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13977	10.1371/journal.pone.0013977	http://dx.doi.org/10.1371/journal.pone.0013977			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103046	Green Published, gold, Green Submitted			2022-12-27	WOS:000284147700022
J	Mukhopadhyay, A; Bandyopadhyay, S; Maulik, U				Mukhopadhyay, Anirban; Bandyopadhyay, Sanghamitra; Maulik, Ujjwal			Multi-Class Clustering of Cancer Subtypes through SVM Based Ensemble of Pareto-Optimal Solutions for Gene Marker Identification	PLOS ONE			English	Article							EXPRESSION; CLASSIFICATION; ALGORITHM; DIFFERENTIATION; PREDICTION; PATTERNS; TUMOR	With the advancement of microarray technology, it is now possible to study the expression profiles of thousands of genes across different experimental conditions or tissue samples simultaneously. Microarray cancer datasets, organized as samples versus genes fashion, are being used for classification of tissue samples into benign and malignant or their subtypes. They are also useful for identifying potential gene markers for each cancer subtype, which helps in successful diagnosis of particular cancer types. In this article, we have presented an unsupervised cancer classification technique based on multiobjective genetic clustering of the tissue samples. In this regard, a real-coded encoding of the cluster centers is used and cluster compactness and separation are simultaneously optimized. The resultant set of near-Pareto-optimal solutions contains a number of non-dominated solutions. A novel approach to combine the clustering information possessed by the non-dominated solutions through Support Vector Machine (SVM) classifier has been proposed. Final clustering is obtained by consensus among the clusterings yielded by different kernel functions. The performance of the proposed multiobjective clustering method has been compared with that of several other microarray clustering algorithms for three publicly available benchmark cancer datasets. Moreover, statistical significance tests have been conducted to establish the statistical superiority of the proposed clustering method. Furthermore, relevant gene markers have been identified using the clustering result produced by the proposed clustering method and demonstrated visually. Biological relationships among the gene markers are also studied based on gene ontology. The results obtained are found to be promising and can possibly have important impact in the area of unsupervised cancer classification as well as gene marker identification for multiple cancer subtypes.	[Mukhopadhyay, Anirban] Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India; [Bandyopadhyay, Sanghamitra] Indian Stat Inst, Machine Intelligence Unit, Kolkata, W Bengal, India; [Maulik, Ujjwal] Jadavpur Univ, Dept Comp Sci & Engn, Kolkata, W Bengal, India	Kalyani University; Indian Statistical Institute; Indian Statistical Institute Kolkata; Jadavpur University	Mukhopadhyay, A (corresponding author), Univ Kalyani, Dept Comp Sci & Engn, Kalyani 741235, W Bengal, India.	anirban@klyuniv.ac.in	Mukhopadhyay, Anirban/ABB-5739-2021; Bandyopadhyay, Sanghamitra/AAO-7010-2020; Bandyopadhyay, Sanghamitra/AAP-4578-2020; Maulik, Ujjwal/AAO-8754-2020; Bandyopadhyay, Sanghamitra/A-6597-2010; Mukhopadhyay, Anirban/H-3220-2012	Mukhopadhyay, Anirban/0000-0001-8128-3521; Bandyopadhyay, Sanghamitra/0000-0001-6370-2083; Maulik, Ujjwal/0000-0003-1167-0774	Department of Science and Technology, India [DST/INT/MEX/RPO-04/2008(ii)]	Department of Science and Technology, India(Department of Science & Technology (India))	SB and UM acknowledge Department of Science and Technology, India (Grant No. DST/INT/MEX/RPO-04/2008(ii)) for partially supporting this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Bandyopadhyay S, 2007, BIOINFORMATICS, V23, P2859, DOI 10.1093/bioinformatics/btm418; Bandyopadhyay S, 2007, IEEE T GEOSCI REMOTE, V45, P1506, DOI 10.1109/TGRS.2007.892604; Chlenski A, 2002, CANCER RES, V62, P7357; Coello CAC, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.1597059; Crammer K., 2001, J MACHINE LEARNING R, V2, P265; de Souto MCP, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-497; Deb K, 2003, BIOSYSTEMS, V72, P111, DOI 10.1016/S0303-2647(03)00138-2; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Deb K., 2001, MULTIOBJECTIVE OPTIM; Goldberg D.E., 1989, GENETIC ALGORITHMS S; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Handl J, 2007, IEEE T EVOLUT COMPUT, V11, P56, DOI 10.1109/TEVC.2006.877146; HEDBORG F, 1995, AM J PATHOL, V146, P833; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK., 1988, TECHNOMETRICS; Khan J, 2001, NAT MED, V7, P673, DOI 10.1038/89044; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; KUMAR KP, 2007, P 15 INT C ADV COMP, P75; Kwon S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-23; Luo Fei, 2008, 2008 2nd International Conference on Bioinformatics and Biomedical Engineering (ICBBE '08), P1912, DOI 10.1109/ICBBE.2008.807; Maulik U, 2003, IEEE T GEOSCI REMOTE, V41, P1075, DOI 10.1109/TGRS.2003.810924; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; Maulik U, 2000, PATTERN RECOGN, V33, P1455, DOI 10.1016/S0031-3203(99)00137-5; MELINO G, 1993, NEUROSCI LETT, V151, P187, DOI 10.1016/0304-3940(93)90017-F; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Schaefer KL, 2004, CANCER RES, V64, P3395, DOI 10.1158/0008-5472.CAN-03-0809; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tamayo P, 1999, P NATL ACAD SCI USA, V96, P2907, DOI 10.1073/pnas.96.6.2907; Vapnik V., 1998, STAT LEARNING THEORY; Ward T, 1998, J VIROL, V72, P5360, DOI 10.1128/JVI.72.7.5360-5365.1998; Yeung KY, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-5-r34; Zitzler E., 1998, EVOLUTIONARY ALGORIT, V1-43, P1; Zitzler E, 2001, EVOLUTIONARY METHODS	37	36	36	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13803	10.1371/journal.pone.0013803	http://dx.doi.org/10.1371/journal.pone.0013803			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103052	Green Published, gold			2022-12-27	WOS:000284147700003
J	Chen, JP; Rossiter, SJ; Flanders, JR; Sun, YH; Hua, PY; Miller-Butterworth, C; Liu, XS; Rajan, KE; Zhang, SY				Chen, Jinping; Rossiter, Stephen J.; Flanders, Jonathan R.; Sun, Yanhong; Hua, Panyu; Miller-Butterworth, Cassandra; Liu, Xusheng; Rajan, Koilmani E.; Zhang, Shuyi			Contrasting Genetic Structure in Two Co-Distributed Species of Old World Fruit Bat	PLOS ONE			English	Article							GREATER HORSESHOE BAT; CYNOPTERUS-SPHINX; COMPARATIVE PHYLOGEOGRAPHY; SOCIAL-STRUCTURE; ROUSETTUS-LESCHENAULTI; COMPUTER-PROGRAM; POPULATION; CONSEQUENCES; MITOCHONDRIAL; DISTANCES	The fulvous fruit bat (Rousettus leschenaulti) and the greater short-nosed fruit bat (Cynopterus sphinx) are two abundant and widely co-distributed Old World fruit bats in Southeast and East Asia. The former species forms large colonies in caves while the latter roots in small groups in trees. To test whether these differences in social organization and roosting ecology are associated with contrasting patterns of gene flow, we used mtDNA and nuclear loci to characterize population genetic subdivision and phylogeographic histories in both species sampled from China, Vietnam and India. Our analyses from R. leschenaulti using both types of marker revealed little evidence of genetic structure across the study region. On the other hand, C. sphinx showed significant genetic mtDNA differentiation between the samples from India compared with China and Vietnam, as well as greater structuring of microsatellite genotypes within China. Demographic analyses indicated signatures of past rapid population expansion in both taxa, with more recent demographic growth in C. sphinx. Therefore, the relative genetic homogeneity in R. leschenaulti is unlikely to reflect past events. Instead we suggest that the absence of substructure in R. leschenaulti is a consequence of higher levels of gene flow among colonies, and that greater vagility in this species is an adaptation associated with cave roosting.	[Chen, Jinping; Sun, Yanhong] Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China; [Rossiter, Stephen J.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Flanders, Jonathan R.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Sun, Yanhong; Liu, Xusheng] Huazhong Normal Univ, Wuhan, Peoples R China; [Hua, Panyu; Zhang, Shuyi] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China; [Miller-Butterworth, Cassandra] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Rajan, Koilmani E.] Bharathidasan Univ, Sch Life Sci, Dept Anim Sci, Tiruchirappalli, Tamil Nadu, India	Guangdong Academy of Sciences; Institute of Zoology, Guangdong Academy of Sciences; University of London; Queen Mary University London; University of Bristol; Central China Normal University; East China Normal University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Bharathidasan University	Chen, JP (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	s.j.rossiter@qmul.ac.uk; syzhang@bio.ecnu.edu.cn	Miller-Butterworth, Cassandra/H-5994-2013; Zhang, Shuyi/B-5117-2011; Rossiter, Stephen J/E-2111-2011; Rajan, Koilman Emmanuvel/GSM-7214-2022	Flanders, Jon/0000-0001-7296-9601; Rossiter, Stephen/0000-0002-3881-4515	National "985" Project; National Science Foundation [31071905]; Guangdong Province Academy of Science [CX2007]; Royal Society (UK)	National "985" Project; National Science Foundation(National Science Foundation (NSF)); Guangdong Province Academy of Science; Royal Society (UK)(Royal Society of London)	This work was supported by the Key Construction Program of the National "985" Project to SY Zhang and a National Science Foundation grant (31071905) and innovation project grant (CX2007) of Guangdong Province Academy of Science to JP Chen. S Rossiter is supported by a Royal Society Research Fellowship (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADVANI R, 1982, Saeugetierkundliche Mitteilungen, V30, P49; Aeshita M, 2006, ACTA CHIROPTEROL, V8, P417, DOI 10.3161/1733-5329(2006)8[417:OAMVIT]2.0.CO;2; Anderson B, 2004, EVOLUTION, V58, P1730, DOI 10.1111/j.0014-3820.2004.tb00457.x; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Arbogast BS, 1998, SCIENCE, V282, P1955; Bailey NW, 2007, MOL ECOL, V16, P2079, DOI 10.1111/j.1365-294X.2007.03265.x; BELKHIR K, 2004, GENETIX 4 05 WINDOWS; Campbell P, 2004, MOL PHYLOGENET EVOL, V33, P764, DOI 10.1016/j.ympev.2004.06.019; Castella V, 2000, MOL ECOL, V9, P1761, DOI 10.1046/j.1365-294x.2000.01069.x; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; EXCOFFIER L, 2009, ARLEQUIN VERSION 3 0, P47; Flanders J, 2009, MOL ECOL, V18, P306, DOI 10.1111/j.1365-294X.2008.04021.x; FLANDERS JR, 2010, J BIOGEOGRA IN PRESS; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hardy OJ, 2003, GENETICS, V163, P1467; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kraaijeveld-Smit FJL, 2007, OIKOS, V116, P1819, DOI 10.1111/j.0030-1299.2007.16087.x; Li G, 2006, J MAMMAL, V87, P1234, DOI 10.1644/05-MAMM-A-395R2.1; Michalakis Y, 1996, GENETICS, V142, P1061; Mickleburgh S.P., 1992, OLD WORLD FRUIT BATS; Miller-Butterworth CM, 2003, NATURE, V424, P187, DOI 10.1038/nature01742; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Qu JY, 2009, MOL PHYLOGENET EVOL, V52, P125, DOI 10.1016/j.ympev.2009.03.015; Qu Y, 2010, MOL ECOL, V19, P338, DOI 10.1111/j.1365-294X.2009.04445.x; Racey P.A., 1982, P57; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rossiter SJ, 2007, MOL ECOL, V16, P4699, DOI 10.1111/j.1365-294X.2007.03546.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shilton LA, 1999, P ROY SOC B-BIOL SCI, V266, P219, DOI 10.1098/rspb.1999.0625; Simmons N.B., 2005, MAMMAL SPECIES WORLD; Storz JF, 2001, EVOLUTION, V55, P1224; Storz JF, 2001, EVOLUTION, V55, P1215; Storz JF, 2000, J ZOOL, V251, P151; Struebig MJ, 2009, BIOL CONSERV, V142, P2089, DOI 10.1016/j.biocon.2009.04.005; Vanlalnghaka C, 2005, BIOL RHYTHM RES, V36, P453, DOI 10.1080/09291010500287568; Wang Y. X., 2003, COMPLETE CHECKLIST M; Zink RM, 1996, EVOLUTION, V50, P308, DOI 10.1111/j.1558-5646.1996.tb04494.x	45	24	26	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13903	10.1371/journal.pone.0013903	http://dx.doi.org/10.1371/journal.pone.0013903			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085717	gold, Green Published, Green Accepted			2022-12-27	WOS:000284036800010
J	Sune, G; Sarro, E; Puigmule, M; Lopez-Hellin, J; Zufferey, M; Pertel, T; Luban, J; Meseguer, A				Sune, Guillermo; Sarro, Eduard; Puigmule, Marta; Lopez-Hellin, Joan; Zufferey, Madeleine; Pertel, Thomas; Luban, Jeremy; Meseguer, Anna			Cyclophilin B Interacts with Sodium-Potassium ATPase and Is Required for Pump Activity in Proximal Tubule Cells of the Kidney	PLOS ONE			English	Article							CYCLOSPORINE-INDUCED NEPHROTOXICITY; PROTEIN-KINASE-C; NA+-K+-ATPASE; BETA-SUBUNIT; NA,K-ATPASE; INHIBITION; TRAFFICKING; MECHANISMS; COMPLEXES; APOPTOSIS	Cyclophilins (Cyps), the intracellular receptors for Cyclosporine A (CsA), are responsible for peptidyl-prolyl cis-trans isomerisation and for chaperoning several membrane proteins. Those functions are inhibited upon CsA binding. Albeit its great benefits as immunosuppressant, the use of CsA has been limited by undesirable nephrotoxic effects, including sodium retention, hypertension, hyperkalemia, interstial fibrosis and progressive renal failure in transplant recipients. In this report, we focused on the identification of novel CypB-interacting proteins to understand the role of CypB in kidney function and, in turn, to gain further insight into the molecular mechanisms of CsA-induced toxicity. By means of yeast two-hybrid screens with human kidney cDNA, we discovered a novel interaction between CypB and the membrane Na/K-ATPase beta 1 subunit protein (Na/K-beta 1) that was confirmed by pull-down, co-immunoprecipitation and confocal microscopy, in proximal tubule-derived HK-2 cells. The Na/K-ATPase pump, a key plasma membrane transporter, is responsible for maintenance of electrical Na+ and K+ gradients across the membrane. We showed that CypB silencing produced similar effects on Na/K-ATPase activity than CsA treatment in HK-2 cells. It was also observed an enrichment of both alpha and beta subunits in the ER, what suggested a possible failure on the maturation and routing of the pump from this compartment towards the plasma membrane. These data indicate that CypB through its interaction with Na/K-beta 1 might regulate maturation and trafficking of the pump through the secretory pathway, offering new insights into the relationship between cyclophilins and the nephrotoxic effects of CsA.	[Sune, Guillermo; Sarro, Eduard; Puigmule, Marta; Lopez-Hellin, Joan; Meseguer, Anna] Hosp Univ Vall dHebron, Inst Recerca Vall dHebron VHIR, CIBBIM, Barcelona, Spain; [Meseguer, Anna] Univ Autonoma Barcelona, Fac Med, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Zufferey, Madeleine; Pertel, Thomas; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; University of Barcelona; University of Geneva	Sune, G (corresponding author), Hosp Univ Vall dHebron, Inst Recerca Vall dHebron VHIR, CIBBIM, Barcelona, Spain.	ameseguer@ir.vhebron.net	Sarró Tauler, Eduard/M-1660-2014; Navarro, Anna Meseguer/M-2222-2014; Lopez-Hellin, Joan/M-2234-2014	Sarró Tauler, Eduard/0000-0001-7723-2916; Navarro, Anna Meseguer/0000-0003-3833-2249; Lopez-Hellin, Joan/0000-0001-7286-3882; Puigmule, Marta/0000-0001-7881-8839; Luban, Jeremy/0000-0001-5650-4054; Pertel, Thomas/0000-0002-2286-6011	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion [FIS PI081351]; Ministerio de Educacion y Ciencia (MEC) [SAF2005-05167]; Fundacio La Marato de TV3 [002230]; Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena; Swiss National Science Foundation; National Institute of Allergy and Infectious Diseases (USA)	Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Fundacio La Marato de TV3; Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institute of Allergy and Infectious Diseases (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants FIS PI081351 (Instituto de Salud Carlos III, Ministerio de Ciencia e Innovacion) SAF2005-05167 from Ministerio de Educacion y Ciencia (MEC), grant 002230 from Fundacio La Marato de TV3, from Fundacion Renal Inigo Alvarez de Toledo (FRIAT), Fundacion SENEFRO y Fundacion Mutua Madrilena to Dr. Anna Meseguer (AM). Funding was also provided by grants from the Swiss National Science Foundation and the National Institute of Allergy and Infectious Diseases (USA) to Dr. Jeremy Luban. Guillermo Sune was a predoctoral recipient fellow (FPI) from the CIRIT (Consell Interdepartamental de Recerca i Innovacio Tecnologica). Anna Meseguer's research group holds the Quality Mention from the Generalitat de Catalunya (2009SGR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baer PC, 1999, EXP NEPHROL, V7, P306; Baldridge D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010560; BATLLE DC, 1986, CLIN NEPHROL, V25, pS62; BLAIR JT, 1982, J PATHOL, V138, P163, DOI 10.1002/path.1711380206; Bobadilla NA, 2007, AM J PHYSIOL-RENAL, V293, pF2, DOI 10.1152/ajprenal.00072.2007; BOREL JF, 1990, PHARMACOL REV, V41, P259; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; CAPASSO G, 1990, AM J HYPERTENS, V3, P204, DOI 10.1093/ajh/3.3.204; Chen YL, 2009, J BIOL CHEM, V284, P14881, DOI 10.1074/jbc.M109.003574; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Espineda CE, 2004, MOL BIOL CELL, V15, P1364, DOI 10.1091/mbc.E03-09-0646; Fang F, 2009, AM J PATHOL, V174, P297, DOI 10.2353/ajpath.2009.080753; GEERING K, 1989, AM J PHYSIOL, V257, pC851, DOI 10.1152/ajpcell.1989.257.5.C851; Geering K, 1996, J CELL BIOL, V133, P1193, DOI 10.1083/jcb.133.6.1193; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; Healy E, 1998, KIDNEY INT, V54, P1955, DOI 10.1046/j.1523-1755.1998.00202.x; KAMEL KS, 1992, J AM SOC NEPHROL, V2, P1279; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim J, 2008, J CELL SCI, V121, P3636, DOI 10.1242/jcs.028654; LEA JP, 1994, KIDNEY INT, V46, P647, DOI 10.1038/ki.1994.317; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Marks AR, 1996, PHYSIOL REV, V76, P631, DOI 10.1152/physrev.1996.76.3.631; Meunier L, 2002, MOL BIOL CELL, V13, P4456, DOI 10.1091/mbc.E02-05-0311; MORELLO R, 2007, NAT GENET, V39, P359; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Ominato M, 1996, J MEMBRANE BIOL, V152, P235, DOI 10.1007/s002329900101; Oriji GK, 1999, AM J HYPERTENS, V12, P1091, DOI 10.1016/S0895-7061(99)00089-8; PRICE ER, 1994, P NATL ACAD SCI USA, V91, P3931, DOI 10.1073/pnas.91.9.3931; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; Puigmule M, 2009, NEPHROL DIAL TRANSPL, V24, P2672, DOI 10.1093/ndt/gfp149; Rajasekaran AK, 2003, ANN NY ACAD SCI, V986, P649, DOI 10.1111/j.1749-6632.2003.tb07276.x; Rajasekaran SA, 2009, FRONT BIOSCI-LANDMRK, V14, P2130, DOI 10.2741/3367; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sarro E, 2008, KIDNEY INT, V73, P77, DOI 10.1038/sj.ki.5002638; Seki T, 2005, J PHARMACOL SCI, V97, P132, DOI 10.1254/jphs.FP0040574; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; Stabach PR, 2008, AM J PHYSIOL-CELL PH, V295, pC1202, DOI 10.1152/ajpcell.00273.2008; Streblow DN, 1998, VIROLOGY, V245, P197, DOI 10.1006/viro.1998.9155; SUTHERLAND DER, 1984, AM J KIDNEY DIS, V3, P456, DOI 10.1016/S0272-6386(84)80010-4; SUZUKI S, 1987, TRANSPLANTATION, V44, P363, DOI 10.1097/00007890-198709000-00008; Taylor P, 1997, PROG BIOPHYS MOL BIO, V67, P155, DOI 10.1016/S0079-6107(97)00014-X; TUMLIN JA, 1993, KIDNEY INT, V43, P246, DOI 10.1038/ki.1993.38; Ueno S, 1997, BIOSCIENCE REP, V17, P173, DOI 10.1023/A:1027333529412; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; Yurchenko V, 2010, CLIN EXP IMMUNOL, V160, P305, DOI 10.1111/j.1365-2249.2010.04115.x	47	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13930	10.1371/journal.pone.0013930	http://dx.doi.org/10.1371/journal.pone.0013930			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085665	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800021
J	Van Dyck, S; Flammang, P; Meriaux, C; Bonnel, D; Salzet, M; Fournier, I; Wisztorski, M				Van Dyck, Severine; Flammang, Patrick; Meriaux, Celine; Bonnel, David; Salzet, Michel; Fournier, Isabelle; Wisztorski, Maxence			Localization of Secondary Metabolites in Marine Invertebrates: Contribution of MALDI MSI for the Study of Saponins in Cuvierian Tubules of H. forskali	PLOS ONE			English	Article							IMAGING MASS-SPECTROMETRY; DIRECT TISSUE-ANALYSIS; SEA-CUCUMBERS; TRITERPENE GLYCOSIDES; TROPICAL HOLOTHURIANS; NATURAL-PRODUCTS; ECHINODERMATA; HOLOTHUROIDEA; DEFENSE; MIXTURE	Background: Several species of sea cucumbers of the family Holothuriidae possess a particular mechanical defense system called the Cuvierian tubules (Ct). It is also a chemical defense system as triterpene glycosides (saponins) appear to be particularly concentrated in Ct. In the present study, the precise localization of saponins in the Ct of Holothuria forskali is investigated. Classical histochemical labeling using lectin was firstly performed but did not generate any conclusive results. Thus, MALDI mass spectrometry Imaging (MALDI-MSI) was directly applied and completed by statistical multivariate tests. A comparison between the tubules of relaxed and stressed animals was realized. Results: These analyses allowed the detection of three groups of ions, corresponding to the isomeric saponins of the tubules. Saponins detected at m/z 1287 and 1303 were the most abundant and were apparently localized in the connective tissue of the tubules of both relaxed and stressed individuals. Saponins at m/z 1125 and 1141 were detected in lower amount and were present in tissues of relaxed animals. Finally, saponin ions at 1433, 1449, 1463 and 1479 were observed in some Ct of stressed holothuroids in the outer part of the connective tissue. The saponin group m/z 14xx seems therefore to be stress-specific and could originate from modifications of the saponins with m/z of 11xx. Conclusions: All the results taken together indicate a complex chemical defense mechanism with, for a single organ, different sets of saponins originating from different cell populations and presenting different responses to stress. The present study also reflects that MALDI-MSI is a valuable tool for chemical ecology studies in which specific chemical signalling molecules like allelochemicals or pheromones have to be tracked. This report represents one of the very first studies using these tools to provide a functional and ecological understanding of the role of natural products from marine invertebrates.	[Van Dyck, Severine; Flammang, Patrick] Univ Mons UMONS, Marine Biol Lab, Mons, Belgium; [Meriaux, Celine; Bonnel, David; Salzet, Michel; Fournier, Isabelle; Wisztorski, Maxence] Univ Lille Nord France USTL, Lab Neuroimmunol & Neurochim Evolut, Villeneuve Dascq, France	University of Mons; Universite de Lille - ISITE; Universite de Lille	Van Dyck, S (corresponding author), Univ Mons UMONS, Marine Biol Lab, Mons, Belgium.	maxence.wisztorski@univ-lille1.fr	Flammang, Patrick/H-9465-2019; FOURNIER, Isabelle/H-9195-2015; Wisztorski, Maxence/F-4380-2010; Salzet, Michel/A-7675-2011	Flammang, Patrick/0000-0001-9938-1154; FOURNIER, Isabelle/0000-0003-1096-5044; Wisztorski, Maxence/0000-0003-1320-075X; Salzet, Michel/0000-0003-4318-0817; Meriaux, Celine/0000-0002-2413-2599	Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche; Conseil Regional Nord-Pas de Calais; FRIA (Belgium); Fund for Scientific Research of Belgium; FRFC [2.4535.10]; Institut du Cancer	Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche(Centre National de la Recherche Scientifique (CNRS)); Conseil Regional Nord-Pas de Calais(Region Hauts-de-France); FRIA (Belgium)(Fonds de la Recherche Scientifique - FNRS); Fund for Scientific Research of Belgium; FRFC(Fonds de la Recherche Scientifique - FNRS); Institut du Cancer(Institut National du Cancer (INCA) France)	The MALDI Imaging Team was supported by the Centre National de la Recherche Scientifique (CNRS), Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, Agence Nationale de la Recherche, the Institut du Cancer, the Conseil Regional Nord-Pas de Calais. SVD benefited from a FRIA doctoral grant (Belgium). PF is Senior Research Associate of the Fund for Scientific Research of Belgium (F.R.S.-FNRS). Work was supported by a FRFC Grant no 2.4535.10. This study is a contribution of the "Centre Interuniversitaire de Biologie Marine" (CIBIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKUS GJ, 1968, MAR BIOL, V2, P23, DOI 10.1007/BF00351634; Becker PT, 2010, BIOLOGICAL ADHESIVE SYSTEMS: FROM NATURE TO TECHNICAL AND MEDICAL APPLICATION, P87, DOI 10.1007/978-3-7091-0286-2_6; BINGHAM BL, 1986, J EXP MAR BIOL ECOL, V98, P311, DOI 10.1016/0022-0981(86)90220-0; DASILVA J, 1986, MAR BEHAV PHYSIOL, V12, P133, DOI 10.1080/10236248609378640; ELYAKOV GB, 1973, COMP BIOCHEM PHYSIOL, V44, P325, DOI 10.1016/0305-0491(73)90005-9; Esquenazi E, 2009, P NATL ACAD SCI USA, V106, P7269, DOI 10.1073/pnas.0902840106; Fang SP, 1998, RAPID COMMUN MASS SP, V12, P589, DOI 10.1002/(SICI)1097-0231(19980529)12:10<589::AID-RCM200>3.0.CO;2-Q; Flammang P, 2002, INTEGR COMP BIOL, V42, P1107, DOI 10.1093/icb/42.6.1107; Francese S, 2009, COMB CHEM HIGH T SCR, V12, P156, DOI 10.2174/138620709787315454; Franck J, 2009, MOL CELL PROTEOMICS, V8, P2023, DOI 10.1074/mcp.R800016-MCP200; Francour P, 1997, INVERTEBR BIOL, V116, P52, DOI 10.2307/3226924; GOLDSTEIN U, 1986, LECTINS; Guo MQ, 2006, ANAL CHIM ACTA, V557, P198, DOI 10.1016/j.aca.2005.10.056; Hamel JF, 2000, MAR FRESHW BEHAV PHY, V33, P115, DOI 10.1080/10236240009387085; Hayat MA, 1993, STAINS CYTOCHEMICAL; Hsieh Yunsheng, 2007, Journal of Pharmacological and Toxicological Methods, V55, P193, DOI 10.1016/j.vascn.2006.06.004; Kalinin V.I., 1996, Echinoderm Studies, V5, P139; Kalinin VI, 2000, J THEOR BIOL, V206, P151, DOI 10.1006/jtbi.2000.2110; Kalinin VI, 1996, TOXICON, V34, P475, DOI 10.1016/0041-0101(95)00142-5; KALYANI G A, 1988, Indian Journal of Natural Products, V4, P3; KOBAYASHI M, 1991, CHEM PHARM BULL, V39, P2282; Lemaire R, 2006, ANAL CHEM, V78, P7145, DOI 10.1021/ac060565z; Lemaire R, 2006, ANAL CHEM, V78, P809, DOI 10.1021/ac0514669; Madl T, 2006, J AM SOC MASS SPECTR, V17, P795, DOI 10.1016/j.jasms.2006.02.013; MASSIN C, 1976, CAH BIOL MAR, V17, P45; POPOV AM, 2002, IZV AKAD NAUK BIOL+, V2, P155; Seeley EH, 2008, J AM SOC MASS SPECTR, V19, P1069, DOI 10.1016/j.jasms.2008.03.016; Simmons TL, 2008, P NATL ACAD SCI USA, V105, P4587, DOI 10.1073/pnas.0709851105; SMITH DF, 1983, BIOCHEM BIOPH RES CO, V115, P360, DOI 10.1016/0006-291X(83)91012-4; Van de Plas R, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P458; Van Dyck S, 2010, MAR DRUGS, V8, P173, DOI 10.3390/md8010173; Van Dyck S, 2009, COMP BIOCHEM PHYS B, V152, P124, DOI 10.1016/j.cbpb.2008.10.011; VANDENSPIEGEL D, 1987, MAR BIOL, V96, P263, DOI 10.1007/BF00427026; Vandenspiegel D, 2000, BIOL BULL-US, V198, P34, DOI 10.2307/1542802; VANDYCK S, 2010, J EXP BIOL UNPUB; Verbist J.F., 1993, Echinoderm Studies, V4, P111; Wisztorski M, 2008, DEV NEUROBIOL, V68, P845, DOI 10.1002/dneu.20623	37	35	35	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13923	10.1371/journal.pone.0013923	http://dx.doi.org/10.1371/journal.pone.0013923			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZN	21085713	Green Published, gold, Green Submitted			2022-12-27	WOS:000284036800014
J	Ovchinnikov, IV; Kholina, OI				Ovchinnikov, Igor V.; Kholina, Olga I.			Genome Digging: Insight into the Mitochondrial Genome of Homo	PLOS ONE			English	Article							DNA POLYMORPHISMS; MIDDLE PLEISTOCENE; DIVERGENCE TIMES; NEANDERTHAL DNA; SEQUENCE; EVOLUTION; RECONSTRUCTION; SCHIZOPHRENIA; PSEUDOGENES; DIVERSITY	Background: A fraction of the Neanderthal mitochondrial genome sequence has a similarity with a 5,839-bp nuclear DNA sequence of mitochondrial origin (numt) on the human chromosome 1. This fact has never been interpreted. Although this phenomenon may be attributed to contamination and mosaic assembly of Neanderthal mtDNA from short sequencing reads, we explain the mysterious similarity by integration of this numt (mtAncestor-1) into the nuclear genome of the common ancestor of Neanderthals and modern humans not long before their reproductive split. Principal Findings: Exploiting bioinformatics, we uncovered an additional numt (mtAncestor-2) with a high similarity to the Neanderthal mtDNA and indicated that both numts represent almost identical replicas of the mtDNA sequences ancestral to the mitochondrial genomes of Neanderthals and modern humans. In the proteins, encoded by mtDNA, the majority of amino acids distinguishing chimpanzees from humans and Neanderthals were acquired by the ancestral hominins. The overall rate of nonsynonymous evolution in Neanderthal mitochondrial protein-coding genes is not higher than in other lineages. The model incorporating the ancestral hominin mtDNA sequences estimates the average divergence age of the mtDNAs of Neanderthals and modern humans to be 450,000-485,000 years. The mtAncestor-1 and mtAncestor-2 sequences were incorporated into the nuclear genome approximately 620,000 years and 2,885,000 years ago, respectively. Conclusions: This study provides the first insight into the evolution of the mitochondrial DNA in hominins ancestral to Neanderthals and humans. We hypothesize that mtAncestor-1 and mtAncestor-2 are likely to be molecular fossils of the mtDNAs of Homo heidelbergensis and a stem Homo lineage. The d(N)/d(S) dynamics suggests that the effective population size of extinct hominins was low. However, the hominin lineage ancestral to humans, Neanderthals and H. heidelbergensis, had a larger effective population size and possessed genetic diversity comparable with those of chimpanzee and gorilla.	[Ovchinnikov, Igor V.] Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA; [Ovchinnikov, Igor V.] Univ N Dakota, Forens Sci Program, Grand Forks, ND 58201 USA	University of North Dakota Grand Forks; University of North Dakota Grand Forks	Ovchinnikov, IV (corresponding author), Univ N Dakota, Dept Biol, Grand Forks, ND 58202 USA.	igor.ovtchinnikov@und.edu						Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Belle EMS, 2005, GENE, V355, P58, DOI 10.1016/j.gene.2005.05.019; Bensasson D, 2001, TRENDS ECOL EVOL, V16, P314, DOI 10.1016/S0169-5347(01)02151-6; Bensasson D, 2003, J MOL EVOL, V57, P343, DOI 10.1007/s00239-003-2485-7; Bensasson D, 2001, MOL BIOL EVOL, V18, P246, DOI 10.1093/oxfordjournals.molbev.a003798; Briggs AW, 2009, SCIENCE, V325, P318, DOI 10.1126/science.1174462; Chang BSW, 2002, MOL BIOL EVOL, V19, P1483, DOI 10.1093/oxfordjournals.molbev.a004211; Crow TJ, 1995, EUR NEUROPSYCHOPHARM, V5, P59, DOI 10.1016/0924-977X(95)00032-K; Dean B, 2009, AUST NZ J PSYCHIAT, V43, P13, DOI 10.1080/00048670802534416; Evans PD, 2006, P NATL ACAD SCI USA, V103, P18178, DOI 10.1073/pnas.0606966103; GOJOBORI T, 1982, J MOL EVOL, V18, P360, DOI 10.1007/BF01733904; Gonder MK, 2007, MOL BIOL EVOL, V24, P757, DOI 10.1093/molbev/msl209; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; Hardy J, 2005, BIOCHEM SOC T, V33, P582, DOI 10.1042/BST0330582; Hazkani-Covo E, 2007, MOL BIOL EVOL, V24, P13, DOI 10.1093/molbev/msl149; Hazkani-Covo E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000834; Herrnstadt C, 1999, GENOMICS, V60, P67, DOI 10.1006/geno.1999.5907; HIGUCHI R, 1984, NATURE, V312, P282, DOI 10.1038/312282a0; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; JURKA J, 1995, NUCLEIC ACIDS RES, V23, P170, DOI 10.1093/nar/23.1.170; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2001, MOL PSYCHIATR, V6, P625, DOI 10.1038/sj.mp.4000926; Kazuno AA, 2006, PLOS GENET, V2, P1167, DOI 10.1371/journal.pgen.0020128; Khaitovich P, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r124; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krings M, 1997, CELL, V90, P19, DOI 10.1016/S0092-8674(00)80310-4; Krishnan NM, 2004, MOL BIOL EVOL, V21, P1871, DOI 10.1093/molbev/msh198; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Lascaro D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-267; Levy Samuel, 2007, PLoS Biol, V5, pe254, DOI 10.1371/journal.pbio.0050254; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McMahon FJ, 2000, AM J PSYCHIAT, V157, P1058, DOI 10.1176/appi.ajp.157.7.1058; Niemi AK, 2005, EUR J HUM GENET, V13, P166, DOI 10.1038/sj.ejhg.5201308; Noonan JP, 2006, SCIENCE, V314, P1113, DOI 10.1126/science.1131412; Ovchinnikov IV, 2000, NATURE, V404, P490, DOI 10.1038/35006625; Prabakaran S, 2004, MOL PSYCHIATR, V9, P684, DOI 10.1038/sj.mp.4001511; Premo LS, 2009, P NATL ACAD SCI USA, V106, P33, DOI 10.1073/pnas.0809194105; Raaum RL, 2005, J HUM EVOL, V48, P237, DOI 10.1016/j.jhevol.2004.11.007; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rand DM, 1996, MOL BIOL EVOL, V13, P735, DOI 10.1093/oxfordjournals.molbev.a025634; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Rightmire G.P., 2000, Human Evolution, V15, P63, DOI 10.1007/BF02436235; Rightmire GP, 2008, EVOL ANTHROPOL, V17, P8, DOI 10.1002/evan.20160; Rightmire GP, 2009, P NATL ACAD SCI USA, V106, P16046, DOI 10.1073/pnas.0903930106; Rightmire GP, 1998, EVOL ANTHROPOL, V6, P218, DOI 10.1002/(SICI)1520-6505(1998)6:6<218::AID-EVAN4>3.0.CO;2-6; Robson SL, 2008, J ANAT, V212, P394, DOI 10.1111/j.1469-7580.2008.00867.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruff CB, 1997, NATURE, V387, P173, DOI 10.1038/387173a0; Ruiz-Pesini E, 2007, NUCLEIC ACIDS RES, V35, pD823, DOI 10.1093/nar/gkl927; STACKHOUSE J, 1990, FEBS LETT, V262, P104, DOI 10.1016/0014-5793(90)80164-E; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Tvrdik P, 2006, DEV CELL, V11, P239, DOI 10.1016/j.devcel.2006.06.016; van der Walt JM, 2004, NEUROSCI LETT, V365, P28, DOI 10.1016/j.neulet.2004.04.051; van der Walt JM, 2003, AM J HUM GENET, V72, P804, DOI 10.1086/373937; Weaver TD, 2008, P NATL ACAD SCI USA, V105, P4645, DOI 10.1073/pnas.0709079105; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Yang ZH, 2006, MOL BIOL EVOL, V23, P212, DOI 10.1093/molbev/msj024; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e14278	10.1371/journal.pone.0014278	http://dx.doi.org/10.1371/journal.pone.0014278			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151557	gold, Green Submitted, Green Published			2022-12-27	WOS:000285135800010
J	Rosen, O; Manor, R; Weil, S; Gafni, O; Linial, A; Aflalo, ED; Ventura, T; Sagi, A				Rosen, Ohad; Manor, Rivka; Weil, Simy; Gafni, Ohad; Linial, Assaf; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir			A Sexual Shift Induced by Silencing of a Single Insulin-Like Gene in Crayfish: Ovarian Upregulation and Testicular Degeneration	PLOS ONE			English	Article							CHERAX-QUADRICARINATUS DECAPODA; ANDROGENIC GLAND HORMONE; RED CLAW CRAYFISH; REPRODUCTIVE-SYSTEM; MOLECULAR-CLONING; GROWTH-FACTOR; INTERSEX; IMPLANTATION; CDNA; DISRUPTION	In sequential hermaphrodites, intersexuality occurs naturally, usually as a transition state during sexual re-differentiation processes. In crustaceans, male sexual differentiation is controlled by the male-specific androgenic gland (AG). An AG-specific insulin-like gene, previously identified in the red-claw crayfish Cherax quadricarinatus (designated Cq-IAG), was found in this study to be the prominent transcript in an AG cDNA subtractive library. In C. quadricarinatus, sexual plasticity is exhibited by intersex individuals in the form of an active male reproductive system and male secondary sex characters, along with a constantly arrested ovary. This intersexuality was exploited to follow changes caused by single gene silencing, accomplished via dsRNA injection. Cq-IAG silencing induced dramatic sex-related alterations, including male feature feminization, a reduction in sperm production, extensive testicular degeneration, expression of the vitellogenin gene, and accumulation of yolk proteins in the developing oocytes. Upon silencing of the gene, AG cells hypertrophied, possibly to compensate for low hormone levels, as reflected in the poor production of the insulin-like hormone (and revealed by immunohistochemistry). These results demonstrate both the functionality of Cq-IAG as an androgenic hormone-encoding gene and the dependence of male gonad viability on the Cq-IAG product. This study is the first to provide evidence that silencing an insulin-like gene in intersex C. quadricarinatus feminizes male-related phenotypes. These findings, moreover, contribute to the understanding of the regulation of sexual shifts, whether naturally occurring in sequential hermaphrodites or abnormally induced by endocrine disruptors found in the environment, and offer insight into an unusual gender-related link to the evolution of insulins.	[Rosen, Ohad; Manor, Rivka; Weil, Simy; Gafni, Ohad; Linial, Assaf; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Rosen, Ohad; Manor, Rivka; Gafni, Ohad; Aflalo, Eliahu D.; Ventura, Tomer; Sagi, Amir] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Rosen, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel.	sagia@bgu.ac.il	Aflalo, Eliahu/F-1484-2012; Ventura, T./H-9832-2019	Ventura, T./0000-0002-0777-2367; Sagi, Amir/0000-0002-4229-1059; Aflalo, Eli/0000-0003-1385-2387	United States-Israel Binational Agricultural Research and Development Fund (BARD) [QB-9308-06]; Australia-Israel Scientific Exchange Foundation (AISEF)	United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation); Australia-Israel Scientific Exchange Foundation (AISEF)	This research was supported by Research Grant No. QB-9308-06 from the United States-Israel Binational Agricultural Research and Development Fund (BARD) and a fellowship (to O.R.) from the Australia-Israel Scientific Exchange Foundation (AISEF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdu U, 2002, GEN COMP ENDOCR, V127, P263, DOI 10.1016/S0016-6480(02)00053-9; Aflalo ED, 2006, AQUACULTURE, V256, P468, DOI 10.1016/j.aquaculture.2006.01.035; BAUER RT, 1986, BIOL BULL, V170, P11, DOI 10.2307/1541377; Bauer RT, 2002, BIOL BULL-US, V203, P347, DOI 10.2307/1543577; Belgacem YH, 2006, J NEUROBIOL, V66, P19, DOI 10.1002/neu.20193; Biondi B, 2008, ENDOCR REV, V29, P76, DOI 10.1210/er.2006-0043; Boscolo H. K., 2005, Braz. J. Biol., V65, P29, DOI 10.1590/S1519-69842005000100006; BROOK HJ, 1994, BIOL BULL, V187, P99, DOI 10.2307/1542169; Charniaux-Cotton H., 1988, Endocrinology of selected invertebrate types., P279; CHARNIAUX-COTTON HELENE, 1962, GEN AND COMP ENDOCRINOL SUPPL, V1, P241, DOI 10.1016/0016-6480(62)90095-3; CHARNIAUXCOTTON H, 1958, CR HEBD ACAD SCI, V246, P2814; CHARNIAUXCOTTON H, 1954, CR HEBD ACAD SCI, V238, P953; Glenner H, 2006, SCIENCE, V314, P1883, DOI 10.1126/science.1129844; Kawamura K, 2004, P NATL ACAD SCI USA, V101, P7323, DOI 10.1073/pnas.0307061101; Khalaila I, 1999, J EXP ZOOL, V283, P286, DOI 10.1002/(SICI)1097-010X(19990215)283:3&lt;286::AID-JEZ6&gt;3.0.CO;2-R; Khalaila I, 2002, GEN COMP ENDOCR, V127, P147, DOI 10.1016/S0016-6480(02)00031-X; Khalaila I, 2001, GEN COMP ENDOCR, V121, P242, DOI 10.1006/gcen.2001.7607; Kloas W, 2009, ANN NY ACAD SCI, V1163, P187, DOI 10.1111/j.1749-6632.2009.04453.x; Kokokiris L, 2006, GEN COMP ENDOCR, V149, P42, DOI 10.1016/j.ygcen.2006.05.002; Lelbach A., 2005, ACTA PHYSIOLOGICA HUNGARICA, V92, P97, DOI 10.1556/APhysiol.92.2005.2.1; Lugo JM, 2006, FEBS J, V273, P5669, DOI 10.1111/j.1742-4658.2006.05555.x; Maniatis T., 1982, MOL CLONING; Manor R, 2004, INVERTEBR REPROD DEV, V45, P151, DOI 10.1080/07924259.2004.9652584; Manor R, 2007, GEN COMP ENDOCR, V150, P326, DOI 10.1016/j.ygcen.2006.09.006; Nakahara Y, 2006, J INSECT PHYSIOL, V52, P105, DOI 10.1016/j.jinsphys.2005.09.009; Nandi S, 1999, BIOL REPROD, V61, P70, DOI 10.1095/biolreprod61.1.70; Nef S, 2003, NATURE, V426, P291, DOI 10.1038/nature02059; Nijhout HF, 2002, P NATL ACAD SCI USA, V99, P15446, DOI 10.1073/pnas.242548399; Ohira T, 2003, ZOOL SCI, V20, P75, DOI 10.2108/zsj.20.75; Okuno A, 2002, PEPTIDES, V23, P567, DOI 10.1016/S0196-9781(01)00635-0; Okuno A, 1999, BIOCHEM BIOPH RES CO, V264, P419, DOI 10.1006/bbrc.1999.1522; Olmstead AW, 2007, INT J BIOL SCI, V3, P77; Parnes S, 2003, GENET RES, V82, P107, DOI 10.1017/S0016672303006372; Sagi A, 1999, GEN COMP ENDOCR, V115, P37, DOI 10.1006/gcen.1999.7277; Sagi A, 1996, BIOL BULL, V190, P16, DOI 10.2307/1542672; Sagi A, 2002, INVERTEBR REPROD DEV, V41, P27, DOI 10.1080/07924259.2002.9652732; Shechter A, 2008, P NATL ACAD SCI USA, V105, P7129, DOI 10.1073/pnas.0800193105; Suzuki S, 1998, GEN COMP ENDOCR, V111, P367, DOI 10.1006/gcen.1998.7121; Taketomi Y, 1996, J CRUSTACEAN BIOL, V16, P232, DOI 10.2307/1548879; Telonis-Scott M, 2009, GENETICS, V181, P421, DOI 10.1534/genetics.108.096743; THORNE M J, 1991, Memoirs of the Queensland Museum, V31, P277; Uchida D, 2002, J EXP BIOL, V205, P711; Ventura T, 2009, ENDOCRINOLOGY, V150, P1278, DOI 10.1210/en.2008-0906; WARNER RR, 1975, AM NAT, V109, P61, DOI 10.1086/282974	44	111	117	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15281	10.1371/journal.pone.0015281	http://dx.doi.org/10.1371/journal.pone.0015281			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	692ES	21151555	Green Published, Green Submitted, gold			2022-12-27	WOS:000285135800023
J	Simpson-Lavy, KJ; Brandeis, M				Simpson-Lavy, Kobi J.; Brandeis, Michael			Cdk1 and SUMO Regulate Swe1 Stability	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SYNAPTONEMAL COMPLEX; BUDDING YEAST; PROTEIN SMT3P; DNA-REPAIR; SUMOYLATION; LIGASE; PHOSPHORYLATION; RECOMBINATION; MORPHOGENESIS	The Swe1/Wee1 kinase phosphorylates and inhibits Cdk1-Clb2 and is a major mitotic switch. Swe1 levels are controlled by ubiquitin mediated degradation, which is regulated by interactions with various mitotic kinases. We have recently reported that Swe1 levels are capable of sensing the progress of the cell cycle by measuring the levels of Cdk1-Clb2, Cdc5 and Hsl1. We report here a novel mechanism that regulates the levels of Swe1. We show that S. cerevisiae Swe1 is modified by Smt3/SUMO on residue K594 in a Cdk1 dependant manner. A degradation of the swe1(K594R) mutant that cannot be modified by Smt3 is considerably delayed in comparison to wild type Swe1. Swe1(K594R) cells express elevated levels of Swe1 protein and demonstrate higher levels of Swe1 activity as manifested by Cdk1-Y19 phosphorylation. Interestingly this mutant is not targeted, like wild type Swe1, to the bud neck where Swe1 degradation takes place. We show that Swe1 is SUMOylated by the Siz1 SUMO ligase, and consequently siz1 Delta cells express elevated levels of Swe1 protein and activity. Finally we show that swe1(K594R) cells are sensitive to osmotic stress, which is in line with their compromised regulation of Swe1 degradation.	[Simpson-Lavy, Kobi J.; Brandeis, Michael] Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Simpson-Lavy, KJ (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Silberman Inst Life Sci, IL-91904 Jerusalem, Israel.	brandeis@cc.huji.ac.il			US-Israel Binational Science Foundation [BSF 2007288]; Israel Cancer Research Fund (ICRF)	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Cancer Research Fund (ICRF)	This research was funded by grant BSF 2007288 from the US-Israel Binational Science Foundation, and a grant from the Israel Cancer Research Fund (ICRF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2000, CELL, V102, P245, DOI 10.1016/S0092-8674(00)00029-5; Asano S, 2005, EMBO J, V24, P2194, DOI 10.1038/sj.emboj.7600683; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; BOOHER RN, 1993, EMBO J, V12, P3417, DOI 10.1002/j.1460-2075.1993.tb06016.x; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Chen XL, 2005, MOL CELL BIOL, V25, P4311, DOI 10.1128/MCB.25.10.4311-4320.2005; Cheng CH, 2006, GENE DEV, V20, P2067, DOI 10.1101/gad.1430406; Clotet J, 2006, EMBO J, V25, P2338, DOI 10.1038/sj.emboj.7601095; Harvey SL, 2005, CELL, V122, P407, DOI 10.1016/j.cell.2005.05.029; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hood-DeGrenier JK, 2007, CURR GENET, V51, P1, DOI 10.1007/s00294-006-0102-1; Hu FF, 2005, P NATL ACAD SCI USA, V102, P8910, DOI 10.1073/pnas.0406987102; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kats ES, 2009, MOL CELL BIOL, V29, P5226, DOI 10.1128/MCB.00894-09; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu H, 2006, MOL BIOL CELL, V17, P2746, DOI 10.1091/mbc.E05-11-1093; Longtine MS, 2000, MOL CELL BIOL, V20, P4049, DOI 10.1128/MCB.20.11.4049-4061.2000; McMillan JN, 2002, MOL BIOL CELL, V13, P3560, DOI 10.1091/mbc.E02-05-0283; O'Rourke SM, 2002, TRENDS GENET, V18, P405, DOI 10.1016/S0168-9525(02)02723-3; Reindle A, 2006, J CELL SCI, V119, P4749, DOI 10.1242/jcs.03243; RUSSELL P, 1989, CELL, V57, P295, DOI 10.1016/0092-8674(89)90967-7; Sakchaisri K, 2004, P NATL ACAD SCI USA, V101, P4124, DOI 10.1073/pnas.0400641101; SIMPSONLAVY KJA, 2010, CELL CYCLE IN PRESS; Takahashi T, 2001, MOL GENET GENOMICS, V265, P1112, DOI 10.1007/s004380100510; Takahashi Y, 2005, J BIOL CHEM, V280, P35822, DOI 10.1074/jbc.M506794200; Takahashi Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000215; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 6	2010	5	12							e15089	10.1371/journal.pone.0015089	http://dx.doi.org/10.1371/journal.pone.0015089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690IB	21151918	Green Published, gold, Green Submitted			2022-12-27	WOS:000284995300014
J	Strigo, IA; Simmons, AN; Matthews, SC; Craig, AD				Strigo, Irina A.; Simmons, Alan N.; Matthews, Scott C.; Craig, Arthur D. (Bud)			The Relationship between Amygdala Activation and Passive Exposure Time to an Aversive Cue during a Continuous Performance Task	PLOS ONE			English	Article							COGNITIVE MODULATION; EMOTION; PAIN; ANTICIPATION; ATTENTION; BRAIN; ANXIETY; HUMANS; FEAR	The allocation of attention modulates negative emotional processing in the amygdala. However, the role of passive exposure time to emotional signals in the modulation of amygdala activity during active task performance has not been examined. In two functional Magnetic Resonance Imaging (fMRI) experiments conducted in two different groups of healthy human subjects, we examined activation in the amygdala due to cued anticipation of painful stimuli while subjects performed a simple continuous performance task (CPT) with either a fixed or a parametrically varied trial duration. In the first experiment (N = 16), engagement in the CPT during a task with fixed trial duration produced the expected attenuation of amygdala activation, but close analysis suggested that the attenuation occurred during the period of active engagement in CPT, and that amygdala activity increased proportionately during the remainder of each trial, when subjects were passively exposed to the pain cue. In the second experiment (N = 12), the duration of each trial was parametrically varied, and we found that amygdala activation was linearly related to the time of passive exposure to the anticipatory cue. We suggest that amygdala activation during negative anticipatory processing depends directly on the passive exposure time to the negative cue.	[Strigo, Irina A.; Simmons, Alan N.; Matthews, Scott C.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Strigo, Irina A.; Simmons, Alan N.; Matthews, Scott C.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Craig, Arthur D. (Bud)] Barrow Neurol Inst, Div Neurosurg, Phoenix, AZ 85013 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Barrow Neurological Institute	Strigo, IA (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	istrigo@ucsd.edu	strigo, irina A/L-9882-2016; Simmons, Alan N/A-9815-2008	strigo, irina A/0000-0002-8799-716X; Simmons, Alan N/0000-0003-3963-2112	National Institute of Mental Health (NIMH) [MH080003]; Barrow Neurological Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH080003, R00MH080003] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Barrow Neurological Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health (NIMH) to IAS (MH080003) and the Barrow Neurological Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorapanth P, 2000, NAT NEUROSCI, V3, P74, DOI 10.1038/71145; Bantick SJ, 2002, BRAIN, V125, P310, DOI 10.1093/brain/awf022; Blair KS, 2007, NEUROIMAGE, V35, P430, DOI 10.1016/j.neuroimage.2006.11.048; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dalton KM, 2005, NAT NEUROSCI, V8, P519, DOI 10.1038/nn1421; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Erk S, 2006, EUR J NEUROSCI, V24, P1227, DOI 10.1111/j.1460-9568.2006.04976.x; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; Gozzi A, 2010, NEURON, V67, P656, DOI 10.1016/j.neuron.2010.07.008; Herwig U, 2007, NEUROIMAGE, V37, P652, DOI 10.1016/j.neuroimage.2007.05.023; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LeDoux J. E., 1996, EMOTIONAL BRAIN; Ledoux JE, 2001, AM J PSYCHIAT, V158, P1953, DOI 10.1176/appi.ajp.158.12.1953; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; PAPE HC, PHYSL REV, V90, P419; Pessoa L, 2002, P NATL ACAD SCI USA, V99, P11458, DOI 10.1073/pnas.172403899; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Schaefer A, 2006, J NEUROSCI, V26, P10120, DOI 10.1523/JNEUROSCI.2567-06.2006; Schaefer SM, 2002, J COGNITIVE NEUROSCI, V14, P913, DOI 10.1162/089892902760191135; Simmons A, 2006, BIOL PSYCHIAT, V60, P402, DOI 10.1016/j.biopsych.2006.04.038; SPITZER RL, 1992, ARCH GEN PSYCHIAT, V49, P624; Strigo IA, 2008, ARCH GEN PSYCHIAT, V65, P1275, DOI 10.1001/archpsyc.65.11.1275; Talairach J., 1988, COPLANAR STEREOTAXIC; Tracey I, 2002, J NEUROSCI, V22, P2748, DOI 10.1523/JNEUROSCI.22-07-02748.2002; Valet M, 2004, PAIN, V109, P399, DOI 10.1016/j.pain.2004.02.033; van Reekum CM, 2007, NEUROIMAGE, V36, P1041, DOI 10.1016/j.neuroimage.2007.03.052; Wiech K, 2005, NEUROIMAGE, V27, P59, DOI 10.1016/j.neuroimage.2005.03.044; Yantis S., 1996, CONVERGING OPERATION, P45, DOI DOI 10.1037/10187-002	30	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e15093	10.1371/journal.pone.0015093	http://dx.doi.org/10.1371/journal.pone.0015093			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124739	gold, Green Published, Green Submitted			2022-12-27	WOS:000284686500037
J	Wang, BZ; Xu, R; Quan, FS; Kang, SM; Wang, L; Compans, RW				Wang, Bao-Zhong; Xu, Rui; Quan, Fu-Shi; Kang, Sang-Moo; Wang, Li; Compans, Richard W.			Intranasal Immunization with Influenza VLPs Incorporating Membrane-Anchored Flagellin Induces Strong Heterosubtypic Protection	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; SIMIAN IMMUNODEFICIENCY VIRUS; GRAM-NEGATIVE FLAGELLIN; MUCOSAL IMMUNIZATION; IMMUNE-RESPONSES; EFFECTIVE ADJUVANT; CROSS-PROTECTION; VACCINE; DELIVERY; CHALLENGE	We demonstrated previously that the incorporation of a membrane-anchored form of flagellin into influenza virus-like particles (VLPs) improved the immunogenicity of VLPs significantly, inducing partially protective heterosubtypic immunity by intramuscular immunization. Because the efficacy of mucosal vaccination is highly dependent on an adjuvant, and is particularly effective for preventing mucosal infections such as influenza, we determined whether the membrane-anchored flagellin is an efficient adjuvant for VLP vaccines by a mucosal immunization route. We compared the adjuvant effect of membrane-anchored and soluble flagellins for immunization with influenza A/PR8 (H1N1) VLPs by the intranasal route in a mouse model. The results demonstrate that membrane-anchored flagellin is an effective adjuvant for intranasal (IN) immunization, inducing enhanced systemic and mucosal antibody responses. High cellular responses were also observed as shown by cytokine production in splenocyte cultures when stimulated with viral antigens. All mice immunized with flagellin-containing VLPs survived challenge with a high lethal dose of homologous virus as well as a high dose heterosubtypic virus challenge (40 LD(50) of A/Philippines/82, H3N2). In contrast, no protection was observed with a standard HA/M1 VLP group upon heterosubtypic challenge. Soluble flagellin exhibited a moderate adjuvant effect when co-administered with VLPs by the mucosal route, as indicated by enhanced systemic and mucosal responses and partial heterosubtypic protection. The membrane-anchored form of flagellin incorporated together with antigen into influenza VLPs is effective as an adjuvant by the mucosal route and unlike standard VLPs, immunization with such chimeric VLPs elicits protective immunity to challenge with a distantly related influenza A virus.	[Wang, Bao-Zhong] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Emory University	Wang, BZ (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rcompan@emory.edu	Quan, Fu-Shi/V-1826-2019; Compans, Richard W/I-4087-2013	Compans, Richard W/0000-0003-2360-335X; Wang, Bao-Zhong/0000-0002-1561-4318	National Institutes of Health [AI068003, AI074579]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074579, R01AI068003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by grants from the National Institutes of Health (AI068003 & AI074579). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaldi F, 2008, VACCINE, V26, P1525, DOI 10.1016/j.vaccine.2008.01.019; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; COMPANS RW, 1974, J VIROL, V14, P1307, DOI 10.1128/JVI.14.5.1307-1309.1974; Cuadros C, 2004, INFECT IMMUN, V72, P2810, DOI 10.1128/IAI.72.5.2810-2816.2004; Eriksson K, 2002, CURR OPIN IMMUNOL, V14, P666, DOI 10.1016/S0952-7915(02)00384-9; Freytag LC, 2005, VACCINE, V23, P1804, DOI 10.1016/j.vaccine.2004.11.010; Fujihashi K, 2002, VACCINE, V20, P2431, DOI 10.1016/S0264-410X(02)00155-X; GREGORIADIS G, 1990, IMMUNOL TODAY, V11, P89, DOI 10.1016/0167-5699(90)90034-7; Hay AJ, 2001, PHILOS T R SOC B, V356, P1861, DOI 10.1098/rstb.2001.0999; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Kang SM, 2003, J VIROL, V77, P9823, DOI 10.1128/JVI.77.18.9823-9830.2003; Kang SM, 2003, J VIROL, V77, P3615, DOI 10.1128/JVI.77.6.3615-3623.2003; Kreijtz JHCM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007790; KUNOSAKAI H, 1994, VACCINE, V12, P1303, DOI 10.1016/S0264-410X(94)80056-6; Levi R, 1996, VACCINE, V14, P85, DOI 10.1016/0264-410X(95)00088-I; McCluskie MJ, 2001, VACCINE, V19, P3759, DOI 10.1016/S0264-410X(01)00088-3; McSorley SJ, 2002, J IMMUNOL, V169, P3914, DOI 10.4049/jimmunol.169.7.3914; Mestecky J, 2005, MUCOSAL IMMUNOLOGY, 3RD EDITION, P153, DOI 10.1016/B978-012491543-5/50013-9; Mizel SB, 2003, J IMMUNOL, V170, P6217, DOI 10.4049/jimmunol.170.12.6217; Moors MA, 2001, INFECT IMMUN, V69, P4424, DOI 10.1128/IAI.69.7.4424-4429.2001; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Neutra MR, 2006, NAT REV IMMUNOL, V6, P148, DOI 10.1038/nri1777; NOVAK M, 1993, VACCINE, V11, P55, DOI 10.1016/0264-410X(93)90339-Y; Nugent J, 1998, J CLIN PHARM THER, V23, P257; OKADA H, 1995, CRIT REV THER DRUG, V12, P1; Palese P, 2002, J CLIN INVEST, V110, P9, DOI 10.1172/JCI200215999; PARHAM P, 2000, IMMUNE SYSTEM, P31; Poland GA, 2007, VACCINE, V25, P3057, DOI 10.1016/j.vaccine.2007.01.050; Quan FS, 2008, J VIROL, V82, P1350, DOI 10.1128/JVI.01615-07; Quan FS, 2007, J VIROL, V81, P3514, DOI 10.1128/JVI.02052-06; Reed L. J., 1938, AM J HYG, V27, P5; Sambhara S, 2001, CELL IMMUNOL, V211, P143, DOI 10.1006/cimm.2001.1835; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; Sha Z, 2000, J VIROL, V74, P4999, DOI 10.1128/JVI.74.11.4999-5005.2000; Singh M, 1999, NAT BIOTECHNOL, V17, P1075, DOI 10.1038/15058; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Takada A, 2003, VACCINE, V21, P3212, DOI 10.1016/S0264-410X(03)00234-2; Takahashi I, 2009, CURR OPIN IMMUNOL, V21, P352, DOI 10.1016/j.coi.2009.04.002; Takahashi T, 2007, NEW ENGL J MED, V356, P1172; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tumpey TM, 2001, J VIROL, V75, P5141, DOI 10.1128/JVI.75.11.5141-5150.2001; Vyas SP, 2007, EXPERT REV VACCINES, V6, P401, DOI 10.1586/14760584.6.3.401; Wang BZ, 2008, J VIROL, V82, P11813, DOI 10.1128/JVI.01076-08	45	71	80	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e13972	10.1371/journal.pone.0013972	http://dx.doi.org/10.1371/journal.pone.0013972			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124769	Green Submitted, Green Published, gold			2022-12-27	WOS:000284686500002
J	Wakakuwa, M; Terakita, A; Koyanagi, M; Stavenga, DG; Shichida, Y; Arikawa, K				Wakakuwa, Motohiro; Terakita, Akihisa; Koyanagi, Mitsumasa; Stavenga, Doekele G.; Shichida, Yoshinori; Arikawa, Kentaro			Evolution and Mechanism of Spectral Tuning of Blue-Absorbing Visual Pigments in Butterflies	PLOS ONE			English	Article							COLOR-VISION; MESSENGER-RNAS; RED RECEPTORS; RHODOPSIN; EYE; EXPRESSION; RETINA; PHOTORECEPTORS; HETEROGENEITY; LOCALIZATION	The eyes of flower-visiting butterflies are often spectrally highly complex with multiple opsin genes generated by gene duplication, providing an interesting system for a comparative study of color vision. The Small White butterfly, Pieris rapae, has duplicated blue opsins, PrB and PrV, which are expressed in the blue (lambda(max) = 453 nm) and violet receptors (lambda(max) = 425 nm), respectively. To reveal accurate absorption profiles and the molecular basis of the spectral tuning of these visual pigments, we successfully modified our honeybee opsin expression system based on HEK293s cells, and expressed PrB and PrV, the first lepidopteran opsins ever expressed in cultured cells. We reconstituted the expressed visual pigments in vitro, and analysed them spectroscopically. Both reconstituted visual pigments had two photointerconvertible states, rhodopsin and metarhodopsin, with absorption peak wavelengths 450 nm and 485 nm for PrB and 420 nm and 482 nm for PrV. We furthermore introduced site-directed mutations to the opsins and found that two amino acid substitutions, at positions 116 and 177, were crucial for the spectral tuning. This tuning mechanism appears to be specific for invertebrates and is partially shared by other pierid and lycaenid butterfly species.	[Wakakuwa, Motohiro; Arikawa, Kentaro] Sokendai, Lab Neuroethol, Hayama, Kanagawa, Japan; [Wakakuwa, Motohiro; Shichida, Yoshinori] Kyoto Univ, Dept Biophys, Grad Sch Sci, Kyoto, Japan; [Terakita, Akihisa; Koyanagi, Mitsumasa] Osaka City Univ, Dept Biol & Geosci, Grad Sch Sci, Osaka 558, Japan; [Stavenga, Doekele G.] Univ Groningen, Dept Neurobiophys, Groningen, Netherlands	Graduate University for Advanced Studies - Japan; Kyoto University; Osaka Metropolitan University; University of Groningen	Wakakuwa, M (corresponding author), Sokendai, Lab Neuroethol, Hayama, Kanagawa, Japan.	arikawa@soken.ac.jp		Koyanagi, Mitsumasa/0000-0002-7741-918X; Terakita, Akihisa/0000-0002-8379-8913	JSPS (Japan Society for the Promotion of Science) [21247009, 19207006]; MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) [INSECT-1101]; Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD) [FA8655-08-1-3012]; Grants-in-Aid for Scientific Research [22687005] Funding Source: KAKEN	JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan)(Ministry of Agriculture Forestry & Fisheries - Japan); Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS (Japan Society for the Promotion of Science) grants No. 21247009 to KA and No. 19207006 to AT, MAFF (Ministry of Agriculture, Forestry and Fisheries of Japan) grant No. INSECT-1101 to KA. DGS is supported by Air Force Office of Scientific Research/The European Office of Aerospace Research and Development (AFOSR/EOARD) grant No. FA8655-08-1-3012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Arikawa K, 2003, J COMP PHYSIOL A, V189, P791, DOI 10.1007/s00359-003-0454-7; Awata H, 2009, J COMP PHYSIOL A, V195, P401, DOI 10.1007/s00359-009-0418-7; BERNARD GD, 1991, P NATL ACAD SCI USA, V88, P2783, DOI 10.1073/pnas.88.7.2783; Briscoe AD, 2000, J MOL EVOL, V51, P110, DOI 10.1007/s002390010071; Briscoe AD, 2003, J COMP NEUROL, V458, P334, DOI 10.1002/cne.10582; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Briscoe AD, 2010, P NATL ACAD SCI USA, V107, P3628, DOI 10.1073/pnas.0910085107; Frentiu FD, 2007, P NATL ACAD SCI USA, V104, P8634, DOI 10.1073/pnas.0701447104; Govardovskii VI, 2000, VISUAL NEUROSCI, V17, P509, DOI 10.1017/S0952523800174036; KAYADA S, 1995, COMP BIOCHEM PHYS B, V110, P599, DOI 10.1016/0305-0491(94)00179-X; Kitamoto J, 1998, J EXP BIOL, V201, P1255; Koyanagi M, 2002, FEBS LETT, V531, P525, DOI 10.1016/S0014-5793(02)03616-5; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Nagata T, 2002, J PHYS CHEM A, V106, P1969, DOI 10.1021/jp0124488; OBARA Y, 1968, P JPN ACAD, V44, P829, DOI 10.2183/pjab1945.44.829; Pirih P, 2010, J COMP PHYSIOL A, V196, P501, DOI 10.1007/s00359-010-0538-0; Qiu X, 2003, J COMP PHYSIOL A, V189, P81, DOI 10.1007/s00359-002-0380-0; Qiu XD, 2003, J EXP BIOL, V206, P2787, DOI 10.1242/jeb.00493; Salcedo E, 2003, J NEUROSCI, V23, P10873; Salcedo E, 2009, J BIOL CHEM, V284, P5717, DOI 10.1074/jbc.M807368200; Sauman I, 2005, NEURON, V46, P457, DOI 10.1016/j.neuron.2005.03.014; SEKI T, 1987, EXP BIOL, V47, P95; Sison-Mangus MP, 2006, J EXP BIOL, V209, P3079, DOI 10.1242/jeb.02360; Spaethe J, 2005, J EXP BIOL, V208, P2347, DOI 10.1242/jeb.01634; STAVENGA DG, J COMP PH A IN PRESS; Terakita A, 2000, P NATL ACAD SCI USA, V97, P14263, DOI 10.1073/pnas.260349597; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; Wakakuwa M, 2005, NATURWISSENSCHAFTEN, V92, P464, DOI 10.1007/s00114-005-0018-5; Wakakuwa M, 2004, J EXP BIOL, V207, P2803, DOI 10.1242/jeb.01078; White RH, 2003, J EXP BIOL, V206, P3337, DOI 10.1242/jeb.00571	31	26	26	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e15015	10.1371/journal.pone.0015015	http://dx.doi.org/10.1371/journal.pone.0015015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124838	Green Published, gold, Green Submitted			2022-12-27	WOS:000284572000018
J	Weiss, SM; Saint, DA				Weiss, Steven M.; Saint, David A.			The Persistent Sodium Current Blocker Riluzole Is Antiarrhythmic and Anti-Ischaemic in a Pig Model of Acute Myocardial Infarction	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; SPINAL-CORD; ISCHEMIA; ARRHYTHMIAS; REPERFUSION; FIBRILLATION; HEART; TACHYCARDIA; TARGET	Background: The potential of the cardiac persistent sodium current as a target for protection of the myocardium from ischaemia and reperfusion injury is gaining increasing interest. We have investigated the anti-ischaemic and antiarrhythmic effects of riluzole, a selective INaP blocker, in an open chest pig model of infarction. Methods and Principal Findings: The left anterior descending coronary artery (LAD) was ligated in 27 anesthetised pigs (landrace or large white, either sex, 20-35 kg) which had received riluzole (8 mg/kg IP; n = 6), lidocaine (2.5-12 mg/kg bolus plus 0.05-0.24 mg/kg/min; n = 11) or vehicle (n = 10) 50 min prior. Arrhythmias could be delineated into phase 1a (0 to 20 min), phase 1b (20 to 50 min) and phase 2 (from 50 min to termination at 180 min) and were classified as premature ventricular contractions (PVCs), non-sustained ventricular tachycardia (VT) or ventricular fibrillation (VF) (spontaneously reverting within 15 s) or sustained VT or VF (ie. requiring cardioversion at 15 s). Riluzole reduced the average number of all arrhythmias in Phase 2 (PVCs from 484+/-119 to 32+/-13; non sustained arrhythmias from 8.9+/-4.4 to 0.7+/-0.5; sustained arrhythmias from 3.9+/-2.2 to 0.5+/-0.4); lidocaine reduced the average number of non-sustained and sustained arrhythmias (to 0.4+/-0.3 and 0.4+/-0.3 respectively) but not PVCs (to 390+/-234). Riluzole and lidocaine reduced the average number of sustained arrhythmias in phase 1b (from 1.8+/-0.4 to 0.17+/-0.13 (p < 0.02) and to 0.55+/-0.26 (p = ns) respectively). Neither lidocaine or riluzole changed the ECG intervals: there was no statistical significance between groups at time zero (just before ligation) for any ECG measure. During the course of the 3 hour period of the ischaemia R-R, and P-R intervals shortened slightly in control and riluzole groups (not significantly different from each other) but not in the lidocaine group (significantly different from control). QRS and QTc did not change appreciably in any group Riluzole reduced the degree of histopathological tissue damage across the infarct zone considerably more than did lidocaine. Conclusions: At the doses used, riluzole was at least as effective as lidocaine at reducing the number of episodes of ischaemic VT or VF in pigs, and much more effective at reducing the number of PVCs. We propose that this is related to the ability of riluzole to block cardiac persistent sodium current.	[Weiss, Steven M.] Australian Natl Univ, Canberra, ACT, Australia; [Saint, David A.] Univ Adelaide, Adelaide, SA, Australia	Australian National University; University of Adelaide	Weiss, SM (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.	david.saint@adelaide.edu.au			Australian National University	Australian National University(Australian National University)	This work was supported by general funds from the Australian National University (for S. Weiss' PhD work). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ates O, 2007, J CLIN NEUROSCI, V14, P658, DOI 10.1016/j.jocn.2006.03.023; Bae HJ, 2000, NEUROSCI LETT, V294, P29, DOI 10.1016/S0304-3940(00)01536-6; Baptiste DC, 2006, J NEUROTRAUM, V23, P318, DOI 10.1089/neu.2006.23.318; Barrett TD, 1997, J PHARMACOL TOX MET, V37, P27, DOI 10.1016/S1056-8719(96)00145-1; Bernus O, 2005, EUROPACE, V7, pS93, DOI 10.1016/j.eupc.2005.03.018; Bryson HM, 1996, DRUGS, V52, P549, DOI 10.2165/00003495-199652040-00010; Cascio WE, 2005, J ELECTROCARDIOL, V38, P55, DOI 10.1016/j.jelectrocard.2005.06.019; Cheema AN, 1998, CIRCULATION, V98, P2030, DOI 10.1161/01.CIR.98.19.2030; Clements-Jewery H, 2002, BRIT J PHARMACOL, V135, P807, DOI 10.1038/sj.bjp.0704509; Clements-Jewery H, 2005, BRIT J PHARMACOL, V145, P551, DOI 10.1038/sj.bjp.0706231; Clements-Jewery H, 2007, CARDIOVASC RES, V73, P761, DOI 10.1016/j.cardiores.2006.12.017; Curtis MJ, 1998, CARDIOVASC RES, V39, P194, DOI 10.1016/S0008-6363(98)00083-2; Dekker LRC, 1998, CIRCULATION, V97, P1724, DOI 10.1161/01.CIR.97.17.1724; DILLY SG, 1988, J PHYSIOL-LONDON, V402, P315, DOI 10.1113/jphysiol.1988.sp017206; Gumina RJ, 2000, EUR J PHARMACOL, V396, P119, DOI 10.1016/S0014-2999(00)00200-4; HARRIS AS, 1950, CIRCULATION, V1, P1318, DOI 10.1161/01.CIR.1.6.1318; Heurteaux C, 2006, NEUROSCIENCE, V137, P241, DOI 10.1016/j.neuroscience.2005.08.083; Ju YK, 1996, J PHYSIOL-LONDON, V497, P337, DOI 10.1113/jphysiol.1996.sp021772; JU YK, 1992, BRIT J PHARMACOL, V107, P311, DOI 10.1111/j.1476-5381.1992.tb12743.x; Lamanauskas N, 2008, EUR J NEUROSCI, V27, P2501, DOI 10.1111/j.1460-9568.2008.06211.x; Meesman W., 1982, EARLY ARRHYTHMIAS RE, P93; Parker KK, 2004, J APPL PHYSIOL, V97, P377, DOI 10.1152/japplphysiol.01235.2001; Pratt CM, 1998, AM J CARDIOL, V81, p1C, DOI 10.1016/S0002-9149(98)00180-5; PUGSLEY MK, 1995, LIFE SCI, V57, P1219, DOI 10.1016/0024-3205(95)02070-Y; Remme CA, 2000, CARDIOVASC DRUG THER, V14, P17, DOI 10.1023/A:1007882819423; Riley MP, 2008, J CARDIOVASC ELECTR, V19, P224, DOI 10.1111/j.1540-8167.2007.01007.x; RUSSELL DC, 1984, AM J CARDIOL, V53, P307, DOI 10.1016/0002-9149(84)90444-2; Saint DA, 2008, BRIT J PHARMACOL, V153, P1133, DOI 10.1038/sj.bjp.0707492; SAINT DA, 1992, J PHYSIOL-LONDON, V453, P219, DOI 10.1113/jphysiol.1992.sp019225; Satoh H, 2003, MOL CELL BIOCHEM, V242, P11, DOI 10.1023/A:1021192318882; Sedlis S P, 1992, Cardiovasc Clin, V22, P3; Swerdlow CD, 2007, PACE, V30, P258, DOI 10.1111/j.1540-8159.2007.00659.x; Vacher B, 2009, BRIT J PHARMACOL, V156, P214, DOI 10.1111/j.1476-5381.2008.00062.x; WAINWRIGHT CL, 1988, EUR J PHARMACOL, V145, P183, DOI 10.1016/0014-2999(88)90229-4; WALKER MJA, 1988, CARDIOVASC RES, V22, P447, DOI 10.1093/cvr/22.7.447; Weiss S, 2010, BRIT J PHARMACOL, V160, P1072, DOI 10.1111/j.1476-5381.2010.00766.x; Weiss Steven M., 1993, Journal of Clinical Engineering, V18, P347; Yan GX, 2004, CIRCULATION, V110, P1036, DOI 10.1161/01.CIR.0000140258.09964.19	38	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 24	2010	5	11							e14103	10.1371/journal.pone.0014103	http://dx.doi.org/10.1371/journal.pone.0014103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684TK	21124787	Green Published, Green Submitted, gold			2022-12-27	WOS:000284572000005
J	Petheo, GL; Orient, A; Barath, M; Kovacs, I; Rethi, B; Lanyi, A; Rajki, A; Rajnavolgyi, E; Geiszt, M				Petheo, Gabor L.; Orient, Anna; Barath, Monika; Kovacs, Istvan; Rethi, Bence; Lanyi, Arpad; Rajki, Aniko; Rajnavoelgyi, Eva; Geiszt, Miklos			Molecular and Functional Characterization of H(v)1 Proton Channel in Human Granulocytes	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; SUPEROXIDE-PRODUCTION; HUMAN-NEUTROPHILS; REACTIVE OXYGEN; 2 PORES; VOLTAGE; HV1; CONDUCTANCE; SUBUNIT; DIFFERENTIATION	Voltage-gated proton current (I-Hv) has been characterized in several cell types, but the majority of the data was collected in phagocytes, especially in human granulocytes. The prevailing view about the role of I-Hv in phagocytes is that it is an essential supporter of the intense and sustained activity of Nox2 (the core enzyme of the phagocyte NADPH oxidase complex) during respiratory burst. Recently H(v)1, a voltage-gated proton channel, was cloned, and leukocytes from H(v)1 knockout mice display impaired respiratory burst. On the other hand, hardly anything is known about H(v)1 in human granulocytes. Using qPCR and a self made antibody, we detected a significant amount of H(v)1 in human eosinophil and neutrophil granulocytes and in PLB-985 leukemia cells. Using different crosslinking agents and detergents in reducing and non-reducing PAGE, significant expression of H(v)1 homodimers, but not that of higher-order multimers, could be detected in granulocytes. Results of subcellular fractionation and confocal imaging indicate that H(v)1 is resident in both plasmalemmal and granular membrane compartments of resting neutrophils. Furthermore, it is also demonstrated that H(v)1 accumulates in phagosome wall during zymosan engulfment together with, but independently of Nox2. During granulocytic differentiation early and parallel upregulation of H(v)1 and Nox2 expression was observed in PLB-985 cells. The upregulation of H(v)1 or Nox2 expression did not require the normal expression of the other molecule. Using RNA interference, we obtained strong correlation between H(v)1 expression and I-Hv density in PLB-985 cells. It is also demonstrated that a massive reduction in H(v)1 expression can limit the Nox2 mediated superoxide production of PLB-985 granulocytes. In summary, beside monomers native H(v)1 forms stable proton channel dimer in resting and activated human granulocytes. The expression pattern of H(v)1 in granulocytes is optimized to support intense NADPH oxidase activity.	[Petheo, Gabor L.; Orient, Anna; Kovacs, Istvan; Rajki, Aniko; Geiszt, Miklos] Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary; [Petheo, Gabor L.; Rajki, Aniko] Hungarian Acad Sci, Lab Neurobiochem & Mol Physiol, Budapest, Hungary; [Barath, Monika; Rethi, Bence; Lanyi, Arpad; Rajnavoelgyi, Eva] Univ Debrecen, Inst Immunol, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary	Semmelweis University; Hungarian Academy of Sciences; University of Debrecen	Petheo, GL (corresponding author), Semmelweis Univ, Fac Med, Dept Physiol, H-1085 Budapest, Hungary.	gabor.petheo@eok.sote.hu	Petheő, Gábor/O-1149-2017; Rethi, Bence/C-5770-2013; Rajnavölgyi, Éva/D-4384-2013	Petheő, Gábor/0000-0002-1773-4129; Rethi, Bence/0000-0001-8220-5015; 	Hungarian National Science Foundation [OTKA F-68023, NF-72669, 042573, K-63700]; Council for Medical Research [ETT 615/2006]; Cystic Fibrosis Foundation (USA); Hungarian Academy of Sciences	Hungarian National Science Foundation; Council for Medical Research; Cystic Fibrosis Foundation (USA); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work was supported by the Hungarian National Science Foundation (OTKA F-68023, NF-72669, 042573, K-63700), the Council for Medical Research (ETT 615/2006) and the Cystic Fibrosis Foundation (USA). A.L. and G.L.P. are recipients of Bolyai Research Fellowships from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annunziato L, 2002, NEUROBIOL AGING, V23, P819, DOI 10.1016/S0197-4580(02)00069-6; Banfi B, 1999, J EXP MED, V190, P183, DOI 10.1084/jem.190.2.183; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Burritt JB, 2000, EUR J HAEMATOL, V65, P407, DOI 10.1034/j.1600-0609.2000.065006407.x; Capasso M, 2010, NAT IMMUNOL, V11, P265, DOI 10.1038/ni.1843; DeCoursey TE, 2000, P NATL ACAD SCI USA, V97, P6885, DOI 10.1073/pnas.100047297; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; Drexler HG, 2003, LEUKEMIA, V17, P416, DOI 10.1038/sj.leu.2402799; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; GINSEL LA, 1990, BLOOD, V76, P2105; Henderson LM, 2002, J GEN PHYSIOL, V120, P759, DOI 10.1085/jgp.20028708; HLADKY SB, 1972, BIOCHIM BIOPHYS ACTA, V274, P294, DOI 10.1016/0005-2736(72)90178-2; KJELDSEN L, 1992, BIOCHEM J, V287, P603, DOI 10.1042/bj2870603; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034; LI SJ, 2010, J BIOL CHEM; Lishko PV, 2010, CELL, V140, P327, DOI 10.1016/j.cell.2009.12.053; Maturana A, 2002, J GEN PHYSIOL, V120, P781, DOI 10.1085/jgp.20028713; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy R, 2006, BBA-BIOENERGETICS, V1757, P996, DOI 10.1016/j.bbabio.2006.01.005; Musset B, 2008, J PHYSIOL-LONDON, V586, P2477, DOI 10.1113/jphysiol.2007.149427; MUSSET B, 2010, J PHYSL; NAKAMURA M, 1987, BLOOD, V69, P1404; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Pedruzzi E, 2002, BRIT J HAEMATOL, V117, P719, DOI 10.1046/j.1365-2141.2002.03521.x; Petheo GL, 2003, J GEN PHYSIOL, V122, P713, DOI 10.1085/jgp.200308891; QU AY, 1994, AM J PHYSIOL, V266, pC1263, DOI 10.1152/ajpcell.1994.266.5.C1263; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Shepherd V L, 1986, Semin Respir Infect, V1, P99; Suenaga T, 2007, EUR J IMMUNOL, V37, P3197, DOI 10.1002/eji.200737052; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Tombola F, 2010, NAT STRUCT MOL BIOL, V17, P44, DOI 10.1038/nsmb.1738; Tsang JLY, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-32; van Bruggen R, 2004, J BIOL CHEM, V279, P9097, DOI 10.1074/jbc.M309284200; van Manen HJ, 2003, J AM CHEM SOC, V125, P12112, DOI 10.1021/ja036973r; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832	43	47	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e14081	10.1371/journal.pone.0014081	http://dx.doi.org/10.1371/journal.pone.0014081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124855	gold, Green Submitted, Green Published			2022-12-27	WOS:000284527900004
J	Sun, YP; Bi, YH; Pu, JA; Hu, YX; Wang, JJ; Gao, HJ; Liu, LQ; Xu, Q; Tan, YY; Liu, MD; Guo, X; Yang, HC; Liu, JH				Sun, Yipeng; Bi, Yuhai; Pu, Juan; Hu, Yanxin; Wang, Jingjing; Gao, Huijie; Liu, Linqing; Xu, Qi; Tan, Yuanyuan; Liu, Mengda; Guo, Xin; Yang, Hanchun; Liu, Jinhua			Guinea Pig Model for Evaluating the Potential Public Health Risk of Swine and Avian Influenza Viruses	PLOS ONE			English	Article							RECEPTOR SPECIFICITY; HUMAN TISSUES; HUMAN AIRWAY; H1N1 VIRUS; A VIRUS; HUMANS; ORIGIN; TRANSMISSION; EMERGENCE; INFECTION	Background: The influenza viruses circulating in animals sporadically transmit to humans and pose pandemic threats. Animal models to evaluate the potential public health risk potential of these viruses are needed. Methodology/Principal Findings: We investigated the guinea pig as a mammalian model for the study of the replication and transmission characteristics of selected swine H1N1, H1N2, H3N2 and avian H9N2 influenza viruses, compared to those of pandemic (H1N1) 2009 and seasonal human H1N1, H3N2 influenza viruses. The swine and avian influenza viruses investigated were restricted to the respiratory system of guinea pigs and shed at high titers in nasal tracts without prior adaptation, similar to human strains. None of the swine and avian influenza viruses showed transmissibility among guinea pigs; in contrast, pandemic (H1N1) 2009 virus transmitted from infected guinea pigs to all animals and seasonal human influenza viruses could also horizontally transmit in guinea pigs. The analysis of the receptor distribution in the guinea pig respiratory tissues by lectin histochemistry indicated that both SA alpha 2,3-Gal and SA alpha 2,6-Gal receptors widely presented in the nasal tract and the trachea, while SA alpha 2,3-Gal receptor was the main receptor in the lung. Conclusions/Significance: We propose that the guinea pig could serve as a useful mammalian model to evaluate the potential public health threat of swine and avian influenza viruses.	[Sun, Yipeng; Bi, Yuhai; Pu, Juan; Hu, Yanxin; Wang, Jingjing; Gao, Huijie; Liu, Linqing; Xu, Qi; Tan, Yuanyuan; Liu, Mengda; Guo, Xin; Yang, Hanchun; Liu, Jinhua] China Agr Univ, Coll Vet Med, Key Lab Zoonosis Minist Agr, Beijing 100094, Peoples R China; [Liu, Jinhua] Shandong Anim Dis Control Ctr, Jinan, Shandong, Peoples R China; [Bi, Yuhai] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China	China Agricultural University; Chinese Academy of Sciences; Institute of Microbiology, CAS	Sun, YP (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Zoonosis Minist Agr, Beijing 100094, Peoples R China.	ljh@cau.edu.cn		Bi, Yuhai/0000-0002-5595-363X; Liu, Mengda/0000-0003-4039-9143	National Science Fund for Distinguished Young Scholars [31025029]; National Basic Research Program (973 Program) [2011CB504702]; National Natural Science Foundation of China [30901072]; Fundamental Research Funds for the Central Universities [2009JC02]; Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) [20090008120007]; Program for Cheung Kong Scholars; Innovative Research Teams in Chinese Universities [IRT0866]; Taishan Scholar Foundation	National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Basic Research Program (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Program for Cheung Kong Scholars; Innovative Research Teams in Chinese Universities; Taishan Scholar Foundation	This work was supported by the National Science Fund for Distinguished Young Scholars (31025029; http://www.nsfc.gov.cn/Portal0/InfoModule_537/30599.htm), the National Basic Research Program (973 Program) (2011CB504702; http://www.973.gov.cn/AreaAppl.aspx), the National Natural Science Foundation of China (30901072; http://www.nsfc.gov.cn/nsfc2009/index.htm), the Fundamental Research Funds for the Central Universities (2009JC02; http://kyy.cau.edu.cn/ArticleRead.aspx?uid = 527&cid = 114), the Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP) (20090008120007; http://www.cutech.edu.cn/cn/zxgz/2009/02/1229478100938120.htm) and the Program for Cheung Kong Scholars and Innovative Research Teams in Chinese Universities (No. IRT0866; http://www.cksp.edu.cn). Jinhua Liu was funded by Taishan Scholar Foundation (http://rsxx.sdau.edu.cn/tsxzdzgg.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien N, 2010, J INFECT DIS, V201, P1178, DOI 10.1086/651507; BI Y, EMERG INFECT DIS, V16, P1162; Bouvier NM, 2008, J VIROL, V82, P10052, DOI 10.1128/JVI.01226-08; Butt KM, 2005, J CLIN MICROBIOL, V43, P5760, DOI 10.1128/JCM.43.11.5760-5767.2005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Gao YW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000709; Ibricevic A, 2006, J VIROL, V80, P7469, DOI 10.1128/JVI.02677-05; Kwon YK, 2009, VET PATHOL, V46, P138, DOI 10.1354/vp.46-1-138; Lamb FH, 1919, J AMER MED ASSOC, V72, P1056, DOI 10.1001/jama.1919.02610150014005; Lowen AC, 2008, J VIROL, V82, P5650, DOI 10.1128/JVI.00325-08; Lowen AC, 2006, P NATL ACAD SCI USA, V103, P9988, DOI 10.1073/pnas.0604157103; Maher JA, 2004, LAB ANIMAL, V33, P50, DOI 10.1038/laban1004-50; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Peiris JSM, 2009, REV SCI TECH OIE, V28, P161, DOI 10.20506/rst.28.1.1871; Ressmeyer AR, 2006, EUR RESPIR J, V28, P603, DOI 10.1183/09031936.06.00004206; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Shaoqing Y, 2009, ALLERGOL IMMUNOPATH, V37, P180, DOI 10.1016/j.aller.2009.03.002; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Steel J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000252; Sun Y, 2010, VET MICROBIOL; Tang XH, 2009, J GEN VIROL, V90, P386, DOI 10.1099/vir.0.007054-0; Van Hoeven N, 2009, J VIROL, V83, P2851, DOI 10.1128/JVI.02174-08; Wang L, 2005, AM J PHYSIOL-LUNG C, V289, pL902, DOI 10.1152/ajplung.00005.2005; Yao L, 2008, FASEB J, V22, P733, DOI 10.1096/fj.06-7880com; Yu SQ, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-23	31	41	44	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 23	2010	5	11							e15537	10.1371/journal.pone.0015537	http://dx.doi.org/10.1371/journal.pone.0015537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	684DM	21124850	Green Published, Green Submitted, gold			2022-12-27	WOS:000284527900024
J	Bonifaci, N; Gorski, B; Masojc, B; Wokolorczyk, D; Jakubowska, A; Debniak, T; Berenguer, A; Musach, JS; Brunet, J; Dopazo, J; Narod, SA; Lubinski, J; Lazaro, C; Cybulski, C; Pujana, MA				Bonifaci, Nuria; Gorski, Bohdan; Masojc, Bartlomiej; Wokolorczyk, Dominika; Jakubowska, Anna; Debniak, Tadeusz; Berenguer, Antoni; Serra Musach, Jordi; Brunet, Joan; Dopazo, Joaquin; Narod, Steven A.; Lubinski, Jan; Lazaro, Conxi; Cybulski, Cezary; Angel Pujana, Miguel			Exploring the Link between Germline and Somatic Genetic Alterations in Breast Carcinogenesis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CANCER SUSCEPTIBILITY LOCI; BRCA2 MUTATION CARRIERS; FAMILIAL GASTRIC-CANCER; COLORECTAL-CANCER; EXPRESSION SIGNATURE; COMMON VARIANTS; RISK; PATHWAYS; ALLELES	Recent genome-wide association studies (GWASs) have identified candidate genes contributing to cancer risk through low-penetrance mutations. Many of these genes were unexpected and, intriguingly, included well-known players in carcinogenesis at the somatic level. To assess the hypothesis of a germline-somatic link in carcinogenesis, we evaluated the distribution of somatic gene labels within the ordered results of a breast cancer risk GWAS. This analysis suggested frequent influence on risk of genetic variation in loci encoding for "driver kinases" (i.e., kinases encoded by genes that showed higher somatic mutation rates than expected by chance and, therefore, whose deregulation may contribute to cancer development and/or progression). Assessment of these predictions using a population-based case-control study in Poland replicated the association for rs3732568 in EPHB1 (odds ratio (OR) = 0.79; 95% confidence interval (CI): 0.63-0.98; P-trend = 0.031). Analyses by early age at diagnosis and by estrogen receptor alpha (ER alpha) tumor status indicated potential associations for rs6852678 in CDKL2 (OR = 0.32, 95% CI: 0.10-1.00; P-recessive = 0.044) and rs10878640 in DYRK2 (OR = 2.39, 95% CI: 1.32-4.30; P-dominant = 0.003), and for rs12765929, rs9836340, rs4707795 in BMPR1A, EPHA3 and EPHA7, respectively (ER alpha tumor status P-interaction<0.05). The identification of three novel candidates as EPH receptor genes might indicate a link between perturbed compartmentalization of early neoplastic lesions and breast cancer risk and progression. Together, these data may lay the foundations for replication in additional populations and could potentially increase our knowledge of the underlying molecular mechanisms of breast carcinogenesis.	[Bonifaci, Nuria; Berenguer, Antoni; Serra Musach, Jordi; Angel Pujana, Miguel] Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Spanish Biomed Res Ctr Network Epidemiol & Publ H, Barcelona, Spain; [Gorski, Bohdan; Masojc, Bartlomiej; Wokolorczyk, Dominika; Jakubowska, Anna; Debniak, Tadeusz; Lubinski, Jan; Cybulski, Cezary] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland; [Brunet, Joan] IdIBGi, Catalan Inst Oncol, Hereditary Canc Programme, Girona, Spain; [Dopazo, Joaquin] Funct Genom Node & Spanish Biomed Res Ctr Network, Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [Narod, Steven A.] Univ Toronto, Womens Coll Res Inst, Toronto, ON, Canada; [Narod, Steven A.] Womens Coll Hosp, Toronto, ON M5S 1B2, Canada; [Lazaro, Conxi] IDIBELL, Catalan Inst Oncol, Hereditary Canc Programme, Barcelona, Spain; [Angel Pujana, Miguel] IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pomeranian Medical University; Catalan Institute of Oncology; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Prince Felipe Research Center; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona	Bonifaci, N (corresponding author), Inst Invest Biomed Bellvitge IDIBELL, Biomarkers & Susceptibil Unit, Catalan Inst Oncol, Spanish Biomed Res Ctr Network Epidemiol & Publ H, Barcelona, Spain.	cezarycy@sci.pam.szczecin.pl; mapujana@iconcologia.net	bonifaci, nuria/B-8104-2019; Jakubowska, Anna/O-8050-2014; Dopazo, Joaquin/A-9270-2014; GARCIA, CONXI LAZARO/Q-2410-2016; Pujana, Miquel Angel/N-3127-2014; Narod, Steven A/AAA-6112-2022; Brunet, Joan/C-5292-2018	bonifaci, nuria/0000-0002-8193-6825; Jakubowska, Anna/0000-0002-5650-0501; Dopazo, Joaquin/0000-0003-3318-120X; GARCIA, CONXI LAZARO/0000-0002-7198-5906; Pujana, Miquel Angel/0000-0003-3222-4044; Berenguer-LLergo, Antoni/0000-0002-3742-8161; Brunet, Joan/0000-0003-1945-3512; Lubinski, Jan/0000-0003-2931-3003	Spanish Society of Medical Oncology; Ramon Areces Foundation XV and FIS [09/02483]; Biomedical Research Centre Network for Epidemiology and Public Health group; "Roses contra el Cancer" Foundation; Spanish Ministry of Science and Innovation; IDIBELL; RTICCC [RD06/0020/0028]	Spanish Society of Medical Oncology; Ramon Areces Foundation XV and FIS; Biomedical Research Centre Network for Epidemiology and Public Health group; "Roses contra el Cancer" Foundation; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); IDIBELL; RTICCC	The work was supported by the Spanish Society of Medical Oncology 2009 grant to JB and MAP, the Ramon Areces Foundation XV and FIS (09/02483) grants, and the Biomedical Research Centre Network for Epidemiology and Public Health group 55 to MAP, and the "Roses contra el Cancer" Foundation and RTICCC RD06/0020/0028 grants to JB. MAP was supported by the "Ramon y Cajal" Young Investigator program of the Spanish Ministry of Science and Innovation and NB by an IDIBELL fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Antoniou AC, 2008, AM J HUM GENET, V82, P937, DOI 10.1016/j.ajhg.2008.02.008; Antoniou AC, 2007, AM J HUM GENET, V81, P1186, DOI 10.1086/522611; Antoniou AC, 2009, HUM MOL GENET, V18, P4442, DOI 10.1093/hmg/ddp372; Ayers M, 2004, J CLIN ONCOL, V22, P2284, DOI 10.1200/JCO.2004.05.166; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonifaci N, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-62; Brantley-Sieders DM, 2008, J CLIN INVEST, V118, P64, DOI 10.1172/JCI33154; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang JC, 2005, J CLIN ONCOL, V23, P1169, DOI 10.1200/JCO.2005.03.156; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; CLAUS EB, 1990, ANN HUM GENET, V54, P169, DOI 10.1111/j.1469-1809.1990.tb00373.x; Colditz GA, 2005, NAT REV CANCER, V5, P388, DOI 10.1038/nrc1608; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Dunning AM, 2009, HUM MOL GENET, V18, P1131, DOI 10.1093/hmg/ddn429; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Easton DF, 2008, HUM MOL GENET, V17, pR109, DOI 10.1093/hmg/ddn287; Emery LA, 2009, AM J PATHOL, V175, P1292, DOI 10.2353/ajpath.2009.090115; Forbes SA, 2010, NUCLEIC ACIDS RES, V38, pD652, DOI 10.1093/nar/gkp995; Furney SJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-3; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia-Closas M, 2008, CLIN CANCER RES, V14, P8000, DOI 10.1158/1078-0432.CCR-08-0975; Gorski B, 2000, AM J HUM GENET, V66, P1963, DOI 10.1086/302922; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hansen RM, 2005, J PATHOL, V207, P27, DOI 10.1002/path.1816; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kraft P, 2009, EPIDEMIOLOGY, V20, P508, DOI 10.1097/EDE.0b013e3181a93b98; Levy L, 2006, CYTOKINE GROWTH F R, V17, P41, DOI 10.1016/j.cytogfr.2005.09.009; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Ma XJ, 2004, CANCER CELL, V5, P607, DOI 10.1016/j.ccr.2004.05.015; McMurray HR, 2008, NATURE, V453, P1112, DOI 10.1038/nature06973; Medina I, 2009, NUCLEIC ACIDS RES, V37, pW340, DOI 10.1093/nar/gkp481; Menashe I, 2010, CANCER RES, V70, P4453, DOI 10.1158/0008-5472.CAN-09-4502; Merlos-Suarez A, 2008, CURR OPIN CELL BIOL, V20, P194, DOI 10.1016/j.ceb.2008.01.011; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pomerantz MM, 2009, NAT GENET, V41, P882, DOI 10.1038/ng.403; Ramaswamy S, 2003, NAT GENET, V33, P49, DOI 10.1038/ng1060; Richards FM, 1999, HUM MOL GENET, V8, P607, DOI 10.1093/hmg/8.4.607; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Schnitt SJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2228; Sole X, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-12; Sotelo J, 2010, P NATL ACAD SCI USA, V107, P3001, DOI 10.1073/pnas.0906067107; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stanley SM, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-94; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taglienti CA, 1996, ONCOGENE, V13, P2563; Taira N, 2010, J BIOL CHEM, V285, P4909, DOI 10.1074/jbc.M109.042341; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Turnbull C, 2010, NAT GENET, V42, P504, DOI 10.1038/ng.586; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vaught D, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2207; Wang XD, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r255; Wheeler JMD, 2001, GUT, V48, P367, DOI 10.1136/gut.48.3.367; Wokolorczyk D, 2008, CANCER RES, V68, P9982, DOI 10.1158/0008-5472.CAN-08-1838; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	68	28	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14078	10.1371/journal.pone.0014078	http://dx.doi.org/10.1371/journal.pone.0014078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124932	Green Published, gold, Green Submitted			2022-12-27	WOS:000284467200011
J	Mittelman, K; Ziv, K; Maoz, T; Kleinberger, T				Mittelman, Karin; Ziv, Keren; Maoz, Tsofnat; Kleinberger, Tamar			The Cytosolic Tail of the Golgi Apyrase Ynd1 Mediates E4orf4-Induced Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							ADENOVIRUS E4ORF4 PROTEIN; PHOSPHATASE 2A; CELL-DEATH; P53-INDEPENDENT APOPTOSIS; TRANSFORMED-CELLS; B-ALPHA; SUBUNIT; YEAST; ACTIVATION; INTERACTS	The adenovirus E4 open reading frame 4 (E4orf4) protein contributes to regulation of the progression of virus infection. When expressed individually, E4orf4 was shown to induce non-classical transformed cell-specific apoptosis in mammalian cells. At least some of the mechanisms underlying E4orf4-induced toxicity are conserved from yeast to mammals, including the requirement for an interaction of E4orf4 with protein phosphatase 2A (PP2A). A genetic screen in yeast revealed that the Golgi apyrase Ynd1 associates with E4orf4 and contributes to E4orf4-induced toxicity, independently of Ynd1 apyrase activity. Ynd1 and PP2A were shown to contribute additively to E4orf4-induced toxicity in yeast, and to interact genetically and physically. A mammalian orthologue of Ynd1 was shown to bind E4orf4 in mammalian cells, confirming the evolutionary conservation of this interaction. Here, we use mutation analysis to identify the cytosolic tail of Ynd1 as the protein domain required for mediation of the E4orf4 toxic signal and for the interaction with E4orf4. We also show that E4orf4 associates with cellular membranes in yeast and is localized at their cytoplasmic face. However, E4orf4 is membrane-associated even in the absence of Ynd1, suggesting that additional membrane proteins may mediate E4orf4 localization. Based on our results and on a previous report describing a collection of Ynd1 protein partners, we propose that the Ynd1 cytoplasmic tail acts as a scaffold, interacting with a multi-protein complex, whose targeting by E4orf4 leads to cell death.	[Mittelman, Karin; Ziv, Keren; Maoz, Tsofnat; Kleinberger, Tamar] Technion Israel Inst Technol, Fac Med, Dept Mol Microbiol, Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Mittelman, K (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	tamark@tx.technion.ac.il			Israel Science Foundation [769/07]; Deutsche Forschungsgemeinschaft (DFG)	Israel Science Foundation(Israel Science Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Israel Science Foundation (Grant 769/07) and by the Deutsche Forschungsgemeinschaft (DFG) within the framework of the German-Israeli Project Cooperation (DIP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afifi R, 2001, J VIROL, V75, P4444, DOI 10.1128/JVI.75.9.4444-4447.2001; Ben-Israel H, 2008, J VIROL, V82, P9381, DOI 10.1128/JVI.00791-08; Biederbick A, 1999, J CELL SCI, V112, P2473; Bondesson M, 1996, J VIROL, V70, P3844, DOI 10.1128/JVI.70.6.3844-3851.1996; Champagne C, 2004, J BIOL CHEM, V279, P25905, DOI 10.1074/jbc.M400933200; Gingras MC, 2002, MOL CELL BIOL, V22, P41, DOI 10.1128/MCB.22.1.41-56.2002; Hobdy-Henderson KC, 2003, TRAFFIC, V4, P681, DOI 10.1034/j.1600-0854.2003.00124.x; Kanopka A, 1998, NATURE, V393, P185, DOI 10.1038/30277; KLEINBERGER T, 1993, J VIROL, V67, P7556, DOI 10.1128/JVI.67.12.7556-7560.1993; Kornitzer D, 2001, J CELL BIOL, V154, P331, DOI 10.1083/jcb.200104104; Landry MC, 2009, MOL BIOL CELL, V20, P4091, DOI 10.1091/mbc.E09-01-0057; Lavoie JN, 1998, J CELL BIOL, V140, P637, DOI 10.1083/jcb.140.3.637; Lavoie JN, 2000, J CELL BIOL, V150, P1037, DOI 10.1083/jcb.150.5.1037; Livne A, 2001, J VIROL, V75, P789, DOI 10.1128/JVI.75.2.789-798.2001; Mannervik M, 1999, VIROLOGY, V256, P313, DOI 10.1006/viro.1999.9663; Maoz T, 2005, J BIOL CHEM, V280, P41270, DOI 10.1074/jbc.M507281200; Marcellus RC, 1998, J VIROL, V72, P7144, DOI 10.1128/JVI.72.9.7144-7153.1998; Marcellus RC, 2000, J VIROL, V74, P7869, DOI 10.1128/JVI.74.17.7869-7877.2000; Matsuyama S, 1999, CURR OPIN MICROBIOL, V2, P618, DOI 10.1016/S1369-5274(99)00031-4; Miller JP, 2005, P NATL ACAD SCI USA, V102, P12123, DOI 10.1073/pnas.0505482102; Miron MJ, 2004, ONCOGENE, V23, P7458, DOI 10.1038/sj.onc.1207919; Mui MZ, 2010, J VIROL, V84, P4798, DOI 10.1128/JVI.02434-09; MULLER U, 1992, J VIROL, V66, P5867; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; O'Shea C, 2005, EMBO J, V24, P1211, DOI 10.1038/sj.emboj.7600597; Okamoto CT, 2000, AM J PHYSIOL-CELL PH, V279, pC369, DOI 10.1152/ajpcell.2000.279.2.C369; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Roopchand DE, 2001, ONCOGENE, V20, P5279, DOI 10.1038/sj.onc.1204693; Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06; Sherman F., 1982, METHODS YEAST GENETI; Shtrichman R, 2000, ONCOGENE, V19, P3757, DOI 10.1038/sj.onc.1203705; Shtrichman R, 1999, P NATL ACAD SCI USA, V96, P10080, DOI 10.1073/pnas.96.18.10080; Shtrichman R, 1998, J VIROL, V72, P2975, DOI 10.1128/JVI.72.4.2975-2982.1998; TORRES JZ, MOL BIOL CELL, V21, P897; Zhong XT, 1999, J BIOL CHEM, V274, P32704, DOI 10.1074/jbc.274.46.32704; Zhong XT, 2005, FEBS LETT, V579, P5643, DOI 10.1016/j.febslet.2005.09.036; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200; Zimmermann H, 2001, DRUG DEVELOP RES, V52, P44, DOI 10.1002/ddr.1097	38	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e15539	10.1371/journal.pone.0015539	http://dx.doi.org/10.1371/journal.pone.0015539			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124936	gold, Green Published, Green Submitted			2022-12-27	WOS:000284467200022
J	Croizier, S; Franchi-Bernard, G; Colard, C; Poncet, F; La Roche, A; Risold, PY				Croizier, Sophie; Franchi-Bernard, Gabrielle; Colard, Claude; Poncet, Fabrice; La Roche, Annie; Risold, Pierre-Yves			A Comparative Analysis Shows Morphofunctional Differences between the Rat and Mouse Melanin-Concentrating Hormone Systems	PLOS ONE			English	Article							HYPOCRETIN/OREXIN-CONTAINING NEURONS; LATERAL DORSAL HYPOTHALAMUS; RECEPTOR-DEFICIENT MICE; VENTRAL DIENCEPHALON; EXPRESSION PATTERNS; MCH NEURONS; PEPTIDE; PROJECTIONS; BRAIN; TIME	Sub-populations of neurons producing melanin-concentrating hormone (MCH) are characterized by distinct projection patterns, birthdates and CART/NK3 expression in rat. Evidence for such sub-populations has not been reported in other species. However, given that genetically engineered mouse lines are now commonly used as experimental models, a better characterization of the anatomy and morphofunctionnal organization of MCH system in this species is then necessary. Combining multiple immunohistochemistry experiments with in situ hybridization, tract tracing or BrdU injections, evidence supporting the hypothesis that rat and mouse MCH systems are not identical was obtained: sub-populations of MCH neurons also exist in mouse, but their relative abundance is different. Furthermore, divergences in the distribution of MCH axons were observed, in particular in the ventromedial hypothalamus. These differences suggest that rat and mouse MCH neurons are differentially involved in anatomical networks that control feeding and the sleep/wake cycle.	[Croizier, Sophie; Franchi-Bernard, Gabrielle; Colard, Claude; Poncet, Fabrice; La Roche, Annie; Risold, Pierre-Yves] Univ Franche Comte, Fac Med & Pharmacie, F-25030 Besancon, France	Universite de Franche-Comte	Croizier, S (corresponding author), Univ Franche Comte, Fac Med & Pharmacie, F-25030 Besancon, France.	pierre-yves.risold@univ-fcomte.fr	Risold, Pierre-Yves/AAJ-9535-2021; Risold, Pierre-Yves/M-7730-2018	Risold, Pierre-Yves/0000-0001-6801-591X; Croizier, Sophie/0000-0002-0076-1008	Research French Ministry	Research French Ministry	This work was supported by the Research French Ministry. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CR, 2003, ENDOCRINOLOGY, V144, P3943, DOI 10.1210/en.2003-0149; ALTMAN J, 1978, J COMP NEUROL, V182, P945, DOI 10.1002/cne.901820511; ALTMAN J, 1986, ADV ANAT EMBRYOL CEL, V100, P1; ALTMAN J, 1978, J COMP NEUROL, V182, P973, DOI 10.1002/cne.901820512; Amiot C, 2005, EUR J NEUROSCI, V22, P531, DOI 10.1111/j.1460-9568.2005.04224.x; BITTENCOURT JC, 1992, J COMP NEUROL, V319, P218, DOI 10.1002/cne.903190204; Brischoux F, 2002, EUR J NEUROSCI, V16, P1672, DOI 10.1046/j.1460-9568.2002.02229.x; Brischoux F, 2001, EUR J NEUROSCI, V13, P1733, DOI 10.1046/j.0953-816x.2001.01552.x; Broberger C, 1999, BRAIN RES, V848, pA18; BUGNON C, 1991, J HISTOCHEM CYTOCHEM, V39, P859, DOI 10.1177/39.6.2033243; CANTERAS NS, 1992, J COMP NEUROL, V324, P195, DOI 10.1002/cne.903240205; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Chung SJ, 2009, P NATL ACAD SCI USA, V106, P6772, DOI 10.1073/pnas.0811331106; Cvetkovic V, 2004, J NEUROCHEM, V91, P911, DOI 10.1111/j.1471-4159.2004.02776.x; Cvetkovic V, 2003, NEUROSCIENCE, V116, P31, DOI 10.1016/S0306-4522(02)00557-2; FELLMANN D, 1989, NEUROSCI LETT, V106, P23, DOI 10.1016/0304-3940(89)90196-1; FELLMANN D, 1987, NEUROSCI LETT, V74, P275, DOI 10.1016/0304-3940(87)90309-0; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; Griffond B, 2002, INT REV CYTOL, V213, P233; Griffond B, 2009, PEPTIDES, V30, P2045, DOI 10.1016/j.peptides.2009.07.008; Hahn JD, 2010, BRAIN RES REV, V64, P14, DOI 10.1016/j.brainresrev.2010.02.002; Hahn JD, 2010, NEUROSCI LETT, V468, P12, DOI 10.1016/j.neulet.2009.10.047; Hanriot L, 2007, J COMP NEUROL, V505, P147, DOI 10.1002/cne.21482; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Li Y, 2009, J NEUROSCI, V29, P15195, DOI 10.1523/JNEUROSCI.4203-09.2009; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Markakis EA, 1997, BRAIN RES REV, V24, P255, DOI 10.1016/S0165-0173(97)00006-4; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Marsteller DA, 2009, EUR J PHARMACOL, V602, P66, DOI 10.1016/j.ejphar.2008.10.051; Peyron C, 1998, J NEUROSCI, V18, P9996; Pissios P, 2009, PEPTIDES, V30, P2040, DOI 10.1016/j.peptides.2009.05.002; Rao Y, 2008, J NEUROSCI, V28, P9101, DOI 10.1523/JNEUROSCI.1766-08.2008; Risold PY, 2009, PEPTIDES, V30, P1969, DOI 10.1016/j.peptides.2009.07.016; RISOLD PY, 1992, NEUROSCI LETT, V136, P145, DOI 10.1016/0304-3940(92)90035-6; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Sita LV, 2007, NEUROSCIENCE, V148, P949, DOI 10.1016/j.neuroscience.2007.07.010; SKOFITSCH G, 1985, BRAIN RES BULL, V15, P635, DOI 10.1016/0361-9230(85)90213-8; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Swanson L. W, 1998, BRAIN MAPS STRUCTURE; Swanson LW, 2005, NEUROSCI LETT, V387, P80, DOI 10.1016/j.neulet.2005.06.066; Thompson RH, 1996, J COMP NEUROL, V376, P143, DOI 10.1002/(SICI)1096-9861(19961202)376:1<143::AID-CNE9>3.0.CO;2-3; van den Pol AN, 2004, NEURON, V42, P635, DOI 10.1016/S0896-6273(04)00251-X; Vrang N, 1999, J Neurosci, V19, pRC5; ZAMIR N, 1986, P NATL ACAD SCI USA, V83, P1528, DOI 10.1073/pnas.83.5.1528	44	35	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 17	2010	5	11							e15471	10.1371/journal.pone.0015471	http://dx.doi.org/10.1371/journal.pone.0015471			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	681OY	21103352	Green Submitted, Green Published, gold			2022-12-27	WOS:000284327800021
J	Stephens, GJ; Johnson-Kerner, B; Bialek, W; Ryu, WS				Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William; Ryu, William S.			From Modes to Movement in the Behavior of Caenorhabditis elegans	PLOS ONE			English	Article							SELF-PROPULSION; THERMOTAXIS; MECHANISM; DOPAMINE; GENETICS	Organisms move through the world by changing their shape, and here we explore the mapping from shape space to movements in the nematode Caenorhabditis elegans as it crawls on an agar plate. We characterize the statistics of the trajectories through the correlation functions of the orientation angular velocity, orientation angle and the mean-squared displacement, and we find that the loss of orientational memory has significant contributions from both abrupt, large amplitude turning events and the continuous dynamics between these events. Further, we discover long-time persistence of orientational memory in the intervals between abrupt turns. Building on recent work demonstrating that C. elegans movements are restricted to a low-dimensional shape space, we construct a map from the dynamics in this shape space to the trajectory of the worm along the agar. We use this connection to illustrate that changes in the continuous dynamics reveal subtle differences in movement strategy that occur among mutants defective in two classes of dopamine receptors.	[Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William] Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA; [Stephens, Greg J.; Johnson-Kerner, Bethany; Bialek, William] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA; [Ryu, William S.] Univ Toronto, Banting & Best Dept Med Res, Dept Phys, Toronto, ON, Canada	Princeton University; Princeton University; University of Toronto	Stephens, GJ (corresponding author), Princeton Univ, Joseph Henry Labs Phys, Princeton, NJ 08544 USA.	gstephen@Princeton.EDU; wryu@physics.utoronto.ca		Stephens, Greg/0000-0003-3135-3514	National Institutes of Health [P50 GM071508, R01 EY017210]; National Science Foundation [PHY-0650617]; Swartz Foundation; NATIONAL EYE INSTITUTE [R01EY017210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Swartz Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health grants P50 GM071508 and R01 EY017210, by National Science Foundation grant PHY-0650617, and by the Swartz Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartumeus F, 2003, P NATL ACAD SCI USA, V100, P12771, DOI 10.1073/pnas.2137243100; BELL WJ, 1991, SEARCH BEHAV BEHAV E; Berg, 2018, RANDOM WALKS BIOL; BERG HC, 2004, BIOL MED PHYS BIOMED, P1; Biron D, 2008, P NATL ACAD SCI USA, V105, P11002, DOI 10.1073/pnas.0805004105; BRENNER S, 1974, GENETICS, V77, P71; BRENNER S, 1973, BRIT MED BULL, V29, P269, DOI 10.1093/oxfordjournals.bmb.a071019; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Chase DL, 2004, NAT NEUROSCI, V7, P1096, DOI 10.1038/nn1316; Childress S., 1981, MECH SWIMMING FLYING; d'Avella A, 1998, P NATL ACAD SCI USA, V95, P7711, DOI 10.1073/pnas.95.13.7711; Edwards AM, 2007, NATURE, V449, P1044, DOI 10.1038/nature06199; Faumont S, 2006, J NEUROPHYSIOL, V95, P1976, DOI 10.1152/jn.01050.2005; Geng W, 2003, GENETICS, V165, P1117; Gray JM, 2005, P NATL ACAD SCI USA, V102, P3184, DOI 10.1073/pnas.0409009101; Hills T, 2004, J NEUROSCI, V24, P1217, DOI 10.1523/JNEUROSCI.1569-03.2004; Huang KM, 2006, J NEUROSCI METH, V158, P323, DOI 10.1016/j.jneumeth.2006.06.007; Iino Y, 2009, J NEUROSCI, V29, P5370, DOI 10.1523/JNEUROSCI.3633-08.2009; LIGHTHILL J, 2006, MATH BIOFLUIDDYNAMIC; Osborne LC, 2005, NATURE, V437, P412, DOI 10.1038/nature03961; Pierce-Shimomura JT, 1999, J NEUROSCI, V19, P9557; Ramot D, 2008, J NEUROSCI, V28, P12546, DOI 10.1523/JNEUROSCI.2857-08.2008; Ryu WS, 2002, J NEUROSCI, V22, P5727; Sanger TD, 2000, J NEUROSCI, V20, P1066, DOI 10.1523/JNEUROSCI.20-03-01066.2000; Santello M, 1998, J NEUROSCI, V18, P10105; SHAPERE A, 1989, J FLUID MECH, V198, P557, DOI 10.1017/S002211208900025X; SHAPERE A, 1987, PHYS REV LETT, V58, P2051, DOI 10.1103/PhysRevLett.58.2051; SHAPERE A, 1989, J FLUID MECH, V198, P587, DOI 10.1017/S0022112089000261; Srivastava N, 2009, J NEUROPHYSIOL, V102, P1172, DOI 10.1152/jn.90952.2008; Stephens GJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000028	30	34	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e13914	10.1371/journal.pone.0013914	http://dx.doi.org/10.1371/journal.pone.0013914			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103370	Green Published, Green Submitted, gold			2022-12-27	WOS:000284257400003
J	Yokoyama, T; Masujin, K; Schmerr, MJ; Shu, YJ; Okada, H; Iwamaru, Y; Imamura, M; Matsuura, Y; Murayama, Y; Mohri, S				Yokoyama, Takashi; Masujin, Kentaro; Schmerr, Mary Jo; Shu, Yujing; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Murayama, Yuichi; Mohri, Shirou			Intraspecies Prion Transmission Results in Selection of Sheep Scrapie Strains	PLOS ONE			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; MOLECULAR ANALYSIS; INTERSPECIES TRANSMISSION; ABNORMAL ISOFORM; PROTEIN; BSE; PRPSC; SIMILARITIES; ISOLATE; CH1641	Background: Sheep scrapie is caused by multiple prion strains, which have been classified on the basis of their biological characteristics in inbred mice. The heterogeneity of natural scrapie prions in individual sheep and in sheep flocks has not been clearly defined. Methodology/Principal Findings: In this study, we intravenously injected 2 sheep (Suffolk and Corriedale) with material from a natural case of sheep scrapie (Suffolk breed). These 3 sheep had identical prion protein (PrP) genotypes. The protease-resistant core of PrP (PrPres) in the experimental Suffolk sheep was similar to that in the original Suffolk sheep. In contrast, PrPres in the Corriedale sheep differed from the original PrPres but resembled the unusual scrapie isolate, CH1641. This unusual PrPres was not detected in the original sheep. The PrPres distributions in the brain and peripheral tissues differed between the 2 breeds of challenged sheep. A transmission study in wild-type and TgBoPrP mice, which overexpressing bovine PrP, led to the selection of different prion strains. The pathological features of prion diseases are thought to depend on the dominantly propagated strain. Conclusions/Significance: Our results indicate that prion strain selection occurs after both inter-and intraspecies transmission. The unusual scrapie prion was a hidden or an unexpressed component in typical sheep scrapie.	[Yokoyama, Takashi; Masujin, Kentaro; Shu, Yujing; Okada, Hiroyuki; Iwamaru, Yoshifumi; Imamura, Morikazu; Matsuura, Yuichi; Murayama, Yuichi; Mohri, Shirou] Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Schmerr, Mary Jo] Iowa State Univ, Ames Lab, Ames, IA USA	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory	Yokoyama, T (corresponding author), Natl Inst Anim Hlth, Pr Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	tyoko@affrc.go.jp	Mohri, Shirou/AAK-1281-2020; Matsuura, Yuichi/AAF-3170-2021	Matsuura, Yuichi/0000-0003-3383-7918	Ministry of Agriculture, Forestry, and Fisheries of Japan; Ministry of Health, Labour and Welfare of Japan; Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan)	Ministry of Agriculture, Forestry, and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan)	This work was supported by grants from the BSE control project of the Ministry of Agriculture, Forestry, and Fisheries of Japan, and in part by grants from the Ministry of Health, Labour and Welfare of Japan and in part by grants from Bio-oriented Technology Research Advancement Institution ( Tokyo, Japan). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apetri AC, 2004, J BIOL CHEM, V279, P18008, DOI 10.1074/jbc.M313581200; Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010310; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Bencsik AA, 2005, J HISTOCHEM CYTOCHEM, V53, P1199, DOI 10.1369/jhc.5C6703.2005; BESSEN RA, 1994, J VIROL, V68, P7859, DOI 10.1128/JVI.68.12.7859-7868.1994; BRUCE ME, 1996, PRION DIS, P223; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Eloit M, 2005, VET REC, V156, P523, DOI 10.1136/vr.156.16.523-b; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Furuoka H, 2007, J COMP PATHOL, V136, P9, DOI 10.1016/j.jcpa.2006.09.002; Hayashi H, 2004, J VET MED SCI, V66, P515, DOI 10.1292/jvms.66.515; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Hope J, 1999, J GEN VIROL, V80, P1, DOI 10.1099/0022-1317-80-1-1; Jeffrey M, 2006, J COMP PATHOL, V134, P17, DOI 10.1016/j.jcpa.2005.06.005; Kim CL, 2004, VIROLOGY, V320, P40, DOI 10.1016/j.virol.2003.10.026; KIMBERLIN RH, 1978, J GEN VIROL, V39, P487, DOI 10.1099/0022-1317-39-3-487; Konold Timm, 2006, BMC Vet Res, V2, P31, DOI 10.1186/1746-6148-2-31; Lee HS, 2001, J INFECT DIS, V183, P192, DOI 10.1086/317935; Legname G, 2005, P NATL ACAD SCI USA, V102, P2168, DOI 10.1073/pnas.0409079102; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Mabbott NA, 2001, J GEN VIROL, V82, P2307, DOI 10.1099/0022-1317-82-10-2307; Masujin K, 2009, ARCH VIROL, V154, P1929, DOI 10.1007/s00705-009-0534-2; Masujin K, 2008, PRION, V2, P123, DOI 10.4161/pri.2.3.7437; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Polymenidou M, 2005, LANCET NEUROL, V4, P805, DOI 10.1016/S1474-4422(05)70225-8; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Scott MR, 1999, P NATL ACAD SCI USA, V96, P15137, DOI 10.1073/pnas.96.26.15137; Shimada K, 2005, MICROBIOL IMMUNOL, V49, P801, DOI 10.1111/j.1348-0421.2005.tb03660.x; SHINAGAWA M, 1985, MICROBIOL IMMUNOL, V29, P543, DOI 10.1111/j.1348-0421.1985.tb00856.x; Siso S, 2010, J COMP PATHOL, V142, P27, DOI 10.1016/j.jcpa.2009.06.002; Stack M, 2006, J GEN VIROL, V87, P2099, DOI 10.1099/vir.0.81254-0; Stack MJ, 2002, ACTA NEUROPATHOL, V104, P279, DOI 10.1007/s00401-002-0556-2; TELLING GC, 1995, CELL, V83, P79, DOI 10.1016/0092-8674(95)90236-8; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Ushiki-Kaku Y, 2010, J BIOL CHEM, V285, P11931, DOI 10.1074/jbc.M109.058859; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1994, GENE DEV, V8, P959, DOI 10.1101/gad.8.8.959; WILESMITH JW, 1991, VET REC, V128, P199, DOI 10.1136/vr.128.9.199; Yokoyama T, 2001, J BIOL CHEM, V276, P11265, DOI 10.1074/jbc.M008734200; Yokoyama T, 2009, J GEN VIROL, V90, P261, DOI 10.1099/vir.0.004754-0; Yull HM, 2006, AM J PATHOL, V168, P151, DOI 10.2353/ajpath.2006.050766	50	25	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2010	5	11							e15450	10.1371/journal.pone.0015450	http://dx.doi.org/10.1371/journal.pone.0015450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	680TI	21103326	Green Submitted, Green Published, gold			2022-12-27	WOS:000284257400024
J	Chapman, J; Miles, PD; Ofrecio, JM; Neels, JG; Yu, JG; Resnik, JL; Wilkes, J; Talukdar, S; Thapar, D; Johnson, K; Sears, DD				Chapman, Justin; Miles, Philip D.; Ofrecio, Jachelle M.; Neels, Jaap G.; Yu, Joseph G.; Resnik, Jamie L.; Wilkes, Jason; Talukdar, Saswata; Thapar, Divya; Johnson, Kristen; Sears, Dorothy D.			Osteopontin Is Required for the Early Onset of High Fat Diet-Induced Insulin Resistance in Mice	PLOS ONE			English	Article							ADIPOSE-TISSUE; PPAR-GAMMA; ADIPOGENIC DIFFERENTIATION; SIGNALING PATHWAYS; ADIPOCYTE DEATH; GENE-EXPRESSION; DEFICIENT MICE; UP-REGULATION; BONE-MARROW; STEM-CELLS	Background: Insulin resistance is manifested in muscle, adipose tissue, and liver and is associated with adipose tissue inflammation. The cellular components and mechanisms that regulate the onset of diet-induced insulin resistance are not clearly defined. Methodology and Principal Findings: We initially observed osteopontin (OPN) mRNA over-expression in adipose tissue of obese, insulin resistant humans and rats which was normalized by thiazolidinedione (TZD) treatment in both species. OPN regulates inflammation and is implicated in pathogenic maladies resulting from chronic obesity. Thus, we tested the hypothesis that OPN is involved in the early development of insulin resistance using a 2-4 week high fat diet (HFD) model. OPN KO mice fed HFD for 2 weeks were completely protected from the severe skeletal muscle, liver and adipose tissue insulin resistance that developed in wild type (WT) controls, as determined by hyperinsulinemic euglycemic clamp and acute insulin-stimulation studies. Although two-week HFD did not alter body weight or plasma free fatty acids and cytokines in either strain, HFD-induced hyperleptinemia, increased adipose tissue inflammation (macrophages and cytokines), and adipocyte hypertrophy were significant in WT mice and blunted or absent in OPN KO mice. Adipose tissue OPN protein isoform expression was significantly altered in 2- and 4-week HFD-fed WT mice but total OPN protein was unchanged. OPN KO bone marrow stromal cells were more osteogenic and less adipogenic than WT cells in vitro. Interestingly, the two differentiation pathways were inversely affected by HFD in WT cells in vitro. Conclusions: The OPN KO phenotypes we report reflect protection from insulin resistance that is associated with changes in adipocyte biology and adipose tissue inflammatory status. OPN is a key component in the development of HFD-induced insulin resistance.	[Chapman, Justin] Pfizer Inc, San Diego, CA USA; [Miles, Philip D.; Ofrecio, Jachelle M.; Yu, Joseph G.; Wilkes, Jason; Talukdar, Saswata; Thapar, Divya; Johnson, Kristen; Sears, Dorothy D.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Neels, Jaap G.] Univ Nice Sophia Antipolis, Inserm U907, Nice, France; [Resnik, Jamie L.] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA	Pfizer; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; University of California System; University of California San Diego	Chapman, J (corresponding author), Pfizer Inc, San Diego, CA USA.	dsears@ucsd.edu	Neels, Jaap G/F-5534-2010; Sears, Dorothy D/AHE-5524-2022	Neels, Jaap G/0000-0002-5900-8395; Sears, Dorothy D/0000-0002-9260-3540; Talukdar, Saswata/0000-0003-3042-0025; Johnson, Kristen/0000-0003-0788-7217	National Institutes of Health (NIH) [K01-DK62025, P30 DK063491]; American Heart Association [0635408N]; University of California [bio03-10383]; Pfizer Inc; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062025, P30DK063491] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of California(University of California System); Pfizer Inc(Pfizer); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Support for this research was provided by National Institutes of Health (NIH) grants K01-DK62025 (DDS) and P30 DK063491 (DDS), an American Heart Association Scientist Development Grant, 0635408N (JGN), and the University of California Discovery Program Project #bio03-10383 with matching grant funds provided by Pfizer Inc (JMO, DDS). JC, a Pfizer employee, participated as a collaborator on the project as described. No other person or entity of Pfizer Inc. had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERESFORD JN, 1992, J CELL SCI, V102, P341; Berger JP, 2005, TRENDS PHARMACOL SCI, V26, P244, DOI 10.1016/j.tips.2005.03.003; Bertola A, 2009, DIABETES, V58, P125, DOI 10.2337/db08-0400; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Chae S, 2009, INT J ONCOL, V35, P1409, DOI 10.3892/ijo_00000458; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Denhardt DT, 2001, ANNU REV PHARMACOL, V41, P723, DOI 10.1146/annurev.pharmtox.41.1.723; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; FREDERICH RC, 1995, J CLIN INVEST, V96, P1658, DOI 10.1172/JCI118206; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gregoire FM, 2001, EXP BIOL MED, V226, P997, DOI 10.1177/153537020122601106; Harmey D, 2006, J BONE MINER RES, V21, P1377, DOI 10.1359/JBMR.060619; Hennige AM, 2006, FASEB J, V20, P1206, DOI 10.1096/fj.05-4635fje; Hevener AL, 2001, DIABETES, V50, P2316, DOI 10.2337/diabetes.50.10.2316; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; HSIAO G, 2010, MULTITISSUE SE UNPUB; Ishijima M, 2006, EXP CELL RES, V312, P3075, DOI 10.1016/j.yexcr.2006.06.003; Keen HL, 2004, FASEB J, V18, pA1219; Kiefer F. W, 2010, DIABETES; Kiefer FW, 2008, ENDOCRINOLOGY, V149, P1350, DOI 10.1210/en.2007-1312; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; KRAEGEN EW, 1991, DIABETES, V40, P1397, DOI 10.2337/diabetes.40.11.1397; Kveiborg M, 2004, MOL CELL BIOL, V24, P2820, DOI 10.1128/MCB.24.7.2820-2830.2004; Lee RH, 2004, CELL PHYSIOL BIOCHEM, V14, P311, DOI 10.1159/000080341; Lofgren P, 2005, J CLIN ENDOCR METAB, V90, P6207, DOI 10.1210/jc.2005-0596; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028; Nakajima I, 1998, DIFFERENTIATION, V63, P193, DOI 10.1111/j.1432-0436.1998.00193.x; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nomiyama T, 2007, J CLIN INVEST, V117, P2877, DOI 10.1172/JCI31986; Ogawa D, 2005, CIRC RES, V96, P59, DOI 10.1161/01.RES.0000163630.86796.17; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Oyama Y, 2000, J Atheroscler Thromb, V7, P77; Oyama Y, 2002, CIRC RES, V90, P348, DOI 10.1161/hh0302.105098; Parhami F, 1999, J BONE MINER RES, V14, P2067, DOI 10.1359/jbmr.1999.14.12.2067; Park SY, 2005, DIABETES, V54, P3530, DOI 10.2337/diabetes.54.12.3530; Patani N, 2008, ANTICANCER RES, V28, P4105; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5; REVERS RR, 1984, J CLIN INVEST, V73, P664, DOI 10.1172/JCI111258; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Ross SE, 2002, MOL CELL BIOL, V22, P5989, DOI 10.1128/MCB.22.16.5989-5999.2002; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG264, DOI 10.1152/ajpgi.00002.2004; Sanchez-Margalet V, 2003, CLIN EXP IMMUNOL, V133, P11, DOI 10.1046/j.1365-2249.2003.02190.x; Sciaudone M, 2003, ENDOCRINOLOGY, V144, P5631, DOI 10.1210/en.2003-0463; Sears DD, 2009, P NATL ACAD SCI USA, V106, P18745, DOI 10.1073/pnas.0903032106; Sears DD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007250; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; SHAUL ME, 2010, DIABETES IN PRESS; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; STEELE R, 1959, ANN NY ACAD SCI, V82, P420, DOI 10.1111/j.1749-6632.1959.tb44923.x; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yamauchi T, 2001, J BIOL CHEM, V276, P41245, DOI 10.1074/jbc.M103241200; Yoshitake H, 1999, P NATL ACAD SCI USA, V96, P8156, DOI 10.1073/pnas.96.14.8156	63	59	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13959	10.1371/journal.pone.0013959	http://dx.doi.org/10.1371/journal.pone.0013959			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103061	Green Published, Green Submitted, gold			2022-12-27	WOS:000284147700010
J	Glynn, JR; Kayuni, N; Floyd, S; Banda, E; Francis-Chizororo, M; Tanton, C; Molesworth, A; Hemmings, J; Crampin, AC; French, N				Glynn, Judith R.; Kayuni, Ndoliwe; Floyd, Sian; Banda, Emmanuel; Francis-Chizororo, Monica; Tanton, Clare; Molesworth, Anna; Hemmings, Joanne; Crampin, Amelia C.; French, Neil			Age at Menarche, Schooling, and Sexual Debut in Northern Malawi	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; PREMARITAL SEX; HIV-INFECTION; 1ST SEX; TRENDS; BEHAVIOR; HEALTH; TANZANIA; MARRIAGE; KARONGA	Background: Age at sexual debut is a key behavioural indicator used in HIV behavioural surveillance. Early age at menarche may precipitate early sex through perceived readiness for sex, or through school drop-out, but this is rarely studied. We investigated trends and circumstances of sexual debut in relation to schooling and age at menarche. Methods and Findings: A cross-sectional sexual behaviour survey was conducted on all individuals age 15-59 within a demographic surveillance site in Karonga District, Malawi. Time trends were assessed using birth cohorts. Survival analysis was used to estimate the median age at menarche, sexual debut and first marriage. The 25(th) centile was used to define "early" sex, and analyses of risk factors for early sex were restricted to those who had reached that age, and were done using logistic regression. Of the 8232 women and 7338 men resident in the area, 88% and 78%, respectively, were seen, and, 94% and 92% of these were interviewed. The median reported age at first sex was 17.5 for women and 18.8 for men. For women, ages at menarche, sexual debut and first marriage did not differ by birth cohort. For men, age at sexual debut and first marriage decreased slightly in later birth cohorts. For both men and women increased schooling was associated with later sexual debut and a longer delay between sexual debut and first marriage, but the associations were stronger for women. Earlier age at menarche was strongly associated with earlier sexual debut and marriage and lower schooling levels. In women early sexual debut (<16 years) was less likely in those with menarche at age 14-15 (odds ratio (OR) 0.31, 95%CI 0.26-0.36), and >= 16 (OR 0.04, 95%CI 0.02-0.05) compared to those with menarche at <14. The proportion of women who completed primary school was 46% in those with menarche at <14, 60% in those with menarche at 14-15 and 70% in those with menarche at >= 16. The association between age at menarche and schooling was partly explained by age at sexual debut. The association between age at menarche and early sex was not altered by adjusting for schooling. Conclusions: Women with early menarche start sex and marry early, leading to school drop-out. It is important to find ways to support those who reach menarche early to access the same opportunities as other young women.	[Glynn, Judith R.; Floyd, Sian; Francis-Chizororo, Monica; Molesworth, Anna; Hemmings, Joanne; Crampin, Amelia C.; French, Neil] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England; [Kayuni, Ndoliwe; Banda, Emmanuel; Francis-Chizororo, Monica; Crampin, Amelia C.] Karonga Prevent Study, Chilumba, Malawi; [Tanton, Clare] UCL, Ctr Sexual Hlth & HIV Res, Res Dept Infect & Populat Hlth, London, England	University of London; London School of Hygiene & Tropical Medicine; Malawi Epidemiology and Intervention Research Unit; University of London; University College London	Glynn, JR (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London WC1, England.	judith.glynn@lshtm.ac.uk	French, Neil/A-2994-2012	Crampin, Amelia/0000-0002-1513-4330; French, Neil/0000-0003-4814-8293; Tanton, Clare/0000-0002-4612-1858	Wellcome Trust [079828/Z/06/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The study was funded by The Wellcome Trust (079828/Z/06/Z) with contributions from LEPRA (www.leprahealthinaction.org; no grant number used by LEPRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellis MA, 2006, J EPIDEMIOL COMMUN H, V60, P910, DOI 10.1136/jech.2006.049379; Biddlecom A, 2008, STUD FAMILY PLANN, V39, P337, DOI 10.1111/j.1728-4465.2008.00179.x; BLEDSOE C., 1993, SOCIAL DYNAMICS ADOL; Boileau C, 2009, SEX TRANSM INFECT, V85, pI27, DOI 10.1136/sti.2008.033969; Buga GAB, 1996, S AFR MED J, V86, P523; Cremin I, 2009, SEX TRANSM INFECT, V85, pI34, DOI 10.1136/sti.2008.033431; Downing J, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-446; DOWSETT G, 2009, YOUNG PEOPLE RISK TA; Hargreaves JR, 2008, AIDS, V22, P403, DOI 10.1097/QAD.0b013e3282f2aac3; Jahn A, 2007, DEMOGR RES, V16, P219, DOI 10.4054/DemRes.2007.16.8; Jukes M, 2008, AIDS, V22, pS41, DOI 10.1097/01.aids.0000341776.71253.04; LLOYD CB, 2008, MARRIAGE CHILDBIRTH; Mensch BS, 2001, STUD FAMILY PLANN, V32, P285, DOI 10.1111/j.1728-4465.2001.00285.x; Morris B, 2000, ANIMALS ANCESTORS ET; Munthali Alister C, 2007, Afr J Reprod Health, V11, P150, DOI 10.2307/25549737; Pearson J., 2008, WATERLINES, V27, P48, DOI DOI 10.3362/1756-3488.2008.005; Slaymaker E, 2009, SEX TRANSM INFECT, V85, pI12, DOI 10.1136/sti.2008.034009; SOMMER M, 2009, J ADOLESC; Sommer M, 2009, CULT HEALTH SEX, V11, P383, DOI 10.1080/13691050902722372; *UNAIDS WHO, 2000, 2 GEN SURV HIV NEXT; UNICEF, 2010, WAT SAN HYG ANN REP; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013; White RG, 2007, EPIDEMIOL INFECT, V135, P922, DOI 10.1017/S0950268806007680; Wringe A, 2009, SEX TRANSM INFECT, V85, pI56, DOI 10.1136/sti.2008.033423; Zaba B, 2009, SEX TRANSM INFECT, V85, pI20, DOI 10.1136/sti.2008.033704	25	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2010	5	12							e15334	10.1371/journal.pone.0015334	http://dx.doi.org/10.1371/journal.pone.0015334			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	692ES	21151570	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000285135800026
J	Peng, H; Qi, J; Dong, ZZ; Zhang, JT				Peng, Hui; Qi, Jing; Dong, Zizheng; Zhang, Jian-Ting			Dynamic vs Static ABCG2 Inhibitors to Sensitize Drug Resistant Cancer Cells	PLOS ONE			English	Article							MEDIATED PROTEASOMAL DEGRADATION; MULTIDRUG TRANSPORTER ABCG2; AMINO-TERMINUS; BINDING; OLIGOMERIZATION; PROTEIN; DOMAIN	Human ABCG2, a member of the ATP-binding cassette transporter superfamily, plays a key role in multidrug resistance and protecting cancer stem cells. ABCG2-knockout had no apparent adverse effect on the development, biochemistry, and life of mice. Thus, ABCG2 is an interesting and promising target for development of chemo-sensitizing agents for better treatment of drug resistant cancers and for eliminating cancer stem cells. Previously, we reported a novel two mode-acting ABCG2 inhibitor, PZ-39, that induces ABCG2 degradation in addition to inhibiting its activity. In this manuscript, we report our recent progresses in identifying two different groups of ABCG2 inhibitors with one inhibiting only ABCG2 function (static) and the other induces ABCG2 degradation in lysosome in addition to inhibiting its function (dynamic). Thus, the inhibitor-induced ABCG2 degradation may be more common than we previously anticipated and further investigation of the dynamic inhibitors that induce ABCG2 degradation may provide a more effective way of sensitizing ABCG2-mediated MDR in cancer chemotherapy.	[Peng, Hui; Qi, Jing; Dong, Zizheng; Zhang, Jian-Ting] Indiana Univ, Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Zhang, Jian-Ting] Indiana Univ, Sch Med, IU Simon Canc Ctr, Indianapolis, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Peng, H (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, Dept Mol Immunol, Beijing 100730, Peoples R China.	jianzhan@iupui.edu	Zhang, Jian-Ting/L-8334-2015		National Institutes of Health [CA113384, CA120221]; Showalter Foundation; Department of Defense Breast Cancer Research; NNSF of China [30873083]; NATIONAL CANCER INSTITUTE [R01CA113384, R01CA120221] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Showalter Foundation; Department of Defense Breast Cancer Research(United States Department of Defense); NNSF of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by National Institutes of Health grants CA113384 and CA120221 (JTZ) and by a Showalter Foundation grant (ZD). Jing Qi is a recipient of the Department of Defense Breast Cancer Research Program Postdoctoral Fellowship. Hui Peng is currently supported, in part, by NNSF of China grant No. 30873083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed-Belkacem A, 2006, ANTI-CANCER DRUG, V17, P239, DOI 10.1097/00001813-200603000-00001; Chen Q, 2006, J BIOL CHEM, V281, P31152, DOI 10.1074/jbc.M603529200; Dai CL, 2009, BIOCHEM PHARMACOL, V78, P355, DOI 10.1016/j.bcp.2009.04.023; Dai CL, 2009, CANCER LETT, V279, P74, DOI 10.1016/j.canlet.2009.01.027; Gagnon AW, 1998, J BIOL CHEM, V273, P6976, DOI 10.1074/jbc.273.12.6976; Henrich CJ, 2007, MOL CANCER THER, V6, P3271, DOI 10.1158/1535-7163.MCT-07-0352; Henrich CJ, 2009, ACS CHEM BIOL, V4, P637, DOI 10.1021/cb900134c; Horton JK, 1998, CELL PHYSIOL BIOCHEM, V8, P246, DOI 10.1159/000016287; Liu Y, 2006, CANCER RES, V66, P3248, DOI 10.1158/0008-5472.CAN-05-3801; McDevitt CA, 2006, STRUCTURE, V14, P1623, DOI 10.1016/j.str.2006.08.014; Mo W, 2009, EXPERT OPIN DRUG MET, V5, P1049, DOI 10.1517/17425250903124371; Nakagawa H, 2008, BIOCHEM J, V411, P623, DOI 10.1042/BJ20071229; Nakagawa H, 2009, FEBS J, V276, P7237, DOI 10.1111/j.1742-4658.2009.07423.x; Ozvegy-Laczka C, 2005, J BIOL CHEM, V280, P4219, DOI 10.1074/jbc.M411338200; Peng H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005676; Wakabayashi K, 2007, J BIOL CHEM, V282, P27841, DOI 10.1074/jbc.C700133200; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Xu JK, 2007, CANCER RES, V67, P4373, DOI 10.1158/0008-5472.CAN-06-3169; Xu JK, 2007, CURR MED CHEM, V14, P689, DOI 10.2174/092986707780059580; Yang YY, 2007, J BIOL CHEM, V282, P8821, DOI 10.1074/jbc.M700152200; Yang YY, 2002, J BIOL CHEM, V277, P44268, DOI 10.1074/jbc.M207003200; Zhang Jian-Ting, 2007, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V32, P531; Zheng LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005172	23	33	39	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 7	2010	5	12							e15276	10.1371/journal.pone.0015276	http://dx.doi.org/10.1371/journal.pone.0015276			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	690XB	21151870	Green Submitted, Green Published, gold			2022-12-27	WOS:000285041800014
J	Orr, MT; Wu, J; Fang, M; Sigal, LJ; Spee, P; Egebjerg, T; Dissen, E; Fossum, S; Phillips, JH; Lanier, LL				Orr, Mark T.; Wu, Jun; Fang, Min; Sigal, Luis J.; Spee, Pieter; Egebjerg, Thomas; Dissen, Erik; Fossum, Sigbjorn; Phillips, Joseph H.; Lanier, Lewis L.			Development and Function of CD94-Deficient Natural Killer Cells	PLOS ONE			English	Article							MHC CLASS-I; HUMAN CYTOMEGALOVIRUS-INFECTION; C-TYPE LECTINS; INHIBITORY RECEPTORS; NK CELLS; CD94 DEFINES; RECOGNITION; CD94/NKG2A; EXPRESSION; BINDING	The CD94 transmembrane-anchored glycoprotein forms disulfide-bonded heterodimers with the NKG2A subunit to form an inhibitory receptor or with the NKG2C or NKG2E subunits to assemble a receptor complex with activating DAP12 signaling proteins. CD94 receptors expressed on human and mouse NK cells and T cells have been proposed to be important in NK cell tolerance to self, play an important role in NK cell development, and contribute to NK cell-mediated immunity to certain infections including human cytomegalovirus. We generated a gene-targeted CD94-deficient mouse to understand the role of CD94 receptors in NK cell biology. CD94-deficient NK cells develop normally and efficiently kill NK cell-susceptible targets. Lack of these CD94 receptors does not alter control of mouse cytomegalovirus, lymphocytic choriomeningitis virus, vaccinia virus, or Listeria monocytogenes. Thus, the expression of CD94 and its associated NKG2A, NKG2C, and NKG2E subunits is dispensable for NK cell development, education, and many NK cell functions.	[Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Orr, Mark T.; Lanier, Lewis L.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Wu, Jun; Phillips, Joseph H.] DNAX Res Inst Molec & Cellular Biol Inc, Palo Alto, CA USA; [Fang, Min; Sigal, Luis J.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Spee, Pieter; Egebjerg, Thomas] Novo Nordisk AS, Dept NK Cell Biol, Malov, Denmark; [Dissen, Erik; Fossum, Sigbjorn] Univ Oslo, Inst Basic Med Sci, Dept Anat, Oslo, Norway	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.; Fox Chase Cancer Center; Novo Nordisk; University of Oslo	Orr, MT (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	Lewis.Lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014; Sigal, Luis/AAL-1849-2021	Lanier, Lewis L/0000-0003-1308-3952; Orr, Mark/0000-0003-2684-4722; Sigal, Luis/0000-0001-6642-5472; Fang, Min/0000-0002-5278-1430	Merck; Novo Nordisk; National Institute of Allergy and Infectious Diseases (NIAID) [R21AI077021, R01AI065544]; National Institutes of Health (NIH) [AI066897]; National Cancer Institute (NCI) [CA006927]; William J. Avery Fellowship; Cancer Research Institute; NATIONAL CANCER INSTITUTE [P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065544, R21AI077021, R37AI066897] Funding Source: NIH RePORTER	Merck(Merck & Company); Novo Nordisk(Novo Nordisk); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); William J. Avery Fellowship; Cancer Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.H.P. is an employee of Merck; P. S. and T. E. are employees of Novo Nordisk. Merck and Novo Nordisk provided salary support for the authors, as indicated, and provided financial support for some experiments performed in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was also supported by National Institute of Allergy and Infectious Diseases (NIAID) grants R21AI077021 and R01AI065544 to L.J.S., National Institutes of Health (NIH) grant AI066897 to L.L.L. and National Cancer Institute (NCI) grant CA006927 to FCCC. M.F. was partly supported by the William J. Avery Fellowship. M.T.O. was supported by a fellowship from the Cancer Research Institute. L.L.L. is an American Cancer Society Professor.	Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Berg SF, 1998, EUR J IMMUNOL, V28, P444, DOI 10.1002/(SICI)1521-4141(199802)28:02&lt;444::AID-IMMU444&gt;3.0.CO;2-M; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Brooks AG, 1997, J EXP MED, V185, P795, DOI 10.1084/jem.185.4.795; Carretero M, 1997, EUR J IMMUNOL, V27, P563, DOI 10.1002/eji.1830270230; Cavanaugh VJ, 2007, J GEN VIROL, V88, P1440, DOI 10.1099/vir.0.82444-0; CHANG CW, 1995, EUR J IMMUNOL, V25, P2433, DOI 10.1002/eji.1830250904; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Guma M, 2006, BLOOD, V107, P3624, DOI 10.1182/blood-2005-09-3682; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Guma M, 2006, J INFECT DIS, V194, P38, DOI 10.1086/504719; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Ho EL, 1998, P NATL ACAD SCI USA, V95, P6320, DOI 10.1073/pnas.95.11.6320; Houchins JP, 1997, J IMMUNOL, V158, P3603; HOUCHINS JP, 1991, J EXP MED, V173, P1017, DOI 10.1084/jem.173.4.1017; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kaiser BK, 2005, J IMMUNOL, V174, P2878, DOI 10.4049/jimmunol.174.5.2878; Kaiser BK, 2008, P NATL ACAD SCI USA, V105, P6696, DOI 10.1073/pnas.0802736105; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kim S, 2002, NAT IMMUNOL, V3, P523, DOI 10.1038/ni796; Kuboto A, 1999, J IMMUNOL, V163, P212; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, IMMUNITY, V8, P693, DOI 10.1016/S1074-7613(00)80574-9; Lazetic S, 1996, J IMMUNOL, V157, P4741; Lee N, 1998, J IMMUNOL, V160, P4951; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Makrigiannis AP, 2001, J IMMUNOL, V166, P5034, DOI 10.4049/jimmunol.166.8.5034; Moser JM, 2002, NAT IMMUNOL, V3, P189, DOI 10.1038/ni757; ORR MT, 2010, CURR TOP MI IN PRESS; Petrie EJ, 2008, J EXP MED, V205, P725, DOI 10.1084/jem.20072525; Phillips JH, 1996, IMMUNITY, V5, P163, DOI 10.1016/S1074-7613(00)80492-6; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rodriguez A, 1998, IMMUNOGENETICS, V47, P305, DOI 10.1007/s002510050362; Sivakumar PV, 1999, J IMMUNOL, V162, P6976; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sullivan LC, 2007, IMMUNITY, V27, P900, DOI 10.1016/j.immuni.2007.10.013; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Van Beneden K, 2001, J IMMUNOL, V166, P4302, DOI 10.4049/jimmunol.166.7.4302; Vance RE, 2002, P NATL ACAD SCI USA, V99, P868, DOI 10.1073/pnas.022500599; Vance RE, 1997, EUR J IMMUNOL, V27, P3236, DOI 10.1002/eji.1830271222; Vance RE, 1998, J EXP MED, V188, P1841, DOI 10.1084/jem.188.10.1841; Yu JH, 2009, J IMMUNOL, V183, P4968, DOI 10.4049/jimmunol.0900907	53	36	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2010	5	12							e15184	10.1371/journal.pone.0015184	http://dx.doi.org/10.1371/journal.pone.0015184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	689PF	21151939	Green Submitted, Green Published, gold			2022-12-27	WOS:000284939600030
J	Pu, SY; Turinsky, AL; Vlasblom, J; On, T; Xiong, XJ; Emili, A; Zhang, ZL; Greenblatt, J; Parkinson, J; Wodak, SJ				Pu, Shuye; Turinsky, Andrei L.; Vlasblom, James; On, Tuan; Xiong, Xuejian; Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack; Parkinson, John; Wodak, Shoshana J.			Expanding the Landscape of Chromatin Modification (CM)-Related Functional Domains and Genes in Human	PLOS ONE			English	Article							DNA-BINDING; LYSINE METHYLATION; PROTEIN COMPLEXES; SWIRM DOMAIN; FAMILY; EVOLUTION; RECOGNITION; ACETYLATION; DEMETHYLASE; PREDICTION	Chromatin modification (CM) plays a key role in regulating transcription, DNA replication, repair and recombination. However, our knowledge of these processes in humans remains very limited. Here we use computational approaches to study proteins and functional domains involved in CM in humans. We analyze the abundance and the pair-wise domain-domain co-occurrences of 25 well-documented CM domains in 5 model organisms: yeast, worm, fly, mouse and human. Results show that domains involved in histone methylation, DNA methylation, and histone variants are remarkably expanded in metazoan, reflecting the increased demand for cell type-specific gene regulation. We find that CM domains tend to co-occur with a limited number of partner domains and are hence not promiscuous. This property is exploited to identify 47 potentially novel CM domains, including 24 DNA-binding domains, whose role in CM has received little attention so far. Lastly, we use a consensus Machine Learning approach to predict 379 novel CM genes (coding for 329 proteins) in humans based on domain compositions. Several of these predictions are supported by very recent experimental studies and others are slated for experimental verification. Identification of novel CM genes and domains in humans will aid our understanding of fundamental epigenetic processes that are important for stem cell differentiation and cancer biology. Information on all the candidate CM domains and genes reported here is publicly available.	[Pu, Shuye; Turinsky, Andrei L.; Vlasblom, James; On, Tuan; Xiong, Xuejian; Parkinson, John; Wodak, Shoshana J.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON M5G 1X8, Canada; [Vlasblom, James; Parkinson, John; Wodak, Shoshana J.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [On, Tuan; Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack; Parkinson, John; Wodak, Shoshana J.] Univ Toronto, Dept Mol Genet, Toronto, ON, Canada; [Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack] Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON, Canada; [Emili, Andrew; Zhang, Zhaolei; Greenblatt, Jack] Banting & Best Dept Med Res, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University of Toronto; University of Toronto	Pu, SY (corresponding author), Hosp Sick Children, Program Mol Struct & Funct, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	shoshana@sickkids.ca	Parkinson, John/A-4424-2008	Parkinson, John/0000-0001-9815-1189; wodak, shoshana/0000-0002-0701-6545	Canadian Institutes of Health Research (CIHR TEAM) [82940]; Hospital for Sick Children; Ontario Genomics Institute; Ontario Ministry of Research and Innovation; Genome Canada; Canadian Institutes for Health Research; Sickkids Foundation, Toronto, Canada	Canadian Institutes of Health Research (CIHR TEAM)(Canadian Institutes of Health Research (CIHR)); Hospital for Sick Children(University of Toronto); Ontario Genomics Institute; Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Genome Canada(Genome Canada); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Sickkids Foundation, Toronto, Canada	This work was funded by a grant from the Canadian Institutes of Health Research (CIHR TEAM Grant #82940). S.J.W. is a Tier 1 Canada Research Chair in Computational Biology and Bioinformatics and acknowledges support from the Canadian Institutes for Health Research, the Hospital for Sick Children and the Sickkids Foundation, Toronto, Canada. J.G. acknowledges support from Ontario Genomics Institute and Genome Canada. J.P. is supported by a CIHR New Investigators award and an Early Researcher award from the Ontario Ministry of Research and Innovation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apic Gordana, 2003, Journal of Structural and Functional Genomics, V4, P67, DOI 10.1023/A:1026113408773; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Bao Yunhe, 2007, Cell, V129, P632, DOI 10.1016/j.cell.2007.04.018; Basu MK, 2008, GENOME RES, V18, P449, DOI 10.1101/gr.6943508; BAXEVANIS AD, 1995, NUCLEIC ACIDS RES, V23, P2685, DOI 10.1093/nar/23.14.2685; Ben-Hur A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S2; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chothia C, 2003, SCIENCE, V300, P1701, DOI 10.1126/science.1085371; Chou KC, 2002, J BIOL CHEM, V277, P45765, DOI 10.1074/jbc.M204161200; Da GP, 2006, P NATL ACAD SCI USA, V103, P2057, DOI 10.1073/pnas.0510949103; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dhasarathy A, 2008, MUTAT RES-FUND MOL M, V647, P39, DOI 10.1016/j.mrfmmm.2008.07.007; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; EISEN JA, 1995, NUCLEIC ACIDS RES, V23, P2715, DOI 10.1093/nar/23.14.2715; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Gondor A, 2009, NATURE, V461, P212, DOI 10.1038/nature08453; Goodson HV, 2002, J CELL SCI, V115, P2619; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Hayete B, 2005, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2005, P127; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Joachims T., 1999, ADV KERNEL METHODS S; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kilkenny ML, 2008, GENE DEV, V22, P2034, DOI 10.1101/gad.472808; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUMAR S, 1994, NUCLEIC ACIDS RES, V22, P1, DOI 10.1093/nar/22.1.1; Lall S, 2007, NAT STRUCT MOL BIOL, V14, P1110, DOI 10.1038/nsmb1107-1110; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Li SS, 2009, J BIOL CHEM, V284, P9411, DOI 10.1074/jbc.M809617200; Lobley AE, 2008, NUCLEIC ACIDS RES, V36, pW297, DOI 10.1093/nar/gkn193; MAK AB, 2010, MOL CELL PROTEOMICS; Marfella CGA, 2007, MUTAT RES-FUND MOL M, V618, P30, DOI 10.1016/j.mrfmmm.2006.07.012; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mujtaba S, 2007, ONCOGENE, V26, P5521, DOI 10.1038/sj.onc.1210618; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; ON T, 2010, PROTEINS IN PRESS; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Ostlund G, 2010, NUCLEIC ACIDS RES, V38, pD196, DOI 10.1093/nar/gkp931; Pillus L, 2008, CURR OPIN CELL BIOL, V20, P326, DOI 10.1016/j.ceb.2008.04.009; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Pu SY, 2009, NUCLEIC ACIDS RES, V37, P825, DOI 10.1093/nar/gkn1005; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; Rodriguez MC, 2008, FRONT BIOSCI-LANDMRK, V13, P5905, DOI 10.2741/3125; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sampath V, 2009, MOL CELL BIOL, V29, P2532, DOI 10.1128/MCB.01682-08; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Singhal M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-199; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; van Rijsbergen C. J., 1979, INFORM RETIREVAL; Vogel C, 2005, J MOL BIOL, V346, P355, DOI 10.1016/j.jmb.2004.11.050; Vogel C, 2004, CURR OPIN STRUC BIOL, V14, P208, DOI 10.1016/j.sbi.2004.03.011; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Vucetic S, 2005, BIOINFORMATICS, V21, P137, DOI 10.1093/bioinformatics/bth476; Wang Y, 2009, MOL CELL, V33, P428, DOI 10.1016/j.molcel.2009.02.002; Weiner J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-285; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Zhou XF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-294	81	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 29	2010	5	11							e14122	10.1371/journal.pone.0014122	http://dx.doi.org/10.1371/journal.pone.0014122			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	686HD	21124763	Green Submitted, gold, Green Published			2022-12-27	WOS:000284686500010
J	Gomes, NCM; Cleary, DFR; Pinto, FN; Egas, C; Almeida, A; Cunha, A; Mendonca-Hagler, LCS; Smalla, K				Gomes, Newton C. M.; Cleary, Daniel F. R.; Pinto, Fernando N.; Egas, Conceicao; Almeida, Adelaide; Cunha, Angela; Mendonca-Hagler, Leda C. S.; Smalla, Kornelia			Taking Root: Enduring Effect of Rhizosphere Bacterial Colonization in Mangroves	PLOS ONE			English	Article							DIVERSITY; COMMUNITIES; SEDIMENTS; RESTORATION; PATTERNS; WORLD	Background: Mangrove forests are of global ecological and economic importance, but are also one of the world's most threatened ecosystems. Here we present a case study examining the influence of the rhizosphere on the structural composition and diversity of mangrove bacterial communities and the implications for mangrove reforestation approaches using nursery-raised plants. Methodology/Principal Findings: A barcoded pyrosequencing approach was used to assess bacterial diversity in the rhizosphere of plants in a nursery setting, nursery-raised transplants and native (non-transplanted) plants in the same mangrove habitat. In addition to this, we also assessed bacterial composition in the bulk sediment in order to ascertain if the roots of mangrove plants affect sediment bacterial composition. We found that mangrove roots appear to influence bacterial abundance and composition in the rhizosphere. Due to the sheer abundance of roots in mangrove habitat, such an effect can have an important impact on the maintenance of bacterial guilds involved in nutrient cycling and other key ecosystem functions. Surprisingly, we also noted a marked impact of initial nursery conditions on the rhizosphere bacterial composition of replanted mangrove trees. This result is intriguing because mangroves are periodically inundated with seawater and represent a highly dynamic environment compared to the more controlled nursery environment. Conclusions/Significance: In as far as microbial diversity and composition influences plant growth and health, this study indicates that nursery conditions and early microbial colonization patterns of the replants are key factors that should be considered during reforestation projects. In addition to this, our results provide information on the role of the mangrove rhizosphere as a habitat for bacteria from estuarine sediments.	[Gomes, Newton C. M.; Cleary, Daniel F. R.; Almeida, Adelaide; Cunha, Angela] Univ Aveiro, CESAM, P-3800 Aveiro, Portugal; [Gomes, Newton C. M.; Cleary, Daniel F. R.; Almeida, Adelaide; Cunha, Angela] Univ Aveiro, Dept Biol, P-3800 Aveiro, Portugal; [Pinto, Fernando N.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil; [Egas, Conceicao] Biocant Biotechnol Innovat Ctr, Cantanhede, Portugal; [Egas, Conceicao] Univ Coimbra, Ctr Neurosci & Cellular Biol, Coimbra, Portugal; [Mendonca-Hagler, Leda C. S.] Univ Fed Rio de Janeiro, Inst Microbiol, BR-21941 Rio De Janeiro, Brazil; [Smalla, Kornelia] Julius Kuhn Inst Cultivated Crops, Braunschweig, Germany	Universidade de Aveiro; Universidade de Aveiro; Universidade Federal do Rio de Janeiro; Universidade de Coimbra; Universidade Federal do Rio de Janeiro; Julius Kuhn-Institut	Gomes, NCM (corresponding author), Univ Aveiro, CESAM, P-3800 Aveiro, Portugal.	gomesncm@ua.pt	Gomes, Newton Carlos Marcial/K-3211-2015; Almeida, Adelaide/D-9899-2011; Cleary, Daniel/D-2582-2012; Cunha, Angela/AAC-3830-2019; Gomes, Newton Carlos Marcial/AAV-4603-2021; Cleary, Daniel/ABA-9393-2021; Smalla, Kornelia/H-4002-2011; Gomes, Newton CM/F-7430-2012; Cunha, Angela/E-9537-2011; Egas, Conceição/K-4866-2014	Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Almeida, Adelaide/0000-0002-8422-8664; Cleary, Daniel/0000-0002-6143-3390; Cunha, Angela/0000-0002-9118-3521; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Cleary, Daniel/0000-0002-6143-3390; Gomes, Newton CM/0000-0003-1934-0091; Cunha, Angela/0000-0002-9118-3521; Egas, Conceição/0000-0002-2307-5414	Deutsche Forschungsgemeinschaft [SM59/4-1, 4-2]; FAPERJ-Brazil; Centre for Environmental and Marine Studies (CESAM, Portugal)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); FAPERJ-Brazil(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Centre for Environmental and Marine Studies (CESAM, Portugal)	This study was funded by the Deutsche Forschungsgemeinschaft SM59/4-1 and 4-2 (http://www.dfg.de/en/index.jsp), FAPERJ-Brazil (http://www.faperj.br/) and Centre for Environmental and Marine Studies (CESAM, Portugal) (http://www.cesam.ua.pt/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aburto-Oropeza O, 2008, P NATL ACAD SCI USA, V105, P10456, DOI 10.1073/pnas.0804601105; Campbell BJ, 2006, NAT REV MICROBIOL, V4, P458, DOI 10.1038/nrmicro1414; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Elster C, 2000, FOREST ECOL MANAG, V131, P201, DOI 10.1016/S0378-1127(99)00214-5; Flores-Mireles AL, 2007, APPL ENVIRON MICROB, V73, P7308, DOI 10.1128/AEM.01892-06; GATTENLOHNER U, MANGROVE REHABILITAT; Gomes NCM, 2001, PLANT SOIL, V232, P167, DOI 10.1023/A:1010350406708; Gomes NCM, 2008, FEMS MICROBIOL ECOL, V66, P96, DOI 10.1111/j.1574-6941.2008.00519.x; Gomes NCM, 2007, APPL ENVIRON MICROB, V73, P7392, DOI 10.1128/AEM.01099-07; Grayston SJ, 1998, SOIL BIOL BIOCHEM, V30, P369, DOI 10.1016/S0038-0717(97)00124-7; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Harris J, 2009, SCIENCE, V325, P573, DOI 10.1126/science.1172975; HOFLICH G, 1994, EXPERIENTIA, V50, P897, DOI 10.1007/BF01923476; Imhoff JF, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P846, DOI 10.1007/0-387-30746-x_31; Kathiresan K, 2005, ESTUAR COAST SHELF S, V65, P601, DOI 10.1016/j.ecss.2005.06.022; Kersters K, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 5, THIRD EDITION, P3, DOI 10.1007/0-387-30745-1_1; Kirui BYK, 2008, HYDROBIOLOGIA, V603, P171, DOI 10.1007/s10750-007-9270-3; Lyimo TJ, 2009, FEMS MICROBIOL ECOL, V70, P483, DOI 10.1111/j.1574-6941.2009.00765.x; MCKEE KL, 1993, J ECOL, V81, P477, DOI 10.2307/2261526; MCKEE KL, 1995, OECOLOGIA, V101, P448, DOI 10.1007/BF00329423; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; Oksanen J., 2008, VEGAN COMMUNITY ECOL; Philippot L, 2009, PLANT SOIL, V321, P61, DOI 10.1007/s11104-008-9796-9; Pinhassi J, 2004, APPL ENVIRON MICROB, V70, P6753, DOI 10.1128/AEM.70.11.6753-6766.2004; Primavera J. H., 2008, Wetlands Ecology and Management, V16, P345, DOI 10.1007/s11273-008-9101-y; ROBERTSON AI, 1995, HYDROBIOLOGIA, V295, P311, DOI 10.1007/BF00029138; Sievert SM, 2008, APPL ENVIRON MICROB, V74, P1145, DOI 10.1128/AEM.01844-07; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Sorensen J., 1997, Modern soil microbiology., P21; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Toledo G, 2001, HYDROBIOLOGIA, V444, P101, DOI 10.1023/A:1017552305401; VOGT KA, 1986, ADV ECOL RES, V15, P303, DOI 10.1016/S0065-2504(08)60122-1; WILSON JB, 1991, J VEG SCI, V2, P35, DOI 10.2307/3235896; Yuan SY, 2007, J ENVIRON SCI HEAL B, V42, P63, DOI 10.1080/03601230601020860; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhang M, 2009, CHEMOSPHERE, V76, P677, DOI 10.1016/j.chemosphere.2009.03.066	37	86	88	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2010	5	11							e14065	10.1371/journal.pone.0014065	http://dx.doi.org/10.1371/journal.pone.0014065			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	683HW	21124923	gold, Green Published, Green Submitted			2022-12-27	WOS:000284467200005
J	Djuardi, Y; Sartono, E; Wibowo, H; Supali, T; Yazdanbakhsh, M				Djuardi, Yenny; Sartono, Erliyani; Wibowo, Heri; Supali, Taniawati; Yazdanbakhsh, Maria			A Longitudinal Study of BCG Vaccination in Early Childhood: The Development of Innate and Adaptive Immune Responses	PLOS ONE			English	Article							BACILLUS-CALMETTE-GUERIN; MYCOBACTERIAL ANTIGENS; BLASTOCYSTIS-HOMINIS; CYTOKINE RESPONSES; NORTHERN MALAWI; GUINEA-BISSAU; WEST-AFRICA; SCAR SIZE; IN-UTERO; TUBERCULOSIS	BCG vaccine drives a strong T helper 1 cellular immunity which is essential for the protection against mycobacteria, however recent studies suggest that BCG vaccination can have non-specific beneficial effects unrelated to tuberculosis. In the present cohort study the development of cytokine profiles following BCG vaccination was investigated. Immune responses to PPD were assessed before vaccination and at ages of 5 months, 1 year, and 2 years, followed by BCG scar measurement at 4 years of age. BCG was shown to induce both Th1 and Th2 type responses against PPD at about 5 months of age after vaccination, and while Th1 response was sustained, Th2 responses declined over time. However, BCG scar size was strongly correlated with Th2 responses to PPD at 5 months of age. Importantly, we observed no clear effects of BCG vaccination on innate immune responses in terms of early IL-10 or TNF-alpha production whereas some alterations in general adaptive immune responses to PHA were observed.	[Djuardi, Yenny; Wibowo, Heri; Supali, Taniawati] Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia; [Djuardi, Yenny; Sartono, Erliyani; Yazdanbakhsh, Maria] Leiden Univ, Med Ctr, Dept Parasitol, Leiden, Netherlands	University of Indonesia; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Djuardi, Y (corresponding author), Univ Indonesia, Fac Med, Dept Parasitol, Jakarta, Indonesia.	y.djuardi@lumc.nl	Djuardi, Yenny/AGP-5890-2022; Yazdanbakhsh, Maria/AAI-3996-2020	Yazdanbakhsh, Maria/0000-0002-7666-1441; Wibowo, Heri/0000-0001-7708-5135	Netherlands Foundation for the Advancement of Tropical Research [W93-364, W93-468]; European Union [MEST-CT-2005-020524-GALTRAIN]	Netherlands Foundation for the Advancement of Tropical Research; European Union(European Commission)	This study was supported by The Netherlands Foundation for the Advancement of Tropical Research (W93-364 and W93-468) and European Union Grant (MEST-CT-2005-020524-GALTRAIN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng HS, 2003, PARASITOL RES, V90, P48, DOI 10.1007/s00436-002-0804-3; Dagci H, 2002, ACTA TROP, V81, P1, DOI 10.1016/S0001-706X(01)00191-7; Dai Guixiang, 1998, Frontiers in Bioscience, V3, pE110; Djuardi Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007711; Elliott AM, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-115; Ellner JJ, 2000, CLIN INFECT DIS, V30, pS279, DOI 10.1086/313874; Eriksson M, 2007, CLIN EXP IMMUNOL, V150, P469, DOI 10.1111/j.1365-2249.2007.03515.x; Finan C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003485; Floyd S, 2000, INT J TUBERC LUNG D, V4, P1133; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; Kirch AK, 2004, PEDIAT ALLERG IMM-UK, V15, P133, DOI 10.1046/j.1399-3038.2003.00126.x; Kristensen I, 2000, BRIT MED J, V321, P1435, DOI 10.1136/bmj.321.7274.1435; Lalor MK, 2010, VACCINE, V28, P1635, DOI 10.1016/j.vaccine.2009.11.004; LALOR MK, 2009, J INFECT DIS, V201, P409; Lu CT, 2009, J MICROBIOL IMMUNOL, V42, P505; MADURA LJ, 2007, IMMUNOLOGY, V121, P276; Malhotra I, 1997, J CLIN INVEST, V99, P1759, DOI 10.1172/JCI119340; Malhotra I, 2006, J INFECT DIS, V193, P1005, DOI 10.1086/500472; Malhotra I, 1999, J IMMUNOL, V162, P6843; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Oriente A, 2000, J PHARMACOL EXP THER, V292, P988; Ota MOC, 2002, J IMMUNOL, V168, P919, DOI 10.4049/jimmunol.168.2.919; Pfefferle PI, 2010, J ALLERGY CLIN IMMUN, V125, P108, DOI 10.1016/j.jaci.2009.09.019; Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016; Reiman RM, 2006, INFECT IMMUN, V74, P1471, DOI 10.1128/IAI.74.3.1471-1479.2006; Stensballe LG, 2005, VACCINE, V23, P1251, DOI 10.1016/j.vaccine.2004.09.006; Stenzel DJ, 1996, CLIN MICROBIOL REV, V9, P563, DOI 10.1128/CMR.9.4.563; Sterne JAC, 1996, TUBERCLE LUNG DIS, V77, P117, DOI 10.1016/S0962-8479(96)90025-8; Weir RE, 2006, CLIN EXP IMMUNOL, V146, P390, DOI 10.1111/j.1365-2249.2006.03222.x; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	30	47	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14066	10.1371/journal.pone.0014066	http://dx.doi.org/10.1371/journal.pone.0014066			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124909	Green Submitted, Green Published, gold			2022-12-27	WOS:000284400100014
J	Stofanko, M; Kwon, SY; Badenhorst, P				Stofanko, Martin; Kwon, So Yeon; Badenhorst, Paul			Lineage Tracing of Lamellocytes Demonstrates Drosophila Macrophage Plasticity	PLOS ONE			English	Article							CELLULAR IMMUNE-RESPONSE; LYMPH GLAND; HEMOCYTES; REVEALS; PROTEIN; SCREEN; SYSTEM; GENES; EYE; DIFFERENTIATION	Leukocyte-like cells called hemocytes have key functions in Drosophila innate immunity. Three hemocyte types occur: plasmatocytes, crystal cells, and lamellocytes. In the absence of qimmune challenge, plasmatocytes are the predominant hemocyte type detected, while crystal cells and lamellocytes are rare. However, upon infestation by parasitic wasps, or in melanotic mutant strains, large numbers of lamellocytes differentiate and encapsulate material recognized as "non-self". Current models speculate that lamellocytes, plasmatocytes and crystal cells are distinct lineages that arise from a common prohemocyte progenitor. We show here that over-expression of the CoREST-interacting transcription factor Chn in plasmatocytes induces lamellocyte differentiation, both in circulation and in lymph glands. Lamellocyte increases are accompanied by the extinction of plasmatocyte markers suggesting that plasmatocytes are transformed into lamellocytes. Consistent with this, timed induction of Chn over-expression induces rapid lamellocyte differentiation within 18 hours. We detect double-positive intermediates between plasmatocytes and lamellocytes, and show that isolated plasmatocytes can be triggered to differentiate into lamellocytes in vitro, either in response to Chn over-expression, or following activation of the JAK/STAT pathway. Finally, we have marked plasmatocytes and show by lineage tracing that these differentiate into lamellocytes in response to the Drosophila parasite model Leptopilina boulardi. Taken together, our data suggest that lamellocytes arise from plasmatocytes and that plasmatocytes may be inherently plastic, possessing the ability to differentiate further into lamellocytes upon appropriate challenge.	[Stofanko, Martin; Kwon, So Yeon; Badenhorst, Paul] Univ Birmingham, Inst Biomed Res, Edgbaston, England	University of Birmingham	Stofanko, M (corresponding author), Univ Birmingham, Inst Biomed Res, Edgbaston, England.	p.w.badenhorst@bham.ac.uk	Kwon, So Yeon/M-5625-2014	Kwon, So Yeon/0000-0002-8490-9101; /0000-0002-2542-0250	Medical Research Council; Cancer Research UK	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK)	This work was supported by funding from the Medical Research Council and Cancer Research UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Avet-Rochex A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-65; Bataille L, 2005, DEVELOPMENT, V132, P4635, DOI 10.1242/dev.02034; Carrera P, 1998, P NATL ACAD SCI USA, V95, P10779, DOI 10.1073/pnas.95.18.10779; Crew JR, 1997, DEV GENES EVOL, V206, P481, DOI 10.1007/s004270050079; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Dallman JE, 2004, J NEUROSCI, V24, P7186, DOI 10.1523/JNEUROSCI.0238-04.2004; Escudero LM, 2005, DEVELOPMENT, V132, P1211, DOI 10.1242/dev.01691; Frandsen Joel L., 2008, Proceedings of the National Academy of Sciences of the United States of America, V105, P14952, DOI 10.1073/pnas.0808208105; Goto A, 2003, DEV BIOL, V264, P582, DOI 10.1016/j.ydbio.2003.06.001; Hartenstein V, 2006, ANNU REV CELL DEV BI, V22, P677, DOI 10.1146/annurev.cellbio.22.010605.093317; Holz A, 2003, DEVELOPMENT, V130, P4955, DOI 10.1242/dev.00702; Honti V, 2010, MOL IMMUNOL, V47, P1997, DOI 10.1016/j.molimm.2010.04.017; JONES SL, 1999, PHAGOCYTOSIS; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KANIA A, 1995, GENETICS, V139, P1663; Kurucz E, 2003, P NATL ACAD SCI USA, V100, P2622, DOI 10.1073/pnas.0436940100; Kurucz E, 2007, ACTA BIOL HUNG, V58, P95, DOI 10.1556/ABiol.58.2007.Suppl.8; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Markus R, 2009, P NATL ACAD SCI USA, V106, P4805, DOI 10.1073/pnas.0801766106; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Meister M, 2003, CELL MICROBIOL, V5, P573, DOI 10.1046/j.1462-5822.2003.00302.x; Miccio A, 2010, EMBO J, V29, P442, DOI 10.1038/emboj.2009.336; O'Shea John J, 2008, Nat Immunol, V9, P450, DOI 10.1038/ni0508-450; Qiu P, 1998, DEVELOPMENT, V125, P1909; RIZKI MOHAMMED TAHIR MIRZA, 1957, J MORPH, V100, P437, DOI 10.1002/jmor.1051000303; RIZKI TM, 1992, DEV COMP IMMUNOL, V16, P103, DOI 10.1016/0145-305X(92)90011-Z; Rizki TM, 1957, J MORPHOL, V100, P459; Rus F, 2006, GENE EXPR PATTERNS, V6, P928, DOI 10.1016/j.modgep.2006.03.005; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2003, NATURE, V422, P735, DOI 10.1038/nature01550; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Sorrentino RP, 2002, DEV BIOL, V243, P65, DOI 10.1006/dbio.2001.0542; Stofanko M, 2008, GENETICS, V180, P253, DOI 10.1534/genetics.108.089094; Stout RD, 2009, J LEUKOCYTE BIOL, V86, P1105, DOI 10.1189/jlb.0209073; Stramer B, 2005, J CELL BIOL, V168, P567, DOI 10.1083/jcb.200405120; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; TEPASS U, 1994, DEVELOPMENT, V120, P1829; Tsuda L, 2006, EMBO J, V25, P3191, DOI 10.1038/sj.emboj.7601179; Varol C, 2009, IMMUNOL CELL BIOL, V87, P30, DOI 10.1038/icb.2008.90; Waltzer L, 2002, EMBO J, V21, P5477, DOI 10.1093/emboj/cdf545; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101	48	76	80	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2010	5	11							e14051	10.1371/journal.pone.0014051	http://dx.doi.org/10.1371/journal.pone.0014051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	682JY	21124962	Green Submitted, Green Published, gold			2022-12-27	WOS:000284400100005
J	Yildirim, S; Yeoman, CJ; Sipos, M; Torralba, M; Wilson, BA; Goldberg, TL; Stumpf, RM; Leigh, SR; White, BA; Nelson, KE				Yildirim, Suleyman; Yeoman, Carl J.; Sipos, Maksim; Torralba, Manolito; Wilson, Brenda A.; Goldberg, Tony L.; Stumpf, Rebecca M.; Leigh, Steven R.; White, Bryan A.; Nelson, Karen E.			Characterization of the Fecal Microbiome from Non-Human Wild Primates Reveals Species Specific Microbial Communities	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL DIVERSITY; EVOLUTION; CHIMPANZEES; MICROORGANISMS; SYMBIONTS; SYSTEM; HEALTH; ENERGY; TWINS	Background: Host-associated microbes comprise an integral part of animal digestive systems and these interactions have a long evolutionary history. It has been hypothesized that the gastrointestinal microbiome of humans and other non-human primates may have played significant roles in host evolution by facilitating a range of dietary adaptations. We have undertaken a comparative sequencing survey of the gastrointestinal microbiomes of several non-human primate species, with the goal of better understanding how these microbiomes relate to the evolution of non-human primate diversity. Here we present a comparative analysis of gastrointestinal microbial communities from three different species of Old World wild monkeys. Methodology/Principal Findings: We analyzed fecal samples from three different wild non-human primate species (black-and-white colobus [Colubus guereza], red colobus [Piliocolobus tephrosceles], and red-tailed guenon [Cercopithecus ascanius]). Three samples from each species were subjected to small subunit rRNA tag pyrosequencing. Firmicutes comprised the vast majority of the phyla in each sample. Other phyla represented were Bacterioidetes, Proteobacteria, Spirochaetes, Actinobacteria, Verrucomicrobia, Lentisphaerae, Tenericutes, Planctomycetes, Fibrobacateres, and TM7. Bray-Curtis similarity analysis of these microbiomes indicated that microbial community composition within the same primate species are more similar to each other than to those of different primate species. Comparison of fecal microbiota from non-human primates with microbiota of human stool samples obtained in previous studies revealed that the gut microbiota of these primates are distinct and reflect host phylogeny. Conclusion/Significance: Our analysis provides evidence that the fecal microbiomes of wild primates co-vary with their hosts, and that this is manifested in higher intraspecies similarity among wild primate species, perhaps reflecting species specificity of the microbiome in addition to dietary influences. These results contribute to the limited body of primate microbiome studies and provide a framework for comparative microbiome analysis between human and non-human primates as well as a comparative evolutionary understanding of the human microbiome.	[Yildirim, Suleyman; Yeoman, Carl J.; Wilson, Brenda A.; Stumpf, Rebecca M.; Leigh, Steven R.; White, Bryan A.] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Sipos, Maksim] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Torralba, Manolito; Nelson, Karen E.] J Craig Venter Inst, Rockville, MD USA; [Wilson, Brenda A.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Goldberg, Tony L.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA; [Stumpf, Rebecca M.; Leigh, Steven R.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [White, Bryan A.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; J. Craig Venter Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Yildirim, S (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	bwhite44@illinois.edu	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Yildirim, Suleyman/0000-0002-2752-1223; LEIGH, STEVEN/0000-0001-6844-7122	National Science Foundation [0935347]	National Science Foundation(National Science Foundation (NSF))	This project is funded by the National Science Foundation (grant no. 0935347). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO LC, 1995, CURR ANTHROPOL, V36, P199, DOI 10.1086/204350; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; BOTTA GA, 1994, CLIN INFECT DIS, V18, pS260, DOI 10.1093/clinids/18.Supplement_4.S260; Brownlie JC, 2009, TRENDS MICROBIOL, V17, P348, DOI 10.1016/j.tim.2009.05.005; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Fish JL, 2003, AM J PHYS ANTHROPOL, V120, P171, DOI 10.1002/ajpa.10136; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Flint HJ, 2008, ANN NY ACAD SCI, V1125, P280, DOI 10.1196/annals.1419.022; Frey JC, 2006, APPL ENVIRON MICROB, V72, P3788, DOI 10.1128/AEM.72.5.3788-3792.2006; Goldberg TL, 2008, EMERG INFECT DIS, V14, P1375, DOI [10.3201/eid14.9.071196, 10.3201/eid1409.071196]; Gorley C.K., 2006, GETTING STARTED PRIM; Griswold KE, 1999, CURR MICROBIOL, V39, P187, DOI 10.1007/s002849900443; Hickman C. S., 2005, INFLUENCE COOPERATIV, P3; Holmstrom K, 2004, ANAEROBE, V10, P197, DOI 10.1016/j.anaerobe.2004.01.004; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; JAFFE KE, 2007, PRIMATES PERSPECTIVE, P203; Kisidayova S, 2009, AM J PRIMATOL, V71, P548, DOI 10.1002/ajp.20687; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lambert JE, 2002, GUENONS DIVERSITY AD, P303; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McFall-Ngai MJ, 2002, DEV BIOL, V242, P1, DOI 10.1006/dbio.2001.0522; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Moran NA, 2008, ANNU REV GENET, V42, P165, DOI 10.1146/annurev.genet.41.110306.130119; Nicholson JK, 2005, NAT REV MICROBIOL, V3, P431, DOI 10.1038/nrmicro1152; Oh PL, 2010, ISME J, V4, P377, DOI 10.1038/ismej.2009.123; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schloss PD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008230; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schultze M, 1998, ANNU REV GENET, V32, P33, DOI 10.1146/annurev.genet.32.1.33; Szekely BA, 2010, AM J PRIMATOL, V72, P566, DOI 10.1002/ajp.20809; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uenishi G, 2007, AM J PRIMATOL, V69, P367, DOI 10.1002/ajp.20351; Ungar PS, 2006, ANNU REV ANTHROPOL, V35, P209, DOI 10.1146/annurev.anthro.35.081705.123153; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wasserman MD, 2003, J ANIM ECOL, V72, P650, DOI 10.1046/j.1365-2656.2003.00736.x; Wood B, 1999, NATURE, V400, P219, DOI 10.1038/22227; Xu B, 2010, AM J PRIMATOL, V72, P699, DOI 10.1002/ajp.20826; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09	49	154	160	1	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2010	5	11							e13963	10.1371/journal.pone.0013963	http://dx.doi.org/10.1371/journal.pone.0013963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	679FT	21103066	gold, Green Published			2022-12-27	WOS:000284147700013
J	Chen, CH; Gau, V; Zhang, DD; Liao, JC; Wang, FY; Wong, PK				Chen, Chia Hsiang; Gau, Vincent; Zhang, Donna D.; Liao, Joseph C.; Wang, Fei-Yue; Wong, Pak Kin			Statistical Metamodeling for Revealing Synergistic Antimicrobial Interactions	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; COMBINATORY DRUGS; ESCHERICHIA-COLI; ESSENTIAL OILS; OPTIMIZATION; GENTAMICIN; DISCOVERY; TRIMETHOPRIM; CONSTITUENTS; ANTIBIOTICS	Many bacterial pathogens are becoming drug resistant faster than we can develop new antimicrobials. To address this threat in public health, a metamodel antimicrobial cocktail optimization (MACO) scheme is demonstrated for rapid screening of potent antibiotic cocktails using uropathogenic clinical isolates as model systems. With the MACO scheme, only 18 parallel trials were required to determine a potent antimicrobial cocktail out of hundreds of possible combinations. In particular, trimethoprim and gentamicin were identified to work synergistically for inhibiting the bacterial growth. Sensitivity analysis indicated gentamicin functions as a synergist for trimethoprim, and reduces its minimum inhibitory concentration for 40-fold. Validation study also confirmed that the trimethoprim-gentamicin synergistic cocktail effectively inhibited the growths of multiple strains of uropathogenic clinical isolates. With its effectiveness and simplicity, the MACO scheme possesses the potential to serve as a generic platform for identifying synergistic antimicrobial cocktails toward management of bacterial infection in the future.	[Chen, Chia Hsiang; Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA; [Gau, Vincent] GeneFluidics Inc, Monterey Pk, CA USA; [Zhang, Donna D.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Liao, Joseph C.] Stanford Univ, Dept Urol, Stanford, CA 94305 USA; [Wang, Fei-Yue] Chinese Acad Sci, Inst Automat, Key Lab Complex Syst & Intelligence Sci, Beijing, Peoples R China; [Wong, Pak Kin] Univ Arizona, Biomed Engn & Bio5 Inst, Tucson, AZ 85721 USA	University of Arizona; University of Arizona; Stanford University; Chinese Academy of Sciences; Institute of Automation, CAS; University of Arizona	Chen, CH (corresponding author), Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA.	pak@email.arizona.edu	Zhang, Donna/B-1015-2012; Liao, Joseph C/J-5874-2015; Wong, Pak Kin/A-7974-2012	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463	National Institutes of Health [1DP2OD007161-01]; National Institutes of Health National Institute of Allergy and Infectious Diseases [1U01AI082457-01, R43AI088756-01]; National Institutes of Health National Institute of Child Health and Human Development [R43HD065303-01]; National Science Foundation [0900899]; GeneFluidics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R43HD065303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI082457, R44AI088756, R43AI088756] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD007161] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Science Foundation(National Science Foundation (NSF)); GeneFluidics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health Director's New Innovator Award (1DP2OD007161-01), National Institutes of Health National Institute of Allergy and Infectious Diseases (1U01AI082457-01; R43AI088756-01), National Institutes of Health National Institute of Child Health and Human Development (R43HD065303-01) and National Science Foundation (0900899). VG, who is the director of GeneFluidics Inc., designed the experiments and analyzed the result. NIH and NSF had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; VG is the director of GeneFluidics Inc. JCL and PKW are co-investigators in research grants of GeneFluidics. These affiliations do not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Antony J, 2003, DESIGN EXPT ENG SCI; Bonabeau E, 2000, NATURE, V406, P39, DOI 10.1038/35017500; BUSHBY SRM, 1968, BRIT J PHARMACOL, V33, P72, DOI 10.1111/j.1476-5381.1968.tb00475.x; Chang ST, 2001, J ETHNOPHARMACOL, V77, P123, DOI 10.1016/S0378-8741(01)00273-2; Chen CH, 2010, ANAL CHEM, V82, P1012, DOI 10.1021/ac9022764; Clardy J, 2006, NAT BIOTECHNOL, V24, P1541, DOI 10.1038/nbt1266; CLSI, 2006, PERF STAND ANT SUSC; Feala JD, 2010, WIRES SYST BIOL MED, V2, P181, DOI 10.1002/wsbm.51; FORREST RD, 1982, J ROY SOC MED, V75, P198; FORREST S, 1993, SCIENCE, V261, P872, DOI 10.1126/science.8346439; Friedman M, 2004, J FOOD PROTECT, V67, P1774, DOI 10.4315/0362-028X-67.8.1774; Hartmann A.K., 2002, OPTIMIZATION ALGORIT; HEWITT WL, 1974, POSTGRAD MED J, V50, P55; Inouye Shigeharu, 2001, Journal of Antimicrobial Chemotherapy, V47, P565, DOI 10.1093/jac/47.5.565; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kollef MH, 2001, ANN INTERN MED, V134, P298, DOI 10.7326/0003-4819-134-4-200102200-00014; Kolusheva S, 2000, NAT BIOTECHNOL, V18, P225, DOI 10.1038/72697; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Mach K. E., 2009, J UROL; MACH KE, J UROLOGY IN PRESS; PAISLEY JW, 1978, ANTIMICROB AGENTS CH, V14, P656, DOI 10.1128/AAC.14.5.656; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pinner RW, 1996, JAMA-J AM MED ASSOC, V275, P189, DOI 10.1001/jama.275.3.189; Projan SJ, 2003, CURR OPIN MICROBIOL, V6, P427, DOI 10.1016/j.mib.2003.08.003; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Queipo NV, 2005, PROG AEROSP SCI, V41, P1, DOI 10.1016/j.paerosci.2005.02.001; Schreiber SL, 2000, SCIENCE, V287, P1964, DOI 10.1126/science.287.5460.1964; Sun CP, 2009, INTEGR BIOL-UK, V1, P123, DOI 10.1039/b815225j; Sundin DP, 2001, J AM SOC NEPHROL, V12, P114, DOI 10.1681/ASN.V121114; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Walsh C., 2003, ANTIBIOTICS ACTIONS; Wong PK, 2008, P NATL ACAD SCI USA, V105, P5105, DOI 10.1073/pnas.0800823105; Wu J, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1035; Zinner RG, 2009, MOL CANCER THER, V8, P521, DOI 10.1158/1535-7163.MCT-08-0937; Zinner S H, 1982, Eur J Clin Microbiol, V1, P144, DOI 10.1007/BF02019614	36	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 11	2010	5	11							e15472	10.1371/journal.pone.0015472	http://dx.doi.org/10.1371/journal.pone.0015472			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	678OA	21124958	Green Published, gold, Green Submitted			2022-12-27	WOS:000284087800026
J	Gutfraind, A				Gutfraind, Alexander			Optimizing Topological Cascade Resilience Based on the Structure of Terrorist Networks	PLOS ONE			English	Article								Complex socioeconomic networks such as information, finance and even terrorist networks need resilience to cascades - to prevent the failure of a single node from causing a far-reaching domino effect. We show that terrorist and guerrilla networks are uniquely cascade-resilient while maintaining high efficiency, but they become more vulnerable beyond a certain threshold. We also introduce an optimization method for constructing networks with high passive cascade resilience. The optimal networks are found to be based on cells, where each cell has a star topology. Counterintuitively, we find that there are conditions where networks should not be modified to stop cascades because doing so would come at a disproportionate loss of efficiency. Implementation of these findings can lead to more cascade-resilient networks in many diverse areas.	Los Alamos Natl Lab, Ctr Nonlinear Studies & T5 D6, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Gutfraind, A (corresponding author), Los Alamos Natl Lab, Ctr Nonlinear Studies & T5 D6, Los Alamos, NM USA.	agutfraind.research@gmail.com	Gutfraind, Alexander/E-9641-2011	GUTFRAIND, ALEXANDER/0000-0002-3324-2220	Department of Energy at the Los Alamos National Laboratory [LA-UR 10-01563, DE-AC52-06NA25396]; Defense Threat Reduction Agency	Department of Energy at the Los Alamos National Laboratory; Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work was supported by the Department of Energy at the Los Alamos National Laboratory (LA-UR 10-01563) under contract DE-AC52-06NA25396 through the Laboratory Directed Research and Development program, and by the Defense Threat Reduction Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, CONNECTIONS; BAKER WE, 1993, AM SOCIOL REV, V58, P837, DOI 10.2307/2095954; Battiston S, 2007, J ECON DYN CONTROL, V31, P2061, DOI 10.1016/j.jedc.2007.01.004; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; Centola D, 2007, AM J SOCIOL, V113, P702, DOI 10.1086/521848; Crepey P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.046131; Dobson I, 2007, CHAOS, V17, DOI 10.1063/1.2737822; Draief M, 2008, ANN APPL PROBAB, V18, P359, DOI 10.1214/07-AAP470; Guimera R, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.065103; Gunther G., 1978, P ENGL MAN C NUM MAT, P285; Huang W, 2007, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2007/01/P01014; Iori G, 2008, J ECON DYN CONTROL, V32, P259, DOI 10.1016/j.jedc.2007.01.032; JOHNSON JK, 2010, 49 IEEE C DEC UNPUB; Kempe D., 2003, P 9 ACM SIGKDD INT C, V11, P105, DOI DOI 10.1145/956750.956769; Klau GW, 2005, LECT NOTES COMPUT SC, V3418, P417; Lai YC, 2004, LECT NOTES PHYS, V650, P299; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; Lindelauf R.H., 2008, HETEROGENEOUS COVERT; Lindelauf R, 2009, SOC NETWORKS, V31, P126, DOI 10.1016/j.socnet.2008.12.003; Miksche F.O., 1950, SECRET FORCES; Morselli C, 2007, SOC NETWORKS, V29, P143, DOI 10.1016/j.socnet.2006.05.001; Motter AE, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098701; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065103; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Raab J, 2003, J PUBL ADM RES THEOR, V13, P413, DOI 10.1093/jopart/mug029; Ripeanu M, 2002, IEEE INTERNET COMPUT, V6, P50, DOI 10.1109/4236.978369; Rodriguez J., 2004, WORKING PAPERS EPP L; Sageman M, 2008, LEADERLESS JIHAD: TERROR NETWORKS IN THE TWENTY-FIRST CENTURY, P1; Sharp G., 2003, DICTATORSHIP DEMOCRA; U.S. Government, 2007, 9 11 COMM REP; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Woo G, 2009, MATHEMATICAL METHODS IN COUNTERTERRORISM, P205, DOI 10.1007/978-3-211-09442-6_12; ZAWODNY JK, 1978, TERRORISM, V1, P277	39	28	28	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13448	10.1371/journal.pone.0013448	http://dx.doi.org/10.1371/journal.pone.0013448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZN	21085710	Green Submitted, Green Published, gold			2022-12-27	WOS:000284036800003
J	Holmes, EA; James, EL; Kilford, EJ; Deeprose, C				Holmes, Emily A.; James, Ella L.; Kilford, Emma J.; Deeprose, Catherine			Key Steps in Developing a Cognitive Vaccine against Traumatic Flashbacks: Visuospatial Tetris versus Verbal Pub Quiz	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; WORKING-MEMORY; AUTOBIOGRAPHICAL MEMORIES; INTRUSIVE IMAGES; EYE-MOVEMENTS; SUPPRESSION; PTSD; RECONSOLIDATION; INTERFERENCE; VIVIDNESS	Background: Flashbacks (intrusive memories of a traumatic event) are the hallmark feature of Post Traumatic Stress Disorder, however preventative interventions are lacking. Tetris may offer a 'cognitive vaccine' [1] against flashback development after trauma exposure. We previously reported that playing the computer game Tetris soon after viewing traumatic material reduced flashbacks compared to no-task [1]. However, two criticisms need to be addressed for clinical translation: (1) Would all games have this effect via distraction/enjoyment, or might some games even be harmful? (2) Would effects be found if administered several hours post-trauma? Accordingly, we tested Tetris versus an alternative computer game - Pub Quiz - which we hypothesized not to be helpful (Experiments 1 and 2), and extended the intervention interval to 4 hours (Experiment 2). Methodology/Principal Findings: The trauma film paradigm was used as an experimental analog for flashback development in healthy volunteers. In both experiments, participants viewed traumatic film footage of death and injury before completing one of the following: (1) no-task control condition (2) Tetris or (3) Pub Quiz. Flashbacks were monitored for 1 week. Experiment 1: 30 min after the traumatic film, playing Tetris led to a significant reduction in flashbacks compared to no-task control, whereas Pub Quiz led to a significant increase in flashbacks. Experiment 2: 4 hours post-film, playing Tetris led to a significant reduction in flashbacks compared to no-task control, whereas Pub Quiz did not. Conclusions/Significance: First, computer games can have differential effects post-trauma, as predicted by a cognitive science formulation of trauma memory. In both Experiments, playing Tetris post-trauma film reduced flashbacks. Pub Quiz did not have this effect, even increasing flashbacks in Experiment 1. Thus not all computer games are beneficial or merely distracting post-trauma - some may be harmful. Second, the beneficial effects of Tetris are retained at 4 hours post-trauma. Clinically, this delivers a feasible time-window to administer a post-trauma "cognitive vaccine''.	[Holmes, Emily A.; James, Ella L.; Kilford, Emma J.; Deeprose, Catherine] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Holmes, EA (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	emily.holmes@psych.ox.ac.uk	Holmes, Emily/ABD-4367-2020; Holmes, Emily/D-8075-2011; James, Ella/D-8795-2011; Kilford, Emma/I-2686-2013; Deeprose, Catherine/G-3459-2012; Kilford, Emma Jayne/ABH-7688-2020	Holmes, Emily/0000-0001-7319-3112; Kilford, Emma/0000-0002-0360-3769; 	Royal Society; Wellcome Trust; Colt Foundation	Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust); Colt Foundation	Emily A. Holmes has received fellowship funding from the Royal Society and the Wellcome Trust. Ella L. James was supported by a Wellcome Trust Vacation Scholarship and a Colt Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anderson MC, 2004, SCIENCE, V303, P232, DOI 10.1126/science.1089504; Anderson MC, 2001, NATURE, V410, P366, DOI 10.1038/35066572; Anderson MC, 2009, CURR DIR PSYCHOL SCI, V18, P189, DOI 10.1111/j.1467-8721.2009.01634.x; Andrade J, 1997, BRIT J CLIN PSYCHOL, V36, P209, DOI 10.1111/j.2044-8260.1997.tb01408.x; [Anonymous], GLOB BURD DIS 2004 U; Baddeley AD, 2000, J EXP PSYCHOL GEN, V129, P126, DOI 10.1037//0096-3445.129.1.126; *BLUE PLAN SOFTW, 2007, TETR ZON; Bolger N, 2003, ANNU REV PSYCHOL, V54, P579, DOI 10.1146/annurev.psych.54.101601.145030; Bourne C, 2010, J BEHAV THER EXP PSY, V41, P316, DOI 10.1016/j.jbtep.2010.03.001; Breslau N, 2009, TRAUMA VIOLENCE ABUS, V10, P198, DOI 10.1177/1524838009334448; Brewin CR, 2003, CLIN PSYCHOL REV, V23, P339, DOI 10.1016/S0272-7358(03)00033-3; Brewin CR, 2001, BEHAV RES THER, V39, P373, DOI 10.1016/S0005-7967(00)00087-5; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Dalgleish T, 2004, PSYCHOL BULL, V130, P228, DOI 10.1037/0033-2909.130.2.228; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dewar MT, 2007, CORTEX, V43, P616, DOI 10.1016/S0010-9452(08)70492-1; Ehlers A, 2004, MEMORY, V12, P403, DOI 10.1080/09658210444000025; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Engelhard IM, 2010, BEHAV RES THER, V48, P442, DOI 10.1016/j.brat.2010.01.003; Foa EB, 1995, POSTTRAUMATIC DIAGNO; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; Grey N, 2008, MEMORY, V16, P788, DOI 10.1080/09658210802266446; Gunter RW, 2008, BEHAV RES THER, V46, P913, DOI 10.1016/j.brat.2008.04.006; Hagenaars MA, 2010, MEMORY, V18, P76, DOI 10.1080/09658210903476522; HAIER RJ, 1992, BRAIN RES, V570, P134, DOI 10.1016/0006-8993(92)90573-R; Henry M, 2007, AM J BIOETHICS, V7, P12, DOI 10.1080/15265160701518474; Holmes EA, 2004, J EXP PSYCHOL GEN, V133, P3, DOI 10.1037/0096-3445.133.1.3; HOLMES EA, 2010, BRIT J PSYCHIAT ONLI, V190, pA81; Holmes EA, 2007, SCIENCE, V318, P1722; Holmes EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004153; Kato PM, 2010, REV GEN PSYCHOL, V14, P113, DOI 10.1037/a0019441; Kavanagh DJ, 2001, BRIT J CLIN PSYCHOL, V40, P267, DOI 10.1348/014466501163689; Kemps E, 2004, INT J EAT DISORDER, V36, P31, DOI 10.1002/eat.20005; Kemps E, 2007, MEMORY, V15, P412, DOI 10.1080/09658210701262017; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Krans J, 2009, MEMORY, V17, P809, DOI 10.1080/09658210903130780; Lee JLC, 2009, TRENDS NEUROSCI, V32, P413, DOI 10.1016/j.tins.2009.05.002; Liao SM, 2008, NEUROETHICS-NETH, V1, P85, DOI 10.1007/s12152-008-9009-5; Lilley SA, 2009, BRIT J CLIN PSYCHOL, V48, P309, DOI 10.1348/014466508X398943; May J, 2010, BEHAV RES THER, V48, P476, DOI 10.1016/j.brat.2010.02.001; McIsaac HK, 2004, PSYCHOL SCI, V15, P248, DOI 10.1111/j.0956-7976.2004.00660.x; *NIH CLIN EXC, 2005, CG026 NIH CLIN EXC; O'Donnell ML, 2007, BEHAV RES THER, V45, P601, DOI 10.1016/j.brat.2006.03.015; Paivio A., 2007, MIND ITS EVOLUTION D; PEARSON DG, INT J COGNI IN PRESS; Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3; Riccio DC, 2006, LEARN MEMORY, V13, P536, DOI 10.1101/lm.290706; Rona RJ, 2009, J PSYCHIATR RES, V43, P649, DOI 10.1016/j.jpsychires.2008.09.006; *RORSCH SOFTW, 2008, PUB QUIZ MACH 2008; Rose S, 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000560; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stuart ADP, 2006, BEHAV RES THER, V44, P611, DOI 10.1016/j.brat.2005.04.004; VALLAR G, 1982, Q J EXP PSYCHOL-A, V34, P53, DOI 10.1080/14640748208400857; van den Hout M, 2001, BRIT J CLIN PSYCHOL, V40, P121; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; *WHO, 2003, WORLD HLTH REP 2001; *WHO, 2003, MENT HLTH EM MENT SO; Wixted JT, 2005, CURR DIR PSYCHOL SCI, V14, P6, DOI 10.1111/j.0963-7214.2005.00324.x	61	136	139	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 10	2010	5	11							e13706	10.1371/journal.pone.0013706	http://dx.doi.org/10.1371/journal.pone.0013706			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	677ZN	21085661	Green Published, Green Submitted, gold			2022-12-27	WOS:000284036800005
J	Kresse, SH; Ohnstad, HO; Bjerkehagen, B; Myklebost, O; Meza-Zepeda, LA				Kresse, Stine H.; Ohnstad, Hege O.; Bjerkehagen, Bodil; Myklebost, Ola; Meza-Zepeda, Leonardo A.			DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation	PLOS ONE			English	Article							SOFT-TISSUE TUMORS; IMBALANCES; GENE; REVEALS; LEIOMYOSARCOMA; CHROMOSOME-13; OSTEOSARCOMAS; DELETIONS; TARGET; CGH	Background: Malignant fibrous histiocytomas (MFHs), or undifferentiated pleomorphic sarcomas, are in general high-grade tumours with extensive chromosomal aberrations. In order to identify recurrent chromosomal regions of gain and loss, as well as novel gene targets of potential importance for MFH development and/or progression, we have analysed DNA copy number changes in 33 MFHs using microarray-based comparative genomic hybridisation (array CGH). Principal findings: In general, the tumours showed numerous gains and losses of large chromosomal regions. The most frequent minimal recurrent regions of gain were 1p33-p32.3, 1p31.3-p31.2 and 1p21.3 (all gained in 58% of the samples), as well as 1q21.2-q21.3 and 20q13.2 (both 55%). The most frequent minimal recurrent regions of loss were 10q25.3-q26.11, 13q13.3-q14.2 and 13q14.3-q21.1 (all lost in 64% of the samples), as well as 2q36.3-q37.2 (61%), 1q41 (55%) and 16q12.1-q12.2 (52%). Statistical analyses revealed that gain of 1p33-p32.3 and 1p21.3 was significantly associated with better patient survival (P = 0.021 and 0.046, respectively). Comparison with similar array CGH data from 44 leiomyosarcomas identified seven chromosomal regions; 1p36.32-p35.2, 1p21.3-p21.1, 1q32.1-q42.13, 2q14.1-q22.2, 4q33-q34.3, 6p25.1-p21.32 and 7p22.3-p13, which were significantly different in copy number between the MFHs and leiomyosarcomas. Conclusions: A number of recurrent regions of gain and loss have been identified, some of which were associated with better patient survival. Several specific chromosomal regions with significant differences in copy number between MFHs and leiomyosarcomas were identified, and these aberrations may be used as additional tools for the differential diagnosis of MFHs and leiomyosarcomas.	[Kresse, Stine H.; Ohnstad, Hege O.; Myklebost, Ola; Meza-Zepeda, Leonardo A.] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Bjerkehagen, Bodil] Oslo Univ Hosp, Norwegian Radium Hosp, Pathol Clin, Oslo, Norway; [Myklebost, Ola; Meza-Zepeda, Leonardo A.] Univ Oslo, Dept Mol Biosci, Norwegian Microarray Consortium, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo	Kresse, SH (corresponding author), Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway.	leonardm@rr-research.no	Meza-Zepeda, Leonardo Andres/CAG-5229-2022; Myklebost, Ola/E-9335-2010	Meza-Zepeda, Leonardo Andres/0000-0003-3056-212X; Myklebost, Ola/0000-0002-2866-3223	Norwegian Research Council; Norwegian Cancer Society	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian Cancer Society(Norwegian Cancer Society)	Microarray analyses were supported by the FUnctional GEnomic (FUGE) Platform for Microarray Technology (Norwegian Microarray Consortium, www.microarray.no), funded by the Norwegian Research Council (www.forskningsradet.no). The present study was supported by The Norwegian Cancer Society (www.kreftforeningen.no). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carneiro A, 2009, LAB INVEST, V89, P668, DOI 10.1038/labinvest.2009.18; Chibon F, 2004, GENE CHROMOSOME CANC, V40, P32, DOI 10.1002/gcc.20012; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; Chibon F, 2000, CANCER RES, V60, P6339; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Fletcher CDM, 2006, HISTOPATHOLOGY, V48, P3, DOI 10.1111/j.1365-2559.2005.02284.x; Fletcher CDM, 2002, WHO CLASSIFICATION T; Guillou L, 2010, VIRCHOWS ARCH, V456, P201, DOI 10.1007/s00428-009-0853-4; Hinze R, 1999, INT J MOL MED, V3, P75; Idbaih A, 2005, LAB INVEST, V85, P176, DOI 10.1038/labinvest.3700202; Kresse SH, 2009, GENE CHROMOSOME CANC, V48, P679, DOI 10.1002/gcc.20675; Larramendy ML, 2008, CANCER GENET CYTOGEN, V187, P1, DOI 10.1016/j.cancergencyto.2008.06.005; Larramendy ML, 1997, AM J PATHOL, V151, P1153; Lau CC, 2004, GENE CHROMOSOME CANC, V39, P11, DOI 10.1002/gcc.10291; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Mairal A, 1999, CANCER GENET CYTOGEN, V111, P134, DOI 10.1016/S0165-4608(98)00227-1; Meza-Zepeda LA, 2006, CANCER RES, V66, P8984, DOI 10.1158/0008-5472.CAN-06-1972; Ozaki T, 2002, INT J CANCER, V102, P355, DOI 10.1002/ijc.10709; Parente F, 1999, CANCER GENET CYTOGEN, V115, P89, DOI 10.1016/S0165-4608(99)00082-5; Sakabe T, 1999, CANCER RES, V59, P511; Simons A, 2000, CANCER GENET CYTOGEN, V118, P89, DOI 10.1016/S0165-4608(99)00178-8; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang JB, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-74; Weiss SW, 2008, ENZINGER WEISSS SOFT, P303; Weng WH, 2003, BRIT J CANCER, V89, P720, DOI 10.1038/sj.bjc.6601069	25	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2010	5	11							e15378	10.1371/journal.pone.0015378	http://dx.doi.org/10.1371/journal.pone.0015378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	677ZE	21085701	Green Published, gold, Green Submitted			2022-12-27	WOS:000284035900024
J	Schaub, M; Martinez, N; Tagmann-Ioset, A; Weisshaupt, N; Maurer, ML; Reichlin, TS; Abadi, F; Zbinden, N; Jenni, L; Arlettaz, R				Schaub, Michael; Martinez, Nicolas; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael			Patches of Bare Ground as a Staple Commodity for Declining Ground-Foraging Insectivorous Farmland Birds	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; AGRICULTURAL INTENSIFICATION; TERRESTRIAL ECOSYSTEMS; PROMOTING BIODIVERSITY; HABITAT STRUCTURE; PREDATION RISK; FOOD RESOURCES; GRASSLAND; MANAGEMENT; LANDSCAPES	Conceived to combat widescale biodiversity erosion in farmland, agri-environment schemes have largely failed to deliver their promises despite massive financial support. While several common species have shown to react positively to existing measures, rare species have continued to decline in most European countries. Of particular concern is the status of insectivorous farmland birds that forage on the ground. We modelled the foraging habitat preferences of four declining insectivorous bird species (hoopoe, wryneck, woodlark, common redstart) inhabiting fruit tree plantations, orchards and vineyards. All species preferred foraging in habitat mosaics consisting of patches of grass and bare ground, with an optimal, species-specific bare ground coverage of 30-70% at the foraging patch scale. In the study areas, birds thrived in intensively cultivated farmland where such ground vegetation mosaics existed. Not promoted by conventional agri-environment schemes until now, patches of bare ground should be implemented throughout grassland in order to prevent further decline of insectivorous farmland birds.	[Schaub, Michael; Tagmann-Ioset, Aline; Weisshaupt, Nadja; Maurer, Melanie L.; Reichlin, Thomas S.; Abadi, Fitsum; Arlettaz, Raphael] Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland; [Schaub, Michael; Martinez, Nicolas; Reichlin, Thomas S.; Zbinden, Niklaus; Jenni, Lukas; Arlettaz, Raphael] Swiss Ornithol Inst, Sempach, Switzerland	University of Bern; Swiss Ornithological Institute	Schaub, M (corresponding author), Univ Bern, Div Conservat Biol, Inst Ecol & Evolut, Bern, Switzerland.	raphael.arlettaz@iee.unibe.ch	Arlettaz, Raphaël/O-2182-2016	Arlettaz, Raphaël/0000-0001-6360-5339; Walter, Jens/0000-0003-1754-172X; Schaub, Michael/0000-0003-2745-0557	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	University of Bern; Swiss Ornithological Institute; Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles)	Most funding was provided by the University of Bern and the Swiss Ornithological Institute. Reduced additional funding was provided by the Ignace Marietan Foundation (Societe Valaisanne de Sciences Naturelles) in the form of an MSc grant to Melanie Maurer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson PW, 2005, J APPL ECOL, V42, P932, DOI 10.1111/j.1365-2664.2005.01070.x; Benton TG, 2003, TRENDS ECOL EVOL, V18, P182, DOI 10.1016/S0169-5347(03)00011-9; Birrer S, 2007, J ORNITHOL, V148, pS295, DOI 10.1007/s10336-007-0237-y; Boatman ND, 2004, IBIS, V146, P131, DOI 10.1111/j.1474-919X.2004.00347.x; Britschgi A, 2006, BIOL CONSERV, V130, P193, DOI 10.1016/j.biocon.2005.12.013; Buckingham DL, 2006, AGR ECOSYST ENVIRON, V112, P21, DOI 10.1016/j.agee.2005.06.019; Buckingham DL, 2004, IBIS, V146, P163, DOI 10.1111/j.1474-919X.2004.00350.x; Butler SJ, 2004, IBIS, V146, P123, DOI 10.1111/j.1474-919X.2004.00352.x; COUDRAIN V, 2010, J ORNITHOL EARLY; Cresswell W, 2008, IBIS, V150, P3, DOI 10.1111/j.1474-919X.2007.00793.x; Davey CM, 2010, IBIS, V152, P459, DOI 10.1111/j.1474-919X.2009.01001.x; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Devereux CL, 2006, AGR ECOSYST ENVIRON, V117, P57, DOI 10.1016/j.agee.2006.03.007; Donald PF, 2007, SCIENCE, V317, P810, DOI 10.1126/science.1146002; Donald PF, 2006, AGR ECOSYST ENVIRON, V116, P189, DOI 10.1016/j.agee.2006.02.007; Donald PF, 2001, P ROY SOC B-BIOL SCI, V268, P25, DOI 10.1098/rspb.2000.1325; Douglas DJT, 2009, J APPL ECOL, V46, P353, DOI 10.1111/j.1365-2664.2009.01613.x; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Galloway JN, 2002, AMBIO, V31, P64, DOI 10.1639/0044-7447(2002)031[0064:RNATWY]2.0.CO;2; Haberl H, 2007, P NATL ACAD SCI USA, V104, P12942, DOI 10.1073/pnas.0704243104; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Knop E, 2006, J APPL ECOL, V43, P120, DOI 10.1111/j.1365-2664.2005.01113.x; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Martinez N, 2010, J ORNITHOL, V151, P297, DOI 10.1007/s10336-009-0455-6; Mermod M, 2009, IBIS, V151, P731, DOI 10.1111/j.1474-919X.2009.00956.x; Moorcroft D, 2002, J APPL ECOL, V39, P535, DOI 10.1046/j.1365-2664.2002.00730.x; Morris MG, 2000, BIOL CONSERV, V95, P129, DOI 10.1016/S0006-3207(00)00028-8; Perkins AJ, 2000, BIOL CONSERV, V95, P279, DOI 10.1016/S0006-3207(00)00042-2; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson RA, 2002, J APPL ECOL, V39, P157, DOI 10.1046/j.1365-2664.2002.00695.x; Royle J. A., 2008, HIERARCHICAL MODELIN; SCHIMEL DS, 1995, GLOBAL CHANGE BIOL, V1, P77, DOI 10.1111/j.1365-2486.1995.tb00008.x; Sierro Antoine, 2009, Nos Oiseaux, V56, P129; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Taylor ME, 2009, AGR ECOSYST ENVIRON, V130, P9, DOI 10.1016/j.agee.2008.11.004; Vickery JA, 2001, J APPL ECOL, V38, P647, DOI 10.1046/j.1365-2664.2001.00626.x; Whittingham MJ, 2007, J APPL ECOL, V44, P1, DOI 10.1111/j.1365-2664.2006.01263.x; Whittingham MJ, 2004, IBIS, V146, P210, DOI 10.1111/j.1474-919X.2004.00370.x	41	301	309	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2010	5	10							e13115	10.1371/journal.pone.0013115	http://dx.doi.org/10.1371/journal.pone.0013115			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	659LQ	20949083	Green Published, gold			2022-12-27	WOS:000282568400002
J	Hu, CX; Hoene, M; Zhao, XJ; Haring, HU; Schleicher, E; Lehmann, R; Han, XL; Xu, GW; Weigert, C				Hu, Chunxiu; Hoene, Miriam; Zhao, Xinjie; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Han, Xianlin; Xu, Guowang; Weigert, Cora			Lipidomics Analysis Reveals Efficient Storage of Hepatic Triacylglycerides Enriched in Unsaturated Fatty Acids after One Bout of Exercise in Mice	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; POSTPRANDIAL LIPEMIA; ENDURANCE EXERCISE; PROLONGED EXERCISE; SKELETAL-MUSCLE; ADIPOSE-TISSUE; SINGLE BOUT; TRIGLYCERIDE SECRETION; INSULIN SENSITIVITY; VLDL-TRIGLYCERIDE	Background: Endurance exercise induces lipolysis, increases circulating concentrations of free fatty acids (FFA) and the uptake and oxidation of fatty acids in the working muscle. Less is known about the regulation of lipid metabolism in the liver during and post-exercise. Methodology/Principal Findings: We performed an ultra fast liquid chromatography-mass spectrometry (UFLC-MS) based lipidomics analysis of liver tissue samples obtained from C57Bl/6J mice immediately after a 60 min treadmill run of moderate intensity, and after 3 h of recovery. The PLS-DA scores plot for 115 quantified lipid molecular species revealed a clear separation of the hepatic lipid profile of sedentary from recovering mice, but not from mice immediately after running. 21 lipid species were considered to be most responsible for the difference in the hepatic lipid profiles, including 17 triacylglycerides (TG), one lysophosphatidylcholine (LPC) and three phosphatidylcholines (PC). TG species were found to be more abundant in the recovery phase, while PC species were decreased. The degree of accumulation of individual TG species correlated well with the amount of theoretical energy stored whereas no increase was found for TG species containing only saturated or one monounsaturated fatty acid. Total liver TG content as assayed by an enzymatic method was increased to 163% in the recovery phase, while it was significantly decreased in skeletal muscle by the exercise bout and remained less in the recovery phase. Results from fasted and refed mice indicate that fasting-induced lipolysis was associated with a pronounced accumulation of hepatic TG, which is reversed by refeeding for 5 h. Thus food intake per se did not elevate hepatic TG. Conclusion: These data indicate that high availability of FFA induced by endurance exercise or fasting resulted in a transient hepatic TG accumulation, while muscle TG content was decreased during exercise presumably due to increased muscle fatty acid oxidation.	[Hu, Chunxiu; Zhao, Xinjie; Xu, Guowang] Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Univ Hosp Tuebingen, Div Endocrinol, Dept Internal Med, Tubingen, Germany; [Han, Xianlin] Washington Univ, Sch Med, Dept Med, Div Bioorgan Chem & Mol Pharmacol, St Louis, MO 63110 USA; [Hoene, Miriam; Haering, Hans U.; Schleicher, Erwin; Lehmann, Rainer; Weigert, Cora] Paul Langerhans Inst Tuebingen, Tubingen, Germany	Chinese Academy of Sciences; Dalian Institute of Chemical Physics, CAS; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Washington University (WUSTL)	Hu, CX (corresponding author), Chinese Acad Sci, Dalian Inst Chem Phys, CAS Key Lab Separat Sci Analyt Chem, Dalian, Peoples R China.	xugw@dicp.ac.cn; Cora.Weigert@med.uni-tuebingen.de	Lehmann, Rainer/AAF-4281-2019; Xu, Guowang/L-6910-2014; Wang, Congrong/HDM-0959-2022	Lehmann, Rainer/0000-0003-1218-6810; Xu, Guowang/0000-0003-4298-3554; Hu, Cheng/0000-0003-4314-2386; Wang, Congrong/0000-0002-8645-1114	Deutsche Forschungsgemeinschaft [WE 4176, GRK 1302/1]; Federal Ministry of Education and Research [FKZ 01GI0803-04]; German Federal Ministry of Education and Research (BMBF); Sino-German Center for Research Promotion [GZ 364]; State Ministry of Science and Technology of China [2006CB503902]; National Natural Science Foundation of China [20835006]; Chinese Academy of Sciences [KSCX1-YW-02]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Sino-German Center for Research Promotion; State Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the Deutsche Forschungsgemeinschaft to C. W. (WE 4176) and to E. S. (GRK 1302/1), by the Kompetenznetz Diabetes mellitus (Competence Network for Diabetes mellitus) funded by the Federal Ministry of Education and Research to R. L. and H. U. H. (FKZ 01GI0803-04), by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.), the Sino-German Center for Research Promotion to R. L. and G. X. (DFG and NSFC, GZ 364), the 973 Project of the State Ministry of Science and Technology of China to G. X. (No. 2006CB503902), the National Natural Science Foundation of China to G. X. (No. 20835006), and the Knowledge Innovation Program of the Chinese Academy of Sciences to G. X. (KSCX1-YW-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBORG G, 1974, J CLIN INVEST, V53, P1080, DOI 10.1172/JCI107645; ALDRED HE, 1994, METABOLISM, V43, P836, DOI 10.1016/0026-0495(94)90263-1; Andersson A, 1998, AM J PHYSIOL-ENDOC M, V274, pE432, DOI 10.1152/ajpendo.1998.274.3.E432; ANNUZZI G, 1987, METABOLISM, V36, P438, DOI 10.1016/0026-0495(87)90040-0; Bijlsma S, 2006, ANAL CHEM, V78, P567, DOI 10.1021/ac051495j; Borsheim E, 1999, MED SCI SPORT EXER, V31, P522; Burguera B, 2000, AM J PHYSIOL-ENDOC M, V278, pE113, DOI 10.1152/ajpendo.2000.278.1.E113; CHEN ZY, 1992, AM J PHYSIOL, V263, pR233, DOI 10.1152/ajpregu.1992.263.2.R233; CULLINANE E, 1982, METABOLISM, V31, P844, DOI 10.1016/0026-0495(82)90085-3; Eriksson L, 2001, MULTI AND MEGAVARIAT; Fernandez C, 2008, AM J PHYSIOL-ENDOC M, V295, pE179, DOI 10.1152/ajpendo.00282.2007; Gauthier MS, 2004, INT J OBESITY, V28, P1064, DOI 10.1038/sj.ijo.0802628; Gill JMR, 2001, EUR J CLIN INVEST, V31, P201, DOI 10.1046/j.1365-2362.2001.00799.x; GORSKI J, 1988, EUR J APPL PHYSIOL, V57, P554, DOI 10.1007/BF00418461; Han XL, 2004, BIOCHEMISTRY-US, V43, P15584, DOI 10.1021/bi048307o; Herd SL, 1998, BRIT J NUTR, V80, P57, DOI 10.1017/S0007114598001779; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; HOLLOSZY JO, 1964, AM J CARDIOL, V14, P753, DOI 10.1016/0002-9149(64)90004-9; Hu CX, 2008, J PROTEOME RES, V7, P4982, DOI 10.1021/pr800373m; Jensen MD, 2003, ACTA PHYSIOL SCAND, V178, P385, DOI 10.1046/j.1365-201X.2003.01167.x; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Larson-Meyer DE, 2006, DIABETES CARE, V29, P1337, DOI 10.2337/dc05-2565; Leon AS, 2001, MED SCI SPORT EXER, V33, pS502, DOI 10.1097/00005768-200106001-00021; Li ZZ, 2009, J BIOL CHEM, V284, P5637, DOI 10.1074/jbc.M807616200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Magkos F, 2006, AM J PHYSIOL-ENDOC M, V290, pE355, DOI 10.1152/ajpendo.00259.2005; Magkos F, 2008, J APPL PHYSIOL, V105, P1228, DOI 10.1152/japplphysiol.90761.2008; Magkos F, 2007, AM J PHYSIOL-ENDOC M, V292, pE1568, DOI 10.1152/ajpendo.00636.2006; Mitchell TW, 2004, J APPL PHYSIOL, V97, P1823, DOI 10.1152/japplphysiol.00344.2004; MONDON CE, 1984, J APPL PHYSIOL, V57, P1466, DOI 10.1152/jappl.1984.57.5.1466; Nielsen HB, 2007, J APPL PHYSIOL, V103, P1227, DOI 10.1152/japplphysiol.00027.2007; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Petridou A, 2005, EUR J APPL PHYSIOL, V94, P84, DOI 10.1007/s00421-004-1294-z; Rector RS, 2008, AM J PHYSIOL-GASTR L, V294, pG619, DOI 10.1152/ajpgi.00428.2007; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; SADY SP, 1988, METABOLISM, V37, P568, DOI 10.1016/0026-0495(88)90173-4; Schafer S, 2007, EUR J CLIN INVEST, V37, P535, DOI 10.1111/j.1365-2362.2007.01820.x; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; SIMONELLI C, 1978, AM J PHYSIOL, V234, pE221, DOI 10.1152/ajpendo.1978.234.3.E221; Tamura Y, 2005, J CLIN ENDOCR METAB, V90, P3191, DOI 10.1210/jc.2004-1959; Thamer C, 2007, OBESITY, V15, P531, DOI 10.1038/oby.2007.568; TRISCARI J, 1980, METABOLISM, V29, P377, DOI 10.1016/0026-0495(80)90013-X; Tsekouras YE, 2008, AM J PHYSIOL-ENDOC M, V295, pE851, DOI 10.1152/ajpendo.90545.2008; Tsekouras YE, 2009, CLIN SCI, V116, P147, DOI 10.1042/CS20080078; van Ginneken V, 2007, BBA-MOL CELL BIOL L, V1771, P1263, DOI 10.1016/j.bbalip.2007.07.007; Vance DE, 2008, CURR OPIN LIPIDOL, V19, P229, DOI 10.1097/MOL.0b013e3282fee935; Vieira VJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1164, DOI 10.1152/ajpendo.00054.2009; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Ziogas GG, 1997, MED SCI SPORT EXER, V29, P986, DOI 10.1097/00005768-199708000-00002	49	71	72	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2010	5	10							e13318	10.1371/journal.pone.0013318	http://dx.doi.org/10.1371/journal.pone.0013318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	663FZ	20967198	Green Published, gold			2022-12-27	WOS:000282869800021
J	Hunt, ME; Scherrer, MP; Ferrari, FD; Matz, MV				Hunt, Marguerite E.; Scherrer, Michael P.; Ferrari, Frank D.; Matz, Mikhail V.			Very Bright Green Fluorescent Proteins from the Pontellid Copepod Pontella mimocerami	PLOS ONE			English	Article							CORAL; REPORTER; RED; GFP; AMPHIOXUS; DIVERSITY; EVOLUTION; MUTANTS; EMBRYOS; MARKER	Background: Fluorescent proteins (FP) homologous to the green fluorescent protein (GFP) from the jellyfish Aequorea victoria have revolutionized biomedical research due to their usefulness as genetically encoded fluorescent labels. Fluorescent proteins from copepods are particularly promising due to their high brightness and rapid fluorescence development. Results: Here we report two novel FPs from Pontella mimocerami (Copepoda, Calanoida, Pontellidae), which were identified via fluorescence screening of a bacterial cDNA expression library prepared from the whole-body total RNA of the animal. The proteins are very similar in sequence and spectroscopic properties. They possess high molar extinction coefficients (79,000 M(-1) cm(-)) and quantum yields (0.92), which make them more than two-fold brighter than the most common FP marker, EGFP. Both proteins form oligomers, which we were able to counteract to some extent by mutagenesis of the N-terminal region; however, this particular modification resulted in substantial drop in brightness. Conclusions: The spectroscopic characteristics of the two P. mimocerami proteins place them among the brightest green FPs ever described. These proteins may therefore become valuable additions to the in vivo imaging toolkit.	[Hunt, Marguerite E.; Scherrer, Michael P.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Ferrari, Frank D.] Smithsonian Inst, Dept Invertebrate Zool, Natl Museum Nat Hist, Suitland, MD USA; [Matz, Mikhail V.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; Smithsonian Institution; Smithsonian National Museum of Natural History; University of Texas System; University of Texas Austin	Hunt, ME (corresponding author), Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	matz@mail.utexas.edu	Matz, Mikhail V/K-4392-2017	Matz, Mikhail V/0000-0001-5453-9819; Janga, Sarath Chandra/0000-0001-7351-6268	National Institutes of Health [R01 GM078247]; Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ocean Exploration program of the National Oceanic and Atmospheric Administration; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Ocean Exploration program of the National Oceanic and Atmospheric Administration ("Operation Deep Scope 2007''), and the National Institutes of Health grant R01 GM078247 to M. V. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMSTERDAM A, 1995, DEV BIOL, V171, P123, DOI 10.1006/dbio.1995.1265; Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984; Bomati EK, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-77; Bryan B., 2001, United States Patent, Patent No. 6232107; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHUDAKOV DM, FLUORESCENT IN PRESS; Cormack B, 1998, CURR OPIN MICROBIOL, V1, P406, DOI 10.1016/S1369-5274(98)80057-X; Deheyn DD, 2007, BIOL BULL-US, V213, P95, DOI 10.2307/25066625; DRUMMOND AJ, 2009, GENEIOUS V4 8; Evdokimov AG, 2006, EMBO REP, V7, P1006, DOI 10.1038/sj.embor.7400787; Fleminger A., 1957, Tulane Studies in Zoology, V5, P19; Gross LA, 2000, P NATL ACAD SCI USA, V97, P11990, DOI 10.1073/pnas.97.22.11990; Gurskaya NG, 2003, BIOCHEM J, V373, P403, DOI 10.1042/BJ20021966; Harvey E.N., 1952, BIOLUMINESCENCE; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HERRING PJ, 1988, HYDROBIOLOGIA, V167, P183, DOI 10.1007/BF00026304; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IKAWA M, 1995, FEBS LETT, V375, P125, DOI 10.1016/0014-5793(95)01162-8; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; LAND MF, 1988, J EXP BIOL, V140, P381; Masuda H, 2006, GENE, V372, P18, DOI 10.1016/j.gene.2005.11.031; Matz MV, 2006, METHOD BIOCHEM ANAL, V47, P139; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 1999, NAT BIOTECHNOL, V17, P1227; Ohtsuka S, 2001, HYDROBIOLOGIA, V453, P441, DOI 10.1023/A:1013162605809; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; Shagin DA, 2004, MOL BIOL EVOL, V21, P841, DOI 10.1093/molbev/msh079; Shagin DA, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.18.e23; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SHEEN J, 1995, PLANT J, V8, P777, DOI 10.1046/j.1365-313X.1995.08050777.x; SHINE J, 1975, NATURE, V254, P34, DOI 10.1038/254034a0; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; Yanushevich YG, 2002, FEBS LETT, V511, P11, DOI 10.1016/S0014-5793(01)03263-X	35	87	90	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JUL 14	2010	5	7							e11517	10.1371/journal.pone.0011517	http://dx.doi.org/10.1371/journal.pone.0011517			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625HA	20644720	gold, Green Published			2022-12-27	WOS:000279884900005
J	Suhr, ST; Chang, EA; Rodriguez, RM; Wang, K; Ross, PJ; Beyhan, Z; Murthy, S; Cibelli, JB				Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.			Telomere Dynamics in Human Cells Reprogrammed to Pluripotency	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; CLONING; CANCER; LENGTH	Background: Human induced pluripotent stem cells (IPSCs) have enormous potential in the development of cellular models of human disease and represent a potential source of autologous cells and tissues for therapeutic use. A question remains as to the biological age of IPSCs, in particular when isolated from older subjects. Studies of cloned animals indicate that somatic cells reprogrammed to pluripotency variably display telomere elongation, a common indicator of cell "rejuvenation.'' Methodology/Principal Findings: We examined telomere lengths in human skin fibroblasts isolated from younger and older subjects, fibroblasts converted to IPSCs, and IPSCs redifferentiated through teratoma formation and explant culture. In IPSCs analyzed at passage five (P5), telomeres were significantly elongated in 6/7 lines by >40% and approximated telomere lengths in human embryonic stem cells (hESCs). In cell lines derived from three IPSC-teratoma explants cultured to P5, two displayed telomeres shortened to lengths similar to input fibroblasts while the third line retained elongated telomeres. Conclusions/Significance: While these results reveal some heterogeneity in the reprogramming process with respect to telomere length, human somatic cells reprogrammed to pluripotency generally displayed elongated telomeres that suggest that they will not age prematurely when isolated from subjects of essentially any age.	[Suhr, Steven T.; Chang, Eun Ah; Rodriguez, Ramon M.; Wang, Kai; Ross, Pablo J.; Beyhan, Zeki; Murthy, Shashanka; Cibelli, Jose B.] Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA; [Ross, Pablo J.; Cibelli, Jose B.] Programa Andaluz Terapia Celular & Med Regenerat, Andalucia, Spain	Michigan State University	Suhr, ST (corresponding author), Michigan State Univ, Cellular Reprogramming Lab, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@anr.msu.edu	Rodriguez, Ramon Maria/AAF-9376-2019; wang, kai/G-4932-2011	Rodriguez, Ramon Maria/0000-0002-6770-5123; Goissis, Marcelo/0000-0002-7382-7477; Cibelli, Jose/0000-0002-2176-3854; Perkins, Guy/0000-0002-1834-6646	Naylor Family Foundation	Naylor Family Foundation	Funding was obtained from the Naylor Family Foundation, Michigan State University Vice President for Research and Graduate Studies and The Michigan Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; Cheung ALM, 2008, FRONT BIOSCI-LANDMRK, V13, P2075, DOI 10.2741/2825; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Greenberg RA, 1999, ONCOGENE, V18, P1219, DOI 10.1038/sj.onc.1202669; Harley CB, 2008, NAT REV CANCER, V8, P167, DOI 10.1038/nrc2275; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Harrington L, 2004, ONCOGENE, V23, P7283, DOI 10.1038/sj.onc.1207948; Hug N, 2006, CHROMOSOMA, V115, P413, DOI 10.1007/s00412-006-0067-3; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Kubota C, 2004, NAT BIOTECHNOL, V22, P693, DOI 10.1038/nbt975; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Niida H, 2000, MOL CELL BIOL, V20, P4115, DOI 10.1128/MCB.20.11.4115-4127.2000; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riethman H, 2008, ANNU REV GENOM HUM G, V9, P1, DOI 10.1146/annurev.genom.8.021506.172017; Rosler ES, 2004, DEV DYNAM, V229, P259, DOI 10.1002/dvdy.10430; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	216	221	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2009	4	12							e8124	10.1371/journal.pone.0008124	http://dx.doi.org/10.1371/journal.pone.0008124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533MU	19956585	Green Published, gold, Green Submitted			2022-12-27	WOS:000272828800018
